{"BGC0001413.1|Cystobactamide_2 # 4021 # 5949 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GGGG;rbs_spacer=10bp;gc_cont=0.606": {"gnl|BL_ORD_ID|1196|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 4021, "orf_end": 5949, "orf_from": "BGC0001413.1|Cystobactamide_2 ", "model_name": "IND-5", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1306", "ARO_accession": "3002261", "ARO_name": "IND-5", "ARO_category": {"36199": {"category_aro_accession": "3000060", "category_aro_cvterm_id": "36199", "category_aro_name": "IND beta-lactamase", "category_aro_description": "IND beta-lactamases are class B carbapenem-hydrolyzing beta-lactamases.", "category_aro_class_name": "AMR Gene Family"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.55486, "max_identities": 14, "bit_score": 25.7942, "cvterm_id": "36916", "query": "MMNDELLEFLFEMDLLNRPHVYSNTPINNGEGLLKHVTVVSKEKDAIVLRVPEKYAQLTS", "match": "M N ++ +F+ E  + N  H+Y    +  G+    +   +  +K  ++  VP + AQ  S", "sequence_from_db": "MFNAQVKDFVIEPPIKNNLHIYKTFGVFGGKEYSANSVYLVTKKGVVLFDVPWEKAQYQS", "sequence_from_broadstreet": "MKKRIQFFMVSMMLAPMFNAQVKDFVIEPPIKNNLHIYKTFGVFGGKEYSANSVYLVTKKGVVLFDVPWEKAQYQSLMDTIKKRHNLPVIAVFATHSHDDRAGDLSFFNNKGIKTYATSKTNEFLKKDGKATSTEIIKTGKPYRIGGEEFTVDFLGEGHTADNVVVWFPKYNVLDGGCLVKSNSATDLGYIKEANVEQWPITIDKLKAKYSKATLIIPGHDDWKGGGHVEHTLELLNKK", "dna_sequence_from_broadstreet": "ATGAAAAAAAGAATTCAGTTCTTTATGGTTTCAATGATGCTTGCTCCAATGTTTAATGCGCAGGTAAAGGATTTTGTAATTGAGCCACCCATTAAAAATAACTTACATATTTATAAAACATTTGGAGTATTTGGTGGTAAAGAATATTCTGCCAACTCAGTATATCTTGTCACTAAAAAAGGAGTCGTTTTATTTGATGTTCCCTGGGAAAAAGCACAATACCAAAGCCTGATGGATACAATCAAAAAACGTCATAACCTACCGGTTATTGCTGTATTTGCTACGCATTCCCATGATGACCGCGCTGGAGATCTAAGCTTTTTCAATAATAAAGGGATTAAAACCTATGCTACCAGCAAAACCAATGAGTTTTTGAAAAAAGACGGAAAAGCAACATCCACTGAAATCATAAAAACAGGAAAGCCTTACCGCATTGGAGGCGAAGAATTTACTGTTGATTTTCTGGGTGAAGGGCATACTGCTGATAATGTAGTGGTATGGTTTCCAAAATACAATGTACTGGATGGTGGTTGTCTGGTAAAAAGTAATTCAGCTACTGATTTAGGATATATTAAAGAAGCCAATGTGGAACAATGGCCAATAACCATAGATAAACTGAAGGCTAAATATTCAAAGGCAACATTGATTATTCCAGGACATGATGACTGGAAAGGCGGAGGACATGTTGAGCACACTCTTGAACTTCTTAACAAAAAATAA", "partial": "0", "query_start": 5557, "query_end": 5736, "hit_start": 48, "hit_end": 228, "orf_dna_sequence": "ATGGCCAACCAGCGGGTCGCATTCATTGAGTTGACGGTCTTCTCTGGCGTTTATCCCTTGGCCTCTGGCTACATGCGTGGCGTGGCCGAGCAGAACCCCTTGATCAGGGAGTCGTGCAGCTTCGAAATCCACTCGATCTGCATCAACGACGACCGATTCGAAGACAAGCTCAACAAGATCGATGCCGATGTCTACGCGATCTCTTGCTATGTCTGGAACATGGGCTTCGTGAAGCGGTGGCTCCCCACCCTCACCGCCCGCAAGCCCAACGCGCACATCATCCTTGGCGGTCCGCAGGTGATGAACCACGGGGCGCAGTACCTGGATCCGGGCAACGAGCGGGTGGTGCTCTGCAACGGTGAGGGTGAGTATACCTTCGCGAACTACCTGGCCGAACTCTGCTCCCCCCAGCCCGACCTTGGCAAGGTCAAGGGCCTCTCCTTCTACCGGAACGGAGAGCTGATCACGACCGAGCCCCAAGCGCGCATCCAGGATCTGAACACGGTCCCATCTCCCTACCTGGAAGGCTACTTCGACAGCGAGAAGTACGTGTGGGCGCCCCTTGAGACGAACCGGGGATGCCCCTACCAGTGCACCTACTGCTTCTGGGGGGCGGCGACCAACTCGCGCGTGTTCAAGTCCGACATGGACCGGGTCAAGGCGGAGATCACCTGGCTCAGCCAGCACCGGGCGTTCTACATCTTCATCACCGACGCGAATTTCGGCATGCTGACCCGCGACATTGAGATCGCCCAGCACATCGCCGAGTGCAAGCGGAAGTATGGCTATCCGCTCACCATTTGGCTGAGCGCGGCGAAGAACTCGCCTGACCGGGTCACGCAGATCACGCGGATCCTGAGCCAGGAGGGTTTGATCTCCACCCAGCCGGTCTCGCTCCAGACGATGGACGCGAACACGCTGAAGAGCGTGAAGCGCGGCAACATCAAGGAGAGCGCCTACCTGAGCCTCCAGGAAGAACTGCACCGCAGCAAGCTCTCCTCGTTCGTGGAGATGATCTGGCCGCTTCCCGGCGAGACGCTGGAGACCTTCAGGGAGGGCATCGGGAAGCTCTGCAGCTACGACGCCGACGCGATCCTCATCCACCACCTCCTGCTCATCAACAACGTGCCGATGAACAGCCAGCGCGAGGAGTTCAAGCTGGAGGTGTCGAATGATGAAGACCCGAACAGCGAGGCGCAGGTCGTCGTCGCGACGAAGGACGTTACCCGCGAGGAATACAAGGAGGGTGTGCGGTTCGGGTATCATCTCACGAGCCTGTACAGCCTGCGCGCACTCCGCTTCGTCGGGAGGTACCTCGACAAGCAGGGGCGGCTGGCCTTCAAGGACTTGATCTCCTCGTTCTCGGAGTACTGCAAGCGGAACCCTGACCACCCCTACACGCAGTACATCACCAGCGTGATCGACGGGACCAGCCAGTCGAAGTTCAGCGCCAACGGCGGCATCTTCCACGTCACACTTCACGAGTTCCGCAGAGAGTTCGACCAACTGCTCTTCGGGTTCATTCAAACCCTGGGCATGATGAACGATGAGCTGCTGGAGTTCCTGTTCGAGATGGATCTCCTCAACCGTCCGCACGTGTACAGCAACACGCCCATCAATAATGGCGAAGGGTTGCTGAAACACGTGACGGTCGTCTCGAAGGAGAAGGATGCCATTGTCCTGCGCGTTCCCGAAAAGTACGCGCAGCTCACGTCTGAGCTACTCGGGCTCGAGGGCGCTCCCAGCACGAGCCTGCGCGTGAAGTACCGCGGGACTCAAATGCCGTTCATGGCGAACAAGCCGTACGAGGACAACCTCTCCTACTGCGAGGCGAAGCTCCACAAGATGGGAAGCATACTTCCGGTCTGGGAGTCGGCCGTCCCTTCGCGCACACCGGTCCGGCGGCCACAAGTGGCCGTCGCGGGCTGA", "orf_prot_sequence": "MANQRVAFIELTVFSGVYPLASGYMRGVAEQNPLIRESCSFEIHSICINDDRFEDKLNKIDADVYAISCYVWNMGFVKRWLPTLTARKPNAHIILGGPQVMNHGAQYLDPGNERVVLCNGEGEYTFANYLAELCSPQPDLGKVKGLSFYRNGELITTEPQARIQDLNTVPSPYLEGYFDSEKYVWAPLETNRGCPYQCTYCFWGAATNSRVFKSDMDRVKAEITWLSQHRAFYIFITDANFGMLTRDIEIAQHIAECKRKYGYPLTIWLSAAKNSPDRVTQITRILSQEGLISTQPVSLQTMDANTLKSVKRGNIKESAYLSLQEELHRSKLSSFVEMIWPLPGETLETFREGIGKLCSYDADAILIHHLLLINNVPMNSQREEFKLEVSNDEDPNSEAQVVVATKDVTREEYKEGVRFGYHLTSLYSLRALRFVGRYLDKQGRLAFKDLISSFSEYCKRNPDHPYTQYITSVIDGTSQSKFSANGGIFHVTLHEFRREFDQLLFGFIQTLGMMNDELLEFLFEMDLLNRPHVYSNTPINNGEGLLKHVTVVSKEKDAIVLRVPEKYAQLTSELLGLEGAPSTSLRVKYRGTQMPFMANKPYEDNLSYCEAKLHKMGSILPVWESAVPSRTPVRRPQVAVAG", "perc_identity": 23.33}}, "BGC0001413.1|Cystobactamide_3 # 6058 # 7092 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.635": {"gnl|BL_ORD_ID|4755|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 6058, "orf_end": 7092, "orf_from": "BGC0001413.1|Cystobactamide_3 ", "model_name": "mreA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "450", "model_id": "5749", "ARO_accession": "3007050", "ARO_name": "mreA", "ARO_category": {"36003": {"category_aro_accession": "0010002", "category_aro_cvterm_id": "36003", "category_aro_name": "major facilitator superfamily (MFS) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Major facilitator superfamily (MFS) transporters and ABC transporters comprise the two largest and most functionally diverse of the transporter superfamilies. However, MFS transporters are distinct from ABC transporters in both their primary sequence and structure and in the mechanism of energy coupling. As secondary transporters they are, like RND and SMR transporters, energized by the electrochemical proton gradient.", "category_aro_class_name": "AMR Gene Family"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.65568, "max_identities": 18, "bit_score": 27.335, "cvterm_id": "36847", "query": "LKLVWSEMEESARLAIGQLLPEFIREYLSPKMMAE-YERVVLEQLGLA--AEHIERILSETYSEPPLEDFRARYPLSGY", "match": "LK+V     E+ RL   +  PE +    SP+  +E ++   +++L L     H  ++ S+ + +  +   RA+  + G+", "sequence_from_db": "LKIVVLTFNETPRLTFARFQPELLLHLTSPEKRSEKFQEYGVDELYLMNFTSHFSKVSSDLFIKKYIYGLRAKAAVVGF", "sequence_from_broadstreet": "MMKIHYINDYKDIQAKEDCVLVLGYFDGLHLGHKALFDKAKKIATEKNLKIVVLTFNETPRLTFARFQPELLLHLTSPEKRSEKFQEYGVDELYLMNFTSHFSKVSSDLFIKKYIYGLRAKAAVVGFDYKFGHNRTSGDYLARNFKGPVYIIDEISEGGEKISSTRIRQLITEGNVEKANQLLGYEFSTCGMVVHGDARGRTIGFPTANLAPINRTYLPADGVYISNVLINGKYYRAMTSIGKNITFGGTELRLEANIFDFDGDIYGETIEIFWLKRIREMVKFNGIDDLVKQLKKDKEIALNWKKDSQTL", "dna_sequence_from_broadstreet": "ATCATGAAAATCCATTACATTAATGATTATAAAGATATTCAAGCTAAAGAAGATTGCGTCTTAGTTTTGGGCTATTTTGATGGCTTACATCTGGGACATAAAGCCCTCTTTGATAAAGCTAAAAAAATCGCGACCGAAAAAAATTTGAAAATTGTCGTCTTAACGTTTAATGAGACACCTCGTCTAACCTTCGCTCGCTTCCAACCTGAATTATTGCTACATCTTACCTCTCCAGAAAAACGTTCTGAAAAATTTCAAGAGTATGGCGTCGATGAGTTATATTTAATGAATTTTACCAGTCATTTTTCAAAAGTATCTTCTGACCTTTTTATTAAGAAATATATTTATGGTCTCAGAGCAAAAGCTGCTGTTGTCGGTTTTGATTATAAGTTCGGTCATAATCGTACCAGTGGTGATTATCTAGCGCGTAATTTCAAGGGACCAGTCTATATTATTGATGAAATTTCTGAAGGTGGTGAAAAAATCTCTTCTACACGTATTCGTCAATTGATTACAGAGGGTAATGTTGAGAAAGCTAACCAACTTTTGGGTTATGAGTTTTCAACCTGTGGCATGGTAGTACATGGAGATGCTAGAGGACGAACTATAGGGTTCCCAACTGCTAATCTAGCTCCTATTAATCGCACTTACTTACCTGCAGACGGTGTTTATATTTCCAATGTTCTGATTAATGGAAAATATTATAGAGCAATGACGAGCATTGGAAAAAATATCACTTTTGGTGGTACAGAACTTCGTTTAGAAGCTAATATCTTTGATTTTGATGGCGACATTTATGGAGAAACTATTGAAATTTTCTGGTTAAAAAGAATCAGAGAAATGGTAAAGTTTAATGGTATTGACGATCTTGTAAAACAACTTAAAAAAGATAAAGAAATTGCTTTAAATTGGAAAAAAGATAGTCAAACTCTTTAA", "partial": "0", "query_start": 6778, "query_end": 7005, "hit_start": 144, "hit_end": 381, "orf_dna_sequence": "ATGCAGCAATACGGTGCCGTCGGAGAAGCCAGAGTGAATGGGACGACAGGGAAGACAGGGTTGGTAGCAGAAAGGTCGGGCGCGATTTCCCCGAGGGACTACAAGTCCAAGGAGTTGGTGTGGGATTCGCTTGCCGCCACACGCAGCAAGCCCCGGCGCGTACTGCCGGAGGGGGACGTGGTCGGGCACCTGTACCCGCCGGCCAAGGCGGCCCTGCTCACCCACCCGCTCATGAAGAACCTTCCGCCCGAGACGCTGCGGCTGTTCTTCATCCACTCCGCCTACAAGTTCATGGGGGACATCGCCATCTTCGAGACGGAGACCGTCAACGAGGTGGCGATGAAGATCGCCAACGGTCACACGCCCATCACGTTCCCGGACGACATCCGCCACGACGCGCTCACCGTCATCATCGATGAGGCCTATCACGCCTACGTGGCACGCGACTTCATGCGGCAGATCGAGCAGCGCACGGGCGTCAAGCCGCTGCCCCTGGGAACGGAAACGGACCTGTCCAGGGCCATGGCTTTCGGCAAGCACCGGCTGCCCGAGACGCTGCACGGGCTCTGGGAAATCATCGCCGTCTGCATCGGGGAAAACACACTCACCAAGGATCTGCTGAACCTGACGGGTGAGAAGTCCTTCAACGAAGTGCTCCATCAGGTGATGGAGGACCATGTTCGCGACGAGGGCCGCCACGCGGTCCTCTTCATGAACGTGCTCAAGCTGGTGTGGAGTGAGATGGAGGAGAGCGCCCGGCTCGCCATCGGTCAGCTGCTGCCAGAGTTCATCCGCGAGTACCTCAGCCCGAAGATGATGGCGGAGTACGAGCGCGTCGTGCTGGAGCAGCTCGGTCTAGCGGCCGAGCACATCGAGCGGATCCTCTCCGAGACGTACTCGGAGCCGCCGCTGGAGGATTTCCGCGCGCGATATCCCCTCTCCGGGTACCTGGTCTACGTGCTGATGCAGTGCGACGTCCTGTCGCACGCGCCGACGCGCGAGGCGTTCCGCCGATTCAAGCTGCTCGCCCACTGA", "orf_prot_sequence": "MQQYGAVGEARVNGTTGKTGLVAERSGAISPRDYKSKELVWDSLAATRSKPRRVLPEGDVVGHLYPPAKAALLTHPLMKNLPPETLRLFFIHSAYKFMGDIAIFETETVNEVAMKIANGHTPITFPDDIRHDALTVIIDEAYHAYVARDFMRQIEQRTGVKPLPLGTETDLSRAMAFGKHRLPETLHGLWEIIAVCIGENTLTKDLLNLTGEKSFNEVLHQVMEDHVRDEGRHAVLFMNVLKLVWSEMEESARLAIGQLLPEFIREYLSPKMMAEYERVVLEQLGLAAEHIERILSETYSEPPLEDFRARYPLSGYLVYVLMQCDVLSHAPTREAFRRFKLLAH", "perc_identity": 22.78}, "gnl|BL_ORD_ID|574|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 6058, "orf_end": 7092, "orf_from": "BGC0001413.1|Cystobactamide_3 ", "model_name": "adeJ", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "2000", "model_id": "630", "ARO_accession": "3000781", "ARO_name": "adeJ", "ARO_category": {"36005": {"category_aro_accession": "0010004", "category_aro_cvterm_id": "36005", "category_aro_name": "resistance-nodulation-cell division (RND) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Resistance-nodulation-division (RND) proteins are found in both prokaryotic and eukaryotic cells and have diverse substrate specificities and physiological roles. However, there are relatively few RND transporters and they are secondary transporters, energized not by ATP binding/hydrolysis but by proton movement down the transmembrane electrochemical gradient.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "36308": {"category_aro_accession": "3000169", "category_aro_cvterm_id": "36308", "category_aro_name": "rifampin", "category_aro_description": "Rifampin is a semi-synthetic rifamycin, and inhibits RNA synthesis by binding to RNA polymerase. Rifampin is the mainstay agent for the treatment of tuberculosis, leprosy and complicated Gram-positive infections.", "category_aro_class_name": "Antibiotic"}, "36309": {"category_aro_accession": "3000170", "category_aro_cvterm_id": "36309", "category_aro_name": "imipenem", "category_aro_description": "Imipenem is a broad-spectrum antibiotic and is usually taken with cilastatin, which prevents hydrolysis of imipenem by renal dehydropeptidase-I. It is resistant to hydrolysis by most other beta-lactamases. Notable exceptions are the KPC beta-lactamases and Ambler Class B enzymes.", "category_aro_class_name": "Antibiotic"}, "36327": {"category_aro_accession": "3000188", "category_aro_cvterm_id": "36327", "category_aro_name": "trimethoprim", "category_aro_description": "Trimethoprim is a synthetic 5-(3,4,5- trimethoxybenzyl) pyrimidine inhibitor of dihydrofolate reductase, inhibiting synthesis of tetrahydrofolic acid. Tetrahydrofolic acid is an essential precursor in the de novo synthesis of the DNA nucleotide thymidine. Trimethoprim is a bacteriostatic antibiotic mainly used in the prophylaxis and treatment of urinary tract infections in combination with sulfamethoxazole, a sulfonamide antibiotic.", "category_aro_class_name": "Antibiotic"}, "36524": {"category_aro_accession": "3000385", "category_aro_cvterm_id": "36524", "category_aro_name": "chloramphenicol", "category_aro_description": "Chloramphenicol is a bacteriostatic antimicrobial originally derived from the bacterium Streptomyces venezuelae. It was the first antibiotic to be manufactured synthetically on a large scale. It functions by inhibiting peptidyl transferase activity of the bacterial ribosome, binding to A2451 and A2452 residues in the 23S rRNA of the 50S ribosomal subunit and preventing peptide bond formation.", "category_aro_class_name": "Antibiotic"}, "40523": {"category_aro_accession": "3003832", "category_aro_cvterm_id": "40523", "category_aro_name": "ticarcillin", "category_aro_description": "Ticarcillin is a carboxypenicillin used for the treatment of Gram-negative bacteria, particularly P. aeruginosa. Ticarcillin's antibiotic properties arise from its ability to prevent cross-linking of peptidoglycan during cell wall synthesis, when the bacteria try to divide, causing cell death.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36296": {"category_aro_accession": "3000157", "category_aro_cvterm_id": "36296", "category_aro_name": "rifamycin antibiotic", "category_aro_description": "Rifamycin antibiotics are a group of broad-spectrum ansamycin antibiotics that inhibit bacterial RNA polymerase by binding to a highly conserved region, blocking the oligonucleotide exit tunnel, and preventing the extension of nascent mRNAs.", "category_aro_class_name": "Drug Class"}, "36310": {"category_aro_accession": "3000171", "category_aro_cvterm_id": "36310", "category_aro_name": "diaminopyrimidine antibiotic", "category_aro_description": "Diaminopyrimidines are a class of organic compounds containing a pyrimidine ring substituted by two amine groups.  They are inhibitors of dihydrofolate reductase, an enzyme critical for DNA synthesis.", "category_aro_class_name": "Drug Class"}, "36526": {"category_aro_accession": "3000387", "category_aro_cvterm_id": "36526", "category_aro_name": "phenicol antibiotic", "category_aro_description": "Phenicols are broad spectrum bacteriostatic antibiotics acting on bacterial protein synthesis. More specifically, the phenicols block peptide elongation by binding to the peptidyltansferase centre of the 70S ribosome.", "category_aro_class_name": "Drug Class"}, "40360": {"category_aro_accession": "3003706", "category_aro_cvterm_id": "40360", "category_aro_name": "penem", "category_aro_description": "Penems are a class of unsaturated beta-lactam antibiotics with a broad spectrum of antibacterial activity and have a structure which renders them highly resistant to beta-lactamases. All penems are all synthetically made and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. They are structurally similar to carbapenems, however, where carbapenems have a carbon, penems have a sulfur.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.24537, "max_identities": 11, "bit_score": 27.335, "cvterm_id": "35507", "query": "LAAEHIERILSETYSEPPLEDFRARYPLSGYLV", "match": "+  E++ER++SE +++P     R+   +SG LV", "sequence_from_db": "VVVENVERVMSEDHTDPVTATSRSMQQISGALV", "sequence_from_broadstreet": "MAQFFIHRPIFAWVIALVIMLAGILTLTKMPIAQYPTIAPPTVTIAATYPGASAETVENTVTQIIEQQMNGLDGLRYISSNSAGNGQASIQLNFEQGVDPDIAQVQVQNKLQSATALLPEDVQRQGVTVTKSGASFLQVIAFYSPDNNLSDSDIKDYVNSSIKEPLSRVAGVGEVQVFGGSYAMRIWLDPAKLTSYQLTPSDIATALQAQNSQVAVGQLGGAPAVQGQVLNATVNAQSLLQTPEQFKNIFLKNTASGAEVRLKDVARVELGSDNYQFDSKFNGKPAAGLAIKIATGANALDTAEAVEQRLSELRKNYPTGLADKLAYDTTPFIRLSIESVVHTLIEAVILVFIVMFLFLQNWRATIIPTLAVPVVVLGTFAVINIFGFSINTLTMFAMVLAIGLLVDDAIVVVENVERVMSEDHTDPVTATSRSMQQISGALVGITSVLTAVFVPMAFFGGTTGVIYRQFSITLVTAMVLSLIVALTFTPALCATILKQHDPNKEPSNNIFARFFRSFNNGFDRMSHSYQNGVSRMLKGKIFSGVLYAVVVALLVFLFQKLPSSFLPEEDQGVVMTLVQLPPNATLDRTGKVIDTMTNFFMNEKDTVESIFTVSGFSFTGVGQNAGIGFVKLKDWSKRTTPETQIGSLIQRGMALNMIIKDASYVMPLQLPAMPELGVTAGFNLQLKDSSGQGHEKLIAARNTILGLASQDKRLVGVRPNGQEDTPQYQINVDQAQAGAMGVSIAEINNTMRIAWGGSYINDFVDRGRVKKVYVQGDAGSRMMPEDLNKWYVRNNKGEMVPFSAFATGEWTYGSPRLERYNGVSSVNIQGTPAPGVSSGDAMKAMEEIIGKLPSMGLQGFDYEWTGLSLEERESGAQAPFLYALSLLIVFLCLAALYESWSIPFSVLLVVPLGVIGAIVLTYLGMIIKGDPNLSNNIYFQVAIIAVIGLSAKNAILIVEFAKELQEKGEDLLDATLHAAKMRLRPIIMTTLAFGFGVLPLALSTGAGAGSQHSVGFGVLGGVLSATFLGIFFIPVFYVWIRSMFKYKPKTINTQEHKS", "dna_sequence_from_broadstreet": "ATGGCACAATTTTTTATTCATCGCCCCATATTTGCGTGGGTGATTGCATTAGTCATTATGTTGGCGGGTATTCTTACGCTAACAAAAATGCCTATTGCACAATATCCAACGATTGCACCACCAACCGTAACGATTGCTGCGACTTATCCTGGTGCATCGGCTGAAACAGTTGAAAATACTGTAACCCAGATCATTGAACAACAAATGAATGGTCTTGATGGCTTACGTTATATTTCATCTAACAGTGCTGGTAATGGTCAGGCATCTATTCAATTAAACTTTGAACAAGGTGTTGACCCTGATATTGCACAGGTTCAAGTTCAAAACAAATTGCAATCTGCAACTGCGCTTTTACCTGAAGATGTACAACGTCAAGGTGTAACAGTTACTAAATCTGGTGCGAGCTTCTTGCAAGTTATTGCATTCTATTCACCAGATAACAACCTGTCAGACTCTGACATTAAAGACTACGTAAACTCGTCAATTAAAGAACCGCTTAGCCGTGTTGCCGGTGTTGGTGAGGTACAGGTCTTCGGTGGCTCATACGCAATGCGTATCTGGCTTGATCCAGCTAAATTAACAAGCTATCAACTTACTCCTAGTGATATTGCAACTGCCTTACAAGCGCAGAACTCGCAAGTTGCCGTAGGTCAGTTAGGTGGTGCTCCGGCTGTACAAGGTCAAGTTCTTAACGCAACAGTAAATGCACAAAGCTTATTGCAGACTCCTGAACAGTTTAAAAATATCTTCTTAAAGAACACAGCATCAGGTGCTGAGGTTCGATTAAAAGATGTTGCTCGCGTAGAATTAGGTTCGGATAACTATCAATTCGACTCGAAGTTTAACGGTAAACCGGCAGCTGGTCTTGCAATTAAAATTGCAACAGGTGCTAACGCACTCGACACAGCCGAAGCAGTTGAACAACGTTTATCTGAACTACGTAAGAACTATCCAACAGGTCTTGCAGATAAACTGGCTTATGACACGACTCCATTTATCCGTCTTTCAATTGAAAGTGTAGTACACACATTAATTGAAGCCGTGATTTTGGTATTCATTGTCATGTTCCTATTCTTACAAAACTGGCGTGCAACGATTATTCCAACGCTTGCAGTTCCAGTAGTTGTATTAGGTACATTTGCGGTCATTAATATCTTTGGCTTCTCAATTAACACCTTAACCATGTTCGCTATGGTATTGGCAATCGGTCTTCTGGTCGACGACGCCATTGTTGTAGTCGAAAACGTTGAACGTGTGATGAGTGAAGACCATACCGATCCGGTTACGGCCACTTCTCGCTCAATGCAGCAGATTTCTGGTGCGTTAGTAGGTATTACCAGCGTATTGACAGCGGTATTCGTACCAATGGCTTTCTTTGGTGGTACAACAGGTGTAATTTACCGCCAGTTCTCGATTACCCTTGTAACTGCAATGGTTCTGTCGTTAATTGTAGCGTTGACGTTCACACCGGCACTTTGTGCAACTATCTTGAAACAGCATGATCCTAATAAAGAACCAAGCAATAATATCTTTGCGCGTTTCTTTAGAAGCTTTAACAATGGTTTTGACCGCATGTCGCATAGCTACCAAAATGGTGTTAGCCGCATGCTTAAAGGCAAAATCTTCTCTGGCGTGCTCTATGCTGTTGTAGTTGCCCTTTTAGTCTTCTTGTTCCAAAAACTCCCGTCTTCATTCTTACCAGAAGAAGATCAGGGTGTGGTCATGACACTTGTACAATTACCACCAAATGCAACGCTTGACCGTACCGGTAAAGTGATTGATACCATGACTAACTTCTTTATGAATGAAAAAGATACCGTGGAATCTATTTTCACTGTTTCTGGTTTCTCATTCACAGGTGTTGGTCAAAACGCGGGTATTGGCTTCGTTAAGTTGAAAGACTGGAGCAAACGTACGACACCAGAAACTCAAATTGGTTCATTGATTCAGCGTGGTATGGCATTAAATATGATCATTAAAGATGCATCATACGTTATGCCGTTACAGCTTCCAGCAATGCCTGAACTTGGTGTAACTGCCGGATTTAACTTGCAGCTTAAAGATTCAAGTGGTCAAGGCCATGAGAAACTGATTGCAGCTCGTAACACGATTTTAGGTTTGGCATCACAAGATAAACGTCTTGTAGGTGTGCGTCCAAATGGTCAGGAAGATACTCCTCAGTATCAAATTAATGTAGATCAGGCTCAAGCTGGTGCTATGGGCGTTAGTATTGCCGAAATCAACAATACAATGCGTATTGCATGGGGTGGCTCATACATTAACGATTTCGTTGACCGTGGTCGTGTGAAAAAAGTTTATGTTCAAGGTGATGCGGGCAGCCGTATGATGCCTGAAGACTTAAACAAATGGTATGTACGTAATAACAAAGGTGAGATGGTTCCATTCTCGGCATTTGCTACAGGCGAATGGACGTATGGTTCTCCACGTCTCGAACGTTATAACGGCGTGTCATCGGTTAACATTCAAGGTACACCTGCACCTGGCGTGAGCTCTGGTGATGCCATGAAAGCAATGGAAGAAATTATTGGTAAGTTACCATCTATGGGCTTACAAGGTTTCGACTATGAGTGGACAGGCTTATCACTTGAAGAACGTGAGTCTGGTGCTCAAGCGCCGTTCTTATACGCACTTTCATTGTTAATCGTATTCCTTTGCTTGGCTGCACTATATGAAAGCTGGTCAATTCCGTTCTCGGTTTTACTTGTGGTACCACTTGGTGTCATTGGTGCAATCGTATTGACCTACTTGGGCATGATTATTAAAGGAGATCCAAATCTCTCAAATAACATTTACTTCCAGGTAGCGATTATTGCGGTTATCGGTCTTTCTGCAAAAAATGCGATCTTGATTGTTGAATTCGCAAAAGAATTGCAGGAAAAAGGTGAAGATCTACTTGATGCAACCTTACATGCTGCAAAAATGCGTTTACGTCCAATTATCATGACCACCCTTGCCTTCGGTTTCGGTGTACTTCCACTTGCACTTTCAACAGGTGCCGGTGCAGGAAGTCAGCACTCTGTAGGCTTTGGTGTACTTGGTGGCGTACTCAGCGCGACGTTCTTAGGAATCTTCTTTATCCCTGTATTCTATGTGTGGATTCGTAGTATGTTTAAGTACAAACCAAAAACCATAAACACTCAGGAGCATAAATCGTGA", "partial": "0", "query_start": 6913, "query_end": 7011, "hit_start": 1230, "hit_end": 1329, "orf_dna_sequence": "ATGCAGCAATACGGTGCCGTCGGAGAAGCCAGAGTGAATGGGACGACAGGGAAGACAGGGTTGGTAGCAGAAAGGTCGGGCGCGATTTCCCCGAGGGACTACAAGTCCAAGGAGTTGGTGTGGGATTCGCTTGCCGCCACACGCAGCAAGCCCCGGCGCGTACTGCCGGAGGGGGACGTGGTCGGGCACCTGTACCCGCCGGCCAAGGCGGCCCTGCTCACCCACCCGCTCATGAAGAACCTTCCGCCCGAGACGCTGCGGCTGTTCTTCATCCACTCCGCCTACAAGTTCATGGGGGACATCGCCATCTTCGAGACGGAGACCGTCAACGAGGTGGCGATGAAGATCGCCAACGGTCACACGCCCATCACGTTCCCGGACGACATCCGCCACGACGCGCTCACCGTCATCATCGATGAGGCCTATCACGCCTACGTGGCACGCGACTTCATGCGGCAGATCGAGCAGCGCACGGGCGTCAAGCCGCTGCCCCTGGGAACGGAAACGGACCTGTCCAGGGCCATGGCTTTCGGCAAGCACCGGCTGCCCGAGACGCTGCACGGGCTCTGGGAAATCATCGCCGTCTGCATCGGGGAAAACACACTCACCAAGGATCTGCTGAACCTGACGGGTGAGAAGTCCTTCAACGAAGTGCTCCATCAGGTGATGGAGGACCATGTTCGCGACGAGGGCCGCCACGCGGTCCTCTTCATGAACGTGCTCAAGCTGGTGTGGAGTGAGATGGAGGAGAGCGCCCGGCTCGCCATCGGTCAGCTGCTGCCAGAGTTCATCCGCGAGTACCTCAGCCCGAAGATGATGGCGGAGTACGAGCGCGTCGTGCTGGAGCAGCTCGGTCTAGCGGCCGAGCACATCGAGCGGATCCTCTCCGAGACGTACTCGGAGCCGCCGCTGGAGGATTTCCGCGCGCGATATCCCCTCTCCGGGTACCTGGTCTACGTGCTGATGCAGTGCGACGTCCTGTCGCACGCGCCGACGCGCGAGGCGTTCCGCCGATTCAAGCTGCTCGCCCACTGA", "orf_prot_sequence": "MQQYGAVGEARVNGTTGKTGLVAERSGAISPRDYKSKELVWDSLAATRSKPRRVLPEGDVVGHLYPPAKAALLTHPLMKNLPPETLRLFFIHSAYKFMGDIAIFETETVNEVAMKIANGHTPITFPDDIRHDALTVIIDEAYHAYVARDFMRQIEQRTGVKPLPLGTETDLSRAMAFGKHRLPETLHGLWEIIAVCIGENTLTKDLLNLTGEKSFNEVLHQVMEDHVRDEGRHAVLFMNVLKLVWSEMEESARLAIGQLLPEFIREYLSPKMMAEYERVVLEQLGLAAEHIERILSETYSEPPLEDFRARYPLSGYLVYVLMQCDVLSHAPTREAFRRFKLLAH", "perc_identity": 33.33}, "gnl|BL_ORD_ID|1025|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 6058, "orf_end": 7092, "orf_from": "BGC0001413.1|Cystobactamide_3 ", "model_name": "APH(3')-VIa", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "1121", "ARO_accession": "3002652", "ARO_name": "APH(3')-VIa", "ARO_category": {"36265": {"category_aro_accession": "3000126", "category_aro_cvterm_id": "36265", "category_aro_name": "APH(3')", "category_aro_description": "A category of aminoglycoside O-phosphotransferase enzymes with modification regiospecificity based at the 3'-hydroxyl group of the respective antibiotic. These enzymes inactivate aminoglycoside antibiotics, specifically kanamycin and neomycin, by the ATP-dependent phosphorylation of the 3'-hydroxyl group of the compound.", "category_aro_class_name": "AMR Gene Family"}, "35924": {"category_aro_accession": "0000005", "category_aro_cvterm_id": "35924", "category_aro_name": "neomycin", "category_aro_description": "Neomycin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Neomycin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35932": {"category_aro_accession": "0000013", "category_aro_cvterm_id": "35932", "category_aro_name": "amikacin", "category_aro_description": "Amikacin is an aminoglycoside antibiotic that works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35940": {"category_aro_accession": "0000021", "category_aro_cvterm_id": "35940", "category_aro_name": "ribostamycin", "category_aro_description": "Ribostamycin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Ribostamycin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35943": {"category_aro_accession": "0000024", "category_aro_cvterm_id": "35943", "category_aro_name": "butirosin", "category_aro_description": "Butirosin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Butirosin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35966": {"category_aro_accession": "0000049", "category_aro_cvterm_id": "35966", "category_aro_name": "kanamycin A", "category_aro_description": "Kanamycin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Kanamycin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "36996": {"category_aro_accession": "3000652", "category_aro_cvterm_id": "36996", "category_aro_name": "isepamicin", "category_aro_description": "A semi-synthetic derivative of gentamicin B (hydroxyamino propionyl genamicin B). It is modified to combat microbial inactivation and has a slightly larger spectrum of activity compared to other aminoglycosides, including Ser marcescens, Enterobacteria, and K pneumoniae.", "category_aro_class_name": "Antibiotic"}, "36999": {"category_aro_accession": "3000655", "category_aro_cvterm_id": "36999", "category_aro_name": "gentamicin B", "category_aro_description": "Gentamicin B is a semisynthetic aminoglycoside antibacterial.", "category_aro_class_name": "Antibiotic"}, "37001": {"category_aro_accession": "3000657", "category_aro_cvterm_id": "37001", "category_aro_name": "paromomycin", "category_aro_description": "An aminoglycoside antibiotic used for the treatment of parasitic infections. It is similar to neomycin sharing a similar spectrum of activity, but its hydroxyl group at the 6'-position instead of an amino group makes it resistant to AAC(6') modifying enzymes.", "category_aro_class_name": "Antibiotic"}, "46133": {"category_aro_accession": "3007382", "category_aro_cvterm_id": "46133", "category_aro_name": "gentamicin", "category_aro_description": "Gentamicin is a commonly used aminoglycoside antibiotic derived from members of the Micromonospora genus of bacteria. It acts by binding the 30S ribosomal subunit, thus inhibiting protein synthesis. Gentamicin is typically used to treat Gram-negative infections of the repiratory and urinary tract, as well as infections of the bone and soft tissue. It also exhibits considerable nephrotoxicity and ototoxicity. Gentamicin is administered as a mixture of gentamicin type C (which makes about around 80% of the complex) and types A, B, and X (distributed in the remaining 20% of the complex).", "category_aro_class_name": "Antibiotic"}, "35935": {"category_aro_accession": "0000016", "category_aro_cvterm_id": "35935", "category_aro_name": "aminoglycoside antibiotic", "category_aro_description": "Aminoglycosides are a group of antibiotics that are mostly effective against Gram-negative bacteria. These molecules consist of aminated sugars attached to a dibasic cyclitol. Aminoglycosides work by binding to the bacterial 30S ribosomal subunit (some work by binding to the 50S subunit), inhibiting the translocation of the peptidyl-tRNA from the A-site to the P-site and also causing misreading of mRNA, leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.46452, "max_identities": 10, "bit_score": 25.0238, "cvterm_id": "35507", "query": "DYKSKELVWDSLAATRSKPRRVLPEGDVVG", "match": "D+K+   +W+ L  TR + R V   GD+  ", "sequence_from_db": "DHKTYLSLWNELTETRVEERLVFSHGDITD", "sequence_from_broadstreet": "MELPNIIQQFIGNSVLEPNKIGQSPSDVYSFNRNNETFFLKRSSTLYTETTYSVSREAKMLSWLSEKLKVPELIMTFQDEQFEFMITKAINAKPISALFLTDQELLAIYKEALNLLNSIAIIDCPFISNIDHRLKESKFFIDNQLLDDIDQDDFDTELWGDHKTYLSLWNELTETRVEERLVFSHGDITDSNIFIDKFNEIYFLDLGRAGLADEFVDISFVERCLREDASEETAKIFLKHLKNDRPDKRNYFLKLDELN", "dna_sequence_from_broadstreet": "ATGGAATTGCCCAATATTATTCAACAATTTATCGGAAACAGCGTTTTAGAGCCAAATAAAATTGGTCAGTCGCCATCGGATGTTTATTCTTTTAATCGAAATAATGAAACTTTTTTTCTTAAGCGATCTAGCACTTTATATACAGAGACCACATACAGTGTCTCTCGTGAAGCGAAAATGTTGAGTTGGCTCTCTGAGAAATTAAAGGTGCCTGAACTCATCATGACTTTTCAGGATGAGCAGTTTGAATTCATGATCACTAAAGCGATCAATGCAAAACCAATTTCAGCGCTTTTTTTAACAGACCAAGAATTGCTTGCTATCTATAAGGAGGCACTCAATCTGTTAAATTCAATTGCTATTATTGATTGTCCATTTATTTCAAACATTGATCATCGGTTAAAAGAGTCAAAATTTTTTATTGATAACCAACTCCTTGACGATATAGATCAAGATGATTTTGACACTGAATTATGGGGAGACCATAAAACTTACCTAAGTCTATGGAATGAGTTAACCGAGACTCGTGTTGAAGAAAGATTGGTTTTTTCTCATGGCGATATCACGGATAGTAATATTTTTATAGATAAATTCAATGAAATTTATTTTTTAGATCTTGGTCGTGCTGGGTTAGCAGATGAATTTGTAGATATATCCTTTGTTGAACGTTGCCTAAGAGAGGATGCATCGGAGGAAACTGCGAAAATATTTTTAAAGCATTTAAAAAATGATAGACCTGACAAAAGGAATTATTTTTTAAAACTTGATGAATTGAATTGA", "partial": "0", "query_start": 6154, "query_end": 6243, "hit_start": 480, "hit_end": 570, "orf_dna_sequence": "ATGCAGCAATACGGTGCCGTCGGAGAAGCCAGAGTGAATGGGACGACAGGGAAGACAGGGTTGGTAGCAGAAAGGTCGGGCGCGATTTCCCCGAGGGACTACAAGTCCAAGGAGTTGGTGTGGGATTCGCTTGCCGCCACACGCAGCAAGCCCCGGCGCGTACTGCCGGAGGGGGACGTGGTCGGGCACCTGTACCCGCCGGCCAAGGCGGCCCTGCTCACCCACCCGCTCATGAAGAACCTTCCGCCCGAGACGCTGCGGCTGTTCTTCATCCACTCCGCCTACAAGTTCATGGGGGACATCGCCATCTTCGAGACGGAGACCGTCAACGAGGTGGCGATGAAGATCGCCAACGGTCACACGCCCATCACGTTCCCGGACGACATCCGCCACGACGCGCTCACCGTCATCATCGATGAGGCCTATCACGCCTACGTGGCACGCGACTTCATGCGGCAGATCGAGCAGCGCACGGGCGTCAAGCCGCTGCCCCTGGGAACGGAAACGGACCTGTCCAGGGCCATGGCTTTCGGCAAGCACCGGCTGCCCGAGACGCTGCACGGGCTCTGGGAAATCATCGCCGTCTGCATCGGGGAAAACACACTCACCAAGGATCTGCTGAACCTGACGGGTGAGAAGTCCTTCAACGAAGTGCTCCATCAGGTGATGGAGGACCATGTTCGCGACGAGGGCCGCCACGCGGTCCTCTTCATGAACGTGCTCAAGCTGGTGTGGAGTGAGATGGAGGAGAGCGCCCGGCTCGCCATCGGTCAGCTGCTGCCAGAGTTCATCCGCGAGTACCTCAGCCCGAAGATGATGGCGGAGTACGAGCGCGTCGTGCTGGAGCAGCTCGGTCTAGCGGCCGAGCACATCGAGCGGATCCTCTCCGAGACGTACTCGGAGCCGCCGCTGGAGGATTTCCGCGCGCGATATCCCCTCTCCGGGTACCTGGTCTACGTGCTGATGCAGTGCGACGTCCTGTCGCACGCGCCGACGCGCGAGGCGTTCCGCCGATTCAAGCTGCTCGCCCACTGA", "orf_prot_sequence": "MQQYGAVGEARVNGTTGKTGLVAERSGAISPRDYKSKELVWDSLAATRSKPRRVLPEGDVVGHLYPPAKAALLTHPLMKNLPPETLRLFFIHSAYKFMGDIAIFETETVNEVAMKIANGHTPITFPDDIRHDALTVIIDEAYHAYVARDFMRQIEQRTGVKPLPLGTETDLSRAMAFGKHRLPETLHGLWEIIAVCIGENTLTKDLLNLTGEKSFNEVLHQVMEDHVRDEGRHAVLFMNVLKLVWSEMEESARLAIGQLLPEFIREYLSPKMMAEYERVVLEQLGLAAEHIERILSETYSEPPLEDFRARYPLSGYLVYVLMQCDVLSHAPTREAFRRFKLLAH", "perc_identity": 33.33}}, "BGC0001413.1|Cystobactamide_4 # 7134 # 7982 # -1 # ID=1_4;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.657": {"gnl|BL_ORD_ID|2021|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 7134, "orf_end": 7982, "orf_from": "BGC0001413.1|Cystobactamide_4 ", "model_name": "mexN", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1900", "model_id": "2217", "ARO_accession": "3003705", "ARO_name": "mexN", "ARO_category": {"36005": {"category_aro_accession": "0010004", "category_aro_cvterm_id": "36005", "category_aro_name": "resistance-nodulation-cell division (RND) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Resistance-nodulation-division (RND) proteins are found in both prokaryotic and eukaryotic cells and have diverse substrate specificities and physiological roles. However, there are relatively few RND transporters and they are secondary transporters, energized not by ATP binding/hydrolysis but by proton movement down the transmembrane electrochemical gradient.", "category_aro_class_name": "AMR Gene Family"}, "36524": {"category_aro_accession": "3000385", "category_aro_cvterm_id": "36524", "category_aro_name": "chloramphenicol", "category_aro_description": "Chloramphenicol is a bacteriostatic antimicrobial originally derived from the bacterium Streptomyces venezuelae. It was the first antibiotic to be manufactured synthetically on a large scale. It functions by inhibiting peptidyl transferase activity of the bacterial ribosome, binding to A2451 and A2452 residues in the 23S rRNA of the 50S ribosomal subunit and preventing peptide bond formation.", "category_aro_class_name": "Antibiotic"}, "36595": {"category_aro_accession": "3000456", "category_aro_cvterm_id": "36595", "category_aro_name": "thiamphenicol", "category_aro_description": "Derivative of Chloramphenicol. The nitro group (-NO2) is substituted by a sulfomethyl group (-SO2CH3).", "category_aro_class_name": "Antibiotic"}, "36526": {"category_aro_accession": "3000387", "category_aro_cvterm_id": "36526", "category_aro_name": "phenicol antibiotic", "category_aro_description": "Phenicols are broad spectrum bacteriostatic antibiotics acting on bacterial protein synthesis. More specifically, the phenicols block peptide elongation by binding to the peptidyltansferase centre of the 70S ribosome.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.61686, "max_identities": 27, "bit_score": 26.9498, "cvterm_id": "36752", "query": "VSVDLADDWPAALKKSGFDPGVPTLWLIEGLLV-----YLTEAQVTLLMARVNALSVPESIVLIDVVGRSILDSSRVKLMHDLARQFGTDEPEVILRPI", "match": "+ VD+ +D    ++ S  +  + TL L  GL+V     +L +   TL++A V A+S+  S   + V+G ++ + + V L+  +A  F  D+  V++  I", "sequence_from_db": "IEVDVLNDRTRTIRSSLHEVEL-TLLLTIGLVVLVMGLFLRQLSATLIVATVLAVSLSASFAAMYVLGFTLNNLTLVALI--IAVGFIVDDAIVVVENI", "sequence_from_broadstreet": "MTPRAGISGWCVRHPIATALLTLASLLLGLLAFLRLGVAPLPEADFPTIQINALLPGGSPETMASSVATPLEVQFSAIPGITEMTSSSALGTTTLTLQFSLDKSIDVAAQEVQAAINAAAGRLPVDMPNLPTWRKVNPADSPIMILRVNSEMMPLIELSDYAETILARQLSQVNGVGQIFVVGQQRPAIRIQAQPEKLAAYQLTLADLRQSLQSASVNLAKGALYGEGRVSTLAANDQLFNASDYDDLVVAYRQGAPVFLKDVARIVSAPEDDYVQAWPNGVPGVALVILRQPGANIVDTADAIQAALPRLREMLPATIEVDVLNDRTRTIRSSLHEVELTLLLTIGLVVLVMGLFLRQLSATLIVATVLAVSLSASFAAMYVLGFTLNNLTLVALIIAVGFIVDDAIVVVENIHRHLEAGASKVEAALKGAAEIGFTVISISFSLIAAFIPLLFMGGIVGRLFREFAVSVTVAILISVVASLTLAPMLASRFMPALRHAEAPRKGFAEWLTGGYERGLRWALGHQRLMLVGFAFTVLVAVAGYVGIPKGFFPLQDTAFVIGTSQAAEDISYDDMVAKHRQLAEIIASDPAVQSYNHAVGVTGGSQSLANGRFWIVLKDRGERDVSVGEFIDRLRPQLAKVPGIMLYLRAAQDINLSSGPSRTQYQYALRSSDSTQLALWAQRLTERLKQVPGLMDVSNDLQVGASVTALDIDRVAAARFGLSAEDVSQTLYDAFGQRQVGEYQTEVNQYKVVLELDARQRGRAESLDWFYLRSPLSGEMVPLSAIAKVAAPRSGPLQINHNGMFPAVNLSFNLAAGVSLGEAVQAVQRAQEEIGMPSTIIGVFQGAAQAFQSSLASQPLLILAALIAVYIILGVLYESFVHPLTILSTLPSAGIGAVFLLWAWGQDFSIMALIGIVLLIGIVKKNGILMVDFAIVAQREQGMSAEQAIYQACLTRFRPIMMTTLAALLGAIPLMIGFGTGSELRQPLGIAVVGGLLVSQVLTLFSTPVVYLALERLFHRRGTTTSDGGTAGATAT", "dna_sequence_from_broadstreet": "GTGACGCCGCGCGCCGGGATTTCCGGCTGGTGCGTACGGCACCCGATCGCCACCGCGCTGCTGACCCTGGCCTCGCTGCTGCTGGGGCTGCTGGCGTTCCTCCGGCTCGGTGTGGCGCCGTTGCCGGAGGCGGACTTCCCGACCATCCAGATCAACGCCTTGCTGCCCGGCGGTAGCCCGGAGACCATGGCCTCGTCGGTGGCCACCCCCTTGGAAGTGCAGTTCAGCGCGATTCCCGGGATCACCGAGATGACTTCCAGCAGCGCCCTGGGCACCACCACCCTGACCCTGCAGTTCAGCCTCGACAAGAGCATCGACGTCGCCGCCCAGGAGGTCCAGGCGGCGATCAACGCCGCGGCCGGGCGGCTGCCGGTGGACATGCCGAACCTGCCGACCTGGCGCAAGGTCAACCCGGCGGACAGCCCGATCATGATCCTGCGGGTCAACTCGGAGATGATGCCGCTGATCGAACTCAGCGATTACGCCGAGACCATCCTCGCCCGCCAGCTCAGCCAGGTGAACGGCGTGGGGCAGATCTTCGTGGTCGGCCAGCAGCGCCCGGCGATCCGCATCCAGGCCCAGCCGGAGAAGCTCGCCGCCTACCAGCTGACCCTGGCCGACCTGCGCCAGTCGTTGCAGTCGGCCAGCGTCAACCTGGCCAAGGGCGCGCTCTACGGCGAGGGGCGGGTGTCGACCCTCGCGGCCAACGACCAGTTGTTCAACGCCAGCGACTATGACGACCTGGTGGTCGCCTACCGCCAGGGCGCGCCGGTGTTCCTCAAGGACGTGGCGCGGATCGTCTCGGCGCCCGAGGACGACTACGTGCAGGCCTGGCCGAACGGCGTGCCCGGGGTGGCGCTGGTGATCCTGCGCCAGCCTGGGGCGAACATCGTCGATACCGCCGACGCGATCCAGGCCGCGCTGCCACGCCTGCGCGAGATGCTCCCGGCGACCATCGAGGTAGACGTGCTCAACGACCGCACCCGGACCATCCGCTCGTCGTTGCACGAGGTCGAACTGACCCTGCTGCTGACCATTGGCCTGGTGGTGCTGGTGATGGGCCTGTTCCTCCGCCAGCTGTCGGCGACCCTGATCGTCGCCACGGTGCTGGCGGTGTCCCTGAGCGCCAGCTTCGCGGCGATGTACGTGCTCGGCTTCACCCTCAACAACCTGACCCTGGTGGCGCTGATCATCGCTGTCGGCTTCATCGTCGACGACGCCATCGTGGTCGTGGAGAACATCCACCGACACCTGGAAGCGGGCGCCTCGAAGGTCGAGGCGGCGCTCAAGGGCGCGGCGGAGATCGGCTTTACCGTGATTTCCATCAGCTTCTCGCTGATCGCCGCGTTCATTCCCCTGCTGTTCATGGGCGGGATCGTCGGCCGGCTGTTCCGCGAATTCGCGGTCAGCGTGACGGTGGCGATCCTGATCTCGGTGGTCGCTTCGCTGACCCTGGCGCCGATGCTGGCTTCGCGCTTCATGCCGGCATTGCGGCATGCCGAAGCGCCGAGAAAGGGCTTCGCCGAATGGCTGACCGGCGGCTACGAACGCGGCCTGCGCTGGGCGCTCGGGCACCAGCGGCTGATGCTGGTCGGCTTCGCCTTTACCGTGCTGGTGGCGGTGGCCGGCTACGTCGGGATTCCCAAGGGTTTCTTCCCCTTGCAGGACACCGCCTTCGTCATCGGCACGAGCCAGGCTGCCGAGGATATCTCCTACGACGACATGGTCGCCAAGCACCGGCAACTGGCCGAGATCATCGCCAGCGACCCGGCGGTGCAGAGCTACAACCATGCGGTGGGCGTCACCGGCGGTAGCCAGAGCCTGGCCAACGGACGTTTCTGGATCGTCCTCAAGGACCGTGGCGAGCGCGATGTCTCGGTCGGCGAGTTCATCGACCGGCTGCGCCCGCAACTGGCCAAGGTGCCGGGAATCATGCTCTACCTGCGCGCGGCGCAGGACATCAACCTCAGTTCCGGACCCTCGCGGACCCAGTACCAGTACGCCCTGCGCAGCAGCGACAGCACCCAGCTGGCGCTCTGGGCGCAACGCCTCACCGAGCGCCTGAAGCAGGTGCCGGGGCTGATGGATGTGTCCAACGACCTGCAGGTCGGCGCCAGCGTCACCGCGCTGGACATCGACCGGGTGGCCGCGGCGCGTTTCGGCCTCAGCGCCGAGGATGTCAGCCAGACCCTCTACGACGCCTTCGGCCAGCGCCAGGTCGGCGAGTACCAGACCGAGGTCAACCAGTACAAGGTGGTCCTCGAACTCGATGCGCGCCAGCGCGGCCGCGCGGAAAGCCTGGACTGGTTCTACCTGCGCTCGCCGCTGAGCGGCGAGATGGTCCCGCTGTCGGCCATCGCCAAGGTCGCGGCGCCGCGCTCCGGGCCGCTGCAGATCAACCACAACGGCATGTTCCCGGCGGTCAACCTGTCCTTCAACCTGGCTGCCGGGGTGTCCCTCGGCGAGGCGGTGCAGGCGGTGCAGCGCGCCCAGGAGGAGATCGGCATGCCCTCGACCATTATCGGCGTGTTCCAGGGCGCGGCGCAGGCCTTCCAGAGCTCGCTGGCCTCGCAACCGCTGCTGATCCTCGCCGCGCTGATCGCGGTGTACATCATCCTCGGCGTGCTCTACGAGAGTTTCGTACATCCGCTGACGATCCTCTCGACCCTGCCCTCGGCGGGGATCGGCGCGGTGTTCCTGCTCTGGGCCTGGGGCCAGGACTTCTCGATCATGGCGCTGATCGGCATCGTGCTGCTGATCGGCATCGTCAAGAAGAACGGCATCCTCATGGTCGACTTCGCCATCGTCGCCCAGCGCGAGCAGGGCATGAGCGCGGAGCAGGCGATCTACCAGGCCTGCCTGACCCGTTTCCGGCCGATCATGATGACCACCCTGGCCGCGCTGCTGGGCGCGATACCCCTGATGATCGGCTTCGGCACCGGTTCCGAGCTGCGCCAGCCTCTGGGCATCGCGGTGGTCGGCGGGCTGCTGGTGAGCCAGGTGCTGACCCTGTTCAGCACGCCGGTGGTATACCTGGCCCTGGAGCGGCTGTTCCACCGGCGCGGGACGACGACCTCGGACGGCGGAACCGCTGGGGCGACGGCGACATGA", "partial": "0", "query_start": 7572, "query_end": 7853, "hit_start": 954, "hit_end": 1242, "orf_dna_sequence": "TTGACGTGTTGCCGAACCCTTAACCCATCTCACGAGGCGGCGGTCATAAAACATATGCAAGAGATCGGCCAGACGGCACTTTGGGTGGCGGGAATGCGCGCGCTTGAGACCGAGCGTTCCAACCCACTGTTCCGGGATCCCTTTGCCCGTCGACTCGCCGGTGACACGCTCGTCGAGGAGCTGCGGCGCCGCAATGCCGGTGAGGGCGCCATGCCTCCCGCCATCGAGGTTCGCACGCGCTGGCTCGATGATCAGATCACGCTGGGGTTGGGCCGCGGCATCCGCCAGATCGTCATCCTCGCCGCGGGAATGGATGCCCGCGCCTACCGTTTGGCCTGGCCGGGAGACACGCGGCTGTTCGAGCTCGACCACGACGCCGTGCTCCAGGACAAGGAGGCGAAGCTGACCGGCGTCGCGCCGAAATGTGAGCGACATGCCGTGTCGGTCGATCTGGCCGATGACTGGCCGGCGGCGCTGAAGAAAAGCGGATTCGATCCCGGCGTGCCCACCCTGTGGCTCATCGAGGGATTGCTCGTCTACCTCACCGAGGCGCAGGTCACGCTGCTCATGGCCCGTGTCAACGCCCTGAGCGTTCCCGAGAGCATCGTCCTCATCGACGTCGTTGGCCGTTCGATTTTGGACTCCTCGCGCGTCAAGTTGATGCACGACCTCGCCCGCCAGTTCGGCACCGACGAGCCCGAGGTGATTCTAAGGCCGATTGGCTGGGACCCCCACGTCTACACCACCGCGGCCATCGGGAAGCAGCTCGGGCGCTGGCCCTTCCCCGTGGCGCCACGCGGCACCCCCGGTGTGCCCCAGGGATACCTGGTGCACGGAGTCAAGCGCTGA", "orf_prot_sequence": "MTCCRTLNPSHEAAVIKHMQEIGQTALWVAGMRALETERSNPLFRDPFARRLAGDTLVEELRRRNAGEGAMPPAIEVRTRWLDDQITLGLGRGIRQIVILAAGMDARAYRLAWPGDTRLFELDHDAVLQDKEAKLTGVAPKCERHAVSVDLADDWPAALKKSGFDPGVPTLWLIEGLLVYLTEAQVTLLMARVNALSVPESIVLIDVVGRSILDSSRVKLMHDLARQFGTDEPEVILRPIGWDPHVYTTAAIGKQLGRWPFPVAPRGTPGVPQGYLVHGVKR", "perc_identity": 27.27}}, "BGC0001413.1|Cystobactamide_5 # 8001 # 8702 # -1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.689": {"gnl|BL_ORD_ID|4939|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8001, "orf_end": 8702, "orf_from": "BGC0001413.1|Cystobactamide_5 ", "model_name": "EBR-5", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "350", "model_id": "5931", "ARO_accession": "3007437", "ARO_name": "EBR-5", "ARO_category": {"41368": {"category_aro_accession": "3004204", "category_aro_cvterm_id": "41368", "category_aro_name": "EBR beta-lactamase", "category_aro_description": "EBR beta-lactamases are Class B beta-lactamases first isolated from Empedobacter brevis and are able to hydrolyze penicillins, cephalosporins, and carbapenems.", "category_aro_class_name": "AMR Gene Family"}, "35977": {"category_aro_accession": "0000060", "category_aro_cvterm_id": "35977", "category_aro_name": "ceftazidime", "category_aro_description": "Ceftazidime is a third-generation cephalosporin antibiotic. Like other third-generation cephalosporins, it has broad spectrum activity against Gram-positive and Gram-negative bacteria. Unlike most third-generation agents, it is active against Pseudomonas aeruginosa, however it has weaker activity against Gram-positive microorganisms and is not used for such infections.", "category_aro_class_name": "Antibiotic"}, "35980": {"category_aro_accession": "0000063", "category_aro_cvterm_id": "35980", "category_aro_name": "cefuroxime", "category_aro_description": "Cefuroxime is a second-generation cephalosporin antibiotic with increased stability with beta-lactamases than first-generation cephalosporins. Cefuroxime is active against Gram-positive organisms but less active against methicillin-resistant strains.", "category_aro_class_name": "Antibiotic"}, "35995": {"category_aro_accession": "0000078", "category_aro_cvterm_id": "35995", "category_aro_name": "piperacillin", "category_aro_description": "Piperacillin is an acetylureidopenicillin and has an extended spectrum of targets relative to other beta-lactam antibiotics. It inhibits cell wall synthesis in bacteria, and is usually taken with the beta-lactamase inhibitor tazobactam to overcome penicillin-resistant bacteria.", "category_aro_class_name": "Antibiotic"}, "36981": {"category_aro_accession": "3000637", "category_aro_cvterm_id": "36981", "category_aro_name": "ampicillin", "category_aro_description": "Ampicillin is a penicillin derivative that is highly acid stable, with its activity similar to benzylpenicillin.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "40933": {"category_aro_accession": "3004006", "category_aro_cvterm_id": "40933", "category_aro_name": "ceftiofur", "category_aro_description": "Ceftiofur is a third-generation broad spectrum cephalosporin and beta-lactam antibiotic. It causes cell lysis by disrupting peptidoglycan cross-linkage and cell wall formation by binding to PBPs.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.98196, "max_identities": 19, "bit_score": 26.5646, "cvterm_id": "46203", "query": "FKLQLRTTNVPAARAFYTALFGEG-AANADIVPLPEQAI------ARGAPAHWLGYVGVEDVDE", "match": "F+++L  T       F    FG+G  A+  +V  P+  +       +GA A  LGY+G  +V E", "sequence_from_db": "FEIELGKTYRFGKEKFVIEYFGQGHTADNLVVWFPKYKVLNGGCLIKGADAKNLGYIGEANVTE", "sequence_from_broadstreet": "MKKVFSFVTLIGTFAFGQIKPIQIDSINSHLYVYQTFNSFQGIDYNANGMFLITDKGIILFDVPWQKSQYQTMNDLVLEKYHLPVIAVFVTHSHEDRAGDLSFYNELNIPTYASSFTNSILKKEGKATSKFEIELGKTYRFGKEKFVIEYFGQGHTADNLVVWFPKYKVLNGGCLIKGADAKNLGYIGEANVTEWPKTVQKLVTKHPKINQVIPGHDNWKANGHIENTFKLLEK", "dna_sequence_from_broadstreet": "ATGAAAAAAGTATTTTCTTTTGTCACATTGATTGGAACGTTTGCATTTGGTCAAATAAAACCGATTCAAATAGATTCTATTAATTCTCATCTTTACGTTTATCAAACATTTAATTCATTTCAAGGCATTGATTATAATGCGAATGGAATGTTTTTGATCACTGATAAAGGAATTATTTTGTTTGACGTGCCTTGGCAAAAATCTCAGTATCAAACAATGAATGATCTTGTATTAGAGAAATATCATTTACCAGTTATTGCTGTTTTTGTCACACATTCACACGAAGATAGAGCAGGGGATTTAAGCTTTTACAATGAATTAAATATCCCAACATACGCTTCATCTTTCACTAATTCTATTTTAAAAAAGGAAGGAAAAGCAACTTCGAAATTTGAAATAGAATTAGGTAAAACCTATAGATTTGGTAAAGAAAAATTTGTCATCGAATATTTTGGACAAGGTCATACAGCGGATAATCTTGTGGTTTGGTTTCCGAAATATAAGGTTTTGAATGGAGGTTGTTTGATCAAAGGAGCAGATGCAAAAAATTTAGGTTATATTGGTGAAGCTAATGTTACTGAATGGCCAAAAACAGTTCAGAAATTAGTAACGAAACATCCAAAAATTAACCAAGTTATTCCAGGTCATGATAATTGGAAAGCAAATGGGCATATAGAAAATACGTTTAAACTTTTAGAAAAATAA", "partial": "0", "query_start": 8013, "query_end": 8183, "hit_start": 390, "hit_end": 582, "orf_dna_sequence": "ATGAAACGGTTCTTCAAGCTCCAGTTGCGCACCACCAACGTCCCCGCGGCACGGGCGTTCTACACGGCTCTGTTCGGTGAGGGCGCCGCCAACGCAGACATCGTGCCGCTGCCCGAGCAGGCGATTGCCCGCGGCGCACCCGCCCATTGGCTGGGTTACGTCGGCGTCGAGGACGTCGATGAAGCGGTGCGCTCGTTCGTGGGGCGCGGGGCGACCCAGCTCGGCCCGACCCACCCGACGAACGACGGCGGGCGCGTCGCGATCCTCCGCGATCCTGGAGGGGCGACCTTCGCCGTGGCGACGGCACCGGCAACGACGAGAGCGCTCCAGCCGGAGGTGGTCTGGCAGCAGCTCTATGCCGCGAACGTGCAACAGACGGCCGCCTCGTATTGCGACCTGTTCGGATGGCGGCTCTCGGATCGCCGCGACCTTGGTGCGCTGGGGGTTCACCAGGAGTTCACCTGGCGCTCGGACGAGCCGAGCGCCGGCTCGGTCGTGGACGTGGCGGGGCTCAAGGGGGTCCATTCACACTGGCTGTTCCATTTCCGCGTCGCCGCGCTCGATCCCGCGATGGAGGTCGTCCGCAAGGCCGGAGGCGTCGTCATCGGCCCCATGGAACTTCCGAATGGCGATCGCATCGCCGTGTGCGAGGATCCGCAACGGGCGGCGTTCGCGCTTCGCGAATCCAGCCACGGACGCTGA", "orf_prot_sequence": "MKRFFKLQLRTTNVPAARAFYTALFGEGAANADIVPLPEQAIARGAPAHWLGYVGVEDVDEAVRSFVGRGATQLGPTHPTNDGGRVAILRDPGGATFAVATAPATTRALQPEVVWQQLYAANVQQTAASYCDLFGWRLSDRRDLGALGVHQEFTWRSDEPSAGSVVDVAGLKGVHSHWLFHFRVAALDPAMEVVRKAGGVVIGPMELPNGDRIAVCEDPQRAAFALRESSHGR", "perc_identity": 29.69}}, "BGC0001413.1|Cystobactamide_6 # 8736 # 9215 # -1 # ID=1_6;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.602": {"gnl|BL_ORD_ID|1062|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrVC5", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1150", "ARO_accession": "3002802", "ARO_name": "QnrVC5", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.92346e-07, "max_identities": 37, "bit_score": 45.0542, "cvterm_id": "39525", "query": "SRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQ---------FEQCDLRYSSFL-----KLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVV", "match": "S L D  F+ C L     +      + F++  L G ++S    M  V             C+L Y++F      K +L + R++G +   A+F + DL+   F+      C +QGC L+ +       +  DP+   + G ++       L + LG++V", "sequence_from_db": "SDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFSQASFMNQVSNRMYFCSAYITGCNLSYANFERQCIEKCDLFENRWIGANLSGASFKESDLSRGVFSEGCWSQCRLQGCDLSHSEL-----YGLDPRKVDLTGVKICSWQQEQLLEQLGLIV", "sequence_from_broadstreet": "MDKTDQLYVQADFSHQDMSGQYFKNCKFFCCSFKRANLRDTQFVDCSFIERGELEGCDFSYSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFSQASFMNQVSNRMYFCSAYITGCNLSYANFERQCIEKCDLFENRWIGANLSGASFKESDLSRGVFSEGCWSQCRLQGCDLSHSELYGLDPRKVDLTGVKICSWQQEQLLEQLGLIVVPD", "dna_sequence_from_broadstreet": "ATGGATAAAACAGACCAGTTATATGTACAAGCAGACTTTTCACATCAAGACATGAGTGGTCAGTATTTTAAAAATTGCAAATTTTTCTGCTGTTCCTTTAAACGAGCGAACCTCCGCGATACACAATTTGTAGATTGTTCTTTCATTGAACGAGGTGAATTAGAGGGGTGTGATTTTTCTTACTCGGATCTTAGAGATGCATCTTTTAAAAACTGCAGTCTTTCAATGTCGTATTTCAAAGGTGCAAATTGTTTTGGTATCGAGTTCAGAGAATGCGATTTAAAGGGTGCCAATTTTTCTCAAGCTAGCTTCATGAATCAGGTATCGAACAGAATGTATTTTTGTTCAGCTTATATAACAGGTTGTAATCTTTCATACGCCAACTTTGAAAGGCAGTGTATCGAAAAGTGTGATTTGTTTGAGAATAGATGGATTGGCGCAAATCTGAGTGGTGCATCATTTAAAGAGTCTGATTTAAGTCGGGGAGTATTTTCTGAAGGGTGTTGGAGCCAGTGTAGGTTGCAAGGTTGTGATTTGAGCCACTCGGAGTTGTATGGTTTAGACCCTCGGAAAGTTGACCTTACAGGTGTAAAAATCTGTTCGTGGCAGCAAGAACAACTTTTAGAGCAATTAGGTTTAATAGTAGTTCCTGACTAA", "partial": "0", "query_start": 8760, "query_end": 9194, "hit_start": 183, "hit_end": 645, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 23.27}, "gnl|BL_ORD_ID|1062|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrVC5", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1150", "ARO_accession": "3002802", "ARO_name": "QnrVC5", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000296254, "max_identities": 25, "bit_score": 36.965, "cvterm_id": "39525", "query": "MPDVQFEQCDLRYSSFLKLNLRKTRFVGCS----------------AREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARST", "match": "M    F+ C     SF + NLR T+FV CS                 R+A+F +  L+ S F G +  G   + C L   NF++++", "sequence_from_db": "MSGQYFKNCKFFCCSFKRANLRDTQFVDCSFIERGELEGCDFSYSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFSQAS", "sequence_from_broadstreet": "MDKTDQLYVQADFSHQDMSGQYFKNCKFFCCSFKRANLRDTQFVDCSFIERGELEGCDFSYSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFSQASFMNQVSNRMYFCSAYITGCNLSYANFERQCIEKCDLFENRWIGANLSGASFKESDLSRGVFSEGCWSQCRLQGCDLSHSELYGLDPRKVDLTGVKICSWQQEQLLEQLGLIVVPD", "dna_sequence_from_broadstreet": "ATGGATAAAACAGACCAGTTATATGTACAAGCAGACTTTTCACATCAAGACATGAGTGGTCAGTATTTTAAAAATTGCAAATTTTTCTGCTGTTCCTTTAAACGAGCGAACCTCCGCGATACACAATTTGTAGATTGTTCTTTCATTGAACGAGGTGAATTAGAGGGGTGTGATTTTTCTTACTCGGATCTTAGAGATGCATCTTTTAAAAACTGCAGTCTTTCAATGTCGTATTTCAAAGGTGCAAATTGTTTTGGTATCGAGTTCAGAGAATGCGATTTAAAGGGTGCCAATTTTTCTCAAGCTAGCTTCATGAATCAGGTATCGAACAGAATGTATTTTTGTTCAGCTTATATAACAGGTTGTAATCTTTCATACGCCAACTTTGAAAGGCAGTGTATCGAAAAGTGTGATTTGTTTGAGAATAGATGGATTGGCGCAAATCTGAGTGGTGCATCATTTAAAGAGTCTGATTTAAGTCGGGGAGTATTTTCTGAAGGGTGTTGGAGCCAGTGTAGGTTGCAAGGTTGTGATTTGAGCCACTCGGAGTTGTATGGTTTAGACCCTCGGAAAGTTGACCTTACAGGTGTAAAAATCTGTTCGTGGCAGCAAGAACAACTTTTAGAGCAATTAGGTTTAATAGTAGTTCCTGACTAA", "partial": "0", "query_start": 8889, "query_end": 9098, "hit_start": 51, "hit_end": 309, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 29.07}, "gnl|BL_ORD_ID|1062|hsp_num:2": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrVC5", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1150", "ARO_accession": "3002802", "ARO_name": "QnrVC5", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0115567, "max_identities": 24, "bit_score": 32.3426, "cvterm_id": "39525", "query": "ALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFT--------GTDMPGCT--MQGCVLTKTNFAR", "match": "+ +    +DT+ +   +   G +    F   DLR +SF   +L  + F G +     F + DL  ++F+           M  C+  + GC L+  NF R", "sequence_from_db": "SFKRANLRDTQFVDCSFIERGELEGCDFSYSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFSQASFMNQVSNRMYFCSAYITGCNLSYANFER", "sequence_from_broadstreet": "MDKTDQLYVQADFSHQDMSGQYFKNCKFFCCSFKRANLRDTQFVDCSFIERGELEGCDFSYSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFSQASFMNQVSNRMYFCSAYITGCNLSYANFERQCIEKCDLFENRWIGANLSGASFKESDLSRGVFSEGCWSQCRLQGCDLSHSELYGLDPRKVDLTGVKICSWQQEQLLEQLGLIVVPD", "dna_sequence_from_broadstreet": "ATGGATAAAACAGACCAGTTATATGTACAAGCAGACTTTTCACATCAAGACATGAGTGGTCAGTATTTTAAAAATTGCAAATTTTTCTGCTGTTCCTTTAAACGAGCGAACCTCCGCGATACACAATTTGTAGATTGTTCTTTCATTGAACGAGGTGAATTAGAGGGGTGTGATTTTTCTTACTCGGATCTTAGAGATGCATCTTTTAAAAACTGCAGTCTTTCAATGTCGTATTTCAAAGGTGCAAATTGTTTTGGTATCGAGTTCAGAGAATGCGATTTAAAGGGTGCCAATTTTTCTCAAGCTAGCTTCATGAATCAGGTATCGAACAGAATGTATTTTTGTTCAGCTTATATAACAGGTTGTAATCTTTCATACGCCAACTTTGAAAGGCAGTGTATCGAAAAGTGTGATTTGTTTGAGAATAGATGGATTGGCGCAAATCTGAGTGGTGCATCATTTAAAGAGTCTGATTTAAGTCGGGGAGTATTTTCTGAAGGGTGTTGGAGCCAGTGTAGGTTGCAAGGTTGTGATTTGAGCCACTCGGAGTTGTATGGTTTAGACCCTCGGAAAGTTGACCTTACAGGTGTAAAAATCTGTTCGTGGCAGCAAGAACAACTTTTAGAGCAATTAGGTTTAATAGTAGTTCCTGACTAA", "partial": "0", "query_start": 8823, "query_end": 9092, "hit_start": 93, "hit_end": 393, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 24.0}, "gnl|BL_ORD_ID|734|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "mfpA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "350", "model_id": "801", "ARO_accession": "3003035", "ARO_name": "mfpA", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.3496e-07, "max_identities": 45, "bit_score": 44.669, "cvterm_id": "39507", "query": "DCVFEGCD-----LLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNF-----------------ARSTNFIFDP-------------KANQVKGTRVGVETAVALAQALGMVVDG", "match": "DC F G D     L R+  E+       F    L      G     +  FE+  L +S+F + ++  + FV C  R     DVD   +   G D+ G  + GC L +T+                  AR+T    D              +   + G RV V+ AVA A A G+ + G", "sequence_from_db": "DCEFTGRDFRDEDLSRLHTERAMFSECDFSGVNLAESQHRG-SAFRNCTFERTTLWHSTFAQCSMLGSVFVACRLRPLTLDDVDFTLAVLGGNDLRGLNLTGCRLRETSLVDTDLRKCVLRGADLSGARTTGARLDDADLRGATVDPVLWRTASLVGARVDVDQAVAFAAAHGLCLAG", "sequence_from_broadstreet": "MQQWVDCEFTGRDFRDEDLSRLHTERAMFSECDFSGVNLAESQHRGSAFRNCTFERTTLWHSTFAQCSMLGSVFVACRLRPLTLDDVDFTLAVLGGNDLRGLNLTGCRLRETSLVDTDLRKCVLRGADLSGARTTGARLDDADLRGATVDPVLWRTASLVGARVDVDQAVAFAAAHGLCLAGG", "dna_sequence_from_broadstreet": "TTGCAGCAGTGGGTTGATTGCGAATTCACCGGTCGAGACTTCCGCGACGAGGACCTTAGCCGCCTGCACACCGAACGGGCGATGTTCAGCGAATGCGATTTCAGCGGCGTGAATCTGGCCGAGTCACAACACCGAGGGTCGGCGTTTCGTAATTGCACCTTCGAACGGACGACACTGTGGCACAGCACATTTGCCCAGTGCAGCATGTTGGGCTCGGTCTTCGTGGCTTGCCGGCTGCGGCCGCTGACGTTGGACGACGTGGATTTCACGCTCGCCGTGCTCGGCGGAAATGATCTGCGTGGTCTCAACTTGACCGGCTGCCGGTTGCGAGAGACCAGCCTGGTGGATACCGACTTGCGCAAGTGCGTGCTGCGCGGCGCCGACCTCAGTGGTGCCCGTACCACGGGCGCCCGGCTGGATGACGCCGACTTGCGGGGCGCGACCGTGGACCCGGTATTGTGGCGGACCGCGTCGTTGGTGGGTGCGCGTGTCGACGTCGACCAAGCCGTGGCCTTTGCGGCGGCGCACGGGCTGTGCTTGGCAGGGGGCTAG", "partial": "0", "query_start": 8772, "query_end": 9200, "hit_start": 15, "hit_end": 546, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 25.28}, "gnl|BL_ORD_ID|4916|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrAS", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5907", "ARO_accession": "3004668", "ARO_name": "QnrAS", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.63723e-07, "max_identities": 44, "bit_score": 44.669, "cvterm_id": "46173", "query": "SRLEDCVF------EGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLK----------LNLRKTRFVGCSAREANFIDV-----DLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIF---------------DPKANQVKGTRVGVETAVALAQALGMVV", "match": "SR  DCVF      EGC       +   LR  +FK  RL   ++ G      V+F +CDL+ ++F++          +        GC+   ANF  +     DL E+ + G ++ G + +G  L++  F+  +   F               DP+   + G ++       L + LG+VV", "sequence_from_db": "SRFVDCVFIEQGAIEGCHF-----DYSDLRDASFKRCRLTMSNFKGANCFG-VEFRECDLKGANFVQASFVNQISHQMYFCSAYITGCNLSYANFERLCIEKCDLFENKWNGANLQGASFKGSDLSRGAFSEDSWGQFRMQDANLCHCELDGLDPRRIDLTGVKICAWQQEQLLEPLGLVV", "sequence_from_broadstreet": "MAKYNEIFDNVDFSKQDLRESYFEGCKFYRCDFNRTNLRDSRFVDCVFIEQGAIEGCHFDYSDLRDASFKRCRLTMSNFKGANCFGVEFRECDLKGANFVQASFVNQISHQMYFCSAYITGCNLSYANFERLCIEKCDLFENKWNGANLQGASFKGSDLSRGAFSEDSWGQFRMQDANLCHCELDGLDPRRIDLTGVKICAWQQEQLLEPLGLVVLPD", "dna_sequence_from_broadstreet": "ATGGCTAAATATAATGAAATATTCGATAACGTGGATTTTTCGAAACAAGATTTAAGAGAATCCTATTTTGAAGGGTGTAAGTTTTATCGATGTGATTTCAATCGAACCAATCTGAGAGACTCCCGATTTGTTGATTGTGTTTTTATCGAACAGGGGGCAATTGAAGGTTGTCATTTTGATTACAGTGACTTAAGGGACGCATCATTTAAACGCTGTCGCTTAACCATGTCTAATTTTAAAGGCGCAAATTGCTTTGGTGTCGAATTTAGAGAGTGTGATTTAAAAGGAGCTAATTTTGTTCAAGCCAGTTTTGTTAATCAAATAAGTCATCAAATGTATTTCTGCTCTGCTTATATTACGGGGTGTAATTTGTCTTATGCGAATTTTGAACGCCTATGTATCGAGAAATGTGACTTGTTTGAGAACAAATGGAACGGAGCTAATTTACAAGGGGCATCTTTTAAGGGTTCGGACCTTTCTCGTGGCGCATTCTCTGAAGACTCGTGGGGTCAATTTAGAATGCAAGATGCAAACTTATGTCATTGTGAATTGGATGGTTTAGATCCCCGTAGAATTGATTTAACCGGTGTTAAGATCTGTGCATGGCAACAAGAGCAATTATTAGAGCCATTAGGATTAGTGGTACTGCCTGACTAA", "partial": "0", "query_start": 8760, "query_end": 9194, "hit_start": 120, "hit_end": 645, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 24.31}, "gnl|BL_ORD_ID|4916|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrAS", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5907", "ARO_accession": "3004668", "ARO_name": "QnrAS", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.33179e-05, "max_identities": 32, "bit_score": 38.891, "cvterm_id": "46173", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFT--------GTDMPGCT--MQGCVLTKTNFAR", "match": "+  L +  FEGC   R    +  LR     D+R +   +   G +    F+  DLR +SF +  L  + F G +     F + DL  ++F            M  C+  + GC L+  NF R", "sequence_from_db": "KQDLRESYFEGCKFYRCDFNRTNLR-----DSRFVDCVFIEQGAIEGCHFDYSDLRDASFKRCRLTMSNFKGANCFGVEFRECDLKGANFVQASFVNQISHQMYFCSAYITGCNLSYANFER", "sequence_from_broadstreet": "MAKYNEIFDNVDFSKQDLRESYFEGCKFYRCDFNRTNLRDSRFVDCVFIEQGAIEGCHFDYSDLRDASFKRCRLTMSNFKGANCFGVEFRECDLKGANFVQASFVNQISHQMYFCSAYITGCNLSYANFERLCIEKCDLFENKWNGANLQGASFKGSDLSRGAFSEDSWGQFRMQDANLCHCELDGLDPRRIDLTGVKICAWQQEQLLEPLGLVVLPD", "dna_sequence_from_broadstreet": "ATGGCTAAATATAATGAAATATTCGATAACGTGGATTTTTCGAAACAAGATTTAAGAGAATCCTATTTTGAAGGGTGTAAGTTTTATCGATGTGATTTCAATCGAACCAATCTGAGAGACTCCCGATTTGTTGATTGTGTTTTTATCGAACAGGGGGCAATTGAAGGTTGTCATTTTGATTACAGTGACTTAAGGGACGCATCATTTAAACGCTGTCGCTTAACCATGTCTAATTTTAAAGGCGCAAATTGCTTTGGTGTCGAATTTAGAGAGTGTGATTTAAAAGGAGCTAATTTTGTTCAAGCCAGTTTTGTTAATCAAATAAGTCATCAAATGTATTTCTGCTCTGCTTATATTACGGGGTGTAATTTGTCTTATGCGAATTTTGAACGCCTATGTATCGAGAAATGTGACTTGTTTGAGAACAAATGGAACGGAGCTAATTTACAAGGGGCATCTTTTAAGGGTTCGGACCTTTCTCGTGGCGCATTCTCTGAAGACTCGTGGGGTCAATTTAGAATGCAAGATGCAAACTTATGTCATTGTGAATTGGATGGTTTAGATCCCCGTAGAATTGATTTAACCGGTGTTAAGATCTGTGCATGGCAACAAGAGCAATTATTAGAGCCATTAGGATTAGTGGTACTGCCTGACTAA", "partial": "0", "query_start": 8757, "query_end": 9092, "hit_start": 42, "hit_end": 393, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 26.23}, "gnl|BL_ORD_ID|4916|hsp_num:2": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrAS", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5907", "ARO_accession": "3004668", "ARO_name": "QnrAS", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00410742, "max_identities": 23, "bit_score": 33.4982, "cvterm_id": "46173", "query": "FEQCDLRYSSFLKLNLRKTRFVGC----------------SAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARST", "match": "FE C      F + NLR +RFV C                  R+A+F    L  S+F G +  G   + C L   NF +++", "sequence_from_db": "FEGCKFYRCDFNRTNLRDSRFVDCVFIEQGAIEGCHFDYSDLRDASFKRCRLTMSNFKGANCFGVEFRECDLKGANFVQAS", "sequence_from_broadstreet": "MAKYNEIFDNVDFSKQDLRESYFEGCKFYRCDFNRTNLRDSRFVDCVFIEQGAIEGCHFDYSDLRDASFKRCRLTMSNFKGANCFGVEFRECDLKGANFVQASFVNQISHQMYFCSAYITGCNLSYANFERLCIEKCDLFENKWNGANLQGASFKGSDLSRGAFSEDSWGQFRMQDANLCHCELDGLDPRRIDLTGVKICAWQQEQLLEPLGLVVLPD", "dna_sequence_from_broadstreet": "ATGGCTAAATATAATGAAATATTCGATAACGTGGATTTTTCGAAACAAGATTTAAGAGAATCCTATTTTGAAGGGTGTAAGTTTTATCGATGTGATTTCAATCGAACCAATCTGAGAGACTCCCGATTTGTTGATTGTGTTTTTATCGAACAGGGGGCAATTGAAGGTTGTCATTTTGATTACAGTGACTTAAGGGACGCATCATTTAAACGCTGTCGCTTAACCATGTCTAATTTTAAAGGCGCAAATTGCTTTGGTGTCGAATTTAGAGAGTGTGATTTAAAAGGAGCTAATTTTGTTCAAGCCAGTTTTGTTAATCAAATAAGTCATCAAATGTATTTCTGCTCTGCTTATATTACGGGGTGTAATTTGTCTTATGCGAATTTTGAACGCCTATGTATCGAGAAATGTGACTTGTTTGAGAACAAATGGAACGGAGCTAATTTACAAGGGGCATCTTTTAAGGGTTCGGACCTTTCTCGTGGCGCATTCTCTGAAGACTCGTGGGGTCAATTTAGAATGCAAGATGCAAACTTATGTCATTGTGAATTGGATGGTTTAGATCCCCGTAGAATTGATTTAACCGGTGTTAAGATCTGTGCATGGCAACAAGAGCAATTATTAGAGCCATTAGGATTAGTGGTACTGCCTGACTAA", "partial": "0", "query_start": 8904, "query_end": 9098, "hit_start": 66, "hit_end": 309, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 28.4}, "gnl|BL_ORD_ID|4916|hsp_num:3": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrAS", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5907", "ARO_accession": "3004668", "ARO_name": "QnrAS", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.48107, "max_identities": 11, "bit_score": 23.8682, "cvterm_id": "46173", "query": "FIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFI", "match": "F +VD ++ D   +   GC    C   +TN  R + F+", "sequence_from_db": "FDNVDFSKQDLRESYFEGCKFYRCDFNRTNL-RDSRFV", "sequence_from_broadstreet": "MAKYNEIFDNVDFSKQDLRESYFEGCKFYRCDFNRTNLRDSRFVDCVFIEQGAIEGCHFDYSDLRDASFKRCRLTMSNFKGANCFGVEFRECDLKGANFVQASFVNQISHQMYFCSAYITGCNLSYANFERLCIEKCDLFENKWNGANLQGASFKGSDLSRGAFSEDSWGQFRMQDANLCHCELDGLDPRRIDLTGVKICAWQQEQLLEPLGLVVLPD", "dna_sequence_from_broadstreet": "ATGGCTAAATATAATGAAATATTCGATAACGTGGATTTTTCGAAACAAGATTTAAGAGAATCCTATTTTGAAGGGTGTAAGTTTTATCGATGTGATTTCAATCGAACCAATCTGAGAGACTCCCGATTTGTTGATTGTGTTTTTATCGAACAGGGGGCAATTGAAGGTTGTCATTTTGATTACAGTGACTTAAGGGACGCATCATTTAAACGCTGTCGCTTAACCATGTCTAATTTTAAAGGCGCAAATTGCTTTGGTGTCGAATTTAGAGAGTGTGATTTAAAAGGAGCTAATTTTGTTCAAGCCAGTTTTGTTAATCAAATAAGTCATCAAATGTATTTCTGCTCTGCTTATATTACGGGGTGTAATTTGTCTTATGCGAATTTTGAACGCCTATGTATCGAGAAATGTGACTTGTTTGAGAACAAATGGAACGGAGCTAATTTACAAGGGGCATCTTTTAAGGGTTCGGACCTTTCTCGTGGCGCATTCTCTGAAGACTCGTGGGGTCAATTTAGAATGCAAGATGCAAACTTATGTCATTGTGAATTGGATGGTTTAGATCCCCGTAGAATTGATTTAACCGGTGTTAAGATCTGTGCATGGCAACAAGAGCAATTATTAGAGCCATTAGGATTAGTGGTACTGCCTGACTAA", "partial": "0", "query_start": 8994, "query_end": 9107, "hit_start": 21, "hit_end": 132, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 28.95}, "gnl|BL_ORD_ID|408|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrVC4", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "452", "ARO_accession": "3002801", "ARO_name": "QnrVC4", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.0178e-06, "max_identities": 36, "bit_score": 43.8986, "cvterm_id": "36936", "query": "SRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQ---------FEQCDLRYSSFL-----KLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVV", "match": "S L D  F+ C L     +      + F++  L G +++    M  V             C+L Y++F      K +L + R++G +   A+F + DL+   F+      C +QGC L+ +       +  DP+   + G ++       L + LG++V", "sequence_from_db": "SDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFAQASFMNQVSNRMYFCSAYITGCNLSYANFERQCIEKCDLFENRWIGANLSGASFKESDLSRGVFSEGCWSQCRLQGCDLSHSEL-----YGLDPRKVDLTGVKICSWQQEQLLEQLGLIV", "sequence_from_broadstreet": "MDKTDQLYVQADFSHQDMSGQYFKNCKFFCCSFKRANLRDTQFVDCSFIERGELEGCDFSYSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFAQASFMNQVSNRMYFCSAYITGCNLSYANFERQCIEKCDLFENRWIGANLSGASFKESDLSRGVFSEGCWSQCRLQGCDLSHSELYGLDPRKVDLTGVKICSWQQEQLLEQLGLIVVPD", "dna_sequence_from_broadstreet": "ATGGATAAAACAGACCAGTTATATGTACAAGCAGACTTTTCACATCAAGACATGAGTGGTCAGTATTTTAAAAATTGCAAATTTTTCTGCTGTTCCTTTAAACGAGCGAACCTCCGCGATACACAATTTGTAGATTGTTCTTTCATTGAACGAGGTGAATTAGAGGGGTGTGATTTTTCTTACTCGGATCTTAGAGATGCATCTTTTAAAAACTGCAGTCTTTCAATGTCGTATTTCAAAGGTGCAAATTGTTTTGGTATCGAGTTCAGAGAATGCGATTTAAAGGGTGCCAATTTTGCTCAAGCTAGCTTCATGAATCAGGTATCGAACAGAATGTATTTTTGTTCAGCTTATATAACAGGTTGTAATCTTTCATACGCCAACTTTGAAAGGCAGTGTATCGAAAAGTGTGATTTGTTTGAGAATAGATGGATTGGCGCAAATCTGAGTGGTGCATCATTTAAAGAGTCTGATTTAAGTCGGGGAGTATTTTCTGAAGGGTGTTGGAGCCAGTGTAGGTTGCAAGGTTGTGATTTGAGCCACTCGGAGTTGTATGGTTTAGACCCTCGGAAAGTTGACCTTACAGGTGTAAAAATCTGTTCGTGGCAGCAAGAACAACTTTTAGAGCAATTAGGTTTAATAGTAGTTCCTGACTAA", "partial": "0", "query_start": 8760, "query_end": 9194, "hit_start": 183, "hit_end": 645, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.64}, "gnl|BL_ORD_ID|408|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrVC4", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "452", "ARO_accession": "3002801", "ARO_name": "QnrVC4", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000116604, "max_identities": 26, "bit_score": 38.1206, "cvterm_id": "36936", "query": "MPDVQFEQCDLRYSSFLKLNLRKTRFVGCS----------------AREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARST", "match": "M    F+ C     SF + NLR T+FV CS                 R+A+F +  L+ S F G +  G   + C L   NFA+++", "sequence_from_db": "MSGQYFKNCKFFCCSFKRANLRDTQFVDCSFIERGELEGCDFSYSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFAQAS", "sequence_from_broadstreet": "MDKTDQLYVQADFSHQDMSGQYFKNCKFFCCSFKRANLRDTQFVDCSFIERGELEGCDFSYSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFAQASFMNQVSNRMYFCSAYITGCNLSYANFERQCIEKCDLFENRWIGANLSGASFKESDLSRGVFSEGCWSQCRLQGCDLSHSELYGLDPRKVDLTGVKICSWQQEQLLEQLGLIVVPD", "dna_sequence_from_broadstreet": "ATGGATAAAACAGACCAGTTATATGTACAAGCAGACTTTTCACATCAAGACATGAGTGGTCAGTATTTTAAAAATTGCAAATTTTTCTGCTGTTCCTTTAAACGAGCGAACCTCCGCGATACACAATTTGTAGATTGTTCTTTCATTGAACGAGGTGAATTAGAGGGGTGTGATTTTTCTTACTCGGATCTTAGAGATGCATCTTTTAAAAACTGCAGTCTTTCAATGTCGTATTTCAAAGGTGCAAATTGTTTTGGTATCGAGTTCAGAGAATGCGATTTAAAGGGTGCCAATTTTGCTCAAGCTAGCTTCATGAATCAGGTATCGAACAGAATGTATTTTTGTTCAGCTTATATAACAGGTTGTAATCTTTCATACGCCAACTTTGAAAGGCAGTGTATCGAAAAGTGTGATTTGTTTGAGAATAGATGGATTGGCGCAAATCTGAGTGGTGCATCATTTAAAGAGTCTGATTTAAGTCGGGGAGTATTTTCTGAAGGGTGTTGGAGCCAGTGTAGGTTGCAAGGTTGTGATTTGAGCCACTCGGAGTTGTATGGTTTAGACCCTCGGAAAGTTGACCTTACAGGTGTAAAAATCTGTTCGTGGCAGCAAGAACAACTTTTAGAGCAATTAGGTTTAATAGTAGTTCCTGACTAA", "partial": "0", "query_start": 8889, "query_end": 9098, "hit_start": 51, "hit_end": 309, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 30.23}, "gnl|BL_ORD_ID|408|hsp_num:2": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrVC4", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "452", "ARO_accession": "3002801", "ARO_name": "QnrVC4", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0174644, "max_identities": 24, "bit_score": 31.5722, "cvterm_id": "36936", "query": "ALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFT--------GTDMPGCT--MQGCVLTKTNFAR", "match": "+ +    +DT+ +   +   G +    F   DLR +SF   +L  + F G +     F + DL  ++F            M  C+  + GC L+  NF R", "sequence_from_db": "SFKRANLRDTQFVDCSFIERGELEGCDFSYSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFAQASFMNQVSNRMYFCSAYITGCNLSYANFER", "sequence_from_broadstreet": "MDKTDQLYVQADFSHQDMSGQYFKNCKFFCCSFKRANLRDTQFVDCSFIERGELEGCDFSYSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFAQASFMNQVSNRMYFCSAYITGCNLSYANFERQCIEKCDLFENRWIGANLSGASFKESDLSRGVFSEGCWSQCRLQGCDLSHSELYGLDPRKVDLTGVKICSWQQEQLLEQLGLIVVPD", "dna_sequence_from_broadstreet": "ATGGATAAAACAGACCAGTTATATGTACAAGCAGACTTTTCACATCAAGACATGAGTGGTCAGTATTTTAAAAATTGCAAATTTTTCTGCTGTTCCTTTAAACGAGCGAACCTCCGCGATACACAATTTGTAGATTGTTCTTTCATTGAACGAGGTGAATTAGAGGGGTGTGATTTTTCTTACTCGGATCTTAGAGATGCATCTTTTAAAAACTGCAGTCTTTCAATGTCGTATTTCAAAGGTGCAAATTGTTTTGGTATCGAGTTCAGAGAATGCGATTTAAAGGGTGCCAATTTTGCTCAAGCTAGCTTCATGAATCAGGTATCGAACAGAATGTATTTTTGTTCAGCTTATATAACAGGTTGTAATCTTTCATACGCCAACTTTGAAAGGCAGTGTATCGAAAAGTGTGATTTGTTTGAGAATAGATGGATTGGCGCAAATCTGAGTGGTGCATCATTTAAAGAGTCTGATTTAAGTCGGGGAGTATTTTCTGAAGGGTGTTGGAGCCAGTGTAGGTTGCAAGGTTGTGATTTGAGCCACTCGGAGTTGTATGGTTTAGACCCTCGGAAAGTTGACCTTACAGGTGTAAAAATCTGTTCGTGGCAGCAAGAACAACTTTTAGAGCAATTAGGTTTAATAGTAGTTCCTGACTAA", "partial": "0", "query_start": 8823, "query_end": 9092, "hit_start": 93, "hit_end": 393, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 24.0}, "gnl|BL_ORD_ID|408|hsp_num:3": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrVC4", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "452", "ARO_accession": "3002801", "ARO_name": "QnrVC4", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.458059, "max_identities": 20, "bit_score": 27.335, "cvterm_id": "36936", "query": "DVQFEQCDLRYSSFLKLNLRKTRFVGCSAREAN-----FIDVDLAE------SDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVG", "match": "D  + Q D  +        +  +F  CS + AN     F+D    E       DF+ +D+   + + C L+ + F  +  F  + +   +KG    ", "sequence_from_db": "DQLYVQADFSHQDMSGQYFKNCKFFCCSFKRANLRDTQFVDCSFIERGELEGCDFSYSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFA", "sequence_from_broadstreet": "MDKTDQLYVQADFSHQDMSGQYFKNCKFFCCSFKRANLRDTQFVDCSFIERGELEGCDFSYSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFAQASFMNQVSNRMYFCSAYITGCNLSYANFERQCIEKCDLFENRWIGANLSGASFKESDLSRGVFSEGCWSQCRLQGCDLSHSELYGLDPRKVDLTGVKICSWQQEQLLEQLGLIVVPD", "dna_sequence_from_broadstreet": "ATGGATAAAACAGACCAGTTATATGTACAAGCAGACTTTTCACATCAAGACATGAGTGGTCAGTATTTTAAAAATTGCAAATTTTTCTGCTGTTCCTTTAAACGAGCGAACCTCCGCGATACACAATTTGTAGATTGTTCTTTCATTGAACGAGGTGAATTAGAGGGGTGTGATTTTTCTTACTCGGATCTTAGAGATGCATCTTTTAAAAACTGCAGTCTTTCAATGTCGTATTTCAAAGGTGCAAATTGTTTTGGTATCGAGTTCAGAGAATGCGATTTAAAGGGTGCCAATTTTGCTCAAGCTAGCTTCATGAATCAGGTATCGAACAGAATGTATTTTTGTTCAGCTTATATAACAGGTTGTAATCTTTCATACGCCAACTTTGAAAGGCAGTGTATCGAAAAGTGTGATTTGTTTGAGAATAGATGGATTGGCGCAAATCTGAGTGGTGCATCATTTAAAGAGTCTGATTTAAGTCGGGGAGTATTTTCTGAAGGGTGTTGGAGCCAGTGTAGGTTGCAAGGTTGTGATTTGAGCCACTCGGAGTTGTATGGTTTAGACCCTCGGAAAGTTGACCTTACAGGTGTAAAAATCTGTTCGTGGCAGCAAGAACAACTTTTAGAGCAATTAGGTTTAATAGTAGTTCCTGACTAA", "partial": "0", "query_start": 8895, "query_end": 9149, "hit_start": 12, "hit_end": 300, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 20.83}, "gnl|BL_ORD_ID|503|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB28", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "552", "ARO_accession": "3002743", "ARO_name": "QnrB28", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.28279e-06, "max_identities": 37, "bit_score": 43.5134, "cvterm_id": "36915", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL       ++   +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G     A F   DL+  +F+  D        C LT +          D +   ++G ++    A  L + LG+ V G", "sequence_from_db": "RAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVAGATFSGSDLSGGEFSAFDWRAANFTHCDLTNSELGD-----LDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "sequence_from_broadstreet": "MTLALVSEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVAGATFSGSDLSGGEFSAFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTAGCGAAAAAATTGACAGAAACCGCTTCACCGGGGAAAAAGTTGAAAACAGTACTTTTTTTAACTGTGATTTTTCAGGGGCCGATCTTAGCGGCACTGAATTTATCGGCTGTCAGTTTTATGATCGCGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTTAAAAGTTGCGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCCCTGGGAATTGAAATTCGCCACTGCCGCGCGCAGGGTTCAGATTTTCGCGGCGCGAGTTTTATGAACATGATCACCACGCGGACCTGGTTTTGCAGCGCATACATCACGAATACCAATCTAAGCTACGCCAACTTTTCGAAGGTTGTCCTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGAACTCAGGTAGCGGGTGCAACGTTCAGTGGATCAGATCTCTCGGGAGGTGAATTTTCAGCGTTCGACTGGCGGGCCGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGTGTAGATTTACAAGGCGTCAAATTGGATAGCTATCAGGCAGCGTTGCTGATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 171, "hit_end": 642, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.84}, "gnl|BL_ORD_ID|503|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB28", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "552", "ARO_accession": "3002743", "ARO_name": "QnrB28", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.13172, "max_identities": 15, "bit_score": 29.261, "cvterm_id": "36915", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MTLALVSEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVAGATFSGSDLSGGEFSAFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTAGCGAAAAAATTGACAGAAACCGCTTCACCGGGGAAAAAGTTGAAAACAGTACTTTTTTTAACTGTGATTTTTCAGGGGCCGATCTTAGCGGCACTGAATTTATCGGCTGTCAGTTTTATGATCGCGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTTAAAAGTTGCGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCCCTGGGAATTGAAATTCGCCACTGCCGCGCGCAGGGTTCAGATTTTCGCGGCGCGAGTTTTATGAACATGATCACCACGCGGACCTGGTTTTGCAGCGCATACATCACGAATACCAATCTAAGCTACGCCAACTTTTCGAAGGTTGTCCTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGAACTCAGGTAGCGGGTGCAACGTTCAGTGGATCAGATCTCTCGGGAGGTGAATTTTCAGCGTTCGACTGGCGGGCCGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGTGTAGATTTACAAGGCGTCAAATTGGATAGCTATCAGGCAGCGTTGCTGATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 27, "hit_end": 177, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|973|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB73", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1063", "ARO_accession": "3002785", "ARO_name": "QnrB73", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.63525e-06, "max_identities": 36, "bit_score": 43.5134, "cvterm_id": "36915", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL       ++   +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G     A F   DL+  +F+  D        C LT +          D +   ++G ++    A  L + LG+ + G", "sequence_from_db": "RAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVAGATFSGSDLSGGEFSAFDWRAANFTHCDLTNSELGD-----LDIRGVDLQGVKLDSYQAALLMERLGIAIIG", "sequence_from_broadstreet": "MSLALVSEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVAGATFSGSDLSGGEFSAFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGAGTCTGGCACTAGTTAGCGAAAAAATTGACAGAAACCGCTTCACCGGGGAAAAAGTTGAAAACAGTACTTTTTTTAACTGTGATTTTTCAGGGGCCGATCTTAGCGGCACTGAATTTATCGGCTGTCAGTTTTATGATCGCGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTTAAAAGTTGCGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCTCTGGGAATTGAAATTCGCCACTGCCGCGCGCAGGGTTCAGATTTTCGCGGCGCGAGTTTTATGAACATGATCACCACGCGGACCTGGTTTTGCAGCGCATACATCACGAATACCAATCTAAGCTACGCCAACTTTTCGAAGGTTGTCCTGGAAAAGTGCGAGCTGTGGGAAAATCGCTGGATGGGAACTCAGGTAGCGGGTGCAACGTTCAGTGGATCAGATCTCTCGGGCGGTGAATTTTCAGCGTTCGACTGGCGGGCCGCAAACTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGTGTAGATTTACAAGGCGTCAAATTGGATAGCTATCAGGCAGCGTTGCTGATGGAGCGGCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 171, "hit_end": 642, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.22}, "gnl|BL_ORD_ID|973|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB73", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1063", "ARO_accession": "3002785", "ARO_name": "QnrB73", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.138009, "max_identities": 15, "bit_score": 28.8758, "cvterm_id": "36915", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MSLALVSEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVAGATFSGSDLSGGEFSAFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGAGTCTGGCACTAGTTAGCGAAAAAATTGACAGAAACCGCTTCACCGGGGAAAAAGTTGAAAACAGTACTTTTTTTAACTGTGATTTTTCAGGGGCCGATCTTAGCGGCACTGAATTTATCGGCTGTCAGTTTTATGATCGCGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTTAAAAGTTGCGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCTCTGGGAATTGAAATTCGCCACTGCCGCGCGCAGGGTTCAGATTTTCGCGGCGCGAGTTTTATGAACATGATCACCACGCGGACCTGGTTTTGCAGCGCATACATCACGAATACCAATCTAAGCTACGCCAACTTTTCGAAGGTTGTCCTGGAAAAGTGCGAGCTGTGGGAAAATCGCTGGATGGGAACTCAGGTAGCGGGTGCAACGTTCAGTGGATCAGATCTCTCGGGCGGTGAATTTTCAGCGTTCGACTGGCGGGCCGCAAACTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGTGTAGATTTACAAGGCGTCAAATTGGATAGCTATCAGGCAGCGTTGCTGATGGAGCGGCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 27, "hit_end": 177, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|525|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB65", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "577", "ARO_accession": "3002777", "ARO_name": "QnrB65", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.02429e-06, "max_identities": 37, "bit_score": 43.1282, "cvterm_id": "36915", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL       +    +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G     A F   DL+  +F+  D     +  C LT +          D +   ++G ++    A  L + LG+ V G", "sequence_from_db": "RANLKDAIFKSCDLSMADFRNINALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGD-----LDIRGVDLQGVKLDSYQASLLLERLGIAVMG", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRANLKDAIFKSCDLSMADFRNINALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLLERLGIAVMG", "dna_sequence_from_broadstreet": "ATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGAGAAAGTCGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATTGGCTGCCAGTTTTATGATCGAGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCTAACCTGAAGGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCGGATTTCAGAAATATCAATGCGCTGGGAATCGAAATTCGCCACTGCCGGGCACAAGGGGCAGATTTTCGCGGCGCAAGCTTTATGAATATGATCACCACCCGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCTAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGTACTCAGGTGCTGGGCGCAACGTTCAGTGGATCAGACCTCTCTGGCGGCGAGTTTTCATCCTTCGACTGGCGAGCAGCAAACGTTACGCACTGTGATTTGACCAATTCGGAACTGGGCGATTTAGATATCCGTGGGGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGCTCCTGGAACGTCTTGGCATCGCTGTCATGGGTTAA", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 171, "hit_end": 642, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.84}, "gnl|BL_ORD_ID|525|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB65", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "577", "ARO_accession": "3002777", "ARO_name": "QnrB65", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0380057, "max_identities": 13, "bit_score": 30.8018, "cvterm_id": "36915", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTN", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC  ++ N", "sequence_from_db": "IDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAN", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRANLKDAIFKSCDLSMADFRNINALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLLERLGIAVMG", "dna_sequence_from_broadstreet": "ATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGAGAAAGTCGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATTGGCTGCCAGTTTTATGATCGAGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCTAACCTGAAGGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCGGATTTCAGAAATATCAATGCGCTGGGAATCGAAATTCGCCACTGCCGGGCACAAGGGGCAGATTTTCGCGGCGCAAGCTTTATGAATATGATCACCACCCGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCTAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGTACTCAGGTGCTGGGCGCAACGTTCAGTGGATCAGACCTCTCTGGCGGCGAGTTTTCATCCTTCGACTGGCGAGCAGCAAACGTTACGCACTGTGATTTGACCAATTCGGAACTGGGCGATTTAGATATCCGTGGGGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGCTCCTGGAACGTCTTGGCATCGCTGTCATGGGTTAA", "partial": "0", "query_start": 8949, "query_end": 9083, "hit_start": 27, "hit_end": 180, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 25.49}, "gnl|BL_ORD_ID|1643|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB44", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1789", "ARO_accession": "3002759", "ARO_name": "QnrB44", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.50542e-06, "max_identities": 38, "bit_score": 42.743, "cvterm_id": "35914", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL        +   +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G     A F   DL+  +FT  D        C LT +          D +   ++G ++    A  L + LG+ V G", "sequence_from_db": "RAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFTTFDWRAANFTHCDLTNSELGD-----LDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFTTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTAAGTGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGTGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTACGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTCATTGGTTAA", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 171, "hit_end": 642, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 23.46}, "gnl|BL_ORD_ID|1643|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB44", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1789", "ARO_accession": "3002759", "ARO_name": "QnrB44", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.174237, "max_identities": 15, "bit_score": 28.8758, "cvterm_id": "35914", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFTTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTAAGTGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGTGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTACGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTCATTGGTTAA", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 27, "hit_end": 177, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|1455|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB27", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1590", "ARO_accession": "3002742", "ARO_name": "QnrB27", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.55444e-06, "max_identities": 37, "bit_score": 42.743, "cvterm_id": "39584", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL        +   +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G     A F   DL+  +F+  D        C LT +          D +   ++G ++    A  L + LG+ V G", "sequence_from_db": "RAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVAGATFSGSDLSGGEFSAFDWRAANFTHCDLTNSELGD-----LDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "sequence_from_broadstreet": "MTLALVSEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVAGATFSGSDLSGGEFSAFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTAGCGAAAAAATTGACAGAAACCGCTTCACCGGGGAAAAAGTTGAAAACAGTACTTTTTTTAACTGTGATTTTTCAGGGGCCGATCTTAGCGGCACTGAATTTATCGGCTGTCAGTTTTATGATCGCGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTTAAAAGTTGCGATTTATCCATGGCGGATTTTCGCAACGCCAGTGCCCTGGGAATTGAAATTCGCCACTGCCGCGCGCAGGGTTCAGATTTTCGCGGCGCGAGTTTTATGAACATGATCACCACGCGGACCTGGTTTTGCAGCGCATACATCACGAATACCAATCTAAGCTACGCCAACTTTTCGAAGGTTGTCCTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGAACTCAGGTAGCGGGTGCAACGTTCAGTGGATCAGATCTCTCGGGCGGTGAATTTTCAGCGTTCGACTGGCGGGCCGCAAACTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGTGTAGATTTACAAGGCGTCAAATTGGATAGCTATCAGGCAGCGTTGCTGATGGAGCGGCTTGGCATCGCGGTGATTGGCTAG", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 171, "hit_end": 642, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.84}, "gnl|BL_ORD_ID|1455|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB27", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1590", "ARO_accession": "3002742", "ARO_name": "QnrB27", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.135458, "max_identities": 15, "bit_score": 28.8758, "cvterm_id": "39584", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MTLALVSEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVAGATFSGSDLSGGEFSAFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTAGCGAAAAAATTGACAGAAACCGCTTCACCGGGGAAAAAGTTGAAAACAGTACTTTTTTTAACTGTGATTTTTCAGGGGCCGATCTTAGCGGCACTGAATTTATCGGCTGTCAGTTTTATGATCGCGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTTAAAAGTTGCGATTTATCCATGGCGGATTTTCGCAACGCCAGTGCCCTGGGAATTGAAATTCGCCACTGCCGCGCGCAGGGTTCAGATTTTCGCGGCGCGAGTTTTATGAACATGATCACCACGCGGACCTGGTTTTGCAGCGCATACATCACGAATACCAATCTAAGCTACGCCAACTTTTCGAAGGTTGTCCTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGAACTCAGGTAGCGGGTGCAACGTTCAGTGGATCAGATCTCTCGGGCGGTGAATTTTCAGCGTTCGACTGGCGGGCCGCAAACTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGTGTAGATTTACAAGGCGTCAAATTGGATAGCTATCAGGCAGCGTTGCTGATGGAGCGGCTTGGCATCGCGGTGATTGGCTAG", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 27, "hit_end": 177, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|1868|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB43", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "2028", "ARO_accession": "3002758", "ARO_name": "QnrB43", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.60441e-06, "max_identities": 38, "bit_score": 42.743, "cvterm_id": "35914", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL        +   +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G     A F   DLA  +F+  D        C LT +          D +   ++G ++    A  L + LG+ V G", "sequence_from_db": "RAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLAGGEFSTFDWRAANFTHCDLTNSELGD-----LDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLAGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTGCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGCTGCTCATGGAACGTCTTGGCATCGCGGTAATTGGTTAA", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 171, "hit_end": 642, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 23.46}, "gnl|BL_ORD_ID|1868|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB43", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "2028", "ARO_accession": "3002758", "ARO_name": "QnrB43", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.174237, "max_identities": 15, "bit_score": 28.8758, "cvterm_id": "35914", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLAGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTGCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGCTGCTCATGGAACGTCTTGGCATCGCGGTAATTGGTTAA", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 27, "hit_end": 177, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|961|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB33", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1048", "ARO_accession": "3002748", "ARO_name": "QnrB33", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.78711e-06, "max_identities": 37, "bit_score": 42.743, "cvterm_id": "39584", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL        +   +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G     A F   DL+  +F+  D        C LT +          D +   ++G ++    A  L + LG+ V G", "sequence_from_db": "RAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVAGATFSGSDLSGGEFSAFDWRAANFTHCDLTNSELGD-----LDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "sequence_from_broadstreet": "MTLALVSEKIDRNRFTGEKVENSTFFNCDFSGADLSSTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVAGATFSGSDLSGGEFSAFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTAGCGAAAAAATTGACAGAAACCGCTTCACCGGGGAAAAAGTTGAAAACAGTACTTTTTTTAACTGTGATTTTTCAGGGGCCGATCTTAGCAGCACTGAATTTATCGGCTGTCAGTTTTATGATCGCGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTTAAAAGTTGCGATTTATCCATGGCGGATTTTCGCAACGCCAGTGCCCTGGGAATTGAAATTCGCCACTGCCGCGCGCAGGGTTCAGATTTTCGCGGCGCGAGTTTTATGAACATGATCACCACGCGGACCTGGTTTTGCAGCGCATACATCACGAATACCAATCTAAGCTACGCCAACTTTTCGAAGGTTGTCCTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGAACTCAGGTAGCGGGTGCAACGTTCAGTGGATCAGATCTCTCGGGCGGTGAATTTTCAGCGTTCGACTGGCGGGCCGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGTGTAGATTTACAAGGCGTCAAATTGGATAGCTATCAGGCAGCGTTGCTGATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 171, "hit_end": 642, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.84}, "gnl|BL_ORD_ID|961|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB33", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1048", "ARO_accession": "3002748", "ARO_name": "QnrB33", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.903365, "max_identities": 14, "bit_score": 26.5646, "cvterm_id": "39584", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D + T+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTGEKVENSTFFNCDFSGADLSSTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MTLALVSEKIDRNRFTGEKVENSTFFNCDFSGADLSSTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVAGATFSGSDLSGGEFSAFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTAGCGAAAAAATTGACAGAAACCGCTTCACCGGGGAAAAAGTTGAAAACAGTACTTTTTTTAACTGTGATTTTTCAGGGGCCGATCTTAGCAGCACTGAATTTATCGGCTGTCAGTTTTATGATCGCGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTTAAAAGTTGCGATTTATCCATGGCGGATTTTCGCAACGCCAGTGCCCTGGGAATTGAAATTCGCCACTGCCGCGCGCAGGGTTCAGATTTTCGCGGCGCGAGTTTTATGAACATGATCACCACGCGGACCTGGTTTTGCAGCGCATACATCACGAATACCAATCTAAGCTACGCCAACTTTTCGAAGGTTGTCCTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGAACTCAGGTAGCGGGTGCAACGTTCAGTGGATCAGATCTCTCGGGCGGTGAATTTTCAGCGTTCGACTGGCGGGCCGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGTGTAGATTTACAAGGCGTCAAATTGGATAGCTATCAGGCAGCGTTGCTGATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 27, "hit_end": 177, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 25.45}, "gnl|BL_ORD_ID|764|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB55", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "827", "ARO_accession": "3002768", "ARO_name": "QnrB55", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.25405e-06, "max_identities": 37, "bit_score": 42.3578, "cvterm_id": "39585", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL       +    +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G     A F   DL+  +F+  D     +  C LT +          D +   ++G ++    A  L + LG+ V G", "sequence_from_db": "RANLKDAIFKSCDLSMADFRNINALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGD-----LDIRGVDLQGVKLDSYQASLLLERLGIAVMG", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQLYDRESQKGCNFSRANLKDAIFKSCDLSMADFRNINALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLLERLGIAVMG", "dna_sequence_from_broadstreet": "ATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGAAAAAGTTGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTGAGCGGCACTGAATTTATTGGCTGCCAGTTATATGATCGAGAAAGTCAGAAAGGATGTAATTTTAGTCGCGCTAACCTGAAAGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCTGATTTCAGGAATATCAATGCGCTGGGAATCGAAATTCGCCACTGCCGGGCACAAGGGTCAGATTTTCGCGGCGCAAGTTTTATGAATATGATCACCACCCGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGTACTCAGGTGCTGGGCGCAACGTTCAGTGGATCAGACCTCTCTGGCGGCGAGTTTTCATCCTTCGACTGGCGAGCAGCAAACGTTACGCACTGTGATTTGACCAATTCGGAACTGGGCGATTTAGATATCCGCGGGGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGCTCCTGGAACGTCTTGGTATCGCTGTCATGGGTTAA", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 171, "hit_end": 642, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.84}, "gnl|BL_ORD_ID|764|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB55", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "827", "ARO_accession": "3002768", "ARO_name": "QnrB55", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0330251, "max_identities": 13, "bit_score": 30.8018, "cvterm_id": "39585", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTM------QGCVLTKTNF", "match": "+ + RF G     + F + D + +D +GT+  GC +      +GC  ++ N ", "sequence_from_db": "IDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQLYDRESQKGCNFSRANL", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQLYDRESQKGCNFSRANLKDAIFKSCDLSMADFRNINALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLLERLGIAVMG", "dna_sequence_from_broadstreet": "ATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGAAAAAGTTGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTGAGCGGCACTGAATTTATTGGCTGCCAGTTATATGATCGAGAAAGTCAGAAAGGATGTAATTTTAGTCGCGCTAACCTGAAAGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCTGATTTCAGGAATATCAATGCGCTGGGAATCGAAATTCGCCACTGCCGGGCACAAGGGTCAGATTTTCGCGGCGCAAGTTTTATGAATATGATCACCACCCGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGTACTCAGGTGCTGGGCGCAACGTTCAGTGGATCAGACCTCTCTGGCGGCGAGTTTTCATCCTTCGACTGGCGAGCAGCAAACGTTACGCACTGTGATTTGACCAATTCGGAACTGGGCGATTTAGATATCCGCGGGGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGCTCCTGGAACGTCTTGGTATCGCTGTCATGGGTTAA", "partial": "0", "query_start": 8949, "query_end": 9086, "hit_start": 27, "hit_end": 183, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 25.0}, "gnl|BL_ORD_ID|764|hsp_num:2": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB55", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "827", "ARO_accession": "3002768", "ARO_name": "QnrB55", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.85674, "max_identities": 26, "bit_score": 23.8682, "cvterm_id": "39585", "query": "VFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFI", "match": "V E  D  R   EK+   + TF +    G D SG   +    +++   +  +F + NL+   F  C          DL+ +DF   +  G  ++ C    ++F R  +F+", "sequence_from_db": "VGEKIDRNRFTGEKV--ENSTFFNCDFSGADLSGTEFIGCQLYDRESQKGCNFSRANLKDAIFKSC----------DLSMADFRNINALGIEIRHCRAQGSDF-RGASFM", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQLYDRESQKGCNFSRANLKDAIFKSCDLSMADFRNINALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLLERLGIAVMG", "dna_sequence_from_broadstreet": "ATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGAAAAAGTTGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTGAGCGGCACTGAATTTATTGGCTGCCAGTTATATGATCGAGAAAGTCAGAAAGGATGTAATTTTAGTCGCGCTAACCTGAAAGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCTGATTTCAGGAATATCAATGCGCTGGGAATCGAAATTCGCCACTGCCGGGCACAAGGGTCAGATTTTCGCGGCGCAAGTTTTATGAATATGATCACCACCCGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGTACTCAGGTGCTGGGCGCAACGTTCAGTGGATCAGACCTCTCTGGCGGCGAGTTTTCATCCTTCGACTGGCGAGCAGCAAACGTTACGCACTGTGATTTGACCAATTCGGAACTGGGCGATTTAGATATCCGCGGGGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGCTCCTGGAACGTCTTGGTATCGCTGTCATGGGTTAA", "partial": "0", "query_start": 8778, "query_end": 9107, "hit_start": 15, "hit_end": 306, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 23.64}, "gnl|BL_ORD_ID|1568|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB4", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1707", "ARO_accession": "3002718", "ARO_name": "QnrB4", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.2857e-06, "max_identities": 37, "bit_score": 42.3578, "cvterm_id": "35914", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL       +    +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G     A F   DL+  +F+  D     +  C LT +          D +   ++G ++    A  L + LG+ V G", "sequence_from_db": "RANLKDAIFKSCDLSMADFRNINALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGD-----LDIRGVDLQGVKLDSYQASLLLERLGIAVMG", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRANLKDAIFKSCDLSMADFRNINALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLLERLGIAVMG", "dna_sequence_from_broadstreet": "ATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGAAAAAGTTGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTTAGCGGCACTGAATTTATTGGCTGCCAGTTTTATGATCGAGAAAGTCAGAAAGGATGTAATTTTAGTCGCGCTAACCTGAAAGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCTGATTTCAGGAATATCAATGCGCTGGGAATCGAAATTCGCCACTGCCGGGCACAAGGGTCAGATTTTCGCGGCGCAAGTTTTATGAATATGATCACCACCCGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGTACTCAGGTGCTGGGCGCAACGTTCAGTGGATCAGACCTCTCTGGCGGCGAGTTTTCATCCTTCGACTGGCGAGCAGCAAACGTTACGCACTGTGATTTGACCAATTCGGAACTGGGCGATTTAGATATCCGCGGGGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGCTCCTGGAACGTCTTGGTATCGCTGTCATGGGTTAA", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 171, "hit_end": 642, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.84}, "gnl|BL_ORD_ID|1568|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB4", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1707", "ARO_accession": "3002718", "ARO_name": "QnrB4", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0373006, "max_identities": 13, "bit_score": 30.8018, "cvterm_id": "35914", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTN", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC  ++ N", "sequence_from_db": "IDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAN", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRANLKDAIFKSCDLSMADFRNINALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLLERLGIAVMG", "dna_sequence_from_broadstreet": "ATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGAAAAAGTTGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTTAGCGGCACTGAATTTATTGGCTGCCAGTTTTATGATCGAGAAAGTCAGAAAGGATGTAATTTTAGTCGCGCTAACCTGAAAGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCTGATTTCAGGAATATCAATGCGCTGGGAATCGAAATTCGCCACTGCCGGGCACAAGGGTCAGATTTTCGCGGCGCAAGTTTTATGAATATGATCACCACCCGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGTACTCAGGTGCTGGGCGCAACGTTCAGTGGATCAGACCTCTCTGGCGGCGAGTTTTCATCCTTCGACTGGCGAGCAGCAAACGTTACGCACTGTGATTTGACCAATTCGGAACTGGGCGATTTAGATATCCGCGGGGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGCTCCTGGAACGTCTTGGTATCGCTGTCATGGGTTAA", "partial": "0", "query_start": 8949, "query_end": 9083, "hit_start": 27, "hit_end": 180, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 25.49}, "gnl|BL_ORD_ID|529|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB19", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "581", "ARO_accession": "3002734", "ARO_name": "QnrB19", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.44858e-06, "max_identities": 37, "bit_score": 42.3578, "cvterm_id": "35914", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL       ++   +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G     A F   DL+  +F+  D        C LT +          D +   ++G ++    A  L + LG+ V G", "sequence_from_db": "RAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGD-----LDIRGVDLQGVKLDSYQASLLMERLGIAVIG", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGGTGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGTGCCTTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACTAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAGCTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 171, "hit_end": 642, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.84}, "gnl|BL_ORD_ID|529|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB19", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "581", "ARO_accession": "3002734", "ARO_name": "QnrB19", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.132955, "max_identities": 15, "bit_score": 29.261, "cvterm_id": "35914", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGGTGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGTGCCTTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACTAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAGCTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 27, "hit_end": 177, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|323|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB24", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "354", "ARO_accession": "3002739", "ARO_name": "QnrB24", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.53673e-06, "max_identities": 37, "bit_score": 42.3578, "cvterm_id": "36915", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL  +     +   +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G     A F   DL+  +F+  D        C LT +          D +   ++G ++    A  L + LG+ V G", "sequence_from_db": "RAMLKDAIFKSCDLSMVDFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGD-----LDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADMSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMVDFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCACTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACATGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGTGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTGATTGGCTAG", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 207, "hit_end": 678, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.84}, "gnl|BL_ORD_ID|323|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB24", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "354", "ARO_accession": "3002739", "ARO_name": "QnrB24", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.203349, "max_identities": 15, "bit_score": 28.4906, "cvterm_id": "36915", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTGEKIENSTFFNCDFSGADMSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADMSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMVDFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCACTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACATGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGTGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTGATTGGCTAG", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 63, "hit_end": 213, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|703|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB7", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "765", "ARO_accession": "3002721", "ARO_name": "QnrB7", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.6902e-06, "max_identities": 37, "bit_score": 42.3578, "cvterm_id": "36884", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL        +   +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G     A F   DL+  +FT  D        C LT +          D +   ++G ++    A  L + LG+ + G", "sequence_from_db": "RAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFTTFDWRAANFTHCDLTNSELGD-----LDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFTTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTAAGTGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTACGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 171, "hit_end": 642, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.84}, "gnl|BL_ORD_ID|703|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB7", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "765", "ARO_accession": "3002721", "ARO_name": "QnrB7", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.175869, "max_identities": 15, "bit_score": 28.8758, "cvterm_id": "36884", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFTTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTAAGTGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTACGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 27, "hit_end": 177, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|1009|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB29", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1102", "ARO_accession": "3002744", "ARO_name": "QnrB29", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.78336e-06, "max_identities": 37, "bit_score": 42.3578, "cvterm_id": "36915", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL  +     +   +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G     A F   DL+  +F+  D        C LT +          D +   ++G ++    A  L + LG+ V G", "sequence_from_db": "RAMLKDAIFKSCDLSMVDFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGD-----LDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMVDFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCACTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGTGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTGATTGGCTAG", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 207, "hit_end": 678, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.84}, "gnl|BL_ORD_ID|1009|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB29", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1102", "ARO_accession": "3002744", "ARO_name": "QnrB29", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.16417, "max_identities": 15, "bit_score": 28.8758, "cvterm_id": "36915", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMVDFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCACTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGTGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTGATTGGCTAG", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 63, "hit_end": 213, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|1153|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB68", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1257", "ARO_accession": "3002780", "ARO_name": "QnrB68", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.87304e-06, "max_identities": 37, "bit_score": 42.3578, "cvterm_id": "39584", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL       ++   +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G     A F   DL+  +F+  D        C LT +          D +   ++G ++    A  L + LG+ V G", "sequence_from_db": "RAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVMGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGD-----LDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVMGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTAATGGGTGCGACGTTTAGTGGTTCAGATCTCTCCGGTGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 171, "hit_end": 642, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.84}, "gnl|BL_ORD_ID|1153|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB68", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1257", "ARO_accession": "3002780", "ARO_name": "QnrB68", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.135458, "max_identities": 15, "bit_score": 28.8758, "cvterm_id": "39584", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVMGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTAATGGGTGCGACGTTTAGTGGTTCAGATCTCTCCGGTGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 27, "hit_end": 177, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|1668|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB5", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1809", "ARO_accession": "3002719", "ARO_name": "QnrB5", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.20597e-06, "max_identities": 36, "bit_score": 42.3578, "cvterm_id": "35665", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL       ++   +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G     A F   DL+  +F+  D        C LT +          D +   ++G ++    A  L + LG+ + G", "sequence_from_db": "RAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGD-----LDIRGVDLQGVKLDSYQASLLMERLGIAIIG", "sequence_from_broadstreet": "MTPLLYKNTGIDMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAACACAGGCATAGATATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGGTGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGTGCCTTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACTAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAGCTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 207, "hit_end": 678, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.22}, "gnl|BL_ORD_ID|1668|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB5", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1809", "ARO_accession": "3002719", "ARO_name": "QnrB5", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.131292, "max_identities": 15, "bit_score": 29.261, "cvterm_id": "35665", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MTPLLYKNTGIDMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAACACAGGCATAGATATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGGTGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGTGCCTTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACTAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAGCTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 63, "hit_end": 213, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|1717|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrVC7", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1859", "ARO_accession": "3003193", "ARO_name": "QnrVC7", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.26434e-06, "max_identities": 35, "bit_score": 42.3578, "cvterm_id": "36789", "query": "SRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQ---------FEQCDLRYSSFL-----KLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVV", "match": "S L D  F+ C L     +      + F++  L G +++    M  V             C+L Y++F      K +L + R++G +    +F + DL+   F+      C +QGC L+ +       +  DP+   + G ++       L + LG++V", "sequence_from_db": "SDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFAQASFMNQVSNRMYFCSAYITGCNLSYANFERQCIEKCDLFENRWIGANLSGTSFKESDLSRGVFSEGCWSQCRLQGCDLSHSEL-----YGLDPRKVDLTGVKICSWQQEQLLEQLGLIV", "sequence_from_broadstreet": "MDKTDQLYVQADFSHQDLSGQYFKNCKFFCCSFKRANLRDTQFVDCSFIERGELEGCDFSYSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFAQASFMNQVSNRMYFCSAYITGCNLSYANFERQCIEKCDLFENRWIGANLSGTSFKESDLSRGVFSEGCWSQCRLQGCDLSHSELYGLDPRKVDLTGVKICSWQQEQLLEQLGLIVVPD", "dna_sequence_from_broadstreet": "ATGGATAAAACAGACCAGTTATATGTACAAGCTGACTTTTCACATCAAGACTTGAGTGGTCAGTATTTTAAAAATTGCAAATTTTTCTGCTGTTCCTTTAAACGGGCAAACCTCCGCGATACACAATTTGTAGATTGTTCTTTCATTGAACGAGGAGAATTAGAGGGGTGTGATTTTTCTTACTCGGATCTTAGAGACGCATCTTTTAAAAACTGCAGTCTTTCAATGTCGTATTTCAAAGGTGCAAATTGTTTTGGTATCGAGTTCAGAGAGTGCGATTTAAAGGGGGCAAATTTTGCTCAAGCTAGCTTCATGAATCAGGTATCGAACAGAATGTATTTTTGTTCAGCCTATATAACAGGTTGTAATCTGTCATACGCAAATTTTGAAAGGCAGTGTATCGAAAAGTGTGATTTGTTTGAGAATAGATGGATTGGTGCAAATTTGAGTGGGACATCATTTAAAGAGTCTGATTTAAGTCGGGGAGTATTTTCTGAAGGGTGCTGGAGCCAGTGTAGGTTGCAAGGTTGTGATTTGAGCCACTCGGAGCTGTATGGTTTAGACCCCCGGAAAGTTGACCTTACAGGTGTAAAAATCTGTTCGTGGCAACAAGAACAACTTTTAGAGCAATTAGGTTTAATAGTAGTTCCTGACTAA", "partial": "0", "query_start": 8760, "query_end": 9194, "hit_start": 183, "hit_end": 645, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.01}, "gnl|BL_ORD_ID|1717|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrVC7", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1859", "ARO_accession": "3003193", "ARO_name": "QnrVC7", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000196855, "max_identities": 25, "bit_score": 37.3502, "cvterm_id": "36789", "query": "FEQCDLRYSSFLKLNLRKTRFVGCS----------------AREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARST", "match": "F+ C     SF + NLR T+FV CS                 R+A+F +  L+ S F G +  G   + C L   NFA+++", "sequence_from_db": "FKNCKFFCCSFKRANLRDTQFVDCSFIERGELEGCDFSYSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFAQAS", "sequence_from_broadstreet": "MDKTDQLYVQADFSHQDLSGQYFKNCKFFCCSFKRANLRDTQFVDCSFIERGELEGCDFSYSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFAQASFMNQVSNRMYFCSAYITGCNLSYANFERQCIEKCDLFENRWIGANLSGTSFKESDLSRGVFSEGCWSQCRLQGCDLSHSELYGLDPRKVDLTGVKICSWQQEQLLEQLGLIVVPD", "dna_sequence_from_broadstreet": "ATGGATAAAACAGACCAGTTATATGTACAAGCTGACTTTTCACATCAAGACTTGAGTGGTCAGTATTTTAAAAATTGCAAATTTTTCTGCTGTTCCTTTAAACGGGCAAACCTCCGCGATACACAATTTGTAGATTGTTCTTTCATTGAACGAGGAGAATTAGAGGGGTGTGATTTTTCTTACTCGGATCTTAGAGACGCATCTTTTAAAAACTGCAGTCTTTCAATGTCGTATTTCAAAGGTGCAAATTGTTTTGGTATCGAGTTCAGAGAGTGCGATTTAAAGGGGGCAAATTTTGCTCAAGCTAGCTTCATGAATCAGGTATCGAACAGAATGTATTTTTGTTCAGCCTATATAACAGGTTGTAATCTGTCATACGCAAATTTTGAAAGGCAGTGTATCGAAAAGTGTGATTTGTTTGAGAATAGATGGATTGGTGCAAATTTGAGTGGGACATCATTTAAAGAGTCTGATTTAAGTCGGGGAGTATTTTCTGAAGGGTGCTGGAGCCAGTGTAGGTTGCAAGGTTGTGATTTGAGCCACTCGGAGCTGTATGGTTTAGACCCCCGGAAAGTTGACCTTACAGGTGTAAAAATCTGTTCGTGGCAACAAGAACAACTTTTAGAGCAATTAGGTTTAATAGTAGTTCCTGACTAA", "partial": "0", "query_start": 8904, "query_end": 9098, "hit_start": 66, "hit_end": 309, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 30.86}, "gnl|BL_ORD_ID|1717|hsp_num:2": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrVC7", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1859", "ARO_accession": "3003193", "ARO_name": "QnrVC7", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0177951, "max_identities": 24, "bit_score": 31.5722, "cvterm_id": "36789", "query": "ALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFT--------GTDMPGCT--MQGCVLTKTNFAR", "match": "+ +    +DT+ +   +   G +    F   DLR +SF   +L  + F G +     F + DL  ++F            M  C+  + GC L+  NF R", "sequence_from_db": "SFKRANLRDTQFVDCSFIERGELEGCDFSYSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFAQASFMNQVSNRMYFCSAYITGCNLSYANFER", "sequence_from_broadstreet": "MDKTDQLYVQADFSHQDLSGQYFKNCKFFCCSFKRANLRDTQFVDCSFIERGELEGCDFSYSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFAQASFMNQVSNRMYFCSAYITGCNLSYANFERQCIEKCDLFENRWIGANLSGTSFKESDLSRGVFSEGCWSQCRLQGCDLSHSELYGLDPRKVDLTGVKICSWQQEQLLEQLGLIVVPD", "dna_sequence_from_broadstreet": "ATGGATAAAACAGACCAGTTATATGTACAAGCTGACTTTTCACATCAAGACTTGAGTGGTCAGTATTTTAAAAATTGCAAATTTTTCTGCTGTTCCTTTAAACGGGCAAACCTCCGCGATACACAATTTGTAGATTGTTCTTTCATTGAACGAGGAGAATTAGAGGGGTGTGATTTTTCTTACTCGGATCTTAGAGACGCATCTTTTAAAAACTGCAGTCTTTCAATGTCGTATTTCAAAGGTGCAAATTGTTTTGGTATCGAGTTCAGAGAGTGCGATTTAAAGGGGGCAAATTTTGCTCAAGCTAGCTTCATGAATCAGGTATCGAACAGAATGTATTTTTGTTCAGCCTATATAACAGGTTGTAATCTGTCATACGCAAATTTTGAAAGGCAGTGTATCGAAAAGTGTGATTTGTTTGAGAATAGATGGATTGGTGCAAATTTGAGTGGGACATCATTTAAAGAGTCTGATTTAAGTCGGGGAGTATTTTCTGAAGGGTGCTGGAGCCAGTGTAGGTTGCAAGGTTGTGATTTGAGCCACTCGGAGCTGTATGGTTTAGACCCCCGGAAAGTTGACCTTACAGGTGTAAAAATCTGTTCGTGGCAACAAGAACAACTTTTAGAGCAATTAGGTTTAATAGTAGTTCCTGACTAA", "partial": "0", "query_start": 8823, "query_end": 9092, "hit_start": 93, "hit_end": 393, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 24.0}, "gnl|BL_ORD_ID|1717|hsp_num:3": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrVC7", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1859", "ARO_accession": "3003193", "ARO_name": "QnrVC7", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.413561, "max_identities": 20, "bit_score": 27.7202, "cvterm_id": "36789", "query": "DVQFEQCDLRYSSFLKLNLRKTRFVGCSAREAN-----FIDVDLAE------SDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVG", "match": "D  + Q D  +        +  +F  CS + AN     F+D    E       DF+ +D+   + + C L+ + F  +  F  + +   +KG    ", "sequence_from_db": "DQLYVQADFSHQDLSGQYFKNCKFFCCSFKRANLRDTQFVDCSFIERGELEGCDFSYSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFA", "sequence_from_broadstreet": "MDKTDQLYVQADFSHQDLSGQYFKNCKFFCCSFKRANLRDTQFVDCSFIERGELEGCDFSYSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFAQASFMNQVSNRMYFCSAYITGCNLSYANFERQCIEKCDLFENRWIGANLSGTSFKESDLSRGVFSEGCWSQCRLQGCDLSHSELYGLDPRKVDLTGVKICSWQQEQLLEQLGLIVVPD", "dna_sequence_from_broadstreet": "ATGGATAAAACAGACCAGTTATATGTACAAGCTGACTTTTCACATCAAGACTTGAGTGGTCAGTATTTTAAAAATTGCAAATTTTTCTGCTGTTCCTTTAAACGGGCAAACCTCCGCGATACACAATTTGTAGATTGTTCTTTCATTGAACGAGGAGAATTAGAGGGGTGTGATTTTTCTTACTCGGATCTTAGAGACGCATCTTTTAAAAACTGCAGTCTTTCAATGTCGTATTTCAAAGGTGCAAATTGTTTTGGTATCGAGTTCAGAGAGTGCGATTTAAAGGGGGCAAATTTTGCTCAAGCTAGCTTCATGAATCAGGTATCGAACAGAATGTATTTTTGTTCAGCCTATATAACAGGTTGTAATCTGTCATACGCAAATTTTGAAAGGCAGTGTATCGAAAAGTGTGATTTGTTTGAGAATAGATGGATTGGTGCAAATTTGAGTGGGACATCATTTAAAGAGTCTGATTTAAGTCGGGGAGTATTTTCTGAAGGGTGCTGGAGCCAGTGTAGGTTGCAAGGTTGTGATTTGAGCCACTCGGAGCTGTATGGTTTAGACCCCCGGAAAGTTGACCTTACAGGTGTAAAAATCTGTTCGTGGCAACAAGAACAACTTTTAGAGCAATTAGGTTTAATAGTAGTTCCTGACTAA", "partial": "0", "query_start": 8895, "query_end": 9149, "hit_start": 12, "hit_end": 300, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 20.83}, "gnl|BL_ORD_ID|1084|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB22", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1174", "ARO_accession": "3002737", "ARO_name": "QnrB22", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.3285e-06, "max_identities": 37, "bit_score": 42.3578, "cvterm_id": "39583", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL       +    +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G     A F   DL+  +F+  D     +  C LT +          D +   ++G ++    A  L + LG+ V G", "sequence_from_db": "RANLKDAIFKSCDLSMADFRNINALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGD-----LDIRVVDLQGVKLDSYQASLLLERLGIAVMG", "sequence_from_broadstreet": "MMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLCGTEFIGCQFYDRESQKGCNFSRANLKDAIFKSCDLSMADFRNINALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGDLDIRVVDLQGVKLDSYQASLLLERLGIAVMG", "dna_sequence_from_broadstreet": "ATGATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGAAAAAGTCGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTTTGCGGTACTGAATTTATTGGCTGCCAGTTTTATGATCGAGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCTAACCTGAAGGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCGGATTTCAGAAATATCAATGCGCTGGGAATCGAAATTCGCCACTGCCGGGCACAAGGGTCAGATTTTCGCGGCGCAAGCTTTATGAATATGATCACCACCCGCACCTGGTTTTGTAGCGCTTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCTAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAGAACCGCTGGATGGGTACTCAGGTGCTGGGCGCAACGTTCAGTGGATCAGACCTCTCTGGCGGCGAGTTTTCATCCTTCGACTGGCGAGCAGCAAACGTAACGCACTGTGATTTGACCAATTCGGAACTGGGCGATTTAGATATCCGGGTAGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGCTCCTGGAACGTCTTGGTATCGCTGTCATGGGTTAA", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 174, "hit_end": 645, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.84}, "gnl|BL_ORD_ID|1084|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB22", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1174", "ARO_accession": "3002737", "ARO_name": "QnrB22", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.090884, "max_identities": 13, "bit_score": 29.6462, "cvterm_id": "39583", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTN", "match": "+ + RF G     + F + D + +D  GT+  GC      + +GC  ++ N", "sequence_from_db": "IDRNRFTGEKVENSTFFNCDFSGADLCGTEFIGCQFYDRESQKGCNFSRAN", "sequence_from_broadstreet": "MMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLCGTEFIGCQFYDRESQKGCNFSRANLKDAIFKSCDLSMADFRNINALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGDLDIRVVDLQGVKLDSYQASLLLERLGIAVMG", "dna_sequence_from_broadstreet": "ATGATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGAAAAAGTCGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTTTGCGGTACTGAATTTATTGGCTGCCAGTTTTATGATCGAGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCTAACCTGAAGGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCGGATTTCAGAAATATCAATGCGCTGGGAATCGAAATTCGCCACTGCCGGGCACAAGGGTCAGATTTTCGCGGCGCAAGCTTTATGAATATGATCACCACCCGCACCTGGTTTTGTAGCGCTTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCTAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAGAACCGCTGGATGGGTACTCAGGTGCTGGGCGCAACGTTCAGTGGATCAGACCTCTCTGGCGGCGAGTTTTCATCCTTCGACTGGCGAGCAGCAAACGTAACGCACTGTGATTTGACCAATTCGGAACTGGGCGATTTAGATATCCGGGTAGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGCTCCTGGAACGTCTTGGTATCGCTGTCATGGGTTAA", "partial": "0", "query_start": 8949, "query_end": 9083, "hit_start": 30, "hit_end": 183, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 25.49}, "gnl|BL_ORD_ID|1886|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB72", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "2049", "ARO_accession": "3002784", "ARO_name": "QnrB72", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.34951e-06, "max_identities": 37, "bit_score": 42.3578, "cvterm_id": "39586", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFE---------QCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL       ++   +  +  R  G D+ G   M  +              +L Y++F K+ L K      R++G     A F   DL+  +F+  D        C LT +          D +   ++G ++    A  L + LG+ V G", "sequence_from_db": "RAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITMRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGD-----LDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "sequence_from_broadstreet": "MTLALVCEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITMRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTTGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCATGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTTAGTGGTTCAGATCTCTCCGGTGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 171, "hit_end": 642, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.84}, "gnl|BL_ORD_ID|1886|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB72", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "2049", "ARO_accession": "3002784", "ARO_name": "QnrB72", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.139302, "max_identities": 15, "bit_score": 28.8758, "cvterm_id": "39586", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MTLALVCEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITMRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTTGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCATGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTTAGTGGTTCAGATCTCTCCGGTGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 27, "hit_end": 177, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|120|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB10", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "139", "ARO_accession": "3002724", "ARO_name": "QnrB10", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.45598e-06, "max_identities": 37, "bit_score": 42.3578, "cvterm_id": "36915", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDV---------QFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL       ++   +  +  R  G D+ G   M  +              +L Y++F K+ L K      R++G     A F   DL+  +F+  D        C LT +          D +   ++G ++    A  L + LG+ V G", "sequence_from_db": "RAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGD-----LDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "sequence_from_broadstreet": "MLSLLYKNTGIDMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGTTGTCATTACTGTATAAAAACACAGGCATAGATATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGGTGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGTCGCGCACAAGGCGCAGATTTTCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCCGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGACTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 207, "hit_end": 678, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.84}, "gnl|BL_ORD_ID|120|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB10", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "139", "ARO_accession": "3002724", "ARO_name": "QnrB10", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.132521, "max_identities": 15, "bit_score": 29.261, "cvterm_id": "36915", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MLSLLYKNTGIDMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGTTGTCATTACTGTATAAAAACACAGGCATAGATATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGGTGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGTCGCGCACAAGGCGCAGATTTTCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCCGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGACTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 63, "hit_end": 213, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|863|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB70", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "938", "ARO_accession": "3002782", "ARO_name": "QnrB70", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.56487e-06, "max_identities": 37, "bit_score": 41.9726, "cvterm_id": "39584", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL       ++   +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G     A F   DL+  +F+  D        C LT +          D +   ++G ++    A  L + LG+ V G", "sequence_from_db": "RAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGD-----LDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "sequence_from_broadstreet": "MTLVLVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGTATTAGTAGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTTAGTGGTTCAGATCTCTCCGGTGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 171, "hit_end": 642, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.84}, "gnl|BL_ORD_ID|863|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB70", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "938", "ARO_accession": "3002782", "ARO_name": "QnrB70", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.129286, "max_identities": 15, "bit_score": 29.261, "cvterm_id": "39584", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MTLVLVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGTATTAGTAGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTTAGTGGTTCAGATCTCTCCGGTGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 27, "hit_end": 177, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|349|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB61", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "382", "ARO_accession": "3002774", "ARO_name": "QnrB61", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.56487e-06, "max_identities": 37, "bit_score": 41.9726, "cvterm_id": "39584", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL       ++   +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G     A F   DL+  +F+  D        C LT +          D +   ++G ++    A  L + LG+ V G", "sequence_from_db": "RAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGD-----LDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTSEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCAGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 171, "hit_end": 642, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.84}, "gnl|BL_ORD_ID|349|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB61", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "382", "ARO_accession": "3002774", "ARO_name": "QnrB61", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.911782, "max_identities": 14, "bit_score": 26.5646, "cvterm_id": "39584", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF       + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTSEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTSEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCAGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 27, "hit_end": 177, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 25.45}, "gnl|BL_ORD_ID|1506|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB57", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1636", "ARO_accession": "3002770", "ARO_name": "QnrB57", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.6756e-06, "max_identities": 36, "bit_score": 41.9726, "cvterm_id": "36915", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL        +   +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G     A F   DL+  +F+  D        C LT +          D +   ++G ++    A  L + LG+ + G", "sequence_from_db": "RAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGN-----LDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGNLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTAACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGCTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 207, "hit_end": 678, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.22}, "gnl|BL_ORD_ID|1506|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB57", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1636", "ARO_accession": "3002770", "ARO_name": "QnrB57", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.165705, "max_identities": 15, "bit_score": 28.8758, "cvterm_id": "36915", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGNLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTAACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGCTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 63, "hit_end": 213, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|1453|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB50", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1588", "ARO_accession": "3002765", "ARO_name": "QnrB50", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.79085e-06, "max_identities": 37, "bit_score": 41.9726, "cvterm_id": "36915", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL       ++   +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G     A F   DL+  +F+  D        C LT +          D +   ++G ++    A  L + LG+ V G", "sequence_from_db": "RAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGD-----LDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "sequence_from_broadstreet": "MTLALVGEKIDRKRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAAGCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 171, "hit_end": 642, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.84}, "gnl|BL_ORD_ID|1453|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB50", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1588", "ARO_accession": "3002765", "ARO_name": "QnrB50", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.171019, "max_identities": 15, "bit_score": 28.8758, "cvterm_id": "36915", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRKRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MTLALVGEKIDRKRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAAGCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 27, "hit_end": 177, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|354|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB71", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "388", "ARO_accession": "3002783", "ARO_name": "QnrB71", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.93175e-06, "max_identities": 37, "bit_score": 41.9726, "cvterm_id": "39584", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL       ++   +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G     A F   DL+  +F+  D        C LT +          D +   ++G ++    A  L + LG+ V G", "sequence_from_db": "RAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGD-----LDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "sequence_from_broadstreet": "MTLALVGEKIGRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGGCAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 171, "hit_end": 642, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.84}, "gnl|BL_ORD_ID|354|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB71", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "388", "ARO_accession": "3002783", "ARO_name": "QnrB71", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.140608, "max_identities": 15, "bit_score": 28.8758, "cvterm_id": "39584", "query": "KTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "RNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MTLALVGEKIGRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGGCAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 8955, "query_end": 9095, "hit_start": 33, "hit_end": 177, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 28.3}, "gnl|BL_ORD_ID|1549|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB67", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1683", "ARO_accession": "3002779", "ARO_name": "QnrB67", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.02796e-06, "max_identities": 37, "bit_score": 41.9726, "cvterm_id": "39584", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL       ++   +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G     A F   DL+  +F+  D        C LT +          D +   ++G ++    A  L + LG+ V G", "sequence_from_db": "RAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGD-----LDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "sequence_from_broadstreet": "MTLALVCEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTTGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAACTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACTAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 171, "hit_end": 642, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.84}, "gnl|BL_ORD_ID|1549|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB67", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1683", "ARO_accession": "3002779", "ARO_name": "QnrB67", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.140608, "max_identities": 15, "bit_score": 28.8758, "cvterm_id": "39584", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MTLALVCEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTTGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAACTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACTAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 27, "hit_end": 177, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|787|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB62", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "852", "ARO_accession": "3002775", "ARO_name": "QnrB62", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.50613e-06, "max_identities": 36, "bit_score": 41.9726, "cvterm_id": "36915", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL       ++   +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G     A F   DL+  +F+  D        C LT +          D +   ++G ++    A  L + LG+ + G", "sequence_from_db": "RAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGD-----LDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "sequence_from_broadstreet": "MTPLLYKNTGIDMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAACACAGGCATAGATATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAAAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTTAGTGGTTCAGATCTCTCCGGTGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGACTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 207, "hit_end": 678, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.22}, "gnl|BL_ORD_ID|787|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB62", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "852", "ARO_accession": "3002775", "ARO_name": "QnrB62", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.132521, "max_identities": 15, "bit_score": 29.261, "cvterm_id": "36915", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MTPLLYKNTGIDMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAACACAGGCATAGATATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAAAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTTAGTGGTTCAGATCTCTCCGGTGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGACTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 63, "hit_end": 213, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|377|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB6", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "417", "ARO_accession": "3002720", "ARO_name": "QnrB6", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.66726e-06, "max_identities": 37, "bit_score": 41.9726, "cvterm_id": "36950", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL        +   +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G     A F   DL+  +F+  D        C LT +          D +   ++G ++    A  L + LG+ V G", "sequence_from_db": "RAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGD-----LDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 207, "hit_end": 678, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.84}, "gnl|BL_ORD_ID|377|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB6", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "417", "ARO_accession": "3002720", "ARO_name": "QnrB6", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.170397, "max_identities": 15, "bit_score": 28.8758, "cvterm_id": "36950", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 63, "hit_end": 213, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|779|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB14", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "843", "ARO_accession": "3002728", "ARO_name": "QnrB14", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.06173e-06, "max_identities": 36, "bit_score": 41.9726, "cvterm_id": "36915", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL        +   +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G     A F   DL+  +F+  D        C LT +          D +   ++G ++    A  L + LG+ + G", "sequence_from_db": "RAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGD-----LDIRGVDLQGVKLDNYQASLLTERLGIAIIG", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIDNSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLTERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTCGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGATAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATCTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGGGACTTAGATATTCGGGGCGTTGATTTACAGGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCACGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 207, "hit_end": 678, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.22}, "gnl|BL_ORD_ID|779|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB14", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "843", "ARO_accession": "3002728", "ARO_name": "QnrB14", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.292225, "max_identities": 15, "bit_score": 28.1054, "cvterm_id": "36915", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTGEKIDNSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIDNSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLTERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTCGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGATAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATCTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGGGACTTAGATATTCGGGGCGTTGATTTACAGGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCACGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 63, "hit_end": 213, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|490|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB59", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "539", "ARO_accession": "3002772", "ARO_name": "QnrB59", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.12027e-06, "max_identities": 36, "bit_score": 41.9726, "cvterm_id": "36915", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL       ++   +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G     A F   DL+  +F+  D        C LT +          D +   ++G ++    A  L + LG+ + G", "sequence_from_db": "RAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGD-----LDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "sequence_from_broadstreet": "MLSLLYKNTGIDMTLALVGEKIDRNRFTSEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGTTGTCATTACTGTATAAAAACACAGGCATAGATATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCAGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACACGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 207, "hit_end": 678, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.22}, "gnl|BL_ORD_ID|490|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB59", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "539", "ARO_accession": "3002772", "ARO_name": "QnrB59", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.849293, "max_identities": 14, "bit_score": 26.5646, "cvterm_id": "36915", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF       + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTSEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MLSLLYKNTGIDMTLALVGEKIDRNRFTSEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGTTGTCATTACTGTATAAAAACACAGGCATAGATATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCAGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACACGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 63, "hit_end": 213, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 25.45}, "gnl|BL_ORD_ID|99|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB18", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "116", "ARO_accession": "3002733", "ARO_name": "QnrB18", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.12027e-06, "max_identities": 37, "bit_score": 41.9726, "cvterm_id": "36915", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL        +   +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G     A F   DL+  +F+  D        C LT +          D +   ++G ++    A  L + LG+ V G", "sequence_from_db": "RAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGD-----LDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIDNSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGATAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGGGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAGCGACTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 207, "hit_end": 678, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.84}, "gnl|BL_ORD_ID|99|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB18", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "116", "ARO_accession": "3002733", "ARO_name": "QnrB18", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.289522, "max_identities": 15, "bit_score": 28.1054, "cvterm_id": "36915", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTGEKIDNSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIDNSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGATAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGGGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAGCGACTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 63, "hit_end": 213, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|244|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB36", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "272", "ARO_accession": "3002751", "ARO_name": "QnrB36", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.15831e-06, "max_identities": 37, "bit_score": 41.5874, "cvterm_id": "36915", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL       ++   +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G     A F   DL+  +F+  D        C LT +          D +   ++G ++    A  L + LG+ V G", "sequence_from_db": "RAMLKDTIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGD-----LDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDTIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATACCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 171, "hit_end": 642, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.84}, "gnl|BL_ORD_ID|244|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB36", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "272", "ARO_accession": "3002751", "ARO_name": "QnrB36", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.135458, "max_identities": 15, "bit_score": 28.8758, "cvterm_id": "36915", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDTIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATACCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 27, "hit_end": 177, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|1346|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB26", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1470", "ARO_accession": "3002741", "ARO_name": "QnrB26", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.36012e-06, "max_identities": 37, "bit_score": 41.5874, "cvterm_id": "36943", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL        +   +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G     A F   DL+  +F+  D        C LT +          D +   ++G ++    A  L + LG+ V G", "sequence_from_db": "RAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGD-----LDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGVKIDRNRFTGEKIENGTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGTAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATGGTACATTTTTTAATTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCGAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 207, "hit_end": 678, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.84}, "gnl|BL_ORD_ID|1346|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB26", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1470", "ARO_accession": "3002741", "ARO_name": "QnrB26", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.158169, "max_identities": 15, "bit_score": 28.8758, "cvterm_id": "36943", "query": "SFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + + + + RF G       F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "ALVGVKIDRNRFTGEKIENGTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGVKIDRNRFTGEKIENGTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGTAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATGGTACATTTTTTAATTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCGAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 8931, "query_end": 9095, "hit_start": 45, "hit_end": 213, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 24.59}, "gnl|BL_ORD_ID|212|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrS8", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "234", "ARO_accession": "3002797", "ARO_name": "QnrS8", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.51832e-06, "max_identities": 32, "bit_score": 41.5874, "cvterm_id": "35915", "query": "LEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGV-DWSG----LGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCT--MQGCVLTKTNFAR", "match": "L D  F  C L+R    +  LR  TF + + +   D  G    +  + D  F+QC L  ++F   N     F  C  + ANF   + A        M  C+  + GC L+  N  R", "sequence_from_db": "LSDLTFTACTLIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQ--VSNRMYFCSAFISGCNLSYANMER", "sequence_from_broadstreet": "METYNHTYRHHNFSHKDLSDLTFTACTLIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACAATCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCACCGCTTGCACACTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 8766, "query_end": 9092, "hit_start": 51, "hit_end": 393, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.59}, "gnl|BL_ORD_ID|212|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrS8", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "234", "ARO_accession": "3002797", "ARO_name": "QnrS8", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.065e-05, "max_identities": 28, "bit_score": 41.2022, "cvterm_id": "35915", "query": "MPDVQFEQCDLRYSSFLKLNLRKTRFVGCS----------------AREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNF", "match": "+ D+ F  C L  S F + NLR T FV C                  R+A+F    LA ++F+  +  G   + C L   NF+R TNF", "sequence_from_db": "LSDLTFTACTLIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSR-TNF", "sequence_from_broadstreet": "METYNHTYRHHNFSHKDLSDLTFTACTLIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACAATCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCACCGCTTGCACACTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 8889, "query_end": 9104, "hit_start": 51, "hit_end": 312, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 31.82}, "gnl|BL_ORD_ID|48|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB47", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "58", "ARO_accession": "3002762", "ARO_name": "QnrB47", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.848e-06, "max_identities": 37, "bit_score": 41.5874, "cvterm_id": "36915", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L D +F+ CDL       ++   +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G     A F   DL+  +F+  D        C LT +          D +   ++G ++    A  L + LG+ V G", "sequence_from_db": "RAMLRDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGD-----LDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLRDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAGAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGTGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 171, "hit_end": 642, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.84}, "gnl|BL_ORD_ID|48|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB47", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "58", "ARO_accession": "3002762", "ARO_name": "QnrB47", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.136728, "max_identities": 15, "bit_score": 28.8758, "cvterm_id": "36915", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLRDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAGAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGTGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 27, "hit_end": 177, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|4920|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB78", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5911", "ARO_accession": "3003190", "ARO_name": "QnrB78", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.46911e-06, "max_identities": 36, "bit_score": 41.5874, "cvterm_id": "36915", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL        +   +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G     A F   DL+  +F+  D        C LT +          D ++  ++G ++    A  L + LG+ + G", "sequence_from_db": "RAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGD-----LDIRSVDLQGVKLDNYQASLLMERLGIAIIG", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRSVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTAAGTGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGAGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 171, "hit_end": 642, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.22}, "gnl|BL_ORD_ID|4920|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB78", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5911", "ARO_accession": "3003190", "ARO_name": "QnrB78", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.179178, "max_identities": 15, "bit_score": 28.8758, "cvterm_id": "36915", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRSVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTAAGTGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGAGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 27, "hit_end": 177, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|1159|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB56", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1263", "ARO_accession": "3002769", "ARO_name": "QnrB56", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.63369e-06, "max_identities": 36, "bit_score": 41.5874, "cvterm_id": "36915", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL       ++   +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G     A F   DL+  +F+  D        C LT +          D +   ++G ++    A  L + LG+ + G", "sequence_from_db": "RAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAGNFTHCDLTNSELGD-----LDIRGVDLQGVKLDSYQASLLMERLGIAIIG", "sequence_from_broadstreet": "MTPLLYKNTGIDMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAGNFTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAACACAGGCATAGATATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGGTGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTTCGCGGTGCAAGCTTTATGAATATGATCACCACGCGTACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGGAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAGCTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 207, "hit_end": 678, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.22}, "gnl|BL_ORD_ID|1159|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB56", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1263", "ARO_accession": "3002769", "ARO_name": "QnrB56", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.135013, "max_identities": 15, "bit_score": 29.261, "cvterm_id": "36915", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MTPLLYKNTGIDMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAGNFTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAACACAGGCATAGATATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGGTGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTTCGCGGTGCAAGCTTTATGAATATGATCACCACGCGTACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGGAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAGCTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 63, "hit_end": 213, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|1111|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB45", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1209", "ARO_accession": "3002760", "ARO_name": "QnrB45", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.76287e-06, "max_identities": 37, "bit_score": 41.5874, "cvterm_id": "35914", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL        +   +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G     A F   DL+  +F+  D        C LT +          D +   ++G ++    A  L + LG+ V G", "sequence_from_db": "RTMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGD-----LDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRTMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTACGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTGATTGGTTAA", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 171, "hit_end": 642, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.84}, "gnl|BL_ORD_ID|1111|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB45", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1209", "ARO_accession": "3002760", "ARO_name": "QnrB45", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0731478, "max_identities": 13, "bit_score": 30.0314, "cvterm_id": "35914", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKT", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC  ++T", "sequence_from_db": "IDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRT", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRTMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTACGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTGATTGGTTAA", "partial": "0", "query_start": 8949, "query_end": 9080, "hit_start": 27, "hit_end": 177, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 26.0}, "gnl|BL_ORD_ID|821|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB37", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "891", "ARO_accession": "3002752", "ARO_name": "QnrB37", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.99072e-06, "max_identities": 36, "bit_score": 41.5874, "cvterm_id": "36915", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL       ++   +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G     A F   DL+  +F+  D     +  C LT +          D +   ++G ++    A  + + LG+ V G", "sequence_from_db": "RAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGD-----LDVRGVDLQGVKLDSYQASLILERLGIAVIG", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGDLDVRGVDLQGVKLDSYQASLILERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTTGCGTTAGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGAGAAAGTCGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAGTTTATTGGCTGCCAATTTTATGATCGAGAGAGCCAGAAAGGGTGTAATTTTAGCCGCGCTATCCTGAAAGATGCCATTTTCAAAAGTTGCGATCTCTCCATGGCGGATTTCAGGAATGTGAGTGCGCTGGGAATCGAAATTCGCCACTGCCGCGCACAAGGTTCAGATTTTCGCGGCGCAAGCTTTATGAATATGATTACCACACGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGAACTCAGGTACTGGGGGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGTGAGTTTTCGTCGTTCGACTGGCGAGCCGCAAACGTTACGCACTGTGATTTGACCAATTCAGAACTGGGCGATCTCGATGTCCGGGGTGTTGATTTGCAAGGAGTCAAACTGGACAGCTACCAGGCATCGTTGATCCTGGAACGTCTTGGCATCGCTGTCATTGGTTAA", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 171, "hit_end": 642, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.22}, "gnl|BL_ORD_ID|821|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB37", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "891", "ARO_accession": "3002752", "ARO_name": "QnrB37", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.123393, "max_identities": 15, "bit_score": 29.261, "cvterm_id": "36915", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGDLDVRGVDLQGVKLDSYQASLILERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTTGCGTTAGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGAGAAAGTCGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAGTTTATTGGCTGCCAATTTTATGATCGAGAGAGCCAGAAAGGGTGTAATTTTAGCCGCGCTATCCTGAAAGATGCCATTTTCAAAAGTTGCGATCTCTCCATGGCGGATTTCAGGAATGTGAGTGCGCTGGGAATCGAAATTCGCCACTGCCGCGCACAAGGTTCAGATTTTCGCGGCGCAAGCTTTATGAATATGATTACCACACGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGAACTCAGGTACTGGGGGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGTGAGTTTTCGTCGTTCGACTGGCGAGCCGCAAACGTTACGCACTGTGATTTGACCAATTCAGAACTGGGCGATCTCGATGTCCGGGGTGTTGATTTGCAAGGAGTCAAACTGGACAGCTACCAGGCATCGTTGATCCTGGAACGTCTTGGCATCGCTGTCATTGGTTAA", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 27, "hit_end": 177, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|316|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB23", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "346", "ARO_accession": "3002738", "ARO_name": "QnrB23", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.48404e-06, "max_identities": 36, "bit_score": 41.5874, "cvterm_id": "36915", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL        +   +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G     A F   DL+  +F+  D        C LT +          D +   ++G ++    A  L + LG+ + G", "sequence_from_db": "RAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGD-----LDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFYCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTTACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGGGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 207, "hit_end": 678, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.22}, "gnl|BL_ORD_ID|316|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB23", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "346", "ARO_accession": "3002738", "ARO_name": "QnrB23", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.575457, "max_identities": 15, "bit_score": 27.335, "cvterm_id": "36915", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F   D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTGEKIENSTFFYCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFYCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTTACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGGGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 63, "hit_end": 213, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|661|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB32", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "716", "ARO_accession": "3002747", "ARO_name": "QnrB32", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.6314e-06, "max_identities": 36, "bit_score": 41.2022, "cvterm_id": "36915", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL        +   +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G     A F   DL+  +F+  D        C LT +          D +   ++G ++    A  L + LG+ + G", "sequence_from_db": "RAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNSNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGD-----LDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNSNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTAAGTGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTAAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACTCAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 171, "hit_end": 642, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.22}, "gnl|BL_ORD_ID|661|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB32", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "716", "ARO_accession": "3002747", "ARO_name": "QnrB32", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.174237, "max_identities": 15, "bit_score": 28.8758, "cvterm_id": "36915", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNSNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTAAGTGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTAAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACTCAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 27, "hit_end": 177, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|32|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB58", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "40", "ARO_accession": "3002771", "ARO_name": "QnrB58", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.64849e-06, "max_identities": 36, "bit_score": 41.2022, "cvterm_id": "36915", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL        +   +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G     A F   DL+  +F+  D        C LT +          D +   ++G ++    A  L + LG+ + G", "sequence_from_db": "RAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGD-----LDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIDNSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGATAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGGGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 207, "hit_end": 678, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.22}, "gnl|BL_ORD_ID|32|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB58", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "40", "ARO_accession": "3002771", "ARO_name": "QnrB58", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.292225, "max_identities": 15, "bit_score": 28.1054, "cvterm_id": "36915", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTGEKIDNSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIDNSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGATAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGGGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 63, "hit_end": 213, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|645|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrS9", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "699", "ARO_accession": "3002798", "ARO_name": "QnrS9", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.78589e-06, "max_identities": 31, "bit_score": 41.2022, "cvterm_id": "35915", "query": "LEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGV-DWSG----LGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCT--MQGCVLTKTNFAR", "match": "L D  F  C  +R    +  LR  TF + + +   D  G    +  + D  F+QC L  ++F   N     F  C  + ANF   + A        M  C+  + GC L+  N  R", "sequence_from_db": "LSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFFRTNFAHQ--VSNRMYFCSAFISGCNLSYANMER", "sequence_from_broadstreet": "METYNHTYRHHNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFFRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACAATCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCACCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTTCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 8766, "query_end": 9092, "hit_start": 51, "hit_end": 393, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 26.72}, "gnl|BL_ORD_ID|645|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrS9", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "699", "ARO_accession": "3002798", "ARO_name": "QnrS9", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000116604, "max_identities": 24, "bit_score": 38.1206, "cvterm_id": "35915", "query": "MPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGT", "match": "+ D+ F  C    S F + NLR T FV C   E      D+    F   D+   + Q C L   NF+ +  +  + +A  +KG ", "sequence_from_db": "LSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQG----DIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGA", "sequence_from_broadstreet": "METYNHTYRHHNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFFRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACAATCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCACCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTTCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 8889, "query_end": 9140, "hit_start": 51, "hit_end": 291, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 28.57}, "gnl|BL_ORD_ID|4925|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB76", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5919", "ARO_accession": "3003188", "ARO_name": "QnrB76", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.81612e-06, "max_identities": 36, "bit_score": 41.2022, "cvterm_id": "43754", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL        +   +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G     A F   DL+  +F+  D        C LT +          D +   ++G ++    A  L + LG+ + G", "sequence_from_db": "RAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGD-----LDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGTGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 207, "hit_end": 678, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.22}, "gnl|BL_ORD_ID|4925|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB76", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5919", "ARO_accession": "3003188", "ARO_name": "QnrB76", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.170397, "max_identities": 15, "bit_score": 28.8758, "cvterm_id": "43754", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGTGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 63, "hit_end": 213, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|1072|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB34", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1160", "ARO_accession": "3002749", "ARO_name": "QnrB34", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.27561e-06, "max_identities": 36, "bit_score": 41.2022, "cvterm_id": "39583", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL       ++   +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G     A F   DL+  +F+  D        C LT +          D +   ++G ++    A  + + LG+ V G", "sequence_from_db": "RAILKDAIFKSCDLSMAGFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGD-----LDVRGVDLQGVKLDSYQASLILERLGIAVIG", "sequence_from_broadstreet": "MMTLALVGEKIDRNRFTGAKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMAGFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGVDLQGVKLDSYQASLILERLGIAVIG", "dna_sequence_from_broadstreet": "ATGATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGATTCACTGGTGCGAAAGTTGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTCAGCGGTACTGAGTTTATTGGCTGCCAGTTCTATGATCGAGAGAGCCAGAAAGGGTGTAATTTTAGTCGCGCTATCCTGAAAGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCGGGTTTCAGGAATGTGAGCGCGCTGGGAATCGAAATTCGCCACTGCCGCGCACAAGGTTCAGATTTTCGCGGCGCAAGCTTTATGAATATGATTACCACACGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGTTGGATGGGTACTCAGGTACTGGGGGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGTGAGTTTTCGTCGTTCGACTGGCGGGCCGCAAACTTTACGCACTGTGATTTGACCAATTCAGAACTGGGCGATCTCGATGTCCGGGGTGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGATCCTGGAACGTCTTGGCATCGCTGTCATTGGTTAA", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 174, "hit_end": 645, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.22}, "gnl|BL_ORD_ID|1072|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB34", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1160", "ARO_accession": "3002749", "ARO_name": "QnrB34", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0485897, "max_identities": 15, "bit_score": 30.4166, "cvterm_id": "39583", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTGAKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MMTLALVGEKIDRNRFTGAKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMAGFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGVDLQGVKLDSYQASLILERLGIAVIG", "dna_sequence_from_broadstreet": "ATGATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGATTCACTGGTGCGAAAGTTGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTCAGCGGTACTGAGTTTATTGGCTGCCAGTTCTATGATCGAGAGAGCCAGAAAGGGTGTAATTTTAGTCGCGCTATCCTGAAAGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCGGGTTTCAGGAATGTGAGCGCGCTGGGAATCGAAATTCGCCACTGCCGCGCACAAGGTTCAGATTTTCGCGGCGCAAGCTTTATGAATATGATTACCACACGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGTTGGATGGGTACTCAGGTACTGGGGGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGTGAGTTTTCGTCGTTCGACTGGCGGGCCGCAAACTTTACGCACTGTGATTTGACCAATTCAGAACTGGGCGATCTCGATGTCCGGGGTGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGATCCTGGAACGTCTTGGCATCGCTGTCATTGGTTAA", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 30, "hit_end": 180, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|1445|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB9", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1579", "ARO_accession": "3002723", "ARO_name": "QnrB9", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.4135e-06, "max_identities": 36, "bit_score": 41.2022, "cvterm_id": "36915", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL        +   +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G     A F   DL+  +F+  D        C LT +          D +   ++G ++    A  L + LG+ + G", "sequence_from_db": "RAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGD-----LDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTAAGTGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 171, "hit_end": 642, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.22}, "gnl|BL_ORD_ID|1445|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB9", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1579", "ARO_accession": "3002723", "ARO_name": "QnrB9", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.172621, "max_identities": 15, "bit_score": 28.8758, "cvterm_id": "36915", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTAAGTGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 27, "hit_end": 177, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|1175|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB12", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1280", "ARO_accession": "3002726", "ARO_name": "QnrB12", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.45603e-06, "max_identities": 36, "bit_score": 41.2022, "cvterm_id": "39583", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL       ++   +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G     A F   DL+  +F+  D        C LT +          D +   ++G ++    A  + + LG+ V G", "sequence_from_db": "RAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGD-----LDVRGVDLQGVKLDSYQASLILERLGIAVIG", "sequence_from_broadstreet": "MMTLALVGEKIDRNRFTGAKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGVDLQGVKLDSYQASLILERLGIAVIG", "dna_sequence_from_broadstreet": "ATGATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAACAGATTCACTGGTGCGAAAGTTGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTCAGCGGCACTGAGTTTATTGGCTGTCAGTTCTATGATCGAGAGAGCCAGAAAGGGTGTAATTTTAGTCGCGCTATCCTGAAAGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCGGATTTCAGGAATGTGAGCGCGCTGGGAATCGAAATTCGCCACTGCCGCGCACAAGGTTCAGATTTTCGCGGCGCAAGCTTTATGAATATGATTACCACACGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGTTGGATGGGTACTCAGGTACTGGGGGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGTGAGTTTTCGTCGTTCGACTGGCGGGCCGCAAACTTTACGCACTGTGATTTGACCAATTCAGAACTGGGCGATCTCGATGTCCGGGGTGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGATCCTGGAACGTCTTGGCATCGCTGTCATTGGTTAA", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 174, "hit_end": 645, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.22}, "gnl|BL_ORD_ID|1175|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB12", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1280", "ARO_accession": "3002726", "ARO_name": "QnrB12", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0459374, "max_identities": 15, "bit_score": 30.4166, "cvterm_id": "39583", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTGAKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MMTLALVGEKIDRNRFTGAKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGVDLQGVKLDSYQASLILERLGIAVIG", "dna_sequence_from_broadstreet": "ATGATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAACAGATTCACTGGTGCGAAAGTTGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTCAGCGGCACTGAGTTTATTGGCTGTCAGTTCTATGATCGAGAGAGCCAGAAAGGGTGTAATTTTAGTCGCGCTATCCTGAAAGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCGGATTTCAGGAATGTGAGCGCGCTGGGAATCGAAATTCGCCACTGCCGCGCACAAGGTTCAGATTTTCGCGGCGCAAGCTTTATGAATATGATTACCACACGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGTTGGATGGGTACTCAGGTACTGGGGGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGTGAGTTTTCGTCGTTCGACTGGCGGGCCGCAAACTTTACGCACTGTGATTTGACCAATTCAGAACTGGGCGATCTCGATGTCCGGGGTGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGATCCTGGAACGTCTTGGCATCGCTGTCATTGGTTAA", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 30, "hit_end": 180, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|1255|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB69", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1369", "ARO_accession": "3002781", "ARO_name": "QnrB69", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.01677e-05, "max_identities": 36, "bit_score": 41.2022, "cvterm_id": "36915", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL       ++   +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G     A F   DL+  +F+  D        C LT +          D +   ++G ++    A  + + LG+ V G", "sequence_from_db": "RAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGD-----LDVRGVDLQGVKLDSYQASLILERLGIAVIG", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGVDLQGVKLDSYQASLILERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGAGAAAGTCGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAGTTTATTGGCTGCCAATTTTATGATCGAGAGAGCCAGAAAGGGTGTAATTTTAGCCGCGCTATCCTGAAAGATGCCATTTTCAAAAGTTGCGATCTCTCCATGGCGGATTTCAGAAATGTGAGTGCGCTGGGAATCGAAATTCGCCACTGCCGCGCACAAGGTTCAGATTTTCGCGGCGCAAGCTTTATGAATATGATTACCACACGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGTACTCAGGTACTTGGCGCAACGTTCAGTGGATCGGACCTCTCTGGCGGCGAGTTTTCATCGTTCGACTGGCGGGCAGCAAACTTTACGCACTGTGATTTGACCAATTCAGAACTGGGCGATCTCGATGTCCGGGGTGTTGATTTGCAAGGCGTTAAACTGGACAGCTACCAGGCATCGTTGATCCTGGAACGTCTTGGCATCGCTGTCATTGGTTAA", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 171, "hit_end": 642, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.22}, "gnl|BL_ORD_ID|1255|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB69", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1369", "ARO_accession": "3002781", "ARO_name": "QnrB69", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.128085, "max_identities": 15, "bit_score": 29.261, "cvterm_id": "36915", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGVDLQGVKLDSYQASLILERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGAGAAAGTCGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAGTTTATTGGCTGCCAATTTTATGATCGAGAGAGCCAGAAAGGGTGTAATTTTAGCCGCGCTATCCTGAAAGATGCCATTTTCAAAAGTTGCGATCTCTCCATGGCGGATTTCAGAAATGTGAGTGCGCTGGGAATCGAAATTCGCCACTGCCGCGCACAAGGTTCAGATTTTCGCGGCGCAAGCTTTATGAATATGATTACCACACGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGTACTCAGGTACTTGGCGCAACGTTCAGTGGATCGGACCTCTCTGGCGGCGAGTTTTCATCGTTCGACTGGCGGGCAGCAAACTTTACGCACTGTGATTTGACCAATTCAGAACTGGGCGATCTCGATGTCCGGGGTGTTGATTTGCAAGGCGTTAAACTGGACAGCTACCAGGCATCGTTGATCCTGGAACGTCTTGGCATCGCTGTCATTGGTTAA", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 27, "hit_end": 177, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|1435|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB16", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1564", "ARO_accession": "3002731", "ARO_name": "QnrB16", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.05791e-05, "max_identities": 36, "bit_score": 41.2022, "cvterm_id": "36915", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL        +   +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G     A F   DL+  +F+  D        C LT +          D +   ++G ++    A  L + LG+ + G", "sequence_from_db": "RAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGD-----LDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "sequence_from_broadstreet": "MTPLLYIKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATATAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTACCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGGGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 207, "hit_end": 678, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.22}, "gnl|BL_ORD_ID|1435|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB16", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1564", "ARO_accession": "3002731", "ARO_name": "QnrB16", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.168819, "max_identities": 15, "bit_score": 28.8758, "cvterm_id": "36915", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MTPLLYIKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATATAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTACCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGGGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 63, "hit_end": 213, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|371|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB11", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "411", "ARO_accession": "3002725", "ARO_name": "QnrB11", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.10311e-05, "max_identities": 36, "bit_score": 41.2022, "cvterm_id": "36915", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL       ++   +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G     A F   DL+  +F+  D        C LT +          D +   ++G ++    A  + + LG+ V G", "sequence_from_db": "RAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGD-----LDVRGVDLQGVKLDSYQASLILERLGIAVMG", "sequence_from_broadstreet": "MMTLALVGEKIDRNRFTGAKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGVDLQGVKLDSYQASLILERLGIAVMG", "dna_sequence_from_broadstreet": "ATGATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGATTCACTGGTGCGAAAGTTGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGCGCCGACCTCAGCGGCACTGAGTTTATTGGCTGCCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCTATCCTGAAAGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCGGATTTCAGGAATGTGAGCGCGCTGGGAATCGAAATTCGCCACTGCCGCGCACAAGGTTCAGATTTTCGCGGCGCAAGCTTTATGAATATGATTACCACACGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGTTGGATGGGTACTCAGGTACTGGGGGCGACGTTCAGTGGTTCGGATCTTTCCGGCGGTGAGTTTTCGTCGTTCGACTGGCGGGCCGCAAACTTTACGCACTGTGATTTGACCAATTCAGAACTGGGCGATCTCGATGTCCGGGGTGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGATCCTGGAACGTCTTGGTATCGCTGTCATGGGTTAA", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 174, "hit_end": 645, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.22}, "gnl|BL_ORD_ID|371|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB11", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "411", "ARO_accession": "3002725", "ARO_name": "QnrB11", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0459374, "max_identities": 15, "bit_score": 30.4166, "cvterm_id": "36915", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTGAKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MMTLALVGEKIDRNRFTGAKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGVDLQGVKLDSYQASLILERLGIAVMG", "dna_sequence_from_broadstreet": "ATGATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGATTCACTGGTGCGAAAGTTGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGCGCCGACCTCAGCGGCACTGAGTTTATTGGCTGCCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCTATCCTGAAAGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCGGATTTCAGGAATGTGAGCGCGCTGGGAATCGAAATTCGCCACTGCCGCGCACAAGGTTCAGATTTTCGCGGCGCAAGCTTTATGAATATGATTACCACACGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGTTGGATGGGTACTCAGGTACTGGGGGCGACGTTCAGTGGTTCGGATCTTTCCGGCGGTGAGTTTTCGTCGTTCGACTGGCGGGCCGCAAACTTTACGCACTGTGATTTGACCAATTCAGAACTGGGCGATCTCGATGTCCGGGGTGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGATCCTGGAACGTCTTGGTATCGCTGTCATGGGTTAA", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 30, "hit_end": 180, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|1627|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrS7", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1775", "ARO_accession": "3002796", "ARO_name": "QnrS7", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.15016e-05, "max_identities": 31, "bit_score": 40.817, "cvterm_id": "35914", "query": "LEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGV-DWSG----LGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCT--MQGCVLTKTNFAR", "match": "L D  F  C  +R    +  LR  TF + + +   D  G    +  + D  F+QC L  ++F   N     F  C  + ANF   + A        M  C+  + GC L+  N  R", "sequence_from_db": "LSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLHDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQ--VSNRMYFCSAFISGCNLSYANMER", "sequence_from_broadstreet": "METYNHTYRHHNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLHDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACAATCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCACCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCGCAGATCTTCATGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 8766, "query_end": 9092, "hit_start": 51, "hit_end": 393, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 26.72}, "gnl|BL_ORD_ID|1627|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrS7", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1775", "ARO_accession": "3002796", "ARO_name": "QnrS7", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.37699e-05, "max_identities": 24, "bit_score": 38.5058, "cvterm_id": "35914", "query": "MPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGT", "match": "+ D+ F  C    S F + NLR T FV C   E      D+    F   D+   + Q C L   NF+ +  +  + +A  +KG ", "sequence_from_db": "LSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQG----DIEGCHFDVADLHDASFQQCQLAMANFSNANCYGIEFRACDLKGA", "sequence_from_broadstreet": "METYNHTYRHHNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLHDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACAATCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCACCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCGCAGATCTTCATGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 8889, "query_end": 9140, "hit_start": 51, "hit_end": 291, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 28.57}, "gnl|BL_ORD_ID|291|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB54", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "324", "ARO_accession": "3002767", "ARO_name": "QnrB54", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.2209e-05, "max_identities": 36, "bit_score": 40.817, "cvterm_id": "36915", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL        +   +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G     A F   DL+  +F+  D        C LT +          D +   ++G ++    A  L + LG+ + G", "sequence_from_db": "RAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGD-----LDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "sequence_from_broadstreet": "MALALVSEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCACTGGCACTCGTTAGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTACCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 171, "hit_end": 642, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.22}, "gnl|BL_ORD_ID|291|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB54", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "324", "ARO_accession": "3002767", "ARO_name": "QnrB54", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.175869, "max_identities": 15, "bit_score": 28.8758, "cvterm_id": "36915", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MALALVSEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCACTGGCACTCGTTAGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTACCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 27, "hit_end": 177, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|1853|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB60", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "2011", "ARO_accession": "3002773", "ARO_name": "QnrB60", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.29348e-05, "max_identities": 37, "bit_score": 40.817, "cvterm_id": "36915", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL       ++   +  +  R  G D+ G   M                 +L Y++F K  L K      R++G     A     DL+  +F+  D        C LT +          D +   ++G ++    AV L + LG+ V G", "sequence_from_db": "RAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGD-----LDIRGVDLQGVKLDSYQAVLLMERLGIAVIG", "sequence_from_broadstreet": "MALALIGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAVLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCATTAATTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGCGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGGTGCTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAGCTATCAGGCCGTATTGCTCATGGAACGTCTTGGCATCGCTGTCATTGGCTAA", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 171, "hit_end": 642, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.84}, "gnl|BL_ORD_ID|1853|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB60", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "2011", "ARO_accession": "3002773", "ARO_name": "QnrB60", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.12455, "max_identities": 15, "bit_score": 29.261, "cvterm_id": "36915", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MALALIGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAVLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCATTAATTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGCGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGGTGCTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAGCTATCAGGCCGTATTGCTCATGGAACGTCTTGGCATCGCTGTCATTGGCTAA", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 27, "hit_end": 177, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|1470|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrC", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1609", "ARO_accession": "3002787", "ARO_name": "QnrC", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.29408e-05, "max_identities": 24, "bit_score": 40.817, "cvterm_id": "36771", "query": "VDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTR", "match": "+D+SG   +    F  C     +F ++NLR  +F+GC+  E+N    D    +F   D+   +   C+L+  NF  +  F  + +   +KG  ", "sequence_from_db": "IDFSG-QDLSSHHFSHCKFFGCNFNRVNLRDAKFMGCTFIESN----DFEGCNFIYADLRDASFMNCMLSMANFQGANCFGLELRECDLKGAN", "sequence_from_broadstreet": "MNYSHKTYDQIDFSGQDLSSHHFSHCKFFGCNFNRVNLRDAKFMGCTFIESNDFEGCNFIYADLRDASFMNCMLSMANFQGANCFGLELRECDLKGANFSQANFVNHVSNKMYFCSAYITGCNLSYANFDKQCLEKCDLFENKWVGASLQGASFKESDLSRGSFSDDFWEQCRIQGCDLTHSELNGLEPRKVDLTGVKICSWQQEQLLEQLGVIVIPDKVF", "dna_sequence_from_broadstreet": "TTGAATTATTCCCATAAAACGTACGATCAAATTGATTTTTCCGGCCAAGATTTGAGCTCTCATCACTTTTCTCACTGTAAATTTTTTGGTTGTAATTTTAATCGAGTGAATTTACGTGATGCTAAATTCATGGGTTGTACATTTATTGAATCGAATGATTTTGAAGGATGTAATTTTATCTATGCAGACCTACGAGATGCTTCATTTATGAATTGCATGCTTTCAATGGCGAATTTCCAAGGGGCAAACTGTTTTGGCCTTGAATTGAGAGAATGCGATTTAAAAGGTGCTAATTTCTCACAGGCAAACTTTGTTAATCATGTTTCTAACAAAATGTATTTTTGCTCTGCTTACATTACGGGTTGTAATTTGTCTTATGCTAATTTCGATAAGCAATGCCTTGAAAAGTGTGATTTATTTGAAAATAAATGGGTAGGTGCAAGCCTGCAAGGGGCCTCTTTTAAAGAGTCAGACTTAAGTAGGGGATCATTTTCTGATGACTTTTGGGAGCAATGCAGAATTCAGGGGTGTGATCTCACTCATTCAGAATTAAATGGCTTAGAACCTCGTAAAGTGGATTTAACTGGCGTGAAAATTTGTTCATGGCAACAAGAGCAGCTTTTGGAGCAGTTGGGGGTGATTGTTATTCCAGACAAAGTGTTTTGA", "partial": "0", "query_start": 8865, "query_end": 9143, "hit_start": 30, "hit_end": 294, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 25.81}, "gnl|BL_ORD_ID|1470|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrC", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1609", "ARO_accession": "3002787", "ARO_name": "QnrC", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.18563e-05, "max_identities": 27, "bit_score": 39.6614, "cvterm_id": "36771", "query": "CDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVV", "match": "C+L Y++F K  L K      ++VG S + A+F + DL+   F+      C +QGC LT +          +P+   + G ++       L + LG++V", "sequence_from_db": "CNLSYANFDKQCLEKCDLFENKWVGASLQGASFKESDLSRGSFSDDFWEQCRIQGCDLTHSELNG-----LEPRKVDLTGVKICSWQQEQLLEQLGVIV", "sequence_from_broadstreet": "MNYSHKTYDQIDFSGQDLSSHHFSHCKFFGCNFNRVNLRDAKFMGCTFIESNDFEGCNFIYADLRDASFMNCMLSMANFQGANCFGLELRECDLKGANFSQANFVNHVSNKMYFCSAYITGCNLSYANFDKQCLEKCDLFENKWVGASLQGASFKESDLSRGSFSDDFWEQCRIQGCDLTHSELNGLEPRKVDLTGVKICSWQQEQLLEQLGVIVIPDKVF", "dna_sequence_from_broadstreet": "TTGAATTATTCCCATAAAACGTACGATCAAATTGATTTTTCCGGCCAAGATTTGAGCTCTCATCACTTTTCTCACTGTAAATTTTTTGGTTGTAATTTTAATCGAGTGAATTTACGTGATGCTAAATTCATGGGTTGTACATTTATTGAATCGAATGATTTTGAAGGATGTAATTTTATCTATGCAGACCTACGAGATGCTTCATTTATGAATTGCATGCTTTCAATGGCGAATTTCCAAGGGGCAAACTGTTTTGGCCTTGAATTGAGAGAATGCGATTTAAAAGGTGCTAATTTCTCACAGGCAAACTTTGTTAATCATGTTTCTAACAAAATGTATTTTTGCTCTGCTTACATTACGGGTTGTAATTTGTCTTATGCTAATTTCGATAAGCAATGCCTTGAAAAGTGTGATTTATTTGAAAATAAATGGGTAGGTGCAAGCCTGCAAGGGGCCTCTTTTAAAGAGTCAGACTTAAGTAGGGGATCATTTTCTGATGACTTTTGGGAGCAATGCAGAATTCAGGGGTGTGATCTCACTCATTCAGAATTAAATGGCTTAGAACCTCGTAAAGTGGATTTAACTGGCGTGAAAATTTGTTCATGGCAACAAGAGCAGCTTTTGGAGCAGTTGGGGGTGATTGTTATTCCAGACAAAGTGTTTTGA", "partial": "0", "query_start": 8913, "query_end": 9194, "hit_start": 363, "hit_end": 645, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|1470|hsp_num:2": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrC", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1609", "ARO_accession": "3002787", "ARO_name": "QnrC", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0104984, "max_identities": 28, "bit_score": 32.3426, "cvterm_id": "36771", "query": "SRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSA-----REANFIDVDLAESDFTG---TDMPGCT--MQGCVLTKTNFAR", "match": "     C F GC+  R          V  +D + MG  +          F   DLR +SF+   L    F G +      RE +    + ++++F       M  C+  + GC L+  NF +", "sequence_from_db": "HHFSHCKFFGCNFNR----------VNLRDAKFMGCTFIESNDFEGCNFIYADLRDASFMNCMLSMANFQGANCFGLELRECDLKGANFSQANFVNHVSNKMYFCSAYITGCNLSYANFDK", "sequence_from_broadstreet": "MNYSHKTYDQIDFSGQDLSSHHFSHCKFFGCNFNRVNLRDAKFMGCTFIESNDFEGCNFIYADLRDASFMNCMLSMANFQGANCFGLELRECDLKGANFSQANFVNHVSNKMYFCSAYITGCNLSYANFDKQCLEKCDLFENKWVGASLQGASFKESDLSRGSFSDDFWEQCRIQGCDLTHSELNGLEPRKVDLTGVKICSWQQEQLLEQLGVIVIPDKVF", "dna_sequence_from_broadstreet": "TTGAATTATTCCCATAAAACGTACGATCAAATTGATTTTTCCGGCCAAGATTTGAGCTCTCATCACTTTTCTCACTGTAAATTTTTTGGTTGTAATTTTAATCGAGTGAATTTACGTGATGCTAAATTCATGGGTTGTACATTTATTGAATCGAATGATTTTGAAGGATGTAATTTTATCTATGCAGACCTACGAGATGCTTCATTTATGAATTGCATGCTTTCAATGGCGAATTTCCAAGGGGCAAACTGTTTTGGCCTTGAATTGAGAGAATGCGATTTAAAAGGTGCTAATTTCTCACAGGCAAACTTTGTTAATCATGTTTCTAACAAAATGTATTTTTGCTCTGCTTACATTACGGGTTGTAATTTGTCTTATGCTAATTTCGATAAGCAATGCCTTGAAAAGTGTGATTTATTTGAAAATAAATGGGTAGGTGCAAGCCTGCAAGGGGCCTCTTTTAAAGAGTCAGACTTAAGTAGGGGATCATTTTCTGATGACTTTTGGGAGCAATGCAGAATTCAGGGGTGTGATCTCACTCATTCAGAATTAAATGGCTTAGAACCTCGTAAAGTGGATTTAACTGGCGTGAAAATTTGTTCATGGCAACAAGAGCAGCTTTTGGAGCAGTTGGGGGTGATTGTTATTCCAGACAAAGTGTTTTGA", "partial": "0", "query_start": 8760, "query_end": 9092, "hit_start": 60, "hit_end": 393, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 23.14}, "gnl|BL_ORD_ID|1714|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB20", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1856", "ARO_accession": "3002735", "ARO_name": "QnrB20", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.30635e-05, "max_identities": 37, "bit_score": 40.817, "cvterm_id": "35914", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL        +   +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G     A F   DL+  +F+  D        C LT +          D +   ++G ++    A  L + LG+ V G", "sequence_from_db": "RAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGD-----LDIRRVDLQGVKLDNYQASLLMERLGIAVIG", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKINRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGCACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTAACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTTCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGGGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGCGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 207, "hit_end": 678, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.84}, "gnl|BL_ORD_ID|1714|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB20", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1856", "ARO_accession": "3002735", "ARO_name": "QnrB20", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.101142, "max_identities": 15, "bit_score": 29.6462, "cvterm_id": "35914", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "INRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKINRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGCACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTAACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTTCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGGGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGCGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 63, "hit_end": 213, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|4921|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB80", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5912", "ARO_accession": "3003192", "ARO_name": "QnrB80", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.35723e-05, "max_identities": 36, "bit_score": 40.817, "cvterm_id": "36915", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL        +   +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G     A F   DL+  +F+  D        C LT +          D +   ++G ++    A  L + LG+ + G", "sequence_from_db": "RAMLKDAIFKSCDLSMADFRNASALDIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGD-----LDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALDIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGACATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTACCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGGGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 171, "hit_end": 642, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.22}, "gnl|BL_ORD_ID|4921|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB80", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5912", "ARO_accession": "3003192", "ARO_name": "QnrB80", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.175869, "max_identities": 15, "bit_score": 28.8758, "cvterm_id": "36915", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALDIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGACATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTACCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGGGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 27, "hit_end": 177, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|238|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB13", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "266", "ARO_accession": "3002727", "ARO_name": "QnrB13", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.56717e-05, "max_identities": 36, "bit_score": 40.817, "cvterm_id": "36915", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL        +   +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G     A F   DL+  +F+  D        C LT +          D +   ++G ++    A  L + LG+ + G", "sequence_from_db": "RAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGD-----LDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGCGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 207, "hit_end": 678, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.22}, "gnl|BL_ORD_ID|238|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB13", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "266", "ARO_accession": "3002727", "ARO_name": "QnrB13", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.175222, "max_identities": 15, "bit_score": 28.8758, "cvterm_id": "36915", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGCGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 63, "hit_end": 213, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|1166|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrS3", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1270", "ARO_accession": "3002792", "ARO_name": "QnrS3", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.74804e-05, "max_identities": 31, "bit_score": 40.4318, "cvterm_id": "35914", "query": "LEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGV-DWSG----LGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCT--MQGCVLTKTNFAR", "match": "L D  F  C  +R    +  LR  TF + + +   D  G    +  + D  F+QC L  ++F   N     F  C  + ANF   + A        M  C+  + GC L+  N  R", "sequence_from_db": "LSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQ--VSNRMYFCSAFISGCNLSYANMER", "sequence_from_broadstreet": "ETYNHTYRHRNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "GAAACCTACAATCATACATATCGGCACCGCAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCACCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "1", "query_start": 8766, "query_end": 9092, "hit_start": 48, "hit_end": 390, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 26.72}, "gnl|BL_ORD_ID|1166|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrS3", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1270", "ARO_accession": "3002792", "ARO_name": "QnrS3", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.2604e-05, "max_identities": 27, "bit_score": 39.6614, "cvterm_id": "35914", "query": "MPDVQFEQCDLRYSSFLKLNLRKTRFVGCS----------------AREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNF", "match": "+ D+ F  C    S F + NLR T FV C                  R+A+F    LA ++F+  +  G   + C L   NF+R TNF", "sequence_from_db": "LSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSR-TNF", "sequence_from_broadstreet": "ETYNHTYRHRNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "GAAACCTACAATCATACATATCGGCACCGCAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCACCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "1", "query_start": 8889, "query_end": 9104, "hit_start": 48, "hit_end": 309, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 30.68}, "gnl|BL_ORD_ID|348|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrS1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "381", "ARO_accession": "3002790", "ARO_name": "QnrS1", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.82387e-05, "max_identities": 31, "bit_score": 40.4318, "cvterm_id": "35711", "query": "LEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGV-DWSG----LGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCT--MQGCVLTKTNFAR", "match": "L D  F  C  +R    +  LR  TF + + +   D  G    +  + D  F+QC L  ++F   N     F  C  + ANF   + A        M  C+  + GC L+  N  R", "sequence_from_db": "LSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQ--VSNRMYFCSAFISGCNLSYANMER", "sequence_from_broadstreet": "METYNHTYRHHNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACAATCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCACCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 8766, "query_end": 9092, "hit_start": 51, "hit_end": 393, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 26.72}, "gnl|BL_ORD_ID|348|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrS1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "381", "ARO_accession": "3002790", "ARO_name": "QnrS1", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.36838e-05, "max_identities": 27, "bit_score": 39.6614, "cvterm_id": "35711", "query": "MPDVQFEQCDLRYSSFLKLNLRKTRFVGCS----------------AREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNF", "match": "+ D+ F  C    S F + NLR T FV C                  R+A+F    LA ++F+  +  G   + C L   NF+R TNF", "sequence_from_db": "LSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSR-TNF", "sequence_from_broadstreet": "METYNHTYRHHNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACAATCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCACCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 8889, "query_end": 9104, "hit_start": 51, "hit_end": 312, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 30.68}, "gnl|BL_ORD_ID|436|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB49", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "484", "ARO_accession": "3002764", "ARO_name": "QnrB49", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.95321e-05, "max_identities": 36, "bit_score": 40.4318, "cvterm_id": "36915", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL        +   +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G     A F   DL+  +F+  D        C LT +          D +   ++G ++    A  L + LG+ + G", "sequence_from_db": "RAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGD-----LDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCACTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTTCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTAGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGGACCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGCGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 207, "hit_end": 678, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.22}, "gnl|BL_ORD_ID|436|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB49", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "484", "ARO_accession": "3002764", "ARO_name": "QnrB49", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.165705, "max_identities": 15, "bit_score": 28.8758, "cvterm_id": "36915", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCACTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTTCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTAGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGGACCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGCGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 63, "hit_end": 213, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|1392|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB64", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1513", "ARO_accession": "3002776", "ARO_name": "QnrB64", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.97468e-05, "max_identities": 36, "bit_score": 40.4318, "cvterm_id": "36915", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL        +   +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G     A F   DL+  +F+  D        C LT +          D +   ++G ++    A  L + LG+ + G", "sequence_from_db": "RAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGD-----LDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "sequence_from_broadstreet": "MALALVGDKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGATAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGTCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTATGCCAATTTTTCGAAAGTCGTGCTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGCGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 171, "hit_end": 642, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.22}, "gnl|BL_ORD_ID|1392|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB64", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1513", "ARO_accession": "3002776", "ARO_name": "QnrB64", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.182549, "max_identities": 15, "bit_score": 28.4906, "cvterm_id": "36915", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MALALVGDKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGATAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGTCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTATGCCAATTTTTCGAAAGTCGTGCTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGCGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 27, "hit_end": 177, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|2054|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrS10", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "425", "model_id": "3320", "ARO_accession": "3004622", "ARO_name": "QnrS10", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.00754e-05, "max_identities": 31, "bit_score": 40.4318, "cvterm_id": "35915", "query": "LEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGV-DWSG----LGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCT--MQGCVLTKTNFAR", "match": "L D  F  C  +R    +  LR  TF + + +   D  G    +  + D  F+QC L  ++F   N     F  C  + ANF   + A        M  C+  + GC L+  N  R", "sequence_from_db": "LSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQ--VSNRMYFCSAFISGCNLSYANMER", "sequence_from_broadstreet": "MEIYSHTYRHHNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAATCTACAGTCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCACCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 8766, "query_end": 9092, "hit_start": 51, "hit_end": 393, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 26.72}, "gnl|BL_ORD_ID|2054|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrS10", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "425", "model_id": "3320", "ARO_accession": "3004622", "ARO_name": "QnrS10", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.21091e-05, "max_identities": 27, "bit_score": 39.6614, "cvterm_id": "35915", "query": "MPDVQFEQCDLRYSSFLKLNLRKTRFVGCS----------------AREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNF", "match": "+ D+ F  C    S F + NLR T FV C                  R+A+F    LA ++F+  +  G   + C L   NF+R TNF", "sequence_from_db": "LSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSR-TNF", "sequence_from_broadstreet": "MEIYSHTYRHHNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAATCTACAGTCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCACCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 8889, "query_end": 9104, "hit_start": 51, "hit_end": 312, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 30.68}, "gnl|BL_ORD_ID|4917|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB39", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5908", "ARO_accession": "3002754", "ARO_name": "QnrB39", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.01299e-05, "max_identities": 36, "bit_score": 40.4318, "cvterm_id": "39643", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL        +   +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G     A F   DL+  +F+  D        C LT +          D +   ++G ++    A  + + LG+ V G", "sequence_from_db": "RAILKDAIFKSCDLSMADFRNASALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGD-----LDVRGVDLQGVKLDSYQASLILERLGIAVIG", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGVKVENSTFFNCDFSGTDLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNASALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGVDLQGVKLDSYQASLILERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCGTTGGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGTGAAAGTTGAAAATAGCACGTTTTTCAACTGTGATTTTTCGGGTACCGACCTTAGCGGCACTGAATTTATTGGCTGCCAGTTTTATGATCGAGAGAGCCAGAAAGGGTGTAATTTTAGTCGCGCTATCCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCCATGGCGGATTTCAGAAATGCCAGCGCGCTGGGAATCGAGATTCGCCACTGCCGCGCGCAAGGTTCGGATTTTCGCGGTGCCAGTTTTATGAATATGATCACCACCCGCACCTGGTTTTGCAGCGCTTATATCACCAATACAAACTTAAGCTACGCCAACTTTTCGAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGTTGGATGGGTACTCAGGTACTGGGGGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGTCGTTCGACTGGCGGGCCGCGAACTTTACGCACTGTGACCTGACCAACTCGGAGCTGGGTGATTTAGACGTCCGTGGGGTGGATTTACAAGGCGTTAAACTGGACAGCTACCAGGCGTCTTTGATCCTGGAGCGTCTTGGCATCGCTGTCATTGGTTAA", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 171, "hit_end": 642, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.22}, "gnl|BL_ORD_ID|4917|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB39", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5908", "ARO_accession": "3002754", "ARO_name": "QnrB39", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0557782, "max_identities": 15, "bit_score": 30.0314, "cvterm_id": "39643", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTGVKVENSTFFNCDFSGTDLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGVKVENSTFFNCDFSGTDLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNASALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGVDLQGVKLDSYQASLILERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCGTTGGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGTGAAAGTTGAAAATAGCACGTTTTTCAACTGTGATTTTTCGGGTACCGACCTTAGCGGCACTGAATTTATTGGCTGCCAGTTTTATGATCGAGAGAGCCAGAAAGGGTGTAATTTTAGTCGCGCTATCCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCCATGGCGGATTTCAGAAATGCCAGCGCGCTGGGAATCGAGATTCGCCACTGCCGCGCGCAAGGTTCGGATTTTCGCGGTGCCAGTTTTATGAATATGATCACCACCCGCACCTGGTTTTGCAGCGCTTATATCACCAATACAAACTTAAGCTACGCCAACTTTTCGAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGTTGGATGGGTACTCAGGTACTGGGGGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGTCGTTCGACTGGCGGGCCGCGAACTTTACGCACTGTGACCTGACCAACTCGGAGCTGGGTGATTTAGACGTCCGTGGGGTGGATTTACAAGGCGTTAAACTGGACAGCTACCAGGCGTCTTTGATCCTGGAGCGTCTTGGCATCGCTGTCATTGGTTAA", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 27, "hit_end": 177, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|2142|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrS12", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "430", "model_id": "3325", "ARO_accession": "3004625", "ARO_name": "QnrS12", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.52703e-05, "max_identities": 25, "bit_score": 40.0466, "cvterm_id": "35914", "query": "MPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGT", "match": "+ D+ F  C    S F + NLR T FV C   E      D+    F  TD+   + Q C L   NF+ +  +  + +A  +KG ", "sequence_from_db": "LSDLTFAACTFIRSDFRRANLRDTTFVNCKFIEQG----DIEGCHFDVTDLRDASFQQCQLAMANFSNANCYGIEFRACDLKGA", "sequence_from_broadstreet": "METYNHTYRHHNFSHKDLSDLTFAACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVTDLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACAATCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCGCCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCACAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 8889, "query_end": 9140, "hit_start": 51, "hit_end": 291, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 29.76}, "gnl|BL_ORD_ID|2142|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrS12", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "430", "model_id": "3325", "ARO_accession": "3004625", "ARO_name": "QnrS12", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.21091e-05, "max_identities": 31, "bit_score": 39.6614, "cvterm_id": "35914", "query": "LEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGV-DWSG----LGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCT--MQGCVLTKTNFAR", "match": "L D  F  C  +R    +  LR  TF + + +   D  G    +  + D  F+QC L  ++F   N     F  C  + ANF   + A        M  C+  + GC L+  N  R", "sequence_from_db": "LSDLTFAACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVTDLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQ--VSNRMYFCSAFISGCNLSYANMER", "sequence_from_broadstreet": "METYNHTYRHHNFSHKDLSDLTFAACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVTDLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACAATCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCGCCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCACAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 8766, "query_end": 9092, "hit_start": 51, "hit_end": 393, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 26.72}, "gnl|BL_ORD_ID|2142|hsp_num:2": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrS12", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "430", "model_id": "3325", "ARO_accession": "3004625", "ARO_name": "QnrS12", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00363397, "max_identities": 39, "bit_score": 33.8834, "cvterm_id": "35914", "query": "SRWVRSRLEDCVFEGCDLLRMVP------EKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRK---------TRFV-GCSAREANFIDV-----DLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIF---------------DPKANQVKGTRVGVETAVALAQALGMVV", "match": "S + R+ L D  F  C  +          +   LR  +F+  +L   ++S       ++F  CDL+ ++F + N            + F+ GC+   AN   V     +L E+ + GT++ G +++   L++  F+      F               DP+     G ++       + +ALG+VV", "sequence_from_db": "SDFRRANLRDTTFVNCKFIEQGDIEGCHFDVTDLRDASFQQCQLAMANFSNANCYG-IEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVV", "sequence_from_broadstreet": "METYNHTYRHHNFSHKDLSDLTFAACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVTDLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACAATCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCGCCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCACAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 8745, "query_end": 9194, "hit_start": 90, "hit_end": 645, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 20.97}, "gnl|BL_ORD_ID|1163|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB40", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1267", "ARO_accession": "3002755", "ARO_name": "QnrB40", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.63387e-05, "max_identities": 36, "bit_score": 40.0466, "cvterm_id": "39584", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L D +F+ CDL       ++   +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G       F   DL+  +F+  D        C LT +          D +   ++G ++    A  L + LG+ V G", "sequence_from_db": "RAMLRDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGTTFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGD-----LDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLRDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGTTFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACTGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAGAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTACGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 171, "hit_end": 642, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.22}, "gnl|BL_ORD_ID|1163|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB40", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1267", "ARO_accession": "3002755", "ARO_name": "QnrB40", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.135458, "max_identities": 15, "bit_score": 28.8758, "cvterm_id": "39584", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLRDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGTTFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACTGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAGAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTACGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 27, "hit_end": 177, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|1882|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB31", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "2044", "ARO_accession": "3002746", "ARO_name": "QnrB31", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.21132e-05, "max_identities": 36, "bit_score": 39.6614, "cvterm_id": "35915", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL        +   +     R  G D+ G   M                 +L Y++F K+ L K      R++G     A F   DL+  +F+  D        C LT +          D +   ++G ++    A  L + LG+ + G", "sequence_from_db": "RAMLKDAIFKSCDLSMADFRNASALGIEISHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGD-----LDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFLCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEISHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAGAAAACAGGTACAAATATGGCTCTGGCGCTCGTGGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTTTATGTGATTTTTCAGGAGCCGACCTGAGCGGCACTGAGTTTATCGGCTGTCAATTCTATGATCGTGAAAGCCAGAAAGGCTGCAATTTTAGTCGTGCGATGTTAAAGGATGCCATTTTTAAAAGCTGCGATTTATCCATGGCGGATTTTCGCAATGCAAGCGCCCTGGGTATTGAGATTTCTCATTGTAGGGCTCAGGGTGCAGATTTTCGCGGCGCAAGCTTTATGAACATGATTACCACGCGCACTTGGTTCTGCAGCGCGTATATCACGAATACGAATCTGTCTTATGCCAATTTTTCGAAAGTCGTGTTGGAGAAGTGTGAGTTATGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCAACTTTCGACTGGCGAGCAGCAAACTTTACACATTGCGATCTCACAAATTCGGAGTTGGGTGACTTAGATATTCGTCGGGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCTTCGTTGCTCATGGAGCGACTTGGCATCGCGATAATTGGTTGA", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 207, "hit_end": 678, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.22}, "gnl|BL_ORD_ID|1882|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB31", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "2044", "ARO_accession": "3002746", "ARO_name": "QnrB31", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.795971, "max_identities": 15, "bit_score": 26.9498, "cvterm_id": "35915", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F   D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTGEKIENSTFFLCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFLCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEISHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAGAAAACAGGTACAAATATGGCTCTGGCGCTCGTGGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTTTATGTGATTTTTCAGGAGCCGACCTGAGCGGCACTGAGTTTATCGGCTGTCAATTCTATGATCGTGAAAGCCAGAAAGGCTGCAATTTTAGTCGTGCGATGTTAAAGGATGCCATTTTTAAAAGCTGCGATTTATCCATGGCGGATTTTCGCAATGCAAGCGCCCTGGGTATTGAGATTTCTCATTGTAGGGCTCAGGGTGCAGATTTTCGCGGCGCAAGCTTTATGAACATGATTACCACGCGCACTTGGTTCTGCAGCGCGTATATCACGAATACGAATCTGTCTTATGCCAATTTTTCGAAAGTCGTGTTGGAGAAGTGTGAGTTATGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCAACTTTCGACTGGCGAGCAGCAAACTTTACACATTGCGATCTCACAAATTCGGAGTTGGGTGACTTAGATATTCGTCGGGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCTTCGTTGCTCATGGAGCGACTTGGCATCGCGATAATTGGTTGA", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 63, "hit_end": 213, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|571|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB46", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "625", "ARO_accession": "3002761", "ARO_name": "QnrB46", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.27327e-05, "max_identities": 36, "bit_score": 39.6614, "cvterm_id": "35915", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL        +   +  +  R  G D+ G   M                 +L Y++F K  L K      R++G     A F   DL+  +F+  D        C LT +          D +   ++G ++    A  L + LG+ + G", "sequence_from_db": "RAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGD-----LDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAGAAAACAGGAACAAATATGGCTCTAGCGCTCGTGGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAAAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGAGCGGACCTGAGCGGCACTGAGTTTATCGGCTGCCAATTTTATGATCGTGAAAGCCAGAAAGGCTGTAATTTTAGCCGTGCGATGTTAAAGGATGCTATTTTTAAAAGCTGCGATTTATCCATGGCCGATTTTCGCAATGCAAGCGCCCTGGGTATTGAGATTCGTCATTGTAGGGCTCAGGGTGCAGATTTTCGCGGCGCAAGCTTTATGAACATGATTACCACGCGAACTTGGTTCTGCAGCGCGTATATCACGAATACGAATCTGTCTTATGCCAATTTTTCGAAAGCAGTGTTGGAGAAGTGTGAATTATGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCAACTTTCGACTGGCGAGCAGCAAACTTTACACATTGCGATCTCACAAATTCGGAGTTGGGTGACTTAGATATTCGTCGGGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCTTCGTTGCTCATGGAGCGACTTGGCATCGCGATAATTGGATGA", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 207, "hit_end": 678, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.22}, "gnl|BL_ORD_ID|571|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB46", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "625", "ARO_accession": "3002761", "ARO_name": "QnrB46", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.17686, "max_identities": 15, "bit_score": 28.8758, "cvterm_id": "35915", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAGAAAACAGGAACAAATATGGCTCTAGCGCTCGTGGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAAAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGAGCGGACCTGAGCGGCACTGAGTTTATCGGCTGCCAATTTTATGATCGTGAAAGCCAGAAAGGCTGTAATTTTAGCCGTGCGATGTTAAAGGATGCTATTTTTAAAAGCTGCGATTTATCCATGGCCGATTTTCGCAATGCAAGCGCCCTGGGTATTGAGATTCGTCATTGTAGGGCTCAGGGTGCAGATTTTCGCGGCGCAAGCTTTATGAACATGATTACCACGCGAACTTGGTTCTGCAGCGCGTATATCACGAATACGAATCTGTCTTATGCCAATTTTTCGAAAGCAGTGTTGGAGAAGTGTGAATTATGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCAACTTTCGACTGGCGAGCAGCAAACTTTACACATTGCGATCTCACAAATTCGGAGTTGGGTGACTTAGATATTCGTCGGGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCTTCGTTGCTCATGGAGCGACTTGGCATCGCGATAATTGGATGA", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 63, "hit_end": 213, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|322|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "353", "ARO_accession": "3002715", "ARO_name": "QnrB2", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.4124e-05, "max_identities": 36, "bit_score": 39.6614, "cvterm_id": "36771", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL        +   +     R  G D+ G   M                 +L Y++F K+ L K      R++G     A F   DL+  +F+  D        C LT +          D +   ++G ++    A  L + LG+ + G", "sequence_from_db": "RAMLKDAIFKSCDLSMADFRNASALGIEISHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGD-----LDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "sequence_from_broadstreet": "MALALVGEKINRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEISHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTAACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTAGCCACTGTCGTGCGCAAGGCGCAGATTTTCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGGGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGCGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 171, "hit_end": 642, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.22}, "gnl|BL_ORD_ID|322|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "353", "ARO_accession": "3002715", "ARO_name": "QnrB2", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.104312, "max_identities": 15, "bit_score": 29.261, "cvterm_id": "36771", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "INRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MALALVGEKINRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEISHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTAACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTAGCCACTGTCGTGCGCAAGGCGCAGATTTTCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGGGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGCGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 27, "hit_end": 177, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|629|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrS4", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "682", "ARO_accession": "3002793", "ARO_name": "QnrS4", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.8514e-05, "max_identities": 24, "bit_score": 39.6614, "cvterm_id": "35767", "query": "MPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGT", "match": "+ D+ F  C    S F + NLR T FV C   E      D+    F   D+   + Q C L   NF+ +  +  + +A  +KG ", "sequence_from_db": "LSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQG----DIEGCHFDAADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGA", "sequence_from_broadstreet": "METYNHTYRHHNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDAADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACAATCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCACCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGCCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 8889, "query_end": 9140, "hit_start": 51, "hit_end": 291, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 28.57}, "gnl|BL_ORD_ID|629|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrS4", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "682", "ARO_accession": "3002793", "ARO_name": "QnrS4", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000840737, "max_identities": 27, "bit_score": 35.4242, "cvterm_id": "35767", "query": "LEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFAR", "match": "L D  F  C  +R    +  LR  TF + + +       G +    F+  DLR +SF +          C    ANF     + ++  G +   C ++G   ++TNFA ", "sequence_from_db": "LSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQ-----GDIEGCHFDAADLRDASFQQ----------CQLAMANF-----SNANCYGIEFRACDLKGANFSRTNFAH", "sequence_from_broadstreet": "METYNHTYRHHNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDAADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACAATCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCACCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGCCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 8766, "query_end": 9092, "hit_start": 51, "hit_end": 318, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 24.77}, "gnl|BL_ORD_ID|629|hsp_num:2": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrS4", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "682", "ARO_accession": "3002793", "ARO_name": "QnrS4", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00212295, "max_identities": 39, "bit_score": 34.2686, "cvterm_id": "35767", "query": "SRWVRSRLEDCVFEGCDLLRMVP------EKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRK---------TRFV-GCSAREANFIDV-----DLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIF---------------DPKANQVKGTRVGVETAVALAQALGMVV", "match": "S + R+ L D  F  C  +          +   LR  +F+  +L   ++S       ++F  CDL+ ++F + N            + F+ GC+   AN   V     +L E+ + GT++ G +++   L++  F+      F               DP+     G ++       + +ALG+VV", "sequence_from_db": "SDFRRANLRDTTFVNCKFIEQGDIEGCHFDAADLRDASFQQCQLAMANFSNANCYG-IEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVV", "sequence_from_broadstreet": "METYNHTYRHHNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDAADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACAATCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCACCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGCCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 8745, "query_end": 9194, "hit_start": 90, "hit_end": 645, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 20.97}, "gnl|BL_ORD_ID|682|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB21", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "740", "ARO_accession": "3002736", "ARO_name": "QnrB21", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.21323e-05, "max_identities": 36, "bit_score": 39.2762, "cvterm_id": "35914", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL       ++   +  +  R  G D+ G   M                 +L Y++F K  L K      R++G     A     DL+  +F+  D        C LT +          D +   ++G ++    A  L + LG+ V G", "sequence_from_db": "RAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGD-----LDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGCGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGGTACTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAGCTATCAGGCCGCATTGCTCATGGAACGTCTTGGCATCGCTGTGATTGGCTAG", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 171, "hit_end": 642, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.22}, "gnl|BL_ORD_ID|682|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB21", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "740", "ARO_accession": "3002736", "ARO_name": "QnrB21", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.129286, "max_identities": 15, "bit_score": 29.261, "cvterm_id": "35914", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGCGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGGTACTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAGCTATCAGGCCGCATTGCTCATGGAACGTCTTGGCATCGCTGTGATTGGCTAG", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 27, "hit_end": 177, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|85|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB38", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "99", "ARO_accession": "3002753", "ARO_name": "QnrB38", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.25378e-05, "max_identities": 36, "bit_score": 39.2762, "cvterm_id": "36915", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL       ++   +  +  R  G D+ G   M                 +L Y++F K  L K      R++G     A     DL+  +F+  D        C LT +          D +   ++G ++    A  L + LG+ V G", "sequence_from_db": "RAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGD-----LDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "sequence_from_broadstreet": "MALALIGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCATTAATTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGCGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGGTACTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAGCTATCAGGCCGCATTGCTCATGGAACGTCTTGGCATCGCTGTCATTGGCTAA", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 171, "hit_end": 642, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.22}, "gnl|BL_ORD_ID|85|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB38", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "99", "ARO_accession": "3002753", "ARO_name": "QnrB38", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.13172, "max_identities": 15, "bit_score": 29.261, "cvterm_id": "36915", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MALALIGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCATTAATTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGCGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGGTACTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAGCTATCAGGCCGCATTGCTCATGGAACGTCTTGGCATCGCTGTCATTGGCTAA", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 27, "hit_end": 177, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|1835|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrA1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1987", "ARO_accession": "3002707", "ARO_name": "QnrA1", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.36147e-05, "max_identities": 30, "bit_score": 39.2762, "cvterm_id": "35915", "query": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLA----------------LRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARST", "match": "+ +SR+ R R   C F  C L     E  +                LR  +FK  RL   ++SG      ++F +CDL+ +     N  + RF    + +  F    ++  +   T++ G  ++ C L + N++ + ", "sequence_from_db": "LSDSRFRRCRFYQCDFSHCQLQDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFG-IEFRECDLKGA-----NFSRARFYNQVSHKMYFCSAYISGCNLAYTNLSGQCLEKCELFENNWSNAN", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLQDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQVSHKMYFCSAYISGCNLAYTNLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCACTGTCAGCTGCAGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTTGAAGGGTGTCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGTCTGTCTTTGGCCAACTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAACTTTTCCCGGGCCCGCTTCTACAATCAAGTCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGTTGCAACCTGGCCTATACCAACTTGAGTGGCCAATGCCTGGAAAAATGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAATCTCAGCGGCGCTTCCTTGATGGGCTCAGATCTCAGCCGCGGCACCTTCTCCCGCGACTGTTGGCAACAGGTCAATCTGCGGGGCTGTGACCTAACCTTTGCCGATCTGGATGGGCTCGACCCCAGACGGGTCAACCTCGAAGGAGTCAAGATCTGTGCCTGGCAACAGGAGCAACTGCTGGAACCCTTGGGAGTAATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 8736, "query_end": 9098, "hit_start": 51, "hit_end": 444, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 21.9}, "gnl|BL_ORD_ID|1835|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrA1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1987", "ARO_accession": "3002707", "ARO_name": "QnrA1", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.023796, "max_identities": 21, "bit_score": 31.187, "cvterm_id": "35915", "query": "FEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAES------DFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGT", "match": "F + DL  S F +    +  F  C  ++A+F D    ES       F+  D+   + + C L+  NF+ +  F  + +   +KG ", "sequence_from_db": "FSRQDLSDSRFRRCRFYQCDFSHCQLQDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGA", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLQDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQVSHKMYFCSAYISGCNLAYTNLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCACTGTCAGCTGCAGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTTGAAGGGTGTCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGTCTGTCTTTGGCCAACTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAACTTTTCCCGGGCCCGCTTCTACAATCAAGTCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGTTGCAACCTGGCCTATACCAACTTGAGTGGCCAATGCCTGGAAAAATGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAATCTCAGCGGCGCTTCCTTGATGGGCTCAGATCTCAGCCGCGGCACCTTCTCCCGCGACTGTTGGCAACAGGTCAATCTGCGGGGCTGTGACCTAACCTTTGCCGATCTGGATGGGCTCGACCCCAGACGGGTCAACCTCGAAGGAGTCAAGATCTGTGCCTGGCAACAGGAGCAACTGCTGGAACCCTTGGGAGTAATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 8904, "query_end": 9140, "hit_start": 36, "hit_end": 291, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 24.71}, "gnl|BL_ORD_ID|1239|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrVC1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1351", "ARO_accession": "3002799", "ARO_name": "QnrVC1", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.48639e-05, "max_identities": 34, "bit_score": 38.891, "cvterm_id": "36789", "query": "LEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQ---------CDLRYSSFL-----KLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVV", "match": "L D  F+ C L     +      +  +D  L G ++S +  +  V  +          C+L Y++F      K +L + R++G + R A+F + DL+   F+        +QGC L+ +       +  DP+   + G ++       L + LG+++", "sequence_from_db": "LRDASFKNCQLSMSHFKGANCFGIELRDCDLKGANFSQVSFVNQVSNKMYFCSAYITGCNLSYANFEQQLIEKCDLFENRWIGANLRGASFKESDLSRGVFSEDCWEQFRVQGCDLSHSEL-----YGLDPRKIDLTGVKICSWQQEQLLEQLGVII", "sequence_from_broadstreet": "MEKSKQLYNQVNFSHQDLQEHIFSNCTFIHCNFKRSNLRDTQFINCTFIEQGALEGCDFSYADLRDASFKNCQLSMSHFKGANCFGIELRDCDLKGANFSQVSFVNQVSNKMYFCSAYITGCNLSYANFEQQLIEKCDLFENRWIGANLRGASFKESDLSRGVFSEDCWEQFRVQGCDLSHSELYGLDPRKIDLTGVKICSWQQEQLLEQLGVIIVPD", "dna_sequence_from_broadstreet": "ATGGAAAAATCAAAGCAATTATATAATCAAGTGAACTTCTCACATCAGGACTTGCAAGAACATATCTTTAGCAATTGTACTTTTATACATTGTAATTTTAAGCGCTCAAACCTCCGAGATACACAGTTCATTAACTGTACTTTCATAGAGCAGGGGGCATTGGAAGGGTGCGATTTTTCTTATGCTGATCTTCGAGATGCTTCATTTAAAAACTGTCAGCTTTCAATGTCCCATTTTAAGGGGGCAAATTGCTTTGGTATTGAACTGAGAGATTGTGATCTTAAAGGAGCAAATTTTAGTCAAGTTAGTTTTGTAAATCAGGTTTCGAATAAAATGTACTTTTGTTCTGCATACATAACAGGTTGTAACTTATCCTATGCCAATTTTGAGCAGCAGCTTATTGAAAAATGTGACCTGTTCGAAAATAGATGGATTGGTGCAAATCTTCGAGGCGCTTCATTTAAAGAATCAGATTTAAGCCGTGGTGTTTTTTCGGAAGACTGCTGGGAACAGTTTAGAGTACAAGGCTGTGATTTAAGCCATTCAGAGCTTTATGGTTTAGATCCTCGAAAGATTGATCTTACGGGTGTAAAAATATGCTCGTGGCAACAGGAACAGTTACTGGAGCAATTAGGGGTAATCATTGTTCCTGACTAA", "partial": "0", "query_start": 8766, "query_end": 9194, "hit_start": 189, "hit_end": 645, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 21.66}, "gnl|BL_ORD_ID|1239|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrVC1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1351", "ARO_accession": "3002799", "ARO_name": "QnrVC1", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00214308, "max_identities": 21, "bit_score": 34.2686, "cvterm_id": "36789", "query": "FEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAES-DFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGT", "match": "F  C   + +F + NLR T+F+ C+     FI+    E  DF+  D+   + + C L+ ++F  +  F  + +   +KG ", "sequence_from_db": "FSNCTFIHCNFKRSNLRDTQFINCT-----FIEQGALEGCDFSYADLRDASFKNCQLSMSHFKGANCFGIELRDCDLKGA", "sequence_from_broadstreet": "MEKSKQLYNQVNFSHQDLQEHIFSNCTFIHCNFKRSNLRDTQFINCTFIEQGALEGCDFSYADLRDASFKNCQLSMSHFKGANCFGIELRDCDLKGANFSQVSFVNQVSNKMYFCSAYITGCNLSYANFEQQLIEKCDLFENRWIGANLRGASFKESDLSRGVFSEDCWEQFRVQGCDLSHSELYGLDPRKIDLTGVKICSWQQEQLLEQLGVIIVPD", "dna_sequence_from_broadstreet": "ATGGAAAAATCAAAGCAATTATATAATCAAGTGAACTTCTCACATCAGGACTTGCAAGAACATATCTTTAGCAATTGTACTTTTATACATTGTAATTTTAAGCGCTCAAACCTCCGAGATACACAGTTCATTAACTGTACTTTCATAGAGCAGGGGGCATTGGAAGGGTGCGATTTTTCTTATGCTGATCTTCGAGATGCTTCATTTAAAAACTGTCAGCTTTCAATGTCCCATTTTAAGGGGGCAAATTGCTTTGGTATTGAACTGAGAGATTGTGATCTTAAAGGAGCAAATTTTAGTCAAGTTAGTTTTGTAAATCAGGTTTCGAATAAAATGTACTTTTGTTCTGCATACATAACAGGTTGTAACTTATCCTATGCCAATTTTGAGCAGCAGCTTATTGAAAAATGTGACCTGTTCGAAAATAGATGGATTGGTGCAAATCTTCGAGGCGCTTCATTTAAAGAATCAGATTTAAGCCGTGGTGTTTTTTCGGAAGACTGCTGGGAACAGTTTAGAGTACAAGGCTGTGATTTAAGCCATTCAGAGCTTTATGGTTTAGATCCTCGAAAGATTGATCTTACGGGTGTAAAAATATGCTCGTGGCAACAGGAACAGTTACTGGAGCAATTAGGGGTAATCATTGTTCCTGACTAA", "partial": "0", "query_start": 8904, "query_end": 9140, "hit_start": 66, "hit_end": 291, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 26.25}, "gnl|BL_ORD_ID|1239|hsp_num:2": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrVC1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1351", "ARO_accession": "3002799", "ARO_name": "QnrVC1", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00284412, "max_identities": 28, "bit_score": 33.8834, "cvterm_id": "36789", "query": "LEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFT--------GTDMPGCT--MQGCVLTKTNFAR", "match": "L++ +F  C  +    ++  LR     DT+ +   +   G +    F   DLR +SF    L  + F G +       D DL  ++F+           M  C+  + GC L+  NF +", "sequence_from_db": "LQEHIFSNCTFIHCNFKRSNLR-----DTQFINCTFIEQGALEGCDFSYADLRDASFKNCQLSMSHFKGANCFGIELRDCDLKGANFSQVSFVNQVSNKMYFCSAYITGCNLSYANFEQ", "sequence_from_broadstreet": "MEKSKQLYNQVNFSHQDLQEHIFSNCTFIHCNFKRSNLRDTQFINCTFIEQGALEGCDFSYADLRDASFKNCQLSMSHFKGANCFGIELRDCDLKGANFSQVSFVNQVSNKMYFCSAYITGCNLSYANFEQQLIEKCDLFENRWIGANLRGASFKESDLSRGVFSEDCWEQFRVQGCDLSHSELYGLDPRKIDLTGVKICSWQQEQLLEQLGVIIVPD", "dna_sequence_from_broadstreet": "ATGGAAAAATCAAAGCAATTATATAATCAAGTGAACTTCTCACATCAGGACTTGCAAGAACATATCTTTAGCAATTGTACTTTTATACATTGTAATTTTAAGCGCTCAAACCTCCGAGATACACAGTTCATTAACTGTACTTTCATAGAGCAGGGGGCATTGGAAGGGTGCGATTTTTCTTATGCTGATCTTCGAGATGCTTCATTTAAAAACTGTCAGCTTTCAATGTCCCATTTTAAGGGGGCAAATTGCTTTGGTATTGAACTGAGAGATTGTGATCTTAAAGGAGCAAATTTTAGTCAAGTTAGTTTTGTAAATCAGGTTTCGAATAAAATGTACTTTTGTTCTGCATACATAACAGGTTGTAACTTATCCTATGCCAATTTTGAGCAGCAGCTTATTGAAAAATGTGACCTGTTCGAAAATAGATGGATTGGTGCAAATCTTCGAGGCGCTTCATTTAAAGAATCAGATTTAAGCCGTGGTGTTTTTTCGGAAGACTGCTGGGAACAGTTTAGAGTACAAGGCTGTGATTTAAGCCATTCAGAGCTTTATGGTTTAGATCCTCGAAAGATTGATCTTACGGGTGTAAAAATATGCTCGTGGCAACAGGAACAGTTACTGGAGCAATTAGGGGTAATCATTGTTCCTGACTAA", "partial": "0", "query_start": 8766, "query_end": 9092, "hit_start": 51, "hit_end": 393, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 23.53}, "gnl|BL_ORD_ID|1613|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB35", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1760", "ARO_accession": "3002750", "ARO_name": "QnrB35", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.11973e-05, "max_identities": 36, "bit_score": 38.891, "cvterm_id": "36915", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL       ++   +  +  R  G D+ G   M                 +L Y++F K  L K      R++G     A     DL+  +F+  D        C LT +          D +   ++G ++    A  L + LG+ V G", "sequence_from_db": "RAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQMLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGD-----LDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "sequence_from_broadstreet": "MALALIGEKIDRNRFTGAKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQMLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCATTAATTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGCAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGCGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGAGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTATGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGATGCTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAGCTATCAGGCCGCGTTGCTCATGGAACGTCTTGGCATCGCTGTCATTGGCTAA", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 171, "hit_end": 642, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.22}, "gnl|BL_ORD_ID|1613|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB35", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1760", "ARO_accession": "3002750", "ARO_name": "QnrB35", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0484762, "max_identities": 15, "bit_score": 30.4166, "cvterm_id": "36915", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTGAKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MALALIGEKIDRNRFTGAKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQMLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCATTAATTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGCAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGCGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGAGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTATGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGATGCTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAGCTATCAGGCCGCGTTGCTCATGGAACGTCTTGGCATCGCTGTCATTGGCTAA", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 27, "hit_end": 177, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|1229|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB8", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1335", "ARO_accession": "3002722", "ARO_name": "QnrB8", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.54343e-05, "max_identities": 36, "bit_score": 38.891, "cvterm_id": "36915", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL       ++   +  +  R  G D+ G   M                 +L Y++F K  L K      R++G     A     DL+  +F+  D        C LT +          D +   ++G ++    A  L + LG+ V G", "sequence_from_db": "RAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGD-----LDIRGVDLQGVKLDNYQAALLMERLGIAVIG", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGCGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGGTACTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAACTATCAGGCCGCATTGCTCATGGAACGTCTTGGCATCGCTGTGATTGGCTAG", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 171, "hit_end": 642, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.22}, "gnl|BL_ORD_ID|1229|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB8", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1335", "ARO_accession": "3002722", "ARO_name": "QnrB8", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.129286, "max_identities": 15, "bit_score": 29.261, "cvterm_id": "36915", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGCGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGGTACTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAACTATCAGGCCGCATTGCTCATGGAACGTCTTGGCATCGCTGTGATTGGCTAG", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 27, "hit_end": 177, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|717|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB25", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "781", "ARO_accession": "3002740", "ARO_name": "QnrB25", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.19989e-05, "max_identities": 35, "bit_score": 38.5058, "cvterm_id": "36915", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDG", "match": "R+ L+D +F+ CDL       ++   +  +  R  G D+ G   M                 +L Y++F K  L K      R++G     A     DL+  +F+  D        C LT +          D +   ++G ++    A  L + LG+ + G", "sequence_from_db": "RAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITSTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGD-----LDIRGVDLQGVKLDSYQAALLMERLGIAIIG", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITSTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGCGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAGTACCAATCTAAGCTACGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGGTGCTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAGCTATCAGGCCGCATTGCTCATGGAACGTCTTGGCATCGCTATCATTGGCTAA", "partial": "0", "query_start": 8757, "query_end": 9200, "hit_start": 171, "hit_end": 642, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 21.6}, "gnl|BL_ORD_ID|717|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB25", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "781", "ARO_accession": "3002740", "ARO_name": "QnrB25", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.136728, "max_identities": 15, "bit_score": 28.8758, "cvterm_id": "36915", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITSTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGCGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAGTACCAATCTAAGCTACGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGGTGCTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAGCTATCAGGCCGCATTGCTCATGGAACGTCTTGGCATCGCTATCATTGGCTAA", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 27, "hit_end": 177, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|1663|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrVC3", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1803", "ARO_accession": "3002800", "ARO_name": "QnrVC3", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.37699e-05, "max_identities": 33, "bit_score": 38.5058, "cvterm_id": "36920", "query": "LEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQ---------CDLRYSSFL-----KLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVV", "match": "L D  F+ C L     +      +  +D  L G +++ +  +  V  +          C+L Y++F      K +L + R++G + R A+F +  L+  DF+        +QGC L+ +       +  DP+   + G ++       L + LG+++", "sequence_from_db": "LRDASFKNCQLSMSHFKGANCFGIELRDCDLKGANFTQVSFVNQVSNKMYFCSAYITGCNLSYANFEQQLIEKCDLFENRWIGANLRGASFTESYLSRGDFSEDCWEQFRVQGCDLSHSEL-----YGLDPRKIDLTGVKICSWQQEQLLEQLGVII", "sequence_from_broadstreet": "MEKSKQLYNQVNFSHQDLQEHIFSNCTFIHCNFKRSNLRDTQFINCTFIEQGALEGCDFSYADLRDASFKNCQLSMSHFKGANCFGIELRDCDLKGANFTQVSFVNQVSNKMYFCSAYITGCNLSYANFEQQLIEKCDLFENRWIGANLRGASFTESYLSRGDFSEDCWEQFRVQGCDLSHSELYGLDPRKIDLTGVKICSWQQEQLLEQLGVIIVPD", "dna_sequence_from_broadstreet": "ATGGAAAAATCAAAGCAATTATATAATCAAGTGAACTTCTCACATCAGGACTTGCAAGAACATATCTTTAGCAATTGTACTTTTATACATTGTAATTTTAAGCGCTCAAACCTCCGAGATACACAGTTCATTAACTGTACTTTCATAGAGCAGGGGGCATTGGAAGGGTGCGATTTTTCTTATGCTGATCTTCGAGATGCTTCATTTAAAAACTGTCAGCTTTCAATGTCCCATTTTAAGGGGGCAAATTGCTTTGGTATTGAACTGAGAGATTGTGATCTTAAAGGAGCAAATTTTACTCAAGTTAGTTTTGTAAATCAGGTTTCGAATAAAATGTACTTTTGTTCTGCATACATAACAGGTTGTAACTTATCCTATGCCAATTTTGAGCAGCAGCTTATTGAAAAATGTGACCTGTTCGAAAATAGATGGATTGGTGCAAATCTTCGAGGCGCTTCATTTACAGAATCATATTTAAGCCGTGGTGATTTTTCGGAAGACTGCTGGGAACAGTTTAGAGTACAAGGCTGTGATTTAAGCCATTCAGAGCTTTATGGTTTAGATCCTCGAAAGATTGATCTTACGGGTGTAAAAATATGCTCGTGGCAACAGGAACAGTTACTGGAGCAATTAGGGGTAATCATTGTTCCTGACTAA", "partial": "0", "query_start": 8766, "query_end": 9194, "hit_start": 189, "hit_end": 645, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 21.02}, "gnl|BL_ORD_ID|1663|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrVC3", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1803", "ARO_accession": "3002800", "ARO_name": "QnrVC3", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00126275, "max_identities": 29, "bit_score": 35.039, "cvterm_id": "36920", "query": "LEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFT--------GTDMPGCT--MQGCVLTKTNFAR", "match": "L++ +F  C  +    ++  LR     DT+ +   +   G +    F   DLR +SF    L  + F G +       D DL  ++FT           M  C+  + GC L+  NF +", "sequence_from_db": "LQEHIFSNCTFIHCNFKRSNLR-----DTQFINCTFIEQGALEGCDFSYADLRDASFKNCQLSMSHFKGANCFGIELRDCDLKGANFTQVSFVNQVSNKMYFCSAYITGCNLSYANFEQ", "sequence_from_broadstreet": "MEKSKQLYNQVNFSHQDLQEHIFSNCTFIHCNFKRSNLRDTQFINCTFIEQGALEGCDFSYADLRDASFKNCQLSMSHFKGANCFGIELRDCDLKGANFTQVSFVNQVSNKMYFCSAYITGCNLSYANFEQQLIEKCDLFENRWIGANLRGASFTESYLSRGDFSEDCWEQFRVQGCDLSHSELYGLDPRKIDLTGVKICSWQQEQLLEQLGVIIVPD", "dna_sequence_from_broadstreet": "ATGGAAAAATCAAAGCAATTATATAATCAAGTGAACTTCTCACATCAGGACTTGCAAGAACATATCTTTAGCAATTGTACTTTTATACATTGTAATTTTAAGCGCTCAAACCTCCGAGATACACAGTTCATTAACTGTACTTTCATAGAGCAGGGGGCATTGGAAGGGTGCGATTTTTCTTATGCTGATCTTCGAGATGCTTCATTTAAAAACTGTCAGCTTTCAATGTCCCATTTTAAGGGGGCAAATTGCTTTGGTATTGAACTGAGAGATTGTGATCTTAAAGGAGCAAATTTTACTCAAGTTAGTTTTGTAAATCAGGTTTCGAATAAAATGTACTTTTGTTCTGCATACATAACAGGTTGTAACTTATCCTATGCCAATTTTGAGCAGCAGCTTATTGAAAAATGTGACCTGTTCGAAAATAGATGGATTGGTGCAAATCTTCGAGGCGCTTCATTTACAGAATCATATTTAAGCCGTGGTGATTTTTCGGAAGACTGCTGGGAACAGTTTAGAGTACAAGGCTGTGATTTAAGCCATTCAGAGCTTTATGGTTTAGATCCTCGAAAGATTGATCTTACGGGTGTAAAAATATGCTCGTGGCAACAGGAACAGTTACTGGAGCAATTAGGGGTAATCATTGTTCCTGACTAA", "partial": "0", "query_start": 8766, "query_end": 9092, "hit_start": 51, "hit_end": 393, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 24.37}, "gnl|BL_ORD_ID|1663|hsp_num:2": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrVC3", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1803", "ARO_accession": "3002800", "ARO_name": "QnrVC3", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00231113, "max_identities": 21, "bit_score": 34.2686, "cvterm_id": "36920", "query": "FEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAES-DFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGT", "match": "F  C   + +F + NLR T+F+ C+     FI+    E  DF+  D+   + + C L+ ++F  +  F  + +   +KG ", "sequence_from_db": "FSNCTFIHCNFKRSNLRDTQFINCT-----FIEQGALEGCDFSYADLRDASFKNCQLSMSHFKGANCFGIELRDCDLKGA", "sequence_from_broadstreet": "MEKSKQLYNQVNFSHQDLQEHIFSNCTFIHCNFKRSNLRDTQFINCTFIEQGALEGCDFSYADLRDASFKNCQLSMSHFKGANCFGIELRDCDLKGANFTQVSFVNQVSNKMYFCSAYITGCNLSYANFEQQLIEKCDLFENRWIGANLRGASFTESYLSRGDFSEDCWEQFRVQGCDLSHSELYGLDPRKIDLTGVKICSWQQEQLLEQLGVIIVPD", "dna_sequence_from_broadstreet": "ATGGAAAAATCAAAGCAATTATATAATCAAGTGAACTTCTCACATCAGGACTTGCAAGAACATATCTTTAGCAATTGTACTTTTATACATTGTAATTTTAAGCGCTCAAACCTCCGAGATACACAGTTCATTAACTGTACTTTCATAGAGCAGGGGGCATTGGAAGGGTGCGATTTTTCTTATGCTGATCTTCGAGATGCTTCATTTAAAAACTGTCAGCTTTCAATGTCCCATTTTAAGGGGGCAAATTGCTTTGGTATTGAACTGAGAGATTGTGATCTTAAAGGAGCAAATTTTACTCAAGTTAGTTTTGTAAATCAGGTTTCGAATAAAATGTACTTTTGTTCTGCATACATAACAGGTTGTAACTTATCCTATGCCAATTTTGAGCAGCAGCTTATTGAAAAATGTGACCTGTTCGAAAATAGATGGATTGGTGCAAATCTTCGAGGCGCTTCATTTACAGAATCATATTTAAGCCGTGGTGATTTTTCGGAAGACTGCTGGGAACAGTTTAGAGTACAAGGCTGTGATTTAAGCCATTCAGAGCTTTATGGTTTAGATCCTCGAAAGATTGATCTTACGGGTGTAAAAATATGCTCGTGGCAACAGGAACAGTTACTGGAGCAATTAGGGGTAATCATTGTTCCTGACTAA", "partial": "0", "query_start": 8904, "query_end": 9140, "hit_start": 66, "hit_end": 291, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 26.25}, "gnl|BL_ORD_ID|2107|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrS11", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "455", "model_id": "3323", "ARO_accession": "3004624", "ARO_name": "QnrS11", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.73761e-05, "max_identities": 31, "bit_score": 38.5058, "cvterm_id": "35914", "query": "TFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCS----------------AREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNF", "match": "T++       D SGL       F  C    S F + NLR T FV C                  R+A+F    LA ++F+  +  G   + C L   NF+R TNF", "sequence_from_db": "TYRHHNFSHKDLSGL------TFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSR-TNF", "sequence_from_broadstreet": "METYNHTYRHHNFSHKDLSGLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACAATCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGGTCTCACCTTCACCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 8838, "query_end": 9104, "hit_start": 18, "hit_end": 312, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 29.52}, "gnl|BL_ORD_ID|2107|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrS11", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "455", "model_id": "3323", "ARO_accession": "3004624", "ARO_name": "QnrS11", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000173952, "max_identities": 29, "bit_score": 37.7354, "cvterm_id": "35914", "query": "VFEGCDLLRMVPEKLALRSVTFKDTRLMGV-DWSG----LGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCT--MQGCVLTKTNFAR", "match": " F  C  +R    +  LR  TF + + +   D  G    +  + D  F+QC L  ++F   N     F  C  + ANF   + A        M  C+  + GC L+  N  R", "sequence_from_db": "TFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQ--VSNRMYFCSAFISGCNLSYANMER", "sequence_from_broadstreet": "METYNHTYRHHNFSHKDLSGLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACAATCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGGTCTCACCTTCACCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 8778, "query_end": 9092, "hit_start": 63, "hit_end": 393, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 25.89}, "gnl|BL_ORD_ID|2107|hsp_num:2": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrS11", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "455", "model_id": "3323", "ARO_accession": "3004624", "ARO_name": "QnrS11", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00346673, "max_identities": 39, "bit_score": 33.8834, "cvterm_id": "35914", "query": "SRWVRSRLEDCVFEGCDLLRMVP------EKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRK---------TRFV-GCSAREANFIDV-----DLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIF---------------DPKANQVKGTRVGVETAVALAQALGMVV", "match": "S + R+ L D  F  C  +          +   LR  +F+  +L   ++S       ++F  CDL+ ++F + N            + F+ GC+   AN   V     +L E+ + GT++ G +++   L++  F+      F               DP+     G ++       + +ALG+VV", "sequence_from_db": "SDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYG-IEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVV", "sequence_from_broadstreet": "METYNHTYRHHNFSHKDLSGLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACAATCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGGTCTCACCTTCACCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 8745, "query_end": 9194, "hit_start": 90, "hit_end": 645, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 20.97}, "gnl|BL_ORD_ID|1449|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrVC6", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1583", "ARO_accession": "3002803", "ARO_name": "QnrVC6", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.72857e-05, "max_identities": 34, "bit_score": 38.1206, "cvterm_id": "39615", "query": "LEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQ---------CDLRYSSFL-----KLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVV", "match": "L D  F+ C L     +      +  +D  L G ++S +  +  V  +          C+L Y++F      K +L + R++G + R A+F + DL+   F+        +QGC L+ +       +  DP+   + G ++       L + LG+++", "sequence_from_db": "LRDASFKDCQLSMSHFKGANCFGIELRDCDLKGANFSQVSFVNQVSNKMYFCSAYITGCNLSYANFEQQLIEKCDLFENRWIGANLRGASFKESDLSRGVFSEDCWEQFRVQGCDLSHSEL-----YGLDPRKIDLTGVKICSWQQEQLLEQLGVII", "sequence_from_broadstreet": "MEKSKQLYNQVNFSHQDLQEHIFSNCTFIHCNFKRSNLRDTQFINCTFIEQGALEGCDFSYADLRDASFKDCQLSMSHFKGANCFGIELRDCDLKGANFSQVSFVNQVSNKMYFCSAYITGCNLSYANFEQQLIEKCDLFENRWIGANLRGASFKESDLSRGVFSEDCWEQFRVQGCDLSHSELYGLDPRKIDLTGVKICSWQQEQLLEQLGVIIVPD", "dna_sequence_from_broadstreet": "ATGGAAAAATCAAAGCAATTATATAATCAAGTGAACTTCTCACATCAGGACTTGCAAGAACATATCTTTAGCAATTGTACTTTTATACATTGTAATTTTAAGCGCTCAAACCTTCGAGATACACAGTTCATTAACTGTACTTTCATAGAGCAGGGGGCACTGGAAGGGTGCGATTTTTCTTATGCTGATCTTCGAGATGCTTCATTTAAAGATTGTCAGCTTTCAATGTCCCATTTTAAGGGGGCAAATTGCTTTGGTATTGAACTGAGAGATTGTGATCTTAAAGGGGCAAATTTTAGCCAAGTTAGTTTTGTAAATCAGGTTTCGAATAAAATGTACTTTTGCTCTGCATACATAACAGGTTGTAACTTATCCTATGCCAATTTTGAGCAGCAGCTTATTGAAAAATGTGACCTGTTCGAAAATAGATGGATTGGTGCAAATCTTCGAGGCGCTTCATTTAAAGAATCAGATTTAAGTCGTGGCGTTTTTTCAGAAGACTGCTGGGAACAGTTTAGAGTACAAGGCTGTGATTTAAGTCATTCAGAGCTTTATGGTTTAGATCCTCGAAAGATTGATCTTACAGGTGTAAAAATATGCTCGTGGCAACAGGAGCAGTTACTGGAGCAATTAGGGGTAATCATTGTTCCTGACTAA", "partial": "0", "query_start": 8766, "query_end": 9194, "hit_start": 189, "hit_end": 645, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 21.66}, "gnl|BL_ORD_ID|1449|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrVC6", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1583", "ARO_accession": "3002803", "ARO_name": "QnrVC6", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000128262, "max_identities": 22, "bit_score": 38.1206, "cvterm_id": "39615", "query": "FEQCDLRYSSFLKLNLRKTRFVGCS----------------AREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFAR", "match": "F  C   + +F + NLR T+F+ C+                 R+A+F D  L+ S F G +  G  ++ C L   NF++", "sequence_from_db": "FSNCTFIHCNFKRSNLRDTQFINCTFIEQGALEGCDFSYADLRDASFKDCQLSMSHFKGANCFGIELRDCDLKGANFSQ", "sequence_from_broadstreet": "MEKSKQLYNQVNFSHQDLQEHIFSNCTFIHCNFKRSNLRDTQFINCTFIEQGALEGCDFSYADLRDASFKDCQLSMSHFKGANCFGIELRDCDLKGANFSQVSFVNQVSNKMYFCSAYITGCNLSYANFEQQLIEKCDLFENRWIGANLRGASFKESDLSRGVFSEDCWEQFRVQGCDLSHSELYGLDPRKIDLTGVKICSWQQEQLLEQLGVIIVPD", "dna_sequence_from_broadstreet": "ATGGAAAAATCAAAGCAATTATATAATCAAGTGAACTTCTCACATCAGGACTTGCAAGAACATATCTTTAGCAATTGTACTTTTATACATTGTAATTTTAAGCGCTCAAACCTTCGAGATACACAGTTCATTAACTGTACTTTCATAGAGCAGGGGGCACTGGAAGGGTGCGATTTTTCTTATGCTGATCTTCGAGATGCTTCATTTAAAGATTGTCAGCTTTCAATGTCCCATTTTAAGGGGGCAAATTGCTTTGGTATTGAACTGAGAGATTGTGATCTTAAAGGGGCAAATTTTAGCCAAGTTAGTTTTGTAAATCAGGTTTCGAATAAAATGTACTTTTGCTCTGCATACATAACAGGTTGTAACTTATCCTATGCCAATTTTGAGCAGCAGCTTATTGAAAAATGTGACCTGTTCGAAAATAGATGGATTGGTGCAAATCTTCGAGGCGCTTCATTTAAAGAATCAGATTTAAGTCGTGGCGTTTTTTCAGAAGACTGCTGGGAACAGTTTAGAGTACAAGGCTGTGATTTAAGTCATTCAGAGCTTTATGGTTTAGATCCTCGAAAGATTGATCTTACAGGTGTAAAAATATGCTCGTGGCAACAGGAGCAGTTACTGGAGCAATTAGGGGTAATCATTGTTCCTGACTAA", "partial": "0", "query_start": 8904, "query_end": 9092, "hit_start": 66, "hit_end": 303, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.85}, "gnl|BL_ORD_ID|1449|hsp_num:2": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrVC6", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1583", "ARO_accession": "3002803", "ARO_name": "QnrVC6", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00464234, "max_identities": 28, "bit_score": 33.4982, "cvterm_id": "39615", "query": "LEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFT--------GTDMPGCT--MQGCVLTKTNFAR", "match": "L++ +F  C  +    ++  LR     DT+ +   +   G +    F   DLR +SF    L  + F G +       D DL  ++F+           M  C+  + GC L+  NF +", "sequence_from_db": "LQEHIFSNCTFIHCNFKRSNLR-----DTQFINCTFIEQGALEGCDFSYADLRDASFKDCQLSMSHFKGANCFGIELRDCDLKGANFSQVSFVNQVSNKMYFCSAYITGCNLSYANFEQ", "sequence_from_broadstreet": "MEKSKQLYNQVNFSHQDLQEHIFSNCTFIHCNFKRSNLRDTQFINCTFIEQGALEGCDFSYADLRDASFKDCQLSMSHFKGANCFGIELRDCDLKGANFSQVSFVNQVSNKMYFCSAYITGCNLSYANFEQQLIEKCDLFENRWIGANLRGASFKESDLSRGVFSEDCWEQFRVQGCDLSHSELYGLDPRKIDLTGVKICSWQQEQLLEQLGVIIVPD", "dna_sequence_from_broadstreet": "ATGGAAAAATCAAAGCAATTATATAATCAAGTGAACTTCTCACATCAGGACTTGCAAGAACATATCTTTAGCAATTGTACTTTTATACATTGTAATTTTAAGCGCTCAAACCTTCGAGATACACAGTTCATTAACTGTACTTTCATAGAGCAGGGGGCACTGGAAGGGTGCGATTTTTCTTATGCTGATCTTCGAGATGCTTCATTTAAAGATTGTCAGCTTTCAATGTCCCATTTTAAGGGGGCAAATTGCTTTGGTATTGAACTGAGAGATTGTGATCTTAAAGGGGCAAATTTTAGCCAAGTTAGTTTTGTAAATCAGGTTTCGAATAAAATGTACTTTTGCTCTGCATACATAACAGGTTGTAACTTATCCTATGCCAATTTTGAGCAGCAGCTTATTGAAAAATGTGACCTGTTCGAAAATAGATGGATTGGTGCAAATCTTCGAGGCGCTTCATTTAAAGAATCAGATTTAAGTCGTGGCGTTTTTTCAGAAGACTGCTGGGAACAGTTTAGAGTACAAGGCTGTGATTTAAGTCATTCAGAGCTTTATGGTTTAGATCCTCGAAAGATTGATCTTACAGGTGTAAAAATATGCTCGTGGCAACAGGAGCAGTTACTGGAGCAATTAGGGGTAATCATTGTTCCTGACTAA", "partial": "0", "query_start": 8766, "query_end": 9092, "hit_start": 51, "hit_end": 393, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 23.53}, "gnl|BL_ORD_ID|356|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrS5", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "393", "ARO_accession": "3002794", "ARO_name": "QnrS5", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000112243, "max_identities": 29, "bit_score": 38.1206, "cvterm_id": "36957", "query": "VFEGCDLLRMVPEKLALRSVTFKDTRLMGV-DWSG----LGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCT--MQGCVLTKTNFAR", "match": " F  C  +R    +  LR  TF + + +   D  G    +  + D  F+QC L  ++F   N     F  C  + ANF   + A        M  C+  + GC L+  N  R", "sequence_from_db": "TFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQ--VSNRMYFCSAFITGCTLSYANMER", "sequence_from_broadstreet": "METYRHTYRHHNFSHKDLSALTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFITGCTLSYANMERVCLERCELFENRWIGTHLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQEQLLEALGIVVFPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACCGTCACACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGCTCTCACCTTCACTGCTTGCACATTTATTCGCAGCGACTTTCGACGAGCTAACTTGCGCGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTGGCGATGGCAAACTTCAGTAACGCCAATTGCTACGGTATTGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCCTTTATTACAGGATGTACTCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAGATGTGAGTTGTTTGAAAATCGCTGGATAGGAACTCATCTAGCGGGTGCATCATTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTAGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCTTGGCAGCAAGAACAGCTTCTCGAAGCACTGGGTATTGTTGTTTTTCCTGACTAG", "partial": "0", "query_start": 8778, "query_end": 9092, "hit_start": 63, "hit_end": 393, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 25.89}, "gnl|BL_ORD_ID|356|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrS5", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "393", "ARO_accession": "3002794", "ARO_name": "QnrS5", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000316621, "max_identities": 26, "bit_score": 36.965, "cvterm_id": "36957", "query": "MPDVQFEQCDLRYSSFLKLNLRKTRFVGCS----------------AREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNF", "match": "+  + F  C    S F + NLR T FV C                  R+A+F    LA ++F+  +  G   + C L   NF+R TNF", "sequence_from_db": "LSALTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSR-TNF", "sequence_from_broadstreet": "METYRHTYRHHNFSHKDLSALTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFITGCTLSYANMERVCLERCELFENRWIGTHLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQEQLLEALGIVVFPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACCGTCACACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGCTCTCACCTTCACTGCTTGCACATTTATTCGCAGCGACTTTCGACGAGCTAACTTGCGCGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTGGCGATGGCAAACTTCAGTAACGCCAATTGCTACGGTATTGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCCTTTATTACAGGATGTACTCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAGATGTGAGTTGTTTGAAAATCGCTGGATAGGAACTCATCTAGCGGGTGCATCATTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTAGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCTTGGCAGCAAGAACAGCTTCTCGAAGCACTGGGTATTGTTGTTTTTCCTGACTAG", "partial": "0", "query_start": 8889, "query_end": 9104, "hit_start": 51, "hit_end": 312, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 29.55}, "gnl|BL_ORD_ID|356|hsp_num:2": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrS5", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "393", "ARO_accession": "3002794", "ARO_name": "QnrS5", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00256386, "max_identities": 40, "bit_score": 34.2686, "cvterm_id": "36957", "query": "SRWVRSRLEDCVFEGCDLLRMVP------EKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRK---------TRFV-GCSAREANFIDV-----DLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIF---------------DPKANQVKGTRVGVETAVALAQALGMVV", "match": "S + R+ L D  F  C  +          +   LR  +F+  +L   ++S       ++F  CDL+ ++F + N            + F+ GC+   AN   V     +L E+ + GT + G +++   L++  F+      F               DP+     G ++       L +ALG+VV", "sequence_from_db": "SDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYG-IEFRACDLKGANFSRTNFAHQVSNRMYFCSAFITGCTLSYANMERVCLERCELFENRWIGTHLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQEQLLEALGIVV", "sequence_from_broadstreet": "METYRHTYRHHNFSHKDLSALTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFITGCTLSYANMERVCLERCELFENRWIGTHLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQEQLLEALGIVVFPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACCGTCACACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGCTCTCACCTTCACTGCTTGCACATTTATTCGCAGCGACTTTCGACGAGCTAACTTGCGCGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTGGCGATGGCAAACTTCAGTAACGCCAATTGCTACGGTATTGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCCTTTATTACAGGATGTACTCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAGATGTGAGTTGTTTGAAAATCGCTGGATAGGAACTCATCTAGCGGGTGCATCATTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTAGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCTTGGCAGCAAGAACAGCTTCTCGAAGCACTGGGTATTGTTGTTTTTCCTGACTAG", "partial": "0", "query_start": 8745, "query_end": 9194, "hit_start": 90, "hit_end": 645, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 21.51}, "gnl|BL_ORD_ID|475|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrD2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "517", "ARO_accession": "3002789", "ARO_name": "QnrD2", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00019606, "max_identities": 35, "bit_score": 37.3502, "cvterm_id": "35743", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVV", "match": "R++L++  F+ CDL     + ++   +   +    G D+ G   M               + +L Y++F ++ L K      R+ G     A F   DL+  +F+  D       GC LT            D +   + G ++  E A  L ++LG++V", "sequence_from_db": "RAKLKNASFKSCDLSMSNFKNISALGLEISECLAQGADFRGANFMNMITTRSWFCSAYITKTNLSYANFSRVILEKCELWENRWNGTVITGAVFRGSDLSCGEFSSFDWSLADFTGCDLTGGALGE-----LDARRTNLDGVKLDGEQAFQLVESLGVIV", "sequence_from_broadstreet": "MEKHFINEKFSRDQFTGNRVKNIAFSNCDFSGVDLTDTEFVDCSFYDRNSLEGCDFNRAKLKNASFKSCDLSMSNFKNISALGLEISECLAQGADFRGANFMNMITTRSWFCSAYITKTNLSYANFSRVILEKCELWENRWNGTVITGAVFRGSDLSCGEFSSFDWSLADFTGCDLTGGALGELDARRTNLDGVKLDGEQAFQLVESLGVIVHR", "dna_sequence_from_broadstreet": "ATGGAAAAGCACTTTATCAATGAAAAGTTTTCACGAGATCAATTTACGGGGAATAGAGTTAAAAATATTGCCTTTTCAAATTGTGATTTTTCAGGGGTTGATTTAACTGATACTGAATTTGTTGATTGTAGTTTTTACGACAGGAATAGCTTGGAAGGGTGTGATTTTAATAGAGCCAAACTAAAAAACGCTAGCTTTAAAAGCTGCGATTTATCAATGAGTAATTTTAAAAACATTAGCGCCTTAGGTCTTGAGATTAGTGAGTGTTTAGCTCAAGGAGCTGATTTTCGAGGGGCTAATTTTATGAATATGATAACTACAAGGTCATGGTTTTGTAGTGCTTATATAACCAAGACAAATCTTAGTTACGCTAATTTTTCTAGAGTCATATTAGAAAAGTGCGAACTGTGGGAAAATCGCTGGAATGGCACTGTGATAACTGGCGCCGTGTTTCGTGGCTCCGATCTTTCTTGTGGGGAGTTTTCATCGTTTGATTGGTCTTTGGCTGATTTTACTGGTTGTGATTTAACGGGTGGGGCGCTTGGCGAGCTTGATGCAAGACGAACTAATTTAGATGGCGTGAAGTTGGATGGAGAACAGGCGTTTCAGCTTGTTGAGAGTTTAGGTGTTATTGTTCACCGATAA", "partial": "0", "query_start": 8757, "query_end": 9194, "hit_start": 171, "hit_end": 636, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 21.88}, "gnl|BL_ORD_ID|475|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrD2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "517", "ARO_accession": "3002789", "ARO_name": "QnrD2", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.84737, "max_identities": 21, "bit_score": 25.0238, "cvterm_id": "35743", "query": "SRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNF", "match": "+R+++  F  CD             V   DT  +   +    ++    F +  L+ +SF   +L  + F   SA     + ++++E    G D  G      + T++ F", "sequence_from_db": "NRVKNIAFSNCDF----------SGVDLTDTEFVDCSFYDRNSLEGCDFNRAKLKNASFKSCDLSMSNFKNISA-----LGLEISECLAQGADFRGANFMNMITTRSWF", "sequence_from_broadstreet": "MEKHFINEKFSRDQFTGNRVKNIAFSNCDFSGVDLTDTEFVDCSFYDRNSLEGCDFNRAKLKNASFKSCDLSMSNFKNISALGLEISECLAQGADFRGANFMNMITTRSWFCSAYITKTNLSYANFSRVILEKCELWENRWNGTVITGAVFRGSDLSCGEFSSFDWSLADFTGCDLTGGALGELDARRTNLDGVKLDGEQAFQLVESLGVIVHR", "dna_sequence_from_broadstreet": "ATGGAAAAGCACTTTATCAATGAAAAGTTTTCACGAGATCAATTTACGGGGAATAGAGTTAAAAATATTGCCTTTTCAAATTGTGATTTTTCAGGGGTTGATTTAACTGATACTGAATTTGTTGATTGTAGTTTTTACGACAGGAATAGCTTGGAAGGGTGTGATTTTAATAGAGCCAAACTAAAAAACGCTAGCTTTAAAAGCTGCGATTTATCAATGAGTAATTTTAAAAACATTAGCGCCTTAGGTCTTGAGATTAGTGAGTGTTTAGCTCAAGGAGCTGATTTTCGAGGGGCTAATTTTATGAATATGATAACTACAAGGTCATGGTTTTGTAGTGCTTATATAACCAAGACAAATCTTAGTTACGCTAATTTTTCTAGAGTCATATTAGAAAAGTGCGAACTGTGGGAAAATCGCTGGAATGGCACTGTGATAACTGGCGCCGTGTTTCGTGGCTCCGATCTTTCTTGTGGGGAGTTTTCATCGTTTGATTGGTCTTTGGCTGATTTTACTGGTTGTGATTTAACGGGTGGGGCGCTTGGCGAGCTTGATGCAAGACGAACTAATTTAGATGGCGTGAAGTTGGATGGAGAACAGGCGTTTCAGCTTGTTGAGAGTTTAGGTGTTATTGTTCACCGATAA", "partial": "0", "query_start": 8760, "query_end": 9086, "hit_start": 51, "hit_end": 333, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 19.27}, "gnl|BL_ORD_ID|475|hsp_num:2": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrD2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "517", "ARO_accession": "3002789", "ARO_name": "QnrD2", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.97064, "max_identities": 18, "bit_score": 24.6386, "cvterm_id": "35743", "query": "FLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARSTNFIFDPKANQVKG-TRVGVETAVALAQA", "match": "F+     + +F G   +   F + D +  D T T+   C      +++GC   +     ++    D   +  K  + +G+E +  LAQ ", "sequence_from_db": "FINEKFSRDQFTGNRVKNIAFSNCDFSGVDLTDTEFVDCSFYDRNSLEGCDFNRAKLKNASFKSCDLSMSNFKNISALGLEISECLAQG", "sequence_from_broadstreet": "MEKHFINEKFSRDQFTGNRVKNIAFSNCDFSGVDLTDTEFVDCSFYDRNSLEGCDFNRAKLKNASFKSCDLSMSNFKNISALGLEISECLAQGADFRGANFMNMITTRSWFCSAYITKTNLSYANFSRVILEKCELWENRWNGTVITGAVFRGSDLSCGEFSSFDWSLADFTGCDLTGGALGELDARRTNLDGVKLDGEQAFQLVESLGVIVHR", "dna_sequence_from_broadstreet": "ATGGAAAAGCACTTTATCAATGAAAAGTTTTCACGAGATCAATTTACGGGGAATAGAGTTAAAAATATTGCCTTTTCAAATTGTGATTTTTCAGGGGTTGATTTAACTGATACTGAATTTGTTGATTGTAGTTTTTACGACAGGAATAGCTTGGAAGGGTGTGATTTTAATAGAGCCAAACTAAAAAACGCTAGCTTTAAAAGCTGCGATTTATCAATGAGTAATTTTAAAAACATTAGCGCCTTAGGTCTTGAGATTAGTGAGTGTTTAGCTCAAGGAGCTGATTTTCGAGGGGCTAATTTTATGAATATGATAACTACAAGGTCATGGTTTTGTAGTGCTTATATAACCAAGACAAATCTTAGTTACGCTAATTTTTCTAGAGTCATATTAGAAAAGTGCGAACTGTGGGAAAATCGCTGGAATGGCACTGTGATAACTGGCGCCGTGTTTCGTGGCTCCGATCTTTCTTGTGGGGAGTTTTCATCGTTTGATTGGTCTTTGGCTGATTTTACTGGTTGTGATTTAACGGGTGGGGCGCTTGGCGAGCTTGATGCAAGACGAACTAATTTAGATGGCGTGAAGTTGGATGGAGAACAGGCGTTTCAGCTTGTTGAGAGTTTAGGTGTTATTGTTCACCGATAA", "partial": "0", "query_start": 8934, "query_end": 9179, "hit_start": 12, "hit_end": 279, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 20.22}, "gnl|BL_ORD_ID|2180|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrS15", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "3326", "ARO_accession": "3004627", "ARO_name": "QnrS15", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000200636, "max_identities": 24, "bit_score": 37.3502, "cvterm_id": "35914", "query": "MPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGT", "match": "+ D+ F  C    S F + NLR T FV C   E      D+    F   D+   + Q C L   NF+ +  +  + +A  +KG ", "sequence_from_db": "LSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQG----DIEGCRFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGA", "sequence_from_broadstreet": "METYNHTYRHHNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCRFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACAATCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCACCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCGCTTTGATGTCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 8889, "query_end": 9140, "hit_start": 51, "hit_end": 291, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 28.57}, "gnl|BL_ORD_ID|2180|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrS15", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "3326", "ARO_accession": "3004627", "ARO_name": "QnrS15", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00162976, "max_identities": 27, "bit_score": 34.6538, "cvterm_id": "35914", "query": "LEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFAR", "match": "L D  F  C  +R    +  LR  TF + + +       G +   +F+  DLR +SF +          C    ANF     + ++  G +   C ++G   ++TNFA ", "sequence_from_db": "LSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQ-----GDIEGCRFDVADLRDASFQQ----------CQLAMANF-----SNANCYGIEFRACDLKGANFSRTNFAH", "sequence_from_broadstreet": "METYNHTYRHHNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCRFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACAATCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCACCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCGCTTTGATGTCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 8766, "query_end": 9092, "hit_start": 51, "hit_end": 318, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 24.77}, "gnl|BL_ORD_ID|758|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrD1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "822", "ARO_accession": "3002788", "ARO_name": "QnrD1", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000298005, "max_identities": 35, "bit_score": 36.965, "cvterm_id": "35711", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVV", "match": "R++L++  F+ CDL     + ++   +   +    G D+ G   M               + +L Y++F ++ L K      R+ G     A F   DL+  +F+  D       GC LT            D +   + G ++  E A+ L ++LG++V", "sequence_from_db": "RAKLKNASFKSCDLSMSNFKNISALGLEISECLAQGADFRGANFMNMITTRSWFCSAYITKTNLSYANFSRVILEKCELWENRWNGTVITGAVFRGSDLSCGEFSSFDWSLADFTGCDLTGGALGE-----LDARRINLDGVKLDGEQALQLVESLGVIV", "sequence_from_broadstreet": "MEKHFINEKFSRDQFTGNRVKNIAFSNCDFSGVDLTDTEFVDCSFYDRNSLEGCDFNRAKLKNASFKSCDLSMSNFKNISALGLEISECLAQGADFRGANFMNMITTRSWFCSAYITKTNLSYANFSRVILEKCELWENRWNGTVITGAVFRGSDLSCGEFSSFDWSLADFTGCDLTGGALGELDARRINLDGVKLDGEQALQLVESLGVIVHR", "dna_sequence_from_broadstreet": "ATGGAAAAGCACTTTATCAATGAAAAGTTTTCACGAGATCAATTTACGGGGAATAGAGTTAAAAATATTGCCTTTTCAAATTGTGATTTTTCAGGGGTTGATTTAACTGATACTGAATTTGTTGATTGTAGTTTTTACGACAGGAATAGCTTGGAAGGGTGTGATTTTAATAGAGCCAAACTAAAAAACGCTAGCTTTAAAAGCTGCGATTTATCAATGAGTAATTTTAAAAACATTAGCGCCTTAGGTCTTGAAATTAGTGAGTGTTTAGCTCAAGGAGCTGATTTTCGAGGGGCTAATTTTATGAATATGATAACTACAAGGTCATGGTTTTGTAGTGCTTATATAACCAAGACAAATCTTAGTTACGCTAATTTTTCTAGAGTCATATTAGAAAAGTGCGAACTGTGGGAAAATCGCTGGAATGGCACTGTGATAACTGGCGCCGTGTTTCGTGGCTCCGATCTTTCTTGTGGGGAGTTTTCATCGTTTGATTGGTCTTTGGCTGATTTTACTGGTTGTGATTTAACGGGTGGGGCGCTTGGCGAGCTTGATGCAAGGCGAATTAATTTAGATGGAGTGAAGTTGGATGGAGAGCAGGCGCTTCAGCTTGTTGAGAGTTTAGGTGTTATTGTTCACCGATAA", "partial": "0", "query_start": 8757, "query_end": 9194, "hit_start": 171, "hit_end": 636, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 21.88}, "gnl|BL_ORD_ID|758|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrD1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "822", "ARO_accession": "3002788", "ARO_name": "QnrD1", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.82118, "max_identities": 21, "bit_score": 25.0238, "cvterm_id": "35711", "query": "SRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNF", "match": "+R+++  F  CD             V   DT  +   +    ++    F +  L+ +SF   +L  + F   SA     + ++++E    G D  G      + T++ F", "sequence_from_db": "NRVKNIAFSNCDF----------SGVDLTDTEFVDCSFYDRNSLEGCDFNRAKLKNASFKSCDLSMSNFKNISA-----LGLEISECLAQGADFRGANFMNMITTRSWF", "sequence_from_broadstreet": "MEKHFINEKFSRDQFTGNRVKNIAFSNCDFSGVDLTDTEFVDCSFYDRNSLEGCDFNRAKLKNASFKSCDLSMSNFKNISALGLEISECLAQGADFRGANFMNMITTRSWFCSAYITKTNLSYANFSRVILEKCELWENRWNGTVITGAVFRGSDLSCGEFSSFDWSLADFTGCDLTGGALGELDARRINLDGVKLDGEQALQLVESLGVIVHR", "dna_sequence_from_broadstreet": "ATGGAAAAGCACTTTATCAATGAAAAGTTTTCACGAGATCAATTTACGGGGAATAGAGTTAAAAATATTGCCTTTTCAAATTGTGATTTTTCAGGGGTTGATTTAACTGATACTGAATTTGTTGATTGTAGTTTTTACGACAGGAATAGCTTGGAAGGGTGTGATTTTAATAGAGCCAAACTAAAAAACGCTAGCTTTAAAAGCTGCGATTTATCAATGAGTAATTTTAAAAACATTAGCGCCTTAGGTCTTGAAATTAGTGAGTGTTTAGCTCAAGGAGCTGATTTTCGAGGGGCTAATTTTATGAATATGATAACTACAAGGTCATGGTTTTGTAGTGCTTATATAACCAAGACAAATCTTAGTTACGCTAATTTTTCTAGAGTCATATTAGAAAAGTGCGAACTGTGGGAAAATCGCTGGAATGGCACTGTGATAACTGGCGCCGTGTTTCGTGGCTCCGATCTTTCTTGTGGGGAGTTTTCATCGTTTGATTGGTCTTTGGCTGATTTTACTGGTTGTGATTTAACGGGTGGGGCGCTTGGCGAGCTTGATGCAAGGCGAATTAATTTAGATGGAGTGAAGTTGGATGGAGAGCAGGCGCTTCAGCTTGTTGAGAGTTTAGGTGTTATTGTTCACCGATAA", "partial": "0", "query_start": 8760, "query_end": 9086, "hit_start": 51, "hit_end": 333, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 19.27}, "gnl|BL_ORD_ID|758|hsp_num:2": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrD1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "822", "ARO_accession": "3002788", "ARO_name": "QnrD1", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.68792, "max_identities": 18, "bit_score": 24.6386, "cvterm_id": "35711", "query": "FLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARSTNFIFDPKANQVKG-TRVGVETAVALAQA", "match": "F+     + +F G   +   F + D +  D T T+   C      +++GC   +     ++    D   +  K  + +G+E +  LAQ ", "sequence_from_db": "FINEKFSRDQFTGNRVKNIAFSNCDFSGVDLTDTEFVDCSFYDRNSLEGCDFNRAKLKNASFKSCDLSMSNFKNISALGLEISECLAQG", "sequence_from_broadstreet": "MEKHFINEKFSRDQFTGNRVKNIAFSNCDFSGVDLTDTEFVDCSFYDRNSLEGCDFNRAKLKNASFKSCDLSMSNFKNISALGLEISECLAQGADFRGANFMNMITTRSWFCSAYITKTNLSYANFSRVILEKCELWENRWNGTVITGAVFRGSDLSCGEFSSFDWSLADFTGCDLTGGALGELDARRINLDGVKLDGEQALQLVESLGVIVHR", "dna_sequence_from_broadstreet": "ATGGAAAAGCACTTTATCAATGAAAAGTTTTCACGAGATCAATTTACGGGGAATAGAGTTAAAAATATTGCCTTTTCAAATTGTGATTTTTCAGGGGTTGATTTAACTGATACTGAATTTGTTGATTGTAGTTTTTACGACAGGAATAGCTTGGAAGGGTGTGATTTTAATAGAGCCAAACTAAAAAACGCTAGCTTTAAAAGCTGCGATTTATCAATGAGTAATTTTAAAAACATTAGCGCCTTAGGTCTTGAAATTAGTGAGTGTTTAGCTCAAGGAGCTGATTTTCGAGGGGCTAATTTTATGAATATGATAACTACAAGGTCATGGTTTTGTAGTGCTTATATAACCAAGACAAATCTTAGTTACGCTAATTTTTCTAGAGTCATATTAGAAAAGTGCGAACTGTGGGAAAATCGCTGGAATGGCACTGTGATAACTGGCGCCGTGTTTCGTGGCTCCGATCTTTCTTGTGGGGAGTTTTCATCGTTTGATTGGTCTTTGGCTGATTTTACTGGTTGTGATTTAACGGGTGGGGCGCTTGGCGAGCTTGATGCAAGGCGAATTAATTTAGATGGAGTGAAGTTGGATGGAGAGCAGGCGCTTCAGCTTGTTGAGAGTTTAGGTGTTATTGTTCACCGATAA", "partial": "0", "query_start": 8934, "query_end": 9179, "hit_start": 12, "hit_end": 279, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 20.22}, "gnl|BL_ORD_ID|869|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB48", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "946", "ARO_accession": "3002763", "ARO_name": "QnrB48", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000377936, "max_identities": 33, "bit_score": 36.5798, "cvterm_id": "36915", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSA--------------------REANFIDVDLAESDFTGTDMPGCTMQGCVL", "match": "R+ L+D +F+ CDL        +   +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G                       R ANF   DL  S+  G D+ G  +QG  L", "sequence_from_db": "RAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGGLDIRGVDLQGVKL", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGGLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGGAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTTCGCGGCGCAAGCTTTATGAATATGATCACCACACGCACCTGGTTTTGCAGCGCATATATAACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGGCTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 8757, "query_end": 9071, "hit_start": 171, "hit_end": 588, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 23.74}, "gnl|BL_ORD_ID|869|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB48", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "946", "ARO_accession": "3002763", "ARO_name": "QnrB48", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.184258, "max_identities": 15, "bit_score": 28.4906, "cvterm_id": "36915", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGGLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGGAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTTCGCGGCGCAAGCTTTATGAATATGATCACCACACGCACCTGGTTTTGCAGCGCATATATAACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGGCTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 27, "hit_end": 177, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|50|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrS6", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "60", "ARO_accession": "3002795", "ARO_name": "QnrS6", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000413021, "max_identities": 27, "bit_score": 36.5798, "cvterm_id": "36810", "query": "MPDVQFEQCDLRYSSFLKLNLRKTRFVGCS----------------AREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKG", "match": "+ D+ F  C      F + NLR   F+ C                  R+A+F    LA ++F+  +  G  ++ C L   NF+R+ NF     ANQV  ", "sequence_from_db": "LSDITFTACTFIRCDFRRANLRDATFINCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIELRECDLKGANFSRA-NF-----ANQVSN", "sequence_from_broadstreet": "METYRHTYRHHSFSHQDLSDITFTACTFIRCDFRRANLRDATFINCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIELRECDLKGANFSRANFANQVSNRMYFCSAFITGCNLSYANMERVCLEKCELYENRWIGTHLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIASWQQEQLLEALGIVVFPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACCGTCACACATATCGACACCACAGTTTTTCACATCAAGATCTAAGTGATATTACTTTCACTGCTTGCACCTTTATCCGATGCGATTTTCGACGTGCTAACTTGCGTGATGCGACATTTATTAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGTTGCCATTTTGATGTCGCAGACCTTCGCGATGCAAGTTTCCAACAATGCCAGCTTGCGATGGCAAACTTTAGTAACGCCAATTGCTACGGTATTGAGTTACGTGAGTGTGATTTAAAAGGGGCCAACTTTTCCCGAGCAAACTTTGCCAATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCCTTTATTACTGGATGTAACCTGTCTTATGCCAATATGGAGCGGGTCTGTTTAGAAAAATGTGAGCTGTATGAAAATCGCTGGATAGGGACTCACCTCGCGGGCGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCTGAAGATGTCTGGGGACAGTTTAGCCTACAGGGTGCTAATTTATGTCACGCCGAACTCGACGGTTTAGATCCTCGAAAAGTCGATACATCAGGTATCAAAATTGCCAGCTGGCAACAAGAACAGCTTCTCGAAGCGTTGGGTATTGTTGTTTTTCCTGACTAG", "partial": "0", "query_start": 8889, "query_end": 9137, "hit_start": 51, "hit_end": 330, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|50|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrS6", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "60", "ARO_accession": "3002795", "ARO_name": "QnrS6", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00750115, "max_identities": 26, "bit_score": 32.7278, "cvterm_id": "36810", "query": "LEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFA", "match": "L D  F  C  +R    +  LR  TF + + +       G +    F+  DLR +SF +          C    ANF     + ++  G ++  C ++G   ++ NFA", "sequence_from_db": "LSDITFTACTFIRCDFRRANLRDATFINCKFIEQ-----GDIEGCHFDVADLRDASFQQ----------CQLAMANF-----SNANCYGIELRECDLKGANFSRANFA", "sequence_from_broadstreet": "METYRHTYRHHSFSHQDLSDITFTACTFIRCDFRRANLRDATFINCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIELRECDLKGANFSRANFANQVSNRMYFCSAFITGCNLSYANMERVCLEKCELYENRWIGTHLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIASWQQEQLLEALGIVVFPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACCGTCACACATATCGACACCACAGTTTTTCACATCAAGATCTAAGTGATATTACTTTCACTGCTTGCACCTTTATCCGATGCGATTTTCGACGTGCTAACTTGCGTGATGCGACATTTATTAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGTTGCCATTTTGATGTCGCAGACCTTCGCGATGCAAGTTTCCAACAATGCCAGCTTGCGATGGCAAACTTTAGTAACGCCAATTGCTACGGTATTGAGTTACGTGAGTGTGATTTAAAAGGGGCCAACTTTTCCCGAGCAAACTTTGCCAATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCCTTTATTACTGGATGTAACCTGTCTTATGCCAATATGGAGCGGGTCTGTTTAGAAAAATGTGAGCTGTATGAAAATCGCTGGATAGGGACTCACCTCGCGGGCGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCTGAAGATGTCTGGGGACAGTTTAGCCTACAGGGTGCTAATTTATGTCACGCCGAACTCGACGGTTTAGATCCTCGAAAAGTCGATACATCAGGTATCAAAATTGCCAGCTGGCAACAAGAACAGCTTCTCGAAGCGTTGGGTATTGTTGTTTTTCCTGACTAG", "partial": "0", "query_start": 8766, "query_end": 9089, "hit_start": 51, "hit_end": 315, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 24.07}, "gnl|BL_ORD_ID|50|hsp_num:2": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrS6", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "60", "ARO_accession": "3002795", "ARO_name": "QnrS6", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00808704, "max_identities": 38, "bit_score": 32.7278, "cvterm_id": "36810", "query": "RSRLEDCVFEGCDLLRMVP------EKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRK---------TRFV-GCSAREANFIDV-----DLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIF---------------DPKANQVKGTRVGVETAVALAQALGMVV", "match": "R+ L D  F  C  +          +   LR  +F+  +L   ++S       ++  +CDL+ ++F + N            + F+ GC+   AN   V     +L E+ + GT + G +++   L++  F+      F               DP+     G ++       L +ALG+VV", "sequence_from_db": "RANLRDATFINCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYG-IELRECDLKGANFSRANFANQVSNRMYFCSAFITGCNLSYANMERVCLEKCELYENRWIGTHLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIASWQQEQLLEALGIVV", "sequence_from_broadstreet": "METYRHTYRHHSFSHQDLSDITFTACTFIRCDFRRANLRDATFINCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIELRECDLKGANFSRANFANQVSNRMYFCSAFITGCNLSYANMERVCLEKCELYENRWIGTHLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIASWQQEQLLEALGIVVFPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACCGTCACACATATCGACACCACAGTTTTTCACATCAAGATCTAAGTGATATTACTTTCACTGCTTGCACCTTTATCCGATGCGATTTTCGACGTGCTAACTTGCGTGATGCGACATTTATTAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGTTGCCATTTTGATGTCGCAGACCTTCGCGATGCAAGTTTCCAACAATGCCAGCTTGCGATGGCAAACTTTAGTAACGCCAATTGCTACGGTATTGAGTTACGTGAGTGTGATTTAAAAGGGGCCAACTTTTCCCGAGCAAACTTTGCCAATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCCTTTATTACTGGATGTAACCTGTCTTATGCCAATATGGAGCGGGTCTGTTTAGAAAAATGTGAGCTGTATGAAAATCGCTGGATAGGGACTCACCTCGCGGGCGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCTGAAGATGTCTGGGGACAGTTTAGCCTACAGGGTGCTAATTTATGTCACGCCGAACTCGACGGTTTAGATCCTCGAAAAGTCGATACATCAGGTATCAAAATTGCCAGCTGGCAACAAGAACAGCTTCTCGAAGCGTTGGGTATTGTTGTTTTTCCTGACTAG", "partial": "0", "query_start": 8757, "query_end": 9194, "hit_start": 102, "hit_end": 645, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 20.88}, "gnl|BL_ORD_ID|1692|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrS2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1832", "ARO_accession": "3002791", "ARO_name": "QnrS2", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000420933, "max_identities": 27, "bit_score": 36.5798, "cvterm_id": "35715", "query": "MPDVQFEQCDLRYSSFLKLNLRKTRFVGCS----------------AREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKG", "match": "+ D+ F  C      F + NLR   F+ C                  R+A+F    LA ++F+  +  G  ++ C L   NF+R+ NF     ANQV  ", "sequence_from_db": "LSDITFTACTFIRCDFRRANLRDATFINCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIELRECDLKGANFSRA-NF-----ANQVSN", "sequence_from_broadstreet": "METYRHTYRHHSFSHQDLSDITFTACTFIRCDFRRANLRDATFINCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIELRECDLKGANFSRANFANQVSNRMYFCSAFITGCNLSYANMERVCLEKCELFENRWIGTHLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIASWQQEQLLEALGIVVFPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACCGTCACACATATCGACACCACAGTTTTTCACATCAAGATCTAAGTGATATTACTTTCACTGCTTGCACCTTTATCCGATGCGATTTTCGACGTGCTAACTTGCGTGATGCGACATTTATTAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGTTGCCATTTTGATGTCGCAGACCTTCGCGATGCAAGTTTCCAACAATGCCAGCTTGCGATGGCAAACTTTAGTAACGCCAATTGCTACGGTATTGAGTTACGTGAGTGTGATTTAAAAGGGGCCAACTTTTCCCGAGCAAACTTTGCCAATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCCTTTATTACTGGATGTAACCTGTCTTATGCCAATATGGAGCGGGTCTGTTTAGAAAAATGTGAGCTGTTTGAAAATCGCTGGATAGGGACTCACCTCGCGGGCGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCTGAAGATGTCTGGGGACAGTTTAGCCTACAGGGTGCTAATTTATGTCACGCCGAACTCGACGGTTTAGATCCTCGAAAAGTCGATACATCAGGTATCAAAATTGCCAGCTGGCAACAAGAACAGCTTCTCGAAGCGTTGGGTATTGTTGTTTTTCCTGACTAG", "partial": "0", "query_start": 8889, "query_end": 9137, "hit_start": 51, "hit_end": 330, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|1692|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrS2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1832", "ARO_accession": "3002791", "ARO_name": "QnrS2", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00771573, "max_identities": 26, "bit_score": 32.7278, "cvterm_id": "35715", "query": "LEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFA", "match": "L D  F  C  +R    +  LR  TF + + +       G +    F+  DLR +SF +          C    ANF     + ++  G ++  C ++G   ++ NFA", "sequence_from_db": "LSDITFTACTFIRCDFRRANLRDATFINCKFIEQ-----GDIEGCHFDVADLRDASFQQ----------CQLAMANF-----SNANCYGIELRECDLKGANFSRANFA", "sequence_from_broadstreet": "METYRHTYRHHSFSHQDLSDITFTACTFIRCDFRRANLRDATFINCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIELRECDLKGANFSRANFANQVSNRMYFCSAFITGCNLSYANMERVCLEKCELFENRWIGTHLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIASWQQEQLLEALGIVVFPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACCGTCACACATATCGACACCACAGTTTTTCACATCAAGATCTAAGTGATATTACTTTCACTGCTTGCACCTTTATCCGATGCGATTTTCGACGTGCTAACTTGCGTGATGCGACATTTATTAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGTTGCCATTTTGATGTCGCAGACCTTCGCGATGCAAGTTTCCAACAATGCCAGCTTGCGATGGCAAACTTTAGTAACGCCAATTGCTACGGTATTGAGTTACGTGAGTGTGATTTAAAAGGGGCCAACTTTTCCCGAGCAAACTTTGCCAATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCCTTTATTACTGGATGTAACCTGTCTTATGCCAATATGGAGCGGGTCTGTTTAGAAAAATGTGAGCTGTTTGAAAATCGCTGGATAGGGACTCACCTCGCGGGCGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCTGAAGATGTCTGGGGACAGTTTAGCCTACAGGGTGCTAATTTATGTCACGCCGAACTCGACGGTTTAGATCCTCGAAAAGTCGATACATCAGGTATCAAAATTGCCAGCTGGCAACAAGAACAGCTTCTCGAAGCGTTGGGTATTGTTGTTTTTCCTGACTAG", "partial": "0", "query_start": 8766, "query_end": 9089, "hit_start": 51, "hit_end": 315, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 24.07}, "gnl|BL_ORD_ID|1692|hsp_num:2": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrS2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1832", "ARO_accession": "3002791", "ARO_name": "QnrS2", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0122264, "max_identities": 38, "bit_score": 32.3426, "cvterm_id": "35715", "query": "RSRLEDCVFEGCDLLRMVP------EKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRK---------TRFV-GCSAREANFIDV-----DLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIF---------------DPKANQVKGTRVGVETAVALAQALGMVV", "match": "R+ L D  F  C  +          +   LR  +F+  +L   ++S       ++  +CDL+ ++F + N            + F+ GC+   AN   V     +L E+ + GT + G +++   L++  F+      F               DP+     G ++       L +ALG+VV", "sequence_from_db": "RANLRDATFINCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYG-IELRECDLKGANFSRANFANQVSNRMYFCSAFITGCNLSYANMERVCLEKCELFENRWIGTHLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIASWQQEQLLEALGIVV", "sequence_from_broadstreet": "METYRHTYRHHSFSHQDLSDITFTACTFIRCDFRRANLRDATFINCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIELRECDLKGANFSRANFANQVSNRMYFCSAFITGCNLSYANMERVCLEKCELFENRWIGTHLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIASWQQEQLLEALGIVVFPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACCGTCACACATATCGACACCACAGTTTTTCACATCAAGATCTAAGTGATATTACTTTCACTGCTTGCACCTTTATCCGATGCGATTTTCGACGTGCTAACTTGCGTGATGCGACATTTATTAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGTTGCCATTTTGATGTCGCAGACCTTCGCGATGCAAGTTTCCAACAATGCCAGCTTGCGATGGCAAACTTTAGTAACGCCAATTGCTACGGTATTGAGTTACGTGAGTGTGATTTAAAAGGGGCCAACTTTTCCCGAGCAAACTTTGCCAATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCCTTTATTACTGGATGTAACCTGTCTTATGCCAATATGGAGCGGGTCTGTTTAGAAAAATGTGAGCTGTTTGAAAATCGCTGGATAGGGACTCACCTCGCGGGCGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCTGAAGATGTCTGGGGACAGTTTAGCCTACAGGGTGCTAATTTATGTCACGCCGAACTCGACGGTTTAGATCCTCGAAAAGTCGATACATCAGGTATCAAAATTGCCAGCTGGCAACAAGAACAGCTTCTCGAAGCGTTGGGTATTGTTGTTTTTCCTGACTAG", "partial": "0", "query_start": 8757, "query_end": 9194, "hit_start": 102, "hit_end": 645, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 20.88}, "gnl|BL_ORD_ID|901|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "975", "ARO_accession": "3002714", "ARO_name": "QnrB1", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00258378, "max_identities": 32, "bit_score": 34.2686, "cvterm_id": "35915", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSA--------------------REANFIDVDLAESDFTGTDMPGCTMQGCVL", "match": "R+ L+D +F+ CDL        +   +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G                       R ANF   DL  S+    D+ G  +QG  L", "sequence_from_db": "RAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWIGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWIGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATAGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAGCGACTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 8757, "query_end": 9071, "hit_start": 171, "hit_end": 588, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 23.02}, "gnl|BL_ORD_ID|901|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "975", "ARO_accession": "3002714", "ARO_name": "QnrB1", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.172621, "max_identities": 15, "bit_score": 28.8758, "cvterm_id": "35915", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWIGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATAGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAGCGACTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 27, "hit_end": 177, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|1839|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB74", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1993", "ARO_accession": "3002786", "ARO_name": "QnrB74", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00276025, "max_identities": 32, "bit_score": 33.8834, "cvterm_id": "35914", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSA--------------------REANFIDVDLAESDFTGTDMPGCTMQGCVL", "match": "R+ L+D +F+ CDL        +   +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G                       R ANF   DL  S+    D+ G  +QG  L", "sequence_from_db": "RAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMIITRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWIGAQVLGATFSGSDFFGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMIITRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWIGAQVLGATFSGSDFFGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACTTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGTTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGTATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATTATCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATAGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATTTCTTCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACTAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 8757, "query_end": 9071, "hit_start": 171, "hit_end": 588, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 23.02}, "gnl|BL_ORD_ID|1839|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB74", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1993", "ARO_accession": "3002786", "ARO_name": "QnrB74", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.174237, "max_identities": 15, "bit_score": 28.8758, "cvterm_id": "35914", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMIITRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWIGAQVLGATFSGSDFFGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACTTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGTTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGTATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATTATCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATAGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATTTCTTCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACTAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 27, "hit_end": 177, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|1839|hsp_num:2": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB74", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1993", "ARO_accession": "3002786", "ARO_name": "QnrB74", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.211896, "max_identities": 30, "bit_score": 28.4906, "cvterm_id": "35914", "query": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLM-GVDWSGLGTMPDVQFEQCDL-----RYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDF-----TGTDMPGCTMQGCVLTK", "match": "+  +R+   ++E+  F  CD               F D     G ++S    + D  F+ CDL     R SS L + +R  R  G   R A+F+++ +  + F     T T++        VL K", "sequence_from_db": "IDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFS-RAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMIITRTWFCSAYITNTNLSYANFSKVVLEK", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMIITRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWIGAQVLGATFSGSDFFGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACTTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGTTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGTATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATTATCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATAGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATTTCTTCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACTAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 8736, "query_end": 9077, "hit_start": 27, "hit_end": 399, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 24.0}, "gnl|BL_ORD_ID|1839|hsp_num:3": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB74", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1993", "ARO_accession": "3002786", "ARO_name": "QnrB74", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.03435, "max_identities": 24, "bit_score": 23.8682, "cvterm_id": "35914", "query": "VFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANF-----IDVDLAESDFTGTDMPGCTMQGCVLTKTNF", "match": "V E  D  R   EK+   + TF +    G D SG   +    +++   +  +F +  L+   F  C    A+F     + +++      G D  G +    ++T+T F", "sequence_from_db": "VGEKIDRNRFTGEKI--ENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMIITRTWF", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMIITRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWIGAQVLGATFSGSDFFGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACTTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGTTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGTATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATTATCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATAGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATTTCTTCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACTAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 8778, "query_end": 9086, "hit_start": 15, "hit_end": 333, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.22}, "gnl|BL_ORD_ID|327|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB42", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "358", "ARO_accession": "3002757", "ARO_name": "QnrB42", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00306214, "max_identities": 32, "bit_score": 33.8834, "cvterm_id": "35915", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSA--------------------REANFIDVDLAESDFTGTDMPGCTMQGCVL", "match": "R+ L+D +F+ CDL        +   +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G                       R ANF   DL  S+    D+ G  +QG  L", "sequence_from_db": "RAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWIGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MALVLVGEKIDRNCFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWIGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGTATTAGTTGGCGAAAAAATTGACAGAAACTGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATAGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAGCGACTTGGCATCGCTATTATTGGCTAA", "partial": "0", "query_start": 8757, "query_end": 9071, "hit_start": 171, "hit_end": 588, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 23.02}, "gnl|BL_ORD_ID|327|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB42", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "358", "ARO_accession": "3002757", "ARO_name": "QnrB42", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.09861, "max_identities": 14, "bit_score": 25.409, "cvterm_id": "35915", "query": "FVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "F G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "FTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MALVLVGEKIDRNCFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWIGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGTATTAGTTGGCGAAAAAATTGACAGAAACTGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATAGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAGCGACTTGGCATCGCTATTATTGGCTAA", "partial": "0", "query_start": 8964, "query_end": 9095, "hit_start": 42, "hit_end": 177, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 28.0}, "gnl|BL_ORD_ID|499|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB3", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "548", "ARO_accession": "3002716", "ARO_name": "QnrB3", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00312976, "max_identities": 32, "bit_score": 33.8834, "cvterm_id": "35914", "query": "RWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSA--------------------REANFIDVDLAESDFTGTDMPGCTMQGCVL", "match": "++ R+ L+D +F+ CDL        +   +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G                       R ANF   DL  S+    D+ G  +QG  L", "sequence_from_db": "KFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCKFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAAATTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCGGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 8748, "query_end": 9071, "hit_start": 198, "hit_end": 624, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.54}, "gnl|BL_ORD_ID|499|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB3", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "548", "ARO_accession": "3002716", "ARO_name": "QnrB3", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.249514, "max_identities": 12, "bit_score": 28.1054, "cvterm_id": "35914", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTK", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC  ++", "sequence_from_db": "IDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCKFSR", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCKFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAAATTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCGGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 8949, "query_end": 9077, "hit_start": 63, "hit_end": 210, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 24.49}, "gnl|BL_ORD_ID|4918|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB75", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5909", "ARO_accession": "3003187", "ARO_name": "QnrB75", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00336505, "max_identities": 32, "bit_score": 33.8834, "cvterm_id": "36915", "query": "RWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSA--------------------REANFIDVDLAESDFTGTDMPGCTMQGCVL", "match": "++ R+ L+D +F+ CDL        +   +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G                       R ANF   DL  S+    D+ G  +QG  L", "sequence_from_db": "KFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGGKFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGGGCAAATTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCGGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGCTAG", "partial": "0", "query_start": 8748, "query_end": 9071, "hit_start": 162, "hit_end": 588, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.54}, "gnl|BL_ORD_ID|4918|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB75", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5909", "ARO_accession": "3003187", "ARO_name": "QnrB75", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.42582, "max_identities": 10, "bit_score": 27.7202, "cvterm_id": "36915", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC", "match": "+ + RF G     + F + D + +D +GT+  GC", "sequence_from_db": "IDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGC", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGGKFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGGGCAAATTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCGGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGCTAG", "partial": "0", "query_start": 8949, "query_end": 9050, "hit_start": 27, "hit_end": 129, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 29.41}, "gnl|BL_ORD_ID|459|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB17", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "498", "ARO_accession": "3002732", "ARO_name": "QnrB17", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00473489, "max_identities": 32, "bit_score": 33.4982, "cvterm_id": "36915", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSA--------------------REANFIDVDLAESDFTGTDMPGCTMQGCVL", "match": "R+ L+D +F+ CDL        +   +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G                       R ANF   DL  S+    D+ G  +QG  L", "sequence_from_db": "RAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCGAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 8757, "query_end": 9071, "hit_start": 207, "hit_end": 624, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 23.02}, "gnl|BL_ORD_ID|459|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB17", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "498", "ARO_accession": "3002732", "ARO_name": "QnrB17", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.173599, "max_identities": 15, "bit_score": 28.8758, "cvterm_id": "36915", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCGAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 63, "hit_end": 213, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|542|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB41", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "594", "ARO_accession": "3002756", "ARO_name": "QnrB41", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00479075, "max_identities": 32, "bit_score": 33.4982, "cvterm_id": "36915", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSA--------------------REANFIDVDLAESDFTGTDMPGCTMQGCVL", "match": "R+ L+D +F+ CDL        +   +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G                       R ANF   DL  S+    D+ G  +QG  L", "sequence_from_db": "RAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGDKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIGS", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGATAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGACTTGGCATCGCGGTGATTGGTAGC", "partial": "1", "query_start": 8757, "query_end": 9071, "hit_start": 207, "hit_end": 624, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 23.02}, "gnl|BL_ORD_ID|542|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB41", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "594", "ARO_accession": "3002756", "ARO_name": "QnrB41", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.177193, "max_identities": 15, "bit_score": 28.8758, "cvterm_id": "36915", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGDKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIGS", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGATAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGACTTGGCATCGCGGTGATTGGTAGC", "partial": "1", "query_start": 8949, "query_end": 9095, "hit_start": 63, "hit_end": 213, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|61|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB66", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "71", "ARO_accession": "3002778", "ARO_name": "QnrB66", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00490609, "max_identities": 32, "bit_score": 33.4982, "cvterm_id": "36915", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSA--------------------REANFIDVDLAESDFTGTDMPGCTMQGCVL", "match": "R+ L+D +F+ CDL        +   +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G                       R ANF   DL  S+    D+ G  +QG  L", "sequence_from_db": "RAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MALALVGEKINRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTAACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCGAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 8757, "query_end": 9071, "hit_start": 171, "hit_end": 588, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 23.02}, "gnl|BL_ORD_ID|61|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB66", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "71", "ARO_accession": "3002778", "ARO_name": "QnrB66", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.102383, "max_identities": 15, "bit_score": 29.261, "cvterm_id": "36915", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "INRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MALALVGEKINRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTAACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCGAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 27, "hit_end": 177, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|1389|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrA2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1508", "ARO_accession": "3002708", "ARO_name": "QnrA2", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00565693, "max_identities": 22, "bit_score": 33.113, "cvterm_id": "36891", "query": "FEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAES------DFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGT", "match": "F + DL  S F +    +  F  C  R+A+F D    ES       F+  D+   + + C L+  NF+ +  F  + +   +KG ", "sequence_from_db": "FSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGA", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQVSHKMYFCAAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGIIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATCGATAAAGTTTTTCAACAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTCTATCAGTGTGACTTCAGCCACTGTCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTTGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCTTGCCGTCTGTCTTTGGCTAACTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAATGCGATCTCAAGGGCGCCAACTTTTCCCGGGCCCGCTTTTACAATCAAGTCAGCCATAAAATGTACTTTTGTGCGGCTTATATCTCAGGCTGCAACCTGGCCTATGCCAATTTGAGTGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAATAACTGGAGCAATGCCAATCTCAGCGGTGCTTCCTTGATGGGCTCCGACCTCAGCCGCGGCACCTTCTCCCGCGACTGTTGGCAACAGGTCAATCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGACTCGATCCCAGGCGGGTCAACCTCGAGGGGGTCAAGATCTGTGCCTGGCAACAGGAGCAACTGTTAGAGCCTCTGGGGATAATAGTGCTTCCGGATTAG", "partial": "0", "query_start": 8904, "query_end": 9140, "hit_start": 36, "hit_end": 291, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 25.88}, "gnl|BL_ORD_ID|1389|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrA2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1508", "ARO_accession": "3002708", "ARO_name": "QnrA2", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.011999, "max_identities": 25, "bit_score": 32.3426, "cvterm_id": "36891", "query": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFT", "match": "+ +SR+ R R   C F  C L          R  +F+D   +       G +    F   DLR +SF    L    F G +     F + DL  ++F+", "sequence_from_db": "LSDSRFRRCRFYQCDFSHCQL----------RDASFEDCSFIES-----GAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFS", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQVSHKMYFCAAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGIIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATCGATAAAGTTTTTCAACAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTCTATCAGTGTGACTTCAGCCACTGTCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTTGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCTTGCCGTCTGTCTTTGGCTAACTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAATGCGATCTCAAGGGCGCCAACTTTTCCCGGGCCCGCTTTTACAATCAAGTCAGCCATAAAATGTACTTTTGTGCGGCTTATATCTCAGGCTGCAACCTGGCCTATGCCAATTTGAGTGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAATAACTGGAGCAATGCCAATCTCAGCGGTGCTTCCTTGATGGGCTCCGACCTCAGCCGCGGCACCTTCTCCCGCGACTGTTGGCAACAGGTCAATCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGACTCGATCCCAGGCGGGTCAACCTCGAGGGGGTCAAGATCTGTGCCTGGCAACAGGAGCAACTGTTAGAGCCTCTGGGGATAATAGTGCTTCCGGATTAG", "partial": "0", "query_start": 8736, "query_end": 9029, "hit_start": 51, "hit_end": 300, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 25.51}, "gnl|BL_ORD_ID|1389|hsp_num:2": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrA2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1508", "ARO_accession": "3002708", "ARO_name": "QnrA2", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0475699, "max_identities": 21, "bit_score": 30.4166, "cvterm_id": "36891", "query": "MPDVQFEQCDLRYSSFLKLNLRKTRFVGCS----------------AREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARS", "match": "+ D +F +C      F    LR   F  CS                 R+A+F    L+ ++F+G +  G   + C L   NF+R+", "sequence_from_db": "LSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRA", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQVSHKMYFCAAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGIIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATCGATAAAGTTTTTCAACAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTCTATCAGTGTGACTTCAGCCACTGTCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTTGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCTTGCCGTCTGTCTTTGGCTAACTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAATGCGATCTCAAGGGCGCCAACTTTTCCCGGGCCCGCTTTTACAATCAAGTCAGCCATAAAATGTACTTTTGTGCGGCTTATATCTCAGGCTGCAACCTGGCCTATGCCAATTTGAGTGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAATAACTGGAGCAATGCCAATCTCAGCGGTGCTTCCTTGATGGGCTCCGACCTCAGCCGCGGCACCTTCTCCCGCGACTGTTGGCAACAGGTCAATCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGACTCGATCCCAGGCGGGTCAACCTCGAGGGGGTCAAGATCTGTGCCTGGCAACAGGAGCAACTGTTAGAGCCTCTGGGGATAATAGTGCTTCCGGATTAG", "partial": "0", "query_start": 8889, "query_end": 9095, "hit_start": 51, "hit_end": 306, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 24.71}, "gnl|BL_ORD_ID|952|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrA7", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1034", "ARO_accession": "3002713", "ARO_name": "QnrA7", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00581889, "max_identities": 22, "bit_score": 33.113, "cvterm_id": "36891", "query": "FEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAES------DFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGT", "match": "F + DL  S F +    +  F  C  R+A+F D    ES       F+  D+   + + C L+  NF+ +  F  + +   +KG ", "sequence_from_db": "FSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGA", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSHGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGCGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGTAACCTGGCCTATGCCAATTTGAGCGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCCACGGCACCTTCTCCCGCGACTGCTGGCAACAGGTAAACCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGGCTCGACCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTCATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 8904, "query_end": 9140, "hit_start": 36, "hit_end": 291, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 25.88}, "gnl|BL_ORD_ID|952|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrA7", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1034", "ARO_accession": "3002713", "ARO_name": "QnrA7", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00880086, "max_identities": 31, "bit_score": 32.7278, "cvterm_id": "36891", "query": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFT--------GTDMPGCT--MQGCVLTKTNFA", "match": "+ +SR+ R R   C F  C L          R  +F+D   +       G +    F   DLR +SF    L    F G +     F + DL  ++F+           M  C+  + GC L   N +", "sequence_from_db": "LSDSRFRRCRFYQCDFSHCQL----------RDASFEDCSFIES-----GAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLS", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSHGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGCGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGTAACCTGGCCTATGCCAATTTGAGCGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCCACGGCACCTTCTCCCGCGACTGCTGGCAACAGGTAAACCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGGCTCGACCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTCATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 8736, "query_end": 9089, "hit_start": 51, "hit_end": 390, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 24.22}, "gnl|BL_ORD_ID|952|hsp_num:2": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrA7", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1034", "ARO_accession": "3002713", "ARO_name": "QnrA7", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0498468, "max_identities": 21, "bit_score": 30.4166, "cvterm_id": "36891", "query": "MPDVQFEQCDLRYSSFLKLNLRKTRFVGCS----------------AREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARS", "match": "+ D +F +C      F    LR   F  CS                 R+A+F    L+ ++F+G +  G   + C L   NF+R+", "sequence_from_db": "LSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRA", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSHGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGCGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGTAACCTGGCCTATGCCAATTTGAGCGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCCACGGCACCTTCTCCCGCGACTGCTGGCAACAGGTAAACCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGGCTCGACCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTCATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 8889, "query_end": 9095, "hit_start": 51, "hit_end": 306, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 24.71}, "gnl|BL_ORD_ID|735|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrA3", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "802", "ARO_accession": "3002709", "ARO_name": "QnrA3", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0058739, "max_identities": 22, "bit_score": 33.113, "cvterm_id": "36891", "query": "FEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAES------DFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGT", "match": "F + DL  S F +    +  F  C  R+A+F D    ES       F+  D+   + + C L+  NF+ +  F  + +   +KG ", "sequence_from_db": "FSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGA", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGTCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGCAACCTGGCCTATGCCAATTTGAGCGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCCGCGGCACCTTCTCCCGCGACTGCTGGCAACAGGTAAACCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGGCTCGATCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTCATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 8904, "query_end": 9140, "hit_start": 36, "hit_end": 291, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 25.88}, "gnl|BL_ORD_ID|735|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrA3", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "802", "ARO_accession": "3002709", "ARO_name": "QnrA3", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00957749, "max_identities": 31, "bit_score": 32.3426, "cvterm_id": "36891", "query": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFT--------GTDMPGCT--MQGCVLTKTNFA", "match": "+ +SR+ R R   C F  C L          R  +F+D   +       G +    F   DLR +SF    L    F G +     F + DL  ++F+           M  C+  + GC L   N +", "sequence_from_db": "LSDSRFRRCRFYQCDFSHCQL----------RDASFEDCSFIES-----GAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLS", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGTCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGCAACCTGGCCTATGCCAATTTGAGCGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCCGCGGCACCTTCTCCCGCGACTGCTGGCAACAGGTAAACCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGGCTCGATCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTCATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 8736, "query_end": 9089, "hit_start": 51, "hit_end": 390, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 24.22}, "gnl|BL_ORD_ID|735|hsp_num:2": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrA3", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "802", "ARO_accession": "3002709", "ARO_name": "QnrA3", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0498468, "max_identities": 21, "bit_score": 30.4166, "cvterm_id": "36891", "query": "MPDVQFEQCDLRYSSFLKLNLRKTRFVGCS----------------AREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARS", "match": "+ D +F +C      F    LR   F  CS                 R+A+F    L+ ++F+G +  G   + C L   NF+R+", "sequence_from_db": "LSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRA", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGTCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGCAACCTGGCCTATGCCAATTTGAGCGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCCGCGGCACCTTCTCCCGCGACTGCTGGCAACAGGTAAACCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGGCTCGATCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTCATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 8889, "query_end": 9095, "hit_start": 51, "hit_end": 306, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 24.71}, "gnl|BL_ORD_ID|1541|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrA6", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1673", "ARO_accession": "3002712", "ARO_name": "QnrA6", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00592943, "max_identities": 22, "bit_score": 33.113, "cvterm_id": "36771", "query": "FEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAES------DFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGT", "match": "F + DL  S F +    +  F  C  R+A+F D    ES       F+  D+   + + C L+  NF+ +  F  + +   +KG ", "sequence_from_db": "FSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAIEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGA", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAIEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSHGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCATCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGTAACCTGGCCTATGCCAATTTGAGCGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCCACGGCACCTTCTCCCGCGACTGCTGGCAACAGGTAAACCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGGCTCGACCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTAATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 8904, "query_end": 9140, "hit_start": 36, "hit_end": 291, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 25.88}, "gnl|BL_ORD_ID|1541|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrA6", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1673", "ARO_accession": "3002712", "ARO_name": "QnrA6", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00702333, "max_identities": 31, "bit_score": 32.7278, "cvterm_id": "36771", "query": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFT--------GTDMPGCT--MQGCVLTKTNFA", "match": "+ +SR+ R R   C F  C L          R  +F+D   +       G +    F   DLR +SF    L    F G +     F + DL  ++F+           M  C+  + GC L   N +", "sequence_from_db": "LSDSRFRRCRFYQCDFSHCQL----------RDASFEDCSFIES-----GAIEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLS", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAIEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSHGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCATCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGTAACCTGGCCTATGCCAATTTGAGCGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCCACGGCACCTTCTCCCGCGACTGCTGGCAACAGGTAAACCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGGCTCGACCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTAATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 8736, "query_end": 9089, "hit_start": 51, "hit_end": 390, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 24.22}, "gnl|BL_ORD_ID|1541|hsp_num:2": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrA6", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1673", "ARO_accession": "3002712", "ARO_name": "QnrA6", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0498468, "max_identities": 24, "bit_score": 30.4166, "cvterm_id": "36771", "query": "LRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLN-LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARS", "match": "L    F+  R    D+S    + D  FE C     SF++   +    F     R+A+F    L+ ++F+G +  G   + C L   NF+R+", "sequence_from_db": "LSDSRFRRCRFYQCDFSHC-QLRDASFEDC-----SFIESGAIEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRA", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAIEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSHGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCATCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGTAACCTGGCCTATGCCAATTTGAGCGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCCACGGCACCTTCTCCCGCGACTGCTGGCAACAGGTAAACCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGGCTCGACCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTAATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 8826, "query_end": 9095, "hit_start": 51, "hit_end": 306, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 26.37}, "gnl|BL_ORD_ID|688|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrA4", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "747", "ARO_accession": "3002710", "ARO_name": "QnrA4", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00598548, "max_identities": 22, "bit_score": 33.113, "cvterm_id": "36891", "query": "FEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAES------DFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGT", "match": "F + DL  S F +    +  F  C  R+A+F D    ES       F+  D+   + + C L+  NF+ +  F  + +   +KG ", "sequence_from_db": "FSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGA", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLNGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGCGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGCAACCTGGCCTATGCCAATTTGAACGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCCGCGGCACCTTCTCCCGCGACTGCTGGCAGCAGGTAAACCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGGCTCGATCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTCATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 8904, "query_end": 9140, "hit_start": 36, "hit_end": 291, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 25.88}, "gnl|BL_ORD_ID|688|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrA4", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "747", "ARO_accession": "3002710", "ARO_name": "QnrA4", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0122264, "max_identities": 25, "bit_score": 32.3426, "cvterm_id": "36891", "query": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFT", "match": "+ +SR+ R R   C F  C L          R  +F+D   +       G +    F   DLR +SF    L    F G +     F + DL  ++F+", "sequence_from_db": "LSDSRFRRCRFYQCDFSHCQL----------RDASFEDCSFIES-----GAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFS", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLNGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGCGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGCAACCTGGCCTATGCCAATTTGAACGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCCGCGGCACCTTCTCCCGCGACTGCTGGCAGCAGGTAAACCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGGCTCGATCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTCATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 8736, "query_end": 9029, "hit_start": 51, "hit_end": 300, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 25.51}, "gnl|BL_ORD_ID|688|hsp_num:2": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrA4", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "747", "ARO_accession": "3002710", "ARO_name": "QnrA4", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0498468, "max_identities": 21, "bit_score": 30.4166, "cvterm_id": "36891", "query": "MPDVQFEQCDLRYSSFLKLNLRKTRFVGCS----------------AREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARS", "match": "+ D +F +C      F    LR   F  CS                 R+A+F    L+ ++F+G +  G   + C L   NF+R+", "sequence_from_db": "LSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRA", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLNGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGCGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGCAACCTGGCCTATGCCAATTTGAACGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCCGCGGCACCTTCTCCCGCGACTGCTGGCAGCAGGTAAACCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGGCTCGATCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTCATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 8889, "query_end": 9095, "hit_start": 51, "hit_end": 306, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 24.71}, "gnl|BL_ORD_ID|4919|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB77", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5910", "ARO_accession": "3003189", "ARO_name": "QnrB77", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00609258, "max_identities": 32, "bit_score": 33.113, "cvterm_id": "36915", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSA--------------------REANFIDVDLAESDFTGTDMPGCTMQGCVL", "match": "R+ L+D +F+ CDL        +   +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G                       R ANF   DL  S+    D+ G  +QG  L", "sequence_from_db": "RAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGTDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGTDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCACAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCGAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGCTAG", "partial": "0", "query_start": 8757, "query_end": 9071, "hit_start": 171, "hit_end": 588, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 23.02}, "gnl|BL_ORD_ID|4919|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB77", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5910", "ARO_accession": "3003189", "ARO_name": "QnrB77", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.179178, "max_identities": 15, "bit_score": 28.8758, "cvterm_id": "36915", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGTDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCACAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCGAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGCTAG", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 27, "hit_end": 177, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|4919|hsp_num:2": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB77", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5910", "ARO_accession": "3003189", "ARO_name": "QnrB77", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.84999, "max_identities": 25, "bit_score": 24.2534, "cvterm_id": "36915", "query": "VFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANF-----IDVDLAESDFTGTDMPGCTMQGCVLTKTNF", "match": "V E  D  R   EK+   + TF +    G D SG   +    +++   +  +F +  L+   F  C    A+F     + +++      GTD  G +    + T+T F", "sequence_from_db": "VGEKIDRNRFTGEKI--ENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGTDFRGASFMNMITTRTWF", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGTDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCACAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCGAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGCTAG", "partial": "0", "query_start": 8778, "query_end": 9086, "hit_start": 15, "hit_end": 333, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 23.15}, "gnl|BL_ORD_ID|162|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrA5", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "179", "ARO_accession": "3002711", "ARO_name": "QnrA5", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00627374, "max_identities": 22, "bit_score": 33.113, "cvterm_id": "36891", "query": "FEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAES------DFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGT", "match": "F + DL  S F +    +  F  C  R+A+F D    ES       F+  D+   + + C L+  NF+ +  F  + +   +KG ", "sequence_from_db": "FSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGA", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSCGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGCAACCTGGCCTATGCCAATTTGAGCGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCTGCGGCACCTTCTCCCGCGACTGCTGGCAGCAGGTAAACCTGCGGGGCTGTGACCTGACTTTTGCCGATCTGGATGGGCTCGATCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTCATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 8904, "query_end": 9140, "hit_start": 36, "hit_end": 291, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 25.88}, "gnl|BL_ORD_ID|162|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrA5", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "179", "ARO_accession": "3002711", "ARO_name": "QnrA5", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00966789, "max_identities": 31, "bit_score": 32.3426, "cvterm_id": "36891", "query": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFT--------GTDMPGCT--MQGCVLTKTNFA", "match": "+ +SR+ R R   C F  C L          R  +F+D   +       G +    F   DLR +SF    L    F G +     F + DL  ++F+           M  C+  + GC L   N +", "sequence_from_db": "LSDSRFRRCRFYQCDFSHCQL----------RDASFEDCSFIES-----GAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLS", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSCGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGCAACCTGGCCTATGCCAATTTGAGCGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCTGCGGCACCTTCTCCCGCGACTGCTGGCAGCAGGTAAACCTGCGGGGCTGTGACCTGACTTTTGCCGATCTGGATGGGCTCGATCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTCATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 8736, "query_end": 9089, "hit_start": 51, "hit_end": 390, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 24.22}, "gnl|BL_ORD_ID|162|hsp_num:2": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrA5", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "179", "ARO_accession": "3002711", "ARO_name": "QnrA5", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0517462, "max_identities": 21, "bit_score": 30.4166, "cvterm_id": "36891", "query": "MPDVQFEQCDLRYSSFLKLNLRKTRFVGCS----------------AREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARS", "match": "+ D +F +C      F    LR   F  CS                 R+A+F    L+ ++F+G +  G   + C L   NF+R+", "sequence_from_db": "LSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRA", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSCGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGCAACCTGGCCTATGCCAATTTGAGCGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCTGCGGCACCTTCTCCCGCGACTGCTGGCAGCAGGTAAACCTGCGGGGCTGTGACCTGACTTTTGCCGATCTGGATGGGCTCGATCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTCATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 8889, "query_end": 9095, "hit_start": 51, "hit_end": 306, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 24.71}, "gnl|BL_ORD_ID|1296|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB15", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1414", "ARO_accession": "3002730", "ARO_name": "QnrB15", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0073643, "max_identities": 32, "bit_score": 32.7278, "cvterm_id": "36915", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSA--------------------REANFIDVDLAESDFTGTDMPGCTMQGCVL", "match": "R+ L+D +F+ CDL            +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G                       R ANF   DL  S+    D+ G  +QG  L", "sequence_from_db": "RAMLKDAIFKSCDLSMADFRNANALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIESSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNANALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAGTAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAATGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 8757, "query_end": 9071, "hit_start": 207, "hit_end": 624, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 23.02}, "gnl|BL_ORD_ID|1296|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB15", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1414", "ARO_accession": "3002730", "ARO_name": "QnrB15", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.180183, "max_identities": 15, "bit_score": 28.8758, "cvterm_id": "36915", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTGEKIESSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIESSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNANALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAGTAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAATGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 63, "hit_end": 213, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|1296|hsp_num:2": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB15", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1414", "ARO_accession": "3002730", "ARO_name": "QnrB15", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.76387, "max_identities": 26, "bit_score": 25.7942, "cvterm_id": "36915", "query": "VFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSA-----REANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNF", "match": "V E  D  R   EK+   S TF +    G D SG   +    +++   +  +F +  L+   F  C       R AN + +++      G D  G +    + T+T F", "sequence_from_db": "VGEKIDRNRFTGEKI--ESSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNANALGIEIRHCRAQGADFRGASFMNMITTRTWF", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIESSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNANALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAGTAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAATGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 8778, "query_end": 9086, "hit_start": 51, "hit_end": 369, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 24.07}, "gnl|BL_ORD_ID|2119|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "qnrE2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "3336", "ARO_accession": "3004637", "ARO_name": "qnrE2", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00831104, "max_identities": 32, "bit_score": 32.7278, "cvterm_id": "35914", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDV---------QFEQCDLRYSSFLKLNLRK-----TRFVGCSA--------------------REANFIDVDLAESDFTGTDMPGCTMQGCVL", "match": "R++L+D +F+ CDL            +  ++ R  G D+ G   M  +            + +L Y++F K+ L K      R+ G                       R ANF   DL  S+    D+ G  +QG  L", "sequence_from_db": "RAQLKDAIFKSCDLSMADFRHSNALGIEIRECRAQGADFRGASFMNMITTRTWFCCAYITKSNLSYANFSKVVLEKCELWENRWNGAQILGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGIDLQGVKL", "sequence_from_broadstreet": "MALIFEGEKIGRNRFTGEKIENAIFRNCDFSGTDLTSSEFIGCQFYDRASQQGGNFNRAQLKDAIFKSCDLSMADFRHSNALGIEIRECRAQGADFRGASFMNMITTRTWFCCAYITKSNLSYANFSKVVLEKCELWENRWNGAQILGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGIDLQGVKLDSYQVSQLMERLGIVVLG", "dna_sequence_from_broadstreet": "ATGGCATTGATTTTTGAAGGCGAAAAAATAGGTCGTAACCGTTTTACCGGCGAGAAAATTGAGAATGCAATCTTTCGTAACTGCGACTTTTCCGGTACGGATTTAACGAGCTCGGAGTTTATCGGCTGTCAGTTCTATGACCGGGCAAGCCAGCAGGGCGGTAACTTTAATCGGGCGCAACTTAAAGATGCTATTTTCAAAAGCTGCGATTTATCGATGGCGGATTTCAGGCATTCAAATGCATTAGGCATCGAAATCCGTGAATGCAGGGCACAAGGGGCCGATTTCCGCGGGGCCAGTTTTATGAACATGATCACCACCCGTACCTGGTTTTGCTGTGCTTACATCACAAAAAGCAACCTGAGCTATGCCAATTTTTCGAAGGTGGTTCTGGAAAAATGCGAGCTGTGGGAAAACCGCTGGAACGGCGCGCAGATACTTGGCGCTACCTTTAGCGGCTCGGATCTGTCTGGGGGCGAGTTCTCATCCTTTGACTGGCGAGCGGCCAATTTTACCCACTGCGATCTGACCAATTCAGAACTGGGTGATCTGGACGTGAGGGGTATTGATTTGCAGGGCGTCAAACTGGACAGCTATCAGGTTTCCCAGTTGATGGAGCGACTTGGCATCGTTGTTTTAGGCTAA", "partial": "0", "query_start": 8757, "query_end": 9071, "hit_start": 171, "hit_end": 588, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 23.02}, "gnl|BL_ORD_ID|2119|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "qnrE2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "3336", "ARO_accession": "3004637", "ARO_name": "qnrE2", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.380866, "max_identities": 22, "bit_score": 27.7202, "cvterm_id": "35914", "query": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNF", "match": "+  +R+   ++E+ +F  CD               F D             + D  F+ CDL  + F               R +N + +++ E    G D  G +    + T+T F", "sequence_from_db": "IGRNRFTGEKIENAIFRNCDFSGTDLTSSEFIGCQFYDRASQQGGNFNRAQLKDAIFKSCDLSMADF---------------RHSNALGIEIRECRAQGADFRGASFMNMITTRTWF", "sequence_from_broadstreet": "MALIFEGEKIGRNRFTGEKIENAIFRNCDFSGTDLTSSEFIGCQFYDRASQQGGNFNRAQLKDAIFKSCDLSMADFRHSNALGIEIRECRAQGADFRGASFMNMITTRTWFCCAYITKSNLSYANFSKVVLEKCELWENRWNGAQILGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGIDLQGVKLDSYQVSQLMERLGIVVLG", "dna_sequence_from_broadstreet": "ATGGCATTGATTTTTGAAGGCGAAAAAATAGGTCGTAACCGTTTTACCGGCGAGAAAATTGAGAATGCAATCTTTCGTAACTGCGACTTTTCCGGTACGGATTTAACGAGCTCGGAGTTTATCGGCTGTCAGTTCTATGACCGGGCAAGCCAGCAGGGCGGTAACTTTAATCGGGCGCAACTTAAAGATGCTATTTTCAAAAGCTGCGATTTATCGATGGCGGATTTCAGGCATTCAAATGCATTAGGCATCGAAATCCGTGAATGCAGGGCACAAGGGGCCGATTTCCGCGGGGCCAGTTTTATGAACATGATCACCACCCGTACCTGGTTTTGCTGTGCTTACATCACAAAAAGCAACCTGAGCTATGCCAATTTTTCGAAGGTGGTTCTGGAAAAATGCGAGCTGTGGGAAAACCGCTGGAACGGCGCGCAGATACTTGGCGCTACCTTTAGCGGCTCGGATCTGTCTGGGGGCGAGTTCTCATCCTTTGACTGGCGAGCGGCCAATTTTACCCACTGCGATCTGACCAATTCAGAACTGGGTGATCTGGACGTGAGGGGTATTGATTTGCAGGGCGTCAAACTGGACAGCTATCAGGTTTCCCAGTTGATGGAGCGACTTGGCATCGTTGTTTTAGGCTAA", "partial": "0", "query_start": 8736, "query_end": 9086, "hit_start": 27, "hit_end": 333, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 18.8}, "gnl|BL_ORD_ID|2118|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "qnrE1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "3335", "ARO_accession": "3004636", "ARO_name": "qnrE1", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00879348, "max_identities": 32, "bit_score": 32.7278, "cvterm_id": "35915", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDV---------QFEQCDLRYSSFLKLNLRK-----TRFVGCSA--------------------REANFIDVDLAESDFTGTDMPGCTMQGCVL", "match": "R++L+D +F+ CDL            +  ++ R  G D+ G   M  +            + +L Y++F K+ L K      R+ G                       R ANF   DL  S+    D+ G  +QG  L", "sequence_from_db": "RAQLKDAIFKSCDLSMADFRHSNALGIEIRECRAQGADFRGASFMNMITTRTWFCCAYITKSNLSYANFSKVVLEKCELWENRWNGAQILGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGIDLQGVKL", "sequence_from_broadstreet": "MALIFEGEKIGRNRFTGEKIENAIFRNCDFSGTDLTSSEFIGCQFYDRESQQGGNFNRAQLKDAIFKSCDLSMADFRHSNALGIEIRECRAQGADFRGASFMNMITTRTWFCCAYITKSNLSYANFSKVVLEKCELWENRWNGAQILGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGIDLQGVKLDSYQVSQLMERLGIAVLG", "dna_sequence_from_broadstreet": "ATGGCATTGATTTTTGAAGGCGAAAAAATAGGTCGTAACCGTTTTACCGGAGAGAAAATAGAGAATGCAATCTTTCGTAACTGCGACTTTTCCGGTACGGATTTAACCAGCTCGGAGTTTATCGGCTGTCAGTTCTATGACCGGGAAAGCCAGCAGGGCGGTAACTTTAATCGGGCGCAACTTAAAGATGCTATTTTCAAAAGCTGCGATTTATCGATGGCGGATTTCAGGCATTCAAATGCATTAGGCATCGAAATCCGTGAATGCAGGGCGCAAGGGGCCGATTTCCGCGGGGCCAGTTTTATGAACATGATCACCACCCGTACCTGGTTTTGCTGTGCTTACATCACAAAAAGCAACCTGAGCTATGCCAATTTTTCGAAGGTGGTTCTGGAAAAATGCGAGCTGTGGGAAAACCGCTGGAACGGCGCGCAGATACTTGGCGCCACCTTTAGCGGCTCGGATCTGTCTGGGGGCGAGTTCTCATCCTTTGACTGGCGAGCGGCCAATTTTACCCACTGCGATCTGACCAATTCAGAACTGGGTGATCTGGACGTGCGGGGTATTGATTTGCAGGGCGTCAAACTGGACAGCTATCAGGTTTCCCAGTTGATGGAGCGACTTGGCATCGCTGTTTTAGGCTAA", "partial": "0", "query_start": 8757, "query_end": 9071, "hit_start": 171, "hit_end": 588, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 23.02}, "gnl|BL_ORD_ID|2118|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "qnrE1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "3335", "ARO_accession": "3004636", "ARO_name": "qnrE1", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.275014, "max_identities": 22, "bit_score": 28.1054, "cvterm_id": "35915", "query": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNF", "match": "+  +R+   ++E+ +F  CD               F D             + D  F+ CDL  + F               R +N + +++ E    G D  G +    + T+T F", "sequence_from_db": "IGRNRFTGEKIENAIFRNCDFSGTDLTSSEFIGCQFYDRESQQGGNFNRAQLKDAIFKSCDLSMADF---------------RHSNALGIEIRECRAQGADFRGASFMNMITTRTWF", "sequence_from_broadstreet": "MALIFEGEKIGRNRFTGEKIENAIFRNCDFSGTDLTSSEFIGCQFYDRESQQGGNFNRAQLKDAIFKSCDLSMADFRHSNALGIEIRECRAQGADFRGASFMNMITTRTWFCCAYITKSNLSYANFSKVVLEKCELWENRWNGAQILGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGIDLQGVKLDSYQVSQLMERLGIAVLG", "dna_sequence_from_broadstreet": "ATGGCATTGATTTTTGAAGGCGAAAAAATAGGTCGTAACCGTTTTACCGGAGAGAAAATAGAGAATGCAATCTTTCGTAACTGCGACTTTTCCGGTACGGATTTAACCAGCTCGGAGTTTATCGGCTGTCAGTTCTATGACCGGGAAAGCCAGCAGGGCGGTAACTTTAATCGGGCGCAACTTAAAGATGCTATTTTCAAAAGCTGCGATTTATCGATGGCGGATTTCAGGCATTCAAATGCATTAGGCATCGAAATCCGTGAATGCAGGGCGCAAGGGGCCGATTTCCGCGGGGCCAGTTTTATGAACATGATCACCACCCGTACCTGGTTTTGCTGTGCTTACATCACAAAAAGCAACCTGAGCTATGCCAATTTTTCGAAGGTGGTTCTGGAAAAATGCGAGCTGTGGGAAAACCGCTGGAACGGCGCGCAGATACTTGGCGCCACCTTTAGCGGCTCGGATCTGTCTGGGGGCGAGTTCTCATCCTTTGACTGGCGAGCGGCCAATTTTACCCACTGCGATCTGACCAATTCAGAACTGGGTGATCTGGACGTGCGGGGTATTGATTTGCAGGGCGTCAAACTGGACAGCTATCAGGTTTCCCAGTTGATGGAGCGACTTGGCATCGCTGTTTTAGGCTAA", "partial": "0", "query_start": 8736, "query_end": 9086, "hit_start": 27, "hit_end": 333, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 18.8}, "gnl|BL_ORD_ID|1788|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB30", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1940", "ARO_accession": "3002745", "ARO_name": "QnrB30", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0511811, "max_identities": 31, "bit_score": 30.4166, "cvterm_id": "39584", "query": "RSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMP---------DVQFEQCDLRYSSFLKLNLRK-----TRFVGCSA--------------------REANFIDVDLAESDFTGTDMPGCTMQGCVL", "match": "R+ L+D +F+  DL        +   +  +  R  G D+ G   M                 +L Y++F K+ L K      R++G                       R ANF   DL  S+    D+ G  +QG  L", "sequence_from_db": "RAMLKDAIFKSSDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSSDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCACTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTAAAAGATGCCATTTTTAAAAGCAGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGGGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 8757, "query_end": 9071, "hit_start": 207, "hit_end": 624, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 22.3}, "gnl|BL_ORD_ID|1788|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "QnrB30", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1940", "ARO_accession": "3002745", "ARO_name": "QnrB30", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.162649, "max_identities": 15, "bit_score": 28.8758, "cvterm_id": "39584", "query": "LRKTRFVGCSAREANFIDVDLAESDFTGTDMPGC------TMQGCVLTKTNFARS", "match": "+ + RF G     + F + D + +D +GT+  GC      + +GC     NF+R+", "sequence_from_db": "IDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGC-----NFSRA", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSSDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCACTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTAAAAGATGCCATTTTTAAAAGCAGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGGGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 8949, "query_end": 9095, "hit_start": 63, "hit_end": 213, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.27}, "gnl|BL_ORD_ID|4851|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "MCR-4.6", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1000", "model_id": "5836", "ARO_accession": "3007231", "ARO_name": "MCR-4.6", "ARO_category": {"41432": {"category_aro_accession": "3004268", "category_aro_cvterm_id": "41432", "category_aro_name": "MCR phosphoethanolamine transferase", "category_aro_description": "A group of mobile colistin resistance genes encode the MCR family of phosphoethanolamine transferases, which catalyze the addition of phosphoethanolamine onto lipid A, thus interfering with the binding of colistin to the cell membrane.", "category_aro_class_name": "AMR Gene Family"}, "36966": {"category_aro_accession": "3000622", "category_aro_cvterm_id": "36966", "category_aro_name": "colistin A", "category_aro_description": "Colistin A, or polymyxin E1, has a 6-octanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "36968": {"category_aro_accession": "3000624", "category_aro_cvterm_id": "36968", "category_aro_name": "colistin B", "category_aro_description": "Colistin B, or polymyxin E2, has a 6-heptanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "36192": {"category_aro_accession": "3000053", "category_aro_cvterm_id": "36192", "category_aro_name": "peptide antibiotic", "category_aro_description": "Peptide antibiotics have a wide range of antibacterial mechanisms, depending on the amino acids that make up the antibiotic, although most act to disrupt the cell membrane in some manner. Subclasses of peptide antibiotics can include additional sidechains of other types, such as lipids in the case of the lipopeptide antibiotics.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.03968, "max_identities": 13, "bit_score": 25.0238, "cvterm_id": "35810", "query": "DFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAV", "match": "D   +D+  C+ +  + T  N    T+FI     N++KG +   +TA+", "sequence_from_db": "DCPRSDIQNCSQEELINTYDNTILYTDFILSEVVNKLKGKQDMFDTAM", "sequence_from_broadstreet": "MISRFKTLSVNQFTFITALFYVAIFNLPLFGIVRKGIEKQPEVDPLFIASMPLFLTFALSFLFSIFTVKYLLKPFFIVLTLLSSSVFFAAYQYNVVFDYGMIENTFQTHPAEALMYVNLASITNLLLTGLLPSYLIYKADIHYQPFFKELLHKLAFMLLMFVGIGIVAFFYYQDYAAFVRNNSELRRYIVPTYFVSSASKYLNEHYLQTPMEYQQLGLDAKNASRNPNTKPNLLVFVVGETARSMSYQYYGYNKPTNAHTQNQGLIAFNDTSSCGTATAVSLPCMFSRMGRADYDPRRANAQDTVIDVLSHSGIKVQWFDNDSGCKGVCDQVENLTIDLKSDPKLCSGQYCFDQVLLNKLDKILAVAPSQDTVIFLHIIGSHGPTYYLRYPPEHRKFIPDCPRSDIQNCSQEELINTYDNTILYTDFILSEVVNKLKGKQDMFDTAMLYLSDHGESLGEKGMYLHGAPYSIAPKEQTSVPMLAWVSNDFSQDNQLNMTCVAQRAEQGGFSHDNLFDSLLGLMNVKTTVYQSQLDIFAPCRY", "dna_sequence_from_broadstreet": "GTGATTTCTAGATTTAAGACGTTATCGGTTAACCAATTCACTTTCATCACTGCGTTGTTTTATGTTGCCATTTTCAATCTACCGCTCTTTGGTATAGTGCGAAAAGGAATTGAAAAACAACCAGAAGTTGATCCCCTTTTCATCGCATCTATGCCGCTATTTTTAACATTTGCGCTGAGTTTTTTGTTTTCAATTTTTACCGTCAAATACCTGCTGAAGCCCTTTTTTATCGTATTGACGTTACTTTCCTCAAGTGTATTTTTTGCAGCCTATCAATACAATGTCGTGTTTGACTACGGCATGATAGAAAACACGTTTCAAACACATCCTGCTGAAGCATTGATGTATGTAAATCTTGCATCAATTACCAATCTACTGCTGACTGGGCTATTACCGTCATATCTTATTTATAAGGCCGATATTCATTATCAGCCCTTTTTTAAGGAGTTATTGCATAAATTAGCCTTTATGCTGCTAATGTTCGTTGGCATTGGGATAGTCGCCTTTTTTTACTATCAAGATTATGCTGCATTTGTTCGAAACAACAGTGAGTTAAGGCGTTACATTGTCCCTACCTATTTTGTCAGTAGTGCATCTAAATATCTCAATGAGCACTATTTGCAGACGCCCATGGAATACCAACAACTTGGCCTAGATGCGAAGAATGCCAGTCGTAACCCGAACACTAAACCTAACTTATTAGTGTTTGTTGTGGGTGAAACTGCGCGCTCAATGAGCTATCAATATTATGGATATAACAAGCCAACCAATGCTCATACCCAAAATCAGGGGCTGATTGCGTTTAACGATACTAGCTCATGCGGCACGGCCACGGCGGTGTCTCTACCCTGTATGTTTTCACGAATGGGGCGGGCAGACTATGATCCTCGCCGTGCTAATGCTCAAGACACAGTGATTGATGTGTTAAGTCATAGTGGTATAAAAGTACAGTGGTTTGATAATGATTCTGGCTGTAAAGGTGTGTGTGATCAGGTTGAAAATCTCACGATAGATTTGAAGAGTGATCCGAAGCTGTGTTCTGGCCAATATTGTTTTGACCAAGTATTGCTCAACAAATTAGATAAAATTCTGGCAGTAGCACCAAGTCAAGATACAGTAATTTTTTTGCATATCATTGGTAGTCATGGACCAACTTATTATCTTAGATACCCGCCAGAGCATCGTAAATTTATACCGGATTGTCCGCGCAGTGATATTCAAAATTGCAGTCAAGAAGAACTGATTAACACCTACGACAACACTATTCTATATACGGATTTTATTCTCAGTGAAGTGGTGAATAAATTAAAAGGTAAGCAGGATATGTTCGATACTGCAATGCTGTATCTCTCTGACCATGGTGAGTCTTTGGGTGAAAAGGGCATGTATTTACATGGTGCGCCCTATAGTATTGCACCGAAAGAACAAACTAGCGTACCAATGCTGGCTTGGGTATCTAATGACTTTAGCCAAGATAATCAGTTGAACATGACTTGTGTTGCACAGCGAGCAGAACAGGGCGGCTTTTCCCACGACAATTTGTTCGACAGTTTGCTAGGACTTATGAATGTAAAAACCACCGTCTATCAGAGCCAACTCGATATTTTTGCACCTTGCAGGTATTAG", "partial": "0", "query_start": 9021, "query_end": 9164, "hit_start": 1197, "hit_end": 1341, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.08}, "gnl|BL_ORD_ID|4717|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "MCR-4.1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1000", "model_id": "2848", "ARO_accession": "3004325", "ARO_name": "MCR-4.1", "ARO_category": {"41432": {"category_aro_accession": "3004268", "category_aro_cvterm_id": "41432", "category_aro_name": "MCR phosphoethanolamine transferase", "category_aro_description": "A group of mobile colistin resistance genes encode the MCR family of phosphoethanolamine transferases, which catalyze the addition of phosphoethanolamine onto lipid A, thus interfering with the binding of colistin to the cell membrane.", "category_aro_class_name": "AMR Gene Family"}, "36966": {"category_aro_accession": "3000622", "category_aro_cvterm_id": "36966", "category_aro_name": "colistin A", "category_aro_description": "Colistin A, or polymyxin E1, has a 6-octanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "36968": {"category_aro_accession": "3000624", "category_aro_cvterm_id": "36968", "category_aro_name": "colistin B", "category_aro_description": "Colistin B, or polymyxin E2, has a 6-heptanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "36192": {"category_aro_accession": "3000053", "category_aro_cvterm_id": "36192", "category_aro_name": "peptide antibiotic", "category_aro_description": "Peptide antibiotics have a wide range of antibacterial mechanisms, depending on the amino acids that make up the antibiotic, although most act to disrupt the cell membrane in some manner. Subclasses of peptide antibiotics can include additional sidechains of other types, such as lipids in the case of the lipopeptide antibiotics.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.03968, "max_identities": 13, "bit_score": 25.0238, "cvterm_id": "41493", "query": "DFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAV", "match": "D   +D+  C+ +  + T  N    T+FI     N++KG +   +TA+", "sequence_from_db": "DCPRSDIQNCSQEELINTYDNTILYTDFILSEVVNKLKGKQDMFDTAM", "sequence_from_broadstreet": "MISRFKTLSVNQFTFITALFYVAIFNLPLFGIVRKGIEKQPEVDPLFIASMPLFLTFALSFLFSIFTVKYLLKPFFIVLTLLSSSVFFAAYQYNVVFDYGMIENTFQTHPAEALMYVNLASITNLLLTGLLPSYLIYKADIHYQPFFKELLHKLAFMLLMFVGIGIVAFFYYQDYAAFVRNNSELRRYIVPTYFVSSASKYLNEHYLQTPMEYQQLGLDAKNASRNPNTKPNLLVVVVGETARSMSYQYYGYNKPTNAHTQNQGLIAFNDTSSCGTATAVSLPCMFSRMGRADYDPRRANAQDTVIDVLSHSGIKVQWFDNDSGCKGVCDQVENLTIDLKSDPKLCSGQYCFDQVLLNKLDKILAVAPSQDTVIFLHIIGSHGPTYYLRYPPEHRKFIPDCPRSDIQNCSQEELINTYDNTILYTDFILSEVVNKLKGKQDMFDTAMLYLSDHGESLGEKGMYLHGAPYSIAPKEQTSVPMLAWVSNDFSQDNQLNMTCVAQRAEQGGFSHDNLFDSLLGLMNVKTTVYQSQLDIFAPCRY", "dna_sequence_from_broadstreet": "GTGATTTCTAGATTTAAGACGTTATCGGTTAACCAATTCACTTTCATCACTGCGTTGTTTTATGTTGCCATTTTCAATCTACCGCTCTTTGGTATAGTGCGAAAAGGAATTGAAAAACAACCAGAAGTTGATCCCCTTTTCATCGCATCTATGCCGCTATTTTTAACATTTGCGCTGAGTTTTTTGTTTTCAATTTTTACCGTCAAATACCTGCTGAAGCCCTTTTTTATCGTATTGACGTTACTTTCCTCAAGTGTATTTTTTGCAGCCTATCAATACAATGTCGTGTTTGACTACGGCATGATAGAAAACACGTTTCAAACACATCCTGCTGAAGCATTGATGTATGTAAATCTTGCATCAATTACCAATCTACTGCTGACTGGGCTATTACCGTCATATCTTATTTATAAGGCCGATATTCATTATCAGCCCTTTTTTAAGGAGTTATTGCATAAATTAGCCTTTATGCTGCTAATGTTCGTTGGCATTGGGATAGTCGCCTTTTTTTACTATCAAGATTATGCTGCATTTGTTCGAAACAACAGTGAGTTAAGGCGTTACATTGTCCCTACCTATTTTGTCAGTAGTGCATCTAAATATCTCAATGAGCACTATTTGCAGACGCCCATGGAATACCAACAACTTGGCCTAGATGCGAAGAATGCCAGTCGTAACCCGAACACTAAACCTAACTTATTAGTGGTTGTTGTGGGTGAAACTGCGCGCTCAATGAGCTATCAATATTATGGATATAACAAGCCAACCAATGCTCATACCCAAAATCAGGGGCTGATTGCGTTTAACGATACTAGCTCATGCGGCACGGCCACGGCGGTGTCTCTACCCTGTATGTTTTCACGAATGGGGCGGGCAGACTATGATCCTCGCCGTGCTAATGCTCAAGACACAGTGATTGATGTGTTAAGTCATAGTGGTATAAAAGTACAGTGGTTTGATAATGATTCTGGCTGTAAAGGTGTGTGTGATCAGGTTGAAAATCTCACGATAGATTTGAAGAGTGATCCGAAGCTGTGTTCTGGCCAATATTGTTTTGACCAAGTATTGCTCAACAAATTAGATAAAATTCTGGCAGTAGCACCAAGTCAAGATACAGTAATTTTTTTGCATATCATTGGTAGTCATGGACCAACTTATTATCTTAGATACCCGCCAGAGCATCGTAAATTTATACCGGATTGTCCGCGCAGTGATATTCAAAATTGCAGTCAAGAAGAACTGATTAACACCTACGACAACACTATTCTATATACGGATTTTATTCTCAGTGAAGTGGTGAATAAATTAAAAGGTAAGCAGGATATGTTCGATACTGCAATGCTGTATCTCTCTGACCATGGTGAGTCTTTGGGTGAAAAGGGCATGTATTTACATGGTGCGCCCTATAGTATTGCACCGAAAGAACAAACTAGCGTACCAATGCTGGCTTGGGTATCTAATGACTTTAGCCAAGATAATCAGTTGAACATGACTTGTGTTGCACAGCGAGCAGAACAGGGCGGCTTTTCCCACGACAATTTGTTCGACAGTTTGCTAGGACTTATGAATGTAAAAACCACCGTCTATCAGAGCCAACTCGATATTTTTGCACCTTGCAGGTATTAG", "partial": "0", "query_start": 9021, "query_end": 9164, "hit_start": 1197, "hit_end": 1341, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.08}, "gnl|BL_ORD_ID|2296|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "MCR-4.5", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1000", "model_id": "3395", "ARO_accession": "3004697", "ARO_name": "MCR-4.5", "ARO_category": {"41432": {"category_aro_accession": "3004268", "category_aro_cvterm_id": "41432", "category_aro_name": "MCR phosphoethanolamine transferase", "category_aro_description": "A group of mobile colistin resistance genes encode the MCR family of phosphoethanolamine transferases, which catalyze the addition of phosphoethanolamine onto lipid A, thus interfering with the binding of colistin to the cell membrane.", "category_aro_class_name": "AMR Gene Family"}, "36966": {"category_aro_accession": "3000622", "category_aro_cvterm_id": "36966", "category_aro_name": "colistin A", "category_aro_description": "Colistin A, or polymyxin E1, has a 6-octanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "36968": {"category_aro_accession": "3000624", "category_aro_cvterm_id": "36968", "category_aro_name": "colistin B", "category_aro_description": "Colistin B, or polymyxin E2, has a 6-heptanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "36192": {"category_aro_accession": "3000053", "category_aro_cvterm_id": "36192", "category_aro_name": "peptide antibiotic", "category_aro_description": "Peptide antibiotics have a wide range of antibacterial mechanisms, depending on the amino acids that make up the antibiotic, although most act to disrupt the cell membrane in some manner. Subclasses of peptide antibiotics can include additional sidechains of other types, such as lipids in the case of the lipopeptide antibiotics.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.03968, "max_identities": 13, "bit_score": 25.0238, "cvterm_id": "35914", "query": "DFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAV", "match": "D   +D+  C+ +  + T  N    T+FI     N++KG +   +TA+", "sequence_from_db": "DCPRSDIQNCSQEELINTYDNTILYTDFILSEVVNKLKGKQDMFDTAM", "sequence_from_broadstreet": "MISRFKTLSVNQFTFITALFYVAIFNLPLFGIVRKGIEKQPEVDPLFIASMPLFLTFALSFLFSIFTVKYLLKPFFIVLTLLSSSVFFAAYQYNVVFDYGMIENTFQTHLAEALMYVNLASITNLLLTGLLPSYLIYKADIHYQPFFKELLHKLAFMLLMFVGIGIVAFFYYQDYAAFVRNNSELRRYIVPTYFVSSASKYLNEHYLQTPMEYQQLGLDAKNASRNPNTKPNLLVVVVGETARSMSYQYYGYNKPTNAHTQNQGLIAFNDTSSCGTATAVSLPCMFSRMGRADYDPRRANAQDTVIDVLSHSGIKVQWFDNDSGCKGVCDRVENLTIDLKSDPKLCSGQYCFDQVLLNKLDKILAVAPSQDTVIFLHIIGSHGPTYYLRYPPEHRKFIPDCPRSDIQNCSQEELINTYDNTILYTDFILSEVVNKLKGKQDMFDTAMLYLSDHGESLGEKGMYLHGAPYSIAPKEQTSVPMLAWVSNDFSQDNQLNMTCVAQRAEQGGFSHDNLFDSLLGLMNVKTTVYQSQLDIFAPCRY", "dna_sequence_from_broadstreet": "GTGATTTCTAGATTTAAGACGTTATCGGTTAACCAATTCACTTTCATCACTGCGTTGTTTTATGTTGCCATTTTCAATCTACCGCTCTTTGGTATAGTGCGAAAAGGAATTGAAAAACAACCAGAAGTTGATCCCCTTTTCATCGCATCTATGCCGCTATTTTTAACATTTGCGCTGAGTTTTTTGTTTTCAATTTTTACCGTCAAATACCTGCTGAAGCCCTTTTTTATCGTATTGACGTTACTTTCCTCAAGTGTATTTTTTGCAGCCTATCAATACAATGTCGTGTTTGACTACGGCATGATAGAAAACACGTTTCAAACACATCTTGCTGAAGCATTGATGTATGTAAATCTTGCATCAATTACCAATCTACTGCTGACTGGGCTATTACCGTCATATCTTATTTATAAGGCCGATATTCATTATCAGCCCTTTTTTAAGGAGTTATTGCATAAATTAGCCTTTATGCTGCTAATGTTCGTTGGCATTGGGATAGTCGCCTTTTTTTACTATCAAGATTATGCTGCATTTGTTCGAAACAACAGTGAGTTAAGGCGTTACATTGTCCCTACCTATTTTGTCAGTAGTGCATCTAAATATCTCAATGAGCACTATTTGCAGACGCCCATGGAATACCAACAACTTGGCCTAGATGCGAAGAATGCCAGTCGTAACCCGAACACTAAACCTAACTTATTAGTGGTTGTTGTGGGTGAAACTGCGCGCTCAATGAGCTATCAATATTATGGATATAACAAGCCAACCAATGCTCATACCCAAAATCAGGGGCTGATTGCGTTTAACGATACTAGCTCATGCGGCACGGCCACGGCGGTGTCTCTACCCTGTATGTTTTCACGAATGGGGCGGGCAGACTATGATCCTCGCCGTGCTAATGCTCAAGACACAGTGATTGATGTGTTAAGTCATAGTGGTATAAAAGTACAGTGGTTTGATAATGATTCTGGCTGTAAAGGTGTGTGTGATCGGGTTGAAAATCTCACGATAGATTTGAAGAGTGATCCGAAGCTGTGTTCTGGCCAATATTGTTTTGACCAAGTATTGCTCAACAAATTAGATAAAATTCTGGCAGTAGCACCAAGTCAAGATACAGTAATTTTTTTGCATATCATTGGTAGTCATGGACCAACTTATTATCTTAGATACCCGCCAGAGCATCGTAAATTTATACCGGATTGTCCGCGCAGTGATATTCAAAATTGCAGTCAAGAAGAACTGATTAACACCTACGACAACACTATTCTATATACGGATTTTATTCTCAGTGAAGTGGTGAATAAATTAAAAGGTAAGCAGGATATGTTCGATACTGCAATGCTGTATCTCTCTGACCATGGTGAGTCTTTGGGTGAAAAGGGCATGTATTTACATGGTGCGCCCTATAGTATTGCACCGAAAGAACAAACTAGCGTACCAATGCTGGCTTGGGTATCTAATGACTTTAGCCAAGATAATCAGTTGAACATGACTTGTGTTGCACAGCGAGCAGAACAGGGCGGCTTTTCCCACGACAATTTGTTCGACAGTTTGCTAGGACTTATGAATGTAAAAACCACCGTCTATCAGAGCCAACTCGATATTTTTGCACCTTGCAGGTATTAG", "partial": "0", "query_start": 9021, "query_end": 9164, "hit_start": 1197, "hit_end": 1341, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.08}, "gnl|BL_ORD_ID|2288|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "MCR-4.4", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1000", "model_id": "3394", "ARO_accession": "3004696", "ARO_name": "MCR-4.4", "ARO_category": {"41432": {"category_aro_accession": "3004268", "category_aro_cvterm_id": "41432", "category_aro_name": "MCR phosphoethanolamine transferase", "category_aro_description": "A group of mobile colistin resistance genes encode the MCR family of phosphoethanolamine transferases, which catalyze the addition of phosphoethanolamine onto lipid A, thus interfering with the binding of colistin to the cell membrane.", "category_aro_class_name": "AMR Gene Family"}, "36966": {"category_aro_accession": "3000622", "category_aro_cvterm_id": "36966", "category_aro_name": "colistin A", "category_aro_description": "Colistin A, or polymyxin E1, has a 6-octanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "36968": {"category_aro_accession": "3000624", "category_aro_cvterm_id": "36968", "category_aro_name": "colistin B", "category_aro_description": "Colistin B, or polymyxin E2, has a 6-heptanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "36192": {"category_aro_accession": "3000053", "category_aro_cvterm_id": "36192", "category_aro_name": "peptide antibiotic", "category_aro_description": "Peptide antibiotics have a wide range of antibacterial mechanisms, depending on the amino acids that make up the antibiotic, although most act to disrupt the cell membrane in some manner. Subclasses of peptide antibiotics can include additional sidechains of other types, such as lipids in the case of the lipopeptide antibiotics.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.03968, "max_identities": 13, "bit_score": 25.0238, "cvterm_id": "35914", "query": "DFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAV", "match": "D   +D+  C+ +  + T  N    T+FI     N++KG +   +TA+", "sequence_from_db": "DCPRSDIQNCSQEELINTYDNTILYTDFILSEVVNKLKGKQDMFDTAM", "sequence_from_broadstreet": "MISRFKTLSVNQFTFITALFYVAIFNLPLFGIVRKGIEKQPEVDPLFIASMPLFLTFALSFLFSIFTVKYLLKPFFIVLTLLSSSVFFAAYQYNVVFDYGMIENTFQTHPAEALMYVNLASITNLLLTGLLPSYLIYKADIHYQPFFKELLHKLAFMLLMFVGIGIVAFFYYQDYAAFVRNNSELRRYIVPTYFVSSASKYLNENYLQTPMEYQQLGLDAKNASRNPNTKPNLLVVVVGETARSMSYQYYGYNKPTNAHTQNQGLIAFNDTSSCGTATAVSLPCMFSRMGRADYDPRRANAQDTVIDVLSHSGIKVQWFDNDSGCKGVCDRVENLTIDLKSDPKLCSGQYCFDQVLLNKLDKILAVAPSQDTVIFLHIIGSHGPTYYLRYPPEHRKFIPDCPRSDIQNCSQEELINTYDNTILYTDFILSEVVNKLKGKQDMFDTAMLYLSDHGESLGEKGMYLHGAPYSIAPKEQTSVPMLAWVSNDFSQDNQLNMTCVAQRAEQGGFSHDNLFDSLLGLMNVKTTVYQSQLDIFAPCRY", "dna_sequence_from_broadstreet": "GTGATTTCTAGATTTAAGACGTTATCGGTTAACCAATTCACTTTCATCACTGCGTTGTTTTATGTTGCCATTTTCAATCTACCGCTCTTTGGTATAGTGCGAAAAGGAATTGAAAAACAACCAGAAGTTGATCCCCTTTTCATCGCATCTATGCCGCTATTTTTAACATTTGCGCTGAGTTTTTTGTTTTCAATTTTTACCGTCAAATACCTGCTGAAGCCCTTTTTTATCGTATTGACGTTACTTTCCTCAAGTGTATTTTTTGCAGCCTATCAATACAATGTCGTGTTTGACTACGGCATGATAGAAAACACGTTTCAAACACATCCTGCTGAAGCATTGATGTATGTAAATCTTGCATCAATTACCAATCTACTGCTGACTGGGCTATTACCGTCATATCTTATTTATAAGGCCGATATTCATTATCAGCCCTTTTTTAAGGAGTTATTGCATAAATTAGCCTTTATGCTGCTAATGTTCGTTGGCATTGGGATAGTCGCCTTTTTTTACTATCAAGATTATGCTGCATTTGTTCGAAACAACAGTGAGTTAAGGCGTTACATTGTCCCTACCTATTTTGTCAGTAGTGCATCTAAATATCTCAATGAGAACTATTTGCAGACGCCCATGGAATACCAACAACTTGGCCTAGATGCGAAGAATGCCAGTCGTAACCCGAACACTAAACCTAACTTATTAGTGGTTGTTGTGGGTGAAACTGCGCGCTCAATGAGCTATCAATATTATGGATATAACAAGCCAACCAATGCTCATACCCAAAATCAGGGGCTGATTGCGTTTAACGATACTAGCTCATGCGGCACGGCCACGGCGGTGTCTCTACCCTGTATGTTTTCACGAATGGGGCGGGCAGACTATGATCCTCGCCGTGCTAATGCTCAAGACACAGTGATTGATGTGTTAAGTCATAGTGGTATAAAAGTACAGTGGTTTGATAATGATTCTGGCTGTAAAGGTGTGTGTGATCGGGTTGAAAATCTCACGATAGATTTGAAGAGTGATCCGAAGCTGTGTTCTGGCCAATATTGTTTTGACCAAGTATTGCTCAACAAATTAGATAAAATTCTGGCAGTAGCACCAAGTCAAGATACAGTAATTTTTTTGCATATCATTGGTAGTCATGGACCAACTTATTATCTTAGATACCCGCCAGAGCATCGTAAATTTATACCGGATTGTCCGCGCAGTGATATTCAAAATTGCAGTCAAGAAGAACTGATTAACACCTACGACAACACTATTCTATATACGGATTTTATTCTCAGTGAAGTGGTGAATAAATTAAAAGGTAAGCAGGATATGTTCGATACTGCAATGCTGTATCTCTCTGACCATGGTGAGTCTTTGGGTGAAAAGGGCATGTATTTACATGGTGCGCCCTATAGTATTGCACCGAAAGAACAAACTAGCGTACCAATGCTGGCTTGGGTATCTAATGACTTTAGCCAAGATAATCAGTTGAACATGACTTGTGTTGCACAGCGAGCAGAACAGGGCGGCTTTTCCCACGACAATTTGTTCGACAGTTTGCTAGGACTTATGAATGTAAAAACCACCGTCTATCAGAGCCAACTCGATATTTTTGCACCTTGCAGGTATTAG", "partial": "0", "query_start": 9021, "query_end": 9164, "hit_start": 1197, "hit_end": 1341, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.08}, "gnl|BL_ORD_ID|2271|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "MCR-4.3", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1000", "model_id": "3393", "ARO_accession": "3004695", "ARO_name": "MCR-4.3", "ARO_category": {"41432": {"category_aro_accession": "3004268", "category_aro_cvterm_id": "41432", "category_aro_name": "MCR phosphoethanolamine transferase", "category_aro_description": "A group of mobile colistin resistance genes encode the MCR family of phosphoethanolamine transferases, which catalyze the addition of phosphoethanolamine onto lipid A, thus interfering with the binding of colistin to the cell membrane.", "category_aro_class_name": "AMR Gene Family"}, "36966": {"category_aro_accession": "3000622", "category_aro_cvterm_id": "36966", "category_aro_name": "colistin A", "category_aro_description": "Colistin A, or polymyxin E1, has a 6-octanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "36968": {"category_aro_accession": "3000624", "category_aro_cvterm_id": "36968", "category_aro_name": "colistin B", "category_aro_description": "Colistin B, or polymyxin E2, has a 6-heptanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "36192": {"category_aro_accession": "3000053", "category_aro_cvterm_id": "36192", "category_aro_name": "peptide antibiotic", "category_aro_description": "Peptide antibiotics have a wide range of antibacterial mechanisms, depending on the amino acids that make up the antibiotic, although most act to disrupt the cell membrane in some manner. Subclasses of peptide antibiotics can include additional sidechains of other types, such as lipids in the case of the lipopeptide antibiotics.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.03968, "max_identities": 13, "bit_score": 25.0238, "cvterm_id": "36884", "query": "DFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAV", "match": "D   +D+  C+ +  + T  N    T+FI     N++KG +   +TA+", "sequence_from_db": "DCPRSDIQNCSQEELINTYDNTILYTDFILSEVVNKLKGKQDMFDTAM", "sequence_from_broadstreet": "MISRFKTLSVNQFTFITALFYVAIFNLPLFGIVRKGIEKQPEVDPLFIASMPLFLTFALSFLFSIFTVKYLLKPFFIVLTLLSSSVFFAAYQYNVVFDYGMIENTFQTHPAEALMYVNLASITNLLLTGLLPSYLIYKADIHYQPFFKELLHKLAFMLLMFVGIGIVAFFYYQDYAAFGRNNSELRRYIVPTYFVSSASKYLNEHYLQTPMEYQQLGLDAKNASRNPNTKPNLLVFVVGETARSMSYQYYGYNKPTNAHTQNQGLIAFNDTSSCGTATAVSLPCMFSRMGRADYDPRRANAQDTVIDVLSHSGIKVQWFDNDSGCKGVCDQVENLTIDLKSDPKLCSGQYCFDQVLLNKLDKILAVAPSQDTVIFLHIIGSHGPTYYLRYPPEHRKFIPDCPRSDIQNCSQEELINTYDNTILYTDFILSEVVNKLKGKQDMFDTAMLYLSDHGESLGEKGMYLHGAPYSIAPKEQTSVPMLAWVSNDFSQDNQLNMTCVAQRAEQGGFSHDNLFDSLLGLMNVKTTVYQSQLDIFAPCRY", "dna_sequence_from_broadstreet": "GTGATTTCTAGATTTAAGACGTTATCGGTTAACCAATTCACTTTCATCACTGCGTTGTTTTATGTTGCCATTTTCAATCTACCGCTCTTTGGTATAGTGCGAAAAGGAATTGAAAAACAACCAGAAGTTGATCCCCTTTTCATCGCATCTATGCCGCTATTTTTAACATTTGCGCTGAGTTTTTTGTTTTCAATTTTTACCGTCAAATACCTGCTGAAGCCCTTTTTTATCGTATTGACGTTACTTTCCTCAAGTGTATTTTTTGCAGCCTATCAATACAATGTCGTGTTTGACTACGGCATGATAGAAAACACGTTTCAAACACATCCTGCTGAAGCATTGATGTATGTAAATCTTGCATCAATTACCAATCTACTGCTGACTGGGCTATTACCGTCATATCTTATTTATAAGGCCGATATTCATTATCAGCCCTTTTTTAAGGAGTTATTGCATAAATTAGCCTTTATGCTGCTAATGTTCGTTGGCATTGGGATAGTCGCCTTTTTTTACTATCAAGATTATGCTGCATTTGGTCGAAACAACAGTGAGTTAAGGCGTTACATTGTCCCTACCTATTTTGTCAGTAGTGCATCTAAATATCTCAATGAGCACTATTTGCAGACGCCCATGGAATACCAACAACTTGGCCTAGATGCGAAGAATGCCAGTCGTAACCCGAACACTAAACCTAACTTATTAGTGTTTGTTGTGGGTGAAACTGCGCGCTCAATGAGCTATCAATATTATGGATATAACAAGCCAACCAATGCTCATACCCAAAATCAGGGGCTGATTGCGTTTAACGATACTAGCTCATGCGGCACGGCCACGGCGGTGTCTCTACCCTGTATGTTTTCACGAATGGGGCGGGCAGACTATGATCCTCGCCGTGCTAATGCTCAAGACACAGTGATTGATGTGTTAAGTCATAGTGGTATAAAAGTACAGTGGTTTGATAATGATTCTGGCTGTAAAGGTGTGTGTGATCAGGTTGAAAATCTCACGATAGATTTGAAGAGTGATCCGAAGCTGTGTTCTGGCCAATATTGTTTTGACCAAGTATTGCTCAACAAATTAGATAAAATTCTGGCAGTAGCACCAAGTCAAGATACAGTAATTTTTTTGCATATCATTGGTAGTCATGGACCAACTTATTATCTTAGATACCCGCCAGAGCATCGTAAATTTATACCGGATTGTCCGCGCAGTGATATTCAAAATTGCAGTCAAGAAGAACTGATTAACACCTACGACAACACTATTCTATATACGGATTTTATTCTCAGTGAAGTGGTGAATAAATTAAAAGGTAAGCAGGATATGTTCGATACTGCAATGCTGTATCTCTCTGACCATGGTGAGTCTTTGGGTGAAAAGGGCATGTATTTACATGGTGCGCCCTATAGTATTGCACCGAAAGAACAAACTAGCGTACCAATGCTGGCTTGGGTATCTAATGACTTTAGCCAAGATAATCAGTTGAACATGACTTGTGTTGCACAGCGAGCAGAACAGGGCGGCTTTTCCCACGACAATTTGTTCGACAGTTTGCTAGGACTTATGAATGTAAAAACCACCGTCTATCAGAGCCAACTCGATATTTTTGCACCTTGCAGGTATTAG", "partial": "0", "query_start": 9021, "query_end": 9164, "hit_start": 1197, "hit_end": 1341, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.08}, "gnl|BL_ORD_ID|2255|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 8736, "orf_end": 9215, "orf_from": "BGC0001413.1|Cystobactamide_6 ", "model_name": "MCR-4.2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1000", "model_id": "3392", "ARO_accession": "3004694", "ARO_name": "MCR-4.2", "ARO_category": {"41432": {"category_aro_accession": "3004268", "category_aro_cvterm_id": "41432", "category_aro_name": "MCR phosphoethanolamine transferase", "category_aro_description": "A group of mobile colistin resistance genes encode the MCR family of phosphoethanolamine transferases, which catalyze the addition of phosphoethanolamine onto lipid A, thus interfering with the binding of colistin to the cell membrane.", "category_aro_class_name": "AMR Gene Family"}, "36966": {"category_aro_accession": "3000622", "category_aro_cvterm_id": "36966", "category_aro_name": "colistin A", "category_aro_description": "Colistin A, or polymyxin E1, has a 6-octanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "36968": {"category_aro_accession": "3000624", "category_aro_cvterm_id": "36968", "category_aro_name": "colistin B", "category_aro_description": "Colistin B, or polymyxin E2, has a 6-heptanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "36192": {"category_aro_accession": "3000053", "category_aro_cvterm_id": "36192", "category_aro_name": "peptide antibiotic", "category_aro_description": "Peptide antibiotics have a wide range of antibacterial mechanisms, depending on the amino acids that make up the antibiotic, although most act to disrupt the cell membrane in some manner. Subclasses of peptide antibiotics can include additional sidechains of other types, such as lipids in the case of the lipopeptide antibiotics.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.03968, "max_identities": 13, "bit_score": 25.0238, "cvterm_id": "35914", "query": "DFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAV", "match": "D   +D+  C+ +  + T  N    T+FI     N++KG +   +TA+", "sequence_from_db": "DCPRSDIQNCSQEELINTYDNTILYTDFILSEVVNKLKGKQDMFDTAM", "sequence_from_broadstreet": "MISRFKTLSVNQFTFITALFYVAIFNLPLFGIVRKGIEKQPEVDPLFIASMPLFLTFALSFLFSIFTVKYLLKPFFIVLTLLSSSVFFAAYQYNVVFDYGMIENTFQTHPAEALMYVNLASITNLLLTGLLPSYLIYKADIHYQPFFKELLHKLAFMLLMFVGIGIVAFFYYQDYAAFVRNNSELRRYIVPTYFVSSASKYLNEHYLQTPMEYQQLGLDAKNASRNPNTKPNLLVVVVGETARSMSYQYYGYNKPTNAHTQNQGLIAFNDTSSCGTATAVSLPCMFSRMGRADYDPRRANAQDTVIDVLSHSGIKVQWFDNDSGCKGVCDRVENLTIDLKSDPKLCSGQYCFDQVLLNKLDKILAVAPSQDTVIFLHIIGSHGPTYYLRYPPEHRKFIPDCPRSDIQNCSQEELINTYDNTILYTDFILSEVVNKLKGKQDMFDTAMLYLSDHGESLGEKGMYLHGAPYSIAPKEQTSVPMLAWVSNDFSQDNQLNMTCVAQRAEQGGFSHDNLFDSLLGLMNVKTTVYQSQLDIFAPCRY", "dna_sequence_from_broadstreet": "GTGATTTCTAGATTTAAGACGTTATCGGTTAACCAATTCACTTTCATCACTGCGTTGTTTTATGTTGCCATTTTCAATCTACCGCTCTTTGGTATAGTGCGAAAAGGAATTGAAAAACAACCAGAAGTTGATCCCCTTTTCATCGCATCTATGCCGCTATTTTTAACATTTGCGCTGAGTTTTTTGTTTTCAATTTTTACCGTCAAATACCTGCTGAAGCCCTTTTTTATCGTATTGACGTTACTTTCCTCAAGTGTATTTTTTGCAGCCTATCAATACAATGTCGTGTTTGACTACGGCATGATAGAAAACACGTTTCAAACACATCCTGCTGAAGCATTGATGTATGTAAATCTTGCATCAATTACCAATCTACTGCTGACTGGGCTATTACCGTCATATCTTATTTATAAGGCCGATATTCATTATCAGCCCTTTTTTAAGGAGTTATTGCATAAATTAGCCTTTATGCTGCTAATGTTCGTTGGCATTGGGATAGTCGCCTTTTTTTACTATCAAGATTATGCTGCATTTGTTCGAAACAACAGTGAGTTAAGGCGTTACATTGTCCCTACCTATTTTGTCAGTAGTGCATCTAAATATCTCAATGAGCACTATTTGCAGACGCCCATGGAATACCAACAACTTGGCCTAGATGCGAAGAATGCCAGTCGTAACCCGAACACTAAACCTAACTTATTAGTGGTTGTTGTGGGTGAAACTGCGCGCTCAATGAGCTATCAATATTATGGATATAACAAGCCAACCAATGCTCATACCCAAAATCAGGGGCTGATTGCGTTTAACGATACTAGCTCATGCGGCACGGCCACGGCGGTGTCTCTACCCTGTATGTTTTCACGAATGGGGCGGGCAGACTATGATCCTCGCCGTGCTAATGCTCAAGACACAGTGATTGATGTGTTAAGTCATAGTGGTATAAAAGTACAGTGGTTTGATAATGATTCTGGCTGTAAAGGTGTGTGTGATCGGGTTGAAAATCTCACGATAGATTTGAAGAGTGATCCGAAGCTGTGTTCTGGCCAATATTGTTTTGACCAAGTATTGCTCAACAAATTAGATAAAATTCTGGCAGTAGCACCAAGTCAAGATACAGTAATTTTTTTGCATATCATTGGTAGTCATGGACCAACTTATTATCTTAGATACCCGCCAGAGCATCGTAAATTTATACCGGATTGTCCGCGCAGTGATATTCAAAATTGCAGTCAAGAAGAACTGATTAACACCTACGACAACACTATTCTATATACGGATTTTATTCTCAGTGAAGTGGTGAATAAATTAAAAGGTAAGCAGGATATGTTCGATACTGCAATGCTGTATCTCTCTGACCATGGTGAGTCTTTGGGTGAAAAGGGCATGTATTTACATGGTGCGCCCTATAGTATTGCACCGAAAGAACAAACTAGCGTACCAATGCTGGCTTGGGTATCTAATGACTTTAGCCAAGATAATCAGTTGAACATGACTTGTGTTGCACAGCGAGCAGAACAGGGCGGCTTTTCCCACGACAATTTGTTCGACAGTTTGCTAGGACTTATGAATGTAAAAACCACCGTCTATCAGAGCCAACTCGATATTTTTGCACCTTGCAGGTATTAG", "partial": "0", "query_start": 9021, "query_end": 9164, "hit_start": 1197, "hit_end": 1341, "orf_dna_sequence": "TTGCCCGAAAGCCGCTGGGTCCGGAGCCGCCTGGAGGATTGTGTATTCGAGGGATGCGATCTCCTGCGGATGGTACCGGAGAAGCTCGCGCTGCGAAGCGTGACCTTCAAAGACACCCGCCTCATGGGCGTGGACTGGAGTGGACTCGGAACCATGCCGGACGTCCAGTTCGAACAGTGCGATCTGCGCTACAGCTCCTTCTTGAAGTTGAATCTACGCAAGACGCGGTTCGTTGGCTGCTCCGCGCGCGAAGCCAACTTCATTGACGTGGACCTCGCCGAGTCGGACTTCACCGGCACCGATATGCCAGGATGCACCATGCAGGGCTGCGTCCTCACCAAGACCAATTTTGCTCGATCGACCAATTTCATCTTCGACCCGAAGGCGAACCAGGTCAAAGGGACGCGTGTTGGCGTGGAGACCGCCGTCGCCCTCGCCCAGGCGTTGGGAATGGTGGTCGACGGCTATCAGACACCCTGA", "orf_prot_sequence": "MPESRWVRSRLEDCVFEGCDLLRMVPEKLALRSVTFKDTRLMGVDWSGLGTMPDVQFEQCDLRYSSFLKLNLRKTRFVGCSAREANFIDVDLAESDFTGTDMPGCTMQGCVLTKTNFARSTNFIFDPKANQVKGTRVGVETAVALAQALGMVVDGYQTP", "perc_identity": 27.08}}, "BGC0001413.1|Cystobactamide_7 # 9687 # 9899 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=GGGG;rbs_spacer=7bp;gc_cont=0.592": {"gnl|BL_ORD_ID|4796|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 9687, "orf_end": 9899, "orf_from": "BGC0001413.1|Cystobactamide_7 ", "model_name": "tet(O/W/32/O)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "900", "model_id": "5792", "ARO_accession": "3007122", "ARO_name": "tet(O/W/32/O)", "ARO_category": {"35921": {"category_aro_accession": "0000002", "category_aro_cvterm_id": "35921", "category_aro_name": "tetracycline-resistant ribosomal protection protein", "category_aro_description": "A family of proteins known to bind to the 30S ribosomal subunit. This interaction prevents tetracycline and tetracycline derivatives from inhibiting ribosomal function. Thus, these proteins confer elevated resistance to tetracycline derivatives as a ribosomal protection protein.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.6862, "max_identities": 9, "bit_score": 21.9422, "cvterm_id": "42569", "query": "PVHREIPGGWKTVGPKGSKETCQSYIQEVWTD", "match": "P+   + G ++ +G +GS   C S  +  +TD", "sequence_from_db": "PLMDAVTGLFQPIGEQGSAALCGSVFKVEYTD", "sequence_from_broadstreet": "MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAVTSFQWEDVKVNIIDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMNIPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIENNDKLLEKYIAGEPISREKLVREEQRRVQDASLFPVYYGSAKKGLGIQPLMDAVTGLFQPIGEQGSAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKGEIVRTDTAYPGEIVILADDTLKLNDILGNEKLLPHKTRIDNPMPLLRTTVEPQKPEQREALLNALAEIADTDPLLHFDIDTVTHEIMLSFLGKVQLEVICSLLEEKYHVGVAMKEPSVIYLERPLRKAEYTIHIEVPPNPFWASIGLSVTPLPLGSGVQYESRVSLGYLNQSFQNAVRDGIRYGLEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYLHFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTNFTNGQGVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA", "dna_sequence_from_broadstreet": "ATGAAAATAATTAACTTAGGCATTCTGGCTCACGTTGACGCAGGAAAGACAACATTAACGGAAAGTTTATTGTATACCAGTGGTGCAATTGCAGAACTAGGGAGCGTAGATGAAGGCACAACAAGGACAGATACAATGAATTTGGAGCGTCAAAGGGGAATCACTATCCAGACAGCAGTGACATCTTTTCAGTGGGAGGATGTAAAAGTCAACATTATAGATACGCCAGGCCATATGGATTTTTTGGCGGAGGTGTACCGCTCTTTGGCTGTTTTAGATGGGGCCATCTTGGTGATCTCCGCTAAAGATGGCGTGCAGGCCCAGACCCGTATTCTGTTCCATGCCCTGCGGAAAATGAACATTCCCACCGTTATCTTTATCAACAAGATCGACCAGGCTGGCGTTGATTTGCAGAGCGTGGTTCAGTCTGTTCGGGATAAGCTCTCCGCCGATATTATCATCAAGCAGACGGTGTCACTGTCCCCGGAAATAGTCCTGGAGGAAAATACCGACATAGAAGCATGGGATGCGGTCATCGAAAATAACGATAAATTATTGGAAAAGTATATCGCAGGAGAACCAATCAGCCGGGAAAAACTTGTGCGGGAGGAACAGCGGCGGGTTCAAGACGCCTCCCTGTTCCCGGTCTATTATGGCAGCGCCAAAAAGGGCCTTGGCATTCAACCGTTGATGGATGCGGTGACAGGGCTGTTCCAACCGATTGGGGAACAGGGGAGCGCCGCCCTATGCGGCAGCGTTTTCAAGGTGGAGTATACAGATTGCGGCCAGCGGCGTGTCTATCTACGGCTATACAGCGGAACGCTGCGCCTGCGGGATACGGTGGCCCTGGCCGGGAGAGAAAAGCTGAAAATCACAGAGATGCGTATTCCATCCAAAGGGGAAATTGTTCGGACAGACACCGCTTATCCGGGAGAAATTGTTATTTTAGCTGATGATACTTTGAAACTGAACGACATTCTAGGAAATGAAAAACTCCTGCCTCATAAAACACGGATTGATAATCCCATGCCATTACTTCGGACAACGGTAGAGCCGCAAAAGCCGGAGCAAAGGGAAGCCCTGTTAAATGCCCTCGCAGAGATTGCTGATACAGACCCTCTTTTGCATTTTGACATTGATACTGTTACACATGAGATTATGTTATCTTTTTTGGGAAAAGTACAGTTAGAAGTTATTTGTTCGCTATTAGAAGAAAAATATCATGTGGGCGTGGCTATGAAAGAGCCTTCGGTTATTTATCTGGAAAGACCGCTTAGAAAAGCAGAATATACCATCCACATAGAAGTCCCGCCCAACCCGTTTTGGGCATCCATCGGACTGTCTGTTACACCACTCCCGCTTGGCTCCGGTGTACAATACGAGAGCCGGGTTTCGCTGGGATACTTGAACCAGAGTTTTCAAAACGCTGTCAGGGATGGTATCCGTTACGGGCTGGAGCAGGGGCTGTATGGATGGAAAGTGACAGACTGTAAAATCTGTTTTGAATATGGATTGTATTATAGTCCTGTAAGTACCCCCGCAGACTTTCGGCTGCTTTCCCCTATCGTATTGGAGCAGGCTTTAAAAAAAGCAGGGACAGAACTATTAGAGCCATATCTCCACTTTGAAATTTATGCACCGCAGGAATATCTCTCACGGGCGTATCATGATGCTCCAAGGTATTGTGCAGATATTGTAAGTACTCAGATAAAGAATGACGAGGTCATTCTGAAAGGAGAAATCCCTGCTAGATGTATTCAAGAATACAGGAACGATTTAACTAATTTCACAAATGGGCAGGGAGTCTGCTTGACAGAGTTAAAAGGATACCAGCCAGCTATTGGTAAATTTATTTGCCAACCCCGCCGCCCGAATAGCCGTATAGATAAGGTTCGGCATATGTTCCACAAGTTAGCTTAA", "partial": "0", "query_start": 9756, "query_end": 9851, "hit_start": 684, "hit_end": 780, "orf_dna_sequence": "ATGAGCATGAACGGGGACGAAGCCGAGTACGTTGTCTTGATCAACGGCGAAGAGCAGTACTCGCTCTGGCCCGTGCACCGCGAAATTCCGGGCGGTTGGAAGACCGTTGGGCCCAAGGGAAGCAAGGAAACGTGTCAGTCCTACATCCAGGAGGTCTGGACGGACATGAGGCCGAAATCGCTACGGGAAGCCCTGACGCGCAGCAACTGCTGA", "orf_prot_sequence": "MSMNGDEAEYVVLINGEEQYSLWPVHREIPGGWKTVGPKGSKETCQSYIQEVWTDMRPKSLREALTRSNC", "perc_identity": 28.12}, "gnl|BL_ORD_ID|4797|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 9687, "orf_end": 9899, "orf_from": "BGC0001413.1|Cystobactamide_7 ", "model_name": "tet(O/W/O)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "900", "model_id": "5793", "ARO_accession": "3007123", "ARO_name": "tet(O/W/O)", "ARO_category": {"35921": {"category_aro_accession": "0000002", "category_aro_cvterm_id": "35921", "category_aro_name": "tetracycline-resistant ribosomal protection protein", "category_aro_description": "A family of proteins known to bind to the 30S ribosomal subunit. This interaction prevents tetracycline and tetracycline derivatives from inhibiting ribosomal function. Thus, these proteins confer elevated resistance to tetracycline derivatives as a ribosomal protection protein.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.32039, "max_identities": 9, "bit_score": 21.9422, "cvterm_id": "36809", "query": "PVHREIPGGWKTVGPKGSKETCQSYIQEVWTD", "match": "P+   + G ++ +G +GS   C S  +  +TD", "sequence_from_db": "PLMDAVTGLFQPIGEQGSATLCGSVFKVEYTD", "sequence_from_broadstreet": "MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAVTSFQWEDVKVNIIDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMNIPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIENNDALLEKYIAGEPISQEKLAREEQRRVQEASLFPVYHGSAKKGLGIQPLMDAVTGLFQPIGEQGSATLCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKGEIVRTDTAYPGEIVILPSDSVRLNDVLGDQTRLPRKRWREAPLPMLRTTIAPKTAAQRERLLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKIETVVKEPTVIYMERPLKAASHTIHIEVPPNPFWASIGLSVTPLPLGSGVQYESRVSLGYLNQSFQNAVRDGIRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYLSFTLYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQGVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA", "dna_sequence_from_broadstreet": "ATGAAAATAATTAACTTAGGCATTCTGGCTCACGTTGACGCAGGAAAGACAACATTAACGGAAAGTTTATTGTATACCAGTGGTGCAATTGCAGAACTAGGGAGCGTAGATGAAGGCACAACAAGGACAGATACAATGAATTTGGAGCGTCAAAGGGGAATCACTATCCAGACAGCAGTGACATCTTTTCAGTGGGAGGATGTAAAAGTCAACATTATAGATACGCCAGGCCATATGGATTTTTTGGCGGAGGTGTACCGCTCTTTGGCTGTTTTAGATGGGGCCATCTTGGTGATCTCCGCGAAAGATGGCGTGCAGGCCCAGACCCGTATTCTGTTCCATGCCCTGCGGAAAATGAACATTCCCACCGTTATCTTTATCAACAAGATCGACCAGGCTGGCGTTGATTTGCAGAGCGTGGTTCAGTCTGTTCGGGATAAGCTCTCCGCCGATATTATCATCAAGCAGACGGTGTCGCTGTCCCCGGAAATAGTCCTGGAGGAAAATACCGACATAGAAGCATGGGATGCGGTCATCGAAAATAACGATGCATTATTGGAAAAGTATATCGCAGGAGAACCAATCAGCCAGGAAAAACTTGCGCGGGAGGAACAGCGGCGGGTTCAAGAAGCCTCCCTGTTTCCGGTCTATCATGGCAGCGCCAAAAAGGGCCTTGGCATTCAACCGTTGATGGATGCGGTGACAGGACTGTTCCAACCGATTGGGGAACAGGGGAGCGCCACCCTATGCGGCAGCGTTTTCAAGGTTGAGTACACCGATTGCGGCCAGCGGCGTGTCTATCTGCGGCTATACAGCGGAACGCTGCGCCTGCGGGATACGGTGGCCCTGGCCGGGAGAGAAAAGCTGAAAATCACAGAGATGCGTATTCCATCCAAAGGGGAAATTGTTCGGACAGACACCGCTTATCCGGGCGAAATTGTTATCCTTCCCAGCGACAGCGTGAGGTTAAACGATGTATTAGGGGATCAAACCCGGCTCCCTCGTAAAAGGTGGCGCGAGGCCCCCCTCCCCATGCTGCGGACGACGATTGCGCCGAAAACGGCAGCGCAAAGAGAACGGCTGCTGGACGCTCTTACGCAACTTGCGGATACTGACCCGCTTTTGCGCTGCGAAGTGGATTCCATCACCCATGAGATCATTCTTTCTTTTTTGGGCCGGGTGCAGTTGGAGGTCGTTTCCGCTTTGCTGTCGGAAAAATACAAGATTGAAACAGTGGTAAAGGAACCCACCGTCATTTATATGGAGCGGCCGCTCAAAGCAGCCAGCCACACCATCCATATCGAGGTGCCGCCCAACCCGTTTTGGGCATCTATCGGACTGTCTGTTACACCACTCCCGCTTGGCTCCGGCGTACAATACGAGAGCCGGGTTTCGCTGGGATACTTGAACCAGAGTTTTCAAAACGCTGTCAGGGATGGTATCCGTTACGGGCTGGAGCAGGGCTTGTTCGGCTGGAACGTAACGGACTGTAAGATTTGCTTTGAATACGGGCTTTATTACAGTCCAGTCAGCACGCCGGCGGACTTCCGCTCATTGGCCCCGATTGTATTGGAACAGGCATTGAAGGAATCGGGGACGCAGCTGCTGGAACCTTATCTCTCCTTCACCCTCTATGCACCGCAGGAATATCTCTCACGGGCGTATCATGATGCTCCAAGGTATTGTGCAGATATTGTAAGTACTCAGATAAAGAATGACGAGGTCATTCTGAAAGGAGAAATCCCTGCTAGATGTATTCAAGAATACAGGAACGATTTAACTTATTTCACAAATGGGCAGGGAGTCTGCTTGACAGAGTTAAAAGGATACCAGCCAGCTATTGGTAAATTTATTTGCCAACCCCGCCGCCCGAATAGCCGTATAGATAAGGTTCGGCATATGTTCCACAAGTTAGCTTAA", "partial": "0", "query_start": 9756, "query_end": 9851, "hit_start": 684, "hit_end": 780, "orf_dna_sequence": "ATGAGCATGAACGGGGACGAAGCCGAGTACGTTGTCTTGATCAACGGCGAAGAGCAGTACTCGCTCTGGCCCGTGCACCGCGAAATTCCGGGCGGTTGGAAGACCGTTGGGCCCAAGGGAAGCAAGGAAACGTGTCAGTCCTACATCCAGGAGGTCTGGACGGACATGAGGCCGAAATCGCTACGGGAAGCCCTGACGCGCAGCAACTGCTGA", "orf_prot_sequence": "MSMNGDEAEYVVLINGEEQYSLWPVHREIPGGWKTVGPKGSKETCQSYIQEVWTDMRPKSLREALTRSNC", "perc_identity": 28.12}, "gnl|BL_ORD_ID|4795|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 9687, "orf_end": 9899, "orf_from": "BGC0001413.1|Cystobactamide_7 ", "model_name": "tet(O/W)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "900", "model_id": "5791", "ARO_accession": "3007121", "ARO_name": "tet(O/W)", "ARO_category": {"35921": {"category_aro_accession": "0000002", "category_aro_cvterm_id": "35921", "category_aro_name": "tetracycline-resistant ribosomal protection protein", "category_aro_description": "A family of proteins known to bind to the 30S ribosomal subunit. This interaction prevents tetracycline and tetracycline derivatives from inhibiting ribosomal function. Thus, these proteins confer elevated resistance to tetracycline derivatives as a ribosomal protection protein.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.40326, "max_identities": 9, "bit_score": 21.9422, "cvterm_id": "36809", "query": "PVHREIPGGWKTVGPKGSKETCQSYIQEVWTD", "match": "P+   + G ++ +G +GS   C S  +  +TD", "sequence_from_db": "PLMDAVTGLFQPIGEQGSATLCGSVFKVEYTD", "sequence_from_broadstreet": "MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAVTSFQWEDVKVNIIDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMNIPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIENNDALLEKYIAGEPISQEKLAREEQRRVQEASLFPVYHGSAKKGLGIQPLMDAVTGLFQPIGEQGSATLCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKGEIVRTDTAYPGEIVILPSDSVRLNDVLGDQTRLPRKRWREAPLPMLRTTIAPKTAAQRERLLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKIETVVKEPTVIYMERPLKAASHTIHIEVPPNPFWASIGLSVTPLPLGSGVQYESRVSLGYLNQSFQNAVRDGIRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYLSFTLYAPQEYLSRAYHDAPKYCATIETAQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGQSVCLTELKGYQAAVGQPVIQPRRPNNRLDKVRHMFQKVM", "dna_sequence_from_broadstreet": "ATGAAAATAATTAACTTAGGCATTCTGGCTCACGTTGACGCAGGAAAGACAACATTAACGGAAAGTTTATTGTATACCAGTGGTGCAATTGCAGAACTAGGGAGCGTAGATGAAGGCACAACAAGGACAGATACAATGAATTTGGAGCGTCAAAGGGGAATCACTATCCAGACAGCAGTGACATCTTTTCAGTGGGAGGATGTAAAAGTCAACATTATAGATACGCCAGGCCATATGGATTTTTTGGCGGAGGTGTACCGCTCTTTGGCTGTTTTAGATGGGGCCATCTTGGTGATCTCCGCGAAAGATGGCGTGCAGGCCCAGACCCGTATTCTGTTCCATGCCCTGCGGAAAATGAACATTCCCACCGTTATCTTTATCAACAAGATCGACCAGGCTGGCGTTGATTTGCAGAGCGTGGTTCAGTCTGTTCGGGATAAGCTCTCCGCCGATATTATCATCAAGCAGACGGTGTCGCTGTCCCCGGAAATAGTCCTGGAGGAAAATACCGACATAGAAGCATGGGATGCGGTCATCGAAAATAACGATGCATTATTGGAAAAGTATATCGCAGGAGAACCAATCAGCCAGGAAAAACTTGCGCGGGAGGAACAGCGGCGGGTTCAAGAAGCCTCCCTGTTTCCGGTCTATCATGGCAGCGCCAAAAAGGGCCTTGGCATTCAACCGTTGATGGATGCGGTGACAGGACTGTTCCAACCGATTGGGGAACAGGGGAGCGCCACCCTATGCGGCAGCGTTTTCAAGGTTGAGTACACCGATTGCGGCCAGCGGCGTGTCTATCTGCGGCTATACAGCGGAACGCTGCGCCTGCGGGATACGGTGGCCCTGGCCGGGAGAGAAAAGCTGAAAATCACAGAGATGCGTATTCCATCCAAAGGGGAAATTGTTCGGACAGACACCGCTTATCCGGGCGAAATTGTTATCCTTCCCAGCGACAGCGTGAGGTTAAACGATGTATTAGGGGATCAAACCCGGCTCCCTCGTAAAAGGTGGCGCGAGGCCCCCCTCCCCATGCTGCGGACGACGATTGCGCCGAAAACGGCAGCGCAAAGAGAACGGCTGCTGGACGCTCTTACGCAACTTGCGGATACTGACCCGCTTTTGCGCTGCGAAGTGGATTCCATCACCCATGAGATCATTCTTTCTTTTTTGGGCCGGGTGCAGTTGGAGGTCGTTTCCGCTTTGCTGTCGGAAAAATACAAGATTGAAACAGTGGTAAAGGAACCCACCGTCATTTATATGGAGCGGCCGCTCAAAGCAGCCAGCCACACCATCCATATCGAGGTGCCGCCCAACCCGTTTTGGGCATCTATCGGACTGTCTGTTACACCACTCCCGCTTGGCTCCGGCGTACAATACGAGAGCCGGGTTTCGCTGGGATACTTGAACCAGAGTTTTCAAAACGCTGTCAGGGATGGTATCCGTTACGGGCTGGAGCAGGGCTTGTTCGGCTGGAACGTAACGGACTGTAAGATTTGCTTTGAATACGGGCTTTATTACAGTCCAGTCAGCACGCCGGCGGACTTCCGCTCATTGGCCCCGATTGTATTGGAACAGGCATTGAAGGAATCGGGGACGCAGCTGCTGGAACCTTATCTCTCCTTCACCCTCTATGCGCCCCAGGAATACCTTTCCAGGGCTTATCATGATGCACCGAAATACTGTGCCACCATCGAAACGGCCCAGGTAAAAAAGGATGAAGTTGTCTTTACTGGCGAGATTCCCGCCCGCTGTATACAGGCATACCGTACTGATCTGGCCTTTTACACCAACGGGCAGAGCGTATGCCTTACAGAGCTAAAAGGGTATCAGGCCGCTGTCGGCCAGCCGGTCATCCAGCCCCGCCGTCCAAACAACCGCCTGGACAAGGTGCGCCATATGTTTCAGAAGGTAATGTAA", "partial": "0", "query_start": 9756, "query_end": 9851, "hit_start": 684, "hit_end": 780, "orf_dna_sequence": "ATGAGCATGAACGGGGACGAAGCCGAGTACGTTGTCTTGATCAACGGCGAAGAGCAGTACTCGCTCTGGCCCGTGCACCGCGAAATTCCGGGCGGTTGGAAGACCGTTGGGCCCAAGGGAAGCAAGGAAACGTGTCAGTCCTACATCCAGGAGGTCTGGACGGACATGAGGCCGAAATCGCTACGGGAAGCCCTGACGCGCAGCAACTGCTGA", "orf_prot_sequence": "MSMNGDEAEYVVLINGEEQYSLWPVHREIPGGWKTVGPKGSKETCQSYIQEVWTDMRPKSLREALTRSNC", "perc_identity": 28.12}, "gnl|BL_ORD_ID|3830|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 9687, "orf_end": 9899, "orf_from": "BGC0001413.1|Cystobactamide_7 ", "model_name": "OXA-574", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "4900", "ARO_accession": "3005795", "ARO_name": "OXA-574", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.9086, "max_identities": 9, "bit_score": 21.557, "cvterm_id": "43682", "query": "WPVHREIPGGWKTVGPKGS", "match": "WPV    PGGW   G  G+", "sequence_from_db": "WPV----PGGWAVQGKTGT", "sequence_from_broadstreet": "MMKLRHAATGALLAALATFAHAERTICTIVADAATGKVVLHEGQCAERVTPASTFKLALAVMGYDHGFLRDEHTPIEHMKAGDPDWGGEAWHQPIDPTLWLKYSVVWYSQRITHAMGAQTLHAYLRKFDYGNMDASGDPGKNNGLDRSWITSSLKISPEEQVGFMRKIVNRQLPVSAHTYEMVDRTVQTWPVPGGWAVQGKTGTAGPGPGNTSPDGTWDQAHAYGWFVGWAKKGTGDDSRTYVFANLIQDDKLEPTSGGLRSRDALLARLPEVLALASH", "dna_sequence_from_broadstreet": "ATGATGAAACTCCGCCACGCCGCGACCGGCGCCCTGCTGGCCGCGCTTGCCACCTTTGCCCATGCCGAGCGCACGATCTGCACGATCGTTGCCGATGCCGCCACCGGCAAGGTTGTTCTGCACGAAGGCCAGTGCGCCGAACGCGTCACGCCTGCGTCCACCTTCAAGCTGGCGCTGGCGGTCATGGGCTACGACCACGGTTTCCTGAGGGACGAGCACACCCCCATCGAGCACATGAAGGCTGGCGACCCCGATTGGGGTGGCGAGGCCTGGCACCAGCCCATCGACCCCACGCTGTGGCTCAAGTACTCCGTGGTCTGGTATTCGCAGCGCATCACGCATGCGATGGGTGCGCAGACGCTGCATGCGTATCTGCGCAAATTCGACTACGGCAACATGGACGCGAGCGGCGATCCGGGGAAGAACAACGGCCTGGACCGCTCGTGGATCACCTCGTCGCTGAAGATCTCGCCGGAGGAGCAGGTGGGCTTCATGCGCAAGATCGTCAACCGCCAGTTGCCGGTGTCTGCGCATACGTATGAGATGGTGGACCGTACGGTGCAGACCTGGCCGGTGCCGGGTGGCTGGGCTGTGCAGGGCAAAACGGGCACTGCTGGGCCGGGCCCCGGCAATACGTCGCCCGATGGCACGTGGGATCAGGCACACGCTTATGGCTGGTTTGTCGGCTGGGCGAAGAAGGGCACGGGTGACGACAGTCGGACCTACGTGTTTGCGAACCTGATCCAGGACGACAAGCTTGAGCCGACATCGGGGGGCTTGCGCTCGCGCGATGCGCTGCTGGCGCGCCTGCCGGAAGTGCTGGCCCTTGCGAGCCACTGA", "partial": "0", "query_start": 9753, "query_end": 9809, "hit_start": 567, "hit_end": 612, "orf_dna_sequence": "ATGAGCATGAACGGGGACGAAGCCGAGTACGTTGTCTTGATCAACGGCGAAGAGCAGTACTCGCTCTGGCCCGTGCACCGCGAAATTCCGGGCGGTTGGAAGACCGTTGGGCCCAAGGGAAGCAAGGAAACGTGTCAGTCCTACATCCAGGAGGTCTGGACGGACATGAGGCCGAAATCGCTACGGGAAGCCCTGACGCGCAGCAACTGCTGA", "orf_prot_sequence": "MSMNGDEAEYVVLINGEEQYSLWPVHREIPGGWKTVGPKGSKETCQSYIQEVWTDMRPKSLREALTRSNC", "perc_identity": 47.37}}, "BGC0001413.1|Cystobactamide_8 # 10025 # 10921 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.622": {"gnl|BL_ORD_ID|1786|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 10025, "orf_end": 10921, "orf_from": "BGC0001413.1|Cystobactamide_8 ", "model_name": "mtrD", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "2130", "model_id": "1938", "ARO_accession": "3000811", "ARO_name": "mtrD", "ARO_category": {"36005": {"category_aro_accession": "0010004", "category_aro_cvterm_id": "36005", "category_aro_name": "resistance-nodulation-cell division (RND) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Resistance-nodulation-division (RND) proteins are found in both prokaryotic and eukaryotic cells and have diverse substrate specificities and physiological roles. However, there are relatively few RND transporters and they are secondary transporters, energized not by ATP binding/hydrolysis but by proton movement down the transmembrane electrochemical gradient.", "category_aro_class_name": "AMR Gene Family"}, "35925": {"category_aro_accession": "0000006", "category_aro_cvterm_id": "35925", "category_aro_name": "erythromycin", "category_aro_description": "Erythromycin is a macrolide antibiotic with a 14-carbon ring that has an antimicrobial spectrum similar to or slightly wider than that of penicillin, and is often used for people that have an allergy to penicillins. Erythromycin may possess bacteriocidal activity, particularly at higher concentrations by binding to the 50S subunit of the bacterial 70S rRNA complex, inhibiting peptidyl-tRNA translocation. Thus, protein synthesis and subsequently structure/function processes critical for life or replication are inhibited.", "category_aro_class_name": "Antibiotic"}, "35971": {"category_aro_accession": "0000054", "category_aro_cvterm_id": "35971", "category_aro_name": "penicillin", "category_aro_description": "Penicillin (sometimes abbreviated PCN) is a beta-lactam antibiotic used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms. It works by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Antibiotic"}, "36297": {"category_aro_accession": "3000158", "category_aro_cvterm_id": "36297", "category_aro_name": "azithromycin", "category_aro_description": "Azithromycin is a 15-membered macrolide and falls under the subclass of azalide. Like other macrolides, azithromycin binds bacterial ribosomes to inhibit protein synthesis. The nitrogen substitution at the C-9a position prevents its degradation.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.51742, "max_identities": 13, "bit_score": 25.7942, "cvterm_id": "39597", "query": "QLSKLHPSLELRLLGKGGHLQIFNDPATLAEYVLGFIDTRASQAA", "match": "+L ++    ++RL G    ++I+ DP  L  Y L F D  ++ +A", "sequence_from_db": "ELQRIEGVGQVRLFGAQRAMRIWVDPKKLQNYNLSFADVGSALSA", "sequence_from_broadstreet": "MAKFFIDRPIFAWVISIFIIAAGIFGIKSLPVSQYPSVAAPTITLRATYPGASAQVMEDSVLSVIERNMNGVEGLDYMSTSADSSGSGSVSLTFTPDTDENLAQVEVQNKLSEVLSTLPATVQQYGVTVSKARSNFLMIVMLSSDVQSTEEMNDYAQRNIVPELQRIEGVGQVRLFGAQRAMRIWVDPKKLQNYNLSFADVGSALSAQNVQISAGSIGSLPAVRGQTVTATVTAQGQLGTAEEFGNVILRANTDGSNVYLKDVARVGLGMEDYSSSTRLNGVNTTGMAVMLSNSGNAMATAKAVKERMATLEKYFPQGMSWKTPYDTSKFVEISIEKVIHTLIEAMVLVFVVMYLFLQNIRYTLIPTIVVPISLLGGFAFISYMGMSINVLTMFAMVLVIGIVVDDAIVVVENVERIMAGEGLPPKEATKKAMGQISGAVIGITAVLISVFVPLAMFSGATGNIYKQFALTMASSIAFSAFLALTLTPALCATMLKTIPKGHHEEKKGFFGWFNKKFNSWTHGYEGRVAKVLRKTFRMMVVYIGLAVVGVFLFMRLPTSFLPTEDQGFVMVSVQLPAGATQERTNATLAQVTQLAKSIPEIENIITVSGFSFSGSGQNMAMGFAILKDWNERTAPGSDAVAIAGKLTGMMMGTLKDGFGIAVVPPPILELGNGSGLSINLQDRNNTGHTALLAKRNELIQKMRASGLFDPSTVRAGGLEDSPQLKIDINRAAAAAQGISFADIRTALASALSSSYVSDFPNQGRLQRVMVQADEDARMQPADILNLTVPNKSGVAVPLSTIATVSWENGTEQSVRFNGYPSMKLSASPATGVSTGQAMAAVQKMVDELGGGYSLEWGGQSREEAKGGSQTLILYGLAVAAVFLVLAALYESWSIPLAVILVIPLGLIGAAAGVTGRNLFEGLLGSVPSFANDIYFQVGFVTVMGLSAKNAILIIEFAKDLQAQGKSAVEAALEAARLRFRPIIMTSFAFILGVVPLYIAGGASSASQRAIGTTVFWGMLIGTLLSVFLVPLFYVVVRKFFKETAHEHEMAVKHAAEAGITGSDDSQH", "dna_sequence_from_broadstreet": "ATGGCTAAATTTTTTATCGACCGCCCCATTTTTGCGTGGGTTATTTCGATTTTCATTATTGCGGCGGGTATTTTCGGCATCAAAAGCCTGCCGGTTTCGCAATATCCGTCCGTCGCCGCCCCGACCATCACCCTGAGGGCCACTTATCCGGGCGCGTCCGCGCAGGTAATGGAAGACAGCGTGCTTTCCGTGATCGAGCGGAATATGAACGGCGTGGAAGGTTTGGATTATATGTCCACTTCCGCCGATTCGAGCGGCAGCGGCAGCGTGAGCCTGACCTTTACGCCCGATACCGACGAGAATCTGGCGCAGGTGGAAGTGCAGAACAAGCTTTCCGAAGTATTGAGCACGCTGCCGGCAACTGTCCAGCAATACGGCGTAACCGTATCCAAGGCGCGTTCCAATTTCCTGATGATTGTGATGCTTTCGTCGGATGTGCAGTCAACCGAAGAGATGAACGACTACGCGCAGCGTAATATCGTTCCCGAGTTGCAGCGTATCGAAGGCGTGGGGCAGGTACGCCTGTTCGGCGCGCAACGCGCGATGCGGATTTGGGTTGATCCTAAGAAACTGCAAAACTACAATTTGTCGTTTGCCGATGTTGGCAGCGCGCTGTCCGCCCAGAACGTCCAGATTTCAGCGGGTTCTATCGGTTCGCTTCCCGCCGTTCGCGGACAGACGGTTACGGCTACCGTAACGGCGCAAGGGCAGTTGGGTACGGCAGAAGAATTCGGCAACGTCATCCTCCGCGCCAATACCGACGGTTCTAATGTTTACCTGAAGGATGTGGCAAGGGTCGGACTGGGTATGGAAGACTATTCTTCCTCAACCCGTCTGAACGGTGTAAATACCACCGGTATGGCGGTGATGCTGTCCAACAGCGGCAATGCGATGGCGACGGCAAAGGCGGTTAAAGAACGCATGGCGACGTTGGAAAAATACTTTCCTCAGGGTATGAGCTGGAAAACCCCTTACGATACTTCCAAATTCGTCGAAATTTCGATTGAAAAAGTGATTCACACTTTAATCGAAGCGATGGTGCTGGTGTTTGTCGTAATGTATCTCTTCCTGCAAAACATCCGTTATACGCTGATTCCGACCATCGTCGTACCGATTTCGCTGTTGGGCGGTTTCGCCTTCATCTCTTATATGGGCATGTCGATTAACGTACTGACCATGTTTGCGATGGTTTTGGTCATCGGCATCGTGGTCGATGACGCGATTGTGGTGGTTGAAAACGTCGAGCGCATTATGGCGGGTGAAGGCTTGCCGCCCAAAGAAGCGACCAAAAAAGCGATGGGTCAGATTTCGGGCGCGGTCATCGGTATTACCGCCGTTCTGATTTCCGTGTTCGTACCGTTGGCGATGTTCAGCGGGGCGACGGGCAATATTTACAAACAGTTTGCCCTGACGATGGCGTCATCAATCGCATTCTCCGCCTTCCTTGCGCTGACCCTTACCCCTGCTTTGTGTGCCACAATGTTGAAGACAATCCCGAAAGGGCATCACGAAGAGAAAAAAGGTTTCTTCGGCTGGTTTAACAAGAAATTCAACAGTTGGACGCACGGTTACGAAGGCCGGGTTGCCAAAGTGCTGCGTAAGACTTTCCGCATGATGGTTGTCTATATCGGCTTGGCGGTTGTGGGCGTGTTCCTGTTTATGCGCCTGCCGACTTCATTCCTGCCGACCGAAGACCAAGGCTTCGTCATGGTCAGCGTGCAACTGCCTGCAGGAGCGACCCAAGAGCGCACCAATGCGACTTTGGCGCAAGTTACCCAACTGGCGAAAAGCATTCCTGAAATAGAAAACATCATTACCGTTTCCGGCTTCAGCTTTTCGGGCAGCGGTCAGAATATGGCGATGGGTTTTGCCATATTGAAAGATTGGAACGAGCGTACCGCGCCCGGCAGCGATGCCGTTGCGATTGCCGGCAAGCTGACGGGTATGATGATGGGGACGCTTAAAGACGGTTTTGGCATCGCCGTCGTCCCGCCTCCGATTCTGGAGTTGGGCAACGGTTCGGGTCTGAGCATCAACCTGCAAGACCGCAACAATACCGGCCATACCGCATTGCTGGCGAAGCGCAACGAGTTGATTCAGAAAATGCGTGCCAGCGGTTTGTTTGACCCCAGCACCGTCCGTGCTGGCGGTTTGGAAGACTCGCCGCAGTTGAAAATCGACATCAACCGTGCCGCGGCGGCGGCGCAAGGCATTTCGTTTGCCGACATCCGCACCGCATTGGCAAGCGCGCTGAGTTCGTCTTATGTCAGCGACTTCCCGAACCAAGGCCGTCTGCAACGCGTGATGGTGCAGGCCGACGAGGATGCCCGTATGCAGCCTGCCGATATTTTGAACCTGACCGTGCCGAACAAATCCGGCGTCGCCGTACCGCTTTCCACCATTGCTACTGTTTCTTGGGAAAACGGTACGGAACAGAGCGTACGCTTCAACGGTTATCCTTCGATGAAGCTGTCCGCTTCGCCTGCAACCGGCGTTTCCACCGGGCAGGCTATGGCGGCGGTTCAAAAAATGGTTGACGAATTGGGCGGCGGTTACAGCCTGGAGTGGGGCGGACAGTCGCGCGAAGAGGCAAAAGGCGGCTCGCAAACCCTGATTTTGTACGGTTTGGCGGTTGCAGCCGTATTTTTGGTACTTGCCGCGCTTTATGAAAGCTGGTCGATTCCGCTGGCGGTCATCCTTGTGATTCCGTTGGGTTTGATCGGTGCGGCTGCGGGCGTAACCGGGCGCAACCTGTTTGAAGGACTGTTGGGCAGCGTTCCCTCGTTCGCCAACGACATCTACTTTCAAGTCGGTTTCGTTACCGTGATGGGTTTGAGTGCGAAAAATGCGATTTTGATTATCGAATTTGCCAAAGACCTTCAAGCGCAAGGGAAAAGCGCGGTTGAAGCCGCTTTGGAAGCCGCCCGCCTGCGTTTCCGTCCGATTATCATGACCTCGTTCGCCTTTATTTTGGGCGTGGTTCCCCTGTATATTGCCGGCGGTGCAAGTTCTGCCAGCCAGCGCGCCATCGGTACAACCGTATTCTGGGGGATGCTCATCGGCACGCTCTTGTCCGTGTTCCTTGTTCCGCTTTTCTATGTGGTGGTGCGCAAATTCTTCAAAGAAACCGCGCACGAACACGAAATGGCAGTAAAACACGCCGCCGAAGCGGGCATCACCGGTTCGGACGACAGCCAACATTAA", "partial": "0", "query_start": 10763, "query_end": 10897, "hit_start": 486, "hit_end": 621, "orf_dna_sequence": "ATGGTCGAACCTGAGCTTGAGGAGGTTCGCTACCTGACCGTGGAGAGCGGCGACGGACGGCAGAGTACCCTCTATGAGTTCGGTCCGAAGGACGCGGAGAAGGTCGTGGTCTTGCCGCCCTACGGAGTCACCTTCTTGCTGGTGGCGCGACTCGCCCGGCTCCTCTCCCAGCGATTCCATGTCTTGATTTGGGAGTCAAGGGGGTGTCCGGACTCCGCCATCCCGGTGTATGACACGGACCTTGGGCTCGCCGACCAGTCAAGGCATTTCTCCGAGGTCCTCAAGCAGCAGGGCTTCGAGGCGTTTCACTTCGTCGGCTGGTGTCAGGCGGCGCAGCTGGCCGTGCATGCCACCGCCAGCGGCCAGGTCAAGCCGCGGACGATGTCTTGGATTGCCCCGGCGGGGCTGGGTTACTCGCTGGTCAAGTCCGAGTTCGATCGATGTGCACTGCCCATCTACCTGGAGATCGAGAAGCATGGCCTGTTGCACGCCGAGAAGCTCGGCAGGCTTCTGAACAAATACAATGGCGTTCCCGCGACGGCGCAGAACGCGGCGGAAAAGCTGACGATGCGCCATTTGGCCGACCCGCGGATGACATACGTCTTCTCCAGGTACATGAAGGCGTATGAAGACAACAGGCTCCTCGCCAAGCAATTTGTCTCGACCGCGCTCGACTCGGTGCCGACGCTGGCCATTCACTGCCGGGACGACACGTACAGCCACTTCTCGGAGTCCGTTCAGCTCTCGAAGCTGCATCCATCCCTCGAGCTTCGCCTACTCGGTAAGGGCGGCCATCTGCAGATCTTCAACGACCCCGCCACACTGGCGGAGTACGTTCTCGGTTTCATCGACACCAGGGCGTCGCAGGCTGCCGCTCCTGCGGTGGCGGGAGCGTAG", "orf_prot_sequence": "MVEPELEEVRYLTVESGDGRQSTLYEFGPKDAEKVVVLPPYGVTFLLVARLARLLSQRFHVLIWESRGCPDSAIPVYDTDLGLADQSRHFSEVLKQQGFEAFHFVGWCQAAQLAVHATASGQVKPRTMSWIAPAGLGYSLVKSEFDRCALPIYLEIEKHGLLHAEKLGRLLNKYNGVPATAQNAAEKLTMRHLADPRMTYVFSRYMKAYEDNRLLAKQFVSTALDSVPTLAIHCRDDTYSHFSESVQLSKLHPSLELRLLGKGGHLQIFNDPATLAEYVLGFIDTRASQAAAPAVAGA", "perc_identity": 28.89}, "gnl|BL_ORD_ID|4956|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 10025, "orf_end": 10921, "orf_from": "BGC0001413.1|Cystobactamide_8 ", "model_name": "EstT", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "600", "model_id": "5948", "ARO_accession": "3007459", "ARO_name": "EstT", "ARO_category": {"36459": {"category_aro_accession": "3000320", "category_aro_cvterm_id": "36459", "category_aro_name": "macrolide esterase", "category_aro_description": "Hydrolytic enzymes that cleave the macrocycle lactone ring of macrolide antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35949": {"category_aro_accession": "0000030", "category_aro_cvterm_id": "35949", "category_aro_name": "tigecycline", "category_aro_description": "Tigecycline is an glycylcycline antibiotic. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35960": {"category_aro_accession": "0000042", "category_aro_cvterm_id": "35960", "category_aro_name": "glycylcycline", "category_aro_description": "Glycylcyclines are a new class of antibiotics derived from tetracycline. These tetracycline analogues are specifically designed to overcome two common mechanisms of tetracycline resistance. Presently, there is only one glycylcycline antibiotic for clinical use: tigecycline. It works by inhibiting action of the prokaryotic 30S ribosome, preventing the binding of aminoacyl-tRNA.", "category_aro_class_name": "Drug Class"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.42798, "max_identities": 15, "bit_score": 25.0238, "cvterm_id": "46223", "query": "PTLAIHCRDDTYSHFSES-VQLSKLHPSLELRLLGKGGHLQI", "match": "PTL IH  DD   H+  +   L K+  S  + L G G  L +", "sequence_from_db": "PTLIIHGTDDKIWHYKNAGFLLEKIKGSNLITLEGTGHELHV", "sequence_from_broadstreet": "MKKKLLWILILGLIIISCKQRKTEMKEKIIKTNGIELCTESFGNKKNPAILLVAGATVSMLYWDTEFCQQLSEKGFFVIRYDNRDVGKSTNYEPGSTPYDIVDLTNDAISILDGYKIDKAHFVGISLGGLISQIASIKFADRVNSLTLMSSGPWGDSDPTIPEMDTSILDFHSKAGTVNWTNEDSVVNYLIQGAELMSGKKQFDKQRSEKLIRAEFNRANNYISMFNHAASQGGGGEEYWNRLNEIKQPTLIIHGTDDKIWHYKNAGFLLEKIKGSNLITLEGTGHELHVDDWKSIIDGIEKHIND", "dna_sequence_from_broadstreet": "ATGAAAAAAAAACTACTTTGGATATTAATTTTAGGACTGATAATAATCAGTTGCAAACAAAGGAAAACAGAAATGAAAGAGAAAATAATTAAAACAAACGGCATTGAACTCTGTACGGAAAGTTTTGGAAATAAGAAAAATCCAGCAATCCTTTTGGTAGCAGGTGCAACCGTATCAATGCTGTATTGGGACACTGAATTTTGCCAACAATTATCTGAAAAAGGATTTTTTGTTATTCGTTACGACAACAGAGATGTAGGAAAATCCACTAATTATGAACCAGGTTCTACTCCATACGATATTGTTGACTTAACTAATGACGCTATTTCAATATTGGATGGCTACAAGATTGACAAAGCACATTTTGTGGGGATTTCTTTGGGCGGACTAATTTCTCAAATAGCATCAATAAAGTTTGCCGACAGAGTTAACTCCTTAACTCTTATGTCATCAGGCCCTTGGGGAGACTCAGACCCAACTATACCTGAAATGGACACGAGTATTTTAGATTTCCATAGTAAAGCAGGTACAGTCAATTGGACAAATGAAGACAGTGTGGTAAACTATTTAATTCAGGGTGCAGAATTAATGAGTGGCAAGAAACAATTTGACAAACAAAGAAGTGAAAAACTGATAAGAGCTGAGTTCAATAGAGCCAACAATTATATAAGTATGTTCAATCACGCTGCATCGCAAGGTGGTGGTGGTGAAGAATATTGGAACAGATTAAACGAAATCAAACAACCCACCTTAATTATCCACGGAACAGACGACAAAATTTGGCATTATAAGAATGCAGGTTTTTTACTAGAAAAAATAAAAGGTTCAAATCTAATCACCCTTGAAGGTACAGGACACGAATTACACGTTGATGATTGGAAATCAATAATTGATGGAATAGAAAAACACATAAATGACTGA", "partial": "0", "query_start": 10706, "query_end": 10828, "hit_start": 744, "hit_end": 870, "orf_dna_sequence": "ATGGTCGAACCTGAGCTTGAGGAGGTTCGCTACCTGACCGTGGAGAGCGGCGACGGACGGCAGAGTACCCTCTATGAGTTCGGTCCGAAGGACGCGGAGAAGGTCGTGGTCTTGCCGCCCTACGGAGTCACCTTCTTGCTGGTGGCGCGACTCGCCCGGCTCCTCTCCCAGCGATTCCATGTCTTGATTTGGGAGTCAAGGGGGTGTCCGGACTCCGCCATCCCGGTGTATGACACGGACCTTGGGCTCGCCGACCAGTCAAGGCATTTCTCCGAGGTCCTCAAGCAGCAGGGCTTCGAGGCGTTTCACTTCGTCGGCTGGTGTCAGGCGGCGCAGCTGGCCGTGCATGCCACCGCCAGCGGCCAGGTCAAGCCGCGGACGATGTCTTGGATTGCCCCGGCGGGGCTGGGTTACTCGCTGGTCAAGTCCGAGTTCGATCGATGTGCACTGCCCATCTACCTGGAGATCGAGAAGCATGGCCTGTTGCACGCCGAGAAGCTCGGCAGGCTTCTGAACAAATACAATGGCGTTCCCGCGACGGCGCAGAACGCGGCGGAAAAGCTGACGATGCGCCATTTGGCCGACCCGCGGATGACATACGTCTTCTCCAGGTACATGAAGGCGTATGAAGACAACAGGCTCCTCGCCAAGCAATTTGTCTCGACCGCGCTCGACTCGGTGCCGACGCTGGCCATTCACTGCCGGGACGACACGTACAGCCACTTCTCGGAGTCCGTTCAGCTCTCGAAGCTGCATCCATCCCTCGAGCTTCGCCTACTCGGTAAGGGCGGCCATCTGCAGATCTTCAACGACCCCGCCACACTGGCGGAGTACGTTCTCGGTTTCATCGACACCAGGGCGTCGCAGGCTGCCGCTCCTGCGGTGGCGGGAGCGTAG", "orf_prot_sequence": "MVEPELEEVRYLTVESGDGRQSTLYEFGPKDAEKVVVLPPYGVTFLLVARLARLLSQRFHVLIWESRGCPDSAIPVYDTDLGLADQSRHFSEVLKQQGFEAFHFVGWCQAAQLAVHATASGQVKPRTMSWIAPAGLGYSLVKSEFDRCALPIYLEIEKHGLLHAEKLGRLLNKYNGVPATAQNAAEKLTMRHLADPRMTYVFSRYMKAYEDNRLLAKQFVSTALDSVPTLAIHCRDDTYSHFSESVQLSKLHPSLELRLLGKGGHLQIFNDPATLAEYVLGFIDTRASQAAAPAVAGA", "perc_identity": 35.71}}, "BGC0001413.1|Cystobactamide_9 # 10931 # 12310 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.649": {"gnl|BL_ORD_ID|1870|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 10931, "orf_end": 12310, "orf_from": "BGC0001413.1|Cystobactamide_9 ", "model_name": "AAC(3)-IXa", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "300", "model_id": "2030", "ARO_accession": "3002543", "ARO_name": "AAC(3)-IXa", "ARO_category": {"36461": {"category_aro_accession": "3000322", "category_aro_cvterm_id": "36461", "category_aro_name": "AAC(3)", "category_aro_description": "A category of aminoglycoside N-acetyltransferase enzymes with modification regiospecificity based at the 3-amino group of the respective antibiotic. These enzymes inactivate aminoglycoside antibiotics through acetylation of the 3-amino group of the compound.", "category_aro_class_name": "AMR Gene Family"}, "35924": {"category_aro_accession": "0000005", "category_aro_cvterm_id": "35924", "category_aro_name": "neomycin", "category_aro_description": "Neomycin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Neomycin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35935": {"category_aro_accession": "0000016", "category_aro_cvterm_id": "35935", "category_aro_name": "aminoglycoside antibiotic", "category_aro_description": "Aminoglycosides are a group of antibiotics that are mostly effective against Gram-negative bacteria. These molecules consist of aminated sugars attached to a dibasic cyclitol. Aminoglycosides work by binding to the bacterial 30S ribosomal subunit (some work by binding to the 50S subunit), inhibiting the translocation of the peptidyl-tRNA from the A-site to the P-site and also causing misreading of mRNA, leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.07084, "max_identities": 23, "bit_score": 27.7202, "cvterm_id": "39506", "query": "EASFAPLARAAKFMMFEEPLHIAMGA-VGLERVLARTAEVTLREGTFDTF----HAGAIPFPVVQKYLNYWAP", "match": "+ASFA L  AA  +M E P     G    L R++A +  V L     DT     HA A+     ++++ Y  P", "sequence_from_db": "DASFAALGPAAAELMAEHPWDHPHGPDTPLARLIAHSGRVLLLGAPLDTMTLLHHAEALADVRSKRFVTYEQP", "sequence_from_broadstreet": "MEEMSLLNHSGGPVTRSRIKHDLADLGLKDGDVVIFHTRMSAIGYVAGGTQTIIGALLDVVGARGTLMVPCGWNNAPPYDFLDWPRDWQDALRAEHPAYDPDLSEADYNNGRLPEALPRWPGAIRSRHPDASFAALGPAAAELMAEHPWDHPHGPDTPLARLIAHSGRVLLLGAPLDTMTLLHHAEALADVRSKRFVTYEQPILVNGQRVWRQFRDIDSEEGAFDYSTVRRGVEPFEAIARDMLSAGIGRQGRVGAADSYLFDAGPVFNFAINWIEAKLKR", "dna_sequence_from_broadstreet": "ATGGAAGAGATGAGCTTACTCAATCACTCCGGCGGTCCCGTTACCCGAAGCCGGATCAAGCATGACCTTGCTGATCTCGGTCTCAAAGACGGAGACGTGGTGATTTTCCACACCCGCATGTCTGCCATCGGGTACGTGGCTGGCGGAACGCAGACAATCATCGGCGCACTCCTCGACGTTGTGGGAGCCCGTGGAACCCTTATGGTGCCCTGTGGCTGGAACAACGCGCCTCCATATGACTTCCTCGATTGGCCACGGGACTGGCAGGACGCCCTGCGAGCAGAGCATCCCGCGTACGACCCGGACCTCAGTGAGGCGGACTACAATAATGGTCGTCTCCCAGAAGCGCTGCCGCGCTGGCCTGGCGCGATCCGAAGTCGGCACCCCGACGCCAGTTTCGCAGCCCTGGGGCCGGCTGCAGCCGAACTGATGGCAGAGCATCCGTGGGACCATCCTCACGGACCCGACACCCCGCTAGCACGGCTGATCGCCCATAGCGGCCGAGTCTTGTTACTTGGCGCTCCATTGGACACCATGACGCTGTTGCATCACGCTGAGGCGTTGGCCGACGTCCGCAGCAAACGGTTCGTGACCTACGAACAACCGATCCTCGTTAACGGCCAGCGGGTGTGGCGACAATTCCGCGATATCGACTCTGAGGAAGGAGCGTTTGACTACTCGACGGTGCGCCGAGGGGTGGAGCCGTTCGAGGCCATTGCACGGGACATGCTCTCGGCAGGAATCGGTCGTCAGGGCAGGGTCGGCGCCGCGGATAGCTACCTGTTTGACGCCGGGCCTGTCTTCAATTTTGCGATCAACTGGATCGAGGCCAAGCTGAAGAGATAG", "partial": "0", "query_start": 11582, "query_end": 11785, "hit_start": 387, "hit_end": 606, "orf_dna_sequence": "ATGATACTTCCCAACAACATCGGCCTCGACGAGCGGACGCAGCTCGCACGGCAGATCTCCTCGTACCAGAAGAAGTTCCACGTGTGGTGGCGCGAGCGGGGGCCCACCGAGTTCCTCGATCGGCAGATGCGCCTTCGCACGCCGACCGGGGCGGTCAGCGGCGTGGACTGGGCCGAGTACAAGACGATGCGTCCCGACGAGTATCGCTGGGGCCTCTTCATGGTGCCGATGGACCAGGACGAGATCGCCTTCGGCGACCACCGTGGCAAGAAGGCGTGGGAGGAGGTTCCGAGCGAATACCGCACGCTGCTGCTGCAGCACATCTGCGTGCAGGCCGACGTGGAGAACGCCGCCGTCGAGCAGAGCCGGCTGCTGACGCAGATGGCGCCGAGCAACCCGGACCTGGAGAACGTGTTCCAGTTCTTCCTCGAGGAGGGGCGCCACACCTGGGCCATGGTTCACCTCCTGCTCGCCCACTTCGGTGAGGACGGGGTCGTCGAGGCCGAAGCGCTCCTGGAGCGGCTGAGCGGTGACCCGAGGAACCCCCGCTTGCTGGAGGCGTTCAACTATCCGACCGAGGACTGGCTGTCCCACTTCATGTGGTGCTTGCTGGCCGACCGGGTTGGCAAGTACCAGATACATGCAGTGACCGAGGCTTCGTTCGCCCCGTTGGCCCGGGCGGCGAAGTTCATGATGTTCGAGGAACCGCTCCACATCGCCATGGGCGCCGTGGGTCTGGAACGAGTGCTGGCCAGGACCGCCGAGGTCACCCTGCGTGAGGGGACGTTCGATACGTTCCACGCGGGGGCGATTCCGTTCCCGGTTGTCCAGAAGTATCTCAATTATTGGGCGCCGAAGGTCTACGACCTCTTCGGAAACGACGGCTCCGAACGCTCGAACGAACTCTTCCGGGCTGGGCTCCGGAGGCCGCGGAATTTCGTGGGAAGCGAATCGCAGATCGTTCGCATCGATGAGCGCATGGGCGACGGACTGACCGTCGTGGAAGTGGAAGGGGAGTGGGCGATCAACGCCATCATGCGACGACAGTTCATCGCCGAAGTGCAAACGCTCATTGATCGCTGGAACGCCAGCCTGCGAGCGCTGGGCGTCGACTTCCAGTTGTACCTCCCTCACGAGCGCTTCAGCAGGACCTATGGCCCCTGCGCCGGTCTGCCCTTCGACGTGGACGGAAAACTGCTCCCCCGCGGCACGGAGGCGAAGCTCGCCGAGTACTTCCCCACACCTCGCGAACTCGCGAACGTCCGCTCGCTGATGCAGCGGGAGCTGGCTCCCGGGCAGTACTCCTCGTGGATCGCCCCGTCCGCGACGCGGCTGAGCGCGCTGGTCCAGGGCAGGAACACGCCCAAGGAGCACGAATGA", "orf_prot_sequence": "MILPNNIGLDERTQLARQISSYQKKFHVWWRERGPTEFLDRQMRLRTPTGAVSGVDWAEYKTMRPDEYRWGLFMVPMDQDEIAFGDHRGKKAWEEVPSEYRTLLLQHICVQADVENAAVEQSRLLTQMAPSNPDLENVFQFFLEEGRHTWAMVHLLLAHFGEDGVVEAEALLERLSGDPRNPRLLEAFNYPTEDWLSHFMWCLLADRVGKYQIHAVTEASFAPLARAAKFMMFEEPLHIAMGAVGLERVLARTAEVTLREGTFDTFHAGAIPFPVVQKYLNYWAPKVYDLFGNDGSERSNELFRAGLRRPRNFVGSESQIVRIDERMGDGLTVVEVEGEWAINAIMRRQFIAEVQTLIDRWNASLRALGVDFQLYLPHERFSRTYGPCAGLPFDVDGKLLPRGTEAKLAEYFPTPRELANVRSLMQRELAPGQYSSWIAPSATRLSALVQGRNTPKEHE", "perc_identity": 31.51}, "gnl|BL_ORD_ID|548|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 10931, "orf_end": 12310, "orf_from": "BGC0001413.1|Cystobactamide_9 ", "model_name": "dfrA20", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "300", "model_id": "601", "ARO_accession": "3003016", "ARO_name": "dfrA20", "ARO_category": {"37617": {"category_aro_accession": "3001218", "category_aro_cvterm_id": "37617", "category_aro_name": "trimethoprim resistant dihydrofolate reductase dfr", "category_aro_description": "Alternative dihydropteroate synthase dfr present on plasmids produces alternate proteins that are less sensitive to trimethoprim from inhibiting its role in folate synthesis, thus conferring trimethoprim resistance.", "category_aro_class_name": "AMR Gene Family"}, "36327": {"category_aro_accession": "3000188", "category_aro_cvterm_id": "36327", "category_aro_name": "trimethoprim", "category_aro_description": "Trimethoprim is a synthetic 5-(3,4,5- trimethoxybenzyl) pyrimidine inhibitor of dihydrofolate reductase, inhibiting synthesis of tetrahydrofolic acid. Tetrahydrofolic acid is an essential precursor in the de novo synthesis of the DNA nucleotide thymidine. Trimethoprim is a bacteriostatic antibiotic mainly used in the prophylaxis and treatment of urinary tract infections in combination with sulfamethoxazole, a sulfonamide antibiotic.", "category_aro_class_name": "Antibiotic"}, "36310": {"category_aro_accession": "3000171", "category_aro_cvterm_id": "36310", "category_aro_name": "diaminopyrimidine antibiotic", "category_aro_description": "Diaminopyrimidines are a class of organic compounds containing a pyrimidine ring substituted by two amine groups.  They are inhibitors of dihydrofolate reductase, an enzyme critical for DNA synthesis.", "category_aro_class_name": "Drug Class"}, "35998": {"category_aro_accession": "0001002", "category_aro_cvterm_id": "35998", "category_aro_name": "antibiotic target replacement", "category_aro_description": "Replacement or substitution of antibiotic action target, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.43625, "max_identities": 8, "bit_score": 25.0238, "cvterm_id": "36867", "query": "GKKAWEEVPSEYRTL", "match": "G+K+WE +P +YR L", "sequence_from_db": "GRKSWESIPQKYRPL", "sequence_from_broadstreet": "MGIKYSLIVAIGKHREMGADNDLLWHLPRDMQFFKETTTGHAVVMGRKSWESIPQKYRPLPNRLNFVLTRDKNYSAEGATVIYDLKEVAQHLEGKNLTCFIIGGAQIYQLALETGLLNEMYVTQVHNTFEEADTFFPFVNWGEWEEEDILEQDKDEKHLYSFNIKKFTR", "dna_sequence_from_broadstreet": "ATGGGTATTAAATATAGCTTAATTGTTGCAATTGGGAAACACCGAGAAATGGGTGCTGACAATGATTTGCTTTGGCACTTACCAAGAGATATGCAATTTTTTAAGGAAACGACAACGGGTCACGCTGTTGTAATGGGAAGAAAAAGTTGGGAATCTATTCCTCAGAAGTACAGACCGCTTCCAAATCGTTTAAACTTCGTTTTAACACGAGATAAAAACTATAGTGCAGAAGGTGCAACAGTGATTTATGATTTAAAAGAAGTCGCACAACATCTTGAAGGAAAAAACTTAACATGCTTCATTATTGGTGGTGCTCAAATCTACCAACTGGCCTTAGAAACAGGACTTTTAAATGAAATGTATGTCACACAAGTACATAACACATTTGAAGAAGCTGACACCTTTTTCCCTTTTGTAAATTGGGGAGAATGGGAAGAAGAAGATATTTTAGAACAAGATAAAGATGAAAAACATCTTTATTCATTTAATATAAAGAAATTTACGCGTTAA", "partial": "0", "query_start": 11195, "query_end": 11239, "hit_start": 135, "hit_end": 180, "orf_dna_sequence": "ATGATACTTCCCAACAACATCGGCCTCGACGAGCGGACGCAGCTCGCACGGCAGATCTCCTCGTACCAGAAGAAGTTCCACGTGTGGTGGCGCGAGCGGGGGCCCACCGAGTTCCTCGATCGGCAGATGCGCCTTCGCACGCCGACCGGGGCGGTCAGCGGCGTGGACTGGGCCGAGTACAAGACGATGCGTCCCGACGAGTATCGCTGGGGCCTCTTCATGGTGCCGATGGACCAGGACGAGATCGCCTTCGGCGACCACCGTGGCAAGAAGGCGTGGGAGGAGGTTCCGAGCGAATACCGCACGCTGCTGCTGCAGCACATCTGCGTGCAGGCCGACGTGGAGAACGCCGCCGTCGAGCAGAGCCGGCTGCTGACGCAGATGGCGCCGAGCAACCCGGACCTGGAGAACGTGTTCCAGTTCTTCCTCGAGGAGGGGCGCCACACCTGGGCCATGGTTCACCTCCTGCTCGCCCACTTCGGTGAGGACGGGGTCGTCGAGGCCGAAGCGCTCCTGGAGCGGCTGAGCGGTGACCCGAGGAACCCCCGCTTGCTGGAGGCGTTCAACTATCCGACCGAGGACTGGCTGTCCCACTTCATGTGGTGCTTGCTGGCCGACCGGGTTGGCAAGTACCAGATACATGCAGTGACCGAGGCTTCGTTCGCCCCGTTGGCCCGGGCGGCGAAGTTCATGATGTTCGAGGAACCGCTCCACATCGCCATGGGCGCCGTGGGTCTGGAACGAGTGCTGGCCAGGACCGCCGAGGTCACCCTGCGTGAGGGGACGTTCGATACGTTCCACGCGGGGGCGATTCCGTTCCCGGTTGTCCAGAAGTATCTCAATTATTGGGCGCCGAAGGTCTACGACCTCTTCGGAAACGACGGCTCCGAACGCTCGAACGAACTCTTCCGGGCTGGGCTCCGGAGGCCGCGGAATTTCGTGGGAAGCGAATCGCAGATCGTTCGCATCGATGAGCGCATGGGCGACGGACTGACCGTCGTGGAAGTGGAAGGGGAGTGGGCGATCAACGCCATCATGCGACGACAGTTCATCGCCGAAGTGCAAACGCTCATTGATCGCTGGAACGCCAGCCTGCGAGCGCTGGGCGTCGACTTCCAGTTGTACCTCCCTCACGAGCGCTTCAGCAGGACCTATGGCCCCTGCGCCGGTCTGCCCTTCGACGTGGACGGAAAACTGCTCCCCCGCGGCACGGAGGCGAAGCTCGCCGAGTACTTCCCCACACCTCGCGAACTCGCGAACGTCCGCTCGCTGATGCAGCGGGAGCTGGCTCCCGGGCAGTACTCCTCGTGGATCGCCCCGTCCGCGACGCGGCTGAGCGCGCTGGTCCAGGGCAGGAACACGCCCAAGGAGCACGAATGA", "orf_prot_sequence": "MILPNNIGLDERTQLARQISSYQKKFHVWWRERGPTEFLDRQMRLRTPTGAVSGVDWAEYKTMRPDEYRWGLFMVPMDQDEIAFGDHRGKKAWEEVPSEYRTLLLQHICVQADVENAAVEQSRLLTQMAPSNPDLENVFQFFLEEGRHTWAMVHLLLAHFGEDGVVEAEALLERLSGDPRNPRLLEAFNYPTEDWLSHFMWCLLADRVGKYQIHAVTEASFAPLARAAKFMMFEEPLHIAMGAVGLERVLARTAEVTLREGTFDTFHAGAIPFPVVQKYLNYWAPKVYDLFGNDGSERSNELFRAGLRRPRNFVGSESQIVRIDERMGDGLTVVEVEGEWAINAIMRRQFIAEVQTLIDRWNASLRALGVDFQLYLPHERFSRTYGPCAGLPFDVDGKLLPRGTEAKLAEYFPTPRELANVRSLMQRELAPGQYSSWIAPSATRLSALVQGRNTPKEHE", "perc_identity": 53.33}, "gnl|BL_ORD_ID|538|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 10931, "orf_end": 12310, "orf_from": "BGC0001413.1|Cystobactamide_9 ", "model_name": "IND-6", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "590", "ARO_accession": "3002262", "ARO_name": "IND-6", "ARO_category": {"36199": {"category_aro_accession": "3000060", "category_aro_cvterm_id": "36199", "category_aro_name": "IND beta-lactamase", "category_aro_description": "IND beta-lactamases are class B carbapenem-hydrolyzing beta-lactamases.", "category_aro_class_name": "AMR Gene Family"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.59641, "max_identities": 20, "bit_score": 25.409, "cvterm_id": "36916", "query": "AGAIPFPVVQKYLNYWAPKVYDLFGNDGSERSNELFRAGLRRPRNFVGSESQIVRIDERMGDGLTVVEV", "match": "AG + F   +    Y  PK       DG   S EL + G  +P  F G E  +    + +G+G T   V", "sequence_from_db": "AGDLSFFNNKGIKTYATPKTNQFLKRDGKATSTELIKPG--KPYRFGGEEFVV----DFLGEGHTADNV", "sequence_from_broadstreet": "MKRRIQFFMVSMMLTPLFSAQVKDFVIEPPIKKNLYIYKTFGVFGGKEYSANSVYLVTKTGVVLFDVPWEKAQYQSLMDTIKKRHNLPVVAVFATHSHDDRAGDLSFFNNKGIKTYATPKTNQFLKRDGKATSTELIKPGKPYRFGGEEFVVDFLGEGHTADNVVVWFPKYKVLDGGCLVKSNSATDLGYIKEANLEQWPKTMHKLKTKYSEAVLIIPGHDEWKGGGHVEHTLELLDKK", "dna_sequence_from_broadstreet": "ATGAAAAGAAGAATTCAGTTCTTTATGGTTTCAATGATGCTTACCCCATTATTCAGTGCCCAGGTAAAAGATTTTGTAATTGAACCGCCAATAAAAAAGAACTTATATATTTATAAAACTTTCGGAGTGTTCGGGGGAAAAGAATATTCTGCCAATTCAGTGTATCTTGTCACCAAAACCGGGGTTGTTTTATTTGATGTTCCCTGGGAAAAAGCGCAATACCAAAGCCTGATGGATACCATCAAAAAACGTCATAATTTACCTGTTGTTGCGGTATTTGCGACACATTCCCATGATGACCGGGCAGGAGATTTAAGCTTTTTCAATAATAAAGGAATTAAAACCTATGCTACTCCTAAAACCAATCAATTTCTGAAAAGAGACGGAAAGGCTACTTCTACAGAGCTCATTAAGCCCGGAAAACCTTACCGCTTTGGCGGAGAGGAATTTGTAGTGGATTTTCTTGGTGAAGGGCATACTGCCGATAATGTAGTGGTATGGTTTCCAAAATATAAAGTGCTGGATGGCGGCTGCCTTGTAAAAAGCAATTCAGCTACCGATTTAGGGTATATCAAAGAAGCTAATCTAGAGCAATGGCCTAAAACCATGCATAAACTGAAAACAAAATATTCAGAAGCAGTATTAATTATTCCCGGACATGATGAATGGAAAGGCGGCGGGCACGTTGAACATACTTTGGAGCTGCTGGATAAGAAATAA", "partial": "0", "query_start": 11732, "query_end": 11938, "hit_start": 303, "hit_end": 492, "orf_dna_sequence": "ATGATACTTCCCAACAACATCGGCCTCGACGAGCGGACGCAGCTCGCACGGCAGATCTCCTCGTACCAGAAGAAGTTCCACGTGTGGTGGCGCGAGCGGGGGCCCACCGAGTTCCTCGATCGGCAGATGCGCCTTCGCACGCCGACCGGGGCGGTCAGCGGCGTGGACTGGGCCGAGTACAAGACGATGCGTCCCGACGAGTATCGCTGGGGCCTCTTCATGGTGCCGATGGACCAGGACGAGATCGCCTTCGGCGACCACCGTGGCAAGAAGGCGTGGGAGGAGGTTCCGAGCGAATACCGCACGCTGCTGCTGCAGCACATCTGCGTGCAGGCCGACGTGGAGAACGCCGCCGTCGAGCAGAGCCGGCTGCTGACGCAGATGGCGCCGAGCAACCCGGACCTGGAGAACGTGTTCCAGTTCTTCCTCGAGGAGGGGCGCCACACCTGGGCCATGGTTCACCTCCTGCTCGCCCACTTCGGTGAGGACGGGGTCGTCGAGGCCGAAGCGCTCCTGGAGCGGCTGAGCGGTGACCCGAGGAACCCCCGCTTGCTGGAGGCGTTCAACTATCCGACCGAGGACTGGCTGTCCCACTTCATGTGGTGCTTGCTGGCCGACCGGGTTGGCAAGTACCAGATACATGCAGTGACCGAGGCTTCGTTCGCCCCGTTGGCCCGGGCGGCGAAGTTCATGATGTTCGAGGAACCGCTCCACATCGCCATGGGCGCCGTGGGTCTGGAACGAGTGCTGGCCAGGACCGCCGAGGTCACCCTGCGTGAGGGGACGTTCGATACGTTCCACGCGGGGGCGATTCCGTTCCCGGTTGTCCAGAAGTATCTCAATTATTGGGCGCCGAAGGTCTACGACCTCTTCGGAAACGACGGCTCCGAACGCTCGAACGAACTCTTCCGGGCTGGGCTCCGGAGGCCGCGGAATTTCGTGGGAAGCGAATCGCAGATCGTTCGCATCGATGAGCGCATGGGCGACGGACTGACCGTCGTGGAAGTGGAAGGGGAGTGGGCGATCAACGCCATCATGCGACGACAGTTCATCGCCGAAGTGCAAACGCTCATTGATCGCTGGAACGCCAGCCTGCGAGCGCTGGGCGTCGACTTCCAGTTGTACCTCCCTCACGAGCGCTTCAGCAGGACCTATGGCCCCTGCGCCGGTCTGCCCTTCGACGTGGACGGAAAACTGCTCCCCCGCGGCACGGAGGCGAAGCTCGCCGAGTACTTCCCCACACCTCGCGAACTCGCGAACGTCCGCTCGCTGATGCAGCGGGAGCTGGCTCCCGGGCAGTACTCCTCGTGGATCGCCCCGTCCGCGACGCGGCTGAGCGCGCTGGTCCAGGGCAGGAACACGCCCAAGGAGCACGAATGA", "orf_prot_sequence": "MILPNNIGLDERTQLARQISSYQKKFHVWWRERGPTEFLDRQMRLRTPTGAVSGVDWAEYKTMRPDEYRWGLFMVPMDQDEIAFGDHRGKKAWEEVPSEYRTLLLQHICVQADVENAAVEQSRLLTQMAPSNPDLENVFQFFLEEGRHTWAMVHLLLAHFGEDGVVEAEALLERLSGDPRNPRLLEAFNYPTEDWLSHFMWCLLADRVGKYQIHAVTEASFAPLARAAKFMMFEEPLHIAMGAVGLERVLARTAEVTLREGTFDTFHAGAIPFPVVQKYLNYWAPKVYDLFGNDGSERSNELFRAGLRRPRNFVGSESQIVRIDERMGDGLTVVEVEGEWAINAIMRRQFIAEVQTLIDRWNASLRALGVDFQLYLPHERFSRTYGPCAGLPFDVDGKLLPRGTEAKLAEYFPTPRELANVRSLMQRELAPGQYSSWIAPSATRLSALVQGRNTPKEHE", "perc_identity": 28.99}}, "BGC0001413.1|Cystobactamide_11 # 14721 # 15452 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=GGGG;rbs_spacer=7bp;gc_cont=0.641": {"gnl|BL_ORD_ID|2308|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 14721, "orf_end": 15452, "orf_from": "BGC0001413.1|Cystobactamide_11 ", "model_name": "tetA(46)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1100", "model_id": "2643", "ARO_accession": "3004032", "ARO_name": "tetA(46)", "ARO_category": {"36002": {"category_aro_accession": "0010001", "category_aro_cvterm_id": "36002", "category_aro_name": "ATP-binding cassette (ABC) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. ATP-binding cassette (ABC) transporters are present in all cells of all organisms and use the energy of ATP binding/hydrolysis to transport substrates across cell membranes.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.49547, "max_identities": 13, "bit_score": 27.335, "cvterm_id": "41065", "query": "HFLSAKSAPHYPNNRSKISGLNDE--DFLRAIRKM", "match": "+FLS K   +   NR  ++ LNDE  + +  IR M", "sequence_from_db": "YFLSRKQEEYVEQNREAVAQLNDEVLESIEGIRVM", "sequence_from_broadstreet": "MIRAIWEYIRERKWRYVKIAMVLILYDYTLLIPTQVIQRLVDHLSQQTLTQSNFVWDMVLLVGSAILNYLTAFYWQLRLFQSSVHFKATLQGQAFRKLVAMRRPFFEKFRSGDLLTRFTTDVDGMADMAGYGMMVLLFGGGLFAFIIPTMFFISWQLTLISFIPMIFLVVSTYFLSRKQEEYVEQNREAVAQLNDEVLESIEGIRVMRAYSRRDQQVKQFQKKTASLSKTGDKIASIQYSFGPLALLFIGFSTVLLLLFGGQSLASGQLSLGKLLALQLYLVFLIEPMWMMTDLILVYQTGQMSYKKLKEVIDETDDLEPDGTHYLEQIDSVEFKDYSFSYPGAERKSLSGIDWTIQRGQTVGIVGRTGAGKTTLVRQFLRQYPVGEGEFLVNQQPIVDYNRHSIEEKIGYVSQEHILFSKSIRENIALGKKGASQEDLMEAVAQAAFADDLERMSHGMDTLIGEKGVSVSGGQKQRISLARAFLRDADLLLLDDSLSAVDAKTEQAIIDTIQKERKDKTTIIVSHRLSAVHQADWIIVLDQGQIVEEGRASDLLAQEGWYYEQYQRQQKQEGE", "dna_sequence_from_broadstreet": "ATGATCAGAGCTATTTGGGAGTATATCAGGGAGCGCAAGTGGCGATATGTGAAGATCGCTATGGTACTGATTCTTTATGATTACACTTTATTGATCCCGACGCAAGTCATTCAGCGCTTAGTGGATCATTTGAGTCAGCAGACGCTGACGCAATCGAACTTTGTATGGGATATGGTCCTCTTGGTGGGATCAGCCATCCTCAATTACCTGACGGCTTTTTATTGGCAGTTGCGACTCTTTCAGTCGTCAGTCCATTTCAAGGCGACCCTTCAGGGACAAGCTTTTCGTAAGCTAGTAGCTATGCGGCGTCCCTTTTTTGAGAAATTTCGCTCAGGGGACCTCTTGACGCGCTTTACGACGGATGTGGATGGCATGGCCGATATGGCTGGTTACGGGATGATGGTGCTCCTGTTTGGCGGTGGCTTGTTTGCCTTTATTATTCCGACCATGTTTTTCATTTCTTGGCAATTAACCTTGATTTCCTTTATTCCCATGATCTTCCTTGTCGTCTCTACCTATTTTTTGAGTAGAAAGCAGGAGGAGTATGTTGAGCAAAACCGGGAAGCGGTTGCTCAGTTGAACGATGAAGTCTTGGAGTCCATCGAAGGGATCCGGGTCATGCGGGCCTATAGTAGACGGGATCAGCAGGTCAAACAGTTTCAGAAGAAAACGGCTAGTCTATCCAAAACAGGGGACAAAATTGCTTCTATCCAATATTCTTTTGGCCCCTTAGCCCTGTTGTTTATTGGATTCTCGACAGTCTTGCTCCTGCTATTTGGAGGACAGTCCCTAGCAAGTGGGCAGTTGAGCCTTGGCAAGCTATTGGCCTTGCAACTGTATTTGGTCTTTTTAATTGAGCCTATGTGGATGATGACGGACCTGATCTTGGTCTATCAGACAGGGCAAATGTCCTATAAAAAACTAAAAGAAGTGATTGATGAGACAGATGATCTTGAGCCAGATGGTACACACTATTTAGAGCAGATCGATTCGGTAGAGTTTAAGGATTATTCCTTCAGTTATCCTGGTGCTGAGCGAAAGAGCCTATCAGGCATTGATTGGACTATCCAGCGAGGACAGACGGTTGGAATTGTTGGTCGTACCGGTGCAGGAAAGACTACCCTGGTTCGACAATTCTTGCGGCAATACCCAGTTGGTGAGGGAGAATTCTTGGTCAACCAGCAACCGATCGTGGACTACAACCGACACTCGATTGAAGAAAAAATTGGTTATGTTTCCCAAGAACATATTTTATTTTCTAAGTCTATCCGTGAGAATATAGCGCTTGGTAAAAAAGGAGCCAGCCAAGAAGACTTGATGGAAGCAGTAGCCCAAGCTGCTTTTGCGGATGATCTCGAGCGGATGTCTCATGGAATGGACACCCTGATCGGTGAGAAAGGGGTCTCTGTATCAGGAGGTCAAAAACAGCGGATCTCTTTGGCGCGTGCCTTCTTAAGAGATGCAGATCTCTTGTTGTTAGATGATTCCCTTTCGGCAGTGGATGCGAAGACCGAACAGGCCATTATTGACACCATTCAAAAAGAACGAAAAGACAAGACGACCATCATTGTTTCTCATCGCTTGTCGGCTGTCCATCAGGCTGATTGGATCATCGTCTTGGATCAAGGACAGATTGTTGAAGAAGGCAGGGCTAGTGATTTATTAGCTCAAGAGGGCTGGTATTATGAACAATACCAACGGCAACAAAAACAGGAAGGAGAATAA", "partial": "0", "query_start": 15045, "query_end": 15143, "hit_start": 516, "hit_end": 621, "orf_dna_sequence": "ATGATTGCGTTCAACCCGCAGGCGCGGCCCAGGCTGCGGCTCTTCTGCTTTCCGTACGCCGGTGGCGACGCGAACATCTTCCGGGACTGGGCCGCGGCGATGCCCGAGGGGGTCGAGGTCCTCGGCGTTCAGTACCCCGGGCGCGGTACCAACCTGGCGTTGCCGCCGATCAGCGACTGTGACGAGATGGCGTCACAACTGCTGGCGGTGATGACGCCGTTGCTTGGCATCAACTTCGCTTTTTTCGGCCACAGCAATGGCGCCTTGATCAGCTTCGAGGTGGCGCGAAGGCTCCACGACGAACTGAAGGGCCGCATGCGGCATCACTTCCTGTCGGCCAAGTCCGCCCCTCACTACCCGAACAACAGGAGTAAGATCAGCGGCCTCAACGACGAGGACTTTCTCCGGGCGATCCGGAAGATGGGCGGTACGCCCCAGGAAGTGCTCGACGACGCCCGGCTGATGCAGATTCTGCTGCCAAGACTGCGCGCGGACTTCGCGCTCGGCGAGACGTATGTGTTTCGCCCCGGACCCACCCTGACGTGCGACGTCAGCATCCTGCGAGGCGAGAGCGACCACCTGGTCGACGGCGAGTTCGTCCAGCGGTGGTCCGAGCTGACGACGGGCGGCGCGAGCCAGTACGCAATAGATGGTGGCCATTTCTTCCTGAATTCCCACAAGTCGCAGGTCGTGGCGCTCGTGCGAGCGGCACTGCTTGAGTGTGTGTTGTAG", "orf_prot_sequence": "MIAFNPQARPRLRLFCFPYAGGDANIFRDWAAAMPEGVEVLGVQYPGRGTNLALPPISDCDEMASQLLAVMTPLLGINFAFFGHSNGALISFEVARRLHDELKGRMRHHFLSAKSAPHYPNNRSKISGLNDEDFLRAIRKMGGTPQEVLDDARLMQILLPRLRADFALGETYVFRPGPTLTCDVSILRGESDHLVDGEFVQRWSELTTGGASQYAIDGGHFFLNSHKSQVVALVRAALLECVL", "perc_identity": 37.14}, "gnl|BL_ORD_ID|4765|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 14721, "orf_end": 15452, "orf_from": "BGC0001413.1|Cystobactamide_11 ", "model_name": "Erm(50)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "5762", "ARO_accession": "3007032", "ARO_name": "Erm(50)", "ARO_category": {"36699": {"category_aro_accession": "3000560", "category_aro_cvterm_id": "36699", "category_aro_name": "Erm 23S ribosomal RNA methyltransferase", "category_aro_description": "Erm proteins are part of the RNA methyltransferase family and methylate A2058 (E. coli nomenclature) of the 23S ribosomal RNA conferring degrees of resistance to Macrolides, Lincosamides and Streptogramin b. This is called the MLSb phenotype.", "category_aro_class_name": "AMR Gene Family"}, "35946": {"category_aro_accession": "0000027", "category_aro_cvterm_id": "35946", "category_aro_name": "roxithromycin", "category_aro_description": "Roxithromycin is a semi-synthetic, 14-carbon ring macrolide antibiotic derived from erythromycin. It is used to treat respiratory tract, urinary and soft tissue infections. Roxithromycin may possess bacteriocidal activity, particularly at higher concentrations by binding to the 50S subunit of the bacterial 70S rRNA complex, protein synthesis and subsequently structure/function processes critical for life or replication are inhibited.", "category_aro_class_name": "Antibiotic"}, "35982": {"category_aro_accession": "0000065", "category_aro_cvterm_id": "35982", "category_aro_name": "clarithromycin", "category_aro_description": "Clarithromycin is a methyl derivative of erythromycin, sharing the 14-carbon macrolide ring. The antibiotic binds to the 50S subunit of the ribosome and is used to treat pharyngitis, tonsillitis, acute maxillary sinusitis, acute bacterial exacerbation of chronic bronchitis, pneumonia (especially atypical pneumonias associated with Chlamydia pneumoniae or TWAR), and skin structure infections.", "category_aro_class_name": "Antibiotic"}, "35983": {"category_aro_accession": "0000066", "category_aro_cvterm_id": "35983", "category_aro_name": "clindamycin", "category_aro_description": "Clindamycin is a lincosamide antibiotic that blocks A-site aminoacyl-tRNA binding. It is usually used to treat infections with anaerobic bacteria but can also be used to treat some protozoal diseases, such as malaria.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.3787, "max_identities": 13, "bit_score": 24.6386, "cvterm_id": "40344", "query": "FRPGPTLTCDVSILRGESDHLVDGEFVQRWSE", "match": "FRP PT+   V ++R   + LVD      WSE", "sequence_from_db": "FRPRPTVDAGVLVIRRREEPLVD------WSE", "sequence_from_broadstreet": "MPTYRPNKGRHENGQNYLVNEATIRRIVDLVPVNASVPVIEIGPGHGALTFPLQDRVLAAGGSLTAVEIDPASVRWLEKRLRPEVHLYEQDVLDFVLPDGPHVLVGNLPFHLTTAILRHVLHSPGWTHAVLLVQWEVARRRAGVGGATMMTAQWWPWVDFEQYGRVPSTHFRPRPTVDAGVLVIRRREEPLVDWSERARYASFVHDVFTGKGRGVADIVSRVVGRRRARRCAQVLREAGVPAHALPKQLDAGQWATLFTAVGC", "dna_sequence_from_broadstreet": "ATGCCTACCTACAGGCCGAACAAGGGCCGTCACGAGAACGGCCAGAACTACCTCGTCAATGAGGCGACGATCAGACGGATCGTCGACCTCGTCCCCGTCAACGCCTCCGTCCCGGTCATCGAGATCGGCCCGGGACACGGGGCGCTGACCTTTCCCCTTCAGGATCGTGTCTTGGCTGCCGGTGGATCGTTGACCGCCGTCGAGATCGACCCGGCCTCTGTCCGGTGGTTGGAGAAGCGGCTGCGCCCGGAGGTCCACCTGTACGAGCAGGATGTCCTTGATTTTGTGCTTCCGGACGGCCCGCACGTCCTGGTGGGGAACCTGCCGTTCCACCTGACCACCGCGATCCTGCGGCACGTCCTTCACTCACCGGGGTGGACCCACGCGGTGCTCCTGGTGCAGTGGGAGGTCGCGCGCCGCCGCGCCGGTGTCGGTGGTGCCACGATGATGACTGCCCAGTGGTGGCCGTGGGTCGACTTCGAACAGTACGGGCGGGTGCCGTCCACGCATTTCCGTCCCCGCCCCACCGTCGACGCCGGTGTCCTGGTGATACGTCGCCGGGAGGAACCTCTCGTGGACTGGTCGGAGCGTGCGCGGTACGCGTCCTTCGTCCATGACGTGTTCACCGGCAAGGGCCGTGGCGTCGCCGACATCGTGTCCCGGGTTGTGGGGCGTCGGCGTGCGCGACGGTGTGCCCAGGTCTTGCGTGAGGCCGGTGTTCCGGCACACGCACTGCCGAAACAGTTGGACGCGGGGCAGTGGGCCACACTGTTTACGGCCGTGGGGTGCTAA", "partial": "0", "query_start": 15240, "query_end": 15335, "hit_start": 510, "hit_end": 588, "orf_dna_sequence": "ATGATTGCGTTCAACCCGCAGGCGCGGCCCAGGCTGCGGCTCTTCTGCTTTCCGTACGCCGGTGGCGACGCGAACATCTTCCGGGACTGGGCCGCGGCGATGCCCGAGGGGGTCGAGGTCCTCGGCGTTCAGTACCCCGGGCGCGGTACCAACCTGGCGTTGCCGCCGATCAGCGACTGTGACGAGATGGCGTCACAACTGCTGGCGGTGATGACGCCGTTGCTTGGCATCAACTTCGCTTTTTTCGGCCACAGCAATGGCGCCTTGATCAGCTTCGAGGTGGCGCGAAGGCTCCACGACGAACTGAAGGGCCGCATGCGGCATCACTTCCTGTCGGCCAAGTCCGCCCCTCACTACCCGAACAACAGGAGTAAGATCAGCGGCCTCAACGACGAGGACTTTCTCCGGGCGATCCGGAAGATGGGCGGTACGCCCCAGGAAGTGCTCGACGACGCCCGGCTGATGCAGATTCTGCTGCCAAGACTGCGCGCGGACTTCGCGCTCGGCGAGACGTATGTGTTTCGCCCCGGACCCACCCTGACGTGCGACGTCAGCATCCTGCGAGGCGAGAGCGACCACCTGGTCGACGGCGAGTTCGTCCAGCGGTGGTCCGAGCTGACGACGGGCGGCGCGAGCCAGTACGCAATAGATGGTGGCCATTTCTTCCTGAATTCCCACAAGTCGCAGGTCGTGGCGCTCGTGCGAGCGGCACTGCTTGAGTGTGTGTTGTAG", "orf_prot_sequence": "MIAFNPQARPRLRLFCFPYAGGDANIFRDWAAAMPEGVEVLGVQYPGRGTNLALPPISDCDEMASQLLAVMTPLLGINFAFFGHSNGALISFEVARRLHDELKGRMRHHFLSAKSAPHYPNNRSKISGLNDEDFLRAIRKMGGTPQEVLDDARLMQILLPRLRADFALGETYVFRPGPTLTCDVSILRGESDHLVDGEFVQRWSELTTGGASQYAIDGGHFFLNSHKSQVVALVRAALLECVL", "perc_identity": 40.62}}, "BGC0001413.1|Cystobactamide_12 # 15475 # 16512 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.627": {"gnl|BL_ORD_ID|4755|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15475, "orf_end": 16512, "orf_from": "BGC0001413.1|Cystobactamide_12 ", "model_name": "mreA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "450", "model_id": "5749", "ARO_accession": "3007050", "ARO_name": "mreA", "ARO_category": {"36003": {"category_aro_accession": "0010002", "category_aro_cvterm_id": "36003", "category_aro_name": "major facilitator superfamily (MFS) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Major facilitator superfamily (MFS) transporters and ABC transporters comprise the two largest and most functionally diverse of the transporter superfamilies. However, MFS transporters are distinct from ABC transporters in both their primary sequence and structure and in the mechanism of energy coupling. As secondary transporters they are, like RND and SMR transporters, energized by the electrochemical proton gradient.", "category_aro_class_name": "AMR Gene Family"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.765815, "max_identities": 20, "bit_score": 28.4906, "cvterm_id": "36847", "query": "LDVILLTNFLHHFDEAGCEKILKKAHAALKEGGRVLTFEFIANEDRTSPP-LAATFS---MMMLGTTPGGETYAYSDLERM", "match": "+D + L NF  HF +   +  +KK    L+    V+ F++    +RTS   LA  F     ++   + GGE  + + + ++", "sequence_from_db": "VDELYLMNFTSHFSKVSSDLFIKKYIYGLRAKAAVVGFDYKFGHNRTSGDYLARNFKGPVYIIDEISEGGEKISSTRIRQL", "sequence_from_broadstreet": "MMKIHYINDYKDIQAKEDCVLVLGYFDGLHLGHKALFDKAKKIATEKNLKIVVLTFNETPRLTFARFQPELLLHLTSPEKRSEKFQEYGVDELYLMNFTSHFSKVSSDLFIKKYIYGLRAKAAVVGFDYKFGHNRTSGDYLARNFKGPVYIIDEISEGGEKISSTRIRQLITEGNVEKANQLLGYEFSTCGMVVHGDARGRTIGFPTANLAPINRTYLPADGVYISNVLINGKYYRAMTSIGKNITFGGTELRLEANIFDFDGDIYGETIEIFWLKRIREMVKFNGIDDLVKQLKKDKEIALNWKKDSQTL", "dna_sequence_from_broadstreet": "ATCATGAAAATCCATTACATTAATGATTATAAAGATATTCAAGCTAAAGAAGATTGCGTCTTAGTTTTGGGCTATTTTGATGGCTTACATCTGGGACATAAAGCCCTCTTTGATAAAGCTAAAAAAATCGCGACCGAAAAAAATTTGAAAATTGTCGTCTTAACGTTTAATGAGACACCTCGTCTAACCTTCGCTCGCTTCCAACCTGAATTATTGCTACATCTTACCTCTCCAGAAAAACGTTCTGAAAAATTTCAAGAGTATGGCGTCGATGAGTTATATTTAATGAATTTTACCAGTCATTTTTCAAAAGTATCTTCTGACCTTTTTATTAAGAAATATATTTATGGTCTCAGAGCAAAAGCTGCTGTTGTCGGTTTTGATTATAAGTTCGGTCATAATCGTACCAGTGGTGATTATCTAGCGCGTAATTTCAAGGGACCAGTCTATATTATTGATGAAATTTCTGAAGGTGGTGAAAAAATCTCTTCTACACGTATTCGTCAATTGATTACAGAGGGTAATGTTGAGAAAGCTAACCAACTTTTGGGTTATGAGTTTTCAACCTGTGGCATGGTAGTACATGGAGATGCTAGAGGACGAACTATAGGGTTCCCAACTGCTAATCTAGCTCCTATTAATCGCACTTACTTACCTGCAGACGGTGTTTATATTTCCAATGTTCTGATTAATGGAAAATATTATAGAGCAATGACGAGCATTGGAAAAAATATCACTTTTGGTGGTACAGAACTTCGTTTAGAAGCTAATATCTTTGATTTTGATGGCGACATTTATGGAGAAACTATTGAAATTTTCTGGTTAAAAAGAATCAGAGAAATGGTAAAGTTTAATGGTATTGACGATCTTGTAAAACAACTTAAAAAAGATAAAGAAATTGCTTTAAATTGGAAAAAAGATAGTCAAACTCTTTAA", "partial": "0", "query_start": 16186, "query_end": 16416, "hit_start": 267, "hit_end": 510, "orf_dna_sequence": "ATGACCGCTCAGAACCAAGCCTCCGCGTTTTCTTTCGATCTCTTCTACACGACGGTCAATGCGTACTACCGGACCGCCGCCGTCAAGGCGGCCATCGAGCTCGGCGTGTTCGACGTCGTTGGCGAGAAGGGCAAGACCCTGGCCGAGATCGCGAAGGCCTGCAACGCGTCGCCGCGTGGCATCCGCATTCTCTGCCGGTTCCTCGTGTCGATCGGGTTCCTCAAGAATGCGGGTGAGTTGTTCTTCCTCACGCGAGAGATGGCCCTGTTTCTGGACAAGAAGTCGCCCGGCTATCTGGGCGGCAGCATTGATTTCCTTCTGTCGCCGTACATCATGGACGGCTTCAAGGACCTCGCGTCGGTGGTGCGGACGGGCGAGTTGACGCTGCCGGAAAAAGGGGTGGTGGCGCCAGATCATCCGCAGTGGGTGACGTTCGCGCGCGCGATGGCGCCGATGATGTCCCTGCCATCCCTCCTGCTCGCGGAACTGGCGGACCGCCAGGCGAACCAGCCGCTCAAGGTGCTCGATGTCGCCGCCGGCCACGGCCTCTTCGGCCTGGCCATCGCCCAGCGGAATCCGAAGGCGCATGTGACGTTCCTCGACTGGGAAAACGTGCTACAGGTGGCGCGCGAGAACGCGACGAAGGCGGGAGTTCTCGACAGGGTCGAGTTCCGCCCGGGAGATGCCTTCTCCGTGGACTTCGGCAAGGAGCTGGACGTCATCCTCCTGACGAACTTCTTGCATCACTTCGACGAGGCGGGCTGCGAGAAGATCCTCAAGAAGGCCCACGCTGCCCTGAAGGAGGGCGGCCGTGTGCTGACGTTCGAGTTCATCGCGAACGAGGACCGGACGTCGCCTCCGCTTGCCGCCACGTTCAGCATGATGATGCTCGGCACGACGCCCGGCGGTGAGACCTACGCCTACTCCGATCTGGAGCGGATGTTCAAGAACACGGGTTACGATCAAGTCGAGCTCAAGGCCATTCCTCCCGCGATGGAGAAGGTCGTCGTTTCGATCAAGGGCAAAGCGCAGCTCTGA", "orf_prot_sequence": "MTAQNQASAFSFDLFYTTVNAYYRTAAVKAAIELGVFDVVGEKGKTLAEIAKACNASPRGIRILCRFLVSIGFLKNAGELFFLTREMALFLDKKSPGYLGGSIDFLLSPYIMDGFKDLASVVRTGELTLPEKGVVAPDHPQWVTFARAMAPMMSLPSLLLAELADRQANQPLKVLDVAAGHGLFGLAIAQRNPKAHVTFLDWENVLQVARENATKAGVLDRVEFRPGDAFSVDFGKELDVILLTNFLHHFDEAGCEKILKKAHAALKEGGRVLTFEFIANEDRTSPPLAATFSMMMLGTTPGGETYAYSDLERMFKNTGYDQVELKAIPPAMEKVVVSIKGKAQL", "perc_identity": 24.69}, "gnl|BL_ORD_ID|2390|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15475, "orf_end": 16512, "orf_from": "BGC0001413.1|Cystobactamide_12 ", "model_name": "kamB", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "2770", "ARO_accession": "3004102", "ARO_name": "kamB", "ARO_category": {"41436": {"category_aro_accession": "3004272", "category_aro_cvterm_id": "41436", "category_aro_name": "16S rRNA methyltransferase (A1408)", "category_aro_description": "Methyltransferases that methylate the A1408 position of 16S rRNA, which is part of an aminoglycoside binding site.", "category_aro_class_name": "AMR Gene Family"}, "35924": {"category_aro_accession": "0000005", "category_aro_cvterm_id": "35924", "category_aro_name": "neomycin", "category_aro_description": "Neomycin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Neomycin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35955": {"category_aro_accession": "0000037", "category_aro_cvterm_id": "35955", "category_aro_name": "apramycin", "category_aro_description": "Apramycin is an aminoglycoside antibiotic used to treat different types of bacterial infections in animals. Apramycin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35966": {"category_aro_accession": "0000049", "category_aro_cvterm_id": "35966", "category_aro_name": "kanamycin A", "category_aro_description": "Kanamycin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Kanamycin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35935": {"category_aro_accession": "0000016", "category_aro_cvterm_id": "35935", "category_aro_name": "aminoglycoside antibiotic", "category_aro_description": "Aminoglycosides are a group of antibiotics that are mostly effective against Gram-negative bacteria. These molecules consist of aminated sugars attached to a dibasic cyclitol. Aminoglycosides work by binding to the bacterial 30S ribosomal subunit (some work by binding to the 50S subunit), inhibiting the translocation of the peptidyl-tRNA from the A-site to the P-site and also causing misreading of mRNA, leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.40796, "max_identities": 12, "bit_score": 25.0238, "cvterm_id": "41214", "query": "VLDVAAGHGLFGLAIAQRNPKAHVTFLD", "match": "VLDV  G G     +A++NP   V  LD", "sequence_from_db": "VLDVGTGDGKHPYKVARQNPSRLVVALD", "sequence_from_broadstreet": "MRRVVGKRVQEFSDAEFEQLRSQYDDVVLDVGTGDGKHPYKVARQNPSRLVVALDADKSRMEKISAKAAAKPAKGGLPNLLYLWATAERLPPLSGVGELHVLMPWGSLLRGVLGSSPEMLRGMAAVCRPGASFLVALNLHAWRPSVPEVGEHPEPTPDSADEWLAPRYAEAGWKLADCRYLEPEEVAGLETSWTRRLHSSRDRFDVLALTGTISP", "dna_sequence_from_broadstreet": "ATGCGCCGCGTGGTGGGCAAGCGGGTCCAGGAGTTCTCCGACGCCGAGTTCGAGCAGCTACGGAGTCAGTACGACGACGTGGTGCTCGACGTCGGCACCGGCGACGGGAAGCATCCGTACAAGGTCGCCCGCCAGAACCCCTCCCGGCTGGTGGTGGCGCTCGACGCCGACAAGAGCCGGATGGAGAAGATCTCGGCGAAGGCGGCGGCCAAGCCCGCGAAGGGCGGCCTGCCCAACCTGCTGTACCTGTGGGCCACCGCCGAGCGGCTCCCCCCGTTGTCGGGGGTGGGCGAGCTGCACGTCCTCATGCCGTGGGGCAGCCTGCTGCGCGGGGTCCTCGGCTCCTCGCCGGAGATGCTGCGCGGGATGGCGGCGGTGTGCCGGCCGGGCGCGTCCTTCCTGGTCGCGCTGAACCTGCACGCCTGGCGGCCCTCGGTGCCGGAGGTGGGCGAGCACCCCGAGCCCACCCCGGACTCCGCCGACGAGTGGCTGGCGCCCCGCTACGCCGAGGCCGGGTGGAAGCTCGCCGACTGCCGCTACCTGGAGCCGGAGGAGGTGGCGGGTCTGGAGACCTCCTGGACCCGCCGTCTGCACTCCTCCCGCGACCGGTTCGACGTGCTCGCGCTCACCGGCACGATCAGTCCGTGA", "partial": "0", "query_start": 15994, "query_end": 16077, "hit_start": 81, "hit_end": 165, "orf_dna_sequence": "ATGACCGCTCAGAACCAAGCCTCCGCGTTTTCTTTCGATCTCTTCTACACGACGGTCAATGCGTACTACCGGACCGCCGCCGTCAAGGCGGCCATCGAGCTCGGCGTGTTCGACGTCGTTGGCGAGAAGGGCAAGACCCTGGCCGAGATCGCGAAGGCCTGCAACGCGTCGCCGCGTGGCATCCGCATTCTCTGCCGGTTCCTCGTGTCGATCGGGTTCCTCAAGAATGCGGGTGAGTTGTTCTTCCTCACGCGAGAGATGGCCCTGTTTCTGGACAAGAAGTCGCCCGGCTATCTGGGCGGCAGCATTGATTTCCTTCTGTCGCCGTACATCATGGACGGCTTCAAGGACCTCGCGTCGGTGGTGCGGACGGGCGAGTTGACGCTGCCGGAAAAAGGGGTGGTGGCGCCAGATCATCCGCAGTGGGTGACGTTCGCGCGCGCGATGGCGCCGATGATGTCCCTGCCATCCCTCCTGCTCGCGGAACTGGCGGACCGCCAGGCGAACCAGCCGCTCAAGGTGCTCGATGTCGCCGCCGGCCACGGCCTCTTCGGCCTGGCCATCGCCCAGCGGAATCCGAAGGCGCATGTGACGTTCCTCGACTGGGAAAACGTGCTACAGGTGGCGCGCGAGAACGCGACGAAGGCGGGAGTTCTCGACAGGGTCGAGTTCCGCCCGGGAGATGCCTTCTCCGTGGACTTCGGCAAGGAGCTGGACGTCATCCTCCTGACGAACTTCTTGCATCACTTCGACGAGGCGGGCTGCGAGAAGATCCTCAAGAAGGCCCACGCTGCCCTGAAGGAGGGCGGCCGTGTGCTGACGTTCGAGTTCATCGCGAACGAGGACCGGACGTCGCCTCCGCTTGCCGCCACGTTCAGCATGATGATGCTCGGCACGACGCCCGGCGGTGAGACCTACGCCTACTCCGATCTGGAGCGGATGTTCAAGAACACGGGTTACGATCAAGTCGAGCTCAAGGCCATTCCTCCCGCGATGGAGAAGGTCGTCGTTTCGATCAAGGGCAAAGCGCAGCTCTGA", "orf_prot_sequence": "MTAQNQASAFSFDLFYTTVNAYYRTAAVKAAIELGVFDVVGEKGKTLAEIAKACNASPRGIRILCRFLVSIGFLKNAGELFFLTREMALFLDKKSPGYLGGSIDFLLSPYIMDGFKDLASVVRTGELTLPEKGVVAPDHPQWVTFARAMAPMMSLPSLLLAELADRQANQPLKVLDVAAGHGLFGLAIAQRNPKAHVTFLDWENVLQVARENATKAGVLDRVEFRPGDAFSVDFGKELDVILLTNFLHHFDEAGCEKILKKAHAALKEGGRVLTFEFIANEDRTSPPLAATFSMMMLGTTPGGETYAYSDLERMFKNTGYDQVELKAIPPAMEKVVVSIKGKAQL", "perc_identity": 42.86}}, "BGC0001413.1|Cystobactamide_13 # 16552 # 22530 # 1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.662": {"gnl|BL_ORD_ID|4935|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 16552, "orf_end": 22530, "orf_from": "BGC0001413.1|Cystobactamide_13 ", "model_name": "almE", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1000", "model_id": "5928", "ARO_accession": "3007433", "ARO_name": "almE", "ARO_category": {"46184": {"category_aro_accession": "3007428", "category_aro_cvterm_id": "46184", "category_aro_name": "polymyxin resistance operon", "category_aro_description": "Operon or gene clusters confering resistance to polymyxin antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "46188": {"category_aro_accession": "3007432", "category_aro_cvterm_id": "46188", "category_aro_name": "alm glycyltransferase", "category_aro_description": "Glycyl transferase associated with polymyxin resistance operons not interacting with lipid A.", "category_aro_class_name": "AMR Gene Family"}, "36966": {"category_aro_accession": "3000622", "category_aro_cvterm_id": "36966", "category_aro_name": "colistin A", "category_aro_description": "Colistin A, or polymyxin E1, has a 6-octanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "36968": {"category_aro_accession": "3000624", "category_aro_cvterm_id": "36968", "category_aro_name": "colistin B", "category_aro_description": "Colistin B, or polymyxin E2, has a 6-heptanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "36192": {"category_aro_accession": "3000053", "category_aro_cvterm_id": "36192", "category_aro_name": "peptide antibiotic", "category_aro_description": "Peptide antibiotics have a wide range of antibacterial mechanisms, depending on the amino acids that make up the antibiotic, although most act to disrupt the cell membrane in some manner. Subclasses of peptide antibiotics can include additional sidechains of other types, such as lipids in the case of the lipopeptide antibiotics.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.42794e-22, "max_identities": 132, "bit_score": 99.3673, "cvterm_id": "36789", "query": "LLDSEDANVISRS--NETGISLDLSKSVVDLFNLQVERAPDATACLGRQGRLTYGELNRRTNQLAHHLIARGVGPDVPVGVLFERSAEQLIAILGVLKAGGCYVPLDPQYPADYMQQVLTDARPRMVVSSRALGERLRS-------------------------------GEEQIVYLDDEQLLARETRDPPVKVLPEQLAYVMYTSGSSGVPKGVMVPHRQILNWLHALLARVPFGENEVVAQKTSTSFAISVKELFAGLVAGVPQVFIDDATVRDVASFVRELEQWRVTRLYTFPSQLAAILSSVNGAYERLRSLRHLYISIEPCPTELLAKLRAA--MPWVTPWYIYGCTEIN-DVTYCDPGDQAGNTGFVPIGRPIRNTRVFVLDEE-----LRMVPVGAMGEMYVESLSTARGYWGLPELTAERFIANPHAEDGSRLYKTGDLARYLPDGSLEFLGRRDYEVKIRGYRVDVRQVEKVLGAHPDILEVAVVGWPL--GGANPQLVAYVVPRAKGAAP--IQEIRDYLSASLPAYMVPTIFQVLAALPRLPNDKVD", "match": "LL  E   V+     N+  +  +   S+  L  +Q  R   A A   +Q   TY E+      L+ +   +GV     V +L  R      AI      G  Y+PL+ +   + +Q+ L   +   ++       RL S                                  QI   D E L+A+   D        + AY+M TSGS+G PK + V +  +  ++  +    P    + V Q +  +F +SV ++F  L++G     + +      A F+R  +   +T   + P+ +   L         L SLR  +   +    +L  + + A   P +    +YG TE    +TY      +G    VPIGR      + +++E+         P G  GE+ +       GY   P  T   F  +    +G   Y++GD+     +G L  LGRRD++VKI G RV++ ++E V+        VA+V WPL   G     VA+V    +      + + +  L+ +     VP  +  +  LPR  N K D", "sequence_from_db": "LLQREGYGVVHNQFINKMAMCCETRHSI--LAAIQANR--HAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQR---VAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNE-----HEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQ---LTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVIN---LYGPTECTIAITYHRFVAHSGMAS-VPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQH----EGRIWYRSGDIVTK-SNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTF----VPKRWYAIEQLPRNANGKTD", "sequence_from_broadstreet": "MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH", "dna_sequence_from_broadstreet": "ATGCCATACAATTCTGCGACAGATTTGTTACAGAGAGAGGGTTATGGTGTCGTGCATAACCAATTTATCAATAAAATGGCGATGTGCTGCGAGACAAGACACTCTATTTTGGCGGCCATTCAGGCTAACCGACATGCCCCTGCATTATGGGTTAAACAGAAAACCTACACCTATCAAGAGATGACCGATATGGCACTCTCATTGAGTGACTATTGGCATTTACAGGGCGTGCAGCGAGTTGCGATCCTTTCGGTACGCGATCTCGCGGCTTATTCTGCGATTTGGGCGAGCTATTTGGGCGGTATGACTTATATTCCGCTCAATGCGCGAGCAACAACAGAACAGATCCAAGAGACGCTGATCGCGACACAATGTGATTCCATCATGGTAGACGCGCAGCAATTGAGTCGTTTGTCCTCCTTACTAGATACTTGCATTGACCGATTACACATTTATGCGCTGCCTGATGTGGATATGGAACCGTTACGTCAGCAATATCCTCAGCACACTTTTCACACAGTGCAAATAACCGAACAAGATGTGGAATTACTGGTAGCGAAATACCATTTAGACAATGAACATGAGTACGCTTATATCATGCAAACCTCAGGTTCGACTGGTAAACCCAAACGTATTGCGGTCAGCTACAGTAATTTGCATTGCTATATCAGTCAAATTGACAAACTATTTCCACTCAATGCGCAAGATCGAGTGGGGCAATATTCTGATTTGACTTTTGATCTTTCGGTACATGATATTTTTTACAGTTTGATCTCTGGTGCTTGTTTATATGTTGTGCCTGAATTAGCGAAATTAAGTCCAGCGGAATTTATTCGTCACCATCAATTAACGGTATGGCTTTCTGTGCCTACTGTTATTGAGTTGGCCCTACAAAGACAAACCTTAACCCCACACAGTTTACCTTCTCTGCGACTGAGTTTTTTCTGCGGACAAGCCTTGCTGCATGATTTAGCCGAACAATGGCAACAGGCCACCCAGCAGCCGGTGATCAATCTGTATGGTCCAACAGAGTGCACGATTGCTATTACCTATCATCGATTTGTCGCCCATTCAGGTATGGCATCGGTGCCGATTGGCCGTGCTTTTGAAGAGGAGTGTTTAGCCATCATCAACGAACAAGGTGAATTGATGCGCTTTGAATCTGCACCCGAGGGGTATCGCGGAGAATTACTTCTGTCGGGCAAACAATTAGTCAATGGTTATCTGAATGATCCGCTGAATACGCAAAGTGCCTTTTTCCAGCACGAAGGGCGTATTTGGTATCGTTCAGGTGACATTGTCACTAAATCAAATGGCGTGCTGATTCATCTTGGGCGTCGCGATCACCAAGTGAAAATTGCCGGACAACGGGTGGAATTAGAAGAGATTGAAACCGTTGTTCGCCGCGTGACTCAAGCGCACAGCGTGGCGATAGTGCCTTGGCCTTTAAGTGAGTCGGGCTATGCCAGCGGCACGGTGGCGTTTGTGGATACCCATACCCAATGGCAACCAGATCTGTGGTTGAGCCAATGCAAACAACAATTAAATCCAACTTTTGTGCCTAAGCGTTGGTATGCCATTGAACAATTACCAAGAAATGCCAATGGCAAAACCGATATTAAAGCTTTACAACAACAATTAGCGAGTCAGACATATGAAACAAGCCATTGA", "partial": "0", "query_start": 16579, "query_end": 18120, "hit_start": 24, "hit_end": 1617, "orf_dna_sequence": "ATGGCCACCAAATTGTCTGACTTCGCGCTCCTCGACTCCGAAGACGCCAACGTCATCTCCCGCTCGAACGAGACGGGGATATCGCTGGATCTGTCCAAGAGCGTGGTTGACTTGTTCAACCTCCAGGTCGAGAGGGCGCCTGACGCCACGGCGTGTCTCGGCCGCCAGGGGCGCTTGACTTACGGAGAACTCAACCGGCGGACGAACCAGCTCGCGCATCACCTGATCGCGCGAGGCGTCGGGCCGGATGTTCCCGTGGGCGTCCTGTTCGAGCGCTCCGCCGAGCAGCTCATCGCCATCCTGGGCGTCCTCAAGGCGGGCGGGTGTTATGTCCCGTTGGATCCGCAGTACCCCGCCGATTACATGCAGCAGGTCCTGACGGACGCCCGGCCGCGGATGGTGGTGTCGAGCCGGGCGCTCGGCGAGCGCCTCCGCTCGGGCGAGGAGCAGATCGTCTACCTCGATGACGAACAGCTCCTGGCGCGCGAGACCCGCGACCCGCCTGTGAAGGTGTTGCCGGAGCAGCTCGCGTACGTGATGTACACGTCGGGCTCGTCCGGAGTGCCGAAGGGCGTCATGGTGCCCCATCGCCAGATCCTCAACTGGCTGCATGCACTCCTGGCGCGGGTGCCGTTCGGCGAGAACGAAGTGGTGGCCCAGAAGACGTCCACGTCATTCGCCATCTCAGTGAAGGAACTCTTCGCGGGATTGGTCGCGGGTGTCCCGCAGGTCTTCATCGACGATGCGACTGTCCGCGACGTTGCCAGCTTCGTTCGTGAGCTGGAGCAGTGGCGCGTCACGCGGCTCTATACTTTTCCCTCCCAGCTGGCGGCGATTCTCTCGAGCGTGAATGGCGCGTACGAGCGCCTCCGCTCGCTGCGCCACCTGTACATCTCGATCGAGCCCTGCCCAACAGAGCTGCTGGCGAAGCTCCGGGCGGCGATGCCGTGGGTCACCCCCTGGTACATCTATGGCTGCACCGAGATCAACGACGTCACCTACTGCGACCCAGGGGACCAGGCTGGCAACACGGGCTTCGTGCCGATCGGGCGGCCCATCCGCAACACGCGGGTGTTCGTCCTCGACGAAGAGCTCCGGATGGTGCCCGTCGGCGCGATGGGTGAGATGTACGTGGAGAGCCTGAGCACGGCGCGGGGCTACTGGGGCCTTCCCGAGTTGACGGCGGAGCGGTTCATCGCCAACCCTCACGCGGAGGACGGTTCGCGCCTGTACAAGACAGGCGACCTCGCCCGCTACCTGCCGGATGGTTCCCTGGAGTTCCTCGGGCGCCGGGACTACGAGGTGAAGATCCGCGGGTATCGCGTGGACGTCCGGCAGGTCGAGAAGGTCCTCGGGGCGCATCCCGACATCCTCGAGGTGGCGGTGGTGGGCTGGCCGCTCGGCGGGGCGAATCCACAACTGGTCGCCTACGTCGTGCCGAGGGCGAAGGGGGCTGCTCCCATCCAGGAGATCCGGGACTACCTGTCGGCGTCCCTGCCGGCCTACATGGTGCCGACGATCTTCCAGGTGCTGGCGGCGCTGCCACGTCTTCCCAATGACAAGGTGGATCGGTTGAGCCTGCCCGACCCCAAGGTGGAGGAGCAGACCGAGGGGTACGTGGCGCCTCGCACGGAAACCGAGAAGGTACTGGCCGAAATCTGGAGCGACGTCCTCAGCCAGGGCCGGGCCCCCCTGACCGTCGGCGCGACGCACAACTTTTTCGAACTGGGAGGCCATTCGCTTCTCGCCGCCCAGATGTTCTCGCGGATCCGGCAGAAGTTCGATCTCGAACTGCCCATCAACACCCTGTTCGAGACCCCCGTGCTGGAGGGCTTTGCGAGCGCCGTCGACGCGGCTCTTGCCGAGCGGAACGGTCCGGCGCAGAGGCTGATCAGCATGACGGACCGCGGCCAGGCGCTTCCGCTGTCGCACGTCCAGGAGCGGCTCTGGTTCGTGCACGAGCACATGGTCGAGCAGCGGAGCAGCTACAACGTTGCCTTCGCCTGCCACATGCGTGGCAAGGGGCTGTCGATGCCGGCGCTGCGCGCCGCCATCAACGGGCTGGTGGCTCGCCACGAGACCTTGCGGACGACGTTCGTCGTCTCCGAGGGCGGAGGAGATCCCGTCCAGCGGATCGCCGACTCCCTGTGGATCGAGGTTCCGCTATATGAGGTCGATGCGTCGGAAGTCCCGGCCCGCATGGCGGCCCACGCGGGCCACGTGTTCGACCTTGCGAAGGGCCCCCTGCTGAAGACCTCGGTCCTGCGGGTGACGCCCGATCACCACGTGTTCTTGATGAACATGCATCACATCATCTGTGATGGGTGGTCGATCGACATCCTGCTGCGGGACCTCTACGAGTTCTACAAGGCGGCCGAGACGGGCTCGCAGCCGAACCTGCCGGTCCTGCCAATCCAGTATGCCGACTACTCCGTGTGGCAGCGTCAGCAGGACCTCAGCAGTCACCTCGACTACTGGAAGAAGACGCTCGAGGGCTACCAGGAAGGGTTGTCGCTTCCGTACGACTTCGCCCGCCCGTCCAACAGGACCTGGCGTGCCGCGAGTGTCCGGCACCAGTACCCGGCGGAACTCGCCACCCGTCTGTCGGAGGTGAGCAAGAGCCATCAGGCGACGGTGTTCATGACGTTGATGGCCAGCACGGCAATCGTGCTGAACCGGTACACGGGTCGGGATGATCTGTGCGTGGGTGCCACGGTGGCGGGCCGTGACCACTTCGAGCTCGAGAACCTGATTGGCTTCTTCGTCAACATCCTCGCCATCAGGCTCGACCTCAGCGGGAATCCCACGGCCGAGACGGTGCTGCAGCGGGCGCGAGCGCAGGTGCTGGAAGGCATGAAGCATCGCGACCTGCCGTTCGAGCACATCCTGGCGGCGCTGCAGAAGCAGCGCGACAGCAGCCAGATTCCCCTGGTGCCGGTGATGGTCCGCCACCAGAACTTCCCGACAGTGACCTCGCAGGAGCAGGGGCTCGACCTGGGTATCGGGGAGATCGAGTTTGGTGAGCGGACGACGCCCAACGAGCTCGACATCCAGTTCATCGGCGAGGGAAGCACGCTGGAGGTGGTGGTCGAGTACGCGAAGGATCTGTTCTCCGAGCGCACGATCCAGCGGCTCATCACGCACTTGCAGCAGGTGCTGCAGACTCTCGTGGACAAGCCGGACTGCCGGCTGACGGATTTTCCGCTGGTGGCCGGGGACGCGCTGCAGGGCGGTGTGTCGGGCTCCGGGGGCGCGACGAAGACCGGCAAGCTCGACGTGTCGAAGAGCCCGGTCGAGTTGTTCAACGAGCGGGTAGAGGCCTCGCCGGACGCGGTCGCCTGCATGGGCGCGGACGGAAGCCTGACCTACCGGGAGCTGGACCGAAGGGCCAATCAGGTCGCCCGCCACCTGATGGGGCGAGGGGTGGGGCGGGAGACGCGGGTGGGGTTGTGGTTCGAGCGCTCGCCGGACCTGCTGGTCGCACTCCTGGGCATACTCAAGGCGGGGGGCTGCTTCGTTCCGCTCGATCCGAGCTATCCGCAGGAGTACATCAACAACATCGTCGCCGATGCGCAGCCGCTTCTGGTGATGTCGAGCCGGGCGCTGGGCTCACGCCTGTCACTGGAGGCAGGGCGGCTGGTGTACCTCGATGACGCGCTGGCGGCGTCCACCGATGCGAGCGATCCCCAGGTGCGCATCGACCCGGAGCAGCTCATCTACGTCATGTACACCTCCGGTTCCACCGGTCTGCCGAAGGGGGTGCTCGTTCCCCATCGGCAGATCCTGAACTGGCTGTACCCGCTGTGGGCGATGGTGCCCTTCGGGCAGGACGAGGTGGTGGCGCAGAAGACATCCACGGCCTTCGCGGTCTCGATGAAGGAGCTCTTCACGGGGCTGCTGGCGGGCGTGCCCCAGGTATTCATCGACGGCACCGTGGTCAAGGACGCGGCGGCCTTCGTGCTCCACCTGGAGCGATGGCGGGTCACCCGGCTGTACACGCTCCCGTCGCACCTCGATGCCATCCTGTCCCACGTCGACGGGGCGGCGGAGCGCCTGCGGTCCCTGCGGCATGTCATCCTCGCGGGGGAGCCGTGCCCCGTTGAGCTGATGGAGAAGCTGCGCGAGACCCTGCCGTCGTGCACGGCGTGGTTCAACTACGGCTGTACCGAGGTCAACGACATCTCCTACTGCGTCCCGAACGAGCAGTTCCACAGCTCGGGGTTCGTGCCGATCGGCCGGCCCATCCAGTACACCCGGGCGCTGGTGCTCGACGACGAGCTGCGGACGGTGCCGGTGGGCATCATGGGGGAGATTTACGTCGAGAGCCCGGGGACGGCGCGGGGCTACTGGAGGCAGCCGGATTTGACGGCCGAGCGGTTCATCCCCAACCCGTTCGGCGAGCCGGGTAGCCGTCTCTACCGTACGGGCGATATGGCGCGATGCCTTGAGGATGGCTCGCTGGAGTTCTTGGGGCGCCGGGACTACGAGGTCAAGATCCGTGGCCATCGCGTGGACGTCCGCCAGGTCGAGAAGATCCTCGCGAGCCACCCGGAAGTCCTCGAGTCGGCGGTGTTGGGCTGGCCACGGGGGGCGAAGAACCCTCAGTTGCTTGCCTACGCCGCCACGAAGCCGGGCCGTCCCCTGTCGACTGAAAACGTGCGGGAGTACCTGTCGGCCCGCTTGCCGACGTACATGGTGCCAACGCTCTACCAGTTCCTGCCAGCGCTGCCGCGCCTGCCCAATGGCAAGCTCGACCGCTTCGGGCTGCCCGATCACAAGAAAGTCGAGGTGGGCGGCGTCTACGTCGCCCCGCAGACGCCGACGGAGAAGGTCTTGGCGGGACTGTGGGCCGAGTGCCTCAAGCAGGGCGACATGCCCGCGCCGCAGGTTGGCCGCTTGCACAACTTCTTCGACCTCGGTGGGCACTCGCTGCTCGCCAATCGCGTACTGATGCAGGTGCAGCGGCATTTCGGGGTCAGCCTGGGCATCAGTGCGTTGTTCGGTTCTCCGGTGCTGAATGACTTCGCGGCGGCCATCGACAAGGCGCTCGGGACCGAGGAGCCAGGCGAGGAAGGTTCGAGCGACGCACGAGAGGTCGCTGCGAAGGACACCTCCGTGCTCGTGCCGCTCTCCACCCACGGGACGCTGCCGAGCCTGTTCTGCGTCCATCCGGTGGGCGGGCAGGTCCATGCCTACCGCGAGCTCGCCCAGGCGATGGAGAAGCACGCCAGCATGTACGCGCTCCAGTCGGAGGGCGCCCGTGAGTTCGACACAATCGAGACCTTGGCGCGCTTCTACGCCGATGCGATCCGCGGGGCTCAGCCCGACGGGAGCTACCGTCTCCTCGGATGGTCTTCTGGTGGGCTCATCACCCTGGCGATTGCTCGCGAGCTGGAGCACCAGGGCTGCGCCGTGGAGTACGTGGGCCTCGTGGATTCAAAGCCAATCCCGCGGTTGGCGGGTGAGCGCGGCTGGGCGTCGCTGATCGCGGCGACGAACATCCTGGGCGCGATGCGGGGGCGCGGCTTCTCGGTCGCCGAGGTCGATGCTGCCGGGAAGATCCTCGAGTCGCGCGGATGGACGGAGGAGTCCTTCGACTCGGAGGGGCATGCGGCGTTGGAGGAGTTGGCTCGGCACTTCGGCATCACCGTCGCGCAAGAGTCATCGGAGTACCTCCTGGCCCGGTTCAAGACCACGAAGTACTACTTGTCGCTGTTCGCTGGCTTCAAGCCGGCGGCGCTCGGGCCGGAGACGTACCTCTATGAGGCTTCAGAGCGGGTCGGAGCCACCTCGAACGACGACACGGGCGAGTGGGGGGACGCGCTGGATCGCAAGGCCCTGCGGGCGAACATCGTGCAGGTGCCAGGCAATCACTATACTGTCCTGCAGGGAGAGAACGTGCTGCAACTGGCGGGGCGGATCGCCGAAGCCTTGTCTGCGATCGACAACTCGGTGGTAACGAGGACGCGAGCTTCGTGA", "orf_prot_sequence": "MATKLSDFALLDSEDANVISRSNETGISLDLSKSVVDLFNLQVERAPDATACLGRQGRLTYGELNRRTNQLAHHLIARGVGPDVPVGVLFERSAEQLIAILGVLKAGGCYVPLDPQYPADYMQQVLTDARPRMVVSSRALGERLRSGEEQIVYLDDEQLLARETRDPPVKVLPEQLAYVMYTSGSSGVPKGVMVPHRQILNWLHALLARVPFGENEVVAQKTSTSFAISVKELFAGLVAGVPQVFIDDATVRDVASFVRELEQWRVTRLYTFPSQLAAILSSVNGAYERLRSLRHLYISIEPCPTELLAKLRAAMPWVTPWYIYGCTEINDVTYCDPGDQAGNTGFVPIGRPIRNTRVFVLDEELRMVPVGAMGEMYVESLSTARGYWGLPELTAERFIANPHAEDGSRLYKTGDLARYLPDGSLEFLGRRDYEVKIRGYRVDVRQVEKVLGAHPDILEVAVVGWPLGGANPQLVAYVVPRAKGAAPIQEIRDYLSASLPAYMVPTIFQVLAALPRLPNDKVDRLSLPDPKVEEQTEGYVAPRTETEKVLAEIWSDVLSQGRAPLTVGATHNFFELGGHSLLAAQMFSRIRQKFDLELPINTLFETPVLEGFASAVDAALAERNGPAQRLISMTDRGQALPLSHVQERLWFVHEHMVEQRSSYNVAFACHMRGKGLSMPALRAAINGLVARHETLRTTFVVSEGGGDPVQRIADSLWIEVPLYEVDASEVPARMAAHAGHVFDLAKGPLLKTSVLRVTPDHHVFLMNMHHIICDGWSIDILLRDLYEFYKAAETGSQPNLPVLPIQYADYSVWQRQQDLSSHLDYWKKTLEGYQEGLSLPYDFARPSNRTWRAASVRHQYPAELATRLSEVSKSHQATVFMTLMASTAIVLNRYTGRDDLCVGATVAGRDHFELENLIGFFVNILAIRLDLSGNPTAETVLQRARAQVLEGMKHRDLPFEHILAALQKQRDSSQIPLVPVMVRHQNFPTVTSQEQGLDLGIGEIEFGERTTPNELDIQFIGEGSTLEVVVEYAKDLFSERTIQRLITHLQQVLQTLVDKPDCRLTDFPLVAGDALQGGVSGSGGATKTGKLDVSKSPVELFNERVEASPDAVACMGADGSLTYRELDRRANQVARHLMGRGVGRETRVGLWFERSPDLLVALLGILKAGGCFVPLDPSYPQEYINNIVADAQPLLVMSSRALGSRLSLEAGRLVYLDDALAASTDASDPQVRIDPEQLIYVMYTSGSTGLPKGVLVPHRQILNWLYPLWAMVPFGQDEVVAQKTSTAFAVSMKELFTGLLAGVPQVFIDGTVVKDAAAFVLHLERWRVTRLYTLPSHLDAILSHVDGAAERLRSLRHVILAGEPCPVELMEKLRETLPSCTAWFNYGCTEVNDISYCVPNEQFHSSGFVPIGRPIQYTRALVLDDELRTVPVGIMGEIYVESPGTARGYWRQPDLTAERFIPNPFGEPGSRLYRTGDMARCLEDGSLEFLGRRDYEVKIRGHRVDVRQVEKILASHPEVLESAVLGWPRGAKNPQLLAYAATKPGRPLSTENVREYLSARLPTYMVPTLYQFLPALPRLPNGKLDRFGLPDHKKVEVGGVYVAPQTPTEKVLAGLWAECLKQGDMPAPQVGRLHNFFDLGGHSLLANRVLMQVQRHFGVSLGISALFGSPVLNDFAAAIDKALGTEEPGEEGSSDAREVAAKDTSVLVPLSTHGTLPSLFCVHPVGGQVHAYRELAQAMEKHASMYALQSEGAREFDTIETLARFYADAIRGAQPDGSYRLLGWSSGGLITLAIARELEHQGCAVEYVGLVDSKPIPRLAGERGWASLIAATNILGAMRGRGFSVAEVDAAGKILESRGWTEESFDSEGHAALEELARHFGITVAQESSEYLLARFKTTKYYLSLFAGFKPAALGPETYLYEASERVGATSNDDTGEWGDALDRKALRANIVQVPGNHYTVLQGENVLQLAGRIAEALSAIDNSVVTRTRAS", "perc_identity": 23.61}, "gnl|BL_ORD_ID|4935|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 16552, "orf_end": 22530, "orf_from": "BGC0001413.1|Cystobactamide_13 ", "model_name": "almE", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1000", "model_id": "5928", "ARO_accession": "3007433", "ARO_name": "almE", "ARO_category": {"46184": {"category_aro_accession": "3007428", "category_aro_cvterm_id": "46184", "category_aro_name": "polymyxin resistance operon", "category_aro_description": "Operon or gene clusters confering resistance to polymyxin antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "46188": {"category_aro_accession": "3007432", "category_aro_cvterm_id": "46188", "category_aro_name": "alm glycyltransferase", "category_aro_description": "Glycyl transferase associated with polymyxin resistance operons not interacting with lipid A.", "category_aro_class_name": "AMR Gene Family"}, "36966": {"category_aro_accession": "3000622", "category_aro_cvterm_id": "36966", "category_aro_name": "colistin A", "category_aro_description": "Colistin A, or polymyxin E1, has a 6-octanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "36968": {"category_aro_accession": "3000624", "category_aro_cvterm_id": "36968", "category_aro_name": "colistin B", "category_aro_description": "Colistin B, or polymyxin E2, has a 6-heptanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "36192": {"category_aro_accession": "3000053", "category_aro_cvterm_id": "36192", "category_aro_name": "peptide antibiotic", "category_aro_description": "Peptide antibiotics have a wide range of antibacterial mechanisms, depending on the amino acids that make up the antibiotic, although most act to disrupt the cell membrane in some manner. Subclasses of peptide antibiotics can include additional sidechains of other types, such as lipids in the case of the lipopeptide antibiotics.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.37983e-21, "max_identities": 126, "bit_score": 98.5969, "cvterm_id": "36789", "query": "VEASPDAVACMGADGSLTYRELDRRANQVARHLMGRGVGRETRVGLWFERSPDLLVALLGILKAGGCFVPLDPSYPQEYI---------NNIVADAQPLLVMSS--RALGSRLSLEAGRLVYLDDALAASTDASDPQVRI---DPEQLI------------YVMYTSGSTGLPKGVLVPHRQILNWLYPLWAMVPFGQDEVVAQKTSTAFAVSMKELFTGLLAGVPQVFIDGTVVKDAAAFVLHLERWRVTRLYTLPSHLDAILSHVDGAAERLRSLRHVILAGEPCPVELMEKLRETLPSCTAWFNYGCTEVNDISYCVPNEQFH----SSGF--VPIGRPIQYTRALVLDDE-----LRTVPVGIMGEIYVESPGTARGYWRQPDLTAERFIPNPFGEPGSRLYRTGDMARCLEDGSLEFLGRRDYEVKIRGHRVDVRQVEKILASHPEVLESAVLGWPRG----AKNPQLLAYAATKPGRPLSTENVREYLSARLPTYMVPTLYQFLPALPRLPNGKLD", "match": "++A+  A A      + TY+E+   A  ++ +   +GV    RV +   R      A+      G  ++PL+     E I         ++I+ DAQ L  +SS       RL + A   V ++         +   V+I   D E L+            Y+M TSGSTG PK + V +  +  ++  +  + P    + V Q +   F +S+ ++F  L++G     +        A F+ H +   +T   ++P+ ++  L         L SLR     G+    +L E+ ++          YG TE      C     +H     SG   VPIGR  +     +++++       + P G  GE+ +       GY   P  T   F    F   G   YR+GD+     +G L  LGRRD++VKI G RV++ ++E ++    +    A++ WP      A          T+    L     ++ L+   PT+ VP  +  +  LPR  NGK D", "sequence_from_db": "IQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGV---QRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQ---LTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINL-YGPTE------CTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAF----FQHEGRIWYRSGDIV-TKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLN---PTF-VPKRWYAIEQLPRNANGKTD", "sequence_from_broadstreet": "MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH", "dna_sequence_from_broadstreet": "ATGCCATACAATTCTGCGACAGATTTGTTACAGAGAGAGGGTTATGGTGTCGTGCATAACCAATTTATCAATAAAATGGCGATGTGCTGCGAGACAAGACACTCTATTTTGGCGGCCATTCAGGCTAACCGACATGCCCCTGCATTATGGGTTAAACAGAAAACCTACACCTATCAAGAGATGACCGATATGGCACTCTCATTGAGTGACTATTGGCATTTACAGGGCGTGCAGCGAGTTGCGATCCTTTCGGTACGCGATCTCGCGGCTTATTCTGCGATTTGGGCGAGCTATTTGGGCGGTATGACTTATATTCCGCTCAATGCGCGAGCAACAACAGAACAGATCCAAGAGACGCTGATCGCGACACAATGTGATTCCATCATGGTAGACGCGCAGCAATTGAGTCGTTTGTCCTCCTTACTAGATACTTGCATTGACCGATTACACATTTATGCGCTGCCTGATGTGGATATGGAACCGTTACGTCAGCAATATCCTCAGCACACTTTTCACACAGTGCAAATAACCGAACAAGATGTGGAATTACTGGTAGCGAAATACCATTTAGACAATGAACATGAGTACGCTTATATCATGCAAACCTCAGGTTCGACTGGTAAACCCAAACGTATTGCGGTCAGCTACAGTAATTTGCATTGCTATATCAGTCAAATTGACAAACTATTTCCACTCAATGCGCAAGATCGAGTGGGGCAATATTCTGATTTGACTTTTGATCTTTCGGTACATGATATTTTTTACAGTTTGATCTCTGGTGCTTGTTTATATGTTGTGCCTGAATTAGCGAAATTAAGTCCAGCGGAATTTATTCGTCACCATCAATTAACGGTATGGCTTTCTGTGCCTACTGTTATTGAGTTGGCCCTACAAAGACAAACCTTAACCCCACACAGTTTACCTTCTCTGCGACTGAGTTTTTTCTGCGGACAAGCCTTGCTGCATGATTTAGCCGAACAATGGCAACAGGCCACCCAGCAGCCGGTGATCAATCTGTATGGTCCAACAGAGTGCACGATTGCTATTACCTATCATCGATTTGTCGCCCATTCAGGTATGGCATCGGTGCCGATTGGCCGTGCTTTTGAAGAGGAGTGTTTAGCCATCATCAACGAACAAGGTGAATTGATGCGCTTTGAATCTGCACCCGAGGGGTATCGCGGAGAATTACTTCTGTCGGGCAAACAATTAGTCAATGGTTATCTGAATGATCCGCTGAATACGCAAAGTGCCTTTTTCCAGCACGAAGGGCGTATTTGGTATCGTTCAGGTGACATTGTCACTAAATCAAATGGCGTGCTGATTCATCTTGGGCGTCGCGATCACCAAGTGAAAATTGCCGGACAACGGGTGGAATTAGAAGAGATTGAAACCGTTGTTCGCCGCGTGACTCAAGCGCACAGCGTGGCGATAGTGCCTTGGCCTTTAAGTGAGTCGGGCTATGCCAGCGGCACGGTGGCGTTTGTGGATACCCATACCCAATGGCAACCAGATCTGTGGTTGAGCCAATGCAAACAACAATTAAATCCAACTTTTGTGCCTAAGCGTTGGTATGCCATTGAACAATTACCAAGAAATGCCAATGGCAAAACCGATATTAAAGCTTTACAACAACAATTAGCGAGTCAGACATATGAAACAAGCCATTGA", "partial": "0", "query_start": 19864, "query_end": 21306, "hit_start": 117, "hit_end": 1617, "orf_dna_sequence": "ATGGCCACCAAATTGTCTGACTTCGCGCTCCTCGACTCCGAAGACGCCAACGTCATCTCCCGCTCGAACGAGACGGGGATATCGCTGGATCTGTCCAAGAGCGTGGTTGACTTGTTCAACCTCCAGGTCGAGAGGGCGCCTGACGCCACGGCGTGTCTCGGCCGCCAGGGGCGCTTGACTTACGGAGAACTCAACCGGCGGACGAACCAGCTCGCGCATCACCTGATCGCGCGAGGCGTCGGGCCGGATGTTCCCGTGGGCGTCCTGTTCGAGCGCTCCGCCGAGCAGCTCATCGCCATCCTGGGCGTCCTCAAGGCGGGCGGGTGTTATGTCCCGTTGGATCCGCAGTACCCCGCCGATTACATGCAGCAGGTCCTGACGGACGCCCGGCCGCGGATGGTGGTGTCGAGCCGGGCGCTCGGCGAGCGCCTCCGCTCGGGCGAGGAGCAGATCGTCTACCTCGATGACGAACAGCTCCTGGCGCGCGAGACCCGCGACCCGCCTGTGAAGGTGTTGCCGGAGCAGCTCGCGTACGTGATGTACACGTCGGGCTCGTCCGGAGTGCCGAAGGGCGTCATGGTGCCCCATCGCCAGATCCTCAACTGGCTGCATGCACTCCTGGCGCGGGTGCCGTTCGGCGAGAACGAAGTGGTGGCCCAGAAGACGTCCACGTCATTCGCCATCTCAGTGAAGGAACTCTTCGCGGGATTGGTCGCGGGTGTCCCGCAGGTCTTCATCGACGATGCGACTGTCCGCGACGTTGCCAGCTTCGTTCGTGAGCTGGAGCAGTGGCGCGTCACGCGGCTCTATACTTTTCCCTCCCAGCTGGCGGCGATTCTCTCGAGCGTGAATGGCGCGTACGAGCGCCTCCGCTCGCTGCGCCACCTGTACATCTCGATCGAGCCCTGCCCAACAGAGCTGCTGGCGAAGCTCCGGGCGGCGATGCCGTGGGTCACCCCCTGGTACATCTATGGCTGCACCGAGATCAACGACGTCACCTACTGCGACCCAGGGGACCAGGCTGGCAACACGGGCTTCGTGCCGATCGGGCGGCCCATCCGCAACACGCGGGTGTTCGTCCTCGACGAAGAGCTCCGGATGGTGCCCGTCGGCGCGATGGGTGAGATGTACGTGGAGAGCCTGAGCACGGCGCGGGGCTACTGGGGCCTTCCCGAGTTGACGGCGGAGCGGTTCATCGCCAACCCTCACGCGGAGGACGGTTCGCGCCTGTACAAGACAGGCGACCTCGCCCGCTACCTGCCGGATGGTTCCCTGGAGTTCCTCGGGCGCCGGGACTACGAGGTGAAGATCCGCGGGTATCGCGTGGACGTCCGGCAGGTCGAGAAGGTCCTCGGGGCGCATCCCGACATCCTCGAGGTGGCGGTGGTGGGCTGGCCGCTCGGCGGGGCGAATCCACAACTGGTCGCCTACGTCGTGCCGAGGGCGAAGGGGGCTGCTCCCATCCAGGAGATCCGGGACTACCTGTCGGCGTCCCTGCCGGCCTACATGGTGCCGACGATCTTCCAGGTGCTGGCGGCGCTGCCACGTCTTCCCAATGACAAGGTGGATCGGTTGAGCCTGCCCGACCCCAAGGTGGAGGAGCAGACCGAGGGGTACGTGGCGCCTCGCACGGAAACCGAGAAGGTACTGGCCGAAATCTGGAGCGACGTCCTCAGCCAGGGCCGGGCCCCCCTGACCGTCGGCGCGACGCACAACTTTTTCGAACTGGGAGGCCATTCGCTTCTCGCCGCCCAGATGTTCTCGCGGATCCGGCAGAAGTTCGATCTCGAACTGCCCATCAACACCCTGTTCGAGACCCCCGTGCTGGAGGGCTTTGCGAGCGCCGTCGACGCGGCTCTTGCCGAGCGGAACGGTCCGGCGCAGAGGCTGATCAGCATGACGGACCGCGGCCAGGCGCTTCCGCTGTCGCACGTCCAGGAGCGGCTCTGGTTCGTGCACGAGCACATGGTCGAGCAGCGGAGCAGCTACAACGTTGCCTTCGCCTGCCACATGCGTGGCAAGGGGCTGTCGATGCCGGCGCTGCGCGCCGCCATCAACGGGCTGGTGGCTCGCCACGAGACCTTGCGGACGACGTTCGTCGTCTCCGAGGGCGGAGGAGATCCCGTCCAGCGGATCGCCGACTCCCTGTGGATCGAGGTTCCGCTATATGAGGTCGATGCGTCGGAAGTCCCGGCCCGCATGGCGGCCCACGCGGGCCACGTGTTCGACCTTGCGAAGGGCCCCCTGCTGAAGACCTCGGTCCTGCGGGTGACGCCCGATCACCACGTGTTCTTGATGAACATGCATCACATCATCTGTGATGGGTGGTCGATCGACATCCTGCTGCGGGACCTCTACGAGTTCTACAAGGCGGCCGAGACGGGCTCGCAGCCGAACCTGCCGGTCCTGCCAATCCAGTATGCCGACTACTCCGTGTGGCAGCGTCAGCAGGACCTCAGCAGTCACCTCGACTACTGGAAGAAGACGCTCGAGGGCTACCAGGAAGGGTTGTCGCTTCCGTACGACTTCGCCCGCCCGTCCAACAGGACCTGGCGTGCCGCGAGTGTCCGGCACCAGTACCCGGCGGAACTCGCCACCCGTCTGTCGGAGGTGAGCAAGAGCCATCAGGCGACGGTGTTCATGACGTTGATGGCCAGCACGGCAATCGTGCTGAACCGGTACACGGGTCGGGATGATCTGTGCGTGGGTGCCACGGTGGCGGGCCGTGACCACTTCGAGCTCGAGAACCTGATTGGCTTCTTCGTCAACATCCTCGCCATCAGGCTCGACCTCAGCGGGAATCCCACGGCCGAGACGGTGCTGCAGCGGGCGCGAGCGCAGGTGCTGGAAGGCATGAAGCATCGCGACCTGCCGTTCGAGCACATCCTGGCGGCGCTGCAGAAGCAGCGCGACAGCAGCCAGATTCCCCTGGTGCCGGTGATGGTCCGCCACCAGAACTTCCCGACAGTGACCTCGCAGGAGCAGGGGCTCGACCTGGGTATCGGGGAGATCGAGTTTGGTGAGCGGACGACGCCCAACGAGCTCGACATCCAGTTCATCGGCGAGGGAAGCACGCTGGAGGTGGTGGTCGAGTACGCGAAGGATCTGTTCTCCGAGCGCACGATCCAGCGGCTCATCACGCACTTGCAGCAGGTGCTGCAGACTCTCGTGGACAAGCCGGACTGCCGGCTGACGGATTTTCCGCTGGTGGCCGGGGACGCGCTGCAGGGCGGTGTGTCGGGCTCCGGGGGCGCGACGAAGACCGGCAAGCTCGACGTGTCGAAGAGCCCGGTCGAGTTGTTCAACGAGCGGGTAGAGGCCTCGCCGGACGCGGTCGCCTGCATGGGCGCGGACGGAAGCCTGACCTACCGGGAGCTGGACCGAAGGGCCAATCAGGTCGCCCGCCACCTGATGGGGCGAGGGGTGGGGCGGGAGACGCGGGTGGGGTTGTGGTTCGAGCGCTCGCCGGACCTGCTGGTCGCACTCCTGGGCATACTCAAGGCGGGGGGCTGCTTCGTTCCGCTCGATCCGAGCTATCCGCAGGAGTACATCAACAACATCGTCGCCGATGCGCAGCCGCTTCTGGTGATGTCGAGCCGGGCGCTGGGCTCACGCCTGTCACTGGAGGCAGGGCGGCTGGTGTACCTCGATGACGCGCTGGCGGCGTCCACCGATGCGAGCGATCCCCAGGTGCGCATCGACCCGGAGCAGCTCATCTACGTCATGTACACCTCCGGTTCCACCGGTCTGCCGAAGGGGGTGCTCGTTCCCCATCGGCAGATCCTGAACTGGCTGTACCCGCTGTGGGCGATGGTGCCCTTCGGGCAGGACGAGGTGGTGGCGCAGAAGACATCCACGGCCTTCGCGGTCTCGATGAAGGAGCTCTTCACGGGGCTGCTGGCGGGCGTGCCCCAGGTATTCATCGACGGCACCGTGGTCAAGGACGCGGCGGCCTTCGTGCTCCACCTGGAGCGATGGCGGGTCACCCGGCTGTACACGCTCCCGTCGCACCTCGATGCCATCCTGTCCCACGTCGACGGGGCGGCGGAGCGCCTGCGGTCCCTGCGGCATGTCATCCTCGCGGGGGAGCCGTGCCCCGTTGAGCTGATGGAGAAGCTGCGCGAGACCCTGCCGTCGTGCACGGCGTGGTTCAACTACGGCTGTACCGAGGTCAACGACATCTCCTACTGCGTCCCGAACGAGCAGTTCCACAGCTCGGGGTTCGTGCCGATCGGCCGGCCCATCCAGTACACCCGGGCGCTGGTGCTCGACGACGAGCTGCGGACGGTGCCGGTGGGCATCATGGGGGAGATTTACGTCGAGAGCCCGGGGACGGCGCGGGGCTACTGGAGGCAGCCGGATTTGACGGCCGAGCGGTTCATCCCCAACCCGTTCGGCGAGCCGGGTAGCCGTCTCTACCGTACGGGCGATATGGCGCGATGCCTTGAGGATGGCTCGCTGGAGTTCTTGGGGCGCCGGGACTACGAGGTCAAGATCCGTGGCCATCGCGTGGACGTCCGCCAGGTCGAGAAGATCCTCGCGAGCCACCCGGAAGTCCTCGAGTCGGCGGTGTTGGGCTGGCCACGGGGGGCGAAGAACCCTCAGTTGCTTGCCTACGCCGCCACGAAGCCGGGCCGTCCCCTGTCGACTGAAAACGTGCGGGAGTACCTGTCGGCCCGCTTGCCGACGTACATGGTGCCAACGCTCTACCAGTTCCTGCCAGCGCTGCCGCGCCTGCCCAATGGCAAGCTCGACCGCTTCGGGCTGCCCGATCACAAGAAAGTCGAGGTGGGCGGCGTCTACGTCGCCCCGCAGACGCCGACGGAGAAGGTCTTGGCGGGACTGTGGGCCGAGTGCCTCAAGCAGGGCGACATGCCCGCGCCGCAGGTTGGCCGCTTGCACAACTTCTTCGACCTCGGTGGGCACTCGCTGCTCGCCAATCGCGTACTGATGCAGGTGCAGCGGCATTTCGGGGTCAGCCTGGGCATCAGTGCGTTGTTCGGTTCTCCGGTGCTGAATGACTTCGCGGCGGCCATCGACAAGGCGCTCGGGACCGAGGAGCCAGGCGAGGAAGGTTCGAGCGACGCACGAGAGGTCGCTGCGAAGGACACCTCCGTGCTCGTGCCGCTCTCCACCCACGGGACGCTGCCGAGCCTGTTCTGCGTCCATCCGGTGGGCGGGCAGGTCCATGCCTACCGCGAGCTCGCCCAGGCGATGGAGAAGCACGCCAGCATGTACGCGCTCCAGTCGGAGGGCGCCCGTGAGTTCGACACAATCGAGACCTTGGCGCGCTTCTACGCCGATGCGATCCGCGGGGCTCAGCCCGACGGGAGCTACCGTCTCCTCGGATGGTCTTCTGGTGGGCTCATCACCCTGGCGATTGCTCGCGAGCTGGAGCACCAGGGCTGCGCCGTGGAGTACGTGGGCCTCGTGGATTCAAAGCCAATCCCGCGGTTGGCGGGTGAGCGCGGCTGGGCGTCGCTGATCGCGGCGACGAACATCCTGGGCGCGATGCGGGGGCGCGGCTTCTCGGTCGCCGAGGTCGATGCTGCCGGGAAGATCCTCGAGTCGCGCGGATGGACGGAGGAGTCCTTCGACTCGGAGGGGCATGCGGCGTTGGAGGAGTTGGCTCGGCACTTCGGCATCACCGTCGCGCAAGAGTCATCGGAGTACCTCCTGGCCCGGTTCAAGACCACGAAGTACTACTTGTCGCTGTTCGCTGGCTTCAAGCCGGCGGCGCTCGGGCCGGAGACGTACCTCTATGAGGCTTCAGAGCGGGTCGGAGCCACCTCGAACGACGACACGGGCGAGTGGGGGGACGCGCTGGATCGCAAGGCCCTGCGGGCGAACATCGTGCAGGTGCCAGGCAATCACTATACTGTCCTGCAGGGAGAGAACGTGCTGCAACTGGCGGGGCGGATCGCCGAAGCCTTGTCTGCGATCGACAACTCGGTGGTAACGAGGACGCGAGCTTCGTGA", "orf_prot_sequence": "MATKLSDFALLDSEDANVISRSNETGISLDLSKSVVDLFNLQVERAPDATACLGRQGRLTYGELNRRTNQLAHHLIARGVGPDVPVGVLFERSAEQLIAILGVLKAGGCYVPLDPQYPADYMQQVLTDARPRMVVSSRALGERLRSGEEQIVYLDDEQLLARETRDPPVKVLPEQLAYVMYTSGSSGVPKGVMVPHRQILNWLHALLARVPFGENEVVAQKTSTSFAISVKELFAGLVAGVPQVFIDDATVRDVASFVRELEQWRVTRLYTFPSQLAAILSSVNGAYERLRSLRHLYISIEPCPTELLAKLRAAMPWVTPWYIYGCTEINDVTYCDPGDQAGNTGFVPIGRPIRNTRVFVLDEELRMVPVGAMGEMYVESLSTARGYWGLPELTAERFIANPHAEDGSRLYKTGDLARYLPDGSLEFLGRRDYEVKIRGYRVDVRQVEKVLGAHPDILEVAVVGWPLGGANPQLVAYVVPRAKGAAPIQEIRDYLSASLPAYMVPTIFQVLAALPRLPNDKVDRLSLPDPKVEEQTEGYVAPRTETEKVLAEIWSDVLSQGRAPLTVGATHNFFELGGHSLLAAQMFSRIRQKFDLELPINTLFETPVLEGFASAVDAALAERNGPAQRLISMTDRGQALPLSHVQERLWFVHEHMVEQRSSYNVAFACHMRGKGLSMPALRAAINGLVARHETLRTTFVVSEGGGDPVQRIADSLWIEVPLYEVDASEVPARMAAHAGHVFDLAKGPLLKTSVLRVTPDHHVFLMNMHHIICDGWSIDILLRDLYEFYKAAETGSQPNLPVLPIQYADYSVWQRQQDLSSHLDYWKKTLEGYQEGLSLPYDFARPSNRTWRAASVRHQYPAELATRLSEVSKSHQATVFMTLMASTAIVLNRYTGRDDLCVGATVAGRDHFELENLIGFFVNILAIRLDLSGNPTAETVLQRARAQVLEGMKHRDLPFEHILAALQKQRDSSQIPLVPVMVRHQNFPTVTSQEQGLDLGIGEIEFGERTTPNELDIQFIGEGSTLEVVVEYAKDLFSERTIQRLITHLQQVLQTLVDKPDCRLTDFPLVAGDALQGGVSGSGGATKTGKLDVSKSPVELFNERVEASPDAVACMGADGSLTYRELDRRANQVARHLMGRGVGRETRVGLWFERSPDLLVALLGILKAGGCFVPLDPSYPQEYINNIVADAQPLLVMSSRALGSRLSLEAGRLVYLDDALAASTDASDPQVRIDPEQLIYVMYTSGSTGLPKGVLVPHRQILNWLYPLWAMVPFGQDEVVAQKTSTAFAVSMKELFTGLLAGVPQVFIDGTVVKDAAAFVLHLERWRVTRLYTLPSHLDAILSHVDGAAERLRSLRHVILAGEPCPVELMEKLRETLPSCTAWFNYGCTEVNDISYCVPNEQFHSSGFVPIGRPIQYTRALVLDDELRTVPVGIMGEIYVESPGTARGYWRQPDLTAERFIPNPFGEPGSRLYRTGDMARCLEDGSLEFLGRRDYEVKIRGHRVDVRQVEKILASHPEVLESAVLGWPRGAKNPQLLAYAATKPGRPLSTENVREYLSARLPTYMVPTLYQFLPALPRLPNGKLDRFGLPDHKKVEVGGVYVAPQTPTEKVLAGLWAECLKQGDMPAPQVGRLHNFFDLGGHSLLANRVLMQVQRHFGVSLGISALFGSPVLNDFAAAIDKALGTEEPGEEGSSDAREVAAKDTSVLVPLSTHGTLPSLFCVHPVGGQVHAYRELAQAMEKHASMYALQSEGAREFDTIETLARFYADAIRGAQPDGSYRLLGWSSGGLITLAIARELEHQGCAVEYVGLVDSKPIPRLAGERGWASLIAATNILGAMRGRGFSVAEVDAAGKILESRGWTEESFDSEGHAALEELARHFGITVAQESSEYLLARFKTTKYYLSLFAGFKPAALGPETYLYEASERVGATSNDDTGEWGDALDRKALRANIVQVPGNHYTVLQGENVLQLAGRIAEALSAIDNSVVTRTRAS", "perc_identity": 24.14}, "gnl|BL_ORD_ID|934|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 16552, "orf_end": 22530, "orf_from": "BGC0001413.1|Cystobactamide_13 ", "model_name": "APH(2'')-IIIa", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "550", "model_id": "1013", "ARO_accession": "3002636", "ARO_name": "APH(2'')-IIIa", "ARO_category": {"36267": {"category_aro_accession": "3000128", "category_aro_cvterm_id": "36267", "category_aro_name": "APH(2'')", "category_aro_description": "A category of aminoglycoside O-phosphotransferase enzymes with modification regiospecificity based at the 2''-hydroxyl group of the respective antibiotic. These enzymes inactivate aminoglycoside antibiotics, specifically kanamycin, tobramycin and amikacin, by the ATP-dependent phosphorylation of the 3'-hydroxyl group of the compound.", "category_aro_class_name": "AMR Gene Family"}, "35932": {"category_aro_accession": "0000013", "category_aro_cvterm_id": "35932", "category_aro_name": "amikacin", "category_aro_description": "Amikacin is an aminoglycoside antibiotic that works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35966": {"category_aro_accession": "0000049", "category_aro_cvterm_id": "35966", "category_aro_name": "kanamycin A", "category_aro_description": "Kanamycin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Kanamycin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35969": {"category_aro_accession": "0000052", "category_aro_cvterm_id": "35969", "category_aro_name": "tobramycin", "category_aro_description": "Tobramycin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Tobramycin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "40942": {"category_aro_accession": "3004015", "category_aro_cvterm_id": "40942", "category_aro_name": "gentamicin A", "category_aro_description": "Gentamicin A is part of a complex of broad spectrum aminoglycoside antibiotics. Gentamicin inhibits protein synthesis, resulting in bacterial cell death.", "category_aro_class_name": "Antibiotic"}, "46133": {"category_aro_accession": "3007382", "category_aro_cvterm_id": "46133", "category_aro_name": "gentamicin", "category_aro_description": "Gentamicin is a commonly used aminoglycoside antibiotic derived from members of the Micromonospora genus of bacteria. It acts by binding the 30S ribosomal subunit, thus inhibiting protein synthesis. Gentamicin is typically used to treat Gram-negative infections of the repiratory and urinary tract, as well as infections of the bone and soft tissue. It also exhibits considerable nephrotoxicity and ototoxicity. Gentamicin is administered as a mixture of gentamicin type C (which makes about around 80% of the complex) and types A, B, and X (distributed in the remaining 20% of the complex).", "category_aro_class_name": "Antibiotic"}, "35935": {"category_aro_accession": "0000016", "category_aro_cvterm_id": "35935", "category_aro_name": "aminoglycoside antibiotic", "category_aro_description": "Aminoglycosides are a group of antibiotics that are mostly effective against Gram-negative bacteria. These molecules consist of aminated sugars attached to a dibasic cyclitol. Aminoglycosides work by binding to the bacterial 30S ribosomal subunit (some work by binding to the 50S subunit), inhibiting the translocation of the peptidyl-tRNA from the A-site to the P-site and also causing misreading of mRNA, leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.755485, "max_identities": 21, "bit_score": 31.187, "cvterm_id": "36781", "query": "LLAYAATKPGRPLSTENVREYLSARLPTYMVPTLYQFLPALPRLPNGKLDRFGLPDH", "match": "LL+ A      PL  E++R+YL+ R  +YM   +Y      PRL +G L     PDH", "sequence_from_db": "LLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYT--RYTPRLIHGDLS----PDH", "sequence_from_broadstreet": "MKQNKLHYTTMIMTQFPDISIQSVESLGEGFRNYAILVNGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGMAVFPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISDPDYDYVYLLEDCGELFTRQVMAYRGEVDLDTHIRKVSLFVTFDQVSYLLEGLRARDQDWISEGLELLEEDKANNFGANSA", "dna_sequence_from_broadstreet": "ATGAAACAAAATAAACTTCACTATACCACAATGATAATGACTCAGTTCCCAGATATAAGCATACAATCCGTCGAGTCGCTTGGTGAGGGCTTTAGGAATTACGCGATCCTCGTCAATGGAGATTGGGTTTTTCGTTTTCCCAAGAGTCAACAAGGTGCAGACGAATTGAACAAAGAAATCCAATTGCTACCTCTGTTGGTCGGTTGTGTTAAGGTGAATATTCCACAGTATGTATATATCGGAAAGCGAAGTGATGGAAATCCCTTCGTGGGCTACCGTAAAGTCCAAGGCCAAATCTTGGGTGAAGACGGGATGGCCGTTTTTCCCGATGATGCAAAAGATCGACTGGCGCTGCAACTTGCTGAGTTCATGAATGAGCTAAGCGCATTTCCTGTTGAAACTGCCATATCAGCCGGGGTTCCTGTTACAAACCTGAAAAATAAAATTCTCTTGCTATCGGAAGCTGTGGAGGATCAGGTGTTCCCTCTTCTTGATGAGTCTTTAAGGGACTATCTCACGCTGCGCTTCCAATCCTATATGACTCATCCGGTATATACACGATATACGCCGAGACTAATTCACGGCGATTTGTCACCTGATCATTTTTTGACGAATTTGAATTCACGTCAGACCCCATTAACAGGCATTATCGATTTTGGTGATGCCGCAATAAGTGATCCCGATTATGATTATGTATACCTTTTGGAAGATTGCGGCGAGCTGTTTACTCGGCAAGTGATGGCTTATAGAGGCGAGGTTGACTTGGATACTCACATCAGAAAAGTCTCCTTGTTCGTAACGTTCGATCAAGTCAGTTACCTGTTAGAAGGCTTAAGGGCAAGGGATCAGGACTGGATTTCTGAAGGGTTAGAGCTTTTGGAAGAGGATAAGGCCAACAATTTTGGTGCGAACAGTGCTTAA", "partial": "0", "query_start": 21157, "query_end": 21327, "hit_start": 450, "hit_end": 603, "orf_dna_sequence": "ATGGCCACCAAATTGTCTGACTTCGCGCTCCTCGACTCCGAAGACGCCAACGTCATCTCCCGCTCGAACGAGACGGGGATATCGCTGGATCTGTCCAAGAGCGTGGTTGACTTGTTCAACCTCCAGGTCGAGAGGGCGCCTGACGCCACGGCGTGTCTCGGCCGCCAGGGGCGCTTGACTTACGGAGAACTCAACCGGCGGACGAACCAGCTCGCGCATCACCTGATCGCGCGAGGCGTCGGGCCGGATGTTCCCGTGGGCGTCCTGTTCGAGCGCTCCGCCGAGCAGCTCATCGCCATCCTGGGCGTCCTCAAGGCGGGCGGGTGTTATGTCCCGTTGGATCCGCAGTACCCCGCCGATTACATGCAGCAGGTCCTGACGGACGCCCGGCCGCGGATGGTGGTGTCGAGCCGGGCGCTCGGCGAGCGCCTCCGCTCGGGCGAGGAGCAGATCGTCTACCTCGATGACGAACAGCTCCTGGCGCGCGAGACCCGCGACCCGCCTGTGAAGGTGTTGCCGGAGCAGCTCGCGTACGTGATGTACACGTCGGGCTCGTCCGGAGTGCCGAAGGGCGTCATGGTGCCCCATCGCCAGATCCTCAACTGGCTGCATGCACTCCTGGCGCGGGTGCCGTTCGGCGAGAACGAAGTGGTGGCCCAGAAGACGTCCACGTCATTCGCCATCTCAGTGAAGGAACTCTTCGCGGGATTGGTCGCGGGTGTCCCGCAGGTCTTCATCGACGATGCGACTGTCCGCGACGTTGCCAGCTTCGTTCGTGAGCTGGAGCAGTGGCGCGTCACGCGGCTCTATACTTTTCCCTCCCAGCTGGCGGCGATTCTCTCGAGCGTGAATGGCGCGTACGAGCGCCTCCGCTCGCTGCGCCACCTGTACATCTCGATCGAGCCCTGCCCAACAGAGCTGCTGGCGAAGCTCCGGGCGGCGATGCCGTGGGTCACCCCCTGGTACATCTATGGCTGCACCGAGATCAACGACGTCACCTACTGCGACCCAGGGGACCAGGCTGGCAACACGGGCTTCGTGCCGATCGGGCGGCCCATCCGCAACACGCGGGTGTTCGTCCTCGACGAAGAGCTCCGGATGGTGCCCGTCGGCGCGATGGGTGAGATGTACGTGGAGAGCCTGAGCACGGCGCGGGGCTACTGGGGCCTTCCCGAGTTGACGGCGGAGCGGTTCATCGCCAACCCTCACGCGGAGGACGGTTCGCGCCTGTACAAGACAGGCGACCTCGCCCGCTACCTGCCGGATGGTTCCCTGGAGTTCCTCGGGCGCCGGGACTACGAGGTGAAGATCCGCGGGTATCGCGTGGACGTCCGGCAGGTCGAGAAGGTCCTCGGGGCGCATCCCGACATCCTCGAGGTGGCGGTGGTGGGCTGGCCGCTCGGCGGGGCGAATCCACAACTGGTCGCCTACGTCGTGCCGAGGGCGAAGGGGGCTGCTCCCATCCAGGAGATCCGGGACTACCTGTCGGCGTCCCTGCCGGCCTACATGGTGCCGACGATCTTCCAGGTGCTGGCGGCGCTGCCACGTCTTCCCAATGACAAGGTGGATCGGTTGAGCCTGCCCGACCCCAAGGTGGAGGAGCAGACCGAGGGGTACGTGGCGCCTCGCACGGAAACCGAGAAGGTACTGGCCGAAATCTGGAGCGACGTCCTCAGCCAGGGCCGGGCCCCCCTGACCGTCGGCGCGACGCACAACTTTTTCGAACTGGGAGGCCATTCGCTTCTCGCCGCCCAGATGTTCTCGCGGATCCGGCAGAAGTTCGATCTCGAACTGCCCATCAACACCCTGTTCGAGACCCCCGTGCTGGAGGGCTTTGCGAGCGCCGTCGACGCGGCTCTTGCCGAGCGGAACGGTCCGGCGCAGAGGCTGATCAGCATGACGGACCGCGGCCAGGCGCTTCCGCTGTCGCACGTCCAGGAGCGGCTCTGGTTCGTGCACGAGCACATGGTCGAGCAGCGGAGCAGCTACAACGTTGCCTTCGCCTGCCACATGCGTGGCAAGGGGCTGTCGATGCCGGCGCTGCGCGCCGCCATCAACGGGCTGGTGGCTCGCCACGAGACCTTGCGGACGACGTTCGTCGTCTCCGAGGGCGGAGGAGATCCCGTCCAGCGGATCGCCGACTCCCTGTGGATCGAGGTTCCGCTATATGAGGTCGATGCGTCGGAAGTCCCGGCCCGCATGGCGGCCCACGCGGGCCACGTGTTCGACCTTGCGAAGGGCCCCCTGCTGAAGACCTCGGTCCTGCGGGTGACGCCCGATCACCACGTGTTCTTGATGAACATGCATCACATCATCTGTGATGGGTGGTCGATCGACATCCTGCTGCGGGACCTCTACGAGTTCTACAAGGCGGCCGAGACGGGCTCGCAGCCGAACCTGCCGGTCCTGCCAATCCAGTATGCCGACTACTCCGTGTGGCAGCGTCAGCAGGACCTCAGCAGTCACCTCGACTACTGGAAGAAGACGCTCGAGGGCTACCAGGAAGGGTTGTCGCTTCCGTACGACTTCGCCCGCCCGTCCAACAGGACCTGGCGTGCCGCGAGTGTCCGGCACCAGTACCCGGCGGAACTCGCCACCCGTCTGTCGGAGGTGAGCAAGAGCCATCAGGCGACGGTGTTCATGACGTTGATGGCCAGCACGGCAATCGTGCTGAACCGGTACACGGGTCGGGATGATCTGTGCGTGGGTGCCACGGTGGCGGGCCGTGACCACTTCGAGCTCGAGAACCTGATTGGCTTCTTCGTCAACATCCTCGCCATCAGGCTCGACCTCAGCGGGAATCCCACGGCCGAGACGGTGCTGCAGCGGGCGCGAGCGCAGGTGCTGGAAGGCATGAAGCATCGCGACCTGCCGTTCGAGCACATCCTGGCGGCGCTGCAGAAGCAGCGCGACAGCAGCCAGATTCCCCTGGTGCCGGTGATGGTCCGCCACCAGAACTTCCCGACAGTGACCTCGCAGGAGCAGGGGCTCGACCTGGGTATCGGGGAGATCGAGTTTGGTGAGCGGACGACGCCCAACGAGCTCGACATCCAGTTCATCGGCGAGGGAAGCACGCTGGAGGTGGTGGTCGAGTACGCGAAGGATCTGTTCTCCGAGCGCACGATCCAGCGGCTCATCACGCACTTGCAGCAGGTGCTGCAGACTCTCGTGGACAAGCCGGACTGCCGGCTGACGGATTTTCCGCTGGTGGCCGGGGACGCGCTGCAGGGCGGTGTGTCGGGCTCCGGGGGCGCGACGAAGACCGGCAAGCTCGACGTGTCGAAGAGCCCGGTCGAGTTGTTCAACGAGCGGGTAGAGGCCTCGCCGGACGCGGTCGCCTGCATGGGCGCGGACGGAAGCCTGACCTACCGGGAGCTGGACCGAAGGGCCAATCAGGTCGCCCGCCACCTGATGGGGCGAGGGGTGGGGCGGGAGACGCGGGTGGGGTTGTGGTTCGAGCGCTCGCCGGACCTGCTGGTCGCACTCCTGGGCATACTCAAGGCGGGGGGCTGCTTCGTTCCGCTCGATCCGAGCTATCCGCAGGAGTACATCAACAACATCGTCGCCGATGCGCAGCCGCTTCTGGTGATGTCGAGCCGGGCGCTGGGCTCACGCCTGTCACTGGAGGCAGGGCGGCTGGTGTACCTCGATGACGCGCTGGCGGCGTCCACCGATGCGAGCGATCCCCAGGTGCGCATCGACCCGGAGCAGCTCATCTACGTCATGTACACCTCCGGTTCCACCGGTCTGCCGAAGGGGGTGCTCGTTCCCCATCGGCAGATCCTGAACTGGCTGTACCCGCTGTGGGCGATGGTGCCCTTCGGGCAGGACGAGGTGGTGGCGCAGAAGACATCCACGGCCTTCGCGGTCTCGATGAAGGAGCTCTTCACGGGGCTGCTGGCGGGCGTGCCCCAGGTATTCATCGACGGCACCGTGGTCAAGGACGCGGCGGCCTTCGTGCTCCACCTGGAGCGATGGCGGGTCACCCGGCTGTACACGCTCCCGTCGCACCTCGATGCCATCCTGTCCCACGTCGACGGGGCGGCGGAGCGCCTGCGGTCCCTGCGGCATGTCATCCTCGCGGGGGAGCCGTGCCCCGTTGAGCTGATGGAGAAGCTGCGCGAGACCCTGCCGTCGTGCACGGCGTGGTTCAACTACGGCTGTACCGAGGTCAACGACATCTCCTACTGCGTCCCGAACGAGCAGTTCCACAGCTCGGGGTTCGTGCCGATCGGCCGGCCCATCCAGTACACCCGGGCGCTGGTGCTCGACGACGAGCTGCGGACGGTGCCGGTGGGCATCATGGGGGAGATTTACGTCGAGAGCCCGGGGACGGCGCGGGGCTACTGGAGGCAGCCGGATTTGACGGCCGAGCGGTTCATCCCCAACCCGTTCGGCGAGCCGGGTAGCCGTCTCTACCGTACGGGCGATATGGCGCGATGCCTTGAGGATGGCTCGCTGGAGTTCTTGGGGCGCCGGGACTACGAGGTCAAGATCCGTGGCCATCGCGTGGACGTCCGCCAGGTCGAGAAGATCCTCGCGAGCCACCCGGAAGTCCTCGAGTCGGCGGTGTTGGGCTGGCCACGGGGGGCGAAGAACCCTCAGTTGCTTGCCTACGCCGCCACGAAGCCGGGCCGTCCCCTGTCGACTGAAAACGTGCGGGAGTACCTGTCGGCCCGCTTGCCGACGTACATGGTGCCAACGCTCTACCAGTTCCTGCCAGCGCTGCCGCGCCTGCCCAATGGCAAGCTCGACCGCTTCGGGCTGCCCGATCACAAGAAAGTCGAGGTGGGCGGCGTCTACGTCGCCCCGCAGACGCCGACGGAGAAGGTCTTGGCGGGACTGTGGGCCGAGTGCCTCAAGCAGGGCGACATGCCCGCGCCGCAGGTTGGCCGCTTGCACAACTTCTTCGACCTCGGTGGGCACTCGCTGCTCGCCAATCGCGTACTGATGCAGGTGCAGCGGCATTTCGGGGTCAGCCTGGGCATCAGTGCGTTGTTCGGTTCTCCGGTGCTGAATGACTTCGCGGCGGCCATCGACAAGGCGCTCGGGACCGAGGAGCCAGGCGAGGAAGGTTCGAGCGACGCACGAGAGGTCGCTGCGAAGGACACCTCCGTGCTCGTGCCGCTCTCCACCCACGGGACGCTGCCGAGCCTGTTCTGCGTCCATCCGGTGGGCGGGCAGGTCCATGCCTACCGCGAGCTCGCCCAGGCGATGGAGAAGCACGCCAGCATGTACGCGCTCCAGTCGGAGGGCGCCCGTGAGTTCGACACAATCGAGACCTTGGCGCGCTTCTACGCCGATGCGATCCGCGGGGCTCAGCCCGACGGGAGCTACCGTCTCCTCGGATGGTCTTCTGGTGGGCTCATCACCCTGGCGATTGCTCGCGAGCTGGAGCACCAGGGCTGCGCCGTGGAGTACGTGGGCCTCGTGGATTCAAAGCCAATCCCGCGGTTGGCGGGTGAGCGCGGCTGGGCGTCGCTGATCGCGGCGACGAACATCCTGGGCGCGATGCGGGGGCGCGGCTTCTCGGTCGCCGAGGTCGATGCTGCCGGGAAGATCCTCGAGTCGCGCGGATGGACGGAGGAGTCCTTCGACTCGGAGGGGCATGCGGCGTTGGAGGAGTTGGCTCGGCACTTCGGCATCACCGTCGCGCAAGAGTCATCGGAGTACCTCCTGGCCCGGTTCAAGACCACGAAGTACTACTTGTCGCTGTTCGCTGGCTTCAAGCCGGCGGCGCTCGGGCCGGAGACGTACCTCTATGAGGCTTCAGAGCGGGTCGGAGCCACCTCGAACGACGACACGGGCGAGTGGGGGGACGCGCTGGATCGCAAGGCCCTGCGGGCGAACATCGTGCAGGTGCCAGGCAATCACTATACTGTCCTGCAGGGAGAGAACGTGCTGCAACTGGCGGGGCGGATCGCCGAAGCCTTGTCTGCGATCGACAACTCGGTGGTAACGAGGACGCGAGCTTCGTGA", "orf_prot_sequence": "MATKLSDFALLDSEDANVISRSNETGISLDLSKSVVDLFNLQVERAPDATACLGRQGRLTYGELNRRTNQLAHHLIARGVGPDVPVGVLFERSAEQLIAILGVLKAGGCYVPLDPQYPADYMQQVLTDARPRMVVSSRALGERLRSGEEQIVYLDDEQLLARETRDPPVKVLPEQLAYVMYTSGSSGVPKGVMVPHRQILNWLHALLARVPFGENEVVAQKTSTSFAISVKELFAGLVAGVPQVFIDDATVRDVASFVRELEQWRVTRLYTFPSQLAAILSSVNGAYERLRSLRHLYISIEPCPTELLAKLRAAMPWVTPWYIYGCTEINDVTYCDPGDQAGNTGFVPIGRPIRNTRVFVLDEELRMVPVGAMGEMYVESLSTARGYWGLPELTAERFIANPHAEDGSRLYKTGDLARYLPDGSLEFLGRRDYEVKIRGYRVDVRQVEKVLGAHPDILEVAVVGWPLGGANPQLVAYVVPRAKGAAPIQEIRDYLSASLPAYMVPTIFQVLAALPRLPNDKVDRLSLPDPKVEEQTEGYVAPRTETEKVLAEIWSDVLSQGRAPLTVGATHNFFELGGHSLLAAQMFSRIRQKFDLELPINTLFETPVLEGFASAVDAALAERNGPAQRLISMTDRGQALPLSHVQERLWFVHEHMVEQRSSYNVAFACHMRGKGLSMPALRAAINGLVARHETLRTTFVVSEGGGDPVQRIADSLWIEVPLYEVDASEVPARMAAHAGHVFDLAKGPLLKTSVLRVTPDHHVFLMNMHHIICDGWSIDILLRDLYEFYKAAETGSQPNLPVLPIQYADYSVWQRQQDLSSHLDYWKKTLEGYQEGLSLPYDFARPSNRTWRAASVRHQYPAELATRLSEVSKSHQATVFMTLMASTAIVLNRYTGRDDLCVGATVAGRDHFELENLIGFFVNILAIRLDLSGNPTAETVLQRARAQVLEGMKHRDLPFEHILAALQKQRDSSQIPLVPVMVRHQNFPTVTSQEQGLDLGIGEIEFGERTTPNELDIQFIGEGSTLEVVVEYAKDLFSERTIQRLITHLQQVLQTLVDKPDCRLTDFPLVAGDALQGGVSGSGGATKTGKLDVSKSPVELFNERVEASPDAVACMGADGSLTYRELDRRANQVARHLMGRGVGRETRVGLWFERSPDLLVALLGILKAGGCFVPLDPSYPQEYINNIVADAQPLLVMSSRALGSRLSLEAGRLVYLDDALAASTDASDPQVRIDPEQLIYVMYTSGSTGLPKGVLVPHRQILNWLYPLWAMVPFGQDEVVAQKTSTAFAVSMKELFTGLLAGVPQVFIDGTVVKDAAAFVLHLERWRVTRLYTLPSHLDAILSHVDGAAERLRSLRHVILAGEPCPVELMEKLRETLPSCTAWFNYGCTEVNDISYCVPNEQFHSSGFVPIGRPIQYTRALVLDDELRTVPVGIMGEIYVESPGTARGYWRQPDLTAERFIPNPFGEPGSRLYRTGDMARCLEDGSLEFLGRRDYEVKIRGHRVDVRQVEKILASHPEVLESAVLGWPRGAKNPQLLAYAATKPGRPLSTENVREYLSARLPTYMVPTLYQFLPALPRLPNGKLDRFGLPDHKKVEVGGVYVAPQTPTEKVLAGLWAECLKQGDMPAPQVGRLHNFFDLGGHSLLANRVLMQVQRHFGVSLGISALFGSPVLNDFAAAIDKALGTEEPGEEGSSDAREVAAKDTSVLVPLSTHGTLPSLFCVHPVGGQVHAYRELAQAMEKHASMYALQSEGAREFDTIETLARFYADAIRGAQPDGSYRLLGWSSGGLITLAIARELEHQGCAVEYVGLVDSKPIPRLAGERGWASLIAATNILGAMRGRGFSVAEVDAAGKILESRGWTEESFDSEGHAALEELARHFGITVAQESSEYLLARFKTTKYYLSLFAGFKPAALGPETYLYEASERVGATSNDDTGEWGDALDRKALRANIVQVPGNHYTVLQGENVLQLAGRIAEALSAIDNSVVTRTRAS", "perc_identity": 36.84}, "gnl|BL_ORD_ID|4965|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 16552, "orf_end": 22530, "orf_from": "BGC0001413.1|Cystobactamide_13 ", "model_name": "AAC(6')-I-48", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "275", "model_id": "3338", "ARO_accession": "3004638", "ARO_name": "AAC(6')-I-48", "ARO_category": {"36484": {"category_aro_accession": "3000345", "category_aro_cvterm_id": "36484", "category_aro_name": "AAC(6')", "category_aro_description": "A category of aminoglycoside N-acetyltransferase enzymes with modification regiospecificity based at the 6'-amino group of the respective antibiotic. These enzymes inactivate aminoglycoside antibiotics through acetylation of the 6-amino group of the compound.", "category_aro_class_name": "AMR Gene Family"}, "35926": {"category_aro_accession": "0000007", "category_aro_cvterm_id": "35926", "category_aro_name": "dibekacin", "category_aro_description": "Dibekacin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Dibekacin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35932": {"category_aro_accession": "0000013", "category_aro_cvterm_id": "35932", "category_aro_name": "amikacin", "category_aro_description": "Amikacin is an aminoglycoside antibiotic that works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35953": {"category_aro_accession": "0000035", "category_aro_cvterm_id": "35953", "category_aro_name": "sisomicin", "category_aro_description": "Sisomicin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Sisomicin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35956": {"category_aro_accession": "0000038", "category_aro_cvterm_id": "35956", "category_aro_name": "netilmicin", "category_aro_description": "Netilmicin is a member of the aminoglycoside family of antibiotics. These antibiotics have the ability to kill a wide variety of bacteria by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth. Netilmicin is not absorbed from the gut and is therefore only given by injection or infusion. It is only used in the treatment of serious infections particularly those resistant to gentamicin.", "category_aro_class_name": "Antibiotic"}, "35969": {"category_aro_accession": "0000052", "category_aro_cvterm_id": "35969", "category_aro_name": "tobramycin", "category_aro_description": "Tobramycin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Tobramycin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "46128": {"category_aro_accession": "3007378", "category_aro_cvterm_id": "46128", "category_aro_name": "2'-N-ethylnetilmicin", "category_aro_description": "2'-N-ethylnetilmicin is an aminoglycoside antibiotic and a derivative of netilmicin.", "category_aro_class_name": "Antibiotic"}, "46129": {"category_aro_accession": "3007379", "category_aro_cvterm_id": "46129", "category_aro_name": "5-episisomicin", "category_aro_description": "5-episosomicin is a semisynthetic aminoglycoside antibiotic similar to sisomicin.", "category_aro_class_name": "Antibiotic"}, "35935": {"category_aro_accession": "0000016", "category_aro_cvterm_id": "35935", "category_aro_name": "aminoglycoside antibiotic", "category_aro_description": "Aminoglycosides are a group of antibiotics that are mostly effective against Gram-negative bacteria. These molecules consist of aminated sugars attached to a dibasic cyclitol. Aminoglycosides work by binding to the bacterial 30S ribosomal subunit (some work by binding to the 50S subunit), inhibiting the translocation of the peptidyl-tRNA from the A-site to the P-site and also causing misreading of mRNA, leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.06833, "max_identities": 30, "bit_score": 28.1054, "cvterm_id": "36752", "query": "AQPDGSYRLLGWSSGGLITLAIARELEHQGCAVEYVGLVDSKPIPRLAGERGWASLIAATNILGAMRGRGFSVAEVDAAGKILESRGWTEESFDSE", "match": "A+PD   + L  S GGL     A  L       +YV   +S P+  L G            ++ A RG G + A V AA      RG TE + D+E", "sequence_from_db": "AEPDRFGQFLFLSPGGL-----AEGLVEVALRTDYVNGTESSPVAFLEG----------VFVVPASRGLGIARALVAAAEGWARDRGCTEFASDAE", "sequence_from_broadstreet": "MSKLGPTKPAPSMANTPVGNVVPCKTPDHPGWLELRLQLWPDGSTEEFLPEMAAACAEPDRFGQFLFLSPGGLAEGLVEVALRTDYVNGTESSPVAFLEGVFVVPASRGLGIARALVAAAEGWARDRGCTEFASDAEVSNVGSHAMHAALGFVETERVVFFRKVVAP", "dna_sequence_from_broadstreet": "ATGAGCAAGTTAGGTCCCACTAAACCTGCACCGAGCATGGCGAACACTCCGGTTGGAAACGTCGTGCCATGCAAGACGCCAGATCACCCTGGCTGGCTTGAGTTGCGCCTGCAGCTGTGGCCAGATGGCTCAACCGAGGAGTTCCTTCCCGAGATGGCTGCGGCCTGCGCTGAACCCGACCGCTTCGGCCAGTTTTTGTTCCTGTCGCCGGGCGGCTTGGCGGAGGGCCTGGTCGAGGTGGCGCTTCGCACGGACTACGTCAACGGCACCGAAAGCTCGCCAGTCGCCTTTCTCGAAGGCGTCTTCGTGGTGCCAGCGAGTCGAGGCCTTGGCATCGCCAGAGCGCTGGTGGCTGCGGCGGAAGGCTGGGCTAGAGATCGTGGCTGCACTGAGTTCGCCTCGGACGCCGAGGTCAGCAACGTTGGTAGTCACGCCATGCACGCCGCTCTTGGTTTCGTCGAAACTGAGCGCGTCGTGTTCTTCCGTAAGGTCGTGGCACCGTGA", "partial": "0", "query_start": 21868, "query_end": 22155, "hit_start": 168, "hit_end": 411, "orf_dna_sequence": "ATGGCCACCAAATTGTCTGACTTCGCGCTCCTCGACTCCGAAGACGCCAACGTCATCTCCCGCTCGAACGAGACGGGGATATCGCTGGATCTGTCCAAGAGCGTGGTTGACTTGTTCAACCTCCAGGTCGAGAGGGCGCCTGACGCCACGGCGTGTCTCGGCCGCCAGGGGCGCTTGACTTACGGAGAACTCAACCGGCGGACGAACCAGCTCGCGCATCACCTGATCGCGCGAGGCGTCGGGCCGGATGTTCCCGTGGGCGTCCTGTTCGAGCGCTCCGCCGAGCAGCTCATCGCCATCCTGGGCGTCCTCAAGGCGGGCGGGTGTTATGTCCCGTTGGATCCGCAGTACCCCGCCGATTACATGCAGCAGGTCCTGACGGACGCCCGGCCGCGGATGGTGGTGTCGAGCCGGGCGCTCGGCGAGCGCCTCCGCTCGGGCGAGGAGCAGATCGTCTACCTCGATGACGAACAGCTCCTGGCGCGCGAGACCCGCGACCCGCCTGTGAAGGTGTTGCCGGAGCAGCTCGCGTACGTGATGTACACGTCGGGCTCGTCCGGAGTGCCGAAGGGCGTCATGGTGCCCCATCGCCAGATCCTCAACTGGCTGCATGCACTCCTGGCGCGGGTGCCGTTCGGCGAGAACGAAGTGGTGGCCCAGAAGACGTCCACGTCATTCGCCATCTCAGTGAAGGAACTCTTCGCGGGATTGGTCGCGGGTGTCCCGCAGGTCTTCATCGACGATGCGACTGTCCGCGACGTTGCCAGCTTCGTTCGTGAGCTGGAGCAGTGGCGCGTCACGCGGCTCTATACTTTTCCCTCCCAGCTGGCGGCGATTCTCTCGAGCGTGAATGGCGCGTACGAGCGCCTCCGCTCGCTGCGCCACCTGTACATCTCGATCGAGCCCTGCCCAACAGAGCTGCTGGCGAAGCTCCGGGCGGCGATGCCGTGGGTCACCCCCTGGTACATCTATGGCTGCACCGAGATCAACGACGTCACCTACTGCGACCCAGGGGACCAGGCTGGCAACACGGGCTTCGTGCCGATCGGGCGGCCCATCCGCAACACGCGGGTGTTCGTCCTCGACGAAGAGCTCCGGATGGTGCCCGTCGGCGCGATGGGTGAGATGTACGTGGAGAGCCTGAGCACGGCGCGGGGCTACTGGGGCCTTCCCGAGTTGACGGCGGAGCGGTTCATCGCCAACCCTCACGCGGAGGACGGTTCGCGCCTGTACAAGACAGGCGACCTCGCCCGCTACCTGCCGGATGGTTCCCTGGAGTTCCTCGGGCGCCGGGACTACGAGGTGAAGATCCGCGGGTATCGCGTGGACGTCCGGCAGGTCGAGAAGGTCCTCGGGGCGCATCCCGACATCCTCGAGGTGGCGGTGGTGGGCTGGCCGCTCGGCGGGGCGAATCCACAACTGGTCGCCTACGTCGTGCCGAGGGCGAAGGGGGCTGCTCCCATCCAGGAGATCCGGGACTACCTGTCGGCGTCCCTGCCGGCCTACATGGTGCCGACGATCTTCCAGGTGCTGGCGGCGCTGCCACGTCTTCCCAATGACAAGGTGGATCGGTTGAGCCTGCCCGACCCCAAGGTGGAGGAGCAGACCGAGGGGTACGTGGCGCCTCGCACGGAAACCGAGAAGGTACTGGCCGAAATCTGGAGCGACGTCCTCAGCCAGGGCCGGGCCCCCCTGACCGTCGGCGCGACGCACAACTTTTTCGAACTGGGAGGCCATTCGCTTCTCGCCGCCCAGATGTTCTCGCGGATCCGGCAGAAGTTCGATCTCGAACTGCCCATCAACACCCTGTTCGAGACCCCCGTGCTGGAGGGCTTTGCGAGCGCCGTCGACGCGGCTCTTGCCGAGCGGAACGGTCCGGCGCAGAGGCTGATCAGCATGACGGACCGCGGCCAGGCGCTTCCGCTGTCGCACGTCCAGGAGCGGCTCTGGTTCGTGCACGAGCACATGGTCGAGCAGCGGAGCAGCTACAACGTTGCCTTCGCCTGCCACATGCGTGGCAAGGGGCTGTCGATGCCGGCGCTGCGCGCCGCCATCAACGGGCTGGTGGCTCGCCACGAGACCTTGCGGACGACGTTCGTCGTCTCCGAGGGCGGAGGAGATCCCGTCCAGCGGATCGCCGACTCCCTGTGGATCGAGGTTCCGCTATATGAGGTCGATGCGTCGGAAGTCCCGGCCCGCATGGCGGCCCACGCGGGCCACGTGTTCGACCTTGCGAAGGGCCCCCTGCTGAAGACCTCGGTCCTGCGGGTGACGCCCGATCACCACGTGTTCTTGATGAACATGCATCACATCATCTGTGATGGGTGGTCGATCGACATCCTGCTGCGGGACCTCTACGAGTTCTACAAGGCGGCCGAGACGGGCTCGCAGCCGAACCTGCCGGTCCTGCCAATCCAGTATGCCGACTACTCCGTGTGGCAGCGTCAGCAGGACCTCAGCAGTCACCTCGACTACTGGAAGAAGACGCTCGAGGGCTACCAGGAAGGGTTGTCGCTTCCGTACGACTTCGCCCGCCCGTCCAACAGGACCTGGCGTGCCGCGAGTGTCCGGCACCAGTACCCGGCGGAACTCGCCACCCGTCTGTCGGAGGTGAGCAAGAGCCATCAGGCGACGGTGTTCATGACGTTGATGGCCAGCACGGCAATCGTGCTGAACCGGTACACGGGTCGGGATGATCTGTGCGTGGGTGCCACGGTGGCGGGCCGTGACCACTTCGAGCTCGAGAACCTGATTGGCTTCTTCGTCAACATCCTCGCCATCAGGCTCGACCTCAGCGGGAATCCCACGGCCGAGACGGTGCTGCAGCGGGCGCGAGCGCAGGTGCTGGAAGGCATGAAGCATCGCGACCTGCCGTTCGAGCACATCCTGGCGGCGCTGCAGAAGCAGCGCGACAGCAGCCAGATTCCCCTGGTGCCGGTGATGGTCCGCCACCAGAACTTCCCGACAGTGACCTCGCAGGAGCAGGGGCTCGACCTGGGTATCGGGGAGATCGAGTTTGGTGAGCGGACGACGCCCAACGAGCTCGACATCCAGTTCATCGGCGAGGGAAGCACGCTGGAGGTGGTGGTCGAGTACGCGAAGGATCTGTTCTCCGAGCGCACGATCCAGCGGCTCATCACGCACTTGCAGCAGGTGCTGCAGACTCTCGTGGACAAGCCGGACTGCCGGCTGACGGATTTTCCGCTGGTGGCCGGGGACGCGCTGCAGGGCGGTGTGTCGGGCTCCGGGGGCGCGACGAAGACCGGCAAGCTCGACGTGTCGAAGAGCCCGGTCGAGTTGTTCAACGAGCGGGTAGAGGCCTCGCCGGACGCGGTCGCCTGCATGGGCGCGGACGGAAGCCTGACCTACCGGGAGCTGGACCGAAGGGCCAATCAGGTCGCCCGCCACCTGATGGGGCGAGGGGTGGGGCGGGAGACGCGGGTGGGGTTGTGGTTCGAGCGCTCGCCGGACCTGCTGGTCGCACTCCTGGGCATACTCAAGGCGGGGGGCTGCTTCGTTCCGCTCGATCCGAGCTATCCGCAGGAGTACATCAACAACATCGTCGCCGATGCGCAGCCGCTTCTGGTGATGTCGAGCCGGGCGCTGGGCTCACGCCTGTCACTGGAGGCAGGGCGGCTGGTGTACCTCGATGACGCGCTGGCGGCGTCCACCGATGCGAGCGATCCCCAGGTGCGCATCGACCCGGAGCAGCTCATCTACGTCATGTACACCTCCGGTTCCACCGGTCTGCCGAAGGGGGTGCTCGTTCCCCATCGGCAGATCCTGAACTGGCTGTACCCGCTGTGGGCGATGGTGCCCTTCGGGCAGGACGAGGTGGTGGCGCAGAAGACATCCACGGCCTTCGCGGTCTCGATGAAGGAGCTCTTCACGGGGCTGCTGGCGGGCGTGCCCCAGGTATTCATCGACGGCACCGTGGTCAAGGACGCGGCGGCCTTCGTGCTCCACCTGGAGCGATGGCGGGTCACCCGGCTGTACACGCTCCCGTCGCACCTCGATGCCATCCTGTCCCACGTCGACGGGGCGGCGGAGCGCCTGCGGTCCCTGCGGCATGTCATCCTCGCGGGGGAGCCGTGCCCCGTTGAGCTGATGGAGAAGCTGCGCGAGACCCTGCCGTCGTGCACGGCGTGGTTCAACTACGGCTGTACCGAGGTCAACGACATCTCCTACTGCGTCCCGAACGAGCAGTTCCACAGCTCGGGGTTCGTGCCGATCGGCCGGCCCATCCAGTACACCCGGGCGCTGGTGCTCGACGACGAGCTGCGGACGGTGCCGGTGGGCATCATGGGGGAGATTTACGTCGAGAGCCCGGGGACGGCGCGGGGCTACTGGAGGCAGCCGGATTTGACGGCCGAGCGGTTCATCCCCAACCCGTTCGGCGAGCCGGGTAGCCGTCTCTACCGTACGGGCGATATGGCGCGATGCCTTGAGGATGGCTCGCTGGAGTTCTTGGGGCGCCGGGACTACGAGGTCAAGATCCGTGGCCATCGCGTGGACGTCCGCCAGGTCGAGAAGATCCTCGCGAGCCACCCGGAAGTCCTCGAGTCGGCGGTGTTGGGCTGGCCACGGGGGGCGAAGAACCCTCAGTTGCTTGCCTACGCCGCCACGAAGCCGGGCCGTCCCCTGTCGACTGAAAACGTGCGGGAGTACCTGTCGGCCCGCTTGCCGACGTACATGGTGCCAACGCTCTACCAGTTCCTGCCAGCGCTGCCGCGCCTGCCCAATGGCAAGCTCGACCGCTTCGGGCTGCCCGATCACAAGAAAGTCGAGGTGGGCGGCGTCTACGTCGCCCCGCAGACGCCGACGGAGAAGGTCTTGGCGGGACTGTGGGCCGAGTGCCTCAAGCAGGGCGACATGCCCGCGCCGCAGGTTGGCCGCTTGCACAACTTCTTCGACCTCGGTGGGCACTCGCTGCTCGCCAATCGCGTACTGATGCAGGTGCAGCGGCATTTCGGGGTCAGCCTGGGCATCAGTGCGTTGTTCGGTTCTCCGGTGCTGAATGACTTCGCGGCGGCCATCGACAAGGCGCTCGGGACCGAGGAGCCAGGCGAGGAAGGTTCGAGCGACGCACGAGAGGTCGCTGCGAAGGACACCTCCGTGCTCGTGCCGCTCTCCACCCACGGGACGCTGCCGAGCCTGTTCTGCGTCCATCCGGTGGGCGGGCAGGTCCATGCCTACCGCGAGCTCGCCCAGGCGATGGAGAAGCACGCCAGCATGTACGCGCTCCAGTCGGAGGGCGCCCGTGAGTTCGACACAATCGAGACCTTGGCGCGCTTCTACGCCGATGCGATCCGCGGGGCTCAGCCCGACGGGAGCTACCGTCTCCTCGGATGGTCTTCTGGTGGGCTCATCACCCTGGCGATTGCTCGCGAGCTGGAGCACCAGGGCTGCGCCGTGGAGTACGTGGGCCTCGTGGATTCAAAGCCAATCCCGCGGTTGGCGGGTGAGCGCGGCTGGGCGTCGCTGATCGCGGCGACGAACATCCTGGGCGCGATGCGGGGGCGCGGCTTCTCGGTCGCCGAGGTCGATGCTGCCGGGAAGATCCTCGAGTCGCGCGGATGGACGGAGGAGTCCTTCGACTCGGAGGGGCATGCGGCGTTGGAGGAGTTGGCTCGGCACTTCGGCATCACCGTCGCGCAAGAGTCATCGGAGTACCTCCTGGCCCGGTTCAAGACCACGAAGTACTACTTGTCGCTGTTCGCTGGCTTCAAGCCGGCGGCGCTCGGGCCGGAGACGTACCTCTATGAGGCTTCAGAGCGGGTCGGAGCCACCTCGAACGACGACACGGGCGAGTGGGGGGACGCGCTGGATCGCAAGGCCCTGCGGGCGAACATCGTGCAGGTGCCAGGCAATCACTATACTGTCCTGCAGGGAGAGAACGTGCTGCAACTGGCGGGGCGGATCGCCGAAGCCTTGTCTGCGATCGACAACTCGGTGGTAACGAGGACGCGAGCTTCGTGA", "orf_prot_sequence": "MATKLSDFALLDSEDANVISRSNETGISLDLSKSVVDLFNLQVERAPDATACLGRQGRLTYGELNRRTNQLAHHLIARGVGPDVPVGVLFERSAEQLIAILGVLKAGGCYVPLDPQYPADYMQQVLTDARPRMVVSSRALGERLRSGEEQIVYLDDEQLLARETRDPPVKVLPEQLAYVMYTSGSSGVPKGVMVPHRQILNWLHALLARVPFGENEVVAQKTSTSFAISVKELFAGLVAGVPQVFIDDATVRDVASFVRELEQWRVTRLYTFPSQLAAILSSVNGAYERLRSLRHLYISIEPCPTELLAKLRAAMPWVTPWYIYGCTEINDVTYCDPGDQAGNTGFVPIGRPIRNTRVFVLDEELRMVPVGAMGEMYVESLSTARGYWGLPELTAERFIANPHAEDGSRLYKTGDLARYLPDGSLEFLGRRDYEVKIRGYRVDVRQVEKVLGAHPDILEVAVVGWPLGGANPQLVAYVVPRAKGAAPIQEIRDYLSASLPAYMVPTIFQVLAALPRLPNDKVDRLSLPDPKVEEQTEGYVAPRTETEKVLAEIWSDVLSQGRAPLTVGATHNFFELGGHSLLAAQMFSRIRQKFDLELPINTLFETPVLEGFASAVDAALAERNGPAQRLISMTDRGQALPLSHVQERLWFVHEHMVEQRSSYNVAFACHMRGKGLSMPALRAAINGLVARHETLRTTFVVSEGGGDPVQRIADSLWIEVPLYEVDASEVPARMAAHAGHVFDLAKGPLLKTSVLRVTPDHHVFLMNMHHIICDGWSIDILLRDLYEFYKAAETGSQPNLPVLPIQYADYSVWQRQQDLSSHLDYWKKTLEGYQEGLSLPYDFARPSNRTWRAASVRHQYPAELATRLSEVSKSHQATVFMTLMASTAIVLNRYTGRDDLCVGATVAGRDHFELENLIGFFVNILAIRLDLSGNPTAETVLQRARAQVLEGMKHRDLPFEHILAALQKQRDSSQIPLVPVMVRHQNFPTVTSQEQGLDLGIGEIEFGERTTPNELDIQFIGEGSTLEVVVEYAKDLFSERTIQRLITHLQQVLQTLVDKPDCRLTDFPLVAGDALQGGVSGSGGATKTGKLDVSKSPVELFNERVEASPDAVACMGADGSLTYRELDRRANQVARHLMGRGVGRETRVGLWFERSPDLLVALLGILKAGGCFVPLDPSYPQEYINNIVADAQPLLVMSSRALGSRLSLEAGRLVYLDDALAASTDASDPQVRIDPEQLIYVMYTSGSTGLPKGVLVPHRQILNWLYPLWAMVPFGQDEVVAQKTSTAFAVSMKELFTGLLAGVPQVFIDGTVVKDAAAFVLHLERWRVTRLYTLPSHLDAILSHVDGAAERLRSLRHVILAGEPCPVELMEKLRETLPSCTAWFNYGCTEVNDISYCVPNEQFHSSGFVPIGRPIQYTRALVLDDELRTVPVGIMGEIYVESPGTARGYWRQPDLTAERFIPNPFGEPGSRLYRTGDMARCLEDGSLEFLGRRDYEVKIRGHRVDVRQVEKILASHPEVLESAVLGWPRGAKNPQLLAYAATKPGRPLSTENVREYLSARLPTYMVPTLYQFLPALPRLPNGKLDRFGLPDHKKVEVGGVYVAPQTPTEKVLAGLWAECLKQGDMPAPQVGRLHNFFDLGGHSLLANRVLMQVQRHFGVSLGISALFGSPVLNDFAAAIDKALGTEEPGEEGSSDAREVAAKDTSVLVPLSTHGTLPSLFCVHPVGGQVHAYRELAQAMEKHASMYALQSEGAREFDTIETLARFYADAIRGAQPDGSYRLLGWSSGGLITLAIARELEHQGCAVEYVGLVDSKPIPRLAGERGWASLIAATNILGAMRGRGFSVAEVDAAGKILESRGWTEESFDSEGHAALEELARHFGITVAQESSEYLLARFKTTKYYLSLFAGFKPAALGPETYLYEASERVGATSNDDTGEWGDALDRKALRANIVQVPGNHYTVLQGENVLQLAGRIAEALSAIDNSVVTRTRAS", "perc_identity": 31.25}}, "BGC0001413.1|Cystobactamide_14 # 22598 # 25525 # 1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.618": {"gnl|BL_ORD_ID|4935|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 22598, "orf_end": 25525, "orf_from": "BGC0001413.1|Cystobactamide_14 ", "model_name": "almE", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1000", "model_id": "5928", "ARO_accession": "3007433", "ARO_name": "almE", "ARO_category": {"46184": {"category_aro_accession": "3007428", "category_aro_cvterm_id": "46184", "category_aro_name": "polymyxin resistance operon", "category_aro_description": "Operon or gene clusters confering resistance to polymyxin antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "46188": {"category_aro_accession": "3007432", "category_aro_cvterm_id": "46188", "category_aro_name": "alm glycyltransferase", "category_aro_description": "Glycyl transferase associated with polymyxin resistance operons not interacting with lipid A.", "category_aro_class_name": "AMR Gene Family"}, "36966": {"category_aro_accession": "3000622", "category_aro_cvterm_id": "36966", "category_aro_name": "colistin A", "category_aro_description": "Colistin A, or polymyxin E1, has a 6-octanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "36968": {"category_aro_accession": "3000624", "category_aro_cvterm_id": "36968", "category_aro_name": "colistin B", "category_aro_description": "Colistin B, or polymyxin E2, has a 6-heptanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "36192": {"category_aro_accession": "3000053", "category_aro_cvterm_id": "36192", "category_aro_name": "peptide antibiotic", "category_aro_description": "Peptide antibiotics have a wide range of antibacterial mechanisms, depending on the amino acids that make up the antibiotic, although most act to disrupt the cell membrane in some manner. Subclasses of peptide antibiotics can include additional sidechains of other types, such as lipids in the case of the lipopeptide antibiotics.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.73939e-32, "max_identities": 126, "bit_score": 129.028, "cvterm_id": "36789", "query": "LFELQADRIPDAVAARAGNESLTYRELNFRANQLARYLVAKGVVPRGSVAVLMNRTPACLVSLLAIIKAGAAYVPVDAGLPAKRVDYILTDSGATCVLTDRET----RSLLDE--PRSASTLVIDVDDPSIYSGETSNLGLAVDPEQQ-----------------VYCIYTSGSTGLPKGVMVQHRALMNYVWWAKKQYVTDAVESFALYSSLSFDLTVTSIFVPLISGRCIDVYPDLGEDVPVINRVLEDNKVDVVKLTPA--HLALLRNTDLSQS--RLKVLILGGEDLRAETAGDVHKRLDGRAVIYNEYGPTETVVGCMIHRYDPAVDLHGSVPIGVGIDNMRIYLLDD-----RRRPVKPGEVGEIYIGGDGVTLGYKDKPQVTADHFISNPFVEGERLYASGDLGRVNERGALVFLGRKDLQIKLRGYRIELGEIESAL", "match": "L  +QA+R   A A     ++ TY+E+   A  L+ Y   +GV     VA+L  R  A   ++ A    G  Y+P++A    +++   L  +    ++ D +      SLLD    R     + DVD   +      +    V   +Q                  Y + TSGSTG PK + V +  L  Y+    K +  +A +    YS L+FDL+V  IF  LISG C+ V P+L +  P     +  +++ V    P    LAL R T    S   L++    G+ L  + A +  ++   + VI N YGPTE  +    HR+     +  SVPIG   +   + ++++     R      G  GE+ + G  +  GY + P  T   F  +   EG   Y SGD+      G L+ LGR+D Q+K+ G R+EL EIE+ +", "sequence_from_db": "LAAIQANR--HAPALWVKQKTYTYQEMTDMALSLSDYWHLQGV---QRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPA--EFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLA-EQWQQATQQPVI-NLYGPTECTIAITYHRFVAHSGM-ASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQH---EGRIWYRSGDI-VTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVV", "sequence_from_broadstreet": "MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH", "dna_sequence_from_broadstreet": "ATGCCATACAATTCTGCGACAGATTTGTTACAGAGAGAGGGTTATGGTGTCGTGCATAACCAATTTATCAATAAAATGGCGATGTGCTGCGAGACAAGACACTCTATTTTGGCGGCCATTCAGGCTAACCGACATGCCCCTGCATTATGGGTTAAACAGAAAACCTACACCTATCAAGAGATGACCGATATGGCACTCTCATTGAGTGACTATTGGCATTTACAGGGCGTGCAGCGAGTTGCGATCCTTTCGGTACGCGATCTCGCGGCTTATTCTGCGATTTGGGCGAGCTATTTGGGCGGTATGACTTATATTCCGCTCAATGCGCGAGCAACAACAGAACAGATCCAAGAGACGCTGATCGCGACACAATGTGATTCCATCATGGTAGACGCGCAGCAATTGAGTCGTTTGTCCTCCTTACTAGATACTTGCATTGACCGATTACACATTTATGCGCTGCCTGATGTGGATATGGAACCGTTACGTCAGCAATATCCTCAGCACACTTTTCACACAGTGCAAATAACCGAACAAGATGTGGAATTACTGGTAGCGAAATACCATTTAGACAATGAACATGAGTACGCTTATATCATGCAAACCTCAGGTTCGACTGGTAAACCCAAACGTATTGCGGTCAGCTACAGTAATTTGCATTGCTATATCAGTCAAATTGACAAACTATTTCCACTCAATGCGCAAGATCGAGTGGGGCAATATTCTGATTTGACTTTTGATCTTTCGGTACATGATATTTTTTACAGTTTGATCTCTGGTGCTTGTTTATATGTTGTGCCTGAATTAGCGAAATTAAGTCCAGCGGAATTTATTCGTCACCATCAATTAACGGTATGGCTTTCTGTGCCTACTGTTATTGAGTTGGCCCTACAAAGACAAACCTTAACCCCACACAGTTTACCTTCTCTGCGACTGAGTTTTTTCTGCGGACAAGCCTTGCTGCATGATTTAGCCGAACAATGGCAACAGGCCACCCAGCAGCCGGTGATCAATCTGTATGGTCCAACAGAGTGCACGATTGCTATTACCTATCATCGATTTGTCGCCCATTCAGGTATGGCATCGGTGCCGATTGGCCGTGCTTTTGAAGAGGAGTGTTTAGCCATCATCAACGAACAAGGTGAATTGATGCGCTTTGAATCTGCACCCGAGGGGTATCGCGGAGAATTACTTCTGTCGGGCAAACAATTAGTCAATGGTTATCTGAATGATCCGCTGAATACGCAAAGTGCCTTTTTCCAGCACGAAGGGCGTATTTGGTATCGTTCAGGTGACATTGTCACTAAATCAAATGGCGTGCTGATTCATCTTGGGCGTCGCGATCACCAAGTGAAAATTGCCGGACAACGGGTGGAATTAGAAGAGATTGAAACCGTTGTTCGCCGCGTGACTCAAGCGCACAGCGTGGCGATAGTGCCTTGGCCTTTAAGTGAGTCGGGCTATGCCAGCGGCACGGTGGCGTTTGTGGATACCCATACCCAATGGCAACCAGATCTGTGGTTGAGCCAATGCAAACAACAATTAAATCCAACTTTTGTGCCTAAGCGTTGGTATGCCATTGAACAATTACCAAGAAATGCCAATGGCAAAACCGATATTAAAGCTTTACAACAACAATTAGCGAGTCAGACATATGAAACAAGCCATTGA", "partial": "0", "query_start": 22706, "query_end": 23944, "hit_start": 108, "hit_end": 1401, "orf_dna_sequence": "ATGGACAATCGAGAGATCGCACCCACCCAATCGGCGCGCACGCGTGATGCGTACACGGCGGTACCACCAGCCAAGGCCGAGTATCCGTCGGACGTCTGTGTGCACCAACTGTTCGAGTTGCAGGCGGACAGGATTCCCGACGCCGTTGCGGCGAGGGCGGGGAACGAGTCCCTGACCTACCGGGAGCTGAACTTCCGGGCGAATCAGCTCGCCCGGTACCTTGTTGCGAAAGGCGTGGTCCCGCGAGGCTCGGTGGCCGTGCTGATGAACCGGACCCCTGCGTGTCTGGTCTCACTGCTCGCCATCATCAAGGCGGGCGCGGCGTACGTTCCGGTGGACGCCGGATTGCCCGCCAAACGGGTGGACTACATTCTGACGGACAGCGGCGCGACCTGCGTCCTGACCGACAGGGAGACGCGGTCACTCCTCGACGAGCCGCGGTCGGCTTCGACGCTCGTCATCGACGTGGATGATCCATCCATCTATTCGGGCGAGACCAGCAACCTCGGGCTCGCTGTCGATCCCGAGCAGCAGGTCTACTGCATCTACACCTCGGGTTCGACGGGCCTTCCCAAAGGCGTGATGGTCCAGCACCGCGCGCTGATGAACTACGTCTGGTGGGCGAAGAAGCAGTACGTCACCGACGCGGTCGAGAGTTTTGCCCTGTACTCCTCGTTGTCGTTCGACCTCACGGTCACCTCCATCTTCGTTCCGCTGATCTCCGGACGCTGCATCGATGTGTACCCGGACCTGGGCGAGGACGTCCCCGTCATCAACCGGGTACTGGAGGACAATAAGGTCGATGTCGTGAAGCTCACGCCGGCCCACCTTGCCCTGCTCAGGAACACGGACCTATCGCAAAGCCGGCTGAAAGTGCTCATCCTGGGAGGAGAGGACCTCCGAGCGGAGACGGCGGGGGACGTCCACAAGCGGCTGGACGGCCGGGCGGTGATCTACAACGAGTACGGCCCCACGGAGACCGTCGTGGGGTGCATGATTCACCGCTACGACCCCGCGGTGGATCTGCACGGGTCGGTGCCGATTGGAGTGGGCATCGACAACATGCGGATCTACTTGCTCGACGACCGTCGGCGTCCCGTCAAGCCAGGAGAGGTTGGCGAGATTTACATCGGAGGCGACGGTGTGACCCTGGGGTACAAGGACAAGCCTCAAGTCACGGCGGACCACTTCATCTCCAATCCGTTCGTGGAAGGGGAGCGGTTGTACGCCAGTGGCGACCTCGGCCGGGTGAATGAGCGCGGCGCGCTCGTCTTCCTCGGCCGGAAGGATTTGCAGATCAAGCTGCGGGGGTACCGGATCGAGCTGGGCGAGATCGAGAGCGCCCTTCTCTCCTATCCGGGGATCAAGGAATGCATCGTCGATTCGACCAAGACCGCGCAGAGCCAGGCCGCCGCTCAGCTCACCTACTGCACCAAGTGTGGTCTGGCGTCGAGCTTCCCGAATACGACGTACTCCGCCGAGGGGGTCTGCAACCACTGCGAGGCCTTCGACAAGTACCGCAGCGTCGTCGACGACTACTTCAGCACGATGGATGAGCTGCAGTCGATCGTCACCGAGATGAAGAGCATCCACAACTCGAAGTACGACTGCATCGTGGCGCTCAGCGGCGGAAAAGACAGCACGTATGCACTCTGCCGGATGATCGAAACCGGTGCCCGTGTATTGGCCTTCACGTTGGATAACGGCTACATCTCGGAGGAGGCGAAGCAGAACATCAACCGGGTCGTTGCCCGGCTGGGAGTGGATCACCGCTATCTCTCGACCGGCCACATGAAGGAGATCTTCGTCGACAGCCTGAAGCGACACAGCAATGTGTGCAACGGCTGCTTCAAGACCATCTACACGTTTGCGATCAACCTGGCGCAGGAGGTCGGCGTCAAGCACGTGGTCATGGGGTTGTCAAAGGGCCAACTGTTCGAAACGCGCCTCTCGGCCTTGTTCCGCACGTCGACCTTCGACAACGCCGCCTTCGAGAAGAGCCTCGTCGACGCGCGAAAGATCTACCATCGCATCGATGATGCCGTGAGCCGCCTGCTCGACACTACTTGCGTCAAGAACGACAAGGTCATCGAGAACATCAGGTTCGTGGACTTCTATCGTTATTGCCACGCCAGCCGTCAGGAGATGTACGACTACATCCAGGAGAGAGTCGGGTGGGCCAGGCCGATTGACACCGGGCGGTCGACGAACTGTCTCCTCAATGATGTTGGCATCTACGTTCACAACAAGGAGCGCAGGTACCACAACTACTCCCTGCCCTACAGCTGGGACGTCCGGATGGGCCACATCAGCAGGGAAGAGGCGATGAGAGAGCTCGACGACTCGGCCGACATCGACGTCGAGAGGGTCGAGGGCATCATCAAGGACCTTGGCTACGAGCTGAACGACCAGGTGGTGGGCTCGGCGGAAGCCCAGCTGGTCGCCTACTATGTCTCCGCGGAGGAGTTCCCCGCGTCCGACCTGCGGCAGTTCCTGTCGGAGATTCTGCCGGAGTACATGGTACCCAGGTCGTTCGTCCAGCTGGACAGCATCCCGCTGACGCCCAATGGCAAGGTCAATCGTCAGGCCCTGCCGAAGCCTGACCTGCTTCGGAAGGCCGGCACCGACGGACAAGCCGCACCCCGAACACCGGTGGAGAAGCAGTTGGCGGAGCTGTGGAAGGAGGTGCTGCAGGTCGACAGTGTCGGGATCCACGACAACTTCTTCGAGATGGGCGGGCACTCGCTTCCGGCGCTCATGCTGCTCTACAAGATCGACAGTCAGTTCCATAAGACGATCAGCATCCAGGAGTTCTCGAAGGTCCCCACCATCAGCGCGCTCGCGGCGCATCTCGGCAGTGACACCGAAGCGGTGCCGCCAGGGCTGGGCGAGGTCGTCGATCAGAGCGCGCCTGCATACAGGGGATAA", "orf_prot_sequence": "MDNREIAPTQSARTRDAYTAVPPAKAEYPSDVCVHQLFELQADRIPDAVAARAGNESLTYRELNFRANQLARYLVAKGVVPRGSVAVLMNRTPACLVSLLAIIKAGAAYVPVDAGLPAKRVDYILTDSGATCVLTDRETRSLLDEPRSASTLVIDVDDPSIYSGETSNLGLAVDPEQQVYCIYTSGSTGLPKGVMVQHRALMNYVWWAKKQYVTDAVESFALYSSLSFDLTVTSIFVPLISGRCIDVYPDLGEDVPVINRVLEDNKVDVVKLTPAHLALLRNTDLSQSRLKVLILGGEDLRAETAGDVHKRLDGRAVIYNEYGPTETVVGCMIHRYDPAVDLHGSVPIGVGIDNMRIYLLDDRRRPVKPGEVGEIYIGGDGVTLGYKDKPQVTADHFISNPFVEGERLYASGDLGRVNERGALVFLGRKDLQIKLRGYRIELGEIESALLSYPGIKECIVDSTKTAQSQAAAQLTYCTKCGLASSFPNTTYSAEGVCNHCEAFDKYRSVVDDYFSTMDELQSIVTEMKSIHNSKYDCIVALSGGKDSTYALCRMIETGARVLAFTLDNGYISEEAKQNINRVVARLGVDHRYLSTGHMKEIFVDSLKRHSNVCNGCFKTIYTFAINLAQEVGVKHVVMGLSKGQLFETRLSALFRTSTFDNAAFEKSLVDARKIYHRIDDAVSRLLDTTCVKNDKVIENIRFVDFYRYCHASRQEMYDYIQERVGWARPIDTGRSTNCLLNDVGIYVHNKERRYHNYSLPYSWDVRMGHISREEAMRELDDSADIDVERVEGIIKDLGYELNDQVVGSAEAQLVAYYVSAEEFPASDLRQFLSEILPEYMVPRSFVQLDSIPLTPNGKVNRQALPKPDLLRKAGTDGQAAPRTPVEKQLAELWKEVLQVDSVGIHDNFFEMGGHSLPALMLLYKIDSQFHKTISIQEFSKVPTISALAAHLGSDTEAVPPGLGEVVDQSAPAYRG", "perc_identity": 28.31}}, "BGC0001413.1|Cystobactamide_17 # 27422 # 41059 # 1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.661": {"gnl|BL_ORD_ID|4935|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 27422, "orf_end": 41059, "orf_from": "BGC0001413.1|Cystobactamide_17 ", "model_name": "almE", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1000", "model_id": "5928", "ARO_accession": "3007433", "ARO_name": "almE", "ARO_category": {"46184": {"category_aro_accession": "3007428", "category_aro_cvterm_id": "46184", "category_aro_name": "polymyxin resistance operon", "category_aro_description": "Operon or gene clusters confering resistance to polymyxin antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "46188": {"category_aro_accession": "3007432", "category_aro_cvterm_id": "46188", "category_aro_name": "alm glycyltransferase", "category_aro_description": "Glycyl transferase associated with polymyxin resistance operons not interacting with lipid A.", "category_aro_class_name": "AMR Gene Family"}, "36966": {"category_aro_accession": "3000622", "category_aro_cvterm_id": "36966", "category_aro_name": "colistin A", "category_aro_description": "Colistin A, or polymyxin E1, has a 6-octanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "36968": {"category_aro_accession": "3000624", "category_aro_cvterm_id": "36968", "category_aro_name": "colistin B", "category_aro_description": "Colistin B, or polymyxin E2, has a 6-heptanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "36192": {"category_aro_accession": "3000053", "category_aro_cvterm_id": "36192", "category_aro_name": "peptide antibiotic", "category_aro_description": "Peptide antibiotics have a wide range of antibacterial mechanisms, depending on the amino acids that make up the antibiotic, although most act to disrupt the cell membrane in some manner. Subclasses of peptide antibiotics can include additional sidechains of other types, such as lipids in the case of the lipopeptide antibiotics.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.15585e-30, "max_identities": 132, "bit_score": 126.716, "cvterm_id": "36789", "query": "RQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGSYIEQ---------ILEDAAPQVVLGKRGRADGVRVDVW---------LELDGAQRLTDEALAAQEEGELEGAER--PESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELN-DVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQ-----LRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSRE", "match": "+  TY+++   A  ++      GV    RVA+LS R      A+ A +  G  Y+P++ +     I++         I+ DA     L         R+ ++         L     Q         +++ EL  A+       + A +M TSGSTG+PK + V YS LH ++    +  PL   + + Q + + F +SV ++   L++G    +VPE L K  ++ A+ I   ++T    VP+ +   L+        L SL+     G+AL   + E+ ++      + N YG TE    +TYH      G    VPIGR      + +++EQ         P G  GEL +    +  GY   P  T   F  +      G   YR+GD+V   ++G L +LGRRD+++K+ G RV++ ++E V           +  WPL  S                 P        + L    VP  +  +E+LPR  NGK D  +L +   S + E", "sequence_from_db": "KTYTYQEMTDMALSLSDYWHLQGV---QRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPE-LAK--LSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVI-NLYGPTECTIAITYHRFVAHSG-MASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQH-----EGRIWYRSGDIV-TKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYE", "sequence_from_broadstreet": "MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH", "dna_sequence_from_broadstreet": "ATGCCATACAATTCTGCGACAGATTTGTTACAGAGAGAGGGTTATGGTGTCGTGCATAACCAATTTATCAATAAAATGGCGATGTGCTGCGAGACAAGACACTCTATTTTGGCGGCCATTCAGGCTAACCGACATGCCCCTGCATTATGGGTTAAACAGAAAACCTACACCTATCAAGAGATGACCGATATGGCACTCTCATTGAGTGACTATTGGCATTTACAGGGCGTGCAGCGAGTTGCGATCCTTTCGGTACGCGATCTCGCGGCTTATTCTGCGATTTGGGCGAGCTATTTGGGCGGTATGACTTATATTCCGCTCAATGCGCGAGCAACAACAGAACAGATCCAAGAGACGCTGATCGCGACACAATGTGATTCCATCATGGTAGACGCGCAGCAATTGAGTCGTTTGTCCTCCTTACTAGATACTTGCATTGACCGATTACACATTTATGCGCTGCCTGATGTGGATATGGAACCGTTACGTCAGCAATATCCTCAGCACACTTTTCACACAGTGCAAATAACCGAACAAGATGTGGAATTACTGGTAGCGAAATACCATTTAGACAATGAACATGAGTACGCTTATATCATGCAAACCTCAGGTTCGACTGGTAAACCCAAACGTATTGCGGTCAGCTACAGTAATTTGCATTGCTATATCAGTCAAATTGACAAACTATTTCCACTCAATGCGCAAGATCGAGTGGGGCAATATTCTGATTTGACTTTTGATCTTTCGGTACATGATATTTTTTACAGTTTGATCTCTGGTGCTTGTTTATATGTTGTGCCTGAATTAGCGAAATTAAGTCCAGCGGAATTTATTCGTCACCATCAATTAACGGTATGGCTTTCTGTGCCTACTGTTATTGAGTTGGCCCTACAAAGACAAACCTTAACCCCACACAGTTTACCTTCTCTGCGACTGAGTTTTTTCTGCGGACAAGCCTTGCTGCATGATTTAGCCGAACAATGGCAACAGGCCACCCAGCAGCCGGTGATCAATCTGTATGGTCCAACAGAGTGCACGATTGCTATTACCTATCATCGATTTGTCGCCCATTCAGGTATGGCATCGGTGCCGATTGGCCGTGCTTTTGAAGAGGAGTGTTTAGCCATCATCAACGAACAAGGTGAATTGATGCGCTTTGAATCTGCACCCGAGGGGTATCGCGGAGAATTACTTCTGTCGGGCAAACAATTAGTCAATGGTTATCTGAATGATCCGCTGAATACGCAAAGTGCCTTTTTCCAGCACGAAGGGCGTATTTGGTATCGTTCAGGTGACATTGTCACTAAATCAAATGGCGTGCTGATTCATCTTGGGCGTCGCGATCACCAAGTGAAAATTGCCGGACAACGGGTGGAATTAGAAGAGATTGAAACCGTTGTTCGCCGCGTGACTCAAGCGCACAGCGTGGCGATAGTGCCTTGGCCTTTAAGTGAGTCGGGCTATGCCAGCGGCACGGTGGCGTTTGTGGATACCCATACCCAATGGCAACCAGATCTGTGGTTGAGCCAATGCAAACAACAATTAAATCCAACTTTTGTGCCTAAGCGTTGGTATGCCATTGAACAATTACCAAGAAATGCCAATGGCAAAACCGATATTAAAGCTTTACAACAACAATTAGCGAGTCAGACATATGAAACAAGCCATTGA", "partial": "0", "query_start": 28298, "query_end": 29761, "hit_start": 159, "hit_end": 1659, "orf_dna_sequence": "ATGCTGCTGGAGGGAGAGCTGGAGGGGTACGAGGACGGGTTGGAACTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGCATAGCTACCCGCCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCGAGGACGTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGGGGCGTTGGGGGATCTGAGCGGGTCCACCGTCGACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGCGGTGGTGCTGGAGGGATTCGAGCACGAGGCGTTGCCGTGCCAGATTCCCTTGGTGCCGGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAAGAGGATGGTGGAGCACCACCAGCGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGTGCGGCTGCACGAGGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGAAGCTACATCGAGCAGATACTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGCTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGAGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGACCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCGGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGCTGCCGAACGGGAAGCTGGACCGGTTGTCGCTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAGCCTCGGCGGGCACTCCCTCCTGGCTGCCCAGCTGATTTCGCGCATACGGGCGACCTTCCGCGTGGAAGTGGCGATGGCCACGGTGTTCGAGTCCCCCACGGTGGAGCCGCTCGCCCGCCACATCGAGGAGAAGCTCAAGGACGAGTCTCGGGTCCAGCTCTCCAACGTTGTGCCGGTCGAGCGGACGCAGGAGATTCCGCTCTCCTACCTGCAGGAGCGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACATCACCTGGACGTTGCACTTCGCCGGCAAGGGTTTCTCGGTGGAGGCGTTGCGGACGGCCTTCGATGAGCTGGTGGCCAGACACGAGACACTGCGCACGTGGTTCCAGGTGGGGGAGGGGACAGAGCAGGCCGTACAGGTCATCGGGGAGCCCTGGTCGATGGAGCTGCCGCTGAGAGAGGTGGCGGGGACGGAGGTGACGGCGGCAATCAATGAGATGTCCCGACAGGTCTTCGACTTGAGAGCGGGACGGTTGCTGACGGCGGCGGTCCTGAGGGTGGCGGAGGATGAGCACATCCTCGTCAGCAACATCCACCACATCATCACGGACGGCTGGTCGTTCGGGGTGATGCTGCGGGAGCTGAGGGAGTTGTACGAGGCAGCGGTGCGGGGGAAGAGAGCGGAGCTGCCGCCGCTGACGGTGCAGTACGGCGACTATGCGGTGTGGCAGAGGAAGCAGGACCTGAGCGAGCACCTGGCGTACTGGAAGGGGAAGGTGGAGGAGTACGAGGACGGGTTGGAGCTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGTATAGCTACCCACCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCCAGGACGTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGAGCTGGAGAGCCTCATCGGGTTCTTCATCAACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGCGGTGGTGCTGGAGGGATTCGAGCACCAGGAGTTGCCGTTCGAGCACCTGCTGAAGGCGCTGAGGCGGCAGCGGGACAGCAGCCAGATTCCCTTGGTGCCAGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAGGAGGATGGTGGAGCACCACCAGCGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGGGCTGCACGAGGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGACACTACATCGAGCAGATATTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGTTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGGGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGGCCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCAGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGTTGCCGAACGGGAAGCTGGACCGGCTGTCGTTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAGCCTCGGCGGGCACTCCCTCCTGGCTGCCCAGGTGGTCTCAAGGATTGGCAAGGAGCTTGGCACTCAGATCTCGATCGCCGATCTGTTTCAAAGGCCCACGATTGAACAGCTCTGTGAGCTGATTGGAGGACTGGACGATCAGACCCAGAGGGAGCTCGCCCTCGCTCCGTCGGGGAACACCGAGGCGGTGCTCTCGTTCGCGCAAGAGCGCATGTGGTTCCTGCACAACTTCGTCAAGGGCATGCCCTACAACACGCCAGGGCTCGACCACCTGACGGGTGAGCTCGATGTCGCGGCGCTAGAAAAGGCCATCCGCGCGGTCATCCGTCGCCACGAGCCCCTGCGGACGAATTTCGTCGAGAAGGACGGGGTGCTGTCCCAGTTGGTGGGGACGGAAGAACGCTTCCGCCTGACCGTGACTCCCATCCGCGACGAGAGCGAGGTCGCGCGGCTCATGGAAGCCGTGATCCAAACGCCAGTCGATCTGGAGCGGGAGTTGATGATCCGGGCTTATCTCTACCGGGTCGACCCGCGGAATCACTACCTGTTCACCACCATCCATCACATCGCCTTCGATGGCTGGTCGACATCGATCTTCTACCGTGAGCTGGCTGCGTACTACGCCGCGTTTCTCCGGCGCGAAGACAGTCCGCTGCCCGCGCTGGAAATCTCCTATCAGGACTATGCCCGCTGGGAGCGGGCCCATTTCCAGGACGAGGTGTTGGCGGAAAAACTGAGGTACTGGCGGCAGCGGCTGTCGGGCGCTCGGCCCCTCGTACTTCCGACCACCTACCATCGGCCGCCCATCCAGAGTTTCGCTGGCGCCGTCGTGAACTTCGAGATCGATCGCTCCATCACCGAGCGGTTGAAGACGCTGTTCGCCGAGTCGGGCACCACGATGTACATGGTGTTGCTCGGCGCGTTCTCCGTGGTGCTGCAGCGCTACTCCGGTCAGGACGACATCTGCATCGGCTCCCCCGTGGCGAACCGGGGTCACATCCAGACAGAAGGGCTGATCGGCTTGTTCGTCAACACCCTGGTGATGAGGGTGGATGCCGCCGGGAATCCCCGTTTCATCGACCTGCTGGCGCGCATTCAACGGACAGCCATCGATGCTTACGCGAACCAAGAAGTGCCCTTCGAGAAGATCGTGGACGACCTGCAGGTCGCGAGAGACACGGCCCGATCTCCGCTCGTGCAGGTCATTCTCAACTTCCACAACACGCCTCCTCAATCCGAGCTGGAACTGCAGGGGGTGACCCTCACGCGGATGCCGGTGCACAACGGCACGGCCAAGTTCGAGCTCTCCATCGACGTCGCGGAGACGAGCGCCGGTCTAACGGGATTCGTGGAGTACGCGACGGATCTGTTCAGCGAGAACTTCATCCGGCGGATGATCGGCCACCTCGAGGTGGTGCTGGACGCGGTCGGTCGCGATCCGCGGGCGCCTATCCATGAGTTGCCACTGCTCACCCGGCAGGATCAGTTGGACCTACTGTCGCGGAGCGGCCACACAGCCCCCGCGGTGGAACACGTCGAGTTGATCCCTCATACGTTCGAGCGGCGCGTCCAGGAGAGCCCTCAAGCGATTGCCCTGGTCTGCGGTGACGAGCGCGTCACCTACTCCGCGCTCAACCGCCGGGCCAGCCAGATTGCCCGCCGCCTGCGCGCCGCAGGGATCGGACCGGACACCCTCGTCGGGCTTTGCGCGGGGCGCTCCATCGAGCTGGTCTGCGGCGTCCTTGGCATCTTGAAGGCGGGCGGTGCGTACGTGCCAATCGACCCCACCTCCTCGCCCGAGGTGATCTACGACGTCCTGTATGAGTCGAAGGTGCGGCATCTGTTGACCGAGTCGCGCCTGGTCGGGGGACTGCCGGTCGATGACCAGGAAATCCTGCTCCTGGATACCCCCGCGGACGGTGAAGGGGACAAGGCTGTTGCTGACCGGGAGGAGCCACCTGACCTTGGCGAGGTCAGCCTCACTCCCGAGTGCTTGGCGTACGTCAACTTCACCTCCGACTCCGGTGGGGCGCCGAGGGGCATCGCCGTCCGCCATGGGGCGCTGGCTCGCCGGATGGCCGCCGGCCACGCACAGTACCTGGCCAATTCCGCCGTACGTTTCCTGCTGAAGGCGCCGCTCACGTTCGACCTGGCGGTCGCGGAGCTGTTCCAGTGGATCGTCAGCGGCGGCAGCCTGAGCATCCTCGACCCCAATGCCGACCGCGACGCCTCTGCCTTCCTCGCGCAGGTGCGCAGGGACTCGATTGGCGTCCTCTACTGCGTCCCCTCCGAACTCTCGACGCTGGTGAGCCACCTGGAGCGCGAGCGTGAAAGGGTGCATGAGCTGAACACCCTCCGGTTCATCTTCTGCGGCGGGGATACCCTGGCGGTTACCGTCGTCGAGCGTCTCGGGGTACTGGTGCGGGCCGGCCAGCTCCCGCTGCGGCTGGTCAACGTCTATGGGACGAAGGAGACGGGAATCGGCGCGGGTTGCTTCGAGTGCGCGCTGGACGCGAACGACCCCAGCGCCGAACTCCCGCCGGGACGGCTCTCGCATGAGCGGATGCCCATCGGCGGGCCCGCCCAGAACCTGTGGTTCTATGTGGTGCAACCCAACGGTGGCCTGGCTCCGTTGGGCATCCCGGGGGAACTGTACGTCGGCGGCGCGCAACTCGCCGACGCCCGTTTCGGCGACGAGCCCACGGCGACCCACCCCGGCTTCGTCCCGAACCCCTTCCGGAGCGGAGCGGAGAAGGACTGGCTGTACAAGACGGGGGACCTCGTCCGCTGGCTGCCTCAGGGGCCGCTCGAGCTGGTCAGCGCGGCTCGGGAGCGCGACGGAGGCGGGGACCACCGGCTCGATCGCGGCTTCATCGAGGCGCGCATGCGTCGTGTGGCCATTGTCCGCGACGCCGTGGTGGCCTACGTCCCGGATCGCCAGGACAGGGCCCGGTTGGTGGCCTACGTCGTTCTGAAGGAGTCGCCCGCGGCGGACGTGGAGCCGCGCGAAGGGCGGGAAACGCTGAAGGCTCGGATCAGCGCCGAACTTGGGAGCACGTTGCCGGAGTACATGCTTCCGGCCGCCTACGTGTTCATGGACAGCCTGCCGTTGACGGCTTACGGGAGGATCGACCGGAAAGCCCTGCCCGAGCCGGAGGATGACCGCCACGGTGGTAGTGCGATCGCCTACGTGGCCCCGCGCGGGCCCACGGAGAAGGCACTGGCGCACATTTGGCAGCAAGTGCTGAAACGCCCCCAGGTCGGACTGCGAGACAACTTCTTTGAGCTGGGCGGGCACTCAGTGGCGGCCATCCAACTGGTGTCCGTGAGCCGGAAGCACCTGGAGGTCGAAGTCCCCCTCAGCCTGATCTTCGAATCGCCGGTCCTGGAGGCGATGGCGCGCGGCATCGAAGCGCTGCAACAGCAGGGCCGCAGCGGCGCGGTGTCGTCGATCCATCGGGTGGAGCGGACCGGACCGCTGCCTCTGGCGTACGTGCAGGAGAGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACATCACCTGGACGTTGCACTTCGCCGGCAAGGGTTTCTCGGTGGAGGCGTTGCGGACGGCCTTCGATGAGCTGGTGGCCAGACACGAGACACTGCGCACGTGGTTCCAGGTGGGGGAGGGGACAGAGCAGGCCGTACAGGTCATCGGGGAGCCCTGGTCGATGGAGCTGCCGCTGAGAGAGGTGGCGGGGACGGAGGTGACGGCGGCAATCAATGAGATGTCCCGGCAGGTCTTCGACTTGAGAGCGGGACGGTTGCTGACGGCGGCGGTCCTGAGGGTGGCGGAGGATGAGCACATCCTCGTCAGCAACATCCACCACATCATCACGGACGGCTGGTCGTTCGGGGTGATGCTGCGGGAGCTGAGGGAGTTGTACGAGGCCGCGGTGCGGGGGGAGCGAGCGGAGCTGCCGCCGCTGACGGTGCAGTACGGCGACTATGCGGTATGGCAGAGGAAGCAGGACCTGAGCGAGCACCTGGCGTACTGGAAGGGGAAGGTGGAGGGGGACGAGGACGGGTTGGAGCTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGTATAGCTACCACCCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCGAGGACCTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGAACTGGAGAGCCTCATCGGGTTCTTCATCAACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGTGGTGGTGCTGGAGGGATTCGAGCACCAGGAGTTGCCGTTCGAGCACCTGCTGAAGGCGCTGAGGCGGCAGCGGGACAGCAGCCAGATTCCCTTGGTGCCAGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAGGAGGATGGTGGAGCACCACCAACGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGGGCTGCACGAAGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGAAGCTACATCGAGCAGATACTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGCTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGAGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGACCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCAGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGTTGCCGAACGGGAAGCTGGACCGGCTGTCGTTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAACCTCGGCGGGCACTCCCTCCTGGCTTCCCAGCTGATTTCGCGCATACGGGCGACCTTCCGCGTGGAAGTGGCGATGGCCACGGTGTTCGAGTCCCCCACGGTGGAGCCGCTCGCCCGCCACATCGAGGAGAAGCTCAAGGACGAGTCTCGGGTCCAGCTCTCCAACGTTGTGCCGGTCGAGCGGACGCAGGAGCTTCCGCTCTCCTACCTGCAGGAGAGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACGGAACGATCGGGCTCCGGCTTCGGGGTCCTCTGTCAATCCCCGCGCTCAGGGCCACCTTCCACGATCTGGTCGCCCGTCACGAGAGCCTGCGCACCGTCTTCCGGGTCCCCGAAGGCCGCACCACGCCGGTGCAGGTGATTCTTGATTCGATGGATCTGGACATCCCGGTCCGCGATGCAACCGAGGCCGACATCATCCCGGGCATGGATGAGCTGGCGGGTCACATCTACGACATGGAGAAGGGTCCGCTGTTCATGGTTCGCCTCTTGCGGCTGGCCGAGGACTCCCACGTTCTCCTGATGGGGATGCATCACATCGTCTACGACGCATGGTCACAGTTCAATGTGATGAGTCGCGATATCAACCTGCTCTACTCGGCGCACGTGACGGGAATCGAGGCACGGCTTCCCGCGCTTCCCATCCAGTACGCCGACTTCTCGGTGTGGCAGCGCCAGCAGGACTTCCGTCACCACCTGGACTACTGGAAGTCCACACTGGGCGACTACCGGGATGATCTCGAGCTGCCGTATGACTACCCGCGGCCGCCCAGCCGGACATGGCACGCGACCCGATTCACCTTCCGGTATCCGGATGCACTGGCGCGCGCGTTCGCCAGGTTCAATCAGTCCCATCAGTCGACGCTGTTCATGGGGCTGCTGACCAGCTTCGCGATCGTGCTCAGGCACTACACCGGCCGGAACGACATCTGCATCGGAACGACAACGGCGGGGCGCGCCCAGTTGGAGTTGGAGAACCTCGTTGGCTTCTTCATCAACATCCTGCCGTTGCGCATCAATCTGGCGGGTGACCCCGACATCAGCGAGCTCATGAATCGAGCGAAGAAGAGCGTCTTGGGCGCCTTCGAGCATCAAGCTCTGCCGTTCGAGCGTCTCCTCAGTGCCCTCAACAAACAGCGTGACAGCAGCCATATCCCGCTGGTTCCCGTCATGTTGCGCCACCAGAACTTCCCGACGGCGATGACCGGCAAGTGGGCCGATGGTGTGGACATGGAGGTCATCGAGCGCGACGAGCGCACGACGCCCAACGAGCTGGACCTCCAGTTCTTTGGCGACGACACCTACTTGCATGCTGTCGTCGAGTTCCCCGCGCAGCTCTTCTCCGAGGTGACCGTCCGGCGTCTGATGCAGCGTCACCAGAAGGTCATAGAGTTCATGTGCGCGACGCTGGGGGCTCGGTGA", "orf_prot_sequence": "MLLEGELEGYEDGLELPYDFPRTSNRAWRAATFQHSYPPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGREDVCIGTTVAGRAQVGALGDLSGSTVDILPLRLDLSGAPSLHEVLRRTKAVVLEGFEHEALPCQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVKRMVEHHQRVLEALVEGLEEVRLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGSYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFSLGGHSLLAAQLISRIRATFRVEVAMATVFESPTVEPLARHIEEKLKDESRVQLSNVVPVERTQEIPLSYLQERLWFVHEHMKEQRTSYNITWTLHFAGKGFSVEALRTAFDELVARHETLRTWFQVGEGTEQAVQVIGEPWSMELPLREVAGTEVTAAINEMSRQVFDLRAGRLLTAAVLRVAEDEHILVSNIHHIITDGWSFGVMLRELRELYEAAVRGKRAELPPLTVQYGDYAVWQRKQDLSEHLAYWKGKVEEYEDGLELPYDFPRTSNRAWRAATFQYSYPPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGRQDVCIGTTVAGRAQVELESLIGFFINILPLRLDLSGAPSLHEVLRRTKAVVLEGFEHQELPFEHLLKALRRQRDSSQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVRRMVEHHQRVLEALVEGLEEGLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGHYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFSLGGHSLLAAQVVSRIGKELGTQISIADLFQRPTIEQLCELIGGLDDQTQRELALAPSGNTEAVLSFAQERMWFLHNFVKGMPYNTPGLDHLTGELDVAALEKAIRAVIRRHEPLRTNFVEKDGVLSQLVGTEERFRLTVTPIRDESEVARLMEAVIQTPVDLERELMIRAYLYRVDPRNHYLFTTIHHIAFDGWSTSIFYRELAAYYAAFLRREDSPLPALEISYQDYARWERAHFQDEVLAEKLRYWRQRLSGARPLVLPTTYHRPPIQSFAGAVVNFEIDRSITERLKTLFAESGTTMYMVLLGAFSVVLQRYSGQDDICIGSPVANRGHIQTEGLIGLFVNTLVMRVDAAGNPRFIDLLARIQRTAIDAYANQEVPFEKIVDDLQVARDTARSPLVQVILNFHNTPPQSELELQGVTLTRMPVHNGTAKFELSIDVAETSAGLTGFVEYATDLFSENFIRRMIGHLEVVLDAVGRDPRAPIHELPLLTRQDQLDLLSRSGHTAPAVEHVELIPHTFERRVQESPQAIALVCGDERVTYSALNRRASQIARRLRAAGIGPDTLVGLCAGRSIELVCGVLGILKAGGAYVPIDPTSSPEVIYDVLYESKVRHLLTESRLVGGLPVDDQEILLLDTPADGEGDKAVADREEPPDLGEVSLTPECLAYVNFTSDSGGAPRGIAVRHGALARRMAAGHAQYLANSAVRFLLKAPLTFDLAVAELFQWIVSGGSLSILDPNADRDASAFLAQVRRDSIGVLYCVPSELSTLVSHLERERERVHELNTLRFIFCGGDTLAVTVVERLGVLVRAGQLPLRLVNVYGTKETGIGAGCFECALDANDPSAELPPGRLSHERMPIGGPAQNLWFYVVQPNGGLAPLGIPGELYVGGAQLADARFGDEPTATHPGFVPNPFRSGAEKDWLYKTGDLVRWLPQGPLELVSAARERDGGGDHRLDRGFIEARMRRVAIVRDAVVAYVPDRQDRARLVAYVVLKESPAADVEPREGRETLKARISAELGSTLPEYMLPAAYVFMDSLPLTAYGRIDRKALPEPEDDRHGGSAIAYVAPRGPTEKALAHIWQQVLKRPQVGLRDNFFELGGHSVAAIQLVSVSRKHLEVEVPLSLIFESPVLEAMARGIEALQQQGRSGAVSSIHRVERTGPLPLAYVQERLWFVHEHMKEQRTSYNITWTLHFAGKGFSVEALRTAFDELVARHETLRTWFQVGEGTEQAVQVIGEPWSMELPLREVAGTEVTAAINEMSRQVFDLRAGRLLTAAVLRVAEDEHILVSNIHHIITDGWSFGVMLRELRELYEAAVRGERAELPPLTVQYGDYAVWQRKQDLSEHLAYWKGKVEGDEDGLELPYDFPRTSNRAWRAATFQYSYHPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGREDLCIGTTVAGRAQVELESLIGFFINILPLRLDLSGAPSLHEVLRRTKVVVLEGFEHQELPFEHLLKALRRQRDSSQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVRRMVEHHQRVLEALVEGLEEGLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGSYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFNLGGHSLLASQLISRIRATFRVEVAMATVFESPTVEPLARHIEEKLKDESRVQLSNVVPVERTQELPLSYLQERLWFVHEHMKEQRTSYNGTIGLRLRGPLSIPALRATFHDLVARHESLRTVFRVPEGRTTPVQVILDSMDLDIPVRDATEADIIPGMDELAGHIYDMEKGPLFMVRLLRLAEDSHVLLMGMHHIVYDAWSQFNVMSRDINLLYSAHVTGIEARLPALPIQYADFSVWQRQQDFRHHLDYWKSTLGDYRDDLELPYDYPRPPSRTWHATRFTFRYPDALARAFARFNQSHQSTLFMGLLTSFAIVLRHYTGRNDICIGTTTAGRAQLELENLVGFFINILPLRINLAGDPDISELMNRAKKSVLGAFEHQALPFERLLSALNKQRDSSHIPLVPVMLRHQNFPTAMTGKWADGVDMEVIERDERTTPNELDLQFFGDDTYLHAVVEFPAQLFSEVTVRRLMQRHQKVIEFMCATLGAR", "perc_identity": 25.68}, "gnl|BL_ORD_ID|4935|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 27422, "orf_end": 41059, "orf_from": "BGC0001413.1|Cystobactamide_17 ", "model_name": "almE", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1000", "model_id": "5928", "ARO_accession": "3007433", "ARO_name": "almE", "ARO_category": {"46184": {"category_aro_accession": "3007428", "category_aro_cvterm_id": "46184", "category_aro_name": "polymyxin resistance operon", "category_aro_description": "Operon or gene clusters confering resistance to polymyxin antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "46188": {"category_aro_accession": "3007432", "category_aro_cvterm_id": "46188", "category_aro_name": "alm glycyltransferase", "category_aro_description": "Glycyl transferase associated with polymyxin resistance operons not interacting with lipid A.", "category_aro_class_name": "AMR Gene Family"}, "36966": {"category_aro_accession": "3000622", "category_aro_cvterm_id": "36966", "category_aro_name": "colistin A", "category_aro_description": "Colistin A, or polymyxin E1, has a 6-octanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "36968": {"category_aro_accession": "3000624", "category_aro_cvterm_id": "36968", "category_aro_name": "colistin B", "category_aro_description": "Colistin B, or polymyxin E2, has a 6-heptanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "36192": {"category_aro_accession": "3000053", "category_aro_cvterm_id": "36192", "category_aro_name": "peptide antibiotic", "category_aro_description": "Peptide antibiotics have a wide range of antibacterial mechanisms, depending on the amino acids that make up the antibiotic, although most act to disrupt the cell membrane in some manner. Subclasses of peptide antibiotics can include additional sidechains of other types, such as lipids in the case of the lipopeptide antibiotics.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.15585e-30, "max_identities": 132, "bit_score": 126.716, "cvterm_id": "36789", "query": "RQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGSYIEQ---------ILEDAAPQVVLGKRGRADGVRVDVW---------LELDGAQRLTDEALAAQEEGELEGAER--PESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELN-DVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQ-----LRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSRE", "match": "+  TY+++   A  ++      GV    RVA+LS R      A+ A +  G  Y+P++ +     I++         I+ DA     L         R+ ++         L     Q         +++ EL  A+       + A +M TSGSTG+PK + V YS LH ++    +  PL   + + Q + + F +SV ++   L++G    +VPE L K  ++ A+ I   ++T    VP+ +   L+        L SL+     G+AL   + E+ ++      + N YG TE    +TYH      G    VPIGR      + +++EQ         P G  GEL +    +  GY   P  T   F  +      G   YR+GD+V   ++G L +LGRRD+++K+ G RV++ ++E V           +  WPL  S                 P        + L    VP  +  +E+LPR  NGK D  +L +   S + E", "sequence_from_db": "KTYTYQEMTDMALSLSDYWHLQGV---QRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPE-LAK--LSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVI-NLYGPTECTIAITYHRFVAHSG-MASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQH-----EGRIWYRSGDIV-TKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYE", "sequence_from_broadstreet": "MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH", "dna_sequence_from_broadstreet": "ATGCCATACAATTCTGCGACAGATTTGTTACAGAGAGAGGGTTATGGTGTCGTGCATAACCAATTTATCAATAAAATGGCGATGTGCTGCGAGACAAGACACTCTATTTTGGCGGCCATTCAGGCTAACCGACATGCCCCTGCATTATGGGTTAAACAGAAAACCTACACCTATCAAGAGATGACCGATATGGCACTCTCATTGAGTGACTATTGGCATTTACAGGGCGTGCAGCGAGTTGCGATCCTTTCGGTACGCGATCTCGCGGCTTATTCTGCGATTTGGGCGAGCTATTTGGGCGGTATGACTTATATTCCGCTCAATGCGCGAGCAACAACAGAACAGATCCAAGAGACGCTGATCGCGACACAATGTGATTCCATCATGGTAGACGCGCAGCAATTGAGTCGTTTGTCCTCCTTACTAGATACTTGCATTGACCGATTACACATTTATGCGCTGCCTGATGTGGATATGGAACCGTTACGTCAGCAATATCCTCAGCACACTTTTCACACAGTGCAAATAACCGAACAAGATGTGGAATTACTGGTAGCGAAATACCATTTAGACAATGAACATGAGTACGCTTATATCATGCAAACCTCAGGTTCGACTGGTAAACCCAAACGTATTGCGGTCAGCTACAGTAATTTGCATTGCTATATCAGTCAAATTGACAAACTATTTCCACTCAATGCGCAAGATCGAGTGGGGCAATATTCTGATTTGACTTTTGATCTTTCGGTACATGATATTTTTTACAGTTTGATCTCTGGTGCTTGTTTATATGTTGTGCCTGAATTAGCGAAATTAAGTCCAGCGGAATTTATTCGTCACCATCAATTAACGGTATGGCTTTCTGTGCCTACTGTTATTGAGTTGGCCCTACAAAGACAAACCTTAACCCCACACAGTTTACCTTCTCTGCGACTGAGTTTTTTCTGCGGACAAGCCTTGCTGCATGATTTAGCCGAACAATGGCAACAGGCCACCCAGCAGCCGGTGATCAATCTGTATGGTCCAACAGAGTGCACGATTGCTATTACCTATCATCGATTTGTCGCCCATTCAGGTATGGCATCGGTGCCGATTGGCCGTGCTTTTGAAGAGGAGTGTTTAGCCATCATCAACGAACAAGGTGAATTGATGCGCTTTGAATCTGCACCCGAGGGGTATCGCGGAGAATTACTTCTGTCGGGCAAACAATTAGTCAATGGTTATCTGAATGATCCGCTGAATACGCAAAGTGCCTTTTTCCAGCACGAAGGGCGTATTTGGTATCGTTCAGGTGACATTGTCACTAAATCAAATGGCGTGCTGATTCATCTTGGGCGTCGCGATCACCAAGTGAAAATTGCCGGACAACGGGTGGAATTAGAAGAGATTGAAACCGTTGTTCGCCGCGTGACTCAAGCGCACAGCGTGGCGATAGTGCCTTGGCCTTTAAGTGAGTCGGGCTATGCCAGCGGCACGGTGGCGTTTGTGGATACCCATACCCAATGGCAACCAGATCTGTGGTTGAGCCAATGCAAACAACAATTAAATCCAACTTTTGTGCCTAAGCGTTGGTATGCCATTGAACAATTACCAAGAAATGCCAATGGCAAAACCGATATTAAAGCTTTACAACAACAATTAGCGAGTCAGACATATGAAACAAGCCATTGA", "partial": "0", "query_start": 38027, "query_end": 39490, "hit_start": 159, "hit_end": 1659, "orf_dna_sequence": "ATGCTGCTGGAGGGAGAGCTGGAGGGGTACGAGGACGGGTTGGAACTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGCATAGCTACCCGCCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCGAGGACGTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGGGGCGTTGGGGGATCTGAGCGGGTCCACCGTCGACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGCGGTGGTGCTGGAGGGATTCGAGCACGAGGCGTTGCCGTGCCAGATTCCCTTGGTGCCGGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAAGAGGATGGTGGAGCACCACCAGCGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGTGCGGCTGCACGAGGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGAAGCTACATCGAGCAGATACTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGCTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGAGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGACCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCGGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGCTGCCGAACGGGAAGCTGGACCGGTTGTCGCTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAGCCTCGGCGGGCACTCCCTCCTGGCTGCCCAGCTGATTTCGCGCATACGGGCGACCTTCCGCGTGGAAGTGGCGATGGCCACGGTGTTCGAGTCCCCCACGGTGGAGCCGCTCGCCCGCCACATCGAGGAGAAGCTCAAGGACGAGTCTCGGGTCCAGCTCTCCAACGTTGTGCCGGTCGAGCGGACGCAGGAGATTCCGCTCTCCTACCTGCAGGAGCGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACATCACCTGGACGTTGCACTTCGCCGGCAAGGGTTTCTCGGTGGAGGCGTTGCGGACGGCCTTCGATGAGCTGGTGGCCAGACACGAGACACTGCGCACGTGGTTCCAGGTGGGGGAGGGGACAGAGCAGGCCGTACAGGTCATCGGGGAGCCCTGGTCGATGGAGCTGCCGCTGAGAGAGGTGGCGGGGACGGAGGTGACGGCGGCAATCAATGAGATGTCCCGACAGGTCTTCGACTTGAGAGCGGGACGGTTGCTGACGGCGGCGGTCCTGAGGGTGGCGGAGGATGAGCACATCCTCGTCAGCAACATCCACCACATCATCACGGACGGCTGGTCGTTCGGGGTGATGCTGCGGGAGCTGAGGGAGTTGTACGAGGCAGCGGTGCGGGGGAAGAGAGCGGAGCTGCCGCCGCTGACGGTGCAGTACGGCGACTATGCGGTGTGGCAGAGGAAGCAGGACCTGAGCGAGCACCTGGCGTACTGGAAGGGGAAGGTGGAGGAGTACGAGGACGGGTTGGAGCTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGTATAGCTACCCACCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCCAGGACGTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGAGCTGGAGAGCCTCATCGGGTTCTTCATCAACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGCGGTGGTGCTGGAGGGATTCGAGCACCAGGAGTTGCCGTTCGAGCACCTGCTGAAGGCGCTGAGGCGGCAGCGGGACAGCAGCCAGATTCCCTTGGTGCCAGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAGGAGGATGGTGGAGCACCACCAGCGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGGGCTGCACGAGGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGACACTACATCGAGCAGATATTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGTTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGGGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGGCCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCAGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGTTGCCGAACGGGAAGCTGGACCGGCTGTCGTTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAGCCTCGGCGGGCACTCCCTCCTGGCTGCCCAGGTGGTCTCAAGGATTGGCAAGGAGCTTGGCACTCAGATCTCGATCGCCGATCTGTTTCAAAGGCCCACGATTGAACAGCTCTGTGAGCTGATTGGAGGACTGGACGATCAGACCCAGAGGGAGCTCGCCCTCGCTCCGTCGGGGAACACCGAGGCGGTGCTCTCGTTCGCGCAAGAGCGCATGTGGTTCCTGCACAACTTCGTCAAGGGCATGCCCTACAACACGCCAGGGCTCGACCACCTGACGGGTGAGCTCGATGTCGCGGCGCTAGAAAAGGCCATCCGCGCGGTCATCCGTCGCCACGAGCCCCTGCGGACGAATTTCGTCGAGAAGGACGGGGTGCTGTCCCAGTTGGTGGGGACGGAAGAACGCTTCCGCCTGACCGTGACTCCCATCCGCGACGAGAGCGAGGTCGCGCGGCTCATGGAAGCCGTGATCCAAACGCCAGTCGATCTGGAGCGGGAGTTGATGATCCGGGCTTATCTCTACCGGGTCGACCCGCGGAATCACTACCTGTTCACCACCATCCATCACATCGCCTTCGATGGCTGGTCGACATCGATCTTCTACCGTGAGCTGGCTGCGTACTACGCCGCGTTTCTCCGGCGCGAAGACAGTCCGCTGCCCGCGCTGGAAATCTCCTATCAGGACTATGCCCGCTGGGAGCGGGCCCATTTCCAGGACGAGGTGTTGGCGGAAAAACTGAGGTACTGGCGGCAGCGGCTGTCGGGCGCTCGGCCCCTCGTACTTCCGACCACCTACCATCGGCCGCCCATCCAGAGTTTCGCTGGCGCCGTCGTGAACTTCGAGATCGATCGCTCCATCACCGAGCGGTTGAAGACGCTGTTCGCCGAGTCGGGCACCACGATGTACATGGTGTTGCTCGGCGCGTTCTCCGTGGTGCTGCAGCGCTACTCCGGTCAGGACGACATCTGCATCGGCTCCCCCGTGGCGAACCGGGGTCACATCCAGACAGAAGGGCTGATCGGCTTGTTCGTCAACACCCTGGTGATGAGGGTGGATGCCGCCGGGAATCCCCGTTTCATCGACCTGCTGGCGCGCATTCAACGGACAGCCATCGATGCTTACGCGAACCAAGAAGTGCCCTTCGAGAAGATCGTGGACGACCTGCAGGTCGCGAGAGACACGGCCCGATCTCCGCTCGTGCAGGTCATTCTCAACTTCCACAACACGCCTCCTCAATCCGAGCTGGAACTGCAGGGGGTGACCCTCACGCGGATGCCGGTGCACAACGGCACGGCCAAGTTCGAGCTCTCCATCGACGTCGCGGAGACGAGCGCCGGTCTAACGGGATTCGTGGAGTACGCGACGGATCTGTTCAGCGAGAACTTCATCCGGCGGATGATCGGCCACCTCGAGGTGGTGCTGGACGCGGTCGGTCGCGATCCGCGGGCGCCTATCCATGAGTTGCCACTGCTCACCCGGCAGGATCAGTTGGACCTACTGTCGCGGAGCGGCCACACAGCCCCCGCGGTGGAACACGTCGAGTTGATCCCTCATACGTTCGAGCGGCGCGTCCAGGAGAGCCCTCAAGCGATTGCCCTGGTCTGCGGTGACGAGCGCGTCACCTACTCCGCGCTCAACCGCCGGGCCAGCCAGATTGCCCGCCGCCTGCGCGCCGCAGGGATCGGACCGGACACCCTCGTCGGGCTTTGCGCGGGGCGCTCCATCGAGCTGGTCTGCGGCGTCCTTGGCATCTTGAAGGCGGGCGGTGCGTACGTGCCAATCGACCCCACCTCCTCGCCCGAGGTGATCTACGACGTCCTGTATGAGTCGAAGGTGCGGCATCTGTTGACCGAGTCGCGCCTGGTCGGGGGACTGCCGGTCGATGACCAGGAAATCCTGCTCCTGGATACCCCCGCGGACGGTGAAGGGGACAAGGCTGTTGCTGACCGGGAGGAGCCACCTGACCTTGGCGAGGTCAGCCTCACTCCCGAGTGCTTGGCGTACGTCAACTTCACCTCCGACTCCGGTGGGGCGCCGAGGGGCATCGCCGTCCGCCATGGGGCGCTGGCTCGCCGGATGGCCGCCGGCCACGCACAGTACCTGGCCAATTCCGCCGTACGTTTCCTGCTGAAGGCGCCGCTCACGTTCGACCTGGCGGTCGCGGAGCTGTTCCAGTGGATCGTCAGCGGCGGCAGCCTGAGCATCCTCGACCCCAATGCCGACCGCGACGCCTCTGCCTTCCTCGCGCAGGTGCGCAGGGACTCGATTGGCGTCCTCTACTGCGTCCCCTCCGAACTCTCGACGCTGGTGAGCCACCTGGAGCGCGAGCGTGAAAGGGTGCATGAGCTGAACACCCTCCGGTTCATCTTCTGCGGCGGGGATACCCTGGCGGTTACCGTCGTCGAGCGTCTCGGGGTACTGGTGCGGGCCGGCCAGCTCCCGCTGCGGCTGGTCAACGTCTATGGGACGAAGGAGACGGGAATCGGCGCGGGTTGCTTCGAGTGCGCGCTGGACGCGAACGACCCCAGCGCCGAACTCCCGCCGGGACGGCTCTCGCATGAGCGGATGCCCATCGGCGGGCCCGCCCAGAACCTGTGGTTCTATGTGGTGCAACCCAACGGTGGCCTGGCTCCGTTGGGCATCCCGGGGGAACTGTACGTCGGCGGCGCGCAACTCGCCGACGCCCGTTTCGGCGACGAGCCCACGGCGACCCACCCCGGCTTCGTCCCGAACCCCTTCCGGAGCGGAGCGGAGAAGGACTGGCTGTACAAGACGGGGGACCTCGTCCGCTGGCTGCCTCAGGGGCCGCTCGAGCTGGTCAGCGCGGCTCGGGAGCGCGACGGAGGCGGGGACCACCGGCTCGATCGCGGCTTCATCGAGGCGCGCATGCGTCGTGTGGCCATTGTCCGCGACGCCGTGGTGGCCTACGTCCCGGATCGCCAGGACAGGGCCCGGTTGGTGGCCTACGTCGTTCTGAAGGAGTCGCCCGCGGCGGACGTGGAGCCGCGCGAAGGGCGGGAAACGCTGAAGGCTCGGATCAGCGCCGAACTTGGGAGCACGTTGCCGGAGTACATGCTTCCGGCCGCCTACGTGTTCATGGACAGCCTGCCGTTGACGGCTTACGGGAGGATCGACCGGAAAGCCCTGCCCGAGCCGGAGGATGACCGCCACGGTGGTAGTGCGATCGCCTACGTGGCCCCGCGCGGGCCCACGGAGAAGGCACTGGCGCACATTTGGCAGCAAGTGCTGAAACGCCCCCAGGTCGGACTGCGAGACAACTTCTTTGAGCTGGGCGGGCACTCAGTGGCGGCCATCCAACTGGTGTCCGTGAGCCGGAAGCACCTGGAGGTCGAAGTCCCCCTCAGCCTGATCTTCGAATCGCCGGTCCTGGAGGCGATGGCGCGCGGCATCGAAGCGCTGCAACAGCAGGGCCGCAGCGGCGCGGTGTCGTCGATCCATCGGGTGGAGCGGACCGGACCGCTGCCTCTGGCGTACGTGCAGGAGAGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACATCACCTGGACGTTGCACTTCGCCGGCAAGGGTTTCTCGGTGGAGGCGTTGCGGACGGCCTTCGATGAGCTGGTGGCCAGACACGAGACACTGCGCACGTGGTTCCAGGTGGGGGAGGGGACAGAGCAGGCCGTACAGGTCATCGGGGAGCCCTGGTCGATGGAGCTGCCGCTGAGAGAGGTGGCGGGGACGGAGGTGACGGCGGCAATCAATGAGATGTCCCGGCAGGTCTTCGACTTGAGAGCGGGACGGTTGCTGACGGCGGCGGTCCTGAGGGTGGCGGAGGATGAGCACATCCTCGTCAGCAACATCCACCACATCATCACGGACGGCTGGTCGTTCGGGGTGATGCTGCGGGAGCTGAGGGAGTTGTACGAGGCCGCGGTGCGGGGGGAGCGAGCGGAGCTGCCGCCGCTGACGGTGCAGTACGGCGACTATGCGGTATGGCAGAGGAAGCAGGACCTGAGCGAGCACCTGGCGTACTGGAAGGGGAAGGTGGAGGGGGACGAGGACGGGTTGGAGCTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGTATAGCTACCACCCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCGAGGACCTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGAACTGGAGAGCCTCATCGGGTTCTTCATCAACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGTGGTGGTGCTGGAGGGATTCGAGCACCAGGAGTTGCCGTTCGAGCACCTGCTGAAGGCGCTGAGGCGGCAGCGGGACAGCAGCCAGATTCCCTTGGTGCCAGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAGGAGGATGGTGGAGCACCACCAACGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGGGCTGCACGAAGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGAAGCTACATCGAGCAGATACTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGCTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGAGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGACCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCAGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGTTGCCGAACGGGAAGCTGGACCGGCTGTCGTTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAACCTCGGCGGGCACTCCCTCCTGGCTTCCCAGCTGATTTCGCGCATACGGGCGACCTTCCGCGTGGAAGTGGCGATGGCCACGGTGTTCGAGTCCCCCACGGTGGAGCCGCTCGCCCGCCACATCGAGGAGAAGCTCAAGGACGAGTCTCGGGTCCAGCTCTCCAACGTTGTGCCGGTCGAGCGGACGCAGGAGCTTCCGCTCTCCTACCTGCAGGAGAGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACGGAACGATCGGGCTCCGGCTTCGGGGTCCTCTGTCAATCCCCGCGCTCAGGGCCACCTTCCACGATCTGGTCGCCCGTCACGAGAGCCTGCGCACCGTCTTCCGGGTCCCCGAAGGCCGCACCACGCCGGTGCAGGTGATTCTTGATTCGATGGATCTGGACATCCCGGTCCGCGATGCAACCGAGGCCGACATCATCCCGGGCATGGATGAGCTGGCGGGTCACATCTACGACATGGAGAAGGGTCCGCTGTTCATGGTTCGCCTCTTGCGGCTGGCCGAGGACTCCCACGTTCTCCTGATGGGGATGCATCACATCGTCTACGACGCATGGTCACAGTTCAATGTGATGAGTCGCGATATCAACCTGCTCTACTCGGCGCACGTGACGGGAATCGAGGCACGGCTTCCCGCGCTTCCCATCCAGTACGCCGACTTCTCGGTGTGGCAGCGCCAGCAGGACTTCCGTCACCACCTGGACTACTGGAAGTCCACACTGGGCGACTACCGGGATGATCTCGAGCTGCCGTATGACTACCCGCGGCCGCCCAGCCGGACATGGCACGCGACCCGATTCACCTTCCGGTATCCGGATGCACTGGCGCGCGCGTTCGCCAGGTTCAATCAGTCCCATCAGTCGACGCTGTTCATGGGGCTGCTGACCAGCTTCGCGATCGTGCTCAGGCACTACACCGGCCGGAACGACATCTGCATCGGAACGACAACGGCGGGGCGCGCCCAGTTGGAGTTGGAGAACCTCGTTGGCTTCTTCATCAACATCCTGCCGTTGCGCATCAATCTGGCGGGTGACCCCGACATCAGCGAGCTCATGAATCGAGCGAAGAAGAGCGTCTTGGGCGCCTTCGAGCATCAAGCTCTGCCGTTCGAGCGTCTCCTCAGTGCCCTCAACAAACAGCGTGACAGCAGCCATATCCCGCTGGTTCCCGTCATGTTGCGCCACCAGAACTTCCCGACGGCGATGACCGGCAAGTGGGCCGATGGTGTGGACATGGAGGTCATCGAGCGCGACGAGCGCACGACGCCCAACGAGCTGGACCTCCAGTTCTTTGGCGACGACACCTACTTGCATGCTGTCGTCGAGTTCCCCGCGCAGCTCTTCTCCGAGGTGACCGTCCGGCGTCTGATGCAGCGTCACCAGAAGGTCATAGAGTTCATGTGCGCGACGCTGGGGGCTCGGTGA", "orf_prot_sequence": "MLLEGELEGYEDGLELPYDFPRTSNRAWRAATFQHSYPPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGREDVCIGTTVAGRAQVGALGDLSGSTVDILPLRLDLSGAPSLHEVLRRTKAVVLEGFEHEALPCQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVKRMVEHHQRVLEALVEGLEEVRLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGSYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFSLGGHSLLAAQLISRIRATFRVEVAMATVFESPTVEPLARHIEEKLKDESRVQLSNVVPVERTQEIPLSYLQERLWFVHEHMKEQRTSYNITWTLHFAGKGFSVEALRTAFDELVARHETLRTWFQVGEGTEQAVQVIGEPWSMELPLREVAGTEVTAAINEMSRQVFDLRAGRLLTAAVLRVAEDEHILVSNIHHIITDGWSFGVMLRELRELYEAAVRGKRAELPPLTVQYGDYAVWQRKQDLSEHLAYWKGKVEEYEDGLELPYDFPRTSNRAWRAATFQYSYPPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGRQDVCIGTTVAGRAQVELESLIGFFINILPLRLDLSGAPSLHEVLRRTKAVVLEGFEHQELPFEHLLKALRRQRDSSQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVRRMVEHHQRVLEALVEGLEEGLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGHYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFSLGGHSLLAAQVVSRIGKELGTQISIADLFQRPTIEQLCELIGGLDDQTQRELALAPSGNTEAVLSFAQERMWFLHNFVKGMPYNTPGLDHLTGELDVAALEKAIRAVIRRHEPLRTNFVEKDGVLSQLVGTEERFRLTVTPIRDESEVARLMEAVIQTPVDLERELMIRAYLYRVDPRNHYLFTTIHHIAFDGWSTSIFYRELAAYYAAFLRREDSPLPALEISYQDYARWERAHFQDEVLAEKLRYWRQRLSGARPLVLPTTYHRPPIQSFAGAVVNFEIDRSITERLKTLFAESGTTMYMVLLGAFSVVLQRYSGQDDICIGSPVANRGHIQTEGLIGLFVNTLVMRVDAAGNPRFIDLLARIQRTAIDAYANQEVPFEKIVDDLQVARDTARSPLVQVILNFHNTPPQSELELQGVTLTRMPVHNGTAKFELSIDVAETSAGLTGFVEYATDLFSENFIRRMIGHLEVVLDAVGRDPRAPIHELPLLTRQDQLDLLSRSGHTAPAVEHVELIPHTFERRVQESPQAIALVCGDERVTYSALNRRASQIARRLRAAGIGPDTLVGLCAGRSIELVCGVLGILKAGGAYVPIDPTSSPEVIYDVLYESKVRHLLTESRLVGGLPVDDQEILLLDTPADGEGDKAVADREEPPDLGEVSLTPECLAYVNFTSDSGGAPRGIAVRHGALARRMAAGHAQYLANSAVRFLLKAPLTFDLAVAELFQWIVSGGSLSILDPNADRDASAFLAQVRRDSIGVLYCVPSELSTLVSHLERERERVHELNTLRFIFCGGDTLAVTVVERLGVLVRAGQLPLRLVNVYGTKETGIGAGCFECALDANDPSAELPPGRLSHERMPIGGPAQNLWFYVVQPNGGLAPLGIPGELYVGGAQLADARFGDEPTATHPGFVPNPFRSGAEKDWLYKTGDLVRWLPQGPLELVSAARERDGGGDHRLDRGFIEARMRRVAIVRDAVVAYVPDRQDRARLVAYVVLKESPAADVEPREGRETLKARISAELGSTLPEYMLPAAYVFMDSLPLTAYGRIDRKALPEPEDDRHGGSAIAYVAPRGPTEKALAHIWQQVLKRPQVGLRDNFFELGGHSVAAIQLVSVSRKHLEVEVPLSLIFESPVLEAMARGIEALQQQGRSGAVSSIHRVERTGPLPLAYVQERLWFVHEHMKEQRTSYNITWTLHFAGKGFSVEALRTAFDELVARHETLRTWFQVGEGTEQAVQVIGEPWSMELPLREVAGTEVTAAINEMSRQVFDLRAGRLLTAAVLRVAEDEHILVSNIHHIITDGWSFGVMLRELRELYEAAVRGERAELPPLTVQYGDYAVWQRKQDLSEHLAYWKGKVEGDEDGLELPYDFPRTSNRAWRAATFQYSYHPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGREDLCIGTTVAGRAQVELESLIGFFINILPLRLDLSGAPSLHEVLRRTKVVVLEGFEHQELPFEHLLKALRRQRDSSQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVRRMVEHHQRVLEALVEGLEEGLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGSYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFNLGGHSLLASQLISRIRATFRVEVAMATVFESPTVEPLARHIEEKLKDESRVQLSNVVPVERTQELPLSYLQERLWFVHEHMKEQRTSYNGTIGLRLRGPLSIPALRATFHDLVARHESLRTVFRVPEGRTTPVQVILDSMDLDIPVRDATEADIIPGMDELAGHIYDMEKGPLFMVRLLRLAEDSHVLLMGMHHIVYDAWSQFNVMSRDINLLYSAHVTGIEARLPALPIQYADFSVWQRQQDFRHHLDYWKSTLGDYRDDLELPYDYPRPPSRTWHATRFTFRYPDALARAFARFNQSHQSTLFMGLLTSFAIVLRHYTGRNDICIGTTTAGRAQLELENLVGFFINILPLRINLAGDPDISELMNRAKKSVLGAFEHQALPFERLLSALNKQRDSSHIPLVPVMLRHQNFPTAMTGKWADGVDMEVIERDERTTPNELDLQFFGDDTYLHAVVEFPAQLFSEVTVRRLMQRHQKVIEFMCATLGAR", "perc_identity": 25.68}, "gnl|BL_ORD_ID|4935|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 27422, "orf_end": 41059, "orf_from": "BGC0001413.1|Cystobactamide_17 ", "model_name": "almE", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1000", "model_id": "5928", "ARO_accession": "3007433", "ARO_name": "almE", "ARO_category": {"46184": {"category_aro_accession": "3007428", "category_aro_cvterm_id": "46184", "category_aro_name": "polymyxin resistance operon", "category_aro_description": "Operon or gene clusters confering resistance to polymyxin antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "46188": {"category_aro_accession": "3007432", "category_aro_cvterm_id": "46188", "category_aro_name": "alm glycyltransferase", "category_aro_description": "Glycyl transferase associated with polymyxin resistance operons not interacting with lipid A.", "category_aro_class_name": "AMR Gene Family"}, "36966": {"category_aro_accession": "3000622", "category_aro_cvterm_id": "36966", "category_aro_name": "colistin A", "category_aro_description": "Colistin A, or polymyxin E1, has a 6-octanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "36968": {"category_aro_accession": "3000624", "category_aro_cvterm_id": "36968", "category_aro_name": "colistin B", "category_aro_description": "Colistin B, or polymyxin E2, has a 6-heptanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "36192": {"category_aro_accession": "3000053", "category_aro_cvterm_id": "36192", "category_aro_name": "peptide antibiotic", "category_aro_description": "Peptide antibiotics have a wide range of antibacterial mechanisms, depending on the amino acids that make up the antibiotic, although most act to disrupt the cell membrane in some manner. Subclasses of peptide antibiotics can include additional sidechains of other types, such as lipids in the case of the lipopeptide antibiotics.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.64454e-30, "max_identities": 132, "bit_score": 126.331, "cvterm_id": "36789", "query": "RQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGHYIEQ---------ILEDAAPQVVLGKRGRADGVRVDVW---------LELDGAQRLTDEALAAQEEGELEGAER--PESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELN-DVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQ-----LRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSRE", "match": "+  TY+++   A  ++      GV    RVA+LS R      A+ A +  G  Y+P++ +     I++         I+ DA     L         R+ ++         L     Q         +++ EL  A+       + A +M TSGSTG+PK + V YS LH ++    +  PL   + + Q + + F +SV ++   L++G    +VPE L K  ++ A+ I   ++T    VP+ +   L+        L SL+     G+AL   + E+ ++      + N YG TE    +TYH      G    VPIGR      + +++EQ         P G  GEL +    +  GY   P  T   F  +      G   YR+GD+V   ++G L +LGRRD+++K+ G RV++ ++E V           +  WPL  S                 P        + L    VP  +  +E+LPR  NGK D  +L +   S + E", "sequence_from_db": "KTYTYQEMTDMALSLSDYWHLQGV---QRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPE-LAK--LSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVI-NLYGPTECTIAITYHRFVAHSG-MASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQH-----EGRIWYRSGDIV-TKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYE", "sequence_from_broadstreet": "MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH", "dna_sequence_from_broadstreet": "ATGCCATACAATTCTGCGACAGATTTGTTACAGAGAGAGGGTTATGGTGTCGTGCATAACCAATTTATCAATAAAATGGCGATGTGCTGCGAGACAAGACACTCTATTTTGGCGGCCATTCAGGCTAACCGACATGCCCCTGCATTATGGGTTAAACAGAAAACCTACACCTATCAAGAGATGACCGATATGGCACTCTCATTGAGTGACTATTGGCATTTACAGGGCGTGCAGCGAGTTGCGATCCTTTCGGTACGCGATCTCGCGGCTTATTCTGCGATTTGGGCGAGCTATTTGGGCGGTATGACTTATATTCCGCTCAATGCGCGAGCAACAACAGAACAGATCCAAGAGACGCTGATCGCGACACAATGTGATTCCATCATGGTAGACGCGCAGCAATTGAGTCGTTTGTCCTCCTTACTAGATACTTGCATTGACCGATTACACATTTATGCGCTGCCTGATGTGGATATGGAACCGTTACGTCAGCAATATCCTCAGCACACTTTTCACACAGTGCAAATAACCGAACAAGATGTGGAATTACTGGTAGCGAAATACCATTTAGACAATGAACATGAGTACGCTTATATCATGCAAACCTCAGGTTCGACTGGTAAACCCAAACGTATTGCGGTCAGCTACAGTAATTTGCATTGCTATATCAGTCAAATTGACAAACTATTTCCACTCAATGCGCAAGATCGAGTGGGGCAATATTCTGATTTGACTTTTGATCTTTCGGTACATGATATTTTTTACAGTTTGATCTCTGGTGCTTGTTTATATGTTGTGCCTGAATTAGCGAAATTAAGTCCAGCGGAATTTATTCGTCACCATCAATTAACGGTATGGCTTTCTGTGCCTACTGTTATTGAGTTGGCCCTACAAAGACAAACCTTAACCCCACACAGTTTACCTTCTCTGCGACTGAGTTTTTTCTGCGGACAAGCCTTGCTGCATGATTTAGCCGAACAATGGCAACAGGCCACCCAGCAGCCGGTGATCAATCTGTATGGTCCAACAGAGTGCACGATTGCTATTACCTATCATCGATTTGTCGCCCATTCAGGTATGGCATCGGTGCCGATTGGCCGTGCTTTTGAAGAGGAGTGTTTAGCCATCATCAACGAACAAGGTGAATTGATGCGCTTTGAATCTGCACCCGAGGGGTATCGCGGAGAATTACTTCTGTCGGGCAAACAATTAGTCAATGGTTATCTGAATGATCCGCTGAATACGCAAAGTGCCTTTTTCCAGCACGAAGGGCGTATTTGGTATCGTTCAGGTGACATTGTCACTAAATCAAATGGCGTGCTGATTCATCTTGGGCGTCGCGATCACCAAGTGAAAATTGCCGGACAACGGGTGGAATTAGAAGAGATTGAAACCGTTGTTCGCCGCGTGACTCAAGCGCACAGCGTGGCGATAGTGCCTTGGCCTTTAAGTGAGTCGGGCTATGCCAGCGGCACGGTGGCGTTTGTGGATACCCATACCCAATGGCAACCAGATCTGTGGTTGAGCCAATGCAAACAACAATTAAATCCAACTTTTGTGCCTAAGCGTTGGTATGCCATTGAACAATTACCAAGAAATGCCAATGGCAAAACCGATATTAAAGCTTTACAACAACAATTAGCGAGTCAGACATATGAAACAAGCCATTGA", "partial": "0", "query_start": 31520, "query_end": 32983, "hit_start": 159, "hit_end": 1659, "orf_dna_sequence": "ATGCTGCTGGAGGGAGAGCTGGAGGGGTACGAGGACGGGTTGGAACTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGCATAGCTACCCGCCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCGAGGACGTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGGGGCGTTGGGGGATCTGAGCGGGTCCACCGTCGACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGCGGTGGTGCTGGAGGGATTCGAGCACGAGGCGTTGCCGTGCCAGATTCCCTTGGTGCCGGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAAGAGGATGGTGGAGCACCACCAGCGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGTGCGGCTGCACGAGGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGAAGCTACATCGAGCAGATACTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGCTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGAGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGACCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCGGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGCTGCCGAACGGGAAGCTGGACCGGTTGTCGCTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAGCCTCGGCGGGCACTCCCTCCTGGCTGCCCAGCTGATTTCGCGCATACGGGCGACCTTCCGCGTGGAAGTGGCGATGGCCACGGTGTTCGAGTCCCCCACGGTGGAGCCGCTCGCCCGCCACATCGAGGAGAAGCTCAAGGACGAGTCTCGGGTCCAGCTCTCCAACGTTGTGCCGGTCGAGCGGACGCAGGAGATTCCGCTCTCCTACCTGCAGGAGCGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACATCACCTGGACGTTGCACTTCGCCGGCAAGGGTTTCTCGGTGGAGGCGTTGCGGACGGCCTTCGATGAGCTGGTGGCCAGACACGAGACACTGCGCACGTGGTTCCAGGTGGGGGAGGGGACAGAGCAGGCCGTACAGGTCATCGGGGAGCCCTGGTCGATGGAGCTGCCGCTGAGAGAGGTGGCGGGGACGGAGGTGACGGCGGCAATCAATGAGATGTCCCGACAGGTCTTCGACTTGAGAGCGGGACGGTTGCTGACGGCGGCGGTCCTGAGGGTGGCGGAGGATGAGCACATCCTCGTCAGCAACATCCACCACATCATCACGGACGGCTGGTCGTTCGGGGTGATGCTGCGGGAGCTGAGGGAGTTGTACGAGGCAGCGGTGCGGGGGAAGAGAGCGGAGCTGCCGCCGCTGACGGTGCAGTACGGCGACTATGCGGTGTGGCAGAGGAAGCAGGACCTGAGCGAGCACCTGGCGTACTGGAAGGGGAAGGTGGAGGAGTACGAGGACGGGTTGGAGCTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGTATAGCTACCCACCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCCAGGACGTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGAGCTGGAGAGCCTCATCGGGTTCTTCATCAACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGCGGTGGTGCTGGAGGGATTCGAGCACCAGGAGTTGCCGTTCGAGCACCTGCTGAAGGCGCTGAGGCGGCAGCGGGACAGCAGCCAGATTCCCTTGGTGCCAGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAGGAGGATGGTGGAGCACCACCAGCGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGGGCTGCACGAGGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGACACTACATCGAGCAGATATTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGTTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGGGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGGCCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCAGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGTTGCCGAACGGGAAGCTGGACCGGCTGTCGTTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAGCCTCGGCGGGCACTCCCTCCTGGCTGCCCAGGTGGTCTCAAGGATTGGCAAGGAGCTTGGCACTCAGATCTCGATCGCCGATCTGTTTCAAAGGCCCACGATTGAACAGCTCTGTGAGCTGATTGGAGGACTGGACGATCAGACCCAGAGGGAGCTCGCCCTCGCTCCGTCGGGGAACACCGAGGCGGTGCTCTCGTTCGCGCAAGAGCGCATGTGGTTCCTGCACAACTTCGTCAAGGGCATGCCCTACAACACGCCAGGGCTCGACCACCTGACGGGTGAGCTCGATGTCGCGGCGCTAGAAAAGGCCATCCGCGCGGTCATCCGTCGCCACGAGCCCCTGCGGACGAATTTCGTCGAGAAGGACGGGGTGCTGTCCCAGTTGGTGGGGACGGAAGAACGCTTCCGCCTGACCGTGACTCCCATCCGCGACGAGAGCGAGGTCGCGCGGCTCATGGAAGCCGTGATCCAAACGCCAGTCGATCTGGAGCGGGAGTTGATGATCCGGGCTTATCTCTACCGGGTCGACCCGCGGAATCACTACCTGTTCACCACCATCCATCACATCGCCTTCGATGGCTGGTCGACATCGATCTTCTACCGTGAGCTGGCTGCGTACTACGCCGCGTTTCTCCGGCGCGAAGACAGTCCGCTGCCCGCGCTGGAAATCTCCTATCAGGACTATGCCCGCTGGGAGCGGGCCCATTTCCAGGACGAGGTGTTGGCGGAAAAACTGAGGTACTGGCGGCAGCGGCTGTCGGGCGCTCGGCCCCTCGTACTTCCGACCACCTACCATCGGCCGCCCATCCAGAGTTTCGCTGGCGCCGTCGTGAACTTCGAGATCGATCGCTCCATCACCGAGCGGTTGAAGACGCTGTTCGCCGAGTCGGGCACCACGATGTACATGGTGTTGCTCGGCGCGTTCTCCGTGGTGCTGCAGCGCTACTCCGGTCAGGACGACATCTGCATCGGCTCCCCCGTGGCGAACCGGGGTCACATCCAGACAGAAGGGCTGATCGGCTTGTTCGTCAACACCCTGGTGATGAGGGTGGATGCCGCCGGGAATCCCCGTTTCATCGACCTGCTGGCGCGCATTCAACGGACAGCCATCGATGCTTACGCGAACCAAGAAGTGCCCTTCGAGAAGATCGTGGACGACCTGCAGGTCGCGAGAGACACGGCCCGATCTCCGCTCGTGCAGGTCATTCTCAACTTCCACAACACGCCTCCTCAATCCGAGCTGGAACTGCAGGGGGTGACCCTCACGCGGATGCCGGTGCACAACGGCACGGCCAAGTTCGAGCTCTCCATCGACGTCGCGGAGACGAGCGCCGGTCTAACGGGATTCGTGGAGTACGCGACGGATCTGTTCAGCGAGAACTTCATCCGGCGGATGATCGGCCACCTCGAGGTGGTGCTGGACGCGGTCGGTCGCGATCCGCGGGCGCCTATCCATGAGTTGCCACTGCTCACCCGGCAGGATCAGTTGGACCTACTGTCGCGGAGCGGCCACACAGCCCCCGCGGTGGAACACGTCGAGTTGATCCCTCATACGTTCGAGCGGCGCGTCCAGGAGAGCCCTCAAGCGATTGCCCTGGTCTGCGGTGACGAGCGCGTCACCTACTCCGCGCTCAACCGCCGGGCCAGCCAGATTGCCCGCCGCCTGCGCGCCGCAGGGATCGGACCGGACACCCTCGTCGGGCTTTGCGCGGGGCGCTCCATCGAGCTGGTCTGCGGCGTCCTTGGCATCTTGAAGGCGGGCGGTGCGTACGTGCCAATCGACCCCACCTCCTCGCCCGAGGTGATCTACGACGTCCTGTATGAGTCGAAGGTGCGGCATCTGTTGACCGAGTCGCGCCTGGTCGGGGGACTGCCGGTCGATGACCAGGAAATCCTGCTCCTGGATACCCCCGCGGACGGTGAAGGGGACAAGGCTGTTGCTGACCGGGAGGAGCCACCTGACCTTGGCGAGGTCAGCCTCACTCCCGAGTGCTTGGCGTACGTCAACTTCACCTCCGACTCCGGTGGGGCGCCGAGGGGCATCGCCGTCCGCCATGGGGCGCTGGCTCGCCGGATGGCCGCCGGCCACGCACAGTACCTGGCCAATTCCGCCGTACGTTTCCTGCTGAAGGCGCCGCTCACGTTCGACCTGGCGGTCGCGGAGCTGTTCCAGTGGATCGTCAGCGGCGGCAGCCTGAGCATCCTCGACCCCAATGCCGACCGCGACGCCTCTGCCTTCCTCGCGCAGGTGCGCAGGGACTCGATTGGCGTCCTCTACTGCGTCCCCTCCGAACTCTCGACGCTGGTGAGCCACCTGGAGCGCGAGCGTGAAAGGGTGCATGAGCTGAACACCCTCCGGTTCATCTTCTGCGGCGGGGATACCCTGGCGGTTACCGTCGTCGAGCGTCTCGGGGTACTGGTGCGGGCCGGCCAGCTCCCGCTGCGGCTGGTCAACGTCTATGGGACGAAGGAGACGGGAATCGGCGCGGGTTGCTTCGAGTGCGCGCTGGACGCGAACGACCCCAGCGCCGAACTCCCGCCGGGACGGCTCTCGCATGAGCGGATGCCCATCGGCGGGCCCGCCCAGAACCTGTGGTTCTATGTGGTGCAACCCAACGGTGGCCTGGCTCCGTTGGGCATCCCGGGGGAACTGTACGTCGGCGGCGCGCAACTCGCCGACGCCCGTTTCGGCGACGAGCCCACGGCGACCCACCCCGGCTTCGTCCCGAACCCCTTCCGGAGCGGAGCGGAGAAGGACTGGCTGTACAAGACGGGGGACCTCGTCCGCTGGCTGCCTCAGGGGCCGCTCGAGCTGGTCAGCGCGGCTCGGGAGCGCGACGGAGGCGGGGACCACCGGCTCGATCGCGGCTTCATCGAGGCGCGCATGCGTCGTGTGGCCATTGTCCGCGACGCCGTGGTGGCCTACGTCCCGGATCGCCAGGACAGGGCCCGGTTGGTGGCCTACGTCGTTCTGAAGGAGTCGCCCGCGGCGGACGTGGAGCCGCGCGAAGGGCGGGAAACGCTGAAGGCTCGGATCAGCGCCGAACTTGGGAGCACGTTGCCGGAGTACATGCTTCCGGCCGCCTACGTGTTCATGGACAGCCTGCCGTTGACGGCTTACGGGAGGATCGACCGGAAAGCCCTGCCCGAGCCGGAGGATGACCGCCACGGTGGTAGTGCGATCGCCTACGTGGCCCCGCGCGGGCCCACGGAGAAGGCACTGGCGCACATTTGGCAGCAAGTGCTGAAACGCCCCCAGGTCGGACTGCGAGACAACTTCTTTGAGCTGGGCGGGCACTCAGTGGCGGCCATCCAACTGGTGTCCGTGAGCCGGAAGCACCTGGAGGTCGAAGTCCCCCTCAGCCTGATCTTCGAATCGCCGGTCCTGGAGGCGATGGCGCGCGGCATCGAAGCGCTGCAACAGCAGGGCCGCAGCGGCGCGGTGTCGTCGATCCATCGGGTGGAGCGGACCGGACCGCTGCCTCTGGCGTACGTGCAGGAGAGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACATCACCTGGACGTTGCACTTCGCCGGCAAGGGTTTCTCGGTGGAGGCGTTGCGGACGGCCTTCGATGAGCTGGTGGCCAGACACGAGACACTGCGCACGTGGTTCCAGGTGGGGGAGGGGACAGAGCAGGCCGTACAGGTCATCGGGGAGCCCTGGTCGATGGAGCTGCCGCTGAGAGAGGTGGCGGGGACGGAGGTGACGGCGGCAATCAATGAGATGTCCCGGCAGGTCTTCGACTTGAGAGCGGGACGGTTGCTGACGGCGGCGGTCCTGAGGGTGGCGGAGGATGAGCACATCCTCGTCAGCAACATCCACCACATCATCACGGACGGCTGGTCGTTCGGGGTGATGCTGCGGGAGCTGAGGGAGTTGTACGAGGCCGCGGTGCGGGGGGAGCGAGCGGAGCTGCCGCCGCTGACGGTGCAGTACGGCGACTATGCGGTATGGCAGAGGAAGCAGGACCTGAGCGAGCACCTGGCGTACTGGAAGGGGAAGGTGGAGGGGGACGAGGACGGGTTGGAGCTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGTATAGCTACCACCCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCGAGGACCTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGAACTGGAGAGCCTCATCGGGTTCTTCATCAACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGTGGTGGTGCTGGAGGGATTCGAGCACCAGGAGTTGCCGTTCGAGCACCTGCTGAAGGCGCTGAGGCGGCAGCGGGACAGCAGCCAGATTCCCTTGGTGCCAGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAGGAGGATGGTGGAGCACCACCAACGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGGGCTGCACGAAGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGAAGCTACATCGAGCAGATACTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGCTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGAGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGACCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCAGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGTTGCCGAACGGGAAGCTGGACCGGCTGTCGTTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAACCTCGGCGGGCACTCCCTCCTGGCTTCCCAGCTGATTTCGCGCATACGGGCGACCTTCCGCGTGGAAGTGGCGATGGCCACGGTGTTCGAGTCCCCCACGGTGGAGCCGCTCGCCCGCCACATCGAGGAGAAGCTCAAGGACGAGTCTCGGGTCCAGCTCTCCAACGTTGTGCCGGTCGAGCGGACGCAGGAGCTTCCGCTCTCCTACCTGCAGGAGAGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACGGAACGATCGGGCTCCGGCTTCGGGGTCCTCTGTCAATCCCCGCGCTCAGGGCCACCTTCCACGATCTGGTCGCCCGTCACGAGAGCCTGCGCACCGTCTTCCGGGTCCCCGAAGGCCGCACCACGCCGGTGCAGGTGATTCTTGATTCGATGGATCTGGACATCCCGGTCCGCGATGCAACCGAGGCCGACATCATCCCGGGCATGGATGAGCTGGCGGGTCACATCTACGACATGGAGAAGGGTCCGCTGTTCATGGTTCGCCTCTTGCGGCTGGCCGAGGACTCCCACGTTCTCCTGATGGGGATGCATCACATCGTCTACGACGCATGGTCACAGTTCAATGTGATGAGTCGCGATATCAACCTGCTCTACTCGGCGCACGTGACGGGAATCGAGGCACGGCTTCCCGCGCTTCCCATCCAGTACGCCGACTTCTCGGTGTGGCAGCGCCAGCAGGACTTCCGTCACCACCTGGACTACTGGAAGTCCACACTGGGCGACTACCGGGATGATCTCGAGCTGCCGTATGACTACCCGCGGCCGCCCAGCCGGACATGGCACGCGACCCGATTCACCTTCCGGTATCCGGATGCACTGGCGCGCGCGTTCGCCAGGTTCAATCAGTCCCATCAGTCGACGCTGTTCATGGGGCTGCTGACCAGCTTCGCGATCGTGCTCAGGCACTACACCGGCCGGAACGACATCTGCATCGGAACGACAACGGCGGGGCGCGCCCAGTTGGAGTTGGAGAACCTCGTTGGCTTCTTCATCAACATCCTGCCGTTGCGCATCAATCTGGCGGGTGACCCCGACATCAGCGAGCTCATGAATCGAGCGAAGAAGAGCGTCTTGGGCGCCTTCGAGCATCAAGCTCTGCCGTTCGAGCGTCTCCTCAGTGCCCTCAACAAACAGCGTGACAGCAGCCATATCCCGCTGGTTCCCGTCATGTTGCGCCACCAGAACTTCCCGACGGCGATGACCGGCAAGTGGGCCGATGGTGTGGACATGGAGGTCATCGAGCGCGACGAGCGCACGACGCCCAACGAGCTGGACCTCCAGTTCTTTGGCGACGACACCTACTTGCATGCTGTCGTCGAGTTCCCCGCGCAGCTCTTCTCCGAGGTGACCGTCCGGCGTCTGATGCAGCGTCACCAGAAGGTCATAGAGTTCATGTGCGCGACGCTGGGGGCTCGGTGA", "orf_prot_sequence": "MLLEGELEGYEDGLELPYDFPRTSNRAWRAATFQHSYPPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGREDVCIGTTVAGRAQVGALGDLSGSTVDILPLRLDLSGAPSLHEVLRRTKAVVLEGFEHEALPCQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVKRMVEHHQRVLEALVEGLEEVRLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGSYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFSLGGHSLLAAQLISRIRATFRVEVAMATVFESPTVEPLARHIEEKLKDESRVQLSNVVPVERTQEIPLSYLQERLWFVHEHMKEQRTSYNITWTLHFAGKGFSVEALRTAFDELVARHETLRTWFQVGEGTEQAVQVIGEPWSMELPLREVAGTEVTAAINEMSRQVFDLRAGRLLTAAVLRVAEDEHILVSNIHHIITDGWSFGVMLRELRELYEAAVRGKRAELPPLTVQYGDYAVWQRKQDLSEHLAYWKGKVEEYEDGLELPYDFPRTSNRAWRAATFQYSYPPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGRQDVCIGTTVAGRAQVELESLIGFFINILPLRLDLSGAPSLHEVLRRTKAVVLEGFEHQELPFEHLLKALRRQRDSSQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVRRMVEHHQRVLEALVEGLEEGLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGHYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFSLGGHSLLAAQVVSRIGKELGTQISIADLFQRPTIEQLCELIGGLDDQTQRELALAPSGNTEAVLSFAQERMWFLHNFVKGMPYNTPGLDHLTGELDVAALEKAIRAVIRRHEPLRTNFVEKDGVLSQLVGTEERFRLTVTPIRDESEVARLMEAVIQTPVDLERELMIRAYLYRVDPRNHYLFTTIHHIAFDGWSTSIFYRELAAYYAAFLRREDSPLPALEISYQDYARWERAHFQDEVLAEKLRYWRQRLSGARPLVLPTTYHRPPIQSFAGAVVNFEIDRSITERLKTLFAESGTTMYMVLLGAFSVVLQRYSGQDDICIGSPVANRGHIQTEGLIGLFVNTLVMRVDAAGNPRFIDLLARIQRTAIDAYANQEVPFEKIVDDLQVARDTARSPLVQVILNFHNTPPQSELELQGVTLTRMPVHNGTAKFELSIDVAETSAGLTGFVEYATDLFSENFIRRMIGHLEVVLDAVGRDPRAPIHELPLLTRQDQLDLLSRSGHTAPAVEHVELIPHTFERRVQESPQAIALVCGDERVTYSALNRRASQIARRLRAAGIGPDTLVGLCAGRSIELVCGVLGILKAGGAYVPIDPTSSPEVIYDVLYESKVRHLLTESRLVGGLPVDDQEILLLDTPADGEGDKAVADREEPPDLGEVSLTPECLAYVNFTSDSGGAPRGIAVRHGALARRMAAGHAQYLANSAVRFLLKAPLTFDLAVAELFQWIVSGGSLSILDPNADRDASAFLAQVRRDSIGVLYCVPSELSTLVSHLERERERVHELNTLRFIFCGGDTLAVTVVERLGVLVRAGQLPLRLVNVYGTKETGIGAGCFECALDANDPSAELPPGRLSHERMPIGGPAQNLWFYVVQPNGGLAPLGIPGELYVGGAQLADARFGDEPTATHPGFVPNPFRSGAEKDWLYKTGDLVRWLPQGPLELVSAARERDGGGDHRLDRGFIEARMRRVAIVRDAVVAYVPDRQDRARLVAYVVLKESPAADVEPREGRETLKARISAELGSTLPEYMLPAAYVFMDSLPLTAYGRIDRKALPEPEDDRHGGSAIAYVAPRGPTEKALAHIWQQVLKRPQVGLRDNFFELGGHSVAAIQLVSVSRKHLEVEVPLSLIFESPVLEAMARGIEALQQQGRSGAVSSIHRVERTGPLPLAYVQERLWFVHEHMKEQRTSYNITWTLHFAGKGFSVEALRTAFDELVARHETLRTWFQVGEGTEQAVQVIGEPWSMELPLREVAGTEVTAAINEMSRQVFDLRAGRLLTAAVLRVAEDEHILVSNIHHIITDGWSFGVMLRELRELYEAAVRGERAELPPLTVQYGDYAVWQRKQDLSEHLAYWKGKVEGDEDGLELPYDFPRTSNRAWRAATFQYSYHPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGREDLCIGTTVAGRAQVELESLIGFFINILPLRLDLSGAPSLHEVLRRTKVVVLEGFEHQELPFEHLLKALRRQRDSSQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVRRMVEHHQRVLEALVEGLEEGLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGSYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFNLGGHSLLASQLISRIRATFRVEVAMATVFESPTVEPLARHIEEKLKDESRVQLSNVVPVERTQELPLSYLQERLWFVHEHMKEQRTSYNGTIGLRLRGPLSIPALRATFHDLVARHESLRTVFRVPEGRTTPVQVILDSMDLDIPVRDATEADIIPGMDELAGHIYDMEKGPLFMVRLLRLAEDSHVLLMGMHHIVYDAWSQFNVMSRDINLLYSAHVTGIEARLPALPIQYADFSVWQRQQDFRHHLDYWKSTLGDYRDDLELPYDYPRPPSRTWHATRFTFRYPDALARAFARFNQSHQSTLFMGLLTSFAIVLRHYTGRNDICIGTTTAGRAQLELENLVGFFINILPLRINLAGDPDISELMNRAKKSVLGAFEHQALPFERLLSALNKQRDSSHIPLVPVMLRHQNFPTAMTGKWADGVDMEVIERDERTTPNELDLQFFGDDTYLHAVVEFPAQLFSEVTVRRLMQRHQKVIEFMCATLGAR", "perc_identity": 25.68}, "gnl|BL_ORD_ID|4935|hsp_num:3": {"type_match": "Loose", "orf_strand": "+", "orf_start": 27422, "orf_end": 41059, "orf_from": "BGC0001413.1|Cystobactamide_17 ", "model_name": "almE", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1000", "model_id": "5928", "ARO_accession": "3007433", "ARO_name": "almE", "ARO_category": {"46184": {"category_aro_accession": "3007428", "category_aro_cvterm_id": "46184", "category_aro_name": "polymyxin resistance operon", "category_aro_description": "Operon or gene clusters confering resistance to polymyxin antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "46188": {"category_aro_accession": "3007432", "category_aro_cvterm_id": "46188", "category_aro_name": "alm glycyltransferase", "category_aro_description": "Glycyl transferase associated with polymyxin resistance operons not interacting with lipid A.", "category_aro_class_name": "AMR Gene Family"}, "36966": {"category_aro_accession": "3000622", "category_aro_cvterm_id": "36966", "category_aro_name": "colistin A", "category_aro_description": "Colistin A, or polymyxin E1, has a 6-octanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "36968": {"category_aro_accession": "3000624", "category_aro_cvterm_id": "36968", "category_aro_name": "colistin B", "category_aro_description": "Colistin B, or polymyxin E2, has a 6-heptanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "36192": {"category_aro_accession": "3000053", "category_aro_cvterm_id": "36192", "category_aro_name": "peptide antibiotic", "category_aro_description": "Peptide antibiotics have a wide range of antibacterial mechanisms, depending on the amino acids that make up the antibiotic, although most act to disrupt the cell membrane in some manner. Subclasses of peptide antibiotics can include additional sidechains of other types, such as lipids in the case of the lipopeptide antibiotics.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.67773e-16, "max_identities": 133, "bit_score": 82.4185, "cvterm_id": "36789", "query": "DLLSRSGHTAPAVEHVELIPHTFERR------VQESPQAIALVCGDERVTYSALNRRASQIARRLRAAGIGPDTLVGLCAGRSIELVCGVLGILKAGGAYVPIDPTSSPEVIYDVLYESKVRHLLTESRLVGGLPVDDQEILLLDTPADGEGDKAVAD------REEPPD--LGEVSLTPECL---------------AYVNFTSDSGGAPRGIAVRHGALARRMAAGHAQYLANSAVRFLLKAPLTFDLAVAELFQWIVSGGSLSILDPNADRDASAFLAQVRRDSIGVLYCVPSELSTLVSHLERERERVHELNTLRFIFCGGDTLAVTVVERLGVLVRAGQLPLRLVNVYGTKETGIGAGCFECALDANDPSAELPPGRLSHERMPIGGPAQNLWFYVVQPNGGL-----APLGIPGELYVGGAQLADARFGDEPTATHPGFVPNPFRSGAEKDWLYKTGDLVRWLPQGPLELVSAARERDGGGDHRLDRGFIEARMRRVAIVRDAVVAYVPDRQD--RARLVAYVVLKESPAADVEPREGRETLKARISAELGSTLPEYMLPAAYVFMDSLPLTAYGRIDRKALPE", "match": "DLL R G+     + +  +    E R      +Q +  A AL    +  TY  +   A  ++      G+     V + + R +     +      G  Y+P++  ++ E I + L  ++   ++ +++ +  L        LLDT  D     A+ D      R++ P      V +T + +               AY+  TS S G P+ IAV +  L   ++     +  N+  R    + LTFDL+V ++F  ++SG  L ++   A    + F   +R   + V   VP+ +      L+R+    H L +LR  F  G  L   + E+     +A Q P  ++N+YG  E  I          A+   A +P GR   E              ++   G L     AP G  GEL + G QL +    D P  T   F  +  R      W Y++GD+V     G L  +     +      R++   IE  +RRV       +   P  +    +  VA+V        D   +   +   ++   +L  T     +P  +  ++ LP  A G+ D KAL +", "sequence_from_db": "DLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGV---QRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSS------LLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEF---IRHHQLTVWLSVPTVIELA---LQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQ---QATQQP--VINLYGPTECTIAITYHR--FVAHSGMASVPIGRAFEEEC----------LAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLND-PLNTQSAFFQHEGRI-----W-YRSGDIVT-KSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFV--------DTHTQWQPDLWLSQCKQQLNPTF----VPKRWYAIEQLPRNANGKTDIKALQQ", "sequence_from_broadstreet": "MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH", "dna_sequence_from_broadstreet": "ATGCCATACAATTCTGCGACAGATTTGTTACAGAGAGAGGGTTATGGTGTCGTGCATAACCAATTTATCAATAAAATGGCGATGTGCTGCGAGACAAGACACTCTATTTTGGCGGCCATTCAGGCTAACCGACATGCCCCTGCATTATGGGTTAAACAGAAAACCTACACCTATCAAGAGATGACCGATATGGCACTCTCATTGAGTGACTATTGGCATTTACAGGGCGTGCAGCGAGTTGCGATCCTTTCGGTACGCGATCTCGCGGCTTATTCTGCGATTTGGGCGAGCTATTTGGGCGGTATGACTTATATTCCGCTCAATGCGCGAGCAACAACAGAACAGATCCAAGAGACGCTGATCGCGACACAATGTGATTCCATCATGGTAGACGCGCAGCAATTGAGTCGTTTGTCCTCCTTACTAGATACTTGCATTGACCGATTACACATTTATGCGCTGCCTGATGTGGATATGGAACCGTTACGTCAGCAATATCCTCAGCACACTTTTCACACAGTGCAAATAACCGAACAAGATGTGGAATTACTGGTAGCGAAATACCATTTAGACAATGAACATGAGTACGCTTATATCATGCAAACCTCAGGTTCGACTGGTAAACCCAAACGTATTGCGGTCAGCTACAGTAATTTGCATTGCTATATCAGTCAAATTGACAAACTATTTCCACTCAATGCGCAAGATCGAGTGGGGCAATATTCTGATTTGACTTTTGATCTTTCGGTACATGATATTTTTTACAGTTTGATCTCTGGTGCTTGTTTATATGTTGTGCCTGAATTAGCGAAATTAAGTCCAGCGGAATTTATTCGTCACCATCAATTAACGGTATGGCTTTCTGTGCCTACTGTTATTGAGTTGGCCCTACAAAGACAAACCTTAACCCCACACAGTTTACCTTCTCTGCGACTGAGTTTTTTCTGCGGACAAGCCTTGCTGCATGATTTAGCCGAACAATGGCAACAGGCCACCCAGCAGCCGGTGATCAATCTGTATGGTCCAACAGAGTGCACGATTGCTATTACCTATCATCGATTTGTCGCCCATTCAGGTATGGCATCGGTGCCGATTGGCCGTGCTTTTGAAGAGGAGTGTTTAGCCATCATCAACGAACAAGGTGAATTGATGCGCTTTGAATCTGCACCCGAGGGGTATCGCGGAGAATTACTTCTGTCGGGCAAACAATTAGTCAATGGTTATCTGAATGATCCGCTGAATACGCAAAGTGCCTTTTTCCAGCACGAAGGGCGTATTTGGTATCGTTCAGGTGACATTGTCACTAAATCAAATGGCGTGCTGATTCATCTTGGGCGTCGCGATCACCAAGTGAAAATTGCCGGACAACGGGTGGAATTAGAAGAGATTGAAACCGTTGTTCGCCGCGTGACTCAAGCGCACAGCGTGGCGATAGTGCCTTGGCCTTTAAGTGAGTCGGGCTATGCCAGCGGCACGGTGGCGTTTGTGGATACCCATACCCAATGGCAACCAGATCTGTGGTTGAGCCAATGCAAACAACAATTAAATCCAACTTTTGTGCCTAAGCGTTGGTATGCCATTGAACAATTACCAAGAAATGCCAATGGCAAAACCGATATTAAAGCTTTACAACAACAATTAGCGAGTCAGACATATGAAACAAGCCATTGA", "partial": "0", "query_start": 34574, "query_end": 36235, "hit_start": 21, "hit_end": 1635, "orf_dna_sequence": "ATGCTGCTGGAGGGAGAGCTGGAGGGGTACGAGGACGGGTTGGAACTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGCATAGCTACCCGCCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCGAGGACGTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGGGGCGTTGGGGGATCTGAGCGGGTCCACCGTCGACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGCGGTGGTGCTGGAGGGATTCGAGCACGAGGCGTTGCCGTGCCAGATTCCCTTGGTGCCGGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAAGAGGATGGTGGAGCACCACCAGCGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGTGCGGCTGCACGAGGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGAAGCTACATCGAGCAGATACTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGCTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGAGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGACCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCGGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGCTGCCGAACGGGAAGCTGGACCGGTTGTCGCTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAGCCTCGGCGGGCACTCCCTCCTGGCTGCCCAGCTGATTTCGCGCATACGGGCGACCTTCCGCGTGGAAGTGGCGATGGCCACGGTGTTCGAGTCCCCCACGGTGGAGCCGCTCGCCCGCCACATCGAGGAGAAGCTCAAGGACGAGTCTCGGGTCCAGCTCTCCAACGTTGTGCCGGTCGAGCGGACGCAGGAGATTCCGCTCTCCTACCTGCAGGAGCGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACATCACCTGGACGTTGCACTTCGCCGGCAAGGGTTTCTCGGTGGAGGCGTTGCGGACGGCCTTCGATGAGCTGGTGGCCAGACACGAGACACTGCGCACGTGGTTCCAGGTGGGGGAGGGGACAGAGCAGGCCGTACAGGTCATCGGGGAGCCCTGGTCGATGGAGCTGCCGCTGAGAGAGGTGGCGGGGACGGAGGTGACGGCGGCAATCAATGAGATGTCCCGACAGGTCTTCGACTTGAGAGCGGGACGGTTGCTGACGGCGGCGGTCCTGAGGGTGGCGGAGGATGAGCACATCCTCGTCAGCAACATCCACCACATCATCACGGACGGCTGGTCGTTCGGGGTGATGCTGCGGGAGCTGAGGGAGTTGTACGAGGCAGCGGTGCGGGGGAAGAGAGCGGAGCTGCCGCCGCTGACGGTGCAGTACGGCGACTATGCGGTGTGGCAGAGGAAGCAGGACCTGAGCGAGCACCTGGCGTACTGGAAGGGGAAGGTGGAGGAGTACGAGGACGGGTTGGAGCTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGTATAGCTACCCACCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCCAGGACGTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGAGCTGGAGAGCCTCATCGGGTTCTTCATCAACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGCGGTGGTGCTGGAGGGATTCGAGCACCAGGAGTTGCCGTTCGAGCACCTGCTGAAGGCGCTGAGGCGGCAGCGGGACAGCAGCCAGATTCCCTTGGTGCCAGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAGGAGGATGGTGGAGCACCACCAGCGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGGGCTGCACGAGGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGACACTACATCGAGCAGATATTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGTTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGGGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGGCCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCAGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGTTGCCGAACGGGAAGCTGGACCGGCTGTCGTTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAGCCTCGGCGGGCACTCCCTCCTGGCTGCCCAGGTGGTCTCAAGGATTGGCAAGGAGCTTGGCACTCAGATCTCGATCGCCGATCTGTTTCAAAGGCCCACGATTGAACAGCTCTGTGAGCTGATTGGAGGACTGGACGATCAGACCCAGAGGGAGCTCGCCCTCGCTCCGTCGGGGAACACCGAGGCGGTGCTCTCGTTCGCGCAAGAGCGCATGTGGTTCCTGCACAACTTCGTCAAGGGCATGCCCTACAACACGCCAGGGCTCGACCACCTGACGGGTGAGCTCGATGTCGCGGCGCTAGAAAAGGCCATCCGCGCGGTCATCCGTCGCCACGAGCCCCTGCGGACGAATTTCGTCGAGAAGGACGGGGTGCTGTCCCAGTTGGTGGGGACGGAAGAACGCTTCCGCCTGACCGTGACTCCCATCCGCGACGAGAGCGAGGTCGCGCGGCTCATGGAAGCCGTGATCCAAACGCCAGTCGATCTGGAGCGGGAGTTGATGATCCGGGCTTATCTCTACCGGGTCGACCCGCGGAATCACTACCTGTTCACCACCATCCATCACATCGCCTTCGATGGCTGGTCGACATCGATCTTCTACCGTGAGCTGGCTGCGTACTACGCCGCGTTTCTCCGGCGCGAAGACAGTCCGCTGCCCGCGCTGGAAATCTCCTATCAGGACTATGCCCGCTGGGAGCGGGCCCATTTCCAGGACGAGGTGTTGGCGGAAAAACTGAGGTACTGGCGGCAGCGGCTGTCGGGCGCTCGGCCCCTCGTACTTCCGACCACCTACCATCGGCCGCCCATCCAGAGTTTCGCTGGCGCCGTCGTGAACTTCGAGATCGATCGCTCCATCACCGAGCGGTTGAAGACGCTGTTCGCCGAGTCGGGCACCACGATGTACATGGTGTTGCTCGGCGCGTTCTCCGTGGTGCTGCAGCGCTACTCCGGTCAGGACGACATCTGCATCGGCTCCCCCGTGGCGAACCGGGGTCACATCCAGACAGAAGGGCTGATCGGCTTGTTCGTCAACACCCTGGTGATGAGGGTGGATGCCGCCGGGAATCCCCGTTTCATCGACCTGCTGGCGCGCATTCAACGGACAGCCATCGATGCTTACGCGAACCAAGAAGTGCCCTTCGAGAAGATCGTGGACGACCTGCAGGTCGCGAGAGACACGGCCCGATCTCCGCTCGTGCAGGTCATTCTCAACTTCCACAACACGCCTCCTCAATCCGAGCTGGAACTGCAGGGGGTGACCCTCACGCGGATGCCGGTGCACAACGGCACGGCCAAGTTCGAGCTCTCCATCGACGTCGCGGAGACGAGCGCCGGTCTAACGGGATTCGTGGAGTACGCGACGGATCTGTTCAGCGAGAACTTCATCCGGCGGATGATCGGCCACCTCGAGGTGGTGCTGGACGCGGTCGGTCGCGATCCGCGGGCGCCTATCCATGAGTTGCCACTGCTCACCCGGCAGGATCAGTTGGACCTACTGTCGCGGAGCGGCCACACAGCCCCCGCGGTGGAACACGTCGAGTTGATCCCTCATACGTTCGAGCGGCGCGTCCAGGAGAGCCCTCAAGCGATTGCCCTGGTCTGCGGTGACGAGCGCGTCACCTACTCCGCGCTCAACCGCCGGGCCAGCCAGATTGCCCGCCGCCTGCGCGCCGCAGGGATCGGACCGGACACCCTCGTCGGGCTTTGCGCGGGGCGCTCCATCGAGCTGGTCTGCGGCGTCCTTGGCATCTTGAAGGCGGGCGGTGCGTACGTGCCAATCGACCCCACCTCCTCGCCCGAGGTGATCTACGACGTCCTGTATGAGTCGAAGGTGCGGCATCTGTTGACCGAGTCGCGCCTGGTCGGGGGACTGCCGGTCGATGACCAGGAAATCCTGCTCCTGGATACCCCCGCGGACGGTGAAGGGGACAAGGCTGTTGCTGACCGGGAGGAGCCACCTGACCTTGGCGAGGTCAGCCTCACTCCCGAGTGCTTGGCGTACGTCAACTTCACCTCCGACTCCGGTGGGGCGCCGAGGGGCATCGCCGTCCGCCATGGGGCGCTGGCTCGCCGGATGGCCGCCGGCCACGCACAGTACCTGGCCAATTCCGCCGTACGTTTCCTGCTGAAGGCGCCGCTCACGTTCGACCTGGCGGTCGCGGAGCTGTTCCAGTGGATCGTCAGCGGCGGCAGCCTGAGCATCCTCGACCCCAATGCCGACCGCGACGCCTCTGCCTTCCTCGCGCAGGTGCGCAGGGACTCGATTGGCGTCCTCTACTGCGTCCCCTCCGAACTCTCGACGCTGGTGAGCCACCTGGAGCGCGAGCGTGAAAGGGTGCATGAGCTGAACACCCTCCGGTTCATCTTCTGCGGCGGGGATACCCTGGCGGTTACCGTCGTCGAGCGTCTCGGGGTACTGGTGCGGGCCGGCCAGCTCCCGCTGCGGCTGGTCAACGTCTATGGGACGAAGGAGACGGGAATCGGCGCGGGTTGCTTCGAGTGCGCGCTGGACGCGAACGACCCCAGCGCCGAACTCCCGCCGGGACGGCTCTCGCATGAGCGGATGCCCATCGGCGGGCCCGCCCAGAACCTGTGGTTCTATGTGGTGCAACCCAACGGTGGCCTGGCTCCGTTGGGCATCCCGGGGGAACTGTACGTCGGCGGCGCGCAACTCGCCGACGCCCGTTTCGGCGACGAGCCCACGGCGACCCACCCCGGCTTCGTCCCGAACCCCTTCCGGAGCGGAGCGGAGAAGGACTGGCTGTACAAGACGGGGGACCTCGTCCGCTGGCTGCCTCAGGGGCCGCTCGAGCTGGTCAGCGCGGCTCGGGAGCGCGACGGAGGCGGGGACCACCGGCTCGATCGCGGCTTCATCGAGGCGCGCATGCGTCGTGTGGCCATTGTCCGCGACGCCGTGGTGGCCTACGTCCCGGATCGCCAGGACAGGGCCCGGTTGGTGGCCTACGTCGTTCTGAAGGAGTCGCCCGCGGCGGACGTGGAGCCGCGCGAAGGGCGGGAAACGCTGAAGGCTCGGATCAGCGCCGAACTTGGGAGCACGTTGCCGGAGTACATGCTTCCGGCCGCCTACGTGTTCATGGACAGCCTGCCGTTGACGGCTTACGGGAGGATCGACCGGAAAGCCCTGCCCGAGCCGGAGGATGACCGCCACGGTGGTAGTGCGATCGCCTACGTGGCCCCGCGCGGGCCCACGGAGAAGGCACTGGCGCACATTTGGCAGCAAGTGCTGAAACGCCCCCAGGTCGGACTGCGAGACAACTTCTTTGAGCTGGGCGGGCACTCAGTGGCGGCCATCCAACTGGTGTCCGTGAGCCGGAAGCACCTGGAGGTCGAAGTCCCCCTCAGCCTGATCTTCGAATCGCCGGTCCTGGAGGCGATGGCGCGCGGCATCGAAGCGCTGCAACAGCAGGGCCGCAGCGGCGCGGTGTCGTCGATCCATCGGGTGGAGCGGACCGGACCGCTGCCTCTGGCGTACGTGCAGGAGAGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACATCACCTGGACGTTGCACTTCGCCGGCAAGGGTTTCTCGGTGGAGGCGTTGCGGACGGCCTTCGATGAGCTGGTGGCCAGACACGAGACACTGCGCACGTGGTTCCAGGTGGGGGAGGGGACAGAGCAGGCCGTACAGGTCATCGGGGAGCCCTGGTCGATGGAGCTGCCGCTGAGAGAGGTGGCGGGGACGGAGGTGACGGCGGCAATCAATGAGATGTCCCGGCAGGTCTTCGACTTGAGAGCGGGACGGTTGCTGACGGCGGCGGTCCTGAGGGTGGCGGAGGATGAGCACATCCTCGTCAGCAACATCCACCACATCATCACGGACGGCTGGTCGTTCGGGGTGATGCTGCGGGAGCTGAGGGAGTTGTACGAGGCCGCGGTGCGGGGGGAGCGAGCGGAGCTGCCGCCGCTGACGGTGCAGTACGGCGACTATGCGGTATGGCAGAGGAAGCAGGACCTGAGCGAGCACCTGGCGTACTGGAAGGGGAAGGTGGAGGGGGACGAGGACGGGTTGGAGCTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGTATAGCTACCACCCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCGAGGACCTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGAACTGGAGAGCCTCATCGGGTTCTTCATCAACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGTGGTGGTGCTGGAGGGATTCGAGCACCAGGAGTTGCCGTTCGAGCACCTGCTGAAGGCGCTGAGGCGGCAGCGGGACAGCAGCCAGATTCCCTTGGTGCCAGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAGGAGGATGGTGGAGCACCACCAACGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGGGCTGCACGAAGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGAAGCTACATCGAGCAGATACTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGCTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGAGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGACCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCAGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGTTGCCGAACGGGAAGCTGGACCGGCTGTCGTTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAACCTCGGCGGGCACTCCCTCCTGGCTTCCCAGCTGATTTCGCGCATACGGGCGACCTTCCGCGTGGAAGTGGCGATGGCCACGGTGTTCGAGTCCCCCACGGTGGAGCCGCTCGCCCGCCACATCGAGGAGAAGCTCAAGGACGAGTCTCGGGTCCAGCTCTCCAACGTTGTGCCGGTCGAGCGGACGCAGGAGCTTCCGCTCTCCTACCTGCAGGAGAGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACGGAACGATCGGGCTCCGGCTTCGGGGTCCTCTGTCAATCCCCGCGCTCAGGGCCACCTTCCACGATCTGGTCGCCCGTCACGAGAGCCTGCGCACCGTCTTCCGGGTCCCCGAAGGCCGCACCACGCCGGTGCAGGTGATTCTTGATTCGATGGATCTGGACATCCCGGTCCGCGATGCAACCGAGGCCGACATCATCCCGGGCATGGATGAGCTGGCGGGTCACATCTACGACATGGAGAAGGGTCCGCTGTTCATGGTTCGCCTCTTGCGGCTGGCCGAGGACTCCCACGTTCTCCTGATGGGGATGCATCACATCGTCTACGACGCATGGTCACAGTTCAATGTGATGAGTCGCGATATCAACCTGCTCTACTCGGCGCACGTGACGGGAATCGAGGCACGGCTTCCCGCGCTTCCCATCCAGTACGCCGACTTCTCGGTGTGGCAGCGCCAGCAGGACTTCCGTCACCACCTGGACTACTGGAAGTCCACACTGGGCGACTACCGGGATGATCTCGAGCTGCCGTATGACTACCCGCGGCCGCCCAGCCGGACATGGCACGCGACCCGATTCACCTTCCGGTATCCGGATGCACTGGCGCGCGCGTTCGCCAGGTTCAATCAGTCCCATCAGTCGACGCTGTTCATGGGGCTGCTGACCAGCTTCGCGATCGTGCTCAGGCACTACACCGGCCGGAACGACATCTGCATCGGAACGACAACGGCGGGGCGCGCCCAGTTGGAGTTGGAGAACCTCGTTGGCTTCTTCATCAACATCCTGCCGTTGCGCATCAATCTGGCGGGTGACCCCGACATCAGCGAGCTCATGAATCGAGCGAAGAAGAGCGTCTTGGGCGCCTTCGAGCATCAAGCTCTGCCGTTCGAGCGTCTCCTCAGTGCCCTCAACAAACAGCGTGACAGCAGCCATATCCCGCTGGTTCCCGTCATGTTGCGCCACCAGAACTTCCCGACGGCGATGACCGGCAAGTGGGCCGATGGTGTGGACATGGAGGTCATCGAGCGCGACGAGCGCACGACGCCCAACGAGCTGGACCTCCAGTTCTTTGGCGACGACACCTACTTGCATGCTGTCGTCGAGTTCCCCGCGCAGCTCTTCTCCGAGGTGACCGTCCGGCGTCTGATGCAGCGTCACCAGAAGGTCATAGAGTTCATGTGCGCGACGCTGGGGGCTCGGTGA", "orf_prot_sequence": "MLLEGELEGYEDGLELPYDFPRTSNRAWRAATFQHSYPPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGREDVCIGTTVAGRAQVGALGDLSGSTVDILPLRLDLSGAPSLHEVLRRTKAVVLEGFEHEALPCQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVKRMVEHHQRVLEALVEGLEEVRLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGSYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFSLGGHSLLAAQLISRIRATFRVEVAMATVFESPTVEPLARHIEEKLKDESRVQLSNVVPVERTQEIPLSYLQERLWFVHEHMKEQRTSYNITWTLHFAGKGFSVEALRTAFDELVARHETLRTWFQVGEGTEQAVQVIGEPWSMELPLREVAGTEVTAAINEMSRQVFDLRAGRLLTAAVLRVAEDEHILVSNIHHIITDGWSFGVMLRELRELYEAAVRGKRAELPPLTVQYGDYAVWQRKQDLSEHLAYWKGKVEEYEDGLELPYDFPRTSNRAWRAATFQYSYPPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGRQDVCIGTTVAGRAQVELESLIGFFINILPLRLDLSGAPSLHEVLRRTKAVVLEGFEHQELPFEHLLKALRRQRDSSQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVRRMVEHHQRVLEALVEGLEEGLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGHYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFSLGGHSLLAAQVVSRIGKELGTQISIADLFQRPTIEQLCELIGGLDDQTQRELALAPSGNTEAVLSFAQERMWFLHNFVKGMPYNTPGLDHLTGELDVAALEKAIRAVIRRHEPLRTNFVEKDGVLSQLVGTEERFRLTVTPIRDESEVARLMEAVIQTPVDLERELMIRAYLYRVDPRNHYLFTTIHHIAFDGWSTSIFYRELAAYYAAFLRREDSPLPALEISYQDYARWERAHFQDEVLAEKLRYWRQRLSGARPLVLPTTYHRPPIQSFAGAVVNFEIDRSITERLKTLFAESGTTMYMVLLGAFSVVLQRYSGQDDICIGSPVANRGHIQTEGLIGLFVNTLVMRVDAAGNPRFIDLLARIQRTAIDAYANQEVPFEKIVDDLQVARDTARSPLVQVILNFHNTPPQSELELQGVTLTRMPVHNGTAKFELSIDVAETSAGLTGFVEYATDLFSENFIRRMIGHLEVVLDAVGRDPRAPIHELPLLTRQDQLDLLSRSGHTAPAVEHVELIPHTFERRVQESPQAIALVCGDERVTYSALNRRASQIARRLRAAGIGPDTLVGLCAGRSIELVCGVLGILKAGGAYVPIDPTSSPEVIYDVLYESKVRHLLTESRLVGGLPVDDQEILLLDTPADGEGDKAVADREEPPDLGEVSLTPECLAYVNFTSDSGGAPRGIAVRHGALARRMAAGHAQYLANSAVRFLLKAPLTFDLAVAELFQWIVSGGSLSILDPNADRDASAFLAQVRRDSIGVLYCVPSELSTLVSHLERERERVHELNTLRFIFCGGDTLAVTVVERLGVLVRAGQLPLRLVNVYGTKETGIGAGCFECALDANDPSAELPPGRLSHERMPIGGPAQNLWFYVVQPNGGLAPLGIPGELYVGGAQLADARFGDEPTATHPGFVPNPFRSGAEKDWLYKTGDLVRWLPQGPLELVSAARERDGGGDHRLDRGFIEARMRRVAIVRDAVVAYVPDRQDRARLVAYVVLKESPAADVEPREGRETLKARISAELGSTLPEYMLPAAYVFMDSLPLTAYGRIDRKALPEPEDDRHGGSAIAYVAPRGPTEKALAHIWQQVLKRPQVGLRDNFFELGGHSVAAIQLVSVSRKHLEVEVPLSLIFESPVLEAMARGIEALQQQGRSGAVSSIHRVERTGPLPLAYVQERLWFVHEHMKEQRTSYNITWTLHFAGKGFSVEALRTAFDELVARHETLRTWFQVGEGTEQAVQVIGEPWSMELPLREVAGTEVTAAINEMSRQVFDLRAGRLLTAAVLRVAEDEHILVSNIHHIITDGWSFGVMLRELRELYEAAVRGERAELPPLTVQYGDYAVWQRKQDLSEHLAYWKGKVEGDEDGLELPYDFPRTSNRAWRAATFQYSYHPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGREDLCIGTTVAGRAQVELESLIGFFINILPLRLDLSGAPSLHEVLRRTKVVVLEGFEHQELPFEHLLKALRRQRDSSQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVRRMVEHHQRVLEALVEGLEEGLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGSYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFNLGGHSLLASQLISRIRATFRVEVAMATVFESPTVEPLARHIEEKLKDESRVQLSNVVPVERTQELPLSYLQERLWFVHEHMKEQRTSYNGTIGLRLRGPLSIPALRATFHDLVARHESLRTVFRVPEGRTTPVQVILDSMDLDIPVRDATEADIIPGMDELAGHIYDMEKGPLFMVRLLRLAEDSHVLLMGMHHIVYDAWSQFNVMSRDINLLYSAHVTGIEARLPALPIQYADFSVWQRQQDFRHHLDYWKSTLGDYRDDLELPYDYPRPPSRTWHATRFTFRYPDALARAFARFNQSHQSTLFMGLLTSFAIVLRHYTGRNDICIGTTTAGRAQLELENLVGFFINILPLRINLAGDPDISELMNRAKKSVLGAFEHQALPFERLLSALNKQRDSSHIPLVPVMLRHQNFPTAMTGKWADGVDMEVIERDERTTPNELDLQFFGDDTYLHAVVEFPAQLFSEVTVRRLMQRHQKVIEFMCATLGAR", "perc_identity": 22.54}, "gnl|BL_ORD_ID|3396|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 27422, "orf_end": 41059, "orf_from": "BGC0001413.1|Cystobactamide_17 ", "model_name": "CMH-3", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "4465", "ARO_accession": "3006855", "ARO_name": "CMH-3", "ARO_category": {"42891": {"category_aro_accession": "3004776", "category_aro_cvterm_id": "42891", "category_aro_name": "CMH beta-lactamase", "category_aro_description": "CMH is a class C beta-lactamase gene family belonging to Enterobacter cloacae.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.253641, "max_identities": 25, "bit_score": 34.2686, "cvterm_id": "36884", "query": "VMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEE", "match": "+ VP+++  N+    +E   +     ML   A     +VK++ S ++A +A   +P++ ++  +ALAQ    WRV          GA+ +G G E", "sequence_from_db": "INVPHAEEPNYAWGYREGKAVHVSPGMLDAEAYGVKSNVKDMASWVMANMAPETLPQSTLQQGIALAQS-RYWRV----------GAMYQGLGWE", "sequence_from_broadstreet": "MMKKSLSCALLLSVACSAFAAPMSEKQLADVVERTVTPLMKAQAIPGMAVAVIYQGQPHYFTFGKADVAANKPVTPQTLFELGSVSKTFTGVLGGDAIARKEISLADPVTKYWPELTGKQWQGIRLLDLATYTAGGLPLQVPDDVTDNASLLRFYQSWQPKWAPGTTRLYANTSIGLFGSLAVKPSGMRFEQAMAERVFKPLKLNHTWINVPHAEEPNYAWGYREGKAVHVSPGMLDAEAYGVKSNVKDMASWVMANMAPETLPQSTLQQGIALAQSRYWRVGAMYQGLGWEMLNWPVDAKTVVDGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLANKSYPNPVRVETAYRILETLQ", "dna_sequence_from_broadstreet": "ATGATGAAAAAATCCCTAAGCTGCGCCCTGCTGCTCAGCGTTGCCTGCTCTGCTTTTGCCGCACCGATGTCAGAAAAACAGCTGGCTGACGTCGTGGAACGTACCGTTACGCCCCTGATGAAGGCGCAGGCCATACCCGGAATGGCCGTGGCCGTCATTTATCAGGGCCAGCCACACTATTTTACTTTCGGTAAAGCAGACGTCGCGGCGAATAAGCCCGTCACGCCGCAAACCTTATTTGAGCTGGGCTCCGTCAGCAAAACCTTCACCGGCGTGCTGGGTGGCGATGCCATTGCCCGCAAAGAGATTTCGCTGGCCGACCCGGTCACGAAATATTGGCCTGAATTGACGGGCAAGCAGTGGCAAGGCATTCGCCTGCTCGACCTGGCAACCTATACCGCAGGCGGATTGCCGTTGCAGGTACCGGATGATGTCACCGATAACGCCTCTCTGCTGCGTTTCTACCAGTCCTGGCAGCCAAAGTGGGCCCCGGGTACCACGCGTCTGTACGCCAACACCAGCATCGGCCTGTTTGGCTCACTGGCCGTTAAACCGTCCGGCATGCGCTTCGAGCAGGCCATGGCGGAGCGGGTCTTTAAGCCCCTGAAACTCAACCATACGTGGATAAACGTTCCACACGCTGAAGAGCCCAACTACGCATGGGGTTATCGTGAGGGAAAAGCGGTCCACGTTTCGCCTGGTATGCTGGATGCAGAAGCCTATGGTGTGAAATCTAACGTCAAAGATATGGCGAGCTGGGTGATGGCCAATATGGCACCTGAGACACTCCCGCAGTCCACTCTGCAGCAGGGTATTGCGCTGGCGCAGTCTCGCTACTGGCGCGTGGGTGCCATGTATCAAGGGTTAGGCTGGGAGATGCTCAACTGGCCGGTCGACGCCAAAACCGTGGTGGATGGCAGCGATAATAAGGTTGCACTGGCGCCGTTGCCGGTCGCAGAAGTGAATCCTCCGGCTCCGCCAGTAAAAGCCTCCTGGGTGCATAAAACGGGCTCTACGGGTGGGTTTGGCAGCTACGTGGCGTTTATTCCTGAAAAGCAGATCGGTATTGTGATGCTCGCAAATAAAAGTTATCCGAACCCGGTACGGGTGGAAACGGCTTACCGTATTCTCGAGACGCTACAGTAA", "partial": "0", "query_start": 28721, "query_end": 29005, "hit_start": 624, "hit_end": 876, "orf_dna_sequence": "ATGCTGCTGGAGGGAGAGCTGGAGGGGTACGAGGACGGGTTGGAACTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGCATAGCTACCCGCCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCGAGGACGTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGGGGCGTTGGGGGATCTGAGCGGGTCCACCGTCGACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGCGGTGGTGCTGGAGGGATTCGAGCACGAGGCGTTGCCGTGCCAGATTCCCTTGGTGCCGGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAAGAGGATGGTGGAGCACCACCAGCGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGTGCGGCTGCACGAGGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGAAGCTACATCGAGCAGATACTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGCTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGAGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGACCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCGGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGCTGCCGAACGGGAAGCTGGACCGGTTGTCGCTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAGCCTCGGCGGGCACTCCCTCCTGGCTGCCCAGCTGATTTCGCGCATACGGGCGACCTTCCGCGTGGAAGTGGCGATGGCCACGGTGTTCGAGTCCCCCACGGTGGAGCCGCTCGCCCGCCACATCGAGGAGAAGCTCAAGGACGAGTCTCGGGTCCAGCTCTCCAACGTTGTGCCGGTCGAGCGGACGCAGGAGATTCCGCTCTCCTACCTGCAGGAGCGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACATCACCTGGACGTTGCACTTCGCCGGCAAGGGTTTCTCGGTGGAGGCGTTGCGGACGGCCTTCGATGAGCTGGTGGCCAGACACGAGACACTGCGCACGTGGTTCCAGGTGGGGGAGGGGACAGAGCAGGCCGTACAGGTCATCGGGGAGCCCTGGTCGATGGAGCTGCCGCTGAGAGAGGTGGCGGGGACGGAGGTGACGGCGGCAATCAATGAGATGTCCCGACAGGTCTTCGACTTGAGAGCGGGACGGTTGCTGACGGCGGCGGTCCTGAGGGTGGCGGAGGATGAGCACATCCTCGTCAGCAACATCCACCACATCATCACGGACGGCTGGTCGTTCGGGGTGATGCTGCGGGAGCTGAGGGAGTTGTACGAGGCAGCGGTGCGGGGGAAGAGAGCGGAGCTGCCGCCGCTGACGGTGCAGTACGGCGACTATGCGGTGTGGCAGAGGAAGCAGGACCTGAGCGAGCACCTGGCGTACTGGAAGGGGAAGGTGGAGGAGTACGAGGACGGGTTGGAGCTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGTATAGCTACCCACCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCCAGGACGTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGAGCTGGAGAGCCTCATCGGGTTCTTCATCAACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGCGGTGGTGCTGGAGGGATTCGAGCACCAGGAGTTGCCGTTCGAGCACCTGCTGAAGGCGCTGAGGCGGCAGCGGGACAGCAGCCAGATTCCCTTGGTGCCAGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAGGAGGATGGTGGAGCACCACCAGCGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGGGCTGCACGAGGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGACACTACATCGAGCAGATATTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGTTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGGGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGGCCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCAGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGTTGCCGAACGGGAAGCTGGACCGGCTGTCGTTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAGCCTCGGCGGGCACTCCCTCCTGGCTGCCCAGGTGGTCTCAAGGATTGGCAAGGAGCTTGGCACTCAGATCTCGATCGCCGATCTGTTTCAAAGGCCCACGATTGAACAGCTCTGTGAGCTGATTGGAGGACTGGACGATCAGACCCAGAGGGAGCTCGCCCTCGCTCCGTCGGGGAACACCGAGGCGGTGCTCTCGTTCGCGCAAGAGCGCATGTGGTTCCTGCACAACTTCGTCAAGGGCATGCCCTACAACACGCCAGGGCTCGACCACCTGACGGGTGAGCTCGATGTCGCGGCGCTAGAAAAGGCCATCCGCGCGGTCATCCGTCGCCACGAGCCCCTGCGGACGAATTTCGTCGAGAAGGACGGGGTGCTGTCCCAGTTGGTGGGGACGGAAGAACGCTTCCGCCTGACCGTGACTCCCATCCGCGACGAGAGCGAGGTCGCGCGGCTCATGGAAGCCGTGATCCAAACGCCAGTCGATCTGGAGCGGGAGTTGATGATCCGGGCTTATCTCTACCGGGTCGACCCGCGGAATCACTACCTGTTCACCACCATCCATCACATCGCCTTCGATGGCTGGTCGACATCGATCTTCTACCGTGAGCTGGCTGCGTACTACGCCGCGTTTCTCCGGCGCGAAGACAGTCCGCTGCCCGCGCTGGAAATCTCCTATCAGGACTATGCCCGCTGGGAGCGGGCCCATTTCCAGGACGAGGTGTTGGCGGAAAAACTGAGGTACTGGCGGCAGCGGCTGTCGGGCGCTCGGCCCCTCGTACTTCCGACCACCTACCATCGGCCGCCCATCCAGAGTTTCGCTGGCGCCGTCGTGAACTTCGAGATCGATCGCTCCATCACCGAGCGGTTGAAGACGCTGTTCGCCGAGTCGGGCACCACGATGTACATGGTGTTGCTCGGCGCGTTCTCCGTGGTGCTGCAGCGCTACTCCGGTCAGGACGACATCTGCATCGGCTCCCCCGTGGCGAACCGGGGTCACATCCAGACAGAAGGGCTGATCGGCTTGTTCGTCAACACCCTGGTGATGAGGGTGGATGCCGCCGGGAATCCCCGTTTCATCGACCTGCTGGCGCGCATTCAACGGACAGCCATCGATGCTTACGCGAACCAAGAAGTGCCCTTCGAGAAGATCGTGGACGACCTGCAGGTCGCGAGAGACACGGCCCGATCTCCGCTCGTGCAGGTCATTCTCAACTTCCACAACACGCCTCCTCAATCCGAGCTGGAACTGCAGGGGGTGACCCTCACGCGGATGCCGGTGCACAACGGCACGGCCAAGTTCGAGCTCTCCATCGACGTCGCGGAGACGAGCGCCGGTCTAACGGGATTCGTGGAGTACGCGACGGATCTGTTCAGCGAGAACTTCATCCGGCGGATGATCGGCCACCTCGAGGTGGTGCTGGACGCGGTCGGTCGCGATCCGCGGGCGCCTATCCATGAGTTGCCACTGCTCACCCGGCAGGATCAGTTGGACCTACTGTCGCGGAGCGGCCACACAGCCCCCGCGGTGGAACACGTCGAGTTGATCCCTCATACGTTCGAGCGGCGCGTCCAGGAGAGCCCTCAAGCGATTGCCCTGGTCTGCGGTGACGAGCGCGTCACCTACTCCGCGCTCAACCGCCGGGCCAGCCAGATTGCCCGCCGCCTGCGCGCCGCAGGGATCGGACCGGACACCCTCGTCGGGCTTTGCGCGGGGCGCTCCATCGAGCTGGTCTGCGGCGTCCTTGGCATCTTGAAGGCGGGCGGTGCGTACGTGCCAATCGACCCCACCTCCTCGCCCGAGGTGATCTACGACGTCCTGTATGAGTCGAAGGTGCGGCATCTGTTGACCGAGTCGCGCCTGGTCGGGGGACTGCCGGTCGATGACCAGGAAATCCTGCTCCTGGATACCCCCGCGGACGGTGAAGGGGACAAGGCTGTTGCTGACCGGGAGGAGCCACCTGACCTTGGCGAGGTCAGCCTCACTCCCGAGTGCTTGGCGTACGTCAACTTCACCTCCGACTCCGGTGGGGCGCCGAGGGGCATCGCCGTCCGCCATGGGGCGCTGGCTCGCCGGATGGCCGCCGGCCACGCACAGTACCTGGCCAATTCCGCCGTACGTTTCCTGCTGAAGGCGCCGCTCACGTTCGACCTGGCGGTCGCGGAGCTGTTCCAGTGGATCGTCAGCGGCGGCAGCCTGAGCATCCTCGACCCCAATGCCGACCGCGACGCCTCTGCCTTCCTCGCGCAGGTGCGCAGGGACTCGATTGGCGTCCTCTACTGCGTCCCCTCCGAACTCTCGACGCTGGTGAGCCACCTGGAGCGCGAGCGTGAAAGGGTGCATGAGCTGAACACCCTCCGGTTCATCTTCTGCGGCGGGGATACCCTGGCGGTTACCGTCGTCGAGCGTCTCGGGGTACTGGTGCGGGCCGGCCAGCTCCCGCTGCGGCTGGTCAACGTCTATGGGACGAAGGAGACGGGAATCGGCGCGGGTTGCTTCGAGTGCGCGCTGGACGCGAACGACCCCAGCGCCGAACTCCCGCCGGGACGGCTCTCGCATGAGCGGATGCCCATCGGCGGGCCCGCCCAGAACCTGTGGTTCTATGTGGTGCAACCCAACGGTGGCCTGGCTCCGTTGGGCATCCCGGGGGAACTGTACGTCGGCGGCGCGCAACTCGCCGACGCCCGTTTCGGCGACGAGCCCACGGCGACCCACCCCGGCTTCGTCCCGAACCCCTTCCGGAGCGGAGCGGAGAAGGACTGGCTGTACAAGACGGGGGACCTCGTCCGCTGGCTGCCTCAGGGGCCGCTCGAGCTGGTCAGCGCGGCTCGGGAGCGCGACGGAGGCGGGGACCACCGGCTCGATCGCGGCTTCATCGAGGCGCGCATGCGTCGTGTGGCCATTGTCCGCGACGCCGTGGTGGCCTACGTCCCGGATCGCCAGGACAGGGCCCGGTTGGTGGCCTACGTCGTTCTGAAGGAGTCGCCCGCGGCGGACGTGGAGCCGCGCGAAGGGCGGGAAACGCTGAAGGCTCGGATCAGCGCCGAACTTGGGAGCACGTTGCCGGAGTACATGCTTCCGGCCGCCTACGTGTTCATGGACAGCCTGCCGTTGACGGCTTACGGGAGGATCGACCGGAAAGCCCTGCCCGAGCCGGAGGATGACCGCCACGGTGGTAGTGCGATCGCCTACGTGGCCCCGCGCGGGCCCACGGAGAAGGCACTGGCGCACATTTGGCAGCAAGTGCTGAAACGCCCCCAGGTCGGACTGCGAGACAACTTCTTTGAGCTGGGCGGGCACTCAGTGGCGGCCATCCAACTGGTGTCCGTGAGCCGGAAGCACCTGGAGGTCGAAGTCCCCCTCAGCCTGATCTTCGAATCGCCGGTCCTGGAGGCGATGGCGCGCGGCATCGAAGCGCTGCAACAGCAGGGCCGCAGCGGCGCGGTGTCGTCGATCCATCGGGTGGAGCGGACCGGACCGCTGCCTCTGGCGTACGTGCAGGAGAGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACATCACCTGGACGTTGCACTTCGCCGGCAAGGGTTTCTCGGTGGAGGCGTTGCGGACGGCCTTCGATGAGCTGGTGGCCAGACACGAGACACTGCGCACGTGGTTCCAGGTGGGGGAGGGGACAGAGCAGGCCGTACAGGTCATCGGGGAGCCCTGGTCGATGGAGCTGCCGCTGAGAGAGGTGGCGGGGACGGAGGTGACGGCGGCAATCAATGAGATGTCCCGGCAGGTCTTCGACTTGAGAGCGGGACGGTTGCTGACGGCGGCGGTCCTGAGGGTGGCGGAGGATGAGCACATCCTCGTCAGCAACATCCACCACATCATCACGGACGGCTGGTCGTTCGGGGTGATGCTGCGGGAGCTGAGGGAGTTGTACGAGGCCGCGGTGCGGGGGGAGCGAGCGGAGCTGCCGCCGCTGACGGTGCAGTACGGCGACTATGCGGTATGGCAGAGGAAGCAGGACCTGAGCGAGCACCTGGCGTACTGGAAGGGGAAGGTGGAGGGGGACGAGGACGGGTTGGAGCTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGTATAGCTACCACCCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCGAGGACCTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGAACTGGAGAGCCTCATCGGGTTCTTCATCAACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGTGGTGGTGCTGGAGGGATTCGAGCACCAGGAGTTGCCGTTCGAGCACCTGCTGAAGGCGCTGAGGCGGCAGCGGGACAGCAGCCAGATTCCCTTGGTGCCAGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAGGAGGATGGTGGAGCACCACCAACGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGGGCTGCACGAAGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGAAGCTACATCGAGCAGATACTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGCTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGAGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGACCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCAGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGTTGCCGAACGGGAAGCTGGACCGGCTGTCGTTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAACCTCGGCGGGCACTCCCTCCTGGCTTCCCAGCTGATTTCGCGCATACGGGCGACCTTCCGCGTGGAAGTGGCGATGGCCACGGTGTTCGAGTCCCCCACGGTGGAGCCGCTCGCCCGCCACATCGAGGAGAAGCTCAAGGACGAGTCTCGGGTCCAGCTCTCCAACGTTGTGCCGGTCGAGCGGACGCAGGAGCTTCCGCTCTCCTACCTGCAGGAGAGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACGGAACGATCGGGCTCCGGCTTCGGGGTCCTCTGTCAATCCCCGCGCTCAGGGCCACCTTCCACGATCTGGTCGCCCGTCACGAGAGCCTGCGCACCGTCTTCCGGGTCCCCGAAGGCCGCACCACGCCGGTGCAGGTGATTCTTGATTCGATGGATCTGGACATCCCGGTCCGCGATGCAACCGAGGCCGACATCATCCCGGGCATGGATGAGCTGGCGGGTCACATCTACGACATGGAGAAGGGTCCGCTGTTCATGGTTCGCCTCTTGCGGCTGGCCGAGGACTCCCACGTTCTCCTGATGGGGATGCATCACATCGTCTACGACGCATGGTCACAGTTCAATGTGATGAGTCGCGATATCAACCTGCTCTACTCGGCGCACGTGACGGGAATCGAGGCACGGCTTCCCGCGCTTCCCATCCAGTACGCCGACTTCTCGGTGTGGCAGCGCCAGCAGGACTTCCGTCACCACCTGGACTACTGGAAGTCCACACTGGGCGACTACCGGGATGATCTCGAGCTGCCGTATGACTACCCGCGGCCGCCCAGCCGGACATGGCACGCGACCCGATTCACCTTCCGGTATCCGGATGCACTGGCGCGCGCGTTCGCCAGGTTCAATCAGTCCCATCAGTCGACGCTGTTCATGGGGCTGCTGACCAGCTTCGCGATCGTGCTCAGGCACTACACCGGCCGGAACGACATCTGCATCGGAACGACAACGGCGGGGCGCGCCCAGTTGGAGTTGGAGAACCTCGTTGGCTTCTTCATCAACATCCTGCCGTTGCGCATCAATCTGGCGGGTGACCCCGACATCAGCGAGCTCATGAATCGAGCGAAGAAGAGCGTCTTGGGCGCCTTCGAGCATCAAGCTCTGCCGTTCGAGCGTCTCCTCAGTGCCCTCAACAAACAGCGTGACAGCAGCCATATCCCGCTGGTTCCCGTCATGTTGCGCCACCAGAACTTCCCGACGGCGATGACCGGCAAGTGGGCCGATGGTGTGGACATGGAGGTCATCGAGCGCGACGAGCGCACGACGCCCAACGAGCTGGACCTCCAGTTCTTTGGCGACGACACCTACTTGCATGCTGTCGTCGAGTTCCCCGCGCAGCTCTTCTCCGAGGTGACCGTCCGGCGTCTGATGCAGCGTCACCAGAAGGTCATAGAGTTCATGTGCGCGACGCTGGGGGCTCGGTGA", "orf_prot_sequence": "MLLEGELEGYEDGLELPYDFPRTSNRAWRAATFQHSYPPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGREDVCIGTTVAGRAQVGALGDLSGSTVDILPLRLDLSGAPSLHEVLRRTKAVVLEGFEHEALPCQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVKRMVEHHQRVLEALVEGLEEVRLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGSYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFSLGGHSLLAAQLISRIRATFRVEVAMATVFESPTVEPLARHIEEKLKDESRVQLSNVVPVERTQEIPLSYLQERLWFVHEHMKEQRTSYNITWTLHFAGKGFSVEALRTAFDELVARHETLRTWFQVGEGTEQAVQVIGEPWSMELPLREVAGTEVTAAINEMSRQVFDLRAGRLLTAAVLRVAEDEHILVSNIHHIITDGWSFGVMLRELRELYEAAVRGKRAELPPLTVQYGDYAVWQRKQDLSEHLAYWKGKVEEYEDGLELPYDFPRTSNRAWRAATFQYSYPPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGRQDVCIGTTVAGRAQVELESLIGFFINILPLRLDLSGAPSLHEVLRRTKAVVLEGFEHQELPFEHLLKALRRQRDSSQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVRRMVEHHQRVLEALVEGLEEGLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGHYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFSLGGHSLLAAQVVSRIGKELGTQISIADLFQRPTIEQLCELIGGLDDQTQRELALAPSGNTEAVLSFAQERMWFLHNFVKGMPYNTPGLDHLTGELDVAALEKAIRAVIRRHEPLRTNFVEKDGVLSQLVGTEERFRLTVTPIRDESEVARLMEAVIQTPVDLERELMIRAYLYRVDPRNHYLFTTIHHIAFDGWSTSIFYRELAAYYAAFLRREDSPLPALEISYQDYARWERAHFQDEVLAEKLRYWRQRLSGARPLVLPTTYHRPPIQSFAGAVVNFEIDRSITERLKTLFAESGTTMYMVLLGAFSVVLQRYSGQDDICIGSPVANRGHIQTEGLIGLFVNTLVMRVDAAGNPRFIDLLARIQRTAIDAYANQEVPFEKIVDDLQVARDTARSPLVQVILNFHNTPPQSELELQGVTLTRMPVHNGTAKFELSIDVAETSAGLTGFVEYATDLFSENFIRRMIGHLEVVLDAVGRDPRAPIHELPLLTRQDQLDLLSRSGHTAPAVEHVELIPHTFERRVQESPQAIALVCGDERVTYSALNRRASQIARRLRAAGIGPDTLVGLCAGRSIELVCGVLGILKAGGAYVPIDPTSSPEVIYDVLYESKVRHLLTESRLVGGLPVDDQEILLLDTPADGEGDKAVADREEPPDLGEVSLTPECLAYVNFTSDSGGAPRGIAVRHGALARRMAAGHAQYLANSAVRFLLKAPLTFDLAVAELFQWIVSGGSLSILDPNADRDASAFLAQVRRDSIGVLYCVPSELSTLVSHLERERERVHELNTLRFIFCGGDTLAVTVVERLGVLVRAGQLPLRLVNVYGTKETGIGAGCFECALDANDPSAELPPGRLSHERMPIGGPAQNLWFYVVQPNGGLAPLGIPGELYVGGAQLADARFGDEPTATHPGFVPNPFRSGAEKDWLYKTGDLVRWLPQGPLELVSAARERDGGGDHRLDRGFIEARMRRVAIVRDAVVAYVPDRQDRARLVAYVVLKESPAADVEPREGRETLKARISAELGSTLPEYMLPAAYVFMDSLPLTAYGRIDRKALPEPEDDRHGGSAIAYVAPRGPTEKALAHIWQQVLKRPQVGLRDNFFELGGHSVAAIQLVSVSRKHLEVEVPLSLIFESPVLEAMARGIEALQQQGRSGAVSSIHRVERTGPLPLAYVQERLWFVHEHMKEQRTSYNITWTLHFAGKGFSVEALRTAFDELVARHETLRTWFQVGEGTEQAVQVIGEPWSMELPLREVAGTEVTAAINEMSRQVFDLRAGRLLTAAVLRVAEDEHILVSNIHHIITDGWSFGVMLRELRELYEAAVRGERAELPPLTVQYGDYAVWQRKQDLSEHLAYWKGKVEGDEDGLELPYDFPRTSNRAWRAATFQYSYHPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGREDLCIGTTVAGRAQVELESLIGFFINILPLRLDLSGAPSLHEVLRRTKVVVLEGFEHQELPFEHLLKALRRQRDSSQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVRRMVEHHQRVLEALVEGLEEGLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGSYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFNLGGHSLLASQLISRIRATFRVEVAMATVFESPTVEPLARHIEEKLKDESRVQLSNVVPVERTQELPLSYLQERLWFVHEHMKEQRTSYNGTIGLRLRGPLSIPALRATFHDLVARHESLRTVFRVPEGRTTPVQVILDSMDLDIPVRDATEADIIPGMDELAGHIYDMEKGPLFMVRLLRLAEDSHVLLMGMHHIVYDAWSQFNVMSRDINLLYSAHVTGIEARLPALPIQYADFSVWQRQQDFRHHLDYWKSTLGDYRDDLELPYDYPRPPSRTWHATRFTFRYPDALARAFARFNQSHQSTLFMGLLTSFAIVLRHYTGRNDICIGTTTAGRAQLELENLVGFFINILPLRINLAGDPDISELMNRAKKSVLGAFEHQALPFERLLSALNKQRDSSHIPLVPVMLRHQNFPTAMTGKWADGVDMEVIERDERTTPNELDLQFFGDDTYLHAVVEFPAQLFSEVTVRRLMQRHQKVIEFMCATLGAR", "perc_identity": 26.32}, "gnl|BL_ORD_ID|3396|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 27422, "orf_end": 41059, "orf_from": "BGC0001413.1|Cystobactamide_17 ", "model_name": "CMH-3", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "4465", "ARO_accession": "3006855", "ARO_name": "CMH-3", "ARO_category": {"42891": {"category_aro_accession": "3004776", "category_aro_cvterm_id": "42891", "category_aro_name": "CMH beta-lactamase", "category_aro_description": "CMH is a class C beta-lactamase gene family belonging to Enterobacter cloacae.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.253641, "max_identities": 25, "bit_score": 34.2686, "cvterm_id": "36884", "query": "VMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEE", "match": "+ VP+++  N+    +E   +     ML   A     +VK++ S ++A +A   +P++ ++  +ALAQ    WRV          GA+ +G G E", "sequence_from_db": "INVPHAEEPNYAWGYREGKAVHVSPGMLDAEAYGVKSNVKDMASWVMANMAPETLPQSTLQQGIALAQS-RYWRV----------GAMYQGLGWE", "sequence_from_broadstreet": "MMKKSLSCALLLSVACSAFAAPMSEKQLADVVERTVTPLMKAQAIPGMAVAVIYQGQPHYFTFGKADVAANKPVTPQTLFELGSVSKTFTGVLGGDAIARKEISLADPVTKYWPELTGKQWQGIRLLDLATYTAGGLPLQVPDDVTDNASLLRFYQSWQPKWAPGTTRLYANTSIGLFGSLAVKPSGMRFEQAMAERVFKPLKLNHTWINVPHAEEPNYAWGYREGKAVHVSPGMLDAEAYGVKSNVKDMASWVMANMAPETLPQSTLQQGIALAQSRYWRVGAMYQGLGWEMLNWPVDAKTVVDGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLANKSYPNPVRVETAYRILETLQ", "dna_sequence_from_broadstreet": "ATGATGAAAAAATCCCTAAGCTGCGCCCTGCTGCTCAGCGTTGCCTGCTCTGCTTTTGCCGCACCGATGTCAGAAAAACAGCTGGCTGACGTCGTGGAACGTACCGTTACGCCCCTGATGAAGGCGCAGGCCATACCCGGAATGGCCGTGGCCGTCATTTATCAGGGCCAGCCACACTATTTTACTTTCGGTAAAGCAGACGTCGCGGCGAATAAGCCCGTCACGCCGCAAACCTTATTTGAGCTGGGCTCCGTCAGCAAAACCTTCACCGGCGTGCTGGGTGGCGATGCCATTGCCCGCAAAGAGATTTCGCTGGCCGACCCGGTCACGAAATATTGGCCTGAATTGACGGGCAAGCAGTGGCAAGGCATTCGCCTGCTCGACCTGGCAACCTATACCGCAGGCGGATTGCCGTTGCAGGTACCGGATGATGTCACCGATAACGCCTCTCTGCTGCGTTTCTACCAGTCCTGGCAGCCAAAGTGGGCCCCGGGTACCACGCGTCTGTACGCCAACACCAGCATCGGCCTGTTTGGCTCACTGGCCGTTAAACCGTCCGGCATGCGCTTCGAGCAGGCCATGGCGGAGCGGGTCTTTAAGCCCCTGAAACTCAACCATACGTGGATAAACGTTCCACACGCTGAAGAGCCCAACTACGCATGGGGTTATCGTGAGGGAAAAGCGGTCCACGTTTCGCCTGGTATGCTGGATGCAGAAGCCTATGGTGTGAAATCTAACGTCAAAGATATGGCGAGCTGGGTGATGGCCAATATGGCACCTGAGACACTCCCGCAGTCCACTCTGCAGCAGGGTATTGCGCTGGCGCAGTCTCGCTACTGGCGCGTGGGTGCCATGTATCAAGGGTTAGGCTGGGAGATGCTCAACTGGCCGGTCGACGCCAAAACCGTGGTGGATGGCAGCGATAATAAGGTTGCACTGGCGCCGTTGCCGGTCGCAGAAGTGAATCCTCCGGCTCCGCCAGTAAAAGCCTCCTGGGTGCATAAAACGGGCTCTACGGGTGGGTTTGGCAGCTACGTGGCGTTTATTCCTGAAAAGCAGATCGGTATTGTGATGCTCGCAAATAAAAGTTATCCGAACCCGGTACGGGTGGAAACGGCTTACCGTATTCTCGAGACGCTACAGTAA", "partial": "0", "query_start": 31943, "query_end": 32227, "hit_start": 624, "hit_end": 876, "orf_dna_sequence": "ATGCTGCTGGAGGGAGAGCTGGAGGGGTACGAGGACGGGTTGGAACTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGCATAGCTACCCGCCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCGAGGACGTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGGGGCGTTGGGGGATCTGAGCGGGTCCACCGTCGACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGCGGTGGTGCTGGAGGGATTCGAGCACGAGGCGTTGCCGTGCCAGATTCCCTTGGTGCCGGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAAGAGGATGGTGGAGCACCACCAGCGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGTGCGGCTGCACGAGGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGAAGCTACATCGAGCAGATACTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGCTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGAGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGACCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCGGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGCTGCCGAACGGGAAGCTGGACCGGTTGTCGCTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAGCCTCGGCGGGCACTCCCTCCTGGCTGCCCAGCTGATTTCGCGCATACGGGCGACCTTCCGCGTGGAAGTGGCGATGGCCACGGTGTTCGAGTCCCCCACGGTGGAGCCGCTCGCCCGCCACATCGAGGAGAAGCTCAAGGACGAGTCTCGGGTCCAGCTCTCCAACGTTGTGCCGGTCGAGCGGACGCAGGAGATTCCGCTCTCCTACCTGCAGGAGCGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACATCACCTGGACGTTGCACTTCGCCGGCAAGGGTTTCTCGGTGGAGGCGTTGCGGACGGCCTTCGATGAGCTGGTGGCCAGACACGAGACACTGCGCACGTGGTTCCAGGTGGGGGAGGGGACAGAGCAGGCCGTACAGGTCATCGGGGAGCCCTGGTCGATGGAGCTGCCGCTGAGAGAGGTGGCGGGGACGGAGGTGACGGCGGCAATCAATGAGATGTCCCGACAGGTCTTCGACTTGAGAGCGGGACGGTTGCTGACGGCGGCGGTCCTGAGGGTGGCGGAGGATGAGCACATCCTCGTCAGCAACATCCACCACATCATCACGGACGGCTGGTCGTTCGGGGTGATGCTGCGGGAGCTGAGGGAGTTGTACGAGGCAGCGGTGCGGGGGAAGAGAGCGGAGCTGCCGCCGCTGACGGTGCAGTACGGCGACTATGCGGTGTGGCAGAGGAAGCAGGACCTGAGCGAGCACCTGGCGTACTGGAAGGGGAAGGTGGAGGAGTACGAGGACGGGTTGGAGCTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGTATAGCTACCCACCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCCAGGACGTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGAGCTGGAGAGCCTCATCGGGTTCTTCATCAACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGCGGTGGTGCTGGAGGGATTCGAGCACCAGGAGTTGCCGTTCGAGCACCTGCTGAAGGCGCTGAGGCGGCAGCGGGACAGCAGCCAGATTCCCTTGGTGCCAGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAGGAGGATGGTGGAGCACCACCAGCGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGGGCTGCACGAGGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGACACTACATCGAGCAGATATTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGTTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGGGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGGCCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCAGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGTTGCCGAACGGGAAGCTGGACCGGCTGTCGTTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAGCCTCGGCGGGCACTCCCTCCTGGCTGCCCAGGTGGTCTCAAGGATTGGCAAGGAGCTTGGCACTCAGATCTCGATCGCCGATCTGTTTCAAAGGCCCACGATTGAACAGCTCTGTGAGCTGATTGGAGGACTGGACGATCAGACCCAGAGGGAGCTCGCCCTCGCTCCGTCGGGGAACACCGAGGCGGTGCTCTCGTTCGCGCAAGAGCGCATGTGGTTCCTGCACAACTTCGTCAAGGGCATGCCCTACAACACGCCAGGGCTCGACCACCTGACGGGTGAGCTCGATGTCGCGGCGCTAGAAAAGGCCATCCGCGCGGTCATCCGTCGCCACGAGCCCCTGCGGACGAATTTCGTCGAGAAGGACGGGGTGCTGTCCCAGTTGGTGGGGACGGAAGAACGCTTCCGCCTGACCGTGACTCCCATCCGCGACGAGAGCGAGGTCGCGCGGCTCATGGAAGCCGTGATCCAAACGCCAGTCGATCTGGAGCGGGAGTTGATGATCCGGGCTTATCTCTACCGGGTCGACCCGCGGAATCACTACCTGTTCACCACCATCCATCACATCGCCTTCGATGGCTGGTCGACATCGATCTTCTACCGTGAGCTGGCTGCGTACTACGCCGCGTTTCTCCGGCGCGAAGACAGTCCGCTGCCCGCGCTGGAAATCTCCTATCAGGACTATGCCCGCTGGGAGCGGGCCCATTTCCAGGACGAGGTGTTGGCGGAAAAACTGAGGTACTGGCGGCAGCGGCTGTCGGGCGCTCGGCCCCTCGTACTTCCGACCACCTACCATCGGCCGCCCATCCAGAGTTTCGCTGGCGCCGTCGTGAACTTCGAGATCGATCGCTCCATCACCGAGCGGTTGAAGACGCTGTTCGCCGAGTCGGGCACCACGATGTACATGGTGTTGCTCGGCGCGTTCTCCGTGGTGCTGCAGCGCTACTCCGGTCAGGACGACATCTGCATCGGCTCCCCCGTGGCGAACCGGGGTCACATCCAGACAGAAGGGCTGATCGGCTTGTTCGTCAACACCCTGGTGATGAGGGTGGATGCCGCCGGGAATCCCCGTTTCATCGACCTGCTGGCGCGCATTCAACGGACAGCCATCGATGCTTACGCGAACCAAGAAGTGCCCTTCGAGAAGATCGTGGACGACCTGCAGGTCGCGAGAGACACGGCCCGATCTCCGCTCGTGCAGGTCATTCTCAACTTCCACAACACGCCTCCTCAATCCGAGCTGGAACTGCAGGGGGTGACCCTCACGCGGATGCCGGTGCACAACGGCACGGCCAAGTTCGAGCTCTCCATCGACGTCGCGGAGACGAGCGCCGGTCTAACGGGATTCGTGGAGTACGCGACGGATCTGTTCAGCGAGAACTTCATCCGGCGGATGATCGGCCACCTCGAGGTGGTGCTGGACGCGGTCGGTCGCGATCCGCGGGCGCCTATCCATGAGTTGCCACTGCTCACCCGGCAGGATCAGTTGGACCTACTGTCGCGGAGCGGCCACACAGCCCCCGCGGTGGAACACGTCGAGTTGATCCCTCATACGTTCGAGCGGCGCGTCCAGGAGAGCCCTCAAGCGATTGCCCTGGTCTGCGGTGACGAGCGCGTCACCTACTCCGCGCTCAACCGCCGGGCCAGCCAGATTGCCCGCCGCCTGCGCGCCGCAGGGATCGGACCGGACACCCTCGTCGGGCTTTGCGCGGGGCGCTCCATCGAGCTGGTCTGCGGCGTCCTTGGCATCTTGAAGGCGGGCGGTGCGTACGTGCCAATCGACCCCACCTCCTCGCCCGAGGTGATCTACGACGTCCTGTATGAGTCGAAGGTGCGGCATCTGTTGACCGAGTCGCGCCTGGTCGGGGGACTGCCGGTCGATGACCAGGAAATCCTGCTCCTGGATACCCCCGCGGACGGTGAAGGGGACAAGGCTGTTGCTGACCGGGAGGAGCCACCTGACCTTGGCGAGGTCAGCCTCACTCCCGAGTGCTTGGCGTACGTCAACTTCACCTCCGACTCCGGTGGGGCGCCGAGGGGCATCGCCGTCCGCCATGGGGCGCTGGCTCGCCGGATGGCCGCCGGCCACGCACAGTACCTGGCCAATTCCGCCGTACGTTTCCTGCTGAAGGCGCCGCTCACGTTCGACCTGGCGGTCGCGGAGCTGTTCCAGTGGATCGTCAGCGGCGGCAGCCTGAGCATCCTCGACCCCAATGCCGACCGCGACGCCTCTGCCTTCCTCGCGCAGGTGCGCAGGGACTCGATTGGCGTCCTCTACTGCGTCCCCTCCGAACTCTCGACGCTGGTGAGCCACCTGGAGCGCGAGCGTGAAAGGGTGCATGAGCTGAACACCCTCCGGTTCATCTTCTGCGGCGGGGATACCCTGGCGGTTACCGTCGTCGAGCGTCTCGGGGTACTGGTGCGGGCCGGCCAGCTCCCGCTGCGGCTGGTCAACGTCTATGGGACGAAGGAGACGGGAATCGGCGCGGGTTGCTTCGAGTGCGCGCTGGACGCGAACGACCCCAGCGCCGAACTCCCGCCGGGACGGCTCTCGCATGAGCGGATGCCCATCGGCGGGCCCGCCCAGAACCTGTGGTTCTATGTGGTGCAACCCAACGGTGGCCTGGCTCCGTTGGGCATCCCGGGGGAACTGTACGTCGGCGGCGCGCAACTCGCCGACGCCCGTTTCGGCGACGAGCCCACGGCGACCCACCCCGGCTTCGTCCCGAACCCCTTCCGGAGCGGAGCGGAGAAGGACTGGCTGTACAAGACGGGGGACCTCGTCCGCTGGCTGCCTCAGGGGCCGCTCGAGCTGGTCAGCGCGGCTCGGGAGCGCGACGGAGGCGGGGACCACCGGCTCGATCGCGGCTTCATCGAGGCGCGCATGCGTCGTGTGGCCATTGTCCGCGACGCCGTGGTGGCCTACGTCCCGGATCGCCAGGACAGGGCCCGGTTGGTGGCCTACGTCGTTCTGAAGGAGTCGCCCGCGGCGGACGTGGAGCCGCGCGAAGGGCGGGAAACGCTGAAGGCTCGGATCAGCGCCGAACTTGGGAGCACGTTGCCGGAGTACATGCTTCCGGCCGCCTACGTGTTCATGGACAGCCTGCCGTTGACGGCTTACGGGAGGATCGACCGGAAAGCCCTGCCCGAGCCGGAGGATGACCGCCACGGTGGTAGTGCGATCGCCTACGTGGCCCCGCGCGGGCCCACGGAGAAGGCACTGGCGCACATTTGGCAGCAAGTGCTGAAACGCCCCCAGGTCGGACTGCGAGACAACTTCTTTGAGCTGGGCGGGCACTCAGTGGCGGCCATCCAACTGGTGTCCGTGAGCCGGAAGCACCTGGAGGTCGAAGTCCCCCTCAGCCTGATCTTCGAATCGCCGGTCCTGGAGGCGATGGCGCGCGGCATCGAAGCGCTGCAACAGCAGGGCCGCAGCGGCGCGGTGTCGTCGATCCATCGGGTGGAGCGGACCGGACCGCTGCCTCTGGCGTACGTGCAGGAGAGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACATCACCTGGACGTTGCACTTCGCCGGCAAGGGTTTCTCGGTGGAGGCGTTGCGGACGGCCTTCGATGAGCTGGTGGCCAGACACGAGACACTGCGCACGTGGTTCCAGGTGGGGGAGGGGACAGAGCAGGCCGTACAGGTCATCGGGGAGCCCTGGTCGATGGAGCTGCCGCTGAGAGAGGTGGCGGGGACGGAGGTGACGGCGGCAATCAATGAGATGTCCCGGCAGGTCTTCGACTTGAGAGCGGGACGGTTGCTGACGGCGGCGGTCCTGAGGGTGGCGGAGGATGAGCACATCCTCGTCAGCAACATCCACCACATCATCACGGACGGCTGGTCGTTCGGGGTGATGCTGCGGGAGCTGAGGGAGTTGTACGAGGCCGCGGTGCGGGGGGAGCGAGCGGAGCTGCCGCCGCTGACGGTGCAGTACGGCGACTATGCGGTATGGCAGAGGAAGCAGGACCTGAGCGAGCACCTGGCGTACTGGAAGGGGAAGGTGGAGGGGGACGAGGACGGGTTGGAGCTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGTATAGCTACCACCCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCGAGGACCTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGAACTGGAGAGCCTCATCGGGTTCTTCATCAACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGTGGTGGTGCTGGAGGGATTCGAGCACCAGGAGTTGCCGTTCGAGCACCTGCTGAAGGCGCTGAGGCGGCAGCGGGACAGCAGCCAGATTCCCTTGGTGCCAGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAGGAGGATGGTGGAGCACCACCAACGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGGGCTGCACGAAGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGAAGCTACATCGAGCAGATACTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGCTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGAGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGACCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCAGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGTTGCCGAACGGGAAGCTGGACCGGCTGTCGTTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAACCTCGGCGGGCACTCCCTCCTGGCTTCCCAGCTGATTTCGCGCATACGGGCGACCTTCCGCGTGGAAGTGGCGATGGCCACGGTGTTCGAGTCCCCCACGGTGGAGCCGCTCGCCCGCCACATCGAGGAGAAGCTCAAGGACGAGTCTCGGGTCCAGCTCTCCAACGTTGTGCCGGTCGAGCGGACGCAGGAGCTTCCGCTCTCCTACCTGCAGGAGAGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACGGAACGATCGGGCTCCGGCTTCGGGGTCCTCTGTCAATCCCCGCGCTCAGGGCCACCTTCCACGATCTGGTCGCCCGTCACGAGAGCCTGCGCACCGTCTTCCGGGTCCCCGAAGGCCGCACCACGCCGGTGCAGGTGATTCTTGATTCGATGGATCTGGACATCCCGGTCCGCGATGCAACCGAGGCCGACATCATCCCGGGCATGGATGAGCTGGCGGGTCACATCTACGACATGGAGAAGGGTCCGCTGTTCATGGTTCGCCTCTTGCGGCTGGCCGAGGACTCCCACGTTCTCCTGATGGGGATGCATCACATCGTCTACGACGCATGGTCACAGTTCAATGTGATGAGTCGCGATATCAACCTGCTCTACTCGGCGCACGTGACGGGAATCGAGGCACGGCTTCCCGCGCTTCCCATCCAGTACGCCGACTTCTCGGTGTGGCAGCGCCAGCAGGACTTCCGTCACCACCTGGACTACTGGAAGTCCACACTGGGCGACTACCGGGATGATCTCGAGCTGCCGTATGACTACCCGCGGCCGCCCAGCCGGACATGGCACGCGACCCGATTCACCTTCCGGTATCCGGATGCACTGGCGCGCGCGTTCGCCAGGTTCAATCAGTCCCATCAGTCGACGCTGTTCATGGGGCTGCTGACCAGCTTCGCGATCGTGCTCAGGCACTACACCGGCCGGAACGACATCTGCATCGGAACGACAACGGCGGGGCGCGCCCAGTTGGAGTTGGAGAACCTCGTTGGCTTCTTCATCAACATCCTGCCGTTGCGCATCAATCTGGCGGGTGACCCCGACATCAGCGAGCTCATGAATCGAGCGAAGAAGAGCGTCTTGGGCGCCTTCGAGCATCAAGCTCTGCCGTTCGAGCGTCTCCTCAGTGCCCTCAACAAACAGCGTGACAGCAGCCATATCCCGCTGGTTCCCGTCATGTTGCGCCACCAGAACTTCCCGACGGCGATGACCGGCAAGTGGGCCGATGGTGTGGACATGGAGGTCATCGAGCGCGACGAGCGCACGACGCCCAACGAGCTGGACCTCCAGTTCTTTGGCGACGACACCTACTTGCATGCTGTCGTCGAGTTCCCCGCGCAGCTCTTCTCCGAGGTGACCGTCCGGCGTCTGATGCAGCGTCACCAGAAGGTCATAGAGTTCATGTGCGCGACGCTGGGGGCTCGGTGA", "orf_prot_sequence": "MLLEGELEGYEDGLELPYDFPRTSNRAWRAATFQHSYPPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGREDVCIGTTVAGRAQVGALGDLSGSTVDILPLRLDLSGAPSLHEVLRRTKAVVLEGFEHEALPCQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVKRMVEHHQRVLEALVEGLEEVRLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGSYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFSLGGHSLLAAQLISRIRATFRVEVAMATVFESPTVEPLARHIEEKLKDESRVQLSNVVPVERTQEIPLSYLQERLWFVHEHMKEQRTSYNITWTLHFAGKGFSVEALRTAFDELVARHETLRTWFQVGEGTEQAVQVIGEPWSMELPLREVAGTEVTAAINEMSRQVFDLRAGRLLTAAVLRVAEDEHILVSNIHHIITDGWSFGVMLRELRELYEAAVRGKRAELPPLTVQYGDYAVWQRKQDLSEHLAYWKGKVEEYEDGLELPYDFPRTSNRAWRAATFQYSYPPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGRQDVCIGTTVAGRAQVELESLIGFFINILPLRLDLSGAPSLHEVLRRTKAVVLEGFEHQELPFEHLLKALRRQRDSSQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVRRMVEHHQRVLEALVEGLEEGLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGHYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFSLGGHSLLAAQVVSRIGKELGTQISIADLFQRPTIEQLCELIGGLDDQTQRELALAPSGNTEAVLSFAQERMWFLHNFVKGMPYNTPGLDHLTGELDVAALEKAIRAVIRRHEPLRTNFVEKDGVLSQLVGTEERFRLTVTPIRDESEVARLMEAVIQTPVDLERELMIRAYLYRVDPRNHYLFTTIHHIAFDGWSTSIFYRELAAYYAAFLRREDSPLPALEISYQDYARWERAHFQDEVLAEKLRYWRQRLSGARPLVLPTTYHRPPIQSFAGAVVNFEIDRSITERLKTLFAESGTTMYMVLLGAFSVVLQRYSGQDDICIGSPVANRGHIQTEGLIGLFVNTLVMRVDAAGNPRFIDLLARIQRTAIDAYANQEVPFEKIVDDLQVARDTARSPLVQVILNFHNTPPQSELELQGVTLTRMPVHNGTAKFELSIDVAETSAGLTGFVEYATDLFSENFIRRMIGHLEVVLDAVGRDPRAPIHELPLLTRQDQLDLLSRSGHTAPAVEHVELIPHTFERRVQESPQAIALVCGDERVTYSALNRRASQIARRLRAAGIGPDTLVGLCAGRSIELVCGVLGILKAGGAYVPIDPTSSPEVIYDVLYESKVRHLLTESRLVGGLPVDDQEILLLDTPADGEGDKAVADREEPPDLGEVSLTPECLAYVNFTSDSGGAPRGIAVRHGALARRMAAGHAQYLANSAVRFLLKAPLTFDLAVAELFQWIVSGGSLSILDPNADRDASAFLAQVRRDSIGVLYCVPSELSTLVSHLERERERVHELNTLRFIFCGGDTLAVTVVERLGVLVRAGQLPLRLVNVYGTKETGIGAGCFECALDANDPSAELPPGRLSHERMPIGGPAQNLWFYVVQPNGGLAPLGIPGELYVGGAQLADARFGDEPTATHPGFVPNPFRSGAEKDWLYKTGDLVRWLPQGPLELVSAARERDGGGDHRLDRGFIEARMRRVAIVRDAVVAYVPDRQDRARLVAYVVLKESPAADVEPREGRETLKARISAELGSTLPEYMLPAAYVFMDSLPLTAYGRIDRKALPEPEDDRHGGSAIAYVAPRGPTEKALAHIWQQVLKRPQVGLRDNFFELGGHSVAAIQLVSVSRKHLEVEVPLSLIFESPVLEAMARGIEALQQQGRSGAVSSIHRVERTGPLPLAYVQERLWFVHEHMKEQRTSYNITWTLHFAGKGFSVEALRTAFDELVARHETLRTWFQVGEGTEQAVQVIGEPWSMELPLREVAGTEVTAAINEMSRQVFDLRAGRLLTAAVLRVAEDEHILVSNIHHIITDGWSFGVMLRELRELYEAAVRGERAELPPLTVQYGDYAVWQRKQDLSEHLAYWKGKVEGDEDGLELPYDFPRTSNRAWRAATFQYSYHPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGREDLCIGTTVAGRAQVELESLIGFFINILPLRLDLSGAPSLHEVLRRTKVVVLEGFEHQELPFEHLLKALRRQRDSSQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVRRMVEHHQRVLEALVEGLEEGLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGSYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFNLGGHSLLASQLISRIRATFRVEVAMATVFESPTVEPLARHIEEKLKDESRVQLSNVVPVERTQELPLSYLQERLWFVHEHMKEQRTSYNGTIGLRLRGPLSIPALRATFHDLVARHESLRTVFRVPEGRTTPVQVILDSMDLDIPVRDATEADIIPGMDELAGHIYDMEKGPLFMVRLLRLAEDSHVLLMGMHHIVYDAWSQFNVMSRDINLLYSAHVTGIEARLPALPIQYADFSVWQRQQDFRHHLDYWKSTLGDYRDDLELPYDYPRPPSRTWHATRFTFRYPDALARAFARFNQSHQSTLFMGLLTSFAIVLRHYTGRNDICIGTTTAGRAQLELENLVGFFINILPLRINLAGDPDISELMNRAKKSVLGAFEHQALPFERLLSALNKQRDSSHIPLVPVMLRHQNFPTAMTGKWADGVDMEVIERDERTTPNELDLQFFGDDTYLHAVVEFPAQLFSEVTVRRLMQRHQKVIEFMCATLGAR", "perc_identity": 26.32}, "gnl|BL_ORD_ID|3396|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 27422, "orf_end": 41059, "orf_from": "BGC0001413.1|Cystobactamide_17 ", "model_name": "CMH-3", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "4465", "ARO_accession": "3006855", "ARO_name": "CMH-3", "ARO_category": {"42891": {"category_aro_accession": "3004776", "category_aro_cvterm_id": "42891", "category_aro_name": "CMH beta-lactamase", "category_aro_description": "CMH is a class C beta-lactamase gene family belonging to Enterobacter cloacae.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.253641, "max_identities": 25, "bit_score": 34.2686, "cvterm_id": "36884", "query": "VMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEE", "match": "+ VP+++  N+    +E   +     ML   A     +VK++ S ++A +A   +P++ ++  +ALAQ    WRV          GA+ +G G E", "sequence_from_db": "INVPHAEEPNYAWGYREGKAVHVSPGMLDAEAYGVKSNVKDMASWVMANMAPETLPQSTLQQGIALAQS-RYWRV----------GAMYQGLGWE", "sequence_from_broadstreet": "MMKKSLSCALLLSVACSAFAAPMSEKQLADVVERTVTPLMKAQAIPGMAVAVIYQGQPHYFTFGKADVAANKPVTPQTLFELGSVSKTFTGVLGGDAIARKEISLADPVTKYWPELTGKQWQGIRLLDLATYTAGGLPLQVPDDVTDNASLLRFYQSWQPKWAPGTTRLYANTSIGLFGSLAVKPSGMRFEQAMAERVFKPLKLNHTWINVPHAEEPNYAWGYREGKAVHVSPGMLDAEAYGVKSNVKDMASWVMANMAPETLPQSTLQQGIALAQSRYWRVGAMYQGLGWEMLNWPVDAKTVVDGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLANKSYPNPVRVETAYRILETLQ", "dna_sequence_from_broadstreet": "ATGATGAAAAAATCCCTAAGCTGCGCCCTGCTGCTCAGCGTTGCCTGCTCTGCTTTTGCCGCACCGATGTCAGAAAAACAGCTGGCTGACGTCGTGGAACGTACCGTTACGCCCCTGATGAAGGCGCAGGCCATACCCGGAATGGCCGTGGCCGTCATTTATCAGGGCCAGCCACACTATTTTACTTTCGGTAAAGCAGACGTCGCGGCGAATAAGCCCGTCACGCCGCAAACCTTATTTGAGCTGGGCTCCGTCAGCAAAACCTTCACCGGCGTGCTGGGTGGCGATGCCATTGCCCGCAAAGAGATTTCGCTGGCCGACCCGGTCACGAAATATTGGCCTGAATTGACGGGCAAGCAGTGGCAAGGCATTCGCCTGCTCGACCTGGCAACCTATACCGCAGGCGGATTGCCGTTGCAGGTACCGGATGATGTCACCGATAACGCCTCTCTGCTGCGTTTCTACCAGTCCTGGCAGCCAAAGTGGGCCCCGGGTACCACGCGTCTGTACGCCAACACCAGCATCGGCCTGTTTGGCTCACTGGCCGTTAAACCGTCCGGCATGCGCTTCGAGCAGGCCATGGCGGAGCGGGTCTTTAAGCCCCTGAAACTCAACCATACGTGGATAAACGTTCCACACGCTGAAGAGCCCAACTACGCATGGGGTTATCGTGAGGGAAAAGCGGTCCACGTTTCGCCTGGTATGCTGGATGCAGAAGCCTATGGTGTGAAATCTAACGTCAAAGATATGGCGAGCTGGGTGATGGCCAATATGGCACCTGAGACACTCCCGCAGTCCACTCTGCAGCAGGGTATTGCGCTGGCGCAGTCTCGCTACTGGCGCGTGGGTGCCATGTATCAAGGGTTAGGCTGGGAGATGCTCAACTGGCCGGTCGACGCCAAAACCGTGGTGGATGGCAGCGATAATAAGGTTGCACTGGCGCCGTTGCCGGTCGCAGAAGTGAATCCTCCGGCTCCGCCAGTAAAAGCCTCCTGGGTGCATAAAACGGGCTCTACGGGTGGGTTTGGCAGCTACGTGGCGTTTATTCCTGAAAAGCAGATCGGTATTGTGATGCTCGCAAATAAAAGTTATCCGAACCCGGTACGGGTGGAAACGGCTTACCGTATTCTCGAGACGCTACAGTAA", "partial": "0", "query_start": 38450, "query_end": 38734, "hit_start": 624, "hit_end": 876, "orf_dna_sequence": "ATGCTGCTGGAGGGAGAGCTGGAGGGGTACGAGGACGGGTTGGAACTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGCATAGCTACCCGCCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCGAGGACGTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGGGGCGTTGGGGGATCTGAGCGGGTCCACCGTCGACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGCGGTGGTGCTGGAGGGATTCGAGCACGAGGCGTTGCCGTGCCAGATTCCCTTGGTGCCGGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAAGAGGATGGTGGAGCACCACCAGCGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGTGCGGCTGCACGAGGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGAAGCTACATCGAGCAGATACTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGCTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGAGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGACCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCGGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGCTGCCGAACGGGAAGCTGGACCGGTTGTCGCTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAGCCTCGGCGGGCACTCCCTCCTGGCTGCCCAGCTGATTTCGCGCATACGGGCGACCTTCCGCGTGGAAGTGGCGATGGCCACGGTGTTCGAGTCCCCCACGGTGGAGCCGCTCGCCCGCCACATCGAGGAGAAGCTCAAGGACGAGTCTCGGGTCCAGCTCTCCAACGTTGTGCCGGTCGAGCGGACGCAGGAGATTCCGCTCTCCTACCTGCAGGAGCGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACATCACCTGGACGTTGCACTTCGCCGGCAAGGGTTTCTCGGTGGAGGCGTTGCGGACGGCCTTCGATGAGCTGGTGGCCAGACACGAGACACTGCGCACGTGGTTCCAGGTGGGGGAGGGGACAGAGCAGGCCGTACAGGTCATCGGGGAGCCCTGGTCGATGGAGCTGCCGCTGAGAGAGGTGGCGGGGACGGAGGTGACGGCGGCAATCAATGAGATGTCCCGACAGGTCTTCGACTTGAGAGCGGGACGGTTGCTGACGGCGGCGGTCCTGAGGGTGGCGGAGGATGAGCACATCCTCGTCAGCAACATCCACCACATCATCACGGACGGCTGGTCGTTCGGGGTGATGCTGCGGGAGCTGAGGGAGTTGTACGAGGCAGCGGTGCGGGGGAAGAGAGCGGAGCTGCCGCCGCTGACGGTGCAGTACGGCGACTATGCGGTGTGGCAGAGGAAGCAGGACCTGAGCGAGCACCTGGCGTACTGGAAGGGGAAGGTGGAGGAGTACGAGGACGGGTTGGAGCTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGTATAGCTACCCACCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCCAGGACGTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGAGCTGGAGAGCCTCATCGGGTTCTTCATCAACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGCGGTGGTGCTGGAGGGATTCGAGCACCAGGAGTTGCCGTTCGAGCACCTGCTGAAGGCGCTGAGGCGGCAGCGGGACAGCAGCCAGATTCCCTTGGTGCCAGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAGGAGGATGGTGGAGCACCACCAGCGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGGGCTGCACGAGGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGACACTACATCGAGCAGATATTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGTTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGGGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGGCCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCAGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGTTGCCGAACGGGAAGCTGGACCGGCTGTCGTTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAGCCTCGGCGGGCACTCCCTCCTGGCTGCCCAGGTGGTCTCAAGGATTGGCAAGGAGCTTGGCACTCAGATCTCGATCGCCGATCTGTTTCAAAGGCCCACGATTGAACAGCTCTGTGAGCTGATTGGAGGACTGGACGATCAGACCCAGAGGGAGCTCGCCCTCGCTCCGTCGGGGAACACCGAGGCGGTGCTCTCGTTCGCGCAAGAGCGCATGTGGTTCCTGCACAACTTCGTCAAGGGCATGCCCTACAACACGCCAGGGCTCGACCACCTGACGGGTGAGCTCGATGTCGCGGCGCTAGAAAAGGCCATCCGCGCGGTCATCCGTCGCCACGAGCCCCTGCGGACGAATTTCGTCGAGAAGGACGGGGTGCTGTCCCAGTTGGTGGGGACGGAAGAACGCTTCCGCCTGACCGTGACTCCCATCCGCGACGAGAGCGAGGTCGCGCGGCTCATGGAAGCCGTGATCCAAACGCCAGTCGATCTGGAGCGGGAGTTGATGATCCGGGCTTATCTCTACCGGGTCGACCCGCGGAATCACTACCTGTTCACCACCATCCATCACATCGCCTTCGATGGCTGGTCGACATCGATCTTCTACCGTGAGCTGGCTGCGTACTACGCCGCGTTTCTCCGGCGCGAAGACAGTCCGCTGCCCGCGCTGGAAATCTCCTATCAGGACTATGCCCGCTGGGAGCGGGCCCATTTCCAGGACGAGGTGTTGGCGGAAAAACTGAGGTACTGGCGGCAGCGGCTGTCGGGCGCTCGGCCCCTCGTACTTCCGACCACCTACCATCGGCCGCCCATCCAGAGTTTCGCTGGCGCCGTCGTGAACTTCGAGATCGATCGCTCCATCACCGAGCGGTTGAAGACGCTGTTCGCCGAGTCGGGCACCACGATGTACATGGTGTTGCTCGGCGCGTTCTCCGTGGTGCTGCAGCGCTACTCCGGTCAGGACGACATCTGCATCGGCTCCCCCGTGGCGAACCGGGGTCACATCCAGACAGAAGGGCTGATCGGCTTGTTCGTCAACACCCTGGTGATGAGGGTGGATGCCGCCGGGAATCCCCGTTTCATCGACCTGCTGGCGCGCATTCAACGGACAGCCATCGATGCTTACGCGAACCAAGAAGTGCCCTTCGAGAAGATCGTGGACGACCTGCAGGTCGCGAGAGACACGGCCCGATCTCCGCTCGTGCAGGTCATTCTCAACTTCCACAACACGCCTCCTCAATCCGAGCTGGAACTGCAGGGGGTGACCCTCACGCGGATGCCGGTGCACAACGGCACGGCCAAGTTCGAGCTCTCCATCGACGTCGCGGAGACGAGCGCCGGTCTAACGGGATTCGTGGAGTACGCGACGGATCTGTTCAGCGAGAACTTCATCCGGCGGATGATCGGCCACCTCGAGGTGGTGCTGGACGCGGTCGGTCGCGATCCGCGGGCGCCTATCCATGAGTTGCCACTGCTCACCCGGCAGGATCAGTTGGACCTACTGTCGCGGAGCGGCCACACAGCCCCCGCGGTGGAACACGTCGAGTTGATCCCTCATACGTTCGAGCGGCGCGTCCAGGAGAGCCCTCAAGCGATTGCCCTGGTCTGCGGTGACGAGCGCGTCACCTACTCCGCGCTCAACCGCCGGGCCAGCCAGATTGCCCGCCGCCTGCGCGCCGCAGGGATCGGACCGGACACCCTCGTCGGGCTTTGCGCGGGGCGCTCCATCGAGCTGGTCTGCGGCGTCCTTGGCATCTTGAAGGCGGGCGGTGCGTACGTGCCAATCGACCCCACCTCCTCGCCCGAGGTGATCTACGACGTCCTGTATGAGTCGAAGGTGCGGCATCTGTTGACCGAGTCGCGCCTGGTCGGGGGACTGCCGGTCGATGACCAGGAAATCCTGCTCCTGGATACCCCCGCGGACGGTGAAGGGGACAAGGCTGTTGCTGACCGGGAGGAGCCACCTGACCTTGGCGAGGTCAGCCTCACTCCCGAGTGCTTGGCGTACGTCAACTTCACCTCCGACTCCGGTGGGGCGCCGAGGGGCATCGCCGTCCGCCATGGGGCGCTGGCTCGCCGGATGGCCGCCGGCCACGCACAGTACCTGGCCAATTCCGCCGTACGTTTCCTGCTGAAGGCGCCGCTCACGTTCGACCTGGCGGTCGCGGAGCTGTTCCAGTGGATCGTCAGCGGCGGCAGCCTGAGCATCCTCGACCCCAATGCCGACCGCGACGCCTCTGCCTTCCTCGCGCAGGTGCGCAGGGACTCGATTGGCGTCCTCTACTGCGTCCCCTCCGAACTCTCGACGCTGGTGAGCCACCTGGAGCGCGAGCGTGAAAGGGTGCATGAGCTGAACACCCTCCGGTTCATCTTCTGCGGCGGGGATACCCTGGCGGTTACCGTCGTCGAGCGTCTCGGGGTACTGGTGCGGGCCGGCCAGCTCCCGCTGCGGCTGGTCAACGTCTATGGGACGAAGGAGACGGGAATCGGCGCGGGTTGCTTCGAGTGCGCGCTGGACGCGAACGACCCCAGCGCCGAACTCCCGCCGGGACGGCTCTCGCATGAGCGGATGCCCATCGGCGGGCCCGCCCAGAACCTGTGGTTCTATGTGGTGCAACCCAACGGTGGCCTGGCTCCGTTGGGCATCCCGGGGGAACTGTACGTCGGCGGCGCGCAACTCGCCGACGCCCGTTTCGGCGACGAGCCCACGGCGACCCACCCCGGCTTCGTCCCGAACCCCTTCCGGAGCGGAGCGGAGAAGGACTGGCTGTACAAGACGGGGGACCTCGTCCGCTGGCTGCCTCAGGGGCCGCTCGAGCTGGTCAGCGCGGCTCGGGAGCGCGACGGAGGCGGGGACCACCGGCTCGATCGCGGCTTCATCGAGGCGCGCATGCGTCGTGTGGCCATTGTCCGCGACGCCGTGGTGGCCTACGTCCCGGATCGCCAGGACAGGGCCCGGTTGGTGGCCTACGTCGTTCTGAAGGAGTCGCCCGCGGCGGACGTGGAGCCGCGCGAAGGGCGGGAAACGCTGAAGGCTCGGATCAGCGCCGAACTTGGGAGCACGTTGCCGGAGTACATGCTTCCGGCCGCCTACGTGTTCATGGACAGCCTGCCGTTGACGGCTTACGGGAGGATCGACCGGAAAGCCCTGCCCGAGCCGGAGGATGACCGCCACGGTGGTAGTGCGATCGCCTACGTGGCCCCGCGCGGGCCCACGGAGAAGGCACTGGCGCACATTTGGCAGCAAGTGCTGAAACGCCCCCAGGTCGGACTGCGAGACAACTTCTTTGAGCTGGGCGGGCACTCAGTGGCGGCCATCCAACTGGTGTCCGTGAGCCGGAAGCACCTGGAGGTCGAAGTCCCCCTCAGCCTGATCTTCGAATCGCCGGTCCTGGAGGCGATGGCGCGCGGCATCGAAGCGCTGCAACAGCAGGGCCGCAGCGGCGCGGTGTCGTCGATCCATCGGGTGGAGCGGACCGGACCGCTGCCTCTGGCGTACGTGCAGGAGAGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACATCACCTGGACGTTGCACTTCGCCGGCAAGGGTTTCTCGGTGGAGGCGTTGCGGACGGCCTTCGATGAGCTGGTGGCCAGACACGAGACACTGCGCACGTGGTTCCAGGTGGGGGAGGGGACAGAGCAGGCCGTACAGGTCATCGGGGAGCCCTGGTCGATGGAGCTGCCGCTGAGAGAGGTGGCGGGGACGGAGGTGACGGCGGCAATCAATGAGATGTCCCGGCAGGTCTTCGACTTGAGAGCGGGACGGTTGCTGACGGCGGCGGTCCTGAGGGTGGCGGAGGATGAGCACATCCTCGTCAGCAACATCCACCACATCATCACGGACGGCTGGTCGTTCGGGGTGATGCTGCGGGAGCTGAGGGAGTTGTACGAGGCCGCGGTGCGGGGGGAGCGAGCGGAGCTGCCGCCGCTGACGGTGCAGTACGGCGACTATGCGGTATGGCAGAGGAAGCAGGACCTGAGCGAGCACCTGGCGTACTGGAAGGGGAAGGTGGAGGGGGACGAGGACGGGTTGGAGCTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGTATAGCTACCACCCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCGAGGACCTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGAACTGGAGAGCCTCATCGGGTTCTTCATCAACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGTGGTGGTGCTGGAGGGATTCGAGCACCAGGAGTTGCCGTTCGAGCACCTGCTGAAGGCGCTGAGGCGGCAGCGGGACAGCAGCCAGATTCCCTTGGTGCCAGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAGGAGGATGGTGGAGCACCACCAACGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGGGCTGCACGAAGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGAAGCTACATCGAGCAGATACTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGCTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGAGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGACCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCAGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGTTGCCGAACGGGAAGCTGGACCGGCTGTCGTTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAACCTCGGCGGGCACTCCCTCCTGGCTTCCCAGCTGATTTCGCGCATACGGGCGACCTTCCGCGTGGAAGTGGCGATGGCCACGGTGTTCGAGTCCCCCACGGTGGAGCCGCTCGCCCGCCACATCGAGGAGAAGCTCAAGGACGAGTCTCGGGTCCAGCTCTCCAACGTTGTGCCGGTCGAGCGGACGCAGGAGCTTCCGCTCTCCTACCTGCAGGAGAGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACGGAACGATCGGGCTCCGGCTTCGGGGTCCTCTGTCAATCCCCGCGCTCAGGGCCACCTTCCACGATCTGGTCGCCCGTCACGAGAGCCTGCGCACCGTCTTCCGGGTCCCCGAAGGCCGCACCACGCCGGTGCAGGTGATTCTTGATTCGATGGATCTGGACATCCCGGTCCGCGATGCAACCGAGGCCGACATCATCCCGGGCATGGATGAGCTGGCGGGTCACATCTACGACATGGAGAAGGGTCCGCTGTTCATGGTTCGCCTCTTGCGGCTGGCCGAGGACTCCCACGTTCTCCTGATGGGGATGCATCACATCGTCTACGACGCATGGTCACAGTTCAATGTGATGAGTCGCGATATCAACCTGCTCTACTCGGCGCACGTGACGGGAATCGAGGCACGGCTTCCCGCGCTTCCCATCCAGTACGCCGACTTCTCGGTGTGGCAGCGCCAGCAGGACTTCCGTCACCACCTGGACTACTGGAAGTCCACACTGGGCGACTACCGGGATGATCTCGAGCTGCCGTATGACTACCCGCGGCCGCCCAGCCGGACATGGCACGCGACCCGATTCACCTTCCGGTATCCGGATGCACTGGCGCGCGCGTTCGCCAGGTTCAATCAGTCCCATCAGTCGACGCTGTTCATGGGGCTGCTGACCAGCTTCGCGATCGTGCTCAGGCACTACACCGGCCGGAACGACATCTGCATCGGAACGACAACGGCGGGGCGCGCCCAGTTGGAGTTGGAGAACCTCGTTGGCTTCTTCATCAACATCCTGCCGTTGCGCATCAATCTGGCGGGTGACCCCGACATCAGCGAGCTCATGAATCGAGCGAAGAAGAGCGTCTTGGGCGCCTTCGAGCATCAAGCTCTGCCGTTCGAGCGTCTCCTCAGTGCCCTCAACAAACAGCGTGACAGCAGCCATATCCCGCTGGTTCCCGTCATGTTGCGCCACCAGAACTTCCCGACGGCGATGACCGGCAAGTGGGCCGATGGTGTGGACATGGAGGTCATCGAGCGCGACGAGCGCACGACGCCCAACGAGCTGGACCTCCAGTTCTTTGGCGACGACACCTACTTGCATGCTGTCGTCGAGTTCCCCGCGCAGCTCTTCTCCGAGGTGACCGTCCGGCGTCTGATGCAGCGTCACCAGAAGGTCATAGAGTTCATGTGCGCGACGCTGGGGGCTCGGTGA", "orf_prot_sequence": "MLLEGELEGYEDGLELPYDFPRTSNRAWRAATFQHSYPPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGREDVCIGTTVAGRAQVGALGDLSGSTVDILPLRLDLSGAPSLHEVLRRTKAVVLEGFEHEALPCQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVKRMVEHHQRVLEALVEGLEEVRLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGSYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFSLGGHSLLAAQLISRIRATFRVEVAMATVFESPTVEPLARHIEEKLKDESRVQLSNVVPVERTQEIPLSYLQERLWFVHEHMKEQRTSYNITWTLHFAGKGFSVEALRTAFDELVARHETLRTWFQVGEGTEQAVQVIGEPWSMELPLREVAGTEVTAAINEMSRQVFDLRAGRLLTAAVLRVAEDEHILVSNIHHIITDGWSFGVMLRELRELYEAAVRGKRAELPPLTVQYGDYAVWQRKQDLSEHLAYWKGKVEEYEDGLELPYDFPRTSNRAWRAATFQYSYPPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGRQDVCIGTTVAGRAQVELESLIGFFINILPLRLDLSGAPSLHEVLRRTKAVVLEGFEHQELPFEHLLKALRRQRDSSQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVRRMVEHHQRVLEALVEGLEEGLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGHYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFSLGGHSLLAAQVVSRIGKELGTQISIADLFQRPTIEQLCELIGGLDDQTQRELALAPSGNTEAVLSFAQERMWFLHNFVKGMPYNTPGLDHLTGELDVAALEKAIRAVIRRHEPLRTNFVEKDGVLSQLVGTEERFRLTVTPIRDESEVARLMEAVIQTPVDLERELMIRAYLYRVDPRNHYLFTTIHHIAFDGWSTSIFYRELAAYYAAFLRREDSPLPALEISYQDYARWERAHFQDEVLAEKLRYWRQRLSGARPLVLPTTYHRPPIQSFAGAVVNFEIDRSITERLKTLFAESGTTMYMVLLGAFSVVLQRYSGQDDICIGSPVANRGHIQTEGLIGLFVNTLVMRVDAAGNPRFIDLLARIQRTAIDAYANQEVPFEKIVDDLQVARDTARSPLVQVILNFHNTPPQSELELQGVTLTRMPVHNGTAKFELSIDVAETSAGLTGFVEYATDLFSENFIRRMIGHLEVVLDAVGRDPRAPIHELPLLTRQDQLDLLSRSGHTAPAVEHVELIPHTFERRVQESPQAIALVCGDERVTYSALNRRASQIARRLRAAGIGPDTLVGLCAGRSIELVCGVLGILKAGGAYVPIDPTSSPEVIYDVLYESKVRHLLTESRLVGGLPVDDQEILLLDTPADGEGDKAVADREEPPDLGEVSLTPECLAYVNFTSDSGGAPRGIAVRHGALARRMAAGHAQYLANSAVRFLLKAPLTFDLAVAELFQWIVSGGSLSILDPNADRDASAFLAQVRRDSIGVLYCVPSELSTLVSHLERERERVHELNTLRFIFCGGDTLAVTVVERLGVLVRAGQLPLRLVNVYGTKETGIGAGCFECALDANDPSAELPPGRLSHERMPIGGPAQNLWFYVVQPNGGLAPLGIPGELYVGGAQLADARFGDEPTATHPGFVPNPFRSGAEKDWLYKTGDLVRWLPQGPLELVSAARERDGGGDHRLDRGFIEARMRRVAIVRDAVVAYVPDRQDRARLVAYVVLKESPAADVEPREGRETLKARISAELGSTLPEYMLPAAYVFMDSLPLTAYGRIDRKALPEPEDDRHGGSAIAYVAPRGPTEKALAHIWQQVLKRPQVGLRDNFFELGGHSVAAIQLVSVSRKHLEVEVPLSLIFESPVLEAMARGIEALQQQGRSGAVSSIHRVERTGPLPLAYVQERLWFVHEHMKEQRTSYNITWTLHFAGKGFSVEALRTAFDELVARHETLRTWFQVGEGTEQAVQVIGEPWSMELPLREVAGTEVTAAINEMSRQVFDLRAGRLLTAAVLRVAEDEHILVSNIHHIITDGWSFGVMLRELRELYEAAVRGERAELPPLTVQYGDYAVWQRKQDLSEHLAYWKGKVEGDEDGLELPYDFPRTSNRAWRAATFQYSYHPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGREDLCIGTTVAGRAQVELESLIGFFINILPLRLDLSGAPSLHEVLRRTKVVVLEGFEHQELPFEHLLKALRRQRDSSQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVRRMVEHHQRVLEALVEGLEEGLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGSYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFNLGGHSLLASQLISRIRATFRVEVAMATVFESPTVEPLARHIEEKLKDESRVQLSNVVPVERTQELPLSYLQERLWFVHEHMKEQRTSYNGTIGLRLRGPLSIPALRATFHDLVARHESLRTVFRVPEGRTTPVQVILDSMDLDIPVRDATEADIIPGMDELAGHIYDMEKGPLFMVRLLRLAEDSHVLLMGMHHIVYDAWSQFNVMSRDINLLYSAHVTGIEARLPALPIQYADFSVWQRQQDFRHHLDYWKSTLGDYRDDLELPYDYPRPPSRTWHATRFTFRYPDALARAFARFNQSHQSTLFMGLLTSFAIVLRHYTGRNDICIGTTTAGRAQLELENLVGFFINILPLRINLAGDPDISELMNRAKKSVLGAFEHQALPFERLLSALNKQRDSSHIPLVPVMLRHQNFPTAMTGKWADGVDMEVIERDERTTPNELDLQFFGDDTYLHAVVEFPAQLFSEVTVRRLMQRHQKVIEFMCATLGAR", "perc_identity": 26.32}, "gnl|BL_ORD_ID|3395|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 27422, "orf_end": 41059, "orf_from": "BGC0001413.1|Cystobactamide_17 ", "model_name": "CMH-2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "4464", "ARO_accession": "3006854", "ARO_name": "CMH-2", "ARO_category": {"42891": {"category_aro_accession": "3004776", "category_aro_cvterm_id": "42891", "category_aro_name": "CMH beta-lactamase", "category_aro_description": "CMH is a class C beta-lactamase gene family belonging to Enterobacter cloacae.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.93437, "max_identities": 24, "bit_score": 32.3426, "cvterm_id": "35915", "query": "VMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEE", "match": "+ VP+++  ++    +E   +     ML   A     +VK++ S ++A +A   +P++ ++  +ALAQ    WRV          GA+ +G G E", "sequence_from_db": "INVPHAEESHYAWGYREGKAVHVSPGMLDAEAYGVKSNVKDMASWVMANMAPETLPQSTLQQGIALAQS-RYWRV----------GAMYQGLGWE", "sequence_from_broadstreet": "MMTKSLSCALLLSVACSAFAAPMSEKQLADVVERTVTPLMKAQAIPGMAVAVIYQGQPHYFTFGKADVAANKPVTPQTLFELGSVSKTFTGVLGGDAIARKEISLADPVTKYWPELTGKQWQGIRLLDLATYTAGGLPLQVPDAVTDNASLLRFYQSWQPKWAPGTTRLYANTSIGLFGSLAVKPSGMRFEEAMTERVFKPLKLNHTWINVPHAEESHYAWGYREGKAVHVSPGMLDAEAYGVKSNVKDMASWVMANMAPETLPQSTLQQGIALAQSRYWRVGAMYQGLGWEMLNWPVDAKTVVDGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLANKSYPNPVRVETAYRILDALQ", "dna_sequence_from_broadstreet": "ATGATGACAAAATCCCTAAGCTGCGCGCTGCTGCTCAGCGTTGCCTGCTCTGCTTTTGCCGCGCCGATGTCAGAAAAACAGCTGGCTGACGTCGTGGAACGTACCGTTACGCCTCTGATGAAGGCGCAGGCCATACCCGGAATGGCCGTGGCCGTCATTTATCAGGGCCAGCCACACTATTTTACTTTCGGTAAAGCAGACGTTGCGGCGAATAAGCCCGTCACGCCGCAAACCTTATTTGAGCTGGGCTCCGTCAGCAAAACCTTCACCGGCGTGCTGGGTGGCGATGCCATTGCCCGCAAAGAGATTTCGCTGGCCGACCCGGTCACAAAATATTGGCCTGAATTGACGGGCAAGCAGTGGCAAGGCATTCGCCTGCTAGACCTGGCAACCTATACCGCAGGTGGATTGCCGTTGCAGGTGCCGGATGCTGTCACCGATAACGCCTCTCTGCTGCGTTTCTACCAGTCCTGGCAGCCAAAGTGGGCCCCGGGTACTACGCGTCTGTACGCCAACACCAGCATCGGTTTGTTTGGCTCACTGGCGGTTAAACCTTCCGGCATGCGCTTTGAGGAGGCCATGACGGAGCGGGTCTTTAAGCCCCTGAAACTCAACCATACGTGGATAAACGTTCCACACGCTGAAGAGTCGCACTACGCATGGGGTTATCGTGAGGGAAAAGCGGTCCACGTTTCGCCTGGTATGCTGGATGCAGAAGCCTATGGCGTGAAATCTAACGTCAAAGATATGGCGAGCTGGGTGATGGCCAATATGGCACCTGAGACACTCCCGCAGTCCACTCTGCAGCAGGGTATTGCGCTGGCGCAGTCTCGCTACTGGCGCGTGGGTGCCATGTATCAAGGGTTAGGCTGGGAGATGCTCAACTGGCCGGTCGACGCCAAAACCGTGGTGGATGGCAGCGATAATAAGGTCGCACTGGCGCCGTTGCCGGTCGCAGAAGTGAATCCTCCGGCTCCGCCAGTAAAAGCCTCCTGGGTGCATAAAACGGGCTCTACGGGTGGGTTTGGCAGCTACGTGGCGTTTATTCCTGAAAAGCAGATCGGTATTGTGATGCTCGCAAATAAAAGCTATCCGAACCCGGTACGGGTGGAAACGGCTTACCGTATCCTCGACGCGCTACAGTAA", "partial": "0", "query_start": 28721, "query_end": 29005, "hit_start": 624, "hit_end": 876, "orf_dna_sequence": "ATGCTGCTGGAGGGAGAGCTGGAGGGGTACGAGGACGGGTTGGAACTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGCATAGCTACCCGCCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCGAGGACGTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGGGGCGTTGGGGGATCTGAGCGGGTCCACCGTCGACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGCGGTGGTGCTGGAGGGATTCGAGCACGAGGCGTTGCCGTGCCAGATTCCCTTGGTGCCGGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAAGAGGATGGTGGAGCACCACCAGCGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGTGCGGCTGCACGAGGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGAAGCTACATCGAGCAGATACTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGCTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGAGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGACCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCGGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGCTGCCGAACGGGAAGCTGGACCGGTTGTCGCTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAGCCTCGGCGGGCACTCCCTCCTGGCTGCCCAGCTGATTTCGCGCATACGGGCGACCTTCCGCGTGGAAGTGGCGATGGCCACGGTGTTCGAGTCCCCCACGGTGGAGCCGCTCGCCCGCCACATCGAGGAGAAGCTCAAGGACGAGTCTCGGGTCCAGCTCTCCAACGTTGTGCCGGTCGAGCGGACGCAGGAGATTCCGCTCTCCTACCTGCAGGAGCGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACATCACCTGGACGTTGCACTTCGCCGGCAAGGGTTTCTCGGTGGAGGCGTTGCGGACGGCCTTCGATGAGCTGGTGGCCAGACACGAGACACTGCGCACGTGGTTCCAGGTGGGGGAGGGGACAGAGCAGGCCGTACAGGTCATCGGGGAGCCCTGGTCGATGGAGCTGCCGCTGAGAGAGGTGGCGGGGACGGAGGTGACGGCGGCAATCAATGAGATGTCCCGACAGGTCTTCGACTTGAGAGCGGGACGGTTGCTGACGGCGGCGGTCCTGAGGGTGGCGGAGGATGAGCACATCCTCGTCAGCAACATCCACCACATCATCACGGACGGCTGGTCGTTCGGGGTGATGCTGCGGGAGCTGAGGGAGTTGTACGAGGCAGCGGTGCGGGGGAAGAGAGCGGAGCTGCCGCCGCTGACGGTGCAGTACGGCGACTATGCGGTGTGGCAGAGGAAGCAGGACCTGAGCGAGCACCTGGCGTACTGGAAGGGGAAGGTGGAGGAGTACGAGGACGGGTTGGAGCTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGTATAGCTACCCACCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCCAGGACGTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGAGCTGGAGAGCCTCATCGGGTTCTTCATCAACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGCGGTGGTGCTGGAGGGATTCGAGCACCAGGAGTTGCCGTTCGAGCACCTGCTGAAGGCGCTGAGGCGGCAGCGGGACAGCAGCCAGATTCCCTTGGTGCCAGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAGGAGGATGGTGGAGCACCACCAGCGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGGGCTGCACGAGGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGACACTACATCGAGCAGATATTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGTTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGGGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGGCCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCAGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGTTGCCGAACGGGAAGCTGGACCGGCTGTCGTTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAGCCTCGGCGGGCACTCCCTCCTGGCTGCCCAGGTGGTCTCAAGGATTGGCAAGGAGCTTGGCACTCAGATCTCGATCGCCGATCTGTTTCAAAGGCCCACGATTGAACAGCTCTGTGAGCTGATTGGAGGACTGGACGATCAGACCCAGAGGGAGCTCGCCCTCGCTCCGTCGGGGAACACCGAGGCGGTGCTCTCGTTCGCGCAAGAGCGCATGTGGTTCCTGCACAACTTCGTCAAGGGCATGCCCTACAACACGCCAGGGCTCGACCACCTGACGGGTGAGCTCGATGTCGCGGCGCTAGAAAAGGCCATCCGCGCGGTCATCCGTCGCCACGAGCCCCTGCGGACGAATTTCGTCGAGAAGGACGGGGTGCTGTCCCAGTTGGTGGGGACGGAAGAACGCTTCCGCCTGACCGTGACTCCCATCCGCGACGAGAGCGAGGTCGCGCGGCTCATGGAAGCCGTGATCCAAACGCCAGTCGATCTGGAGCGGGAGTTGATGATCCGGGCTTATCTCTACCGGGTCGACCCGCGGAATCACTACCTGTTCACCACCATCCATCACATCGCCTTCGATGGCTGGTCGACATCGATCTTCTACCGTGAGCTGGCTGCGTACTACGCCGCGTTTCTCCGGCGCGAAGACAGTCCGCTGCCCGCGCTGGAAATCTCCTATCAGGACTATGCCCGCTGGGAGCGGGCCCATTTCCAGGACGAGGTGTTGGCGGAAAAACTGAGGTACTGGCGGCAGCGGCTGTCGGGCGCTCGGCCCCTCGTACTTCCGACCACCTACCATCGGCCGCCCATCCAGAGTTTCGCTGGCGCCGTCGTGAACTTCGAGATCGATCGCTCCATCACCGAGCGGTTGAAGACGCTGTTCGCCGAGTCGGGCACCACGATGTACATGGTGTTGCTCGGCGCGTTCTCCGTGGTGCTGCAGCGCTACTCCGGTCAGGACGACATCTGCATCGGCTCCCCCGTGGCGAACCGGGGTCACATCCAGACAGAAGGGCTGATCGGCTTGTTCGTCAACACCCTGGTGATGAGGGTGGATGCCGCCGGGAATCCCCGTTTCATCGACCTGCTGGCGCGCATTCAACGGACAGCCATCGATGCTTACGCGAACCAAGAAGTGCCCTTCGAGAAGATCGTGGACGACCTGCAGGTCGCGAGAGACACGGCCCGATCTCCGCTCGTGCAGGTCATTCTCAACTTCCACAACACGCCTCCTCAATCCGAGCTGGAACTGCAGGGGGTGACCCTCACGCGGATGCCGGTGCACAACGGCACGGCCAAGTTCGAGCTCTCCATCGACGTCGCGGAGACGAGCGCCGGTCTAACGGGATTCGTGGAGTACGCGACGGATCTGTTCAGCGAGAACTTCATCCGGCGGATGATCGGCCACCTCGAGGTGGTGCTGGACGCGGTCGGTCGCGATCCGCGGGCGCCTATCCATGAGTTGCCACTGCTCACCCGGCAGGATCAGTTGGACCTACTGTCGCGGAGCGGCCACACAGCCCCCGCGGTGGAACACGTCGAGTTGATCCCTCATACGTTCGAGCGGCGCGTCCAGGAGAGCCCTCAAGCGATTGCCCTGGTCTGCGGTGACGAGCGCGTCACCTACTCCGCGCTCAACCGCCGGGCCAGCCAGATTGCCCGCCGCCTGCGCGCCGCAGGGATCGGACCGGACACCCTCGTCGGGCTTTGCGCGGGGCGCTCCATCGAGCTGGTCTGCGGCGTCCTTGGCATCTTGAAGGCGGGCGGTGCGTACGTGCCAATCGACCCCACCTCCTCGCCCGAGGTGATCTACGACGTCCTGTATGAGTCGAAGGTGCGGCATCTGTTGACCGAGTCGCGCCTGGTCGGGGGACTGCCGGTCGATGACCAGGAAATCCTGCTCCTGGATACCCCCGCGGACGGTGAAGGGGACAAGGCTGTTGCTGACCGGGAGGAGCCACCTGACCTTGGCGAGGTCAGCCTCACTCCCGAGTGCTTGGCGTACGTCAACTTCACCTCCGACTCCGGTGGGGCGCCGAGGGGCATCGCCGTCCGCCATGGGGCGCTGGCTCGCCGGATGGCCGCCGGCCACGCACAGTACCTGGCCAATTCCGCCGTACGTTTCCTGCTGAAGGCGCCGCTCACGTTCGACCTGGCGGTCGCGGAGCTGTTCCAGTGGATCGTCAGCGGCGGCAGCCTGAGCATCCTCGACCCCAATGCCGACCGCGACGCCTCTGCCTTCCTCGCGCAGGTGCGCAGGGACTCGATTGGCGTCCTCTACTGCGTCCCCTCCGAACTCTCGACGCTGGTGAGCCACCTGGAGCGCGAGCGTGAAAGGGTGCATGAGCTGAACACCCTCCGGTTCATCTTCTGCGGCGGGGATACCCTGGCGGTTACCGTCGTCGAGCGTCTCGGGGTACTGGTGCGGGCCGGCCAGCTCCCGCTGCGGCTGGTCAACGTCTATGGGACGAAGGAGACGGGAATCGGCGCGGGTTGCTTCGAGTGCGCGCTGGACGCGAACGACCCCAGCGCCGAACTCCCGCCGGGACGGCTCTCGCATGAGCGGATGCCCATCGGCGGGCCCGCCCAGAACCTGTGGTTCTATGTGGTGCAACCCAACGGTGGCCTGGCTCCGTTGGGCATCCCGGGGGAACTGTACGTCGGCGGCGCGCAACTCGCCGACGCCCGTTTCGGCGACGAGCCCACGGCGACCCACCCCGGCTTCGTCCCGAACCCCTTCCGGAGCGGAGCGGAGAAGGACTGGCTGTACAAGACGGGGGACCTCGTCCGCTGGCTGCCTCAGGGGCCGCTCGAGCTGGTCAGCGCGGCTCGGGAGCGCGACGGAGGCGGGGACCACCGGCTCGATCGCGGCTTCATCGAGGCGCGCATGCGTCGTGTGGCCATTGTCCGCGACGCCGTGGTGGCCTACGTCCCGGATCGCCAGGACAGGGCCCGGTTGGTGGCCTACGTCGTTCTGAAGGAGTCGCCCGCGGCGGACGTGGAGCCGCGCGAAGGGCGGGAAACGCTGAAGGCTCGGATCAGCGCCGAACTTGGGAGCACGTTGCCGGAGTACATGCTTCCGGCCGCCTACGTGTTCATGGACAGCCTGCCGTTGACGGCTTACGGGAGGATCGACCGGAAAGCCCTGCCCGAGCCGGAGGATGACCGCCACGGTGGTAGTGCGATCGCCTACGTGGCCCCGCGCGGGCCCACGGAGAAGGCACTGGCGCACATTTGGCAGCAAGTGCTGAAACGCCCCCAGGTCGGACTGCGAGACAACTTCTTTGAGCTGGGCGGGCACTCAGTGGCGGCCATCCAACTGGTGTCCGTGAGCCGGAAGCACCTGGAGGTCGAAGTCCCCCTCAGCCTGATCTTCGAATCGCCGGTCCTGGAGGCGATGGCGCGCGGCATCGAAGCGCTGCAACAGCAGGGCCGCAGCGGCGCGGTGTCGTCGATCCATCGGGTGGAGCGGACCGGACCGCTGCCTCTGGCGTACGTGCAGGAGAGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACATCACCTGGACGTTGCACTTCGCCGGCAAGGGTTTCTCGGTGGAGGCGTTGCGGACGGCCTTCGATGAGCTGGTGGCCAGACACGAGACACTGCGCACGTGGTTCCAGGTGGGGGAGGGGACAGAGCAGGCCGTACAGGTCATCGGGGAGCCCTGGTCGATGGAGCTGCCGCTGAGAGAGGTGGCGGGGACGGAGGTGACGGCGGCAATCAATGAGATGTCCCGGCAGGTCTTCGACTTGAGAGCGGGACGGTTGCTGACGGCGGCGGTCCTGAGGGTGGCGGAGGATGAGCACATCCTCGTCAGCAACATCCACCACATCATCACGGACGGCTGGTCGTTCGGGGTGATGCTGCGGGAGCTGAGGGAGTTGTACGAGGCCGCGGTGCGGGGGGAGCGAGCGGAGCTGCCGCCGCTGACGGTGCAGTACGGCGACTATGCGGTATGGCAGAGGAAGCAGGACCTGAGCGAGCACCTGGCGTACTGGAAGGGGAAGGTGGAGGGGGACGAGGACGGGTTGGAGCTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGTATAGCTACCACCCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCGAGGACCTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGAACTGGAGAGCCTCATCGGGTTCTTCATCAACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGTGGTGGTGCTGGAGGGATTCGAGCACCAGGAGTTGCCGTTCGAGCACCTGCTGAAGGCGCTGAGGCGGCAGCGGGACAGCAGCCAGATTCCCTTGGTGCCAGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAGGAGGATGGTGGAGCACCACCAACGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGGGCTGCACGAAGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGAAGCTACATCGAGCAGATACTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGCTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGAGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGACCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCAGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGTTGCCGAACGGGAAGCTGGACCGGCTGTCGTTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAACCTCGGCGGGCACTCCCTCCTGGCTTCCCAGCTGATTTCGCGCATACGGGCGACCTTCCGCGTGGAAGTGGCGATGGCCACGGTGTTCGAGTCCCCCACGGTGGAGCCGCTCGCCCGCCACATCGAGGAGAAGCTCAAGGACGAGTCTCGGGTCCAGCTCTCCAACGTTGTGCCGGTCGAGCGGACGCAGGAGCTTCCGCTCTCCTACCTGCAGGAGAGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACGGAACGATCGGGCTCCGGCTTCGGGGTCCTCTGTCAATCCCCGCGCTCAGGGCCACCTTCCACGATCTGGTCGCCCGTCACGAGAGCCTGCGCACCGTCTTCCGGGTCCCCGAAGGCCGCACCACGCCGGTGCAGGTGATTCTTGATTCGATGGATCTGGACATCCCGGTCCGCGATGCAACCGAGGCCGACATCATCCCGGGCATGGATGAGCTGGCGGGTCACATCTACGACATGGAGAAGGGTCCGCTGTTCATGGTTCGCCTCTTGCGGCTGGCCGAGGACTCCCACGTTCTCCTGATGGGGATGCATCACATCGTCTACGACGCATGGTCACAGTTCAATGTGATGAGTCGCGATATCAACCTGCTCTACTCGGCGCACGTGACGGGAATCGAGGCACGGCTTCCCGCGCTTCCCATCCAGTACGCCGACTTCTCGGTGTGGCAGCGCCAGCAGGACTTCCGTCACCACCTGGACTACTGGAAGTCCACACTGGGCGACTACCGGGATGATCTCGAGCTGCCGTATGACTACCCGCGGCCGCCCAGCCGGACATGGCACGCGACCCGATTCACCTTCCGGTATCCGGATGCACTGGCGCGCGCGTTCGCCAGGTTCAATCAGTCCCATCAGTCGACGCTGTTCATGGGGCTGCTGACCAGCTTCGCGATCGTGCTCAGGCACTACACCGGCCGGAACGACATCTGCATCGGAACGACAACGGCGGGGCGCGCCCAGTTGGAGTTGGAGAACCTCGTTGGCTTCTTCATCAACATCCTGCCGTTGCGCATCAATCTGGCGGGTGACCCCGACATCAGCGAGCTCATGAATCGAGCGAAGAAGAGCGTCTTGGGCGCCTTCGAGCATCAAGCTCTGCCGTTCGAGCGTCTCCTCAGTGCCCTCAACAAACAGCGTGACAGCAGCCATATCCCGCTGGTTCCCGTCATGTTGCGCCACCAGAACTTCCCGACGGCGATGACCGGCAAGTGGGCCGATGGTGTGGACATGGAGGTCATCGAGCGCGACGAGCGCACGACGCCCAACGAGCTGGACCTCCAGTTCTTTGGCGACGACACCTACTTGCATGCTGTCGTCGAGTTCCCCGCGCAGCTCTTCTCCGAGGTGACCGTCCGGCGTCTGATGCAGCGTCACCAGAAGGTCATAGAGTTCATGTGCGCGACGCTGGGGGCTCGGTGA", "orf_prot_sequence": "MLLEGELEGYEDGLELPYDFPRTSNRAWRAATFQHSYPPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGREDVCIGTTVAGRAQVGALGDLSGSTVDILPLRLDLSGAPSLHEVLRRTKAVVLEGFEHEALPCQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVKRMVEHHQRVLEALVEGLEEVRLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGSYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFSLGGHSLLAAQLISRIRATFRVEVAMATVFESPTVEPLARHIEEKLKDESRVQLSNVVPVERTQEIPLSYLQERLWFVHEHMKEQRTSYNITWTLHFAGKGFSVEALRTAFDELVARHETLRTWFQVGEGTEQAVQVIGEPWSMELPLREVAGTEVTAAINEMSRQVFDLRAGRLLTAAVLRVAEDEHILVSNIHHIITDGWSFGVMLRELRELYEAAVRGKRAELPPLTVQYGDYAVWQRKQDLSEHLAYWKGKVEEYEDGLELPYDFPRTSNRAWRAATFQYSYPPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGRQDVCIGTTVAGRAQVELESLIGFFINILPLRLDLSGAPSLHEVLRRTKAVVLEGFEHQELPFEHLLKALRRQRDSSQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVRRMVEHHQRVLEALVEGLEEGLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGHYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFSLGGHSLLAAQVVSRIGKELGTQISIADLFQRPTIEQLCELIGGLDDQTQRELALAPSGNTEAVLSFAQERMWFLHNFVKGMPYNTPGLDHLTGELDVAALEKAIRAVIRRHEPLRTNFVEKDGVLSQLVGTEERFRLTVTPIRDESEVARLMEAVIQTPVDLERELMIRAYLYRVDPRNHYLFTTIHHIAFDGWSTSIFYRELAAYYAAFLRREDSPLPALEISYQDYARWERAHFQDEVLAEKLRYWRQRLSGARPLVLPTTYHRPPIQSFAGAVVNFEIDRSITERLKTLFAESGTTMYMVLLGAFSVVLQRYSGQDDICIGSPVANRGHIQTEGLIGLFVNTLVMRVDAAGNPRFIDLLARIQRTAIDAYANQEVPFEKIVDDLQVARDTARSPLVQVILNFHNTPPQSELELQGVTLTRMPVHNGTAKFELSIDVAETSAGLTGFVEYATDLFSENFIRRMIGHLEVVLDAVGRDPRAPIHELPLLTRQDQLDLLSRSGHTAPAVEHVELIPHTFERRVQESPQAIALVCGDERVTYSALNRRASQIARRLRAAGIGPDTLVGLCAGRSIELVCGVLGILKAGGAYVPIDPTSSPEVIYDVLYESKVRHLLTESRLVGGLPVDDQEILLLDTPADGEGDKAVADREEPPDLGEVSLTPECLAYVNFTSDSGGAPRGIAVRHGALARRMAAGHAQYLANSAVRFLLKAPLTFDLAVAELFQWIVSGGSLSILDPNADRDASAFLAQVRRDSIGVLYCVPSELSTLVSHLERERERVHELNTLRFIFCGGDTLAVTVVERLGVLVRAGQLPLRLVNVYGTKETGIGAGCFECALDANDPSAELPPGRLSHERMPIGGPAQNLWFYVVQPNGGLAPLGIPGELYVGGAQLADARFGDEPTATHPGFVPNPFRSGAEKDWLYKTGDLVRWLPQGPLELVSAARERDGGGDHRLDRGFIEARMRRVAIVRDAVVAYVPDRQDRARLVAYVVLKESPAADVEPREGRETLKARISAELGSTLPEYMLPAAYVFMDSLPLTAYGRIDRKALPEPEDDRHGGSAIAYVAPRGPTEKALAHIWQQVLKRPQVGLRDNFFELGGHSVAAIQLVSVSRKHLEVEVPLSLIFESPVLEAMARGIEALQQQGRSGAVSSIHRVERTGPLPLAYVQERLWFVHEHMKEQRTSYNITWTLHFAGKGFSVEALRTAFDELVARHETLRTWFQVGEGTEQAVQVIGEPWSMELPLREVAGTEVTAAINEMSRQVFDLRAGRLLTAAVLRVAEDEHILVSNIHHIITDGWSFGVMLRELRELYEAAVRGERAELPPLTVQYGDYAVWQRKQDLSEHLAYWKGKVEGDEDGLELPYDFPRTSNRAWRAATFQYSYHPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGREDLCIGTTVAGRAQVELESLIGFFINILPLRLDLSGAPSLHEVLRRTKVVVLEGFEHQELPFEHLLKALRRQRDSSQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVRRMVEHHQRVLEALVEGLEEGLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGSYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFNLGGHSLLASQLISRIRATFRVEVAMATVFESPTVEPLARHIEEKLKDESRVQLSNVVPVERTQELPLSYLQERLWFVHEHMKEQRTSYNGTIGLRLRGPLSIPALRATFHDLVARHESLRTVFRVPEGRTTPVQVILDSMDLDIPVRDATEADIIPGMDELAGHIYDMEKGPLFMVRLLRLAEDSHVLLMGMHHIVYDAWSQFNVMSRDINLLYSAHVTGIEARLPALPIQYADFSVWQRQQDFRHHLDYWKSTLGDYRDDLELPYDYPRPPSRTWHATRFTFRYPDALARAFARFNQSHQSTLFMGLLTSFAIVLRHYTGRNDICIGTTTAGRAQLELENLVGFFINILPLRINLAGDPDISELMNRAKKSVLGAFEHQALPFERLLSALNKQRDSSHIPLVPVMLRHQNFPTAMTGKWADGVDMEVIERDERTTPNELDLQFFGDDTYLHAVVEFPAQLFSEVTVRRLMQRHQKVIEFMCATLGAR", "perc_identity": 25.26}, "gnl|BL_ORD_ID|3395|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 27422, "orf_end": 41059, "orf_from": "BGC0001413.1|Cystobactamide_17 ", "model_name": "CMH-2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "4464", "ARO_accession": "3006854", "ARO_name": "CMH-2", "ARO_category": {"42891": {"category_aro_accession": "3004776", "category_aro_cvterm_id": "42891", "category_aro_name": "CMH beta-lactamase", "category_aro_description": "CMH is a class C beta-lactamase gene family belonging to Enterobacter cloacae.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.93437, "max_identities": 24, "bit_score": 32.3426, "cvterm_id": "35915", "query": "VMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEE", "match": "+ VP+++  ++    +E   +     ML   A     +VK++ S ++A +A   +P++ ++  +ALAQ    WRV          GA+ +G G E", "sequence_from_db": "INVPHAEESHYAWGYREGKAVHVSPGMLDAEAYGVKSNVKDMASWVMANMAPETLPQSTLQQGIALAQS-RYWRV----------GAMYQGLGWE", "sequence_from_broadstreet": "MMTKSLSCALLLSVACSAFAAPMSEKQLADVVERTVTPLMKAQAIPGMAVAVIYQGQPHYFTFGKADVAANKPVTPQTLFELGSVSKTFTGVLGGDAIARKEISLADPVTKYWPELTGKQWQGIRLLDLATYTAGGLPLQVPDAVTDNASLLRFYQSWQPKWAPGTTRLYANTSIGLFGSLAVKPSGMRFEEAMTERVFKPLKLNHTWINVPHAEESHYAWGYREGKAVHVSPGMLDAEAYGVKSNVKDMASWVMANMAPETLPQSTLQQGIALAQSRYWRVGAMYQGLGWEMLNWPVDAKTVVDGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLANKSYPNPVRVETAYRILDALQ", "dna_sequence_from_broadstreet": "ATGATGACAAAATCCCTAAGCTGCGCGCTGCTGCTCAGCGTTGCCTGCTCTGCTTTTGCCGCGCCGATGTCAGAAAAACAGCTGGCTGACGTCGTGGAACGTACCGTTACGCCTCTGATGAAGGCGCAGGCCATACCCGGAATGGCCGTGGCCGTCATTTATCAGGGCCAGCCACACTATTTTACTTTCGGTAAAGCAGACGTTGCGGCGAATAAGCCCGTCACGCCGCAAACCTTATTTGAGCTGGGCTCCGTCAGCAAAACCTTCACCGGCGTGCTGGGTGGCGATGCCATTGCCCGCAAAGAGATTTCGCTGGCCGACCCGGTCACAAAATATTGGCCTGAATTGACGGGCAAGCAGTGGCAAGGCATTCGCCTGCTAGACCTGGCAACCTATACCGCAGGTGGATTGCCGTTGCAGGTGCCGGATGCTGTCACCGATAACGCCTCTCTGCTGCGTTTCTACCAGTCCTGGCAGCCAAAGTGGGCCCCGGGTACTACGCGTCTGTACGCCAACACCAGCATCGGTTTGTTTGGCTCACTGGCGGTTAAACCTTCCGGCATGCGCTTTGAGGAGGCCATGACGGAGCGGGTCTTTAAGCCCCTGAAACTCAACCATACGTGGATAAACGTTCCACACGCTGAAGAGTCGCACTACGCATGGGGTTATCGTGAGGGAAAAGCGGTCCACGTTTCGCCTGGTATGCTGGATGCAGAAGCCTATGGCGTGAAATCTAACGTCAAAGATATGGCGAGCTGGGTGATGGCCAATATGGCACCTGAGACACTCCCGCAGTCCACTCTGCAGCAGGGTATTGCGCTGGCGCAGTCTCGCTACTGGCGCGTGGGTGCCATGTATCAAGGGTTAGGCTGGGAGATGCTCAACTGGCCGGTCGACGCCAAAACCGTGGTGGATGGCAGCGATAATAAGGTCGCACTGGCGCCGTTGCCGGTCGCAGAAGTGAATCCTCCGGCTCCGCCAGTAAAAGCCTCCTGGGTGCATAAAACGGGCTCTACGGGTGGGTTTGGCAGCTACGTGGCGTTTATTCCTGAAAAGCAGATCGGTATTGTGATGCTCGCAAATAAAAGCTATCCGAACCCGGTACGGGTGGAAACGGCTTACCGTATCCTCGACGCGCTACAGTAA", "partial": "0", "query_start": 31943, "query_end": 32227, "hit_start": 624, "hit_end": 876, "orf_dna_sequence": "ATGCTGCTGGAGGGAGAGCTGGAGGGGTACGAGGACGGGTTGGAACTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGCATAGCTACCCGCCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCGAGGACGTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGGGGCGTTGGGGGATCTGAGCGGGTCCACCGTCGACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGCGGTGGTGCTGGAGGGATTCGAGCACGAGGCGTTGCCGTGCCAGATTCCCTTGGTGCCGGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAAGAGGATGGTGGAGCACCACCAGCGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGTGCGGCTGCACGAGGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGAAGCTACATCGAGCAGATACTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGCTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGAGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGACCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCGGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGCTGCCGAACGGGAAGCTGGACCGGTTGTCGCTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAGCCTCGGCGGGCACTCCCTCCTGGCTGCCCAGCTGATTTCGCGCATACGGGCGACCTTCCGCGTGGAAGTGGCGATGGCCACGGTGTTCGAGTCCCCCACGGTGGAGCCGCTCGCCCGCCACATCGAGGAGAAGCTCAAGGACGAGTCTCGGGTCCAGCTCTCCAACGTTGTGCCGGTCGAGCGGACGCAGGAGATTCCGCTCTCCTACCTGCAGGAGCGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACATCACCTGGACGTTGCACTTCGCCGGCAAGGGTTTCTCGGTGGAGGCGTTGCGGACGGCCTTCGATGAGCTGGTGGCCAGACACGAGACACTGCGCACGTGGTTCCAGGTGGGGGAGGGGACAGAGCAGGCCGTACAGGTCATCGGGGAGCCCTGGTCGATGGAGCTGCCGCTGAGAGAGGTGGCGGGGACGGAGGTGACGGCGGCAATCAATGAGATGTCCCGACAGGTCTTCGACTTGAGAGCGGGACGGTTGCTGACGGCGGCGGTCCTGAGGGTGGCGGAGGATGAGCACATCCTCGTCAGCAACATCCACCACATCATCACGGACGGCTGGTCGTTCGGGGTGATGCTGCGGGAGCTGAGGGAGTTGTACGAGGCAGCGGTGCGGGGGAAGAGAGCGGAGCTGCCGCCGCTGACGGTGCAGTACGGCGACTATGCGGTGTGGCAGAGGAAGCAGGACCTGAGCGAGCACCTGGCGTACTGGAAGGGGAAGGTGGAGGAGTACGAGGACGGGTTGGAGCTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGTATAGCTACCCACCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCCAGGACGTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGAGCTGGAGAGCCTCATCGGGTTCTTCATCAACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGCGGTGGTGCTGGAGGGATTCGAGCACCAGGAGTTGCCGTTCGAGCACCTGCTGAAGGCGCTGAGGCGGCAGCGGGACAGCAGCCAGATTCCCTTGGTGCCAGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAGGAGGATGGTGGAGCACCACCAGCGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGGGCTGCACGAGGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGACACTACATCGAGCAGATATTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGTTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGGGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGGCCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCAGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGTTGCCGAACGGGAAGCTGGACCGGCTGTCGTTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAGCCTCGGCGGGCACTCCCTCCTGGCTGCCCAGGTGGTCTCAAGGATTGGCAAGGAGCTTGGCACTCAGATCTCGATCGCCGATCTGTTTCAAAGGCCCACGATTGAACAGCTCTGTGAGCTGATTGGAGGACTGGACGATCAGACCCAGAGGGAGCTCGCCCTCGCTCCGTCGGGGAACACCGAGGCGGTGCTCTCGTTCGCGCAAGAGCGCATGTGGTTCCTGCACAACTTCGTCAAGGGCATGCCCTACAACACGCCAGGGCTCGACCACCTGACGGGTGAGCTCGATGTCGCGGCGCTAGAAAAGGCCATCCGCGCGGTCATCCGTCGCCACGAGCCCCTGCGGACGAATTTCGTCGAGAAGGACGGGGTGCTGTCCCAGTTGGTGGGGACGGAAGAACGCTTCCGCCTGACCGTGACTCCCATCCGCGACGAGAGCGAGGTCGCGCGGCTCATGGAAGCCGTGATCCAAACGCCAGTCGATCTGGAGCGGGAGTTGATGATCCGGGCTTATCTCTACCGGGTCGACCCGCGGAATCACTACCTGTTCACCACCATCCATCACATCGCCTTCGATGGCTGGTCGACATCGATCTTCTACCGTGAGCTGGCTGCGTACTACGCCGCGTTTCTCCGGCGCGAAGACAGTCCGCTGCCCGCGCTGGAAATCTCCTATCAGGACTATGCCCGCTGGGAGCGGGCCCATTTCCAGGACGAGGTGTTGGCGGAAAAACTGAGGTACTGGCGGCAGCGGCTGTCGGGCGCTCGGCCCCTCGTACTTCCGACCACCTACCATCGGCCGCCCATCCAGAGTTTCGCTGGCGCCGTCGTGAACTTCGAGATCGATCGCTCCATCACCGAGCGGTTGAAGACGCTGTTCGCCGAGTCGGGCACCACGATGTACATGGTGTTGCTCGGCGCGTTCTCCGTGGTGCTGCAGCGCTACTCCGGTCAGGACGACATCTGCATCGGCTCCCCCGTGGCGAACCGGGGTCACATCCAGACAGAAGGGCTGATCGGCTTGTTCGTCAACACCCTGGTGATGAGGGTGGATGCCGCCGGGAATCCCCGTTTCATCGACCTGCTGGCGCGCATTCAACGGACAGCCATCGATGCTTACGCGAACCAAGAAGTGCCCTTCGAGAAGATCGTGGACGACCTGCAGGTCGCGAGAGACACGGCCCGATCTCCGCTCGTGCAGGTCATTCTCAACTTCCACAACACGCCTCCTCAATCCGAGCTGGAACTGCAGGGGGTGACCCTCACGCGGATGCCGGTGCACAACGGCACGGCCAAGTTCGAGCTCTCCATCGACGTCGCGGAGACGAGCGCCGGTCTAACGGGATTCGTGGAGTACGCGACGGATCTGTTCAGCGAGAACTTCATCCGGCGGATGATCGGCCACCTCGAGGTGGTGCTGGACGCGGTCGGTCGCGATCCGCGGGCGCCTATCCATGAGTTGCCACTGCTCACCCGGCAGGATCAGTTGGACCTACTGTCGCGGAGCGGCCACACAGCCCCCGCGGTGGAACACGTCGAGTTGATCCCTCATACGTTCGAGCGGCGCGTCCAGGAGAGCCCTCAAGCGATTGCCCTGGTCTGCGGTGACGAGCGCGTCACCTACTCCGCGCTCAACCGCCGGGCCAGCCAGATTGCCCGCCGCCTGCGCGCCGCAGGGATCGGACCGGACACCCTCGTCGGGCTTTGCGCGGGGCGCTCCATCGAGCTGGTCTGCGGCGTCCTTGGCATCTTGAAGGCGGGCGGTGCGTACGTGCCAATCGACCCCACCTCCTCGCCCGAGGTGATCTACGACGTCCTGTATGAGTCGAAGGTGCGGCATCTGTTGACCGAGTCGCGCCTGGTCGGGGGACTGCCGGTCGATGACCAGGAAATCCTGCTCCTGGATACCCCCGCGGACGGTGAAGGGGACAAGGCTGTTGCTGACCGGGAGGAGCCACCTGACCTTGGCGAGGTCAGCCTCACTCCCGAGTGCTTGGCGTACGTCAACTTCACCTCCGACTCCGGTGGGGCGCCGAGGGGCATCGCCGTCCGCCATGGGGCGCTGGCTCGCCGGATGGCCGCCGGCCACGCACAGTACCTGGCCAATTCCGCCGTACGTTTCCTGCTGAAGGCGCCGCTCACGTTCGACCTGGCGGTCGCGGAGCTGTTCCAGTGGATCGTCAGCGGCGGCAGCCTGAGCATCCTCGACCCCAATGCCGACCGCGACGCCTCTGCCTTCCTCGCGCAGGTGCGCAGGGACTCGATTGGCGTCCTCTACTGCGTCCCCTCCGAACTCTCGACGCTGGTGAGCCACCTGGAGCGCGAGCGTGAAAGGGTGCATGAGCTGAACACCCTCCGGTTCATCTTCTGCGGCGGGGATACCCTGGCGGTTACCGTCGTCGAGCGTCTCGGGGTACTGGTGCGGGCCGGCCAGCTCCCGCTGCGGCTGGTCAACGTCTATGGGACGAAGGAGACGGGAATCGGCGCGGGTTGCTTCGAGTGCGCGCTGGACGCGAACGACCCCAGCGCCGAACTCCCGCCGGGACGGCTCTCGCATGAGCGGATGCCCATCGGCGGGCCCGCCCAGAACCTGTGGTTCTATGTGGTGCAACCCAACGGTGGCCTGGCTCCGTTGGGCATCCCGGGGGAACTGTACGTCGGCGGCGCGCAACTCGCCGACGCCCGTTTCGGCGACGAGCCCACGGCGACCCACCCCGGCTTCGTCCCGAACCCCTTCCGGAGCGGAGCGGAGAAGGACTGGCTGTACAAGACGGGGGACCTCGTCCGCTGGCTGCCTCAGGGGCCGCTCGAGCTGGTCAGCGCGGCTCGGGAGCGCGACGGAGGCGGGGACCACCGGCTCGATCGCGGCTTCATCGAGGCGCGCATGCGTCGTGTGGCCATTGTCCGCGACGCCGTGGTGGCCTACGTCCCGGATCGCCAGGACAGGGCCCGGTTGGTGGCCTACGTCGTTCTGAAGGAGTCGCCCGCGGCGGACGTGGAGCCGCGCGAAGGGCGGGAAACGCTGAAGGCTCGGATCAGCGCCGAACTTGGGAGCACGTTGCCGGAGTACATGCTTCCGGCCGCCTACGTGTTCATGGACAGCCTGCCGTTGACGGCTTACGGGAGGATCGACCGGAAAGCCCTGCCCGAGCCGGAGGATGACCGCCACGGTGGTAGTGCGATCGCCTACGTGGCCCCGCGCGGGCCCACGGAGAAGGCACTGGCGCACATTTGGCAGCAAGTGCTGAAACGCCCCCAGGTCGGACTGCGAGACAACTTCTTTGAGCTGGGCGGGCACTCAGTGGCGGCCATCCAACTGGTGTCCGTGAGCCGGAAGCACCTGGAGGTCGAAGTCCCCCTCAGCCTGATCTTCGAATCGCCGGTCCTGGAGGCGATGGCGCGCGGCATCGAAGCGCTGCAACAGCAGGGCCGCAGCGGCGCGGTGTCGTCGATCCATCGGGTGGAGCGGACCGGACCGCTGCCTCTGGCGTACGTGCAGGAGAGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACATCACCTGGACGTTGCACTTCGCCGGCAAGGGTTTCTCGGTGGAGGCGTTGCGGACGGCCTTCGATGAGCTGGTGGCCAGACACGAGACACTGCGCACGTGGTTCCAGGTGGGGGAGGGGACAGAGCAGGCCGTACAGGTCATCGGGGAGCCCTGGTCGATGGAGCTGCCGCTGAGAGAGGTGGCGGGGACGGAGGTGACGGCGGCAATCAATGAGATGTCCCGGCAGGTCTTCGACTTGAGAGCGGGACGGTTGCTGACGGCGGCGGTCCTGAGGGTGGCGGAGGATGAGCACATCCTCGTCAGCAACATCCACCACATCATCACGGACGGCTGGTCGTTCGGGGTGATGCTGCGGGAGCTGAGGGAGTTGTACGAGGCCGCGGTGCGGGGGGAGCGAGCGGAGCTGCCGCCGCTGACGGTGCAGTACGGCGACTATGCGGTATGGCAGAGGAAGCAGGACCTGAGCGAGCACCTGGCGTACTGGAAGGGGAAGGTGGAGGGGGACGAGGACGGGTTGGAGCTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGTATAGCTACCACCCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCGAGGACCTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGAACTGGAGAGCCTCATCGGGTTCTTCATCAACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGTGGTGGTGCTGGAGGGATTCGAGCACCAGGAGTTGCCGTTCGAGCACCTGCTGAAGGCGCTGAGGCGGCAGCGGGACAGCAGCCAGATTCCCTTGGTGCCAGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAGGAGGATGGTGGAGCACCACCAACGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGGGCTGCACGAAGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGAAGCTACATCGAGCAGATACTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGCTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGAGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGACCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCAGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGTTGCCGAACGGGAAGCTGGACCGGCTGTCGTTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAACCTCGGCGGGCACTCCCTCCTGGCTTCCCAGCTGATTTCGCGCATACGGGCGACCTTCCGCGTGGAAGTGGCGATGGCCACGGTGTTCGAGTCCCCCACGGTGGAGCCGCTCGCCCGCCACATCGAGGAGAAGCTCAAGGACGAGTCTCGGGTCCAGCTCTCCAACGTTGTGCCGGTCGAGCGGACGCAGGAGCTTCCGCTCTCCTACCTGCAGGAGAGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACGGAACGATCGGGCTCCGGCTTCGGGGTCCTCTGTCAATCCCCGCGCTCAGGGCCACCTTCCACGATCTGGTCGCCCGTCACGAGAGCCTGCGCACCGTCTTCCGGGTCCCCGAAGGCCGCACCACGCCGGTGCAGGTGATTCTTGATTCGATGGATCTGGACATCCCGGTCCGCGATGCAACCGAGGCCGACATCATCCCGGGCATGGATGAGCTGGCGGGTCACATCTACGACATGGAGAAGGGTCCGCTGTTCATGGTTCGCCTCTTGCGGCTGGCCGAGGACTCCCACGTTCTCCTGATGGGGATGCATCACATCGTCTACGACGCATGGTCACAGTTCAATGTGATGAGTCGCGATATCAACCTGCTCTACTCGGCGCACGTGACGGGAATCGAGGCACGGCTTCCCGCGCTTCCCATCCAGTACGCCGACTTCTCGGTGTGGCAGCGCCAGCAGGACTTCCGTCACCACCTGGACTACTGGAAGTCCACACTGGGCGACTACCGGGATGATCTCGAGCTGCCGTATGACTACCCGCGGCCGCCCAGCCGGACATGGCACGCGACCCGATTCACCTTCCGGTATCCGGATGCACTGGCGCGCGCGTTCGCCAGGTTCAATCAGTCCCATCAGTCGACGCTGTTCATGGGGCTGCTGACCAGCTTCGCGATCGTGCTCAGGCACTACACCGGCCGGAACGACATCTGCATCGGAACGACAACGGCGGGGCGCGCCCAGTTGGAGTTGGAGAACCTCGTTGGCTTCTTCATCAACATCCTGCCGTTGCGCATCAATCTGGCGGGTGACCCCGACATCAGCGAGCTCATGAATCGAGCGAAGAAGAGCGTCTTGGGCGCCTTCGAGCATCAAGCTCTGCCGTTCGAGCGTCTCCTCAGTGCCCTCAACAAACAGCGTGACAGCAGCCATATCCCGCTGGTTCCCGTCATGTTGCGCCACCAGAACTTCCCGACGGCGATGACCGGCAAGTGGGCCGATGGTGTGGACATGGAGGTCATCGAGCGCGACGAGCGCACGACGCCCAACGAGCTGGACCTCCAGTTCTTTGGCGACGACACCTACTTGCATGCTGTCGTCGAGTTCCCCGCGCAGCTCTTCTCCGAGGTGACCGTCCGGCGTCTGATGCAGCGTCACCAGAAGGTCATAGAGTTCATGTGCGCGACGCTGGGGGCTCGGTGA", "orf_prot_sequence": "MLLEGELEGYEDGLELPYDFPRTSNRAWRAATFQHSYPPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGREDVCIGTTVAGRAQVGALGDLSGSTVDILPLRLDLSGAPSLHEVLRRTKAVVLEGFEHEALPCQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVKRMVEHHQRVLEALVEGLEEVRLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGSYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFSLGGHSLLAAQLISRIRATFRVEVAMATVFESPTVEPLARHIEEKLKDESRVQLSNVVPVERTQEIPLSYLQERLWFVHEHMKEQRTSYNITWTLHFAGKGFSVEALRTAFDELVARHETLRTWFQVGEGTEQAVQVIGEPWSMELPLREVAGTEVTAAINEMSRQVFDLRAGRLLTAAVLRVAEDEHILVSNIHHIITDGWSFGVMLRELRELYEAAVRGKRAELPPLTVQYGDYAVWQRKQDLSEHLAYWKGKVEEYEDGLELPYDFPRTSNRAWRAATFQYSYPPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGRQDVCIGTTVAGRAQVELESLIGFFINILPLRLDLSGAPSLHEVLRRTKAVVLEGFEHQELPFEHLLKALRRQRDSSQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVRRMVEHHQRVLEALVEGLEEGLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGHYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFSLGGHSLLAAQVVSRIGKELGTQISIADLFQRPTIEQLCELIGGLDDQTQRELALAPSGNTEAVLSFAQERMWFLHNFVKGMPYNTPGLDHLTGELDVAALEKAIRAVIRRHEPLRTNFVEKDGVLSQLVGTEERFRLTVTPIRDESEVARLMEAVIQTPVDLERELMIRAYLYRVDPRNHYLFTTIHHIAFDGWSTSIFYRELAAYYAAFLRREDSPLPALEISYQDYARWERAHFQDEVLAEKLRYWRQRLSGARPLVLPTTYHRPPIQSFAGAVVNFEIDRSITERLKTLFAESGTTMYMVLLGAFSVVLQRYSGQDDICIGSPVANRGHIQTEGLIGLFVNTLVMRVDAAGNPRFIDLLARIQRTAIDAYANQEVPFEKIVDDLQVARDTARSPLVQVILNFHNTPPQSELELQGVTLTRMPVHNGTAKFELSIDVAETSAGLTGFVEYATDLFSENFIRRMIGHLEVVLDAVGRDPRAPIHELPLLTRQDQLDLLSRSGHTAPAVEHVELIPHTFERRVQESPQAIALVCGDERVTYSALNRRASQIARRLRAAGIGPDTLVGLCAGRSIELVCGVLGILKAGGAYVPIDPTSSPEVIYDVLYESKVRHLLTESRLVGGLPVDDQEILLLDTPADGEGDKAVADREEPPDLGEVSLTPECLAYVNFTSDSGGAPRGIAVRHGALARRMAAGHAQYLANSAVRFLLKAPLTFDLAVAELFQWIVSGGSLSILDPNADRDASAFLAQVRRDSIGVLYCVPSELSTLVSHLERERERVHELNTLRFIFCGGDTLAVTVVERLGVLVRAGQLPLRLVNVYGTKETGIGAGCFECALDANDPSAELPPGRLSHERMPIGGPAQNLWFYVVQPNGGLAPLGIPGELYVGGAQLADARFGDEPTATHPGFVPNPFRSGAEKDWLYKTGDLVRWLPQGPLELVSAARERDGGGDHRLDRGFIEARMRRVAIVRDAVVAYVPDRQDRARLVAYVVLKESPAADVEPREGRETLKARISAELGSTLPEYMLPAAYVFMDSLPLTAYGRIDRKALPEPEDDRHGGSAIAYVAPRGPTEKALAHIWQQVLKRPQVGLRDNFFELGGHSVAAIQLVSVSRKHLEVEVPLSLIFESPVLEAMARGIEALQQQGRSGAVSSIHRVERTGPLPLAYVQERLWFVHEHMKEQRTSYNITWTLHFAGKGFSVEALRTAFDELVARHETLRTWFQVGEGTEQAVQVIGEPWSMELPLREVAGTEVTAAINEMSRQVFDLRAGRLLTAAVLRVAEDEHILVSNIHHIITDGWSFGVMLRELRELYEAAVRGERAELPPLTVQYGDYAVWQRKQDLSEHLAYWKGKVEGDEDGLELPYDFPRTSNRAWRAATFQYSYHPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGREDLCIGTTVAGRAQVELESLIGFFINILPLRLDLSGAPSLHEVLRRTKVVVLEGFEHQELPFEHLLKALRRQRDSSQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVRRMVEHHQRVLEALVEGLEEGLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGSYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFNLGGHSLLASQLISRIRATFRVEVAMATVFESPTVEPLARHIEEKLKDESRVQLSNVVPVERTQELPLSYLQERLWFVHEHMKEQRTSYNGTIGLRLRGPLSIPALRATFHDLVARHESLRTVFRVPEGRTTPVQVILDSMDLDIPVRDATEADIIPGMDELAGHIYDMEKGPLFMVRLLRLAEDSHVLLMGMHHIVYDAWSQFNVMSRDINLLYSAHVTGIEARLPALPIQYADFSVWQRQQDFRHHLDYWKSTLGDYRDDLELPYDYPRPPSRTWHATRFTFRYPDALARAFARFNQSHQSTLFMGLLTSFAIVLRHYTGRNDICIGTTTAGRAQLELENLVGFFINILPLRINLAGDPDISELMNRAKKSVLGAFEHQALPFERLLSALNKQRDSSHIPLVPVMLRHQNFPTAMTGKWADGVDMEVIERDERTTPNELDLQFFGDDTYLHAVVEFPAQLFSEVTVRRLMQRHQKVIEFMCATLGAR", "perc_identity": 25.26}, "gnl|BL_ORD_ID|3395|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 27422, "orf_end": 41059, "orf_from": "BGC0001413.1|Cystobactamide_17 ", "model_name": "CMH-2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "4464", "ARO_accession": "3006854", "ARO_name": "CMH-2", "ARO_category": {"42891": {"category_aro_accession": "3004776", "category_aro_cvterm_id": "42891", "category_aro_name": "CMH beta-lactamase", "category_aro_description": "CMH is a class C beta-lactamase gene family belonging to Enterobacter cloacae.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.93437, "max_identities": 24, "bit_score": 32.3426, "cvterm_id": "35915", "query": "VMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEE", "match": "+ VP+++  ++    +E   +     ML   A     +VK++ S ++A +A   +P++ ++  +ALAQ    WRV          GA+ +G G E", "sequence_from_db": "INVPHAEESHYAWGYREGKAVHVSPGMLDAEAYGVKSNVKDMASWVMANMAPETLPQSTLQQGIALAQS-RYWRV----------GAMYQGLGWE", "sequence_from_broadstreet": "MMTKSLSCALLLSVACSAFAAPMSEKQLADVVERTVTPLMKAQAIPGMAVAVIYQGQPHYFTFGKADVAANKPVTPQTLFELGSVSKTFTGVLGGDAIARKEISLADPVTKYWPELTGKQWQGIRLLDLATYTAGGLPLQVPDAVTDNASLLRFYQSWQPKWAPGTTRLYANTSIGLFGSLAVKPSGMRFEEAMTERVFKPLKLNHTWINVPHAEESHYAWGYREGKAVHVSPGMLDAEAYGVKSNVKDMASWVMANMAPETLPQSTLQQGIALAQSRYWRVGAMYQGLGWEMLNWPVDAKTVVDGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLANKSYPNPVRVETAYRILDALQ", "dna_sequence_from_broadstreet": "ATGATGACAAAATCCCTAAGCTGCGCGCTGCTGCTCAGCGTTGCCTGCTCTGCTTTTGCCGCGCCGATGTCAGAAAAACAGCTGGCTGACGTCGTGGAACGTACCGTTACGCCTCTGATGAAGGCGCAGGCCATACCCGGAATGGCCGTGGCCGTCATTTATCAGGGCCAGCCACACTATTTTACTTTCGGTAAAGCAGACGTTGCGGCGAATAAGCCCGTCACGCCGCAAACCTTATTTGAGCTGGGCTCCGTCAGCAAAACCTTCACCGGCGTGCTGGGTGGCGATGCCATTGCCCGCAAAGAGATTTCGCTGGCCGACCCGGTCACAAAATATTGGCCTGAATTGACGGGCAAGCAGTGGCAAGGCATTCGCCTGCTAGACCTGGCAACCTATACCGCAGGTGGATTGCCGTTGCAGGTGCCGGATGCTGTCACCGATAACGCCTCTCTGCTGCGTTTCTACCAGTCCTGGCAGCCAAAGTGGGCCCCGGGTACTACGCGTCTGTACGCCAACACCAGCATCGGTTTGTTTGGCTCACTGGCGGTTAAACCTTCCGGCATGCGCTTTGAGGAGGCCATGACGGAGCGGGTCTTTAAGCCCCTGAAACTCAACCATACGTGGATAAACGTTCCACACGCTGAAGAGTCGCACTACGCATGGGGTTATCGTGAGGGAAAAGCGGTCCACGTTTCGCCTGGTATGCTGGATGCAGAAGCCTATGGCGTGAAATCTAACGTCAAAGATATGGCGAGCTGGGTGATGGCCAATATGGCACCTGAGACACTCCCGCAGTCCACTCTGCAGCAGGGTATTGCGCTGGCGCAGTCTCGCTACTGGCGCGTGGGTGCCATGTATCAAGGGTTAGGCTGGGAGATGCTCAACTGGCCGGTCGACGCCAAAACCGTGGTGGATGGCAGCGATAATAAGGTCGCACTGGCGCCGTTGCCGGTCGCAGAAGTGAATCCTCCGGCTCCGCCAGTAAAAGCCTCCTGGGTGCATAAAACGGGCTCTACGGGTGGGTTTGGCAGCTACGTGGCGTTTATTCCTGAAAAGCAGATCGGTATTGTGATGCTCGCAAATAAAAGCTATCCGAACCCGGTACGGGTGGAAACGGCTTACCGTATCCTCGACGCGCTACAGTAA", "partial": "0", "query_start": 38450, "query_end": 38734, "hit_start": 624, "hit_end": 876, "orf_dna_sequence": "ATGCTGCTGGAGGGAGAGCTGGAGGGGTACGAGGACGGGTTGGAACTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGCATAGCTACCCGCCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCGAGGACGTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGGGGCGTTGGGGGATCTGAGCGGGTCCACCGTCGACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGCGGTGGTGCTGGAGGGATTCGAGCACGAGGCGTTGCCGTGCCAGATTCCCTTGGTGCCGGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAAGAGGATGGTGGAGCACCACCAGCGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGTGCGGCTGCACGAGGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGAAGCTACATCGAGCAGATACTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGCTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGAGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGACCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCGGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGCTGCCGAACGGGAAGCTGGACCGGTTGTCGCTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAGCCTCGGCGGGCACTCCCTCCTGGCTGCCCAGCTGATTTCGCGCATACGGGCGACCTTCCGCGTGGAAGTGGCGATGGCCACGGTGTTCGAGTCCCCCACGGTGGAGCCGCTCGCCCGCCACATCGAGGAGAAGCTCAAGGACGAGTCTCGGGTCCAGCTCTCCAACGTTGTGCCGGTCGAGCGGACGCAGGAGATTCCGCTCTCCTACCTGCAGGAGCGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACATCACCTGGACGTTGCACTTCGCCGGCAAGGGTTTCTCGGTGGAGGCGTTGCGGACGGCCTTCGATGAGCTGGTGGCCAGACACGAGACACTGCGCACGTGGTTCCAGGTGGGGGAGGGGACAGAGCAGGCCGTACAGGTCATCGGGGAGCCCTGGTCGATGGAGCTGCCGCTGAGAGAGGTGGCGGGGACGGAGGTGACGGCGGCAATCAATGAGATGTCCCGACAGGTCTTCGACTTGAGAGCGGGACGGTTGCTGACGGCGGCGGTCCTGAGGGTGGCGGAGGATGAGCACATCCTCGTCAGCAACATCCACCACATCATCACGGACGGCTGGTCGTTCGGGGTGATGCTGCGGGAGCTGAGGGAGTTGTACGAGGCAGCGGTGCGGGGGAAGAGAGCGGAGCTGCCGCCGCTGACGGTGCAGTACGGCGACTATGCGGTGTGGCAGAGGAAGCAGGACCTGAGCGAGCACCTGGCGTACTGGAAGGGGAAGGTGGAGGAGTACGAGGACGGGTTGGAGCTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGTATAGCTACCCACCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCCAGGACGTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGAGCTGGAGAGCCTCATCGGGTTCTTCATCAACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGCGGTGGTGCTGGAGGGATTCGAGCACCAGGAGTTGCCGTTCGAGCACCTGCTGAAGGCGCTGAGGCGGCAGCGGGACAGCAGCCAGATTCCCTTGGTGCCAGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAGGAGGATGGTGGAGCACCACCAGCGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGGGCTGCACGAGGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGACACTACATCGAGCAGATATTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGTTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGGGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGGCCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCAGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGTTGCCGAACGGGAAGCTGGACCGGCTGTCGTTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAGCCTCGGCGGGCACTCCCTCCTGGCTGCCCAGGTGGTCTCAAGGATTGGCAAGGAGCTTGGCACTCAGATCTCGATCGCCGATCTGTTTCAAAGGCCCACGATTGAACAGCTCTGTGAGCTGATTGGAGGACTGGACGATCAGACCCAGAGGGAGCTCGCCCTCGCTCCGTCGGGGAACACCGAGGCGGTGCTCTCGTTCGCGCAAGAGCGCATGTGGTTCCTGCACAACTTCGTCAAGGGCATGCCCTACAACACGCCAGGGCTCGACCACCTGACGGGTGAGCTCGATGTCGCGGCGCTAGAAAAGGCCATCCGCGCGGTCATCCGTCGCCACGAGCCCCTGCGGACGAATTTCGTCGAGAAGGACGGGGTGCTGTCCCAGTTGGTGGGGACGGAAGAACGCTTCCGCCTGACCGTGACTCCCATCCGCGACGAGAGCGAGGTCGCGCGGCTCATGGAAGCCGTGATCCAAACGCCAGTCGATCTGGAGCGGGAGTTGATGATCCGGGCTTATCTCTACCGGGTCGACCCGCGGAATCACTACCTGTTCACCACCATCCATCACATCGCCTTCGATGGCTGGTCGACATCGATCTTCTACCGTGAGCTGGCTGCGTACTACGCCGCGTTTCTCCGGCGCGAAGACAGTCCGCTGCCCGCGCTGGAAATCTCCTATCAGGACTATGCCCGCTGGGAGCGGGCCCATTTCCAGGACGAGGTGTTGGCGGAAAAACTGAGGTACTGGCGGCAGCGGCTGTCGGGCGCTCGGCCCCTCGTACTTCCGACCACCTACCATCGGCCGCCCATCCAGAGTTTCGCTGGCGCCGTCGTGAACTTCGAGATCGATCGCTCCATCACCGAGCGGTTGAAGACGCTGTTCGCCGAGTCGGGCACCACGATGTACATGGTGTTGCTCGGCGCGTTCTCCGTGGTGCTGCAGCGCTACTCCGGTCAGGACGACATCTGCATCGGCTCCCCCGTGGCGAACCGGGGTCACATCCAGACAGAAGGGCTGATCGGCTTGTTCGTCAACACCCTGGTGATGAGGGTGGATGCCGCCGGGAATCCCCGTTTCATCGACCTGCTGGCGCGCATTCAACGGACAGCCATCGATGCTTACGCGAACCAAGAAGTGCCCTTCGAGAAGATCGTGGACGACCTGCAGGTCGCGAGAGACACGGCCCGATCTCCGCTCGTGCAGGTCATTCTCAACTTCCACAACACGCCTCCTCAATCCGAGCTGGAACTGCAGGGGGTGACCCTCACGCGGATGCCGGTGCACAACGGCACGGCCAAGTTCGAGCTCTCCATCGACGTCGCGGAGACGAGCGCCGGTCTAACGGGATTCGTGGAGTACGCGACGGATCTGTTCAGCGAGAACTTCATCCGGCGGATGATCGGCCACCTCGAGGTGGTGCTGGACGCGGTCGGTCGCGATCCGCGGGCGCCTATCCATGAGTTGCCACTGCTCACCCGGCAGGATCAGTTGGACCTACTGTCGCGGAGCGGCCACACAGCCCCCGCGGTGGAACACGTCGAGTTGATCCCTCATACGTTCGAGCGGCGCGTCCAGGAGAGCCCTCAAGCGATTGCCCTGGTCTGCGGTGACGAGCGCGTCACCTACTCCGCGCTCAACCGCCGGGCCAGCCAGATTGCCCGCCGCCTGCGCGCCGCAGGGATCGGACCGGACACCCTCGTCGGGCTTTGCGCGGGGCGCTCCATCGAGCTGGTCTGCGGCGTCCTTGGCATCTTGAAGGCGGGCGGTGCGTACGTGCCAATCGACCCCACCTCCTCGCCCGAGGTGATCTACGACGTCCTGTATGAGTCGAAGGTGCGGCATCTGTTGACCGAGTCGCGCCTGGTCGGGGGACTGCCGGTCGATGACCAGGAAATCCTGCTCCTGGATACCCCCGCGGACGGTGAAGGGGACAAGGCTGTTGCTGACCGGGAGGAGCCACCTGACCTTGGCGAGGTCAGCCTCACTCCCGAGTGCTTGGCGTACGTCAACTTCACCTCCGACTCCGGTGGGGCGCCGAGGGGCATCGCCGTCCGCCATGGGGCGCTGGCTCGCCGGATGGCCGCCGGCCACGCACAGTACCTGGCCAATTCCGCCGTACGTTTCCTGCTGAAGGCGCCGCTCACGTTCGACCTGGCGGTCGCGGAGCTGTTCCAGTGGATCGTCAGCGGCGGCAGCCTGAGCATCCTCGACCCCAATGCCGACCGCGACGCCTCTGCCTTCCTCGCGCAGGTGCGCAGGGACTCGATTGGCGTCCTCTACTGCGTCCCCTCCGAACTCTCGACGCTGGTGAGCCACCTGGAGCGCGAGCGTGAAAGGGTGCATGAGCTGAACACCCTCCGGTTCATCTTCTGCGGCGGGGATACCCTGGCGGTTACCGTCGTCGAGCGTCTCGGGGTACTGGTGCGGGCCGGCCAGCTCCCGCTGCGGCTGGTCAACGTCTATGGGACGAAGGAGACGGGAATCGGCGCGGGTTGCTTCGAGTGCGCGCTGGACGCGAACGACCCCAGCGCCGAACTCCCGCCGGGACGGCTCTCGCATGAGCGGATGCCCATCGGCGGGCCCGCCCAGAACCTGTGGTTCTATGTGGTGCAACCCAACGGTGGCCTGGCTCCGTTGGGCATCCCGGGGGAACTGTACGTCGGCGGCGCGCAACTCGCCGACGCCCGTTTCGGCGACGAGCCCACGGCGACCCACCCCGGCTTCGTCCCGAACCCCTTCCGGAGCGGAGCGGAGAAGGACTGGCTGTACAAGACGGGGGACCTCGTCCGCTGGCTGCCTCAGGGGCCGCTCGAGCTGGTCAGCGCGGCTCGGGAGCGCGACGGAGGCGGGGACCACCGGCTCGATCGCGGCTTCATCGAGGCGCGCATGCGTCGTGTGGCCATTGTCCGCGACGCCGTGGTGGCCTACGTCCCGGATCGCCAGGACAGGGCCCGGTTGGTGGCCTACGTCGTTCTGAAGGAGTCGCCCGCGGCGGACGTGGAGCCGCGCGAAGGGCGGGAAACGCTGAAGGCTCGGATCAGCGCCGAACTTGGGAGCACGTTGCCGGAGTACATGCTTCCGGCCGCCTACGTGTTCATGGACAGCCTGCCGTTGACGGCTTACGGGAGGATCGACCGGAAAGCCCTGCCCGAGCCGGAGGATGACCGCCACGGTGGTAGTGCGATCGCCTACGTGGCCCCGCGCGGGCCCACGGAGAAGGCACTGGCGCACATTTGGCAGCAAGTGCTGAAACGCCCCCAGGTCGGACTGCGAGACAACTTCTTTGAGCTGGGCGGGCACTCAGTGGCGGCCATCCAACTGGTGTCCGTGAGCCGGAAGCACCTGGAGGTCGAAGTCCCCCTCAGCCTGATCTTCGAATCGCCGGTCCTGGAGGCGATGGCGCGCGGCATCGAAGCGCTGCAACAGCAGGGCCGCAGCGGCGCGGTGTCGTCGATCCATCGGGTGGAGCGGACCGGACCGCTGCCTCTGGCGTACGTGCAGGAGAGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACATCACCTGGACGTTGCACTTCGCCGGCAAGGGTTTCTCGGTGGAGGCGTTGCGGACGGCCTTCGATGAGCTGGTGGCCAGACACGAGACACTGCGCACGTGGTTCCAGGTGGGGGAGGGGACAGAGCAGGCCGTACAGGTCATCGGGGAGCCCTGGTCGATGGAGCTGCCGCTGAGAGAGGTGGCGGGGACGGAGGTGACGGCGGCAATCAATGAGATGTCCCGGCAGGTCTTCGACTTGAGAGCGGGACGGTTGCTGACGGCGGCGGTCCTGAGGGTGGCGGAGGATGAGCACATCCTCGTCAGCAACATCCACCACATCATCACGGACGGCTGGTCGTTCGGGGTGATGCTGCGGGAGCTGAGGGAGTTGTACGAGGCCGCGGTGCGGGGGGAGCGAGCGGAGCTGCCGCCGCTGACGGTGCAGTACGGCGACTATGCGGTATGGCAGAGGAAGCAGGACCTGAGCGAGCACCTGGCGTACTGGAAGGGGAAGGTGGAGGGGGACGAGGACGGGTTGGAGCTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGTATAGCTACCACCCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCGAGGACCTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGAACTGGAGAGCCTCATCGGGTTCTTCATCAACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGTGGTGGTGCTGGAGGGATTCGAGCACCAGGAGTTGCCGTTCGAGCACCTGCTGAAGGCGCTGAGGCGGCAGCGGGACAGCAGCCAGATTCCCTTGGTGCCAGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAGGAGGATGGTGGAGCACCACCAACGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGGGCTGCACGAAGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGAAGCTACATCGAGCAGATACTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGCTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGAGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGACCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCAGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGTTGCCGAACGGGAAGCTGGACCGGCTGTCGTTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAACCTCGGCGGGCACTCCCTCCTGGCTTCCCAGCTGATTTCGCGCATACGGGCGACCTTCCGCGTGGAAGTGGCGATGGCCACGGTGTTCGAGTCCCCCACGGTGGAGCCGCTCGCCCGCCACATCGAGGAGAAGCTCAAGGACGAGTCTCGGGTCCAGCTCTCCAACGTTGTGCCGGTCGAGCGGACGCAGGAGCTTCCGCTCTCCTACCTGCAGGAGAGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACGGAACGATCGGGCTCCGGCTTCGGGGTCCTCTGTCAATCCCCGCGCTCAGGGCCACCTTCCACGATCTGGTCGCCCGTCACGAGAGCCTGCGCACCGTCTTCCGGGTCCCCGAAGGCCGCACCACGCCGGTGCAGGTGATTCTTGATTCGATGGATCTGGACATCCCGGTCCGCGATGCAACCGAGGCCGACATCATCCCGGGCATGGATGAGCTGGCGGGTCACATCTACGACATGGAGAAGGGTCCGCTGTTCATGGTTCGCCTCTTGCGGCTGGCCGAGGACTCCCACGTTCTCCTGATGGGGATGCATCACATCGTCTACGACGCATGGTCACAGTTCAATGTGATGAGTCGCGATATCAACCTGCTCTACTCGGCGCACGTGACGGGAATCGAGGCACGGCTTCCCGCGCTTCCCATCCAGTACGCCGACTTCTCGGTGTGGCAGCGCCAGCAGGACTTCCGTCACCACCTGGACTACTGGAAGTCCACACTGGGCGACTACCGGGATGATCTCGAGCTGCCGTATGACTACCCGCGGCCGCCCAGCCGGACATGGCACGCGACCCGATTCACCTTCCGGTATCCGGATGCACTGGCGCGCGCGTTCGCCAGGTTCAATCAGTCCCATCAGTCGACGCTGTTCATGGGGCTGCTGACCAGCTTCGCGATCGTGCTCAGGCACTACACCGGCCGGAACGACATCTGCATCGGAACGACAACGGCGGGGCGCGCCCAGTTGGAGTTGGAGAACCTCGTTGGCTTCTTCATCAACATCCTGCCGTTGCGCATCAATCTGGCGGGTGACCCCGACATCAGCGAGCTCATGAATCGAGCGAAGAAGAGCGTCTTGGGCGCCTTCGAGCATCAAGCTCTGCCGTTCGAGCGTCTCCTCAGTGCCCTCAACAAACAGCGTGACAGCAGCCATATCCCGCTGGTTCCCGTCATGTTGCGCCACCAGAACTTCCCGACGGCGATGACCGGCAAGTGGGCCGATGGTGTGGACATGGAGGTCATCGAGCGCGACGAGCGCACGACGCCCAACGAGCTGGACCTCCAGTTCTTTGGCGACGACACCTACTTGCATGCTGTCGTCGAGTTCCCCGCGCAGCTCTTCTCCGAGGTGACCGTCCGGCGTCTGATGCAGCGTCACCAGAAGGTCATAGAGTTCATGTGCGCGACGCTGGGGGCTCGGTGA", "orf_prot_sequence": "MLLEGELEGYEDGLELPYDFPRTSNRAWRAATFQHSYPPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGREDVCIGTTVAGRAQVGALGDLSGSTVDILPLRLDLSGAPSLHEVLRRTKAVVLEGFEHEALPCQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVKRMVEHHQRVLEALVEGLEEVRLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGSYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFSLGGHSLLAAQLISRIRATFRVEVAMATVFESPTVEPLARHIEEKLKDESRVQLSNVVPVERTQEIPLSYLQERLWFVHEHMKEQRTSYNITWTLHFAGKGFSVEALRTAFDELVARHETLRTWFQVGEGTEQAVQVIGEPWSMELPLREVAGTEVTAAINEMSRQVFDLRAGRLLTAAVLRVAEDEHILVSNIHHIITDGWSFGVMLRELRELYEAAVRGKRAELPPLTVQYGDYAVWQRKQDLSEHLAYWKGKVEEYEDGLELPYDFPRTSNRAWRAATFQYSYPPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGRQDVCIGTTVAGRAQVELESLIGFFINILPLRLDLSGAPSLHEVLRRTKAVVLEGFEHQELPFEHLLKALRRQRDSSQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVRRMVEHHQRVLEALVEGLEEGLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGHYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFSLGGHSLLAAQVVSRIGKELGTQISIADLFQRPTIEQLCELIGGLDDQTQRELALAPSGNTEAVLSFAQERMWFLHNFVKGMPYNTPGLDHLTGELDVAALEKAIRAVIRRHEPLRTNFVEKDGVLSQLVGTEERFRLTVTPIRDESEVARLMEAVIQTPVDLERELMIRAYLYRVDPRNHYLFTTIHHIAFDGWSTSIFYRELAAYYAAFLRREDSPLPALEISYQDYARWERAHFQDEVLAEKLRYWRQRLSGARPLVLPTTYHRPPIQSFAGAVVNFEIDRSITERLKTLFAESGTTMYMVLLGAFSVVLQRYSGQDDICIGSPVANRGHIQTEGLIGLFVNTLVMRVDAAGNPRFIDLLARIQRTAIDAYANQEVPFEKIVDDLQVARDTARSPLVQVILNFHNTPPQSELELQGVTLTRMPVHNGTAKFELSIDVAETSAGLTGFVEYATDLFSENFIRRMIGHLEVVLDAVGRDPRAPIHELPLLTRQDQLDLLSRSGHTAPAVEHVELIPHTFERRVQESPQAIALVCGDERVTYSALNRRASQIARRLRAAGIGPDTLVGLCAGRSIELVCGVLGILKAGGAYVPIDPTSSPEVIYDVLYESKVRHLLTESRLVGGLPVDDQEILLLDTPADGEGDKAVADREEPPDLGEVSLTPECLAYVNFTSDSGGAPRGIAVRHGALARRMAAGHAQYLANSAVRFLLKAPLTFDLAVAELFQWIVSGGSLSILDPNADRDASAFLAQVRRDSIGVLYCVPSELSTLVSHLERERERVHELNTLRFIFCGGDTLAVTVVERLGVLVRAGQLPLRLVNVYGTKETGIGAGCFECALDANDPSAELPPGRLSHERMPIGGPAQNLWFYVVQPNGGLAPLGIPGELYVGGAQLADARFGDEPTATHPGFVPNPFRSGAEKDWLYKTGDLVRWLPQGPLELVSAARERDGGGDHRLDRGFIEARMRRVAIVRDAVVAYVPDRQDRARLVAYVVLKESPAADVEPREGRETLKARISAELGSTLPEYMLPAAYVFMDSLPLTAYGRIDRKALPEPEDDRHGGSAIAYVAPRGPTEKALAHIWQQVLKRPQVGLRDNFFELGGHSVAAIQLVSVSRKHLEVEVPLSLIFESPVLEAMARGIEALQQQGRSGAVSSIHRVERTGPLPLAYVQERLWFVHEHMKEQRTSYNITWTLHFAGKGFSVEALRTAFDELVARHETLRTWFQVGEGTEQAVQVIGEPWSMELPLREVAGTEVTAAINEMSRQVFDLRAGRLLTAAVLRVAEDEHILVSNIHHIITDGWSFGVMLRELRELYEAAVRGERAELPPLTVQYGDYAVWQRKQDLSEHLAYWKGKVEGDEDGLELPYDFPRTSNRAWRAATFQYSYHPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGREDLCIGTTVAGRAQVELESLIGFFINILPLRLDLSGAPSLHEVLRRTKVVVLEGFEHQELPFEHLLKALRRQRDSSQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVRRMVEHHQRVLEALVEGLEEGLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGSYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFNLGGHSLLASQLISRIRATFRVEVAMATVFESPTVEPLARHIEEKLKDESRVQLSNVVPVERTQELPLSYLQERLWFVHEHMKEQRTSYNGTIGLRLRGPLSIPALRATFHDLVARHESLRTVFRVPEGRTTPVQVILDSMDLDIPVRDATEADIIPGMDELAGHIYDMEKGPLFMVRLLRLAEDSHVLLMGMHHIVYDAWSQFNVMSRDINLLYSAHVTGIEARLPALPIQYADFSVWQRQQDFRHHLDYWKSTLGDYRDDLELPYDYPRPPSRTWHATRFTFRYPDALARAFARFNQSHQSTLFMGLLTSFAIVLRHYTGRNDICIGTTTAGRAQLELENLVGFFINILPLRINLAGDPDISELMNRAKKSVLGAFEHQALPFERLLSALNKQRDSSHIPLVPVMLRHQNFPTAMTGKWADGVDMEVIERDERTTPNELDLQFFGDDTYLHAVVEFPAQLFSEVTVRRLMQRHQKVIEFMCATLGAR", "perc_identity": 25.26}, "gnl|BL_ORD_ID|2641|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 27422, "orf_end": 41059, "orf_from": "BGC0001413.1|Cystobactamide_17 ", "model_name": "CMH-1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "3576", "ARO_accession": "3004777", "ARO_name": "CMH-1", "ARO_category": {"42891": {"category_aro_accession": "3004776", "category_aro_cvterm_id": "42891", "category_aro_name": "CMH beta-lactamase", "category_aro_description": "CMH is a class C beta-lactamase gene family belonging to Enterobacter cloacae.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.25062, "max_identities": 24, "bit_score": 31.9574, "cvterm_id": "36884", "query": "VMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEE", "match": "+ VP+++  ++    +E   +     ML   A     +VK++ S ++A +A   +P++ ++  +ALAQ    WRV          GA+ +G G E", "sequence_from_db": "INVPHAEEPHYAWGYREGKAVHVSPGMLDAEAYGVKSNVKDMASWVMANMAPETLPQSTLQQGIALAQS-RYWRV----------GAMYQGLGWE", "sequence_from_broadstreet": "MMTKSLSCALLLSVACSAFAAPMSEKQLADVVERTVTPLMKAQAIPGMAVAVIYQGQPHYFTFGKADVAANKPVTPQTLFELGSVSKTFTGVLGGDAIARKEISLADPVTKYWPELTGKQWQGIRLLDLATYTAGGLPLQVPDDVTDNASLLRFYQSWQPKWAPGTTRLYANTSIGLFGSLAVKPSGMCFEQAMAERVFKPLKLNHTWINVPHAEEPHYAWGYREGKAVHVSPGMLDAEAYGVKSNVKDMASWVMANMAPETLPQSTLQQGIALAQSRYWRVGAMYQGLGWEMLNWPVDAKTVVDGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLANKSYPNPVRVETAYRILDALQ", "dna_sequence_from_broadstreet": "ATGATGACAAAATCCCTAAGCTGCGCGCTGCTGCTCAGCGTTGCCTGCTCTGCTTTTGCCGCGCCGATGTCAGAAAAACAGCTGGCTGACGTCGTGGAACGTACCGTTACGCCTCTGATGAAGGCGCAGGCCATACCCGGAATGGCCGTGGCCGTCATTTATCAGGGCCAGCCACACTATTTTACTTTCGGTAAAGCAGACGTCGCGGCGAATAAGCCCGTCACGCCGCAAACCTTATTTGAGCTGGGCTCCGTCAGCAAAACCTTCACCGGCGTGCTGGGTGGCGATGCCATTGCCCGCAAAGAGATTTCGCTGGCCGACCCGGTCACGAAATATTGGCCTGAATTGACGGGCAAGCAGTGGCAAGGCATTCGCCTGCTAGACCTGGCAACCTATACCGCAGGCGGATTGCCGTTGCAGGTACCGGATGATGTCACCGATAACGCCTCTCTGCTGCGTTTCTACCAGTCCTGGCAGCCAAAGTGGGCCCCGGGTACCACGCGTCTGTACGCCAACACCAGCATCGGTTTGTTTGGCTCACTGGCCGTTAAACCGTCCGGCATGTGCTTCGAGCAGGCCATGGCGGAGCGGGTCTTTAAGCCCCTGAAACTCAACCATACGTGGATAAACGTTCCACACGCTGAAGAACCGCACTACGCATGGGGTTATCGTGAGGGAAAAGCGGTCCACGTTTCGCCTGGTATGCTGGATGCAGAAGCCTATGGCGTGAAATCTAACGTCAAAGATATGGCGAGTTGGGTGATGGCCAATATGGCACCTGAGACACTCCCGCAGTCCACTCTGCAGCAGGGTATTGCGCTGGCGCAGTCTCGCTACTGGCGCGTGGGTGCCATGTATCAAGGGTTAGGCTGGGAGATGCTCAACTGGCCGGTCGATGCCAAAACCGTGGTGGATGGCAGCGATAATAAGGTCGCACTGGCGCCGTTGCCGGTCGCAGAAGTGAATCCTCCGGCTCCGCCAGTAAAAGCCTCCTGGGTGCATAAAACGGGCTCTACGGGTGGGTTTGGCAGCTACGTGGCGTTTATTCCTGAAAAGCAGATCGGTATTGTGATGCTCGCAAATAAAAGCTATCCGAACCCGGTACGGGTGGAAACGGCTTACCGTATCCTCGACGCGCTACAGTAA", "partial": "0", "query_start": 28721, "query_end": 29005, "hit_start": 624, "hit_end": 876, "orf_dna_sequence": "ATGCTGCTGGAGGGAGAGCTGGAGGGGTACGAGGACGGGTTGGAACTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGCATAGCTACCCGCCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCGAGGACGTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGGGGCGTTGGGGGATCTGAGCGGGTCCACCGTCGACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGCGGTGGTGCTGGAGGGATTCGAGCACGAGGCGTTGCCGTGCCAGATTCCCTTGGTGCCGGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAAGAGGATGGTGGAGCACCACCAGCGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGTGCGGCTGCACGAGGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGAAGCTACATCGAGCAGATACTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGCTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGAGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGACCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCGGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGCTGCCGAACGGGAAGCTGGACCGGTTGTCGCTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAGCCTCGGCGGGCACTCCCTCCTGGCTGCCCAGCTGATTTCGCGCATACGGGCGACCTTCCGCGTGGAAGTGGCGATGGCCACGGTGTTCGAGTCCCCCACGGTGGAGCCGCTCGCCCGCCACATCGAGGAGAAGCTCAAGGACGAGTCTCGGGTCCAGCTCTCCAACGTTGTGCCGGTCGAGCGGACGCAGGAGATTCCGCTCTCCTACCTGCAGGAGCGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACATCACCTGGACGTTGCACTTCGCCGGCAAGGGTTTCTCGGTGGAGGCGTTGCGGACGGCCTTCGATGAGCTGGTGGCCAGACACGAGACACTGCGCACGTGGTTCCAGGTGGGGGAGGGGACAGAGCAGGCCGTACAGGTCATCGGGGAGCCCTGGTCGATGGAGCTGCCGCTGAGAGAGGTGGCGGGGACGGAGGTGACGGCGGCAATCAATGAGATGTCCCGACAGGTCTTCGACTTGAGAGCGGGACGGTTGCTGACGGCGGCGGTCCTGAGGGTGGCGGAGGATGAGCACATCCTCGTCAGCAACATCCACCACATCATCACGGACGGCTGGTCGTTCGGGGTGATGCTGCGGGAGCTGAGGGAGTTGTACGAGGCAGCGGTGCGGGGGAAGAGAGCGGAGCTGCCGCCGCTGACGGTGCAGTACGGCGACTATGCGGTGTGGCAGAGGAAGCAGGACCTGAGCGAGCACCTGGCGTACTGGAAGGGGAAGGTGGAGGAGTACGAGGACGGGTTGGAGCTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGTATAGCTACCCACCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCCAGGACGTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGAGCTGGAGAGCCTCATCGGGTTCTTCATCAACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGCGGTGGTGCTGGAGGGATTCGAGCACCAGGAGTTGCCGTTCGAGCACCTGCTGAAGGCGCTGAGGCGGCAGCGGGACAGCAGCCAGATTCCCTTGGTGCCAGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAGGAGGATGGTGGAGCACCACCAGCGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGGGCTGCACGAGGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGACACTACATCGAGCAGATATTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGTTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGGGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGGCCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCAGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGTTGCCGAACGGGAAGCTGGACCGGCTGTCGTTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAGCCTCGGCGGGCACTCCCTCCTGGCTGCCCAGGTGGTCTCAAGGATTGGCAAGGAGCTTGGCACTCAGATCTCGATCGCCGATCTGTTTCAAAGGCCCACGATTGAACAGCTCTGTGAGCTGATTGGAGGACTGGACGATCAGACCCAGAGGGAGCTCGCCCTCGCTCCGTCGGGGAACACCGAGGCGGTGCTCTCGTTCGCGCAAGAGCGCATGTGGTTCCTGCACAACTTCGTCAAGGGCATGCCCTACAACACGCCAGGGCTCGACCACCTGACGGGTGAGCTCGATGTCGCGGCGCTAGAAAAGGCCATCCGCGCGGTCATCCGTCGCCACGAGCCCCTGCGGACGAATTTCGTCGAGAAGGACGGGGTGCTGTCCCAGTTGGTGGGGACGGAAGAACGCTTCCGCCTGACCGTGACTCCCATCCGCGACGAGAGCGAGGTCGCGCGGCTCATGGAAGCCGTGATCCAAACGCCAGTCGATCTGGAGCGGGAGTTGATGATCCGGGCTTATCTCTACCGGGTCGACCCGCGGAATCACTACCTGTTCACCACCATCCATCACATCGCCTTCGATGGCTGGTCGACATCGATCTTCTACCGTGAGCTGGCTGCGTACTACGCCGCGTTTCTCCGGCGCGAAGACAGTCCGCTGCCCGCGCTGGAAATCTCCTATCAGGACTATGCCCGCTGGGAGCGGGCCCATTTCCAGGACGAGGTGTTGGCGGAAAAACTGAGGTACTGGCGGCAGCGGCTGTCGGGCGCTCGGCCCCTCGTACTTCCGACCACCTACCATCGGCCGCCCATCCAGAGTTTCGCTGGCGCCGTCGTGAACTTCGAGATCGATCGCTCCATCACCGAGCGGTTGAAGACGCTGTTCGCCGAGTCGGGCACCACGATGTACATGGTGTTGCTCGGCGCGTTCTCCGTGGTGCTGCAGCGCTACTCCGGTCAGGACGACATCTGCATCGGCTCCCCCGTGGCGAACCGGGGTCACATCCAGACAGAAGGGCTGATCGGCTTGTTCGTCAACACCCTGGTGATGAGGGTGGATGCCGCCGGGAATCCCCGTTTCATCGACCTGCTGGCGCGCATTCAACGGACAGCCATCGATGCTTACGCGAACCAAGAAGTGCCCTTCGAGAAGATCGTGGACGACCTGCAGGTCGCGAGAGACACGGCCCGATCTCCGCTCGTGCAGGTCATTCTCAACTTCCACAACACGCCTCCTCAATCCGAGCTGGAACTGCAGGGGGTGACCCTCACGCGGATGCCGGTGCACAACGGCACGGCCAAGTTCGAGCTCTCCATCGACGTCGCGGAGACGAGCGCCGGTCTAACGGGATTCGTGGAGTACGCGACGGATCTGTTCAGCGAGAACTTCATCCGGCGGATGATCGGCCACCTCGAGGTGGTGCTGGACGCGGTCGGTCGCGATCCGCGGGCGCCTATCCATGAGTTGCCACTGCTCACCCGGCAGGATCAGTTGGACCTACTGTCGCGGAGCGGCCACACAGCCCCCGCGGTGGAACACGTCGAGTTGATCCCTCATACGTTCGAGCGGCGCGTCCAGGAGAGCCCTCAAGCGATTGCCCTGGTCTGCGGTGACGAGCGCGTCACCTACTCCGCGCTCAACCGCCGGGCCAGCCAGATTGCCCGCCGCCTGCGCGCCGCAGGGATCGGACCGGACACCCTCGTCGGGCTTTGCGCGGGGCGCTCCATCGAGCTGGTCTGCGGCGTCCTTGGCATCTTGAAGGCGGGCGGTGCGTACGTGCCAATCGACCCCACCTCCTCGCCCGAGGTGATCTACGACGTCCTGTATGAGTCGAAGGTGCGGCATCTGTTGACCGAGTCGCGCCTGGTCGGGGGACTGCCGGTCGATGACCAGGAAATCCTGCTCCTGGATACCCCCGCGGACGGTGAAGGGGACAAGGCTGTTGCTGACCGGGAGGAGCCACCTGACCTTGGCGAGGTCAGCCTCACTCCCGAGTGCTTGGCGTACGTCAACTTCACCTCCGACTCCGGTGGGGCGCCGAGGGGCATCGCCGTCCGCCATGGGGCGCTGGCTCGCCGGATGGCCGCCGGCCACGCACAGTACCTGGCCAATTCCGCCGTACGTTTCCTGCTGAAGGCGCCGCTCACGTTCGACCTGGCGGTCGCGGAGCTGTTCCAGTGGATCGTCAGCGGCGGCAGCCTGAGCATCCTCGACCCCAATGCCGACCGCGACGCCTCTGCCTTCCTCGCGCAGGTGCGCAGGGACTCGATTGGCGTCCTCTACTGCGTCCCCTCCGAACTCTCGACGCTGGTGAGCCACCTGGAGCGCGAGCGTGAAAGGGTGCATGAGCTGAACACCCTCCGGTTCATCTTCTGCGGCGGGGATACCCTGGCGGTTACCGTCGTCGAGCGTCTCGGGGTACTGGTGCGGGCCGGCCAGCTCCCGCTGCGGCTGGTCAACGTCTATGGGACGAAGGAGACGGGAATCGGCGCGGGTTGCTTCGAGTGCGCGCTGGACGCGAACGACCCCAGCGCCGAACTCCCGCCGGGACGGCTCTCGCATGAGCGGATGCCCATCGGCGGGCCCGCCCAGAACCTGTGGTTCTATGTGGTGCAACCCAACGGTGGCCTGGCTCCGTTGGGCATCCCGGGGGAACTGTACGTCGGCGGCGCGCAACTCGCCGACGCCCGTTTCGGCGACGAGCCCACGGCGACCCACCCCGGCTTCGTCCCGAACCCCTTCCGGAGCGGAGCGGAGAAGGACTGGCTGTACAAGACGGGGGACCTCGTCCGCTGGCTGCCTCAGGGGCCGCTCGAGCTGGTCAGCGCGGCTCGGGAGCGCGACGGAGGCGGGGACCACCGGCTCGATCGCGGCTTCATCGAGGCGCGCATGCGTCGTGTGGCCATTGTCCGCGACGCCGTGGTGGCCTACGTCCCGGATCGCCAGGACAGGGCCCGGTTGGTGGCCTACGTCGTTCTGAAGGAGTCGCCCGCGGCGGACGTGGAGCCGCGCGAAGGGCGGGAAACGCTGAAGGCTCGGATCAGCGCCGAACTTGGGAGCACGTTGCCGGAGTACATGCTTCCGGCCGCCTACGTGTTCATGGACAGCCTGCCGTTGACGGCTTACGGGAGGATCGACCGGAAAGCCCTGCCCGAGCCGGAGGATGACCGCCACGGTGGTAGTGCGATCGCCTACGTGGCCCCGCGCGGGCCCACGGAGAAGGCACTGGCGCACATTTGGCAGCAAGTGCTGAAACGCCCCCAGGTCGGACTGCGAGACAACTTCTTTGAGCTGGGCGGGCACTCAGTGGCGGCCATCCAACTGGTGTCCGTGAGCCGGAAGCACCTGGAGGTCGAAGTCCCCCTCAGCCTGATCTTCGAATCGCCGGTCCTGGAGGCGATGGCGCGCGGCATCGAAGCGCTGCAACAGCAGGGCCGCAGCGGCGCGGTGTCGTCGATCCATCGGGTGGAGCGGACCGGACCGCTGCCTCTGGCGTACGTGCAGGAGAGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACATCACCTGGACGTTGCACTTCGCCGGCAAGGGTTTCTCGGTGGAGGCGTTGCGGACGGCCTTCGATGAGCTGGTGGCCAGACACGAGACACTGCGCACGTGGTTCCAGGTGGGGGAGGGGACAGAGCAGGCCGTACAGGTCATCGGGGAGCCCTGGTCGATGGAGCTGCCGCTGAGAGAGGTGGCGGGGACGGAGGTGACGGCGGCAATCAATGAGATGTCCCGGCAGGTCTTCGACTTGAGAGCGGGACGGTTGCTGACGGCGGCGGTCCTGAGGGTGGCGGAGGATGAGCACATCCTCGTCAGCAACATCCACCACATCATCACGGACGGCTGGTCGTTCGGGGTGATGCTGCGGGAGCTGAGGGAGTTGTACGAGGCCGCGGTGCGGGGGGAGCGAGCGGAGCTGCCGCCGCTGACGGTGCAGTACGGCGACTATGCGGTATGGCAGAGGAAGCAGGACCTGAGCGAGCACCTGGCGTACTGGAAGGGGAAGGTGGAGGGGGACGAGGACGGGTTGGAGCTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGTATAGCTACCACCCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCGAGGACCTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGAACTGGAGAGCCTCATCGGGTTCTTCATCAACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGTGGTGGTGCTGGAGGGATTCGAGCACCAGGAGTTGCCGTTCGAGCACCTGCTGAAGGCGCTGAGGCGGCAGCGGGACAGCAGCCAGATTCCCTTGGTGCCAGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAGGAGGATGGTGGAGCACCACCAACGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGGGCTGCACGAAGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGAAGCTACATCGAGCAGATACTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGCTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGAGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGACCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCAGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGTTGCCGAACGGGAAGCTGGACCGGCTGTCGTTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAACCTCGGCGGGCACTCCCTCCTGGCTTCCCAGCTGATTTCGCGCATACGGGCGACCTTCCGCGTGGAAGTGGCGATGGCCACGGTGTTCGAGTCCCCCACGGTGGAGCCGCTCGCCCGCCACATCGAGGAGAAGCTCAAGGACGAGTCTCGGGTCCAGCTCTCCAACGTTGTGCCGGTCGAGCGGACGCAGGAGCTTCCGCTCTCCTACCTGCAGGAGAGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACGGAACGATCGGGCTCCGGCTTCGGGGTCCTCTGTCAATCCCCGCGCTCAGGGCCACCTTCCACGATCTGGTCGCCCGTCACGAGAGCCTGCGCACCGTCTTCCGGGTCCCCGAAGGCCGCACCACGCCGGTGCAGGTGATTCTTGATTCGATGGATCTGGACATCCCGGTCCGCGATGCAACCGAGGCCGACATCATCCCGGGCATGGATGAGCTGGCGGGTCACATCTACGACATGGAGAAGGGTCCGCTGTTCATGGTTCGCCTCTTGCGGCTGGCCGAGGACTCCCACGTTCTCCTGATGGGGATGCATCACATCGTCTACGACGCATGGTCACAGTTCAATGTGATGAGTCGCGATATCAACCTGCTCTACTCGGCGCACGTGACGGGAATCGAGGCACGGCTTCCCGCGCTTCCCATCCAGTACGCCGACTTCTCGGTGTGGCAGCGCCAGCAGGACTTCCGTCACCACCTGGACTACTGGAAGTCCACACTGGGCGACTACCGGGATGATCTCGAGCTGCCGTATGACTACCCGCGGCCGCCCAGCCGGACATGGCACGCGACCCGATTCACCTTCCGGTATCCGGATGCACTGGCGCGCGCGTTCGCCAGGTTCAATCAGTCCCATCAGTCGACGCTGTTCATGGGGCTGCTGACCAGCTTCGCGATCGTGCTCAGGCACTACACCGGCCGGAACGACATCTGCATCGGAACGACAACGGCGGGGCGCGCCCAGTTGGAGTTGGAGAACCTCGTTGGCTTCTTCATCAACATCCTGCCGTTGCGCATCAATCTGGCGGGTGACCCCGACATCAGCGAGCTCATGAATCGAGCGAAGAAGAGCGTCTTGGGCGCCTTCGAGCATCAAGCTCTGCCGTTCGAGCGTCTCCTCAGTGCCCTCAACAAACAGCGTGACAGCAGCCATATCCCGCTGGTTCCCGTCATGTTGCGCCACCAGAACTTCCCGACGGCGATGACCGGCAAGTGGGCCGATGGTGTGGACATGGAGGTCATCGAGCGCGACGAGCGCACGACGCCCAACGAGCTGGACCTCCAGTTCTTTGGCGACGACACCTACTTGCATGCTGTCGTCGAGTTCCCCGCGCAGCTCTTCTCCGAGGTGACCGTCCGGCGTCTGATGCAGCGTCACCAGAAGGTCATAGAGTTCATGTGCGCGACGCTGGGGGCTCGGTGA", "orf_prot_sequence": "MLLEGELEGYEDGLELPYDFPRTSNRAWRAATFQHSYPPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGREDVCIGTTVAGRAQVGALGDLSGSTVDILPLRLDLSGAPSLHEVLRRTKAVVLEGFEHEALPCQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVKRMVEHHQRVLEALVEGLEEVRLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGSYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFSLGGHSLLAAQLISRIRATFRVEVAMATVFESPTVEPLARHIEEKLKDESRVQLSNVVPVERTQEIPLSYLQERLWFVHEHMKEQRTSYNITWTLHFAGKGFSVEALRTAFDELVARHETLRTWFQVGEGTEQAVQVIGEPWSMELPLREVAGTEVTAAINEMSRQVFDLRAGRLLTAAVLRVAEDEHILVSNIHHIITDGWSFGVMLRELRELYEAAVRGKRAELPPLTVQYGDYAVWQRKQDLSEHLAYWKGKVEEYEDGLELPYDFPRTSNRAWRAATFQYSYPPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGRQDVCIGTTVAGRAQVELESLIGFFINILPLRLDLSGAPSLHEVLRRTKAVVLEGFEHQELPFEHLLKALRRQRDSSQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVRRMVEHHQRVLEALVEGLEEGLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGHYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFSLGGHSLLAAQVVSRIGKELGTQISIADLFQRPTIEQLCELIGGLDDQTQRELALAPSGNTEAVLSFAQERMWFLHNFVKGMPYNTPGLDHLTGELDVAALEKAIRAVIRRHEPLRTNFVEKDGVLSQLVGTEERFRLTVTPIRDESEVARLMEAVIQTPVDLERELMIRAYLYRVDPRNHYLFTTIHHIAFDGWSTSIFYRELAAYYAAFLRREDSPLPALEISYQDYARWERAHFQDEVLAEKLRYWRQRLSGARPLVLPTTYHRPPIQSFAGAVVNFEIDRSITERLKTLFAESGTTMYMVLLGAFSVVLQRYSGQDDICIGSPVANRGHIQTEGLIGLFVNTLVMRVDAAGNPRFIDLLARIQRTAIDAYANQEVPFEKIVDDLQVARDTARSPLVQVILNFHNTPPQSELELQGVTLTRMPVHNGTAKFELSIDVAETSAGLTGFVEYATDLFSENFIRRMIGHLEVVLDAVGRDPRAPIHELPLLTRQDQLDLLSRSGHTAPAVEHVELIPHTFERRVQESPQAIALVCGDERVTYSALNRRASQIARRLRAAGIGPDTLVGLCAGRSIELVCGVLGILKAGGAYVPIDPTSSPEVIYDVLYESKVRHLLTESRLVGGLPVDDQEILLLDTPADGEGDKAVADREEPPDLGEVSLTPECLAYVNFTSDSGGAPRGIAVRHGALARRMAAGHAQYLANSAVRFLLKAPLTFDLAVAELFQWIVSGGSLSILDPNADRDASAFLAQVRRDSIGVLYCVPSELSTLVSHLERERERVHELNTLRFIFCGGDTLAVTVVERLGVLVRAGQLPLRLVNVYGTKETGIGAGCFECALDANDPSAELPPGRLSHERMPIGGPAQNLWFYVVQPNGGLAPLGIPGELYVGGAQLADARFGDEPTATHPGFVPNPFRSGAEKDWLYKTGDLVRWLPQGPLELVSAARERDGGGDHRLDRGFIEARMRRVAIVRDAVVAYVPDRQDRARLVAYVVLKESPAADVEPREGRETLKARISAELGSTLPEYMLPAAYVFMDSLPLTAYGRIDRKALPEPEDDRHGGSAIAYVAPRGPTEKALAHIWQQVLKRPQVGLRDNFFELGGHSVAAIQLVSVSRKHLEVEVPLSLIFESPVLEAMARGIEALQQQGRSGAVSSIHRVERTGPLPLAYVQERLWFVHEHMKEQRTSYNITWTLHFAGKGFSVEALRTAFDELVARHETLRTWFQVGEGTEQAVQVIGEPWSMELPLREVAGTEVTAAINEMSRQVFDLRAGRLLTAAVLRVAEDEHILVSNIHHIITDGWSFGVMLRELRELYEAAVRGERAELPPLTVQYGDYAVWQRKQDLSEHLAYWKGKVEGDEDGLELPYDFPRTSNRAWRAATFQYSYHPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGREDLCIGTTVAGRAQVELESLIGFFINILPLRLDLSGAPSLHEVLRRTKVVVLEGFEHQELPFEHLLKALRRQRDSSQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVRRMVEHHQRVLEALVEGLEEGLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGSYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFNLGGHSLLASQLISRIRATFRVEVAMATVFESPTVEPLARHIEEKLKDESRVQLSNVVPVERTQELPLSYLQERLWFVHEHMKEQRTSYNGTIGLRLRGPLSIPALRATFHDLVARHESLRTVFRVPEGRTTPVQVILDSMDLDIPVRDATEADIIPGMDELAGHIYDMEKGPLFMVRLLRLAEDSHVLLMGMHHIVYDAWSQFNVMSRDINLLYSAHVTGIEARLPALPIQYADFSVWQRQQDFRHHLDYWKSTLGDYRDDLELPYDYPRPPSRTWHATRFTFRYPDALARAFARFNQSHQSTLFMGLLTSFAIVLRHYTGRNDICIGTTTAGRAQLELENLVGFFINILPLRINLAGDPDISELMNRAKKSVLGAFEHQALPFERLLSALNKQRDSSHIPLVPVMLRHQNFPTAMTGKWADGVDMEVIERDERTTPNELDLQFFGDDTYLHAVVEFPAQLFSEVTVRRLMQRHQKVIEFMCATLGAR", "perc_identity": 25.26}, "gnl|BL_ORD_ID|2641|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 27422, "orf_end": 41059, "orf_from": "BGC0001413.1|Cystobactamide_17 ", "model_name": "CMH-1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "3576", "ARO_accession": "3004777", "ARO_name": "CMH-1", "ARO_category": {"42891": {"category_aro_accession": "3004776", "category_aro_cvterm_id": "42891", "category_aro_name": "CMH beta-lactamase", "category_aro_description": "CMH is a class C beta-lactamase gene family belonging to Enterobacter cloacae.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.25062, "max_identities": 24, "bit_score": 31.9574, "cvterm_id": "36884", "query": "VMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEE", "match": "+ VP+++  ++    +E   +     ML   A     +VK++ S ++A +A   +P++ ++  +ALAQ    WRV          GA+ +G G E", "sequence_from_db": "INVPHAEEPHYAWGYREGKAVHVSPGMLDAEAYGVKSNVKDMASWVMANMAPETLPQSTLQQGIALAQS-RYWRV----------GAMYQGLGWE", "sequence_from_broadstreet": "MMTKSLSCALLLSVACSAFAAPMSEKQLADVVERTVTPLMKAQAIPGMAVAVIYQGQPHYFTFGKADVAANKPVTPQTLFELGSVSKTFTGVLGGDAIARKEISLADPVTKYWPELTGKQWQGIRLLDLATYTAGGLPLQVPDDVTDNASLLRFYQSWQPKWAPGTTRLYANTSIGLFGSLAVKPSGMCFEQAMAERVFKPLKLNHTWINVPHAEEPHYAWGYREGKAVHVSPGMLDAEAYGVKSNVKDMASWVMANMAPETLPQSTLQQGIALAQSRYWRVGAMYQGLGWEMLNWPVDAKTVVDGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLANKSYPNPVRVETAYRILDALQ", "dna_sequence_from_broadstreet": "ATGATGACAAAATCCCTAAGCTGCGCGCTGCTGCTCAGCGTTGCCTGCTCTGCTTTTGCCGCGCCGATGTCAGAAAAACAGCTGGCTGACGTCGTGGAACGTACCGTTACGCCTCTGATGAAGGCGCAGGCCATACCCGGAATGGCCGTGGCCGTCATTTATCAGGGCCAGCCACACTATTTTACTTTCGGTAAAGCAGACGTCGCGGCGAATAAGCCCGTCACGCCGCAAACCTTATTTGAGCTGGGCTCCGTCAGCAAAACCTTCACCGGCGTGCTGGGTGGCGATGCCATTGCCCGCAAAGAGATTTCGCTGGCCGACCCGGTCACGAAATATTGGCCTGAATTGACGGGCAAGCAGTGGCAAGGCATTCGCCTGCTAGACCTGGCAACCTATACCGCAGGCGGATTGCCGTTGCAGGTACCGGATGATGTCACCGATAACGCCTCTCTGCTGCGTTTCTACCAGTCCTGGCAGCCAAAGTGGGCCCCGGGTACCACGCGTCTGTACGCCAACACCAGCATCGGTTTGTTTGGCTCACTGGCCGTTAAACCGTCCGGCATGTGCTTCGAGCAGGCCATGGCGGAGCGGGTCTTTAAGCCCCTGAAACTCAACCATACGTGGATAAACGTTCCACACGCTGAAGAACCGCACTACGCATGGGGTTATCGTGAGGGAAAAGCGGTCCACGTTTCGCCTGGTATGCTGGATGCAGAAGCCTATGGCGTGAAATCTAACGTCAAAGATATGGCGAGTTGGGTGATGGCCAATATGGCACCTGAGACACTCCCGCAGTCCACTCTGCAGCAGGGTATTGCGCTGGCGCAGTCTCGCTACTGGCGCGTGGGTGCCATGTATCAAGGGTTAGGCTGGGAGATGCTCAACTGGCCGGTCGATGCCAAAACCGTGGTGGATGGCAGCGATAATAAGGTCGCACTGGCGCCGTTGCCGGTCGCAGAAGTGAATCCTCCGGCTCCGCCAGTAAAAGCCTCCTGGGTGCATAAAACGGGCTCTACGGGTGGGTTTGGCAGCTACGTGGCGTTTATTCCTGAAAAGCAGATCGGTATTGTGATGCTCGCAAATAAAAGCTATCCGAACCCGGTACGGGTGGAAACGGCTTACCGTATCCTCGACGCGCTACAGTAA", "partial": "0", "query_start": 31943, "query_end": 32227, "hit_start": 624, "hit_end": 876, "orf_dna_sequence": "ATGCTGCTGGAGGGAGAGCTGGAGGGGTACGAGGACGGGTTGGAACTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGCATAGCTACCCGCCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCGAGGACGTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGGGGCGTTGGGGGATCTGAGCGGGTCCACCGTCGACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGCGGTGGTGCTGGAGGGATTCGAGCACGAGGCGTTGCCGTGCCAGATTCCCTTGGTGCCGGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAAGAGGATGGTGGAGCACCACCAGCGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGTGCGGCTGCACGAGGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGAAGCTACATCGAGCAGATACTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGCTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGAGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGACCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCGGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGCTGCCGAACGGGAAGCTGGACCGGTTGTCGCTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAGCCTCGGCGGGCACTCCCTCCTGGCTGCCCAGCTGATTTCGCGCATACGGGCGACCTTCCGCGTGGAAGTGGCGATGGCCACGGTGTTCGAGTCCCCCACGGTGGAGCCGCTCGCCCGCCACATCGAGGAGAAGCTCAAGGACGAGTCTCGGGTCCAGCTCTCCAACGTTGTGCCGGTCGAGCGGACGCAGGAGATTCCGCTCTCCTACCTGCAGGAGCGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACATCACCTGGACGTTGCACTTCGCCGGCAAGGGTTTCTCGGTGGAGGCGTTGCGGACGGCCTTCGATGAGCTGGTGGCCAGACACGAGACACTGCGCACGTGGTTCCAGGTGGGGGAGGGGACAGAGCAGGCCGTACAGGTCATCGGGGAGCCCTGGTCGATGGAGCTGCCGCTGAGAGAGGTGGCGGGGACGGAGGTGACGGCGGCAATCAATGAGATGTCCCGACAGGTCTTCGACTTGAGAGCGGGACGGTTGCTGACGGCGGCGGTCCTGAGGGTGGCGGAGGATGAGCACATCCTCGTCAGCAACATCCACCACATCATCACGGACGGCTGGTCGTTCGGGGTGATGCTGCGGGAGCTGAGGGAGTTGTACGAGGCAGCGGTGCGGGGGAAGAGAGCGGAGCTGCCGCCGCTGACGGTGCAGTACGGCGACTATGCGGTGTGGCAGAGGAAGCAGGACCTGAGCGAGCACCTGGCGTACTGGAAGGGGAAGGTGGAGGAGTACGAGGACGGGTTGGAGCTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGTATAGCTACCCACCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCCAGGACGTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGAGCTGGAGAGCCTCATCGGGTTCTTCATCAACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGCGGTGGTGCTGGAGGGATTCGAGCACCAGGAGTTGCCGTTCGAGCACCTGCTGAAGGCGCTGAGGCGGCAGCGGGACAGCAGCCAGATTCCCTTGGTGCCAGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAGGAGGATGGTGGAGCACCACCAGCGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGGGCTGCACGAGGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGACACTACATCGAGCAGATATTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGTTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGGGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGGCCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCAGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGTTGCCGAACGGGAAGCTGGACCGGCTGTCGTTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAGCCTCGGCGGGCACTCCCTCCTGGCTGCCCAGGTGGTCTCAAGGATTGGCAAGGAGCTTGGCACTCAGATCTCGATCGCCGATCTGTTTCAAAGGCCCACGATTGAACAGCTCTGTGAGCTGATTGGAGGACTGGACGATCAGACCCAGAGGGAGCTCGCCCTCGCTCCGTCGGGGAACACCGAGGCGGTGCTCTCGTTCGCGCAAGAGCGCATGTGGTTCCTGCACAACTTCGTCAAGGGCATGCCCTACAACACGCCAGGGCTCGACCACCTGACGGGTGAGCTCGATGTCGCGGCGCTAGAAAAGGCCATCCGCGCGGTCATCCGTCGCCACGAGCCCCTGCGGACGAATTTCGTCGAGAAGGACGGGGTGCTGTCCCAGTTGGTGGGGACGGAAGAACGCTTCCGCCTGACCGTGACTCCCATCCGCGACGAGAGCGAGGTCGCGCGGCTCATGGAAGCCGTGATCCAAACGCCAGTCGATCTGGAGCGGGAGTTGATGATCCGGGCTTATCTCTACCGGGTCGACCCGCGGAATCACTACCTGTTCACCACCATCCATCACATCGCCTTCGATGGCTGGTCGACATCGATCTTCTACCGTGAGCTGGCTGCGTACTACGCCGCGTTTCTCCGGCGCGAAGACAGTCCGCTGCCCGCGCTGGAAATCTCCTATCAGGACTATGCCCGCTGGGAGCGGGCCCATTTCCAGGACGAGGTGTTGGCGGAAAAACTGAGGTACTGGCGGCAGCGGCTGTCGGGCGCTCGGCCCCTCGTACTTCCGACCACCTACCATCGGCCGCCCATCCAGAGTTTCGCTGGCGCCGTCGTGAACTTCGAGATCGATCGCTCCATCACCGAGCGGTTGAAGACGCTGTTCGCCGAGTCGGGCACCACGATGTACATGGTGTTGCTCGGCGCGTTCTCCGTGGTGCTGCAGCGCTACTCCGGTCAGGACGACATCTGCATCGGCTCCCCCGTGGCGAACCGGGGTCACATCCAGACAGAAGGGCTGATCGGCTTGTTCGTCAACACCCTGGTGATGAGGGTGGATGCCGCCGGGAATCCCCGTTTCATCGACCTGCTGGCGCGCATTCAACGGACAGCCATCGATGCTTACGCGAACCAAGAAGTGCCCTTCGAGAAGATCGTGGACGACCTGCAGGTCGCGAGAGACACGGCCCGATCTCCGCTCGTGCAGGTCATTCTCAACTTCCACAACACGCCTCCTCAATCCGAGCTGGAACTGCAGGGGGTGACCCTCACGCGGATGCCGGTGCACAACGGCACGGCCAAGTTCGAGCTCTCCATCGACGTCGCGGAGACGAGCGCCGGTCTAACGGGATTCGTGGAGTACGCGACGGATCTGTTCAGCGAGAACTTCATCCGGCGGATGATCGGCCACCTCGAGGTGGTGCTGGACGCGGTCGGTCGCGATCCGCGGGCGCCTATCCATGAGTTGCCACTGCTCACCCGGCAGGATCAGTTGGACCTACTGTCGCGGAGCGGCCACACAGCCCCCGCGGTGGAACACGTCGAGTTGATCCCTCATACGTTCGAGCGGCGCGTCCAGGAGAGCCCTCAAGCGATTGCCCTGGTCTGCGGTGACGAGCGCGTCACCTACTCCGCGCTCAACCGCCGGGCCAGCCAGATTGCCCGCCGCCTGCGCGCCGCAGGGATCGGACCGGACACCCTCGTCGGGCTTTGCGCGGGGCGCTCCATCGAGCTGGTCTGCGGCGTCCTTGGCATCTTGAAGGCGGGCGGTGCGTACGTGCCAATCGACCCCACCTCCTCGCCCGAGGTGATCTACGACGTCCTGTATGAGTCGAAGGTGCGGCATCTGTTGACCGAGTCGCGCCTGGTCGGGGGACTGCCGGTCGATGACCAGGAAATCCTGCTCCTGGATACCCCCGCGGACGGTGAAGGGGACAAGGCTGTTGCTGACCGGGAGGAGCCACCTGACCTTGGCGAGGTCAGCCTCACTCCCGAGTGCTTGGCGTACGTCAACTTCACCTCCGACTCCGGTGGGGCGCCGAGGGGCATCGCCGTCCGCCATGGGGCGCTGGCTCGCCGGATGGCCGCCGGCCACGCACAGTACCTGGCCAATTCCGCCGTACGTTTCCTGCTGAAGGCGCCGCTCACGTTCGACCTGGCGGTCGCGGAGCTGTTCCAGTGGATCGTCAGCGGCGGCAGCCTGAGCATCCTCGACCCCAATGCCGACCGCGACGCCTCTGCCTTCCTCGCGCAGGTGCGCAGGGACTCGATTGGCGTCCTCTACTGCGTCCCCTCCGAACTCTCGACGCTGGTGAGCCACCTGGAGCGCGAGCGTGAAAGGGTGCATGAGCTGAACACCCTCCGGTTCATCTTCTGCGGCGGGGATACCCTGGCGGTTACCGTCGTCGAGCGTCTCGGGGTACTGGTGCGGGCCGGCCAGCTCCCGCTGCGGCTGGTCAACGTCTATGGGACGAAGGAGACGGGAATCGGCGCGGGTTGCTTCGAGTGCGCGCTGGACGCGAACGACCCCAGCGCCGAACTCCCGCCGGGACGGCTCTCGCATGAGCGGATGCCCATCGGCGGGCCCGCCCAGAACCTGTGGTTCTATGTGGTGCAACCCAACGGTGGCCTGGCTCCGTTGGGCATCCCGGGGGAACTGTACGTCGGCGGCGCGCAACTCGCCGACGCCCGTTTCGGCGACGAGCCCACGGCGACCCACCCCGGCTTCGTCCCGAACCCCTTCCGGAGCGGAGCGGAGAAGGACTGGCTGTACAAGACGGGGGACCTCGTCCGCTGGCTGCCTCAGGGGCCGCTCGAGCTGGTCAGCGCGGCTCGGGAGCGCGACGGAGGCGGGGACCACCGGCTCGATCGCGGCTTCATCGAGGCGCGCATGCGTCGTGTGGCCATTGTCCGCGACGCCGTGGTGGCCTACGTCCCGGATCGCCAGGACAGGGCCCGGTTGGTGGCCTACGTCGTTCTGAAGGAGTCGCCCGCGGCGGACGTGGAGCCGCGCGAAGGGCGGGAAACGCTGAAGGCTCGGATCAGCGCCGAACTTGGGAGCACGTTGCCGGAGTACATGCTTCCGGCCGCCTACGTGTTCATGGACAGCCTGCCGTTGACGGCTTACGGGAGGATCGACCGGAAAGCCCTGCCCGAGCCGGAGGATGACCGCCACGGTGGTAGTGCGATCGCCTACGTGGCCCCGCGCGGGCCCACGGAGAAGGCACTGGCGCACATTTGGCAGCAAGTGCTGAAACGCCCCCAGGTCGGACTGCGAGACAACTTCTTTGAGCTGGGCGGGCACTCAGTGGCGGCCATCCAACTGGTGTCCGTGAGCCGGAAGCACCTGGAGGTCGAAGTCCCCCTCAGCCTGATCTTCGAATCGCCGGTCCTGGAGGCGATGGCGCGCGGCATCGAAGCGCTGCAACAGCAGGGCCGCAGCGGCGCGGTGTCGTCGATCCATCGGGTGGAGCGGACCGGACCGCTGCCTCTGGCGTACGTGCAGGAGAGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACATCACCTGGACGTTGCACTTCGCCGGCAAGGGTTTCTCGGTGGAGGCGTTGCGGACGGCCTTCGATGAGCTGGTGGCCAGACACGAGACACTGCGCACGTGGTTCCAGGTGGGGGAGGGGACAGAGCAGGCCGTACAGGTCATCGGGGAGCCCTGGTCGATGGAGCTGCCGCTGAGAGAGGTGGCGGGGACGGAGGTGACGGCGGCAATCAATGAGATGTCCCGGCAGGTCTTCGACTTGAGAGCGGGACGGTTGCTGACGGCGGCGGTCCTGAGGGTGGCGGAGGATGAGCACATCCTCGTCAGCAACATCCACCACATCATCACGGACGGCTGGTCGTTCGGGGTGATGCTGCGGGAGCTGAGGGAGTTGTACGAGGCCGCGGTGCGGGGGGAGCGAGCGGAGCTGCCGCCGCTGACGGTGCAGTACGGCGACTATGCGGTATGGCAGAGGAAGCAGGACCTGAGCGAGCACCTGGCGTACTGGAAGGGGAAGGTGGAGGGGGACGAGGACGGGTTGGAGCTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGTATAGCTACCACCCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCGAGGACCTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGAACTGGAGAGCCTCATCGGGTTCTTCATCAACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGTGGTGGTGCTGGAGGGATTCGAGCACCAGGAGTTGCCGTTCGAGCACCTGCTGAAGGCGCTGAGGCGGCAGCGGGACAGCAGCCAGATTCCCTTGGTGCCAGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAGGAGGATGGTGGAGCACCACCAACGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGGGCTGCACGAAGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGAAGCTACATCGAGCAGATACTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGCTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGAGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGACCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCAGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGTTGCCGAACGGGAAGCTGGACCGGCTGTCGTTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAACCTCGGCGGGCACTCCCTCCTGGCTTCCCAGCTGATTTCGCGCATACGGGCGACCTTCCGCGTGGAAGTGGCGATGGCCACGGTGTTCGAGTCCCCCACGGTGGAGCCGCTCGCCCGCCACATCGAGGAGAAGCTCAAGGACGAGTCTCGGGTCCAGCTCTCCAACGTTGTGCCGGTCGAGCGGACGCAGGAGCTTCCGCTCTCCTACCTGCAGGAGAGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACGGAACGATCGGGCTCCGGCTTCGGGGTCCTCTGTCAATCCCCGCGCTCAGGGCCACCTTCCACGATCTGGTCGCCCGTCACGAGAGCCTGCGCACCGTCTTCCGGGTCCCCGAAGGCCGCACCACGCCGGTGCAGGTGATTCTTGATTCGATGGATCTGGACATCCCGGTCCGCGATGCAACCGAGGCCGACATCATCCCGGGCATGGATGAGCTGGCGGGTCACATCTACGACATGGAGAAGGGTCCGCTGTTCATGGTTCGCCTCTTGCGGCTGGCCGAGGACTCCCACGTTCTCCTGATGGGGATGCATCACATCGTCTACGACGCATGGTCACAGTTCAATGTGATGAGTCGCGATATCAACCTGCTCTACTCGGCGCACGTGACGGGAATCGAGGCACGGCTTCCCGCGCTTCCCATCCAGTACGCCGACTTCTCGGTGTGGCAGCGCCAGCAGGACTTCCGTCACCACCTGGACTACTGGAAGTCCACACTGGGCGACTACCGGGATGATCTCGAGCTGCCGTATGACTACCCGCGGCCGCCCAGCCGGACATGGCACGCGACCCGATTCACCTTCCGGTATCCGGATGCACTGGCGCGCGCGTTCGCCAGGTTCAATCAGTCCCATCAGTCGACGCTGTTCATGGGGCTGCTGACCAGCTTCGCGATCGTGCTCAGGCACTACACCGGCCGGAACGACATCTGCATCGGAACGACAACGGCGGGGCGCGCCCAGTTGGAGTTGGAGAACCTCGTTGGCTTCTTCATCAACATCCTGCCGTTGCGCATCAATCTGGCGGGTGACCCCGACATCAGCGAGCTCATGAATCGAGCGAAGAAGAGCGTCTTGGGCGCCTTCGAGCATCAAGCTCTGCCGTTCGAGCGTCTCCTCAGTGCCCTCAACAAACAGCGTGACAGCAGCCATATCCCGCTGGTTCCCGTCATGTTGCGCCACCAGAACTTCCCGACGGCGATGACCGGCAAGTGGGCCGATGGTGTGGACATGGAGGTCATCGAGCGCGACGAGCGCACGACGCCCAACGAGCTGGACCTCCAGTTCTTTGGCGACGACACCTACTTGCATGCTGTCGTCGAGTTCCCCGCGCAGCTCTTCTCCGAGGTGACCGTCCGGCGTCTGATGCAGCGTCACCAGAAGGTCATAGAGTTCATGTGCGCGACGCTGGGGGCTCGGTGA", "orf_prot_sequence": "MLLEGELEGYEDGLELPYDFPRTSNRAWRAATFQHSYPPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGREDVCIGTTVAGRAQVGALGDLSGSTVDILPLRLDLSGAPSLHEVLRRTKAVVLEGFEHEALPCQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVKRMVEHHQRVLEALVEGLEEVRLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGSYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFSLGGHSLLAAQLISRIRATFRVEVAMATVFESPTVEPLARHIEEKLKDESRVQLSNVVPVERTQEIPLSYLQERLWFVHEHMKEQRTSYNITWTLHFAGKGFSVEALRTAFDELVARHETLRTWFQVGEGTEQAVQVIGEPWSMELPLREVAGTEVTAAINEMSRQVFDLRAGRLLTAAVLRVAEDEHILVSNIHHIITDGWSFGVMLRELRELYEAAVRGKRAELPPLTVQYGDYAVWQRKQDLSEHLAYWKGKVEEYEDGLELPYDFPRTSNRAWRAATFQYSYPPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGRQDVCIGTTVAGRAQVELESLIGFFINILPLRLDLSGAPSLHEVLRRTKAVVLEGFEHQELPFEHLLKALRRQRDSSQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVRRMVEHHQRVLEALVEGLEEGLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGHYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFSLGGHSLLAAQVVSRIGKELGTQISIADLFQRPTIEQLCELIGGLDDQTQRELALAPSGNTEAVLSFAQERMWFLHNFVKGMPYNTPGLDHLTGELDVAALEKAIRAVIRRHEPLRTNFVEKDGVLSQLVGTEERFRLTVTPIRDESEVARLMEAVIQTPVDLERELMIRAYLYRVDPRNHYLFTTIHHIAFDGWSTSIFYRELAAYYAAFLRREDSPLPALEISYQDYARWERAHFQDEVLAEKLRYWRQRLSGARPLVLPTTYHRPPIQSFAGAVVNFEIDRSITERLKTLFAESGTTMYMVLLGAFSVVLQRYSGQDDICIGSPVANRGHIQTEGLIGLFVNTLVMRVDAAGNPRFIDLLARIQRTAIDAYANQEVPFEKIVDDLQVARDTARSPLVQVILNFHNTPPQSELELQGVTLTRMPVHNGTAKFELSIDVAETSAGLTGFVEYATDLFSENFIRRMIGHLEVVLDAVGRDPRAPIHELPLLTRQDQLDLLSRSGHTAPAVEHVELIPHTFERRVQESPQAIALVCGDERVTYSALNRRASQIARRLRAAGIGPDTLVGLCAGRSIELVCGVLGILKAGGAYVPIDPTSSPEVIYDVLYESKVRHLLTESRLVGGLPVDDQEILLLDTPADGEGDKAVADREEPPDLGEVSLTPECLAYVNFTSDSGGAPRGIAVRHGALARRMAAGHAQYLANSAVRFLLKAPLTFDLAVAELFQWIVSGGSLSILDPNADRDASAFLAQVRRDSIGVLYCVPSELSTLVSHLERERERVHELNTLRFIFCGGDTLAVTVVERLGVLVRAGQLPLRLVNVYGTKETGIGAGCFECALDANDPSAELPPGRLSHERMPIGGPAQNLWFYVVQPNGGLAPLGIPGELYVGGAQLADARFGDEPTATHPGFVPNPFRSGAEKDWLYKTGDLVRWLPQGPLELVSAARERDGGGDHRLDRGFIEARMRRVAIVRDAVVAYVPDRQDRARLVAYVVLKESPAADVEPREGRETLKARISAELGSTLPEYMLPAAYVFMDSLPLTAYGRIDRKALPEPEDDRHGGSAIAYVAPRGPTEKALAHIWQQVLKRPQVGLRDNFFELGGHSVAAIQLVSVSRKHLEVEVPLSLIFESPVLEAMARGIEALQQQGRSGAVSSIHRVERTGPLPLAYVQERLWFVHEHMKEQRTSYNITWTLHFAGKGFSVEALRTAFDELVARHETLRTWFQVGEGTEQAVQVIGEPWSMELPLREVAGTEVTAAINEMSRQVFDLRAGRLLTAAVLRVAEDEHILVSNIHHIITDGWSFGVMLRELRELYEAAVRGERAELPPLTVQYGDYAVWQRKQDLSEHLAYWKGKVEGDEDGLELPYDFPRTSNRAWRAATFQYSYHPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGREDLCIGTTVAGRAQVELESLIGFFINILPLRLDLSGAPSLHEVLRRTKVVVLEGFEHQELPFEHLLKALRRQRDSSQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVRRMVEHHQRVLEALVEGLEEGLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGSYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFNLGGHSLLASQLISRIRATFRVEVAMATVFESPTVEPLARHIEEKLKDESRVQLSNVVPVERTQELPLSYLQERLWFVHEHMKEQRTSYNGTIGLRLRGPLSIPALRATFHDLVARHESLRTVFRVPEGRTTPVQVILDSMDLDIPVRDATEADIIPGMDELAGHIYDMEKGPLFMVRLLRLAEDSHVLLMGMHHIVYDAWSQFNVMSRDINLLYSAHVTGIEARLPALPIQYADFSVWQRQQDFRHHLDYWKSTLGDYRDDLELPYDYPRPPSRTWHATRFTFRYPDALARAFARFNQSHQSTLFMGLLTSFAIVLRHYTGRNDICIGTTTAGRAQLELENLVGFFINILPLRINLAGDPDISELMNRAKKSVLGAFEHQALPFERLLSALNKQRDSSHIPLVPVMLRHQNFPTAMTGKWADGVDMEVIERDERTTPNELDLQFFGDDTYLHAVVEFPAQLFSEVTVRRLMQRHQKVIEFMCATLGAR", "perc_identity": 25.26}, "gnl|BL_ORD_ID|2641|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 27422, "orf_end": 41059, "orf_from": "BGC0001413.1|Cystobactamide_17 ", "model_name": "CMH-1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "3576", "ARO_accession": "3004777", "ARO_name": "CMH-1", "ARO_category": {"42891": {"category_aro_accession": "3004776", "category_aro_cvterm_id": "42891", "category_aro_name": "CMH beta-lactamase", "category_aro_description": "CMH is a class C beta-lactamase gene family belonging to Enterobacter cloacae.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.25062, "max_identities": 24, "bit_score": 31.9574, "cvterm_id": "36884", "query": "VMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEE", "match": "+ VP+++  ++    +E   +     ML   A     +VK++ S ++A +A   +P++ ++  +ALAQ    WRV          GA+ +G G E", "sequence_from_db": "INVPHAEEPHYAWGYREGKAVHVSPGMLDAEAYGVKSNVKDMASWVMANMAPETLPQSTLQQGIALAQS-RYWRV----------GAMYQGLGWE", "sequence_from_broadstreet": "MMTKSLSCALLLSVACSAFAAPMSEKQLADVVERTVTPLMKAQAIPGMAVAVIYQGQPHYFTFGKADVAANKPVTPQTLFELGSVSKTFTGVLGGDAIARKEISLADPVTKYWPELTGKQWQGIRLLDLATYTAGGLPLQVPDDVTDNASLLRFYQSWQPKWAPGTTRLYANTSIGLFGSLAVKPSGMCFEQAMAERVFKPLKLNHTWINVPHAEEPHYAWGYREGKAVHVSPGMLDAEAYGVKSNVKDMASWVMANMAPETLPQSTLQQGIALAQSRYWRVGAMYQGLGWEMLNWPVDAKTVVDGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLANKSYPNPVRVETAYRILDALQ", "dna_sequence_from_broadstreet": "ATGATGACAAAATCCCTAAGCTGCGCGCTGCTGCTCAGCGTTGCCTGCTCTGCTTTTGCCGCGCCGATGTCAGAAAAACAGCTGGCTGACGTCGTGGAACGTACCGTTACGCCTCTGATGAAGGCGCAGGCCATACCCGGAATGGCCGTGGCCGTCATTTATCAGGGCCAGCCACACTATTTTACTTTCGGTAAAGCAGACGTCGCGGCGAATAAGCCCGTCACGCCGCAAACCTTATTTGAGCTGGGCTCCGTCAGCAAAACCTTCACCGGCGTGCTGGGTGGCGATGCCATTGCCCGCAAAGAGATTTCGCTGGCCGACCCGGTCACGAAATATTGGCCTGAATTGACGGGCAAGCAGTGGCAAGGCATTCGCCTGCTAGACCTGGCAACCTATACCGCAGGCGGATTGCCGTTGCAGGTACCGGATGATGTCACCGATAACGCCTCTCTGCTGCGTTTCTACCAGTCCTGGCAGCCAAAGTGGGCCCCGGGTACCACGCGTCTGTACGCCAACACCAGCATCGGTTTGTTTGGCTCACTGGCCGTTAAACCGTCCGGCATGTGCTTCGAGCAGGCCATGGCGGAGCGGGTCTTTAAGCCCCTGAAACTCAACCATACGTGGATAAACGTTCCACACGCTGAAGAACCGCACTACGCATGGGGTTATCGTGAGGGAAAAGCGGTCCACGTTTCGCCTGGTATGCTGGATGCAGAAGCCTATGGCGTGAAATCTAACGTCAAAGATATGGCGAGTTGGGTGATGGCCAATATGGCACCTGAGACACTCCCGCAGTCCACTCTGCAGCAGGGTATTGCGCTGGCGCAGTCTCGCTACTGGCGCGTGGGTGCCATGTATCAAGGGTTAGGCTGGGAGATGCTCAACTGGCCGGTCGATGCCAAAACCGTGGTGGATGGCAGCGATAATAAGGTCGCACTGGCGCCGTTGCCGGTCGCAGAAGTGAATCCTCCGGCTCCGCCAGTAAAAGCCTCCTGGGTGCATAAAACGGGCTCTACGGGTGGGTTTGGCAGCTACGTGGCGTTTATTCCTGAAAAGCAGATCGGTATTGTGATGCTCGCAAATAAAAGCTATCCGAACCCGGTACGGGTGGAAACGGCTTACCGTATCCTCGACGCGCTACAGTAA", "partial": "0", "query_start": 38450, "query_end": 38734, "hit_start": 624, "hit_end": 876, "orf_dna_sequence": "ATGCTGCTGGAGGGAGAGCTGGAGGGGTACGAGGACGGGTTGGAACTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGCATAGCTACCCGCCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCGAGGACGTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGGGGCGTTGGGGGATCTGAGCGGGTCCACCGTCGACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGCGGTGGTGCTGGAGGGATTCGAGCACGAGGCGTTGCCGTGCCAGATTCCCTTGGTGCCGGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAAGAGGATGGTGGAGCACCACCAGCGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGTGCGGCTGCACGAGGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGAAGCTACATCGAGCAGATACTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGCTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGAGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGACCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCGGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGCTGCCGAACGGGAAGCTGGACCGGTTGTCGCTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAGCCTCGGCGGGCACTCCCTCCTGGCTGCCCAGCTGATTTCGCGCATACGGGCGACCTTCCGCGTGGAAGTGGCGATGGCCACGGTGTTCGAGTCCCCCACGGTGGAGCCGCTCGCCCGCCACATCGAGGAGAAGCTCAAGGACGAGTCTCGGGTCCAGCTCTCCAACGTTGTGCCGGTCGAGCGGACGCAGGAGATTCCGCTCTCCTACCTGCAGGAGCGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACATCACCTGGACGTTGCACTTCGCCGGCAAGGGTTTCTCGGTGGAGGCGTTGCGGACGGCCTTCGATGAGCTGGTGGCCAGACACGAGACACTGCGCACGTGGTTCCAGGTGGGGGAGGGGACAGAGCAGGCCGTACAGGTCATCGGGGAGCCCTGGTCGATGGAGCTGCCGCTGAGAGAGGTGGCGGGGACGGAGGTGACGGCGGCAATCAATGAGATGTCCCGACAGGTCTTCGACTTGAGAGCGGGACGGTTGCTGACGGCGGCGGTCCTGAGGGTGGCGGAGGATGAGCACATCCTCGTCAGCAACATCCACCACATCATCACGGACGGCTGGTCGTTCGGGGTGATGCTGCGGGAGCTGAGGGAGTTGTACGAGGCAGCGGTGCGGGGGAAGAGAGCGGAGCTGCCGCCGCTGACGGTGCAGTACGGCGACTATGCGGTGTGGCAGAGGAAGCAGGACCTGAGCGAGCACCTGGCGTACTGGAAGGGGAAGGTGGAGGAGTACGAGGACGGGTTGGAGCTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGTATAGCTACCCACCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCCAGGACGTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGAGCTGGAGAGCCTCATCGGGTTCTTCATCAACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGCGGTGGTGCTGGAGGGATTCGAGCACCAGGAGTTGCCGTTCGAGCACCTGCTGAAGGCGCTGAGGCGGCAGCGGGACAGCAGCCAGATTCCCTTGGTGCCAGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAGGAGGATGGTGGAGCACCACCAGCGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGGGCTGCACGAGGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGACACTACATCGAGCAGATATTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGTTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGGGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGGCCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCAGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGTTGCCGAACGGGAAGCTGGACCGGCTGTCGTTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAGCCTCGGCGGGCACTCCCTCCTGGCTGCCCAGGTGGTCTCAAGGATTGGCAAGGAGCTTGGCACTCAGATCTCGATCGCCGATCTGTTTCAAAGGCCCACGATTGAACAGCTCTGTGAGCTGATTGGAGGACTGGACGATCAGACCCAGAGGGAGCTCGCCCTCGCTCCGTCGGGGAACACCGAGGCGGTGCTCTCGTTCGCGCAAGAGCGCATGTGGTTCCTGCACAACTTCGTCAAGGGCATGCCCTACAACACGCCAGGGCTCGACCACCTGACGGGTGAGCTCGATGTCGCGGCGCTAGAAAAGGCCATCCGCGCGGTCATCCGTCGCCACGAGCCCCTGCGGACGAATTTCGTCGAGAAGGACGGGGTGCTGTCCCAGTTGGTGGGGACGGAAGAACGCTTCCGCCTGACCGTGACTCCCATCCGCGACGAGAGCGAGGTCGCGCGGCTCATGGAAGCCGTGATCCAAACGCCAGTCGATCTGGAGCGGGAGTTGATGATCCGGGCTTATCTCTACCGGGTCGACCCGCGGAATCACTACCTGTTCACCACCATCCATCACATCGCCTTCGATGGCTGGTCGACATCGATCTTCTACCGTGAGCTGGCTGCGTACTACGCCGCGTTTCTCCGGCGCGAAGACAGTCCGCTGCCCGCGCTGGAAATCTCCTATCAGGACTATGCCCGCTGGGAGCGGGCCCATTTCCAGGACGAGGTGTTGGCGGAAAAACTGAGGTACTGGCGGCAGCGGCTGTCGGGCGCTCGGCCCCTCGTACTTCCGACCACCTACCATCGGCCGCCCATCCAGAGTTTCGCTGGCGCCGTCGTGAACTTCGAGATCGATCGCTCCATCACCGAGCGGTTGAAGACGCTGTTCGCCGAGTCGGGCACCACGATGTACATGGTGTTGCTCGGCGCGTTCTCCGTGGTGCTGCAGCGCTACTCCGGTCAGGACGACATCTGCATCGGCTCCCCCGTGGCGAACCGGGGTCACATCCAGACAGAAGGGCTGATCGGCTTGTTCGTCAACACCCTGGTGATGAGGGTGGATGCCGCCGGGAATCCCCGTTTCATCGACCTGCTGGCGCGCATTCAACGGACAGCCATCGATGCTTACGCGAACCAAGAAGTGCCCTTCGAGAAGATCGTGGACGACCTGCAGGTCGCGAGAGACACGGCCCGATCTCCGCTCGTGCAGGTCATTCTCAACTTCCACAACACGCCTCCTCAATCCGAGCTGGAACTGCAGGGGGTGACCCTCACGCGGATGCCGGTGCACAACGGCACGGCCAAGTTCGAGCTCTCCATCGACGTCGCGGAGACGAGCGCCGGTCTAACGGGATTCGTGGAGTACGCGACGGATCTGTTCAGCGAGAACTTCATCCGGCGGATGATCGGCCACCTCGAGGTGGTGCTGGACGCGGTCGGTCGCGATCCGCGGGCGCCTATCCATGAGTTGCCACTGCTCACCCGGCAGGATCAGTTGGACCTACTGTCGCGGAGCGGCCACACAGCCCCCGCGGTGGAACACGTCGAGTTGATCCCTCATACGTTCGAGCGGCGCGTCCAGGAGAGCCCTCAAGCGATTGCCCTGGTCTGCGGTGACGAGCGCGTCACCTACTCCGCGCTCAACCGCCGGGCCAGCCAGATTGCCCGCCGCCTGCGCGCCGCAGGGATCGGACCGGACACCCTCGTCGGGCTTTGCGCGGGGCGCTCCATCGAGCTGGTCTGCGGCGTCCTTGGCATCTTGAAGGCGGGCGGTGCGTACGTGCCAATCGACCCCACCTCCTCGCCCGAGGTGATCTACGACGTCCTGTATGAGTCGAAGGTGCGGCATCTGTTGACCGAGTCGCGCCTGGTCGGGGGACTGCCGGTCGATGACCAGGAAATCCTGCTCCTGGATACCCCCGCGGACGGTGAAGGGGACAAGGCTGTTGCTGACCGGGAGGAGCCACCTGACCTTGGCGAGGTCAGCCTCACTCCCGAGTGCTTGGCGTACGTCAACTTCACCTCCGACTCCGGTGGGGCGCCGAGGGGCATCGCCGTCCGCCATGGGGCGCTGGCTCGCCGGATGGCCGCCGGCCACGCACAGTACCTGGCCAATTCCGCCGTACGTTTCCTGCTGAAGGCGCCGCTCACGTTCGACCTGGCGGTCGCGGAGCTGTTCCAGTGGATCGTCAGCGGCGGCAGCCTGAGCATCCTCGACCCCAATGCCGACCGCGACGCCTCTGCCTTCCTCGCGCAGGTGCGCAGGGACTCGATTGGCGTCCTCTACTGCGTCCCCTCCGAACTCTCGACGCTGGTGAGCCACCTGGAGCGCGAGCGTGAAAGGGTGCATGAGCTGAACACCCTCCGGTTCATCTTCTGCGGCGGGGATACCCTGGCGGTTACCGTCGTCGAGCGTCTCGGGGTACTGGTGCGGGCCGGCCAGCTCCCGCTGCGGCTGGTCAACGTCTATGGGACGAAGGAGACGGGAATCGGCGCGGGTTGCTTCGAGTGCGCGCTGGACGCGAACGACCCCAGCGCCGAACTCCCGCCGGGACGGCTCTCGCATGAGCGGATGCCCATCGGCGGGCCCGCCCAGAACCTGTGGTTCTATGTGGTGCAACCCAACGGTGGCCTGGCTCCGTTGGGCATCCCGGGGGAACTGTACGTCGGCGGCGCGCAACTCGCCGACGCCCGTTTCGGCGACGAGCCCACGGCGACCCACCCCGGCTTCGTCCCGAACCCCTTCCGGAGCGGAGCGGAGAAGGACTGGCTGTACAAGACGGGGGACCTCGTCCGCTGGCTGCCTCAGGGGCCGCTCGAGCTGGTCAGCGCGGCTCGGGAGCGCGACGGAGGCGGGGACCACCGGCTCGATCGCGGCTTCATCGAGGCGCGCATGCGTCGTGTGGCCATTGTCCGCGACGCCGTGGTGGCCTACGTCCCGGATCGCCAGGACAGGGCCCGGTTGGTGGCCTACGTCGTTCTGAAGGAGTCGCCCGCGGCGGACGTGGAGCCGCGCGAAGGGCGGGAAACGCTGAAGGCTCGGATCAGCGCCGAACTTGGGAGCACGTTGCCGGAGTACATGCTTCCGGCCGCCTACGTGTTCATGGACAGCCTGCCGTTGACGGCTTACGGGAGGATCGACCGGAAAGCCCTGCCCGAGCCGGAGGATGACCGCCACGGTGGTAGTGCGATCGCCTACGTGGCCCCGCGCGGGCCCACGGAGAAGGCACTGGCGCACATTTGGCAGCAAGTGCTGAAACGCCCCCAGGTCGGACTGCGAGACAACTTCTTTGAGCTGGGCGGGCACTCAGTGGCGGCCATCCAACTGGTGTCCGTGAGCCGGAAGCACCTGGAGGTCGAAGTCCCCCTCAGCCTGATCTTCGAATCGCCGGTCCTGGAGGCGATGGCGCGCGGCATCGAAGCGCTGCAACAGCAGGGCCGCAGCGGCGCGGTGTCGTCGATCCATCGGGTGGAGCGGACCGGACCGCTGCCTCTGGCGTACGTGCAGGAGAGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACATCACCTGGACGTTGCACTTCGCCGGCAAGGGTTTCTCGGTGGAGGCGTTGCGGACGGCCTTCGATGAGCTGGTGGCCAGACACGAGACACTGCGCACGTGGTTCCAGGTGGGGGAGGGGACAGAGCAGGCCGTACAGGTCATCGGGGAGCCCTGGTCGATGGAGCTGCCGCTGAGAGAGGTGGCGGGGACGGAGGTGACGGCGGCAATCAATGAGATGTCCCGGCAGGTCTTCGACTTGAGAGCGGGACGGTTGCTGACGGCGGCGGTCCTGAGGGTGGCGGAGGATGAGCACATCCTCGTCAGCAACATCCACCACATCATCACGGACGGCTGGTCGTTCGGGGTGATGCTGCGGGAGCTGAGGGAGTTGTACGAGGCCGCGGTGCGGGGGGAGCGAGCGGAGCTGCCGCCGCTGACGGTGCAGTACGGCGACTATGCGGTATGGCAGAGGAAGCAGGACCTGAGCGAGCACCTGGCGTACTGGAAGGGGAAGGTGGAGGGGGACGAGGACGGGTTGGAGCTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGTATAGCTACCACCCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCGAGGACCTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGAACTGGAGAGCCTCATCGGGTTCTTCATCAACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGTGGTGGTGCTGGAGGGATTCGAGCACCAGGAGTTGCCGTTCGAGCACCTGCTGAAGGCGCTGAGGCGGCAGCGGGACAGCAGCCAGATTCCCTTGGTGCCAGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAGGAGGATGGTGGAGCACCACCAACGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGGGCTGCACGAAGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGAAGCTACATCGAGCAGATACTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGCTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGAGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGACCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCAGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGTTGCCGAACGGGAAGCTGGACCGGCTGTCGTTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAACCTCGGCGGGCACTCCCTCCTGGCTTCCCAGCTGATTTCGCGCATACGGGCGACCTTCCGCGTGGAAGTGGCGATGGCCACGGTGTTCGAGTCCCCCACGGTGGAGCCGCTCGCCCGCCACATCGAGGAGAAGCTCAAGGACGAGTCTCGGGTCCAGCTCTCCAACGTTGTGCCGGTCGAGCGGACGCAGGAGCTTCCGCTCTCCTACCTGCAGGAGAGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACGGAACGATCGGGCTCCGGCTTCGGGGTCCTCTGTCAATCCCCGCGCTCAGGGCCACCTTCCACGATCTGGTCGCCCGTCACGAGAGCCTGCGCACCGTCTTCCGGGTCCCCGAAGGCCGCACCACGCCGGTGCAGGTGATTCTTGATTCGATGGATCTGGACATCCCGGTCCGCGATGCAACCGAGGCCGACATCATCCCGGGCATGGATGAGCTGGCGGGTCACATCTACGACATGGAGAAGGGTCCGCTGTTCATGGTTCGCCTCTTGCGGCTGGCCGAGGACTCCCACGTTCTCCTGATGGGGATGCATCACATCGTCTACGACGCATGGTCACAGTTCAATGTGATGAGTCGCGATATCAACCTGCTCTACTCGGCGCACGTGACGGGAATCGAGGCACGGCTTCCCGCGCTTCCCATCCAGTACGCCGACTTCTCGGTGTGGCAGCGCCAGCAGGACTTCCGTCACCACCTGGACTACTGGAAGTCCACACTGGGCGACTACCGGGATGATCTCGAGCTGCCGTATGACTACCCGCGGCCGCCCAGCCGGACATGGCACGCGACCCGATTCACCTTCCGGTATCCGGATGCACTGGCGCGCGCGTTCGCCAGGTTCAATCAGTCCCATCAGTCGACGCTGTTCATGGGGCTGCTGACCAGCTTCGCGATCGTGCTCAGGCACTACACCGGCCGGAACGACATCTGCATCGGAACGACAACGGCGGGGCGCGCCCAGTTGGAGTTGGAGAACCTCGTTGGCTTCTTCATCAACATCCTGCCGTTGCGCATCAATCTGGCGGGTGACCCCGACATCAGCGAGCTCATGAATCGAGCGAAGAAGAGCGTCTTGGGCGCCTTCGAGCATCAAGCTCTGCCGTTCGAGCGTCTCCTCAGTGCCCTCAACAAACAGCGTGACAGCAGCCATATCCCGCTGGTTCCCGTCATGTTGCGCCACCAGAACTTCCCGACGGCGATGACCGGCAAGTGGGCCGATGGTGTGGACATGGAGGTCATCGAGCGCGACGAGCGCACGACGCCCAACGAGCTGGACCTCCAGTTCTTTGGCGACGACACCTACTTGCATGCTGTCGTCGAGTTCCCCGCGCAGCTCTTCTCCGAGGTGACCGTCCGGCGTCTGATGCAGCGTCACCAGAAGGTCATAGAGTTCATGTGCGCGACGCTGGGGGCTCGGTGA", "orf_prot_sequence": "MLLEGELEGYEDGLELPYDFPRTSNRAWRAATFQHSYPPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGREDVCIGTTVAGRAQVGALGDLSGSTVDILPLRLDLSGAPSLHEVLRRTKAVVLEGFEHEALPCQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVKRMVEHHQRVLEALVEGLEEVRLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGSYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFSLGGHSLLAAQLISRIRATFRVEVAMATVFESPTVEPLARHIEEKLKDESRVQLSNVVPVERTQEIPLSYLQERLWFVHEHMKEQRTSYNITWTLHFAGKGFSVEALRTAFDELVARHETLRTWFQVGEGTEQAVQVIGEPWSMELPLREVAGTEVTAAINEMSRQVFDLRAGRLLTAAVLRVAEDEHILVSNIHHIITDGWSFGVMLRELRELYEAAVRGKRAELPPLTVQYGDYAVWQRKQDLSEHLAYWKGKVEEYEDGLELPYDFPRTSNRAWRAATFQYSYPPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGRQDVCIGTTVAGRAQVELESLIGFFINILPLRLDLSGAPSLHEVLRRTKAVVLEGFEHQELPFEHLLKALRRQRDSSQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVRRMVEHHQRVLEALVEGLEEGLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGHYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFSLGGHSLLAAQVVSRIGKELGTQISIADLFQRPTIEQLCELIGGLDDQTQRELALAPSGNTEAVLSFAQERMWFLHNFVKGMPYNTPGLDHLTGELDVAALEKAIRAVIRRHEPLRTNFVEKDGVLSQLVGTEERFRLTVTPIRDESEVARLMEAVIQTPVDLERELMIRAYLYRVDPRNHYLFTTIHHIAFDGWSTSIFYRELAAYYAAFLRREDSPLPALEISYQDYARWERAHFQDEVLAEKLRYWRQRLSGARPLVLPTTYHRPPIQSFAGAVVNFEIDRSITERLKTLFAESGTTMYMVLLGAFSVVLQRYSGQDDICIGSPVANRGHIQTEGLIGLFVNTLVMRVDAAGNPRFIDLLARIQRTAIDAYANQEVPFEKIVDDLQVARDTARSPLVQVILNFHNTPPQSELELQGVTLTRMPVHNGTAKFELSIDVAETSAGLTGFVEYATDLFSENFIRRMIGHLEVVLDAVGRDPRAPIHELPLLTRQDQLDLLSRSGHTAPAVEHVELIPHTFERRVQESPQAIALVCGDERVTYSALNRRASQIARRLRAAGIGPDTLVGLCAGRSIELVCGVLGILKAGGAYVPIDPTSSPEVIYDVLYESKVRHLLTESRLVGGLPVDDQEILLLDTPADGEGDKAVADREEPPDLGEVSLTPECLAYVNFTSDSGGAPRGIAVRHGALARRMAAGHAQYLANSAVRFLLKAPLTFDLAVAELFQWIVSGGSLSILDPNADRDASAFLAQVRRDSIGVLYCVPSELSTLVSHLERERERVHELNTLRFIFCGGDTLAVTVVERLGVLVRAGQLPLRLVNVYGTKETGIGAGCFECALDANDPSAELPPGRLSHERMPIGGPAQNLWFYVVQPNGGLAPLGIPGELYVGGAQLADARFGDEPTATHPGFVPNPFRSGAEKDWLYKTGDLVRWLPQGPLELVSAARERDGGGDHRLDRGFIEARMRRVAIVRDAVVAYVPDRQDRARLVAYVVLKESPAADVEPREGRETLKARISAELGSTLPEYMLPAAYVFMDSLPLTAYGRIDRKALPEPEDDRHGGSAIAYVAPRGPTEKALAHIWQQVLKRPQVGLRDNFFELGGHSVAAIQLVSVSRKHLEVEVPLSLIFESPVLEAMARGIEALQQQGRSGAVSSIHRVERTGPLPLAYVQERLWFVHEHMKEQRTSYNITWTLHFAGKGFSVEALRTAFDELVARHETLRTWFQVGEGTEQAVQVIGEPWSMELPLREVAGTEVTAAINEMSRQVFDLRAGRLLTAAVLRVAEDEHILVSNIHHIITDGWSFGVMLRELRELYEAAVRGERAELPPLTVQYGDYAVWQRKQDLSEHLAYWKGKVEGDEDGLELPYDFPRTSNRAWRAATFQYSYHPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGREDLCIGTTVAGRAQVELESLIGFFINILPLRLDLSGAPSLHEVLRRTKVVVLEGFEHQELPFEHLLKALRRQRDSSQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVRRMVEHHQRVLEALVEGLEEGLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGSYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFNLGGHSLLASQLISRIRATFRVEVAMATVFESPTVEPLARHIEEKLKDESRVQLSNVVPVERTQELPLSYLQERLWFVHEHMKEQRTSYNGTIGLRLRGPLSIPALRATFHDLVARHESLRTVFRVPEGRTTPVQVILDSMDLDIPVRDATEADIIPGMDELAGHIYDMEKGPLFMVRLLRLAEDSHVLLMGMHHIVYDAWSQFNVMSRDINLLYSAHVTGIEARLPALPIQYADFSVWQRQQDFRHHLDYWKSTLGDYRDDLELPYDYPRPPSRTWHATRFTFRYPDALARAFARFNQSHQSTLFMGLLTSFAIVLRHYTGRNDICIGTTTAGRAQLELENLVGFFINILPLRINLAGDPDISELMNRAKKSVLGAFEHQALPFERLLSALNKQRDSSHIPLVPVMLRHQNFPTAMTGKWADGVDMEVIERDERTTPNELDLQFFGDDTYLHAVVEFPAQLFSEVTVRRLMQRHQKVIEFMCATLGAR", "perc_identity": 25.26}, "gnl|BL_ORD_ID|3397|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 27422, "orf_end": 41059, "orf_from": "BGC0001413.1|Cystobactamide_17 ", "model_name": "CMH-4", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "4466", "ARO_accession": "3006856", "ARO_name": "CMH-4", "ARO_category": {"42891": {"category_aro_accession": "3004776", "category_aro_cvterm_id": "42891", "category_aro_name": "CMH beta-lactamase", "category_aro_description": "CMH is a class C beta-lactamase gene family belonging to Enterobacter cloacae.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.29425, "max_identities": 24, "bit_score": 31.9574, "cvterm_id": "36884", "query": "VMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEE", "match": "+ VP+++  ++    +E   +     ML   A     +VK++ S ++A +A   +P++ ++  +ALAQ    WRV          GA+ +G G E", "sequence_from_db": "INVPHAEEPHYAWGYREGKAVHVSPGMLDAEAYGVKSNVKDMASWVMANMAPETLPQSTLQQGIALAQS-RYWRV----------GAMYQGLGWE", "sequence_from_broadstreet": "MMKKSLSCALLLSVACSAFAAPMSEKQLADVVERTVTPLMKAQAIPGMAVAVIYQGQPHYFTFGKADVAANKPVTPQTLFELGSVSKTFTGVLGGDAIARKEISLADPVTKYWPELTGKQWQGIRLLDLATYTAGGLPLQVPDDVTDNASLLRFYQSWQPKWAPGTTRLYANTSIGLFGSLAVKPSGMRFEQAMAERVFKPLKLNHTWINVPHAEEPHYAWGYREGKAVHVSPGMLDAEAYGVKSNVKDMASWVMANMAPETLPQSTLQQGIALAQSRYWRVGAMYQGLGWEMLNWPVDAKTVVDGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLANKSYPNPVRVETAYRILDALQ", "dna_sequence_from_broadstreet": "ATGATGAAAAAATCCCTAAGCTGCGCCCTGCTGCTCAGCGTTGCCTGCTCTGCTTTTGCCGCGCCGATGTCAGAAAAACAGCTGGCTGACGTCGTGGAACGTACCGTTACGCCCCTGATGAAGGCGCAGGCCATACCCGGAATGGCCGTGGCCGTCATTTATCAGGGCCAGCCACACTATTTTACTTTCGGTAAAGCAGACGTCGCGGCGAATAAGCCCGTCACGCCGCAAACCTTATTTGAACTGGGCTCCGTCAGTAAAACCTTCACTGGCGTGCTGGGTGGCGATGCCATTGCCCGCAAAGAGATTTCGCTGGCCGACCCGGTCACGAAATATTGGCCTGAATTGACGGGCAAGCAGTGGCAAGGCATTCGCCTGCTCGACCTGGCAACCTATACGGCAGGCGGATTGCCGTTGCAGGTACCGGATGATGTTACCGATAACGCCTCTCTGCTGCGTTTCTACCAGTCCTGGCAGCCAAAGTGGGCCCCGGGTACCACGCGTCTGTACGCCAACACCAGCATCGGCCTGTTTGGCTCACTGGCCGTTAAACCGTCCGGCATGCGCTTCGAGCAGGCCATGGCGGAGCGGGTCTTTAAGCCCCTGAAACTCAACCATACGTGGATAAACGTTCCACACGCTGAAGAGCCGCACTACGCATGGGGTTATCGTGAGGGAAAAGCGGTCCACGTTTCGCCTGGTATGCTGGATGCAGAAGCCTATGGTGTGAAATCTAACGTCAAAGATATGGCGAGCTGGGTGATGGCCAATATGGCACCTGAGACACTCCCGCAGTCCACTCTGCAGCAGGGTATTGCGCTGGCGCAGTCTCGCTACTGGCGCGTGGGTGCCATGTATCAAGGGTTAGGCTGGGAGATGCTCAACTGGCCGGTCGATGCCAAAACCGTGGTGGATGGCAGCGACAATAAGGTCGCACTGGCGCCGTTGCCGGTCGCAGAAGTGAATCCTCCGGCTCCGCCAGTAAAAGCCTCCTGGGTGCATAAAACGGGCTCTACGGGTGGGTTTGGCAGCTACGTGGCGTTTATTCCTGAAAAGCAGATCGGTATTGTGATGCTCGCAAATAAAAGCTATCCGAACCCGGTACGGGTGGAAACGGCTTACCGTATCCTCGACGCGCTACAGTAA", "partial": "0", "query_start": 28721, "query_end": 29005, "hit_start": 624, "hit_end": 876, "orf_dna_sequence": "ATGCTGCTGGAGGGAGAGCTGGAGGGGTACGAGGACGGGTTGGAACTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGCATAGCTACCCGCCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCGAGGACGTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGGGGCGTTGGGGGATCTGAGCGGGTCCACCGTCGACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGCGGTGGTGCTGGAGGGATTCGAGCACGAGGCGTTGCCGTGCCAGATTCCCTTGGTGCCGGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAAGAGGATGGTGGAGCACCACCAGCGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGTGCGGCTGCACGAGGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGAAGCTACATCGAGCAGATACTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGCTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGAGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGACCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCGGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGCTGCCGAACGGGAAGCTGGACCGGTTGTCGCTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAGCCTCGGCGGGCACTCCCTCCTGGCTGCCCAGCTGATTTCGCGCATACGGGCGACCTTCCGCGTGGAAGTGGCGATGGCCACGGTGTTCGAGTCCCCCACGGTGGAGCCGCTCGCCCGCCACATCGAGGAGAAGCTCAAGGACGAGTCTCGGGTCCAGCTCTCCAACGTTGTGCCGGTCGAGCGGACGCAGGAGATTCCGCTCTCCTACCTGCAGGAGCGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACATCACCTGGACGTTGCACTTCGCCGGCAAGGGTTTCTCGGTGGAGGCGTTGCGGACGGCCTTCGATGAGCTGGTGGCCAGACACGAGACACTGCGCACGTGGTTCCAGGTGGGGGAGGGGACAGAGCAGGCCGTACAGGTCATCGGGGAGCCCTGGTCGATGGAGCTGCCGCTGAGAGAGGTGGCGGGGACGGAGGTGACGGCGGCAATCAATGAGATGTCCCGACAGGTCTTCGACTTGAGAGCGGGACGGTTGCTGACGGCGGCGGTCCTGAGGGTGGCGGAGGATGAGCACATCCTCGTCAGCAACATCCACCACATCATCACGGACGGCTGGTCGTTCGGGGTGATGCTGCGGGAGCTGAGGGAGTTGTACGAGGCAGCGGTGCGGGGGAAGAGAGCGGAGCTGCCGCCGCTGACGGTGCAGTACGGCGACTATGCGGTGTGGCAGAGGAAGCAGGACCTGAGCGAGCACCTGGCGTACTGGAAGGGGAAGGTGGAGGAGTACGAGGACGGGTTGGAGCTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGTATAGCTACCCACCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCCAGGACGTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGAGCTGGAGAGCCTCATCGGGTTCTTCATCAACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGCGGTGGTGCTGGAGGGATTCGAGCACCAGGAGTTGCCGTTCGAGCACCTGCTGAAGGCGCTGAGGCGGCAGCGGGACAGCAGCCAGATTCCCTTGGTGCCAGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAGGAGGATGGTGGAGCACCACCAGCGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGGGCTGCACGAGGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGACACTACATCGAGCAGATATTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGTTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGGGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGGCCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCAGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGTTGCCGAACGGGAAGCTGGACCGGCTGTCGTTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAGCCTCGGCGGGCACTCCCTCCTGGCTGCCCAGGTGGTCTCAAGGATTGGCAAGGAGCTTGGCACTCAGATCTCGATCGCCGATCTGTTTCAAAGGCCCACGATTGAACAGCTCTGTGAGCTGATTGGAGGACTGGACGATCAGACCCAGAGGGAGCTCGCCCTCGCTCCGTCGGGGAACACCGAGGCGGTGCTCTCGTTCGCGCAAGAGCGCATGTGGTTCCTGCACAACTTCGTCAAGGGCATGCCCTACAACACGCCAGGGCTCGACCACCTGACGGGTGAGCTCGATGTCGCGGCGCTAGAAAAGGCCATCCGCGCGGTCATCCGTCGCCACGAGCCCCTGCGGACGAATTTCGTCGAGAAGGACGGGGTGCTGTCCCAGTTGGTGGGGACGGAAGAACGCTTCCGCCTGACCGTGACTCCCATCCGCGACGAGAGCGAGGTCGCGCGGCTCATGGAAGCCGTGATCCAAACGCCAGTCGATCTGGAGCGGGAGTTGATGATCCGGGCTTATCTCTACCGGGTCGACCCGCGGAATCACTACCTGTTCACCACCATCCATCACATCGCCTTCGATGGCTGGTCGACATCGATCTTCTACCGTGAGCTGGCTGCGTACTACGCCGCGTTTCTCCGGCGCGAAGACAGTCCGCTGCCCGCGCTGGAAATCTCCTATCAGGACTATGCCCGCTGGGAGCGGGCCCATTTCCAGGACGAGGTGTTGGCGGAAAAACTGAGGTACTGGCGGCAGCGGCTGTCGGGCGCTCGGCCCCTCGTACTTCCGACCACCTACCATCGGCCGCCCATCCAGAGTTTCGCTGGCGCCGTCGTGAACTTCGAGATCGATCGCTCCATCACCGAGCGGTTGAAGACGCTGTTCGCCGAGTCGGGCACCACGATGTACATGGTGTTGCTCGGCGCGTTCTCCGTGGTGCTGCAGCGCTACTCCGGTCAGGACGACATCTGCATCGGCTCCCCCGTGGCGAACCGGGGTCACATCCAGACAGAAGGGCTGATCGGCTTGTTCGTCAACACCCTGGTGATGAGGGTGGATGCCGCCGGGAATCCCCGTTTCATCGACCTGCTGGCGCGCATTCAACGGACAGCCATCGATGCTTACGCGAACCAAGAAGTGCCCTTCGAGAAGATCGTGGACGACCTGCAGGTCGCGAGAGACACGGCCCGATCTCCGCTCGTGCAGGTCATTCTCAACTTCCACAACACGCCTCCTCAATCCGAGCTGGAACTGCAGGGGGTGACCCTCACGCGGATGCCGGTGCACAACGGCACGGCCAAGTTCGAGCTCTCCATCGACGTCGCGGAGACGAGCGCCGGTCTAACGGGATTCGTGGAGTACGCGACGGATCTGTTCAGCGAGAACTTCATCCGGCGGATGATCGGCCACCTCGAGGTGGTGCTGGACGCGGTCGGTCGCGATCCGCGGGCGCCTATCCATGAGTTGCCACTGCTCACCCGGCAGGATCAGTTGGACCTACTGTCGCGGAGCGGCCACACAGCCCCCGCGGTGGAACACGTCGAGTTGATCCCTCATACGTTCGAGCGGCGCGTCCAGGAGAGCCCTCAAGCGATTGCCCTGGTCTGCGGTGACGAGCGCGTCACCTACTCCGCGCTCAACCGCCGGGCCAGCCAGATTGCCCGCCGCCTGCGCGCCGCAGGGATCGGACCGGACACCCTCGTCGGGCTTTGCGCGGGGCGCTCCATCGAGCTGGTCTGCGGCGTCCTTGGCATCTTGAAGGCGGGCGGTGCGTACGTGCCAATCGACCCCACCTCCTCGCCCGAGGTGATCTACGACGTCCTGTATGAGTCGAAGGTGCGGCATCTGTTGACCGAGTCGCGCCTGGTCGGGGGACTGCCGGTCGATGACCAGGAAATCCTGCTCCTGGATACCCCCGCGGACGGTGAAGGGGACAAGGCTGTTGCTGACCGGGAGGAGCCACCTGACCTTGGCGAGGTCAGCCTCACTCCCGAGTGCTTGGCGTACGTCAACTTCACCTCCGACTCCGGTGGGGCGCCGAGGGGCATCGCCGTCCGCCATGGGGCGCTGGCTCGCCGGATGGCCGCCGGCCACGCACAGTACCTGGCCAATTCCGCCGTACGTTTCCTGCTGAAGGCGCCGCTCACGTTCGACCTGGCGGTCGCGGAGCTGTTCCAGTGGATCGTCAGCGGCGGCAGCCTGAGCATCCTCGACCCCAATGCCGACCGCGACGCCTCTGCCTTCCTCGCGCAGGTGCGCAGGGACTCGATTGGCGTCCTCTACTGCGTCCCCTCCGAACTCTCGACGCTGGTGAGCCACCTGGAGCGCGAGCGTGAAAGGGTGCATGAGCTGAACACCCTCCGGTTCATCTTCTGCGGCGGGGATACCCTGGCGGTTACCGTCGTCGAGCGTCTCGGGGTACTGGTGCGGGCCGGCCAGCTCCCGCTGCGGCTGGTCAACGTCTATGGGACGAAGGAGACGGGAATCGGCGCGGGTTGCTTCGAGTGCGCGCTGGACGCGAACGACCCCAGCGCCGAACTCCCGCCGGGACGGCTCTCGCATGAGCGGATGCCCATCGGCGGGCCCGCCCAGAACCTGTGGTTCTATGTGGTGCAACCCAACGGTGGCCTGGCTCCGTTGGGCATCCCGGGGGAACTGTACGTCGGCGGCGCGCAACTCGCCGACGCCCGTTTCGGCGACGAGCCCACGGCGACCCACCCCGGCTTCGTCCCGAACCCCTTCCGGAGCGGAGCGGAGAAGGACTGGCTGTACAAGACGGGGGACCTCGTCCGCTGGCTGCCTCAGGGGCCGCTCGAGCTGGTCAGCGCGGCTCGGGAGCGCGACGGAGGCGGGGACCACCGGCTCGATCGCGGCTTCATCGAGGCGCGCATGCGTCGTGTGGCCATTGTCCGCGACGCCGTGGTGGCCTACGTCCCGGATCGCCAGGACAGGGCCCGGTTGGTGGCCTACGTCGTTCTGAAGGAGTCGCCCGCGGCGGACGTGGAGCCGCGCGAAGGGCGGGAAACGCTGAAGGCTCGGATCAGCGCCGAACTTGGGAGCACGTTGCCGGAGTACATGCTTCCGGCCGCCTACGTGTTCATGGACAGCCTGCCGTTGACGGCTTACGGGAGGATCGACCGGAAAGCCCTGCCCGAGCCGGAGGATGACCGCCACGGTGGTAGTGCGATCGCCTACGTGGCCCCGCGCGGGCCCACGGAGAAGGCACTGGCGCACATTTGGCAGCAAGTGCTGAAACGCCCCCAGGTCGGACTGCGAGACAACTTCTTTGAGCTGGGCGGGCACTCAGTGGCGGCCATCCAACTGGTGTCCGTGAGCCGGAAGCACCTGGAGGTCGAAGTCCCCCTCAGCCTGATCTTCGAATCGCCGGTCCTGGAGGCGATGGCGCGCGGCATCGAAGCGCTGCAACAGCAGGGCCGCAGCGGCGCGGTGTCGTCGATCCATCGGGTGGAGCGGACCGGACCGCTGCCTCTGGCGTACGTGCAGGAGAGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACATCACCTGGACGTTGCACTTCGCCGGCAAGGGTTTCTCGGTGGAGGCGTTGCGGACGGCCTTCGATGAGCTGGTGGCCAGACACGAGACACTGCGCACGTGGTTCCAGGTGGGGGAGGGGACAGAGCAGGCCGTACAGGTCATCGGGGAGCCCTGGTCGATGGAGCTGCCGCTGAGAGAGGTGGCGGGGACGGAGGTGACGGCGGCAATCAATGAGATGTCCCGGCAGGTCTTCGACTTGAGAGCGGGACGGTTGCTGACGGCGGCGGTCCTGAGGGTGGCGGAGGATGAGCACATCCTCGTCAGCAACATCCACCACATCATCACGGACGGCTGGTCGTTCGGGGTGATGCTGCGGGAGCTGAGGGAGTTGTACGAGGCCGCGGTGCGGGGGGAGCGAGCGGAGCTGCCGCCGCTGACGGTGCAGTACGGCGACTATGCGGTATGGCAGAGGAAGCAGGACCTGAGCGAGCACCTGGCGTACTGGAAGGGGAAGGTGGAGGGGGACGAGGACGGGTTGGAGCTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGTATAGCTACCACCCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCGAGGACCTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGAACTGGAGAGCCTCATCGGGTTCTTCATCAACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGTGGTGGTGCTGGAGGGATTCGAGCACCAGGAGTTGCCGTTCGAGCACCTGCTGAAGGCGCTGAGGCGGCAGCGGGACAGCAGCCAGATTCCCTTGGTGCCAGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAGGAGGATGGTGGAGCACCACCAACGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGGGCTGCACGAAGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGAAGCTACATCGAGCAGATACTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGCTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGAGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGACCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCAGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGTTGCCGAACGGGAAGCTGGACCGGCTGTCGTTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAACCTCGGCGGGCACTCCCTCCTGGCTTCCCAGCTGATTTCGCGCATACGGGCGACCTTCCGCGTGGAAGTGGCGATGGCCACGGTGTTCGAGTCCCCCACGGTGGAGCCGCTCGCCCGCCACATCGAGGAGAAGCTCAAGGACGAGTCTCGGGTCCAGCTCTCCAACGTTGTGCCGGTCGAGCGGACGCAGGAGCTTCCGCTCTCCTACCTGCAGGAGAGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACGGAACGATCGGGCTCCGGCTTCGGGGTCCTCTGTCAATCCCCGCGCTCAGGGCCACCTTCCACGATCTGGTCGCCCGTCACGAGAGCCTGCGCACCGTCTTCCGGGTCCCCGAAGGCCGCACCACGCCGGTGCAGGTGATTCTTGATTCGATGGATCTGGACATCCCGGTCCGCGATGCAACCGAGGCCGACATCATCCCGGGCATGGATGAGCTGGCGGGTCACATCTACGACATGGAGAAGGGTCCGCTGTTCATGGTTCGCCTCTTGCGGCTGGCCGAGGACTCCCACGTTCTCCTGATGGGGATGCATCACATCGTCTACGACGCATGGTCACAGTTCAATGTGATGAGTCGCGATATCAACCTGCTCTACTCGGCGCACGTGACGGGAATCGAGGCACGGCTTCCCGCGCTTCCCATCCAGTACGCCGACTTCTCGGTGTGGCAGCGCCAGCAGGACTTCCGTCACCACCTGGACTACTGGAAGTCCACACTGGGCGACTACCGGGATGATCTCGAGCTGCCGTATGACTACCCGCGGCCGCCCAGCCGGACATGGCACGCGACCCGATTCACCTTCCGGTATCCGGATGCACTGGCGCGCGCGTTCGCCAGGTTCAATCAGTCCCATCAGTCGACGCTGTTCATGGGGCTGCTGACCAGCTTCGCGATCGTGCTCAGGCACTACACCGGCCGGAACGACATCTGCATCGGAACGACAACGGCGGGGCGCGCCCAGTTGGAGTTGGAGAACCTCGTTGGCTTCTTCATCAACATCCTGCCGTTGCGCATCAATCTGGCGGGTGACCCCGACATCAGCGAGCTCATGAATCGAGCGAAGAAGAGCGTCTTGGGCGCCTTCGAGCATCAAGCTCTGCCGTTCGAGCGTCTCCTCAGTGCCCTCAACAAACAGCGTGACAGCAGCCATATCCCGCTGGTTCCCGTCATGTTGCGCCACCAGAACTTCCCGACGGCGATGACCGGCAAGTGGGCCGATGGTGTGGACATGGAGGTCATCGAGCGCGACGAGCGCACGACGCCCAACGAGCTGGACCTCCAGTTCTTTGGCGACGACACCTACTTGCATGCTGTCGTCGAGTTCCCCGCGCAGCTCTTCTCCGAGGTGACCGTCCGGCGTCTGATGCAGCGTCACCAGAAGGTCATAGAGTTCATGTGCGCGACGCTGGGGGCTCGGTGA", "orf_prot_sequence": "MLLEGELEGYEDGLELPYDFPRTSNRAWRAATFQHSYPPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGREDVCIGTTVAGRAQVGALGDLSGSTVDILPLRLDLSGAPSLHEVLRRTKAVVLEGFEHEALPCQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVKRMVEHHQRVLEALVEGLEEVRLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGSYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFSLGGHSLLAAQLISRIRATFRVEVAMATVFESPTVEPLARHIEEKLKDESRVQLSNVVPVERTQEIPLSYLQERLWFVHEHMKEQRTSYNITWTLHFAGKGFSVEALRTAFDELVARHETLRTWFQVGEGTEQAVQVIGEPWSMELPLREVAGTEVTAAINEMSRQVFDLRAGRLLTAAVLRVAEDEHILVSNIHHIITDGWSFGVMLRELRELYEAAVRGKRAELPPLTVQYGDYAVWQRKQDLSEHLAYWKGKVEEYEDGLELPYDFPRTSNRAWRAATFQYSYPPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGRQDVCIGTTVAGRAQVELESLIGFFINILPLRLDLSGAPSLHEVLRRTKAVVLEGFEHQELPFEHLLKALRRQRDSSQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVRRMVEHHQRVLEALVEGLEEGLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGHYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFSLGGHSLLAAQVVSRIGKELGTQISIADLFQRPTIEQLCELIGGLDDQTQRELALAPSGNTEAVLSFAQERMWFLHNFVKGMPYNTPGLDHLTGELDVAALEKAIRAVIRRHEPLRTNFVEKDGVLSQLVGTEERFRLTVTPIRDESEVARLMEAVIQTPVDLERELMIRAYLYRVDPRNHYLFTTIHHIAFDGWSTSIFYRELAAYYAAFLRREDSPLPALEISYQDYARWERAHFQDEVLAEKLRYWRQRLSGARPLVLPTTYHRPPIQSFAGAVVNFEIDRSITERLKTLFAESGTTMYMVLLGAFSVVLQRYSGQDDICIGSPVANRGHIQTEGLIGLFVNTLVMRVDAAGNPRFIDLLARIQRTAIDAYANQEVPFEKIVDDLQVARDTARSPLVQVILNFHNTPPQSELELQGVTLTRMPVHNGTAKFELSIDVAETSAGLTGFVEYATDLFSENFIRRMIGHLEVVLDAVGRDPRAPIHELPLLTRQDQLDLLSRSGHTAPAVEHVELIPHTFERRVQESPQAIALVCGDERVTYSALNRRASQIARRLRAAGIGPDTLVGLCAGRSIELVCGVLGILKAGGAYVPIDPTSSPEVIYDVLYESKVRHLLTESRLVGGLPVDDQEILLLDTPADGEGDKAVADREEPPDLGEVSLTPECLAYVNFTSDSGGAPRGIAVRHGALARRMAAGHAQYLANSAVRFLLKAPLTFDLAVAELFQWIVSGGSLSILDPNADRDASAFLAQVRRDSIGVLYCVPSELSTLVSHLERERERVHELNTLRFIFCGGDTLAVTVVERLGVLVRAGQLPLRLVNVYGTKETGIGAGCFECALDANDPSAELPPGRLSHERMPIGGPAQNLWFYVVQPNGGLAPLGIPGELYVGGAQLADARFGDEPTATHPGFVPNPFRSGAEKDWLYKTGDLVRWLPQGPLELVSAARERDGGGDHRLDRGFIEARMRRVAIVRDAVVAYVPDRQDRARLVAYVVLKESPAADVEPREGRETLKARISAELGSTLPEYMLPAAYVFMDSLPLTAYGRIDRKALPEPEDDRHGGSAIAYVAPRGPTEKALAHIWQQVLKRPQVGLRDNFFELGGHSVAAIQLVSVSRKHLEVEVPLSLIFESPVLEAMARGIEALQQQGRSGAVSSIHRVERTGPLPLAYVQERLWFVHEHMKEQRTSYNITWTLHFAGKGFSVEALRTAFDELVARHETLRTWFQVGEGTEQAVQVIGEPWSMELPLREVAGTEVTAAINEMSRQVFDLRAGRLLTAAVLRVAEDEHILVSNIHHIITDGWSFGVMLRELRELYEAAVRGERAELPPLTVQYGDYAVWQRKQDLSEHLAYWKGKVEGDEDGLELPYDFPRTSNRAWRAATFQYSYHPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGREDLCIGTTVAGRAQVELESLIGFFINILPLRLDLSGAPSLHEVLRRTKVVVLEGFEHQELPFEHLLKALRRQRDSSQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVRRMVEHHQRVLEALVEGLEEGLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGSYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFNLGGHSLLASQLISRIRATFRVEVAMATVFESPTVEPLARHIEEKLKDESRVQLSNVVPVERTQELPLSYLQERLWFVHEHMKEQRTSYNGTIGLRLRGPLSIPALRATFHDLVARHESLRTVFRVPEGRTTPVQVILDSMDLDIPVRDATEADIIPGMDELAGHIYDMEKGPLFMVRLLRLAEDSHVLLMGMHHIVYDAWSQFNVMSRDINLLYSAHVTGIEARLPALPIQYADFSVWQRQQDFRHHLDYWKSTLGDYRDDLELPYDYPRPPSRTWHATRFTFRYPDALARAFARFNQSHQSTLFMGLLTSFAIVLRHYTGRNDICIGTTTAGRAQLELENLVGFFINILPLRINLAGDPDISELMNRAKKSVLGAFEHQALPFERLLSALNKQRDSSHIPLVPVMLRHQNFPTAMTGKWADGVDMEVIERDERTTPNELDLQFFGDDTYLHAVVEFPAQLFSEVTVRRLMQRHQKVIEFMCATLGAR", "perc_identity": 25.26}, "gnl|BL_ORD_ID|3397|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 27422, "orf_end": 41059, "orf_from": "BGC0001413.1|Cystobactamide_17 ", "model_name": "CMH-4", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "4466", "ARO_accession": "3006856", "ARO_name": "CMH-4", "ARO_category": {"42891": {"category_aro_accession": "3004776", "category_aro_cvterm_id": "42891", "category_aro_name": "CMH beta-lactamase", "category_aro_description": "CMH is a class C beta-lactamase gene family belonging to Enterobacter cloacae.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.29425, "max_identities": 24, "bit_score": 31.9574, "cvterm_id": "36884", "query": "VMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEE", "match": "+ VP+++  ++    +E   +     ML   A     +VK++ S ++A +A   +P++ ++  +ALAQ    WRV          GA+ +G G E", "sequence_from_db": "INVPHAEEPHYAWGYREGKAVHVSPGMLDAEAYGVKSNVKDMASWVMANMAPETLPQSTLQQGIALAQS-RYWRV----------GAMYQGLGWE", "sequence_from_broadstreet": "MMKKSLSCALLLSVACSAFAAPMSEKQLADVVERTVTPLMKAQAIPGMAVAVIYQGQPHYFTFGKADVAANKPVTPQTLFELGSVSKTFTGVLGGDAIARKEISLADPVTKYWPELTGKQWQGIRLLDLATYTAGGLPLQVPDDVTDNASLLRFYQSWQPKWAPGTTRLYANTSIGLFGSLAVKPSGMRFEQAMAERVFKPLKLNHTWINVPHAEEPHYAWGYREGKAVHVSPGMLDAEAYGVKSNVKDMASWVMANMAPETLPQSTLQQGIALAQSRYWRVGAMYQGLGWEMLNWPVDAKTVVDGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLANKSYPNPVRVETAYRILDALQ", "dna_sequence_from_broadstreet": "ATGATGAAAAAATCCCTAAGCTGCGCCCTGCTGCTCAGCGTTGCCTGCTCTGCTTTTGCCGCGCCGATGTCAGAAAAACAGCTGGCTGACGTCGTGGAACGTACCGTTACGCCCCTGATGAAGGCGCAGGCCATACCCGGAATGGCCGTGGCCGTCATTTATCAGGGCCAGCCACACTATTTTACTTTCGGTAAAGCAGACGTCGCGGCGAATAAGCCCGTCACGCCGCAAACCTTATTTGAACTGGGCTCCGTCAGTAAAACCTTCACTGGCGTGCTGGGTGGCGATGCCATTGCCCGCAAAGAGATTTCGCTGGCCGACCCGGTCACGAAATATTGGCCTGAATTGACGGGCAAGCAGTGGCAAGGCATTCGCCTGCTCGACCTGGCAACCTATACGGCAGGCGGATTGCCGTTGCAGGTACCGGATGATGTTACCGATAACGCCTCTCTGCTGCGTTTCTACCAGTCCTGGCAGCCAAAGTGGGCCCCGGGTACCACGCGTCTGTACGCCAACACCAGCATCGGCCTGTTTGGCTCACTGGCCGTTAAACCGTCCGGCATGCGCTTCGAGCAGGCCATGGCGGAGCGGGTCTTTAAGCCCCTGAAACTCAACCATACGTGGATAAACGTTCCACACGCTGAAGAGCCGCACTACGCATGGGGTTATCGTGAGGGAAAAGCGGTCCACGTTTCGCCTGGTATGCTGGATGCAGAAGCCTATGGTGTGAAATCTAACGTCAAAGATATGGCGAGCTGGGTGATGGCCAATATGGCACCTGAGACACTCCCGCAGTCCACTCTGCAGCAGGGTATTGCGCTGGCGCAGTCTCGCTACTGGCGCGTGGGTGCCATGTATCAAGGGTTAGGCTGGGAGATGCTCAACTGGCCGGTCGATGCCAAAACCGTGGTGGATGGCAGCGACAATAAGGTCGCACTGGCGCCGTTGCCGGTCGCAGAAGTGAATCCTCCGGCTCCGCCAGTAAAAGCCTCCTGGGTGCATAAAACGGGCTCTACGGGTGGGTTTGGCAGCTACGTGGCGTTTATTCCTGAAAAGCAGATCGGTATTGTGATGCTCGCAAATAAAAGCTATCCGAACCCGGTACGGGTGGAAACGGCTTACCGTATCCTCGACGCGCTACAGTAA", "partial": "0", "query_start": 31943, "query_end": 32227, "hit_start": 624, "hit_end": 876, "orf_dna_sequence": "ATGCTGCTGGAGGGAGAGCTGGAGGGGTACGAGGACGGGTTGGAACTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGCATAGCTACCCGCCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCGAGGACGTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGGGGCGTTGGGGGATCTGAGCGGGTCCACCGTCGACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGCGGTGGTGCTGGAGGGATTCGAGCACGAGGCGTTGCCGTGCCAGATTCCCTTGGTGCCGGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAAGAGGATGGTGGAGCACCACCAGCGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGTGCGGCTGCACGAGGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGAAGCTACATCGAGCAGATACTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGCTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGAGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGACCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCGGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGCTGCCGAACGGGAAGCTGGACCGGTTGTCGCTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAGCCTCGGCGGGCACTCCCTCCTGGCTGCCCAGCTGATTTCGCGCATACGGGCGACCTTCCGCGTGGAAGTGGCGATGGCCACGGTGTTCGAGTCCCCCACGGTGGAGCCGCTCGCCCGCCACATCGAGGAGAAGCTCAAGGACGAGTCTCGGGTCCAGCTCTCCAACGTTGTGCCGGTCGAGCGGACGCAGGAGATTCCGCTCTCCTACCTGCAGGAGCGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACATCACCTGGACGTTGCACTTCGCCGGCAAGGGTTTCTCGGTGGAGGCGTTGCGGACGGCCTTCGATGAGCTGGTGGCCAGACACGAGACACTGCGCACGTGGTTCCAGGTGGGGGAGGGGACAGAGCAGGCCGTACAGGTCATCGGGGAGCCCTGGTCGATGGAGCTGCCGCTGAGAGAGGTGGCGGGGACGGAGGTGACGGCGGCAATCAATGAGATGTCCCGACAGGTCTTCGACTTGAGAGCGGGACGGTTGCTGACGGCGGCGGTCCTGAGGGTGGCGGAGGATGAGCACATCCTCGTCAGCAACATCCACCACATCATCACGGACGGCTGGTCGTTCGGGGTGATGCTGCGGGAGCTGAGGGAGTTGTACGAGGCAGCGGTGCGGGGGAAGAGAGCGGAGCTGCCGCCGCTGACGGTGCAGTACGGCGACTATGCGGTGTGGCAGAGGAAGCAGGACCTGAGCGAGCACCTGGCGTACTGGAAGGGGAAGGTGGAGGAGTACGAGGACGGGTTGGAGCTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGTATAGCTACCCACCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCCAGGACGTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGAGCTGGAGAGCCTCATCGGGTTCTTCATCAACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGCGGTGGTGCTGGAGGGATTCGAGCACCAGGAGTTGCCGTTCGAGCACCTGCTGAAGGCGCTGAGGCGGCAGCGGGACAGCAGCCAGATTCCCTTGGTGCCAGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAGGAGGATGGTGGAGCACCACCAGCGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGGGCTGCACGAGGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGACACTACATCGAGCAGATATTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGTTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGGGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGGCCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCAGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGTTGCCGAACGGGAAGCTGGACCGGCTGTCGTTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAGCCTCGGCGGGCACTCCCTCCTGGCTGCCCAGGTGGTCTCAAGGATTGGCAAGGAGCTTGGCACTCAGATCTCGATCGCCGATCTGTTTCAAAGGCCCACGATTGAACAGCTCTGTGAGCTGATTGGAGGACTGGACGATCAGACCCAGAGGGAGCTCGCCCTCGCTCCGTCGGGGAACACCGAGGCGGTGCTCTCGTTCGCGCAAGAGCGCATGTGGTTCCTGCACAACTTCGTCAAGGGCATGCCCTACAACACGCCAGGGCTCGACCACCTGACGGGTGAGCTCGATGTCGCGGCGCTAGAAAAGGCCATCCGCGCGGTCATCCGTCGCCACGAGCCCCTGCGGACGAATTTCGTCGAGAAGGACGGGGTGCTGTCCCAGTTGGTGGGGACGGAAGAACGCTTCCGCCTGACCGTGACTCCCATCCGCGACGAGAGCGAGGTCGCGCGGCTCATGGAAGCCGTGATCCAAACGCCAGTCGATCTGGAGCGGGAGTTGATGATCCGGGCTTATCTCTACCGGGTCGACCCGCGGAATCACTACCTGTTCACCACCATCCATCACATCGCCTTCGATGGCTGGTCGACATCGATCTTCTACCGTGAGCTGGCTGCGTACTACGCCGCGTTTCTCCGGCGCGAAGACAGTCCGCTGCCCGCGCTGGAAATCTCCTATCAGGACTATGCCCGCTGGGAGCGGGCCCATTTCCAGGACGAGGTGTTGGCGGAAAAACTGAGGTACTGGCGGCAGCGGCTGTCGGGCGCTCGGCCCCTCGTACTTCCGACCACCTACCATCGGCCGCCCATCCAGAGTTTCGCTGGCGCCGTCGTGAACTTCGAGATCGATCGCTCCATCACCGAGCGGTTGAAGACGCTGTTCGCCGAGTCGGGCACCACGATGTACATGGTGTTGCTCGGCGCGTTCTCCGTGGTGCTGCAGCGCTACTCCGGTCAGGACGACATCTGCATCGGCTCCCCCGTGGCGAACCGGGGTCACATCCAGACAGAAGGGCTGATCGGCTTGTTCGTCAACACCCTGGTGATGAGGGTGGATGCCGCCGGGAATCCCCGTTTCATCGACCTGCTGGCGCGCATTCAACGGACAGCCATCGATGCTTACGCGAACCAAGAAGTGCCCTTCGAGAAGATCGTGGACGACCTGCAGGTCGCGAGAGACACGGCCCGATCTCCGCTCGTGCAGGTCATTCTCAACTTCCACAACACGCCTCCTCAATCCGAGCTGGAACTGCAGGGGGTGACCCTCACGCGGATGCCGGTGCACAACGGCACGGCCAAGTTCGAGCTCTCCATCGACGTCGCGGAGACGAGCGCCGGTCTAACGGGATTCGTGGAGTACGCGACGGATCTGTTCAGCGAGAACTTCATCCGGCGGATGATCGGCCACCTCGAGGTGGTGCTGGACGCGGTCGGTCGCGATCCGCGGGCGCCTATCCATGAGTTGCCACTGCTCACCCGGCAGGATCAGTTGGACCTACTGTCGCGGAGCGGCCACACAGCCCCCGCGGTGGAACACGTCGAGTTGATCCCTCATACGTTCGAGCGGCGCGTCCAGGAGAGCCCTCAAGCGATTGCCCTGGTCTGCGGTGACGAGCGCGTCACCTACTCCGCGCTCAACCGCCGGGCCAGCCAGATTGCCCGCCGCCTGCGCGCCGCAGGGATCGGACCGGACACCCTCGTCGGGCTTTGCGCGGGGCGCTCCATCGAGCTGGTCTGCGGCGTCCTTGGCATCTTGAAGGCGGGCGGTGCGTACGTGCCAATCGACCCCACCTCCTCGCCCGAGGTGATCTACGACGTCCTGTATGAGTCGAAGGTGCGGCATCTGTTGACCGAGTCGCGCCTGGTCGGGGGACTGCCGGTCGATGACCAGGAAATCCTGCTCCTGGATACCCCCGCGGACGGTGAAGGGGACAAGGCTGTTGCTGACCGGGAGGAGCCACCTGACCTTGGCGAGGTCAGCCTCACTCCCGAGTGCTTGGCGTACGTCAACTTCACCTCCGACTCCGGTGGGGCGCCGAGGGGCATCGCCGTCCGCCATGGGGCGCTGGCTCGCCGGATGGCCGCCGGCCACGCACAGTACCTGGCCAATTCCGCCGTACGTTTCCTGCTGAAGGCGCCGCTCACGTTCGACCTGGCGGTCGCGGAGCTGTTCCAGTGGATCGTCAGCGGCGGCAGCCTGAGCATCCTCGACCCCAATGCCGACCGCGACGCCTCTGCCTTCCTCGCGCAGGTGCGCAGGGACTCGATTGGCGTCCTCTACTGCGTCCCCTCCGAACTCTCGACGCTGGTGAGCCACCTGGAGCGCGAGCGTGAAAGGGTGCATGAGCTGAACACCCTCCGGTTCATCTTCTGCGGCGGGGATACCCTGGCGGTTACCGTCGTCGAGCGTCTCGGGGTACTGGTGCGGGCCGGCCAGCTCCCGCTGCGGCTGGTCAACGTCTATGGGACGAAGGAGACGGGAATCGGCGCGGGTTGCTTCGAGTGCGCGCTGGACGCGAACGACCCCAGCGCCGAACTCCCGCCGGGACGGCTCTCGCATGAGCGGATGCCCATCGGCGGGCCCGCCCAGAACCTGTGGTTCTATGTGGTGCAACCCAACGGTGGCCTGGCTCCGTTGGGCATCCCGGGGGAACTGTACGTCGGCGGCGCGCAACTCGCCGACGCCCGTTTCGGCGACGAGCCCACGGCGACCCACCCCGGCTTCGTCCCGAACCCCTTCCGGAGCGGAGCGGAGAAGGACTGGCTGTACAAGACGGGGGACCTCGTCCGCTGGCTGCCTCAGGGGCCGCTCGAGCTGGTCAGCGCGGCTCGGGAGCGCGACGGAGGCGGGGACCACCGGCTCGATCGCGGCTTCATCGAGGCGCGCATGCGTCGTGTGGCCATTGTCCGCGACGCCGTGGTGGCCTACGTCCCGGATCGCCAGGACAGGGCCCGGTTGGTGGCCTACGTCGTTCTGAAGGAGTCGCCCGCGGCGGACGTGGAGCCGCGCGAAGGGCGGGAAACGCTGAAGGCTCGGATCAGCGCCGAACTTGGGAGCACGTTGCCGGAGTACATGCTTCCGGCCGCCTACGTGTTCATGGACAGCCTGCCGTTGACGGCTTACGGGAGGATCGACCGGAAAGCCCTGCCCGAGCCGGAGGATGACCGCCACGGTGGTAGTGCGATCGCCTACGTGGCCCCGCGCGGGCCCACGGAGAAGGCACTGGCGCACATTTGGCAGCAAGTGCTGAAACGCCCCCAGGTCGGACTGCGAGACAACTTCTTTGAGCTGGGCGGGCACTCAGTGGCGGCCATCCAACTGGTGTCCGTGAGCCGGAAGCACCTGGAGGTCGAAGTCCCCCTCAGCCTGATCTTCGAATCGCCGGTCCTGGAGGCGATGGCGCGCGGCATCGAAGCGCTGCAACAGCAGGGCCGCAGCGGCGCGGTGTCGTCGATCCATCGGGTGGAGCGGACCGGACCGCTGCCTCTGGCGTACGTGCAGGAGAGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACATCACCTGGACGTTGCACTTCGCCGGCAAGGGTTTCTCGGTGGAGGCGTTGCGGACGGCCTTCGATGAGCTGGTGGCCAGACACGAGACACTGCGCACGTGGTTCCAGGTGGGGGAGGGGACAGAGCAGGCCGTACAGGTCATCGGGGAGCCCTGGTCGATGGAGCTGCCGCTGAGAGAGGTGGCGGGGACGGAGGTGACGGCGGCAATCAATGAGATGTCCCGGCAGGTCTTCGACTTGAGAGCGGGACGGTTGCTGACGGCGGCGGTCCTGAGGGTGGCGGAGGATGAGCACATCCTCGTCAGCAACATCCACCACATCATCACGGACGGCTGGTCGTTCGGGGTGATGCTGCGGGAGCTGAGGGAGTTGTACGAGGCCGCGGTGCGGGGGGAGCGAGCGGAGCTGCCGCCGCTGACGGTGCAGTACGGCGACTATGCGGTATGGCAGAGGAAGCAGGACCTGAGCGAGCACCTGGCGTACTGGAAGGGGAAGGTGGAGGGGGACGAGGACGGGTTGGAGCTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGTATAGCTACCACCCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCGAGGACCTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGAACTGGAGAGCCTCATCGGGTTCTTCATCAACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGTGGTGGTGCTGGAGGGATTCGAGCACCAGGAGTTGCCGTTCGAGCACCTGCTGAAGGCGCTGAGGCGGCAGCGGGACAGCAGCCAGATTCCCTTGGTGCCAGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAGGAGGATGGTGGAGCACCACCAACGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGGGCTGCACGAAGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGAAGCTACATCGAGCAGATACTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGCTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGAGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGACCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCAGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGTTGCCGAACGGGAAGCTGGACCGGCTGTCGTTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAACCTCGGCGGGCACTCCCTCCTGGCTTCCCAGCTGATTTCGCGCATACGGGCGACCTTCCGCGTGGAAGTGGCGATGGCCACGGTGTTCGAGTCCCCCACGGTGGAGCCGCTCGCCCGCCACATCGAGGAGAAGCTCAAGGACGAGTCTCGGGTCCAGCTCTCCAACGTTGTGCCGGTCGAGCGGACGCAGGAGCTTCCGCTCTCCTACCTGCAGGAGAGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACGGAACGATCGGGCTCCGGCTTCGGGGTCCTCTGTCAATCCCCGCGCTCAGGGCCACCTTCCACGATCTGGTCGCCCGTCACGAGAGCCTGCGCACCGTCTTCCGGGTCCCCGAAGGCCGCACCACGCCGGTGCAGGTGATTCTTGATTCGATGGATCTGGACATCCCGGTCCGCGATGCAACCGAGGCCGACATCATCCCGGGCATGGATGAGCTGGCGGGTCACATCTACGACATGGAGAAGGGTCCGCTGTTCATGGTTCGCCTCTTGCGGCTGGCCGAGGACTCCCACGTTCTCCTGATGGGGATGCATCACATCGTCTACGACGCATGGTCACAGTTCAATGTGATGAGTCGCGATATCAACCTGCTCTACTCGGCGCACGTGACGGGAATCGAGGCACGGCTTCCCGCGCTTCCCATCCAGTACGCCGACTTCTCGGTGTGGCAGCGCCAGCAGGACTTCCGTCACCACCTGGACTACTGGAAGTCCACACTGGGCGACTACCGGGATGATCTCGAGCTGCCGTATGACTACCCGCGGCCGCCCAGCCGGACATGGCACGCGACCCGATTCACCTTCCGGTATCCGGATGCACTGGCGCGCGCGTTCGCCAGGTTCAATCAGTCCCATCAGTCGACGCTGTTCATGGGGCTGCTGACCAGCTTCGCGATCGTGCTCAGGCACTACACCGGCCGGAACGACATCTGCATCGGAACGACAACGGCGGGGCGCGCCCAGTTGGAGTTGGAGAACCTCGTTGGCTTCTTCATCAACATCCTGCCGTTGCGCATCAATCTGGCGGGTGACCCCGACATCAGCGAGCTCATGAATCGAGCGAAGAAGAGCGTCTTGGGCGCCTTCGAGCATCAAGCTCTGCCGTTCGAGCGTCTCCTCAGTGCCCTCAACAAACAGCGTGACAGCAGCCATATCCCGCTGGTTCCCGTCATGTTGCGCCACCAGAACTTCCCGACGGCGATGACCGGCAAGTGGGCCGATGGTGTGGACATGGAGGTCATCGAGCGCGACGAGCGCACGACGCCCAACGAGCTGGACCTCCAGTTCTTTGGCGACGACACCTACTTGCATGCTGTCGTCGAGTTCCCCGCGCAGCTCTTCTCCGAGGTGACCGTCCGGCGTCTGATGCAGCGTCACCAGAAGGTCATAGAGTTCATGTGCGCGACGCTGGGGGCTCGGTGA", "orf_prot_sequence": "MLLEGELEGYEDGLELPYDFPRTSNRAWRAATFQHSYPPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGREDVCIGTTVAGRAQVGALGDLSGSTVDILPLRLDLSGAPSLHEVLRRTKAVVLEGFEHEALPCQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVKRMVEHHQRVLEALVEGLEEVRLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGSYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFSLGGHSLLAAQLISRIRATFRVEVAMATVFESPTVEPLARHIEEKLKDESRVQLSNVVPVERTQEIPLSYLQERLWFVHEHMKEQRTSYNITWTLHFAGKGFSVEALRTAFDELVARHETLRTWFQVGEGTEQAVQVIGEPWSMELPLREVAGTEVTAAINEMSRQVFDLRAGRLLTAAVLRVAEDEHILVSNIHHIITDGWSFGVMLRELRELYEAAVRGKRAELPPLTVQYGDYAVWQRKQDLSEHLAYWKGKVEEYEDGLELPYDFPRTSNRAWRAATFQYSYPPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGRQDVCIGTTVAGRAQVELESLIGFFINILPLRLDLSGAPSLHEVLRRTKAVVLEGFEHQELPFEHLLKALRRQRDSSQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVRRMVEHHQRVLEALVEGLEEGLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGHYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFSLGGHSLLAAQVVSRIGKELGTQISIADLFQRPTIEQLCELIGGLDDQTQRELALAPSGNTEAVLSFAQERMWFLHNFVKGMPYNTPGLDHLTGELDVAALEKAIRAVIRRHEPLRTNFVEKDGVLSQLVGTEERFRLTVTPIRDESEVARLMEAVIQTPVDLERELMIRAYLYRVDPRNHYLFTTIHHIAFDGWSTSIFYRELAAYYAAFLRREDSPLPALEISYQDYARWERAHFQDEVLAEKLRYWRQRLSGARPLVLPTTYHRPPIQSFAGAVVNFEIDRSITERLKTLFAESGTTMYMVLLGAFSVVLQRYSGQDDICIGSPVANRGHIQTEGLIGLFVNTLVMRVDAAGNPRFIDLLARIQRTAIDAYANQEVPFEKIVDDLQVARDTARSPLVQVILNFHNTPPQSELELQGVTLTRMPVHNGTAKFELSIDVAETSAGLTGFVEYATDLFSENFIRRMIGHLEVVLDAVGRDPRAPIHELPLLTRQDQLDLLSRSGHTAPAVEHVELIPHTFERRVQESPQAIALVCGDERVTYSALNRRASQIARRLRAAGIGPDTLVGLCAGRSIELVCGVLGILKAGGAYVPIDPTSSPEVIYDVLYESKVRHLLTESRLVGGLPVDDQEILLLDTPADGEGDKAVADREEPPDLGEVSLTPECLAYVNFTSDSGGAPRGIAVRHGALARRMAAGHAQYLANSAVRFLLKAPLTFDLAVAELFQWIVSGGSLSILDPNADRDASAFLAQVRRDSIGVLYCVPSELSTLVSHLERERERVHELNTLRFIFCGGDTLAVTVVERLGVLVRAGQLPLRLVNVYGTKETGIGAGCFECALDANDPSAELPPGRLSHERMPIGGPAQNLWFYVVQPNGGLAPLGIPGELYVGGAQLADARFGDEPTATHPGFVPNPFRSGAEKDWLYKTGDLVRWLPQGPLELVSAARERDGGGDHRLDRGFIEARMRRVAIVRDAVVAYVPDRQDRARLVAYVVLKESPAADVEPREGRETLKARISAELGSTLPEYMLPAAYVFMDSLPLTAYGRIDRKALPEPEDDRHGGSAIAYVAPRGPTEKALAHIWQQVLKRPQVGLRDNFFELGGHSVAAIQLVSVSRKHLEVEVPLSLIFESPVLEAMARGIEALQQQGRSGAVSSIHRVERTGPLPLAYVQERLWFVHEHMKEQRTSYNITWTLHFAGKGFSVEALRTAFDELVARHETLRTWFQVGEGTEQAVQVIGEPWSMELPLREVAGTEVTAAINEMSRQVFDLRAGRLLTAAVLRVAEDEHILVSNIHHIITDGWSFGVMLRELRELYEAAVRGERAELPPLTVQYGDYAVWQRKQDLSEHLAYWKGKVEGDEDGLELPYDFPRTSNRAWRAATFQYSYHPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGREDLCIGTTVAGRAQVELESLIGFFINILPLRLDLSGAPSLHEVLRRTKVVVLEGFEHQELPFEHLLKALRRQRDSSQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVRRMVEHHQRVLEALVEGLEEGLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGSYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFNLGGHSLLASQLISRIRATFRVEVAMATVFESPTVEPLARHIEEKLKDESRVQLSNVVPVERTQELPLSYLQERLWFVHEHMKEQRTSYNGTIGLRLRGPLSIPALRATFHDLVARHESLRTVFRVPEGRTTPVQVILDSMDLDIPVRDATEADIIPGMDELAGHIYDMEKGPLFMVRLLRLAEDSHVLLMGMHHIVYDAWSQFNVMSRDINLLYSAHVTGIEARLPALPIQYADFSVWQRQQDFRHHLDYWKSTLGDYRDDLELPYDYPRPPSRTWHATRFTFRYPDALARAFARFNQSHQSTLFMGLLTSFAIVLRHYTGRNDICIGTTTAGRAQLELENLVGFFINILPLRINLAGDPDISELMNRAKKSVLGAFEHQALPFERLLSALNKQRDSSHIPLVPVMLRHQNFPTAMTGKWADGVDMEVIERDERTTPNELDLQFFGDDTYLHAVVEFPAQLFSEVTVRRLMQRHQKVIEFMCATLGAR", "perc_identity": 25.26}, "gnl|BL_ORD_ID|3397|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 27422, "orf_end": 41059, "orf_from": "BGC0001413.1|Cystobactamide_17 ", "model_name": "CMH-4", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "4466", "ARO_accession": "3006856", "ARO_name": "CMH-4", "ARO_category": {"42891": {"category_aro_accession": "3004776", "category_aro_cvterm_id": "42891", "category_aro_name": "CMH beta-lactamase", "category_aro_description": "CMH is a class C beta-lactamase gene family belonging to Enterobacter cloacae.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.29425, "max_identities": 24, "bit_score": 31.9574, "cvterm_id": "36884", "query": "VMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEE", "match": "+ VP+++  ++    +E   +     ML   A     +VK++ S ++A +A   +P++ ++  +ALAQ    WRV          GA+ +G G E", "sequence_from_db": "INVPHAEEPHYAWGYREGKAVHVSPGMLDAEAYGVKSNVKDMASWVMANMAPETLPQSTLQQGIALAQS-RYWRV----------GAMYQGLGWE", "sequence_from_broadstreet": "MMKKSLSCALLLSVACSAFAAPMSEKQLADVVERTVTPLMKAQAIPGMAVAVIYQGQPHYFTFGKADVAANKPVTPQTLFELGSVSKTFTGVLGGDAIARKEISLADPVTKYWPELTGKQWQGIRLLDLATYTAGGLPLQVPDDVTDNASLLRFYQSWQPKWAPGTTRLYANTSIGLFGSLAVKPSGMRFEQAMAERVFKPLKLNHTWINVPHAEEPHYAWGYREGKAVHVSPGMLDAEAYGVKSNVKDMASWVMANMAPETLPQSTLQQGIALAQSRYWRVGAMYQGLGWEMLNWPVDAKTVVDGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLANKSYPNPVRVETAYRILDALQ", "dna_sequence_from_broadstreet": "ATGATGAAAAAATCCCTAAGCTGCGCCCTGCTGCTCAGCGTTGCCTGCTCTGCTTTTGCCGCGCCGATGTCAGAAAAACAGCTGGCTGACGTCGTGGAACGTACCGTTACGCCCCTGATGAAGGCGCAGGCCATACCCGGAATGGCCGTGGCCGTCATTTATCAGGGCCAGCCACACTATTTTACTTTCGGTAAAGCAGACGTCGCGGCGAATAAGCCCGTCACGCCGCAAACCTTATTTGAACTGGGCTCCGTCAGTAAAACCTTCACTGGCGTGCTGGGTGGCGATGCCATTGCCCGCAAAGAGATTTCGCTGGCCGACCCGGTCACGAAATATTGGCCTGAATTGACGGGCAAGCAGTGGCAAGGCATTCGCCTGCTCGACCTGGCAACCTATACGGCAGGCGGATTGCCGTTGCAGGTACCGGATGATGTTACCGATAACGCCTCTCTGCTGCGTTTCTACCAGTCCTGGCAGCCAAAGTGGGCCCCGGGTACCACGCGTCTGTACGCCAACACCAGCATCGGCCTGTTTGGCTCACTGGCCGTTAAACCGTCCGGCATGCGCTTCGAGCAGGCCATGGCGGAGCGGGTCTTTAAGCCCCTGAAACTCAACCATACGTGGATAAACGTTCCACACGCTGAAGAGCCGCACTACGCATGGGGTTATCGTGAGGGAAAAGCGGTCCACGTTTCGCCTGGTATGCTGGATGCAGAAGCCTATGGTGTGAAATCTAACGTCAAAGATATGGCGAGCTGGGTGATGGCCAATATGGCACCTGAGACACTCCCGCAGTCCACTCTGCAGCAGGGTATTGCGCTGGCGCAGTCTCGCTACTGGCGCGTGGGTGCCATGTATCAAGGGTTAGGCTGGGAGATGCTCAACTGGCCGGTCGATGCCAAAACCGTGGTGGATGGCAGCGACAATAAGGTCGCACTGGCGCCGTTGCCGGTCGCAGAAGTGAATCCTCCGGCTCCGCCAGTAAAAGCCTCCTGGGTGCATAAAACGGGCTCTACGGGTGGGTTTGGCAGCTACGTGGCGTTTATTCCTGAAAAGCAGATCGGTATTGTGATGCTCGCAAATAAAAGCTATCCGAACCCGGTACGGGTGGAAACGGCTTACCGTATCCTCGACGCGCTACAGTAA", "partial": "0", "query_start": 38450, "query_end": 38734, "hit_start": 624, "hit_end": 876, "orf_dna_sequence": "ATGCTGCTGGAGGGAGAGCTGGAGGGGTACGAGGACGGGTTGGAACTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGCATAGCTACCCGCCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCGAGGACGTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGGGGCGTTGGGGGATCTGAGCGGGTCCACCGTCGACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGCGGTGGTGCTGGAGGGATTCGAGCACGAGGCGTTGCCGTGCCAGATTCCCTTGGTGCCGGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAAGAGGATGGTGGAGCACCACCAGCGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGTGCGGCTGCACGAGGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGAAGCTACATCGAGCAGATACTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGCTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGAGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGACCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCGGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGCTGCCGAACGGGAAGCTGGACCGGTTGTCGCTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAGCCTCGGCGGGCACTCCCTCCTGGCTGCCCAGCTGATTTCGCGCATACGGGCGACCTTCCGCGTGGAAGTGGCGATGGCCACGGTGTTCGAGTCCCCCACGGTGGAGCCGCTCGCCCGCCACATCGAGGAGAAGCTCAAGGACGAGTCTCGGGTCCAGCTCTCCAACGTTGTGCCGGTCGAGCGGACGCAGGAGATTCCGCTCTCCTACCTGCAGGAGCGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACATCACCTGGACGTTGCACTTCGCCGGCAAGGGTTTCTCGGTGGAGGCGTTGCGGACGGCCTTCGATGAGCTGGTGGCCAGACACGAGACACTGCGCACGTGGTTCCAGGTGGGGGAGGGGACAGAGCAGGCCGTACAGGTCATCGGGGAGCCCTGGTCGATGGAGCTGCCGCTGAGAGAGGTGGCGGGGACGGAGGTGACGGCGGCAATCAATGAGATGTCCCGACAGGTCTTCGACTTGAGAGCGGGACGGTTGCTGACGGCGGCGGTCCTGAGGGTGGCGGAGGATGAGCACATCCTCGTCAGCAACATCCACCACATCATCACGGACGGCTGGTCGTTCGGGGTGATGCTGCGGGAGCTGAGGGAGTTGTACGAGGCAGCGGTGCGGGGGAAGAGAGCGGAGCTGCCGCCGCTGACGGTGCAGTACGGCGACTATGCGGTGTGGCAGAGGAAGCAGGACCTGAGCGAGCACCTGGCGTACTGGAAGGGGAAGGTGGAGGAGTACGAGGACGGGTTGGAGCTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGTATAGCTACCCACCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCCAGGACGTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGAGCTGGAGAGCCTCATCGGGTTCTTCATCAACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGCGGTGGTGCTGGAGGGATTCGAGCACCAGGAGTTGCCGTTCGAGCACCTGCTGAAGGCGCTGAGGCGGCAGCGGGACAGCAGCCAGATTCCCTTGGTGCCAGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAGGAGGATGGTGGAGCACCACCAGCGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGGGCTGCACGAGGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGACACTACATCGAGCAGATATTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGTTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGGGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGGCCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCAGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGTTGCCGAACGGGAAGCTGGACCGGCTGTCGTTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAGCCTCGGCGGGCACTCCCTCCTGGCTGCCCAGGTGGTCTCAAGGATTGGCAAGGAGCTTGGCACTCAGATCTCGATCGCCGATCTGTTTCAAAGGCCCACGATTGAACAGCTCTGTGAGCTGATTGGAGGACTGGACGATCAGACCCAGAGGGAGCTCGCCCTCGCTCCGTCGGGGAACACCGAGGCGGTGCTCTCGTTCGCGCAAGAGCGCATGTGGTTCCTGCACAACTTCGTCAAGGGCATGCCCTACAACACGCCAGGGCTCGACCACCTGACGGGTGAGCTCGATGTCGCGGCGCTAGAAAAGGCCATCCGCGCGGTCATCCGTCGCCACGAGCCCCTGCGGACGAATTTCGTCGAGAAGGACGGGGTGCTGTCCCAGTTGGTGGGGACGGAAGAACGCTTCCGCCTGACCGTGACTCCCATCCGCGACGAGAGCGAGGTCGCGCGGCTCATGGAAGCCGTGATCCAAACGCCAGTCGATCTGGAGCGGGAGTTGATGATCCGGGCTTATCTCTACCGGGTCGACCCGCGGAATCACTACCTGTTCACCACCATCCATCACATCGCCTTCGATGGCTGGTCGACATCGATCTTCTACCGTGAGCTGGCTGCGTACTACGCCGCGTTTCTCCGGCGCGAAGACAGTCCGCTGCCCGCGCTGGAAATCTCCTATCAGGACTATGCCCGCTGGGAGCGGGCCCATTTCCAGGACGAGGTGTTGGCGGAAAAACTGAGGTACTGGCGGCAGCGGCTGTCGGGCGCTCGGCCCCTCGTACTTCCGACCACCTACCATCGGCCGCCCATCCAGAGTTTCGCTGGCGCCGTCGTGAACTTCGAGATCGATCGCTCCATCACCGAGCGGTTGAAGACGCTGTTCGCCGAGTCGGGCACCACGATGTACATGGTGTTGCTCGGCGCGTTCTCCGTGGTGCTGCAGCGCTACTCCGGTCAGGACGACATCTGCATCGGCTCCCCCGTGGCGAACCGGGGTCACATCCAGACAGAAGGGCTGATCGGCTTGTTCGTCAACACCCTGGTGATGAGGGTGGATGCCGCCGGGAATCCCCGTTTCATCGACCTGCTGGCGCGCATTCAACGGACAGCCATCGATGCTTACGCGAACCAAGAAGTGCCCTTCGAGAAGATCGTGGACGACCTGCAGGTCGCGAGAGACACGGCCCGATCTCCGCTCGTGCAGGTCATTCTCAACTTCCACAACACGCCTCCTCAATCCGAGCTGGAACTGCAGGGGGTGACCCTCACGCGGATGCCGGTGCACAACGGCACGGCCAAGTTCGAGCTCTCCATCGACGTCGCGGAGACGAGCGCCGGTCTAACGGGATTCGTGGAGTACGCGACGGATCTGTTCAGCGAGAACTTCATCCGGCGGATGATCGGCCACCTCGAGGTGGTGCTGGACGCGGTCGGTCGCGATCCGCGGGCGCCTATCCATGAGTTGCCACTGCTCACCCGGCAGGATCAGTTGGACCTACTGTCGCGGAGCGGCCACACAGCCCCCGCGGTGGAACACGTCGAGTTGATCCCTCATACGTTCGAGCGGCGCGTCCAGGAGAGCCCTCAAGCGATTGCCCTGGTCTGCGGTGACGAGCGCGTCACCTACTCCGCGCTCAACCGCCGGGCCAGCCAGATTGCCCGCCGCCTGCGCGCCGCAGGGATCGGACCGGACACCCTCGTCGGGCTTTGCGCGGGGCGCTCCATCGAGCTGGTCTGCGGCGTCCTTGGCATCTTGAAGGCGGGCGGTGCGTACGTGCCAATCGACCCCACCTCCTCGCCCGAGGTGATCTACGACGTCCTGTATGAGTCGAAGGTGCGGCATCTGTTGACCGAGTCGCGCCTGGTCGGGGGACTGCCGGTCGATGACCAGGAAATCCTGCTCCTGGATACCCCCGCGGACGGTGAAGGGGACAAGGCTGTTGCTGACCGGGAGGAGCCACCTGACCTTGGCGAGGTCAGCCTCACTCCCGAGTGCTTGGCGTACGTCAACTTCACCTCCGACTCCGGTGGGGCGCCGAGGGGCATCGCCGTCCGCCATGGGGCGCTGGCTCGCCGGATGGCCGCCGGCCACGCACAGTACCTGGCCAATTCCGCCGTACGTTTCCTGCTGAAGGCGCCGCTCACGTTCGACCTGGCGGTCGCGGAGCTGTTCCAGTGGATCGTCAGCGGCGGCAGCCTGAGCATCCTCGACCCCAATGCCGACCGCGACGCCTCTGCCTTCCTCGCGCAGGTGCGCAGGGACTCGATTGGCGTCCTCTACTGCGTCCCCTCCGAACTCTCGACGCTGGTGAGCCACCTGGAGCGCGAGCGTGAAAGGGTGCATGAGCTGAACACCCTCCGGTTCATCTTCTGCGGCGGGGATACCCTGGCGGTTACCGTCGTCGAGCGTCTCGGGGTACTGGTGCGGGCCGGCCAGCTCCCGCTGCGGCTGGTCAACGTCTATGGGACGAAGGAGACGGGAATCGGCGCGGGTTGCTTCGAGTGCGCGCTGGACGCGAACGACCCCAGCGCCGAACTCCCGCCGGGACGGCTCTCGCATGAGCGGATGCCCATCGGCGGGCCCGCCCAGAACCTGTGGTTCTATGTGGTGCAACCCAACGGTGGCCTGGCTCCGTTGGGCATCCCGGGGGAACTGTACGTCGGCGGCGCGCAACTCGCCGACGCCCGTTTCGGCGACGAGCCCACGGCGACCCACCCCGGCTTCGTCCCGAACCCCTTCCGGAGCGGAGCGGAGAAGGACTGGCTGTACAAGACGGGGGACCTCGTCCGCTGGCTGCCTCAGGGGCCGCTCGAGCTGGTCAGCGCGGCTCGGGAGCGCGACGGAGGCGGGGACCACCGGCTCGATCGCGGCTTCATCGAGGCGCGCATGCGTCGTGTGGCCATTGTCCGCGACGCCGTGGTGGCCTACGTCCCGGATCGCCAGGACAGGGCCCGGTTGGTGGCCTACGTCGTTCTGAAGGAGTCGCCCGCGGCGGACGTGGAGCCGCGCGAAGGGCGGGAAACGCTGAAGGCTCGGATCAGCGCCGAACTTGGGAGCACGTTGCCGGAGTACATGCTTCCGGCCGCCTACGTGTTCATGGACAGCCTGCCGTTGACGGCTTACGGGAGGATCGACCGGAAAGCCCTGCCCGAGCCGGAGGATGACCGCCACGGTGGTAGTGCGATCGCCTACGTGGCCCCGCGCGGGCCCACGGAGAAGGCACTGGCGCACATTTGGCAGCAAGTGCTGAAACGCCCCCAGGTCGGACTGCGAGACAACTTCTTTGAGCTGGGCGGGCACTCAGTGGCGGCCATCCAACTGGTGTCCGTGAGCCGGAAGCACCTGGAGGTCGAAGTCCCCCTCAGCCTGATCTTCGAATCGCCGGTCCTGGAGGCGATGGCGCGCGGCATCGAAGCGCTGCAACAGCAGGGCCGCAGCGGCGCGGTGTCGTCGATCCATCGGGTGGAGCGGACCGGACCGCTGCCTCTGGCGTACGTGCAGGAGAGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACATCACCTGGACGTTGCACTTCGCCGGCAAGGGTTTCTCGGTGGAGGCGTTGCGGACGGCCTTCGATGAGCTGGTGGCCAGACACGAGACACTGCGCACGTGGTTCCAGGTGGGGGAGGGGACAGAGCAGGCCGTACAGGTCATCGGGGAGCCCTGGTCGATGGAGCTGCCGCTGAGAGAGGTGGCGGGGACGGAGGTGACGGCGGCAATCAATGAGATGTCCCGGCAGGTCTTCGACTTGAGAGCGGGACGGTTGCTGACGGCGGCGGTCCTGAGGGTGGCGGAGGATGAGCACATCCTCGTCAGCAACATCCACCACATCATCACGGACGGCTGGTCGTTCGGGGTGATGCTGCGGGAGCTGAGGGAGTTGTACGAGGCCGCGGTGCGGGGGGAGCGAGCGGAGCTGCCGCCGCTGACGGTGCAGTACGGCGACTATGCGGTATGGCAGAGGAAGCAGGACCTGAGCGAGCACCTGGCGTACTGGAAGGGGAAGGTGGAGGGGGACGAGGACGGGTTGGAGCTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGTATAGCTACCACCCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCGAGGACCTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGAACTGGAGAGCCTCATCGGGTTCTTCATCAACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGTGGTGGTGCTGGAGGGATTCGAGCACCAGGAGTTGCCGTTCGAGCACCTGCTGAAGGCGCTGAGGCGGCAGCGGGACAGCAGCCAGATTCCCTTGGTGCCAGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAGGAGGATGGTGGAGCACCACCAACGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGGGCTGCACGAAGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGAAGCTACATCGAGCAGATACTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGCTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGAGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGACCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCAGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGTTGCCGAACGGGAAGCTGGACCGGCTGTCGTTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAACCTCGGCGGGCACTCCCTCCTGGCTTCCCAGCTGATTTCGCGCATACGGGCGACCTTCCGCGTGGAAGTGGCGATGGCCACGGTGTTCGAGTCCCCCACGGTGGAGCCGCTCGCCCGCCACATCGAGGAGAAGCTCAAGGACGAGTCTCGGGTCCAGCTCTCCAACGTTGTGCCGGTCGAGCGGACGCAGGAGCTTCCGCTCTCCTACCTGCAGGAGAGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACGGAACGATCGGGCTCCGGCTTCGGGGTCCTCTGTCAATCCCCGCGCTCAGGGCCACCTTCCACGATCTGGTCGCCCGTCACGAGAGCCTGCGCACCGTCTTCCGGGTCCCCGAAGGCCGCACCACGCCGGTGCAGGTGATTCTTGATTCGATGGATCTGGACATCCCGGTCCGCGATGCAACCGAGGCCGACATCATCCCGGGCATGGATGAGCTGGCGGGTCACATCTACGACATGGAGAAGGGTCCGCTGTTCATGGTTCGCCTCTTGCGGCTGGCCGAGGACTCCCACGTTCTCCTGATGGGGATGCATCACATCGTCTACGACGCATGGTCACAGTTCAATGTGATGAGTCGCGATATCAACCTGCTCTACTCGGCGCACGTGACGGGAATCGAGGCACGGCTTCCCGCGCTTCCCATCCAGTACGCCGACTTCTCGGTGTGGCAGCGCCAGCAGGACTTCCGTCACCACCTGGACTACTGGAAGTCCACACTGGGCGACTACCGGGATGATCTCGAGCTGCCGTATGACTACCCGCGGCCGCCCAGCCGGACATGGCACGCGACCCGATTCACCTTCCGGTATCCGGATGCACTGGCGCGCGCGTTCGCCAGGTTCAATCAGTCCCATCAGTCGACGCTGTTCATGGGGCTGCTGACCAGCTTCGCGATCGTGCTCAGGCACTACACCGGCCGGAACGACATCTGCATCGGAACGACAACGGCGGGGCGCGCCCAGTTGGAGTTGGAGAACCTCGTTGGCTTCTTCATCAACATCCTGCCGTTGCGCATCAATCTGGCGGGTGACCCCGACATCAGCGAGCTCATGAATCGAGCGAAGAAGAGCGTCTTGGGCGCCTTCGAGCATCAAGCTCTGCCGTTCGAGCGTCTCCTCAGTGCCCTCAACAAACAGCGTGACAGCAGCCATATCCCGCTGGTTCCCGTCATGTTGCGCCACCAGAACTTCCCGACGGCGATGACCGGCAAGTGGGCCGATGGTGTGGACATGGAGGTCATCGAGCGCGACGAGCGCACGACGCCCAACGAGCTGGACCTCCAGTTCTTTGGCGACGACACCTACTTGCATGCTGTCGTCGAGTTCCCCGCGCAGCTCTTCTCCGAGGTGACCGTCCGGCGTCTGATGCAGCGTCACCAGAAGGTCATAGAGTTCATGTGCGCGACGCTGGGGGCTCGGTGA", "orf_prot_sequence": "MLLEGELEGYEDGLELPYDFPRTSNRAWRAATFQHSYPPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGREDVCIGTTVAGRAQVGALGDLSGSTVDILPLRLDLSGAPSLHEVLRRTKAVVLEGFEHEALPCQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVKRMVEHHQRVLEALVEGLEEVRLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGSYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFSLGGHSLLAAQLISRIRATFRVEVAMATVFESPTVEPLARHIEEKLKDESRVQLSNVVPVERTQEIPLSYLQERLWFVHEHMKEQRTSYNITWTLHFAGKGFSVEALRTAFDELVARHETLRTWFQVGEGTEQAVQVIGEPWSMELPLREVAGTEVTAAINEMSRQVFDLRAGRLLTAAVLRVAEDEHILVSNIHHIITDGWSFGVMLRELRELYEAAVRGKRAELPPLTVQYGDYAVWQRKQDLSEHLAYWKGKVEEYEDGLELPYDFPRTSNRAWRAATFQYSYPPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGRQDVCIGTTVAGRAQVELESLIGFFINILPLRLDLSGAPSLHEVLRRTKAVVLEGFEHQELPFEHLLKALRRQRDSSQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVRRMVEHHQRVLEALVEGLEEGLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGHYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFSLGGHSLLAAQVVSRIGKELGTQISIADLFQRPTIEQLCELIGGLDDQTQRELALAPSGNTEAVLSFAQERMWFLHNFVKGMPYNTPGLDHLTGELDVAALEKAIRAVIRRHEPLRTNFVEKDGVLSQLVGTEERFRLTVTPIRDESEVARLMEAVIQTPVDLERELMIRAYLYRVDPRNHYLFTTIHHIAFDGWSTSIFYRELAAYYAAFLRREDSPLPALEISYQDYARWERAHFQDEVLAEKLRYWRQRLSGARPLVLPTTYHRPPIQSFAGAVVNFEIDRSITERLKTLFAESGTTMYMVLLGAFSVVLQRYSGQDDICIGSPVANRGHIQTEGLIGLFVNTLVMRVDAAGNPRFIDLLARIQRTAIDAYANQEVPFEKIVDDLQVARDTARSPLVQVILNFHNTPPQSELELQGVTLTRMPVHNGTAKFELSIDVAETSAGLTGFVEYATDLFSENFIRRMIGHLEVVLDAVGRDPRAPIHELPLLTRQDQLDLLSRSGHTAPAVEHVELIPHTFERRVQESPQAIALVCGDERVTYSALNRRASQIARRLRAAGIGPDTLVGLCAGRSIELVCGVLGILKAGGAYVPIDPTSSPEVIYDVLYESKVRHLLTESRLVGGLPVDDQEILLLDTPADGEGDKAVADREEPPDLGEVSLTPECLAYVNFTSDSGGAPRGIAVRHGALARRMAAGHAQYLANSAVRFLLKAPLTFDLAVAELFQWIVSGGSLSILDPNADRDASAFLAQVRRDSIGVLYCVPSELSTLVSHLERERERVHELNTLRFIFCGGDTLAVTVVERLGVLVRAGQLPLRLVNVYGTKETGIGAGCFECALDANDPSAELPPGRLSHERMPIGGPAQNLWFYVVQPNGGLAPLGIPGELYVGGAQLADARFGDEPTATHPGFVPNPFRSGAEKDWLYKTGDLVRWLPQGPLELVSAARERDGGGDHRLDRGFIEARMRRVAIVRDAVVAYVPDRQDRARLVAYVVLKESPAADVEPREGRETLKARISAELGSTLPEYMLPAAYVFMDSLPLTAYGRIDRKALPEPEDDRHGGSAIAYVAPRGPTEKALAHIWQQVLKRPQVGLRDNFFELGGHSVAAIQLVSVSRKHLEVEVPLSLIFESPVLEAMARGIEALQQQGRSGAVSSIHRVERTGPLPLAYVQERLWFVHEHMKEQRTSYNITWTLHFAGKGFSVEALRTAFDELVARHETLRTWFQVGEGTEQAVQVIGEPWSMELPLREVAGTEVTAAINEMSRQVFDLRAGRLLTAAVLRVAEDEHILVSNIHHIITDGWSFGVMLRELRELYEAAVRGERAELPPLTVQYGDYAVWQRKQDLSEHLAYWKGKVEGDEDGLELPYDFPRTSNRAWRAATFQYSYHPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGREDLCIGTTVAGRAQVELESLIGFFINILPLRLDLSGAPSLHEVLRRTKVVVLEGFEHQELPFEHLLKALRRQRDSSQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVRRMVEHHQRVLEALVEGLEEGLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGSYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFNLGGHSLLASQLISRIRATFRVEVAMATVFESPTVEPLARHIEEKLKDESRVQLSNVVPVERTQELPLSYLQERLWFVHEHMKEQRTSYNGTIGLRLRGPLSIPALRATFHDLVARHESLRTVFRVPEGRTTPVQVILDSMDLDIPVRDATEADIIPGMDELAGHIYDMEKGPLFMVRLLRLAEDSHVLLMGMHHIVYDAWSQFNVMSRDINLLYSAHVTGIEARLPALPIQYADFSVWQRQQDFRHHLDYWKSTLGDYRDDLELPYDYPRPPSRTWHATRFTFRYPDALARAFARFNQSHQSTLFMGLLTSFAIVLRHYTGRNDICIGTTTAGRAQLELENLVGFFINILPLRINLAGDPDISELMNRAKKSVLGAFEHQALPFERLLSALNKQRDSSHIPLVPVMLRHQNFPTAMTGKWADGVDMEVIERDERTTPNELDLQFFGDDTYLHAVVEFPAQLFSEVTVRRLMQRHQKVIEFMCATLGAR", "perc_identity": 25.26}, "gnl|BL_ORD_ID|3399|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 27422, "orf_end": 41059, "orf_from": "BGC0001413.1|Cystobactamide_17 ", "model_name": "CMH-6", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "4468", "ARO_accession": "3006858", "ARO_name": "CMH-6", "ARO_category": {"42891": {"category_aro_accession": "3004776", "category_aro_cvterm_id": "42891", "category_aro_name": "CMH beta-lactamase", "category_aro_description": "CMH is a class C beta-lactamase gene family belonging to Enterobacter cloacae.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.39806, "max_identities": 24, "bit_score": 31.9574, "cvterm_id": "36884", "query": "VMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEE", "match": "+ VP+++  ++    +E   +     ML   A     +VK++ S ++A +A   +P++ ++  +ALAQ    WRV          GA+ +G G E", "sequence_from_db": "INVPHAEEPHYAWGYREGKAVHVSPGMLDAEAYGVKSNVKDMASWVMANMAPETLPQSTLQQGIALAQS-RYWRV----------GAMYQGLGWE", "sequence_from_broadstreet": "MMKKSLSCALLLSVACSAFAAPMSKKQLADVVERTVTPLMKAQAIPGMAVAVIYQGQPHYFTFGKADVAANKPVTPQTLFELGSVSKTFTGVLGGDAIARKEISLADPVTKYWPELTGKQWQSIRLLDLATYTAGGLPLQVPDDVTDNVSLLRFYQSWQPKWAPGTTRLYANTSIGLFGSLAVKPSGMRFEQAMAERVFKPLKLNHTWINVPHAEEPHYAWGYREGKAVHVSPGMLDAEAYGVKSNVKDMASWVMANMAPETLPQSTLQQGIALAQSRYWRVGAMYQGLGWEMLNWPVDAKTVVDGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLANKSYPNPVRVETAYRILETLQ", "dna_sequence_from_broadstreet": "ATGATGAAAAAATCCCTAAGCTGCGCGCTGCTGCTCAGCGTTGCCTGCTCTGCTTTTGCCGCGCCGATGTCAAAAAAACAGCTGGCTGACGTCGTGGAACGTACCGTTACGCCCCTGATGAAGGCGCAGGCCATACCCGGAATGGCCGTGGCCGTCATTTATCAGGGCCAGCCACACTATTTTACTTTCGGTAAAGCAGACGTCGCGGCGAATAAGCCCGTCACGCCGCAAACCTTATTTGAGCTGGGCTCCGTCAGCAAAACCTTCACCGGCGTGCTGGGTGGCGATGCCATTGCCCGCAAAGAGATTTCGCTGGCCGACCCGGTCACGAAATATTGGCCTGAATTGACGGGCAAGCAGTGGCAAAGCATTCGCCTGCTAGACCTGGCAACCTATACCGCAGGCGGATTGCCGTTGCAGGTACCGGATGATGTCACCGATAACGTCTCTCTGCTGCGTTTCTACCAGTCCTGGCAGCCAAAGTGGGCCCCGGGTACCACGCGTCTGTACGCCAACACCAGCATCGGTTTGTTTGGCTCACTGGCCGTCAAACCGTCCGGCATGCGCTTCGAGCAGGCCATGGCGGAGCGGGTCTTTAAGCCCCTGAAACTCAACCATACGTGGATAAACGTTCCACACGCTGAAGAGCCGCACTACGCATGGGGTTATCGTGAGGGAAAAGCGGTCCACGTTTCGCCTGGTATGCTGGATGCAGAAGCCTATGGCGTGAAATCTAACGTCAAAGATATGGCGAGCTGGGTGATGGCCAATATGGCACCTGAGACACTCCCGCAGTCCACTCTGCAGCAGGGTATTGCGCTGGCGCAGTCTCGCTACTGGCGCGTGGGTGCCATGTATCAAGGGTTAGGCTGGGAGATGCTCAACTGGCCGGTCGACGCCAAAACCGTGGTGGATGGCAGCGACAATAAGGTCGCACTGGCGCCGTTGCCGGTCGCAGAAGTGAATCCTCCGGCTCCGCCAGTAAAAGCCTCCTGGGTGCATAAAACGGGCTCTACGGGTGGGTTTGGCAGCTACGTGGCGTTTATTCCTGAAAAGCAGATCGGTATTGTGATGCTCGCAAATAAAAGCTATCCGAACCCGGTACGGGTGGAAACGGCTTACCGTATTCTCGAGACGCTACAGTAA", "partial": "0", "query_start": 28721, "query_end": 29005, "hit_start": 624, "hit_end": 876, "orf_dna_sequence": "ATGCTGCTGGAGGGAGAGCTGGAGGGGTACGAGGACGGGTTGGAACTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGCATAGCTACCCGCCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCGAGGACGTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGGGGCGTTGGGGGATCTGAGCGGGTCCACCGTCGACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGCGGTGGTGCTGGAGGGATTCGAGCACGAGGCGTTGCCGTGCCAGATTCCCTTGGTGCCGGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAAGAGGATGGTGGAGCACCACCAGCGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGTGCGGCTGCACGAGGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGAAGCTACATCGAGCAGATACTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGCTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGAGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGACCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCGGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGCTGCCGAACGGGAAGCTGGACCGGTTGTCGCTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAGCCTCGGCGGGCACTCCCTCCTGGCTGCCCAGCTGATTTCGCGCATACGGGCGACCTTCCGCGTGGAAGTGGCGATGGCCACGGTGTTCGAGTCCCCCACGGTGGAGCCGCTCGCCCGCCACATCGAGGAGAAGCTCAAGGACGAGTCTCGGGTCCAGCTCTCCAACGTTGTGCCGGTCGAGCGGACGCAGGAGATTCCGCTCTCCTACCTGCAGGAGCGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACATCACCTGGACGTTGCACTTCGCCGGCAAGGGTTTCTCGGTGGAGGCGTTGCGGACGGCCTTCGATGAGCTGGTGGCCAGACACGAGACACTGCGCACGTGGTTCCAGGTGGGGGAGGGGACAGAGCAGGCCGTACAGGTCATCGGGGAGCCCTGGTCGATGGAGCTGCCGCTGAGAGAGGTGGCGGGGACGGAGGTGACGGCGGCAATCAATGAGATGTCCCGACAGGTCTTCGACTTGAGAGCGGGACGGTTGCTGACGGCGGCGGTCCTGAGGGTGGCGGAGGATGAGCACATCCTCGTCAGCAACATCCACCACATCATCACGGACGGCTGGTCGTTCGGGGTGATGCTGCGGGAGCTGAGGGAGTTGTACGAGGCAGCGGTGCGGGGGAAGAGAGCGGAGCTGCCGCCGCTGACGGTGCAGTACGGCGACTATGCGGTGTGGCAGAGGAAGCAGGACCTGAGCGAGCACCTGGCGTACTGGAAGGGGAAGGTGGAGGAGTACGAGGACGGGTTGGAGCTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGTATAGCTACCCACCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCCAGGACGTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGAGCTGGAGAGCCTCATCGGGTTCTTCATCAACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGCGGTGGTGCTGGAGGGATTCGAGCACCAGGAGTTGCCGTTCGAGCACCTGCTGAAGGCGCTGAGGCGGCAGCGGGACAGCAGCCAGATTCCCTTGGTGCCAGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAGGAGGATGGTGGAGCACCACCAGCGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGGGCTGCACGAGGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGACACTACATCGAGCAGATATTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGTTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGGGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGGCCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCAGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGTTGCCGAACGGGAAGCTGGACCGGCTGTCGTTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAGCCTCGGCGGGCACTCCCTCCTGGCTGCCCAGGTGGTCTCAAGGATTGGCAAGGAGCTTGGCACTCAGATCTCGATCGCCGATCTGTTTCAAAGGCCCACGATTGAACAGCTCTGTGAGCTGATTGGAGGACTGGACGATCAGACCCAGAGGGAGCTCGCCCTCGCTCCGTCGGGGAACACCGAGGCGGTGCTCTCGTTCGCGCAAGAGCGCATGTGGTTCCTGCACAACTTCGTCAAGGGCATGCCCTACAACACGCCAGGGCTCGACCACCTGACGGGTGAGCTCGATGTCGCGGCGCTAGAAAAGGCCATCCGCGCGGTCATCCGTCGCCACGAGCCCCTGCGGACGAATTTCGTCGAGAAGGACGGGGTGCTGTCCCAGTTGGTGGGGACGGAAGAACGCTTCCGCCTGACCGTGACTCCCATCCGCGACGAGAGCGAGGTCGCGCGGCTCATGGAAGCCGTGATCCAAACGCCAGTCGATCTGGAGCGGGAGTTGATGATCCGGGCTTATCTCTACCGGGTCGACCCGCGGAATCACTACCTGTTCACCACCATCCATCACATCGCCTTCGATGGCTGGTCGACATCGATCTTCTACCGTGAGCTGGCTGCGTACTACGCCGCGTTTCTCCGGCGCGAAGACAGTCCGCTGCCCGCGCTGGAAATCTCCTATCAGGACTATGCCCGCTGGGAGCGGGCCCATTTCCAGGACGAGGTGTTGGCGGAAAAACTGAGGTACTGGCGGCAGCGGCTGTCGGGCGCTCGGCCCCTCGTACTTCCGACCACCTACCATCGGCCGCCCATCCAGAGTTTCGCTGGCGCCGTCGTGAACTTCGAGATCGATCGCTCCATCACCGAGCGGTTGAAGACGCTGTTCGCCGAGTCGGGCACCACGATGTACATGGTGTTGCTCGGCGCGTTCTCCGTGGTGCTGCAGCGCTACTCCGGTCAGGACGACATCTGCATCGGCTCCCCCGTGGCGAACCGGGGTCACATCCAGACAGAAGGGCTGATCGGCTTGTTCGTCAACACCCTGGTGATGAGGGTGGATGCCGCCGGGAATCCCCGTTTCATCGACCTGCTGGCGCGCATTCAACGGACAGCCATCGATGCTTACGCGAACCAAGAAGTGCCCTTCGAGAAGATCGTGGACGACCTGCAGGTCGCGAGAGACACGGCCCGATCTCCGCTCGTGCAGGTCATTCTCAACTTCCACAACACGCCTCCTCAATCCGAGCTGGAACTGCAGGGGGTGACCCTCACGCGGATGCCGGTGCACAACGGCACGGCCAAGTTCGAGCTCTCCATCGACGTCGCGGAGACGAGCGCCGGTCTAACGGGATTCGTGGAGTACGCGACGGATCTGTTCAGCGAGAACTTCATCCGGCGGATGATCGGCCACCTCGAGGTGGTGCTGGACGCGGTCGGTCGCGATCCGCGGGCGCCTATCCATGAGTTGCCACTGCTCACCCGGCAGGATCAGTTGGACCTACTGTCGCGGAGCGGCCACACAGCCCCCGCGGTGGAACACGTCGAGTTGATCCCTCATACGTTCGAGCGGCGCGTCCAGGAGAGCCCTCAAGCGATTGCCCTGGTCTGCGGTGACGAGCGCGTCACCTACTCCGCGCTCAACCGCCGGGCCAGCCAGATTGCCCGCCGCCTGCGCGCCGCAGGGATCGGACCGGACACCCTCGTCGGGCTTTGCGCGGGGCGCTCCATCGAGCTGGTCTGCGGCGTCCTTGGCATCTTGAAGGCGGGCGGTGCGTACGTGCCAATCGACCCCACCTCCTCGCCCGAGGTGATCTACGACGTCCTGTATGAGTCGAAGGTGCGGCATCTGTTGACCGAGTCGCGCCTGGTCGGGGGACTGCCGGTCGATGACCAGGAAATCCTGCTCCTGGATACCCCCGCGGACGGTGAAGGGGACAAGGCTGTTGCTGACCGGGAGGAGCCACCTGACCTTGGCGAGGTCAGCCTCACTCCCGAGTGCTTGGCGTACGTCAACTTCACCTCCGACTCCGGTGGGGCGCCGAGGGGCATCGCCGTCCGCCATGGGGCGCTGGCTCGCCGGATGGCCGCCGGCCACGCACAGTACCTGGCCAATTCCGCCGTACGTTTCCTGCTGAAGGCGCCGCTCACGTTCGACCTGGCGGTCGCGGAGCTGTTCCAGTGGATCGTCAGCGGCGGCAGCCTGAGCATCCTCGACCCCAATGCCGACCGCGACGCCTCTGCCTTCCTCGCGCAGGTGCGCAGGGACTCGATTGGCGTCCTCTACTGCGTCCCCTCCGAACTCTCGACGCTGGTGAGCCACCTGGAGCGCGAGCGTGAAAGGGTGCATGAGCTGAACACCCTCCGGTTCATCTTCTGCGGCGGGGATACCCTGGCGGTTACCGTCGTCGAGCGTCTCGGGGTACTGGTGCGGGCCGGCCAGCTCCCGCTGCGGCTGGTCAACGTCTATGGGACGAAGGAGACGGGAATCGGCGCGGGTTGCTTCGAGTGCGCGCTGGACGCGAACGACCCCAGCGCCGAACTCCCGCCGGGACGGCTCTCGCATGAGCGGATGCCCATCGGCGGGCCCGCCCAGAACCTGTGGTTCTATGTGGTGCAACCCAACGGTGGCCTGGCTCCGTTGGGCATCCCGGGGGAACTGTACGTCGGCGGCGCGCAACTCGCCGACGCCCGTTTCGGCGACGAGCCCACGGCGACCCACCCCGGCTTCGTCCCGAACCCCTTCCGGAGCGGAGCGGAGAAGGACTGGCTGTACAAGACGGGGGACCTCGTCCGCTGGCTGCCTCAGGGGCCGCTCGAGCTGGTCAGCGCGGCTCGGGAGCGCGACGGAGGCGGGGACCACCGGCTCGATCGCGGCTTCATCGAGGCGCGCATGCGTCGTGTGGCCATTGTCCGCGACGCCGTGGTGGCCTACGTCCCGGATCGCCAGGACAGGGCCCGGTTGGTGGCCTACGTCGTTCTGAAGGAGTCGCCCGCGGCGGACGTGGAGCCGCGCGAAGGGCGGGAAACGCTGAAGGCTCGGATCAGCGCCGAACTTGGGAGCACGTTGCCGGAGTACATGCTTCCGGCCGCCTACGTGTTCATGGACAGCCTGCCGTTGACGGCTTACGGGAGGATCGACCGGAAAGCCCTGCCCGAGCCGGAGGATGACCGCCACGGTGGTAGTGCGATCGCCTACGTGGCCCCGCGCGGGCCCACGGAGAAGGCACTGGCGCACATTTGGCAGCAAGTGCTGAAACGCCCCCAGGTCGGACTGCGAGACAACTTCTTTGAGCTGGGCGGGCACTCAGTGGCGGCCATCCAACTGGTGTCCGTGAGCCGGAAGCACCTGGAGGTCGAAGTCCCCCTCAGCCTGATCTTCGAATCGCCGGTCCTGGAGGCGATGGCGCGCGGCATCGAAGCGCTGCAACAGCAGGGCCGCAGCGGCGCGGTGTCGTCGATCCATCGGGTGGAGCGGACCGGACCGCTGCCTCTGGCGTACGTGCAGGAGAGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACATCACCTGGACGTTGCACTTCGCCGGCAAGGGTTTCTCGGTGGAGGCGTTGCGGACGGCCTTCGATGAGCTGGTGGCCAGACACGAGACACTGCGCACGTGGTTCCAGGTGGGGGAGGGGACAGAGCAGGCCGTACAGGTCATCGGGGAGCCCTGGTCGATGGAGCTGCCGCTGAGAGAGGTGGCGGGGACGGAGGTGACGGCGGCAATCAATGAGATGTCCCGGCAGGTCTTCGACTTGAGAGCGGGACGGTTGCTGACGGCGGCGGTCCTGAGGGTGGCGGAGGATGAGCACATCCTCGTCAGCAACATCCACCACATCATCACGGACGGCTGGTCGTTCGGGGTGATGCTGCGGGAGCTGAGGGAGTTGTACGAGGCCGCGGTGCGGGGGGAGCGAGCGGAGCTGCCGCCGCTGACGGTGCAGTACGGCGACTATGCGGTATGGCAGAGGAAGCAGGACCTGAGCGAGCACCTGGCGTACTGGAAGGGGAAGGTGGAGGGGGACGAGGACGGGTTGGAGCTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGTATAGCTACCACCCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCGAGGACCTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGAACTGGAGAGCCTCATCGGGTTCTTCATCAACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGTGGTGGTGCTGGAGGGATTCGAGCACCAGGAGTTGCCGTTCGAGCACCTGCTGAAGGCGCTGAGGCGGCAGCGGGACAGCAGCCAGATTCCCTTGGTGCCAGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAGGAGGATGGTGGAGCACCACCAACGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGGGCTGCACGAAGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGAAGCTACATCGAGCAGATACTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGCTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGAGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGACCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCAGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGTTGCCGAACGGGAAGCTGGACCGGCTGTCGTTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAACCTCGGCGGGCACTCCCTCCTGGCTTCCCAGCTGATTTCGCGCATACGGGCGACCTTCCGCGTGGAAGTGGCGATGGCCACGGTGTTCGAGTCCCCCACGGTGGAGCCGCTCGCCCGCCACATCGAGGAGAAGCTCAAGGACGAGTCTCGGGTCCAGCTCTCCAACGTTGTGCCGGTCGAGCGGACGCAGGAGCTTCCGCTCTCCTACCTGCAGGAGAGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACGGAACGATCGGGCTCCGGCTTCGGGGTCCTCTGTCAATCCCCGCGCTCAGGGCCACCTTCCACGATCTGGTCGCCCGTCACGAGAGCCTGCGCACCGTCTTCCGGGTCCCCGAAGGCCGCACCACGCCGGTGCAGGTGATTCTTGATTCGATGGATCTGGACATCCCGGTCCGCGATGCAACCGAGGCCGACATCATCCCGGGCATGGATGAGCTGGCGGGTCACATCTACGACATGGAGAAGGGTCCGCTGTTCATGGTTCGCCTCTTGCGGCTGGCCGAGGACTCCCACGTTCTCCTGATGGGGATGCATCACATCGTCTACGACGCATGGTCACAGTTCAATGTGATGAGTCGCGATATCAACCTGCTCTACTCGGCGCACGTGACGGGAATCGAGGCACGGCTTCCCGCGCTTCCCATCCAGTACGCCGACTTCTCGGTGTGGCAGCGCCAGCAGGACTTCCGTCACCACCTGGACTACTGGAAGTCCACACTGGGCGACTACCGGGATGATCTCGAGCTGCCGTATGACTACCCGCGGCCGCCCAGCCGGACATGGCACGCGACCCGATTCACCTTCCGGTATCCGGATGCACTGGCGCGCGCGTTCGCCAGGTTCAATCAGTCCCATCAGTCGACGCTGTTCATGGGGCTGCTGACCAGCTTCGCGATCGTGCTCAGGCACTACACCGGCCGGAACGACATCTGCATCGGAACGACAACGGCGGGGCGCGCCCAGTTGGAGTTGGAGAACCTCGTTGGCTTCTTCATCAACATCCTGCCGTTGCGCATCAATCTGGCGGGTGACCCCGACATCAGCGAGCTCATGAATCGAGCGAAGAAGAGCGTCTTGGGCGCCTTCGAGCATCAAGCTCTGCCGTTCGAGCGTCTCCTCAGTGCCCTCAACAAACAGCGTGACAGCAGCCATATCCCGCTGGTTCCCGTCATGTTGCGCCACCAGAACTTCCCGACGGCGATGACCGGCAAGTGGGCCGATGGTGTGGACATGGAGGTCATCGAGCGCGACGAGCGCACGACGCCCAACGAGCTGGACCTCCAGTTCTTTGGCGACGACACCTACTTGCATGCTGTCGTCGAGTTCCCCGCGCAGCTCTTCTCCGAGGTGACCGTCCGGCGTCTGATGCAGCGTCACCAGAAGGTCATAGAGTTCATGTGCGCGACGCTGGGGGCTCGGTGA", "orf_prot_sequence": "MLLEGELEGYEDGLELPYDFPRTSNRAWRAATFQHSYPPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGREDVCIGTTVAGRAQVGALGDLSGSTVDILPLRLDLSGAPSLHEVLRRTKAVVLEGFEHEALPCQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVKRMVEHHQRVLEALVEGLEEVRLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGSYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFSLGGHSLLAAQLISRIRATFRVEVAMATVFESPTVEPLARHIEEKLKDESRVQLSNVVPVERTQEIPLSYLQERLWFVHEHMKEQRTSYNITWTLHFAGKGFSVEALRTAFDELVARHETLRTWFQVGEGTEQAVQVIGEPWSMELPLREVAGTEVTAAINEMSRQVFDLRAGRLLTAAVLRVAEDEHILVSNIHHIITDGWSFGVMLRELRELYEAAVRGKRAELPPLTVQYGDYAVWQRKQDLSEHLAYWKGKVEEYEDGLELPYDFPRTSNRAWRAATFQYSYPPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGRQDVCIGTTVAGRAQVELESLIGFFINILPLRLDLSGAPSLHEVLRRTKAVVLEGFEHQELPFEHLLKALRRQRDSSQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVRRMVEHHQRVLEALVEGLEEGLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGHYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFSLGGHSLLAAQVVSRIGKELGTQISIADLFQRPTIEQLCELIGGLDDQTQRELALAPSGNTEAVLSFAQERMWFLHNFVKGMPYNTPGLDHLTGELDVAALEKAIRAVIRRHEPLRTNFVEKDGVLSQLVGTEERFRLTVTPIRDESEVARLMEAVIQTPVDLERELMIRAYLYRVDPRNHYLFTTIHHIAFDGWSTSIFYRELAAYYAAFLRREDSPLPALEISYQDYARWERAHFQDEVLAEKLRYWRQRLSGARPLVLPTTYHRPPIQSFAGAVVNFEIDRSITERLKTLFAESGTTMYMVLLGAFSVVLQRYSGQDDICIGSPVANRGHIQTEGLIGLFVNTLVMRVDAAGNPRFIDLLARIQRTAIDAYANQEVPFEKIVDDLQVARDTARSPLVQVILNFHNTPPQSELELQGVTLTRMPVHNGTAKFELSIDVAETSAGLTGFVEYATDLFSENFIRRMIGHLEVVLDAVGRDPRAPIHELPLLTRQDQLDLLSRSGHTAPAVEHVELIPHTFERRVQESPQAIALVCGDERVTYSALNRRASQIARRLRAAGIGPDTLVGLCAGRSIELVCGVLGILKAGGAYVPIDPTSSPEVIYDVLYESKVRHLLTESRLVGGLPVDDQEILLLDTPADGEGDKAVADREEPPDLGEVSLTPECLAYVNFTSDSGGAPRGIAVRHGALARRMAAGHAQYLANSAVRFLLKAPLTFDLAVAELFQWIVSGGSLSILDPNADRDASAFLAQVRRDSIGVLYCVPSELSTLVSHLERERERVHELNTLRFIFCGGDTLAVTVVERLGVLVRAGQLPLRLVNVYGTKETGIGAGCFECALDANDPSAELPPGRLSHERMPIGGPAQNLWFYVVQPNGGLAPLGIPGELYVGGAQLADARFGDEPTATHPGFVPNPFRSGAEKDWLYKTGDLVRWLPQGPLELVSAARERDGGGDHRLDRGFIEARMRRVAIVRDAVVAYVPDRQDRARLVAYVVLKESPAADVEPREGRETLKARISAELGSTLPEYMLPAAYVFMDSLPLTAYGRIDRKALPEPEDDRHGGSAIAYVAPRGPTEKALAHIWQQVLKRPQVGLRDNFFELGGHSVAAIQLVSVSRKHLEVEVPLSLIFESPVLEAMARGIEALQQQGRSGAVSSIHRVERTGPLPLAYVQERLWFVHEHMKEQRTSYNITWTLHFAGKGFSVEALRTAFDELVARHETLRTWFQVGEGTEQAVQVIGEPWSMELPLREVAGTEVTAAINEMSRQVFDLRAGRLLTAAVLRVAEDEHILVSNIHHIITDGWSFGVMLRELRELYEAAVRGERAELPPLTVQYGDYAVWQRKQDLSEHLAYWKGKVEGDEDGLELPYDFPRTSNRAWRAATFQYSYHPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGREDLCIGTTVAGRAQVELESLIGFFINILPLRLDLSGAPSLHEVLRRTKVVVLEGFEHQELPFEHLLKALRRQRDSSQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVRRMVEHHQRVLEALVEGLEEGLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGSYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFNLGGHSLLASQLISRIRATFRVEVAMATVFESPTVEPLARHIEEKLKDESRVQLSNVVPVERTQELPLSYLQERLWFVHEHMKEQRTSYNGTIGLRLRGPLSIPALRATFHDLVARHESLRTVFRVPEGRTTPVQVILDSMDLDIPVRDATEADIIPGMDELAGHIYDMEKGPLFMVRLLRLAEDSHVLLMGMHHIVYDAWSQFNVMSRDINLLYSAHVTGIEARLPALPIQYADFSVWQRQQDFRHHLDYWKSTLGDYRDDLELPYDYPRPPSRTWHATRFTFRYPDALARAFARFNQSHQSTLFMGLLTSFAIVLRHYTGRNDICIGTTTAGRAQLELENLVGFFINILPLRINLAGDPDISELMNRAKKSVLGAFEHQALPFERLLSALNKQRDSSHIPLVPVMLRHQNFPTAMTGKWADGVDMEVIERDERTTPNELDLQFFGDDTYLHAVVEFPAQLFSEVTVRRLMQRHQKVIEFMCATLGAR", "perc_identity": 25.26}, "gnl|BL_ORD_ID|3399|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 27422, "orf_end": 41059, "orf_from": "BGC0001413.1|Cystobactamide_17 ", "model_name": "CMH-6", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "4468", "ARO_accession": "3006858", "ARO_name": "CMH-6", "ARO_category": {"42891": {"category_aro_accession": "3004776", "category_aro_cvterm_id": "42891", "category_aro_name": "CMH beta-lactamase", "category_aro_description": "CMH is a class C beta-lactamase gene family belonging to Enterobacter cloacae.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.39806, "max_identities": 24, "bit_score": 31.9574, "cvterm_id": "36884", "query": "VMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEE", "match": "+ VP+++  ++    +E   +     ML   A     +VK++ S ++A +A   +P++ ++  +ALAQ    WRV          GA+ +G G E", "sequence_from_db": "INVPHAEEPHYAWGYREGKAVHVSPGMLDAEAYGVKSNVKDMASWVMANMAPETLPQSTLQQGIALAQS-RYWRV----------GAMYQGLGWE", "sequence_from_broadstreet": "MMKKSLSCALLLSVACSAFAAPMSKKQLADVVERTVTPLMKAQAIPGMAVAVIYQGQPHYFTFGKADVAANKPVTPQTLFELGSVSKTFTGVLGGDAIARKEISLADPVTKYWPELTGKQWQSIRLLDLATYTAGGLPLQVPDDVTDNVSLLRFYQSWQPKWAPGTTRLYANTSIGLFGSLAVKPSGMRFEQAMAERVFKPLKLNHTWINVPHAEEPHYAWGYREGKAVHVSPGMLDAEAYGVKSNVKDMASWVMANMAPETLPQSTLQQGIALAQSRYWRVGAMYQGLGWEMLNWPVDAKTVVDGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLANKSYPNPVRVETAYRILETLQ", "dna_sequence_from_broadstreet": "ATGATGAAAAAATCCCTAAGCTGCGCGCTGCTGCTCAGCGTTGCCTGCTCTGCTTTTGCCGCGCCGATGTCAAAAAAACAGCTGGCTGACGTCGTGGAACGTACCGTTACGCCCCTGATGAAGGCGCAGGCCATACCCGGAATGGCCGTGGCCGTCATTTATCAGGGCCAGCCACACTATTTTACTTTCGGTAAAGCAGACGTCGCGGCGAATAAGCCCGTCACGCCGCAAACCTTATTTGAGCTGGGCTCCGTCAGCAAAACCTTCACCGGCGTGCTGGGTGGCGATGCCATTGCCCGCAAAGAGATTTCGCTGGCCGACCCGGTCACGAAATATTGGCCTGAATTGACGGGCAAGCAGTGGCAAAGCATTCGCCTGCTAGACCTGGCAACCTATACCGCAGGCGGATTGCCGTTGCAGGTACCGGATGATGTCACCGATAACGTCTCTCTGCTGCGTTTCTACCAGTCCTGGCAGCCAAAGTGGGCCCCGGGTACCACGCGTCTGTACGCCAACACCAGCATCGGTTTGTTTGGCTCACTGGCCGTCAAACCGTCCGGCATGCGCTTCGAGCAGGCCATGGCGGAGCGGGTCTTTAAGCCCCTGAAACTCAACCATACGTGGATAAACGTTCCACACGCTGAAGAGCCGCACTACGCATGGGGTTATCGTGAGGGAAAAGCGGTCCACGTTTCGCCTGGTATGCTGGATGCAGAAGCCTATGGCGTGAAATCTAACGTCAAAGATATGGCGAGCTGGGTGATGGCCAATATGGCACCTGAGACACTCCCGCAGTCCACTCTGCAGCAGGGTATTGCGCTGGCGCAGTCTCGCTACTGGCGCGTGGGTGCCATGTATCAAGGGTTAGGCTGGGAGATGCTCAACTGGCCGGTCGACGCCAAAACCGTGGTGGATGGCAGCGACAATAAGGTCGCACTGGCGCCGTTGCCGGTCGCAGAAGTGAATCCTCCGGCTCCGCCAGTAAAAGCCTCCTGGGTGCATAAAACGGGCTCTACGGGTGGGTTTGGCAGCTACGTGGCGTTTATTCCTGAAAAGCAGATCGGTATTGTGATGCTCGCAAATAAAAGCTATCCGAACCCGGTACGGGTGGAAACGGCTTACCGTATTCTCGAGACGCTACAGTAA", "partial": "0", "query_start": 31943, "query_end": 32227, "hit_start": 624, "hit_end": 876, "orf_dna_sequence": "ATGCTGCTGGAGGGAGAGCTGGAGGGGTACGAGGACGGGTTGGAACTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGCATAGCTACCCGCCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCGAGGACGTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGGGGCGTTGGGGGATCTGAGCGGGTCCACCGTCGACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGCGGTGGTGCTGGAGGGATTCGAGCACGAGGCGTTGCCGTGCCAGATTCCCTTGGTGCCGGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAAGAGGATGGTGGAGCACCACCAGCGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGTGCGGCTGCACGAGGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGAAGCTACATCGAGCAGATACTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGCTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGAGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGACCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCGGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGCTGCCGAACGGGAAGCTGGACCGGTTGTCGCTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAGCCTCGGCGGGCACTCCCTCCTGGCTGCCCAGCTGATTTCGCGCATACGGGCGACCTTCCGCGTGGAAGTGGCGATGGCCACGGTGTTCGAGTCCCCCACGGTGGAGCCGCTCGCCCGCCACATCGAGGAGAAGCTCAAGGACGAGTCTCGGGTCCAGCTCTCCAACGTTGTGCCGGTCGAGCGGACGCAGGAGATTCCGCTCTCCTACCTGCAGGAGCGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACATCACCTGGACGTTGCACTTCGCCGGCAAGGGTTTCTCGGTGGAGGCGTTGCGGACGGCCTTCGATGAGCTGGTGGCCAGACACGAGACACTGCGCACGTGGTTCCAGGTGGGGGAGGGGACAGAGCAGGCCGTACAGGTCATCGGGGAGCCCTGGTCGATGGAGCTGCCGCTGAGAGAGGTGGCGGGGACGGAGGTGACGGCGGCAATCAATGAGATGTCCCGACAGGTCTTCGACTTGAGAGCGGGACGGTTGCTGACGGCGGCGGTCCTGAGGGTGGCGGAGGATGAGCACATCCTCGTCAGCAACATCCACCACATCATCACGGACGGCTGGTCGTTCGGGGTGATGCTGCGGGAGCTGAGGGAGTTGTACGAGGCAGCGGTGCGGGGGAAGAGAGCGGAGCTGCCGCCGCTGACGGTGCAGTACGGCGACTATGCGGTGTGGCAGAGGAAGCAGGACCTGAGCGAGCACCTGGCGTACTGGAAGGGGAAGGTGGAGGAGTACGAGGACGGGTTGGAGCTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGTATAGCTACCCACCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCCAGGACGTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGAGCTGGAGAGCCTCATCGGGTTCTTCATCAACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGCGGTGGTGCTGGAGGGATTCGAGCACCAGGAGTTGCCGTTCGAGCACCTGCTGAAGGCGCTGAGGCGGCAGCGGGACAGCAGCCAGATTCCCTTGGTGCCAGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAGGAGGATGGTGGAGCACCACCAGCGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGGGCTGCACGAGGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGACACTACATCGAGCAGATATTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGTTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGGGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGGCCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCAGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGTTGCCGAACGGGAAGCTGGACCGGCTGTCGTTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAGCCTCGGCGGGCACTCCCTCCTGGCTGCCCAGGTGGTCTCAAGGATTGGCAAGGAGCTTGGCACTCAGATCTCGATCGCCGATCTGTTTCAAAGGCCCACGATTGAACAGCTCTGTGAGCTGATTGGAGGACTGGACGATCAGACCCAGAGGGAGCTCGCCCTCGCTCCGTCGGGGAACACCGAGGCGGTGCTCTCGTTCGCGCAAGAGCGCATGTGGTTCCTGCACAACTTCGTCAAGGGCATGCCCTACAACACGCCAGGGCTCGACCACCTGACGGGTGAGCTCGATGTCGCGGCGCTAGAAAAGGCCATCCGCGCGGTCATCCGTCGCCACGAGCCCCTGCGGACGAATTTCGTCGAGAAGGACGGGGTGCTGTCCCAGTTGGTGGGGACGGAAGAACGCTTCCGCCTGACCGTGACTCCCATCCGCGACGAGAGCGAGGTCGCGCGGCTCATGGAAGCCGTGATCCAAACGCCAGTCGATCTGGAGCGGGAGTTGATGATCCGGGCTTATCTCTACCGGGTCGACCCGCGGAATCACTACCTGTTCACCACCATCCATCACATCGCCTTCGATGGCTGGTCGACATCGATCTTCTACCGTGAGCTGGCTGCGTACTACGCCGCGTTTCTCCGGCGCGAAGACAGTCCGCTGCCCGCGCTGGAAATCTCCTATCAGGACTATGCCCGCTGGGAGCGGGCCCATTTCCAGGACGAGGTGTTGGCGGAAAAACTGAGGTACTGGCGGCAGCGGCTGTCGGGCGCTCGGCCCCTCGTACTTCCGACCACCTACCATCGGCCGCCCATCCAGAGTTTCGCTGGCGCCGTCGTGAACTTCGAGATCGATCGCTCCATCACCGAGCGGTTGAAGACGCTGTTCGCCGAGTCGGGCACCACGATGTACATGGTGTTGCTCGGCGCGTTCTCCGTGGTGCTGCAGCGCTACTCCGGTCAGGACGACATCTGCATCGGCTCCCCCGTGGCGAACCGGGGTCACATCCAGACAGAAGGGCTGATCGGCTTGTTCGTCAACACCCTGGTGATGAGGGTGGATGCCGCCGGGAATCCCCGTTTCATCGACCTGCTGGCGCGCATTCAACGGACAGCCATCGATGCTTACGCGAACCAAGAAGTGCCCTTCGAGAAGATCGTGGACGACCTGCAGGTCGCGAGAGACACGGCCCGATCTCCGCTCGTGCAGGTCATTCTCAACTTCCACAACACGCCTCCTCAATCCGAGCTGGAACTGCAGGGGGTGACCCTCACGCGGATGCCGGTGCACAACGGCACGGCCAAGTTCGAGCTCTCCATCGACGTCGCGGAGACGAGCGCCGGTCTAACGGGATTCGTGGAGTACGCGACGGATCTGTTCAGCGAGAACTTCATCCGGCGGATGATCGGCCACCTCGAGGTGGTGCTGGACGCGGTCGGTCGCGATCCGCGGGCGCCTATCCATGAGTTGCCACTGCTCACCCGGCAGGATCAGTTGGACCTACTGTCGCGGAGCGGCCACACAGCCCCCGCGGTGGAACACGTCGAGTTGATCCCTCATACGTTCGAGCGGCGCGTCCAGGAGAGCCCTCAAGCGATTGCCCTGGTCTGCGGTGACGAGCGCGTCACCTACTCCGCGCTCAACCGCCGGGCCAGCCAGATTGCCCGCCGCCTGCGCGCCGCAGGGATCGGACCGGACACCCTCGTCGGGCTTTGCGCGGGGCGCTCCATCGAGCTGGTCTGCGGCGTCCTTGGCATCTTGAAGGCGGGCGGTGCGTACGTGCCAATCGACCCCACCTCCTCGCCCGAGGTGATCTACGACGTCCTGTATGAGTCGAAGGTGCGGCATCTGTTGACCGAGTCGCGCCTGGTCGGGGGACTGCCGGTCGATGACCAGGAAATCCTGCTCCTGGATACCCCCGCGGACGGTGAAGGGGACAAGGCTGTTGCTGACCGGGAGGAGCCACCTGACCTTGGCGAGGTCAGCCTCACTCCCGAGTGCTTGGCGTACGTCAACTTCACCTCCGACTCCGGTGGGGCGCCGAGGGGCATCGCCGTCCGCCATGGGGCGCTGGCTCGCCGGATGGCCGCCGGCCACGCACAGTACCTGGCCAATTCCGCCGTACGTTTCCTGCTGAAGGCGCCGCTCACGTTCGACCTGGCGGTCGCGGAGCTGTTCCAGTGGATCGTCAGCGGCGGCAGCCTGAGCATCCTCGACCCCAATGCCGACCGCGACGCCTCTGCCTTCCTCGCGCAGGTGCGCAGGGACTCGATTGGCGTCCTCTACTGCGTCCCCTCCGAACTCTCGACGCTGGTGAGCCACCTGGAGCGCGAGCGTGAAAGGGTGCATGAGCTGAACACCCTCCGGTTCATCTTCTGCGGCGGGGATACCCTGGCGGTTACCGTCGTCGAGCGTCTCGGGGTACTGGTGCGGGCCGGCCAGCTCCCGCTGCGGCTGGTCAACGTCTATGGGACGAAGGAGACGGGAATCGGCGCGGGTTGCTTCGAGTGCGCGCTGGACGCGAACGACCCCAGCGCCGAACTCCCGCCGGGACGGCTCTCGCATGAGCGGATGCCCATCGGCGGGCCCGCCCAGAACCTGTGGTTCTATGTGGTGCAACCCAACGGTGGCCTGGCTCCGTTGGGCATCCCGGGGGAACTGTACGTCGGCGGCGCGCAACTCGCCGACGCCCGTTTCGGCGACGAGCCCACGGCGACCCACCCCGGCTTCGTCCCGAACCCCTTCCGGAGCGGAGCGGAGAAGGACTGGCTGTACAAGACGGGGGACCTCGTCCGCTGGCTGCCTCAGGGGCCGCTCGAGCTGGTCAGCGCGGCTCGGGAGCGCGACGGAGGCGGGGACCACCGGCTCGATCGCGGCTTCATCGAGGCGCGCATGCGTCGTGTGGCCATTGTCCGCGACGCCGTGGTGGCCTACGTCCCGGATCGCCAGGACAGGGCCCGGTTGGTGGCCTACGTCGTTCTGAAGGAGTCGCCCGCGGCGGACGTGGAGCCGCGCGAAGGGCGGGAAACGCTGAAGGCTCGGATCAGCGCCGAACTTGGGAGCACGTTGCCGGAGTACATGCTTCCGGCCGCCTACGTGTTCATGGACAGCCTGCCGTTGACGGCTTACGGGAGGATCGACCGGAAAGCCCTGCCCGAGCCGGAGGATGACCGCCACGGTGGTAGTGCGATCGCCTACGTGGCCCCGCGCGGGCCCACGGAGAAGGCACTGGCGCACATTTGGCAGCAAGTGCTGAAACGCCCCCAGGTCGGACTGCGAGACAACTTCTTTGAGCTGGGCGGGCACTCAGTGGCGGCCATCCAACTGGTGTCCGTGAGCCGGAAGCACCTGGAGGTCGAAGTCCCCCTCAGCCTGATCTTCGAATCGCCGGTCCTGGAGGCGATGGCGCGCGGCATCGAAGCGCTGCAACAGCAGGGCCGCAGCGGCGCGGTGTCGTCGATCCATCGGGTGGAGCGGACCGGACCGCTGCCTCTGGCGTACGTGCAGGAGAGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACATCACCTGGACGTTGCACTTCGCCGGCAAGGGTTTCTCGGTGGAGGCGTTGCGGACGGCCTTCGATGAGCTGGTGGCCAGACACGAGACACTGCGCACGTGGTTCCAGGTGGGGGAGGGGACAGAGCAGGCCGTACAGGTCATCGGGGAGCCCTGGTCGATGGAGCTGCCGCTGAGAGAGGTGGCGGGGACGGAGGTGACGGCGGCAATCAATGAGATGTCCCGGCAGGTCTTCGACTTGAGAGCGGGACGGTTGCTGACGGCGGCGGTCCTGAGGGTGGCGGAGGATGAGCACATCCTCGTCAGCAACATCCACCACATCATCACGGACGGCTGGTCGTTCGGGGTGATGCTGCGGGAGCTGAGGGAGTTGTACGAGGCCGCGGTGCGGGGGGAGCGAGCGGAGCTGCCGCCGCTGACGGTGCAGTACGGCGACTATGCGGTATGGCAGAGGAAGCAGGACCTGAGCGAGCACCTGGCGTACTGGAAGGGGAAGGTGGAGGGGGACGAGGACGGGTTGGAGCTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGTATAGCTACCACCCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCGAGGACCTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGAACTGGAGAGCCTCATCGGGTTCTTCATCAACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGTGGTGGTGCTGGAGGGATTCGAGCACCAGGAGTTGCCGTTCGAGCACCTGCTGAAGGCGCTGAGGCGGCAGCGGGACAGCAGCCAGATTCCCTTGGTGCCAGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAGGAGGATGGTGGAGCACCACCAACGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGGGCTGCACGAAGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGAAGCTACATCGAGCAGATACTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGCTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGAGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGACCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCAGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGTTGCCGAACGGGAAGCTGGACCGGCTGTCGTTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAACCTCGGCGGGCACTCCCTCCTGGCTTCCCAGCTGATTTCGCGCATACGGGCGACCTTCCGCGTGGAAGTGGCGATGGCCACGGTGTTCGAGTCCCCCACGGTGGAGCCGCTCGCCCGCCACATCGAGGAGAAGCTCAAGGACGAGTCTCGGGTCCAGCTCTCCAACGTTGTGCCGGTCGAGCGGACGCAGGAGCTTCCGCTCTCCTACCTGCAGGAGAGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACGGAACGATCGGGCTCCGGCTTCGGGGTCCTCTGTCAATCCCCGCGCTCAGGGCCACCTTCCACGATCTGGTCGCCCGTCACGAGAGCCTGCGCACCGTCTTCCGGGTCCCCGAAGGCCGCACCACGCCGGTGCAGGTGATTCTTGATTCGATGGATCTGGACATCCCGGTCCGCGATGCAACCGAGGCCGACATCATCCCGGGCATGGATGAGCTGGCGGGTCACATCTACGACATGGAGAAGGGTCCGCTGTTCATGGTTCGCCTCTTGCGGCTGGCCGAGGACTCCCACGTTCTCCTGATGGGGATGCATCACATCGTCTACGACGCATGGTCACAGTTCAATGTGATGAGTCGCGATATCAACCTGCTCTACTCGGCGCACGTGACGGGAATCGAGGCACGGCTTCCCGCGCTTCCCATCCAGTACGCCGACTTCTCGGTGTGGCAGCGCCAGCAGGACTTCCGTCACCACCTGGACTACTGGAAGTCCACACTGGGCGACTACCGGGATGATCTCGAGCTGCCGTATGACTACCCGCGGCCGCCCAGCCGGACATGGCACGCGACCCGATTCACCTTCCGGTATCCGGATGCACTGGCGCGCGCGTTCGCCAGGTTCAATCAGTCCCATCAGTCGACGCTGTTCATGGGGCTGCTGACCAGCTTCGCGATCGTGCTCAGGCACTACACCGGCCGGAACGACATCTGCATCGGAACGACAACGGCGGGGCGCGCCCAGTTGGAGTTGGAGAACCTCGTTGGCTTCTTCATCAACATCCTGCCGTTGCGCATCAATCTGGCGGGTGACCCCGACATCAGCGAGCTCATGAATCGAGCGAAGAAGAGCGTCTTGGGCGCCTTCGAGCATCAAGCTCTGCCGTTCGAGCGTCTCCTCAGTGCCCTCAACAAACAGCGTGACAGCAGCCATATCCCGCTGGTTCCCGTCATGTTGCGCCACCAGAACTTCCCGACGGCGATGACCGGCAAGTGGGCCGATGGTGTGGACATGGAGGTCATCGAGCGCGACGAGCGCACGACGCCCAACGAGCTGGACCTCCAGTTCTTTGGCGACGACACCTACTTGCATGCTGTCGTCGAGTTCCCCGCGCAGCTCTTCTCCGAGGTGACCGTCCGGCGTCTGATGCAGCGTCACCAGAAGGTCATAGAGTTCATGTGCGCGACGCTGGGGGCTCGGTGA", "orf_prot_sequence": "MLLEGELEGYEDGLELPYDFPRTSNRAWRAATFQHSYPPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGREDVCIGTTVAGRAQVGALGDLSGSTVDILPLRLDLSGAPSLHEVLRRTKAVVLEGFEHEALPCQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVKRMVEHHQRVLEALVEGLEEVRLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGSYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFSLGGHSLLAAQLISRIRATFRVEVAMATVFESPTVEPLARHIEEKLKDESRVQLSNVVPVERTQEIPLSYLQERLWFVHEHMKEQRTSYNITWTLHFAGKGFSVEALRTAFDELVARHETLRTWFQVGEGTEQAVQVIGEPWSMELPLREVAGTEVTAAINEMSRQVFDLRAGRLLTAAVLRVAEDEHILVSNIHHIITDGWSFGVMLRELRELYEAAVRGKRAELPPLTVQYGDYAVWQRKQDLSEHLAYWKGKVEEYEDGLELPYDFPRTSNRAWRAATFQYSYPPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGRQDVCIGTTVAGRAQVELESLIGFFINILPLRLDLSGAPSLHEVLRRTKAVVLEGFEHQELPFEHLLKALRRQRDSSQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVRRMVEHHQRVLEALVEGLEEGLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGHYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFSLGGHSLLAAQVVSRIGKELGTQISIADLFQRPTIEQLCELIGGLDDQTQRELALAPSGNTEAVLSFAQERMWFLHNFVKGMPYNTPGLDHLTGELDVAALEKAIRAVIRRHEPLRTNFVEKDGVLSQLVGTEERFRLTVTPIRDESEVARLMEAVIQTPVDLERELMIRAYLYRVDPRNHYLFTTIHHIAFDGWSTSIFYRELAAYYAAFLRREDSPLPALEISYQDYARWERAHFQDEVLAEKLRYWRQRLSGARPLVLPTTYHRPPIQSFAGAVVNFEIDRSITERLKTLFAESGTTMYMVLLGAFSVVLQRYSGQDDICIGSPVANRGHIQTEGLIGLFVNTLVMRVDAAGNPRFIDLLARIQRTAIDAYANQEVPFEKIVDDLQVARDTARSPLVQVILNFHNTPPQSELELQGVTLTRMPVHNGTAKFELSIDVAETSAGLTGFVEYATDLFSENFIRRMIGHLEVVLDAVGRDPRAPIHELPLLTRQDQLDLLSRSGHTAPAVEHVELIPHTFERRVQESPQAIALVCGDERVTYSALNRRASQIARRLRAAGIGPDTLVGLCAGRSIELVCGVLGILKAGGAYVPIDPTSSPEVIYDVLYESKVRHLLTESRLVGGLPVDDQEILLLDTPADGEGDKAVADREEPPDLGEVSLTPECLAYVNFTSDSGGAPRGIAVRHGALARRMAAGHAQYLANSAVRFLLKAPLTFDLAVAELFQWIVSGGSLSILDPNADRDASAFLAQVRRDSIGVLYCVPSELSTLVSHLERERERVHELNTLRFIFCGGDTLAVTVVERLGVLVRAGQLPLRLVNVYGTKETGIGAGCFECALDANDPSAELPPGRLSHERMPIGGPAQNLWFYVVQPNGGLAPLGIPGELYVGGAQLADARFGDEPTATHPGFVPNPFRSGAEKDWLYKTGDLVRWLPQGPLELVSAARERDGGGDHRLDRGFIEARMRRVAIVRDAVVAYVPDRQDRARLVAYVVLKESPAADVEPREGRETLKARISAELGSTLPEYMLPAAYVFMDSLPLTAYGRIDRKALPEPEDDRHGGSAIAYVAPRGPTEKALAHIWQQVLKRPQVGLRDNFFELGGHSVAAIQLVSVSRKHLEVEVPLSLIFESPVLEAMARGIEALQQQGRSGAVSSIHRVERTGPLPLAYVQERLWFVHEHMKEQRTSYNITWTLHFAGKGFSVEALRTAFDELVARHETLRTWFQVGEGTEQAVQVIGEPWSMELPLREVAGTEVTAAINEMSRQVFDLRAGRLLTAAVLRVAEDEHILVSNIHHIITDGWSFGVMLRELRELYEAAVRGERAELPPLTVQYGDYAVWQRKQDLSEHLAYWKGKVEGDEDGLELPYDFPRTSNRAWRAATFQYSYHPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGREDLCIGTTVAGRAQVELESLIGFFINILPLRLDLSGAPSLHEVLRRTKVVVLEGFEHQELPFEHLLKALRRQRDSSQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVRRMVEHHQRVLEALVEGLEEGLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGSYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFNLGGHSLLASQLISRIRATFRVEVAMATVFESPTVEPLARHIEEKLKDESRVQLSNVVPVERTQELPLSYLQERLWFVHEHMKEQRTSYNGTIGLRLRGPLSIPALRATFHDLVARHESLRTVFRVPEGRTTPVQVILDSMDLDIPVRDATEADIIPGMDELAGHIYDMEKGPLFMVRLLRLAEDSHVLLMGMHHIVYDAWSQFNVMSRDINLLYSAHVTGIEARLPALPIQYADFSVWQRQQDFRHHLDYWKSTLGDYRDDLELPYDYPRPPSRTWHATRFTFRYPDALARAFARFNQSHQSTLFMGLLTSFAIVLRHYTGRNDICIGTTTAGRAQLELENLVGFFINILPLRINLAGDPDISELMNRAKKSVLGAFEHQALPFERLLSALNKQRDSSHIPLVPVMLRHQNFPTAMTGKWADGVDMEVIERDERTTPNELDLQFFGDDTYLHAVVEFPAQLFSEVTVRRLMQRHQKVIEFMCATLGAR", "perc_identity": 25.26}, "gnl|BL_ORD_ID|3399|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 27422, "orf_end": 41059, "orf_from": "BGC0001413.1|Cystobactamide_17 ", "model_name": "CMH-6", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "4468", "ARO_accession": "3006858", "ARO_name": "CMH-6", "ARO_category": {"42891": {"category_aro_accession": "3004776", "category_aro_cvterm_id": "42891", "category_aro_name": "CMH beta-lactamase", "category_aro_description": "CMH is a class C beta-lactamase gene family belonging to Enterobacter cloacae.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.39806, "max_identities": 24, "bit_score": 31.9574, "cvterm_id": "36884", "query": "VMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEE", "match": "+ VP+++  ++    +E   +     ML   A     +VK++ S ++A +A   +P++ ++  +ALAQ    WRV          GA+ +G G E", "sequence_from_db": "INVPHAEEPHYAWGYREGKAVHVSPGMLDAEAYGVKSNVKDMASWVMANMAPETLPQSTLQQGIALAQS-RYWRV----------GAMYQGLGWE", "sequence_from_broadstreet": "MMKKSLSCALLLSVACSAFAAPMSKKQLADVVERTVTPLMKAQAIPGMAVAVIYQGQPHYFTFGKADVAANKPVTPQTLFELGSVSKTFTGVLGGDAIARKEISLADPVTKYWPELTGKQWQSIRLLDLATYTAGGLPLQVPDDVTDNVSLLRFYQSWQPKWAPGTTRLYANTSIGLFGSLAVKPSGMRFEQAMAERVFKPLKLNHTWINVPHAEEPHYAWGYREGKAVHVSPGMLDAEAYGVKSNVKDMASWVMANMAPETLPQSTLQQGIALAQSRYWRVGAMYQGLGWEMLNWPVDAKTVVDGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLANKSYPNPVRVETAYRILETLQ", "dna_sequence_from_broadstreet": "ATGATGAAAAAATCCCTAAGCTGCGCGCTGCTGCTCAGCGTTGCCTGCTCTGCTTTTGCCGCGCCGATGTCAAAAAAACAGCTGGCTGACGTCGTGGAACGTACCGTTACGCCCCTGATGAAGGCGCAGGCCATACCCGGAATGGCCGTGGCCGTCATTTATCAGGGCCAGCCACACTATTTTACTTTCGGTAAAGCAGACGTCGCGGCGAATAAGCCCGTCACGCCGCAAACCTTATTTGAGCTGGGCTCCGTCAGCAAAACCTTCACCGGCGTGCTGGGTGGCGATGCCATTGCCCGCAAAGAGATTTCGCTGGCCGACCCGGTCACGAAATATTGGCCTGAATTGACGGGCAAGCAGTGGCAAAGCATTCGCCTGCTAGACCTGGCAACCTATACCGCAGGCGGATTGCCGTTGCAGGTACCGGATGATGTCACCGATAACGTCTCTCTGCTGCGTTTCTACCAGTCCTGGCAGCCAAAGTGGGCCCCGGGTACCACGCGTCTGTACGCCAACACCAGCATCGGTTTGTTTGGCTCACTGGCCGTCAAACCGTCCGGCATGCGCTTCGAGCAGGCCATGGCGGAGCGGGTCTTTAAGCCCCTGAAACTCAACCATACGTGGATAAACGTTCCACACGCTGAAGAGCCGCACTACGCATGGGGTTATCGTGAGGGAAAAGCGGTCCACGTTTCGCCTGGTATGCTGGATGCAGAAGCCTATGGCGTGAAATCTAACGTCAAAGATATGGCGAGCTGGGTGATGGCCAATATGGCACCTGAGACACTCCCGCAGTCCACTCTGCAGCAGGGTATTGCGCTGGCGCAGTCTCGCTACTGGCGCGTGGGTGCCATGTATCAAGGGTTAGGCTGGGAGATGCTCAACTGGCCGGTCGACGCCAAAACCGTGGTGGATGGCAGCGACAATAAGGTCGCACTGGCGCCGTTGCCGGTCGCAGAAGTGAATCCTCCGGCTCCGCCAGTAAAAGCCTCCTGGGTGCATAAAACGGGCTCTACGGGTGGGTTTGGCAGCTACGTGGCGTTTATTCCTGAAAAGCAGATCGGTATTGTGATGCTCGCAAATAAAAGCTATCCGAACCCGGTACGGGTGGAAACGGCTTACCGTATTCTCGAGACGCTACAGTAA", "partial": "0", "query_start": 38450, "query_end": 38734, "hit_start": 624, "hit_end": 876, "orf_dna_sequence": "ATGCTGCTGGAGGGAGAGCTGGAGGGGTACGAGGACGGGTTGGAACTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGCATAGCTACCCGCCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCGAGGACGTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGGGGCGTTGGGGGATCTGAGCGGGTCCACCGTCGACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGCGGTGGTGCTGGAGGGATTCGAGCACGAGGCGTTGCCGTGCCAGATTCCCTTGGTGCCGGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAAGAGGATGGTGGAGCACCACCAGCGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGTGCGGCTGCACGAGGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGAAGCTACATCGAGCAGATACTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGCTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGAGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGACCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCGGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGCTGCCGAACGGGAAGCTGGACCGGTTGTCGCTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAGCCTCGGCGGGCACTCCCTCCTGGCTGCCCAGCTGATTTCGCGCATACGGGCGACCTTCCGCGTGGAAGTGGCGATGGCCACGGTGTTCGAGTCCCCCACGGTGGAGCCGCTCGCCCGCCACATCGAGGAGAAGCTCAAGGACGAGTCTCGGGTCCAGCTCTCCAACGTTGTGCCGGTCGAGCGGACGCAGGAGATTCCGCTCTCCTACCTGCAGGAGCGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACATCACCTGGACGTTGCACTTCGCCGGCAAGGGTTTCTCGGTGGAGGCGTTGCGGACGGCCTTCGATGAGCTGGTGGCCAGACACGAGACACTGCGCACGTGGTTCCAGGTGGGGGAGGGGACAGAGCAGGCCGTACAGGTCATCGGGGAGCCCTGGTCGATGGAGCTGCCGCTGAGAGAGGTGGCGGGGACGGAGGTGACGGCGGCAATCAATGAGATGTCCCGACAGGTCTTCGACTTGAGAGCGGGACGGTTGCTGACGGCGGCGGTCCTGAGGGTGGCGGAGGATGAGCACATCCTCGTCAGCAACATCCACCACATCATCACGGACGGCTGGTCGTTCGGGGTGATGCTGCGGGAGCTGAGGGAGTTGTACGAGGCAGCGGTGCGGGGGAAGAGAGCGGAGCTGCCGCCGCTGACGGTGCAGTACGGCGACTATGCGGTGTGGCAGAGGAAGCAGGACCTGAGCGAGCACCTGGCGTACTGGAAGGGGAAGGTGGAGGAGTACGAGGACGGGTTGGAGCTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGTATAGCTACCCACCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCCAGGACGTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGAGCTGGAGAGCCTCATCGGGTTCTTCATCAACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGCGGTGGTGCTGGAGGGATTCGAGCACCAGGAGTTGCCGTTCGAGCACCTGCTGAAGGCGCTGAGGCGGCAGCGGGACAGCAGCCAGATTCCCTTGGTGCCAGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAGGAGGATGGTGGAGCACCACCAGCGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGGGCTGCACGAGGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGACACTACATCGAGCAGATATTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGTTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGGGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGGCCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCAGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGTTGCCGAACGGGAAGCTGGACCGGCTGTCGTTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAGCCTCGGCGGGCACTCCCTCCTGGCTGCCCAGGTGGTCTCAAGGATTGGCAAGGAGCTTGGCACTCAGATCTCGATCGCCGATCTGTTTCAAAGGCCCACGATTGAACAGCTCTGTGAGCTGATTGGAGGACTGGACGATCAGACCCAGAGGGAGCTCGCCCTCGCTCCGTCGGGGAACACCGAGGCGGTGCTCTCGTTCGCGCAAGAGCGCATGTGGTTCCTGCACAACTTCGTCAAGGGCATGCCCTACAACACGCCAGGGCTCGACCACCTGACGGGTGAGCTCGATGTCGCGGCGCTAGAAAAGGCCATCCGCGCGGTCATCCGTCGCCACGAGCCCCTGCGGACGAATTTCGTCGAGAAGGACGGGGTGCTGTCCCAGTTGGTGGGGACGGAAGAACGCTTCCGCCTGACCGTGACTCCCATCCGCGACGAGAGCGAGGTCGCGCGGCTCATGGAAGCCGTGATCCAAACGCCAGTCGATCTGGAGCGGGAGTTGATGATCCGGGCTTATCTCTACCGGGTCGACCCGCGGAATCACTACCTGTTCACCACCATCCATCACATCGCCTTCGATGGCTGGTCGACATCGATCTTCTACCGTGAGCTGGCTGCGTACTACGCCGCGTTTCTCCGGCGCGAAGACAGTCCGCTGCCCGCGCTGGAAATCTCCTATCAGGACTATGCCCGCTGGGAGCGGGCCCATTTCCAGGACGAGGTGTTGGCGGAAAAACTGAGGTACTGGCGGCAGCGGCTGTCGGGCGCTCGGCCCCTCGTACTTCCGACCACCTACCATCGGCCGCCCATCCAGAGTTTCGCTGGCGCCGTCGTGAACTTCGAGATCGATCGCTCCATCACCGAGCGGTTGAAGACGCTGTTCGCCGAGTCGGGCACCACGATGTACATGGTGTTGCTCGGCGCGTTCTCCGTGGTGCTGCAGCGCTACTCCGGTCAGGACGACATCTGCATCGGCTCCCCCGTGGCGAACCGGGGTCACATCCAGACAGAAGGGCTGATCGGCTTGTTCGTCAACACCCTGGTGATGAGGGTGGATGCCGCCGGGAATCCCCGTTTCATCGACCTGCTGGCGCGCATTCAACGGACAGCCATCGATGCTTACGCGAACCAAGAAGTGCCCTTCGAGAAGATCGTGGACGACCTGCAGGTCGCGAGAGACACGGCCCGATCTCCGCTCGTGCAGGTCATTCTCAACTTCCACAACACGCCTCCTCAATCCGAGCTGGAACTGCAGGGGGTGACCCTCACGCGGATGCCGGTGCACAACGGCACGGCCAAGTTCGAGCTCTCCATCGACGTCGCGGAGACGAGCGCCGGTCTAACGGGATTCGTGGAGTACGCGACGGATCTGTTCAGCGAGAACTTCATCCGGCGGATGATCGGCCACCTCGAGGTGGTGCTGGACGCGGTCGGTCGCGATCCGCGGGCGCCTATCCATGAGTTGCCACTGCTCACCCGGCAGGATCAGTTGGACCTACTGTCGCGGAGCGGCCACACAGCCCCCGCGGTGGAACACGTCGAGTTGATCCCTCATACGTTCGAGCGGCGCGTCCAGGAGAGCCCTCAAGCGATTGCCCTGGTCTGCGGTGACGAGCGCGTCACCTACTCCGCGCTCAACCGCCGGGCCAGCCAGATTGCCCGCCGCCTGCGCGCCGCAGGGATCGGACCGGACACCCTCGTCGGGCTTTGCGCGGGGCGCTCCATCGAGCTGGTCTGCGGCGTCCTTGGCATCTTGAAGGCGGGCGGTGCGTACGTGCCAATCGACCCCACCTCCTCGCCCGAGGTGATCTACGACGTCCTGTATGAGTCGAAGGTGCGGCATCTGTTGACCGAGTCGCGCCTGGTCGGGGGACTGCCGGTCGATGACCAGGAAATCCTGCTCCTGGATACCCCCGCGGACGGTGAAGGGGACAAGGCTGTTGCTGACCGGGAGGAGCCACCTGACCTTGGCGAGGTCAGCCTCACTCCCGAGTGCTTGGCGTACGTCAACTTCACCTCCGACTCCGGTGGGGCGCCGAGGGGCATCGCCGTCCGCCATGGGGCGCTGGCTCGCCGGATGGCCGCCGGCCACGCACAGTACCTGGCCAATTCCGCCGTACGTTTCCTGCTGAAGGCGCCGCTCACGTTCGACCTGGCGGTCGCGGAGCTGTTCCAGTGGATCGTCAGCGGCGGCAGCCTGAGCATCCTCGACCCCAATGCCGACCGCGACGCCTCTGCCTTCCTCGCGCAGGTGCGCAGGGACTCGATTGGCGTCCTCTACTGCGTCCCCTCCGAACTCTCGACGCTGGTGAGCCACCTGGAGCGCGAGCGTGAAAGGGTGCATGAGCTGAACACCCTCCGGTTCATCTTCTGCGGCGGGGATACCCTGGCGGTTACCGTCGTCGAGCGTCTCGGGGTACTGGTGCGGGCCGGCCAGCTCCCGCTGCGGCTGGTCAACGTCTATGGGACGAAGGAGACGGGAATCGGCGCGGGTTGCTTCGAGTGCGCGCTGGACGCGAACGACCCCAGCGCCGAACTCCCGCCGGGACGGCTCTCGCATGAGCGGATGCCCATCGGCGGGCCCGCCCAGAACCTGTGGTTCTATGTGGTGCAACCCAACGGTGGCCTGGCTCCGTTGGGCATCCCGGGGGAACTGTACGTCGGCGGCGCGCAACTCGCCGACGCCCGTTTCGGCGACGAGCCCACGGCGACCCACCCCGGCTTCGTCCCGAACCCCTTCCGGAGCGGAGCGGAGAAGGACTGGCTGTACAAGACGGGGGACCTCGTCCGCTGGCTGCCTCAGGGGCCGCTCGAGCTGGTCAGCGCGGCTCGGGAGCGCGACGGAGGCGGGGACCACCGGCTCGATCGCGGCTTCATCGAGGCGCGCATGCGTCGTGTGGCCATTGTCCGCGACGCCGTGGTGGCCTACGTCCCGGATCGCCAGGACAGGGCCCGGTTGGTGGCCTACGTCGTTCTGAAGGAGTCGCCCGCGGCGGACGTGGAGCCGCGCGAAGGGCGGGAAACGCTGAAGGCTCGGATCAGCGCCGAACTTGGGAGCACGTTGCCGGAGTACATGCTTCCGGCCGCCTACGTGTTCATGGACAGCCTGCCGTTGACGGCTTACGGGAGGATCGACCGGAAAGCCCTGCCCGAGCCGGAGGATGACCGCCACGGTGGTAGTGCGATCGCCTACGTGGCCCCGCGCGGGCCCACGGAGAAGGCACTGGCGCACATTTGGCAGCAAGTGCTGAAACGCCCCCAGGTCGGACTGCGAGACAACTTCTTTGAGCTGGGCGGGCACTCAGTGGCGGCCATCCAACTGGTGTCCGTGAGCCGGAAGCACCTGGAGGTCGAAGTCCCCCTCAGCCTGATCTTCGAATCGCCGGTCCTGGAGGCGATGGCGCGCGGCATCGAAGCGCTGCAACAGCAGGGCCGCAGCGGCGCGGTGTCGTCGATCCATCGGGTGGAGCGGACCGGACCGCTGCCTCTGGCGTACGTGCAGGAGAGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACATCACCTGGACGTTGCACTTCGCCGGCAAGGGTTTCTCGGTGGAGGCGTTGCGGACGGCCTTCGATGAGCTGGTGGCCAGACACGAGACACTGCGCACGTGGTTCCAGGTGGGGGAGGGGACAGAGCAGGCCGTACAGGTCATCGGGGAGCCCTGGTCGATGGAGCTGCCGCTGAGAGAGGTGGCGGGGACGGAGGTGACGGCGGCAATCAATGAGATGTCCCGGCAGGTCTTCGACTTGAGAGCGGGACGGTTGCTGACGGCGGCGGTCCTGAGGGTGGCGGAGGATGAGCACATCCTCGTCAGCAACATCCACCACATCATCACGGACGGCTGGTCGTTCGGGGTGATGCTGCGGGAGCTGAGGGAGTTGTACGAGGCCGCGGTGCGGGGGGAGCGAGCGGAGCTGCCGCCGCTGACGGTGCAGTACGGCGACTATGCGGTATGGCAGAGGAAGCAGGACCTGAGCGAGCACCTGGCGTACTGGAAGGGGAAGGTGGAGGGGGACGAGGACGGGTTGGAGCTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGTATAGCTACCACCCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCGAGGACCTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGAACTGGAGAGCCTCATCGGGTTCTTCATCAACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGTGGTGGTGCTGGAGGGATTCGAGCACCAGGAGTTGCCGTTCGAGCACCTGCTGAAGGCGCTGAGGCGGCAGCGGGACAGCAGCCAGATTCCCTTGGTGCCAGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAGGAGGATGGTGGAGCACCACCAACGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGGGCTGCACGAAGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGAAGCTACATCGAGCAGATACTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGCTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGAGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGACCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCAGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGTTGCCGAACGGGAAGCTGGACCGGCTGTCGTTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAACCTCGGCGGGCACTCCCTCCTGGCTTCCCAGCTGATTTCGCGCATACGGGCGACCTTCCGCGTGGAAGTGGCGATGGCCACGGTGTTCGAGTCCCCCACGGTGGAGCCGCTCGCCCGCCACATCGAGGAGAAGCTCAAGGACGAGTCTCGGGTCCAGCTCTCCAACGTTGTGCCGGTCGAGCGGACGCAGGAGCTTCCGCTCTCCTACCTGCAGGAGAGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACGGAACGATCGGGCTCCGGCTTCGGGGTCCTCTGTCAATCCCCGCGCTCAGGGCCACCTTCCACGATCTGGTCGCCCGTCACGAGAGCCTGCGCACCGTCTTCCGGGTCCCCGAAGGCCGCACCACGCCGGTGCAGGTGATTCTTGATTCGATGGATCTGGACATCCCGGTCCGCGATGCAACCGAGGCCGACATCATCCCGGGCATGGATGAGCTGGCGGGTCACATCTACGACATGGAGAAGGGTCCGCTGTTCATGGTTCGCCTCTTGCGGCTGGCCGAGGACTCCCACGTTCTCCTGATGGGGATGCATCACATCGTCTACGACGCATGGTCACAGTTCAATGTGATGAGTCGCGATATCAACCTGCTCTACTCGGCGCACGTGACGGGAATCGAGGCACGGCTTCCCGCGCTTCCCATCCAGTACGCCGACTTCTCGGTGTGGCAGCGCCAGCAGGACTTCCGTCACCACCTGGACTACTGGAAGTCCACACTGGGCGACTACCGGGATGATCTCGAGCTGCCGTATGACTACCCGCGGCCGCCCAGCCGGACATGGCACGCGACCCGATTCACCTTCCGGTATCCGGATGCACTGGCGCGCGCGTTCGCCAGGTTCAATCAGTCCCATCAGTCGACGCTGTTCATGGGGCTGCTGACCAGCTTCGCGATCGTGCTCAGGCACTACACCGGCCGGAACGACATCTGCATCGGAACGACAACGGCGGGGCGCGCCCAGTTGGAGTTGGAGAACCTCGTTGGCTTCTTCATCAACATCCTGCCGTTGCGCATCAATCTGGCGGGTGACCCCGACATCAGCGAGCTCATGAATCGAGCGAAGAAGAGCGTCTTGGGCGCCTTCGAGCATCAAGCTCTGCCGTTCGAGCGTCTCCTCAGTGCCCTCAACAAACAGCGTGACAGCAGCCATATCCCGCTGGTTCCCGTCATGTTGCGCCACCAGAACTTCCCGACGGCGATGACCGGCAAGTGGGCCGATGGTGTGGACATGGAGGTCATCGAGCGCGACGAGCGCACGACGCCCAACGAGCTGGACCTCCAGTTCTTTGGCGACGACACCTACTTGCATGCTGTCGTCGAGTTCCCCGCGCAGCTCTTCTCCGAGGTGACCGTCCGGCGTCTGATGCAGCGTCACCAGAAGGTCATAGAGTTCATGTGCGCGACGCTGGGGGCTCGGTGA", "orf_prot_sequence": "MLLEGELEGYEDGLELPYDFPRTSNRAWRAATFQHSYPPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGREDVCIGTTVAGRAQVGALGDLSGSTVDILPLRLDLSGAPSLHEVLRRTKAVVLEGFEHEALPCQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVKRMVEHHQRVLEALVEGLEEVRLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGSYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFSLGGHSLLAAQLISRIRATFRVEVAMATVFESPTVEPLARHIEEKLKDESRVQLSNVVPVERTQEIPLSYLQERLWFVHEHMKEQRTSYNITWTLHFAGKGFSVEALRTAFDELVARHETLRTWFQVGEGTEQAVQVIGEPWSMELPLREVAGTEVTAAINEMSRQVFDLRAGRLLTAAVLRVAEDEHILVSNIHHIITDGWSFGVMLRELRELYEAAVRGKRAELPPLTVQYGDYAVWQRKQDLSEHLAYWKGKVEEYEDGLELPYDFPRTSNRAWRAATFQYSYPPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGRQDVCIGTTVAGRAQVELESLIGFFINILPLRLDLSGAPSLHEVLRRTKAVVLEGFEHQELPFEHLLKALRRQRDSSQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVRRMVEHHQRVLEALVEGLEEGLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGHYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFSLGGHSLLAAQVVSRIGKELGTQISIADLFQRPTIEQLCELIGGLDDQTQRELALAPSGNTEAVLSFAQERMWFLHNFVKGMPYNTPGLDHLTGELDVAALEKAIRAVIRRHEPLRTNFVEKDGVLSQLVGTEERFRLTVTPIRDESEVARLMEAVIQTPVDLERELMIRAYLYRVDPRNHYLFTTIHHIAFDGWSTSIFYRELAAYYAAFLRREDSPLPALEISYQDYARWERAHFQDEVLAEKLRYWRQRLSGARPLVLPTTYHRPPIQSFAGAVVNFEIDRSITERLKTLFAESGTTMYMVLLGAFSVVLQRYSGQDDICIGSPVANRGHIQTEGLIGLFVNTLVMRVDAAGNPRFIDLLARIQRTAIDAYANQEVPFEKIVDDLQVARDTARSPLVQVILNFHNTPPQSELELQGVTLTRMPVHNGTAKFELSIDVAETSAGLTGFVEYATDLFSENFIRRMIGHLEVVLDAVGRDPRAPIHELPLLTRQDQLDLLSRSGHTAPAVEHVELIPHTFERRVQESPQAIALVCGDERVTYSALNRRASQIARRLRAAGIGPDTLVGLCAGRSIELVCGVLGILKAGGAYVPIDPTSSPEVIYDVLYESKVRHLLTESRLVGGLPVDDQEILLLDTPADGEGDKAVADREEPPDLGEVSLTPECLAYVNFTSDSGGAPRGIAVRHGALARRMAAGHAQYLANSAVRFLLKAPLTFDLAVAELFQWIVSGGSLSILDPNADRDASAFLAQVRRDSIGVLYCVPSELSTLVSHLERERERVHELNTLRFIFCGGDTLAVTVVERLGVLVRAGQLPLRLVNVYGTKETGIGAGCFECALDANDPSAELPPGRLSHERMPIGGPAQNLWFYVVQPNGGLAPLGIPGELYVGGAQLADARFGDEPTATHPGFVPNPFRSGAEKDWLYKTGDLVRWLPQGPLELVSAARERDGGGDHRLDRGFIEARMRRVAIVRDAVVAYVPDRQDRARLVAYVVLKESPAADVEPREGRETLKARISAELGSTLPEYMLPAAYVFMDSLPLTAYGRIDRKALPEPEDDRHGGSAIAYVAPRGPTEKALAHIWQQVLKRPQVGLRDNFFELGGHSVAAIQLVSVSRKHLEVEVPLSLIFESPVLEAMARGIEALQQQGRSGAVSSIHRVERTGPLPLAYVQERLWFVHEHMKEQRTSYNITWTLHFAGKGFSVEALRTAFDELVARHETLRTWFQVGEGTEQAVQVIGEPWSMELPLREVAGTEVTAAINEMSRQVFDLRAGRLLTAAVLRVAEDEHILVSNIHHIITDGWSFGVMLRELRELYEAAVRGERAELPPLTVQYGDYAVWQRKQDLSEHLAYWKGKVEGDEDGLELPYDFPRTSNRAWRAATFQYSYHPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGREDLCIGTTVAGRAQVELESLIGFFINILPLRLDLSGAPSLHEVLRRTKVVVLEGFEHQELPFEHLLKALRRQRDSSQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVRRMVEHHQRVLEALVEGLEEGLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGSYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFNLGGHSLLASQLISRIRATFRVEVAMATVFESPTVEPLARHIEEKLKDESRVQLSNVVPVERTQELPLSYLQERLWFVHEHMKEQRTSYNGTIGLRLRGPLSIPALRATFHDLVARHESLRTVFRVPEGRTTPVQVILDSMDLDIPVRDATEADIIPGMDELAGHIYDMEKGPLFMVRLLRLAEDSHVLLMGMHHIVYDAWSQFNVMSRDINLLYSAHVTGIEARLPALPIQYADFSVWQRQQDFRHHLDYWKSTLGDYRDDLELPYDYPRPPSRTWHATRFTFRYPDALARAFARFNQSHQSTLFMGLLTSFAIVLRHYTGRNDICIGTTTAGRAQLELENLVGFFINILPLRINLAGDPDISELMNRAKKSVLGAFEHQALPFERLLSALNKQRDSSHIPLVPVMLRHQNFPTAMTGKWADGVDMEVIERDERTTPNELDLQFFGDDTYLHAVVEFPAQLFSEVTVRRLMQRHQKVIEFMCATLGAR", "perc_identity": 25.26}, "gnl|BL_ORD_ID|2778|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 27422, "orf_end": 41059, "orf_from": "BGC0001413.1|Cystobactamide_17 ", "model_name": "eptB", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1000", "model_id": "3791", "ARO_accession": "3005047", "ARO_name": "eptB", "ARO_category": {"41433": {"category_aro_accession": "3004269", "category_aro_cvterm_id": "41433", "category_aro_name": "pmr phosphoethanolamine transferase", "category_aro_description": "This family of phosphoethanolamine transferase catalyze the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine to lipid A, which impedes the binding of colistin to the cell membrane.", "category_aro_class_name": "AMR Gene Family"}, "36593": {"category_aro_accession": "3000454", "category_aro_cvterm_id": "36593", "category_aro_name": "polymyxin B", "category_aro_description": "Polymyxin B is mixture of mostly polymyxins B1 and B2, mainly used for resistant gram-negative infections. They are polypeptides with cationic detergent action on cell membranes.", "category_aro_class_name": "Antibiotic"}, "36966": {"category_aro_accession": "3000622", "category_aro_cvterm_id": "36966", "category_aro_name": "colistin A", "category_aro_description": "Colistin A, or polymyxin E1, has a 6-octanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "36968": {"category_aro_accession": "3000624", "category_aro_cvterm_id": "36968", "category_aro_name": "colistin B", "category_aro_description": "Colistin B, or polymyxin E2, has a 6-heptanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "36192": {"category_aro_accession": "3000053", "category_aro_cvterm_id": "36192", "category_aro_name": "peptide antibiotic", "category_aro_description": "Peptide antibiotics have a wide range of antibacterial mechanisms, depending on the amino acids that make up the antibiotic, although most act to disrupt the cell membrane in some manner. Subclasses of peptide antibiotics can include additional sidechains of other types, such as lipids in the case of the lipopeptide antibiotics.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.12999, "max_identities": 36, "bit_score": 29.6462, "cvterm_id": "43247", "query": "DRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFSLGGHSLLAAQVVSRIGK--ELGTQISIADLFQRPTIEQLCELIGGLDDQTQRELA----------LAPSGNTEAVLSFAQERMWFLHN", "match": "D  SL  P   + +  YVAP G  +  +  I G     +H+G+ D   +          +V+  G   +  T++S+  +F R          GG +D  QR L           L  SGN  A+    Q  MWF  N", "sequence_from_db": "DNKSLINP---AKKFTYVAPEGLDDTYVVFIIGETTRWDHMGILDYSRNTTPELEKEKNLVAFRGYLCDTATKLSLRCMFVRE---------GGAEDNPQRTLKEQNVFAVLHQLGFSGNLYAM----QSEMWFYSN", "sequence_from_broadstreet": "MPQRQAVFYSSFSRFACMKYIRTMTQQKLSFWLALYIGWFMNVAVFFRRFDGYAQEFTFWKGLSGVVELVATVFVTFFLLRLLSLFGRRIWRILATLIVLFSAAASYYMTFLNVVIGYGIIASVMTTDIDLSKEVIGWHLILWLVVVSAPPLLFIWSNRCRHTLLRQLRTPGQRVKNVLIVVLAGLIVWGPIRLLELRQHDVERHSEVDMPSYGGVIANSYLPSNWLSALGLYAWAQVDESSDNKSLINPAKKFTYVAPEGLDDTYVVFIIGETTRWDHMGILDYSRNTTPELEKEKNLVAFRGYLCDTATKLSLRCMFVREGGAEDNPQRTLKEQNVFAVLHQLGFSGNLYAMQSEMWFYSNTMANNIAYREQIGAEPRNRGKSVDDMLLVDEMKRGMAQGNASGKHLIILHTKGSHFNYTQRYPRSFAQWKPECVGVDNKCSKAELINSYDNSVTYVDHFIVSVLDQLRDKKAIVFYAADHGESINEREHLHGTPRKMAPPEQFRVPMMVWMSDKYLENPDHAAAFAHLQQQAAMKVPRRHVELYDTIMGCLGYTSPDGGINENNNWCRWKK", "dna_sequence_from_broadstreet": "GTGCCACAGCGTCAGGCGGTGTTTTATTCTTCTTTTTCCAGGTTTGCTTGCATGAAATATATTAGAACGATGACGCAGCAGAAGCTTAGTTTTTGGCTGGCGCTGTACATCGGCTGGTTTATGAACGTCGCCGTTTTTTTCCGGCGTTTCGATGGTTATGCTCAAGAGTTCACTTTCTGGAAAGGGCTTTCCGGTGTTGTTGAACTGGTTGCCACGGTATTTGTCACCTTCTTCCTGTTACGTCTTCTGTCGCTGTTCGGCCGCCGTATCTGGCGCATTCTGGCGACGCTGATTGTCCTGTTTTCCGCCGCGGCGAGTTACTACATGACGTTCCTCAATGTGGTGATTGGCTACGGGATTATCGCTTCGGTGATGACCACCGATATCGACCTGTCGAAAGAGGTCATCGGCTGGCACCTGATCCTCTGGCTGGTGGTGGTGAGCGCGCCGCCGTTGCTGTTCATCTGGAGCAACCGCTGCCGCCATACGCTGCTGCGCCAGCTGCGCACCCCGGGCCAGCGGGTTAAAAACGTGCTGATCGTGGTGCTGGCCGGACTGATTGTCTGGGGACCCATCCGCCTGCTAGAGCTGCGCCAGCATGATGTGGAGCGCCATTCGGAAGTGGATATGCCGAGCTATGGCGGGGTGATCGCCAACTCTTACCTGCCGTCGAACTGGTTGTCGGCGCTGGGACTGTACGCCTGGGCGCAGGTGGATGAATCCTCAGACAACAAATCGCTGATTAACCCGGCGAAGAAGTTCACCTACGTCGCGCCGGAAGGTCTGGATGATACCTACGTGGTGTTTATCATTGGCGAAACGACCCGCTGGGACCATATGGGCATCCTCGACTATAGCCGCAATACCACGCCAGAGCTGGAGAAAGAGAAGAATCTCGTCGCCTTCCGCGGTTACTTGTGCGATACCGCTACCAAACTGTCGTTACGCTGCATGTTTGTGCGCGAGGGCGGGGCGGAAGATAACCCCCAGCGGACGCTCAAAGAGCAGAATGTCTTTGCCGTGCTGCATCAGCTGGGCTTCAGCGGCAATCTGTACGCCATGCAGAGCGAGATGTGGTTCTACAGCAACACGATGGCCAACAATATCGCCTACCGCGAGCAGATTGGCGCCGAGCCGCGCAACCGCGGTAAGAGCGTTGACGATATGCTGCTGGTGGATGAGATGAAGCGCGGTATGGCGCAGGGCAACGCCTCCGGTAAGCATCTGATCATTCTCCACACCAAAGGCTCCCACTTTAACTACACCCAACGCTACCCGCGCAGCTTCGCCCAGTGGAAACCGGAGTGCGTCGGCGTCGACAACAAGTGCTCGAAAGCGGAACTGATCAATTCCTACGACAATAGCGTGACCTATGTCGATCACTTTATCGTCAGCGTCCTCGACCAGCTGCGGGATAAGAAAGCGATTGTGTTCTATGCCGCCGACCACGGGGAGTCGATTAACGAGCGTGAACACCTGCACGGTACGCCGCGCAAGATGGCGCCGCCGGAGCAGTTCCGCGTGCCGATGATGGTGTGGATGTCGGATAAGTACCTGGAAAATCCCGATCACGCCGCCGCGTTTGCCCATCTGCAGCAGCAGGCTGCGATGAAGGTGCCGCGCCGTCACGTCGAGCTGTACGACACCATTATGGGCTGCCTCGGCTATACCTCGCCGGATGGCGGGATCAATGAGAACAACAACTGGTGCCGGTGGAAAAAGTAA", "partial": "0", "query_start": 32939, "query_end": 33313, "hit_start": 726, "hit_end": 1089, "orf_dna_sequence": "ATGCTGCTGGAGGGAGAGCTGGAGGGGTACGAGGACGGGTTGGAACTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGCATAGCTACCCGCCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCGAGGACGTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGGGGCGTTGGGGGATCTGAGCGGGTCCACCGTCGACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGCGGTGGTGCTGGAGGGATTCGAGCACGAGGCGTTGCCGTGCCAGATTCCCTTGGTGCCGGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAAGAGGATGGTGGAGCACCACCAGCGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGTGCGGCTGCACGAGGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGAAGCTACATCGAGCAGATACTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGCTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGAGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGACCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCGGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGCTGCCGAACGGGAAGCTGGACCGGTTGTCGCTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAGCCTCGGCGGGCACTCCCTCCTGGCTGCCCAGCTGATTTCGCGCATACGGGCGACCTTCCGCGTGGAAGTGGCGATGGCCACGGTGTTCGAGTCCCCCACGGTGGAGCCGCTCGCCCGCCACATCGAGGAGAAGCTCAAGGACGAGTCTCGGGTCCAGCTCTCCAACGTTGTGCCGGTCGAGCGGACGCAGGAGATTCCGCTCTCCTACCTGCAGGAGCGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACATCACCTGGACGTTGCACTTCGCCGGCAAGGGTTTCTCGGTGGAGGCGTTGCGGACGGCCTTCGATGAGCTGGTGGCCAGACACGAGACACTGCGCACGTGGTTCCAGGTGGGGGAGGGGACAGAGCAGGCCGTACAGGTCATCGGGGAGCCCTGGTCGATGGAGCTGCCGCTGAGAGAGGTGGCGGGGACGGAGGTGACGGCGGCAATCAATGAGATGTCCCGACAGGTCTTCGACTTGAGAGCGGGACGGTTGCTGACGGCGGCGGTCCTGAGGGTGGCGGAGGATGAGCACATCCTCGTCAGCAACATCCACCACATCATCACGGACGGCTGGTCGTTCGGGGTGATGCTGCGGGAGCTGAGGGAGTTGTACGAGGCAGCGGTGCGGGGGAAGAGAGCGGAGCTGCCGCCGCTGACGGTGCAGTACGGCGACTATGCGGTGTGGCAGAGGAAGCAGGACCTGAGCGAGCACCTGGCGTACTGGAAGGGGAAGGTGGAGGAGTACGAGGACGGGTTGGAGCTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGTATAGCTACCCACCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCCAGGACGTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGAGCTGGAGAGCCTCATCGGGTTCTTCATCAACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGCGGTGGTGCTGGAGGGATTCGAGCACCAGGAGTTGCCGTTCGAGCACCTGCTGAAGGCGCTGAGGCGGCAGCGGGACAGCAGCCAGATTCCCTTGGTGCCAGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAGGAGGATGGTGGAGCACCACCAGCGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGGGCTGCACGAGGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGACACTACATCGAGCAGATATTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGTTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGGGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGGCCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCAGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGTTGCCGAACGGGAAGCTGGACCGGCTGTCGTTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAGCCTCGGCGGGCACTCCCTCCTGGCTGCCCAGGTGGTCTCAAGGATTGGCAAGGAGCTTGGCACTCAGATCTCGATCGCCGATCTGTTTCAAAGGCCCACGATTGAACAGCTCTGTGAGCTGATTGGAGGACTGGACGATCAGACCCAGAGGGAGCTCGCCCTCGCTCCGTCGGGGAACACCGAGGCGGTGCTCTCGTTCGCGCAAGAGCGCATGTGGTTCCTGCACAACTTCGTCAAGGGCATGCCCTACAACACGCCAGGGCTCGACCACCTGACGGGTGAGCTCGATGTCGCGGCGCTAGAAAAGGCCATCCGCGCGGTCATCCGTCGCCACGAGCCCCTGCGGACGAATTTCGTCGAGAAGGACGGGGTGCTGTCCCAGTTGGTGGGGACGGAAGAACGCTTCCGCCTGACCGTGACTCCCATCCGCGACGAGAGCGAGGTCGCGCGGCTCATGGAAGCCGTGATCCAAACGCCAGTCGATCTGGAGCGGGAGTTGATGATCCGGGCTTATCTCTACCGGGTCGACCCGCGGAATCACTACCTGTTCACCACCATCCATCACATCGCCTTCGATGGCTGGTCGACATCGATCTTCTACCGTGAGCTGGCTGCGTACTACGCCGCGTTTCTCCGGCGCGAAGACAGTCCGCTGCCCGCGCTGGAAATCTCCTATCAGGACTATGCCCGCTGGGAGCGGGCCCATTTCCAGGACGAGGTGTTGGCGGAAAAACTGAGGTACTGGCGGCAGCGGCTGTCGGGCGCTCGGCCCCTCGTACTTCCGACCACCTACCATCGGCCGCCCATCCAGAGTTTCGCTGGCGCCGTCGTGAACTTCGAGATCGATCGCTCCATCACCGAGCGGTTGAAGACGCTGTTCGCCGAGTCGGGCACCACGATGTACATGGTGTTGCTCGGCGCGTTCTCCGTGGTGCTGCAGCGCTACTCCGGTCAGGACGACATCTGCATCGGCTCCCCCGTGGCGAACCGGGGTCACATCCAGACAGAAGGGCTGATCGGCTTGTTCGTCAACACCCTGGTGATGAGGGTGGATGCCGCCGGGAATCCCCGTTTCATCGACCTGCTGGCGCGCATTCAACGGACAGCCATCGATGCTTACGCGAACCAAGAAGTGCCCTTCGAGAAGATCGTGGACGACCTGCAGGTCGCGAGAGACACGGCCCGATCTCCGCTCGTGCAGGTCATTCTCAACTTCCACAACACGCCTCCTCAATCCGAGCTGGAACTGCAGGGGGTGACCCTCACGCGGATGCCGGTGCACAACGGCACGGCCAAGTTCGAGCTCTCCATCGACGTCGCGGAGACGAGCGCCGGTCTAACGGGATTCGTGGAGTACGCGACGGATCTGTTCAGCGAGAACTTCATCCGGCGGATGATCGGCCACCTCGAGGTGGTGCTGGACGCGGTCGGTCGCGATCCGCGGGCGCCTATCCATGAGTTGCCACTGCTCACCCGGCAGGATCAGTTGGACCTACTGTCGCGGAGCGGCCACACAGCCCCCGCGGTGGAACACGTCGAGTTGATCCCTCATACGTTCGAGCGGCGCGTCCAGGAGAGCCCTCAAGCGATTGCCCTGGTCTGCGGTGACGAGCGCGTCACCTACTCCGCGCTCAACCGCCGGGCCAGCCAGATTGCCCGCCGCCTGCGCGCCGCAGGGATCGGACCGGACACCCTCGTCGGGCTTTGCGCGGGGCGCTCCATCGAGCTGGTCTGCGGCGTCCTTGGCATCTTGAAGGCGGGCGGTGCGTACGTGCCAATCGACCCCACCTCCTCGCCCGAGGTGATCTACGACGTCCTGTATGAGTCGAAGGTGCGGCATCTGTTGACCGAGTCGCGCCTGGTCGGGGGACTGCCGGTCGATGACCAGGAAATCCTGCTCCTGGATACCCCCGCGGACGGTGAAGGGGACAAGGCTGTTGCTGACCGGGAGGAGCCACCTGACCTTGGCGAGGTCAGCCTCACTCCCGAGTGCTTGGCGTACGTCAACTTCACCTCCGACTCCGGTGGGGCGCCGAGGGGCATCGCCGTCCGCCATGGGGCGCTGGCTCGCCGGATGGCCGCCGGCCACGCACAGTACCTGGCCAATTCCGCCGTACGTTTCCTGCTGAAGGCGCCGCTCACGTTCGACCTGGCGGTCGCGGAGCTGTTCCAGTGGATCGTCAGCGGCGGCAGCCTGAGCATCCTCGACCCCAATGCCGACCGCGACGCCTCTGCCTTCCTCGCGCAGGTGCGCAGGGACTCGATTGGCGTCCTCTACTGCGTCCCCTCCGAACTCTCGACGCTGGTGAGCCACCTGGAGCGCGAGCGTGAAAGGGTGCATGAGCTGAACACCCTCCGGTTCATCTTCTGCGGCGGGGATACCCTGGCGGTTACCGTCGTCGAGCGTCTCGGGGTACTGGTGCGGGCCGGCCAGCTCCCGCTGCGGCTGGTCAACGTCTATGGGACGAAGGAGACGGGAATCGGCGCGGGTTGCTTCGAGTGCGCGCTGGACGCGAACGACCCCAGCGCCGAACTCCCGCCGGGACGGCTCTCGCATGAGCGGATGCCCATCGGCGGGCCCGCCCAGAACCTGTGGTTCTATGTGGTGCAACCCAACGGTGGCCTGGCTCCGTTGGGCATCCCGGGGGAACTGTACGTCGGCGGCGCGCAACTCGCCGACGCCCGTTTCGGCGACGAGCCCACGGCGACCCACCCCGGCTTCGTCCCGAACCCCTTCCGGAGCGGAGCGGAGAAGGACTGGCTGTACAAGACGGGGGACCTCGTCCGCTGGCTGCCTCAGGGGCCGCTCGAGCTGGTCAGCGCGGCTCGGGAGCGCGACGGAGGCGGGGACCACCGGCTCGATCGCGGCTTCATCGAGGCGCGCATGCGTCGTGTGGCCATTGTCCGCGACGCCGTGGTGGCCTACGTCCCGGATCGCCAGGACAGGGCCCGGTTGGTGGCCTACGTCGTTCTGAAGGAGTCGCCCGCGGCGGACGTGGAGCCGCGCGAAGGGCGGGAAACGCTGAAGGCTCGGATCAGCGCCGAACTTGGGAGCACGTTGCCGGAGTACATGCTTCCGGCCGCCTACGTGTTCATGGACAGCCTGCCGTTGACGGCTTACGGGAGGATCGACCGGAAAGCCCTGCCCGAGCCGGAGGATGACCGCCACGGTGGTAGTGCGATCGCCTACGTGGCCCCGCGCGGGCCCACGGAGAAGGCACTGGCGCACATTTGGCAGCAAGTGCTGAAACGCCCCCAGGTCGGACTGCGAGACAACTTCTTTGAGCTGGGCGGGCACTCAGTGGCGGCCATCCAACTGGTGTCCGTGAGCCGGAAGCACCTGGAGGTCGAAGTCCCCCTCAGCCTGATCTTCGAATCGCCGGTCCTGGAGGCGATGGCGCGCGGCATCGAAGCGCTGCAACAGCAGGGCCGCAGCGGCGCGGTGTCGTCGATCCATCGGGTGGAGCGGACCGGACCGCTGCCTCTGGCGTACGTGCAGGAGAGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACATCACCTGGACGTTGCACTTCGCCGGCAAGGGTTTCTCGGTGGAGGCGTTGCGGACGGCCTTCGATGAGCTGGTGGCCAGACACGAGACACTGCGCACGTGGTTCCAGGTGGGGGAGGGGACAGAGCAGGCCGTACAGGTCATCGGGGAGCCCTGGTCGATGGAGCTGCCGCTGAGAGAGGTGGCGGGGACGGAGGTGACGGCGGCAATCAATGAGATGTCCCGGCAGGTCTTCGACTTGAGAGCGGGACGGTTGCTGACGGCGGCGGTCCTGAGGGTGGCGGAGGATGAGCACATCCTCGTCAGCAACATCCACCACATCATCACGGACGGCTGGTCGTTCGGGGTGATGCTGCGGGAGCTGAGGGAGTTGTACGAGGCCGCGGTGCGGGGGGAGCGAGCGGAGCTGCCGCCGCTGACGGTGCAGTACGGCGACTATGCGGTATGGCAGAGGAAGCAGGACCTGAGCGAGCACCTGGCGTACTGGAAGGGGAAGGTGGAGGGGGACGAGGACGGGTTGGAGCTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGTATAGCTACCACCCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCGAGGACCTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGAACTGGAGAGCCTCATCGGGTTCTTCATCAACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGTGGTGGTGCTGGAGGGATTCGAGCACCAGGAGTTGCCGTTCGAGCACCTGCTGAAGGCGCTGAGGCGGCAGCGGGACAGCAGCCAGATTCCCTTGGTGCCAGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAGGAGGATGGTGGAGCACCACCAACGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGGGCTGCACGAAGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGAAGCTACATCGAGCAGATACTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGCTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGAGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGACCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCAGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGTTGCCGAACGGGAAGCTGGACCGGCTGTCGTTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAACCTCGGCGGGCACTCCCTCCTGGCTTCCCAGCTGATTTCGCGCATACGGGCGACCTTCCGCGTGGAAGTGGCGATGGCCACGGTGTTCGAGTCCCCCACGGTGGAGCCGCTCGCCCGCCACATCGAGGAGAAGCTCAAGGACGAGTCTCGGGTCCAGCTCTCCAACGTTGTGCCGGTCGAGCGGACGCAGGAGCTTCCGCTCTCCTACCTGCAGGAGAGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACGGAACGATCGGGCTCCGGCTTCGGGGTCCTCTGTCAATCCCCGCGCTCAGGGCCACCTTCCACGATCTGGTCGCCCGTCACGAGAGCCTGCGCACCGTCTTCCGGGTCCCCGAAGGCCGCACCACGCCGGTGCAGGTGATTCTTGATTCGATGGATCTGGACATCCCGGTCCGCGATGCAACCGAGGCCGACATCATCCCGGGCATGGATGAGCTGGCGGGTCACATCTACGACATGGAGAAGGGTCCGCTGTTCATGGTTCGCCTCTTGCGGCTGGCCGAGGACTCCCACGTTCTCCTGATGGGGATGCATCACATCGTCTACGACGCATGGTCACAGTTCAATGTGATGAGTCGCGATATCAACCTGCTCTACTCGGCGCACGTGACGGGAATCGAGGCACGGCTTCCCGCGCTTCCCATCCAGTACGCCGACTTCTCGGTGTGGCAGCGCCAGCAGGACTTCCGTCACCACCTGGACTACTGGAAGTCCACACTGGGCGACTACCGGGATGATCTCGAGCTGCCGTATGACTACCCGCGGCCGCCCAGCCGGACATGGCACGCGACCCGATTCACCTTCCGGTATCCGGATGCACTGGCGCGCGCGTTCGCCAGGTTCAATCAGTCCCATCAGTCGACGCTGTTCATGGGGCTGCTGACCAGCTTCGCGATCGTGCTCAGGCACTACACCGGCCGGAACGACATCTGCATCGGAACGACAACGGCGGGGCGCGCCCAGTTGGAGTTGGAGAACCTCGTTGGCTTCTTCATCAACATCCTGCCGTTGCGCATCAATCTGGCGGGTGACCCCGACATCAGCGAGCTCATGAATCGAGCGAAGAAGAGCGTCTTGGGCGCCTTCGAGCATCAAGCTCTGCCGTTCGAGCGTCTCCTCAGTGCCCTCAACAAACAGCGTGACAGCAGCCATATCCCGCTGGTTCCCGTCATGTTGCGCCACCAGAACTTCCCGACGGCGATGACCGGCAAGTGGGCCGATGGTGTGGACATGGAGGTCATCGAGCGCGACGAGCGCACGACGCCCAACGAGCTGGACCTCCAGTTCTTTGGCGACGACACCTACTTGCATGCTGTCGTCGAGTTCCCCGCGCAGCTCTTCTCCGAGGTGACCGTCCGGCGTCTGATGCAGCGTCACCAGAAGGTCATAGAGTTCATGTGCGCGACGCTGGGGGCTCGGTGA", "orf_prot_sequence": "MLLEGELEGYEDGLELPYDFPRTSNRAWRAATFQHSYPPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGREDVCIGTTVAGRAQVGALGDLSGSTVDILPLRLDLSGAPSLHEVLRRTKAVVLEGFEHEALPCQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVKRMVEHHQRVLEALVEGLEEVRLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGSYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFSLGGHSLLAAQLISRIRATFRVEVAMATVFESPTVEPLARHIEEKLKDESRVQLSNVVPVERTQEIPLSYLQERLWFVHEHMKEQRTSYNITWTLHFAGKGFSVEALRTAFDELVARHETLRTWFQVGEGTEQAVQVIGEPWSMELPLREVAGTEVTAAINEMSRQVFDLRAGRLLTAAVLRVAEDEHILVSNIHHIITDGWSFGVMLRELRELYEAAVRGKRAELPPLTVQYGDYAVWQRKQDLSEHLAYWKGKVEEYEDGLELPYDFPRTSNRAWRAATFQYSYPPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGRQDVCIGTTVAGRAQVELESLIGFFINILPLRLDLSGAPSLHEVLRRTKAVVLEGFEHQELPFEHLLKALRRQRDSSQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVRRMVEHHQRVLEALVEGLEEGLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGHYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFSLGGHSLLAAQVVSRIGKELGTQISIADLFQRPTIEQLCELIGGLDDQTQRELALAPSGNTEAVLSFAQERMWFLHNFVKGMPYNTPGLDHLTGELDVAALEKAIRAVIRRHEPLRTNFVEKDGVLSQLVGTEERFRLTVTPIRDESEVARLMEAVIQTPVDLERELMIRAYLYRVDPRNHYLFTTIHHIAFDGWSTSIFYRELAAYYAAFLRREDSPLPALEISYQDYARWERAHFQDEVLAEKLRYWRQRLSGARPLVLPTTYHRPPIQSFAGAVVNFEIDRSITERLKTLFAESGTTMYMVLLGAFSVVLQRYSGQDDICIGSPVANRGHIQTEGLIGLFVNTLVMRVDAAGNPRFIDLLARIQRTAIDAYANQEVPFEKIVDDLQVARDTARSPLVQVILNFHNTPPQSELELQGVTLTRMPVHNGTAKFELSIDVAETSAGLTGFVEYATDLFSENFIRRMIGHLEVVLDAVGRDPRAPIHELPLLTRQDQLDLLSRSGHTAPAVEHVELIPHTFERRVQESPQAIALVCGDERVTYSALNRRASQIARRLRAAGIGPDTLVGLCAGRSIELVCGVLGILKAGGAYVPIDPTSSPEVIYDVLYESKVRHLLTESRLVGGLPVDDQEILLLDTPADGEGDKAVADREEPPDLGEVSLTPECLAYVNFTSDSGGAPRGIAVRHGALARRMAAGHAQYLANSAVRFLLKAPLTFDLAVAELFQWIVSGGSLSILDPNADRDASAFLAQVRRDSIGVLYCVPSELSTLVSHLERERERVHELNTLRFIFCGGDTLAVTVVERLGVLVRAGQLPLRLVNVYGTKETGIGAGCFECALDANDPSAELPPGRLSHERMPIGGPAQNLWFYVVQPNGGLAPLGIPGELYVGGAQLADARFGDEPTATHPGFVPNPFRSGAEKDWLYKTGDLVRWLPQGPLELVSAARERDGGGDHRLDRGFIEARMRRVAIVRDAVVAYVPDRQDRARLVAYVVLKESPAADVEPREGRETLKARISAELGSTLPEYMLPAAYVFMDSLPLTAYGRIDRKALPEPEDDRHGGSAIAYVAPRGPTEKALAHIWQQVLKRPQVGLRDNFFELGGHSVAAIQLVSVSRKHLEVEVPLSLIFESPVLEAMARGIEALQQQGRSGAVSSIHRVERTGPLPLAYVQERLWFVHEHMKEQRTSYNITWTLHFAGKGFSVEALRTAFDELVARHETLRTWFQVGEGTEQAVQVIGEPWSMELPLREVAGTEVTAAINEMSRQVFDLRAGRLLTAAVLRVAEDEHILVSNIHHIITDGWSFGVMLRELRELYEAAVRGERAELPPLTVQYGDYAVWQRKQDLSEHLAYWKGKVEGDEDGLELPYDFPRTSNRAWRAATFQYSYHPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGREDLCIGTTVAGRAQVELESLIGFFINILPLRLDLSGAPSLHEVLRRTKVVVLEGFEHQELPFEHLLKALRRQRDSSQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVRRMVEHHQRVLEALVEGLEEGLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGSYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFNLGGHSLLASQLISRIRATFRVEVAMATVFESPTVEPLARHIEEKLKDESRVQLSNVVPVERTQELPLSYLQERLWFVHEHMKEQRTSYNGTIGLRLRGPLSIPALRATFHDLVARHESLRTVFRVPEGRTTPVQVILDSMDLDIPVRDATEADIIPGMDELAGHIYDMEKGPLFMVRLLRLAEDSHVLLMGMHHIVYDAWSQFNVMSRDINLLYSAHVTGIEARLPALPIQYADFSVWQRQQDFRHHLDYWKSTLGDYRDDLELPYDYPRPPSRTWHATRFTFRYPDALARAFARFNQSHQSTLFMGLLTSFAIVLRHYTGRNDICIGTTTAGRAQLELENLVGFFINILPLRINLAGDPDISELMNRAKKSVLGAFEHQALPFERLLSALNKQRDSSHIPLVPVMLRHQNFPTAMTGKWADGVDMEVIERDERTTPNELDLQFFGDDTYLHAVVEFPAQLFSEVTVRRLMQRHQKVIEFMCATLGAR", "perc_identity": 26.28}, "gnl|BL_ORD_ID|3103|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 27422, "orf_end": 41059, "orf_from": "BGC0001413.1|Cystobactamide_17 ", "model_name": "ACT-50", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "4141", "ARO_accession": "3006245", "ARO_name": "ACT-50", "ARO_category": {"36211": {"category_aro_accession": "3000072", "category_aro_cvterm_id": "36211", "category_aro_name": "ACT beta-lactamase", "category_aro_description": "ACT beta-lactamases, also known as AmpC beta-lactamases, are cephalosporinases that cannot be inhibited by clavulanate. These enzymes are encoded by genes located on the chromosome and can be induced by the presence of beta-lactam antibiotics. However recently, these genes have been found on plasmids and expressed at high constitutive levels in Escherichia coli and Klebsiella pneumoniae.", "category_aro_class_name": "AMR Gene Family"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35962": {"category_aro_accession": "0000044", "category_aro_cvterm_id": "35962", "category_aro_name": "cephamycin", "category_aro_description": "Cephamycins are a group of beta-lactam antibiotics, very similar to cephalosporins. Together with cephalosporins, they form a sub-group of antibiotics known as cephems. Cephamycins are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms. The 7-alpha-methoxy group increases resistance to beta-lactamases.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.28641, "max_identities": 21, "bit_score": 29.261, "cvterm_id": "35506", "query": "MLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEE", "match": "ML   A     +VK++ S ++A +A   + ++ +K  +ALAQ    WRV          GA+ +G G E", "sequence_from_db": "MLDAEAYGIKTNVKDMASWVVANMAPDALQDSSLKQGIALAQS-RYWRV----------GAMYQGLGWE", "sequence_from_broadstreet": "MMKKSLSCALLLSVACSAFAAPMSEKQLAKVVERAVTPLMNAQAIPGMAVAVIYQGQPHYFTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTRYWPELTGKQWQGIRMLDLATYTAGGLPLQVPDDVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGALAVKPSGMSFEEAMTKRVFKPLRLDHTWINVPKAEEAHYAWGYRDGKAVHVSPGMLDAEAYGIKTNVKDMASWVVANMAPDALQDSSLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVDAKTVVGGSDNKVALAPLPAREVNPPVPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLANKSYPNPARVETAYRILDALQ", "dna_sequence_from_broadstreet": "ATGATGAAAAAATCCCTAAGTTGTGCCCTGCTGCTCAGCGTTGCCTGCTCTGCCTTCGCCGCCCCCATGTCAGAAAAACAGCTGGCTAAGGTGGTGGAGCGTGCCGTTACGCCGCTGATGAACGCGCAGGCCATTCCGGGTATGGCGGTGGCGGTAATTTATCAGGGTCAGCCGCACTACTTTACCTTTGGTAAAGCGGATGTCGCGGCGAATAAACCTGTTACGCCTCAAACCTTGTTCGAGCTGGGCTCTATAAGTAAAACCTTCACCGGCGTATTGGGTGGCGATGCGATTGCTCGCGGTGAAATCTCACTGGGTGATCCAGTGACAAGGTACTGGCCTGAACTGACAGGAAAACAGTGGCAGGGCATTCGCATGCTGGATCTGGCAACCTATACCGCAGGGGGGTTGCCGTTACAGGTACCGGATGACGTCACTGATAACGCCTCTCTGCTGCGCTTTTATCAAAACTGGCAGCCGCAGTGGAAGCCGGGCACCACGCGTCTTTATGCCAACGCCAGCATCGGTCTTTTTGGTGCTCTCGCGGTTAAACCCTCCGGCATGAGTTTTGAAGAGGCCATGACGAAGCGGGTCTTTAAGCCGCTCAGGCTCGACCATACGTGGATTAACGTACCAAAAGCGGAAGAGGCGCATTACGCCTGGGGATACCGTGACGGTAAAGCGGTACACGTTTCTCCAGGGATGCTGGACGCTGAAGCCTATGGCATAAAAACCAACGTGAAAGATATGGCGAGCTGGGTGGTGGCAAACATGGCCCCCGATGCCCTTCAGGATAGCTCTCTCAAACAAGGGATAGCCCTGGCACAGTCCCGCTACTGGCGCGTGGGTGCCATGTATCAGGGGTTAGGCTGGGAAATGCTGAACTGGCCGGTCGATGCCAAAACCGTGGTCGGGGGCAGCGACAATAAGGTGGCGCTGGCGCCGTTGCCTGCCAGAGAAGTCAATCCCCCGGTACCGCCGGTTAAGGCCTCCTGGGTACACAAAACGGGTTCAACCGGTGGGTTTGGGAGCTACGTGGCATTTATTCCTGAAAAACAGCTCGGCATTGTGATGCTGGCGAATAAAAGCTATCCGAATCCGGCACGCGTTGAGACGGCATACCGTATCCTCGACGCGCTGCAGTAA", "partial": "0", "query_start": 28799, "query_end": 29005, "hit_start": 702, "hit_end": 876, "orf_dna_sequence": "ATGCTGCTGGAGGGAGAGCTGGAGGGGTACGAGGACGGGTTGGAACTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGCATAGCTACCCGCCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCGAGGACGTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGGGGCGTTGGGGGATCTGAGCGGGTCCACCGTCGACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGCGGTGGTGCTGGAGGGATTCGAGCACGAGGCGTTGCCGTGCCAGATTCCCTTGGTGCCGGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAAGAGGATGGTGGAGCACCACCAGCGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGTGCGGCTGCACGAGGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGAAGCTACATCGAGCAGATACTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGCTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGAGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGACCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCGGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGCTGCCGAACGGGAAGCTGGACCGGTTGTCGCTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAGCCTCGGCGGGCACTCCCTCCTGGCTGCCCAGCTGATTTCGCGCATACGGGCGACCTTCCGCGTGGAAGTGGCGATGGCCACGGTGTTCGAGTCCCCCACGGTGGAGCCGCTCGCCCGCCACATCGAGGAGAAGCTCAAGGACGAGTCTCGGGTCCAGCTCTCCAACGTTGTGCCGGTCGAGCGGACGCAGGAGATTCCGCTCTCCTACCTGCAGGAGCGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACATCACCTGGACGTTGCACTTCGCCGGCAAGGGTTTCTCGGTGGAGGCGTTGCGGACGGCCTTCGATGAGCTGGTGGCCAGACACGAGACACTGCGCACGTGGTTCCAGGTGGGGGAGGGGACAGAGCAGGCCGTACAGGTCATCGGGGAGCCCTGGTCGATGGAGCTGCCGCTGAGAGAGGTGGCGGGGACGGAGGTGACGGCGGCAATCAATGAGATGTCCCGACAGGTCTTCGACTTGAGAGCGGGACGGTTGCTGACGGCGGCGGTCCTGAGGGTGGCGGAGGATGAGCACATCCTCGTCAGCAACATCCACCACATCATCACGGACGGCTGGTCGTTCGGGGTGATGCTGCGGGAGCTGAGGGAGTTGTACGAGGCAGCGGTGCGGGGGAAGAGAGCGGAGCTGCCGCCGCTGACGGTGCAGTACGGCGACTATGCGGTGTGGCAGAGGAAGCAGGACCTGAGCGAGCACCTGGCGTACTGGAAGGGGAAGGTGGAGGAGTACGAGGACGGGTTGGAGCTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGTATAGCTACCCACCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCCAGGACGTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGAGCTGGAGAGCCTCATCGGGTTCTTCATCAACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGCGGTGGTGCTGGAGGGATTCGAGCACCAGGAGTTGCCGTTCGAGCACCTGCTGAAGGCGCTGAGGCGGCAGCGGGACAGCAGCCAGATTCCCTTGGTGCCAGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAGGAGGATGGTGGAGCACCACCAGCGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGGGCTGCACGAGGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGACACTACATCGAGCAGATATTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGTTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGGGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGGCCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCAGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGTTGCCGAACGGGAAGCTGGACCGGCTGTCGTTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAGCCTCGGCGGGCACTCCCTCCTGGCTGCCCAGGTGGTCTCAAGGATTGGCAAGGAGCTTGGCACTCAGATCTCGATCGCCGATCTGTTTCAAAGGCCCACGATTGAACAGCTCTGTGAGCTGATTGGAGGACTGGACGATCAGACCCAGAGGGAGCTCGCCCTCGCTCCGTCGGGGAACACCGAGGCGGTGCTCTCGTTCGCGCAAGAGCGCATGTGGTTCCTGCACAACTTCGTCAAGGGCATGCCCTACAACACGCCAGGGCTCGACCACCTGACGGGTGAGCTCGATGTCGCGGCGCTAGAAAAGGCCATCCGCGCGGTCATCCGTCGCCACGAGCCCCTGCGGACGAATTTCGTCGAGAAGGACGGGGTGCTGTCCCAGTTGGTGGGGACGGAAGAACGCTTCCGCCTGACCGTGACTCCCATCCGCGACGAGAGCGAGGTCGCGCGGCTCATGGAAGCCGTGATCCAAACGCCAGTCGATCTGGAGCGGGAGTTGATGATCCGGGCTTATCTCTACCGGGTCGACCCGCGGAATCACTACCTGTTCACCACCATCCATCACATCGCCTTCGATGGCTGGTCGACATCGATCTTCTACCGTGAGCTGGCTGCGTACTACGCCGCGTTTCTCCGGCGCGAAGACAGTCCGCTGCCCGCGCTGGAAATCTCCTATCAGGACTATGCCCGCTGGGAGCGGGCCCATTTCCAGGACGAGGTGTTGGCGGAAAAACTGAGGTACTGGCGGCAGCGGCTGTCGGGCGCTCGGCCCCTCGTACTTCCGACCACCTACCATCGGCCGCCCATCCAGAGTTTCGCTGGCGCCGTCGTGAACTTCGAGATCGATCGCTCCATCACCGAGCGGTTGAAGACGCTGTTCGCCGAGTCGGGCACCACGATGTACATGGTGTTGCTCGGCGCGTTCTCCGTGGTGCTGCAGCGCTACTCCGGTCAGGACGACATCTGCATCGGCTCCCCCGTGGCGAACCGGGGTCACATCCAGACAGAAGGGCTGATCGGCTTGTTCGTCAACACCCTGGTGATGAGGGTGGATGCCGCCGGGAATCCCCGTTTCATCGACCTGCTGGCGCGCATTCAACGGACAGCCATCGATGCTTACGCGAACCAAGAAGTGCCCTTCGAGAAGATCGTGGACGACCTGCAGGTCGCGAGAGACACGGCCCGATCTCCGCTCGTGCAGGTCATTCTCAACTTCCACAACACGCCTCCTCAATCCGAGCTGGAACTGCAGGGGGTGACCCTCACGCGGATGCCGGTGCACAACGGCACGGCCAAGTTCGAGCTCTCCATCGACGTCGCGGAGACGAGCGCCGGTCTAACGGGATTCGTGGAGTACGCGACGGATCTGTTCAGCGAGAACTTCATCCGGCGGATGATCGGCCACCTCGAGGTGGTGCTGGACGCGGTCGGTCGCGATCCGCGGGCGCCTATCCATGAGTTGCCACTGCTCACCCGGCAGGATCAGTTGGACCTACTGTCGCGGAGCGGCCACACAGCCCCCGCGGTGGAACACGTCGAGTTGATCCCTCATACGTTCGAGCGGCGCGTCCAGGAGAGCCCTCAAGCGATTGCCCTGGTCTGCGGTGACGAGCGCGTCACCTACTCCGCGCTCAACCGCCGGGCCAGCCAGATTGCCCGCCGCCTGCGCGCCGCAGGGATCGGACCGGACACCCTCGTCGGGCTTTGCGCGGGGCGCTCCATCGAGCTGGTCTGCGGCGTCCTTGGCATCTTGAAGGCGGGCGGTGCGTACGTGCCAATCGACCCCACCTCCTCGCCCGAGGTGATCTACGACGTCCTGTATGAGTCGAAGGTGCGGCATCTGTTGACCGAGTCGCGCCTGGTCGGGGGACTGCCGGTCGATGACCAGGAAATCCTGCTCCTGGATACCCCCGCGGACGGTGAAGGGGACAAGGCTGTTGCTGACCGGGAGGAGCCACCTGACCTTGGCGAGGTCAGCCTCACTCCCGAGTGCTTGGCGTACGTCAACTTCACCTCCGACTCCGGTGGGGCGCCGAGGGGCATCGCCGTCCGCCATGGGGCGCTGGCTCGCCGGATGGCCGCCGGCCACGCACAGTACCTGGCCAATTCCGCCGTACGTTTCCTGCTGAAGGCGCCGCTCACGTTCGACCTGGCGGTCGCGGAGCTGTTCCAGTGGATCGTCAGCGGCGGCAGCCTGAGCATCCTCGACCCCAATGCCGACCGCGACGCCTCTGCCTTCCTCGCGCAGGTGCGCAGGGACTCGATTGGCGTCCTCTACTGCGTCCCCTCCGAACTCTCGACGCTGGTGAGCCACCTGGAGCGCGAGCGTGAAAGGGTGCATGAGCTGAACACCCTCCGGTTCATCTTCTGCGGCGGGGATACCCTGGCGGTTACCGTCGTCGAGCGTCTCGGGGTACTGGTGCGGGCCGGCCAGCTCCCGCTGCGGCTGGTCAACGTCTATGGGACGAAGGAGACGGGAATCGGCGCGGGTTGCTTCGAGTGCGCGCTGGACGCGAACGACCCCAGCGCCGAACTCCCGCCGGGACGGCTCTCGCATGAGCGGATGCCCATCGGCGGGCCCGCCCAGAACCTGTGGTTCTATGTGGTGCAACCCAACGGTGGCCTGGCTCCGTTGGGCATCCCGGGGGAACTGTACGTCGGCGGCGCGCAACTCGCCGACGCCCGTTTCGGCGACGAGCCCACGGCGACCCACCCCGGCTTCGTCCCGAACCCCTTCCGGAGCGGAGCGGAGAAGGACTGGCTGTACAAGACGGGGGACCTCGTCCGCTGGCTGCCTCAGGGGCCGCTCGAGCTGGTCAGCGCGGCTCGGGAGCGCGACGGAGGCGGGGACCACCGGCTCGATCGCGGCTTCATCGAGGCGCGCATGCGTCGTGTGGCCATTGTCCGCGACGCCGTGGTGGCCTACGTCCCGGATCGCCAGGACAGGGCCCGGTTGGTGGCCTACGTCGTTCTGAAGGAGTCGCCCGCGGCGGACGTGGAGCCGCGCGAAGGGCGGGAAACGCTGAAGGCTCGGATCAGCGCCGAACTTGGGAGCACGTTGCCGGAGTACATGCTTCCGGCCGCCTACGTGTTCATGGACAGCCTGCCGTTGACGGCTTACGGGAGGATCGACCGGAAAGCCCTGCCCGAGCCGGAGGATGACCGCCACGGTGGTAGTGCGATCGCCTACGTGGCCCCGCGCGGGCCCACGGAGAAGGCACTGGCGCACATTTGGCAGCAAGTGCTGAAACGCCCCCAGGTCGGACTGCGAGACAACTTCTTTGAGCTGGGCGGGCACTCAGTGGCGGCCATCCAACTGGTGTCCGTGAGCCGGAAGCACCTGGAGGTCGAAGTCCCCCTCAGCCTGATCTTCGAATCGCCGGTCCTGGAGGCGATGGCGCGCGGCATCGAAGCGCTGCAACAGCAGGGCCGCAGCGGCGCGGTGTCGTCGATCCATCGGGTGGAGCGGACCGGACCGCTGCCTCTGGCGTACGTGCAGGAGAGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACATCACCTGGACGTTGCACTTCGCCGGCAAGGGTTTCTCGGTGGAGGCGTTGCGGACGGCCTTCGATGAGCTGGTGGCCAGACACGAGACACTGCGCACGTGGTTCCAGGTGGGGGAGGGGACAGAGCAGGCCGTACAGGTCATCGGGGAGCCCTGGTCGATGGAGCTGCCGCTGAGAGAGGTGGCGGGGACGGAGGTGACGGCGGCAATCAATGAGATGTCCCGGCAGGTCTTCGACTTGAGAGCGGGACGGTTGCTGACGGCGGCGGTCCTGAGGGTGGCGGAGGATGAGCACATCCTCGTCAGCAACATCCACCACATCATCACGGACGGCTGGTCGTTCGGGGTGATGCTGCGGGAGCTGAGGGAGTTGTACGAGGCCGCGGTGCGGGGGGAGCGAGCGGAGCTGCCGCCGCTGACGGTGCAGTACGGCGACTATGCGGTATGGCAGAGGAAGCAGGACCTGAGCGAGCACCTGGCGTACTGGAAGGGGAAGGTGGAGGGGGACGAGGACGGGTTGGAGCTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGTATAGCTACCACCCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCGAGGACCTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGAACTGGAGAGCCTCATCGGGTTCTTCATCAACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGTGGTGGTGCTGGAGGGATTCGAGCACCAGGAGTTGCCGTTCGAGCACCTGCTGAAGGCGCTGAGGCGGCAGCGGGACAGCAGCCAGATTCCCTTGGTGCCAGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAGGAGGATGGTGGAGCACCACCAACGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGGGCTGCACGAAGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGAAGCTACATCGAGCAGATACTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGCTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGAGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGACCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCAGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGTTGCCGAACGGGAAGCTGGACCGGCTGTCGTTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAACCTCGGCGGGCACTCCCTCCTGGCTTCCCAGCTGATTTCGCGCATACGGGCGACCTTCCGCGTGGAAGTGGCGATGGCCACGGTGTTCGAGTCCCCCACGGTGGAGCCGCTCGCCCGCCACATCGAGGAGAAGCTCAAGGACGAGTCTCGGGTCCAGCTCTCCAACGTTGTGCCGGTCGAGCGGACGCAGGAGCTTCCGCTCTCCTACCTGCAGGAGAGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACGGAACGATCGGGCTCCGGCTTCGGGGTCCTCTGTCAATCCCCGCGCTCAGGGCCACCTTCCACGATCTGGTCGCCCGTCACGAGAGCCTGCGCACCGTCTTCCGGGTCCCCGAAGGCCGCACCACGCCGGTGCAGGTGATTCTTGATTCGATGGATCTGGACATCCCGGTCCGCGATGCAACCGAGGCCGACATCATCCCGGGCATGGATGAGCTGGCGGGTCACATCTACGACATGGAGAAGGGTCCGCTGTTCATGGTTCGCCTCTTGCGGCTGGCCGAGGACTCCCACGTTCTCCTGATGGGGATGCATCACATCGTCTACGACGCATGGTCACAGTTCAATGTGATGAGTCGCGATATCAACCTGCTCTACTCGGCGCACGTGACGGGAATCGAGGCACGGCTTCCCGCGCTTCCCATCCAGTACGCCGACTTCTCGGTGTGGCAGCGCCAGCAGGACTTCCGTCACCACCTGGACTACTGGAAGTCCACACTGGGCGACTACCGGGATGATCTCGAGCTGCCGTATGACTACCCGCGGCCGCCCAGCCGGACATGGCACGCGACCCGATTCACCTTCCGGTATCCGGATGCACTGGCGCGCGCGTTCGCCAGGTTCAATCAGTCCCATCAGTCGACGCTGTTCATGGGGCTGCTGACCAGCTTCGCGATCGTGCTCAGGCACTACACCGGCCGGAACGACATCTGCATCGGAACGACAACGGCGGGGCGCGCCCAGTTGGAGTTGGAGAACCTCGTTGGCTTCTTCATCAACATCCTGCCGTTGCGCATCAATCTGGCGGGTGACCCCGACATCAGCGAGCTCATGAATCGAGCGAAGAAGAGCGTCTTGGGCGCCTTCGAGCATCAAGCTCTGCCGTTCGAGCGTCTCCTCAGTGCCCTCAACAAACAGCGTGACAGCAGCCATATCCCGCTGGTTCCCGTCATGTTGCGCCACCAGAACTTCCCGACGGCGATGACCGGCAAGTGGGCCGATGGTGTGGACATGGAGGTCATCGAGCGCGACGAGCGCACGACGCCCAACGAGCTGGACCTCCAGTTCTTTGGCGACGACACCTACTTGCATGCTGTCGTCGAGTTCCCCGCGCAGCTCTTCTCCGAGGTGACCGTCCGGCGTCTGATGCAGCGTCACCAGAAGGTCATAGAGTTCATGTGCGCGACGCTGGGGGCTCGGTGA", "orf_prot_sequence": "MLLEGELEGYEDGLELPYDFPRTSNRAWRAATFQHSYPPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGREDVCIGTTVAGRAQVGALGDLSGSTVDILPLRLDLSGAPSLHEVLRRTKAVVLEGFEHEALPCQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVKRMVEHHQRVLEALVEGLEEVRLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGSYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFSLGGHSLLAAQLISRIRATFRVEVAMATVFESPTVEPLARHIEEKLKDESRVQLSNVVPVERTQEIPLSYLQERLWFVHEHMKEQRTSYNITWTLHFAGKGFSVEALRTAFDELVARHETLRTWFQVGEGTEQAVQVIGEPWSMELPLREVAGTEVTAAINEMSRQVFDLRAGRLLTAAVLRVAEDEHILVSNIHHIITDGWSFGVMLRELRELYEAAVRGKRAELPPLTVQYGDYAVWQRKQDLSEHLAYWKGKVEEYEDGLELPYDFPRTSNRAWRAATFQYSYPPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGRQDVCIGTTVAGRAQVELESLIGFFINILPLRLDLSGAPSLHEVLRRTKAVVLEGFEHQELPFEHLLKALRRQRDSSQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVRRMVEHHQRVLEALVEGLEEGLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGHYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFSLGGHSLLAAQVVSRIGKELGTQISIADLFQRPTIEQLCELIGGLDDQTQRELALAPSGNTEAVLSFAQERMWFLHNFVKGMPYNTPGLDHLTGELDVAALEKAIRAVIRRHEPLRTNFVEKDGVLSQLVGTEERFRLTVTPIRDESEVARLMEAVIQTPVDLERELMIRAYLYRVDPRNHYLFTTIHHIAFDGWSTSIFYRELAAYYAAFLRREDSPLPALEISYQDYARWERAHFQDEVLAEKLRYWRQRLSGARPLVLPTTYHRPPIQSFAGAVVNFEIDRSITERLKTLFAESGTTMYMVLLGAFSVVLQRYSGQDDICIGSPVANRGHIQTEGLIGLFVNTLVMRVDAAGNPRFIDLLARIQRTAIDAYANQEVPFEKIVDDLQVARDTARSPLVQVILNFHNTPPQSELELQGVTLTRMPVHNGTAKFELSIDVAETSAGLTGFVEYATDLFSENFIRRMIGHLEVVLDAVGRDPRAPIHELPLLTRQDQLDLLSRSGHTAPAVEHVELIPHTFERRVQESPQAIALVCGDERVTYSALNRRASQIARRLRAAGIGPDTLVGLCAGRSIELVCGVLGILKAGGAYVPIDPTSSPEVIYDVLYESKVRHLLTESRLVGGLPVDDQEILLLDTPADGEGDKAVADREEPPDLGEVSLTPECLAYVNFTSDSGGAPRGIAVRHGALARRMAAGHAQYLANSAVRFLLKAPLTFDLAVAELFQWIVSGGSLSILDPNADRDASAFLAQVRRDSIGVLYCVPSELSTLVSHLERERERVHELNTLRFIFCGGDTLAVTVVERLGVLVRAGQLPLRLVNVYGTKETGIGAGCFECALDANDPSAELPPGRLSHERMPIGGPAQNLWFYVVQPNGGLAPLGIPGELYVGGAQLADARFGDEPTATHPGFVPNPFRSGAEKDWLYKTGDLVRWLPQGPLELVSAARERDGGGDHRLDRGFIEARMRRVAIVRDAVVAYVPDRQDRARLVAYVVLKESPAADVEPREGRETLKARISAELGSTLPEYMLPAAYVFMDSLPLTAYGRIDRKALPEPEDDRHGGSAIAYVAPRGPTEKALAHIWQQVLKRPQVGLRDNFFELGGHSVAAIQLVSVSRKHLEVEVPLSLIFESPVLEAMARGIEALQQQGRSGAVSSIHRVERTGPLPLAYVQERLWFVHEHMKEQRTSYNITWTLHFAGKGFSVEALRTAFDELVARHETLRTWFQVGEGTEQAVQVIGEPWSMELPLREVAGTEVTAAINEMSRQVFDLRAGRLLTAAVLRVAEDEHILVSNIHHIITDGWSFGVMLRELRELYEAAVRGERAELPPLTVQYGDYAVWQRKQDLSEHLAYWKGKVEGDEDGLELPYDFPRTSNRAWRAATFQYSYHPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGREDLCIGTTVAGRAQVELESLIGFFINILPLRLDLSGAPSLHEVLRRTKVVVLEGFEHQELPFEHLLKALRRQRDSSQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVRRMVEHHQRVLEALVEGLEEGLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGSYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFNLGGHSLLASQLISRIRATFRVEVAMATVFESPTVEPLARHIEEKLKDESRVQLSNVVPVERTQELPLSYLQERLWFVHEHMKEQRTSYNGTIGLRLRGPLSIPALRATFHDLVARHESLRTVFRVPEGRTTPVQVILDSMDLDIPVRDATEADIIPGMDELAGHIYDMEKGPLFMVRLLRLAEDSHVLLMGMHHIVYDAWSQFNVMSRDINLLYSAHVTGIEARLPALPIQYADFSVWQRQQDFRHHLDYWKSTLGDYRDDLELPYDYPRPPSRTWHATRFTFRYPDALARAFARFNQSHQSTLFMGLLTSFAIVLRHYTGRNDICIGTTTAGRAQLELENLVGFFINILPLRINLAGDPDISELMNRAKKSVLGAFEHQALPFERLLSALNKQRDSSHIPLVPVMLRHQNFPTAMTGKWADGVDMEVIERDERTTPNELDLQFFGDDTYLHAVVEFPAQLFSEVTVRRLMQRHQKVIEFMCATLGAR", "perc_identity": 30.43}, "gnl|BL_ORD_ID|3103|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 27422, "orf_end": 41059, "orf_from": "BGC0001413.1|Cystobactamide_17 ", "model_name": "ACT-50", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "4141", "ARO_accession": "3006245", "ARO_name": "ACT-50", "ARO_category": {"36211": {"category_aro_accession": "3000072", "category_aro_cvterm_id": "36211", "category_aro_name": "ACT beta-lactamase", "category_aro_description": "ACT beta-lactamases, also known as AmpC beta-lactamases, are cephalosporinases that cannot be inhibited by clavulanate. These enzymes are encoded by genes located on the chromosome and can be induced by the presence of beta-lactam antibiotics. However recently, these genes have been found on plasmids and expressed at high constitutive levels in Escherichia coli and Klebsiella pneumoniae.", "category_aro_class_name": "AMR Gene Family"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35962": {"category_aro_accession": "0000044", "category_aro_cvterm_id": "35962", "category_aro_name": "cephamycin", "category_aro_description": "Cephamycins are a group of beta-lactam antibiotics, very similar to cephalosporins. Together with cephalosporins, they form a sub-group of antibiotics known as cephems. Cephamycins are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms. The 7-alpha-methoxy group increases resistance to beta-lactamases.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.28641, "max_identities": 21, "bit_score": 29.261, "cvterm_id": "35506", "query": "MLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEE", "match": "ML   A     +VK++ S ++A +A   + ++ +K  +ALAQ    WRV          GA+ +G G E", "sequence_from_db": "MLDAEAYGIKTNVKDMASWVVANMAPDALQDSSLKQGIALAQS-RYWRV----------GAMYQGLGWE", "sequence_from_broadstreet": "MMKKSLSCALLLSVACSAFAAPMSEKQLAKVVERAVTPLMNAQAIPGMAVAVIYQGQPHYFTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTRYWPELTGKQWQGIRMLDLATYTAGGLPLQVPDDVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGALAVKPSGMSFEEAMTKRVFKPLRLDHTWINVPKAEEAHYAWGYRDGKAVHVSPGMLDAEAYGIKTNVKDMASWVVANMAPDALQDSSLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVDAKTVVGGSDNKVALAPLPAREVNPPVPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLANKSYPNPARVETAYRILDALQ", "dna_sequence_from_broadstreet": "ATGATGAAAAAATCCCTAAGTTGTGCCCTGCTGCTCAGCGTTGCCTGCTCTGCCTTCGCCGCCCCCATGTCAGAAAAACAGCTGGCTAAGGTGGTGGAGCGTGCCGTTACGCCGCTGATGAACGCGCAGGCCATTCCGGGTATGGCGGTGGCGGTAATTTATCAGGGTCAGCCGCACTACTTTACCTTTGGTAAAGCGGATGTCGCGGCGAATAAACCTGTTACGCCTCAAACCTTGTTCGAGCTGGGCTCTATAAGTAAAACCTTCACCGGCGTATTGGGTGGCGATGCGATTGCTCGCGGTGAAATCTCACTGGGTGATCCAGTGACAAGGTACTGGCCTGAACTGACAGGAAAACAGTGGCAGGGCATTCGCATGCTGGATCTGGCAACCTATACCGCAGGGGGGTTGCCGTTACAGGTACCGGATGACGTCACTGATAACGCCTCTCTGCTGCGCTTTTATCAAAACTGGCAGCCGCAGTGGAAGCCGGGCACCACGCGTCTTTATGCCAACGCCAGCATCGGTCTTTTTGGTGCTCTCGCGGTTAAACCCTCCGGCATGAGTTTTGAAGAGGCCATGACGAAGCGGGTCTTTAAGCCGCTCAGGCTCGACCATACGTGGATTAACGTACCAAAAGCGGAAGAGGCGCATTACGCCTGGGGATACCGTGACGGTAAAGCGGTACACGTTTCTCCAGGGATGCTGGACGCTGAAGCCTATGGCATAAAAACCAACGTGAAAGATATGGCGAGCTGGGTGGTGGCAAACATGGCCCCCGATGCCCTTCAGGATAGCTCTCTCAAACAAGGGATAGCCCTGGCACAGTCCCGCTACTGGCGCGTGGGTGCCATGTATCAGGGGTTAGGCTGGGAAATGCTGAACTGGCCGGTCGATGCCAAAACCGTGGTCGGGGGCAGCGACAATAAGGTGGCGCTGGCGCCGTTGCCTGCCAGAGAAGTCAATCCCCCGGTACCGCCGGTTAAGGCCTCCTGGGTACACAAAACGGGTTCAACCGGTGGGTTTGGGAGCTACGTGGCATTTATTCCTGAAAAACAGCTCGGCATTGTGATGCTGGCGAATAAAAGCTATCCGAATCCGGCACGCGTTGAGACGGCATACCGTATCCTCGACGCGCTGCAGTAA", "partial": "0", "query_start": 32021, "query_end": 32227, "hit_start": 702, "hit_end": 876, "orf_dna_sequence": "ATGCTGCTGGAGGGAGAGCTGGAGGGGTACGAGGACGGGTTGGAACTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGCATAGCTACCCGCCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCGAGGACGTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGGGGCGTTGGGGGATCTGAGCGGGTCCACCGTCGACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGCGGTGGTGCTGGAGGGATTCGAGCACGAGGCGTTGCCGTGCCAGATTCCCTTGGTGCCGGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAAGAGGATGGTGGAGCACCACCAGCGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGTGCGGCTGCACGAGGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGAAGCTACATCGAGCAGATACTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGCTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGAGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGACCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCGGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGCTGCCGAACGGGAAGCTGGACCGGTTGTCGCTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAGCCTCGGCGGGCACTCCCTCCTGGCTGCCCAGCTGATTTCGCGCATACGGGCGACCTTCCGCGTGGAAGTGGCGATGGCCACGGTGTTCGAGTCCCCCACGGTGGAGCCGCTCGCCCGCCACATCGAGGAGAAGCTCAAGGACGAGTCTCGGGTCCAGCTCTCCAACGTTGTGCCGGTCGAGCGGACGCAGGAGATTCCGCTCTCCTACCTGCAGGAGCGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACATCACCTGGACGTTGCACTTCGCCGGCAAGGGTTTCTCGGTGGAGGCGTTGCGGACGGCCTTCGATGAGCTGGTGGCCAGACACGAGACACTGCGCACGTGGTTCCAGGTGGGGGAGGGGACAGAGCAGGCCGTACAGGTCATCGGGGAGCCCTGGTCGATGGAGCTGCCGCTGAGAGAGGTGGCGGGGACGGAGGTGACGGCGGCAATCAATGAGATGTCCCGACAGGTCTTCGACTTGAGAGCGGGACGGTTGCTGACGGCGGCGGTCCTGAGGGTGGCGGAGGATGAGCACATCCTCGTCAGCAACATCCACCACATCATCACGGACGGCTGGTCGTTCGGGGTGATGCTGCGGGAGCTGAGGGAGTTGTACGAGGCAGCGGTGCGGGGGAAGAGAGCGGAGCTGCCGCCGCTGACGGTGCAGTACGGCGACTATGCGGTGTGGCAGAGGAAGCAGGACCTGAGCGAGCACCTGGCGTACTGGAAGGGGAAGGTGGAGGAGTACGAGGACGGGTTGGAGCTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGTATAGCTACCCACCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCCAGGACGTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGAGCTGGAGAGCCTCATCGGGTTCTTCATCAACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGCGGTGGTGCTGGAGGGATTCGAGCACCAGGAGTTGCCGTTCGAGCACCTGCTGAAGGCGCTGAGGCGGCAGCGGGACAGCAGCCAGATTCCCTTGGTGCCAGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAGGAGGATGGTGGAGCACCACCAGCGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGGGCTGCACGAGGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGACACTACATCGAGCAGATATTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGTTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGGGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGGCCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCAGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGTTGCCGAACGGGAAGCTGGACCGGCTGTCGTTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAGCCTCGGCGGGCACTCCCTCCTGGCTGCCCAGGTGGTCTCAAGGATTGGCAAGGAGCTTGGCACTCAGATCTCGATCGCCGATCTGTTTCAAAGGCCCACGATTGAACAGCTCTGTGAGCTGATTGGAGGACTGGACGATCAGACCCAGAGGGAGCTCGCCCTCGCTCCGTCGGGGAACACCGAGGCGGTGCTCTCGTTCGCGCAAGAGCGCATGTGGTTCCTGCACAACTTCGTCAAGGGCATGCCCTACAACACGCCAGGGCTCGACCACCTGACGGGTGAGCTCGATGTCGCGGCGCTAGAAAAGGCCATCCGCGCGGTCATCCGTCGCCACGAGCCCCTGCGGACGAATTTCGTCGAGAAGGACGGGGTGCTGTCCCAGTTGGTGGGGACGGAAGAACGCTTCCGCCTGACCGTGACTCCCATCCGCGACGAGAGCGAGGTCGCGCGGCTCATGGAAGCCGTGATCCAAACGCCAGTCGATCTGGAGCGGGAGTTGATGATCCGGGCTTATCTCTACCGGGTCGACCCGCGGAATCACTACCTGTTCACCACCATCCATCACATCGCCTTCGATGGCTGGTCGACATCGATCTTCTACCGTGAGCTGGCTGCGTACTACGCCGCGTTTCTCCGGCGCGAAGACAGTCCGCTGCCCGCGCTGGAAATCTCCTATCAGGACTATGCCCGCTGGGAGCGGGCCCATTTCCAGGACGAGGTGTTGGCGGAAAAACTGAGGTACTGGCGGCAGCGGCTGTCGGGCGCTCGGCCCCTCGTACTTCCGACCACCTACCATCGGCCGCCCATCCAGAGTTTCGCTGGCGCCGTCGTGAACTTCGAGATCGATCGCTCCATCACCGAGCGGTTGAAGACGCTGTTCGCCGAGTCGGGCACCACGATGTACATGGTGTTGCTCGGCGCGTTCTCCGTGGTGCTGCAGCGCTACTCCGGTCAGGACGACATCTGCATCGGCTCCCCCGTGGCGAACCGGGGTCACATCCAGACAGAAGGGCTGATCGGCTTGTTCGTCAACACCCTGGTGATGAGGGTGGATGCCGCCGGGAATCCCCGTTTCATCGACCTGCTGGCGCGCATTCAACGGACAGCCATCGATGCTTACGCGAACCAAGAAGTGCCCTTCGAGAAGATCGTGGACGACCTGCAGGTCGCGAGAGACACGGCCCGATCTCCGCTCGTGCAGGTCATTCTCAACTTCCACAACACGCCTCCTCAATCCGAGCTGGAACTGCAGGGGGTGACCCTCACGCGGATGCCGGTGCACAACGGCACGGCCAAGTTCGAGCTCTCCATCGACGTCGCGGAGACGAGCGCCGGTCTAACGGGATTCGTGGAGTACGCGACGGATCTGTTCAGCGAGAACTTCATCCGGCGGATGATCGGCCACCTCGAGGTGGTGCTGGACGCGGTCGGTCGCGATCCGCGGGCGCCTATCCATGAGTTGCCACTGCTCACCCGGCAGGATCAGTTGGACCTACTGTCGCGGAGCGGCCACACAGCCCCCGCGGTGGAACACGTCGAGTTGATCCCTCATACGTTCGAGCGGCGCGTCCAGGAGAGCCCTCAAGCGATTGCCCTGGTCTGCGGTGACGAGCGCGTCACCTACTCCGCGCTCAACCGCCGGGCCAGCCAGATTGCCCGCCGCCTGCGCGCCGCAGGGATCGGACCGGACACCCTCGTCGGGCTTTGCGCGGGGCGCTCCATCGAGCTGGTCTGCGGCGTCCTTGGCATCTTGAAGGCGGGCGGTGCGTACGTGCCAATCGACCCCACCTCCTCGCCCGAGGTGATCTACGACGTCCTGTATGAGTCGAAGGTGCGGCATCTGTTGACCGAGTCGCGCCTGGTCGGGGGACTGCCGGTCGATGACCAGGAAATCCTGCTCCTGGATACCCCCGCGGACGGTGAAGGGGACAAGGCTGTTGCTGACCGGGAGGAGCCACCTGACCTTGGCGAGGTCAGCCTCACTCCCGAGTGCTTGGCGTACGTCAACTTCACCTCCGACTCCGGTGGGGCGCCGAGGGGCATCGCCGTCCGCCATGGGGCGCTGGCTCGCCGGATGGCCGCCGGCCACGCACAGTACCTGGCCAATTCCGCCGTACGTTTCCTGCTGAAGGCGCCGCTCACGTTCGACCTGGCGGTCGCGGAGCTGTTCCAGTGGATCGTCAGCGGCGGCAGCCTGAGCATCCTCGACCCCAATGCCGACCGCGACGCCTCTGCCTTCCTCGCGCAGGTGCGCAGGGACTCGATTGGCGTCCTCTACTGCGTCCCCTCCGAACTCTCGACGCTGGTGAGCCACCTGGAGCGCGAGCGTGAAAGGGTGCATGAGCTGAACACCCTCCGGTTCATCTTCTGCGGCGGGGATACCCTGGCGGTTACCGTCGTCGAGCGTCTCGGGGTACTGGTGCGGGCCGGCCAGCTCCCGCTGCGGCTGGTCAACGTCTATGGGACGAAGGAGACGGGAATCGGCGCGGGTTGCTTCGAGTGCGCGCTGGACGCGAACGACCCCAGCGCCGAACTCCCGCCGGGACGGCTCTCGCATGAGCGGATGCCCATCGGCGGGCCCGCCCAGAACCTGTGGTTCTATGTGGTGCAACCCAACGGTGGCCTGGCTCCGTTGGGCATCCCGGGGGAACTGTACGTCGGCGGCGCGCAACTCGCCGACGCCCGTTTCGGCGACGAGCCCACGGCGACCCACCCCGGCTTCGTCCCGAACCCCTTCCGGAGCGGAGCGGAGAAGGACTGGCTGTACAAGACGGGGGACCTCGTCCGCTGGCTGCCTCAGGGGCCGCTCGAGCTGGTCAGCGCGGCTCGGGAGCGCGACGGAGGCGGGGACCACCGGCTCGATCGCGGCTTCATCGAGGCGCGCATGCGTCGTGTGGCCATTGTCCGCGACGCCGTGGTGGCCTACGTCCCGGATCGCCAGGACAGGGCCCGGTTGGTGGCCTACGTCGTTCTGAAGGAGTCGCCCGCGGCGGACGTGGAGCCGCGCGAAGGGCGGGAAACGCTGAAGGCTCGGATCAGCGCCGAACTTGGGAGCACGTTGCCGGAGTACATGCTTCCGGCCGCCTACGTGTTCATGGACAGCCTGCCGTTGACGGCTTACGGGAGGATCGACCGGAAAGCCCTGCCCGAGCCGGAGGATGACCGCCACGGTGGTAGTGCGATCGCCTACGTGGCCCCGCGCGGGCCCACGGAGAAGGCACTGGCGCACATTTGGCAGCAAGTGCTGAAACGCCCCCAGGTCGGACTGCGAGACAACTTCTTTGAGCTGGGCGGGCACTCAGTGGCGGCCATCCAACTGGTGTCCGTGAGCCGGAAGCACCTGGAGGTCGAAGTCCCCCTCAGCCTGATCTTCGAATCGCCGGTCCTGGAGGCGATGGCGCGCGGCATCGAAGCGCTGCAACAGCAGGGCCGCAGCGGCGCGGTGTCGTCGATCCATCGGGTGGAGCGGACCGGACCGCTGCCTCTGGCGTACGTGCAGGAGAGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACATCACCTGGACGTTGCACTTCGCCGGCAAGGGTTTCTCGGTGGAGGCGTTGCGGACGGCCTTCGATGAGCTGGTGGCCAGACACGAGACACTGCGCACGTGGTTCCAGGTGGGGGAGGGGACAGAGCAGGCCGTACAGGTCATCGGGGAGCCCTGGTCGATGGAGCTGCCGCTGAGAGAGGTGGCGGGGACGGAGGTGACGGCGGCAATCAATGAGATGTCCCGGCAGGTCTTCGACTTGAGAGCGGGACGGTTGCTGACGGCGGCGGTCCTGAGGGTGGCGGAGGATGAGCACATCCTCGTCAGCAACATCCACCACATCATCACGGACGGCTGGTCGTTCGGGGTGATGCTGCGGGAGCTGAGGGAGTTGTACGAGGCCGCGGTGCGGGGGGAGCGAGCGGAGCTGCCGCCGCTGACGGTGCAGTACGGCGACTATGCGGTATGGCAGAGGAAGCAGGACCTGAGCGAGCACCTGGCGTACTGGAAGGGGAAGGTGGAGGGGGACGAGGACGGGTTGGAGCTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGTATAGCTACCACCCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCGAGGACCTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGAACTGGAGAGCCTCATCGGGTTCTTCATCAACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGTGGTGGTGCTGGAGGGATTCGAGCACCAGGAGTTGCCGTTCGAGCACCTGCTGAAGGCGCTGAGGCGGCAGCGGGACAGCAGCCAGATTCCCTTGGTGCCAGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAGGAGGATGGTGGAGCACCACCAACGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGGGCTGCACGAAGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGAAGCTACATCGAGCAGATACTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGCTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGAGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGACCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCAGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGTTGCCGAACGGGAAGCTGGACCGGCTGTCGTTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAACCTCGGCGGGCACTCCCTCCTGGCTTCCCAGCTGATTTCGCGCATACGGGCGACCTTCCGCGTGGAAGTGGCGATGGCCACGGTGTTCGAGTCCCCCACGGTGGAGCCGCTCGCCCGCCACATCGAGGAGAAGCTCAAGGACGAGTCTCGGGTCCAGCTCTCCAACGTTGTGCCGGTCGAGCGGACGCAGGAGCTTCCGCTCTCCTACCTGCAGGAGAGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACGGAACGATCGGGCTCCGGCTTCGGGGTCCTCTGTCAATCCCCGCGCTCAGGGCCACCTTCCACGATCTGGTCGCCCGTCACGAGAGCCTGCGCACCGTCTTCCGGGTCCCCGAAGGCCGCACCACGCCGGTGCAGGTGATTCTTGATTCGATGGATCTGGACATCCCGGTCCGCGATGCAACCGAGGCCGACATCATCCCGGGCATGGATGAGCTGGCGGGTCACATCTACGACATGGAGAAGGGTCCGCTGTTCATGGTTCGCCTCTTGCGGCTGGCCGAGGACTCCCACGTTCTCCTGATGGGGATGCATCACATCGTCTACGACGCATGGTCACAGTTCAATGTGATGAGTCGCGATATCAACCTGCTCTACTCGGCGCACGTGACGGGAATCGAGGCACGGCTTCCCGCGCTTCCCATCCAGTACGCCGACTTCTCGGTGTGGCAGCGCCAGCAGGACTTCCGTCACCACCTGGACTACTGGAAGTCCACACTGGGCGACTACCGGGATGATCTCGAGCTGCCGTATGACTACCCGCGGCCGCCCAGCCGGACATGGCACGCGACCCGATTCACCTTCCGGTATCCGGATGCACTGGCGCGCGCGTTCGCCAGGTTCAATCAGTCCCATCAGTCGACGCTGTTCATGGGGCTGCTGACCAGCTTCGCGATCGTGCTCAGGCACTACACCGGCCGGAACGACATCTGCATCGGAACGACAACGGCGGGGCGCGCCCAGTTGGAGTTGGAGAACCTCGTTGGCTTCTTCATCAACATCCTGCCGTTGCGCATCAATCTGGCGGGTGACCCCGACATCAGCGAGCTCATGAATCGAGCGAAGAAGAGCGTCTTGGGCGCCTTCGAGCATCAAGCTCTGCCGTTCGAGCGTCTCCTCAGTGCCCTCAACAAACAGCGTGACAGCAGCCATATCCCGCTGGTTCCCGTCATGTTGCGCCACCAGAACTTCCCGACGGCGATGACCGGCAAGTGGGCCGATGGTGTGGACATGGAGGTCATCGAGCGCGACGAGCGCACGACGCCCAACGAGCTGGACCTCCAGTTCTTTGGCGACGACACCTACTTGCATGCTGTCGTCGAGTTCCCCGCGCAGCTCTTCTCCGAGGTGACCGTCCGGCGTCTGATGCAGCGTCACCAGAAGGTCATAGAGTTCATGTGCGCGACGCTGGGGGCTCGGTGA", "orf_prot_sequence": "MLLEGELEGYEDGLELPYDFPRTSNRAWRAATFQHSYPPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGREDVCIGTTVAGRAQVGALGDLSGSTVDILPLRLDLSGAPSLHEVLRRTKAVVLEGFEHEALPCQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVKRMVEHHQRVLEALVEGLEEVRLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGSYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFSLGGHSLLAAQLISRIRATFRVEVAMATVFESPTVEPLARHIEEKLKDESRVQLSNVVPVERTQEIPLSYLQERLWFVHEHMKEQRTSYNITWTLHFAGKGFSVEALRTAFDELVARHETLRTWFQVGEGTEQAVQVIGEPWSMELPLREVAGTEVTAAINEMSRQVFDLRAGRLLTAAVLRVAEDEHILVSNIHHIITDGWSFGVMLRELRELYEAAVRGKRAELPPLTVQYGDYAVWQRKQDLSEHLAYWKGKVEEYEDGLELPYDFPRTSNRAWRAATFQYSYPPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGRQDVCIGTTVAGRAQVELESLIGFFINILPLRLDLSGAPSLHEVLRRTKAVVLEGFEHQELPFEHLLKALRRQRDSSQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVRRMVEHHQRVLEALVEGLEEGLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGHYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFSLGGHSLLAAQVVSRIGKELGTQISIADLFQRPTIEQLCELIGGLDDQTQRELALAPSGNTEAVLSFAQERMWFLHNFVKGMPYNTPGLDHLTGELDVAALEKAIRAVIRRHEPLRTNFVEKDGVLSQLVGTEERFRLTVTPIRDESEVARLMEAVIQTPVDLERELMIRAYLYRVDPRNHYLFTTIHHIAFDGWSTSIFYRELAAYYAAFLRREDSPLPALEISYQDYARWERAHFQDEVLAEKLRYWRQRLSGARPLVLPTTYHRPPIQSFAGAVVNFEIDRSITERLKTLFAESGTTMYMVLLGAFSVVLQRYSGQDDICIGSPVANRGHIQTEGLIGLFVNTLVMRVDAAGNPRFIDLLARIQRTAIDAYANQEVPFEKIVDDLQVARDTARSPLVQVILNFHNTPPQSELELQGVTLTRMPVHNGTAKFELSIDVAETSAGLTGFVEYATDLFSENFIRRMIGHLEVVLDAVGRDPRAPIHELPLLTRQDQLDLLSRSGHTAPAVEHVELIPHTFERRVQESPQAIALVCGDERVTYSALNRRASQIARRLRAAGIGPDTLVGLCAGRSIELVCGVLGILKAGGAYVPIDPTSSPEVIYDVLYESKVRHLLTESRLVGGLPVDDQEILLLDTPADGEGDKAVADREEPPDLGEVSLTPECLAYVNFTSDSGGAPRGIAVRHGALARRMAAGHAQYLANSAVRFLLKAPLTFDLAVAELFQWIVSGGSLSILDPNADRDASAFLAQVRRDSIGVLYCVPSELSTLVSHLERERERVHELNTLRFIFCGGDTLAVTVVERLGVLVRAGQLPLRLVNVYGTKETGIGAGCFECALDANDPSAELPPGRLSHERMPIGGPAQNLWFYVVQPNGGLAPLGIPGELYVGGAQLADARFGDEPTATHPGFVPNPFRSGAEKDWLYKTGDLVRWLPQGPLELVSAARERDGGGDHRLDRGFIEARMRRVAIVRDAVVAYVPDRQDRARLVAYVVLKESPAADVEPREGRETLKARISAELGSTLPEYMLPAAYVFMDSLPLTAYGRIDRKALPEPEDDRHGGSAIAYVAPRGPTEKALAHIWQQVLKRPQVGLRDNFFELGGHSVAAIQLVSVSRKHLEVEVPLSLIFESPVLEAMARGIEALQQQGRSGAVSSIHRVERTGPLPLAYVQERLWFVHEHMKEQRTSYNITWTLHFAGKGFSVEALRTAFDELVARHETLRTWFQVGEGTEQAVQVIGEPWSMELPLREVAGTEVTAAINEMSRQVFDLRAGRLLTAAVLRVAEDEHILVSNIHHIITDGWSFGVMLRELRELYEAAVRGERAELPPLTVQYGDYAVWQRKQDLSEHLAYWKGKVEGDEDGLELPYDFPRTSNRAWRAATFQYSYHPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGREDLCIGTTVAGRAQVELESLIGFFINILPLRLDLSGAPSLHEVLRRTKVVVLEGFEHQELPFEHLLKALRRQRDSSQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVRRMVEHHQRVLEALVEGLEEGLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGSYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFNLGGHSLLASQLISRIRATFRVEVAMATVFESPTVEPLARHIEEKLKDESRVQLSNVVPVERTQELPLSYLQERLWFVHEHMKEQRTSYNGTIGLRLRGPLSIPALRATFHDLVARHESLRTVFRVPEGRTTPVQVILDSMDLDIPVRDATEADIIPGMDELAGHIYDMEKGPLFMVRLLRLAEDSHVLLMGMHHIVYDAWSQFNVMSRDINLLYSAHVTGIEARLPALPIQYADFSVWQRQQDFRHHLDYWKSTLGDYRDDLELPYDYPRPPSRTWHATRFTFRYPDALARAFARFNQSHQSTLFMGLLTSFAIVLRHYTGRNDICIGTTTAGRAQLELENLVGFFINILPLRINLAGDPDISELMNRAKKSVLGAFEHQALPFERLLSALNKQRDSSHIPLVPVMLRHQNFPTAMTGKWADGVDMEVIERDERTTPNELDLQFFGDDTYLHAVVEFPAQLFSEVTVRRLMQRHQKVIEFMCATLGAR", "perc_identity": 30.43}, "gnl|BL_ORD_ID|3103|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 27422, "orf_end": 41059, "orf_from": "BGC0001413.1|Cystobactamide_17 ", "model_name": "ACT-50", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "4141", "ARO_accession": "3006245", "ARO_name": "ACT-50", "ARO_category": {"36211": {"category_aro_accession": "3000072", "category_aro_cvterm_id": "36211", "category_aro_name": "ACT beta-lactamase", "category_aro_description": "ACT beta-lactamases, also known as AmpC beta-lactamases, are cephalosporinases that cannot be inhibited by clavulanate. These enzymes are encoded by genes located on the chromosome and can be induced by the presence of beta-lactam antibiotics. However recently, these genes have been found on plasmids and expressed at high constitutive levels in Escherichia coli and Klebsiella pneumoniae.", "category_aro_class_name": "AMR Gene Family"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35962": {"category_aro_accession": "0000044", "category_aro_cvterm_id": "35962", "category_aro_name": "cephamycin", "category_aro_description": "Cephamycins are a group of beta-lactam antibiotics, very similar to cephalosporins. Together with cephalosporins, they form a sub-group of antibiotics known as cephems. Cephamycins are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms. The 7-alpha-methoxy group increases resistance to beta-lactamases.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.28641, "max_identities": 21, "bit_score": 29.261, "cvterm_id": "35506", "query": "MLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEE", "match": "ML   A     +VK++ S ++A +A   + ++ +K  +ALAQ    WRV          GA+ +G G E", "sequence_from_db": "MLDAEAYGIKTNVKDMASWVVANMAPDALQDSSLKQGIALAQS-RYWRV----------GAMYQGLGWE", "sequence_from_broadstreet": "MMKKSLSCALLLSVACSAFAAPMSEKQLAKVVERAVTPLMNAQAIPGMAVAVIYQGQPHYFTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTRYWPELTGKQWQGIRMLDLATYTAGGLPLQVPDDVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGALAVKPSGMSFEEAMTKRVFKPLRLDHTWINVPKAEEAHYAWGYRDGKAVHVSPGMLDAEAYGIKTNVKDMASWVVANMAPDALQDSSLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVDAKTVVGGSDNKVALAPLPAREVNPPVPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLANKSYPNPARVETAYRILDALQ", "dna_sequence_from_broadstreet": "ATGATGAAAAAATCCCTAAGTTGTGCCCTGCTGCTCAGCGTTGCCTGCTCTGCCTTCGCCGCCCCCATGTCAGAAAAACAGCTGGCTAAGGTGGTGGAGCGTGCCGTTACGCCGCTGATGAACGCGCAGGCCATTCCGGGTATGGCGGTGGCGGTAATTTATCAGGGTCAGCCGCACTACTTTACCTTTGGTAAAGCGGATGTCGCGGCGAATAAACCTGTTACGCCTCAAACCTTGTTCGAGCTGGGCTCTATAAGTAAAACCTTCACCGGCGTATTGGGTGGCGATGCGATTGCTCGCGGTGAAATCTCACTGGGTGATCCAGTGACAAGGTACTGGCCTGAACTGACAGGAAAACAGTGGCAGGGCATTCGCATGCTGGATCTGGCAACCTATACCGCAGGGGGGTTGCCGTTACAGGTACCGGATGACGTCACTGATAACGCCTCTCTGCTGCGCTTTTATCAAAACTGGCAGCCGCAGTGGAAGCCGGGCACCACGCGTCTTTATGCCAACGCCAGCATCGGTCTTTTTGGTGCTCTCGCGGTTAAACCCTCCGGCATGAGTTTTGAAGAGGCCATGACGAAGCGGGTCTTTAAGCCGCTCAGGCTCGACCATACGTGGATTAACGTACCAAAAGCGGAAGAGGCGCATTACGCCTGGGGATACCGTGACGGTAAAGCGGTACACGTTTCTCCAGGGATGCTGGACGCTGAAGCCTATGGCATAAAAACCAACGTGAAAGATATGGCGAGCTGGGTGGTGGCAAACATGGCCCCCGATGCCCTTCAGGATAGCTCTCTCAAACAAGGGATAGCCCTGGCACAGTCCCGCTACTGGCGCGTGGGTGCCATGTATCAGGGGTTAGGCTGGGAAATGCTGAACTGGCCGGTCGATGCCAAAACCGTGGTCGGGGGCAGCGACAATAAGGTGGCGCTGGCGCCGTTGCCTGCCAGAGAAGTCAATCCCCCGGTACCGCCGGTTAAGGCCTCCTGGGTACACAAAACGGGTTCAACCGGTGGGTTTGGGAGCTACGTGGCATTTATTCCTGAAAAACAGCTCGGCATTGTGATGCTGGCGAATAAAAGCTATCCGAATCCGGCACGCGTTGAGACGGCATACCGTATCCTCGACGCGCTGCAGTAA", "partial": "0", "query_start": 38528, "query_end": 38734, "hit_start": 702, "hit_end": 876, "orf_dna_sequence": "ATGCTGCTGGAGGGAGAGCTGGAGGGGTACGAGGACGGGTTGGAACTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGCATAGCTACCCGCCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCGAGGACGTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGGGGCGTTGGGGGATCTGAGCGGGTCCACCGTCGACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGCGGTGGTGCTGGAGGGATTCGAGCACGAGGCGTTGCCGTGCCAGATTCCCTTGGTGCCGGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAAGAGGATGGTGGAGCACCACCAGCGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGTGCGGCTGCACGAGGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGAAGCTACATCGAGCAGATACTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGCTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGAGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGACCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCGGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGCTGCCGAACGGGAAGCTGGACCGGTTGTCGCTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAGCCTCGGCGGGCACTCCCTCCTGGCTGCCCAGCTGATTTCGCGCATACGGGCGACCTTCCGCGTGGAAGTGGCGATGGCCACGGTGTTCGAGTCCCCCACGGTGGAGCCGCTCGCCCGCCACATCGAGGAGAAGCTCAAGGACGAGTCTCGGGTCCAGCTCTCCAACGTTGTGCCGGTCGAGCGGACGCAGGAGATTCCGCTCTCCTACCTGCAGGAGCGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACATCACCTGGACGTTGCACTTCGCCGGCAAGGGTTTCTCGGTGGAGGCGTTGCGGACGGCCTTCGATGAGCTGGTGGCCAGACACGAGACACTGCGCACGTGGTTCCAGGTGGGGGAGGGGACAGAGCAGGCCGTACAGGTCATCGGGGAGCCCTGGTCGATGGAGCTGCCGCTGAGAGAGGTGGCGGGGACGGAGGTGACGGCGGCAATCAATGAGATGTCCCGACAGGTCTTCGACTTGAGAGCGGGACGGTTGCTGACGGCGGCGGTCCTGAGGGTGGCGGAGGATGAGCACATCCTCGTCAGCAACATCCACCACATCATCACGGACGGCTGGTCGTTCGGGGTGATGCTGCGGGAGCTGAGGGAGTTGTACGAGGCAGCGGTGCGGGGGAAGAGAGCGGAGCTGCCGCCGCTGACGGTGCAGTACGGCGACTATGCGGTGTGGCAGAGGAAGCAGGACCTGAGCGAGCACCTGGCGTACTGGAAGGGGAAGGTGGAGGAGTACGAGGACGGGTTGGAGCTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGTATAGCTACCCACCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCCAGGACGTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGAGCTGGAGAGCCTCATCGGGTTCTTCATCAACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGCGGTGGTGCTGGAGGGATTCGAGCACCAGGAGTTGCCGTTCGAGCACCTGCTGAAGGCGCTGAGGCGGCAGCGGGACAGCAGCCAGATTCCCTTGGTGCCAGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAGGAGGATGGTGGAGCACCACCAGCGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGGGCTGCACGAGGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGACACTACATCGAGCAGATATTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGTTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGGGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGGCCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCAGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGTTGCCGAACGGGAAGCTGGACCGGCTGTCGTTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAGCCTCGGCGGGCACTCCCTCCTGGCTGCCCAGGTGGTCTCAAGGATTGGCAAGGAGCTTGGCACTCAGATCTCGATCGCCGATCTGTTTCAAAGGCCCACGATTGAACAGCTCTGTGAGCTGATTGGAGGACTGGACGATCAGACCCAGAGGGAGCTCGCCCTCGCTCCGTCGGGGAACACCGAGGCGGTGCTCTCGTTCGCGCAAGAGCGCATGTGGTTCCTGCACAACTTCGTCAAGGGCATGCCCTACAACACGCCAGGGCTCGACCACCTGACGGGTGAGCTCGATGTCGCGGCGCTAGAAAAGGCCATCCGCGCGGTCATCCGTCGCCACGAGCCCCTGCGGACGAATTTCGTCGAGAAGGACGGGGTGCTGTCCCAGTTGGTGGGGACGGAAGAACGCTTCCGCCTGACCGTGACTCCCATCCGCGACGAGAGCGAGGTCGCGCGGCTCATGGAAGCCGTGATCCAAACGCCAGTCGATCTGGAGCGGGAGTTGATGATCCGGGCTTATCTCTACCGGGTCGACCCGCGGAATCACTACCTGTTCACCACCATCCATCACATCGCCTTCGATGGCTGGTCGACATCGATCTTCTACCGTGAGCTGGCTGCGTACTACGCCGCGTTTCTCCGGCGCGAAGACAGTCCGCTGCCCGCGCTGGAAATCTCCTATCAGGACTATGCCCGCTGGGAGCGGGCCCATTTCCAGGACGAGGTGTTGGCGGAAAAACTGAGGTACTGGCGGCAGCGGCTGTCGGGCGCTCGGCCCCTCGTACTTCCGACCACCTACCATCGGCCGCCCATCCAGAGTTTCGCTGGCGCCGTCGTGAACTTCGAGATCGATCGCTCCATCACCGAGCGGTTGAAGACGCTGTTCGCCGAGTCGGGCACCACGATGTACATGGTGTTGCTCGGCGCGTTCTCCGTGGTGCTGCAGCGCTACTCCGGTCAGGACGACATCTGCATCGGCTCCCCCGTGGCGAACCGGGGTCACATCCAGACAGAAGGGCTGATCGGCTTGTTCGTCAACACCCTGGTGATGAGGGTGGATGCCGCCGGGAATCCCCGTTTCATCGACCTGCTGGCGCGCATTCAACGGACAGCCATCGATGCTTACGCGAACCAAGAAGTGCCCTTCGAGAAGATCGTGGACGACCTGCAGGTCGCGAGAGACACGGCCCGATCTCCGCTCGTGCAGGTCATTCTCAACTTCCACAACACGCCTCCTCAATCCGAGCTGGAACTGCAGGGGGTGACCCTCACGCGGATGCCGGTGCACAACGGCACGGCCAAGTTCGAGCTCTCCATCGACGTCGCGGAGACGAGCGCCGGTCTAACGGGATTCGTGGAGTACGCGACGGATCTGTTCAGCGAGAACTTCATCCGGCGGATGATCGGCCACCTCGAGGTGGTGCTGGACGCGGTCGGTCGCGATCCGCGGGCGCCTATCCATGAGTTGCCACTGCTCACCCGGCAGGATCAGTTGGACCTACTGTCGCGGAGCGGCCACACAGCCCCCGCGGTGGAACACGTCGAGTTGATCCCTCATACGTTCGAGCGGCGCGTCCAGGAGAGCCCTCAAGCGATTGCCCTGGTCTGCGGTGACGAGCGCGTCACCTACTCCGCGCTCAACCGCCGGGCCAGCCAGATTGCCCGCCGCCTGCGCGCCGCAGGGATCGGACCGGACACCCTCGTCGGGCTTTGCGCGGGGCGCTCCATCGAGCTGGTCTGCGGCGTCCTTGGCATCTTGAAGGCGGGCGGTGCGTACGTGCCAATCGACCCCACCTCCTCGCCCGAGGTGATCTACGACGTCCTGTATGAGTCGAAGGTGCGGCATCTGTTGACCGAGTCGCGCCTGGTCGGGGGACTGCCGGTCGATGACCAGGAAATCCTGCTCCTGGATACCCCCGCGGACGGTGAAGGGGACAAGGCTGTTGCTGACCGGGAGGAGCCACCTGACCTTGGCGAGGTCAGCCTCACTCCCGAGTGCTTGGCGTACGTCAACTTCACCTCCGACTCCGGTGGGGCGCCGAGGGGCATCGCCGTCCGCCATGGGGCGCTGGCTCGCCGGATGGCCGCCGGCCACGCACAGTACCTGGCCAATTCCGCCGTACGTTTCCTGCTGAAGGCGCCGCTCACGTTCGACCTGGCGGTCGCGGAGCTGTTCCAGTGGATCGTCAGCGGCGGCAGCCTGAGCATCCTCGACCCCAATGCCGACCGCGACGCCTCTGCCTTCCTCGCGCAGGTGCGCAGGGACTCGATTGGCGTCCTCTACTGCGTCCCCTCCGAACTCTCGACGCTGGTGAGCCACCTGGAGCGCGAGCGTGAAAGGGTGCATGAGCTGAACACCCTCCGGTTCATCTTCTGCGGCGGGGATACCCTGGCGGTTACCGTCGTCGAGCGTCTCGGGGTACTGGTGCGGGCCGGCCAGCTCCCGCTGCGGCTGGTCAACGTCTATGGGACGAAGGAGACGGGAATCGGCGCGGGTTGCTTCGAGTGCGCGCTGGACGCGAACGACCCCAGCGCCGAACTCCCGCCGGGACGGCTCTCGCATGAGCGGATGCCCATCGGCGGGCCCGCCCAGAACCTGTGGTTCTATGTGGTGCAACCCAACGGTGGCCTGGCTCCGTTGGGCATCCCGGGGGAACTGTACGTCGGCGGCGCGCAACTCGCCGACGCCCGTTTCGGCGACGAGCCCACGGCGACCCACCCCGGCTTCGTCCCGAACCCCTTCCGGAGCGGAGCGGAGAAGGACTGGCTGTACAAGACGGGGGACCTCGTCCGCTGGCTGCCTCAGGGGCCGCTCGAGCTGGTCAGCGCGGCTCGGGAGCGCGACGGAGGCGGGGACCACCGGCTCGATCGCGGCTTCATCGAGGCGCGCATGCGTCGTGTGGCCATTGTCCGCGACGCCGTGGTGGCCTACGTCCCGGATCGCCAGGACAGGGCCCGGTTGGTGGCCTACGTCGTTCTGAAGGAGTCGCCCGCGGCGGACGTGGAGCCGCGCGAAGGGCGGGAAACGCTGAAGGCTCGGATCAGCGCCGAACTTGGGAGCACGTTGCCGGAGTACATGCTTCCGGCCGCCTACGTGTTCATGGACAGCCTGCCGTTGACGGCTTACGGGAGGATCGACCGGAAAGCCCTGCCCGAGCCGGAGGATGACCGCCACGGTGGTAGTGCGATCGCCTACGTGGCCCCGCGCGGGCCCACGGAGAAGGCACTGGCGCACATTTGGCAGCAAGTGCTGAAACGCCCCCAGGTCGGACTGCGAGACAACTTCTTTGAGCTGGGCGGGCACTCAGTGGCGGCCATCCAACTGGTGTCCGTGAGCCGGAAGCACCTGGAGGTCGAAGTCCCCCTCAGCCTGATCTTCGAATCGCCGGTCCTGGAGGCGATGGCGCGCGGCATCGAAGCGCTGCAACAGCAGGGCCGCAGCGGCGCGGTGTCGTCGATCCATCGGGTGGAGCGGACCGGACCGCTGCCTCTGGCGTACGTGCAGGAGAGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACATCACCTGGACGTTGCACTTCGCCGGCAAGGGTTTCTCGGTGGAGGCGTTGCGGACGGCCTTCGATGAGCTGGTGGCCAGACACGAGACACTGCGCACGTGGTTCCAGGTGGGGGAGGGGACAGAGCAGGCCGTACAGGTCATCGGGGAGCCCTGGTCGATGGAGCTGCCGCTGAGAGAGGTGGCGGGGACGGAGGTGACGGCGGCAATCAATGAGATGTCCCGGCAGGTCTTCGACTTGAGAGCGGGACGGTTGCTGACGGCGGCGGTCCTGAGGGTGGCGGAGGATGAGCACATCCTCGTCAGCAACATCCACCACATCATCACGGACGGCTGGTCGTTCGGGGTGATGCTGCGGGAGCTGAGGGAGTTGTACGAGGCCGCGGTGCGGGGGGAGCGAGCGGAGCTGCCGCCGCTGACGGTGCAGTACGGCGACTATGCGGTATGGCAGAGGAAGCAGGACCTGAGCGAGCACCTGGCGTACTGGAAGGGGAAGGTGGAGGGGGACGAGGACGGGTTGGAGCTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGTATAGCTACCACCCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCGAGGACCTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGAACTGGAGAGCCTCATCGGGTTCTTCATCAACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGTGGTGGTGCTGGAGGGATTCGAGCACCAGGAGTTGCCGTTCGAGCACCTGCTGAAGGCGCTGAGGCGGCAGCGGGACAGCAGCCAGATTCCCTTGGTGCCAGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAGGAGGATGGTGGAGCACCACCAACGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGGGCTGCACGAAGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGAAGCTACATCGAGCAGATACTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGCTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGAGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGACCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCAGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGTTGCCGAACGGGAAGCTGGACCGGCTGTCGTTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAACCTCGGCGGGCACTCCCTCCTGGCTTCCCAGCTGATTTCGCGCATACGGGCGACCTTCCGCGTGGAAGTGGCGATGGCCACGGTGTTCGAGTCCCCCACGGTGGAGCCGCTCGCCCGCCACATCGAGGAGAAGCTCAAGGACGAGTCTCGGGTCCAGCTCTCCAACGTTGTGCCGGTCGAGCGGACGCAGGAGCTTCCGCTCTCCTACCTGCAGGAGAGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACGGAACGATCGGGCTCCGGCTTCGGGGTCCTCTGTCAATCCCCGCGCTCAGGGCCACCTTCCACGATCTGGTCGCCCGTCACGAGAGCCTGCGCACCGTCTTCCGGGTCCCCGAAGGCCGCACCACGCCGGTGCAGGTGATTCTTGATTCGATGGATCTGGACATCCCGGTCCGCGATGCAACCGAGGCCGACATCATCCCGGGCATGGATGAGCTGGCGGGTCACATCTACGACATGGAGAAGGGTCCGCTGTTCATGGTTCGCCTCTTGCGGCTGGCCGAGGACTCCCACGTTCTCCTGATGGGGATGCATCACATCGTCTACGACGCATGGTCACAGTTCAATGTGATGAGTCGCGATATCAACCTGCTCTACTCGGCGCACGTGACGGGAATCGAGGCACGGCTTCCCGCGCTTCCCATCCAGTACGCCGACTTCTCGGTGTGGCAGCGCCAGCAGGACTTCCGTCACCACCTGGACTACTGGAAGTCCACACTGGGCGACTACCGGGATGATCTCGAGCTGCCGTATGACTACCCGCGGCCGCCCAGCCGGACATGGCACGCGACCCGATTCACCTTCCGGTATCCGGATGCACTGGCGCGCGCGTTCGCCAGGTTCAATCAGTCCCATCAGTCGACGCTGTTCATGGGGCTGCTGACCAGCTTCGCGATCGTGCTCAGGCACTACACCGGCCGGAACGACATCTGCATCGGAACGACAACGGCGGGGCGCGCCCAGTTGGAGTTGGAGAACCTCGTTGGCTTCTTCATCAACATCCTGCCGTTGCGCATCAATCTGGCGGGTGACCCCGACATCAGCGAGCTCATGAATCGAGCGAAGAAGAGCGTCTTGGGCGCCTTCGAGCATCAAGCTCTGCCGTTCGAGCGTCTCCTCAGTGCCCTCAACAAACAGCGTGACAGCAGCCATATCCCGCTGGTTCCCGTCATGTTGCGCCACCAGAACTTCCCGACGGCGATGACCGGCAAGTGGGCCGATGGTGTGGACATGGAGGTCATCGAGCGCGACGAGCGCACGACGCCCAACGAGCTGGACCTCCAGTTCTTTGGCGACGACACCTACTTGCATGCTGTCGTCGAGTTCCCCGCGCAGCTCTTCTCCGAGGTGACCGTCCGGCGTCTGATGCAGCGTCACCAGAAGGTCATAGAGTTCATGTGCGCGACGCTGGGGGCTCGGTGA", "orf_prot_sequence": "MLLEGELEGYEDGLELPYDFPRTSNRAWRAATFQHSYPPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGREDVCIGTTVAGRAQVGALGDLSGSTVDILPLRLDLSGAPSLHEVLRRTKAVVLEGFEHEALPCQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVKRMVEHHQRVLEALVEGLEEVRLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGSYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFSLGGHSLLAAQLISRIRATFRVEVAMATVFESPTVEPLARHIEEKLKDESRVQLSNVVPVERTQEIPLSYLQERLWFVHEHMKEQRTSYNITWTLHFAGKGFSVEALRTAFDELVARHETLRTWFQVGEGTEQAVQVIGEPWSMELPLREVAGTEVTAAINEMSRQVFDLRAGRLLTAAVLRVAEDEHILVSNIHHIITDGWSFGVMLRELRELYEAAVRGKRAELPPLTVQYGDYAVWQRKQDLSEHLAYWKGKVEEYEDGLELPYDFPRTSNRAWRAATFQYSYPPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGRQDVCIGTTVAGRAQVELESLIGFFINILPLRLDLSGAPSLHEVLRRTKAVVLEGFEHQELPFEHLLKALRRQRDSSQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVRRMVEHHQRVLEALVEGLEEGLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGHYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFSLGGHSLLAAQVVSRIGKELGTQISIADLFQRPTIEQLCELIGGLDDQTQRELALAPSGNTEAVLSFAQERMWFLHNFVKGMPYNTPGLDHLTGELDVAALEKAIRAVIRRHEPLRTNFVEKDGVLSQLVGTEERFRLTVTPIRDESEVARLMEAVIQTPVDLERELMIRAYLYRVDPRNHYLFTTIHHIAFDGWSTSIFYRELAAYYAAFLRREDSPLPALEISYQDYARWERAHFQDEVLAEKLRYWRQRLSGARPLVLPTTYHRPPIQSFAGAVVNFEIDRSITERLKTLFAESGTTMYMVLLGAFSVVLQRYSGQDDICIGSPVANRGHIQTEGLIGLFVNTLVMRVDAAGNPRFIDLLARIQRTAIDAYANQEVPFEKIVDDLQVARDTARSPLVQVILNFHNTPPQSELELQGVTLTRMPVHNGTAKFELSIDVAETSAGLTGFVEYATDLFSENFIRRMIGHLEVVLDAVGRDPRAPIHELPLLTRQDQLDLLSRSGHTAPAVEHVELIPHTFERRVQESPQAIALVCGDERVTYSALNRRASQIARRLRAAGIGPDTLVGLCAGRSIELVCGVLGILKAGGAYVPIDPTSSPEVIYDVLYESKVRHLLTESRLVGGLPVDDQEILLLDTPADGEGDKAVADREEPPDLGEVSLTPECLAYVNFTSDSGGAPRGIAVRHGALARRMAAGHAQYLANSAVRFLLKAPLTFDLAVAELFQWIVSGGSLSILDPNADRDASAFLAQVRRDSIGVLYCVPSELSTLVSHLERERERVHELNTLRFIFCGGDTLAVTVVERLGVLVRAGQLPLRLVNVYGTKETGIGAGCFECALDANDPSAELPPGRLSHERMPIGGPAQNLWFYVVQPNGGLAPLGIPGELYVGGAQLADARFGDEPTATHPGFVPNPFRSGAEKDWLYKTGDLVRWLPQGPLELVSAARERDGGGDHRLDRGFIEARMRRVAIVRDAVVAYVPDRQDRARLVAYVVLKESPAADVEPREGRETLKARISAELGSTLPEYMLPAAYVFMDSLPLTAYGRIDRKALPEPEDDRHGGSAIAYVAPRGPTEKALAHIWQQVLKRPQVGLRDNFFELGGHSVAAIQLVSVSRKHLEVEVPLSLIFESPVLEAMARGIEALQQQGRSGAVSSIHRVERTGPLPLAYVQERLWFVHEHMKEQRTSYNITWTLHFAGKGFSVEALRTAFDELVARHETLRTWFQVGEGTEQAVQVIGEPWSMELPLREVAGTEVTAAINEMSRQVFDLRAGRLLTAAVLRVAEDEHILVSNIHHIITDGWSFGVMLRELRELYEAAVRGERAELPPLTVQYGDYAVWQRKQDLSEHLAYWKGKVEGDEDGLELPYDFPRTSNRAWRAATFQYSYHPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGREDLCIGTTVAGRAQVELESLIGFFINILPLRLDLSGAPSLHEVLRRTKVVVLEGFEHQELPFEHLLKALRRQRDSSQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVRRMVEHHQRVLEALVEGLEEGLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGSYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFNLGGHSLLASQLISRIRATFRVEVAMATVFESPTVEPLARHIEEKLKDESRVQLSNVVPVERTQELPLSYLQERLWFVHEHMKEQRTSYNGTIGLRLRGPLSIPALRATFHDLVARHESLRTVFRVPEGRTTPVQVILDSMDLDIPVRDATEADIIPGMDELAGHIYDMEKGPLFMVRLLRLAEDSHVLLMGMHHIVYDAWSQFNVMSRDINLLYSAHVTGIEARLPALPIQYADFSVWQRQQDFRHHLDYWKSTLGDYRDDLELPYDYPRPPSRTWHATRFTFRYPDALARAFARFNQSHQSTLFMGLLTSFAIVLRHYTGRNDICIGTTTAGRAQLELENLVGFFINILPLRINLAGDPDISELMNRAKKSVLGAFEHQALPFERLLSALNKQRDSSHIPLVPVMLRHQNFPTAMTGKWADGVDMEVIERDERTTPNELDLQFFGDDTYLHAVVEFPAQLFSEVTVRRLMQRHQKVIEFMCATLGAR", "perc_identity": 30.43}, "gnl|BL_ORD_ID|450|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 27422, "orf_end": 41059, "orf_from": "BGC0001413.1|Cystobactamide_17 ", "model_name": "OpmD", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "920", "model_id": "442", "ARO_accession": "3000809", "ARO_name": "OpmD", "ARO_category": {"36005": {"category_aro_accession": "0010004", "category_aro_cvterm_id": "36005", "category_aro_name": "resistance-nodulation-cell division (RND) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Resistance-nodulation-division (RND) proteins are found in both prokaryotic and eukaryotic cells and have diverse substrate specificities and physiological roles. However, there are relatively few RND transporters and they are secondary transporters, energized not by ATP binding/hydrolysis but by proton movement down the transmembrane electrochemical gradient.", "category_aro_class_name": "AMR Gene Family"}, "35963": {"category_aro_accession": "0000045", "category_aro_cvterm_id": "35963", "category_aro_name": "acriflavine", "category_aro_description": "Acriflavine is a topical antiseptic. It has the form of an orange or brown powder. It may be harmful in the eyes or if inhaled. Acriflavine is also used as treatment for external fungal infections of aquarium fish.", "category_aro_class_name": "Antibiotic"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "43746": {"category_aro_accession": "3005386", "category_aro_cvterm_id": "43746", "category_aro_name": "disinfecting agents and antiseptics", "category_aro_description": "Disinfectants that can also interact with antimicrobial resistance mechanisms, e.g. molecule efflux, and thus are the targets of disinfectant resistance.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.29377, "max_identities": 19, "bit_score": 29.261, "cvterm_id": "36804", "query": "LPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFSL", "match": "LP G +DRL L  PD+ S+  +  A   +V    AE++  L     +G    FF+L", "sequence_from_db": "LPLGDVDRLILQRPDVVSAERQLAASTEDVGAATAELYPRL----DLGGFIGFFAL", "sequence_from_broadstreet": "MKRSYPNLSRLALALAVGTGLAACSVGPDYQRPQSPPPRVASEHLGEFSGERREAPWWSFFDDPQLVRLVDQALARNHDIREARANLRSARALFDDRWLDQLPQVTSQAGYSRSIEQQLDYDGEPRRRLAESYRAGFDAQWEIDLFGRLGRLSDAALARAEAADADLRLVRLSIAADTARAYFEIQGYQRRLDVARAQVRSWRDTLELTRSSLQLGSGLPEDVENAQANLLRSEAAIPPLTTALESARYRLDVLRGEAPGSGAPILDGGAAAPLAKNLPLGDVDRLILQRPDVVSAERQLAASTEDVGAATAELYPRLDLGGFIGFFALRSGDLGSASRAFELAPSVSWPAFRLGNVRARLRAVEAQSDAALARYQRSLLLAQEDVGNALNQLAEHQRRLVALFQSATHGANALEIANERYRAGAGSYLAVLENQRALYQIREELAQAETASFVNVIALYKALGWGSGDLAPGAGQLAAGETAGANR", "dna_sequence_from_broadstreet": "ATGAAGCGCTCCTACCCGAACCTTTCGCGCCTGGCGCTGGCCCTGGCGGTCGGCACCGGCCTGGCCGCCTGCAGCGTCGGCCCCGACTACCAGCGTCCGCAGTCGCCGCCGCCACGCGTCGCCAGCGAGCACCTCGGCGAGTTCTCCGGCGAGCGGCGGGAAGCGCCCTGGTGGAGTTTCTTCGACGATCCGCAACTGGTGCGCCTGGTCGACCAGGCGCTGGCGCGCAACCACGACATCCGCGAGGCCCGCGCCAACCTGCGCAGCGCCCGCGCGCTGTTCGACGACCGCTGGCTCGACCAGTTGCCGCAGGTCACCAGCCAGGCCGGCTACAGCCGCAGCATCGAACAACAGCTGGACTACGACGGCGAGCCGCGCCGGCGCCTGGCGGAGAGCTACCGCGCCGGCTTCGACGCGCAGTGGGAAATCGACCTGTTCGGCCGCCTCGGCCGACTTTCCGACGCCGCCTTGGCCCGCGCCGAAGCGGCCGACGCCGACCTCCGGCTGGTACGCCTGAGCATCGCCGCCGACACCGCCCGCGCCTACTTCGAGATCCAGGGCTACCAGCGCCGGCTGGACGTGGCGCGCGCCCAGGTGCGCAGTTGGCGCGACACCCTGGAGCTGACCCGCAGCAGCCTGCAACTGGGCAGCGGCCTGCCGGAGGACGTGGAGAACGCCCAGGCCAACCTGCTGCGCAGCGAAGCGGCGATTCCGCCACTGACGACCGCGCTGGAGAGCGCCCGCTATCGCCTCGACGTGCTGCGCGGCGAGGCACCCGGCAGCGGCGCGCCGATCCTCGACGGCGGCGCCGCCGCGCCATTGGCGAAGAACCTGCCGCTGGGCGACGTCGACCGCCTGATCCTCCAGCGCCCCGACGTAGTCAGCGCCGAGCGGCAACTGGCAGCGAGCACCGAAGACGTCGGCGCGGCCACCGCCGAACTCTATCCGCGCCTCGACCTGGGCGGCTTCATCGGTTTCTTCGCCCTGCGCAGCGGCGACCTCGGCAGCGCCTCGCGCGCCTTCGAACTGGCGCCCAGCGTCAGTTGGCCGGCGTTCCGCCTGGGCAACGTGCGGGCCCGCCTGCGCGCCGTCGAGGCGCAGTCCGACGCCGCGCTGGCGCGCTACCAGCGCTCCCTGCTGCTGGCCCAGGAGGACGTCGGCAACGCGCTCAACCAACTGGCCGAACACCAGCGTCGGCTGGTCGCCCTGTTCCAGTCCGCGACCCATGGCGCGAACGCCCTGGAGATCGCCAACGAACGCTACCGCGCCGGCGCCGGCAGCTACCTGGCGGTGCTGGAGAACCAGCGCGCGCTGTACCAGATCCGCGAGGAACTGGCGCAGGCGGAGACCGCCTCGTTCGTCAACGTCATCGCGCTCTACAAGGCGCTCGGCTGGGGCAGCGGCGACCTGGCGCCGGGCGCCGGCCAACTGGCCGCCGGCGAAACCGCCGGGGCCAACCGTTGA", "partial": "0", "query_start": 29699, "query_end": 29866, "hit_start": 831, "hit_end": 987, "orf_dna_sequence": "ATGCTGCTGGAGGGAGAGCTGGAGGGGTACGAGGACGGGTTGGAACTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGCATAGCTACCCGCCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCGAGGACGTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGGGGCGTTGGGGGATCTGAGCGGGTCCACCGTCGACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGCGGTGGTGCTGGAGGGATTCGAGCACGAGGCGTTGCCGTGCCAGATTCCCTTGGTGCCGGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAAGAGGATGGTGGAGCACCACCAGCGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGTGCGGCTGCACGAGGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGAAGCTACATCGAGCAGATACTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGCTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGAGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGACCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCGGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGCTGCCGAACGGGAAGCTGGACCGGTTGTCGCTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAGCCTCGGCGGGCACTCCCTCCTGGCTGCCCAGCTGATTTCGCGCATACGGGCGACCTTCCGCGTGGAAGTGGCGATGGCCACGGTGTTCGAGTCCCCCACGGTGGAGCCGCTCGCCCGCCACATCGAGGAGAAGCTCAAGGACGAGTCTCGGGTCCAGCTCTCCAACGTTGTGCCGGTCGAGCGGACGCAGGAGATTCCGCTCTCCTACCTGCAGGAGCGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACATCACCTGGACGTTGCACTTCGCCGGCAAGGGTTTCTCGGTGGAGGCGTTGCGGACGGCCTTCGATGAGCTGGTGGCCAGACACGAGACACTGCGCACGTGGTTCCAGGTGGGGGAGGGGACAGAGCAGGCCGTACAGGTCATCGGGGAGCCCTGGTCGATGGAGCTGCCGCTGAGAGAGGTGGCGGGGACGGAGGTGACGGCGGCAATCAATGAGATGTCCCGACAGGTCTTCGACTTGAGAGCGGGACGGTTGCTGACGGCGGCGGTCCTGAGGGTGGCGGAGGATGAGCACATCCTCGTCAGCAACATCCACCACATCATCACGGACGGCTGGTCGTTCGGGGTGATGCTGCGGGAGCTGAGGGAGTTGTACGAGGCAGCGGTGCGGGGGAAGAGAGCGGAGCTGCCGCCGCTGACGGTGCAGTACGGCGACTATGCGGTGTGGCAGAGGAAGCAGGACCTGAGCGAGCACCTGGCGTACTGGAAGGGGAAGGTGGAGGAGTACGAGGACGGGTTGGAGCTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGTATAGCTACCCACCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCCAGGACGTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGAGCTGGAGAGCCTCATCGGGTTCTTCATCAACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGCGGTGGTGCTGGAGGGATTCGAGCACCAGGAGTTGCCGTTCGAGCACCTGCTGAAGGCGCTGAGGCGGCAGCGGGACAGCAGCCAGATTCCCTTGGTGCCAGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAGGAGGATGGTGGAGCACCACCAGCGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGGGCTGCACGAGGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGACACTACATCGAGCAGATATTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGTTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGGGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGGCCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCAGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGTTGCCGAACGGGAAGCTGGACCGGCTGTCGTTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAGCCTCGGCGGGCACTCCCTCCTGGCTGCCCAGGTGGTCTCAAGGATTGGCAAGGAGCTTGGCACTCAGATCTCGATCGCCGATCTGTTTCAAAGGCCCACGATTGAACAGCTCTGTGAGCTGATTGGAGGACTGGACGATCAGACCCAGAGGGAGCTCGCCCTCGCTCCGTCGGGGAACACCGAGGCGGTGCTCTCGTTCGCGCAAGAGCGCATGTGGTTCCTGCACAACTTCGTCAAGGGCATGCCCTACAACACGCCAGGGCTCGACCACCTGACGGGTGAGCTCGATGTCGCGGCGCTAGAAAAGGCCATCCGCGCGGTCATCCGTCGCCACGAGCCCCTGCGGACGAATTTCGTCGAGAAGGACGGGGTGCTGTCCCAGTTGGTGGGGACGGAAGAACGCTTCCGCCTGACCGTGACTCCCATCCGCGACGAGAGCGAGGTCGCGCGGCTCATGGAAGCCGTGATCCAAACGCCAGTCGATCTGGAGCGGGAGTTGATGATCCGGGCTTATCTCTACCGGGTCGACCCGCGGAATCACTACCTGTTCACCACCATCCATCACATCGCCTTCGATGGCTGGTCGACATCGATCTTCTACCGTGAGCTGGCTGCGTACTACGCCGCGTTTCTCCGGCGCGAAGACAGTCCGCTGCCCGCGCTGGAAATCTCCTATCAGGACTATGCCCGCTGGGAGCGGGCCCATTTCCAGGACGAGGTGTTGGCGGAAAAACTGAGGTACTGGCGGCAGCGGCTGTCGGGCGCTCGGCCCCTCGTACTTCCGACCACCTACCATCGGCCGCCCATCCAGAGTTTCGCTGGCGCCGTCGTGAACTTCGAGATCGATCGCTCCATCACCGAGCGGTTGAAGACGCTGTTCGCCGAGTCGGGCACCACGATGTACATGGTGTTGCTCGGCGCGTTCTCCGTGGTGCTGCAGCGCTACTCCGGTCAGGACGACATCTGCATCGGCTCCCCCGTGGCGAACCGGGGTCACATCCAGACAGAAGGGCTGATCGGCTTGTTCGTCAACACCCTGGTGATGAGGGTGGATGCCGCCGGGAATCCCCGTTTCATCGACCTGCTGGCGCGCATTCAACGGACAGCCATCGATGCTTACGCGAACCAAGAAGTGCCCTTCGAGAAGATCGTGGACGACCTGCAGGTCGCGAGAGACACGGCCCGATCTCCGCTCGTGCAGGTCATTCTCAACTTCCACAACACGCCTCCTCAATCCGAGCTGGAACTGCAGGGGGTGACCCTCACGCGGATGCCGGTGCACAACGGCACGGCCAAGTTCGAGCTCTCCATCGACGTCGCGGAGACGAGCGCCGGTCTAACGGGATTCGTGGAGTACGCGACGGATCTGTTCAGCGAGAACTTCATCCGGCGGATGATCGGCCACCTCGAGGTGGTGCTGGACGCGGTCGGTCGCGATCCGCGGGCGCCTATCCATGAGTTGCCACTGCTCACCCGGCAGGATCAGTTGGACCTACTGTCGCGGAGCGGCCACACAGCCCCCGCGGTGGAACACGTCGAGTTGATCCCTCATACGTTCGAGCGGCGCGTCCAGGAGAGCCCTCAAGCGATTGCCCTGGTCTGCGGTGACGAGCGCGTCACCTACTCCGCGCTCAACCGCCGGGCCAGCCAGATTGCCCGCCGCCTGCGCGCCGCAGGGATCGGACCGGACACCCTCGTCGGGCTTTGCGCGGGGCGCTCCATCGAGCTGGTCTGCGGCGTCCTTGGCATCTTGAAGGCGGGCGGTGCGTACGTGCCAATCGACCCCACCTCCTCGCCCGAGGTGATCTACGACGTCCTGTATGAGTCGAAGGTGCGGCATCTGTTGACCGAGTCGCGCCTGGTCGGGGGACTGCCGGTCGATGACCAGGAAATCCTGCTCCTGGATACCCCCGCGGACGGTGAAGGGGACAAGGCTGTTGCTGACCGGGAGGAGCCACCTGACCTTGGCGAGGTCAGCCTCACTCCCGAGTGCTTGGCGTACGTCAACTTCACCTCCGACTCCGGTGGGGCGCCGAGGGGCATCGCCGTCCGCCATGGGGCGCTGGCTCGCCGGATGGCCGCCGGCCACGCACAGTACCTGGCCAATTCCGCCGTACGTTTCCTGCTGAAGGCGCCGCTCACGTTCGACCTGGCGGTCGCGGAGCTGTTCCAGTGGATCGTCAGCGGCGGCAGCCTGAGCATCCTCGACCCCAATGCCGACCGCGACGCCTCTGCCTTCCTCGCGCAGGTGCGCAGGGACTCGATTGGCGTCCTCTACTGCGTCCCCTCCGAACTCTCGACGCTGGTGAGCCACCTGGAGCGCGAGCGTGAAAGGGTGCATGAGCTGAACACCCTCCGGTTCATCTTCTGCGGCGGGGATACCCTGGCGGTTACCGTCGTCGAGCGTCTCGGGGTACTGGTGCGGGCCGGCCAGCTCCCGCTGCGGCTGGTCAACGTCTATGGGACGAAGGAGACGGGAATCGGCGCGGGTTGCTTCGAGTGCGCGCTGGACGCGAACGACCCCAGCGCCGAACTCCCGCCGGGACGGCTCTCGCATGAGCGGATGCCCATCGGCGGGCCCGCCCAGAACCTGTGGTTCTATGTGGTGCAACCCAACGGTGGCCTGGCTCCGTTGGGCATCCCGGGGGAACTGTACGTCGGCGGCGCGCAACTCGCCGACGCCCGTTTCGGCGACGAGCCCACGGCGACCCACCCCGGCTTCGTCCCGAACCCCTTCCGGAGCGGAGCGGAGAAGGACTGGCTGTACAAGACGGGGGACCTCGTCCGCTGGCTGCCTCAGGGGCCGCTCGAGCTGGTCAGCGCGGCTCGGGAGCGCGACGGAGGCGGGGACCACCGGCTCGATCGCGGCTTCATCGAGGCGCGCATGCGTCGTGTGGCCATTGTCCGCGACGCCGTGGTGGCCTACGTCCCGGATCGCCAGGACAGGGCCCGGTTGGTGGCCTACGTCGTTCTGAAGGAGTCGCCCGCGGCGGACGTGGAGCCGCGCGAAGGGCGGGAAACGCTGAAGGCTCGGATCAGCGCCGAACTTGGGAGCACGTTGCCGGAGTACATGCTTCCGGCCGCCTACGTGTTCATGGACAGCCTGCCGTTGACGGCTTACGGGAGGATCGACCGGAAAGCCCTGCCCGAGCCGGAGGATGACCGCCACGGTGGTAGTGCGATCGCCTACGTGGCCCCGCGCGGGCCCACGGAGAAGGCACTGGCGCACATTTGGCAGCAAGTGCTGAAACGCCCCCAGGTCGGACTGCGAGACAACTTCTTTGAGCTGGGCGGGCACTCAGTGGCGGCCATCCAACTGGTGTCCGTGAGCCGGAAGCACCTGGAGGTCGAAGTCCCCCTCAGCCTGATCTTCGAATCGCCGGTCCTGGAGGCGATGGCGCGCGGCATCGAAGCGCTGCAACAGCAGGGCCGCAGCGGCGCGGTGTCGTCGATCCATCGGGTGGAGCGGACCGGACCGCTGCCTCTGGCGTACGTGCAGGAGAGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACATCACCTGGACGTTGCACTTCGCCGGCAAGGGTTTCTCGGTGGAGGCGTTGCGGACGGCCTTCGATGAGCTGGTGGCCAGACACGAGACACTGCGCACGTGGTTCCAGGTGGGGGAGGGGACAGAGCAGGCCGTACAGGTCATCGGGGAGCCCTGGTCGATGGAGCTGCCGCTGAGAGAGGTGGCGGGGACGGAGGTGACGGCGGCAATCAATGAGATGTCCCGGCAGGTCTTCGACTTGAGAGCGGGACGGTTGCTGACGGCGGCGGTCCTGAGGGTGGCGGAGGATGAGCACATCCTCGTCAGCAACATCCACCACATCATCACGGACGGCTGGTCGTTCGGGGTGATGCTGCGGGAGCTGAGGGAGTTGTACGAGGCCGCGGTGCGGGGGGAGCGAGCGGAGCTGCCGCCGCTGACGGTGCAGTACGGCGACTATGCGGTATGGCAGAGGAAGCAGGACCTGAGCGAGCACCTGGCGTACTGGAAGGGGAAGGTGGAGGGGGACGAGGACGGGTTGGAGCTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGTATAGCTACCACCCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCGAGGACCTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGAACTGGAGAGCCTCATCGGGTTCTTCATCAACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGTGGTGGTGCTGGAGGGATTCGAGCACCAGGAGTTGCCGTTCGAGCACCTGCTGAAGGCGCTGAGGCGGCAGCGGGACAGCAGCCAGATTCCCTTGGTGCCAGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAGGAGGATGGTGGAGCACCACCAACGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGGGCTGCACGAAGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGAAGCTACATCGAGCAGATACTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGCTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGAGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGACCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCAGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGTTGCCGAACGGGAAGCTGGACCGGCTGTCGTTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAACCTCGGCGGGCACTCCCTCCTGGCTTCCCAGCTGATTTCGCGCATACGGGCGACCTTCCGCGTGGAAGTGGCGATGGCCACGGTGTTCGAGTCCCCCACGGTGGAGCCGCTCGCCCGCCACATCGAGGAGAAGCTCAAGGACGAGTCTCGGGTCCAGCTCTCCAACGTTGTGCCGGTCGAGCGGACGCAGGAGCTTCCGCTCTCCTACCTGCAGGAGAGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACGGAACGATCGGGCTCCGGCTTCGGGGTCCTCTGTCAATCCCCGCGCTCAGGGCCACCTTCCACGATCTGGTCGCCCGTCACGAGAGCCTGCGCACCGTCTTCCGGGTCCCCGAAGGCCGCACCACGCCGGTGCAGGTGATTCTTGATTCGATGGATCTGGACATCCCGGTCCGCGATGCAACCGAGGCCGACATCATCCCGGGCATGGATGAGCTGGCGGGTCACATCTACGACATGGAGAAGGGTCCGCTGTTCATGGTTCGCCTCTTGCGGCTGGCCGAGGACTCCCACGTTCTCCTGATGGGGATGCATCACATCGTCTACGACGCATGGTCACAGTTCAATGTGATGAGTCGCGATATCAACCTGCTCTACTCGGCGCACGTGACGGGAATCGAGGCACGGCTTCCCGCGCTTCCCATCCAGTACGCCGACTTCTCGGTGTGGCAGCGCCAGCAGGACTTCCGTCACCACCTGGACTACTGGAAGTCCACACTGGGCGACTACCGGGATGATCTCGAGCTGCCGTATGACTACCCGCGGCCGCCCAGCCGGACATGGCACGCGACCCGATTCACCTTCCGGTATCCGGATGCACTGGCGCGCGCGTTCGCCAGGTTCAATCAGTCCCATCAGTCGACGCTGTTCATGGGGCTGCTGACCAGCTTCGCGATCGTGCTCAGGCACTACACCGGCCGGAACGACATCTGCATCGGAACGACAACGGCGGGGCGCGCCCAGTTGGAGTTGGAGAACCTCGTTGGCTTCTTCATCAACATCCTGCCGTTGCGCATCAATCTGGCGGGTGACCCCGACATCAGCGAGCTCATGAATCGAGCGAAGAAGAGCGTCTTGGGCGCCTTCGAGCATCAAGCTCTGCCGTTCGAGCGTCTCCTCAGTGCCCTCAACAAACAGCGTGACAGCAGCCATATCCCGCTGGTTCCCGTCATGTTGCGCCACCAGAACTTCCCGACGGCGATGACCGGCAAGTGGGCCGATGGTGTGGACATGGAGGTCATCGAGCGCGACGAGCGCACGACGCCCAACGAGCTGGACCTCCAGTTCTTTGGCGACGACACCTACTTGCATGCTGTCGTCGAGTTCCCCGCGCAGCTCTTCTCCGAGGTGACCGTCCGGCGTCTGATGCAGCGTCACCAGAAGGTCATAGAGTTCATGTGCGCGACGCTGGGGGCTCGGTGA", "orf_prot_sequence": "MLLEGELEGYEDGLELPYDFPRTSNRAWRAATFQHSYPPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGREDVCIGTTVAGRAQVGALGDLSGSTVDILPLRLDLSGAPSLHEVLRRTKAVVLEGFEHEALPCQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVKRMVEHHQRVLEALVEGLEEVRLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGSYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFSLGGHSLLAAQLISRIRATFRVEVAMATVFESPTVEPLARHIEEKLKDESRVQLSNVVPVERTQEIPLSYLQERLWFVHEHMKEQRTSYNITWTLHFAGKGFSVEALRTAFDELVARHETLRTWFQVGEGTEQAVQVIGEPWSMELPLREVAGTEVTAAINEMSRQVFDLRAGRLLTAAVLRVAEDEHILVSNIHHIITDGWSFGVMLRELRELYEAAVRGKRAELPPLTVQYGDYAVWQRKQDLSEHLAYWKGKVEEYEDGLELPYDFPRTSNRAWRAATFQYSYPPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGRQDVCIGTTVAGRAQVELESLIGFFINILPLRLDLSGAPSLHEVLRRTKAVVLEGFEHQELPFEHLLKALRRQRDSSQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVRRMVEHHQRVLEALVEGLEEGLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGHYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFSLGGHSLLAAQVVSRIGKELGTQISIADLFQRPTIEQLCELIGGLDDQTQRELALAPSGNTEAVLSFAQERMWFLHNFVKGMPYNTPGLDHLTGELDVAALEKAIRAVIRRHEPLRTNFVEKDGVLSQLVGTEERFRLTVTPIRDESEVARLMEAVIQTPVDLERELMIRAYLYRVDPRNHYLFTTIHHIAFDGWSTSIFYRELAAYYAAFLRREDSPLPALEISYQDYARWERAHFQDEVLAEKLRYWRQRLSGARPLVLPTTYHRPPIQSFAGAVVNFEIDRSITERLKTLFAESGTTMYMVLLGAFSVVLQRYSGQDDICIGSPVANRGHIQTEGLIGLFVNTLVMRVDAAGNPRFIDLLARIQRTAIDAYANQEVPFEKIVDDLQVARDTARSPLVQVILNFHNTPPQSELELQGVTLTRMPVHNGTAKFELSIDVAETSAGLTGFVEYATDLFSENFIRRMIGHLEVVLDAVGRDPRAPIHELPLLTRQDQLDLLSRSGHTAPAVEHVELIPHTFERRVQESPQAIALVCGDERVTYSALNRRASQIARRLRAAGIGPDTLVGLCAGRSIELVCGVLGILKAGGAYVPIDPTSSPEVIYDVLYESKVRHLLTESRLVGGLPVDDQEILLLDTPADGEGDKAVADREEPPDLGEVSLTPECLAYVNFTSDSGGAPRGIAVRHGALARRMAAGHAQYLANSAVRFLLKAPLTFDLAVAELFQWIVSGGSLSILDPNADRDASAFLAQVRRDSIGVLYCVPSELSTLVSHLERERERVHELNTLRFIFCGGDTLAVTVVERLGVLVRAGQLPLRLVNVYGTKETGIGAGCFECALDANDPSAELPPGRLSHERMPIGGPAQNLWFYVVQPNGGLAPLGIPGELYVGGAQLADARFGDEPTATHPGFVPNPFRSGAEKDWLYKTGDLVRWLPQGPLELVSAARERDGGGDHRLDRGFIEARMRRVAIVRDAVVAYVPDRQDRARLVAYVVLKESPAADVEPREGRETLKARISAELGSTLPEYMLPAAYVFMDSLPLTAYGRIDRKALPEPEDDRHGGSAIAYVAPRGPTEKALAHIWQQVLKRPQVGLRDNFFELGGHSVAAIQLVSVSRKHLEVEVPLSLIFESPVLEAMARGIEALQQQGRSGAVSSIHRVERTGPLPLAYVQERLWFVHEHMKEQRTSYNITWTLHFAGKGFSVEALRTAFDELVARHETLRTWFQVGEGTEQAVQVIGEPWSMELPLREVAGTEVTAAINEMSRQVFDLRAGRLLTAAVLRVAEDEHILVSNIHHIITDGWSFGVMLRELRELYEAAVRGERAELPPLTVQYGDYAVWQRKQDLSEHLAYWKGKVEGDEDGLELPYDFPRTSNRAWRAATFQYSYHPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGREDLCIGTTVAGRAQVELESLIGFFINILPLRLDLSGAPSLHEVLRRTKVVVLEGFEHQELPFEHLLKALRRQRDSSQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVRRMVEHHQRVLEALVEGLEEGLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGSYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFNLGGHSLLASQLISRIRATFRVEVAMATVFESPTVEPLARHIEEKLKDESRVQLSNVVPVERTQELPLSYLQERLWFVHEHMKEQRTSYNGTIGLRLRGPLSIPALRATFHDLVARHESLRTVFRVPEGRTTPVQVILDSMDLDIPVRDATEADIIPGMDELAGHIYDMEKGPLFMVRLLRLAEDSHVLLMGMHHIVYDAWSQFNVMSRDINLLYSAHVTGIEARLPALPIQYADFSVWQRQQDFRHHLDYWKSTLGDYRDDLELPYDYPRPPSRTWHATRFTFRYPDALARAFARFNQSHQSTLFMGLLTSFAIVLRHYTGRNDICIGTTTAGRAQLELENLVGFFINILPLRINLAGDPDISELMNRAKKSVLGAFEHQALPFERLLSALNKQRDSSHIPLVPVMLRHQNFPTAMTGKWADGVDMEVIERDERTTPNELDLQFFGDDTYLHAVVEFPAQLFSEVTVRRLMQRHQKVIEFMCATLGAR", "perc_identity": 33.93}, "gnl|BL_ORD_ID|450|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 27422, "orf_end": 41059, "orf_from": "BGC0001413.1|Cystobactamide_17 ", "model_name": "OpmD", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "920", "model_id": "442", "ARO_accession": "3000809", "ARO_name": "OpmD", "ARO_category": {"36005": {"category_aro_accession": "0010004", "category_aro_cvterm_id": "36005", "category_aro_name": "resistance-nodulation-cell division (RND) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Resistance-nodulation-division (RND) proteins are found in both prokaryotic and eukaryotic cells and have diverse substrate specificities and physiological roles. However, there are relatively few RND transporters and they are secondary transporters, energized not by ATP binding/hydrolysis but by proton movement down the transmembrane electrochemical gradient.", "category_aro_class_name": "AMR Gene Family"}, "35963": {"category_aro_accession": "0000045", "category_aro_cvterm_id": "35963", "category_aro_name": "acriflavine", "category_aro_description": "Acriflavine is a topical antiseptic. It has the form of an orange or brown powder. It may be harmful in the eyes or if inhaled. Acriflavine is also used as treatment for external fungal infections of aquarium fish.", "category_aro_class_name": "Antibiotic"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "43746": {"category_aro_accession": "3005386", "category_aro_cvterm_id": "43746", "category_aro_name": "disinfecting agents and antiseptics", "category_aro_description": "Disinfectants that can also interact with antimicrobial resistance mechanisms, e.g. molecule efflux, and thus are the targets of disinfectant resistance.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.29377, "max_identities": 19, "bit_score": 29.261, "cvterm_id": "36804", "query": "LPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFSL", "match": "LP G +DRL L  PD+ S+  +  A   +V    AE++  L     +G    FF+L", "sequence_from_db": "LPLGDVDRLILQRPDVVSAERQLAASTEDVGAATAELYPRL----DLGGFIGFFAL", "sequence_from_broadstreet": "MKRSYPNLSRLALALAVGTGLAACSVGPDYQRPQSPPPRVASEHLGEFSGERREAPWWSFFDDPQLVRLVDQALARNHDIREARANLRSARALFDDRWLDQLPQVTSQAGYSRSIEQQLDYDGEPRRRLAESYRAGFDAQWEIDLFGRLGRLSDAALARAEAADADLRLVRLSIAADTARAYFEIQGYQRRLDVARAQVRSWRDTLELTRSSLQLGSGLPEDVENAQANLLRSEAAIPPLTTALESARYRLDVLRGEAPGSGAPILDGGAAAPLAKNLPLGDVDRLILQRPDVVSAERQLAASTEDVGAATAELYPRLDLGGFIGFFALRSGDLGSASRAFELAPSVSWPAFRLGNVRARLRAVEAQSDAALARYQRSLLLAQEDVGNALNQLAEHQRRLVALFQSATHGANALEIANERYRAGAGSYLAVLENQRALYQIREELAQAETASFVNVIALYKALGWGSGDLAPGAGQLAAGETAGANR", "dna_sequence_from_broadstreet": "ATGAAGCGCTCCTACCCGAACCTTTCGCGCCTGGCGCTGGCCCTGGCGGTCGGCACCGGCCTGGCCGCCTGCAGCGTCGGCCCCGACTACCAGCGTCCGCAGTCGCCGCCGCCACGCGTCGCCAGCGAGCACCTCGGCGAGTTCTCCGGCGAGCGGCGGGAAGCGCCCTGGTGGAGTTTCTTCGACGATCCGCAACTGGTGCGCCTGGTCGACCAGGCGCTGGCGCGCAACCACGACATCCGCGAGGCCCGCGCCAACCTGCGCAGCGCCCGCGCGCTGTTCGACGACCGCTGGCTCGACCAGTTGCCGCAGGTCACCAGCCAGGCCGGCTACAGCCGCAGCATCGAACAACAGCTGGACTACGACGGCGAGCCGCGCCGGCGCCTGGCGGAGAGCTACCGCGCCGGCTTCGACGCGCAGTGGGAAATCGACCTGTTCGGCCGCCTCGGCCGACTTTCCGACGCCGCCTTGGCCCGCGCCGAAGCGGCCGACGCCGACCTCCGGCTGGTACGCCTGAGCATCGCCGCCGACACCGCCCGCGCCTACTTCGAGATCCAGGGCTACCAGCGCCGGCTGGACGTGGCGCGCGCCCAGGTGCGCAGTTGGCGCGACACCCTGGAGCTGACCCGCAGCAGCCTGCAACTGGGCAGCGGCCTGCCGGAGGACGTGGAGAACGCCCAGGCCAACCTGCTGCGCAGCGAAGCGGCGATTCCGCCACTGACGACCGCGCTGGAGAGCGCCCGCTATCGCCTCGACGTGCTGCGCGGCGAGGCACCCGGCAGCGGCGCGCCGATCCTCGACGGCGGCGCCGCCGCGCCATTGGCGAAGAACCTGCCGCTGGGCGACGTCGACCGCCTGATCCTCCAGCGCCCCGACGTAGTCAGCGCCGAGCGGCAACTGGCAGCGAGCACCGAAGACGTCGGCGCGGCCACCGCCGAACTCTATCCGCGCCTCGACCTGGGCGGCTTCATCGGTTTCTTCGCCCTGCGCAGCGGCGACCTCGGCAGCGCCTCGCGCGCCTTCGAACTGGCGCCCAGCGTCAGTTGGCCGGCGTTCCGCCTGGGCAACGTGCGGGCCCGCCTGCGCGCCGTCGAGGCGCAGTCCGACGCCGCGCTGGCGCGCTACCAGCGCTCCCTGCTGCTGGCCCAGGAGGACGTCGGCAACGCGCTCAACCAACTGGCCGAACACCAGCGTCGGCTGGTCGCCCTGTTCCAGTCCGCGACCCATGGCGCGAACGCCCTGGAGATCGCCAACGAACGCTACCGCGCCGGCGCCGGCAGCTACCTGGCGGTGCTGGAGAACCAGCGCGCGCTGTACCAGATCCGCGAGGAACTGGCGCAGGCGGAGACCGCCTCGTTCGTCAACGTCATCGCGCTCTACAAGGCGCTCGGCTGGGGCAGCGGCGACCTGGCGCCGGGCGCCGGCCAACTGGCCGCCGGCGAAACCGCCGGGGCCAACCGTTGA", "partial": "0", "query_start": 32921, "query_end": 33088, "hit_start": 831, "hit_end": 987, "orf_dna_sequence": "ATGCTGCTGGAGGGAGAGCTGGAGGGGTACGAGGACGGGTTGGAACTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGCATAGCTACCCGCCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCGAGGACGTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGGGGCGTTGGGGGATCTGAGCGGGTCCACCGTCGACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGCGGTGGTGCTGGAGGGATTCGAGCACGAGGCGTTGCCGTGCCAGATTCCCTTGGTGCCGGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAAGAGGATGGTGGAGCACCACCAGCGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGTGCGGCTGCACGAGGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGAAGCTACATCGAGCAGATACTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGCTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGAGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGACCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCGGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGCTGCCGAACGGGAAGCTGGACCGGTTGTCGCTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAGCCTCGGCGGGCACTCCCTCCTGGCTGCCCAGCTGATTTCGCGCATACGGGCGACCTTCCGCGTGGAAGTGGCGATGGCCACGGTGTTCGAGTCCCCCACGGTGGAGCCGCTCGCCCGCCACATCGAGGAGAAGCTCAAGGACGAGTCTCGGGTCCAGCTCTCCAACGTTGTGCCGGTCGAGCGGACGCAGGAGATTCCGCTCTCCTACCTGCAGGAGCGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACATCACCTGGACGTTGCACTTCGCCGGCAAGGGTTTCTCGGTGGAGGCGTTGCGGACGGCCTTCGATGAGCTGGTGGCCAGACACGAGACACTGCGCACGTGGTTCCAGGTGGGGGAGGGGACAGAGCAGGCCGTACAGGTCATCGGGGAGCCCTGGTCGATGGAGCTGCCGCTGAGAGAGGTGGCGGGGACGGAGGTGACGGCGGCAATCAATGAGATGTCCCGACAGGTCTTCGACTTGAGAGCGGGACGGTTGCTGACGGCGGCGGTCCTGAGGGTGGCGGAGGATGAGCACATCCTCGTCAGCAACATCCACCACATCATCACGGACGGCTGGTCGTTCGGGGTGATGCTGCGGGAGCTGAGGGAGTTGTACGAGGCAGCGGTGCGGGGGAAGAGAGCGGAGCTGCCGCCGCTGACGGTGCAGTACGGCGACTATGCGGTGTGGCAGAGGAAGCAGGACCTGAGCGAGCACCTGGCGTACTGGAAGGGGAAGGTGGAGGAGTACGAGGACGGGTTGGAGCTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGTATAGCTACCCACCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCCAGGACGTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGAGCTGGAGAGCCTCATCGGGTTCTTCATCAACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGCGGTGGTGCTGGAGGGATTCGAGCACCAGGAGTTGCCGTTCGAGCACCTGCTGAAGGCGCTGAGGCGGCAGCGGGACAGCAGCCAGATTCCCTTGGTGCCAGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAGGAGGATGGTGGAGCACCACCAGCGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGGGCTGCACGAGGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGACACTACATCGAGCAGATATTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGTTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGGGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGGCCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCAGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGTTGCCGAACGGGAAGCTGGACCGGCTGTCGTTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAGCCTCGGCGGGCACTCCCTCCTGGCTGCCCAGGTGGTCTCAAGGATTGGCAAGGAGCTTGGCACTCAGATCTCGATCGCCGATCTGTTTCAAAGGCCCACGATTGAACAGCTCTGTGAGCTGATTGGAGGACTGGACGATCAGACCCAGAGGGAGCTCGCCCTCGCTCCGTCGGGGAACACCGAGGCGGTGCTCTCGTTCGCGCAAGAGCGCATGTGGTTCCTGCACAACTTCGTCAAGGGCATGCCCTACAACACGCCAGGGCTCGACCACCTGACGGGTGAGCTCGATGTCGCGGCGCTAGAAAAGGCCATCCGCGCGGTCATCCGTCGCCACGAGCCCCTGCGGACGAATTTCGTCGAGAAGGACGGGGTGCTGTCCCAGTTGGTGGGGACGGAAGAACGCTTCCGCCTGACCGTGACTCCCATCCGCGACGAGAGCGAGGTCGCGCGGCTCATGGAAGCCGTGATCCAAACGCCAGTCGATCTGGAGCGGGAGTTGATGATCCGGGCTTATCTCTACCGGGTCGACCCGCGGAATCACTACCTGTTCACCACCATCCATCACATCGCCTTCGATGGCTGGTCGACATCGATCTTCTACCGTGAGCTGGCTGCGTACTACGCCGCGTTTCTCCGGCGCGAAGACAGTCCGCTGCCCGCGCTGGAAATCTCCTATCAGGACTATGCCCGCTGGGAGCGGGCCCATTTCCAGGACGAGGTGTTGGCGGAAAAACTGAGGTACTGGCGGCAGCGGCTGTCGGGCGCTCGGCCCCTCGTACTTCCGACCACCTACCATCGGCCGCCCATCCAGAGTTTCGCTGGCGCCGTCGTGAACTTCGAGATCGATCGCTCCATCACCGAGCGGTTGAAGACGCTGTTCGCCGAGTCGGGCACCACGATGTACATGGTGTTGCTCGGCGCGTTCTCCGTGGTGCTGCAGCGCTACTCCGGTCAGGACGACATCTGCATCGGCTCCCCCGTGGCGAACCGGGGTCACATCCAGACAGAAGGGCTGATCGGCTTGTTCGTCAACACCCTGGTGATGAGGGTGGATGCCGCCGGGAATCCCCGTTTCATCGACCTGCTGGCGCGCATTCAACGGACAGCCATCGATGCTTACGCGAACCAAGAAGTGCCCTTCGAGAAGATCGTGGACGACCTGCAGGTCGCGAGAGACACGGCCCGATCTCCGCTCGTGCAGGTCATTCTCAACTTCCACAACACGCCTCCTCAATCCGAGCTGGAACTGCAGGGGGTGACCCTCACGCGGATGCCGGTGCACAACGGCACGGCCAAGTTCGAGCTCTCCATCGACGTCGCGGAGACGAGCGCCGGTCTAACGGGATTCGTGGAGTACGCGACGGATCTGTTCAGCGAGAACTTCATCCGGCGGATGATCGGCCACCTCGAGGTGGTGCTGGACGCGGTCGGTCGCGATCCGCGGGCGCCTATCCATGAGTTGCCACTGCTCACCCGGCAGGATCAGTTGGACCTACTGTCGCGGAGCGGCCACACAGCCCCCGCGGTGGAACACGTCGAGTTGATCCCTCATACGTTCGAGCGGCGCGTCCAGGAGAGCCCTCAAGCGATTGCCCTGGTCTGCGGTGACGAGCGCGTCACCTACTCCGCGCTCAACCGCCGGGCCAGCCAGATTGCCCGCCGCCTGCGCGCCGCAGGGATCGGACCGGACACCCTCGTCGGGCTTTGCGCGGGGCGCTCCATCGAGCTGGTCTGCGGCGTCCTTGGCATCTTGAAGGCGGGCGGTGCGTACGTGCCAATCGACCCCACCTCCTCGCCCGAGGTGATCTACGACGTCCTGTATGAGTCGAAGGTGCGGCATCTGTTGACCGAGTCGCGCCTGGTCGGGGGACTGCCGGTCGATGACCAGGAAATCCTGCTCCTGGATACCCCCGCGGACGGTGAAGGGGACAAGGCTGTTGCTGACCGGGAGGAGCCACCTGACCTTGGCGAGGTCAGCCTCACTCCCGAGTGCTTGGCGTACGTCAACTTCACCTCCGACTCCGGTGGGGCGCCGAGGGGCATCGCCGTCCGCCATGGGGCGCTGGCTCGCCGGATGGCCGCCGGCCACGCACAGTACCTGGCCAATTCCGCCGTACGTTTCCTGCTGAAGGCGCCGCTCACGTTCGACCTGGCGGTCGCGGAGCTGTTCCAGTGGATCGTCAGCGGCGGCAGCCTGAGCATCCTCGACCCCAATGCCGACCGCGACGCCTCTGCCTTCCTCGCGCAGGTGCGCAGGGACTCGATTGGCGTCCTCTACTGCGTCCCCTCCGAACTCTCGACGCTGGTGAGCCACCTGGAGCGCGAGCGTGAAAGGGTGCATGAGCTGAACACCCTCCGGTTCATCTTCTGCGGCGGGGATACCCTGGCGGTTACCGTCGTCGAGCGTCTCGGGGTACTGGTGCGGGCCGGCCAGCTCCCGCTGCGGCTGGTCAACGTCTATGGGACGAAGGAGACGGGAATCGGCGCGGGTTGCTTCGAGTGCGCGCTGGACGCGAACGACCCCAGCGCCGAACTCCCGCCGGGACGGCTCTCGCATGAGCGGATGCCCATCGGCGGGCCCGCCCAGAACCTGTGGTTCTATGTGGTGCAACCCAACGGTGGCCTGGCTCCGTTGGGCATCCCGGGGGAACTGTACGTCGGCGGCGCGCAACTCGCCGACGCCCGTTTCGGCGACGAGCCCACGGCGACCCACCCCGGCTTCGTCCCGAACCCCTTCCGGAGCGGAGCGGAGAAGGACTGGCTGTACAAGACGGGGGACCTCGTCCGCTGGCTGCCTCAGGGGCCGCTCGAGCTGGTCAGCGCGGCTCGGGAGCGCGACGGAGGCGGGGACCACCGGCTCGATCGCGGCTTCATCGAGGCGCGCATGCGTCGTGTGGCCATTGTCCGCGACGCCGTGGTGGCCTACGTCCCGGATCGCCAGGACAGGGCCCGGTTGGTGGCCTACGTCGTTCTGAAGGAGTCGCCCGCGGCGGACGTGGAGCCGCGCGAAGGGCGGGAAACGCTGAAGGCTCGGATCAGCGCCGAACTTGGGAGCACGTTGCCGGAGTACATGCTTCCGGCCGCCTACGTGTTCATGGACAGCCTGCCGTTGACGGCTTACGGGAGGATCGACCGGAAAGCCCTGCCCGAGCCGGAGGATGACCGCCACGGTGGTAGTGCGATCGCCTACGTGGCCCCGCGCGGGCCCACGGAGAAGGCACTGGCGCACATTTGGCAGCAAGTGCTGAAACGCCCCCAGGTCGGACTGCGAGACAACTTCTTTGAGCTGGGCGGGCACTCAGTGGCGGCCATCCAACTGGTGTCCGTGAGCCGGAAGCACCTGGAGGTCGAAGTCCCCCTCAGCCTGATCTTCGAATCGCCGGTCCTGGAGGCGATGGCGCGCGGCATCGAAGCGCTGCAACAGCAGGGCCGCAGCGGCGCGGTGTCGTCGATCCATCGGGTGGAGCGGACCGGACCGCTGCCTCTGGCGTACGTGCAGGAGAGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACATCACCTGGACGTTGCACTTCGCCGGCAAGGGTTTCTCGGTGGAGGCGTTGCGGACGGCCTTCGATGAGCTGGTGGCCAGACACGAGACACTGCGCACGTGGTTCCAGGTGGGGGAGGGGACAGAGCAGGCCGTACAGGTCATCGGGGAGCCCTGGTCGATGGAGCTGCCGCTGAGAGAGGTGGCGGGGACGGAGGTGACGGCGGCAATCAATGAGATGTCCCGGCAGGTCTTCGACTTGAGAGCGGGACGGTTGCTGACGGCGGCGGTCCTGAGGGTGGCGGAGGATGAGCACATCCTCGTCAGCAACATCCACCACATCATCACGGACGGCTGGTCGTTCGGGGTGATGCTGCGGGAGCTGAGGGAGTTGTACGAGGCCGCGGTGCGGGGGGAGCGAGCGGAGCTGCCGCCGCTGACGGTGCAGTACGGCGACTATGCGGTATGGCAGAGGAAGCAGGACCTGAGCGAGCACCTGGCGTACTGGAAGGGGAAGGTGGAGGGGGACGAGGACGGGTTGGAGCTGCCGTACGACTTCCCGCGGACGTCGAATAGGGCGTGGAGAGCGGCGACGTTCCAGTATAGCTACCACCCCGAGCTGGCGAGGAAGGTGGCGGAGCTCAGCCGGGAGCAGCAGTCCACGCTGTTCATGAGCCTGGTGGCGAGCCTGGCGGTGGTGTTGAACCGGTACACGGGCCGCGAGGACCTGTGCATCGGGACGACGGTGGCGGGCCGAGCGCAGGTGGAACTGGAGAGCCTCATCGGGTTCTTCATCAACATCCTCCCGCTGAGGCTGGACCTGTCGGGCGCTCCGAGCCTTCACGAGGTGCTGCGGAGGACGAAGGTGGTGGTGCTGGAGGGATTCGAGCACCAGGAGTTGCCGTTCGAGCACCTGCTGAAGGCGCTGAGGCGGCAGCGGGACAGCAGCCAGATTCCCTTGGTGCCAGTGGTGGTGAGGCACCAGAACTTCCCGATGGCGCGTCTGGAGGGCTGGAGTGAGGGGGTGGAGCTGAAGAAGTTCGAGCTGGCGGGGGAAAGGACGACGGCGAGCGAGCAGGACTGGCAGTTCTTCGGGGACGGGTCCTCGCTGGAGCTGAGCCTGGAGTACGCGGCGGAGCTGTTCAGCGAGAAGACGGTGAGGAGGATGGTGGAGCACCACCAACGAGTGCTGGAGGCGCTGGTGGAGGGGCTGGAGGAGGGGCTGCACGAAGTGCGGCTGCTGACGGAGGAGGAGGAGGGGCTGCACGGGAGGTTGAACGACACGGCGCGAGAGCTGGAGGAGCGCTGGAGCCTGGCGGAGACGTTCGAGCGTCAGGTGAGGGAGACACCGGAGGCGGTGGCTTGCGTTGGCGTGGAGGTGGCGACGGGAGGGCACTCGCGGCCGACATACCGGCAGCTGACATACCGGCAGCTGAATGCGCGAGCCAACCAGGTGGCACGGAGGCTGAGGGCACTGGGAGTGGGCGCGGAGACACGGGTCGCGGTCTTGAGCGACCGCTCGCCGGAGCTGCTGGTGGCGATGCTGGCGATATTCAAGGCCGGGGGCTGCTACGTGCCGGTGGACCCACAGTACCCGGGAAGCTACATCGAGCAGATACTGGAGGATGCGGCACCGCAGGTGGTGTTGGGCAAGAGGGGAAGAGCGGACGGGGTGCGGGTGGATGTGTGGCTGGAGCTGGATGGAGCGCAACGGCTGACGGACGAGGCGCTGGCGGCACAGGAAGAGGGAGAGCTGGAGGGGGCGGAGAGGCCGGAGAGCCAGCAGTTGGCGTGTTTGATGTACACGTCGGGCTCCACGGGCAGACCGAAGGGGGTGATGGTGCCGTACAGCCAGTTGCACAACTGGCTGGAGGCGGGGAAGGAGCGCTCGCCGCTCGAGCGTGGGGAAGTAATGTTGCAGAAGACGGCAATCGCGTTCGCGGTGTCGGTGAAGGAGCTGCTGAGCGGATTGCTGGCGGGAGTGGCGCAGGTGATGGTGCCGGAGACGCTGGTGAAGGACAGCGTGGCGCTGGCGCAGGAGATAGAGCGGTGGCGGGTGACGAGAATCCACCTGGTGCCATCGCACCTGGGAGCACTGCTGGAGGGGGCGGGGGAAGAGGCGAAGGGGCTGAGGTCGCTGAAGTACGTCATAACGGCGGGGGAGGCACTGGCGCAGGGGGTGAGGGAGGAGGCGAGGAGGAAGCTGCCGGGGGCGCAGTTGTGGAACAACTACGGGTGCACGGAGCTGAATGACGTGACGTACCACCCCGCGAGCGAGGGGGGAGGGGACACGGTATTCGTGCCAATCGGGCGGCCCATCGCGAACACGCGGGTGTACGTGTTGGACGAGCAGTTGAGGCGGGTGCCGGTGGGGGTGATGGGGGAGTTGTATGTGGACAGCGTGGGGATGGCGAGGGGGTATTGGGGCCAGCCAGCGCTGACGGCGGAGCGCTTCATCGCGAACCCGTACGCGAGCCAGCCCGGAGCGAGGTTGTACCGGACGGGAGACATGGTGAGGGTGCTGGCGGACGGCTCGCTGGAGTACCTGGGGAGGCGAGACTACGAGATAAAGGTGAGAGGGCACCGGGTGGACGTGCGCCAGGTGGAGAAGGTGGCGAACGCGCATCCAGCCATCCGCCAGGCGGTGGTGTCGGGATGGCCGTTGGGCTCGAGCAACGCGCAGTTGGTGGCCTACCTGGTGCCGCAGGCGGGCGCGACGGTGGGGCCGCGGCAGGTGAGGGATTACCTGGCGGAGTCGCTGCCAGCGTACATGGTGCCAACGCTATACACGGTGTTGGAGGAGTTGCCGCGGTTGCCGAACGGGAAGCTGGACCGGCTGTCGTTGCCGGAGCCGGACCTGTCGAGCAGCCGAGAGGAGTACGTCGCGCCCCACGGCGAGGTCGAGCGGAAGCTGGCGGAAATCTTCGGCAACCTCCTGGGGCTCGAACATGTCGGCGTCCACGACAACTTCTTCAACCTCGGCGGGCACTCCCTCCTGGCTTCCCAGCTGATTTCGCGCATACGGGCGACCTTCCGCGTGGAAGTGGCGATGGCCACGGTGTTCGAGTCCCCCACGGTGGAGCCGCTCGCCCGCCACATCGAGGAGAAGCTCAAGGACGAGTCTCGGGTCCAGCTCTCCAACGTTGTGCCGGTCGAGCGGACGCAGGAGCTTCCGCTCTCCTACCTGCAGGAGAGGCTGTGGTTCGTGCACGAGCACATGAAGGAGCAGCGGACCAGCTATAACGGAACGATCGGGCTCCGGCTTCGGGGTCCTCTGTCAATCCCCGCGCTCAGGGCCACCTTCCACGATCTGGTCGCCCGTCACGAGAGCCTGCGCACCGTCTTCCGGGTCCCCGAAGGCCGCACCACGCCGGTGCAGGTGATTCTTGATTCGATGGATCTGGACATCCCGGTCCGCGATGCAACCGAGGCCGACATCATCCCGGGCATGGATGAGCTGGCGGGTCACATCTACGACATGGAGAAGGGTCCGCTGTTCATGGTTCGCCTCTTGCGGCTGGCCGAGGACTCCCACGTTCTCCTGATGGGGATGCATCACATCGTCTACGACGCATGGTCACAGTTCAATGTGATGAGTCGCGATATCAACCTGCTCTACTCGGCGCACGTGACGGGAATCGAGGCACGGCTTCCCGCGCTTCCCATCCAGTACGCCGACTTCTCGGTGTGGCAGCGCCAGCAGGACTTCCGTCACCACCTGGACTACTGGAAGTCCACACTGGGCGACTACCGGGATGATCTCGAGCTGCCGTATGACTACCCGCGGCCGCCCAGCCGGACATGGCACGCGACCCGATTCACCTTCCGGTATCCGGATGCACTGGCGCGCGCGTTCGCCAGGTTCAATCAGTCCCATCAGTCGACGCTGTTCATGGGGCTGCTGACCAGCTTCGCGATCGTGCTCAGGCACTACACCGGCCGGAACGACATCTGCATCGGAACGACAACGGCGGGGCGCGCCCAGTTGGAGTTGGAGAACCTCGTTGGCTTCTTCATCAACATCCTGCCGTTGCGCATCAATCTGGCGGGTGACCCCGACATCAGCGAGCTCATGAATCGAGCGAAGAAGAGCGTCTTGGGCGCCTTCGAGCATCAAGCTCTGCCGTTCGAGCGTCTCCTCAGTGCCCTCAACAAACAGCGTGACAGCAGCCATATCCCGCTGGTTCCCGTCATGTTGCGCCACCAGAACTTCCCGACGGCGATGACCGGCAAGTGGGCCGATGGTGTGGACATGGAGGTCATCGAGCGCGACGAGCGCACGACGCCCAACGAGCTGGACCTCCAGTTCTTTGGCGACGACACCTACTTGCATGCTGTCGTCGAGTTCCCCGCGCAGCTCTTCTCCGAGGTGACCGTCCGGCGTCTGATGCAGCGTCACCAGAAGGTCATAGAGTTCATGTGCGCGACGCTGGGGGCTCGGTGA", "orf_prot_sequence": "MLLEGELEGYEDGLELPYDFPRTSNRAWRAATFQHSYPPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGREDVCIGTTVAGRAQVGALGDLSGSTVDILPLRLDLSGAPSLHEVLRRTKAVVLEGFEHEALPCQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVKRMVEHHQRVLEALVEGLEEVRLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGSYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFSLGGHSLLAAQLISRIRATFRVEVAMATVFESPTVEPLARHIEEKLKDESRVQLSNVVPVERTQEIPLSYLQERLWFVHEHMKEQRTSYNITWTLHFAGKGFSVEALRTAFDELVARHETLRTWFQVGEGTEQAVQVIGEPWSMELPLREVAGTEVTAAINEMSRQVFDLRAGRLLTAAVLRVAEDEHILVSNIHHIITDGWSFGVMLRELRELYEAAVRGKRAELPPLTVQYGDYAVWQRKQDLSEHLAYWKGKVEEYEDGLELPYDFPRTSNRAWRAATFQYSYPPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGRQDVCIGTTVAGRAQVELESLIGFFINILPLRLDLSGAPSLHEVLRRTKAVVLEGFEHQELPFEHLLKALRRQRDSSQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVRRMVEHHQRVLEALVEGLEEGLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGHYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFSLGGHSLLAAQVVSRIGKELGTQISIADLFQRPTIEQLCELIGGLDDQTQRELALAPSGNTEAVLSFAQERMWFLHNFVKGMPYNTPGLDHLTGELDVAALEKAIRAVIRRHEPLRTNFVEKDGVLSQLVGTEERFRLTVTPIRDESEVARLMEAVIQTPVDLERELMIRAYLYRVDPRNHYLFTTIHHIAFDGWSTSIFYRELAAYYAAFLRREDSPLPALEISYQDYARWERAHFQDEVLAEKLRYWRQRLSGARPLVLPTTYHRPPIQSFAGAVVNFEIDRSITERLKTLFAESGTTMYMVLLGAFSVVLQRYSGQDDICIGSPVANRGHIQTEGLIGLFVNTLVMRVDAAGNPRFIDLLARIQRTAIDAYANQEVPFEKIVDDLQVARDTARSPLVQVILNFHNTPPQSELELQGVTLTRMPVHNGTAKFELSIDVAETSAGLTGFVEYATDLFSENFIRRMIGHLEVVLDAVGRDPRAPIHELPLLTRQDQLDLLSRSGHTAPAVEHVELIPHTFERRVQESPQAIALVCGDERVTYSALNRRASQIARRLRAAGIGPDTLVGLCAGRSIELVCGVLGILKAGGAYVPIDPTSSPEVIYDVLYESKVRHLLTESRLVGGLPVDDQEILLLDTPADGEGDKAVADREEPPDLGEVSLTPECLAYVNFTSDSGGAPRGIAVRHGALARRMAAGHAQYLANSAVRFLLKAPLTFDLAVAELFQWIVSGGSLSILDPNADRDASAFLAQVRRDSIGVLYCVPSELSTLVSHLERERERVHELNTLRFIFCGGDTLAVTVVERLGVLVRAGQLPLRLVNVYGTKETGIGAGCFECALDANDPSAELPPGRLSHERMPIGGPAQNLWFYVVQPNGGLAPLGIPGELYVGGAQLADARFGDEPTATHPGFVPNPFRSGAEKDWLYKTGDLVRWLPQGPLELVSAARERDGGGDHRLDRGFIEARMRRVAIVRDAVVAYVPDRQDRARLVAYVVLKESPAADVEPREGRETLKARISAELGSTLPEYMLPAAYVFMDSLPLTAYGRIDRKALPEPEDDRHGGSAIAYVAPRGPTEKALAHIWQQVLKRPQVGLRDNFFELGGHSVAAIQLVSVSRKHLEVEVPLSLIFESPVLEAMARGIEALQQQGRSGAVSSIHRVERTGPLPLAYVQERLWFVHEHMKEQRTSYNITWTLHFAGKGFSVEALRTAFDELVARHETLRTWFQVGEGTEQAVQVIGEPWSMELPLREVAGTEVTAAINEMSRQVFDLRAGRLLTAAVLRVAEDEHILVSNIHHIITDGWSFGVMLRELRELYEAAVRGERAELPPLTVQYGDYAVWQRKQDLSEHLAYWKGKVEGDEDGLELPYDFPRTSNRAWRAATFQYSYHPELARKVAELSREQQSTLFMSLVASLAVVLNRYTGREDLCIGTTVAGRAQVELESLIGFFINILPLRLDLSGAPSLHEVLRRTKVVVLEGFEHQELPFEHLLKALRRQRDSSQIPLVPVVVRHQNFPMARLEGWSEGVELKKFELAGERTTASEQDWQFFGDGSSLELSLEYAAELFSEKTVRRMVEHHQRVLEALVEGLEEGLHEVRLLTEEEEGLHGRLNDTARELEERWSLAETFERQVRETPEAVACVGVEVATGGHSRPTYRQLTYRQLNARANQVARRLRALGVGAETRVAVLSDRSPELLVAMLAIFKAGGCYVPVDPQYPGSYIEQILEDAAPQVVLGKRGRADGVRVDVWLELDGAQRLTDEALAAQEEGELEGAERPESQQLACLMYTSGSTGRPKGVMVPYSQLHNWLEAGKERSPLERGEVMLQKTAIAFAVSVKELLSGLLAGVAQVMVPETLVKDSVALAQEIERWRVTRIHLVPSHLGALLEGAGEEAKGLRSLKYVITAGEALAQGVREEARRKLPGAQLWNNYGCTELNDVTYHPASEGGGDTVFVPIGRPIANTRVYVLDEQLRRVPVGVMGELYVDSVGMARGYWGQPALTAERFIANPYASQPGARLYRTGDMVRVLADGSLEYLGRRDYEIKVRGHRVDVRQVEKVANAHPAIRQAVVSGWPLGSSNAQLVAYLVPQAGATVGPRQVRDYLAESLPAYMVPTLYTVLEELPRLPNGKLDRLSLPEPDLSSSREEYVAPHGEVERKLAEIFGNLLGLEHVGVHDNFFNLGGHSLLASQLISRIRATFRVEVAMATVFESPTVEPLARHIEEKLKDESRVQLSNVVPVERTQELPLSYLQERLWFVHEHMKEQRTSYNGTIGLRLRGPLSIPALRATFHDLVARHESLRTVFRVPEGRTTPVQVILDSMDLDIPVRDATEADIIPGMDELAGHIYDMEKGPLFMVRLLRLAEDSHVLLMGMHHIVYDAWSQFNVMSRDINLLYSAHVTGIEARLPALPIQYADFSVWQRQQDFRHHLDYWKSTLGDYRDDLELPYDYPRPPSRTWHATRFTFRYPDALARAFARFNQSHQSTLFMGLLTSFAIVLRHYTGRNDICIGTTTAGRAQLELENLVGFFINILPLRINLAGDPDISELMNRAKKSVLGAFEHQALPFERLLSALNKQRDSSHIPLVPVMLRHQNFPTAMTGKWADGVDMEVIERDERTTPNELDLQFFGDDTYLHAVVEFPAQLFSEVTVRRLMQRHQKVIEFMCATLGAR", "perc_identity": 33.93}}, "BGC0001413.1|Cystobactamide_18 # 41056 # 44127 # 1 # ID=1_18;partial=00;start_type=GTG;rbs_motif=GGGGG;rbs_spacer=4bp;gc_cont=0.670": {"gnl|BL_ORD_ID|4935|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 41056, "orf_end": 44127, "orf_from": "BGC0001413.1|Cystobactamide_18 ", "model_name": "almE", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1000", "model_id": "5928", "ARO_accession": "3007433", "ARO_name": "almE", "ARO_category": {"46184": {"category_aro_accession": "3007428", "category_aro_cvterm_id": "46184", "category_aro_name": "polymyxin resistance operon", "category_aro_description": "Operon or gene clusters confering resistance to polymyxin antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "46188": {"category_aro_accession": "3007432", "category_aro_cvterm_id": "46188", "category_aro_name": "alm glycyltransferase", "category_aro_description": "Glycyl transferase associated with polymyxin resistance operons not interacting with lipid A.", "category_aro_class_name": "AMR Gene Family"}, "36966": {"category_aro_accession": "3000622", "category_aro_cvterm_id": "36966", "category_aro_name": "colistin A", "category_aro_description": "Colistin A, or polymyxin E1, has a 6-octanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "36968": {"category_aro_accession": "3000624", "category_aro_cvterm_id": "36968", "category_aro_name": "colistin B", "category_aro_description": "Colistin B, or polymyxin E2, has a 6-heptanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "36192": {"category_aro_accession": "3000053", "category_aro_cvterm_id": "36192", "category_aro_name": "peptide antibiotic", "category_aro_description": "Peptide antibiotics have a wide range of antibacterial mechanisms, depending on the amino acids that make up the antibiotic, although most act to disrupt the cell membrane in some manner. Subclasses of peptide antibiotics can include additional sidechains of other types, such as lipids in the case of the lipopeptide antibiotics.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.60192e-19, "max_identities": 124, "bit_score": 90.5077, "cvterm_id": "36789", "query": "QSATYAELRRLAAAYARRFRALGLRQGDVVALAAPDGISSVAVMLGCFLGGWVFAPLNHTASAVNFEAMLSSASPRLVLHAASTVARHLPVLSTRRCAE-LASFLPPD----------------ALDGVEGDVTPLPV-----SPEAPAVMLFTSGSTGGPKAVTHTHADFITCSRNYAPYVVELRPDDRVYTPSPTFFAYGLNNLLLSLSAGATHVISVPRNGGMGVAEILARNEVTVLFAVPAVYKLIISKNDRG-LRLPKLRLCISAGEKLPLKLYREARSFFSVNVLDGIGCTEAISTFISNRESYVAPGCTGVVVPG--FE---VKLVNPRGELCRV-----GEVGVLWVRGGALTRGYVNAPDLTEKHFVDG----WFNTQDMFFMDAEYRLYNVGRAGSVIKINSCWFSPEMMESVLQSHPAVKECAVCVV---IDDYGLPRPK-AFIVTGEHERSEPELEHLWAELRVLSKEKLGKDHYPHLFATIKTLPRTSSGKLMRSELAKLLTS", "match": "++ TY E+  +A + +  +   G+++   VA+ +   +++ + +   +LGG  + PLN  A+    +  L +     ++  A  ++R   +L T  C + L  +  PD                 +   E DV  L       +    A ++ TSGSTG PK +  ++++ + C  +    +  L   DRV   S   F   ++++  SL +GA   + VP    +  AE +  +++TV  +VP V +L + +       LP LRL    G+ L   L  + +      V++  G TE       +R  +VA      V  G  FE   + ++N +GEL R      G  G L + G  L  GY+N P  T+  F       W+ + D+    +   L ++GR    +KI       E +E+V++     +  +V +V   + + G      AF+ T  H + +P+   LW       K++L     P  +  I+ LPR ++GK     L + L S", "sequence_from_db": "KTYTYQEMTDMALSLSDYWHLQGVQR---VAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDT--CIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSN-LHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYV-VPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHR--FVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDI-VTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRR--VTQAHSVAIVPWPLSESGYASGTVAFVDT--HTQWQPD---LWLS---QCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLAS", "sequence_from_broadstreet": "MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH", "dna_sequence_from_broadstreet": "ATGCCATACAATTCTGCGACAGATTTGTTACAGAGAGAGGGTTATGGTGTCGTGCATAACCAATTTATCAATAAAATGGCGATGTGCTGCGAGACAAGACACTCTATTTTGGCGGCCATTCAGGCTAACCGACATGCCCCTGCATTATGGGTTAAACAGAAAACCTACACCTATCAAGAGATGACCGATATGGCACTCTCATTGAGTGACTATTGGCATTTACAGGGCGTGCAGCGAGTTGCGATCCTTTCGGTACGCGATCTCGCGGCTTATTCTGCGATTTGGGCGAGCTATTTGGGCGGTATGACTTATATTCCGCTCAATGCGCGAGCAACAACAGAACAGATCCAAGAGACGCTGATCGCGACACAATGTGATTCCATCATGGTAGACGCGCAGCAATTGAGTCGTTTGTCCTCCTTACTAGATACTTGCATTGACCGATTACACATTTATGCGCTGCCTGATGTGGATATGGAACCGTTACGTCAGCAATATCCTCAGCACACTTTTCACACAGTGCAAATAACCGAACAAGATGTGGAATTACTGGTAGCGAAATACCATTTAGACAATGAACATGAGTACGCTTATATCATGCAAACCTCAGGTTCGACTGGTAAACCCAAACGTATTGCGGTCAGCTACAGTAATTTGCATTGCTATATCAGTCAAATTGACAAACTATTTCCACTCAATGCGCAAGATCGAGTGGGGCAATATTCTGATTTGACTTTTGATCTTTCGGTACATGATATTTTTTACAGTTTGATCTCTGGTGCTTGTTTATATGTTGTGCCTGAATTAGCGAAATTAAGTCCAGCGGAATTTATTCGTCACCATCAATTAACGGTATGGCTTTCTGTGCCTACTGTTATTGAGTTGGCCCTACAAAGACAAACCTTAACCCCACACAGTTTACCTTCTCTGCGACTGAGTTTTTTCTGCGGACAAGCCTTGCTGCATGATTTAGCCGAACAATGGCAACAGGCCACCCAGCAGCCGGTGATCAATCTGTATGGTCCAACAGAGTGCACGATTGCTATTACCTATCATCGATTTGTCGCCCATTCAGGTATGGCATCGGTGCCGATTGGCCGTGCTTTTGAAGAGGAGTGTTTAGCCATCATCAACGAACAAGGTGAATTGATGCGCTTTGAATCTGCACCCGAGGGGTATCGCGGAGAATTACTTCTGTCGGGCAAACAATTAGTCAATGGTTATCTGAATGATCCGCTGAATACGCAAAGTGCCTTTTTCCAGCACGAAGGGCGTATTTGGTATCGTTCAGGTGACATTGTCACTAAATCAAATGGCGTGCTGATTCATCTTGGGCGTCGCGATCACCAAGTGAAAATTGCCGGACAACGGGTGGAATTAGAAGAGATTGAAACCGTTGTTCGCCGCGTGACTCAAGCGCACAGCGTGGCGATAGTGCCTTGGCCTTTAAGTGAGTCGGGCTATGCCAGCGGCACGGTGGCGTTTGTGGATACCCATACCCAATGGCAACCAGATCTGTGGTTGAGCCAATGCAAACAACAATTAAATCCAACTTTTGTGCCTAAGCGTTGGTATGCCATTGAACAATTACCAAGAAATGCCAATGGCAAAACCGATATTAAAGCTTTACAACAACAATTAGCGAGTCAGACATATGAAACAAGCCATTGA", "partial": "0", "query_start": 42691, "query_end": 44115, "hit_start": 159, "hit_end": 1647, "orf_dna_sequence": "GTGAACGTGCTCGCTAGGCATTCCACCGGCTCCCACGACGAGCCGGTGGCCGGCGACGTCGAACTCCGCGTCGGTGGCCCCGGTGTGCCGGACGCTCATTCCAGCGAGAGCGTTGAAGTGCTGGCGCGGTGGCTGCGGACCGCCGAGGAGAAGTACCCGGGCGTCATGGGCCCGATCCGCCAGGAGGGCCCCTGGTTCGCCATCCCGTTGACCTGCCCGCGCGGTGCCCGGTCGGCGCGATTCGGCCTCTGGCTCGGGGAACTAGACCGTCAGGGACAGCTCCTCCACATGGTCGCCTCGTATCTGGCGGCCGTGCACCACGTGCTGGTCAGCGTTCGCGAGCCCAGCGCCAACGTGCTGGAGGTGCTGGTCTCTGACTCAACAACGCCATCTGGGCTCAACCGGTTCCTGAACGGCCTGGACTCCGTCCTGGAGATCCTGGCTCACGGGCGCAGCGACCTCCTCCTGCAGCATCTCACGGGCCGGCTGCCCCCCGACGAGATGCCCTTCGTGGAGGACCGTGAGGAGCGCGAGGAGCACCCGGCCACCGATGTCGAGGCCGATGCGGTTGTCTCCGTCCTGTTCCAACCAGTTGACTTCCCGAGCCTGGCGAGGCTGGACGCGAGCCTCCTCGCGTATGACGACGAGGATGCCGGCGCGGTGGGCCGGGTCCTGGGGGAGCTCCTCCAGCCGTTCCTGCTCGACTCCGCCAGGATGACCGTGGGGCGAAAGGCGGTGAGGGTCGATCACATCTGCCTGCCTGGCTTGTTGCGAGCCGACAGCAGAGCGGCGGAGGAGTCGGTTCTCGCGCCCGCCTTGCGCTTGGCGACGAAGCCCGGTCGGCATTTCGTCGCGTTGTGCCGGAACACCGCCCTGCGGCTGGGAGACAGGCTGCCCCACTTGCTCGCGCAGGGCCCGCTCTGCGATGGCGCGTCAACGGCGCTCCTTCTGTTGCAACGGGTGCTGGACACGCTTATCGGGAGCGGGGGACTGAAGGACCATCGCCTCACGCTCGAGCTGGTTGGCGCCGATCCACGGACCGAGGCCGCGTTTCGGGCCCGGACTCCGTGGCTGGTGGCGGAACGGGCCGCTTCGGCTGCATCAACGGATGCACCGCGCGTCGACGTCGTCGTCCTGTTCCCGGCGGCACGGCCGAGCGCGCTCGAGCTGCGGCCAGACAGCGTCGTCATCGACCTTTTTGGCACCTGGAGCCTGAGACCGCGACCCGAGGTTCTGGCGAAGAACATCGTCTACGTGCGAGGGGCCTCGGTCCGTCTCGCCGGAGAGGCCGTCGTCTCGACTCCCTCCTTCGCGCCGGATCGAGTGGAGCCGGCGCTCCTCGAGGCGCTTCTCCGGGAACTCGACGCGGAGGCCAGTAGTGACGGGCTCGCCCACGAGCACCGCCTTGAGATTGGCGGCATTCGCGGGTTCTGGGGTGAGATCCGCCGGGCGGAGTGGGACGCCTTTCATTCGCGCCGCCGGGGGGAGCTGGCGAGGTTTCAGGTGTCGGGGCAGGTGACCGCCGCCAATCCGGGGCTCGCCAGCCTGCCCGATGGGGCGACGAACATCTGCGAATACATCTTCCGGGAAGCGCACCTTCGCTCCGGCTCGTGCCTCGTCGATCCCCAGAGCGGCCAGTCCGCGACCTACGCCGAGCTGCGGCGACTGGCGGCAGCGTACGCGCGGCGGTTTCGGGCATTGGGGCTCCGCCAGGGAGACGTCGTGGCGCTCGCGGCGCCGGATGGGATTTCGTCCGTCGCGGTGATGCTGGGTTGCTTCCTGGGCGGGTGGGTCTTCGCGCCGCTCAACCACACCGCCTCGGCCGTGAACTTCGAGGCGATGTTGAGTTCCGCCAGTCCCCGCCTGGTGCTCCATGCCGCGTCGACGGTCGCCCGCCATCTGCCGGTCCTGAGCACGCGGCGATGCGCGGAACTCGCGTCCTTCCTGCCGCCGGACGCGCTGGACGGCGTGGAGGGGGACGTCACCCCCCTGCCAGTGTCACCGGAAGCCCCCGCCGTCATGCTGTTCACCTCGGGCTCCACGGGGGGGCCGAAGGCAGTGACGCACACCCACGCCGACTTCATCACCTGCAGTCGCAACTACGCACCCTATGTCGTCGAACTCAGACCGGACGATCGTGTCTATACGCCGTCCCCGACCTTCTTCGCCTATGGATTGAACAACTTGCTGCTGTCCCTCAGCGCGGGGGCCACGCACGTGATCTCGGTCCCTCGCAACGGCGGGATGGGTGTCGCGGAGATCCTCGCGCGGAACGAAGTAACCGTGCTCTTCGCGGTTCCCGCCGTCTATAAGCTGATCATCTCGAAGAACGACCGGGGCCTGCGGTTGCCGAAGTTGAGATTGTGCATCTCTGCTGGCGAGAAGCTGCCATTGAAGCTGTATCGGGAGGCGCGAAGCTTCTTCAGCGTGAACGTACTGGACGGGATCGGGTGCACCGAAGCCATCTCGACGTTCATCTCGAACCGGGAGAGTTATGTCGCGCCCGGGTGCACGGGCGTGGTGGTCCCGGGGTTCGAGGTCAAGCTGGTGAACCCGCGTGGCGAGCTCTGCCGGGTGGGAGAGGTGGGCGTCCTCTGGGTTCGGGGTGGGGCGCTGACCCGGGGCTACGTGAACGCCCCCGATCTGACAGAGAAGCACTTCGTGGACGGCTGGTTCAACACCCAGGACATGTTCTTCATGGATGCCGAGTACCGGCTCTACAACGTGGGCAGGGCTGGTTCGGTCATCAAGATCAATTCCTGCTGGTTCTCACCGGAGATGATGGAGTCGGTCCTGCAATCCCATCCAGCGGTGAAGGAGTGTGCCGTCTGCGTCGTCATTGACGACTACGGGTTGCCAAGGCCGAAGGCATTCATCGTCACCGGCGAGCATGAGCGCTCCGAGCCGGAGCTCGAGCACTTGTGGGCCGAGTTGCGCGTTCTGTCGAAAGAGAAGCTTGGGAAGGACCACTACCCGCATCTGTTCGCGACCATCAAAACGCTTCCCCGGACCTCCAGCGGGAAGCTGATGCGGTCCGAACTCGCGAAGCTGCTCACCAGCGGGCCCCCATGA", "orf_prot_sequence": "MNVLARHSTGSHDEPVAGDVELRVGGPGVPDAHSSESVEVLARWLRTAEEKYPGVMGPIRQEGPWFAIPLTCPRGARSARFGLWLGELDRQGQLLHMVASYLAAVHHVLVSVREPSANVLEVLVSDSTTPSGLNRFLNGLDSVLEILAHGRSDLLLQHLTGRLPPDEMPFVEDREEREEHPATDVEADAVVSVLFQPVDFPSLARLDASLLAYDDEDAGAVGRVLGELLQPFLLDSARMTVGRKAVRVDHICLPGLLRADSRAAEESVLAPALRLATKPGRHFVALCRNTALRLGDRLPHLLAQGPLCDGASTALLLLQRVLDTLIGSGGLKDHRLTLELVGADPRTEAAFRARTPWLVAERAASAASTDAPRVDVVVLFPAARPSALELRPDSVVIDLFGTWSLRPRPEVLAKNIVYVRGASVRLAGEAVVSTPSFAPDRVEPALLEALLRELDAEASSDGLAHEHRLEIGGIRGFWGEIRRAEWDAFHSRRRGELARFQVSGQVTAANPGLASLPDGATNICEYIFREAHLRSGSCLVDPQSGQSATYAELRRLAAAYARRFRALGLRQGDVVALAAPDGISSVAVMLGCFLGGWVFAPLNHTASAVNFEAMLSSASPRLVLHAASTVARHLPVLSTRRCAELASFLPPDALDGVEGDVTPLPVSPEAPAVMLFTSGSTGGPKAVTHTHADFITCSRNYAPYVVELRPDDRVYTPSPTFFAYGLNNLLLSLSAGATHVISVPRNGGMGVAEILARNEVTVLFAVPAVYKLIISKNDRGLRLPKLRLCISAGEKLPLKLYREARSFFSVNVLDGIGCTEAISTFISNRESYVAPGCTGVVVPGFEVKLVNPRGELCRVGEVGVLWVRGGALTRGYVNAPDLTEKHFVDGWFNTQDMFFMDAEYRLYNVGRAGSVIKINSCWFSPEMMESVLQSHPAVKECAVCVVIDDYGLPRPKAFIVTGEHERSEPELEHLWAELRVLSKEKLGKDHYPHLFATIKTLPRTSSGKLMRSELAKLLTSGPP", "perc_identity": 24.03}, "gnl|BL_ORD_ID|2604|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 41056, "orf_end": 44127, "orf_from": "BGC0001413.1|Cystobactamide_18 ", "model_name": "CKO-1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "550", "model_id": "3574", "ARO_accession": "3004773", "ARO_name": "CKO-1", "ARO_category": {"42887": {"category_aro_accession": "3004772", "category_aro_cvterm_id": "42887", "category_aro_name": "CKO beta-lactamase", "category_aro_description": "CKO is a class A beta-lactamase gene family found in Citrobacter koseri.", "category_aro_class_name": "AMR Gene Family"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.38675, "max_identities": 19, "bit_score": 28.1054, "cvterm_id": "36934", "query": "GGPKAVTH---THADFITCSRNYAPYVVELRPDDRVYTPSPTFFAYGLNNLLL", "match": " GP+AVT       D IT    Y P +    P D   + +P   A  LN LLL", "sequence_from_db": "NGPQAVTQFLRDSGDTITRLDRYEPELNSAIPGDERDSTTPVAIAQTLNTLLL", "sequence_from_broadstreet": "MRNEEVISMWQRMKWGLCVLAALSGSAMAAPLTAQYVSAIAMQEEQRLHARIGIAVLDTATNSITHYRGEERFPLNSTHKPLLCAALLREVDRKALALSASMQFEPSQLVEYSPITEKHVAPDAMSWAQLCSAAVSYSDNTAANLIARKLNGPQAVTQFLRDSGDTITRLDRYEPELNSAIPGDERDSTTPVAIAQTLNTLLLGNVLQPSSREQLMQWMRDDKVADGLLRSVLPDGWKIADKTGAGDNGSRSIVSVVWPTSQKPLLVVIYITQTPATMAQRDAAIVRIGESLFSTLAVYD", "dna_sequence_from_broadstreet": "ATGAGAAACGAGGAAGTCATTAGTATGTGGCAACGGATGAAATGGGGTCTGTGTGTGCTGGCGGCACTCAGCGGTTCTGCGATGGCCGCACCGCTGACGGCGCAATACGTGTCGGCTATCGCGATGCAGGAAGAACAGCGTCTTCATGCCCGGATTGGCATTGCGGTACTTGATACGGCGACCAACAGTATCACCCATTATCGGGGAGAAGAACGGTTCCCGTTAAACAGTACGCACAAGCCGCTGTTATGCGCAGCGTTATTACGCGAAGTCGACAGGAAGGCGCTGGCGCTTTCTGCTTCAATGCAGTTTGAACCCTCACAACTGGTGGAGTATTCGCCGATTACTGAAAAACATGTGGCGCCAGACGCCATGAGCTGGGCGCAATTGTGCAGCGCGGCGGTAAGCTACAGCGATAACACGGCCGCCAATCTCATCGCCAGGAAGCTCAACGGGCCGCAGGCCGTCACGCAGTTTTTGCGTGATTCGGGGGATACGATAACCCGCCTCGATCGCTATGAGCCCGAACTGAACAGCGCCATTCCCGGTGATGAACGCGACTCCACGACGCCTGTCGCGATAGCGCAGACGCTCAATACGCTACTGCTGGGGAACGTGTTGCAGCCATCCTCAAGAGAGCAGCTTATGCAATGGATGCGGGACGACAAAGTGGCCGACGGTCTGCTGCGTTCGGTCTTGCCGGACGGCTGGAAAATCGCGGATAAAACCGGGGCGGGCGACAACGGCTCGCGTTCTATTGTCAGCGTTGTCTGGCCGACATCACAAAAACCTTTGCTCGTGGTTATCTATATTACACAAACTCCGGCGACAATGGCGCAGCGTGACGCCGCGATTGTCCGTATCGGGGAGTCGCTGTTTTCAACACTCGCAGTCTATGATTAA", "partial": "0", "query_start": 43099, "query_end": 43248, "hit_start": 450, "hit_end": 609, "orf_dna_sequence": "GTGAACGTGCTCGCTAGGCATTCCACCGGCTCCCACGACGAGCCGGTGGCCGGCGACGTCGAACTCCGCGTCGGTGGCCCCGGTGTGCCGGACGCTCATTCCAGCGAGAGCGTTGAAGTGCTGGCGCGGTGGCTGCGGACCGCCGAGGAGAAGTACCCGGGCGTCATGGGCCCGATCCGCCAGGAGGGCCCCTGGTTCGCCATCCCGTTGACCTGCCCGCGCGGTGCCCGGTCGGCGCGATTCGGCCTCTGGCTCGGGGAACTAGACCGTCAGGGACAGCTCCTCCACATGGTCGCCTCGTATCTGGCGGCCGTGCACCACGTGCTGGTCAGCGTTCGCGAGCCCAGCGCCAACGTGCTGGAGGTGCTGGTCTCTGACTCAACAACGCCATCTGGGCTCAACCGGTTCCTGAACGGCCTGGACTCCGTCCTGGAGATCCTGGCTCACGGGCGCAGCGACCTCCTCCTGCAGCATCTCACGGGCCGGCTGCCCCCCGACGAGATGCCCTTCGTGGAGGACCGTGAGGAGCGCGAGGAGCACCCGGCCACCGATGTCGAGGCCGATGCGGTTGTCTCCGTCCTGTTCCAACCAGTTGACTTCCCGAGCCTGGCGAGGCTGGACGCGAGCCTCCTCGCGTATGACGACGAGGATGCCGGCGCGGTGGGCCGGGTCCTGGGGGAGCTCCTCCAGCCGTTCCTGCTCGACTCCGCCAGGATGACCGTGGGGCGAAAGGCGGTGAGGGTCGATCACATCTGCCTGCCTGGCTTGTTGCGAGCCGACAGCAGAGCGGCGGAGGAGTCGGTTCTCGCGCCCGCCTTGCGCTTGGCGACGAAGCCCGGTCGGCATTTCGTCGCGTTGTGCCGGAACACCGCCCTGCGGCTGGGAGACAGGCTGCCCCACTTGCTCGCGCAGGGCCCGCTCTGCGATGGCGCGTCAACGGCGCTCCTTCTGTTGCAACGGGTGCTGGACACGCTTATCGGGAGCGGGGGACTGAAGGACCATCGCCTCACGCTCGAGCTGGTTGGCGCCGATCCACGGACCGAGGCCGCGTTTCGGGCCCGGACTCCGTGGCTGGTGGCGGAACGGGCCGCTTCGGCTGCATCAACGGATGCACCGCGCGTCGACGTCGTCGTCCTGTTCCCGGCGGCACGGCCGAGCGCGCTCGAGCTGCGGCCAGACAGCGTCGTCATCGACCTTTTTGGCACCTGGAGCCTGAGACCGCGACCCGAGGTTCTGGCGAAGAACATCGTCTACGTGCGAGGGGCCTCGGTCCGTCTCGCCGGAGAGGCCGTCGTCTCGACTCCCTCCTTCGCGCCGGATCGAGTGGAGCCGGCGCTCCTCGAGGCGCTTCTCCGGGAACTCGACGCGGAGGCCAGTAGTGACGGGCTCGCCCACGAGCACCGCCTTGAGATTGGCGGCATTCGCGGGTTCTGGGGTGAGATCCGCCGGGCGGAGTGGGACGCCTTTCATTCGCGCCGCCGGGGGGAGCTGGCGAGGTTTCAGGTGTCGGGGCAGGTGACCGCCGCCAATCCGGGGCTCGCCAGCCTGCCCGATGGGGCGACGAACATCTGCGAATACATCTTCCGGGAAGCGCACCTTCGCTCCGGCTCGTGCCTCGTCGATCCCCAGAGCGGCCAGTCCGCGACCTACGCCGAGCTGCGGCGACTGGCGGCAGCGTACGCGCGGCGGTTTCGGGCATTGGGGCTCCGCCAGGGAGACGTCGTGGCGCTCGCGGCGCCGGATGGGATTTCGTCCGTCGCGGTGATGCTGGGTTGCTTCCTGGGCGGGTGGGTCTTCGCGCCGCTCAACCACACCGCCTCGGCCGTGAACTTCGAGGCGATGTTGAGTTCCGCCAGTCCCCGCCTGGTGCTCCATGCCGCGTCGACGGTCGCCCGCCATCTGCCGGTCCTGAGCACGCGGCGATGCGCGGAACTCGCGTCCTTCCTGCCGCCGGACGCGCTGGACGGCGTGGAGGGGGACGTCACCCCCCTGCCAGTGTCACCGGAAGCCCCCGCCGTCATGCTGTTCACCTCGGGCTCCACGGGGGGGCCGAAGGCAGTGACGCACACCCACGCCGACTTCATCACCTGCAGTCGCAACTACGCACCCTATGTCGTCGAACTCAGACCGGACGATCGTGTCTATACGCCGTCCCCGACCTTCTTCGCCTATGGATTGAACAACTTGCTGCTGTCCCTCAGCGCGGGGGCCACGCACGTGATCTCGGTCCCTCGCAACGGCGGGATGGGTGTCGCGGAGATCCTCGCGCGGAACGAAGTAACCGTGCTCTTCGCGGTTCCCGCCGTCTATAAGCTGATCATCTCGAAGAACGACCGGGGCCTGCGGTTGCCGAAGTTGAGATTGTGCATCTCTGCTGGCGAGAAGCTGCCATTGAAGCTGTATCGGGAGGCGCGAAGCTTCTTCAGCGTGAACGTACTGGACGGGATCGGGTGCACCGAAGCCATCTCGACGTTCATCTCGAACCGGGAGAGTTATGTCGCGCCCGGGTGCACGGGCGTGGTGGTCCCGGGGTTCGAGGTCAAGCTGGTGAACCCGCGTGGCGAGCTCTGCCGGGTGGGAGAGGTGGGCGTCCTCTGGGTTCGGGGTGGGGCGCTGACCCGGGGCTACGTGAACGCCCCCGATCTGACAGAGAAGCACTTCGTGGACGGCTGGTTCAACACCCAGGACATGTTCTTCATGGATGCCGAGTACCGGCTCTACAACGTGGGCAGGGCTGGTTCGGTCATCAAGATCAATTCCTGCTGGTTCTCACCGGAGATGATGGAGTCGGTCCTGCAATCCCATCCAGCGGTGAAGGAGTGTGCCGTCTGCGTCGTCATTGACGACTACGGGTTGCCAAGGCCGAAGGCATTCATCGTCACCGGCGAGCATGAGCGCTCCGAGCCGGAGCTCGAGCACTTGTGGGCCGAGTTGCGCGTTCTGTCGAAAGAGAAGCTTGGGAAGGACCACTACCCGCATCTGTTCGCGACCATCAAAACGCTTCCCCGGACCTCCAGCGGGAAGCTGATGCGGTCCGAACTCGCGAAGCTGCTCACCAGCGGGCCCCCATGA", "orf_prot_sequence": "MNVLARHSTGSHDEPVAGDVELRVGGPGVPDAHSSESVEVLARWLRTAEEKYPGVMGPIRQEGPWFAIPLTCPRGARSARFGLWLGELDRQGQLLHMVASYLAAVHHVLVSVREPSANVLEVLVSDSTTPSGLNRFLNGLDSVLEILAHGRSDLLLQHLTGRLPPDEMPFVEDREEREEHPATDVEADAVVSVLFQPVDFPSLARLDASLLAYDDEDAGAVGRVLGELLQPFLLDSARMTVGRKAVRVDHICLPGLLRADSRAAEESVLAPALRLATKPGRHFVALCRNTALRLGDRLPHLLAQGPLCDGASTALLLLQRVLDTLIGSGGLKDHRLTLELVGADPRTEAAFRARTPWLVAERAASAASTDAPRVDVVVLFPAARPSALELRPDSVVIDLFGTWSLRPRPEVLAKNIVYVRGASVRLAGEAVVSTPSFAPDRVEPALLEALLRELDAEASSDGLAHEHRLEIGGIRGFWGEIRRAEWDAFHSRRRGELARFQVSGQVTAANPGLASLPDGATNICEYIFREAHLRSGSCLVDPQSGQSATYAELRRLAAAYARRFRALGLRQGDVVALAAPDGISSVAVMLGCFLGGWVFAPLNHTASAVNFEAMLSSASPRLVLHAASTVARHLPVLSTRRCAELASFLPPDALDGVEGDVTPLPVSPEAPAVMLFTSGSTGGPKAVTHTHADFITCSRNYAPYVVELRPDDRVYTPSPTFFAYGLNNLLLSLSAGATHVISVPRNGGMGVAEILARNEVTVLFAVPAVYKLIISKNDRGLRLPKLRLCISAGEKLPLKLYREARSFFSVNVLDGIGCTEAISTFISNRESYVAPGCTGVVVPGFEVKLVNPRGELCRVGEVGVLWVRGGALTRGYVNAPDLTEKHFVDGWFNTQDMFFMDAEYRLYNVGRAGSVIKINSCWFSPEMMESVLQSHPAVKECAVCVVIDDYGLPRPKAFIVTGEHERSEPELEHLWAELRVLSKEKLGKDHYPHLFATIKTLPRTSSGKLMRSELAKLLTSGPP", "perc_identity": 35.85}, "gnl|BL_ORD_ID|3690|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 41056, "orf_end": 44127, "orf_from": "BGC0001413.1|Cystobactamide_18 ", "model_name": "MAL-1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "600", "model_id": "4760", "ARO_accession": "3006949", "ARO_name": "MAL-1", "ARO_category": {"43882": {"category_aro_accession": "3005422", "category_aro_cvterm_id": "43882", "category_aro_name": "MAL beta-lactamase", "category_aro_description": "MAL beta-lactamase are class A beta-lactamases found in Citrobacter koseri.", "category_aro_class_name": "AMR Gene Family"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.41628, "max_identities": 19, "bit_score": 28.1054, "cvterm_id": "36934", "query": "GGPKAVTH---THADFITCSRNYAPYVVELRPDDRVYTPSPTFFAYGLNNLLL", "match": " GP+AVT       D IT    Y P +    P D   + +P   A  LN LLL", "sequence_from_db": "NGPQAVTQFLRDSGDTITRLDRYEPELNSAIPGDERDSTTPVAIAQTLNTLLL", "sequence_from_broadstreet": "MRNEEVISMWQRMKWGLCVLAALSGSAMAAPLTAQYVSTIATQEEQRLHARIGIAVLDTATNSITHYRGEERFPLNSTHKPLLCAALLREVDRKALALSASTQFESSQLVEYSPITEKHVAPDAMSWAQLCSAAVSYSDNTAANLIARKLNGPQAVTQFLRDSGDTITRLDRYEPELNSAIPGDERDSTTPVAIAQTLNTLLLGNVLQPSSREQLMQWMRDDKVADGLLRSVLPDGWKIADKTGAGDNGSRSIVSVVWPTSQKPLLVVIYITQTPATMAQRDAAIVRIGESLFSTLAVYD", "dna_sequence_from_broadstreet": "ATGAGAAACGAGGAAGTCATTAGTATGTGGCAACGGATGAAATGGGGTTTGTGTGTGCTGGCGGCACTCAGCGGTTCTGCGATGGCCGCACCGCTGACGGCGCAATACGTGTCGACTATCGCGACGCAGGAAGAACAGCGTCTTCATGCCCGGATTGGCATTGCGGTACTTGATACGGCGACCAACAGTATCACCCATTATCGGGGAGAAGAACGGTTCCCGTTAAACAGTACGCACAAGCCGCTGTTATGCGCAGCGTTATTACGCGAAGTCGACAGGAAGGCGCTGGCGCTTTCTGCTTCAACGCAGTTTGAATCCTCGCAGCTGGTGGAGTATTCGCCGATTACTGAAAAACATGTGGCGCCAGACGCCATGAGCTGGGCGCAATTGTGCAGCGCGGCGGTAAGCTACAGCGATAACACGGCCGCCAATCTCATCGCCAGGAAGCTCAACGGGCCGCAGGCCGTCACGCAGTTTTTGCGTGATTCGGGGGATACAATAACCCGCCTCGATCGCTATGAGCCTGAACTGAACAGCGCCATTCCCGGCGATGAACGCGACTCCACGACGCCTGTCGCGATAGCGCAGACGCTCAATACGCTACTGCTGGGGAACGTGTTGCAGCCATCCTCAAGAGAGCAGCTTATGCAGTGGATGCGGGACGACAAAGTGGCTGACGGTCTGCTGCGTTCGGTCTTGCCGGATGGCTGGAAAATCGCGGATAAAACCGGGGCGGGCGACAACGGCTCGCGTTCTATTGTCAGCGTTGTCTGGCCGACATCACAAAAACCTCTGCTCGTGGTTATCTATATTACACAAACTCCGGCGACAATGGCGCAGCGTGACGCCGCGATTGTCCGCATCGGGGAGTCGCTGTTTTCAACACTCGCAGTCTATGATTAA", "partial": "0", "query_start": 43099, "query_end": 43248, "hit_start": 450, "hit_end": 609, "orf_dna_sequence": "GTGAACGTGCTCGCTAGGCATTCCACCGGCTCCCACGACGAGCCGGTGGCCGGCGACGTCGAACTCCGCGTCGGTGGCCCCGGTGTGCCGGACGCTCATTCCAGCGAGAGCGTTGAAGTGCTGGCGCGGTGGCTGCGGACCGCCGAGGAGAAGTACCCGGGCGTCATGGGCCCGATCCGCCAGGAGGGCCCCTGGTTCGCCATCCCGTTGACCTGCCCGCGCGGTGCCCGGTCGGCGCGATTCGGCCTCTGGCTCGGGGAACTAGACCGTCAGGGACAGCTCCTCCACATGGTCGCCTCGTATCTGGCGGCCGTGCACCACGTGCTGGTCAGCGTTCGCGAGCCCAGCGCCAACGTGCTGGAGGTGCTGGTCTCTGACTCAACAACGCCATCTGGGCTCAACCGGTTCCTGAACGGCCTGGACTCCGTCCTGGAGATCCTGGCTCACGGGCGCAGCGACCTCCTCCTGCAGCATCTCACGGGCCGGCTGCCCCCCGACGAGATGCCCTTCGTGGAGGACCGTGAGGAGCGCGAGGAGCACCCGGCCACCGATGTCGAGGCCGATGCGGTTGTCTCCGTCCTGTTCCAACCAGTTGACTTCCCGAGCCTGGCGAGGCTGGACGCGAGCCTCCTCGCGTATGACGACGAGGATGCCGGCGCGGTGGGCCGGGTCCTGGGGGAGCTCCTCCAGCCGTTCCTGCTCGACTCCGCCAGGATGACCGTGGGGCGAAAGGCGGTGAGGGTCGATCACATCTGCCTGCCTGGCTTGTTGCGAGCCGACAGCAGAGCGGCGGAGGAGTCGGTTCTCGCGCCCGCCTTGCGCTTGGCGACGAAGCCCGGTCGGCATTTCGTCGCGTTGTGCCGGAACACCGCCCTGCGGCTGGGAGACAGGCTGCCCCACTTGCTCGCGCAGGGCCCGCTCTGCGATGGCGCGTCAACGGCGCTCCTTCTGTTGCAACGGGTGCTGGACACGCTTATCGGGAGCGGGGGACTGAAGGACCATCGCCTCACGCTCGAGCTGGTTGGCGCCGATCCACGGACCGAGGCCGCGTTTCGGGCCCGGACTCCGTGGCTGGTGGCGGAACGGGCCGCTTCGGCTGCATCAACGGATGCACCGCGCGTCGACGTCGTCGTCCTGTTCCCGGCGGCACGGCCGAGCGCGCTCGAGCTGCGGCCAGACAGCGTCGTCATCGACCTTTTTGGCACCTGGAGCCTGAGACCGCGACCCGAGGTTCTGGCGAAGAACATCGTCTACGTGCGAGGGGCCTCGGTCCGTCTCGCCGGAGAGGCCGTCGTCTCGACTCCCTCCTTCGCGCCGGATCGAGTGGAGCCGGCGCTCCTCGAGGCGCTTCTCCGGGAACTCGACGCGGAGGCCAGTAGTGACGGGCTCGCCCACGAGCACCGCCTTGAGATTGGCGGCATTCGCGGGTTCTGGGGTGAGATCCGCCGGGCGGAGTGGGACGCCTTTCATTCGCGCCGCCGGGGGGAGCTGGCGAGGTTTCAGGTGTCGGGGCAGGTGACCGCCGCCAATCCGGGGCTCGCCAGCCTGCCCGATGGGGCGACGAACATCTGCGAATACATCTTCCGGGAAGCGCACCTTCGCTCCGGCTCGTGCCTCGTCGATCCCCAGAGCGGCCAGTCCGCGACCTACGCCGAGCTGCGGCGACTGGCGGCAGCGTACGCGCGGCGGTTTCGGGCATTGGGGCTCCGCCAGGGAGACGTCGTGGCGCTCGCGGCGCCGGATGGGATTTCGTCCGTCGCGGTGATGCTGGGTTGCTTCCTGGGCGGGTGGGTCTTCGCGCCGCTCAACCACACCGCCTCGGCCGTGAACTTCGAGGCGATGTTGAGTTCCGCCAGTCCCCGCCTGGTGCTCCATGCCGCGTCGACGGTCGCCCGCCATCTGCCGGTCCTGAGCACGCGGCGATGCGCGGAACTCGCGTCCTTCCTGCCGCCGGACGCGCTGGACGGCGTGGAGGGGGACGTCACCCCCCTGCCAGTGTCACCGGAAGCCCCCGCCGTCATGCTGTTCACCTCGGGCTCCACGGGGGGGCCGAAGGCAGTGACGCACACCCACGCCGACTTCATCACCTGCAGTCGCAACTACGCACCCTATGTCGTCGAACTCAGACCGGACGATCGTGTCTATACGCCGTCCCCGACCTTCTTCGCCTATGGATTGAACAACTTGCTGCTGTCCCTCAGCGCGGGGGCCACGCACGTGATCTCGGTCCCTCGCAACGGCGGGATGGGTGTCGCGGAGATCCTCGCGCGGAACGAAGTAACCGTGCTCTTCGCGGTTCCCGCCGTCTATAAGCTGATCATCTCGAAGAACGACCGGGGCCTGCGGTTGCCGAAGTTGAGATTGTGCATCTCTGCTGGCGAGAAGCTGCCATTGAAGCTGTATCGGGAGGCGCGAAGCTTCTTCAGCGTGAACGTACTGGACGGGATCGGGTGCACCGAAGCCATCTCGACGTTCATCTCGAACCGGGAGAGTTATGTCGCGCCCGGGTGCACGGGCGTGGTGGTCCCGGGGTTCGAGGTCAAGCTGGTGAACCCGCGTGGCGAGCTCTGCCGGGTGGGAGAGGTGGGCGTCCTCTGGGTTCGGGGTGGGGCGCTGACCCGGGGCTACGTGAACGCCCCCGATCTGACAGAGAAGCACTTCGTGGACGGCTGGTTCAACACCCAGGACATGTTCTTCATGGATGCCGAGTACCGGCTCTACAACGTGGGCAGGGCTGGTTCGGTCATCAAGATCAATTCCTGCTGGTTCTCACCGGAGATGATGGAGTCGGTCCTGCAATCCCATCCAGCGGTGAAGGAGTGTGCCGTCTGCGTCGTCATTGACGACTACGGGTTGCCAAGGCCGAAGGCATTCATCGTCACCGGCGAGCATGAGCGCTCCGAGCCGGAGCTCGAGCACTTGTGGGCCGAGTTGCGCGTTCTGTCGAAAGAGAAGCTTGGGAAGGACCACTACCCGCATCTGTTCGCGACCATCAAAACGCTTCCCCGGACCTCCAGCGGGAAGCTGATGCGGTCCGAACTCGCGAAGCTGCTCACCAGCGGGCCCCCATGA", "orf_prot_sequence": "MNVLARHSTGSHDEPVAGDVELRVGGPGVPDAHSSESVEVLARWLRTAEEKYPGVMGPIRQEGPWFAIPLTCPRGARSARFGLWLGELDRQGQLLHMVASYLAAVHHVLVSVREPSANVLEVLVSDSTTPSGLNRFLNGLDSVLEILAHGRSDLLLQHLTGRLPPDEMPFVEDREEREEHPATDVEADAVVSVLFQPVDFPSLARLDASLLAYDDEDAGAVGRVLGELLQPFLLDSARMTVGRKAVRVDHICLPGLLRADSRAAEESVLAPALRLATKPGRHFVALCRNTALRLGDRLPHLLAQGPLCDGASTALLLLQRVLDTLIGSGGLKDHRLTLELVGADPRTEAAFRARTPWLVAERAASAASTDAPRVDVVVLFPAARPSALELRPDSVVIDLFGTWSLRPRPEVLAKNIVYVRGASVRLAGEAVVSTPSFAPDRVEPALLEALLRELDAEASSDGLAHEHRLEIGGIRGFWGEIRRAEWDAFHSRRRGELARFQVSGQVTAANPGLASLPDGATNICEYIFREAHLRSGSCLVDPQSGQSATYAELRRLAAAYARRFRALGLRQGDVVALAAPDGISSVAVMLGCFLGGWVFAPLNHTASAVNFEAMLSSASPRLVLHAASTVARHLPVLSTRRCAELASFLPPDALDGVEGDVTPLPVSPEAPAVMLFTSGSTGGPKAVTHTHADFITCSRNYAPYVVELRPDDRVYTPSPTFFAYGLNNLLLSLSAGATHVISVPRNGGMGVAEILARNEVTVLFAVPAVYKLIISKNDRGLRLPKLRLCISAGEKLPLKLYREARSFFSVNVLDGIGCTEAISTFISNRESYVAPGCTGVVVPGFEVKLVNPRGELCRVGEVGVLWVRGGALTRGYVNAPDLTEKHFVDGWFNTQDMFFMDAEYRLYNVGRAGSVIKINSCWFSPEMMESVLQSHPAVKECAVCVVIDDYGLPRPKAFIVTGEHERSEPELEHLWAELRVLSKEKLGKDHYPHLFATIKTLPRTSSGKLMRSELAKLLTSGPP", "perc_identity": 35.85}, "gnl|BL_ORD_ID|2016|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 41056, "orf_end": 44127, "orf_from": "BGC0001413.1|Cystobactamide_18 ", "model_name": "MexK", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1900", "model_id": "2206", "ARO_accession": "3003693", "ARO_name": "MexK", "ARO_category": {"36005": {"category_aro_accession": "0010004", "category_aro_cvterm_id": "36005", "category_aro_name": "resistance-nodulation-cell division (RND) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Resistance-nodulation-division (RND) proteins are found in both prokaryotic and eukaryotic cells and have diverse substrate specificities and physiological roles. However, there are relatively few RND transporters and they are secondary transporters, energized not by ATP binding/hydrolysis but by proton movement down the transmembrane electrochemical gradient.", "category_aro_class_name": "AMR Gene Family"}, "35925": {"category_aro_accession": "0000006", "category_aro_cvterm_id": "35925", "category_aro_name": "erythromycin", "category_aro_description": "Erythromycin is a macrolide antibiotic with a 14-carbon ring that has an antimicrobial spectrum similar to or slightly wider than that of penicillin, and is often used for people that have an allergy to penicillins. Erythromycin may possess bacteriocidal activity, particularly at higher concentrations by binding to the 50S subunit of the bacterial 70S rRNA complex, inhibiting peptidyl-tRNA translocation. Thus, protein synthesis and subsequently structure/function processes critical for life or replication are inhibited.", "category_aro_class_name": "Antibiotic"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "37250": {"category_aro_accession": "3000870", "category_aro_cvterm_id": "37250", "category_aro_name": "triclosan", "category_aro_description": "Triclosan is a common antibacterial agent added to many consumer products as a biocide.  It is an inhibitor of fatty acid biosynthesis by blocking enoyl-carrier protein reductase (FabI).", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "43746": {"category_aro_accession": "3005386", "category_aro_cvterm_id": "43746", "category_aro_name": "disinfecting agents and antiseptics", "category_aro_description": "Disinfectants that can also interact with antimicrobial resistance mechanisms, e.g. molecule efflux, and thus are the targets of disinfectant resistance.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.89322, "max_identities": 34, "bit_score": 28.4906, "cvterm_id": "36804", "query": "LAYDDEDAGAVGRVLGELLQPFLLDSARMTVGRKAVRVDHICLPGLLRADSRAAEESVLAPALRLATKPGRHFVALCRNTALRLG---------DRLPHLLAQGPLCDGASTALLLLQ", "match": "L+ D E A A+G     L Q   L SA         R D+  +  LLR   +   +  L P+L + T+ GR  VAL +   L  G         +RLP +  +  + D +  A L+ Q", "sequence_from_db": "LSIDQERARALGVSTASLSQ--FLQSALTGSHVSFFREDNELIEILLRGTEQERRDLSLLPSLAVPTENGRS-VALSQIATLEYGFEEGIIWHRNRLPTVTVRADIYDDSLPATLVAQ", "sequence_from_broadstreet": "MSFNLSAWALQNRQIVLYLMILLGAVGALSYSKLGQSEDPPFTFKAMVVQTNWPGASAEEVARQVTERIEKKLMETGDYDRIVSFSRPGVSQVTFMAREDIHSSEIPELWYQIRKKISDIRATLPQSIQGPFFNDEFGTTYGNIYALTGKGFDYAVMKDYADRLQLQLQRIRNVGKVELIGLQDEKIWIDLSNTKLATLGLPLAAVQKALEEQNAVASSGFFETASDRVQLRVSGRFDSVEEIRDFPIRVGDRTFRIGDVAEVRRGFNDPPAPRMRFMGEDAIGLAVAMKPGGDILVLGKALETEFARLQQSLPAGLELRKVSDQPAAVRTGVGEFIRVLAEALVIVLLVSFFSLGLRTGLVVALSIPLVLAMTFAAMHYFGIGLHKISLGALVLALGLLVDDAIIAVEMMAVKMEQGYDRLKAASFAWTSTAFPMLTGTLITAAGFLPIATAQSGTGEYTRSLFQVVTIALVVSWFAAVVFVPYLGAKLLPDLARLHAQKHGGSADGYDPYATAFYQRFRRLVEWCVRYRKTVIVLTLAAFVGALLLFRLVPQQFFPPSARLELLLDIKLAEGASLRSTGEEVQRLEKMLQGHDGIDNYVAYVGTGSPRFYLPLDQQLPAASFAQVVVLAKDLESREALRKWLIERMNEDFPHLRSRISRLENGPPVGYPVQFRVSGEDIPQVRELARKVADKMRENPHVVNVHLDWEEPSKVVYLSIDQERARALGVSTASLSQFLQSALTGSHVSFFREDNELIEILLRGTEQERRDLSLLPSLAVPTENGRSVALSQIATLEYGFEEGIIWHRNRLPTVTVRADIYDDSLPATLVAQIAPTLEPIRAELPDGYLLEVGGTVEDAAKGQSSVNAGVPLFIVVVLSLLMVQLRSFSRMAMVFLTAPLGLIGVTLFLLLFRQPFGFVAMLGTIALAGMIMRNSVILVDQIEQDISHGLDRWHAIIEATVRRFRPIVLTALAAVLAMIPLSRSVFFGPMAVAIMGGLIVATVLTLLFLPALYAAWFRVKKDEARA", "dna_sequence_from_broadstreet": "ATGTCCTTCAACCTTTCCGCCTGGGCGTTGCAGAATCGCCAGATCGTCCTGTACCTGATGATCCTGCTTGGCGCGGTCGGCGCGCTGTCCTACAGCAAGCTGGGGCAGAGCGAAGACCCGCCGTTCACCTTCAAGGCCATGGTGGTGCAGACCAACTGGCCGGGCGCCAGCGCCGAAGAGGTGGCCCGGCAGGTCACCGAGCGTATCGAGAAGAAGCTGATGGAAACCGGCGACTACGATCGCATCGTGTCCTTCTCCCGCCCCGGCGTCTCGCAGGTGACCTTCATGGCCCGCGAGGACATCCATTCCAGCGAGATCCCCGAACTCTGGTACCAGATCCGCAAGAAGATCAGCGACATTCGCGCCACCTTGCCGCAAAGCATCCAGGGCCCGTTCTTCAACGACGAGTTCGGCACCACCTACGGCAACATCTATGCGCTCACCGGCAAGGGCTTCGACTACGCGGTGATGAAGGACTATGCCGACCGCCTGCAACTGCAATTGCAGCGGATCAGGAACGTCGGCAAGGTCGAGCTGATCGGCCTGCAGGACGAGAAGATCTGGATCGACCTGTCCAACACCAAGCTGGCCACCCTCGGCCTGCCCCTGGCGGCGGTACAGAAGGCGCTGGAGGAACAGAACGCGGTGGCCTCCTCCGGGTTCTTCGAGACCGCCAGCGACCGCGTGCAGTTGCGCGTTTCCGGGCGTTTCGATTCGGTGGAGGAGATCCGCGACTTCCCCATCCGCGTCGGCGACCGCACCTTCCGCATCGGCGACGTGGCCGAGGTTCGCCGCGGCTTCAACGATCCGCCGGCGCCGCGCATGCGCTTCATGGGCGAGGACGCCATCGGCCTGGCGGTAGCGATGAAGCCGGGCGGCGACATCCTGGTGCTGGGCAAGGCCCTGGAAACCGAGTTCGCCCGCCTGCAGCAGTCGCTGCCGGCCGGACTGGAACTGCGCAAGGTGTCCGACCAGCCGGCGGCGGTACGTACCGGGGTCGGCGAGTTCATCCGGGTGCTGGCCGAGGCGCTGGTGATCGTCCTGCTGGTGAGCTTCTTCTCCCTCGGCCTGCGCACCGGCCTGGTGGTGGCGCTGTCGATCCCGCTGGTGCTGGCGATGACCTTCGCCGCCATGCATTACTTCGGCATCGGCCTGCACAAGATCTCCCTCGGCGCCCTGGTGCTGGCGCTGGGATTACTGGTGGACGACGCGATCATCGCGGTGGAGATGATGGCGGTGAAGATGGAGCAGGGCTACGACCGCCTCAAGGCGGCCAGCTTCGCCTGGACCAGCACCGCCTTCCCGATGCTCACCGGCACCCTGATCACCGCCGCCGGCTTCCTGCCGATCGCCACCGCGCAGTCCGGCACCGGCGAATACACCCGCTCGTTGTTCCAGGTGGTGACCATCGCCCTGGTGGTCTCCTGGTTCGCCGCGGTGGTCTTCGTTCCCTACCTGGGGGCCAAGCTGCTGCCGGACCTGGCCAGGTTGCACGCGCAGAAGCACGGCGGCAGCGCCGATGGCTACGATCCCTATGCTACGGCCTTCTACCAGCGCTTCCGGCGTCTGGTGGAGTGGTGCGTGCGCTACCGCAAGACGGTGATCGTCCTGACTCTCGCGGCCTTCGTCGGCGCGCTGCTGCTGTTCCGCCTGGTGCCGCAGCAGTTCTTCCCGCCCTCGGCGCGCCTGGAGCTGCTGCTGGACATCAAGCTGGCGGAGGGTGCCTCACTGCGCTCTACCGGCGAGGAAGTCCAGCGCCTGGAAAAAATGCTGCAGGGCCATGACGGCATCGACAACTACGTGGCCTACGTCGGCACCGGCTCGCCCCGCTTCTACCTGCCGCTGGACCAGCAATTGCCGGCGGCCAGCTTCGCCCAGGTGGTGGTGCTGGCCAAGGACCTGGAGAGCCGCGAGGCGCTGCGCAAGTGGCTGATCGAGCGGATGAACGAGGACTTCCCGCACCTGCGCAGCCGCATCAGTCGCCTGGAGAACGGGCCGCCGGTGGGCTATCCGGTGCAGTTCCGGGTTTCCGGCGAGGACATCCCGCAGGTTCGCGAACTGGCGCGCAAGGTCGCCGACAAGATGCGCGAGAACCCGCACGTGGTGAATGTGCACCTGGATTGGGAAGAGCCGAGCAAGGTGGTGTACCTGAGCATCGACCAGGAGCGCGCCCGTGCCCTGGGGGTGAGCACCGCCAGCCTGTCGCAGTTCCTGCAGAGCGCGCTGACCGGCTCGCACGTGAGCTTCTTCCGCGAAGACAACGAGCTGATCGAGATCCTCCTGCGCGGCACCGAGCAGGAGCGTCGTGACCTGTCGTTGCTGCCGAGCCTGGCGGTGCCGACCGAGAATGGCCGGAGCGTGGCGCTGTCGCAGATCGCTACGCTCGAATACGGCTTCGAAGAGGGCATCATCTGGCACCGCAACCGCCTGCCGACGGTCACCGTGCGCGCCGATATCTACGACGATTCGCTGCCGGCGACCCTGGTCGCGCAGATCGCCCCGACCCTGGAACCGATCCGCGCCGAGTTGCCGGACGGCTACCTGCTGGAGGTGGGCGGCACGGTGGAGGACGCGGCGAAGGGCCAGAGTTCGGTGAACGCCGGCGTGCCGCTGTTCATCGTGGTGGTGTTGAGCCTGCTGATGGTGCAGTTGCGCAGCTTCTCGCGGATGGCGATGGTATTCCTCACCGCACCGCTGGGCCTGATCGGCGTGACCCTGTTCCTGCTGCTGTTCCGCCAGCCGTTCGGCTTCGTGGCGATGCTCGGGACCATCGCCCTGGCCGGCATGATCATGCGCAACTCGGTGATCCTGGTGGACCAGATCGAACAGGACATCAGCCATGGACTGGATCGCTGGCACGCCATCATCGAGGCTACCGTGCGGCGTTTCAGGCCCATCGTGCTGACCGCGCTGGCGGCGGTGCTGGCGATGATCCCGCTGTCGCGCAGCGTGTTCTTCGGGCCGATGGCGGTGGCGATCATGGGCGGGCTGATCGTCGCCACCGTGCTCACCCTGCTGTTCCTGCCGGCGCTCTATGCCGCCTGGTTCCGCGTGAAGAAGGACGAGGCGCGGGCCTGA", "partial": "0", "query_start": 41686, "query_end": 42012, "hit_start": 2148, "hit_end": 2493, "orf_dna_sequence": "GTGAACGTGCTCGCTAGGCATTCCACCGGCTCCCACGACGAGCCGGTGGCCGGCGACGTCGAACTCCGCGTCGGTGGCCCCGGTGTGCCGGACGCTCATTCCAGCGAGAGCGTTGAAGTGCTGGCGCGGTGGCTGCGGACCGCCGAGGAGAAGTACCCGGGCGTCATGGGCCCGATCCGCCAGGAGGGCCCCTGGTTCGCCATCCCGTTGACCTGCCCGCGCGGTGCCCGGTCGGCGCGATTCGGCCTCTGGCTCGGGGAACTAGACCGTCAGGGACAGCTCCTCCACATGGTCGCCTCGTATCTGGCGGCCGTGCACCACGTGCTGGTCAGCGTTCGCGAGCCCAGCGCCAACGTGCTGGAGGTGCTGGTCTCTGACTCAACAACGCCATCTGGGCTCAACCGGTTCCTGAACGGCCTGGACTCCGTCCTGGAGATCCTGGCTCACGGGCGCAGCGACCTCCTCCTGCAGCATCTCACGGGCCGGCTGCCCCCCGACGAGATGCCCTTCGTGGAGGACCGTGAGGAGCGCGAGGAGCACCCGGCCACCGATGTCGAGGCCGATGCGGTTGTCTCCGTCCTGTTCCAACCAGTTGACTTCCCGAGCCTGGCGAGGCTGGACGCGAGCCTCCTCGCGTATGACGACGAGGATGCCGGCGCGGTGGGCCGGGTCCTGGGGGAGCTCCTCCAGCCGTTCCTGCTCGACTCCGCCAGGATGACCGTGGGGCGAAAGGCGGTGAGGGTCGATCACATCTGCCTGCCTGGCTTGTTGCGAGCCGACAGCAGAGCGGCGGAGGAGTCGGTTCTCGCGCCCGCCTTGCGCTTGGCGACGAAGCCCGGTCGGCATTTCGTCGCGTTGTGCCGGAACACCGCCCTGCGGCTGGGAGACAGGCTGCCCCACTTGCTCGCGCAGGGCCCGCTCTGCGATGGCGCGTCAACGGCGCTCCTTCTGTTGCAACGGGTGCTGGACACGCTTATCGGGAGCGGGGGACTGAAGGACCATCGCCTCACGCTCGAGCTGGTTGGCGCCGATCCACGGACCGAGGCCGCGTTTCGGGCCCGGACTCCGTGGCTGGTGGCGGAACGGGCCGCTTCGGCTGCATCAACGGATGCACCGCGCGTCGACGTCGTCGTCCTGTTCCCGGCGGCACGGCCGAGCGCGCTCGAGCTGCGGCCAGACAGCGTCGTCATCGACCTTTTTGGCACCTGGAGCCTGAGACCGCGACCCGAGGTTCTGGCGAAGAACATCGTCTACGTGCGAGGGGCCTCGGTCCGTCTCGCCGGAGAGGCCGTCGTCTCGACTCCCTCCTTCGCGCCGGATCGAGTGGAGCCGGCGCTCCTCGAGGCGCTTCTCCGGGAACTCGACGCGGAGGCCAGTAGTGACGGGCTCGCCCACGAGCACCGCCTTGAGATTGGCGGCATTCGCGGGTTCTGGGGTGAGATCCGCCGGGCGGAGTGGGACGCCTTTCATTCGCGCCGCCGGGGGGAGCTGGCGAGGTTTCAGGTGTCGGGGCAGGTGACCGCCGCCAATCCGGGGCTCGCCAGCCTGCCCGATGGGGCGACGAACATCTGCGAATACATCTTCCGGGAAGCGCACCTTCGCTCCGGCTCGTGCCTCGTCGATCCCCAGAGCGGCCAGTCCGCGACCTACGCCGAGCTGCGGCGACTGGCGGCAGCGTACGCGCGGCGGTTTCGGGCATTGGGGCTCCGCCAGGGAGACGTCGTGGCGCTCGCGGCGCCGGATGGGATTTCGTCCGTCGCGGTGATGCTGGGTTGCTTCCTGGGCGGGTGGGTCTTCGCGCCGCTCAACCACACCGCCTCGGCCGTGAACTTCGAGGCGATGTTGAGTTCCGCCAGTCCCCGCCTGGTGCTCCATGCCGCGTCGACGGTCGCCCGCCATCTGCCGGTCCTGAGCACGCGGCGATGCGCGGAACTCGCGTCCTTCCTGCCGCCGGACGCGCTGGACGGCGTGGAGGGGGACGTCACCCCCCTGCCAGTGTCACCGGAAGCCCCCGCCGTCATGCTGTTCACCTCGGGCTCCACGGGGGGGCCGAAGGCAGTGACGCACACCCACGCCGACTTCATCACCTGCAGTCGCAACTACGCACCCTATGTCGTCGAACTCAGACCGGACGATCGTGTCTATACGCCGTCCCCGACCTTCTTCGCCTATGGATTGAACAACTTGCTGCTGTCCCTCAGCGCGGGGGCCACGCACGTGATCTCGGTCCCTCGCAACGGCGGGATGGGTGTCGCGGAGATCCTCGCGCGGAACGAAGTAACCGTGCTCTTCGCGGTTCCCGCCGTCTATAAGCTGATCATCTCGAAGAACGACCGGGGCCTGCGGTTGCCGAAGTTGAGATTGTGCATCTCTGCTGGCGAGAAGCTGCCATTGAAGCTGTATCGGGAGGCGCGAAGCTTCTTCAGCGTGAACGTACTGGACGGGATCGGGTGCACCGAAGCCATCTCGACGTTCATCTCGAACCGGGAGAGTTATGTCGCGCCCGGGTGCACGGGCGTGGTGGTCCCGGGGTTCGAGGTCAAGCTGGTGAACCCGCGTGGCGAGCTCTGCCGGGTGGGAGAGGTGGGCGTCCTCTGGGTTCGGGGTGGGGCGCTGACCCGGGGCTACGTGAACGCCCCCGATCTGACAGAGAAGCACTTCGTGGACGGCTGGTTCAACACCCAGGACATGTTCTTCATGGATGCCGAGTACCGGCTCTACAACGTGGGCAGGGCTGGTTCGGTCATCAAGATCAATTCCTGCTGGTTCTCACCGGAGATGATGGAGTCGGTCCTGCAATCCCATCCAGCGGTGAAGGAGTGTGCCGTCTGCGTCGTCATTGACGACTACGGGTTGCCAAGGCCGAAGGCATTCATCGTCACCGGCGAGCATGAGCGCTCCGAGCCGGAGCTCGAGCACTTGTGGGCCGAGTTGCGCGTTCTGTCGAAAGAGAAGCTTGGGAAGGACCACTACCCGCATCTGTTCGCGACCATCAAAACGCTTCCCCGGACCTCCAGCGGGAAGCTGATGCGGTCCGAACTCGCGAAGCTGCTCACCAGCGGGCCCCCATGA", "orf_prot_sequence": "MNVLARHSTGSHDEPVAGDVELRVGGPGVPDAHSSESVEVLARWLRTAEEKYPGVMGPIRQEGPWFAIPLTCPRGARSARFGLWLGELDRQGQLLHMVASYLAAVHHVLVSVREPSANVLEVLVSDSTTPSGLNRFLNGLDSVLEILAHGRSDLLLQHLTGRLPPDEMPFVEDREEREEHPATDVEADAVVSVLFQPVDFPSLARLDASLLAYDDEDAGAVGRVLGELLQPFLLDSARMTVGRKAVRVDHICLPGLLRADSRAAEESVLAPALRLATKPGRHFVALCRNTALRLGDRLPHLLAQGPLCDGASTALLLLQRVLDTLIGSGGLKDHRLTLELVGADPRTEAAFRARTPWLVAERAASAASTDAPRVDVVVLFPAARPSALELRPDSVVIDLFGTWSLRPRPEVLAKNIVYVRGASVRLAGEAVVSTPSFAPDRVEPALLEALLRELDAEASSDGLAHEHRLEIGGIRGFWGEIRRAEWDAFHSRRRGELARFQVSGQVTAANPGLASLPDGATNICEYIFREAHLRSGSCLVDPQSGQSATYAELRRLAAAYARRFRALGLRQGDVVALAAPDGISSVAVMLGCFLGGWVFAPLNHTASAVNFEAMLSSASPRLVLHAASTVARHLPVLSTRRCAELASFLPPDALDGVEGDVTPLPVSPEAPAVMLFTSGSTGGPKAVTHTHADFITCSRNYAPYVVELRPDDRVYTPSPTFFAYGLNNLLLSLSAGATHVISVPRNGGMGVAEILARNEVTVLFAVPAVYKLIISKNDRGLRLPKLRLCISAGEKLPLKLYREARSFFSVNVLDGIGCTEAISTFISNRESYVAPGCTGVVVPGFEVKLVNPRGELCRVGEVGVLWVRGGALTRGYVNAPDLTEKHFVDGWFNTQDMFFMDAEYRLYNVGRAGSVIKINSCWFSPEMMESVLQSHPAVKECAVCVVIDDYGLPRPKAFIVTGEHERSEPELEHLWAELRVLSKEKLGKDHYPHLFATIKTLPRTSSGKLMRSELAKLLTSGPP", "perc_identity": 28.81}, "gnl|BL_ORD_ID|3691|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 41056, "orf_end": 44127, "orf_from": "BGC0001413.1|Cystobactamide_18 ", "model_name": "MAL-2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "600", "model_id": "4761", "ARO_accession": "3006950", "ARO_name": "MAL-2", "ARO_category": {"43882": {"category_aro_accession": "3005422", "category_aro_cvterm_id": "43882", "category_aro_name": "MAL beta-lactamase", "category_aro_description": "MAL beta-lactamase are class A beta-lactamases found in Citrobacter koseri.", "category_aro_class_name": "AMR Gene Family"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.27528, "max_identities": 19, "bit_score": 28.1054, "cvterm_id": "36934", "query": "GGPKAVTH---THADFITCSRNYAPYVVELRPDDRVYTPSPTFFAYGLNNLLL", "match": " GP+AVT       D IT    Y P +    P D   + +P   A  LN LLL", "sequence_from_db": "NGPQAVTQFLRDSGDTITRLDRYEPELNSAIPGDERDSTTPVAIAKTLNTLLL", "sequence_from_broadstreet": "MRNEEVISMWQRMKWGLCVLALSGSAMAAPLTAQYVSAIATQEEQRLHARIGIAVLDTATNSITHYRGEERFPLNSTHKPLLCAALLREVDRKALALSASTQFEPSQLVEYSPITEKHVAPDAMNWAQLCSAAVSYSDNTAANLIARKLNGPQAVTQFLRDSGDTITRLDRYEPELNSAIPGDERDSTTPVAIAKTLNTLLLGNVLQPSSREQLMQWMRDDKVADGLLRSVLPDGWKIADKTGAGDNGSRSIVSVVWPTSQKPLLVVIYITQTPATMAQRDAAIVRIGESLFSTLAVYD", "dna_sequence_from_broadstreet": "ATGAGAAATGAGGAAGTCATTAGTATGTGGCAACGGATGAAATGGGGTCTGTGTGTGCTGGCACTCAGCGGTTCTGCGATGGCCGCACCGCTGACGGCGCAATACGTGTCGGCTATCGCGACGCAGGAAGAACAGCGTCTTCATGCCCGGATTGGCATTGCGGTACTTGATACGGCGACCAACAGTATCACCCATTATCGGGGAGAAGAACGGTTCCCGTTAAACAGTACGCACAAGCCGCTGTTATGCGCAGCGTTATTACGCGAAGTCGACAGGAAGGCGCTGGCGCTTTCTGCTTCAACGCAGTTTGAACCCTCGCAGCTGGTGGAGTATTCGCCGATTACTGAAAAACATGTGGCGCCAGACGCCATGAACTGGGCGCAATTGTGCAGCGCGGCGGTAAGCTACAGCGATAACACGGCCGCCAATCTCATCGCCAGGAAGCTCAACGGGCCGCAGGCCGTCACGCAGTTTTTGCGTGATTCGGGGGATACGATAACCCGCCTCGATCGCTATGAGCCCGAACTGAACAGCGCCATTCCCGGTGATGAACGCGACTCCACGACGCCTGTCGCGATAGCGAAGACGCTCAATACGCTACTGCTGGGGAATGTGTTGCAGCCATCCTCAAGAGAGCAGCTTATGCAATGGATGCGGGACGACAAAGTGGCTGACGGTCTGCTGCGTTCGGTCTTGCCGGACGGCTGGAAAATCGCGGATAAAACCGGGGCGGGCGACAACGGTTCGCGTTCTATTGTCAGCGTTGTCTGGCCGACATCACAAAAACCTTTGCTCGTGGTTATCTATATTACACAAACTCCGGCGACAATGGCGCAGCGTGACGCCGCGATTGTCCGCATCGGGGAGTCGCTGTTTTCAACACTCGCAGTCTATGATTAA", "partial": "0", "query_start": 43099, "query_end": 43248, "hit_start": 447, "hit_end": 606, "orf_dna_sequence": "GTGAACGTGCTCGCTAGGCATTCCACCGGCTCCCACGACGAGCCGGTGGCCGGCGACGTCGAACTCCGCGTCGGTGGCCCCGGTGTGCCGGACGCTCATTCCAGCGAGAGCGTTGAAGTGCTGGCGCGGTGGCTGCGGACCGCCGAGGAGAAGTACCCGGGCGTCATGGGCCCGATCCGCCAGGAGGGCCCCTGGTTCGCCATCCCGTTGACCTGCCCGCGCGGTGCCCGGTCGGCGCGATTCGGCCTCTGGCTCGGGGAACTAGACCGTCAGGGACAGCTCCTCCACATGGTCGCCTCGTATCTGGCGGCCGTGCACCACGTGCTGGTCAGCGTTCGCGAGCCCAGCGCCAACGTGCTGGAGGTGCTGGTCTCTGACTCAACAACGCCATCTGGGCTCAACCGGTTCCTGAACGGCCTGGACTCCGTCCTGGAGATCCTGGCTCACGGGCGCAGCGACCTCCTCCTGCAGCATCTCACGGGCCGGCTGCCCCCCGACGAGATGCCCTTCGTGGAGGACCGTGAGGAGCGCGAGGAGCACCCGGCCACCGATGTCGAGGCCGATGCGGTTGTCTCCGTCCTGTTCCAACCAGTTGACTTCCCGAGCCTGGCGAGGCTGGACGCGAGCCTCCTCGCGTATGACGACGAGGATGCCGGCGCGGTGGGCCGGGTCCTGGGGGAGCTCCTCCAGCCGTTCCTGCTCGACTCCGCCAGGATGACCGTGGGGCGAAAGGCGGTGAGGGTCGATCACATCTGCCTGCCTGGCTTGTTGCGAGCCGACAGCAGAGCGGCGGAGGAGTCGGTTCTCGCGCCCGCCTTGCGCTTGGCGACGAAGCCCGGTCGGCATTTCGTCGCGTTGTGCCGGAACACCGCCCTGCGGCTGGGAGACAGGCTGCCCCACTTGCTCGCGCAGGGCCCGCTCTGCGATGGCGCGTCAACGGCGCTCCTTCTGTTGCAACGGGTGCTGGACACGCTTATCGGGAGCGGGGGACTGAAGGACCATCGCCTCACGCTCGAGCTGGTTGGCGCCGATCCACGGACCGAGGCCGCGTTTCGGGCCCGGACTCCGTGGCTGGTGGCGGAACGGGCCGCTTCGGCTGCATCAACGGATGCACCGCGCGTCGACGTCGTCGTCCTGTTCCCGGCGGCACGGCCGAGCGCGCTCGAGCTGCGGCCAGACAGCGTCGTCATCGACCTTTTTGGCACCTGGAGCCTGAGACCGCGACCCGAGGTTCTGGCGAAGAACATCGTCTACGTGCGAGGGGCCTCGGTCCGTCTCGCCGGAGAGGCCGTCGTCTCGACTCCCTCCTTCGCGCCGGATCGAGTGGAGCCGGCGCTCCTCGAGGCGCTTCTCCGGGAACTCGACGCGGAGGCCAGTAGTGACGGGCTCGCCCACGAGCACCGCCTTGAGATTGGCGGCATTCGCGGGTTCTGGGGTGAGATCCGCCGGGCGGAGTGGGACGCCTTTCATTCGCGCCGCCGGGGGGAGCTGGCGAGGTTTCAGGTGTCGGGGCAGGTGACCGCCGCCAATCCGGGGCTCGCCAGCCTGCCCGATGGGGCGACGAACATCTGCGAATACATCTTCCGGGAAGCGCACCTTCGCTCCGGCTCGTGCCTCGTCGATCCCCAGAGCGGCCAGTCCGCGACCTACGCCGAGCTGCGGCGACTGGCGGCAGCGTACGCGCGGCGGTTTCGGGCATTGGGGCTCCGCCAGGGAGACGTCGTGGCGCTCGCGGCGCCGGATGGGATTTCGTCCGTCGCGGTGATGCTGGGTTGCTTCCTGGGCGGGTGGGTCTTCGCGCCGCTCAACCACACCGCCTCGGCCGTGAACTTCGAGGCGATGTTGAGTTCCGCCAGTCCCCGCCTGGTGCTCCATGCCGCGTCGACGGTCGCCCGCCATCTGCCGGTCCTGAGCACGCGGCGATGCGCGGAACTCGCGTCCTTCCTGCCGCCGGACGCGCTGGACGGCGTGGAGGGGGACGTCACCCCCCTGCCAGTGTCACCGGAAGCCCCCGCCGTCATGCTGTTCACCTCGGGCTCCACGGGGGGGCCGAAGGCAGTGACGCACACCCACGCCGACTTCATCACCTGCAGTCGCAACTACGCACCCTATGTCGTCGAACTCAGACCGGACGATCGTGTCTATACGCCGTCCCCGACCTTCTTCGCCTATGGATTGAACAACTTGCTGCTGTCCCTCAGCGCGGGGGCCACGCACGTGATCTCGGTCCCTCGCAACGGCGGGATGGGTGTCGCGGAGATCCTCGCGCGGAACGAAGTAACCGTGCTCTTCGCGGTTCCCGCCGTCTATAAGCTGATCATCTCGAAGAACGACCGGGGCCTGCGGTTGCCGAAGTTGAGATTGTGCATCTCTGCTGGCGAGAAGCTGCCATTGAAGCTGTATCGGGAGGCGCGAAGCTTCTTCAGCGTGAACGTACTGGACGGGATCGGGTGCACCGAAGCCATCTCGACGTTCATCTCGAACCGGGAGAGTTATGTCGCGCCCGGGTGCACGGGCGTGGTGGTCCCGGGGTTCGAGGTCAAGCTGGTGAACCCGCGTGGCGAGCTCTGCCGGGTGGGAGAGGTGGGCGTCCTCTGGGTTCGGGGTGGGGCGCTGACCCGGGGCTACGTGAACGCCCCCGATCTGACAGAGAAGCACTTCGTGGACGGCTGGTTCAACACCCAGGACATGTTCTTCATGGATGCCGAGTACCGGCTCTACAACGTGGGCAGGGCTGGTTCGGTCATCAAGATCAATTCCTGCTGGTTCTCACCGGAGATGATGGAGTCGGTCCTGCAATCCCATCCAGCGGTGAAGGAGTGTGCCGTCTGCGTCGTCATTGACGACTACGGGTTGCCAAGGCCGAAGGCATTCATCGTCACCGGCGAGCATGAGCGCTCCGAGCCGGAGCTCGAGCACTTGTGGGCCGAGTTGCGCGTTCTGTCGAAAGAGAAGCTTGGGAAGGACCACTACCCGCATCTGTTCGCGACCATCAAAACGCTTCCCCGGACCTCCAGCGGGAAGCTGATGCGGTCCGAACTCGCGAAGCTGCTCACCAGCGGGCCCCCATGA", "orf_prot_sequence": "MNVLARHSTGSHDEPVAGDVELRVGGPGVPDAHSSESVEVLARWLRTAEEKYPGVMGPIRQEGPWFAIPLTCPRGARSARFGLWLGELDRQGQLLHMVASYLAAVHHVLVSVREPSANVLEVLVSDSTTPSGLNRFLNGLDSVLEILAHGRSDLLLQHLTGRLPPDEMPFVEDREEREEHPATDVEADAVVSVLFQPVDFPSLARLDASLLAYDDEDAGAVGRVLGELLQPFLLDSARMTVGRKAVRVDHICLPGLLRADSRAAEESVLAPALRLATKPGRHFVALCRNTALRLGDRLPHLLAQGPLCDGASTALLLLQRVLDTLIGSGGLKDHRLTLELVGADPRTEAAFRARTPWLVAERAASAASTDAPRVDVVVLFPAARPSALELRPDSVVIDLFGTWSLRPRPEVLAKNIVYVRGASVRLAGEAVVSTPSFAPDRVEPALLEALLRELDAEASSDGLAHEHRLEIGGIRGFWGEIRRAEWDAFHSRRRGELARFQVSGQVTAANPGLASLPDGATNICEYIFREAHLRSGSCLVDPQSGQSATYAELRRLAAAYARRFRALGLRQGDVVALAAPDGISSVAVMLGCFLGGWVFAPLNHTASAVNFEAMLSSASPRLVLHAASTVARHLPVLSTRRCAELASFLPPDALDGVEGDVTPLPVSPEAPAVMLFTSGSTGGPKAVTHTHADFITCSRNYAPYVVELRPDDRVYTPSPTFFAYGLNNLLLSLSAGATHVISVPRNGGMGVAEILARNEVTVLFAVPAVYKLIISKNDRGLRLPKLRLCISAGEKLPLKLYREARSFFSVNVLDGIGCTEAISTFISNRESYVAPGCTGVVVPGFEVKLVNPRGELCRVGEVGVLWVRGGALTRGYVNAPDLTEKHFVDGWFNTQDMFFMDAEYRLYNVGRAGSVIKINSCWFSPEMMESVLQSHPAVKECAVCVVIDDYGLPRPKAFIVTGEHERSEPELEHLWAELRVLSKEKLGKDHYPHLFATIKTLPRTSSGKLMRSELAKLLTSGPP", "perc_identity": 35.85}}, "BGC0001413.1|Cystobactamide_19 # 44124 # 44240 # 1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.632": {"gnl|BL_ORD_ID|274|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 44124, "orf_end": 44240, "orf_from": "BGC0001413.1|Cystobactamide_19 ", "model_name": "chrB", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "305", "ARO_accession": "3001302", "ARO_name": "chrB", "ARO_category": {"37697": {"category_aro_accession": "3001298", "category_aro_cvterm_id": "37697", "category_aro_name": "non-erm 23S ribosomal RNA methyltransferase (G748)", "category_aro_description": "Non-erm 23S ribosomal RNA methyltransferases modify guanosine 748 (E. coli numbering) to confer resistance to some macrolides and lincosamides.", "category_aro_class_name": "AMR Gene Family"}, "36284": {"category_aro_accession": "3000145", "category_aro_cvterm_id": "36284", "category_aro_name": "tylosin", "category_aro_description": "Tylosin is a 16-membered macrolide, naturally produced by Streptomyces fradiae. It interacts with the bacterial ribosome 50S subunit to inhibit protein synthesis.", "category_aro_class_name": "Antibiotic"}, "37621": {"category_aro_accession": "3001222", "category_aro_cvterm_id": "37621", "category_aro_name": "chalcomycin", "category_aro_description": "Produced by Streptomyces bikiniensis.", "category_aro_class_name": "Antibiotic"}, "37623": {"category_aro_accession": "3001224", "category_aro_cvterm_id": "37623", "category_aro_name": "mycinamicin", "category_aro_description": "Produced by Micromonospora\u00a0griseorubida.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.54787, "max_identities": 8, "bit_score": 20.4014, "cvterm_id": "39573", "query": "IASLFQTVMRTVPLKDAGSG", "match": "IA+      +T+PL+DA +G", "sequence_from_db": "IAAAVTDAWQTLPLRDAAAG", "sequence_from_broadstreet": "MLNRIVRYLACPHCGASLAQGDRALFCPAGHSFDIAKQGYVNLLPRATKLRADTKEMVEARDAFLSAGHYDPVMDALVDLARRTADPAVPGCVVDIGGGTGHYHAGVMEAFPDAQGLLLDISKYAVRRAAKAHPRIAAAVTDAWQTLPLRDAAAGMVINTFAPRNGPELHRVLHPRGVLLVVTPLPDHLREVIGALGLLQVDEGKESRLAEQLAPHFSAVATEELTRTMALDHQALAHLVGMGPNAWHRDAQRDLETIQRLPAPTRVTLSVRLSAYRLSA", "dna_sequence_from_broadstreet": "ATGCTCAACAGGATCGTGCGCTACCTCGCCTGCCCGCACTGCGGTGCTTCGCTGGCTCAGGGCGACCGCGCACTTTTCTGCCCCGCCGGACACTCCTTCGACATCGCGAAGCAGGGTTATGTGAATCTGCTTCCCAGGGCGACGAAGCTGCGGGCCGACACCAAGGAAATGGTGGAGGCCCGGGACGCATTCCTGTCGGCGGGTCACTACGACCCCGTGATGGATGCGCTGGTCGATCTGGCGCGGCGGACGGCCGATCCGGCCGTGCCCGGCTGTGTGGTCGACATCGGTGGGGGGACGGGCCACTATCACGCCGGGGTCATGGAAGCGTTCCCCGATGCCCAGGGCCTGCTGCTGGACATCTCCAAGTACGCCGTGCGGCGTGCCGCGAAGGCGCATCCGCGGATCGCGGCCGCGGTGACCGACGCCTGGCAGACGCTTCCGCTGCGGGATGCCGCAGCCGGCATGGTGATCAACACGTTCGCTCCCCGCAACGGTCCTGAACTGCATCGCGTTCTCCATCCCCGTGGCGTTCTCCTGGTTGTCACTCCTCTGCCCGATCACCTGCGGGAGGTGATCGGCGCCCTCGGCCTGCTGCAGGTGGACGAAGGCAAGGAGTCGCGTCTCGCGGAGCAGCTCGCTCCGCACTTCTCGGCCGTCGCCACGGAGGAGTTGACCCGGACCATGGCTCTCGACCACCAGGCTCTGGCGCACCTGGTCGGCATGGGGCCCAATGCCTGGCACCGTGACGCGCAGCGGGATCTGGAGACGATCCAGCGGCTGCCGGCGCCGACTCGGGTCACGCTCTCCGTGCGGCTCTCCGCCTACCGGTTGTCGGCGTAG", "partial": "0", "query_start": 44166, "query_end": 44225, "hit_start": 405, "hit_end": 465, "orf_dna_sequence": "ATGAATCCAAAGTTCCTCGGAGGCCTGGGGGCAGGGGTGTGCATCGCCTCTTTGTTCCAGACGGTCATGCGGACCGTGCCGCTCAAGGACGCCGGCTCCGGCGACAGGGCTTGTTAG", "orf_prot_sequence": "MNPKFLGGLGAGVCIASLFQTVMRTVPLKDAGSGDRAC", "perc_identity": 40.0}}, "BGC0001413.1|Cystobactamide_21 # 45462 # 47039 # -1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.686": {"gnl|BL_ORD_ID|4675|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 45462, "orf_end": 47039, "orf_from": "BGC0001413.1|Cystobactamide_21 ", "model_name": "vanT gene in vanC cluster", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "200", "model_id": "734", "ARO_accession": "3002970", "ARO_name": "vanT gene in vanC cluster", "ARO_category": {"36373": {"category_aro_accession": "3000234", "category_aro_cvterm_id": "36373", "category_aro_name": "glycopeptide resistance gene cluster", "category_aro_description": "Genes that when expressed confer resistance to vancomycin and teicoplanin type antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "36511": {"category_aro_accession": "3000372", "category_aro_cvterm_id": "36511", "category_aro_name": "vanT", "category_aro_description": "VanT is a membrane bound serine racemase, converting L-serine to D-serine. It is associated with VanC, which incorporated D-serine into D-Ala-D-Ser terminal end of peptidoglycan subunits that have a decreased binding affinity with vancomycin. It was isolated from Enterococcus gallinarum.", "category_aro_class_name": "AMR Gene Family"}, "35947": {"category_aro_accession": "0000028", "category_aro_cvterm_id": "35947", "category_aro_name": "vancomycin", "category_aro_description": "Vancomycin is a glycopeptide antibiotic used in the prophylaxis and treatment of infections caused by Gram-positive bacteria. Vancomycin inhibits the synthesis of peptidoglycan, the major component of the cell wall of gram-positive bacteria. Its mechanism of action is unusual in that it acts by binding precursors of peptidoglycan, rather than by interacting with an enzyme.", "category_aro_class_name": "Antibiotic"}, "36220": {"category_aro_accession": "3000081", "category_aro_cvterm_id": "36220", "category_aro_name": "glycopeptide antibiotic", "category_aro_description": "Glycopeptide antibiotics are natural products produced non-ribosomally by Actinomycetales bacteria. With the exception of bleomycins, they act by binding the terminal D-Ala-D-Ala in peptidoglycan precursors of the growing bacterial cell wall and are generally active against Gram-positive bacteria.  This inhibits transglycosylation leading to cell death due to osmotic stress.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.2953, "max_identities": 26, "bit_score": 26.5646, "cvterm_id": "36781", "query": "AYSQANEGVSFSNTTFSAPMLVDGYFDARPTERLRGFVL-------GRLTFDPTRKAGSLGIVPTSTSTSNVAADPVVLLDQAWLRFDLDHKLFITVGKQHVKWGTSRFWNPTDFLSPQRR", "match": "A +  +EG+        +P+LV GY   +  + LR + L       G       RK      +   T    +   P +  D     FDL    F+T+   +   G++   NP   +  Q++", "sequence_from_db": "AVATIDEGIRLRKNAVKSPILVLGYTSPKRIKELRRYSLTQSIISEGHAVALSQRKVAIDCHLAIDTGMHRLGVTPTI--DSILSIFDLP---FLTISGVYSHLGSADRLNPDSMIRTQKQ", "sequence_from_broadstreet": "MKNKGIDQFRVIAAMMVVAIHCLPLHYLWPEGDILITLTIFRVAVPFFFMISGYYVFAELAVANSYPSRQRVFNFIKKQLKVYLLATLMFLPLALYSQTIGFDLPVGTLVQVLLVNGILYHLWYFPALITGSLLLTSLLIHVSFKKVFWLAAGLYLIGLGGDSWFGLIQQTPIEPFYTAVFHLLDGTRNGIFFTPLFLCLGVLVRKQSEKRSLSKTALFFLISLIGLLIESAYLHGFSIPKHDSMYLFLPVVLFFLFPLILRWHPHRTWKHPGQLSLWLYLLHPYTIAGTHFLSQKISILQNNLINYLVVLILTIGFICLFLRQKHSWFRHKQTTPVKRAVKEFSKTALLHNLQEIQRIISPKTKVMAVVKADAYGCGAKEVAPVLEQAGIDFFAVATIDEGIRLRKNAVKSPILVLGYTSPKRIKELRRYSLTQSIISEGHAVALSQRKVAIDCHLAIDTGMHRLGVTPTIDSILSIFDLPFLTISGVYSHLGSADRLNPDSMIRTQKQIACFDQILLELDQRQISYGITHLQSSYGILNYPDLNYDYVRPGILLTGSLSDTNEPTKQRVSLQPILTLKAQLITKRVVAKGEAIGYGQTAVANQETTVGVVSIGYCDGLPRSLSNQEFCLSYRGQSLPQIGLICMDMLLIDLSHCPTIPIESEIEILTDWSDTAEQVQTITNELICRIGPRVSARIK", "dna_sequence_from_broadstreet": "ATGAAAAATAAAGGAATCGATCAATTTCGTGTGATTGCAGCCATGATGGTGGTTGCGATCCATTGTCTTCCCCTTCACTATTTATGGCCAGAAGGCGATATCCTAATCACATTGACGATTTTTCGAGTAGCTGTTCCTTTCTTTTTTATGATCAGTGGTTACTATGTGTTTGCAGAACTTGCTGTGGCCAATAGTTATCCTTCGCGACAACGAGTATTCAACTTTATCAAAAAACAGCTAAAAGTCTATCTATTAGCCACACTAATGTTTTTACCATTAGCACTCTATAGTCAAACGATCGGCTTCGATCTACCAGTTGGAACATTAGTACAAGTACTTTTGGTCAATGGCATTCTTTATCATCTTTGGTACTTTCCGGCTTTGATTACTGGGAGCCTGCTCCTAACAAGTTTGCTGATACATGTCTCCTTCAAAAAAGTGTTCTGGCTTGCGGCTGGATTGTACCTGATTGGATTAGGTGGTGATAGTTGGTTTGGACTGATCCAACAGACACCAATCGAACCATTCTATACTGCTGTGTTCCACCTATTAGATGGTACCCGCAACGGTATTTTCTTTACACCATTGTTTTTGTGCTTAGGTGTGCTGGTCAGAAAACAATCAGAGAAAAGAAGTTTATCCAAAACAGCTCTCTTCTTTTTGATCAGTCTTATCGGATTGCTTATTGAGAGTGCGTACTTGCATGGGTTTTCTATACCTAAACATGACAGTATGTATCTCTTCTTGCCTGTTGTACTCTTTTTCTTATTTCCGCTGATCTTGCGCTGGCATCCCCACAGGACTTGGAAGCATCCAGGACAGCTATCTTTGTGGCTTTACCTTTTACATCCTTATACAATTGCCGGCACACACTTTTTGAGCCAAAAAATCAGCATTCTGCAAAACAATCTAATCAACTATTTGGTTGTTTTGATCTTGACGATTGGATTCATTTGCCTCTTTTTAAGACAAAAACACTCATGGTTTAGACACAAACAAACAACGCCCGTTAAAAGGGCCGTAAAAGAATTCTCAAAGACAGCCCTTTTGCATAATCTACAGGAGATCCAGCGGATCATCTCACCGAAAACAAAAGTGATGGCAGTCGTTAAAGCCGATGCCTACGGCTGTGGTGCCAAGGAAGTTGCTCCTGTTTTAGAACAAGCCGGAATTGATTTTTTTGCGGTGGCTACGATTGATGAAGGTATTCGATTGCGGAAAAATGCTGTCAAAAGCCCCATCTTGGTCTTGGGATATACCTCTCCAAAACGCATAAAAGAACTTCGTCGCTACTCATTGACCCAATCGATCATCAGCGAAGGTCATGCTGTAGCATTGTCACAAAGAAAAGTAGCGATTGACTGTCATTTAGCCATCGATACTGGGATGCATCGGTTAGGTGTAACACCGACTATCGATTCGATTCTTTCGATTTTCGATTTGCCCTTCTTGACGATCAGTGGTGTTTATTCTCATCTTGGTTCGGCAGATCGCTTAAATCCTGATAGTATGATTCGCACTCAGAAGCAGATTGCCTGCTTCGATCAGATTCTCCTAGAGTTGGATCAGAGACAGATTTCTTATGGTATCACACACTTACAAAGCAGTTATGGTATTTTGAATTATCCAGACTTAAACTATGATTATGTGCGTCCGGGGATTTTATTGACAGGATCCCTCAGTGATACGAACGAGCCTACAAAACAACGAGTAAGCTTACAGCCTATTCTGACCCTCAAAGCACAGTTGATCACTAAGCGAGTCGTTGCCAAAGGGGAAGCGATCGGTTATGGGCAAACCGCCGTCGCGAATCAAGAAACAACTGTTGGTGTTGTGAGCATCGGCTATTGTGACGGACTGCCCCGTTCTCTATCAAATCAAGAGTTTTGTCTTTCCTATCGCGGTCAGTCCTTGCCGCAGATCGGCTTGATCTGCATGGACATGCTTTTGATAGACTTGAGCCATTGTCCTACGATCCCAATTGAAAGTGAAATTGAAATTCTGACAGATTGGAGCGATACTGCCGAGCAAGTACAAACTATAACCAATGAGTTGATTTGTCGGATCGGTCCACGAGTCAGTGCTAGGATCAAATAG", "partial": "0", "query_start": 45807, "query_end": 46148, "hit_start": 1182, "hit_end": 1530, "orf_dna_sequence": "ATGAGCACGCGCACCTCCCTGGCCCTGGCCGCGTCCCTCGCCGCGCTGCCCGCGCTCGCCCAGGAGCGTCCCAGCGAGGGCGACCTCTTCGGCGGCGACACTCCAGAGACGAAGCCCGCTCCGGCCGATGCGCCCCGCCCCGACGAGAGTTCCCTCTTCGGTGACACCCCCGCGTCCACCCCGGCCGCACAGAGCGCGGCGGCCACCGCGGCCCCCGACAAGCCCTCCGCCACGCCCCAGGACCGGGATGCGCAGGCGCTCGGTGGCCCGTCGGCCACCAACGCCTTCGACACCGAGGAGGCCGTCGAGGATCCGCTGAAGATCGGCGGCCGCTTCTACCTGCGCGCCTACTCACAGGCCAACGAAGGGGTGTCCTTCAGCAACACCACCTTCTCCGCCCCCATGCTGGTGGACGGCTACTTCGATGCCCGCCCCACCGAGCGGCTGCGCGGCTTCGTGCTCGGACGGCTCACCTTCGATCCGACCCGCAAGGCGGGCTCCCTCGGCATCGTCCCCACGAGCACGTCCACCTCCAACGTCGCTGCGGATCCGGTCGTGCTGTTGGATCAGGCCTGGCTGCGCTTCGACCTGGACCACAAGCTCTTCATCACCGTCGGCAAGCAGCACGTGAAGTGGGGCACCTCGCGCTTCTGGAACCCCACCGACTTCCTCTCGCCCCAGCGCAGGGATCCGCTCGCCCTCTTGGACACGCGCACCGGCGCGACCATGCTCAAGATGCACATGCCCTGGGAGGCGAAAGGCTGGAACTTCTACGTCCTCGGCCTGCTCGACAACGCCGGCCCGGCCAATACGCTCGGCCGCGTCGGGGGCGCTGCTCGCGCCGAGGTGGTGCTCGGCCATACGGAACTCGGCGTCGATGCCGTGCTCCAACACGGCCGCAAGCCCCGCTTCGGGCTCGACCTCTCCTCCGGGCTCGGCCCCATCGACATCTACGGCGAACTCGCCCTCAAGAAGGGCTCGGATGCGCCCATGTTCCGCATGCCCCAAGGTGTCTCCCTCGGAGACCTGCTCGGTCAGTTCCAGGGCAATGGCGGCATGCCTCCCGACCTGGGCGCGCTCCCCATAGAGGCGTACTACCCCGAGGGTTACACGCCGCAGGTGAGCGGCGGCGCGACCTGGACGTTCGCCTACTCGGAGAGCGACACCGCCACCGTGGGCGTCGAGTACTTCTACAATTCGATGGGCTATCCCGGCTCGCTGGCCTACCCCTACCTCATCCTCCAGGGCCAGTATCAGCCCTTCTACCTCGGCCGGCACTACGCCGCCGTCTACGCGTTCCTGTCCGGTCCGGGATCCTGGGACAACACCAACTTCATCCTGTCCAACCTGGGCAACCTCTCTGACCGTTCTTTCATCACACGGTTGGACGTGACGCACCGGGCCCTGCGCTATCTCAGCATCGAGGCCTTCATCGCCGCCAACTATGGCCAGCGGGGTGGCGAGTTCCGCTTCGCGCTCAACCTGCCGGCCCTGCGCATGGGCGAGCAGGTGACGCCTCCCATCGCCGTCGCTCCACCTACCATCCAGGCCGGGGTGGGTCTGCGCATCGACCTTTGA", "orf_prot_sequence": "MSTRTSLALAASLAALPALAQERPSEGDLFGGDTPETKPAPADAPRPDESSLFGDTPASTPAAQSAAATAAPDKPSATPQDRDAQALGGPSATNAFDTEEAVEDPLKIGGRFYLRAYSQANEGVSFSNTTFSAPMLVDGYFDARPTERLRGFVLGRLTFDPTRKAGSLGIVPTSTSTSNVAADPVVLLDQAWLRFDLDHKLFITVGKQHVKWGTSRFWNPTDFLSPQRRDPLALLDTRTGATMLKMHMPWEAKGWNFYVLGLLDNAGPANTLGRVGGAARAEVVLGHTELGVDAVLQHGRKPRFGLDLSSGLGPIDIYGELALKKGSDAPMFRMPQGVSLGDLLGQFQGNGGMPPDLGALPIEAYYPEGYTPQVSGGATWTFAYSESDTATVGVEYFYNSMGYPGSLAYPYLILQGQYQPFYLGRHYAAVYAFLSGPGSWDNTNFILSNLGNLSDRSFITRLDVTHRALRYLSIEAFIAANYGQRGGEFRFALNLPALRMGEQVTPPIAVAPPTIQAGVGLRIDL", "perc_identity": 21.49}}, "BGC0001413.1|Cystobactamide_23 # 47827 # 49128 # -1 # ID=1_23;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.648": {"gnl|BL_ORD_ID|446|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 47827, "orf_end": 49128, "orf_from": "BGC0001413.1|Cystobactamide_23 ", "model_name": "macB", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1280", "model_id": "487", "ARO_accession": "3000535", "ARO_name": "macB", "ARO_category": {"36002": {"category_aro_accession": "0010001", "category_aro_cvterm_id": "36002", "category_aro_name": "ATP-binding cassette (ABC) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. ATP-binding cassette (ABC) transporters are present in all cells of all organisms and use the energy of ATP binding/hydrolysis to transport substrates across cell membranes.", "category_aro_class_name": "AMR Gene Family"}, "35925": {"category_aro_accession": "0000006", "category_aro_cvterm_id": "35925", "category_aro_name": "erythromycin", "category_aro_description": "Erythromycin is a macrolide antibiotic with a 14-carbon ring that has an antimicrobial spectrum similar to or slightly wider than that of penicillin, and is often used for people that have an allergy to penicillins. Erythromycin may possess bacteriocidal activity, particularly at higher concentrations by binding to the 50S subunit of the bacterial 70S rRNA complex, inhibiting peptidyl-tRNA translocation. Thus, protein synthesis and subsequently structure/function processes critical for life or replication are inhibited.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.59778e-12, "max_identities": 43, "bit_score": 66.6254, "cvterm_id": "36806", "query": "NWEDEI-SFIKWTVSAMDALTGVLIFVLLIIIAVGIMNTLWIAIRERTREIGTLRAIGMQRWYVLVMFLLEALVLGLLGTTVGALVGMGVCLLINAVDPSVPVPVQLFILSDKLHLIVKPGSVMRAIAFITLCTTFISLIPSFLAARMKPITAM", "match": "N  D I   ++ T   M  L   +  + L++  +G+MN + +++ ERT+EIG   AIG +R  +L  FL+EA+++ ++G  VG  +   V L+ N      P+ +                SV+ A+A  T        +P+  AA++ PI A+", "sequence_from_db": "NNSDSIRQMVESTTGTMKLLISSIALISLVVGGIGVMNIMLVSVTERTKEIGIRMAIGARRGNILQQFLIEAVLICIIGGLVGVGLSAAVSLVFNHFVTDFPMDIS-------------AASVIGAVACSTGIGIAFGFMPANKAAKLNPIDAL", "sequence_from_broadstreet": "MSLIECKNINRYFGSGENRVHILKDISLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAGSGSYRIDGIETAKMQPDELAALRRERFGFIFQRYNLLSSLTARDNVALPAVYMGMGGKERSARADKLLQDLGLASKEGNKPGELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGKNVMEIIRRLHEAGHTVIMVTHDPGIAANANRVIEIRDGEIISDTSKNPEIPASNVGRIQEKASWSFYYDQFVEAFRMSVQAVLAHKMRSLLTMLGIIIGIASVVSVVALGNGSQKKILEDISSMGTNTISIFPGRGFGDRRSGKIKTLTIDDAKIIAKQSYVASATPMTSSGGTLTYRNTDLTASLYGVGEQYFDVRGLKLETGRLFDENDVKEDAQVVVIDQNVKDKLFADSDPLGKTILFRKRPLTVIGVMKKDENAFGNSDVLMLWSPYTTVMHQITGESHTNSITVKIKDNANTRVAEKGLAELLKARHGTEDFFMNNSDSIRQMVESTTGTMKLLISSIALISLVVGGIGVMNIMLVSVTERTKEIGIRMAIGARRGNILQQFLIEAVLICIIGGLVGVGLSAAVSLVFNHFVTDFPMDISAASVIGAVACSTGIGIAFGFMPANKAAKLNPIDALAQD", "dna_sequence_from_broadstreet": "ATGAGCTTGATCGAATGTAAAAACATCAACCGCTATTTCGGCAGCGGCGAGAACCGCGTCCATATTTTGAAAGACATCAGCCTGTCGATAGAGAAGGGTGATTTTGTCGCCATCATCGGGCAGTCCGGTTCGGGCAAGTCCACGCTGATGAACATACTCGGTTGTTTGGATACCGCCGGTTCCGGTTCGTACCGAATCGACGGCATCGAAACTGCCAAAATGCAGCCTGACGAACTGGCGGCATTGCGGCGCGAACGCTTCGGTTTCATCTTCCAACGCTACAACCTCTTAAGCTCGCTGACCGCAAGGGACAACGTCGCGCTGCCAGCCGTGTATATGGGTATGGGAGGCAAAGAGCGTTCCGCGCGGGCGGACAAACTCTTGCAGGATTTGGGTTTGGCAAGTAAAGAGGGCAACAAGCCCGGCGAACTCTCGGGCGGACAGCAGCAGCGCGTCTCCATCGCCCGCGCCCTGATGAACGGCGGAGAAATCATCTTCGCCGACGAGCCGACCGGCGCACTCGATACCGCCAGCGGCAAAAATGTGATGGAAATCATCCGCAGGCTGCACGAAGCCGGGCATACCGTCATTATGGTCACGCACGACCCCGGCATTGCCGCCAATGCCAACCGCGTCATCGAAATCCGGGACGGCGAAATCATTTCCGACACCTCGAAAAATCCCGAAATCCCCGCAAGCAATGTCGGGAGGATTCAGGAAAAAGCCTCGTGGTCGTTTTATTACGACCAGTTTGTCGAAGCCTTCAGAATGTCGGTGCAAGCAGTATTGGCGCACAAAATGCGTTCGCTTCTGACCATGCTCGGCATCATCATCGGTATCGCTTCGGTTGTCTCCGTCGTCGCGCTGGGCAACGGGTCGCAGAAAAAAATCCTCGAAGACATCAGTTCGATGGGGACGAACACCATCAGCATCTTCCCCGGGCGCGGCTTCGGCGACAGGCGCAGCGGCAAAATCAAAACCCTGACCATAGACGACGCAAAAATCATCGCCAAACAAAGCTATGTTGCTTCCGCCACGCCCATGACTTCGAGCGGCGGCACGCTGACCTACCGCAATACCGACCTGACCGCTTCTTTGTACGGCGTGGGCGAACAATATTTCGACGTGCGCGGGCTGAAGCTGGAAACGGGGCGGCTGTTTGATGAGAACGATGTGAAAGAAGACGCGCAAGTCGTCGTCATCGACCAAAATGTCAAAGACAAACTCTTTGCGGACTCGGATCCGTTGGGTAAAACCATTTTGTTCAGGAAACGCCCCTTGACCGTCATCGGCGTGATGAAAAAAGACGAAAACGCTTTCGGCAATTCCGACGTGCTGATGCTTTGGTCGCCCTATACGACGGTGATGCACCAAATCACAGGCGAGAGCCACACCAACTCCATCACCGTCAAAATCAAAGACAATGCCAATACCCGGGTTGCCGAAAAAGGGCTGGCCGAGCTGCTCAAAGCACGGCACGGCACGGAAGACTTCTTTATGAACAACAGCGACAGCATCAGGCAGATGGTCGAAAGCACCACCGGTACGATGAAGCTGCTGATTTCCTCCATCGCCCTGATTTCATTGGTAGTCGGCGGCATCGGCGTGATGAACATTATGCTGGTGTCCGTTACCGAGCGCACCAAAGAAATCGGCATACGGATGGCAATCGGCGCGCGGCGCGGCAATATTTTGCAGCAGTTTTTGATTGAGGCGGTGTTAATCTGCATCATCGGAGGCTTGGTCGGCGTAGGTTTGTCCGCCGCCGTCAGCCTCGTGTTCAATCATTTTGTAACCGATTTCCCGATGGACATTTCGGCGGCATCCGTTATCGGGGCGGTCGCCTGTTCGACCGGAATCGGCATCGCGTTCGGCTTTATGCCTGCCAATAAGGCAGCCAAACTCAATCCGATAGACGCATTGGCGCAGGATTGA", "partial": "0", "query_start": 48655, "query_end": 49113, "hit_start": 1500, "hit_end": 1923, "orf_dna_sequence": "ATGCAACAGCTCCTCCTCATCGCAGTGCGCAACCTGGGCACCCACAAGCGCCGTACGCTTCTGCTGGGCGGCGCCATCGCCGGTGTCACGGCCCTGCTCGTCATCCTCATGGGCCTGTCCAACGGCATGAAGGACACGATGCTCCGGTCCGCCACCACGCTGGTGACCGGGCACGTCAACGTGGCTGGCTTCTACAAGGTGACGGCCGGCCAGTCTGCGCCCGTGGTGACCTCCTACCCCAAGCTGCTCGAGCAGCTGCGCAAGGAAGTCCCCGAGCTGGACTTCTCCGTCCAGCGCACGCGCGGCTGGGTCAAGTTGGTGAGCGAGTCTGGCTCCGTGCAGACGGGAATCGGCGGCATCGACGTAGCGGCCGAGACTGGCATCCGCAAGGTGCTGCAGTTGCGGGAGGGTCGGTTGGAAGACCTGGCGCAACCCAATACCCTCCTCCTCTTCGACGAGCAGGCGAAGCGGCTCGAGGTCAAGGTGGGTGACAGCGTCACCCTCTCCGCGTCCACCATGCGCGGGATCAGCAACACCGTGGACGTACGTGTGGTGGCCATCGCCGCCAACGTGGGCATGCTGAGTTCCTTCAACGTCTTGGTGCCCAACGCCACCCTGCGCGCCCTCTACCAGCTGCGCGAGGACTCCACCGGCGCCCTCATGCTCCACCTCAAGGACATGAGCGCCATCCCCAGCGTGCAGGCGCGCCTCTACAAGCGTCTGCCCGAGTTGGGTTATCAGGTGCTGGAGCATGACCCCCGGGCCTTCTTCATGAAGTTCCAGACCGTCAACCGCGAGGCCTGGACGGGGCAGAAGCTGGACATCACCAACTGGGAGGACGAGATCTCCTTCATCAAGTGGACCGTGTCGGCGATGGACGCCCTCACCGGCGTCCTCATCTTCGTGCTGCTCATCATCATCGCGGTGGGCATCATGAACACCCTGTGGATCGCCATCCGCGAGCGCACCCGGGAAATCGGCACCCTGCGCGCCATCGGCATGCAGCGCTGGTACGTGCTGGTGATGTTCCTCCTGGAGGCGCTCGTGCTCGGACTGCTCGGCACCACGGTGGGCGCCCTCGTGGGCATGGGCGTGTGCCTGCTCATCAACGCCGTGGACCCCTCCGTGCCCGTGCCCGTCCAGCTCTTCATCCTCTCCGACAAGCTCCACCTCATCGTGAAGCCCGGATCGGTGATGAGAGCCATCGCGTTCATCACGCTGTGCACCACCTTCATCTCGCTCATTCCCTCTTTCCTCGCCGCGCGGATGAAGCCCATCACGGCGATGCACCACATCGGGTGA", "orf_prot_sequence": "MQQLLLIAVRNLGTHKRRTLLLGGAIAGVTALLVILMGLSNGMKDTMLRSATTLVTGHVNVAGFYKVTAGQSAPVVTSYPKLLEQLRKEVPELDFSVQRTRGWVKLVSESGSVQTGIGGIDVAAETGIRKVLQLREGRLEDLAQPNTLLLFDEQAKRLEVKVGDSVTLSASTMRGISNTVDVRVVAIAANVGMLSSFNVLVPNATLRALYQLREDSTGALMLHLKDMSAIPSVQARLYKRLPELGYQVLEHDPRAFFMKFQTVNREAWTGQKLDITNWEDEISFIKWTVSAMDALTGVLIFVLLIIIAVGIMNTLWIAIRERTREIGTLRAIGMQRWYVLVMFLLEALVLGLLGTTVGALVGMGVCLLINAVDPSVPVPVQLFILSDKLHLIVKPGSVMRAIAFITLCTTFISLIPSFLAARMKPITAMHHIG", "perc_identity": 27.92}, "gnl|BL_ORD_ID|2411|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 47827, "orf_end": 49128, "orf_from": "BGC0001413.1|Cystobactamide_23 ", "model_name": "AxyY", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1700", "model_id": "2799", "ARO_accession": "3004144", "ARO_name": "AxyY", "ARO_category": {"36005": {"category_aro_accession": "0010004", "category_aro_cvterm_id": "36005", "category_aro_name": "resistance-nodulation-cell division (RND) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Resistance-nodulation-division (RND) proteins are found in both prokaryotic and eukaryotic cells and have diverse substrate specificities and physiological roles. However, there are relatively few RND transporters and they are secondary transporters, energized not by ATP binding/hydrolysis but by proton movement down the transmembrane electrochemical gradient.", "category_aro_class_name": "AMR Gene Family"}, "35925": {"category_aro_accession": "0000006", "category_aro_cvterm_id": "35925", "category_aro_name": "erythromycin", "category_aro_description": "Erythromycin is a macrolide antibiotic with a 14-carbon ring that has an antimicrobial spectrum similar to or slightly wider than that of penicillin, and is often used for people that have an allergy to penicillins. Erythromycin may possess bacteriocidal activity, particularly at higher concentrations by binding to the 50S subunit of the bacterial 70S rRNA complex, inhibiting peptidyl-tRNA translocation. Thus, protein synthesis and subsequently structure/function processes critical for life or replication are inhibited.", "category_aro_class_name": "Antibiotic"}, "35976": {"category_aro_accession": "0000059", "category_aro_cvterm_id": "35976", "category_aro_name": "cefepime", "category_aro_description": "Cefepime (INN) is a fourth-generation cephalosporin antibiotic developed in 1994. It contains an aminothiazolyl group that decreases its affinity with beta-lactamases. Cefepime shows high binding affinity with penicillin-binding proteins and has an extended spectrum of activity against Gram-positive and Gram-negative bacteria, with greater activity against both Gram-negative and Gram-positive organisms than third-generation agents.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35935": {"category_aro_accession": "0000016", "category_aro_cvterm_id": "35935", "category_aro_name": "aminoglycoside antibiotic", "category_aro_description": "Aminoglycosides are a group of antibiotics that are mostly effective against Gram-negative bacteria. These molecules consist of aminated sugars attached to a dibasic cyclitol. Aminoglycosides work by binding to the bacterial 30S ribosomal subunit (some work by binding to the 50S subunit), inhibiting the translocation of the peptidyl-tRNA from the A-site to the P-site and also causing misreading of mRNA, leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.241731, "max_identities": 24, "bit_score": 30.8018, "cvterm_id": "41271", "query": "LGTTVGALVGMGVCLLINAVDPSVPVPVQLFILSDKLHLIVKPGSVMRAIAFITLCTTFISLIPSFLAARMKPITAMHH", "match": "+G   GA+VG+ V L+      SV VP+  F     +  I +  +V  A++        +SL P+  A+ +KP+ A HH", "sequence_from_db": "MGQISGAIVGITVVLV------SVFVPMAFF--DGAVGNIYRQFAVTLAVSIAFSAFLALSLTPALCASLLKPVPAGHH", "sequence_from_broadstreet": "MARFFIDRPVFAWVISLLIALVGLLSIRALPVAQYPDIAPPVVNIGASYPGASAKVVEEAVTAIIEREMNGAPGLMYTSSSSDSTGWASINLTFKQGTNPDIAAVEVQNRLKAVEPRLPESVRRDGVRVEKAADNIQLVVSLKSDGSLDDMQLGELAASNVLQALRRVEGVGKVQSFGAEAAMRIWPDPAKLTALSLTPGDIVSALRSHNARVTIGELGNQAVPKDAPLNASIVAGESLHTPEQFANIPLRALPDGATLRLKDVARVELGGTDYMYLSRVNGLTGTGLGIKLAPGSNAVETTRRIRETMRELAQYFPPGVTWDIPYETSTFVEISIKKVLMTLLEAVALVFCVMYLFMQNLRATLIPTLVVPVALLGTLGVMLGLGYSINVLTMFGMVLAIGILVDDAIVVVENVERIMAEEGLSPHDATVKAMGQISGAIVGITVVLVSVFVPMAFFDGAVGNIYRQFAVTLAVSIAFSAFLALSLTPALCASLLKPVPAGHHEKRGFFGWFNRAFARLTTRYTARVAGVLARPVRFGLAYALVIGVAALLFARLPSSFLPDEDQGSFMAMVILPQGSPQAETMAVVKDVERYMMEHEPVQYVYSVNGFSQYGSGPNSAMFFVTLKDWKERRDASQHVDAVVKRINKAFADRKNLMVFALNSPPLPDLGSTSGFDFRLQDRGGLGYEALTQARQKLLAKAAEHPALTDVVFAGQEEAPQLQLRVDRDKAQAMGVPIDEINTALAVMYGSDYIGDFMLNGQVRRVMVQADGKRRVDVDDISRLHVRNLQGQMVPLSAFATLTWSMGPPQLNRYNGFPSFTINGSAARGHSSGEAMRAMETLAAELPRGIGFDWSGQSYEERLSGNQAPVLFALSVLIVFLALAALYESWSIPLAVILVVPLGVIGALLGVTVRGMPNDIYFKVGLIATIGLSAKNAILIVEVAKDLVRDGQGILSATLEAARLRLRPIVMTSLAFGVGVLPLALATGAASGAQAAIGTGVLGGIITATVLAVFLVPLFFLIVGRMVGMRARPARPDGREPLETTP", "dna_sequence_from_broadstreet": "ATGGCGCGTTTCTTTATCGATCGCCCCGTTTTCGCGTGGGTGATCTCGCTGCTCATCGCGCTGGTCGGCCTGTTGTCGATCCGCGCGCTGCCGGTGGCGCAGTATCCGGACATCGCTCCGCCCGTCGTCAACATCGGCGCCAGCTATCCCGGCGCCTCGGCCAAGGTGGTCGAGGAAGCCGTCACCGCCATCATCGAACGCGAGATGAACGGCGCCCCGGGCCTGATGTACACCTCGTCCAGCAGCGATTCGACCGGCTGGGCCAGCATCAACCTGACCTTCAAGCAGGGCACCAACCCCGACATCGCGGCGGTGGAAGTGCAGAACCGCCTGAAGGCGGTCGAGCCTCGCCTGCCCGAATCGGTGCGGCGCGATGGCGTGCGCGTGGAAAAGGCGGCCGACAACATCCAGCTGGTGGTGTCGTTGAAGTCGGACGGCAGCCTGGACGACATGCAACTGGGCGAGCTGGCCGCCTCCAATGTGCTGCAGGCGCTGCGGCGGGTCGAAGGCGTGGGCAAGGTGCAGTCGTTCGGCGCGGAAGCGGCGATGCGCATCTGGCCGGACCCGGCCAAGCTCACCGCCCTGTCGCTGACGCCGGGCGACATCGTCTCGGCGCTGCGCAGCCACAACGCGCGCGTCACCATCGGCGAACTGGGCAACCAGGCCGTGCCCAAGGACGCGCCGCTGAACGCCAGCATCGTGGCGGGCGAATCGCTGCACACGCCGGAACAGTTCGCCAACATCCCGCTGCGGGCGCTGCCGGACGGCGCCACGCTGCGCCTGAAGGACGTGGCGCGGGTGGAGCTGGGCGGCACCGACTACATGTACCTGTCGCGCGTCAACGGCCTGACCGGCACCGGCCTGGGCATCAAGCTGGCGCCCGGCTCCAACGCCGTCGAAACCACCCGCCGCATCCGCGAGACCATGCGCGAGCTGGCGCAATACTTCCCGCCGGGCGTGACCTGGGACATTCCGTACGAGACCTCCACCTTCGTCGAGATCTCGATCAAGAAGGTCCTGATGACGCTGCTGGAGGCGGTGGCGCTGGTGTTCTGCGTGATGTACCTGTTCATGCAGAACCTGCGCGCCACGCTGATCCCGACCCTGGTGGTGCCGGTGGCGCTGCTGGGCACGCTGGGGGTGATGCTGGGGCTGGGCTATTCGATCAACGTGCTGACGATGTTCGGCATGGTGCTGGCCATCGGCATCCTGGTGGACGACGCCATCGTGGTGGTCGAGAACGTCGAGCGCATCATGGCCGAGGAAGGCCTGTCGCCGCATGACGCCACGGTCAAGGCCATGGGCCAGATCAGCGGCGCCATCGTCGGCATCACCGTGGTGCTGGTGTCGGTGTTCGTGCCGATGGCGTTCTTCGACGGCGCGGTGGGCAACATCTACCGCCAGTTCGCCGTGACGCTGGCGGTGTCGATCGCCTTCTCGGCCTTCCTGGCGCTGTCGCTGACGCCGGCGCTGTGCGCCAGCCTGCTCAAACCCGTCCCGGCCGGCCACCACGAGAAGCGCGGCTTCTTCGGCTGGTTCAACCGCGCCTTCGCGCGCCTGACCACGCGCTATACGGCGCGGGTGGCCGGCGTGCTGGCGCGGCCGGTACGCTTCGGCCTGGCCTATGCGCTGGTGATCGGCGTGGCGGCGTTGCTGTTCGCGCGGCTGCCATCGTCGTTCCTGCCGGACGAGGACCAGGGCAGCTTCATGGCCATGGTGATCCTGCCGCAGGGCTCGCCGCAGGCCGAGACCATGGCGGTGGTCAAGGACGTCGAACGCTACATGATGGAGCACGAGCCGGTGCAGTACGTGTATTCGGTCAACGGCTTCAGCCAGTACGGCAGCGGCCCGAACTCCGCCATGTTCTTCGTCACGCTGAAGGACTGGAAGGAACGCCGCGATGCCTCGCAACACGTGGACGCGGTGGTCAAGCGCATCAACAAGGCGTTCGCGGATCGCAAGAACCTGATGGTGTTCGCGCTGAACTCGCCGCCGCTGCCTGACCTGGGCTCGACCTCGGGCTTCGACTTCCGGCTGCAGGATCGCGGCGGCCTCGGCTACGAAGCCCTGACGCAGGCGCGCCAGAAGCTGCTGGCCAAGGCGGCCGAGCATCCCGCGCTGACGGACGTGGTGTTCGCCGGCCAGGAAGAGGCGCCGCAGCTGCAACTGCGCGTCGACCGCGACAAGGCGCAGGCCATGGGCGTGCCGATCGACGAGATCAACACCGCGCTGGCTGTGATGTACGGCTCGGACTACATCGGCGACTTCATGCTCAACGGCCAGGTTCGGCGCGTGATGGTGCAGGCCGACGGCAAGCGCCGCGTGGACGTGGACGACATCTCGCGCCTGCACGTGCGCAACCTGCAGGGCCAGATGGTGCCGCTGTCGGCGTTCGCCACGCTGACGTGGTCGATGGGGCCGCCGCAGCTGAACCGCTACAACGGCTTCCCGTCGTTCACCATCAACGGCTCGGCGGCGCGCGGCCACAGCAGCGGCGAGGCCATGCGCGCCATGGAGACGCTGGCGGCCGAGCTGCCGCGCGGCATCGGCTTCGACTGGTCGGGCCAATCGTACGAAGAGCGGCTGTCCGGCAACCAGGCGCCGGTGCTGTTCGCGCTGTCGGTGCTGATCGTGTTCCTGGCGCTGGCGGCGCTGTATGAAAGCTGGTCGATTCCGCTGGCGGTGATCCTGGTGGTGCCGCTGGGCGTGATCGGCGCGCTGCTGGGGGTGACCGTGCGCGGCATGCCCAACGACATCTACTTCAAGGTCGGCCTGATCGCCACCATCGGCCTGTCCGCCAAGAACGCGATCCTGATCGTGGAAGTGGCCAAGGACCTGGTGCGCGACGGCCAGGGCATCCTGTCCGCCACGCTGGAAGCGGCGCGGCTGCGGCTGCGGCCGATCGTGATGACCTCGCTGGCCTTTGGCGTGGGCGTGCTGCCGCTGGCGCTGGCCACTGGCGCCGCCTCGGGCGCGCAGGCCGCCATCGGCACCGGCGTGCTGGGCGGGATCATCACGGCGACCGTGCTGGCGGTGTTCCTGGTGCCGCTGTTCTTTCTCATCGTGGGACGCATGGTCGGCATGCGCGCCCGCCCCGCGCGCCCCGACGGCCGCGAACCGCTGGAGACGACGCCATGA", "partial": "0", "query_start": 48883, "query_end": 49119, "hit_start": 1299, "hit_end": 1512, "orf_dna_sequence": "ATGCAACAGCTCCTCCTCATCGCAGTGCGCAACCTGGGCACCCACAAGCGCCGTACGCTTCTGCTGGGCGGCGCCATCGCCGGTGTCACGGCCCTGCTCGTCATCCTCATGGGCCTGTCCAACGGCATGAAGGACACGATGCTCCGGTCCGCCACCACGCTGGTGACCGGGCACGTCAACGTGGCTGGCTTCTACAAGGTGACGGCCGGCCAGTCTGCGCCCGTGGTGACCTCCTACCCCAAGCTGCTCGAGCAGCTGCGCAAGGAAGTCCCCGAGCTGGACTTCTCCGTCCAGCGCACGCGCGGCTGGGTCAAGTTGGTGAGCGAGTCTGGCTCCGTGCAGACGGGAATCGGCGGCATCGACGTAGCGGCCGAGACTGGCATCCGCAAGGTGCTGCAGTTGCGGGAGGGTCGGTTGGAAGACCTGGCGCAACCCAATACCCTCCTCCTCTTCGACGAGCAGGCGAAGCGGCTCGAGGTCAAGGTGGGTGACAGCGTCACCCTCTCCGCGTCCACCATGCGCGGGATCAGCAACACCGTGGACGTACGTGTGGTGGCCATCGCCGCCAACGTGGGCATGCTGAGTTCCTTCAACGTCTTGGTGCCCAACGCCACCCTGCGCGCCCTCTACCAGCTGCGCGAGGACTCCACCGGCGCCCTCATGCTCCACCTCAAGGACATGAGCGCCATCCCCAGCGTGCAGGCGCGCCTCTACAAGCGTCTGCCCGAGTTGGGTTATCAGGTGCTGGAGCATGACCCCCGGGCCTTCTTCATGAAGTTCCAGACCGTCAACCGCGAGGCCTGGACGGGGCAGAAGCTGGACATCACCAACTGGGAGGACGAGATCTCCTTCATCAAGTGGACCGTGTCGGCGATGGACGCCCTCACCGGCGTCCTCATCTTCGTGCTGCTCATCATCATCGCGGTGGGCATCATGAACACCCTGTGGATCGCCATCCGCGAGCGCACCCGGGAAATCGGCACCCTGCGCGCCATCGGCATGCAGCGCTGGTACGTGCTGGTGATGTTCCTCCTGGAGGCGCTCGTGCTCGGACTGCTCGGCACCACGGTGGGCGCCCTCGTGGGCATGGGCGTGTGCCTGCTCATCAACGCCGTGGACCCCTCCGTGCCCGTGCCCGTCCAGCTCTTCATCCTCTCCGACAAGCTCCACCTCATCGTGAAGCCCGGATCGGTGATGAGAGCCATCGCGTTCATCACGCTGTGCACCACCTTCATCTCGCTCATTCCCTCTTTCCTCGCCGCGCGGATGAAGCCCATCACGGCGATGCACCACATCGGGTGA", "orf_prot_sequence": "MQQLLLIAVRNLGTHKRRTLLLGGAIAGVTALLVILMGLSNGMKDTMLRSATTLVTGHVNVAGFYKVTAGQSAPVVTSYPKLLEQLRKEVPELDFSVQRTRGWVKLVSESGSVQTGIGGIDVAAETGIRKVLQLREGRLEDLAQPNTLLLFDEQAKRLEVKVGDSVTLSASTMRGISNTVDVRVVAIAANVGMLSSFNVLVPNATLRALYQLREDSTGALMLHLKDMSAIPSVQARLYKRLPELGYQVLEHDPRAFFMKFQTVNREAWTGQKLDITNWEDEISFIKWTVSAMDALTGVLIFVLLIIIAVGIMNTLWIAIRERTREIGTLRAIGMQRWYVLVMFLLEALVLGLLGTTVGALVGMGVCLLINAVDPSVPVPVQLFILSDKLHLIVKPGSVMRAIAFITLCTTFISLIPSFLAARMKPITAMHHIG", "perc_identity": 30.38}, "gnl|BL_ORD_ID|4727|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 47827, "orf_end": 49128, "orf_from": "BGC0001413.1|Cystobactamide_23 ", "model_name": "salD", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5739", "ARO_accession": "3007028", "ARO_name": "salD", "ARO_category": {"45589": {"category_aro_accession": "3007030", "category_aro_cvterm_id": "45589", "category_aro_name": "sal-type ABC-F protein", "category_aro_description": "Sal proteins are a part of the ABC-F proteins, expressed in staphylococci that confer resistance to group A streptogramin, lincosamide, and pleuromutilin antibiotics through ribosomal protection.", "category_aro_class_name": "AMR Gene Family"}, "35964": {"category_aro_accession": "0000046", "category_aro_cvterm_id": "35964", "category_aro_name": "lincomycin", "category_aro_description": "Lincomycin is a lincosamide antibiotic that comes from the actinomyces Streptomyces lincolnensis. It binds to the 23s portion of the 50S subunit of bacterial ribosomes and inhibit early elongation of peptide chain by inhibiting transpeptidase reaction.", "category_aro_class_name": "Antibiotic"}, "37013": {"category_aro_accession": "3000669", "category_aro_cvterm_id": "37013", "category_aro_name": "virginiamycin M1", "category_aro_description": "Virginiamycin M1 is a streptogramin A antibiotic.", "category_aro_class_name": "Antibiotic"}, "37015": {"category_aro_accession": "3000671", "category_aro_cvterm_id": "37015", "category_aro_name": "tiamulin", "category_aro_description": "Tiamulin is a pleuromutilin derivative currently used in veterinary medicine. It binds to the 23 rRNA of the 50S ribosomal subunit to inhibit protein translation.", "category_aro_class_name": "Antibiotic"}, "37713": {"category_aro_accession": "3001314", "category_aro_cvterm_id": "37713", "category_aro_name": "retapamulin", "category_aro_description": "Retapamulin is a semi-synthetic pleuromutilin antibiotic approved for the treatment of skin infections.", "category_aro_class_name": "Antibiotic"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35952": {"category_aro_accession": "0000034", "category_aro_cvterm_id": "35952", "category_aro_name": "streptogramin A antibiotic", "category_aro_description": "Streptogramin A antibiotics are cyclic polyketide peptide hybrids that bind to the ribosomal peptidyl transfer centre. Structural variation arises from substituting a proline for its desaturated derivative and by its substitution for Ala or Cys. Used alone, streptogramin A antibiotics are bacteriostatic, but is bactericidal when used with streptogramin B antibiotics.", "category_aro_class_name": "Drug Class"}, "37014": {"category_aro_accession": "3000670", "category_aro_cvterm_id": "37014", "category_aro_name": "pleuromutilin antibiotic", "category_aro_description": "Pleuromutilins are natural fungal products that target bacterial protein translation by binding the the 23S rRNA, blocking the ribosome P site at the 50S subunit. They are mostly used for agriculture and veterinary purposes.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.397513, "max_identities": 12, "bit_score": 30.0314, "cvterm_id": "45587", "query": "KLLEQLRKEVPELDFSVQRTRGWVKLVSESGSVQT", "match": "K+ E+ +KE+  L+ +V R + W K  ++S SV+ ", "sequence_from_db": "KVYEKKQKEIKALEATVDRVKNWHKTANQSASVRN", "sequence_from_broadstreet": "MSFYFTEKPFERFGKTLIEEVNLSVEPGEHIAIVGDNGVGKSTLLNAIYNKYNDSTYLMDQELSKYKNETAINYIMSWYPELLDIKLAMQTDYEKIGDYIELNGYEIEEQIILQAKQLNLEESDLDKQMGQLSGGQQTKVALVRAMISEKNLILLDEPTNHLDKQMIHIVVDYIKQAKQSILYVSHHRGFIDETATHIIEITPQATRKFTGNYSQYKSIIDVERETQKKVYEKKQKEIKALEATVDRVKNWHKTANQSASVRNPLEQKRLSKLAQKAKVKESQINQKLEKIKVQQPKSDDRHFHFENQDALNKKYLMQLYDFSITIDGKNIYQNANFEIKDNENIILTGPNGSGKSLLISIIKQSIIPDEGDIYITPSLKIAYFDQKNDNLNYDSTALTMLLNMEGMERSQAQTILASFGFDNQKINLPISQLSMGEKSRLQFVLLYFSNPHLLILDEPTNYFDIATQDLILQMLKQFAGQVMIVTHDEYLKSQITATHWTIKDKKLMNLTLSEKHSPNMVDDTLKLLDDYKSIDEFGHFETDN", "dna_sequence_from_broadstreet": "ATGTCTTTTTATTTTACAGAAAAGCCATTTGAAAGGTTCGGCAAGACATTAATAGAAGAGGTTAATTTAAGTGTTGAACCAGGTGAACATATAGCAATTGTTGGTGATAACGGGGTAGGTAAATCAACATTACTCAATGCAATTTACAATAAATATAATGATTCAACGTATTTGATGGATCAAGAATTATCGAAGTATAAAAATGAAACGGCAATAAATTATATTATGTCGTGGTATCCAGAATTATTAGATATTAAACTTGCTATGCAAACTGATTATGAAAAAATTGGTGACTATATAGAACTTAATGGATATGAAATAGAAGAACAAATCATTTTACAAGCAAAGCAATTAAATTTAGAAGAGTCAGATTTAGATAAACAAATGGGGCAGTTAAGTGGCGGACAACAAACCAAAGTAGCATTAGTTCGAGCAATGATTTCAGAAAAAAATTTAATCTTGTTGGATGAACCAACAAATCACTTAGATAAACAAATGATTCATATTGTCGTGGATTATATAAAGCAAGCAAAGCAAAGTATATTATACGTGTCACATCATAGAGGATTTATCGACGAAACTGCAACGCACATTATTGAAATTACACCACAAGCTACAAGAAAATTTACTGGTAATTATAGTCAATATAAATCCATTATAGATGTTGAAAGAGAAACTCAAAAAAAGGTATACGAGAAAAAGCAAAAAGAAATAAAAGCTTTGGAAGCAACCGTAGATAGAGTTAAAAATTGGCATAAAACTGCGAATCAATCTGCAAGTGTTCGTAATCCGTTAGAGCAAAAGCGTTTGAGTAAATTAGCTCAAAAGGCAAAGGTTAAAGAATCACAAATAAATCAAAAACTTGAAAAGATTAAAGTCCAACAGCCTAAGTCGGATGATCGTCACTTCCATTTTGAGAATCAAGATGCGCTAAATAAAAAATATTTAATGCAATTATATGATTTTAGCATCACTATTGATGGTAAGAATATTTATCAAAATGCAAATTTCGAAATTAAAGATAATGAAAACATTATACTTACTGGCCCGAATGGTAGTGGCAAATCATTATTAATCTCAATTATCAAGCAGTCAATAATACCAGATGAGGGTGATATTTATATAACGCCTTCTCTAAAAATAGCTTATTTTGACCAAAAAAATGACAATTTAAATTATGACAGCACAGCATTAACAATGTTATTAAACATGGAGGGTATGGAACGTAGTCAAGCACAAACGATATTAGCGTCATTTGGATTTGATAACCAAAAAATAAACCTTCCAATTTCTCAATTATCTATGGGAGAGAAAAGTAGATTACAGTTTGTATTATTATATTTCTCAAATCCACATTTATTAATTCTCGACGAACCAACCAATTACTTCGATATTGCTACGCAAGATTTAATATTACAGATGCTAAAGCAATTTGCAGGACAAGTAATGATTGTGACGCATGATGAATACTTGAAATCTCAAATTACAGCGACACATTGGACAATTAAAGATAAAAAGTTAATGAATTTAACATTATCAGAGAAGCATTCACCCAATATGGTGGATGATACATTAAAATTATTAGATGATTATAAGTCGATAGATGAATTCGGACATTTTGAAACAGACAACTAG", "partial": "0", "query_start": 48067, "query_end": 48171, "hit_start": 684, "hit_end": 789, "orf_dna_sequence": "ATGCAACAGCTCCTCCTCATCGCAGTGCGCAACCTGGGCACCCACAAGCGCCGTACGCTTCTGCTGGGCGGCGCCATCGCCGGTGTCACGGCCCTGCTCGTCATCCTCATGGGCCTGTCCAACGGCATGAAGGACACGATGCTCCGGTCCGCCACCACGCTGGTGACCGGGCACGTCAACGTGGCTGGCTTCTACAAGGTGACGGCCGGCCAGTCTGCGCCCGTGGTGACCTCCTACCCCAAGCTGCTCGAGCAGCTGCGCAAGGAAGTCCCCGAGCTGGACTTCTCCGTCCAGCGCACGCGCGGCTGGGTCAAGTTGGTGAGCGAGTCTGGCTCCGTGCAGACGGGAATCGGCGGCATCGACGTAGCGGCCGAGACTGGCATCCGCAAGGTGCTGCAGTTGCGGGAGGGTCGGTTGGAAGACCTGGCGCAACCCAATACCCTCCTCCTCTTCGACGAGCAGGCGAAGCGGCTCGAGGTCAAGGTGGGTGACAGCGTCACCCTCTCCGCGTCCACCATGCGCGGGATCAGCAACACCGTGGACGTACGTGTGGTGGCCATCGCCGCCAACGTGGGCATGCTGAGTTCCTTCAACGTCTTGGTGCCCAACGCCACCCTGCGCGCCCTCTACCAGCTGCGCGAGGACTCCACCGGCGCCCTCATGCTCCACCTCAAGGACATGAGCGCCATCCCCAGCGTGCAGGCGCGCCTCTACAAGCGTCTGCCCGAGTTGGGTTATCAGGTGCTGGAGCATGACCCCCGGGCCTTCTTCATGAAGTTCCAGACCGTCAACCGCGAGGCCTGGACGGGGCAGAAGCTGGACATCACCAACTGGGAGGACGAGATCTCCTTCATCAAGTGGACCGTGTCGGCGATGGACGCCCTCACCGGCGTCCTCATCTTCGTGCTGCTCATCATCATCGCGGTGGGCATCATGAACACCCTGTGGATCGCCATCCGCGAGCGCACCCGGGAAATCGGCACCCTGCGCGCCATCGGCATGCAGCGCTGGTACGTGCTGGTGATGTTCCTCCTGGAGGCGCTCGTGCTCGGACTGCTCGGCACCACGGTGGGCGCCCTCGTGGGCATGGGCGTGTGCCTGCTCATCAACGCCGTGGACCCCTCCGTGCCCGTGCCCGTCCAGCTCTTCATCCTCTCCGACAAGCTCCACCTCATCGTGAAGCCCGGATCGGTGATGAGAGCCATCGCGTTCATCACGCTGTGCACCACCTTCATCTCGCTCATTCCCTCTTTCCTCGCCGCGCGGATGAAGCCCATCACGGCGATGCACCACATCGGGTGA", "orf_prot_sequence": "MQQLLLIAVRNLGTHKRRTLLLGGAIAGVTALLVILMGLSNGMKDTMLRSATTLVTGHVNVAGFYKVTAGQSAPVVTSYPKLLEQLRKEVPELDFSVQRTRGWVKLVSESGSVQTGIGGIDVAAETGIRKVLQLREGRLEDLAQPNTLLLFDEQAKRLEVKVGDSVTLSASTMRGISNTVDVRVVAIAANVGMLSSFNVLVPNATLRALYQLREDSTGALMLHLKDMSAIPSVQARLYKRLPELGYQVLEHDPRAFFMKFQTVNREAWTGQKLDITNWEDEISFIKWTVSAMDALTGVLIFVLLIIIAVGIMNTLWIAIRERTREIGTLRAIGMQRWYVLVMFLLEALVLGLLGTTVGALVGMGVCLLINAVDPSVPVPVQLFILSDKLHLIVKPGSVMRAIAFITLCTTFISLIPSFLAARMKPITAMHHIG", "perc_identity": 34.29}, "gnl|BL_ORD_ID|1640|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 47827, "orf_end": 49128, "orf_from": "BGC0001413.1|Cystobactamide_23 ", "model_name": "mexY", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1800", "model_id": "1786", "ARO_accession": "3003033", "ARO_name": "mexY", "ARO_category": {"36005": {"category_aro_accession": "0010004", "category_aro_cvterm_id": "36005", "category_aro_name": "resistance-nodulation-cell division (RND) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Resistance-nodulation-division (RND) proteins are found in both prokaryotic and eukaryotic cells and have diverse substrate specificities and physiological roles. However, there are relatively few RND transporters and they are secondary transporters, energized not by ATP binding/hydrolysis but by proton movement down the transmembrane electrochemical gradient.", "category_aro_class_name": "AMR Gene Family"}, "35925": {"category_aro_accession": "0000006", "category_aro_cvterm_id": "35925", "category_aro_name": "erythromycin", "category_aro_description": "Erythromycin is a macrolide antibiotic with a 14-carbon ring that has an antimicrobial spectrum similar to or slightly wider than that of penicillin, and is often used for people that have an allergy to penicillins. Erythromycin may possess bacteriocidal activity, particularly at higher concentrations by binding to the 50S subunit of the bacterial 70S rRNA complex, inhibiting peptidyl-tRNA translocation. Thus, protein synthesis and subsequently structure/function processes critical for life or replication are inhibited.", "category_aro_class_name": "Antibiotic"}, "35932": {"category_aro_accession": "0000013", "category_aro_cvterm_id": "35932", "category_aro_name": "amikacin", "category_aro_description": "Amikacin is an aminoglycoside antibiotic that works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35933": {"category_aro_accession": "0000014", "category_aro_cvterm_id": "35933", "category_aro_name": "gentamicin C", "category_aro_description": "Gentamicin C is a mixture of gentamicin C1, gentamicin C1a, and gentamicin C2 (these differ in substituents at position C6'). Gentamicin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35963": {"category_aro_accession": "0000045", "category_aro_cvterm_id": "35963", "category_aro_name": "acriflavine", "category_aro_description": "Acriflavine is a topical antiseptic. It has the form of an orange or brown powder. It may be harmful in the eyes or if inhaled. Acriflavine is also used as treatment for external fungal infections of aquarium fish.", "category_aro_class_name": "Antibiotic"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35969": {"category_aro_accession": "0000052", "category_aro_cvterm_id": "35969", "category_aro_name": "tobramycin", "category_aro_description": "Tobramycin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Tobramycin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35990": {"category_aro_accession": "0000073", "category_aro_cvterm_id": "35990", "category_aro_name": "meropenem", "category_aro_description": "Meropenem is an ultra-broad spectrum injectable antibiotic used to treat a wide variety of infections, including meningitis and pneumonia. It is a beta-lactam and belongs to the subgroup of carbapenem, similar to imipenem and ertapenem.", "category_aro_class_name": "Antibiotic"}, "36524": {"category_aro_accession": "3000385", "category_aro_cvterm_id": "36524", "category_aro_name": "chloramphenicol", "category_aro_description": "Chloramphenicol is a bacteriostatic antimicrobial originally derived from the bacterium Streptomyces venezuelae. It was the first antibiotic to be manufactured synthetically on a large scale. It functions by inhibiting peptidyl transferase activity of the bacterial ribosome, binding to A2451 and A2452 residues in the 23S rRNA of the 50S ribosomal subunit and preventing peptide bond formation.", "category_aro_class_name": "Antibiotic"}, "36998": {"category_aro_accession": "3000654", "category_aro_cvterm_id": "36998", "category_aro_name": "arbekacin", "category_aro_description": "A synthetic derivative (1-N-(4-amino-2-hydroxybutyryl) of dibekacin used in Japan. It is active against methicillin-resistant Staph. aureus and shows synergy with ampicillin when treating gentamicin and vancomycin resistant enterocci.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37007": {"category_aro_accession": "3000663", "category_aro_cvterm_id": "37007", "category_aro_name": "ofloxacin", "category_aro_description": "Ofloxacin is a 6-fluoro, 7-piperazinyl quinolone with a methyl-substituted oxazine ring. It has a broad spectrum of activity including many enterobacteria and mycoplasma but most anaerobes are resistant.", "category_aro_class_name": "Antibiotic"}, "46133": {"category_aro_accession": "3007382", "category_aro_cvterm_id": "46133", "category_aro_name": "gentamicin", "category_aro_description": "Gentamicin is a commonly used aminoglycoside antibiotic derived from members of the Micromonospora genus of bacteria. It acts by binding the 30S ribosomal subunit, thus inhibiting protein synthesis. Gentamicin is typically used to treat Gram-negative infections of the repiratory and urinary tract, as well as infections of the bone and soft tissue. It also exhibits considerable nephrotoxicity and ototoxicity. Gentamicin is administered as a mixture of gentamicin type C (which makes about around 80% of the complex) and types A, B, and X (distributed in the remaining 20% of the complex).", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35935": {"category_aro_accession": "0000016", "category_aro_cvterm_id": "35935", "category_aro_name": "aminoglycoside antibiotic", "category_aro_description": "Aminoglycosides are a group of antibiotics that are mostly effective against Gram-negative bacteria. These molecules consist of aminated sugars attached to a dibasic cyclitol. Aminoglycosides work by binding to the bacterial 30S ribosomal subunit (some work by binding to the 50S subunit), inhibiting the translocation of the peptidyl-tRNA from the A-site to the P-site and also causing misreading of mRNA, leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Drug Class"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35962": {"category_aro_accession": "0000044", "category_aro_cvterm_id": "35962", "category_aro_name": "cephamycin", "category_aro_description": "Cephamycins are a group of beta-lactam antibiotics, very similar to cephalosporins. Together with cephalosporins, they form a sub-group of antibiotics known as cephems. Cephamycins are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms. The 7-alpha-methoxy group increases resistance to beta-lactamases.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36526": {"category_aro_accession": "3000387", "category_aro_cvterm_id": "36526", "category_aro_name": "phenicol antibiotic", "category_aro_description": "Phenicols are broad spectrum bacteriostatic antibiotics acting on bacterial protein synthesis. More specifically, the phenicols block peptide elongation by binding to the peptidyltansferase centre of the 70S ribosome.", "category_aro_class_name": "Drug Class"}, "43746": {"category_aro_accession": "3005386", "category_aro_cvterm_id": "43746", "category_aro_name": "disinfecting agents and antiseptics", "category_aro_description": "Disinfectants that can also interact with antimicrobial resistance mechanisms, e.g. molecule efflux, and thus are the targets of disinfectant resistance.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.890467, "max_identities": 24, "bit_score": 29.261, "cvterm_id": "36804", "query": "GALVGMGVCLLINAVDPSVPVPVQLFILSDKLHLIVKPGSVMRAIAFITLCTTFISLIPSFLAARMKPITAMHH", "match": "GA+VG+ V L+      SV VP+  F  S  +  I +  +V  A++        +SL P+  A  ++PI A HH", "sequence_from_db": "GAIVGITVVLV------SVFVPMAFF--SGAVGNIYRQFAVTLAVSIGFSAFLALSLTPALCATLLRPIDADHH", "sequence_from_broadstreet": "MARFFIDRPVFAWVISLLIVLAGVLAIRFLPVAQYPDIAPPVVNVSATYPGASAKVVEEAVTAIIEREMNGAPGLLYTKATSSTGQASLTLTFRQGVNANLAAVEVQNRLKIVESRLPESVRRDGIYVEKAADSIQLIVTLTSSSGRYDAMELGEIASSNVLQALRRVEGVGKVETWGAEYAMRIWPDPAKLTSMNLSASDLVNAVRRHNARLTVGDIGNLGVPDSAPISATVKVDDTLVTPEQFGEIPLAHPRDGGAIRLRDVARVEFGQSEYGFVSRVNQMTATGLAVKMAPGSNAVATAKRIRATLDELSRYFPEGVSYNIPYDTSAFVEISIRKVVSTLLEAMLLVFAVMYLFMQNFRATLIPTLVVPVALLGTFTVMLGLGFSINVLTMFGMVLAIGILVDDAIIVVENVERLMAEEGLSPHDATVKAMRQISGAIVGITVVLVSVFVPMAFFSGAVGNIYRQFAVTLAVSIGFSAFLALSLTPALCATLLRPIDADHHEKRGFFGWFNRAFLRLTGRYRNAVAGILARPIRWMLVYTLVIGVVALLFVRLPQAFLPEEDQGDFMIMVMQPEGTPMAETMANVGDVERYLAEHEPVAYAYAVGGFSLYGDGTSSAMIFATLKDWSERREASQHVGAIVERINQRFAGLPNRTVYAMNSPPLPDLGSTSGFDFRLQDRGGVGYEALVKARDQLLARAAEDPRLANVMFAGQGEAPQIRLDIDRRKAETLGVSMDEINTTLAVMFGSDYIGDFMHGSQVRKVVVQADRRKRLGIDDIGRLHVRNEQGEMGAAGDVRQGRLDPRPAATDPLQRLSLVQPRGPGRAGLQQREAMQAMEQLMQGTARGIRPRVVRPVLRRTPVAGAQAPALFALSVLIVFLALAALYESWSIPLAVILVVPLGVLGALLGVSLRGLPNDIYFKVGLITIIGLSAKNAILIIEVAKDHYQEGMSLLQATLEAARLRLRPIVMTSLAFGFGVVPLALSSGAGIRAQVAIGTGVLGGIVTATVLAVFLVPLFFLVVGRLFRLRKAPRTGNSPQIPTEQA", "dna_sequence_from_broadstreet": "ATGGCTCGTTTCTTCATTGACCGGCCGGTCTTCGCCTGGGTGATCTCCCTGCTGATCGTGCTCGCCGGGGTCCTGGCGATCCGCTTCCTGCCGGTCGCCCAGTACCCGGACATCGCGCCGCCGGTGGTCAACGTCAGCGCCACGTATCCCGGCGCCTCGGCCAAGGTGGTCGAGGAAGCGGTGACCGCGATCATCGAGCGCGAGATGAACGGCGCGCCCGGCCTGCTCTACACCAAGGCCACCAGCAGCACCGGCCAGGCCTCGCTGACCCTGACCTTCCGCCAGGGCGTGAACGCGAACCTCGCCGCGGTGGAAGTGCAGAACCGCCTGAAGATCGTCGAGTCGCGCCTGCCCGAATCGGTGCGGCGCGACGGCATCTACGTGGAGAAGGCGGCGGACAGCATCCAGCTGATCGTTACCCTTACCTCCTCCAGCGGCCGCTACGACGCCATGGAGCTGGGCGAGATCGCCTCGTCCAACGTGTTGCAGGCGCTGCGCCGGGTGGAGGGCGTGGGCAAGGTCGAGACCTGGGGCGCCGAGTACGCCATGCGCATCTGGCCCGACCCGGCCAAGCTGACCTCGATGAACCTCAGCGCCAGCGACCTGGTCAACGCCGTGCGCCGGCACAACGCCCGCCTCACCGTGGGCGACATCGGCAACCTCGGGGTCCCCGACTCGGCGCCGATCAGCGCCACGGTGAAGGTCGACGACACCCTGGTGACGCCCGAGCAGTTCGGCGAAATTCCGCTGGCGCATCCGCGCGACGGCGGCGCGATCCGCCTGCGCGACGTGGCCCGCGTCGAGTTCGGCCAGAGCGAGTACGGCTTCGTCTCGCGGGTCAACCAAATGACCGCCACCGGCCTGGCGGTGAAGATGGCGCCCGGCTCCAACGCGGTGGCCACCGCCAAGCGCATCCGCGCCACCCTCGACGAGCTGTCGCGCTACTTCCCGGAGGGCGTGAGCTACAACATCCCCTATGACACCTCGGCGTTCGTCGAGATCTCGATCAGGAAGGTGGTCAGCACCCTGCTCGAGGCGATGCTGCTGGTGTTCGCCGTGATGTACCTGTTCATGCAGAACTTCCGCGCCACCCTGATCCCGACACTGGTGGTGCCGGTGGCCCTGCTGGGCACCTTCACGGTGATGCTCGGCCTGGGCTTCTCGATCAACGTGCTGACCATGTTCGGCATGGTCCTGGCGATCGGCATCCTGGTGGACGACGCGATCATCGTGGTGGAGAACGTCGAGCGGCTGATGGCCGAGGAAGGCCTGTCGCCGCACGACGCCACGGTCAAGGCGATGCGCCAGATCAGCGGGGCCATCGTCGGCATCACCGTAGTGCTGGTCTCGGTGTTCGTGCCGATGGCGTTCTTCAGCGGCGCGGTGGGCAACATCTACCGCCAGTTCGCGGTGACCCTGGCGGTCTCCATCGGCTTCTCGGCGTTCCTCGCGCTGTCGCTGACCCCGGCCCTGTGCGCCACCCTGCTGCGCCCGATCGACGCCGACCACCACGAGAAGCGCGGCTTCTTCGGCTGGTTCAACCGCGCCTTCCTGCGCCTGACCGGACGCTACCGCAACGCGGTGGCCGGCATCCTCGCCCGGCCGATCCGCTGGATGCTGGTCTACACCCTGGTCATCGGCGTGGTCGCCCTGCTCTTCGTGCGCCTGCCGCAGGCGTTCCTGCCGGAAGAGGACCAGGGCGACTTCATGATCATGGTGATGCAGCCCGAAGGCACGCCGATGGCGGAGACCATGGCCAACGTCGGCGACGTCGAGCGCTACCTGGCGGAGCACGAACCGGTGGCCTACGCCTATGCGGTCGGCGGCTTCAGCCTGTACGGCGACGGCACCAGCTCGGCGATGATCTTCGCCACCCTGAAGGACTGGTCGGAACGCCGGGAGGCCAGCCAGCACGTCGGCGCCATCGTCGAGCGCATCAACCAGCGCTTCGCCGGCCTGCCCAACCGTACGGTGTATGCGATGAACTCGCCGCCGCTGCCGGACCTGGGTTCCACCAGCGGCTTCGACTTCCGCCTGCAGGACCGTGGCGGGGTTGGCTACGAGGCCCTGGTCAAGGCCCGCGACCAGTTGCTGGCGCGCGCCGCCGAGGACCCGCGCCTGGCCAACGTGATGTTCGCCGGCCAGGGCGAGGCGCCGCAGATCCGCCTGGACATCGACCGGCGCAAGGCGGAGACCCTTGGCGTGAGCATGGACGAGATCAACACCACCCTGGCGGTGATGTTCGGCTCGGACTACATCGGCGACTTCATGCACGGCAGCCAGGTGCGCAAGGTGGTGGTCCAGGCCGACCGGCGCAAGCGCCTGGGCATCGACGACATCGGCCGGCTTCACGTGCGCAACGAGCAGGGCGAGATGGGTGCCGCTGGCGACGTTCGCCAAGGCCGCCTGGACCCTCGGCCCGCCGCAACTGACCCGCTACAACGGCTATCCCTCGTTCAACCTCGAGGGCCAGGCCGCGCCGGGCTACAGCAGCGCGAAGCCATGCAGGCGATGGAGCAATTGATGCAGGGAACTGCCCGAGGCATTCGCCCACGAGTGGTCCGGCCAGTCCTTCGAAGAACGCCTGTTGCCGGCGCCCAGGCGCCGGCGCTGTTCGCCCTCTCGGTGTTGATCGTGTTCCTCGCCCTGGCCGCCCTCTACGAAAGCTGGTCGATCCCGCTGGCGGTGATCCTGGTGGTGCCGCTGGGCGTACTCGGCGCACTGCTCGGGGTGAGCCTGCGCGGTCTGCCCAACGACATCTACTTCAAGGTCGGCCTGATCACCATCATCGGCCTCTCGGCGAAGAACGCCATCCTCATCATCGAGGTGGCCAAGGACCATTACCAGGAAGGCATGAGCCTGCTGCAGGCGACCCTGGAGGCCGCGCGCCTGCGCCTGCGACCGATCGTCATGACCTCGCTGGCGTTCGGTTTCGGCGTGGTCCCGCTGGCGCTCTCCAGCGGCGCCGGTATCCGCGCCCAGGTCGCCATCGGCACCGGGGTGCTCGGCGGGATCGTCACCGCCACGGTACTCGCGGTGTTCCTGGTACCGCTGTTCTTCCTGGTGGTCGGGCGCCTGTTCCGGTTGCGCAAGGCGCCGCGCACCGGCAACTCGCCCCAGATCCCCACGGAGCAAGCCTGA", "partial": "0", "query_start": 48898, "query_end": 49119, "hit_start": 1314, "hit_end": 1512, "orf_dna_sequence": "ATGCAACAGCTCCTCCTCATCGCAGTGCGCAACCTGGGCACCCACAAGCGCCGTACGCTTCTGCTGGGCGGCGCCATCGCCGGTGTCACGGCCCTGCTCGTCATCCTCATGGGCCTGTCCAACGGCATGAAGGACACGATGCTCCGGTCCGCCACCACGCTGGTGACCGGGCACGTCAACGTGGCTGGCTTCTACAAGGTGACGGCCGGCCAGTCTGCGCCCGTGGTGACCTCCTACCCCAAGCTGCTCGAGCAGCTGCGCAAGGAAGTCCCCGAGCTGGACTTCTCCGTCCAGCGCACGCGCGGCTGGGTCAAGTTGGTGAGCGAGTCTGGCTCCGTGCAGACGGGAATCGGCGGCATCGACGTAGCGGCCGAGACTGGCATCCGCAAGGTGCTGCAGTTGCGGGAGGGTCGGTTGGAAGACCTGGCGCAACCCAATACCCTCCTCCTCTTCGACGAGCAGGCGAAGCGGCTCGAGGTCAAGGTGGGTGACAGCGTCACCCTCTCCGCGTCCACCATGCGCGGGATCAGCAACACCGTGGACGTACGTGTGGTGGCCATCGCCGCCAACGTGGGCATGCTGAGTTCCTTCAACGTCTTGGTGCCCAACGCCACCCTGCGCGCCCTCTACCAGCTGCGCGAGGACTCCACCGGCGCCCTCATGCTCCACCTCAAGGACATGAGCGCCATCCCCAGCGTGCAGGCGCGCCTCTACAAGCGTCTGCCCGAGTTGGGTTATCAGGTGCTGGAGCATGACCCCCGGGCCTTCTTCATGAAGTTCCAGACCGTCAACCGCGAGGCCTGGACGGGGCAGAAGCTGGACATCACCAACTGGGAGGACGAGATCTCCTTCATCAAGTGGACCGTGTCGGCGATGGACGCCCTCACCGGCGTCCTCATCTTCGTGCTGCTCATCATCATCGCGGTGGGCATCATGAACACCCTGTGGATCGCCATCCGCGAGCGCACCCGGGAAATCGGCACCCTGCGCGCCATCGGCATGCAGCGCTGGTACGTGCTGGTGATGTTCCTCCTGGAGGCGCTCGTGCTCGGACTGCTCGGCACCACGGTGGGCGCCCTCGTGGGCATGGGCGTGTGCCTGCTCATCAACGCCGTGGACCCCTCCGTGCCCGTGCCCGTCCAGCTCTTCATCCTCTCCGACAAGCTCCACCTCATCGTGAAGCCCGGATCGGTGATGAGAGCCATCGCGTTCATCACGCTGTGCACCACCTTCATCTCGCTCATTCCCTCTTTCCTCGCCGCGCGGATGAAGCCCATCACGGCGATGCACCACATCGGGTGA", "orf_prot_sequence": "MQQLLLIAVRNLGTHKRRTLLLGGAIAGVTALLVILMGLSNGMKDTMLRSATTLVTGHVNVAGFYKVTAGQSAPVVTSYPKLLEQLRKEVPELDFSVQRTRGWVKLVSESGSVQTGIGGIDVAAETGIRKVLQLREGRLEDLAQPNTLLLFDEQAKRLEVKVGDSVTLSASTMRGISNTVDVRVVAIAANVGMLSSFNVLVPNATLRALYQLREDSTGALMLHLKDMSAIPSVQARLYKRLPELGYQVLEHDPRAFFMKFQTVNREAWTGQKLDITNWEDEISFIKWTVSAMDALTGVLIFVLLIIIAVGIMNTLWIAIRERTREIGTLRAIGMQRWYVLVMFLLEALVLGLLGTTVGALVGMGVCLLINAVDPSVPVPVQLFILSDKLHLIVKPGSVMRAIAFITLCTTFISLIPSFLAARMKPITAMHHIG", "perc_identity": 32.43}, "gnl|BL_ORD_ID|1384|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 47827, "orf_end": 49128, "orf_from": "BGC0001413.1|Cystobactamide_23 ", "model_name": "OXA-209", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "1502", "ARO_accession": "3001809", "ARO_name": "OXA-209", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.48614, "max_identities": 8, "bit_score": 27.335, "cvterm_id": "36951", "query": "AWTGQKLDITNWEDEISFIK", "match": " W G+K    NWE++++F K", "sequence_from_db": "KWNGEKRKFKNWEEDLTFKK", "sequence_from_broadstreet": "MKKTFILLNLILLVNLNGYCQTKSLKSNEIVKPEFRNILDSLKVKGAILIYDVKNKTYYSNDFSWTKTGIIPASTFKIPNSIIALETGIIKNDSTIFKWNGEKRKFKNWEEDLTFKKAFQVSCVPCYQEIARKIGVKRMKRYLKKLNYRGMVFDTLTIDQFWLEGESKITQMQQIDFLERLYFSKFPISDRTIKIVKNIMEIERTENYILSGKTGLSSIEEKYNGWFVGYVETKSNVYFFATNVIPTDGLNVDDFISSRINVTKNALKQMNIMK", "dna_sequence_from_broadstreet": "ATGAAAAAAACATTTATACTTCTGAATCTAATTTTATTAGTAAATCTTAATGGATATTGTCAAACTAAAAGTTTAAAATCAAATGAAATTGTAAAACCTGAATTTAGAAATATATTAGATAGTTTAAAGGTAAAAGGAGCAATTTTAATTTATGATGTAAAAAACAAAACTTATTATTCAAATGATTTTTCTTGGACAAAAACTGGAATAATTCCTGCATCGACTTTCAAAATACCAAATTCAATTATTGCGTTAGAAACAGGAATAATCAAAAATGACTCTACAATTTTTAAATGGAATGGTGAAAAACGCAAATTTAAAAATTGGGAAGAAGATTTGACTTTTAAAAAAGCATTTCAAGTTTCTTGTGTTCCTTGTTATCAAGAAATTGCCAGAAAAATTGGTGTGAAAAGGATGAAAAGATATTTGAAAAAATTAAATTACAGAGGAATGGTTTTCGATACTTTGACGATTGATCAATTTTGGTTAGAAGGAGAATCTAAAATTACTCAAATGCAACAAATAGATTTTTTAGAACGATTATACTTTTCAAAATTTCCAATTTCTGATAGGACAATAAAGATTGTCAAAAATATTATGGAAATTGAGCGAACTGAAAATTACATTTTAAGCGGTAAGACTGGATTAAGTTCGATAGAAGAAAAATATAATGGTTGGTTTGTTGGTTATGTTGAAACAAAATCTAATGTTTATTTTTTTGCAACAAATGTAATTCCGACAGACGGATTGAATGTTGATGATTTTATTTCATCGAGAATTAATGTAACAAAAAATGCGTTAAAGCAAATGAATATAATGAAATGA", "partial": "0", "query_start": 48625, "query_end": 48684, "hit_start": 291, "hit_end": 351, "orf_dna_sequence": "ATGCAACAGCTCCTCCTCATCGCAGTGCGCAACCTGGGCACCCACAAGCGCCGTACGCTTCTGCTGGGCGGCGCCATCGCCGGTGTCACGGCCCTGCTCGTCATCCTCATGGGCCTGTCCAACGGCATGAAGGACACGATGCTCCGGTCCGCCACCACGCTGGTGACCGGGCACGTCAACGTGGCTGGCTTCTACAAGGTGACGGCCGGCCAGTCTGCGCCCGTGGTGACCTCCTACCCCAAGCTGCTCGAGCAGCTGCGCAAGGAAGTCCCCGAGCTGGACTTCTCCGTCCAGCGCACGCGCGGCTGGGTCAAGTTGGTGAGCGAGTCTGGCTCCGTGCAGACGGGAATCGGCGGCATCGACGTAGCGGCCGAGACTGGCATCCGCAAGGTGCTGCAGTTGCGGGAGGGTCGGTTGGAAGACCTGGCGCAACCCAATACCCTCCTCCTCTTCGACGAGCAGGCGAAGCGGCTCGAGGTCAAGGTGGGTGACAGCGTCACCCTCTCCGCGTCCACCATGCGCGGGATCAGCAACACCGTGGACGTACGTGTGGTGGCCATCGCCGCCAACGTGGGCATGCTGAGTTCCTTCAACGTCTTGGTGCCCAACGCCACCCTGCGCGCCCTCTACCAGCTGCGCGAGGACTCCACCGGCGCCCTCATGCTCCACCTCAAGGACATGAGCGCCATCCCCAGCGTGCAGGCGCGCCTCTACAAGCGTCTGCCCGAGTTGGGTTATCAGGTGCTGGAGCATGACCCCCGGGCCTTCTTCATGAAGTTCCAGACCGTCAACCGCGAGGCCTGGACGGGGCAGAAGCTGGACATCACCAACTGGGAGGACGAGATCTCCTTCATCAAGTGGACCGTGTCGGCGATGGACGCCCTCACCGGCGTCCTCATCTTCGTGCTGCTCATCATCATCGCGGTGGGCATCATGAACACCCTGTGGATCGCCATCCGCGAGCGCACCCGGGAAATCGGCACCCTGCGCGCCATCGGCATGCAGCGCTGGTACGTGCTGGTGATGTTCCTCCTGGAGGCGCTCGTGCTCGGACTGCTCGGCACCACGGTGGGCGCCCTCGTGGGCATGGGCGTGTGCCTGCTCATCAACGCCGTGGACCCCTCCGTGCCCGTGCCCGTCCAGCTCTTCATCCTCTCCGACAAGCTCCACCTCATCGTGAAGCCCGGATCGGTGATGAGAGCCATCGCGTTCATCACGCTGTGCACCACCTTCATCTCGCTCATTCCCTCTTTCCTCGCCGCGCGGATGAAGCCCATCACGGCGATGCACCACATCGGGTGA", "orf_prot_sequence": "MQQLLLIAVRNLGTHKRRTLLLGGAIAGVTALLVILMGLSNGMKDTMLRSATTLVTGHVNVAGFYKVTAGQSAPVVTSYPKLLEQLRKEVPELDFSVQRTRGWVKLVSESGSVQTGIGGIDVAAETGIRKVLQLREGRLEDLAQPNTLLLFDEQAKRLEVKVGDSVTLSASTMRGISNTVDVRVVAIAANVGMLSSFNVLVPNATLRALYQLREDSTGALMLHLKDMSAIPSVQARLYKRLPELGYQVLEHDPRAFFMKFQTVNREAWTGQKLDITNWEDEISFIKWTVSAMDALTGVLIFVLLIIIAVGIMNTLWIAIRERTREIGTLRAIGMQRWYVLVMFLLEALVLGLLGTTVGALVGMGVCLLINAVDPSVPVPVQLFILSDKLHLIVKPGSVMRAIAFITLCTTFISLIPSFLAARMKPITAMHHIG", "perc_identity": 40.0}, "gnl|BL_ORD_ID|1934|hsp_num:0": {"type_match": "Loose", "snp": {"original": "A", "change": "T", "position": 183}, "query_snp": {"original": "A", "change": "T", "position": 84}, "orf_strand": "-", "orf_start": 47827, "orf_end": 49128, "orf_from": "BGC0001413.1|Cystobactamide_23 ", "model_name": "Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin", "model_type": "protein variant model", "model_type_id": 40293, "pass_evalue": "n/a", "pass_bitscore": 400, "model_id": "489", "ARO_accession": "3003470", "ARO_name": "Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin", "ARO_category": {"40059": {"category_aro_accession": "3003466", "category_aro_cvterm_id": "40059", "category_aro_name": "antibiotic resistant gidB", "category_aro_description": "GidB is a m7G methyltransferase specific for 16S rRNA. Mutations within the gidB gene causes changes in the structure or 16s rRNA, leading to resistance to aminoglycosides.", "category_aro_class_name": "AMR Gene Family"}, "35958": {"category_aro_accession": "0000040", "category_aro_cvterm_id": "35958", "category_aro_name": "streptomycin", "category_aro_description": "Streptomycin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Streptomycin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35935": {"category_aro_accession": "0000016", "category_aro_cvterm_id": "35935", "category_aro_name": "aminoglycoside antibiotic", "category_aro_description": "Aminoglycosides are a group of antibiotics that are mostly effective against Gram-negative bacteria. These molecules consist of aminated sugars attached to a dibasic cyclitol. Aminoglycosides work by binding to the bacterial 30S ribosomal subunit (some work by binding to the 50S subunit), inhibiting the translocation of the peptidyl-tRNA from the A-site to the P-site and also causing misreading of mRNA, leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.7337, "bit_score": 26.1794, "max_identities": 32, "cvterm_id": "39507", "query": "EQLRKEVPELDFSVQRTRGWVKLVSESGSVQTGIGGIDVAAETGIRKVLQLREGRLEDLAQPN-TLLLFDEQAKRLEVKVGDSVTLSASTMRGISNTVDVRVVAIAAN", "match": "E LR+ V +L  +V+  RG     +E   VQ  +GG D A    +  + +L +  +  L +PN  +L    +    EV+    V ++       S  VDVRVV   AN", "sequence_from_db": "EFLREMVTDLGVAVEIVRG----RAEESWVQDQLGGSDAAVSRAVAALDKLTKWSMP-LIRPNGRMLAIKGERAHDEVREHRRVMIA-------SGAVDVRVVTCGAN", "sequence_from_broadstreet": "MSPIEPAASAIFGPRLGLARRYAEALAGPGVERGLVGPREVGRLWDRHLLNCAVIGELLERGDRVVDIGSGAGLPGVPLAIARPDLQVVLLEPLLRRTEFLREMVTDLGVAVEIVRGRAEESWVQDQLGGSDAAVSRAVAALDKLTKWSMPLIRPNGRMLAIKGERAHDEVREHRRVMIASGAVDVRVVTCGANYLRPPATVVFARRGKQIARGSARMASGGTA", "dna_sequence_from_broadstreet": "ATGTCTCCGATCGAGCCCGCGGCGTCTGCGATCTTCGGACCGCGGCTTGGCCTTGCTCGGCGGTACGCCGAAGCGTTGGCGGGACCCGGTGTGGAGCGGGGGCTGGTGGGACCCCGCGAAGTCGGTAGGCTATGGGACCGGCATCTACTGAACTGCGCCGTGATCGGTGAGCTCCTCGAACGCGGTGACCGGGTCGTGGATATCGGTAGCGGAGCCGGGTTGCCGGGCGTGCCATTGGCGATAGCGCGGCCGGACCTCCAGGTAGTTCTCCTAGAACCGCTACTGCGCCGCACCGAGTTTCTTCGAGAGATGGTGACAGATCTGGGCGTGGCCGTTGAGATCGTGCGGGGGCGCGCCGAGGAGTCCTGGGTGCAGGACCAATTGGGCGGCAGCGACGCTGCGGTGTCACGGGCGGTGGCCGCGTTGGACAAGTTGACGAAATGGAGCATGCCGTTGATACGGCCGAACGGGCGAATGCTCGCCATCAAAGGCGAGCGGGCTCACGACGAAGTACGGGAGCACCGGCGTGTGATGATCGCATCGGGCGCGGTTGATGTCAGGGTGGTGACATGTGGCGCGAACTATTTGCGTCCGCCCGCGACCGTGGTGTTCGCACGACGTGGAAAGCAGATCGCCCGAGGGTCGGCACGGATGGCGAGTGGAGGGACGGCGTGA", "partial": "0", "query_start": 48076, "query_end": 48396, "hit_start": 294, "hit_end": 582, "orf_dna_sequence": "ATGCAACAGCTCCTCCTCATCGCAGTGCGCAACCTGGGCACCCACAAGCGCCGTACGCTTCTGCTGGGCGGCGCCATCGCCGGTGTCACGGCCCTGCTCGTCATCCTCATGGGCCTGTCCAACGGCATGAAGGACACGATGCTCCGGTCCGCCACCACGCTGGTGACCGGGCACGTCAACGTGGCTGGCTTCTACAAGGTGACGGCCGGCCAGTCTGCGCCCGTGGTGACCTCCTACCCCAAGCTGCTCGAGCAGCTGCGCAAGGAAGTCCCCGAGCTGGACTTCTCCGTCCAGCGCACGCGCGGCTGGGTCAAGTTGGTGAGCGAGTCTGGCTCCGTGCAGACGGGAATCGGCGGCATCGACGTAGCGGCCGAGACTGGCATCCGCAAGGTGCTGCAGTTGCGGGAGGGTCGGTTGGAAGACCTGGCGCAACCCAATACCCTCCTCCTCTTCGACGAGCAGGCGAAGCGGCTCGAGGTCAAGGTGGGTGACAGCGTCACCCTCTCCGCGTCCACCATGCGCGGGATCAGCAACACCGTGGACGTACGTGTGGTGGCCATCGCCGCCAACGTGGGCATGCTGAGTTCCTTCAACGTCTTGGTGCCCAACGCCACCCTGCGCGCCCTCTACCAGCTGCGCGAGGACTCCACCGGCGCCCTCATGCTCCACCTCAAGGACATGAGCGCCATCCCCAGCGTGCAGGCGCGCCTCTACAAGCGTCTGCCCGAGTTGGGTTATCAGGTGCTGGAGCATGACCCCCGGGCCTTCTTCATGAAGTTCCAGACCGTCAACCGCGAGGCCTGGACGGGGCAGAAGCTGGACATCACCAACTGGGAGGACGAGATCTCCTTCATCAAGTGGACCGTGTCGGCGATGGACGCCCTCACCGGCGTCCTCATCTTCGTGCTGCTCATCATCATCGCGGTGGGCATCATGAACACCCTGTGGATCGCCATCCGCGAGCGCACCCGGGAAATCGGCACCCTGCGCGCCATCGGCATGCAGCGCTGGTACGTGCTGGTGATGTTCCTCCTGGAGGCGCTCGTGCTCGGACTGCTCGGCACCACGGTGGGCGCCCTCGTGGGCATGGGCGTGTGCCTGCTCATCAACGCCGTGGACCCCTCCGTGCCCGTGCCCGTCCAGCTCTTCATCCTCTCCGACAAGCTCCACCTCATCGTGAAGCCCGGATCGGTGATGAGAGCCATCGCGTTCATCACGCTGTGCACCACCTTCATCTCGCTCATTCCCTCTTTCCTCGCCGCGCGGATGAAGCCCATCACGGCGATGCACCACATCGGGTGA", "orf_prot_sequence": "MQQLLLIAVRNLGTHKRRTLLLGGAIAGVTALLVILMGLSNGMKDTMLRSATTLVTGHVNVAGFYKVTAGQSAPVVTSYPKLLEQLRKEVPELDFSVQRTRGWVKLVSESGSVQTGIGGIDVAAETGIRKVLQLREGRLEDLAQPNTLLLFDEQAKRLEVKVGDSVTLSASTMRGISNTVDVRVVAIAANVGMLSSFNVLVPNATLRALYQLREDSTGALMLHLKDMSAIPSVQARLYKRLPELGYQVLEHDPRAFFMKFQTVNREAWTGQKLDITNWEDEISFIKWTVSAMDALTGVLIFVLLIIIAVGIMNTLWIAIRERTREIGTLRAIGMQRWYVLVMFLLEALVLGLLGTTVGALVGMGVCLLINAVDPSVPVPVQLFILSDKLHLIVKPGSVMRAIAFITLCTTFISLIPSFLAARMKPITAMHHIG", "perc_identity": 29.63}}, "BGC0001413.1|Cystobactamide_24 # 49133 # 51238 # -1 # ID=1_24;partial=00;start_type=ATG;rbs_motif=GGGG;rbs_spacer=8bp;gc_cont=0.642": {"gnl|BL_ORD_ID|446|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 49133, "orf_end": 51238, "orf_from": "BGC0001413.1|Cystobactamide_24 ", "model_name": "macB", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1280", "model_id": "487", "ARO_accession": "3000535", "ARO_name": "macB", "ARO_category": {"36002": {"category_aro_accession": "0010001", "category_aro_cvterm_id": "36002", "category_aro_name": "ATP-binding cassette (ABC) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. ATP-binding cassette (ABC) transporters are present in all cells of all organisms and use the energy of ATP binding/hydrolysis to transport substrates across cell membranes.", "category_aro_class_name": "AMR Gene Family"}, "35925": {"category_aro_accession": "0000006", "category_aro_cvterm_id": "35925", "category_aro_name": "erythromycin", "category_aro_description": "Erythromycin is a macrolide antibiotic with a 14-carbon ring that has an antimicrobial spectrum similar to or slightly wider than that of penicillin, and is often used for people that have an allergy to penicillins. Erythromycin may possess bacteriocidal activity, particularly at higher concentrations by binding to the 50S subunit of the bacterial 70S rRNA complex, inhibiting peptidyl-tRNA translocation. Thus, protein synthesis and subsequently structure/function processes critical for life or replication are inhibited.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.57215e-07, "max_identities": 34, "bit_score": 51.6026, "cvterm_id": "36806", "query": "KLVLYFAVFIIFVVALVIINNAMMMATLQRVREVGTLRAIGAQRSFVLSMVLVETVVLGLVFGVLGAAMGGAIMNMLGHVGIPAGNEALYFFFSGPRLFP-SLHLSNLVAAFVIVLVVSALSTFYPAYLATRVSPLQAMQTD", "match": "KL++     I  VV  + + N M+++  +R +E+G   AIGA+R  +L   L+E V++ ++ G++G  +  A+  +  H            F +    FP  +  ++++ A      +     F PA  A +++P+ A+  D", "sequence_from_db": "KLLISSIALISLVVGGIGVMNIMLVSVTERTKEIGIRMAIGARRGNILQQFLIEAVLICIIGGLVGVGLSAAVSLVFNH------------FVTD---FPMDISAASVIGAVACSTGIGIAFGFMPANKAAKLNPIDALAQD", "sequence_from_broadstreet": "MSLIECKNINRYFGSGENRVHILKDISLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAGSGSYRIDGIETAKMQPDELAALRRERFGFIFQRYNLLSSLTARDNVALPAVYMGMGGKERSARADKLLQDLGLASKEGNKPGELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGKNVMEIIRRLHEAGHTVIMVTHDPGIAANANRVIEIRDGEIISDTSKNPEIPASNVGRIQEKASWSFYYDQFVEAFRMSVQAVLAHKMRSLLTMLGIIIGIASVVSVVALGNGSQKKILEDISSMGTNTISIFPGRGFGDRRSGKIKTLTIDDAKIIAKQSYVASATPMTSSGGTLTYRNTDLTASLYGVGEQYFDVRGLKLETGRLFDENDVKEDAQVVVIDQNVKDKLFADSDPLGKTILFRKRPLTVIGVMKKDENAFGNSDVLMLWSPYTTVMHQITGESHTNSITVKIKDNANTRVAEKGLAELLKARHGTEDFFMNNSDSIRQMVESTTGTMKLLISSIALISLVVGGIGVMNIMLVSVTERTKEIGIRMAIGARRGNILQQFLIEAVLICIIGGLVGVGLSAAVSLVFNHFVTDFPMDISAASVIGAVACSTGIGIAFGFMPANKAAKLNPIDALAQD", "dna_sequence_from_broadstreet": "ATGAGCTTGATCGAATGTAAAAACATCAACCGCTATTTCGGCAGCGGCGAGAACCGCGTCCATATTTTGAAAGACATCAGCCTGTCGATAGAGAAGGGTGATTTTGTCGCCATCATCGGGCAGTCCGGTTCGGGCAAGTCCACGCTGATGAACATACTCGGTTGTTTGGATACCGCCGGTTCCGGTTCGTACCGAATCGACGGCATCGAAACTGCCAAAATGCAGCCTGACGAACTGGCGGCATTGCGGCGCGAACGCTTCGGTTTCATCTTCCAACGCTACAACCTCTTAAGCTCGCTGACCGCAAGGGACAACGTCGCGCTGCCAGCCGTGTATATGGGTATGGGAGGCAAAGAGCGTTCCGCGCGGGCGGACAAACTCTTGCAGGATTTGGGTTTGGCAAGTAAAGAGGGCAACAAGCCCGGCGAACTCTCGGGCGGACAGCAGCAGCGCGTCTCCATCGCCCGCGCCCTGATGAACGGCGGAGAAATCATCTTCGCCGACGAGCCGACCGGCGCACTCGATACCGCCAGCGGCAAAAATGTGATGGAAATCATCCGCAGGCTGCACGAAGCCGGGCATACCGTCATTATGGTCACGCACGACCCCGGCATTGCCGCCAATGCCAACCGCGTCATCGAAATCCGGGACGGCGAAATCATTTCCGACACCTCGAAAAATCCCGAAATCCCCGCAAGCAATGTCGGGAGGATTCAGGAAAAAGCCTCGTGGTCGTTTTATTACGACCAGTTTGTCGAAGCCTTCAGAATGTCGGTGCAAGCAGTATTGGCGCACAAAATGCGTTCGCTTCTGACCATGCTCGGCATCATCATCGGTATCGCTTCGGTTGTCTCCGTCGTCGCGCTGGGCAACGGGTCGCAGAAAAAAATCCTCGAAGACATCAGTTCGATGGGGACGAACACCATCAGCATCTTCCCCGGGCGCGGCTTCGGCGACAGGCGCAGCGGCAAAATCAAAACCCTGACCATAGACGACGCAAAAATCATCGCCAAACAAAGCTATGTTGCTTCCGCCACGCCCATGACTTCGAGCGGCGGCACGCTGACCTACCGCAATACCGACCTGACCGCTTCTTTGTACGGCGTGGGCGAACAATATTTCGACGTGCGCGGGCTGAAGCTGGAAACGGGGCGGCTGTTTGATGAGAACGATGTGAAAGAAGACGCGCAAGTCGTCGTCATCGACCAAAATGTCAAAGACAAACTCTTTGCGGACTCGGATCCGTTGGGTAAAACCATTTTGTTCAGGAAACGCCCCTTGACCGTCATCGGCGTGATGAAAAAAGACGAAAACGCTTTCGGCAATTCCGACGTGCTGATGCTTTGGTCGCCCTATACGACGGTGATGCACCAAATCACAGGCGAGAGCCACACCAACTCCATCACCGTCAAAATCAAAGACAATGCCAATACCCGGGTTGCCGAAAAAGGGCTGGCCGAGCTGCTCAAAGCACGGCACGGCACGGAAGACTTCTTTATGAACAACAGCGACAGCATCAGGCAGATGGTCGAAAGCACCACCGGTACGATGAAGCTGCTGATTTCCTCCATCGCCCTGATTTCATTGGTAGTCGGCGGCATCGGCGTGATGAACATTATGCTGGTGTCCGTTACCGAGCGCACCAAAGAAATCGGCATACGGATGGCAATCGGCGCGCGGCGCGGCAATATTTTGCAGCAGTTTTTGATTGAGGCGGTGTTAATCTGCATCATCGGAGGCTTGGTCGGCGTAGGTTTGTCCGCCGCCGTCAGCCTCGTGTTCAATCATTTTGTAACCGATTTCCCGATGGACATTTCGGCGGCATCCGTTATCGGGGCGGTCGCCTGTTCGACCGGAATCGGCATCGCGTTCGGCTTTATGCCTGCCAATAAGGCAGCCAAACTCAATCCGATAGACGCATTGGCGCAGGATTGA", "partial": "0", "query_start": 50810, "query_end": 51232, "hit_start": 1551, "hit_end": 1932, "orf_dna_sequence": "ATGGGCCAACTCAAGCTCCTGCTCCAAGTGGCCCTGCGCAACTTGTTCGTGAGCAGGATCAACCTCCTCATCGGAGGCATCATCTTCTTCGGCACCGTGCTGGTGGTGGTGGGCGGCTCCCTCGTCGACAGCGTGGACGAGGCGATGAGCCGCAGCATTATCGGCAGCGTCGCCGGCCACCTCCAGGTGTACTCGGCCCACTCCAAGGACGAGCTCTCGCTCTTCGGGCAGATGGGCCGCGAACCGGACCTGAGCGCGCTGGATGACTTCTCGCGCATCAAGCAACTGGTACAGCAGCACCCCAACGTGAAGACGGTGGTGCCCATGGGCACCGGCGCCACGTTCATCAACTCGGGAAACACCATCGACCTGACCTTGGCGCGCCTGCGCGACCTCTACAAGAAAGCAGCACAGGGCGACACACCCGAACTCCGCGGGCAGATCCACAGCCTCCAGGCGCATGTGCGTCACATCATCACCTTGCTCGAGGAGGATATGAAGCGGCGCAGGGAAATCATCGACGACAAGACCACGGACCCCGCGGACGCGGAGGCCATGGCCCGCGCCCGTTCCGAGGCCTTCTGGGCGGACTTCGACGAGAAGCCATTCGACTCGCTCGAGTTCCTGGAGAACCGCATCGCCCCGTATATGACGGACGGGGACATGTTGTCCCTGCGCTATGTAGGCACCGACCTGGTCAACTTCCAGAAGACCTTCGACCGCATGCGCATCGTGGAGGGCACGCCGGTGCCCCCGGGGCACCGCGGCATGATGCTCTCCAAGTTCACCTACGAGAACGACTTCAAGCTGAAGACGGCGCACCGGTTGGATCTCATCAAGGAGGCGCGTGATACCAACCACAAGACCATCGCGATGGATCCGCAACTCCAGCGCTGGGTGAAGGAGAACCAGACCCAGACGCGGGAGATCCTCTTCCAGCTCGACGACCTCAAGACGAAGCAGGCCGTGGAGCGGCTCCAGCGCGTGCTGGGCAGCCAGGAGACGGACCTGGGCAAGCTACTGCCCGCCTTCTTCACCATGGATGACGCCAACTTCGACACGCGCTACCAGCAGTTCTACTCCGAGCTGGCGACGCTGCTCGACCTGTACCGCATCCGCATCGGGGACGACCTCACCATCACCGCATTCTCGCGCACCGGCTATGTGCAGAGCGTGAACGTGAAGATCTACGGCACCTACCAGTTCGACGGGCTGGAGAAGTCCGCGGTCGCCGGAGCCCTCAACCTGCTGGACCTGATGTCCTTCCGCGAGCTGTACGGCTATCTCACCGCTGAGAAGAAGGCCGAGCTCGCGGGCCTGCAGAAGGCCAGCGGGGTGCAGCAGGTGAAGCGCGAGGACGCCGAGACGGCGCTCTTTGGCGAGCAGGGCAGCGCCTCGCTGGTGGCCGAGGGGACCGCCGGCCAGATCGACGAGGACAAGCAACTCGACGGGCTCGCCCAGAAGCTGCACCGCGAGGAGCTCGCCTCCCGGGTGTACACGCAGCAGGAAATCGAAAGCGGCGTGGTGCTCAGCACCGCGGTTCTGCTGAAGCATCCGGAGAAGCTGGAGCAGACCCTGGCCGAGCTGCGGAAATCGGCGGACGACGCGAAACTACCCTTGCGGATCATCTCCTGGCAGAAGGCCTCCGGCACGATCGGCCAGTTCGTCCTGGTCGCCAAGCTGGTGCTCTACTTCGCCGTCTTCATCATCTTCGTGGTGGCGCTCGTCATCATCAACAACGCGATGATGATGGCCACGCTGCAGCGGGTGCGCGAGGTGGGCACCCTGCGGGCCATCGGCGCGCAGCGCTCGTTCGTGCTGAGCATGGTGCTGGTGGAAACGGTGGTGCTGGGGCTCGTCTTCGGCGTGCTGGGAGCCGCCATGGGAGGTGCCATCATGAACATGCTCGGCCACGTGGGCATCCCCGCCGGCAACGAGGCGCTCTACTTCTTCTTCTCGGGACCCCGCCTCTTCCCCAGTCTCCACCTGTCAAACCTCGTGGCGGCCTTCGTCATCGTGCTCGTGGTGTCCGCCCTCTCCACCTTCTACCCCGCGTACCTCGCGACCCGGGTCTCGCCTCTCCAGGCGATGCAGACGGACGAGTGA", "orf_prot_sequence": "MGQLKLLLQVALRNLFVSRINLLIGGIIFFGTVLVVVGGSLVDSVDEAMSRSIIGSVAGHLQVYSAHSKDELSLFGQMGREPDLSALDDFSRIKQLVQQHPNVKTVVPMGTGATFINSGNTIDLTLARLRDLYKKAAQGDTPELRGQIHSLQAHVRHIITLLEEDMKRRREIIDDKTTDPADAEAMARARSEAFWADFDEKPFDSLEFLENRIAPYMTDGDMLSLRYVGTDLVNFQKTFDRMRIVEGTPVPPGHRGMMLSKFTYENDFKLKTAHRLDLIKEARDTNHKTIAMDPQLQRWVKENQTQTREILFQLDDLKTKQAVERLQRVLGSQETDLGKLLPAFFTMDDANFDTRYQQFYSELATLLDLYRIRIGDDLTITAFSRTGYVQSVNVKIYGTYQFDGLEKSAVAGALNLLDLMSFRELYGYLTAEKKAELAGLQKASGVQQVKREDAETALFGEQGSASLVAEGTAGQIDEDKQLDGLAQKLHREELASRVYTQQEIESGVVLSTAVLLKHPEKLEQTLAELRKSADDAKLPLRIISWQKASGTIGQFVLVAKLVLYFAVFIIFVVALVIINNAMMMATLQRVREVGTLRAIGAQRSFVLSMVLVETVVLGLVFGVLGAAMGGAIMNMLGHVGIPAGNEALYFFFSGPRLFPSLHLSNLVAAFVIVLVVSALSTFYPAYLATRVSPLQAMQTDE", "perc_identity": 23.94}, "gnl|BL_ORD_ID|2021|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 49133, "orf_end": 51238, "orf_from": "BGC0001413.1|Cystobactamide_24 ", "model_name": "mexN", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1900", "model_id": "2217", "ARO_accession": "3003705", "ARO_name": "mexN", "ARO_category": {"36005": {"category_aro_accession": "0010004", "category_aro_cvterm_id": "36005", "category_aro_name": "resistance-nodulation-cell division (RND) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Resistance-nodulation-division (RND) proteins are found in both prokaryotic and eukaryotic cells and have diverse substrate specificities and physiological roles. However, there are relatively few RND transporters and they are secondary transporters, energized not by ATP binding/hydrolysis but by proton movement down the transmembrane electrochemical gradient.", "category_aro_class_name": "AMR Gene Family"}, "36524": {"category_aro_accession": "3000385", "category_aro_cvterm_id": "36524", "category_aro_name": "chloramphenicol", "category_aro_description": "Chloramphenicol is a bacteriostatic antimicrobial originally derived from the bacterium Streptomyces venezuelae. It was the first antibiotic to be manufactured synthetically on a large scale. It functions by inhibiting peptidyl transferase activity of the bacterial ribosome, binding to A2451 and A2452 residues in the 23S rRNA of the 50S ribosomal subunit and preventing peptide bond formation.", "category_aro_class_name": "Antibiotic"}, "36595": {"category_aro_accession": "3000456", "category_aro_cvterm_id": "36595", "category_aro_name": "thiamphenicol", "category_aro_description": "Derivative of Chloramphenicol. The nitro group (-NO2) is substituted by a sulfomethyl group (-SO2CH3).", "category_aro_class_name": "Antibiotic"}, "36526": {"category_aro_accession": "3000387", "category_aro_cvterm_id": "36526", "category_aro_name": "phenicol antibiotic", "category_aro_description": "Phenicols are broad spectrum bacteriostatic antibiotics acting on bacterial protein synthesis. More specifically, the phenicols block peptide elongation by binding to the peptidyltansferase centre of the 70S ribosome.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.05444, "max_identities": 28, "bit_score": 28.1054, "cvterm_id": "36752", "query": "IGSVAGHLQVYSAHSKDELSLFGQMGREPDLSALDDFSRI-----KQLVQQHPN----VKTVVPMGTGATFINSGNTIDLTLARLRDLYKKAAQGD-----TPELRGQIHSLQ", "match": "+ ++A + Q+++A   D+L +  + G  P    L D +RI        VQ  PN    V  V+    GA  +++ + I   L RLR++     + D     T  +R  +H ++", "sequence_from_db": "VSTLAANDQLFNASDYDDLVVAYRQG-APVF--LKDVARIVSAPEDDYVQAWPNGVPGVALVILRQPGANIVDTADAIQAALPRLREMLPATIEVDVLNDRTRTIRSSLHEVE", "sequence_from_broadstreet": "MTPRAGISGWCVRHPIATALLTLASLLLGLLAFLRLGVAPLPEADFPTIQINALLPGGSPETMASSVATPLEVQFSAIPGITEMTSSSALGTTTLTLQFSLDKSIDVAAQEVQAAINAAAGRLPVDMPNLPTWRKVNPADSPIMILRVNSEMMPLIELSDYAETILARQLSQVNGVGQIFVVGQQRPAIRIQAQPEKLAAYQLTLADLRQSLQSASVNLAKGALYGEGRVSTLAANDQLFNASDYDDLVVAYRQGAPVFLKDVARIVSAPEDDYVQAWPNGVPGVALVILRQPGANIVDTADAIQAALPRLREMLPATIEVDVLNDRTRTIRSSLHEVELTLLLTIGLVVLVMGLFLRQLSATLIVATVLAVSLSASFAAMYVLGFTLNNLTLVALIIAVGFIVDDAIVVVENIHRHLEAGASKVEAALKGAAEIGFTVISISFSLIAAFIPLLFMGGIVGRLFREFAVSVTVAILISVVASLTLAPMLASRFMPALRHAEAPRKGFAEWLTGGYERGLRWALGHQRLMLVGFAFTVLVAVAGYVGIPKGFFPLQDTAFVIGTSQAAEDISYDDMVAKHRQLAEIIASDPAVQSYNHAVGVTGGSQSLANGRFWIVLKDRGERDVSVGEFIDRLRPQLAKVPGIMLYLRAAQDINLSSGPSRTQYQYALRSSDSTQLALWAQRLTERLKQVPGLMDVSNDLQVGASVTALDIDRVAAARFGLSAEDVSQTLYDAFGQRQVGEYQTEVNQYKVVLELDARQRGRAESLDWFYLRSPLSGEMVPLSAIAKVAAPRSGPLQINHNGMFPAVNLSFNLAAGVSLGEAVQAVQRAQEEIGMPSTIIGVFQGAAQAFQSSLASQPLLILAALIAVYIILGVLYESFVHPLTILSTLPSAGIGAVFLLWAWGQDFSIMALIGIVLLIGIVKKNGILMVDFAIVAQREQGMSAEQAIYQACLTRFRPIMMTTLAALLGAIPLMIGFGTGSELRQPLGIAVVGGLLVSQVLTLFSTPVVYLALERLFHRRGTTTSDGGTAGATAT", "dna_sequence_from_broadstreet": "GTGACGCCGCGCGCCGGGATTTCCGGCTGGTGCGTACGGCACCCGATCGCCACCGCGCTGCTGACCCTGGCCTCGCTGCTGCTGGGGCTGCTGGCGTTCCTCCGGCTCGGTGTGGCGCCGTTGCCGGAGGCGGACTTCCCGACCATCCAGATCAACGCCTTGCTGCCCGGCGGTAGCCCGGAGACCATGGCCTCGTCGGTGGCCACCCCCTTGGAAGTGCAGTTCAGCGCGATTCCCGGGATCACCGAGATGACTTCCAGCAGCGCCCTGGGCACCACCACCCTGACCCTGCAGTTCAGCCTCGACAAGAGCATCGACGTCGCCGCCCAGGAGGTCCAGGCGGCGATCAACGCCGCGGCCGGGCGGCTGCCGGTGGACATGCCGAACCTGCCGACCTGGCGCAAGGTCAACCCGGCGGACAGCCCGATCATGATCCTGCGGGTCAACTCGGAGATGATGCCGCTGATCGAACTCAGCGATTACGCCGAGACCATCCTCGCCCGCCAGCTCAGCCAGGTGAACGGCGTGGGGCAGATCTTCGTGGTCGGCCAGCAGCGCCCGGCGATCCGCATCCAGGCCCAGCCGGAGAAGCTCGCCGCCTACCAGCTGACCCTGGCCGACCTGCGCCAGTCGTTGCAGTCGGCCAGCGTCAACCTGGCCAAGGGCGCGCTCTACGGCGAGGGGCGGGTGTCGACCCTCGCGGCCAACGACCAGTTGTTCAACGCCAGCGACTATGACGACCTGGTGGTCGCCTACCGCCAGGGCGCGCCGGTGTTCCTCAAGGACGTGGCGCGGATCGTCTCGGCGCCCGAGGACGACTACGTGCAGGCCTGGCCGAACGGCGTGCCCGGGGTGGCGCTGGTGATCCTGCGCCAGCCTGGGGCGAACATCGTCGATACCGCCGACGCGATCCAGGCCGCGCTGCCACGCCTGCGCGAGATGCTCCCGGCGACCATCGAGGTAGACGTGCTCAACGACCGCACCCGGACCATCCGCTCGTCGTTGCACGAGGTCGAACTGACCCTGCTGCTGACCATTGGCCTGGTGGTGCTGGTGATGGGCCTGTTCCTCCGCCAGCTGTCGGCGACCCTGATCGTCGCCACGGTGCTGGCGGTGTCCCTGAGCGCCAGCTTCGCGGCGATGTACGTGCTCGGCTTCACCCTCAACAACCTGACCCTGGTGGCGCTGATCATCGCTGTCGGCTTCATCGTCGACGACGCCATCGTGGTCGTGGAGAACATCCACCGACACCTGGAAGCGGGCGCCTCGAAGGTCGAGGCGGCGCTCAAGGGCGCGGCGGAGATCGGCTTTACCGTGATTTCCATCAGCTTCTCGCTGATCGCCGCGTTCATTCCCCTGCTGTTCATGGGCGGGATCGTCGGCCGGCTGTTCCGCGAATTCGCGGTCAGCGTGACGGTGGCGATCCTGATCTCGGTGGTCGCTTCGCTGACCCTGGCGCCGATGCTGGCTTCGCGCTTCATGCCGGCATTGCGGCATGCCGAAGCGCCGAGAAAGGGCTTCGCCGAATGGCTGACCGGCGGCTACGAACGCGGCCTGCGCTGGGCGCTCGGGCACCAGCGGCTGATGCTGGTCGGCTTCGCCTTTACCGTGCTGGTGGCGGTGGCCGGCTACGTCGGGATTCCCAAGGGTTTCTTCCCCTTGCAGGACACCGCCTTCGTCATCGGCACGAGCCAGGCTGCCGAGGATATCTCCTACGACGACATGGTCGCCAAGCACCGGCAACTGGCCGAGATCATCGCCAGCGACCCGGCGGTGCAGAGCTACAACCATGCGGTGGGCGTCACCGGCGGTAGCCAGAGCCTGGCCAACGGACGTTTCTGGATCGTCCTCAAGGACCGTGGCGAGCGCGATGTCTCGGTCGGCGAGTTCATCGACCGGCTGCGCCCGCAACTGGCCAAGGTGCCGGGAATCATGCTCTACCTGCGCGCGGCGCAGGACATCAACCTCAGTTCCGGACCCTCGCGGACCCAGTACCAGTACGCCCTGCGCAGCAGCGACAGCACCCAGCTGGCGCTCTGGGCGCAACGCCTCACCGAGCGCCTGAAGCAGGTGCCGGGGCTGATGGATGTGTCCAACGACCTGCAGGTCGGCGCCAGCGTCACCGCGCTGGACATCGACCGGGTGGCCGCGGCGCGTTTCGGCCTCAGCGCCGAGGATGTCAGCCAGACCCTCTACGACGCCTTCGGCCAGCGCCAGGTCGGCGAGTACCAGACCGAGGTCAACCAGTACAAGGTGGTCCTCGAACTCGATGCGCGCCAGCGCGGCCGCGCGGAAAGCCTGGACTGGTTCTACCTGCGCTCGCCGCTGAGCGGCGAGATGGTCCCGCTGTCGGCCATCGCCAAGGTCGCGGCGCCGCGCTCCGGGCCGCTGCAGATCAACCACAACGGCATGTTCCCGGCGGTCAACCTGTCCTTCAACCTGGCTGCCGGGGTGTCCCTCGGCGAGGCGGTGCAGGCGGTGCAGCGCGCCCAGGAGGAGATCGGCATGCCCTCGACCATTATCGGCGTGTTCCAGGGCGCGGCGCAGGCCTTCCAGAGCTCGCTGGCCTCGCAACCGCTGCTGATCCTCGCCGCGCTGATCGCGGTGTACATCATCCTCGGCGTGCTCTACGAGAGTTTCGTACATCCGCTGACGATCCTCTCGACCCTGCCCTCGGCGGGGATCGGCGCGGTGTTCCTGCTCTGGGCCTGGGGCCAGGACTTCTCGATCATGGCGCTGATCGGCATCGTGCTGCTGATCGGCATCGTCAAGAAGAACGGCATCCTCATGGTCGACTTCGCCATCGTCGCCCAGCGCGAGCAGGGCATGAGCGCGGAGCAGGCGATCTACCAGGCCTGCCTGACCCGTTTCCGGCCGATCATGATGACCACCCTGGCCGCGCTGCTGGGCGCGATACCCCTGATGATCGGCTTCGGCACCGGTTCCGAGCTGCGCCAGCCTCTGGGCATCGCGGTGGTCGGCGGGCTGCTGGTGAGCCAGGTGCTGACCCTGTTCAGCACGCCGGTGGTATACCTGGCCCTGGAGCGGCTGTTCCACCGGCGCGGGACGACGACCTCGGACGGCGGAACCGCTGGGGCGACGGCGACATGA", "partial": "0", "query_start": 49292, "query_end": 49588, "hit_start": 687, "hit_end": 1017, "orf_dna_sequence": "ATGGGCCAACTCAAGCTCCTGCTCCAAGTGGCCCTGCGCAACTTGTTCGTGAGCAGGATCAACCTCCTCATCGGAGGCATCATCTTCTTCGGCACCGTGCTGGTGGTGGTGGGCGGCTCCCTCGTCGACAGCGTGGACGAGGCGATGAGCCGCAGCATTATCGGCAGCGTCGCCGGCCACCTCCAGGTGTACTCGGCCCACTCCAAGGACGAGCTCTCGCTCTTCGGGCAGATGGGCCGCGAACCGGACCTGAGCGCGCTGGATGACTTCTCGCGCATCAAGCAACTGGTACAGCAGCACCCCAACGTGAAGACGGTGGTGCCCATGGGCACCGGCGCCACGTTCATCAACTCGGGAAACACCATCGACCTGACCTTGGCGCGCCTGCGCGACCTCTACAAGAAAGCAGCACAGGGCGACACACCCGAACTCCGCGGGCAGATCCACAGCCTCCAGGCGCATGTGCGTCACATCATCACCTTGCTCGAGGAGGATATGAAGCGGCGCAGGGAAATCATCGACGACAAGACCACGGACCCCGCGGACGCGGAGGCCATGGCCCGCGCCCGTTCCGAGGCCTTCTGGGCGGACTTCGACGAGAAGCCATTCGACTCGCTCGAGTTCCTGGAGAACCGCATCGCCCCGTATATGACGGACGGGGACATGTTGTCCCTGCGCTATGTAGGCACCGACCTGGTCAACTTCCAGAAGACCTTCGACCGCATGCGCATCGTGGAGGGCACGCCGGTGCCCCCGGGGCACCGCGGCATGATGCTCTCCAAGTTCACCTACGAGAACGACTTCAAGCTGAAGACGGCGCACCGGTTGGATCTCATCAAGGAGGCGCGTGATACCAACCACAAGACCATCGCGATGGATCCGCAACTCCAGCGCTGGGTGAAGGAGAACCAGACCCAGACGCGGGAGATCCTCTTCCAGCTCGACGACCTCAAGACGAAGCAGGCCGTGGAGCGGCTCCAGCGCGTGCTGGGCAGCCAGGAGACGGACCTGGGCAAGCTACTGCCCGCCTTCTTCACCATGGATGACGCCAACTTCGACACGCGCTACCAGCAGTTCTACTCCGAGCTGGCGACGCTGCTCGACCTGTACCGCATCCGCATCGGGGACGACCTCACCATCACCGCATTCTCGCGCACCGGCTATGTGCAGAGCGTGAACGTGAAGATCTACGGCACCTACCAGTTCGACGGGCTGGAGAAGTCCGCGGTCGCCGGAGCCCTCAACCTGCTGGACCTGATGTCCTTCCGCGAGCTGTACGGCTATCTCACCGCTGAGAAGAAGGCCGAGCTCGCGGGCCTGCAGAAGGCCAGCGGGGTGCAGCAGGTGAAGCGCGAGGACGCCGAGACGGCGCTCTTTGGCGAGCAGGGCAGCGCCTCGCTGGTGGCCGAGGGGACCGCCGGCCAGATCGACGAGGACAAGCAACTCGACGGGCTCGCCCAGAAGCTGCACCGCGAGGAGCTCGCCTCCCGGGTGTACACGCAGCAGGAAATCGAAAGCGGCGTGGTGCTCAGCACCGCGGTTCTGCTGAAGCATCCGGAGAAGCTGGAGCAGACCCTGGCCGAGCTGCGGAAATCGGCGGACGACGCGAAACTACCCTTGCGGATCATCTCCTGGCAGAAGGCCTCCGGCACGATCGGCCAGTTCGTCCTGGTCGCCAAGCTGGTGCTCTACTTCGCCGTCTTCATCATCTTCGTGGTGGCGCTCGTCATCATCAACAACGCGATGATGATGGCCACGCTGCAGCGGGTGCGCGAGGTGGGCACCCTGCGGGCCATCGGCGCGCAGCGCTCGTTCGTGCTGAGCATGGTGCTGGTGGAAACGGTGGTGCTGGGGCTCGTCTTCGGCGTGCTGGGAGCCGCCATGGGAGGTGCCATCATGAACATGCTCGGCCACGTGGGCATCCCCGCCGGCAACGAGGCGCTCTACTTCTTCTTCTCGGGACCCCGCCTCTTCCCCAGTCTCCACCTGTCAAACCTCGTGGCGGCCTTCGTCATCGTGCTCGTGGTGTCCGCCCTCTCCACCTTCTACCCCGCGTACCTCGCGACCCGGGTCTCGCCTCTCCAGGCGATGCAGACGGACGAGTGA", "orf_prot_sequence": "MGQLKLLLQVALRNLFVSRINLLIGGIIFFGTVLVVVGGSLVDSVDEAMSRSIIGSVAGHLQVYSAHSKDELSLFGQMGREPDLSALDDFSRIKQLVQQHPNVKTVVPMGTGATFINSGNTIDLTLARLRDLYKKAAQGDTPELRGQIHSLQAHVRHIITLLEEDMKRRREIIDDKTTDPADAEAMARARSEAFWADFDEKPFDSLEFLENRIAPYMTDGDMLSLRYVGTDLVNFQKTFDRMRIVEGTPVPPGHRGMMLSKFTYENDFKLKTAHRLDLIKEARDTNHKTIAMDPQLQRWVKENQTQTREILFQLDDLKTKQAVERLQRVLGSQETDLGKLLPAFFTMDDANFDTRYQQFYSELATLLDLYRIRIGDDLTITAFSRTGYVQSVNVKIYGTYQFDGLEKSAVAGALNLLDLMSFRELYGYLTAEKKAELAGLQKASGVQQVKREDAETALFGEQGSASLVAEGTAGQIDEDKQLDGLAQKLHREELASRVYTQQEIESGVVLSTAVLLKHPEKLEQTLAELRKSADDAKLPLRIISWQKASGTIGQFVLVAKLVLYFAVFIIFVVALVIINNAMMMATLQRVREVGTLRAIGAQRSFVLSMVLVETVVLGLVFGVLGAAMGGAIMNMLGHVGIPAGNEALYFFFSGPRLFPSLHLSNLVAAFVIVLVVSALSTFYPAYLATRVSPLQAMQTDE", "perc_identity": 24.78}, "gnl|BL_ORD_ID|1522|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 49133, "orf_end": 51238, "orf_from": "BGC0001413.1|Cystobactamide_24 ", "model_name": "vanT gene in vanG cluster", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "175", "model_id": "1561", "ARO_accession": "3002972", "ARO_name": "vanT gene in vanG cluster", "ARO_category": {"36373": {"category_aro_accession": "3000234", "category_aro_cvterm_id": "36373", "category_aro_name": "glycopeptide resistance gene cluster", "category_aro_description": "Genes that when expressed confer resistance to vancomycin and teicoplanin type antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "36511": {"category_aro_accession": "3000372", "category_aro_cvterm_id": "36511", "category_aro_name": "vanT", "category_aro_description": "VanT is a membrane bound serine racemase, converting L-serine to D-serine. It is associated with VanC, which incorporated D-serine into D-Ala-D-Ser terminal end of peptidoglycan subunits that have a decreased binding affinity with vancomycin. It was isolated from Enterococcus gallinarum.", "category_aro_class_name": "AMR Gene Family"}, "35947": {"category_aro_accession": "0000028", "category_aro_cvterm_id": "35947", "category_aro_name": "vancomycin", "category_aro_description": "Vancomycin is a glycopeptide antibiotic used in the prophylaxis and treatment of infections caused by Gram-positive bacteria. Vancomycin inhibits the synthesis of peptidoglycan, the major component of the cell wall of gram-positive bacteria. Its mechanism of action is unusual in that it acts by binding precursors of peptidoglycan, rather than by interacting with an enzyme.", "category_aro_class_name": "Antibiotic"}, "36220": {"category_aro_accession": "3000081", "category_aro_cvterm_id": "36220", "category_aro_name": "glycopeptide antibiotic", "category_aro_description": "Glycopeptide antibiotics are natural products produced non-ribosomally by Actinomycetales bacteria. With the exception of bleomycins, they act by binding the terminal D-Ala-D-Ala in peptidoglycan precursors of the growing bacterial cell wall and are generally active against Gram-positive bacteria.  This inhibits transglycosylation leading to cell death due to osmotic stress.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.6638, "max_identities": 12, "bit_score": 26.5646, "cvterm_id": "35918", "query": "IFFGTVLVVVGGSLVDSVDE-AMSRSIIGSV", "match": "IFF  +  V+GG + DS +  ++ RSI+G +", "sequence_from_db": "IFFAPIFFVLGGYISDSQNRLSLKRSIVGFI", "sequence_from_broadstreet": "MTKNESYSGIDYFRFIAALLIVAIHTSPLSSFSETGNFIFTRIVARVAVPFFFMTSGFFLISRYTCNAEKLGAFIKKTTLIYGVAILLYIPINVYNGYFKMDNLLPNIIKDIVFDGTLYHLWYLPASIIGAAIAWYLVKKVHYRKAFLIASILYIIGLFGDSYYGIVKSVSCLNVFYNLIFQLTDYTRNGIFFAPIFFVLGGYISDSQNRLSLKRSIVGFIVCFALMFGEALTLHHFDIQKHDSMYVLLLPSVYCLFNLLLHFRGKRRTGLRTISLIIYIIHPFMIVVIRLFAKLLHLQSLLVENSLVHYIAVCFASVVLAVVITALLSSLKPKKAKHTADTDRAYLEINLNNLEHNVNTLQKAMSPKCELMAVVKAEAYGHGMYEVTTYLEQIGVSSFAVATIDEGIRLRKYGISSEILILGYTSPSRAKELCKYELTQTLIDYRYSLLLNKQGYDIKAHIKIDTGMHRLGFSTEDKDKILAAFSLKHIKVAGIFTHLCAADSLEENDVAFTNKQIGSFYKVLDWLKSSGLNIPKVHIQSSYGLLNYPELECDYIRVGVALYGVLSSTNDKTKLELDLRPVLSLKAKVVLIRKIKQGESVGYSRAFTATRDSLIAILPIGYADGFPRNLSCGNSYVLIGGRQAPIVGKICMDQLAVDVTDIPNVKTGSIATLIGKDGKEEITAPMVAESAESITNELLSRMGHRLNIIRRA", "dna_sequence_from_broadstreet": "ATGACTAAAAACGAAAGCTATTCTGGCATTGATTATTTTAGATTTATTGCAGCCTTATTGATTGTTGCTATTCATACTTCGCCTCTCTCTTCTTTTAGTGAAACAGGCAACTTTATATTTACACGCATTGTAGCCCGTGTAGCCGTTCCGTTCTTTTTTATGACATCTGGATTTTTTCTGATTTCCAGATATACCTGTAATGCCGAAAAGCTGGGAGCTTTTATAAAAAAGACAACCTTAATTTACGGGGTTGCAATACTCTTATACATACCTATCAATGTTTATAACGGTTATTTCAAAATGGACAACCTTTTGCCAAATATCATAAAAGATATTGTATTTGATGGTACTTTATATCACTTGTGGTATCTTCCTGCATCTATTATCGGAGCTGCGATTGCTTGGTATCTGGTAAAGAAAGTTCATTATCGCAAAGCCTTTTTGATAGCTTCTATACTCTATATCATAGGCTTATTTGGAGATAGTTATTATGGAATTGTGAAAAGCGTTTCCTGCTTAAATGTTTTTTACAATCTAATCTTCCAATTAACAGATTACACAAGAAACGGAATATTTTTTGCCCCAATCTTTTTTGTGCTTGGTGGATATATCTCTGATAGTCAAAACAGACTATCGTTAAAAAGAAGTATAGTAGGATTTATAGTTTGTTTTGCCCTTATGTTTGGAGAAGCCCTTACTTTACATCATTTTGATATACAGAAACATGACAGTATGTATGTGCTTTTACTTCCGAGTGTGTATTGCTTATTTAATCTTCTTCTGCACTTTAGAGGAAAACGCCGCACAGGATTACGGACAATATCATTGATTATCTATATCATTCATCCGTTTATGATTGTTGTAATACGATTGTTTGCCAAATTACTGCATCTGCAAAGCCTGCTTGTTGAAAACAGCCTTGTTCATTATATTGCGGTCTGCTTTGCATCGGTAGTATTAGCAGTGGTTATAACAGCGTTATTGAGCAGTCTGAAACCGAAAAAGGCAAAACATACCGCCGATACGGATAGAGCGTATCTGGAAATCAACCTAAATAATTTAGAGCATAATGTAAACACTTTGCAAAAAGCAATGTCACCTAAATGTGAATTGATGGCGGTTGTAAAAGCGGAAGCCTATGGTCACGGTATGTATGAAGTGACGACATATCTTGAGCAGATAGGAGTTTCTTCATTTGCGGTAGCTACCATTGATGAAGGTATCCGATTGAGAAAATATGGCATCTCTAGCGAAATCCTAATTTTAGGCTATACATCGCCTTCAAGGGCAAAAGAACTTTGTAAGTATGAGCTGACACAAACCTTGATAGATTATAGGTATTCGTTGCTTTTGAATAAACAGGGATATGACATTAAAGCACATATTAAAATTGACACAGGTATGCATAGACTTGGATTTAGCACAGAAGATAAGGATAAAATCCTTGCAGCTTTTTCTTTGAAGCACATCAAAGTTGCGGGAATTTTTACACATTTGTGTGCGGCTGACAGCCTTGAAGAAAATGATGTTGCATTTACAAACAAGCAAATAGGCAGTTTCTATAAAGTGCTTGATTGGCTGAAAAGCAGCGGTTTGAATATACCTAAAGTACATATCCAAAGTAGTTATGGATTATTGAATTATCCAGAGCTTGAATGTGATTATATCAGAGTGGGTGTTGCTCTGTATGGTGTTTTAAGCTCTACTAATGACAAAACAAAATTAGAACTTGATTTAAGACCTGTACTTTCTTTGAAAGCAAAAGTTGTTTTAATTCGGAAGATAAAGCAGGGCGAAAGTGTTGGTTATAGCAGGGCTTTTACTGCAACCCGAGATAGTTTAATTGCCATATTACCAATTGGATATGCAGATGGTTTTCCAAGAAATCTGTCTTGTGGAAATAGTTATGTGCTGATTGGTGGACGACAAGCCCCTATTGTCGGAAAAATCTGTATGGATCAACTTGCAGTTGATGTAACAGATATTCCCAATGTTAAGACTGGAAGTATTGCAACGCTGATTGGTAAAGATGGAAAGGAAGAAATTACAGCACCGATGGTAGCTGAAAGTGCAGAAAGCATAACCAATGAATTGTTAAGCCGTATGGGACACAGATTAAATATTATTCGTAGAGCGTAA", "partial": "0", "query_start": 49214, "query_end": 49303, "hit_start": 570, "hit_end": 663, "orf_dna_sequence": "ATGGGCCAACTCAAGCTCCTGCTCCAAGTGGCCCTGCGCAACTTGTTCGTGAGCAGGATCAACCTCCTCATCGGAGGCATCATCTTCTTCGGCACCGTGCTGGTGGTGGTGGGCGGCTCCCTCGTCGACAGCGTGGACGAGGCGATGAGCCGCAGCATTATCGGCAGCGTCGCCGGCCACCTCCAGGTGTACTCGGCCCACTCCAAGGACGAGCTCTCGCTCTTCGGGCAGATGGGCCGCGAACCGGACCTGAGCGCGCTGGATGACTTCTCGCGCATCAAGCAACTGGTACAGCAGCACCCCAACGTGAAGACGGTGGTGCCCATGGGCACCGGCGCCACGTTCATCAACTCGGGAAACACCATCGACCTGACCTTGGCGCGCCTGCGCGACCTCTACAAGAAAGCAGCACAGGGCGACACACCCGAACTCCGCGGGCAGATCCACAGCCTCCAGGCGCATGTGCGTCACATCATCACCTTGCTCGAGGAGGATATGAAGCGGCGCAGGGAAATCATCGACGACAAGACCACGGACCCCGCGGACGCGGAGGCCATGGCCCGCGCCCGTTCCGAGGCCTTCTGGGCGGACTTCGACGAGAAGCCATTCGACTCGCTCGAGTTCCTGGAGAACCGCATCGCCCCGTATATGACGGACGGGGACATGTTGTCCCTGCGCTATGTAGGCACCGACCTGGTCAACTTCCAGAAGACCTTCGACCGCATGCGCATCGTGGAGGGCACGCCGGTGCCCCCGGGGCACCGCGGCATGATGCTCTCCAAGTTCACCTACGAGAACGACTTCAAGCTGAAGACGGCGCACCGGTTGGATCTCATCAAGGAGGCGCGTGATACCAACCACAAGACCATCGCGATGGATCCGCAACTCCAGCGCTGGGTGAAGGAGAACCAGACCCAGACGCGGGAGATCCTCTTCCAGCTCGACGACCTCAAGACGAAGCAGGCCGTGGAGCGGCTCCAGCGCGTGCTGGGCAGCCAGGAGACGGACCTGGGCAAGCTACTGCCCGCCTTCTTCACCATGGATGACGCCAACTTCGACACGCGCTACCAGCAGTTCTACTCCGAGCTGGCGACGCTGCTCGACCTGTACCGCATCCGCATCGGGGACGACCTCACCATCACCGCATTCTCGCGCACCGGCTATGTGCAGAGCGTGAACGTGAAGATCTACGGCACCTACCAGTTCGACGGGCTGGAGAAGTCCGCGGTCGCCGGAGCCCTCAACCTGCTGGACCTGATGTCCTTCCGCGAGCTGTACGGCTATCTCACCGCTGAGAAGAAGGCCGAGCTCGCGGGCCTGCAGAAGGCCAGCGGGGTGCAGCAGGTGAAGCGCGAGGACGCCGAGACGGCGCTCTTTGGCGAGCAGGGCAGCGCCTCGCTGGTGGCCGAGGGGACCGCCGGCCAGATCGACGAGGACAAGCAACTCGACGGGCTCGCCCAGAAGCTGCACCGCGAGGAGCTCGCCTCCCGGGTGTACACGCAGCAGGAAATCGAAAGCGGCGTGGTGCTCAGCACCGCGGTTCTGCTGAAGCATCCGGAGAAGCTGGAGCAGACCCTGGCCGAGCTGCGGAAATCGGCGGACGACGCGAAACTACCCTTGCGGATCATCTCCTGGCAGAAGGCCTCCGGCACGATCGGCCAGTTCGTCCTGGTCGCCAAGCTGGTGCTCTACTTCGCCGTCTTCATCATCTTCGTGGTGGCGCTCGTCATCATCAACAACGCGATGATGATGGCCACGCTGCAGCGGGTGCGCGAGGTGGGCACCCTGCGGGCCATCGGCGCGCAGCGCTCGTTCGTGCTGAGCATGGTGCTGGTGGAAACGGTGGTGCTGGGGCTCGTCTTCGGCGTGCTGGGAGCCGCCATGGGAGGTGCCATCATGAACATGCTCGGCCACGTGGGCATCCCCGCCGGCAACGAGGCGCTCTACTTCTTCTTCTCGGGACCCCGCCTCTTCCCCAGTCTCCACCTGTCAAACCTCGTGGCGGCCTTCGTCATCGTGCTCGTGGTGTCCGCCCTCTCCACCTTCTACCCCGCGTACCTCGCGACCCGGGTCTCGCCTCTCCAGGCGATGCAGACGGACGAGTGA", "orf_prot_sequence": "MGQLKLLLQVALRNLFVSRINLLIGGIIFFGTVLVVVGGSLVDSVDEAMSRSIIGSVAGHLQVYSAHSKDELSLFGQMGREPDLSALDDFSRIKQLVQQHPNVKTVVPMGTGATFINSGNTIDLTLARLRDLYKKAAQGDTPELRGQIHSLQAHVRHIITLLEEDMKRRREIIDDKTTDPADAEAMARARSEAFWADFDEKPFDSLEFLENRIAPYMTDGDMLSLRYVGTDLVNFQKTFDRMRIVEGTPVPPGHRGMMLSKFTYENDFKLKTAHRLDLIKEARDTNHKTIAMDPQLQRWVKENQTQTREILFQLDDLKTKQAVERLQRVLGSQETDLGKLLPAFFTMDDANFDTRYQQFYSELATLLDLYRIRIGDDLTITAFSRTGYVQSVNVKIYGTYQFDGLEKSAVAGALNLLDLMSFRELYGYLTAEKKAELAGLQKASGVQQVKREDAETALFGEQGSASLVAEGTAGQIDEDKQLDGLAQKLHREELASRVYTQQEIESGVVLSTAVLLKHPEKLEQTLAELRKSADDAKLPLRIISWQKASGTIGQFVLVAKLVLYFAVFIIFVVALVIINNAMMMATLQRVREVGTLRAIGAQRSFVLSMVLVETVVLGLVFGVLGAAMGGAIMNMLGHVGIPAGNEALYFFFSGPRLFPSLHLSNLVAAFVIVLVVSALSTFYPAYLATRVSPLQAMQTDE", "perc_identity": 38.71}}, "BGC0001413.1|Cystobactamide_25 # 51238 # 52080 # -1 # ID=1_25;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.663": {"gnl|BL_ORD_ID|446|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "macB", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1280", "model_id": "487", "ARO_accession": "3000535", "ARO_name": "macB", "ARO_category": {"36002": {"category_aro_accession": "0010001", "category_aro_cvterm_id": "36002", "category_aro_name": "ATP-binding cassette (ABC) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. ATP-binding cassette (ABC) transporters are present in all cells of all organisms and use the energy of ATP binding/hydrolysis to transport substrates across cell membranes.", "category_aro_class_name": "AMR Gene Family"}, "35925": {"category_aro_accession": "0000006", "category_aro_cvterm_id": "35925", "category_aro_name": "erythromycin", "category_aro_description": "Erythromycin is a macrolide antibiotic with a 14-carbon ring that has an antimicrobial spectrum similar to or slightly wider than that of penicillin, and is often used for people that have an allergy to penicillins. Erythromycin may possess bacteriocidal activity, particularly at higher concentrations by binding to the 50S subunit of the bacterial 70S rRNA complex, inhibiting peptidyl-tRNA translocation. Thus, protein synthesis and subsequently structure/function processes critical for life or replication are inhibited.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.2343e-51, "max_identities": 84, "bit_score": 176.407, "cvterm_id": "36806", "query": "IVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKIL", "match": "++    + + +  G+ +V  L+ ++L +  G+F++I G SGSGK+T +N++GC+DTA SG   +DG +T K+   +L  LR    GFIFQ +NL+S L+   NV  P +    +   ER  R   LL+ +GL     ++P ELSGGQ+QRV++ARAL+   +++ ADEPT  LD+ +G+N++++++ L+ + G T I  THD  +  +AN V+ + DG+I+", "sequence_from_db": "LIECKNINRYFGSGENRVHILKDISLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAGSGSYRIDGIETAKMQPDELAALRRERFGFIFQRYNLLSSLTARDNVALPAVYM-GMGGKERSARADKLLQDLGLASKEGNKPGELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGKNVMEIIRRLH-EAGHTVIMVTHDPGIAANANRVIEIRDGEII", "sequence_from_broadstreet": "MSLIECKNINRYFGSGENRVHILKDISLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAGSGSYRIDGIETAKMQPDELAALRRERFGFIFQRYNLLSSLTARDNVALPAVYMGMGGKERSARADKLLQDLGLASKEGNKPGELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGKNVMEIIRRLHEAGHTVIMVTHDPGIAANANRVIEIRDGEIISDTSKNPEIPASNVGRIQEKASWSFYYDQFVEAFRMSVQAVLAHKMRSLLTMLGIIIGIASVVSVVALGNGSQKKILEDISSMGTNTISIFPGRGFGDRRSGKIKTLTIDDAKIIAKQSYVASATPMTSSGGTLTYRNTDLTASLYGVGEQYFDVRGLKLETGRLFDENDVKEDAQVVVIDQNVKDKLFADSDPLGKTILFRKRPLTVIGVMKKDENAFGNSDVLMLWSPYTTVMHQITGESHTNSITVKIKDNANTRVAEKGLAELLKARHGTEDFFMNNSDSIRQMVESTTGTMKLLISSIALISLVVGGIGVMNIMLVSVTERTKEIGIRMAIGARRGNILQQFLIEAVLICIIGGLVGVGLSAAVSLVFNHFVTDFPMDISAASVIGAVACSTGIGIAFGFMPANKAAKLNPIDALAQD", "dna_sequence_from_broadstreet": "ATGAGCTTGATCGAATGTAAAAACATCAACCGCTATTTCGGCAGCGGCGAGAACCGCGTCCATATTTTGAAAGACATCAGCCTGTCGATAGAGAAGGGTGATTTTGTCGCCATCATCGGGCAGTCCGGTTCGGGCAAGTCCACGCTGATGAACATACTCGGTTGTTTGGATACCGCCGGTTCCGGTTCGTACCGAATCGACGGCATCGAAACTGCCAAAATGCAGCCTGACGAACTGGCGGCATTGCGGCGCGAACGCTTCGGTTTCATCTTCCAACGCTACAACCTCTTAAGCTCGCTGACCGCAAGGGACAACGTCGCGCTGCCAGCCGTGTATATGGGTATGGGAGGCAAAGAGCGTTCCGCGCGGGCGGACAAACTCTTGCAGGATTTGGGTTTGGCAAGTAAAGAGGGCAACAAGCCCGGCGAACTCTCGGGCGGACAGCAGCAGCGCGTCTCCATCGCCCGCGCCCTGATGAACGGCGGAGAAATCATCTTCGCCGACGAGCCGACCGGCGCACTCGATACCGCCAGCGGCAAAAATGTGATGGAAATCATCCGCAGGCTGCACGAAGCCGGGCATACCGTCATTATGGTCACGCACGACCCCGGCATTGCCGCCAATGCCAACCGCGTCATCGAAATCCGGGACGGCGAAATCATTTCCGACACCTCGAAAAATCCCGAAATCCCCGCAAGCAATGTCGGGAGGATTCAGGAAAAAGCCTCGTGGTCGTTTTATTACGACCAGTTTGTCGAAGCCTTCAGAATGTCGGTGCAAGCAGTATTGGCGCACAAAATGCGTTCGCTTCTGACCATGCTCGGCATCATCATCGGTATCGCTTCGGTTGTCTCCGTCGTCGCGCTGGGCAACGGGTCGCAGAAAAAAATCCTCGAAGACATCAGTTCGATGGGGACGAACACCATCAGCATCTTCCCCGGGCGCGGCTTCGGCGACAGGCGCAGCGGCAAAATCAAAACCCTGACCATAGACGACGCAAAAATCATCGCCAAACAAAGCTATGTTGCTTCCGCCACGCCCATGACTTCGAGCGGCGGCACGCTGACCTACCGCAATACCGACCTGACCGCTTCTTTGTACGGCGTGGGCGAACAATATTTCGACGTGCGCGGGCTGAAGCTGGAAACGGGGCGGCTGTTTGATGAGAACGATGTGAAAGAAGACGCGCAAGTCGTCGTCATCGACCAAAATGTCAAAGACAAACTCTTTGCGGACTCGGATCCGTTGGGTAAAACCATTTTGTTCAGGAAACGCCCCTTGACCGTCATCGGCGTGATGAAAAAAGACGAAAACGCTTTCGGCAATTCCGACGTGCTGATGCTTTGGTCGCCCTATACGACGGTGATGCACCAAATCACAGGCGAGAGCCACACCAACTCCATCACCGTCAAAATCAAAGACAATGCCAATACCCGGGTTGCCGAAAAAGGGCTGGCCGAGCTGCTCAAAGCACGGCACGGCACGGAAGACTTCTTTATGAACAACAGCGACAGCATCAGGCAGATGGTCGAAAGCACCACCGGTACGATGAAGCTGCTGATTTCCTCCATCGCCCTGATTTCATTGGTAGTCGGCGGCATCGGCGTGATGAACATTATGCTGGTGTCCGTTACCGAGCGCACCAAAGAAATCGGCATACGGATGGCAATCGGCGCGCGGCGCGGCAATATTTTGCAGCAGTTTTTGATTGAGGCGGTGTTAATCTGCATCATCGGAGGCTTGGTCGGCGTAGGTTTGTCCGCCGCCGTCAGCCTCGTGTTCAATCATTTTGTAACCGATTTCCCGATGGACATTTCGGCGGCATCCGTTATCGGGGCGGTCGCCTGTTCGACCGGAATCGGCATCGCGTTCGGCTTTATGCCTGCCAATAAGGCAGCCAAACTCAATCCGATAGACGCATTGGCGCAGGATTGA", "partial": "0", "query_start": 51358, "query_end": 52020, "hit_start": 6, "hit_end": 663, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 38.01}, "gnl|BL_ORD_ID|2808|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "RanA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "3825", "ARO_accession": "3005091", "ARO_name": "RanA", "ARO_category": {"36002": {"category_aro_accession": "0010001", "category_aro_cvterm_id": "36002", "category_aro_name": "ATP-binding cassette (ABC) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. ATP-binding cassette (ABC) transporters are present in all cells of all organisms and use the energy of ATP binding/hydrolysis to transport substrates across cell membranes.", "category_aro_class_name": "AMR Gene Family"}, "35935": {"category_aro_accession": "0000016", "category_aro_cvterm_id": "35935", "category_aro_name": "aminoglycoside antibiotic", "category_aro_description": "Aminoglycosides are a group of antibiotics that are mostly effective against Gram-negative bacteria. These molecules consist of aminated sugars attached to a dibasic cyclitol. Aminoglycosides work by binding to the bacterial 30S ribosomal subunit (some work by binding to the 50S subunit), inhibiting the translocation of the peptidyl-tRNA from the A-site to the P-site and also causing misreading of mRNA, leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.74797e-32, "max_identities": 73, "bit_score": 117.857, "cvterm_id": "43303", "query": "QVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAK-VMTHANAVVRLADG", "match": " V  L+G+T     G+   + G SGSGKT  L  +  V   SSG +  DG++   +   +   +R   IG +FQ   L   ++V +N+ FPL +   L  +E+R RV  ++ +V LE      P+E+SGG ++RVA+ARA+V  PK +  DEP + LD  T   I +L+KE+  +  TT I +THD   V+T    +V L  G", "sequence_from_db": "DVEVLKGITTTFETGKINLVIGQSGSGKTVFLKCLLNVFDPSSGDILFDGRNLSIMGRTEKQEIR-SEIGTVFQGSALFDSMTVEENISFPLDMFTNLTYTEKRKRVKEVIGRVHLENANTKFPSEISGGMQKRVAIARAIVNNPKYLFCDEPNSGLDPNTAIVIDELIKEITEEYNTTTIINTHDMNSVLTIGEKIVYLRKG", "sequence_from_broadstreet": "MIEVKDLRKSFNDVEVLKGITTTFETGKINLVIGQSGSGKTVFLKCLLNVFDPSSGDILFDGRNLSIMGRTEKQEIRSEIGTVFQGSALFDSMTVEENISFPLDMFTNLTYTEKRKRVKEVIGRVHLENANTKFPSEISGGMQKRVAIARAIVNNPKYLFCDEPNSGLDPNTAIVIDELIKEITEEYNTTTIINTHDMNSVLTIGEKIVYLRKGVKEWEGNKDLIIKAENEHLIDFVYSSALFKQVRETMLRNNQTNL", "dna_sequence_from_broadstreet": "ATGATTGAAGTTAAAGATTTAAGAAAAAGTTTTAATGATGTAGAGGTTCTCAAAGGAATTACTACTACTTTTGAAACAGGAAAAATAAACCTTGTCATTGGTCAATCGGGTTCTGGTAAAACAGTGTTTTTGAAGTGTTTACTCAATGTTTTTGACCCTTCTTCAGGAGATATTTTATTTGATGGAAGAAATCTAAGCATTATGGGGCGAACGGAAAAACAAGAAATTCGTTCTGAGATAGGCACGGTATTTCAAGGGAGTGCTTTATTTGACTCTATGACGGTAGAAGAAAATATATCTTTTCCTTTGGATATGTTTACCAATCTCACTTATACCGAAAAAAGAAAAAGAGTAAAAGAAGTAATTGGAAGAGTTCATTTAGAAAATGCTAACACCAAGTTTCCTTCTGAAATATCAGGCGGAATGCAAAAAAGAGTGGCAATAGCTCGTGCAATTGTGAACAATCCAAAATATCTCTTTTGTGACGAACCAAATTCTGGTTTAGACCCTAACACAGCCATTGTAATAGATGAGCTTATAAAAGAAATTACAGAGGAATATAATACTACGACGATTATCAACACCCACGATATGAACTCTGTACTTACTATAGGTGAGAAAATAGTTTATTTAAGAAAAGGTGTTAAAGAGTGGGAAGGTAACAAAGACCTTATTATCAAAGCAGAAAATGAGCATTTAATAGATTTTGTTTACTCTTCAGCTTTGTTTAAGCAAGTAAGGGAAACAATGTTAAGAAATAATCAAACTAATTTATAA", "partial": "0", "query_start": 51406, "query_end": 52011, "hit_start": 36, "hit_end": 642, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 35.96}, "gnl|BL_ORD_ID|1488|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "lmrD", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1320", "model_id": "1624", "ARO_accession": "3002882", "ARO_name": "lmrD", "ARO_category": {"36002": {"category_aro_accession": "0010001", "category_aro_cvterm_id": "36002", "category_aro_name": "ATP-binding cassette (ABC) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. ATP-binding cassette (ABC) transporters are present in all cells of all organisms and use the energy of ATP binding/hydrolysis to transport substrates across cell membranes.", "category_aro_class_name": "AMR Gene Family"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.05775e-23, "max_identities": 64, "bit_score": 97.8265, "cvterm_id": "39577", "query": "PALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVL---SVFQNVEF--PLLLQRKLNASERRTRVMTLLEQV--GLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDR", "match": "P L+ V ++V  G+ +++ GP+GSGKTT +NL+      + G +  DG D +   E  L  LR   +G + Q     SVL   ++  N++F  P   Q ++    + T +   ++ +    E H     +  S GQ+Q++++AR ++T P+L++ DE T+N+D+VT Q I   M E      T+F+ + H  K + +A+ +V L DG++++ ", "sequence_from_db": "PVLKKVNIDVKKGQMVALVGPTGSGKTTVMNLMNRFYDVNGGAIKFDGTDIR---EFDLDSLR-SNVGIVLQE----SVLFDGTIADNIKFGKPNATQEEIETVAKTTHIHDFIDSLPDKYETHVSDDESVFSVGQKQQISIARTILTNPELLILDEATSNVDTVTEQQIQWAM-EAAIAGRTSFVIA-HRLKTILNADKIVVLKDGEVIEE", "sequence_from_broadstreet": "MENTKSTRKMSDTTRAIRFFYLYLKRYKLQFAVIMIFIILATWLQVVSPSLLGDAITNLTKYVTDFFTHQHAGQSQDALQQIAQQLSQQMHQTVDWHNVPEVVKSLPQAAQDQITANLPKGTTLETLKTVATSHAASTSTFMKGMWQLLAVYVATGVSMLIYTLLFSRIVAHSTNRMRKGLFGKLERLTISYFDRHQDGDILARFTSDLDNIQNTLNQALVSVISNAAVFVGVIIQIFNKDVTFAWLTVAASPVAILSAVIIIRQSKKATDKQQEEVSQLNAYMDEKISGQKAIIVEGLQEDSINGFLEHNENVKKRTFAAQAWSGMIFPLMNGFQLLSIAIVIFGGTAYVLNDDSMSIATGLGLLVAFVQYVQSYYNPIMQISSNFGQLQLAITGATRLNVMFDEPEEVRPENGKKFDTIKDGIQIENLDFEYLPGKPVLKKVNIDVKKGQMVALVGPTGSGKTTVMNLMNRFYDVNGGAIKFDGTDIREFDLDSLRSNVGIVLQESVLFDGTIADNIKFGKPNATQEEIETVAKTTHIHDFIDSLPDKYETHVSDDESVFSVGQKQQISIARTILTNPELLILDEATSNVDTVTEQQIQWAMEAAIAGRTSFVIAHRLKTILNADKIVVLKDGEVIEEGNHHELVAQGGFYSELYHNQFVFE", "dna_sequence_from_broadstreet": "ATGGAAAATACCAAATCAACAAGAAAAATGTCTGACACCACACGTGCCATCCGATTTTTTTACCTCTATCTGAAAAGATATAAACTCCAATTTGCTGTAATTATGATTTTCATCATTTTAGCAACTTGGTTACAGGTTGTTTCTCCATCACTTTTGGGGGACGCCATCACTAATTTGACTAAATATGTGACTGACTTCTTTACACATCAACATGCTGGTCAATCCCAAGATGCACTACAACAAATTGCTCAACAATTAAGCCAACAAATGCACCAAACAGTAGATTGGCACAATGTTCCTGAAGTTGTGAAATCTTTGCCACAAGCAGCACAAGACCAAATCACTGCTAATCTTCCTAAAGGAACAACTTTAGAAACACTTAAAACAGTGGCAACTTCACATGCAGCCAGCACTTCTACATTCATGAAAGGAATGTGGCAATTGCTTGCAGTCTATGTAGCAACAGGTGTATCAATGTTGATTTATACCTTGCTCTTTAGTCGTATCGTTGCTCATTCAACAAATCGCATGCGTAAAGGTTTGTTTGGTAAACTTGAACGTTTGACAATTTCATATTTTGACCGTCATCAAGATGGTGATATCCTTGCTCGTTTCACATCTGACTTGGATAACATTCAAAATACTTTAAACCAAGCACTCGTTTCGGTTATTTCAAATGCTGCGGTCTTTGTGGGTGTCATTATCCAGATTTTCAATAAAGATGTGACATTTGCTTGGTTGACAGTTGCTGCTTCTCCAGTTGCCATTTTATCTGCTGTGATTATCATTCGTCAATCGAAAAAAGCAACAGACAAACAACAAGAAGAAGTTTCACAACTTAATGCCTATATGGATGAAAAAATCTCTGGGCAAAAAGCAATTATCGTTGAAGGTTTACAAGAAGATTCTATTAATGGATTCTTGGAACACAATGAAAATGTTAAAAAACGTACCTTTGCTGCTCAAGCATGGTCTGGTATGATTTTCCCATTGATGAATGGTTTCCAACTTTTATCAATTGCCATTGTTATCTTTGGTGGAACGGCCTATGTTCTTAACGATGATAGCATGTCAATTGCCACAGGTTTAGGGCTTTTGGTTGCCTTTGTTCAATACGTTCAAAGTTACTACAACCCAATCATGCAAATTTCATCAAACTTTGGTCAACTTCAACTTGCCATCACAGGGGCAACTCGTCTGAATGTCATGTTTGATGAACCAGAAGAAGTTCGTCCTGAAAATGGTAAGAAATTTGATACGATTAAAGACGGAATTCAAATCGAAAATCTTGATTTTGAATATCTTCCAGGAAAACCAGTCCTCAAAAAAGTTAATATTGATGTTAAAAAAGGACAAATGGTTGCCCTCGTTGGTCCAACTGGTTCAGGTAAAACAACAGTTATGAACTTGATGAACCGTTTCTACGATGTTAATGGTGGAGCAATTAAATTTGATGGAACTGATATTCGTGAATTTGATTTAGATAGCTTGCGTTCAAATGTCGGAATTGTTTTGCAAGAGTCTGTTCTCTTTGATGGAACGATTGCTGATAATATCAAGTTTGGTAAACCAAATGCTACTCAAGAAGAAATTGAAACAGTGGCTAAGACAACTCACATTCATGATTTCATTGATAGCTTACCTGACAAGTACGAAACACATGTTTCAGATGATGAATCAGTCTTCTCAGTTGGTCAAAAACAACAAATTTCTATCGCACGTACCATTTTGACAAATCCAGAACTTTTGATTTTGGATGAAGCAACTTCAAATGTGGATACAGTAACTGAACAACAAATTCAATGGGCGATGGAAGCTGCTATTGCTGGTCGTACTTCATTCGTTATTGCTCACCGTTTGAAAACAATTCTTAATGCAGATAAGATTGTTGTTCTTAAAGATGGTGAAGTTATCGAAGAAGGAAATCACCATGAACTTGTTGCTCAAGGTGGCTTCTACTCTGAACTTTATCACAATCAATTTGTTTTTGAATAA", "partial": "0", "query_start": 51412, "query_end": 52026, "hit_start": 1314, "hit_end": 1920, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 30.19}, "gnl|BL_ORD_ID|2050|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "oleC", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "600", "model_id": "2264", "ARO_accession": "3003748", "ARO_name": "oleC", "ARO_category": {"36002": {"category_aro_accession": "0010001", "category_aro_cvterm_id": "36002", "category_aro_name": "ATP-binding cassette (ABC) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. ATP-binding cassette (ABC) transporters are present in all cells of all organisms and use the energy of ATP binding/hydrolysis to transport substrates across cell membranes.", "category_aro_class_name": "AMR Gene Family"}, "37247": {"category_aro_accession": "3000867", "category_aro_cvterm_id": "37247", "category_aro_name": "oleandomycin", "category_aro_description": "Oleandomycin is a 14-membered macrolide produced by Streptomyces antibioticus. It is ssimilar to erythromycin, and contains a desosamine amino sugar and an oleandrose sugar. It targets the 50S ribosomal subunit to prevent protein synthesis.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.26689e-19, "max_identities": 61, "bit_score": 83.5741, "cvterm_id": "36823", "query": "QVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNAS--ERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTH", "match": "+  AL GV L+V  G  + + GP+G+GKTT + ++  + T  SG  +V G D      RQ   LR   IG   Q  ++   L  ++N+    L+ R L+ S  E R R   LLE+  L + A+      SGG R+R+ +A +++ RP ++  DEPT  LD  T   + D +K +   +G T + +T ", "sequence_from_db": "ETKALDGVDLDVREGTVMGVLGPNGAGKTTLVRILSTLITPDSGQATVAGYDVV----RQPRQLR-RVIGLTGQYASVDEKLPGWENL---YLIGRLLDLSRKEARARADELLERFSLTEAARRPAGTYSGGMRRRLDLAASMIGRPAVLYLDEPTTGLDPRTRNEVWDEVKAMV-GDGVTVLLTTQ", "sequence_from_broadstreet": "MTVRGLVKHYGETKALDGVDLDVREGTVMGVLGPNGAGKTTLVRILSTLITPDSGQATVAGYDVVRQPRQLRRVIGLTGQYASVDEKLPGWENLYLIGRLLDLSRKEARARADELLERFSLTEAARRPAGTYSGGMRRRLDLAASMIGRPAVLYLDEPTTGLDPRTRNEVWDEVKAMVGDGVTVLLTTQYMEEAEQLASELTVVDRGRVIAKGGIEELKARVGGRTLRVRPVDPLQLRPLAGMLDELGITGLASTTVDTETGALLVPILSDEQLTAVVGAVTARGITLSSITTELPSLDEVFLSLTGHRASAPQDAEPARQEVAV", "dna_sequence_from_broadstreet": "GTGACCGTACGGGGGCTGGTCAAGCACTACGGCGAGACCAAGGCGCTGGACGGCGTCGACCTGGACGTGCGCGAGGGCACCGTGATGGGTGTGCTCGGGCCGAACGGCGCCGGCAAGACCACCCTCGTCCGCATCCTGTCCACCCTGATCACCCCGGACTCCGGGCAGGCCACCGTGGCCGGCTACGACGTCGTACGCCAGCCCCGGCAGCTGCGCCGGGTCATCGGGCTCACCGGCCAGTACGCGTCGGTGGACGAGAAGCTCCCGGGCTGGGAGAACCTCTACCTGATCGGCCGGCTGCTGGACCTGTCCCGCAAGGAGGCCCGGGCCCGCGCCGACGAGCTGCTGGAGCGGTTCTCGCTGACCGAGGCCGCCCGGCGCCCGGCCGGCACCTACTCCGGCGGTATGCGGCGCCGACTGGACCTGGCCGCCTCGATGATCGGCCGGCCGGCCGTGCTGTACCTGGACGAGCCGACCACCGGCCTCGACCCGCGCACCCGCAACGAGGTGTGGGACGAGGTCAAGGCGATGGTCGGCGACGGCGTCACCGTGCTGCTCACCACCCAGTACATGGAGGAGGCCGAGCAGCTCGCCTCGGAACTGACCGTGGTGGACCGCGGCCGGGTCATCGCCAAGGGCGGCATCGAGGAGCTGAAGGCCCGCGTCGGCGGGCGCACCCTGCGGGTGCGGCCGGTCGACCCGCTCCAGCTGCGCCCGCTCGCCGGCATGCTGGACGAGCTGGGCATCACCGGGCTGGCTTCCACCACCGTGGACACCGAGACCGGGGCCCTGCTGGTGCCGATCCTCAGCGACGAGCAGCTGACCGCCGTGGTCGGCGCGGTCACCGCGCGCGGCATCACGCTGTCCTCCATCACCACCGAACTGCCCAGCCTGGACGAGGTGTTCCTGTCCCTCACCGGCCACCGCGCCAGTGCCCCGCAGGACGCCGAGCCCGCCCGCCAGGAGGTCGCCGTATGA", "partial": "0", "query_start": 51406, "query_end": 51960, "hit_start": 33, "hit_end": 567, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 32.62}, "gnl|BL_ORD_ID|1911|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "patB", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "2112", "ARO_accession": "3000025", "ARO_name": "patB", "ARO_category": {"36002": {"category_aro_accession": "0010001", "category_aro_cvterm_id": "36002", "category_aro_name": "ATP-binding cassette (ABC) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. ATP-binding cassette (ABC) transporters are present in all cells of all organisms and use the energy of ATP binding/hydrolysis to transport substrates across cell membranes.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.05852e-19, "max_identities": 61, "bit_score": 83.1889, "cvterm_id": "40078", "query": "PALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEF--PLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNE---LSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDR", "match": "P L+ V++    G+  ++ GP+GSGKTT +NLI       +G +  DG+D +      L  LR   +G + Q   L S  ++  N+ F  P   Q  +  + + T +   +E +  +K+     ++    S GQ+Q +++AR L+T P++++ DE T+N+D+VT   I   M E+     T+F+ + H  K + +A+ ++ L DG++++R", "sequence_from_db": "PILKDVSISAPKGQMTAVVGPTGSGKTTIMNLINRFYDVDAGGIYFDGKDIRG---YDLDSLR-SKVGIVLQDSVLFSG-TIRDNIRFGVPDASQEMVEVAAKATHIHDYIESLP-DKYDTLIDDDQSIFSTGQKQLISIARTLMTDPEVLILDEATSNVDTVTESKIQHAM-EVVVAGRTSFVIA-HRLKTILNADQIIVLKDGEVIER", "sequence_from_broadstreet": "MKTVQFFWHYFKVYKFSFVVVILMIVLATFAQALFPVFSGQAVTQLANLVQAYQNGNPELVWQSLSGIMVNLGLLVLVLFISSVIYMCLMTRVIAESTNEMRKGLFGKLAQLTVSFFDRRQDGDILSHFTSDLDNILQAFNESLIQVMSNIVLYIGLILVMFSRNVTLALITIASTPLAFLMLIFIVKMARKYTNLQQKEVGKLNAYMDESISGQKAVIVQGIQEDMMAGFLEQNERVRKATFKGRMFSGILFPVMNGMSLINTAIVIFAGSAVLLNDKSIETSTALGLIVMFAQFSQQYYQPIIQVAASWGSLQLAFTGAERIQEMFDAEEEIRPEKAPTFTKLQESVEISHIVFSYLPDKPILKDVSISAPKGQMTAVVGPTGSGKTTIMNLINRFYDVDAGGIYFDGKDIRGYDLDSLRSKVGIVLQDSVLFSGTIRDNIRFGVPDASQEMVEVAAKATHIHDYIESLPDKYDTLIDDDQSIFSTGQKQLISIARTLMTDPEVLILDEATSNVDTVTESKIQHAMEVVVAGRTSFVIAHRLKTILNADQIIVLKDGEVIERGNHHELLKLGGFYSELYHNQFVFE", "dna_sequence_from_broadstreet": "ATGAAGACAGTTCAATTTTTTTGGCATTATTTTAAGGTCTACAAGTTCTCATTTGTAGTTGTCATCCTGATGATTGTTCTGGCGACTTTTGCCCAAGCCCTCTTTCCAGTCTTTTCTGGACAAGCGGTGACGCAGCTAGCCAATTTAGTTCAAGCTTATCAAAATGGCAATCCAGAACTTGTATGGCAAAGCCTATCAGGAATCATGGTCAATCTTGGCCTGCTGGTTTTGGTTCTATTTATCTCTAGTGTAATATACATGTGTCTCATGACGCGCGTGATTGCAGAATCGACCAACGAGATGCGCAAAGGCCTCTTTGGTAAGCTTGCTCAGTTGACGGTTTCTTTCTTTGACCGTCGACAAGATGGCGATATCCTGTCTCATTTTACCAGTGATTTGGATAATATCCTCCAAGCCTTTAACGAAAGCTTGATTCAGGTCATGAGCAATATTGTTTTATACATTGGTCTGATTCTTGTCATGTTTTCGAGAAATGTGACGCTGGCTCTCATCACCATTGCCAGCACCCCATTGGCTTTCCTTATGCTGATTTTCATCGTGAAAATGGCACGCAAATACACCAACCTCCAGCAGAAAGAGGTAGGGAAGCTCAACGCCTATATGGATGAGAGCATCTCAGGCCAAAAAGCCGTGATTGTGCAAGGAATTCAAGAGGATATGATGGCAGGATTTCTTGAACAAAATGAGCGCGTGCGCAAGGCAACCTTTAAAGGAAGAATGTTCTCAGGAATTCTTTTCCCTGTCATGAATGGGATGAGCCTGATTAATACAGCCATCGTCATCTTTGCTGGTTCGGCTGTACTTTTGAATGATAAGTCTATTGAAACAAGTACAGCCCTAGGTTTGATTGTTATGTTTGCACAATTTTCACAGCAGTACTACCAGCCTATTATCCAAGTTGCAGCGAGTTGGGGAAGCCTTCAGTTGGCCTTTACTGGAGCTGAACGAATTCAGGAAATGTTTGATGCAGAGGAGGAAATCCGACCTGAAAAGGCTCCAACCTTCACTAAGTTGCAAGAAAGTGTTGAAATCAGTCATATCGTTTTTTCATACTTGCCTGATAAACCTATTTTGAAAGATGTCAGCATTTCTGCCCCTAAAGGCCAGATGACAGCAGTTGTTGGGCCGACAGGTTCAGGAAAAACGACTATTATGAACCTCATCAATCGCTTTTATGATGTTGATGCTGGTGGTATTTATTTTGATGGTAAAGACATTCGTGGCTATGACTTAGATAGTCTTAGAAGCAAGGTGGGAATTGTATTGCAAGATTCGGTCTTGTTTAGCGGAACGATTAGAGACAATATCCGATTTGGTGTGCCAGATGCTAGTCAGGAAATGGTTGAGGTAGCAGCAAAAGCAACCCACATTCACGACTATATCGAAAGTTTGCCTGATAAGTACGATACTCTTATTGATGATGACCAGAGCATCTTTTCAACAGGGCAGAAGCAATTGATTTCAATCGCTCGAACCCTGATGACAGATCCAGAAGTTCTCATTCTCGATGAAGCAACTTCAAACGTAGATACGGTGACAGAAAGCAAGATTCAGCATGCCATGGAGGTGGTTGTAGCAGGTAGAACTAGTTTCGTCATTGCCCACCGCTTGAAAACCATTCTCAATGCAGATCAGATTATTGTCCTTAAAGATGGAGAAGTCATTGAACGTGGTAACCACCATGAACTTTTGAAGCTAGGTGGCTTTTATTCAGAACTCTATCACAATCAATTTGTTTTCGAATAA", "partial": "0", "query_start": 51412, "query_end": 52026, "hit_start": 1086, "hit_end": 1692, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 29.05}, "gnl|BL_ORD_ID|2185|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "msbA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1000", "model_id": "2423", "ARO_accession": "3003950", "ARO_name": "msbA", "ARO_category": {"36002": {"category_aro_accession": "0010001", "category_aro_cvterm_id": "36002", "category_aro_name": "ATP-binding cassette (ABC) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. ATP-binding cassette (ABC) transporters are present in all cells of all organisms and use the energy of ATP binding/hydrolysis to transport substrates across cell membranes.", "category_aro_class_name": "AMR Gene Family"}, "37033": {"category_aro_accession": "3000689", "category_aro_cvterm_id": "37033", "category_aro_name": "metronidazole", "category_aro_description": "Metronidazole is a nitroimidazole that is active against anaerobic bacteria and protozoa. It is not effective against aerobic bacteria. Nitroimidazoles act by oxidizing DNA causing strand breaks and cell death.", "category_aro_class_name": "Antibiotic"}, "41239": {"category_aro_accession": "3004115", "category_aro_cvterm_id": "41239", "category_aro_name": "nitroimidazole antibiotic", "category_aro_description": "Nitroimidazoles are a group of drugs that have both antiprotozoal and antibacterial activity, classified with respect to the location of the nitro functional group.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.46735e-18, "max_identities": 68, "bit_score": 82.0333, "cvterm_id": "36849", "query": "VSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQ---RKLNASERRTRVMTLLEQV--GLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDR", "match": "V    VT TY  G+  VPALR + L++  G+ +++ G SGSGK+T  +LI        G + +DG D ++ T   L  LR + +  + Q+ +L +  +V  N+ +    Q    ++  + R    M  + ++  GL+         LSGGQRQR+A+ARAL+    +++ DE T+ LD+ + + I   + EL +   +  I   H    +  A+ +V + DG I++R", "sequence_from_db": "VEFRNVTFTYP-GR-DVPALRNINLKIPAGKTVALVGRSGSGKSTIASLITRFYDIDEGEILMDGHDLREYT---LASLR-NQVALVSQNVHLFND-TVANNIAYARTEQYSREQIEEAARMAYAMDFINKMDNGLDTVIGENGVLLSGGQRQRIAIARALLRDSPILILDEATSALDTESERAIQAALDELQKNRTSLVI--AHRLSTIEKADEIVVVEDGVIVER", "sequence_from_broadstreet": "MHNDKDLSTWQTFRRLWPTIAPFKAGLIVAGVALILNAASDTFMLSLLKPLLDDGFGKTDRSVLVWMPLVVIGLMILRGITSYVSSYCISWVSGKVVMTMRRRLFGHMMGMPVSFFDKQSTGTLLSRITYDSEQVASSSSGALITVVREGASIIGLFIMMFYYSWQLSIILIVLAPIVSIAIRVVSKRFRNISKNMQNTMGQVTTSAEQMLKGHKEVLIFGGQEVETKRFDKVSNRMRLQGMKMVSASSISDPIIQLIASLALAFVLYAASFPSVMDSLTAGTITVVFSSMIALMRPLKSLTNVNAQFQRGMAACQTLFTILDSEQEKDEGKRVIERATGDVEFRNVTFTYPGRDVPALRNINLKIPAGKTVALVGRSGSGKSTIASLITRFYDIDEGEILMDGHDLREYTLASLRNQVALVSQNVHLFNDTVANNIAYARTEQYSREQIEEAARMAYAMDFINKMDNGLDTVIGENGVLLSGGQRQRIAIARALLRDSPILILDEATSALDTESERAIQAALDELQKNRTSLVIAHRLSTIEKADEIVVVEDGVIVERGTHNDLLEHRGVYAQLHKMQFGQ", "dna_sequence_from_broadstreet": "ATGCATAACGACAAAGATCTCTCTACGTGGCAGACATTCCGCCGACTGTGGCCAACCATTGCGCCTTTCAAAGCGGGTCTGATCGTGGCGGGCGTAGCGTTAATCCTCAACGCAGCCAGCGATACCTTCATGTTATCGCTCCTTAAGCCACTTCTTGATGATGGCTTTGGTAAAACAGATCGCTCCGTGCTGGTGTGGATGCCGCTGGTGGTGATCGGGCTGATGATTTTACGTGGTATCACCAGCTATGTCTCCAGCTACTGTATCTCCTGGGTATCAGGAAAGGTGGTAATGACCATGCGTCGCCGCCTGTTTGGTCACATGATGGGAATGCCAGTTTCATTCTTTGACAAACAGTCAACGGGTACGCTGTTGTCACGTATTACCTACGATTCCGAACAGGTTGCTTCTTCTTCTTCCGGCGCACTGATTACTGTTGTGCGTGAAGGTGCGTCGATCATCGGCCTGTTCATCATGATGTTCTATTACAGTTGGCAACTGTCGATCATTTTGATTGTGCTGGCACCGATTGTTTCGATTGCGATTCGCGTTGTATCGAAGCGTTTTCGCAACATCAGTAAAAACATGCAGAACACCATGGGGCAGGTGACCACCAGCGCAGAACAAATGCTGAAGGGCCACAAAGAAGTATTGATTTTCGGTGGTCAGGAAGTGGAAACGAAACGCTTTGATAAAGTCAGCAACCGAATGCGTCTTCAGGGGATGAAAATGGTTTCAGCCTCTTCCATCTCTGATCCGATCATTCAGCTGATCGCCTCTTTGGCGCTGGCGTTTGTTCTGTATGCGGCGAGCTTCCCAAGTGTCATGGATAGCCTGACTGCCGGTACGATTACCGTTGTTTTCTCTTCAATGATTGCACTGATGCGTCCGCTGAAATCGCTGACCAACGTTAACGCCCAGTTCCAGCGCGGTATGGCGGCTTGTCAGACGCTGTTTACCATTCTGGACAGTGAGCAGGAGAAAGATGAAGGTAAGCGCGTGATCGAGCGTGCGACTGGCGACGTGGAATTCCGCAATGTCACCTTTACTTATCCGGGACGTGACGTACCTGCATTGCGTAACATCAACCTGAAAATTCCGGCAGGGAAGACGGTTGCTCTGGTTGGACGCTCTGGTTCGGGTAAATCAACCATCGCCAGCCTGATCACGCGTTTTTACGATATTGATGAAGGCGAAATCCTGATGGATGGTCACGATCTGCGCGAGTATACCCTGGCGTCGTTACGTAACCAGGTTGCTCTGGTGTCGCAGAATGTCCATCTGTTTAACGATACGGTTGCTAACAACATTGCTTACGCACGGACTGAACAGTACAGCCGTGAGCAAATTGAAGAAGCGGCGCGTATGGCCTACGCCATGGACTTCATCAATAAGATGGATAACGGTCTCGATACAGTGATTGGTGAAAACGGCGTGCTGCTCTCTGGCGGTCAGCGTCAGCGTATTGCTATCGCTCGAGCCTTGTTGCGTGATAGCCCGATTCTGATTCTGGACGAAGCTACCTCGGCTCTGGATACCGAATCCGAACGTGCGATTCAGGCGGCACTGGATGAGTTGCAGAAAAACCGTACCTCTCTGGTGATTGCCCACCGCTTGTCTACCATTGAAAAGGCAGACGAAATCGTGGTCGTCGAGGATGGTGTCATTGTGGAACGCGGTACGCATAACGATTTGCTTGAGCACCGCGGCGTTTACGCGCAACTTCACAAAATGCAGTTTGGCCAATGA", "partial": "0", "query_start": 51361, "query_end": 52026, "hit_start": 1023, "hit_end": 1677, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 29.96}, "gnl|BL_ORD_ID|2307|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "tetB(60)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1100", "model_id": "2646", "ARO_accession": "3004036", "ARO_name": "tetB(60)", "ARO_category": {"36002": {"category_aro_accession": "0010001", "category_aro_cvterm_id": "36002", "category_aro_name": "ATP-binding cassette (ABC) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. ATP-binding cassette (ABC) transporters are present in all cells of all organisms and use the energy of ATP binding/hydrolysis to transport substrates across cell membranes.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.47984e-18, "max_identities": 64, "bit_score": 81.2629, "cvterm_id": "36791", "query": "VSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEF------PLLLQR---KLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTG---QNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAE", "match": "+   +V+  Y+ G   VP L+ +   V PG+ ++  G +GSGK++ +NL+      +SG + +DG++T+    R +       +G + Q   L +  ++  NV        P  ++    K+      T+        GL+   K +  + S G+RQ ++ ARA+V  PK+++ DE T+++D+ T    QN I+++     KEG T     H    + HA+ +  L  G+I++R T  E", "sequence_from_db": "IEFKDVSFEYTAG---VPVLKHLNFTVEPGQTVAFVGHTGSGKSSIMNLLFRFYDPTSGAIFIDGKNTRDFNRRSVRS----EMGIVLQDPYLFTG-TIASNVGLNNESIEPETIKEAIIKVGGGHLLTK-----SDKGLDYEVKEKGMDFSSGERQLISFARAIVFDPKILILDEATSHIDTETEEIIQNAINVV-----KEGRTTFMIAHRLSTIAHADQIFVLDKGEIVERGTHDE", "sequence_from_broadstreet": "MRTMKRLLSYLRYEKKGVLIGLFCLLLSTGATLTGPLVAKHIIDNVITPMGQAHDFKAGGLLLWVGIYVTVNLVGVAGAYLNRVYMKTLSNRIAKRIRDEVFEHVQTLPVSYFDHLPAGKVVSRITSDTESVRANFYVSGISTLFSTIVMLVGVYITIFLLNATLGLVLLFLVPVMILWQRTVATKQKKYYSENRELYSQLSGQLNESIQGAGIVQAFQQEEKIVAEYDATATSWVEVGRKELILESYFSWSLVGMLRNITHFGVIYYFSMQFIGGTLGISAGLLYAFIDYINRIYEPIQTFMNVVSGFQQSMAAGDRVFELMDTPSEESGEELFTFDEGCIEFKDVSFEYTAGVPVLKHLNFTVEPGQTVAFVGHTGSGKSSIMNLLFRFYDPTSGAIFIDGKNTRDFNRRSVRSEMGIVLQDPYLFTGTIASNVGLNNESIEPETIKEAIIKVGGGHLLTKSDKGLDYEVKEKGMDFSSGERQLISFARAIVFDPKILILDEATSHIDTETEEIIQNAINVVKEGRTTFMIAHRLSTIAHADQIFVLDKGEIVERGTHDELLQLQGQYAEMVALQKG", "dna_sequence_from_broadstreet": "ATGAGAACGATGAAGCGATTATTAAGCTACCTCCGTTATGAGAAAAAAGGAGTTCTGATTGGACTCTTCTGCCTGTTACTCTCAACAGGAGCAACCTTAACAGGGCCACTCGTTGCGAAACACATTATCGATAATGTGATTACTCCGATGGGGCAGGCGCATGATTTCAAAGCAGGTGGCCTACTTTTATGGGTTGGTATTTACGTGACAGTGAACTTAGTGGGAGTTGCTGGGGCCTATTTAAACCGTGTATATATGAAGACTCTCTCAAACCGTATTGCAAAACGCATTCGTGACGAAGTGTTCGAGCATGTACAAACCTTGCCGGTATCGTACTTCGACCATTTACCAGCTGGGAAAGTGGTTTCTAGAATTACAAGTGATACAGAATCAGTGCGTGCAAACTTCTACGTGAGTGGGATTTCGACGCTTTTCAGTACGATTGTGATGTTGGTAGGTGTTTATATAACCATTTTCTTATTAAACGCAACGCTAGGACTCGTATTATTATTCCTAGTTCCTGTGATGATTCTATGGCAGAGAACCGTTGCTACGAAGCAGAAAAAATACTATTCCGAAAATCGTGAACTCTATAGTCAGTTGAGTGGACAATTAAACGAAAGCATTCAAGGAGCAGGCATCGTTCAAGCCTTCCAGCAAGAAGAAAAAATTGTTGCAGAATATGATGCCACGGCAACTTCTTGGGTAGAAGTTGGTCGTAAGGAATTAATTCTTGAGTCGTACTTCTCGTGGAGTCTTGTCGGCATGCTTCGAAACATTACTCATTTTGGAGTTATCTATTATTTCAGTATGCAGTTTATCGGTGGAACACTCGGGATTTCAGCAGGTCTTTTATATGCATTTATTGACTACATTAATCGTATATATGAGCCGATTCAAACTTTTATGAATGTCGTGTCTGGCTTCCAGCAATCAATGGCTGCTGGTGACCGTGTGTTTGAACTAATGGATACACCGAGCGAGGAATCGGGAGAAGAGCTCTTCACGTTTGATGAAGGATGTATCGAATTTAAAGATGTGAGTTTTGAGTACACAGCGGGAGTTCCTGTGTTGAAACACTTGAATTTCACGGTAGAACCAGGACAGACGGTTGCTTTTGTCGGACATACTGGTTCAGGGAAATCATCCATTATGAACTTACTGTTTCGCTTCTACGACCCAACGAGTGGTGCTATCTTCATCGATGGCAAAAACACACGCGACTTTAACAGACGTAGTGTTCGAAGCGAGATGGGAATCGTTCTTCAAGATCCGTACCTCTTTACAGGAACGATTGCTTCAAACGTAGGGCTCAACAATGAATCGATTGAGCCTGAGACGATAAAAGAGGCGATTATTAAAGTGGGTGGAGGACATCTACTTACGAAGAGTGACAAGGGCTTGGACTACGAGGTGAAAGAAAAAGGAATGGATTTCTCTTCAGGAGAACGCCAACTGATTTCATTTGCTCGTGCGATCGTCTTTGACCCGAAAATCTTAATTTTAGACGAGGCAACTTCGCATATCGATACCGAGACAGAAGAGATTATTCAGAATGCAATTAATGTCGTCAAAGAAGGGCGTACAACCTTTATGATTGCTCACCGACTTTCCACAATTGCTCATGCTGACCAAATTTTTGTGTTGGATAAAGGAGAAATTGTAGAACGTGGAACGCATGATGAATTGCTTCAACTGCAAGGTCAATATGCCGAAATGGTCGCCCTACAAAAAGGATAA", "partial": "0", "query_start": 51361, "query_end": 52041, "hit_start": 1023, "hit_end": 1686, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 26.78}, "gnl|BL_ORD_ID|2243|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "tetA(58)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "650", "model_id": "2517", "ARO_accession": "3003980", "ARO_name": "tetA(58)", "ARO_category": {"36003": {"category_aro_accession": "0010002", "category_aro_cvterm_id": "36003", "category_aro_name": "major facilitator superfamily (MFS) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Major facilitator superfamily (MFS) transporters and ABC transporters comprise the two largest and most functionally diverse of the transporter superfamilies. However, MFS transporters are distinct from ABC transporters in both their primary sequence and structure and in the mechanism of energy coupling. As secondary transporters they are, like RND and SMR transporters, energized by the electrochemical proton gradient.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.79215e-18, "max_identities": 59, "bit_score": 79.337, "cvterm_id": "40862", "query": "ALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTE--RQLTHLRLHTIGFIFQSFNLVSVLSVFQN-VEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTH", "match": "A+ GV L V  G    + GP+G+GKTT + ++  +    +G   + G D +  ++  RQL       IG   Q  ++   LS  +N + F  LL   L   E R +   LLE+ GL + AK      SGG R+R+ +A +L+ +P L+  DEPT  LD  T   + D ++ L    G+T + +T ", "sequence_from_db": "AVDGVDLNVRTGTIYGVLGPNGAGKTTTIRMLATLLRPDAGSARIFGHDVQAESQIVRQL-------IGVTGQYASVDESLSATENLIIFSRLL--GLGRKEARRKAEELLEEFGLSEAAKRPLKNFSGGMRRRLDLAASLIAQPPLIFLDEPTTGLDPRTRSQMWDTIRRLVNT-GSTVLLTTQ", "sequence_from_broadstreet": "MEHAYKKKIEPKPGDLAVEAYGLIKTFGDNRAVDGVDLNVRTGTIYGVLGPNGAGKTTTIRMLATLLRPDAGSARIFGHDVQAESQIVRQLIGVTGQYASVDESLSATENLIIFSRLLGLGRKEARRKAEELLEEFGLSEAAKRPLKNFSGGMRRRLDLAASLIAQPPLIFLDEPTTGLDPRTRSQMWDTIRRLVNTGSTVLLTTQYLEEADQLADRIAVIDYGRVVAEGTADELKMSVGTSSLHLTVEDSVDMDRACHTVEQVLGVHANVSPEAGKITAPMANAGLVTDLLIELRTAGIGLSEMSVQKPTLDEVFLTITGHGVKEDAAQESYESNDREVARV", "dna_sequence_from_broadstreet": "ATGGAGCATGCATACAAAAAGAAAATAGAACCAAAACCTGGCGACTTGGCCGTTGAGGCTTACGGACTGATCAAAACATTCGGAGATAACCGCGCCGTGGATGGGGTGGATCTGAACGTACGTACCGGAACGATCTACGGTGTACTTGGCCCGAATGGGGCAGGCAAGACGACCACCATCCGAATGCTGGCGACCTTGCTAAGACCGGATGCGGGTTCGGCCCGAATCTTCGGACATGATGTGCAGGCGGAATCGCAGATTGTCCGTCAGTTGATCGGGGTAACCGGCCAATACGCGTCGGTGGACGAATCGCTCAGCGCTACGGAGAATCTGATTATATTCTCACGTTTGCTTGGTTTGGGGCGTAAGGAGGCAAGGCGCAAGGCGGAAGAGCTGCTCGAGGAATTCGGTTTGTCGGAAGCCGCGAAGCGGCCGCTAAAAAATTTCTCGGGCGGCATGCGGAGAAGGCTGGATCTGGCGGCAAGCCTGATTGCCCAGCCGCCGCTTATCTTCCTGGATGAACCGACGACGGGGCTGGATCCAAGGACGCGTTCCCAGATGTGGGATACGATCCGCCGATTGGTGAATACCGGTTCAACGGTATTGCTGACCACGCAGTATCTCGAGGAGGCCGACCAGCTGGCAGACCGCATCGCCGTTATCGATTACGGCCGGGTTGTGGCCGAGGGGACGGCCGATGAACTGAAGATGTCGGTGGGCACTTCCTCGCTGCATTTGACTGTCGAGGATTCGGTTGACATGGATCGCGCCTGCCATACCGTGGAACAAGTGTTAGGCGTCCATGCCAATGTATCGCCGGAAGCCGGAAAGATAACGGCGCCGATGGCTAATGCGGGTCTTGTTACAGACCTGCTGATCGAGCTGCGAACAGCAGGAATCGGCTTGTCCGAGATGAGCGTGCAGAAGCCGACCCTGGATGAGGTGTTCCTAACGATCACCGGCCACGGCGTGAAGGAAGACGCTGCCCAAGAGTCTTATGAATCCAATGATCGGGAGGTGGCACGGGTATGA", "partial": "0", "query_start": 51415, "query_end": 51960, "hit_start": 93, "hit_end": 618, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 31.89}, "gnl|BL_ORD_ID|2182|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "efrA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "960", "model_id": "2421", "ARO_accession": "3003948", "ARO_name": "efrA", "ARO_category": {"36002": {"category_aro_accession": "0010001", "category_aro_cvterm_id": "36002", "category_aro_name": "ATP-binding cassette (ABC) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. ATP-binding cassette (ABC) transporters are present in all cells of all organisms and use the energy of ATP binding/hydrolysis to transport substrates across cell membranes.", "category_aro_class_name": "AMR Gene Family"}, "35925": {"category_aro_accession": "0000006", "category_aro_cvterm_id": "35925", "category_aro_name": "erythromycin", "category_aro_description": "Erythromycin is a macrolide antibiotic with a 14-carbon ring that has an antimicrobial spectrum similar to or slightly wider than that of penicillin, and is often used for people that have an allergy to penicillins. Erythromycin may possess bacteriocidal activity, particularly at higher concentrations by binding to the 50S subunit of the bacterial 70S rRNA complex, inhibiting peptidyl-tRNA translocation. Thus, protein synthesis and subsequently structure/function processes critical for life or replication are inhibited.", "category_aro_class_name": "Antibiotic"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "36308": {"category_aro_accession": "3000169", "category_aro_cvterm_id": "36308", "category_aro_name": "rifampin", "category_aro_description": "Rifampin is a semi-synthetic rifamycin, and inhibits RNA synthesis by binding to RNA polymerase. Rifampin is the mainstay agent for the treatment of tuberculosis, leprosy and complicated Gram-positive infections.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "36296": {"category_aro_accession": "3000157", "category_aro_cvterm_id": "36296", "category_aro_name": "rifamycin antibiotic", "category_aro_description": "Rifamycin antibiotics are a group of broad-spectrum ansamycin antibiotics that inhibit bacterial RNA polymerase by binding to a highly conserved region, blocking the oligonucleotide exit tunnel, and preventing the extension of nascent mRNAs.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.88433e-17, "max_identities": 66, "bit_score": 79.337, "cvterm_id": "35918", "query": "STQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRP-----NELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKIL", "match": "+T+  +    VT  Y  G  + P +R V+ +  PGE ++  G +GSGK+T + LI      S G + +DG + K   E +L+ LR + IG+I Q   L+   ++  N+ +       L   ER   +    E V  +      P        SGGQ+QR+A+ARA++  P++ + D+  + LD  T  N+   +K+    E T  I +     +M HA+ +V L +G ++", "sequence_from_db": "ATKGYLEFKNVTFAYP-GHAESPVIRNVSFKASPGETVAFIGSTGSGKSTLIQLIPRFYDVSEGEILIDGVNVK---EYKLSALR-NKIGYIPQK-ALLFTGTIADNLRYG-KEDATLEEMERAIDIAQATEFVSQKPQGYDEPLSEGGTNFSGGQKQRLAIARAIIRNPEIYIFDDSFSALDYQTDANLRARLKK-ETTESTVLIVAQRVGTIM-HADRIVVLNEGDVV", "sequence_from_broadstreet": "MKLMWRYTMRYKKLLFADFICVFGFILIELGLPTILARMIDKGIIPKDMDYVYQQGIWMVVITIIGVAMNILLGYFGARITTNIVRDIRDDLFEKIQTFSHSEYESIGVSSLITRTTNDAYQIMLFMGNILRLGFMTPVMFIASLYMVMRTSPSLGMYVLGALPFLLLAVVGIARLSEPLSKKQQKNLDGINGILRENLSGLRVIRAFVNEKFEESRFNKVNETYTKSSKSLFRLMAAAQPGFFFLFNIVMVLIIWSGTVQISHGDLEVGNLIAFIEYIFHALFSFMLFASVFMMYPRAAVSASRIQEALDMEPAIREEEGVTETATKGYLEFKNVTFAYPGHAESPVIRNVSFKASPGETVAFIGSTGSGKSTLIQLIPRFYDVSEGEILIDGVNVKEYKLSALRNKIGYIPQKALLFTGTIADNLRYGKEDATLEEMERAIDIAQATEFVSQKPQGYDEPLSEGGTNFSGGQKQRLAIARAIIRNPEIYIFDDSFSALDYQTDANLRARLKKETTESTVLIVAQRVGTIMHADRIVVLNEGDVVGIGTHRELLETCPIYYDIAASQLSEEELA", "dna_sequence_from_broadstreet": "TTGAAGTTAATGTGGCGTTACACAATGCGTTATAAGAAATTACTTTTCGCTGATTTTATTTGTGTGTTTGGTTTTATTTTGATTGAATTAGGCTTGCCGACCATTTTAGCACGAATGATTGACAAAGGAATTATTCCTAAAGATATGGACTATGTTTATCAGCAAGGGATTTGGATGGTTGTAATTACGATTATTGGTGTCGCAATGAATATTTTGCTAGGGTACTTTGGTGCCAGAATTACAACAAACATTGTTCGTGATATTCGTGATGATTTATTTGAAAAGATTCAAACTTTCTCACACAGTGAATATGAAAGTATTGGGGTTTCTTCCTTAATTACGCGAACTACCAATGATGCATACCAAATTATGCTCTTCATGGGAAATATTTTACGTCTTGGCTTTATGACGCCAGTGATGTTTATTGCCAGTCTTTACATGGTGATGCGGACGAGTCCGTCGTTAGGAATGTACGTTTTAGGTGCCTTGCCTTTTCTACTGCTAGCAGTTGTCGGAATTGCTCGTTTGTCAGAACCGTTATCTAAAAAGCAACAAAAGAACTTAGATGGAATCAATGGGATTTTAAGAGAAAATCTTTCTGGATTGCGGGTAATACGCGCATTTGTTAATGAAAAATTTGAAGAATCTCGTTTTAATAAAGTCAATGAAACTTACACTAAAAGTTCAAAAAGCCTGTTTCGTTTAATGGCAGCAGCCCAACCAGGGTTCTTTTTCTTATTTAATATTGTAATGGTCTTAATCATTTGGAGCGGGACTGTTCAAATCAGCCATGGGGATTTAGAAGTTGGGAATTTAATAGCTTTTATTGAATATATTTTCCATGCGCTGTTCTCGTTTATGTTATTTGCCAGTGTCTTTATGATGTATCCGCGGGCTGCGGTTTCGGCTTCGCGGATTCAAGAAGCCTTAGACATGGAACCAGCTATTCGTGAAGAAGAAGGCGTAACAGAAACAGCTACTAAAGGCTATCTAGAGTTTAAAAATGTAACCTTTGCCTATCCTGGACATGCGGAAAGCCCAGTCATCCGCAATGTAAGTTTTAAGGCGTCACCTGGTGAAACAGTGGCCTTTATTGGGAGCACAGGTAGTGGGAAATCAACATTAATTCAATTGATTCCACGGTTTTATGATGTATCAGAAGGTGAAATTTTAATCGATGGAGTGAACGTAAAAGAGTACAAACTTAGTGCATTACGCAATAAGATTGGCTATATTCCACAAAAAGCGTTACTTTTTACTGGTACAATTGCTGATAACCTTCGCTACGGTAAGGAAGATGCGACGTTAGAAGAAATGGAACGAGCAATTGACATTGCTCAAGCTACAGAATTTGTTTCACAAAAACCGCAAGGCTATGATGAACCTCTTTCAGAAGGTGGCACGAACTTTTCTGGTGGTCAAAAACAACGTTTAGCTATCGCACGGGCGATTATTCGCAATCCGGAAATTTATATATTTGATGATAGTTTTTCTGCGTTAGATTATCAAACAGATGCAAATTTACGAGCGCGTCTGAAAAAAGAAACAACAGAATCCACTGTTTTAATTGTGGCACAACGTGTTGGAACAATTATGCATGCGGACCGCATTGTTGTTTTAAACGAAGGCGACGTGGTCGGAATTGGCACACATCGTGAATTACTTGAGACTTGTCCAATTTACTATGATATTGCGGCTTCTCAATTGTCAGAGGAGGAATTAGCATGA", "partial": "0", "query_start": 51346, "query_end": 52020, "hit_start": 975, "hit_end": 1638, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 28.7}, "gnl|BL_ORD_ID|2309|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "tetB(46)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1150", "model_id": "2644", "ARO_accession": "3004033", "ARO_name": "tetB(46)", "ARO_category": {"36002": {"category_aro_accession": "0010001", "category_aro_cvterm_id": "36002", "category_aro_name": "ATP-binding cassette (ABC) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. ATP-binding cassette (ABC) transporters are present in all cells of all organisms and use the energy of ATP binding/hydrolysis to transport substrates across cell membranes.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.10216e-17, "max_identities": 69, "bit_score": 78.1814, "cvterm_id": "41065", "query": "VSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVG-------LEKHAKH----RPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGG", "match": "V   +V   Y  GK   P L+ ++++ +PG+ +++ G +GSGK++ +NL+        G + +DGQ+ +  +      LR H +G + Q   L +  ++  NV      Q  ++    R  V   L++VG       LEK   H    + +  S G+RQ ++ AR L   P++++ DE T+++D+ T + I   M  L +K  TTFI + H    +  A+ ++ L++G+I++R      Q    V+ GG", "sequence_from_db": "VVFDDVQFAYEEGK---PVLKDISIQAHPGQTLALVGHTGSGKSSIMNLLYRFYDPQEGEIRIDGQNIRHFSRES---LRSH-MGIVLQDPYLFTG-TIASNVAMS---QEHID----RNAVKDALKKVGAWPFVERLEKGIDHPVVEKGSAFSSGERQLISFARTLYMNPQILILDEATSHIDTETEEIIQKAMAVL-QKGRTTFIIA-HRLSTIQDADQILVLSEGRIVER-----GQHADLVAHGG", "sequence_from_broadstreet": "MKVLKRLLSRITLYPTVFLAGFICLLLATIFSELSPFLLQKMIDGPLTALTHGGGQGDLLQMGGFYLLVLSLGQLISYMGNRILLHGSNQVTASLRDQAFQVMQGLPISYFDDKPAGKIATRIVNDTETLRTQFYNSCMILVIYLVRFLFILGILFYLSPMMGLLLCLVFPIFYGIQYLYKVMTDQPMKDFFDARSEVNTQVNELLHGASMIQLYHQEPGVVEEFEATTQKMLGANDRILLADSIASWTLTELLKFLVIAGILTIAGISFLQGNIGVTAGFLFININYVINLFDLMANLSRQFPNIRRSLETGSRVLAFLDQPLEADGALELKIEKAEVVFDDVQFAYEEGKPVLKDISIQAHPGQTLALVGHTGSGKSSIMNLLYRFYDPQEGEIRIDGQNIRHFSRESLRSHMGIVLQDPYLFTGTIASNVAMSQEHIDRNAVKDALKKVGAWPFVERLEKGIDHPVVEKGSAFSSGERQLISFARTLYMNPQILILDEATSHIDTETEEIIQKAMAVLQKGRTTFIIAHRLSTIQDADQILVLSEGRIVERGQHADLVAHGGIYAQMQAIQQTVE", "dna_sequence_from_broadstreet": "ATGAAAGTATTGAAACGATTATTATCTAGGATCACGCTTTATCCAACTGTCTTTCTTGCTGGCTTCATTTGCCTCTTACTAGCCACCATTTTTTCTGAATTGTCTCCCTTTCTTCTCCAAAAGATGATCGATGGGCCTTTGACTGCATTGACCCACGGTGGAGGACAAGGGGACTTGCTTCAGATGGGAGGATTCTATCTCTTGGTCTTGAGCCTGGGGCAGCTGATTAGCTACATGGGCAATCGGATCTTGCTACATGGAAGTAATCAAGTAACCGCTAGTCTGAGAGACCAAGCCTTTCAAGTCATGCAAGGGCTGCCTATTTCTTATTTTGATGATAAGCCGGCTGGGAAGATCGCGACAAGAATTGTCAATGATACGGAGACCTTGAGGACCCAGTTTTATAACTCTTGTATGATTTTAGTCATCTATTTGGTACGCTTTCTCTTTATCCTAGGGATTCTCTTTTACCTGAGTCCTATGATGGGCCTTCTCTTGTGTTTGGTCTTTCCGATTTTCTATGGGATCCAGTATCTCTACAAGGTCATGACGGACCAGCCTATGAAGGATTTCTTTGATGCGCGAAGCGAGGTCAATACCCAGGTCAATGAACTCTTGCACGGTGCTAGTATGATTCAGCTCTATCATCAAGAGCCTGGTGTGGTGGAGGAGTTTGAAGCCACTACCCAGAAGATGTTAGGAGCAAATGATCGAATCCTCTTAGCCGATTCTATCGCTTCTTGGACCTTGACGGAATTGCTCAAGTTTTTAGTGATTGCAGGCATTTTGACTATCGCTGGGATTTCTTTCCTACAGGGTAATATCGGTGTGACGGCTGGTTTCTTATTTATCAATATTAACTATGTGATTAATCTATTTGATCTCATGGCCAATCTTAGTCGTCAATTCCCAAATATTCGGCGATCCTTAGAAACGGGGAGCCGCGTCCTTGCCTTCTTAGACCAACCGTTAGAGGCCGATGGTGCATTGGAACTGAAGATAGAAAAGGCAGAGGTCGTGTTTGACGACGTTCAATTTGCCTATGAAGAAGGTAAGCCAGTTCTGAAGGATATTTCCATCCAAGCCCATCCAGGTCAAACCCTTGCCTTGGTTGGCCATACTGGTTCGGGTAAATCCTCCATTATGAACTTGCTCTATCGTTTCTATGATCCGCAGGAGGGAGAAATTCGGATCGACGGCCAGAATATTCGCCATTTCTCTAGAGAGAGTCTTCGCTCCCACATGGGCATTGTTCTACAAGATCCTTATCTATTTACAGGAACCATTGCTAGTAATGTGGCCATGAGTCAGGAACACATTGATCGGAATGCGGTCAAAGATGCCTTGAAAAAAGTCGGAGCATGGCCCTTTGTAGAGCGTCTTGAAAAGGGAATCGACCATCCAGTTGTAGAAAAAGGATCGGCCTTTTCAAGTGGCGAACGCCAGTTGATTTCCTTTGCGAGGACGCTCTATATGAATCCGCAAATTCTGATTTTGGATGAGGCAACCTCTCACATCGATACGGAAACAGAAGAAATCATCCAGAAAGCTATGGCTGTCCTGCAAAAGGGCCGGACCACCTTTATCATTGCCCATCGCTTGTCGACTATCCAAGATGCGGATCAGATCTTGGTTCTATCAGAAGGGCGCATTGTCGAACGTGGGCAACATGCAGACTTAGTTGCCCATGGTGGCATCTACGCCCAGATGCAAGCTATCCAACAGACGGTTGAATAA", "partial": "0", "query_start": 51361, "query_end": 52074, "hit_start": 1014, "hit_end": 1695, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 27.71}, "gnl|BL_ORD_ID|1907|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "patA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "2081", "ARO_accession": "3000024", "ARO_name": "patA", "ARO_category": {"36002": {"category_aro_accession": "0010001", "category_aro_cvterm_id": "36002", "category_aro_name": "ATP-binding cassette (ABC) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. ATP-binding cassette (ABC) transporters are present in all cells of all organisms and use the energy of ATP binding/hydrolysis to transport substrates across cell membranes.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.6397e-17, "max_identities": 66, "bit_score": 77.411, "cvterm_id": "40078", "query": "VSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNAS----ERRTRVMTLLEQV-----GLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKE-LNRK-EGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAE", "match": "+S   VT TY + K   P L+ V+  + PG+ + + G +G+GK+T   LI  +     G + + G+D ++++E  L      T+  + Q   L S  ++  N     L Q K NA+    ER   +    E +       E   + R    SGGQ+QR+++AR +V+ P++++ D+ T+ LD+ + +    L++E LN+  +GTT I        + HA+ ++ L  G+++ + T A+", "sequence_from_db": "LSFENVTFTYPMDKE--PMLKDVSFTIEPGQMVGVVGATGAGKSTLAQLIPRLFDPQDGAIKIGGKDIREVSEGTLR----KTVSIVLQRAILFSG-TIADN-----LRQGKGNATLFEMERAANIAQASEFIHRMEKTFESPVEERGTNFSGGQKQRMSIARGIVSNPRILIFDDSTSALDAKSER----LVQEALNKDLKGTTTIIIAQKISSVVHADKILVLNQGRLIGQGTHAD", "sequence_from_broadstreet": "MLIQKIKTYKWQALASLLMTGLMVASSLLQPRYLQEVLGALLTGKYEAIYSIGAWLIGVAVVGLVAGGLNVVLAAYIAQGVSSDLREDAFRKIQTFSYADIEQFNAGNLVVRMTNDINQIQNVVMMTFQILFRLPLLFIGSFILAVQTLPSLWWVIVLMVVLIFGLTAVMMGMMGPRFAKFQTLLERINAIAKENLRGVRVVKSFVQEKEQFAKFTEVSDELLGQNLYIGYAFSVVEPFMMLVGYGAVFLSIWLVAGMVQSDPSVVGSIASFVNYLSQIIFTIVMVGFLGNSVSRAMISMRRIREILDAEPAMTFKDIPDEELVGSLSFENVTFTYPMDKEPMLKDVSFTIEPGQMVGVVGATGAGKSTLAQLIPRLFDPQDGAIKIGGKDIREVSEGTLRKTVSIVLQRAILFSGTIADNLRQGKGNATLFEMERAANIAQASEFIHRMEKTFESPVEERGTNFSGGQKQRMSIARGIVSNPRILIFDDSTSALDAKSERLVQEALNKDLKGTTTIIIAQKISSVVHADKILVLNQGRLIGQGTHADLVANNAVYREIYETQK", "dna_sequence_from_broadstreet": "ATGCTGATTCAGAAAATAAAAACCTACAAGTGGCAGGCCCTGGCTTCGCTCCTGATGACAGGCTTGATGGTTGCTAGTTCACTTCTGCAACCGCGTTATCTGCAGGAAGTCTTAGGCGCCCTCCTTACTGGGAAATATGAAGCTATTTATAGTATCGGGGCTTGGTTGATTGGTGTGGCCGTAGTCGGTCTAGTTGCTGGTGGACTCAATGTTGTCCTCGCAGCCTATATTGCCCAAGGAGTTTCATCCGACCTTCGGGAGGATGCCTTCCGTAAAATTCAAACCTTTTCTTATGCTGATATTGAACAATTTAATGCGGGAAATCTAGTCGTTCGAATGACAAATGATATCAACCAGATTCAGAACGTTGTCATGATGACCTTCCAAATTCTTTTCAGACTTCCCCTCTTGTTCATCGGTTCGTTTATCCTAGCGGTTCAAACCTTACCTTCTCTGTGGTGGGTGATTGTTCTCATGGTAGTCTTGATTTTTGGTTTGACTGCTGTCATGATGGGAATGATGGGGCCTCGTTTTGCCAAGTTTCAAACCCTTCTTGAGCGCATCAATGCCATTGCCAAGGAAAATTTACGTGGCGTTCGTGTGGTCAAGTCCTTTGTCCAAGAAAAAGAGCAATTTGCTAAGTTTACAGAGGTCTCAGACGAGCTTCTTGGTCAAAACCTTTACATTGGTTATGCCTTTTCAGTAGTGGAACCCTTTATGATGTTGGTTGGTTACGGGGCGGTCTTCCTCTCTATTTGGCTGGTCGCGGGAATGGTTCAGTCGGATCCGTCTGTTGTTGGTTCCATCGCTTCTTTTGTTAATTACCTAAGCCAGATTATCTTTACCATTGTTATGGTTGGATTTTTGGGAAATTCTGTCAGCCGTGCCATGATTTCCATGCGTCGTATTCGAGAAATTCTTGACGCAGAGCCAGCTATGACCTTCAAGGATATCCCAGATGAAGAGTTGGTTGGAAGTCTTAGCTTTGAAAATGTGACCTTTACCTATCCAATGGACAAGGAACCGATGCTGAAAGATGTGAGCTTTACTATTGAACCTGGTCAAATGGTTGGTGTAGTTGGAGCGACTGGTGCAGGAAAGTCAACCTTGGCTCAATTGATTCCACGTCTCTTTGATCCACAGGACGGGGCCATTAAAATCGGTGGCAAGGATATTCGAGAAGTGAGTGAAGGAACCCTGCGTAAAACAGTTTCCATCGTTCTCCAACGTGCCATTCTTTTTAGTGGAACGATTGCAGATAACTTGAGACAGGGGAAGGGGAATGCTACTCTATTTGAAATGGAGCGCGCAGCCAATATTGCCCAGGCTAGTGAATTCATTCATCGTATGGAGAAAACCTTTGAAAGTCCAGTTGAAGAACGGGGAACCAATTTCTCTGGTGGACAAAAACAAAGGATGTCGATTGCGCGTGGGATTGTCAGCAATCCACGTATTCTGATTTTTGATGATTCGACCTCAGCCTTGGATGCCAAATCAGAGCGCTTGGTGCAAGAAGCTTTGAATAAGGACTTGAAGGGGACGACAACCATTATTATTGCTCAAAAAATTAGCTCGGTTGTCCATGCAGACAAGATCTTGGTTCTAAATCAAGGACGATTGATTGGTCAAGGTACGCATGCAGACTTGGTTGCCAACAATGCCGTTTACCGTGAAATCTATGAAACACAGAAATGA", "partial": "0", "query_start": 51361, "query_end": 52041, "hit_start": 978, "hit_end": 1644, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 27.73}, "gnl|BL_ORD_ID|315|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "bcrA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "570", "model_id": "345", "ARO_accession": "3002987", "ARO_name": "bcrA", "ARO_category": {"36002": {"category_aro_accession": "0010001", "category_aro_cvterm_id": "36002", "category_aro_name": "ATP-binding cassette (ABC) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. ATP-binding cassette (ABC) transporters are present in all cells of all organisms and use the energy of ATP binding/hydrolysis to transport substrates across cell membranes.", "category_aro_class_name": "AMR Gene Family"}, "35959": {"category_aro_accession": "0000041", "category_aro_cvterm_id": "35959", "category_aro_name": "bacitracin", "category_aro_description": "Bacitracin is a mixture of related cyclic polypeptides produced by organisms of the licheniformis group of Bacillus subtilis var Tracy. Bacitracin interferes with the dephosphorylation of the C55-isoprenyl pyrophosphate, a molecule which carries the building blocks of the peptidoglycan bacterial cell wall outside of the inner membrane.", "category_aro_class_name": "Antibiotic"}, "36973": {"category_aro_accession": "3000629", "category_aro_cvterm_id": "36973", "category_aro_name": "bacitracin A", "category_aro_description": "Bacitracin A is the primary component of bacitracin. It contains many uncommon amino acids and interferes with bacterial cell wall synthesis.", "category_aro_class_name": "Antibiotic"}, "36974": {"category_aro_accession": "3000630", "category_aro_cvterm_id": "36974", "category_aro_name": "bacitracin B", "category_aro_description": "Bacitracin B is a component of bacitracin, an antibiotic mixture that interferes with bacterial cell wall synthesis. It differs from Bacitracin A with a valine instead of an isoleucine in its peptide.", "category_aro_class_name": "Antibiotic"}, "36975": {"category_aro_accession": "3000631", "category_aro_cvterm_id": "36975", "category_aro_name": "bacitracin F", "category_aro_description": "Bacitracin F is a component of bacitracin, an antibiotic mixture that interferes with bacterial cell wall synthesis. It is formed when the thiazoline ring of bacitracin A is oxidatively deaminated.", "category_aro_class_name": "Antibiotic"}, "36192": {"category_aro_accession": "3000053", "category_aro_cvterm_id": "36192", "category_aro_name": "peptide antibiotic", "category_aro_description": "Peptide antibiotics have a wide range of antibacterial mechanisms, depending on the amino acids that make up the antibiotic, although most act to disrupt the cell membrane in some manner. Subclasses of peptide antibiotics can include additional sidechains of other types, such as lipids in the case of the lipopeptide antibiotics.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.90044e-16, "max_identities": 59, "bit_score": 73.559, "cvterm_id": "36834", "query": "IVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHD-AKVMTHANAVVRLADGKILDRI", "match": "I+  T++TK Y   K    ++  + + V  G+     G +G+GKTT + ++  +   +SG + + G++  K  ++++    L  IG I +     + L+  +N    LL+  K+    ++  +  +LE VGL+   K    + S G +QR+ +ARAL+  P+L++ DEPT  LD +  + +  L+  L ++   T   S+H  +++    + V  + +GK+L+ I", "sequence_from_db": "IIKTTDLTKMYGSQK----SVDHLNINVKQGDIYGFLGRNGAGKTTTIRMLLGLIKPTSGQIEIFGENFFK-NKKEI----LRRIGSIVEVPGFYANLTAREN----LLINAKIIGIHKKNAIDEVLEIVGLQHETKKLVGKFSLGMKQRLGIARALLHYPELLILDEPTNGLDPIGIKEMRRLIHSLAKERNITIFISSHILSEIEQLVDHVGIIHEGKLLEEI", "sequence_from_broadstreet": "MSTIIKTTDLTKMYGSQKSVDHLNINVKQGDIYGFLGRNGAGKTTTIRMLLGLIKPTSGQIEIFGENFFKNKKEILRRIGSIVEVPGFYANLTARENLLINAKIIGIHKKNAIDEVLEIVGLQHETKKLVGKFSLGMKQRLGIARALLHYPELLILDEPTNGLDPIGIKEMRRLIHSLAKERNITIFISSHILSEIEQLVDHVGIIHEGKLLEEIPFDHLKKRNRKYLEFQLSDQNKAVVLMEQHFDIHDYEVHQDGIIRVYSHLGQQGKLNKLFVENGIDVLKITMSEDSLEDYFVKLIGGGTIG", "dna_sequence_from_broadstreet": "TTGAGCACAATTATTAAAACGACGGATCTCACGAAAATGTACGGGTCGCAAAAGTCTGTAGACCATCTCAATATCAATGTAAAACAAGGAGATATATACGGCTTTTTGGGACGGAACGGCGCCGGCAAAACGACGACGATCAGAATGCTGCTGGGTCTGATCAAACCGACCAGTGGGCAGATAGAAATTTTCGGAGAAAATTTTTTCAAGAATAAAAAAGAAATTTTAAGAAGAATCGGATCTATCGTGGAAGTGCCCGGCTTTTACGCGAACTTGACGGCGAGGGAAAACCTGCTGATCAATGCGAAAATCATAGGTATCCATAAAAAAAATGCGATCGATGAAGTATTGGAGATCGTGGGCCTGCAGCATGAAACGAAAAAGCTCGTCGGCAAGTTTTCCTTGGGCATGAAACAAAGGCTGGGAATTGCAAGAGCCTTGCTTCACTATCCGGAGCTGTTGATACTGGACGAGCCGACAAACGGCTTGGACCCGATCGGGATCAAAGAAATGAGAAGACTCATTCATTCTCTCGCCAAAGAAAGAAACATCACCATCTTTATATCAAGCCACATTTTGTCTGAAATCGAACAGCTCGTCGATCATGTCGGGATCATTCATGAAGGAAAACTGCTTGAAGAAATTCCGTTTGACCATCTTAAAAAAAGAAACCGCAAATATCTGGAATTTCAATTATCCGATCAAAATAAAGCGGTCGTTCTGATGGAACAGCATTTTGATATTCATGACTACGAAGTTCACCAGGACGGGATCATCCGGGTATACTCCCATTTGGGCCAGCAGGGAAAGCTCAATAAATTGTTTGTCGAAAACGGAATAGACGTATTGAAGATTACGATGAGCGAAGACAGTCTTGAAGACTACTTCGTGAAGTTGATAGGGGGCGGGACGATTGGCTAA", "partial": "0", "query_start": 51358, "query_end": 52029, "hit_start": 9, "hit_end": 645, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 26.22}, "gnl|BL_ORD_ID|2183|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "efrB", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "710", "model_id": "2422", "ARO_accession": "3003949", "ARO_name": "efrB", "ARO_category": {"36002": {"category_aro_accession": "0010001", "category_aro_cvterm_id": "36002", "category_aro_name": "ATP-binding cassette (ABC) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. ATP-binding cassette (ABC) transporters are present in all cells of all organisms and use the energy of ATP binding/hydrolysis to transport substrates across cell membranes.", "category_aro_class_name": "AMR Gene Family"}, "35925": {"category_aro_accession": "0000006", "category_aro_cvterm_id": "35925", "category_aro_name": "erythromycin", "category_aro_description": "Erythromycin is a macrolide antibiotic with a 14-carbon ring that has an antimicrobial spectrum similar to or slightly wider than that of penicillin, and is often used for people that have an allergy to penicillins. Erythromycin may possess bacteriocidal activity, particularly at higher concentrations by binding to the 50S subunit of the bacterial 70S rRNA complex, inhibiting peptidyl-tRNA translocation. Thus, protein synthesis and subsequently structure/function processes critical for life or replication are inhibited.", "category_aro_class_name": "Antibiotic"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "36308": {"category_aro_accession": "3000169", "category_aro_cvterm_id": "36308", "category_aro_name": "rifampin", "category_aro_description": "Rifampin is a semi-synthetic rifamycin, and inhibits RNA synthesis by binding to RNA polymerase. Rifampin is the mainstay agent for the treatment of tuberculosis, leprosy and complicated Gram-positive infections.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "36296": {"category_aro_accession": "3000157", "category_aro_cvterm_id": "36296", "category_aro_name": "rifamycin antibiotic", "category_aro_description": "Rifamycin antibiotics are a group of broad-spectrum ansamycin antibiotics that inhibit bacterial RNA polymerase by binding to a highly conserved region, blocking the oligonucleotide exit tunnel, and preventing the extension of nascent mRNAs.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.93404e-15, "max_identities": 45, "bit_score": 71.633, "cvterm_id": "36779", "query": "PALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASE-------RRTRVMTLLEQV--GLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDS", "match": "P +R +  +V  G+ ++I GP+G+GKTT +NL+      + G + +DG DTKK+    +  +     G + Q   L    ++  N+ F      KL+A++       +   V   +  +  G E       + +S GQ+Q + +ARA+++ PK+++ DE T+++D+", "sequence_from_db": "PLIRNLNFKVDAGQMVAIVGPTGAGKTTLINLLMRFYDVTEGAIKIDGIDTKKMNRSDVRSV----FGMVLQDAWLYKG-TIADNIRFG-----KLDATDYEVVDAAKTANVDHFIRTMPDGYEMEINSEGDNVSLGQKQLLTIARAVISDPKILILDEATSSVDT", "sequence_from_broadstreet": "LDTCRIFRRNAKSPVNIAKHAKFIRRLKWLCSENMTGFSVLKLYVRKKKPLKGFKQVNHRFKWFGFKASFISGLMLPLVQMTAYGTYIGVAVLGSYYVVAGVIVVGQLQAFIQYIWQISQPMGNITQLSAALQSASASTMRIFEILDEPEEELNEQDVPLPEPILGSVEFENVSFSYDPEKPLIRNLNFKVDAGQMVAIVGPTGAGKTTLINLLMRFYDVTEGAIKIDGIDTKKMNRSDVRSVFGMVLQDAWLYKGTIADNIRFGKLDATDYEVVDAAKTANVDHFIRTMPDGYEMEINSEGDNVSLGQKQLLTIARAVISDPKILILDEATSSVDTRLEALIQKAMDRVMEGRTSFVIAHR", "dna_sequence_from_broadstreet": "TTAGATACGTGTCGCATATTCAGGAGGAATGCTAAATCACCAGTAAATATTGCAAAGCATGCAAAATTCATTAGGAGACTTAAATGGTTATGTTCAGAAAATATGACTGGGTTCAGTGTCTTAAAACTATATGTTCGGAAAAAGAAACCCTTGAAAGGCTTTAAACAAGTCAATCATCGTTTTAAATGGTTTGGCTTCAAAGCATCCTTTATCTCAGGATTAATGTTGCCATTGGTTCAAATGACCGCTTATGGGACCTATATCGGGGTAGCTGTCCTTGGTAGTTACTATGTGGTTGCTGGTGTGATCGTAGTGGGGCAGTTACAAGCGTTTATTCAATATATTTGGCAAATTAGCCAACCAATGGGGAATATTACGCAGTTGTCTGCAGCTTTACAAAGCGCTTCAGCTTCGACCATGCGGATTTTTGAAATCCTAGATGAACCAGAAGAAGAACTTAACGAACAAGATGTTCCTTTGCCAGAACCTATTTTAGGCTCTGTTGAATTTGAAAATGTCAGCTTTAGTTATGACCCAGAAAAACCGTTAATTCGTAATTTGAACTTTAAAGTTGATGCGGGCCAAATGGTTGCGATTGTGGGACCAACTGGCGCTGGGAAAACAACCTTAATCAACTTACTGATGCGTTTTTATGATGTAACAGAAGGCGCCATTAAAATTGATGGTATTGACACAAAAAAAATGAACCGTAGTGATGTCCGATCTGTATTTGGAATGGTATTGCAAGATGCTTGGTTGTATAAAGGTACCATTGCAGATAACATTCGTTTTGGGAAGTTGGATGCCACGGATTATGAAGTTGTCGATGCAGCGAAAACGGCCAATGTGGATCACTTCATTCGGACAATGCCAGATGGGTATGAAATGGAAATCAATTCTGAGGGAGATAACGTTTCCCTTGGTCAAAAACAATTGTTGACCATTGCCCGAGCGGTAATTTCTGATCCGAAAATTTTGATTTTAGATGAGGCGACTAGTTCAGTCGATACACGCTTGGAAGCCTTAATTCAAAAAGCAATGGATCGTGTTATGGAAGGACGAACGAGTTTCGTTATTGCCCACCGT", "partial": "1", "query_start": 51412, "query_end": 51882, "hit_start": 543, "hit_end": 1011, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 27.11}, "gnl|BL_ORD_ID|1112|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "novA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1190", "model_id": "1210", "ARO_accession": "3002522", "ARO_name": "novA", "ARO_category": {"36002": {"category_aro_accession": "0010001", "category_aro_cvterm_id": "36002", "category_aro_name": "ATP-binding cassette (ABC) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. ATP-binding cassette (ABC) transporters are present in all cells of all organisms and use the energy of ATP binding/hydrolysis to transport substrates across cell membranes.", "category_aro_class_name": "AMR Gene Family"}, "36250": {"category_aro_accession": "3000111", "category_aro_cvterm_id": "36250", "category_aro_name": "novobiocin", "category_aro_description": "Novobiocin is an aminocoumarin antibiotic produced by Streptomyces spheroides and Streptomyces niveus, and binds DNA gyrase subunit B inhibiting ATP-dependent DNA supercoiling.", "category_aro_class_name": "Antibiotic"}, "36242": {"category_aro_accession": "3000103", "category_aro_cvterm_id": "36242", "category_aro_name": "aminocoumarin antibiotic", "category_aro_description": "Aminocoumarin antibiotics bind DNA gyrase subunit B to inhibit ATP-dependent DNA supercoiling.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.62089e-14, "max_identities": 61, "bit_score": 69.3218, "cvterm_id": "39503", "query": "LRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPL------LLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAE", "match": "L G+ L V  G  +++ GP+GSGK+T   L+  +   + G V +DG D + L    L       +G + Q   L    SV  N+ F         +++   A++    ++TL +  G +     R    SGG++QR+A+AR ++  P +++ DE T+ LD+ T   +   +  L+  EG T I   H    +  A+ +V L  G+I +R T  E", "sequence_from_db": "LHGLDLTVPAGGSLAVVGPTGSGKSTLSYLVPRLYDVTGGRVLLDGVDVRDLAFDTLAR----AVGVVSQETYLFHA-SVADNLRFAKPDATDEEIEKAARAAQIHEHIVTLPD--GYDTLVGERGYRFSGGEKQRLAIARTILRDPPVLVLDEATSALDTRTEHAVQQAIDSLS--EGRTTITIAHRLSTVRDADQIVVLDAGRIAERGTHEE", "sequence_from_broadstreet": "MKSALSTWKPSDRPPDPTLPEPPAQLRRIFRLFRPYRGRLAVVGLLVGASSLVAVASPFMLREILDTAIPQGRTGLLSLLALGMILTAVLSSVFGVVQTLISTTVGQRVMHDLRTAVYAQLQRMPLAFFTRTRTGEVQSRIANDIGGMQATVTSTATSLVSNLTAVIATVVAMLALDWRLTVVSLLLLPVFVWISRRVGRERKRITLQRQKQMATMAATVTESLSVSGILLGRTMGRADSLTRSFAEESERLVDLEVRSNMAGRWRMSVIGIVMAAMPAVIYWAAGFVLQSGGTVVSIGTLVAFVSLQQGLFRPAVSLLATGVQMQTSLALFQRIFEYLDLPVDITEPERPVALDKVRGEVRFDGVDFSYEEKDGNTLHGLDLTVPAGGSLAVVGPTGSGKSTLSYLVPRLYDVTGGRVLLDGVDVRDLAFDTLARAVGVVSQETYLFHASVADNLRFAKPDATDEEIEKAARAAQIHEHIVTLPDGYDTLVGERGYRFSGGEKQRLAIARTILRDPPVLVLDEATSALDTRTEHAVQQAIDSLSEGRTTITIAHRLSTVRDADQIVVLDAGRIAERGTHEELIDRDGRYAALVRRDGAPAPAPVPARDERVGAA", "dna_sequence_from_broadstreet": "ATGAAGTCCGCACTCTCGACCTGGAAGCCCTCGGACCGGCCGCCGGATCCGACACTGCCCGAGCCGCCGGCCCAGCTGCGCCGCATCTTCCGGCTCTTCCGCCCGTACCGCGGCAGGCTCGCCGTCGTCGGCCTGCTCGTCGGCGCCTCGTCGCTGGTGGCCGTCGCCTCGCCGTTCATGCTGCGCGAGATCCTCGACACCGCGATCCCGCAGGGCCGCACCGGGCTGCTCAGCCTGCTCGCCCTCGGCATGATCCTGACCGCCGTCCTCAGCAGCGTCTTCGGCGTCGTCCAGACCCTCATCTCCACGACGGTCGGCCAGCGCGTCATGCACGACCTGCGCACCGCCGTCTACGCGCAGCTCCAGCGCATGCCCCTCGCGTTCTTCACCCGCACCCGCACCGGTGAGGTCCAGTCCCGGATAGCCAACGACATCGGCGGCATGCAGGCGACCGTCACCTCAACCGCCACGTCGCTGGTCTCCAACCTCACCGCCGTCATCGCCACCGTCGTCGCGATGCTCGCGCTGGACTGGCGGCTGACCGTCGTCTCGCTGCTCCTGCTGCCGGTGTTCGTCTGGATCAGCCGCCGCGTCGGCCGTGAGCGCAAACGGATCACCCTGCAACGGCAGAAGCAGATGGCCACGATGGCCGCCACGGTCACGGAGTCGCTGTCGGTCAGCGGCATCCTCCTCGGCCGCACGATGGGGCGCGCCGACTCGCTCACCAGATCCTTCGCCGAGGAGTCCGAGCGACTCGTCGACCTGGAGGTCCGCTCCAACATGGCCGGGCGGTGGCGGATGTCCGTCATCGGCATCGTCATGGCCGCCATGCCCGCCGTCATCTACTGGGCGGCCGGCTTCGTCCTCCAGTCCGGCGGCACGGTCGTCTCCATCGGCACACTCGTCGCCTTCGTCTCCCTCCAGCAGGGCCTCTTCCGCCCGGCCGTGAGCCTGCTCGCCACCGGCGTGCAGATGCAGACGTCCCTCGCGCTCTTCCAGCGCATCTTCGAATATCTCGACCTGCCCGTCGACATCACCGAACCCGAGCGTCCGGTGGCCCTCGACAAGGTCCGGGGCGAAGTGCGCTTCGACGGCGTCGACTTCAGTTACGAGGAGAAGGACGGCAACACCCTCCACGGCCTGGATCTGACCGTCCCGGCCGGCGGCAGCCTCGCCGTCGTCGGTCCCACCGGATCGGGCAAGTCGACCCTGAGCTATCTCGTGCCGCGTCTGTACGACGTGACGGGCGGCCGGGTCCTGCTCGACGGCGTCGACGTACGCGACCTGGCCTTCGACACCCTCGCCCGCGCGGTGGGCGTCGTGTCGCAGGAGACGTATCTCTTCCACGCCTCCGTCGCCGACAACCTCCGCTTCGCCAAACCGGACGCGACGGACGAGGAGATCGAGAAGGCGGCCAGGGCCGCCCAGATCCACGAGCACATCGTCACCCTGCCCGACGGGTACGACACACTGGTCGGCGAGCGCGGATACCGGTTCTCCGGCGGCGAGAAACAGCGCCTCGCGATCGCCCGCACCATCCTGCGCGACCCGCCCGTCCTCGTGCTGGACGAGGCGACGAGCGCGCTCGACACCCGTACCGAACACGCGGTCCAGCAGGCCATCGACTCCCTCTCCGAGGGCCGTACGACCATCACCATCGCCCACCGGCTCTCCACGGTGCGCGACGCCGACCAGATCGTCGTCCTCGACGCCGGTCGCATAGCCGAGCGCGGCACGCACGAGGAGCTGATCGACCGGGACGGCAGGTACGCGGCGCTCGTCCGCCGGGACGGCGCGCCGGCGCCCGCGCCCGTGCCCGCCCGGGACGAGCGCGTGGGCGCCGCCTGA", "partial": "0", "query_start": 51418, "query_end": 52041, "hit_start": 1131, "hit_end": 1746, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 28.5}, "gnl|BL_ORD_ID|2167|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "abcA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "3000", "model_id": "2416", "ARO_accession": "3003942", "ARO_name": "abcA", "ARO_category": {"36002": {"category_aro_accession": "0010001", "category_aro_cvterm_id": "36002", "category_aro_name": "ATP-binding cassette (ABC) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. ATP-binding cassette (ABC) transporters are present in all cells of all organisms and use the energy of ATP binding/hydrolysis to transport substrates across cell membranes.", "category_aro_class_name": "AMR Gene Family"}, "35934": {"category_aro_accession": "0000015", "category_aro_cvterm_id": "35934", "category_aro_name": "methicillin", "category_aro_description": "Derived from penicillin to combat penicillin-resistance, methicillin is insensitive to beta-lactamases (also known as penicillinases) secreted by many penicillin-resistant bacteria. Methicillin is bactericidal, and acts by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Antibiotic"}, "35985": {"category_aro_accession": "0000068", "category_aro_cvterm_id": "35985", "category_aro_name": "daptomycin", "category_aro_description": "Daptomycin is a novel lipopeptide antibiotic used in the treatment of certain infections caused by Gram-positive organisms. Daptomycin interferes with the bacterial cell membrane, reducing membrane potential and inhibiting cell wall synthesis.", "category_aro_class_name": "Antibiotic"}, "36989": {"category_aro_accession": "3000645", "category_aro_cvterm_id": "36989", "category_aro_name": "cefotaxime", "category_aro_description": "Cefotaxime is a semisynthetic cephalosporin taken parenterally. It is resistant to most beta-lactamases and active against Gram-negative rods and cocci due to its aminothiazoyl and methoximino functional groups.", "category_aro_class_name": "Antibiotic"}, "37041": {"category_aro_accession": "3000697", "category_aro_cvterm_id": "37041", "category_aro_name": "moenomycin A1", "category_aro_description": "Moenomycin A1 is a major component of moenomycin mixtures. It is produced by Streptomyces ghanaensis, S. bambergiensis, S. ederensis, and S. geysiriensis.", "category_aro_class_name": "Antibiotic"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36192": {"category_aro_accession": "3000053", "category_aro_cvterm_id": "36192", "category_aro_name": "peptide antibiotic", "category_aro_description": "Peptide antibiotics have a wide range of antibacterial mechanisms, depending on the amino acids that make up the antibiotic, although most act to disrupt the cell membrane in some manner. Subclasses of peptide antibiotics can include additional sidechains of other types, such as lipids in the case of the lipopeptide antibiotics.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.1824e-13, "max_identities": 67, "bit_score": 68.1662, "cvterm_id": "40696", "query": "IQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTAS--SGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERR-----TRVMTLLEQVGLEKHAKHRPNE-LSGGQRQRVAVARALVTRPKLVLA-DEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVM", "match": "++ I S   A+      I    +V     +GK     L  V   V PG   ++ G SG+GKTT L+++    T    SG + VDGQ   +  +R+         G+  Q    +S  +V + +EF  LL++  +   +      T V+ LL+           P E L+  QR+R+ +   L  RP+L+L  DEPT+ LDS T   I+DL+ +L +K G   + + H    M", "sequence_from_db": "VEKIGSDGLAMIERQTAIFQWKDVCFDIKIGKENCRILDHVDGWVKPGILTALMGVSGAGKTTLLDVLATRTTMGIISGEMLVDGQPRDESFQRK--------TGYAQQQDLHLSTATVREALEFSALLRQSAHVPRQEKIDYVTEVIKLLDMTEYADAVIGVPGEGLNVEQRKRLTIGVELAARPQLLLFLDEPTSGLDSQTSWAILDLLDKL-KKNGQAILCTIHQPSAM", "sequence_from_broadstreet": "MNESHEAGKNSSTNVEEREEEVLRLARQFTEQSSYSTAGQTPFAAEAGSALDPNGERFNARAWCKAMLQMHIGDKEAHPLRTLGVAFSNLNVHGFGSDTDYQKSVGNVWLKTLSLARIAFGQKQRKVDILQNLEGLVEAGEMLVVLGPPGSGCSTFLKTIAGETYGFHVDKNSNINFQGIAKQMAHEFRGEAIYTAEVDVHFPKLTVGDTLYFAARARTPRHIPGGVNATQYAGHMRDVIMAMFGISHTKNTIVGNDFIRGVSGGERKRVSIAEACLSNAPLQCWDNSTRGLDSANAIEFCKTLRMQADINGTTACVSLYQAPQAAYDYFDKVLVLYEGREIYFGPTSMAKHYFLQMGFVCPDRQTDADFLTSMTSHLERVVQPGYEDRVPRTPDEFAARWKASPQRAQLMQHIKSYNAKFALDGEYLDKFKQSRRAQQAKAQRVSSPYTLSYVQQVKLCLWRGYQRLKADPSVTISSLFGNTIISLVIASIFYNLKADTSTFFQRGALLFFAVLMNALGCGLEMLTLYAQRGIIEKHSRYALYHPSAEAFSSMIMDLPYKILNAITSNIVLYFMTNLRREPGAFFFFVFTSFILTLTMSMFFRSMASLSRSLVQVLPFSAVLLLGLSMYTGFAIPTGYMLGWARWIAYINPISYGFESLMINEFHNRDFPCMDYVPSGPGYTDVGLNNRVCSTVRSVPGQAFVNGNAYIESAYSYTASHKWRNIGVIFAYMFLLGAVYLVATDFITEKKPKGEILVFPRGHKALKKGKSDEDLEGGGGRSATVEKIGSDGLAMIERQTAIFQWKDVCFDIKIGKENCRILDHVDGWVKPGILTALMGVSGAGKTTLLDVLATRTTMGIISGEMLVDGQPRDESFQRKTGYAQQQDLHLSTATVREALEFSALLRQSAHVPRQEKIDYVTEVIKLLDMTEYADAVIGVPGEGLNVEQRKRLTIGVELAARPQLLLFLDEPTSGLDSQTSWAILDLLDKLKKNGQAILCTIHQPSAMLFQRFDRLLFLQAGGRTVYFGEIGQNSQILIDYFVRNGAPPCPPDANPAEWMLDVIGAAPGSHTSINWFETWRRSPEYARVQEHLAELKHERRHQTNLFRTTSGQKREDKDSYREFAAPFWAQLYQVQVRVFQQIWRSPTYIYSKTALCVLSALFVGFSLFHTPNTIQGLQNQMFGIFMLLTLFGQLIQQIMPHFVAQRALYEVRDRPAKTYSWKAFLIANIVVELPWNSLMSVLMFLCWYYPIGLYRNAEPTDAVHLRGTQMWLMIWTFLLFSSTFAHFMIAAFDAAENAGNLGNLLFLLCLLFCGVLATPDQLPRFWIFMYRVSPFTYLVSGMLSVGISNTNVTCADNEYLRFDPVNGTCGEYMGSYMSNLGGYLADEMATANCSFCPIKETNVFLGRVSSSYSDIWRNFGLMWVFIVFNIFAACSLYWWVRVPRDKKPVAKAE", "dna_sequence_from_broadstreet": "ATGAATGAAAGTCATGAAGCTGGAAAAAATTCCTCTACCAATGTGGAGGAGAGGGAAGAGGAGGTTCTTCGGCTAGCCAGACAGTTCACAGAGCAGAGCAGCTATTCCACGGCGGGACAAACCCCCTTTGCTGCGGAGGCCGGATCGGCCCTGGACCCCAATGGTGAACGCTTCAACGCTCGGGCATGGTGCAAGGCCATGCTGCAGATGCACATTGGGGACAAGGAGGCACACCCACTGCGAACCTTGGGGGTCGCCTTCAGCAATCTCAATGTGCATGGTTTCGGTTCCGACACTGATTACCAGAAAAGCGTCGGCAATGTCTGGTTAAAGACGCTCAGCCTGGCAAGAATAGCATTTGGTCAAAAGCAGCGCAAAGTCGACATTTTGCAGAACTTGGAAGGATTGGTGGAGGCTGGAGAGATGCTCGTCGTACTTGGACCCCCTGGATCTGGATGCTCCACTTTTTTGAAGACCATTGCTGGAGAGACTTACGGCTTTCATGTGGACAAAAACTCAAACATCAATTTCCAAGGCATCGCAAAGCAGATGGCCCACGAGTTCAGGGGTGAAGCCATCTATACCGCAGAGGTTGATGTCCACTTCCCCAAGCTCACGGTTGGAGATACCCTTTATTTCGCGGCTCGTGCCCGAACACCACGACACATTCCTGGGGGGGTGAATGCGACCCAGTATGCCGGCCACATGCGAGACGTGATCATGGCCATGTTTGGTATCAGCCATACGAAGAACACAATTGTCGGAAACGACTTCATCCGCGGTGTATCTGGTGGAGAGCGCAAGCGGGTTAGCATTGCGGAAGCTTGTCTCAGCAATGCACCGCTGCAATGTTGGGACAATTCGACTCGTGGTCTTGATAGTGCGAATGCCATTGAGTTCTGCAAAACCTTACGCATGCAGGCAGATATCAATGGCACCACAGCCTGTGTCTCTCTATATCAAGCTCCCCAGGCTGCGTACGACTATTTCGATAAGGTCCTGGTCCTATACGAAGGTCGCGAGATCTACTTTGGTCCCACATCCATGGCGAAGCACTACTTCCTTCAGATGGGCTTCGTATGCCCTGACCGGCAAACCGATGCCGACTTTCTCACATCTATGACTAGCCATCTTGAGCGTGTTGTTCAGCCTGGTTATGAAGATCGCGTACCTCGAACACCTGATGAGTTCGCTGCACGATGGAAGGCCTCACCACAGCGAGCACAGCTGATGCAACACATCAAGAGTTATAATGCAAAGTTCGCACTGGATGGGGAATACCTGGATAAGTTTAAGCAATCTCGGCGAGCCCAGCAAGCCAAGGCTCAGCGGGTATCATCACCCTACACTCTTTCCTATGTCCAACAGGTGAAACTGTGCCTGTGGCGCGGGTATCAACGATTGAAGGCTGACCCCAGTGTCACAATCTCTTCATTATTCGGAAATACTATCATATCCCTAGTTATCGCCAGTATCTTCTACAACCTCAAGGCTGACACCAGCACCTTTTTTCAGCGTGGTGCTCTTCTCTTCTTTGCTGTTCTTATGAACGCTCTTGGCTGCGGCCTTGAAATGCTGACTCTATACGCGCAACGAGGGATCATCGAGAAGCACTCCCGATACGCTCTCTACCATCCATCTGCTGAAGCTTTTTCATCAATGATAATGGATTTGCCCTATAAGATTCTCAACGCCATTACGTCCAATATAGTTCTGTACTTCATGACCAACTTGAGGAGAGAACCCGGGGCTTTCTTCTTCTTTGTCTTCACTTCGTTCATCCTGACTCTGACCATGTCCATGTTCTTCCGGTCTATGGCATCGCTATCCAGATCCCTTGTCCAAGTTCTGCCCTTCTCCGCCGTGCTACTTCTCGGTCTCAGCATGTACACTGGGTTCGCTATCCCGACTGGATATATGCTGGGCTGGGCTCGCTGGATTGCGTACATCAATCCCATCAGCTATGGCTTTGAGTCACTGATGATCAATGAGTTCCACAACCGCGATTTCCCGTGCATGGACTATGTCCCATCGGGTCCTGGCTATACGGATGTCGGGCTCAACAACCGTGTTTGCTCCACCGTCAGATCAGTGCCTGGACAAGCCTTTGTCAATGGCAATGCTTACATTGAGTCAGCATATAGCTATACCGCTTCTCACAAATGGAGAAACATCGGTGTCATATTCGCTTACATGTTCCTGCTTGGGGCGGTCTATCTCGTTGCTACTGACTTCATCACCGAGAAGAAGCCGAAGGGCGAGATCCTGGTATTTCCTCGCGGACACAAGGCTCTGAAGAAAGGCAAGTCAGATGAGGATCTTGAAGGGGGTGGTGGCCGCAGCGCCACAGTCGAGAAGATCGGCTCAGATGGCCTTGCCATGATTGAACGCCAAACCGCAATCTTCCAGTGGAAGGATGTCTGCTTCGATATCAAGATTGGAAAGGAGAATTGCAGGATTCTTGACCATGTTGACGGATGGGTCAAACCGGGAATCTTGACGGCGCTTATGGGTGTTTCGGGTGCTGGAAAGACCACGCTCTTGGATGTCCTTGCTACGCGCACCACGATGGGGATTATCAGTGGAGAAATGCTCGTCGATGGTCAACCGCGTGATGAGTCCTTTCAACGTAAGACCGGCTATGCTCAGCAACAAGATCTGCATTTGAGTACTGCTACCGTGCGCGAGGCACTTGAGTTCTCTGCTCTTCTACGTCAATCTGCTCACGTTCCTCGTCAAGAGAAGATTGACTACGTGACAGAAGTGATCAAGCTTCTTGACATGACGGAGTATGCTGATGCCGTTATTGGGGTGCCTGGTGAAGGCCTGAACGTTGAGCAACGTAAACGTCTCACAATCGGGGTAGAGCTTGCAGCCAGACCCCAACTCCTCCTTTTCCTAGACGAACCGACCTCAGGACTTGATTCTCAGACATCCTGGGCTATTCTTGATCTCCTCGATAAACTGAAGAAGAACGGCCAGGCTATTTTGTGTACCATCCATCAACCATCTGCCATGCTGTTTCAGCGCTTTGATCGTCTCCTCTTCCTTCAAGCTGGGGGTCGTACTGTCTACTTTGGAGAAATCGGTCAGAACTCGCAAATACTGATTGACTACTTCGTCCGCAACGGTGCCCCTCCATGTCCTCCGGATGCGAATCCTGCCGAATGGATGCTGGATGTGATCGGTGCCGCTCCCGGATCACACACCAGCATCAACTGGTTCGAGACCTGGCGTCGATCCCCCGAATATGCACGAGTCCAAGAGCACCTTGCTGAACTGAAACACGAACGTCGCCACCAAACAAACCTGTTCCGCACTACATCCGGCCAAAAGCGCGAAGACAAAGACAGCTACCGCGAGTTCGCTGCTCCTTTCTGGGCCCAGCTCTACCAAGTCCAAGTACGAGTCTTCCAGCAAATCTGGCGGTCACCCACCTACATCTACTCCAAGACCGCTCTCTGCGTGTTATCCGCTCTCTTCGTCGGCTTCTCCCTTTTCCATACACCCAACACCATCCAAGGCCTCCAGAATCAAATGTTCGGCATCTTCATGCTACTTACCCTGTTCGGCCAGCTTATCCAACAAATCATGCCGCATTTCGTCGCCCAGCGCGCGCTGTATGAAGTCCGCGACCGACCTGCAAAAACCTACTCTTGGAAAGCCTTCCTCATCGCCAACATCGTTGTTGAACTCCCCTGGAACTCGCTCATGTCCGTCCTTATGTTCCTGTGCTGGTACTACCCGATTGGTCTTTACCGCAATGCCGAACCAACTGATGCGGTGCACTTGCGGGGCACGCAAATGTGGCTGATGATCTGGACCTTCCTTCTCTTCTCGTCCACCTTTGCCCATTTTATGATCGCAGCGTTTGACGCCGCCGAGAACGCGGGAAACCTCGGAAACCTGCTTTTCCTGCTTTGTCTGCTTTTCTGCGGCGTGCTAGCGACACCGGATCAGCTCCCACGGTTCTGGATCTTCATGTATCGCGTTTCGCCGTTTACATATCTGGTGAGCGGGATGTTGTCTGTGGGTATATCGAATACGAATGTCACCTGCGCGGACAATGAGTATCTGCGCTTTGACCCCGTCAATGGGACTTGCGGCGAGTACATGGGCTCATACATGTCGAATCTGGGCGGGTACCTTGCAGACGAGATGGCGACTGCGAACTGCAGCTTCTGCCCGATCAAGGAGACGAATGTGTTCCTCGGTAGAGTTTCGTCGAGTTACTCGGATATCTGGAGGAACTTTGGGCTCATGTGGGTATTTATTGTTTTCAATATCTTTGCAGCTTGTTCGCTGTACTGGTGGGTTCGTGTTCCACGAGACAAGAAGCCAGTTGCAAAGGCCGAGTGA", "partial": "0", "query_start": 51307, "query_end": 51975, "hit_start": 2349, "hit_end": 3018, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 28.88}, "gnl|BL_ORD_ID|2167|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "abcA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "3000", "model_id": "2416", "ARO_accession": "3003942", "ARO_name": "abcA", "ARO_category": {"36002": {"category_aro_accession": "0010001", "category_aro_cvterm_id": "36002", "category_aro_name": "ATP-binding cassette (ABC) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. ATP-binding cassette (ABC) transporters are present in all cells of all organisms and use the energy of ATP binding/hydrolysis to transport substrates across cell membranes.", "category_aro_class_name": "AMR Gene Family"}, "35934": {"category_aro_accession": "0000015", "category_aro_cvterm_id": "35934", "category_aro_name": "methicillin", "category_aro_description": "Derived from penicillin to combat penicillin-resistance, methicillin is insensitive to beta-lactamases (also known as penicillinases) secreted by many penicillin-resistant bacteria. Methicillin is bactericidal, and acts by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Antibiotic"}, "35985": {"category_aro_accession": "0000068", "category_aro_cvterm_id": "35985", "category_aro_name": "daptomycin", "category_aro_description": "Daptomycin is a novel lipopeptide antibiotic used in the treatment of certain infections caused by Gram-positive organisms. Daptomycin interferes with the bacterial cell membrane, reducing membrane potential and inhibiting cell wall synthesis.", "category_aro_class_name": "Antibiotic"}, "36989": {"category_aro_accession": "3000645", "category_aro_cvterm_id": "36989", "category_aro_name": "cefotaxime", "category_aro_description": "Cefotaxime is a semisynthetic cephalosporin taken parenterally. It is resistant to most beta-lactamases and active against Gram-negative rods and cocci due to its aminothiazoyl and methoximino functional groups.", "category_aro_class_name": "Antibiotic"}, "37041": {"category_aro_accession": "3000697", "category_aro_cvterm_id": "37041", "category_aro_name": "moenomycin A1", "category_aro_description": "Moenomycin A1 is a major component of moenomycin mixtures. It is produced by Streptomyces ghanaensis, S. bambergiensis, S. ederensis, and S. geysiriensis.", "category_aro_class_name": "Antibiotic"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36192": {"category_aro_accession": "3000053", "category_aro_cvterm_id": "36192", "category_aro_name": "peptide antibiotic", "category_aro_description": "Peptide antibiotics have a wide range of antibacterial mechanisms, depending on the amino acids that make up the antibiotic, although most act to disrupt the cell membrane in some manner. Subclasses of peptide antibiotics can include additional sidechains of other types, such as lipids in the case of the lipopeptide antibiotics.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0023048, "max_identities": 26, "bit_score": 36.5798, "cvterm_id": "40696", "query": "LSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRK---EGTTFIFSTHDA--KVMTHANAVVRLADGK", "match": "+SGG+R+RV++A A ++   L   D  T  LDS    N I+  K L  +    GTT   S + A      + + V+ L +G+", "sequence_from_db": "VSGGERKRVSIAEACLSNAPLQCWDNSTRGLDSA---NAIEFCKTLRMQADINGTTACVSLYQAPQAAYDYFDKVLVLYEGR", "sequence_from_broadstreet": "MNESHEAGKNSSTNVEEREEEVLRLARQFTEQSSYSTAGQTPFAAEAGSALDPNGERFNARAWCKAMLQMHIGDKEAHPLRTLGVAFSNLNVHGFGSDTDYQKSVGNVWLKTLSLARIAFGQKQRKVDILQNLEGLVEAGEMLVVLGPPGSGCSTFLKTIAGETYGFHVDKNSNINFQGIAKQMAHEFRGEAIYTAEVDVHFPKLTVGDTLYFAARARTPRHIPGGVNATQYAGHMRDVIMAMFGISHTKNTIVGNDFIRGVSGGERKRVSIAEACLSNAPLQCWDNSTRGLDSANAIEFCKTLRMQADINGTTACVSLYQAPQAAYDYFDKVLVLYEGREIYFGPTSMAKHYFLQMGFVCPDRQTDADFLTSMTSHLERVVQPGYEDRVPRTPDEFAARWKASPQRAQLMQHIKSYNAKFALDGEYLDKFKQSRRAQQAKAQRVSSPYTLSYVQQVKLCLWRGYQRLKADPSVTISSLFGNTIISLVIASIFYNLKADTSTFFQRGALLFFAVLMNALGCGLEMLTLYAQRGIIEKHSRYALYHPSAEAFSSMIMDLPYKILNAITSNIVLYFMTNLRREPGAFFFFVFTSFILTLTMSMFFRSMASLSRSLVQVLPFSAVLLLGLSMYTGFAIPTGYMLGWARWIAYINPISYGFESLMINEFHNRDFPCMDYVPSGPGYTDVGLNNRVCSTVRSVPGQAFVNGNAYIESAYSYTASHKWRNIGVIFAYMFLLGAVYLVATDFITEKKPKGEILVFPRGHKALKKGKSDEDLEGGGGRSATVEKIGSDGLAMIERQTAIFQWKDVCFDIKIGKENCRILDHVDGWVKPGILTALMGVSGAGKTTLLDVLATRTTMGIISGEMLVDGQPRDESFQRKTGYAQQQDLHLSTATVREALEFSALLRQSAHVPRQEKIDYVTEVIKLLDMTEYADAVIGVPGEGLNVEQRKRLTIGVELAARPQLLLFLDEPTSGLDSQTSWAILDLLDKLKKNGQAILCTIHQPSAMLFQRFDRLLFLQAGGRTVYFGEIGQNSQILIDYFVRNGAPPCPPDANPAEWMLDVIGAAPGSHTSINWFETWRRSPEYARVQEHLAELKHERRHQTNLFRTTSGQKREDKDSYREFAAPFWAQLYQVQVRVFQQIWRSPTYIYSKTALCVLSALFVGFSLFHTPNTIQGLQNQMFGIFMLLTLFGQLIQQIMPHFVAQRALYEVRDRPAKTYSWKAFLIANIVVELPWNSLMSVLMFLCWYYPIGLYRNAEPTDAVHLRGTQMWLMIWTFLLFSSTFAHFMIAAFDAAENAGNLGNLLFLLCLLFCGVLATPDQLPRFWIFMYRVSPFTYLVSGMLSVGISNTNVTCADNEYLRFDPVNGTCGEYMGSYMSNLGGYLADEMATANCSFCPIKETNVFLGRVSSSYSDIWRNFGLMWVFIVFNIFAACSLYWWVRVPRDKKPVAKAE", "dna_sequence_from_broadstreet": "ATGAATGAAAGTCATGAAGCTGGAAAAAATTCCTCTACCAATGTGGAGGAGAGGGAAGAGGAGGTTCTTCGGCTAGCCAGACAGTTCACAGAGCAGAGCAGCTATTCCACGGCGGGACAAACCCCCTTTGCTGCGGAGGCCGGATCGGCCCTGGACCCCAATGGTGAACGCTTCAACGCTCGGGCATGGTGCAAGGCCATGCTGCAGATGCACATTGGGGACAAGGAGGCACACCCACTGCGAACCTTGGGGGTCGCCTTCAGCAATCTCAATGTGCATGGTTTCGGTTCCGACACTGATTACCAGAAAAGCGTCGGCAATGTCTGGTTAAAGACGCTCAGCCTGGCAAGAATAGCATTTGGTCAAAAGCAGCGCAAAGTCGACATTTTGCAGAACTTGGAAGGATTGGTGGAGGCTGGAGAGATGCTCGTCGTACTTGGACCCCCTGGATCTGGATGCTCCACTTTTTTGAAGACCATTGCTGGAGAGACTTACGGCTTTCATGTGGACAAAAACTCAAACATCAATTTCCAAGGCATCGCAAAGCAGATGGCCCACGAGTTCAGGGGTGAAGCCATCTATACCGCAGAGGTTGATGTCCACTTCCCCAAGCTCACGGTTGGAGATACCCTTTATTTCGCGGCTCGTGCCCGAACACCACGACACATTCCTGGGGGGGTGAATGCGACCCAGTATGCCGGCCACATGCGAGACGTGATCATGGCCATGTTTGGTATCAGCCATACGAAGAACACAATTGTCGGAAACGACTTCATCCGCGGTGTATCTGGTGGAGAGCGCAAGCGGGTTAGCATTGCGGAAGCTTGTCTCAGCAATGCACCGCTGCAATGTTGGGACAATTCGACTCGTGGTCTTGATAGTGCGAATGCCATTGAGTTCTGCAAAACCTTACGCATGCAGGCAGATATCAATGGCACCACAGCCTGTGTCTCTCTATATCAAGCTCCCCAGGCTGCGTACGACTATTTCGATAAGGTCCTGGTCCTATACGAAGGTCGCGAGATCTACTTTGGTCCCACATCCATGGCGAAGCACTACTTCCTTCAGATGGGCTTCGTATGCCCTGACCGGCAAACCGATGCCGACTTTCTCACATCTATGACTAGCCATCTTGAGCGTGTTGTTCAGCCTGGTTATGAAGATCGCGTACCTCGAACACCTGATGAGTTCGCTGCACGATGGAAGGCCTCACCACAGCGAGCACAGCTGATGCAACACATCAAGAGTTATAATGCAAAGTTCGCACTGGATGGGGAATACCTGGATAAGTTTAAGCAATCTCGGCGAGCCCAGCAAGCCAAGGCTCAGCGGGTATCATCACCCTACACTCTTTCCTATGTCCAACAGGTGAAACTGTGCCTGTGGCGCGGGTATCAACGATTGAAGGCTGACCCCAGTGTCACAATCTCTTCATTATTCGGAAATACTATCATATCCCTAGTTATCGCCAGTATCTTCTACAACCTCAAGGCTGACACCAGCACCTTTTTTCAGCGTGGTGCTCTTCTCTTCTTTGCTGTTCTTATGAACGCTCTTGGCTGCGGCCTTGAAATGCTGACTCTATACGCGCAACGAGGGATCATCGAGAAGCACTCCCGATACGCTCTCTACCATCCATCTGCTGAAGCTTTTTCATCAATGATAATGGATTTGCCCTATAAGATTCTCAACGCCATTACGTCCAATATAGTTCTGTACTTCATGACCAACTTGAGGAGAGAACCCGGGGCTTTCTTCTTCTTTGTCTTCACTTCGTTCATCCTGACTCTGACCATGTCCATGTTCTTCCGGTCTATGGCATCGCTATCCAGATCCCTTGTCCAAGTTCTGCCCTTCTCCGCCGTGCTACTTCTCGGTCTCAGCATGTACACTGGGTTCGCTATCCCGACTGGATATATGCTGGGCTGGGCTCGCTGGATTGCGTACATCAATCCCATCAGCTATGGCTTTGAGTCACTGATGATCAATGAGTTCCACAACCGCGATTTCCCGTGCATGGACTATGTCCCATCGGGTCCTGGCTATACGGATGTCGGGCTCAACAACCGTGTTTGCTCCACCGTCAGATCAGTGCCTGGACAAGCCTTTGTCAATGGCAATGCTTACATTGAGTCAGCATATAGCTATACCGCTTCTCACAAATGGAGAAACATCGGTGTCATATTCGCTTACATGTTCCTGCTTGGGGCGGTCTATCTCGTTGCTACTGACTTCATCACCGAGAAGAAGCCGAAGGGCGAGATCCTGGTATTTCCTCGCGGACACAAGGCTCTGAAGAAAGGCAAGTCAGATGAGGATCTTGAAGGGGGTGGTGGCCGCAGCGCCACAGTCGAGAAGATCGGCTCAGATGGCCTTGCCATGATTGAACGCCAAACCGCAATCTTCCAGTGGAAGGATGTCTGCTTCGATATCAAGATTGGAAAGGAGAATTGCAGGATTCTTGACCATGTTGACGGATGGGTCAAACCGGGAATCTTGACGGCGCTTATGGGTGTTTCGGGTGCTGGAAAGACCACGCTCTTGGATGTCCTTGCTACGCGCACCACGATGGGGATTATCAGTGGAGAAATGCTCGTCGATGGTCAACCGCGTGATGAGTCCTTTCAACGTAAGACCGGCTATGCTCAGCAACAAGATCTGCATTTGAGTACTGCTACCGTGCGCGAGGCACTTGAGTTCTCTGCTCTTCTACGTCAATCTGCTCACGTTCCTCGTCAAGAGAAGATTGACTACGTGACAGAAGTGATCAAGCTTCTTGACATGACGGAGTATGCTGATGCCGTTATTGGGGTGCCTGGTGAAGGCCTGAACGTTGAGCAACGTAAACGTCTCACAATCGGGGTAGAGCTTGCAGCCAGACCCCAACTCCTCCTTTTCCTAGACGAACCGACCTCAGGACTTGATTCTCAGACATCCTGGGCTATTCTTGATCTCCTCGATAAACTGAAGAAGAACGGCCAGGCTATTTTGTGTACCATCCATCAACCATCTGCCATGCTGTTTCAGCGCTTTGATCGTCTCCTCTTCCTTCAAGCTGGGGGTCGTACTGTCTACTTTGGAGAAATCGGTCAGAACTCGCAAATACTGATTGACTACTTCGTCCGCAACGGTGCCCCTCCATGTCCTCCGGATGCGAATCCTGCCGAATGGATGCTGGATGTGATCGGTGCCGCTCCCGGATCACACACCAGCATCAACTGGTTCGAGACCTGGCGTCGATCCCCCGAATATGCACGAGTCCAAGAGCACCTTGCTGAACTGAAACACGAACGTCGCCACCAAACAAACCTGTTCCGCACTACATCCGGCCAAAAGCGCGAAGACAAAGACAGCTACCGCGAGTTCGCTGCTCCTTTCTGGGCCCAGCTCTACCAAGTCCAAGTACGAGTCTTCCAGCAAATCTGGCGGTCACCCACCTACATCTACTCCAAGACCGCTCTCTGCGTGTTATCCGCTCTCTTCGTCGGCTTCTCCCTTTTCCATACACCCAACACCATCCAAGGCCTCCAGAATCAAATGTTCGGCATCTTCATGCTACTTACCCTGTTCGGCCAGCTTATCCAACAAATCATGCCGCATTTCGTCGCCCAGCGCGCGCTGTATGAAGTCCGCGACCGACCTGCAAAAACCTACTCTTGGAAAGCCTTCCTCATCGCCAACATCGTTGTTGAACTCCCCTGGAACTCGCTCATGTCCGTCCTTATGTTCCTGTGCTGGTACTACCCGATTGGTCTTTACCGCAATGCCGAACCAACTGATGCGGTGCACTTGCGGGGCACGCAAATGTGGCTGATGATCTGGACCTTCCTTCTCTTCTCGTCCACCTTTGCCCATTTTATGATCGCAGCGTTTGACGCCGCCGAGAACGCGGGAAACCTCGGAAACCTGCTTTTCCTGCTTTGTCTGCTTTTCTGCGGCGTGCTAGCGACACCGGATCAGCTCCCACGGTTCTGGATCTTCATGTATCGCGTTTCGCCGTTTACATATCTGGTGAGCGGGATGTTGTCTGTGGGTATATCGAATACGAATGTCACCTGCGCGGACAATGAGTATCTGCGCTTTGACCCCGTCAATGGGACTTGCGGCGAGTACATGGGCTCATACATGTCGAATCTGGGCGGGTACCTTGCAGACGAGATGGCGACTGCGAACTGCAGCTTCTGCCCGATCAAGGAGACGAATGTGTTCCTCGGTAGAGTTTCGTCGAGTTACTCGGATATCTGGAGGAACTTTGGGCTCATGTGGGTATTTATTGTTTTCAATATCTTTGCAGCTTGTTCGCTGTACTGGTGGGTTCGTGTTCCACGAGACAAGAAGCCAGTTGCAAAGGCCGAGTGA", "partial": "0", "query_start": 51784, "query_end": 52014, "hit_start": 783, "hit_end": 1020, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 31.71}, "gnl|BL_ORD_ID|4727|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "salD", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5739", "ARO_accession": "3007028", "ARO_name": "salD", "ARO_category": {"45589": {"category_aro_accession": "3007030", "category_aro_cvterm_id": "45589", "category_aro_name": "sal-type ABC-F protein", "category_aro_description": "Sal proteins are a part of the ABC-F proteins, expressed in staphylococci that confer resistance to group A streptogramin, lincosamide, and pleuromutilin antibiotics through ribosomal protection.", "category_aro_class_name": "AMR Gene Family"}, "35964": {"category_aro_accession": "0000046", "category_aro_cvterm_id": "35964", "category_aro_name": "lincomycin", "category_aro_description": "Lincomycin is a lincosamide antibiotic that comes from the actinomyces Streptomyces lincolnensis. It binds to the 23s portion of the 50S subunit of bacterial ribosomes and inhibit early elongation of peptide chain by inhibiting transpeptidase reaction.", "category_aro_class_name": "Antibiotic"}, "37013": {"category_aro_accession": "3000669", "category_aro_cvterm_id": "37013", "category_aro_name": "virginiamycin M1", "category_aro_description": "Virginiamycin M1 is a streptogramin A antibiotic.", "category_aro_class_name": "Antibiotic"}, "37015": {"category_aro_accession": "3000671", "category_aro_cvterm_id": "37015", "category_aro_name": "tiamulin", "category_aro_description": "Tiamulin is a pleuromutilin derivative currently used in veterinary medicine. It binds to the 23 rRNA of the 50S ribosomal subunit to inhibit protein translation.", "category_aro_class_name": "Antibiotic"}, "37713": {"category_aro_accession": "3001314", "category_aro_cvterm_id": "37713", "category_aro_name": "retapamulin", "category_aro_description": "Retapamulin is a semi-synthetic pleuromutilin antibiotic approved for the treatment of skin infections.", "category_aro_class_name": "Antibiotic"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35952": {"category_aro_accession": "0000034", "category_aro_cvterm_id": "35952", "category_aro_name": "streptogramin A antibiotic", "category_aro_description": "Streptogramin A antibiotics are cyclic polyketide peptide hybrids that bind to the ribosomal peptidyl transfer centre. Structural variation arises from substituting a proline for its desaturated derivative and by its substitution for Ala or Cys. Used alone, streptogramin A antibiotics are bacteriostatic, but is bactericidal when used with streptogramin B antibiotics.", "category_aro_class_name": "Drug Class"}, "37014": {"category_aro_accession": "3000670", "category_aro_cvterm_id": "37014", "category_aro_name": "pleuromutilin antibiotic", "category_aro_description": "Pleuromutilins are natural fungal products that target bacterial protein translation by binding the the 23S rRNA, blocking the ribosome P site at the 50S subunit. They are mostly used for agriculture and veterinary purposes.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.5541e-13, "max_identities": 49, "bit_score": 66.2402, "cvterm_id": "45587", "query": "LRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHT-IGFIFQSF-NLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEK-HAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKE", "match": "+  V L V PGE I+I G +G GK+T LN I                D+  L +++L+  +  T I +I   +  L+ +    Q     +    +LN  E   +++   +Q+ LE+     +  +LSGGQ+ +VA+ RA+++   L+L DEPT +LD      ++D +K+", "sequence_from_db": "IEEVNLSVEPGEHIAIVGDNGVGKSTLLNAIYN-----------KYNDSTYLMDQELSKYKNETAINYIMSWYPELLDIKLAMQTDYEKIGDYIELNGYEIEEQIILQAKQLNLEESDLDKQMGQLSGGQQTKVALVRAMISEKNLILLDEPTNHLDKQMIHIVVDYIKQ", "sequence_from_broadstreet": "MSFYFTEKPFERFGKTLIEEVNLSVEPGEHIAIVGDNGVGKSTLLNAIYNKYNDSTYLMDQELSKYKNETAINYIMSWYPELLDIKLAMQTDYEKIGDYIELNGYEIEEQIILQAKQLNLEESDLDKQMGQLSGGQQTKVALVRAMISEKNLILLDEPTNHLDKQMIHIVVDYIKQAKQSILYVSHHRGFIDETATHIIEITPQATRKFTGNYSQYKSIIDVERETQKKVYEKKQKEIKALEATVDRVKNWHKTANQSASVRNPLEQKRLSKLAQKAKVKESQINQKLEKIKVQQPKSDDRHFHFENQDALNKKYLMQLYDFSITIDGKNIYQNANFEIKDNENIILTGPNGSGKSLLISIIKQSIIPDEGDIYITPSLKIAYFDQKNDNLNYDSTALTMLLNMEGMERSQAQTILASFGFDNQKINLPISQLSMGEKSRLQFVLLYFSNPHLLILDEPTNYFDIATQDLILQMLKQFAGQVMIVTHDEYLKSQITATHWTIKDKKLMNLTLSEKHSPNMVDDTLKLLDDYKSIDEFGHFETDN", "dna_sequence_from_broadstreet": "ATGTCTTTTTATTTTACAGAAAAGCCATTTGAAAGGTTCGGCAAGACATTAATAGAAGAGGTTAATTTAAGTGTTGAACCAGGTGAACATATAGCAATTGTTGGTGATAACGGGGTAGGTAAATCAACATTACTCAATGCAATTTACAATAAATATAATGATTCAACGTATTTGATGGATCAAGAATTATCGAAGTATAAAAATGAAACGGCAATAAATTATATTATGTCGTGGTATCCAGAATTATTAGATATTAAACTTGCTATGCAAACTGATTATGAAAAAATTGGTGACTATATAGAACTTAATGGATATGAAATAGAAGAACAAATCATTTTACAAGCAAAGCAATTAAATTTAGAAGAGTCAGATTTAGATAAACAAATGGGGCAGTTAAGTGGCGGACAACAAACCAAAGTAGCATTAGTTCGAGCAATGATTTCAGAAAAAAATTTAATCTTGTTGGATGAACCAACAAATCACTTAGATAAACAAATGATTCATATTGTCGTGGATTATATAAAGCAAGCAAAGCAAAGTATATTATACGTGTCACATCATAGAGGATTTATCGACGAAACTGCAACGCACATTATTGAAATTACACCACAAGCTACAAGAAAATTTACTGGTAATTATAGTCAATATAAATCCATTATAGATGTTGAAAGAGAAACTCAAAAAAAGGTATACGAGAAAAAGCAAAAAGAAATAAAAGCTTTGGAAGCAACCGTAGATAGAGTTAAAAATTGGCATAAAACTGCGAATCAATCTGCAAGTGTTCGTAATCCGTTAGAGCAAAAGCGTTTGAGTAAATTAGCTCAAAAGGCAAAGGTTAAAGAATCACAAATAAATCAAAAACTTGAAAAGATTAAAGTCCAACAGCCTAAGTCGGATGATCGTCACTTCCATTTTGAGAATCAAGATGCGCTAAATAAAAAATATTTAATGCAATTATATGATTTTAGCATCACTATTGATGGTAAGAATATTTATCAAAATGCAAATTTCGAAATTAAAGATAATGAAAACATTATACTTACTGGCCCGAATGGTAGTGGCAAATCATTATTAATCTCAATTATCAAGCAGTCAATAATACCAGATGAGGGTGATATTTATATAACGCCTTCTCTAAAAATAGCTTATTTTGACCAAAAAAATGACAATTTAAATTATGACAGCACAGCATTAACAATGTTATTAAACATGGAGGGTATGGAACGTAGTCAAGCACAAACGATATTAGCGTCATTTGGATTTGATAACCAAAAAATAAACCTTCCAATTTCTCAATTATCTATGGGAGAGAAAAGTAGATTACAGTTTGTATTATTATATTTCTCAAATCCACATTTATTAATTCTCGACGAACCAACCAATTACTTCGATATTGCTACGCAAGATTTAATATTACAGATGCTAAAGCAATTTGCAGGACAAGTAATGATTGTGACGCATGATGAATACTTGAAATCTCAAATTACAGCGACACATTGGACAATTAAAGATAAAAAGTTAATGAATTTAACATTATCAGAGAAGCATTCACCCAATATGGTGGATGATACATTAAAATTATTAGATGATTATAAGTCGATAGATGAATTCGGACATTTTGAAACAGACAACTAG", "partial": "0", "query_start": 51418, "query_end": 51918, "hit_start": 51, "hit_end": 528, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 28.82}, "gnl|BL_ORD_ID|4727|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "salD", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5739", "ARO_accession": "3007028", "ARO_name": "salD", "ARO_category": {"45589": {"category_aro_accession": "3007030", "category_aro_cvterm_id": "45589", "category_aro_name": "sal-type ABC-F protein", "category_aro_description": "Sal proteins are a part of the ABC-F proteins, expressed in staphylococci that confer resistance to group A streptogramin, lincosamide, and pleuromutilin antibiotics through ribosomal protection.", "category_aro_class_name": "AMR Gene Family"}, "35964": {"category_aro_accession": "0000046", "category_aro_cvterm_id": "35964", "category_aro_name": "lincomycin", "category_aro_description": "Lincomycin is a lincosamide antibiotic that comes from the actinomyces Streptomyces lincolnensis. It binds to the 23s portion of the 50S subunit of bacterial ribosomes and inhibit early elongation of peptide chain by inhibiting transpeptidase reaction.", "category_aro_class_name": "Antibiotic"}, "37013": {"category_aro_accession": "3000669", "category_aro_cvterm_id": "37013", "category_aro_name": "virginiamycin M1", "category_aro_description": "Virginiamycin M1 is a streptogramin A antibiotic.", "category_aro_class_name": "Antibiotic"}, "37015": {"category_aro_accession": "3000671", "category_aro_cvterm_id": "37015", "category_aro_name": "tiamulin", "category_aro_description": "Tiamulin is a pleuromutilin derivative currently used in veterinary medicine. It binds to the 23 rRNA of the 50S ribosomal subunit to inhibit protein translation.", "category_aro_class_name": "Antibiotic"}, "37713": {"category_aro_accession": "3001314", "category_aro_cvterm_id": "37713", "category_aro_name": "retapamulin", "category_aro_description": "Retapamulin is a semi-synthetic pleuromutilin antibiotic approved for the treatment of skin infections.", "category_aro_class_name": "Antibiotic"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35952": {"category_aro_accession": "0000034", "category_aro_cvterm_id": "35952", "category_aro_name": "streptogramin A antibiotic", "category_aro_description": "Streptogramin A antibiotics are cyclic polyketide peptide hybrids that bind to the ribosomal peptidyl transfer centre. Structural variation arises from substituting a proline for its desaturated derivative and by its substitution for Ala or Cys. Used alone, streptogramin A antibiotics are bacteriostatic, but is bactericidal when used with streptogramin B antibiotics.", "category_aro_class_name": "Drug Class"}, "37014": {"category_aro_accession": "3000670", "category_aro_cvterm_id": "37014", "category_aro_name": "pleuromutilin antibiotic", "category_aro_description": "Pleuromutilins are natural fungal products that target bacterial protein translation by binding the the 23S rRNA, blocking the ribosome P site at the 50S subunit. They are mostly used for agriculture and veterinary purposes.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.48826e-05, "max_identities": 46, "bit_score": 41.5874, "cvterm_id": "45587", "query": "RGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRP-NELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAE", "match": "+    E+   E I + GP+GSGK+  +++I        G + +    T  L   ++ +         + S    + L++  N+E              R++  T+L   G +    + P ++LS G++ R+       + P L++ DEPT   D  T   I+ ++K+     G   I  THD  + +   A       K L  +T +E", "sequence_from_db": "QNANFEIKDNENIILTGPNGSGKSLLISIIKQSIIPDEGDIYI----TPSL---KIAYFDQKNDNLNYDS----TALTMLLNME-----------GMERSQAQTILASFGFDNQKINLPISQLSMGEKSRLQFVLLYFSNPHLLILDEPTNYFDIATQDLILQMLKQF---AGQVMIV-THDEYLKSQITATHWTIKDKKLMNLTLSE", "sequence_from_broadstreet": "MSFYFTEKPFERFGKTLIEEVNLSVEPGEHIAIVGDNGVGKSTLLNAIYNKYNDSTYLMDQELSKYKNETAINYIMSWYPELLDIKLAMQTDYEKIGDYIELNGYEIEEQIILQAKQLNLEESDLDKQMGQLSGGQQTKVALVRAMISEKNLILLDEPTNHLDKQMIHIVVDYIKQAKQSILYVSHHRGFIDETATHIIEITPQATRKFTGNYSQYKSIIDVERETQKKVYEKKQKEIKALEATVDRVKNWHKTANQSASVRNPLEQKRLSKLAQKAKVKESQINQKLEKIKVQQPKSDDRHFHFENQDALNKKYLMQLYDFSITIDGKNIYQNANFEIKDNENIILTGPNGSGKSLLISIIKQSIIPDEGDIYITPSLKIAYFDQKNDNLNYDSTALTMLLNMEGMERSQAQTILASFGFDNQKINLPISQLSMGEKSRLQFVLLYFSNPHLLILDEPTNYFDIATQDLILQMLKQFAGQVMIVTHDEYLKSQITATHWTIKDKKLMNLTLSEKHSPNMVDDTLKLLDDYKSIDEFGHFETDN", "dna_sequence_from_broadstreet": "ATGTCTTTTTATTTTACAGAAAAGCCATTTGAAAGGTTCGGCAAGACATTAATAGAAGAGGTTAATTTAAGTGTTGAACCAGGTGAACATATAGCAATTGTTGGTGATAACGGGGTAGGTAAATCAACATTACTCAATGCAATTTACAATAAATATAATGATTCAACGTATTTGATGGATCAAGAATTATCGAAGTATAAAAATGAAACGGCAATAAATTATATTATGTCGTGGTATCCAGAATTATTAGATATTAAACTTGCTATGCAAACTGATTATGAAAAAATTGGTGACTATATAGAACTTAATGGATATGAAATAGAAGAACAAATCATTTTACAAGCAAAGCAATTAAATTTAGAAGAGTCAGATTTAGATAAACAAATGGGGCAGTTAAGTGGCGGACAACAAACCAAAGTAGCATTAGTTCGAGCAATGATTTCAGAAAAAAATTTAATCTTGTTGGATGAACCAACAAATCACTTAGATAAACAAATGATTCATATTGTCGTGGATTATATAAAGCAAGCAAAGCAAAGTATATTATACGTGTCACATCATAGAGGATTTATCGACGAAACTGCAACGCACATTATTGAAATTACACCACAAGCTACAAGAAAATTTACTGGTAATTATAGTCAATATAAATCCATTATAGATGTTGAAAGAGAAACTCAAAAAAAGGTATACGAGAAAAAGCAAAAAGAAATAAAAGCTTTGGAAGCAACCGTAGATAGAGTTAAAAATTGGCATAAAACTGCGAATCAATCTGCAAGTGTTCGTAATCCGTTAGAGCAAAAGCGTTTGAGTAAATTAGCTCAAAAGGCAAAGGTTAAAGAATCACAAATAAATCAAAAACTTGAAAAGATTAAAGTCCAACAGCCTAAGTCGGATGATCGTCACTTCCATTTTGAGAATCAAGATGCGCTAAATAAAAAATATTTAATGCAATTATATGATTTTAGCATCACTATTGATGGTAAGAATATTTATCAAAATGCAAATTTCGAAATTAAAGATAATGAAAACATTATACTTACTGGCCCGAATGGTAGTGGCAAATCATTATTAATCTCAATTATCAAGCAGTCAATAATACCAGATGAGGGTGATATTTATATAACGCCTTCTCTAAAAATAGCTTATTTTGACCAAAAAAATGACAATTTAAATTATGACAGCACAGCATTAACAATGTTATTAAACATGGAGGGTATGGAACGTAGTCAAGCACAAACGATATTAGCGTCATTTGGATTTGATAACCAAAAAATAAACCTTCCAATTTCTCAATTATCTATGGGAGAGAAAAGTAGATTACAGTTTGTATTATTATATTTCTCAAATCCACATTTATTAATTCTCGACGAACCAACCAATTACTTCGATATTGCTACGCAAGATTTAATATTACAGATGCTAAAGCAATTTGCAGGACAAGTAATGATTGTGACGCATGATGAATACTTGAAATCTCAAATTACAGCGACACATTGGACAATTAAAGATAAAAAGTTAATGAATTTAACATTATCAGAGAAGCATTCACCCAATATGGTGGATGATACATTAAAATTATTAGATGATTATAAGTCGATAGATGAATTCGGACATTTTGAAACAGACAACTAG", "partial": "0", "query_start": 51421, "query_end": 52041, "hit_start": 996, "hit_end": 1542, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 22.12}, "gnl|BL_ORD_ID|853|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "carA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1050", "model_id": "928", "ARO_accession": "3002817", "ARO_name": "carA", "ARO_category": {"45630": {"category_aro_accession": "3007068", "category_aro_cvterm_id": "45630", "category_aro_name": "Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins", "category_aro_description": "ABC-F subfamily ATP-binding cassette ribosomal protection proteins of unknown, unclear or miscellaneous classification which nevertheless confer resistance to antibiotics through ribosomal protection and not through antibiotic efflux. These proteins should be further reviewed to elucidate associated genes, their function, origin and classification.", "category_aro_class_name": "AMR Gene Family"}, "37627": {"category_aro_accession": "3001228", "category_aro_cvterm_id": "37627", "category_aro_name": "carbomycin", "category_aro_description": "Produced by Streptomyces halstedii and Streptomyces thermotolerans.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.65916e-12, "max_identities": 65, "bit_score": 62.7734, "cvterm_id": "36843", "query": "VSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRT-----------------------------------------RVMTLLEQVGLEKHAK-HRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTH-ANAVVRLADGKIL", "match": "++L ++TK Y    V    L  +   + PGE + + G +GSGK+T + LI   +   +G V+V               +    +G++ Q+  L    +V   V+  L   R+L    RRT                                         RV   L  +GL    +  R   LSGG+R R+A+A  L + P+L+L DEPT +LD       +D ++E  RK   T +  THD   +      ++ +  GK++", "sequence_from_db": "LALHDITKRYQDHVV----LDRIGFTIKPGEKVGVIGDNGSGKSTLIKLIAGREQPDNGAVTV---------------VAPGGVGYLAQTLELPLEATVQDAVDLALADLRELEEGMRRTEAELAERPYQTGQDPELAGLLESYAALVDRYQARGGYEADSRVEIALHGLGLPGLERGRRLGTLSGGERSRLALAATLASEPELLLLDEPTNDLDD----RAVDWLEEHLRKHKGTVVAVTHDRLFLDRLTTTILEIDSGKVM", "sequence_from_broadstreet": "MSTAQLALHDITKRYQDHVVLDRIGFTIKPGEKVGVIGDNGSGKSTLIKLIAGREQPDNGAVTVVAPGGVGYLAQTLELPLEATVQDAVDLALADLRELEEGMRRTEAELAERPYQTGQDPELAGLLESYAALVDRYQARGGYEADSRVEIALHGLGLPGLERGRRLGTLSGGERSRLALAATLASEPELLLLDEPTNDLDDRAVDWLEEHLRKHKGTVVAVTHDRLFLDRLTTTILEIDSGKVMRYGNGYEGYLAAKAAERQRRLLEYEQWRAELDRSRDLIASNVARLDAIPRKLPFAVFGAGQFRMRGRGHGAMVRIRNAKERVARLTENPVAPPPEPLTFTAEITTEAAQSRETVAELTGVRVGDRLSVDSLHLGPGERLLVTGPNGAGKTTLLRVLSGELEPDSGSLLVSGRVGHLRQEQTPWRPGMTVLQAFSSGRAGDIDEHTEALLSLGLFSPDDLRQRVQDLSYGQRRRIELARLVTEPVDLLLLDEPTNHLSPALVEELEEALTGYQGTVVVVTHDRRMRSRFNGAHLTLQDGRVAEFTAA", "dna_sequence_from_broadstreet": "GTGTCGACAGCGCAACTAGCTCTGCATGACATCACCAAGCGTTACCAGGACCACGTCGTACTCGACCGGATCGGCTTCACCATCAAGCCGGGCGAGAAGGTCGGTGTCATCGGGGACAACGGATCCGGCAAGTCCACGCTGATCAAGCTCATCGCCGGGCGGGAACAGCCGGACAACGGTGCGGTGACGGTGGTCGCGCCCGGTGGCGTCGGCTATCTGGCCCAGACACTGGAGCTGCCGCTGGAGGCCACGGTCCAGGACGCCGTCGATCTGGCCCTGGCCGACCTGCGGGAGCTGGAGGAGGGCATGCGCCGGACCGAGGCCGAGCTGGCCGAACGGCCCTACCAAACGGGCCAAGACCCCGAACTCGCCGGCCTCCTGGAGAGTTACGCCGCGCTGGTGGACCGGTATCAGGCCCGCGGCGGCTACGAGGCCGACTCCCGCGTGGAGATCGCGCTGCACGGGCTCGGGCTGCCCGGGCTGGAACGCGGCCGGCGGCTGGGCACCCTGTCCGGCGGCGAGCGCTCGCGCCTCGCCCTGGCGGCGACGCTGGCCTCGGAACCCGAACTGCTGCTGTTGGACGAGCCGACCAACGACCTGGACGACCGGGCCGTGGACTGGCTGGAGGAACACCTGCGCAAGCACAAAGGCACCGTTGTCGCCGTTACCCACGACCGGCTCTTCCTCGACCGGCTCACCACCACGATCCTGGAGATCGACTCCGGCAAGGTGATGCGCTACGGCAACGGCTACGAGGGCTACCTGGCAGCCAAGGCGGCGGAACGGCAGCGCAGGCTGCTTGAGTACGAGCAGTGGCGCGCCGAGCTGGACCGCAGCCGCGACCTGATCGCGTCCAACGTGGCGCGTCTGGACGCCATCCCACGCAAGCTGCCCTTCGCCGTCTTCGGCGCCGGCCAGTTCCGGATGCGCGGGCGGGGCCATGGTGCGATGGTGCGGATCCGCAACGCCAAGGAACGCGTCGCGCGGCTGACCGAAAACCCGGTCGCGCCGCCGCCCGAGCCGCTCACCTTCACCGCGGAGATCACCACCGAGGCCGCGCAGTCCCGGGAGACGGTGGCCGAACTCACCGGCGTCCGGGTCGGCGACCGGCTCAGCGTCGACTCCCTGCACCTCGGGCCCGGTGAACGGCTGCTGGTCACCGGCCCCAACGGGGCGGGCAAGACGACGCTGCTGCGGGTGCTCTCCGGGGAGCTGGAACCCGACAGCGGATCCCTGCTGGTGTCGGGCCGGGTGGGACACCTGAGGCAGGAACAGACACCATGGCGGCCGGGTATGACGGTGCTTCAGGCGTTCAGCAGCGGACGGGCCGGTGACATCGACGAGCACACCGAGGCGCTGCTCTCCCTCGGGCTGTTCAGCCCGGACGACCTCCGCCAGCGTGTGCAGGACCTGTCGTACGGGCAGCGGCGCCGCATCGAGCTTGCCCGGCTGGTGACGGAGCCGGTCGACCTGCTGCTGCTGGACGAACCCACCAACCACCTCTCGCCCGCGCTCGTCGAGGAACTGGAGGAGGCGCTGACCGGTTATCAGGGCACGGTCGTCGTCGTCACCCACGACCGGCGCATGCGGTCCCGCTTCAACGGCGCCCATCTGACGCTGCAGGACGGGCGCGTCGCCGAGTTCACCGCCGCCTGA", "partial": "0", "query_start": 51361, "query_end": 52020, "hit_start": 15, "hit_end": 735, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 24.71}, "gnl|BL_ORD_ID|853|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "carA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1050", "model_id": "928", "ARO_accession": "3002817", "ARO_name": "carA", "ARO_category": {"45630": {"category_aro_accession": "3007068", "category_aro_cvterm_id": "45630", "category_aro_name": "Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins", "category_aro_description": "ABC-F subfamily ATP-binding cassette ribosomal protection proteins of unknown, unclear or miscellaneous classification which nevertheless confer resistance to antibiotics through ribosomal protection and not through antibiotic efflux. These proteins should be further reviewed to elucidate associated genes, their function, origin and classification.", "category_aro_class_name": "AMR Gene Family"}, "37627": {"category_aro_accession": "3001228", "category_aro_cvterm_id": "37627", "category_aro_name": "carbomycin", "category_aro_description": "Produced by Streptomyces halstedii and Streptomyces thermotolerans.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.77254e-09, "max_identities": 69, "bit_score": 55.0694, "cvterm_id": "36843", "query": "ERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGV---------TLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGF-----IFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRP-KLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHAN-AVVRLADGKI", "match": "ER+  +     A P   +P+    E+T   +  +  V  L GV         +L + PGE + + GP+G+GKTT L ++       SG + V G         ++ HLR     +     + Q+F+      + ++ E  LL     +  + R RV                  +LS GQR+R+ +AR LVT P  L+L DEPT +L       + +L + L   +GT  +  THD ++ +  N A + L DG++", "sequence_from_db": "ERVARLTENPVAPP--PEPLTFTAEITTEAAQSRETVAELTGVRVGDRLSVDSLHLGPGERLLVTGPNGAGKTTLLRVLSGELEPDSGSLLVSG---------RVGHLRQEQTPWRPGMTVLQAFSSGRAGDIDEHTE-ALLSLGLFSPDDLRQRV-----------------QDLSYGQRRRIELAR-LVTEPVDLLLLDEPTNHLSPAL---VEELEEALTGYQGTVVVV-THDRRMRSRFNGAHLTLQDGRV", "sequence_from_broadstreet": "MSTAQLALHDITKRYQDHVVLDRIGFTIKPGEKVGVIGDNGSGKSTLIKLIAGREQPDNGAVTVVAPGGVGYLAQTLELPLEATVQDAVDLALADLRELEEGMRRTEAELAERPYQTGQDPELAGLLESYAALVDRYQARGGYEADSRVEIALHGLGLPGLERGRRLGTLSGGERSRLALAATLASEPELLLLDEPTNDLDDRAVDWLEEHLRKHKGTVVAVTHDRLFLDRLTTTILEIDSGKVMRYGNGYEGYLAAKAAERQRRLLEYEQWRAELDRSRDLIASNVARLDAIPRKLPFAVFGAGQFRMRGRGHGAMVRIRNAKERVARLTENPVAPPPEPLTFTAEITTEAAQSRETVAELTGVRVGDRLSVDSLHLGPGERLLVTGPNGAGKTTLLRVLSGELEPDSGSLLVSGRVGHLRQEQTPWRPGMTVLQAFSSGRAGDIDEHTEALLSLGLFSPDDLRQRVQDLSYGQRRRIELARLVTEPVDLLLLDEPTNHLSPALVEELEEALTGYQGTVVVVTHDRRMRSRFNGAHLTLQDGRVAEFTAA", "dna_sequence_from_broadstreet": "GTGTCGACAGCGCAACTAGCTCTGCATGACATCACCAAGCGTTACCAGGACCACGTCGTACTCGACCGGATCGGCTTCACCATCAAGCCGGGCGAGAAGGTCGGTGTCATCGGGGACAACGGATCCGGCAAGTCCACGCTGATCAAGCTCATCGCCGGGCGGGAACAGCCGGACAACGGTGCGGTGACGGTGGTCGCGCCCGGTGGCGTCGGCTATCTGGCCCAGACACTGGAGCTGCCGCTGGAGGCCACGGTCCAGGACGCCGTCGATCTGGCCCTGGCCGACCTGCGGGAGCTGGAGGAGGGCATGCGCCGGACCGAGGCCGAGCTGGCCGAACGGCCCTACCAAACGGGCCAAGACCCCGAACTCGCCGGCCTCCTGGAGAGTTACGCCGCGCTGGTGGACCGGTATCAGGCCCGCGGCGGCTACGAGGCCGACTCCCGCGTGGAGATCGCGCTGCACGGGCTCGGGCTGCCCGGGCTGGAACGCGGCCGGCGGCTGGGCACCCTGTCCGGCGGCGAGCGCTCGCGCCTCGCCCTGGCGGCGACGCTGGCCTCGGAACCCGAACTGCTGCTGTTGGACGAGCCGACCAACGACCTGGACGACCGGGCCGTGGACTGGCTGGAGGAACACCTGCGCAAGCACAAAGGCACCGTTGTCGCCGTTACCCACGACCGGCTCTTCCTCGACCGGCTCACCACCACGATCCTGGAGATCGACTCCGGCAAGGTGATGCGCTACGGCAACGGCTACGAGGGCTACCTGGCAGCCAAGGCGGCGGAACGGCAGCGCAGGCTGCTTGAGTACGAGCAGTGGCGCGCCGAGCTGGACCGCAGCCGCGACCTGATCGCGTCCAACGTGGCGCGTCTGGACGCCATCCCACGCAAGCTGCCCTTCGCCGTCTTCGGCGCCGGCCAGTTCCGGATGCGCGGGCGGGGCCATGGTGCGATGGTGCGGATCCGCAACGCCAAGGAACGCGTCGCGCGGCTGACCGAAAACCCGGTCGCGCCGCCGCCCGAGCCGCTCACCTTCACCGCGGAGATCACCACCGAGGCCGCGCAGTCCCGGGAGACGGTGGCCGAACTCACCGGCGTCCGGGTCGGCGACCGGCTCAGCGTCGACTCCCTGCACCTCGGGCCCGGTGAACGGCTGCTGGTCACCGGCCCCAACGGGGCGGGCAAGACGACGCTGCTGCGGGTGCTCTCCGGGGAGCTGGAACCCGACAGCGGATCCCTGCTGGTGTCGGGCCGGGTGGGACACCTGAGGCAGGAACAGACACCATGGCGGCCGGGTATGACGGTGCTTCAGGCGTTCAGCAGCGGACGGGCCGGTGACATCGACGAGCACACCGAGGCGCTGCTCTCCCTCGGGCTGTTCAGCCCGGACGACCTCCGCCAGCGTGTGCAGGACCTGTCGTACGGGCAGCGGCGCCGCATCGAGCTTGCCCGGCTGGTGACGGAGCCGGTCGACCTGCTGCTGCTGGACGAACCCACCAACCACCTCTCGCCCGCGCTCGTCGAGGAACTGGAGGAGGCGCTGACCGGTTATCAGGGCACGGTCGTCGTCGTCACCCACGACCGGCGCATGCGGTCCCGCTTCAACGGCGCCCATCTGACGCTGCAGGACGGGCGCGTCGCCGAGTTCACCGCCGCCTGA", "partial": "0", "query_start": 51301, "query_end": 52017, "hit_start": 972, "hit_end": 1635, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 27.06}, "gnl|BL_ORD_ID|1841|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "tlrC", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1020", "model_id": "1997", "ARO_accession": "3002827", "ARO_name": "tlrC", "ARO_category": {"45630": {"category_aro_accession": "3007068", "category_aro_cvterm_id": "45630", "category_aro_name": "Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins", "category_aro_description": "ABC-F subfamily ATP-binding cassette ribosomal protection proteins of unknown, unclear or miscellaneous classification which nevertheless confer resistance to antibiotics through ribosomal protection and not through antibiotic efflux. These proteins should be further reviewed to elucidate associated genes, their function, origin and classification.", "category_aro_class_name": "AMR Gene Family"}, "35964": {"category_aro_accession": "0000046", "category_aro_cvterm_id": "35964", "category_aro_name": "lincomycin", "category_aro_description": "Lincomycin is a lincosamide antibiotic that comes from the actinomyces Streptomyces lincolnensis. It binds to the 23s portion of the 50S subunit of bacterial ribosomes and inhibit early elongation of peptide chain by inhibiting transpeptidase reaction.", "category_aro_class_name": "Antibiotic"}, "36284": {"category_aro_accession": "3000145", "category_aro_cvterm_id": "36284", "category_aro_name": "tylosin", "category_aro_description": "Tylosin is a 16-membered macrolide, naturally produced by Streptomyces fradiae. It interacts with the bacterial ribosome 50S subunit to inhibit protein synthesis.", "category_aro_class_name": "Antibiotic"}, "37623": {"category_aro_accession": "3001224", "category_aro_cvterm_id": "37623", "category_aro_name": "mycinamicin", "category_aro_description": "Produced by Micromonospora\u00a0griseorubida.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.44415e-10, "max_identities": 69, "bit_score": 58.5362, "cvterm_id": "36838", "query": "VSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERR-------------------------------------TRVMTLLEQVGLEKHAKHRP-NELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDR", "match": "+SL  VTK Y    V    L  V+L + PGE   I G +G+GK+T L L+   +   +G V+V               +    +G++ Q+  L    +V   ++  +   R L A  RR                                      RV   L  +GL    + R    LSGG+R R+A+A  L ++P+L+L DEPT +LD    + +  L + L+   G T +  THD   +    A V   DG+ + R", "sequence_from_db": "LSLHGVTKRYDDRVV----LSQVSLAISPGEKAGIIGDNGAGKSTLLRLLAGEERPDAGEVTV---------------IAPGGVGYLPQTLGLPPRATVQDAIDLAMTELRVLEAELRRTEAALAEAATDEALQDALTAYARLTEQYEVRDGYGADARVDAALHGLGLPGLPRDRRLGTLSGGERSRLALAATLASQPELLLLDEPTNDLDD---RAVHWLEEHLSGHRG-TVVTVTHDRVFLDRLTATVLEVDGRGVSR", "sequence_from_broadstreet": "MRTSPSSQLSLHGVTKRYDDRVVLSQVSLAISPGEKAGIIGDNGAGKSTLLRLLAGEERPDAGEVTVIAPGGVGYLPQTLGLPPRATVQDAIDLAMTELRVLEAELRRTEAALAEAATDEALQDALTAYARLTEQYEVRDGYGADARVDAALHGLGLPGLPRDRRLGTLSGGERSRLALAATLASQPELLLLDEPTNDLDDRAVHWLEEHLSGHRGTVVTVTHDRVFLDRLTATVLEVDGRGVSRHGDGYAGYLAAKAAERRRRQQQYDEWRAELDRNRRLAEANVARLDGIPRKMGKAAFGHGAFRARGRDHGAMSRVRNAKERVERLTANPVAPPADRLSLTARIATADGPGEAPAAELDGVVVGSRLRVPKLRLGAAERLLITGPNGAGKSTLLSVLAGELSPDAGAVSVPGRVGHLRQEETPWPAKLTVLEAFAHNRPGDRDEQADRRLSLGLFEPEALRLRVGELSYGQRRRIELARLVSEPVGLLLLDEPTNHLSPALVEELEEALTGYGGALVLVTHDRRMRSRFTGSHLELREGVVSGAR", "dna_sequence_from_broadstreet": "ATGCGTACATCACCTTCCTCCCAGCTTTCCCTGCACGGTGTCACCAAGCGCTACGACGACCGTGTCGTGCTCAGTCAGGTCTCCCTCGCCATCTCCCCGGGGGAGAAGGCCGGCATCATCGGCGACAACGGGGCCGGGAAGTCCACCCTGCTCCGTCTGCTCGCCGGTGAGGAACGGCCCGACGCGGGGGAGGTGACCGTGATCGCGCCCGGCGGTGTCGGCTACCTCCCGCAGACCCTCGGCCTGCCGCCGCGGGCCACGGTGCAGGACGCCATCGATCTGGCCATGACCGAGCTGCGCGTCCTGGAGGCCGAACTGCGCCGTACCGAGGCCGCGTTGGCCGAGGCCGCCACGGACGAGGCCCTGCAGGACGCCCTCACCGCGTACGCCCGTCTGACCGAGCAGTACGAGGTCCGTGACGGCTACGGCGCCGATGCCCGCGTGGACGCCGCGCTGCACGGTCTCGGGCTGCCCGGACTGCCACGTGACCGGCGGCTGGGCACCCTCTCCGGTGGAGAGCGATCGCGGCTGGCGCTGGCGGCCACCCTGGCGTCCCAGCCGGAACTGCTGCTGCTCGACGAGCCGACCAACGACCTGGACGACCGGGCCGTCCACTGGCTGGAGGAACATCTGAGCGGCCACCGCGGCACCGTCGTCACGGTGACCCACGACCGGGTGTTCCTGGACCGGCTCACCGCCACGGTCCTGGAGGTCGACGGCCGCGGCGTCTCCCGCCACGGCGACGGCTACGCGGGGTATCTCGCCGCCAAGGCCGCCGAGCGCCGCCGGCGGCAGCAGCAGTACGACGAGTGGCGCGCCGAACTCGACCGCAACCGCCGGCTGGCCGAGGCCAACGTCGCCCGGCTGGACGGCATCCCGCGCAAGATGGGGAAGGCCGCCTTCGGGCACGGCGCGTTCCGCGCGCGCGGGCGCGACCACGGCGCGATGAGCCGGGTCCGCAACGCCAAGGAGCGGGTCGAGCGGCTCACCGCGAATCCGGTGGCGCCACCGGCGGACCGGCTCTCCCTCACCGCGCGCATCGCCACGGCGGACGGCCCGGGGGAGGCGCCGGCCGCGGAACTCGACGGCGTGGTCGTCGGCAGCCGGCTGCGCGTGCCGAAGCTGCGCCTGGGCGCGGCCGAACGGCTGCTGATCACCGGCCCCAATGGCGCGGGCAAGAGCACCCTGCTGTCCGTGCTGGCCGGGGAACTGAGCCCGGACGCGGGCGCGGTGAGCGTCCCCGGGCGCGTGGGGCATCTGCGCCAGGAGGAGACGCCCTGGCCCGCGAAGCTGACCGTGCTGGAGGCCTTCGCCCACAACCGGCCCGGCGACCGGGACGAACAGGCCGACCGGCGGCTGTCCCTCGGCCTGTTCGAGCCGGAGGCGCTGCGGCTGCGGGTCGGGGAGCTGTCGTACGGTCAGCGCCGCCGCATCGAACTGGCCCGGCTGGTCAGCGAGCCGGTGGGTCTGCTCCTGCTGGACGAGCCCACCAACCACCTCTCACCGGCGCTGGTGGAGGAGTTGGAGGAGGCGCTGACGGGCTACGGGGGCGCGCTGGTGCTGGTCACCCACGACCGGCGGATGCGAAGCCGGTTCACCGGCTCGCATCTGGAGCTGCGCGAGGGCGTCGTCTCCGGCGCACGCTGA", "partial": "0", "query_start": 51361, "query_end": 52026, "hit_start": 24, "hit_end": 735, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 26.54}, "gnl|BL_ORD_ID|1841|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "tlrC", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1020", "model_id": "1997", "ARO_accession": "3002827", "ARO_name": "tlrC", "ARO_category": {"45630": {"category_aro_accession": "3007068", "category_aro_cvterm_id": "45630", "category_aro_name": "Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins", "category_aro_description": "ABC-F subfamily ATP-binding cassette ribosomal protection proteins of unknown, unclear or miscellaneous classification which nevertheless confer resistance to antibiotics through ribosomal protection and not through antibiotic efflux. These proteins should be further reviewed to elucidate associated genes, their function, origin and classification.", "category_aro_class_name": "AMR Gene Family"}, "35964": {"category_aro_accession": "0000046", "category_aro_cvterm_id": "35964", "category_aro_name": "lincomycin", "category_aro_description": "Lincomycin is a lincosamide antibiotic that comes from the actinomyces Streptomyces lincolnensis. It binds to the 23s portion of the 50S subunit of bacterial ribosomes and inhibit early elongation of peptide chain by inhibiting transpeptidase reaction.", "category_aro_class_name": "Antibiotic"}, "36284": {"category_aro_accession": "3000145", "category_aro_cvterm_id": "36284", "category_aro_name": "tylosin", "category_aro_description": "Tylosin is a 16-membered macrolide, naturally produced by Streptomyces fradiae. It interacts with the bacterial ribosome 50S subunit to inhibit protein synthesis.", "category_aro_class_name": "Antibiotic"}, "37623": {"category_aro_accession": "3001224", "category_aro_cvterm_id": "37623", "category_aro_name": "mycinamicin", "category_aro_description": "Produced by Micromonospora\u00a0griseorubida.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.98838e-08, "max_identities": 57, "bit_score": 51.6026, "cvterm_id": "36838", "query": "KVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGL-EKHA-KHRPNELSGGQRQRVAVARALVTRP-KLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMT", "match": "+++VP LR     +   E + I GP+G+GK+T L+++    +  +G VSV G+         + HLR     +  +    ++VL  F +        R  +  E+  R ++L    GL E  A + R  ELS GQR+R+ +AR LV+ P  L+L DEPT +L       +++ ++E     G   +  THD ++ +", "sequence_from_db": "RLRVPKLR-----LGAAERLLITGPNGAGKSTLLSVLAGELSPDAGAVSVPGR---------VGHLRQEETPWPAK----LTVLEAFAH-------NRPGDRDEQADRRLSL----GLFEPEALRLRVGELSYGQRRRIELAR-LVSEPVGLLLLDEPTNHLSPA----LVEELEEALTGYGGALVLVTHDRRMRS", "sequence_from_broadstreet": "MRTSPSSQLSLHGVTKRYDDRVVLSQVSLAISPGEKAGIIGDNGAGKSTLLRLLAGEERPDAGEVTVIAPGGVGYLPQTLGLPPRATVQDAIDLAMTELRVLEAELRRTEAALAEAATDEALQDALTAYARLTEQYEVRDGYGADARVDAALHGLGLPGLPRDRRLGTLSGGERSRLALAATLASQPELLLLDEPTNDLDDRAVHWLEEHLSGHRGTVVTVTHDRVFLDRLTATVLEVDGRGVSRHGDGYAGYLAAKAAERRRRQQQYDEWRAELDRNRRLAEANVARLDGIPRKMGKAAFGHGAFRARGRDHGAMSRVRNAKERVERLTANPVAPPADRLSLTARIATADGPGEAPAAELDGVVVGSRLRVPKLRLGAAERLLITGPNGAGKSTLLSVLAGELSPDAGAVSVPGRVGHLRQEETPWPAKLTVLEAFAHNRPGDRDEQADRRLSLGLFEPEALRLRVGELSYGQRRRIELARLVSEPVGLLLLDEPTNHLSPALVEELEEALTGYGGALVLVTHDRRMRSRFTGSHLELREGVVSGAR", "dna_sequence_from_broadstreet": "ATGCGTACATCACCTTCCTCCCAGCTTTCCCTGCACGGTGTCACCAAGCGCTACGACGACCGTGTCGTGCTCAGTCAGGTCTCCCTCGCCATCTCCCCGGGGGAGAAGGCCGGCATCATCGGCGACAACGGGGCCGGGAAGTCCACCCTGCTCCGTCTGCTCGCCGGTGAGGAACGGCCCGACGCGGGGGAGGTGACCGTGATCGCGCCCGGCGGTGTCGGCTACCTCCCGCAGACCCTCGGCCTGCCGCCGCGGGCCACGGTGCAGGACGCCATCGATCTGGCCATGACCGAGCTGCGCGTCCTGGAGGCCGAACTGCGCCGTACCGAGGCCGCGTTGGCCGAGGCCGCCACGGACGAGGCCCTGCAGGACGCCCTCACCGCGTACGCCCGTCTGACCGAGCAGTACGAGGTCCGTGACGGCTACGGCGCCGATGCCCGCGTGGACGCCGCGCTGCACGGTCTCGGGCTGCCCGGACTGCCACGTGACCGGCGGCTGGGCACCCTCTCCGGTGGAGAGCGATCGCGGCTGGCGCTGGCGGCCACCCTGGCGTCCCAGCCGGAACTGCTGCTGCTCGACGAGCCGACCAACGACCTGGACGACCGGGCCGTCCACTGGCTGGAGGAACATCTGAGCGGCCACCGCGGCACCGTCGTCACGGTGACCCACGACCGGGTGTTCCTGGACCGGCTCACCGCCACGGTCCTGGAGGTCGACGGCCGCGGCGTCTCCCGCCACGGCGACGGCTACGCGGGGTATCTCGCCGCCAAGGCCGCCGAGCGCCGCCGGCGGCAGCAGCAGTACGACGAGTGGCGCGCCGAACTCGACCGCAACCGCCGGCTGGCCGAGGCCAACGTCGCCCGGCTGGACGGCATCCCGCGCAAGATGGGGAAGGCCGCCTTCGGGCACGGCGCGTTCCGCGCGCGCGGGCGCGACCACGGCGCGATGAGCCGGGTCCGCAACGCCAAGGAGCGGGTCGAGCGGCTCACCGCGAATCCGGTGGCGCCACCGGCGGACCGGCTCTCCCTCACCGCGCGCATCGCCACGGCGGACGGCCCGGGGGAGGCGCCGGCCGCGGAACTCGACGGCGTGGTCGTCGGCAGCCGGCTGCGCGTGCCGAAGCTGCGCCTGGGCGCGGCCGAACGGCTGCTGATCACCGGCCCCAATGGCGCGGGCAAGAGCACCCTGCTGTCCGTGCTGGCCGGGGAACTGAGCCCGGACGCGGGCGCGGTGAGCGTCCCCGGGCGCGTGGGGCATCTGCGCCAGGAGGAGACGCCCTGGCCCGCGAAGCTGACCGTGCTGGAGGCCTTCGCCCACAACCGGCCCGGCGACCGGGACGAACAGGCCGACCGGCGGCTGTCCCTCGGCCTGTTCGAGCCGGAGGCGCTGCGGCTGCGGGTCGGGGAGCTGTCGTACGGTCAGCGCCGCCGCATCGAACTGGCCCGGCTGGTCAGCGAGCCGGTGGGTCTGCTCCTGCTGGACGAGCCCACCAACCACCTCTCACCGGCGCTGGTGGAGGAGTTGGAGGAGGCGCTGACGGGCTACGGGGGCGCGCTGGTGCTGGTCACCCACGACCGGCGGATGCGAAGCCGGTTCACCGGCTCGCATCTGGAGCTGCGCGAGGGCGTCGTCTCCGGCGCACGCTGA", "partial": "0", "query_start": 51400, "query_end": 51978, "hit_start": 1104, "hit_end": 1590, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 29.08}, "gnl|BL_ORD_ID|900|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "lmrC", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1050", "model_id": "974", "ARO_accession": "3002881", "ARO_name": "lmrC", "ARO_category": {"45630": {"category_aro_accession": "3007068", "category_aro_cvterm_id": "45630", "category_aro_name": "Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins", "category_aro_description": "ABC-F subfamily ATP-binding cassette ribosomal protection proteins of unknown, unclear or miscellaneous classification which nevertheless confer resistance to antibiotics through ribosomal protection and not through antibiotic efflux. These proteins should be further reviewed to elucidate associated genes, their function, origin and classification.", "category_aro_class_name": "AMR Gene Family"}, "35964": {"category_aro_accession": "0000046", "category_aro_cvterm_id": "35964", "category_aro_name": "lincomycin", "category_aro_description": "Lincomycin is a lincosamide antibiotic that comes from the actinomyces Streptomyces lincolnensis. It binds to the 23s portion of the 50S subunit of bacterial ribosomes and inhibit early elongation of peptide chain by inhibiting transpeptidase reaction.", "category_aro_class_name": "Antibiotic"}, "35983": {"category_aro_accession": "0000066", "category_aro_cvterm_id": "35983", "category_aro_name": "clindamycin", "category_aro_description": "Clindamycin is a lincosamide antibiotic that blocks A-site aminoacyl-tRNA binding. It is usually used to treat infections with anaerobic bacteria but can also be used to treat some protozoal diseases, such as malaria.", "category_aro_class_name": "Antibiotic"}, "37630": {"category_aro_accession": "3001231", "category_aro_cvterm_id": "37630", "category_aro_name": "celesticetin", "category_aro_description": "Produced by Streptomyces caelestis, which also produces the macrolide niddamycin.", "category_aro_class_name": "Antibiotic"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.79042e-10, "max_identities": 66, "bit_score": 57.7658, "cvterm_id": "36862", "query": "GVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSV-LSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHR-PNELSGGQRQRVAVARALVTRP--KLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVM--THANAVVRLADGKILDRITPAE", "match": "GV L +   E I++ GP+GSGK+T L LI      SSG V+         T+R         + ++ Q  +L+ +  SV  N+       R+     +   V   L Q        HR    LSGG+R R  +A  L T P  +L+L DEPT NLD     +   L   LN  +G  F+  +HD   +     +  +RLADG  L+ I  A+", "sequence_from_db": "GVDLGIRGPERIALLGPNGSGKSTLLKLIAGELEPSSGTVTAP-------TDR---------VSYLSQRLDLLDLDASVLDNL-------RRFAPHLQDGEVRYRLAQFLFRGDRVHRTAGWLSGGERLRATLACVLSTDPAPQLLLLDEPTNNLDL---NSAAQLENALNAFQG-AFVVVSHDQAFLRAIGVSRWLRLADG-TLEEIAEAD", "sequence_from_broadstreet": "MADASIVCTNLSFSWPDETPVFDGLSFALGAGRCGLVGPNGAGKSTLLRLAVGELTPTAGSITAQGHVGYLPQSLPLIDGTVDEALEIASIRAALHAIESGDVDEAHFTTVGDHWDIEERTTIVLDRLGLGDVSLDRPLRSLSGGQVLAIGLAAQLLKRPDVLILDEPTNNLDLAARQRLYQVVEEWKGALLVVSHDRELLDRVDTIAELQASELRLYGGNFTAYTEAVELEQENVQRAVRGAEQELRRHKREAQAAQERAQRRASNAKRNKASSGVPRIHAGALQRQAQESAGRAASVHQDRVSQAKAKLDEASQGMREEARLAITLPQTSVPAGRTVLTCHEANVRYGERTLFTGSGVDLGIRGPERIALLGPNGSGKSTLLKLIAGELEPSSGTVTAPTDRVSYLSQRLDLLDLDASVLDNLRRFAPHLQDGEVRYRLAQFLFRGDRVHRTAGWLSGGERLRATLACVLSTDPAPQLLLLDEPTNNLDLNSAAQLENALNAFQGAFVVVSHDQAFLRAIGVSRWLRLADGTLEEIAEADDAWPHRDK", "dna_sequence_from_broadstreet": "ATGGCTGACGCGAGTATTGTCTGCACCAATCTCTCCTTCTCCTGGCCCGACGAGACGCCGGTCTTCGACGGGTTGTCCTTTGCCCTCGGCGCCGGCCGTTGCGGCCTCGTGGGCCCCAATGGCGCGGGAAAGTCCACACTGTTGCGGCTCGCCGTAGGGGAACTCACCCCTACCGCAGGCTCGATCACCGCGCAGGGACATGTCGGGTACCTGCCGCAGTCCCTGCCGCTGATCGACGGCACCGTCGACGAGGCCCTGGAGATCGCCTCCATCCGGGCGGCTCTGCATGCCATCGAGTCAGGTGACGTGGACGAGGCGCACTTCACCACTGTGGGCGATCACTGGGACATCGAGGAACGCACCACGATCGTCCTGGACCGTCTGGGTCTCGGCGACGTGTCCCTTGACCGCCCGCTTCGCTCCCTCAGCGGCGGCCAGGTCCTCGCCATCGGCCTGGCCGCGCAGCTCCTGAAGCGACCCGACGTGCTGATCCTCGACGAACCCACCAACAACCTTGACCTGGCCGCCCGGCAGCGGCTCTACCAGGTCGTCGAAGAGTGGAAGGGGGCCCTCCTCGTCGTCAGCCACGACCGGGAGCTCCTGGACCGCGTAGACACCATCGCCGAGCTGCAGGCATCCGAACTCCGCCTCTACGGTGGCAACTTCACCGCCTACACGGAAGCCGTCGAGCTGGAACAGGAGAACGTGCAGCGCGCGGTGCGCGGGGCGGAGCAGGAGTTGCGCCGCCACAAGCGCGAGGCGCAGGCGGCCCAGGAGCGGGCCCAGCGCCGGGCCAGCAACGCCAAGCGCAACAAGGCTTCGTCGGGGGTGCCCCGTATCCACGCGGGCGCCCTTCAGCGACAGGCTCAGGAATCGGCGGGCCGCGCCGCCTCGGTGCACCAGGACCGGGTGTCCCAGGCCAAGGCCAAGCTGGACGAGGCCAGTCAGGGGATGCGTGAGGAAGCGCGCCTGGCGATCACCCTTCCGCAGACCTCGGTCCCGGCCGGACGCACCGTGTTGACGTGCCATGAGGCCAATGTCCGGTACGGGGAACGGACGTTGTTCACCGGCTCGGGCGTCGACCTCGGGATCCGCGGGCCGGAGCGGATCGCGCTGCTCGGGCCCAACGGCTCGGGCAAGTCAACGCTGTTGAAGCTGATCGCCGGCGAGCTCGAACCCTCCTCGGGGACGGTCACGGCGCCGACGGACCGGGTGTCCTATCTCTCGCAGCGCCTCGATCTGCTCGACTTGGACGCCAGCGTCCTGGACAACCTGCGCCGTTTCGCCCCGCATCTGCAGGACGGCGAAGTCCGCTACCGCCTGGCGCAGTTCCTCTTCCGCGGCGACCGAGTTCATCGCACCGCCGGATGGCTCTCCGGCGGTGAGCGGCTGCGCGCGACCCTGGCGTGTGTCCTGTCCACGGACCCTGCCCCTCAGCTGCTCCTGCTGGACGAGCCGACGAACAACCTCGACCTCAACAGTGCCGCCCAGCTGGAGAACGCGCTCAACGCCTTCCAGGGCGCCTTCGTAGTCGTCAGCCACGACCAGGCGTTCCTGCGCGCCATCGGTGTCTCGCGCTGGCTGCGCCTGGCGGACGGAACCCTGGAGGAGATCGCGGAGGCGGACGACGCGTGGCCTCATCGGGATAAGTGA", "partial": "0", "query_start": 51424, "query_end": 52041, "hit_start": 1074, "hit_end": 1626, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 31.13}, "gnl|BL_ORD_ID|900|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "lmrC", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1050", "model_id": "974", "ARO_accession": "3002881", "ARO_name": "lmrC", "ARO_category": {"45630": {"category_aro_accession": "3007068", "category_aro_cvterm_id": "45630", "category_aro_name": "Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins", "category_aro_description": "ABC-F subfamily ATP-binding cassette ribosomal protection proteins of unknown, unclear or miscellaneous classification which nevertheless confer resistance to antibiotics through ribosomal protection and not through antibiotic efflux. These proteins should be further reviewed to elucidate associated genes, their function, origin and classification.", "category_aro_class_name": "AMR Gene Family"}, "35964": {"category_aro_accession": "0000046", "category_aro_cvterm_id": "35964", "category_aro_name": "lincomycin", "category_aro_description": "Lincomycin is a lincosamide antibiotic that comes from the actinomyces Streptomyces lincolnensis. It binds to the 23s portion of the 50S subunit of bacterial ribosomes and inhibit early elongation of peptide chain by inhibiting transpeptidase reaction.", "category_aro_class_name": "Antibiotic"}, "35983": {"category_aro_accession": "0000066", "category_aro_cvterm_id": "35983", "category_aro_name": "clindamycin", "category_aro_description": "Clindamycin is a lincosamide antibiotic that blocks A-site aminoacyl-tRNA binding. It is usually used to treat infections with anaerobic bacteria but can also be used to treat some protozoal diseases, such as malaria.", "category_aro_class_name": "Antibiotic"}, "37630": {"category_aro_accession": "3001231", "category_aro_cvterm_id": "37630", "category_aro_name": "celesticetin", "category_aro_description": "Produced by Streptomyces caelestis, which also produces the macrolide niddamycin.", "category_aro_class_name": "Antibiotic"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.73981e-08, "max_identities": 49, "bit_score": 52.373, "cvterm_id": "36862", "query": "QVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLV-----------SVLSVFQNVEFPLLLQRKL----NASERRTRVMTLLEQVGLEKHAKHRP-NELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRL", "match": "+ P   G++  +  G    + GP+G+GK+T L L     T ++G ++  G                  +G++ QS  L+           S+ +    +E   + +       +  +   R   +L+++GL   +  RP   LSGGQ   + +A  L+ RP +++ DEPT NLD    Q +  +++E    +G   + S HD +++   + +  L", "sequence_from_db": "ETPVFDGLSFALGAGR-CGLVGPNGAGKSTLLRLAVGELTPTAGSITAQGH-----------------VGYLPQSLPLIDGTVDEALEIASIRAALHAIESGDVDEAHFTTVGDHWDIEERTTIVLDRLGLGDVSLDRPLRSLSGGQVLAIGLAAQLLKRPDVLILDEPTNNLDLAARQRLYQVVEEW---KGALLVVS-HDRELLDRVDTIAEL", "sequence_from_broadstreet": "MADASIVCTNLSFSWPDETPVFDGLSFALGAGRCGLVGPNGAGKSTLLRLAVGELTPTAGSITAQGHVGYLPQSLPLIDGTVDEALEIASIRAALHAIESGDVDEAHFTTVGDHWDIEERTTIVLDRLGLGDVSLDRPLRSLSGGQVLAIGLAAQLLKRPDVLILDEPTNNLDLAARQRLYQVVEEWKGALLVVSHDRELLDRVDTIAELQASELRLYGGNFTAYTEAVELEQENVQRAVRGAEQELRRHKREAQAAQERAQRRASNAKRNKASSGVPRIHAGALQRQAQESAGRAASVHQDRVSQAKAKLDEASQGMREEARLAITLPQTSVPAGRTVLTCHEANVRYGERTLFTGSGVDLGIRGPERIALLGPNGSGKSTLLKLIAGELEPSSGTVTAPTDRVSYLSQRLDLLDLDASVLDNLRRFAPHLQDGEVRYRLAQFLFRGDRVHRTAGWLSGGERLRATLACVLSTDPAPQLLLLDEPTNNLDLNSAAQLENALNAFQGAFVVVSHDQAFLRAIGVSRWLRLADGTLEEIAEADDAWPHRDK", "dna_sequence_from_broadstreet": "ATGGCTGACGCGAGTATTGTCTGCACCAATCTCTCCTTCTCCTGGCCCGACGAGACGCCGGTCTTCGACGGGTTGTCCTTTGCCCTCGGCGCCGGCCGTTGCGGCCTCGTGGGCCCCAATGGCGCGGGAAAGTCCACACTGTTGCGGCTCGCCGTAGGGGAACTCACCCCTACCGCAGGCTCGATCACCGCGCAGGGACATGTCGGGTACCTGCCGCAGTCCCTGCCGCTGATCGACGGCACCGTCGACGAGGCCCTGGAGATCGCCTCCATCCGGGCGGCTCTGCATGCCATCGAGTCAGGTGACGTGGACGAGGCGCACTTCACCACTGTGGGCGATCACTGGGACATCGAGGAACGCACCACGATCGTCCTGGACCGTCTGGGTCTCGGCGACGTGTCCCTTGACCGCCCGCTTCGCTCCCTCAGCGGCGGCCAGGTCCTCGCCATCGGCCTGGCCGCGCAGCTCCTGAAGCGACCCGACGTGCTGATCCTCGACGAACCCACCAACAACCTTGACCTGGCCGCCCGGCAGCGGCTCTACCAGGTCGTCGAAGAGTGGAAGGGGGCCCTCCTCGTCGTCAGCCACGACCGGGAGCTCCTGGACCGCGTAGACACCATCGCCGAGCTGCAGGCATCCGAACTCCGCCTCTACGGTGGCAACTTCACCGCCTACACGGAAGCCGTCGAGCTGGAACAGGAGAACGTGCAGCGCGCGGTGCGCGGGGCGGAGCAGGAGTTGCGCCGCCACAAGCGCGAGGCGCAGGCGGCCCAGGAGCGGGCCCAGCGCCGGGCCAGCAACGCCAAGCGCAACAAGGCTTCGTCGGGGGTGCCCCGTATCCACGCGGGCGCCCTTCAGCGACAGGCTCAGGAATCGGCGGGCCGCGCCGCCTCGGTGCACCAGGACCGGGTGTCCCAGGCCAAGGCCAAGCTGGACGAGGCCAGTCAGGGGATGCGTGAGGAAGCGCGCCTGGCGATCACCCTTCCGCAGACCTCGGTCCCGGCCGGACGCACCGTGTTGACGTGCCATGAGGCCAATGTCCGGTACGGGGAACGGACGTTGTTCACCGGCTCGGGCGTCGACCTCGGGATCCGCGGGCCGGAGCGGATCGCGCTGCTCGGGCCCAACGGCTCGGGCAAGTCAACGCTGTTGAAGCTGATCGCCGGCGAGCTCGAACCCTCCTCGGGGACGGTCACGGCGCCGACGGACCGGGTGTCCTATCTCTCGCAGCGCCTCGATCTGCTCGACTTGGACGCCAGCGTCCTGGACAACCTGCGCCGTTTCGCCCCGCATCTGCAGGACGGCGAAGTCCGCTACCGCCTGGCGCAGTTCCTCTTCCGCGGCGACCGAGTTCATCGCACCGCCGGATGGCTCTCCGGCGGTGAGCGGCTGCGCGCGACCCTGGCGTGTGTCCTGTCCACGGACCCTGCCCCTCAGCTGCTCCTGCTGGACGAGCCGACGAACAACCTCGACCTCAACAGTGCCGCCCAGCTGGAGAACGCGCTCAACGCCTTCCAGGGCGCCTTCGTAGTCGTCAGCCACGACCAGGCGTTCCTGCGCGCCATCGGTGTCTCGCGCTGGCTGCGCCTGGCGGACGGAACCCTGGAGGAGATCGCGGAGGCGGACGACGCGTGGCCTCATCGGGATAAGTGA", "partial": "0", "query_start": 51406, "query_end": 52002, "hit_start": 51, "hit_end": 630, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 22.79}, "gnl|BL_ORD_ID|1073|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "lsaB", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1000", "model_id": "1161", "ARO_accession": "3003111", "ARO_name": "lsaB", "ARO_category": {"41696": {"category_aro_accession": "3004472", "category_aro_cvterm_id": "41696", "category_aro_name": "lsa-type ABC-F protein", "category_aro_description": "A subgroup of the ABC-F protein subfamily of ATP-binding cassette proteins. lsa-type ABC-F proteins confer resistance to streptogramin, lincosamide and pleuromutilin antibiotics through antibiotic target protection of the ribosome.", "category_aro_class_name": "AMR Gene Family"}, "35983": {"category_aro_accession": "0000066", "category_aro_cvterm_id": "35983", "category_aro_name": "clindamycin", "category_aro_description": "Clindamycin is a lincosamide antibiotic that blocks A-site aminoacyl-tRNA binding. It is usually used to treat infections with anaerobic bacteria but can also be used to treat some protozoal diseases, such as malaria.", "category_aro_class_name": "Antibiotic"}, "37716": {"category_aro_accession": "3001317", "category_aro_cvterm_id": "37716", "category_aro_name": "pleuromutilin", "category_aro_description": "Pleuromutilin is a natural product antibiotic produced by Clitopilus passeckerianus. Related antibiotics of clinical significance, such as tiamulin and retapamulin, are semi-synthetic derivatives of this compound.", "category_aro_class_name": "Antibiotic"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "37014": {"category_aro_accession": "3000670", "category_aro_cvterm_id": "37014", "category_aro_name": "pleuromutilin antibiotic", "category_aro_description": "Pleuromutilins are natural fungal products that target bacterial protein translation by binding the the 23S rRNA, blocking the ribosome P site at the 50S subunit. They are mostly used for agriculture and veterinary purposes.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.00927e-10, "max_identities": 57, "bit_score": 56.9954, "cvterm_id": "36794", "query": "QVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLI--------GCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHD", "match": "Q   +   ++ ++ LT+V+  Y    V  P    ++  V  G+ I + G +GSGK++ L LI        G ++T S+ + S   QDT        +HL+     FI +  N +   S+F+ +       RKL+            ++V  EK   H     SGGQ++++ +A++L  +  L + DEP   +D  +   I +L++  N     T +F  HD", "sequence_from_db": "QFEPVEYKSKELIQLTDVSVIYDGQVVNKP----ISFNVEQGDRIVLDGKNGSGKSSILKLILGDPIQYTGTLNTGSNLITSYVQQDT--------SHLKGMLADFIEE--NEIDE-SLFKAI------LRKLD-----------FDRVQFEKDISH----YSGGQKKKLLIAKSLCEKAHLYIWDEPLNFIDIYSRMQIEELIQTFN----PTMVFVEHD", "sequence_from_broadstreet": "MSMIHVQNLTFSYPSSFDNIFEDVSFQIDTDWKLGFIGRNGRGKTTLFNLLLDKFEYRGKIISSVDFNYFPYPVEDKSKYTHEILEEICPQAEDWEFLREIAYLNVDAEAMYRPFETLSNGEQTKVLLVALFLNEGQFLLIDEPTNHLDTEARKTVSNYLRKKKGNILISHDRNFLDGSVDHILSINRADIEVQSGNYSSWKLNFDRQQGHEQATNERLQKDIGRLEQSTKRSAGWSNRVEASKNGTTNSGSKLDKGFVGHKAAKMMKRSKNLEARQQKSIEEKSKLLKNIEKTESLQFEPVEYKSKELIQLTDVSVIYDGQVVNKPISFNVEQGDRIVLDGKNGSGKSSILKLILGDPIQYTGTLNTGSNLITSYVQQDTSHLKGMLADFIEENEIDESLFKAILRKLDFDRVQFEKDISHYSGGQKKKLLIAKSLCEKAHLYIWDEPLNFIDIYSRMQIEELIQTFNPTMVFVEHDQTFQETISTKIIKI", "dna_sequence_from_broadstreet": "ATGTCAATGATACATGTACAAAATTTAACTTTCTCTTATCCGAGTAGTTTTGATAATATCTTTGAAGATGTAAGCTTTCAAATTGATACAGATTGGAAGCTTGGATTTATTGGTCGAAATGGACGAGGGAAAACAACCCTTTTTAATTTATTACTAGATAAATTTGAATATAGGGGGAAAATCATTTCTTCGGTCGATTTTAACTACTTCCCATATCCAGTAGAAGATAAAAGTAAGTATACACATGAAATTTTAGAAGAAATATGCCCTCAAGCTGAGGACTGGGAATTTCTTCGAGAAATAGCTTATTTAAATGTGGATGCCGAAGCCATGTACCGTCCTTTTGAAACTTTATCAAACGGTGAACAAACAAAGGTATTGCTTGTTGCTCTATTTTTAAACGAAGGACAATTTTTATTAATTGATGAACCAACAAATCATTTAGATACTGAAGCTCGTAAGACGGTTTCGAATTACTTGAGGAAGAAAAAAGGGAATATTTTAATTTCTCATGACCGTAACTTTTTAGATGGCAGTGTTGATCATATCTTGTCTATAAATAGAGCAGATATTGAGGTTCAAAGTGGAAATTATTCCTCATGGAAGTTGAACTTTGACCGACAGCAGGGACATGAACAAGCAACAAATGAACGCTTGCAGAAGGATATTGGAAGGTTAGAACAATCTACAAAACGTTCGGCTGGTTGGTCTAACCGAGTCGAAGCTTCAAAAAATGGAACAACGAATTCTGGTTCTAAATTGGACAAAGGTTTTGTAGGACATAAAGCAGCAAAAATGATGAAACGATCTAAGAACCTTGAGGCTCGACAGCAAAAATCGATTGAAGAAAAGTCAAAGCTTCTAAAAAACATTGAAAAAACGGAGTCCCTACAGTTTGAACCAGTGGAATATAAATCGAAGGAACTCATTCAATTAACAGATGTGTCTGTCATATATGATGGGCAAGTTGTCAACAAACCAATAAGTTTTAATGTTGAACAAGGAGATAGAATTGTACTGGATGGAAAGAACGGCAGTGGAAAAAGTAGTATTTTAAAATTAATCTTAGGCGATCCAATACAGTATACAGGCACGTTAAATACGGGTTCTAACCTGATAACTTCTTATGTTCAGCAAGACACCTCTCATTTAAAGGGGATGCTAGCTGACTTTATTGAAGAAAATGAGATTGATGAATCGTTGTTTAAGGCCATCCTGAGAAAGCTAGATTTTGACCGAGTACAGTTTGAAAAAGATATATCTCATTATTCAGGTGGTCAGAAGAAAAAATTGCTTATCGCTAAAAGTTTATGTGAAAAAGCTCACCTATATATTTGGGATGAACCATTAAACTTTATTGATATTTACTCTCGAATGCAAATTGAAGAGCTTATTCAAACCTTTAATCCGACTATGGTTTTTGTTGAACATGACCAGACCTTCCAAGAGACAATATCAACAAAAATAATAAAAATATAA", "partial": "0", "query_start": 51325, "query_end": 51963, "hit_start": 891, "hit_end": 1434, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 25.79}, "gnl|BL_ORD_ID|1073|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "lsaB", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1000", "model_id": "1161", "ARO_accession": "3003111", "ARO_name": "lsaB", "ARO_category": {"41696": {"category_aro_accession": "3004472", "category_aro_cvterm_id": "41696", "category_aro_name": "lsa-type ABC-F protein", "category_aro_description": "A subgroup of the ABC-F protein subfamily of ATP-binding cassette proteins. lsa-type ABC-F proteins confer resistance to streptogramin, lincosamide and pleuromutilin antibiotics through antibiotic target protection of the ribosome.", "category_aro_class_name": "AMR Gene Family"}, "35983": {"category_aro_accession": "0000066", "category_aro_cvterm_id": "35983", "category_aro_name": "clindamycin", "category_aro_description": "Clindamycin is a lincosamide antibiotic that blocks A-site aminoacyl-tRNA binding. It is usually used to treat infections with anaerobic bacteria but can also be used to treat some protozoal diseases, such as malaria.", "category_aro_class_name": "Antibiotic"}, "37716": {"category_aro_accession": "3001317", "category_aro_cvterm_id": "37716", "category_aro_name": "pleuromutilin", "category_aro_description": "Pleuromutilin is a natural product antibiotic produced by Clitopilus passeckerianus. Related antibiotics of clinical significance, such as tiamulin and retapamulin, are semi-synthetic derivatives of this compound.", "category_aro_class_name": "Antibiotic"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "37014": {"category_aro_accession": "3000670", "category_aro_cvterm_id": "37014", "category_aro_name": "pleuromutilin antibiotic", "category_aro_description": "Pleuromutilins are natural fungal products that target bacterial protein translation by binding the the 23S rRNA, blocking the ribosome P site at the 50S subunit. They are mostly used for agriculture and veterinary purposes.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0110835, "max_identities": 20, "bit_score": 34.2686, "cvterm_id": "36794", "query": "VGLEKHAKHRPNE-LSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVM", "match": "+ ++  A +RP E LS G++ +V +    +   + +L DEPT +LD+   + + + ++   +K+G   I  +HD   +", "sequence_from_db": "LNVDAEAMYRPFETLSNGEQTKVLLVALFLNEGQFLLIDEPTNHLDTEARKTVSNYLR---KKKGNILI--SHDRNFL", "sequence_from_broadstreet": "MSMIHVQNLTFSYPSSFDNIFEDVSFQIDTDWKLGFIGRNGRGKTTLFNLLLDKFEYRGKIISSVDFNYFPYPVEDKSKYTHEILEEICPQAEDWEFLREIAYLNVDAEAMYRPFETLSNGEQTKVLLVALFLNEGQFLLIDEPTNHLDTEARKTVSNYLRKKKGNILISHDRNFLDGSVDHILSINRADIEVQSGNYSSWKLNFDRQQGHEQATNERLQKDIGRLEQSTKRSAGWSNRVEASKNGTTNSGSKLDKGFVGHKAAKMMKRSKNLEARQQKSIEEKSKLLKNIEKTESLQFEPVEYKSKELIQLTDVSVIYDGQVVNKPISFNVEQGDRIVLDGKNGSGKSSILKLILGDPIQYTGTLNTGSNLITSYVQQDTSHLKGMLADFIEENEIDESLFKAILRKLDFDRVQFEKDISHYSGGQKKKLLIAKSLCEKAHLYIWDEPLNFIDIYSRMQIEELIQTFNPTMVFVEHDQTFQETISTKIIKI", "dna_sequence_from_broadstreet": "ATGTCAATGATACATGTACAAAATTTAACTTTCTCTTATCCGAGTAGTTTTGATAATATCTTTGAAGATGTAAGCTTTCAAATTGATACAGATTGGAAGCTTGGATTTATTGGTCGAAATGGACGAGGGAAAACAACCCTTTTTAATTTATTACTAGATAAATTTGAATATAGGGGGAAAATCATTTCTTCGGTCGATTTTAACTACTTCCCATATCCAGTAGAAGATAAAAGTAAGTATACACATGAAATTTTAGAAGAAATATGCCCTCAAGCTGAGGACTGGGAATTTCTTCGAGAAATAGCTTATTTAAATGTGGATGCCGAAGCCATGTACCGTCCTTTTGAAACTTTATCAAACGGTGAACAAACAAAGGTATTGCTTGTTGCTCTATTTTTAAACGAAGGACAATTTTTATTAATTGATGAACCAACAAATCATTTAGATACTGAAGCTCGTAAGACGGTTTCGAATTACTTGAGGAAGAAAAAAGGGAATATTTTAATTTCTCATGACCGTAACTTTTTAGATGGCAGTGTTGATCATATCTTGTCTATAAATAGAGCAGATATTGAGGTTCAAAGTGGAAATTATTCCTCATGGAAGTTGAACTTTGACCGACAGCAGGGACATGAACAAGCAACAAATGAACGCTTGCAGAAGGATATTGGAAGGTTAGAACAATCTACAAAACGTTCGGCTGGTTGGTCTAACCGAGTCGAAGCTTCAAAAAATGGAACAACGAATTCTGGTTCTAAATTGGACAAAGGTTTTGTAGGACATAAAGCAGCAAAAATGATGAAACGATCTAAGAACCTTGAGGCTCGACAGCAAAAATCGATTGAAGAAAAGTCAAAGCTTCTAAAAAACATTGAAAAAACGGAGTCCCTACAGTTTGAACCAGTGGAATATAAATCGAAGGAACTCATTCAATTAACAGATGTGTCTGTCATATATGATGGGCAAGTTGTCAACAAACCAATAAGTTTTAATGTTGAACAAGGAGATAGAATTGTACTGGATGGAAAGAACGGCAGTGGAAAAAGTAGTATTTTAAAATTAATCTTAGGCGATCCAATACAGTATACAGGCACGTTAAATACGGGTTCTAACCTGATAACTTCTTATGTTCAGCAAGACACCTCTCATTTAAAGGGGATGCTAGCTGACTTTATTGAAGAAAATGAGATTGATGAATCGTTGTTTAAGGCCATCCTGAGAAAGCTAGATTTTGACCGAGTACAGTTTGAAAAAGATATATCTCATTATTCAGGTGGTCAGAAGAAAAAATTGCTTATCGCTAAAAGTTTATGTGAAAAAGCTCACCTATATATTTGGGATGAACCATTAAACTTTATTGATATTTACTCTCGAATGCAAATTGAAGAGCTTATTCAAACCTTTAATCCGACTATGGTTTTTGTTGAACATGACCAGACCTTCCAAGAGACAATATCAACAAAAATAATAAAAATATAA", "partial": "0", "query_start": 51745, "query_end": 51975, "hit_start": 309, "hit_end": 528, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 25.64}, "gnl|BL_ORD_ID|1952|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "otr(C)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "650", "model_id": "1991", "ARO_accession": "3002894", "ARO_name": "otr(C)", "ARO_category": {"36002": {"category_aro_accession": "0010001", "category_aro_cvterm_id": "36002", "category_aro_name": "ATP-binding cassette (ABC) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. ATP-binding cassette (ABC) transporters are present in all cells of all organisms and use the energy of ATP binding/hydrolysis to transport substrates across cell membranes.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.14151e-10, "max_identities": 39, "bit_score": 55.8398, "cvterm_id": "36773", "query": "FQNVEFPLLLQRKLNASER--RTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTH---DAKVMTHANAVVR----LADGKI", "match": "F   E   ++ R L+ S +  R R   LLE+  L + A     + SGG R+R+ +A +++ RP ++  DEPT  LD  T   + D ++ + R +G T + +T    +A+ + H   V+     +ADGK+", "sequence_from_db": "FSGRENLYMIGRXLDLSRKDARARADELLERFSLTEAAGRAAAKYSGGMRRRLDLAASMIGRPAVLYLDEPTTGLDPRTRNEVWDEVRSMVR-DGATVLLTTQYMEEAEQLAHELTVIDRGRVIADGKV", "sequence_from_broadstreet": "MTRKTISNGARNAVEVRGLVKHFGEVKAVDGVDLDVREGTVLGVLGPXGAAXXRGALPAHVXGPDAGRRPWRFXTWCANRRALRRTIGXHRPVRXGRRESFSGRENLYMIGRXLDLSRKDARARADELLERFSLTEAAGRAAAKYSGGMRRRLDLAASMIGRPAVLYLDEPTTGLDPRTRNEVWDEVRSMVRDGATVLLTTQYMEEAEQLAHELTVIDRGRVIADGKVDELKTKVGGRTLQIRPAHAAELDRMVGAIAQAGLDGIAGATADHEDGVVNVPIVSDEQLSAVVGMLGERGFTISGHQHPSAQLXEVFLAITGQKTSEAADGGPQDGPQDQQGVQDKQYEEVPA", "dna_sequence_from_broadstreet": "ATGACGCGAAAGACGATATCCAACGGCGCGAGGAACGCCGTCGAAGTGCGGGGACTGGTCAAGCACTTCGGCGAGGTGAAGGCCGTGGACGGGGTGGATCTCGATGTGAGGGAAGGCACCGTGCTCGGTGTGCTCGGGCCGANCGGCGCGGCAANANAACGTGGTGCGCTGCCTGCCCACGTTGNTGGTCCGGACGCCGGCAGGCGACCGTGGCGGTTTNAAACGTGGTGCGCCAACCGGCGCGCGTTGCGCCGCACGATCGGCCNTCACCGGCCAGTACGCNTCGGTCGACGAGAAAGCTTCTCCGGCCGNGAGAACCTGTACATGATCGGCCGCNTGCTGGACCTCTCCCGCAAGGACGCCCGCGCGCGGGCCGACGAGCTGCTGGAGCGGTTCTCCCTCACCGAGGCCGCCGGCCGGGCCGCCGCCAAGTACTCCGGCGGTATGCGCCGCCGCCTCGACCTGGCCGCCTCCATGATCGGCAGGCCCGCGGTGCTGTATCTGGACGAGCCGACGACGGGCCTCGACCCCCGCACCCGCAACGAGGTGTGGGACGAGGTCCGCAGCATGGTGCGCGACGGCGCCACGGTCCTGCTCACCACCCAGTACATGGAAGAGGCCGAGCAGCTGGCCCACGAGCTGACGGTCATCGACCGCGGCCGGGTCATCGCCGACGGCAAGGTGGACGAGCTGAAGACCAAGGTCGGCGGCCGTACGCTCCAGATACGCCCGGCGCACGCCGCCGAGCTGGACCGGATGGTCGGCGCCATCGCGCAGGCCGGCCTGGACGGCATCGCGGGCGCCACCGCCGACCACGAGGACGGCGTGGTCAACGTCCCGATCGTCAGCGACGAGCAGCTGTCCGCCGTGGTCGGCATGCTCGGCGAGCGGGGCTTCACGATCTCCGGGCATCAACACCCATCTGCCCAGCTGNACGAGGTGTTCCTGGCCATCACCGGCCAGAAGACCTCGGAGGCCGCCGACGGCGGCCCGCAGGACGGACCGCAGGACCAGCAGGGCGTTCAGGACAAGCAGTACGAGGAGGTTCCGGCATGA", "partial": "0", "query_start": 51658, "query_end": 52017, "hit_start": 300, "hit_end": 684, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 30.23}, "gnl|BL_ORD_ID|2510|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "poxtA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "300", "model_id": "2904", "ARO_accession": "3004470", "ARO_name": "poxtA", "ARO_category": {"45630": {"category_aro_accession": "3007068", "category_aro_cvterm_id": "45630", "category_aro_name": "Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins", "category_aro_description": "ABC-F subfamily ATP-binding cassette ribosomal protection proteins of unknown, unclear or miscellaneous classification which nevertheless confer resistance to antibiotics through ribosomal protection and not through antibiotic efflux. These proteins should be further reviewed to elucidate associated genes, their function, origin and classification.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35986": {"category_aro_accession": "0000069", "category_aro_cvterm_id": "35986", "category_aro_name": "doxycycline", "category_aro_description": "Doxycycline is second generation semi-synthetic derivative of the tetracycline group of antibiotics. It inhibits bacterial protein synthesis by binding to the 30S subunit of the bacterial ribosome and preventing the aminotransferase-tRNA from associating with the ribosome.", "category_aro_class_name": "Antibiotic"}, "35989": {"category_aro_accession": "0000072", "category_aro_cvterm_id": "35989", "category_aro_name": "linezolid", "category_aro_description": "Linezolid is a synthetic antibiotic used for the treatment of serious infections caused by Gram-positive bacteria that are resistant to several other antibiotics. It inhibits protein synthesis by binding to domain V of the 23S rRNA of the 50S subunit of bacterial ribosomes.", "category_aro_class_name": "Antibiotic"}, "36524": {"category_aro_accession": "3000385", "category_aro_cvterm_id": "36524", "category_aro_name": "chloramphenicol", "category_aro_description": "Chloramphenicol is a bacteriostatic antimicrobial originally derived from the bacterium Streptomyces venezuelae. It was the first antibiotic to be manufactured synthetically on a large scale. It functions by inhibiting peptidyl transferase activity of the bacterial ribosome, binding to A2451 and A2452 residues in the 23S rRNA of the 50S ribosomal subunit and preventing peptide bond formation.", "category_aro_class_name": "Antibiotic"}, "36600": {"category_aro_accession": "3000461", "category_aro_cvterm_id": "36600", "category_aro_name": "florfenicol", "category_aro_description": "Florfenicol is a fluorine derivative of chloramphenicol, where the nitro group (-NO2) is substituted by a sulfomethyl group (-SO2CH3) and the hydroxyl group (-OH), by a fluorine group (-F). The action mechanism is the same as chloramphenicol's, where the antibiotic binds to the 23S RNA of the 50S subunit of bacterial ribosomes to inhibit protein synthesis.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36218": {"category_aro_accession": "3000079", "category_aro_cvterm_id": "36218", "category_aro_name": "oxazolidinone antibiotic", "category_aro_description": "Oxazolidinones are a class of synthetic antibiotics discovered the the 1980's.  They inhibit protein synthesis by binding to domain V of the 23S rRNA of the 50S subunit of bacterial ribosomes.  Linezolid is the only member of this class currently in clinical use.", "category_aro_class_name": "Drug Class"}, "36526": {"category_aro_accession": "3000387", "category_aro_cvterm_id": "36526", "category_aro_name": "phenicol antibiotic", "category_aro_description": "Phenicols are broad spectrum bacteriostatic antibiotics acting on bacterial protein synthesis. More specifically, the phenicols block peptide elongation by binding to the peptidyltansferase centre of the 70S ribosome.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.27316e-10, "max_identities": 53, "bit_score": 56.225, "cvterm_id": "35508", "query": "ISIAGPSGSGKTTALNLI-GCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSF----------NLVSVLSVFQNVEFPLLLQRKLNASER---------RTRVMTLLEQVGLEKHAKHRP-NELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMT", "match": "+ I G +G+GKTT   L+ G ++  +  + S + +      E  L    +    F+F+             +   L    N E   LL R     ER          T ++   +++ ++    HRP  ELSGGQ+ ++A AR L ++P+++L DEPT +LD  T   +I   K L    G+  I S HD   + ", "sequence_from_db": "VGIVGVNGAGKTTLFRLLLGELELDNGSLTSGNARIGYLPQEIVLEDEDITVWDFLFEGRPIKKYEQELEEIYKKLETAVNAEQEALLARMGTLQERLEYFDFYEAETILLEFADKMSIDAELYHRPMRELSGGQKSKMAFARLLYSKPEILLLDEPTNHLDVSTKDFVI---KYLKNYRGSVLIIS-HDIDFLN", "sequence_from_broadstreet": "MKGKNMNLAFGLEEIYEDAEFQIGDLDKVGIVGVNGAGKTTLFRLLLGELELDNGSLTSGNARIGYLPQEIVLEDEDITVWDFLFEGRPIKKYEQELEEIYKKLETAVNAEQEALLARMGTLQERLEYFDFYEAETILLEFADKMSIDAELYHRPMRELSGGQKSKMAFARLLYSKPEILLLDEPTNHLDVSTKDFVIKYLKNYRGSVLIISHDIDFLNRIINKIMYINKATHKISVYDGDYYIYKKKYAEEQRIREMAIVQQEKEIKELSDFVQKAKQASQTNHHLKRMGQERALRLDKKRGELQKRNRLYKRVKMDIRPKREGAQVPLEVENITFHYSGYPTLYQNLSFQINGRERFLVVGENGVGKSTLLKLMMGILSPDEGCIRFNQKTDIAYYAQELEQLDENKTVIDNVESEGYTPWQIRAVLSNFLFYDDDVNKKVSVLSPGEKARVALCKILLQKANLLILDEPTNHLDPETQKIIGGNFNLFEGTIIAVSHNPSFVEQIGISRMLILPSGRIEPYSRELLEYYYEINGSVAKF", "dna_sequence_from_broadstreet": "ATGAAAGGTAAAAATATGAATTTAGCCTTTGGGTTGGAAGAAATTTATGAGGATGCTGAGTTTCAAATCGGAGATTTGGATAAGGTCGGTATTGTCGGCGTGAACGGAGCCGGAAAGACCACCTTGTTCCGCCTGCTGTTGGGAGAACTTGAACTTGATAATGGTTCACTGACCAGTGGAAATGCCCGTATTGGTTATCTCCCACAGGAAATTGTCTTGGAAGATGAGGATATTACCGTTTGGGATTTCCTTTTTGAGGGACGTCCGATTAAAAAGTATGAGCAGGAATTGGAAGAAATCTATAAAAAGCTTGAAACCGCAGTCAATGCAGAGCAGGAAGCACTGCTTGCCCGAATGGGAACATTGCAAGAACGCTTGGAGTATTTCGACTTCTATGAGGCAGAAACAATTCTGTTGGAGTTTGCAGATAAAATGAGCATTGATGCAGAATTATATCATCGTCCGATGAGAGAGCTTTCAGGCGGACAAAAATCCAAAATGGCATTTGCCAGACTACTATATTCAAAACCGGAAATTCTATTGTTGGATGAGCCTACCAACCATTTAGATGTCAGCACAAAGGATTTTGTTATAAAATACTTAAAGAATTATAGGGGTTCGGTACTGATTATCAGCCATGATATTGATTTTCTAAATCGGATTATCAACAAAATTATGTACATCAACAAAGCTACCCATAAAATATCTGTTTATGATGGAGACTACTACATCTACAAGAAAAAGTATGCAGAGGAACAGCGGATTCGTGAAATGGCGATTGTACAGCAGGAAAAAGAAATAAAGGAGCTTTCCGATTTTGTACAAAAAGCAAAACAAGCCAGTCAGACCAATCATCACCTCAAACGAATGGGTCAAGAGCGAGCCTTGCGGCTTGATAAAAAGCGTGGAGAGCTGCAAAAGAGAAATCGACTGTACAAGCGTGTGAAGATGGATATTCGCCCCAAGCGTGAAGGGGCACAAGTTCCCTTAGAGGTGGAAAATATCACCTTCCACTATTCGGGGTATCCCACCCTTTATCAGAACCTTTCCTTTCAGATTAACGGAAGAGAACGATTTCTTGTGGTGGGTGAAAACGGTGTCGGTAAATCCACCTTATTGAAATTGATGATGGGTATTCTCAGTCCAGATGAAGGATGCATTCGCTTTAACCAGAAAACTGATATTGCATATTATGCACAGGAACTCGAACAGCTTGATGAAAACAAAACGGTCATTGACAATGTGGAGTCTGAAGGATATACACCGTGGCAAATCAGAGCCGTACTGAGCAACTTCCTGTTTTATGATGACGATGTAAACAAGAAAGTATCTGTGCTGTCCCCTGGAGAAAAAGCAAGGGTTGCCCTTTGCAAAATCCTATTACAGAAAGCCAATCTTTTGATACTGGACGAGCCGACCAACCACCTTGACCCAGAAACGCAGAAAATCATTGGCGGCAACTTCAATTTGTTTGAGGGAACCATTATTGCCGTTAGCCATAACCCATCCTTTGTGGAACAAATCGGAATTAGCCGTATGCTTATTTTGCCCAGCGGTCGAATTGAACCCTATTCCCGTGAGCTGCTTGAGTATTATTATGAAATCAACGGTTCTGTTGCAAAGTTTTAA", "partial": "0", "query_start": 51457, "query_end": 51978, "hit_start": 84, "hit_end": 657, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 27.18}, "gnl|BL_ORD_ID|2510|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "poxtA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "300", "model_id": "2904", "ARO_accession": "3004470", "ARO_name": "poxtA", "ARO_category": {"45630": {"category_aro_accession": "3007068", "category_aro_cvterm_id": "45630", "category_aro_name": "Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins", "category_aro_description": "ABC-F subfamily ATP-binding cassette ribosomal protection proteins of unknown, unclear or miscellaneous classification which nevertheless confer resistance to antibiotics through ribosomal protection and not through antibiotic efflux. These proteins should be further reviewed to elucidate associated genes, their function, origin and classification.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35986": {"category_aro_accession": "0000069", "category_aro_cvterm_id": "35986", "category_aro_name": "doxycycline", "category_aro_description": "Doxycycline is second generation semi-synthetic derivative of the tetracycline group of antibiotics. It inhibits bacterial protein synthesis by binding to the 30S subunit of the bacterial ribosome and preventing the aminotransferase-tRNA from associating with the ribosome.", "category_aro_class_name": "Antibiotic"}, "35989": {"category_aro_accession": "0000072", "category_aro_cvterm_id": "35989", "category_aro_name": "linezolid", "category_aro_description": "Linezolid is a synthetic antibiotic used for the treatment of serious infections caused by Gram-positive bacteria that are resistant to several other antibiotics. It inhibits protein synthesis by binding to domain V of the 23S rRNA of the 50S subunit of bacterial ribosomes.", "category_aro_class_name": "Antibiotic"}, "36524": {"category_aro_accession": "3000385", "category_aro_cvterm_id": "36524", "category_aro_name": "chloramphenicol", "category_aro_description": "Chloramphenicol is a bacteriostatic antimicrobial originally derived from the bacterium Streptomyces venezuelae. It was the first antibiotic to be manufactured synthetically on a large scale. It functions by inhibiting peptidyl transferase activity of the bacterial ribosome, binding to A2451 and A2452 residues in the 23S rRNA of the 50S ribosomal subunit and preventing peptide bond formation.", "category_aro_class_name": "Antibiotic"}, "36600": {"category_aro_accession": "3000461", "category_aro_cvterm_id": "36600", "category_aro_name": "florfenicol", "category_aro_description": "Florfenicol is a fluorine derivative of chloramphenicol, where the nitro group (-NO2) is substituted by a sulfomethyl group (-SO2CH3) and the hydroxyl group (-OH), by a fluorine group (-F). The action mechanism is the same as chloramphenicol's, where the antibiotic binds to the 23S RNA of the 50S subunit of bacterial ribosomes to inhibit protein synthesis.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36218": {"category_aro_accession": "3000079", "category_aro_cvterm_id": "36218", "category_aro_name": "oxazolidinone antibiotic", "category_aro_description": "Oxazolidinones are a class of synthetic antibiotics discovered the the 1980's.  They inhibit protein synthesis by binding to domain V of the 23S rRNA of the 50S subunit of bacterial ribosomes.  Linezolid is the only member of this class currently in clinical use.", "category_aro_class_name": "Drug Class"}, "36526": {"category_aro_accession": "3000387", "category_aro_cvterm_id": "36526", "category_aro_name": "phenicol antibiotic", "category_aro_description": "Phenicols are broad spectrum bacteriostatic antibiotics acting on bacterial protein synthesis. More specifically, the phenicols block peptide elongation by binding to the peptidyltansferase centre of the 70S ribosome.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00155828, "max_identities": 38, "bit_score": 36.965, "cvterm_id": "35508", "query": "IAGPSGSGKTTALNLI--------GCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNII", "match": "+ G +G GK+T L L+        GC+       ++   Q+ ++L E +     + + G+    + + +VLS F      L     +N   ++  V                   LS G++ RVA+ + L+ +  L++ DEPT +LD  T Q II", "sequence_from_db": "VVGENGVGKSTLLKLMMGILSPDEGCIRFNQKTDIAYYAQELEQLDENKTVIDNVESEGYT--PWQIRAVLSNF------LFYDDDVN---KKVSV-------------------LSPGEKARVALCKILLQKANLLILDEPTNHLDPET-QKII", "sequence_from_broadstreet": "MKGKNMNLAFGLEEIYEDAEFQIGDLDKVGIVGVNGAGKTTLFRLLLGELELDNGSLTSGNARIGYLPQEIVLEDEDITVWDFLFEGRPIKKYEQELEEIYKKLETAVNAEQEALLARMGTLQERLEYFDFYEAETILLEFADKMSIDAELYHRPMRELSGGQKSKMAFARLLYSKPEILLLDEPTNHLDVSTKDFVIKYLKNYRGSVLIISHDIDFLNRIINKIMYINKATHKISVYDGDYYIYKKKYAEEQRIREMAIVQQEKEIKELSDFVQKAKQASQTNHHLKRMGQERALRLDKKRGELQKRNRLYKRVKMDIRPKREGAQVPLEVENITFHYSGYPTLYQNLSFQINGRERFLVVGENGVGKSTLLKLMMGILSPDEGCIRFNQKTDIAYYAQELEQLDENKTVIDNVESEGYTPWQIRAVLSNFLFYDDDVNKKVSVLSPGEKARVALCKILLQKANLLILDEPTNHLDPETQKIIGGNFNLFEGTIIAVSHNPSFVEQIGISRMLILPSGRIEPYSRELLEYYYEINGSVAKF", "dna_sequence_from_broadstreet": "ATGAAAGGTAAAAATATGAATTTAGCCTTTGGGTTGGAAGAAATTTATGAGGATGCTGAGTTTCAAATCGGAGATTTGGATAAGGTCGGTATTGTCGGCGTGAACGGAGCCGGAAAGACCACCTTGTTCCGCCTGCTGTTGGGAGAACTTGAACTTGATAATGGTTCACTGACCAGTGGAAATGCCCGTATTGGTTATCTCCCACAGGAAATTGTCTTGGAAGATGAGGATATTACCGTTTGGGATTTCCTTTTTGAGGGACGTCCGATTAAAAAGTATGAGCAGGAATTGGAAGAAATCTATAAAAAGCTTGAAACCGCAGTCAATGCAGAGCAGGAAGCACTGCTTGCCCGAATGGGAACATTGCAAGAACGCTTGGAGTATTTCGACTTCTATGAGGCAGAAACAATTCTGTTGGAGTTTGCAGATAAAATGAGCATTGATGCAGAATTATATCATCGTCCGATGAGAGAGCTTTCAGGCGGACAAAAATCCAAAATGGCATTTGCCAGACTACTATATTCAAAACCGGAAATTCTATTGTTGGATGAGCCTACCAACCATTTAGATGTCAGCACAAAGGATTTTGTTATAAAATACTTAAAGAATTATAGGGGTTCGGTACTGATTATCAGCCATGATATTGATTTTCTAAATCGGATTATCAACAAAATTATGTACATCAACAAAGCTACCCATAAAATATCTGTTTATGATGGAGACTACTACATCTACAAGAAAAAGTATGCAGAGGAACAGCGGATTCGTGAAATGGCGATTGTACAGCAGGAAAAAGAAATAAAGGAGCTTTCCGATTTTGTACAAAAAGCAAAACAAGCCAGTCAGACCAATCATCACCTCAAACGAATGGGTCAAGAGCGAGCCTTGCGGCTTGATAAAAAGCGTGGAGAGCTGCAAAAGAGAAATCGACTGTACAAGCGTGTGAAGATGGATATTCGCCCCAAGCGTGAAGGGGCACAAGTTCCCTTAGAGGTGGAAAATATCACCTTCCACTATTCGGGGTATCCCACCCTTTATCAGAACCTTTCCTTTCAGATTAACGGAAGAGAACGATTTCTTGTGGTGGGTGAAAACGGTGTCGGTAAATCCACCTTATTGAAATTGATGATGGGTATTCTCAGTCCAGATGAAGGATGCATTCGCTTTAACCAGAAAACTGATATTGCATATTATGCACAGGAACTCGAACAGCTTGATGAAAACAAAACGGTCATTGACAATGTGGAGTCTGAAGGATATACACCGTGGCAAATCAGAGCCGTACTGAGCAACTTCCTGTTTTATGATGACGATGTAAACAAGAAAGTATCTGTGCTGTCCCCTGGAGAAAAAGCAAGGGTTGCCCTTTGCAAAATCCTATTACAGAAAGCCAATCTTTTGATACTGGACGAGCCGACCAACCACCTTGACCCAGAAACGCAGAAAATCATTGGCGGCAACTTCAATTTGTTTGAGGGAACCATTATTGCCGTTAGCCATAACCCATCCTTTGTGGAACAAATCGGAATTAGCCGTATGCTTATTTTGCCCAGCGGTCGAATTGAACCCTATTCCCGTGAGCTGCTTGAGTATTATTATGAAATCAACGGTTCTGTTGCAAAGTTTTAA", "partial": "0", "query_start": 51463, "query_end": 51903, "hit_start": 1080, "hit_end": 1452, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 24.52}, "gnl|BL_ORD_ID|2310|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "tetA(60)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1100", "model_id": "2645", "ARO_accession": "3004035", "ARO_name": "tetA(60)", "ARO_category": {"36002": {"category_aro_accession": "0010001", "category_aro_cvterm_id": "36002", "category_aro_name": "ATP-binding cassette (ABC) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. ATP-binding cassette (ABC) transporters are present in all cells of all organisms and use the energy of ATP binding/hydrolysis to transport substrates across cell membranes.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.21282e-09, "max_identities": 55, "bit_score": 55.8398, "cvterm_id": "36791", "query": "QVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQ-----DTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNEL-----------SGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAE", "match": "+ P L+ + L +  GE + I G +GSGKTT L  +          + ++G+     DT+ +      HL      ++ Q   L S     + +   +L  ++    +     +TL      E   K  P+EL           SGGQ+QR+++ARA +   + ++ D+  + +D+ T + II  +++   + G   I S H    + HA+ ++ + +G+I +R T  E", "sequence_from_db": "EAPLLKEINLTLRKGETLGIVGKTGSGKTTLLMQLLHQFPYRGEKLLINGEPLIDYDTQSVA----GHL-----AYVPQEHTLFS-----RTIRENMLFGKEDATDDEIWEALTL---ASFEGDVKRMPDELDTMVGEKGVSLSGGQKQRLSIARAFLRNRECLILDDALSAVDAKTEREIISHLQQ--ERGGCMNIISAHRLSAIRHADEIIVMNEGRISERGTHEE", "sequence_from_broadstreet": "MNDLLKVIINFIKKHPMRYLVSFILMIGSSIAAVYPARIIGQVVDKIVASELNAEWLGTQLVILVGIILVAYITESIWTYFIFIGYYEIQKELRVKLLRNNLRKKIPFYAHFRTGEIITRSSEDVTTIGDMMGFGMFALMNSTLLMSVSIYMMVTTISLPLTIAAILPLPILSYLVYKWGFDLEEEYNKAQNAVSQLNNEVLEMIDGTYVIRAYGQEDAMMDEFRAKTKKAMKQNIIVTEIESRFIPLAQLFMMISFTIALFYGGYLVSTGAILVGDVIAFQVYMGAIMWPMFMIGDIITNYKRGKVATERINEVLKHDDEIERGGTKTLETIESIEFKDFHFMYPGEEAPLLKEINLTLRKGETLGIVGKTGSGKTTLLMQLLHQFPYRGEKLLINGEPLIDYDTQSVAGHLAYVPQEHTLFSRTIRENMLFGKEDATDDEIWEALTLASFEGDVKRMPDELDTMVGEKGVSLSGGQKQRLSIARAFLRNRECLILDDALSAVDAKTEREIISHLQQERGGCMNIISAHRLSAIRHADEIIVMNEGRISERGTHEELLEQRGWYYEQYLTQEMEEEIE", "dna_sequence_from_broadstreet": "ATGAACGATTTATTAAAAGTCATTATTAATTTTATAAAGAAACATCCGATGCGCTACCTTGTTAGTTTTATTTTGATGATCGGAAGTAGTATTGCGGCGGTGTACCCAGCGCGTATTATCGGACAAGTTGTTGATAAAATCGTAGCGAGCGAACTGAATGCCGAGTGGCTTGGGACACAACTCGTGATTTTAGTCGGGATTATTCTTGTGGCGTATATTACGGAGAGTATTTGGACATATTTTATTTTTATTGGGTATTATGAAATTCAAAAAGAATTACGTGTGAAGTTACTACGTAATAATTTACGGAAGAAAATTCCGTTTTATGCGCATTTTAGAACGGGCGAAATTATTACGCGTAGCAGTGAAGACGTTACAACGATTGGCGATATGATGGGGTTTGGGATGTTTGCATTGATGAACTCTACATTGCTGATGAGCGTATCGATTTATATGATGGTCACAACGATTTCATTGCCACTGACCATCGCAGCGATTTTGCCACTGCCAATCCTTTCGTATCTTGTATATAAATGGGGATTCGATTTAGAAGAAGAGTACAACAAGGCGCAAAATGCAGTTTCACAATTAAATAATGAAGTGCTTGAGATGATTGACGGGACGTATGTGATTCGTGCTTACGGGCAAGAAGATGCGATGATGGATGAGTTCAGGGCGAAAACGAAAAAGGCCATGAAACAAAATATTATCGTGACTGAAATTGAATCGCGCTTTATTCCACTGGCGCAATTATTTATGATGATTAGCTTTACCATTGCCCTTTTCTACGGTGGGTATCTAGTATCGACTGGGGCTATTCTAGTCGGGGATGTCATTGCCTTCCAAGTCTATATGGGGGCGATTATGTGGCCGATGTTTATGATTGGCGATATTATTACGAACTATAAACGCGGAAAAGTGGCGACGGAGCGTATTAATGAAGTGTTGAAACATGACGATGAAATTGAACGCGGCGGTACAAAAACGCTCGAGACGATTGAATCCATTGAGTTTAAGGACTTCCATTTTATGTATCCAGGCGAAGAGGCACCATTATTAAAAGAGATTAACCTTACGTTACGTAAAGGCGAGACGCTTGGAATCGTTGGAAAAACGGGTTCTGGGAAGACGACGCTCTTGATGCAATTATTACATCAATTTCCGTACCGAGGAGAGAAGCTGCTCATTAACGGAGAGCCATTGATTGATTACGACACTCAATCGGTGGCAGGGCATCTAGCCTATGTGCCACAAGAACACACCCTTTTCTCACGCACGATTCGCGAGAATATGTTATTCGGAAAAGAGGATGCAACGGATGATGAAATTTGGGAAGCGTTGACGCTAGCCTCTTTTGAAGGAGACGTGAAACGAATGCCAGACGAGCTCGATACGATGGTCGGAGAAAAAGGGGTATCGCTCAGTGGAGGTCAAAAACAACGCTTATCGATTGCTCGTGCTTTCTTACGCAACCGTGAATGCTTAATTTTGGATGATGCGTTATCTGCAGTTGATGCGAAAACGGAAAGGGAAATTATCTCGCACTTGCAACAAGAACGCGGAGGTTGTATGAATATCATTTCTGCGCACAGACTTTCTGCAATTCGTCATGCGGATGAAATTATTGTGATGAATGAAGGACGTATTAGTGAGAGGGGTACCCACGAGGAGCTGCTCGAACAACGAGGATGGTACTATGAACAGTATCTCACACAAGAAATGGAGGAGGAAATCGAATGA", "partial": "0", "query_start": 51406, "query_end": 52041, "hit_start": 1044, "hit_end": 1671, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 24.12}, "gnl|BL_ORD_ID|2230|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "TaeA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1200", "model_id": "2522", "ARO_accession": "3003986", "ARO_name": "TaeA", "ARO_category": {"36002": {"category_aro_accession": "0010001", "category_aro_cvterm_id": "36002", "category_aro_name": "ATP-binding cassette (ABC) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. ATP-binding cassette (ABC) transporters are present in all cells of all organisms and use the energy of ATP binding/hydrolysis to transport substrates across cell membranes.", "category_aro_class_name": "AMR Gene Family"}, "37716": {"category_aro_accession": "3001317", "category_aro_cvterm_id": "37716", "category_aro_name": "pleuromutilin", "category_aro_description": "Pleuromutilin is a natural product antibiotic produced by Clitopilus passeckerianus. Related antibiotics of clinical significance, such as tiamulin and retapamulin, are semi-synthetic derivatives of this compound.", "category_aro_class_name": "Antibiotic"}, "37014": {"category_aro_accession": "3000670", "category_aro_cvterm_id": "37014", "category_aro_name": "pleuromutilin antibiotic", "category_aro_description": "Pleuromutilins are natural fungal products that target bacterial protein translation by binding the the 23S rRNA, blocking the ribosome P site at the 50S subunit. They are mostly used for agriculture and veterinary purposes.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.24167e-09, "max_identities": 60, "bit_score": 55.8398, "cvterm_id": "40862", "query": "IVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQ------------DTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRK----------LNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTH-ANAVVRLADGKIL", "match": "I+++ +VTK+Y   K+     +  +  +   + I I G +G+GK+T L +I  ++   SG +S+  +            D  K   +Q+    L  +  + +    + +L +  + E    LQ+K          L A +  +   T+L ++G+ ++ + +   LSGGQR+RVA+A AL+    L++ DEPT ++D+   +++  L + L ++ G   +  THD   +   AN ++ L  G++ ", "sequence_from_db": "ILTVEQVTKSYG-DKI---LFQDASFGMEDQDKIGIIGVNGTGKSTFLRVIAGLEPPDSGKISMGNRIRVRYLAQNPEFDPDKTVLQQVFEGDLPEMKAVREYTETMELLELHPSHE---ELQQKLLKLNQTLETLQAWQLESDAKTILSKLGI-RNYEAKMGTLSGGQRKRVALAAALIQPSDLLILDEPTNHIDN---ESVAWLEQYLQKRRGALLMI-THDRYFLDRVANVMLELDHGRLF", "sequence_from_broadstreet": "MNILTVEQVTKSYGDKILFQDASFGMEDQDKIGIIGVNGTGKSTFLRVIAGLEPPDSGKISMGNRIRVRYLAQNPEFDPDKTVLQQVFEGDLPEMKAVREYTETMELLELHPSHEELQQKLLKLNQTLETLQAWQLESDAKTILSKLGIRNYEAKMGTLSGGQRKRVALAAALIQPSDLLILDEPTNHIDNESVAWLEQYLQKRRGALLMITHDRYFLDRVANVMLELDHGRLFRYEANYSRFLELKAEREEREAASEQKRQNLLRSELAWIRRGAKARTTKQKARIERFEKLKDQEMVHSSGELDVSVASTRLGRKILEIEGLRMKIDDKTLIQDLSYIAVPEDRIGIVGPNGSGKSTLLNLIAGRIQPGGGEVVLGPTVKLGYFTQEHQEMDGSQRVIEYIKDEAEVVRTADGSAITAAQMLERFLFPPALQWTPIAKLSGGEKRRLYLLRVLMSAPNVLLLDEPTNDLDIQTLSVLEQYLDEFPGVCIVVSHDRFFLDRTVDKIMAFEGDGQIRVHVGSYSEYAEWMQRHGGEASGSKAEASIAKSASGSSDGTDSDSAKEAPRERLKFSYKEQREFDQIDGLIEDTESKLASIQSEMETAGSDAARLQELMKAQEETERELEHLMERWTYLNELAEKIEQSKKS", "dna_sequence_from_broadstreet": "ATGAATATTTTGACCGTCGAACAGGTAACAAAAAGCTATGGAGACAAAATTCTGTTTCAAGATGCATCCTTCGGAATGGAGGATCAGGATAAAATCGGCATTATCGGCGTGAATGGCACGGGGAAATCCACATTTCTGCGGGTCATCGCGGGGCTCGAGCCGCCCGACTCCGGTAAAATATCGATGGGCAATCGCATCCGGGTTCGTTACCTCGCGCAAAATCCGGAGTTTGATCCGGACAAAACCGTCCTGCAGCAGGTGTTTGAGGGCGATCTTCCGGAGATGAAGGCCGTGCGGGAATACACCGAAACGATGGAACTGCTGGAGCTGCATCCAAGTCATGAGGAGCTCCAGCAGAAACTGCTGAAGCTCAATCAGACGCTGGAAACGCTGCAGGCATGGCAGCTTGAAAGCGATGCGAAAACCATCCTGTCCAAGCTGGGGATTCGGAATTATGAAGCGAAGATGGGAACGCTGTCGGGCGGCCAGCGTAAGCGGGTGGCATTAGCCGCCGCCTTGATTCAGCCTTCCGACTTGCTTATTTTGGACGAGCCGACCAACCACATTGACAATGAATCCGTTGCCTGGCTGGAGCAGTATTTGCAGAAGCGCCGCGGCGCGCTGCTCATGATTACGCATGACCGGTATTTTCTGGACCGGGTAGCCAATGTTATGCTGGAGCTGGATCACGGACGGCTGTTTCGATATGAGGCGAACTACAGCCGTTTTCTGGAGCTGAAGGCAGAACGCGAGGAGCGTGAAGCCGCTTCCGAGCAAAAGCGCCAAAATTTGCTGCGGAGCGAGCTTGCCTGGATCCGCAGAGGGGCCAAGGCCCGCACGACCAAGCAGAAGGCGAGGATTGAACGCTTCGAGAAACTCAAGGATCAGGAGATGGTGCACAGCTCCGGTGAACTGGACGTTTCGGTCGCTTCCACCCGCTTGGGACGCAAAATTCTGGAGATTGAAGGTCTCCGGATGAAGATCGACGACAAAACGTTAATTCAGGACCTTTCCTATATCGCCGTTCCCGAGGATCGGATAGGTATCGTAGGCCCGAACGGCAGCGGCAAATCCACGCTGCTCAATCTGATTGCCGGGCGGATTCAGCCGGGTGGCGGGGAAGTCGTGCTCGGACCGACGGTCAAGCTCGGTTATTTCACGCAGGAGCATCAGGAGATGGACGGCAGTCAGCGCGTGATTGAGTATATCAAGGATGAGGCCGAGGTTGTCCGCACGGCGGACGGTTCGGCGATTACCGCAGCCCAGATGCTGGAACGCTTTCTGTTCCCGCCCGCGCTGCAGTGGACGCCGATTGCGAAGCTGTCCGGAGGCGAGAAGCGCCGCTTGTATCTGCTGCGGGTGCTGATGAGCGCACCGAATGTGCTGCTGCTTGATGAACCGACCAATGATTTGGATATCCAGACATTGTCCGTCCTGGAGCAGTATTTGGATGAGTTCCCGGGCGTCTGTATCGTGGTATCCCATGATCGCTTTTTCCTGGATCGAACCGTGGACAAGATTATGGCTTTTGAGGGCGACGGTCAGATTCGTGTCCATGTCGGCTCTTACAGCGAATATGCGGAATGGATGCAGCGTCACGGCGGTGAAGCTTCCGGGAGCAAGGCGGAGGCATCCATAGCCAAATCTGCTTCGGGGAGCAGCGATGGCACGGACAGTGATTCAGCTAAAGAAGCGCCGCGTGAGCGCTTGAAATTCAGTTACAAAGAACAACGGGAGTTTGATCAGATTGACGGGCTCATCGAGGATACCGAGAGCAAGCTCGCTTCGATTCAATCCGAGATGGAGACCGCCGGCAGCGACGCAGCCAGGCTTCAGGAGCTGATGAAGGCTCAGGAGGAAACGGAACGTGAGCTGGAGCATCTGATGGAACGCTGGACCTATCTGAACGAGCTCGCGGAGAAGATTGAACAGAGCAAGAAATCGTAA", "partial": "0", "query_start": 51358, "query_end": 52020, "hit_start": 6, "hit_end": 702, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 24.59}, "gnl|BL_ORD_ID|2230|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "TaeA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1200", "model_id": "2522", "ARO_accession": "3003986", "ARO_name": "TaeA", "ARO_category": {"36002": {"category_aro_accession": "0010001", "category_aro_cvterm_id": "36002", "category_aro_name": "ATP-binding cassette (ABC) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. ATP-binding cassette (ABC) transporters are present in all cells of all organisms and use the energy of ATP binding/hydrolysis to transport substrates across cell membranes.", "category_aro_class_name": "AMR Gene Family"}, "37716": {"category_aro_accession": "3001317", "category_aro_cvterm_id": "37716", "category_aro_name": "pleuromutilin", "category_aro_description": "Pleuromutilin is a natural product antibiotic produced by Clitopilus passeckerianus. Related antibiotics of clinical significance, such as tiamulin and retapamulin, are semi-synthetic derivatives of this compound.", "category_aro_class_name": "Antibiotic"}, "37014": {"category_aro_accession": "3000670", "category_aro_cvterm_id": "37014", "category_aro_name": "pleuromutilin antibiotic", "category_aro_description": "Pleuromutilins are natural fungal products that target bacterial protein translation by binding the the 23S rRNA, blocking the ribosome P site at the 50S subunit. They are mostly used for agriculture and veterinary purposes.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.66989e-05, "max_identities": 47, "bit_score": 42.3578, "cvterm_id": "40862", "query": "PGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKL----TERQLTHLRLHTIGFIFQSFNLV-----SVLSVFQNVE---FPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLD", "match": "P + I I GP+GSGK+T LNLI        G V +    T KL     E Q        I +I     +V     S ++  Q +E   FP  LQ    A                         +LSGG+++R+ + R L++ P ++L DEPT +LD", "sequence_from_db": "PEDRIGIVGPNGSGKSTLLNLIAGRIQPGGGEVVLG--PTVKLGYFTQEHQEMDGSQRVIEYIKDEAEVVRTADGSAITAAQMLERFLFPPALQWTPIA-------------------------KLSGGEKRRLYLLRVLMSAPNVLLLDEPTNDLD", "sequence_from_broadstreet": "MNILTVEQVTKSYGDKILFQDASFGMEDQDKIGIIGVNGTGKSTFLRVIAGLEPPDSGKISMGNRIRVRYLAQNPEFDPDKTVLQQVFEGDLPEMKAVREYTETMELLELHPSHEELQQKLLKLNQTLETLQAWQLESDAKTILSKLGIRNYEAKMGTLSGGQRKRVALAAALIQPSDLLILDEPTNHIDNESVAWLEQYLQKRRGALLMITHDRYFLDRVANVMLELDHGRLFRYEANYSRFLELKAEREEREAASEQKRQNLLRSELAWIRRGAKARTTKQKARIERFEKLKDQEMVHSSGELDVSVASTRLGRKILEIEGLRMKIDDKTLIQDLSYIAVPEDRIGIVGPNGSGKSTLLNLIAGRIQPGGGEVVLGPTVKLGYFTQEHQEMDGSQRVIEYIKDEAEVVRTADGSAITAAQMLERFLFPPALQWTPIAKLSGGEKRRLYLLRVLMSAPNVLLLDEPTNDLDIQTLSVLEQYLDEFPGVCIVVSHDRFFLDRTVDKIMAFEGDGQIRVHVGSYSEYAEWMQRHGGEASGSKAEASIAKSASGSSDGTDSDSAKEAPRERLKFSYKEQREFDQIDGLIEDTESKLASIQSEMETAGSDAARLQELMKAQEETERELEHLMERWTYLNELAEKIEQSKKS", "dna_sequence_from_broadstreet": "ATGAATATTTTGACCGTCGAACAGGTAACAAAAAGCTATGGAGACAAAATTCTGTTTCAAGATGCATCCTTCGGAATGGAGGATCAGGATAAAATCGGCATTATCGGCGTGAATGGCACGGGGAAATCCACATTTCTGCGGGTCATCGCGGGGCTCGAGCCGCCCGACTCCGGTAAAATATCGATGGGCAATCGCATCCGGGTTCGTTACCTCGCGCAAAATCCGGAGTTTGATCCGGACAAAACCGTCCTGCAGCAGGTGTTTGAGGGCGATCTTCCGGAGATGAAGGCCGTGCGGGAATACACCGAAACGATGGAACTGCTGGAGCTGCATCCAAGTCATGAGGAGCTCCAGCAGAAACTGCTGAAGCTCAATCAGACGCTGGAAACGCTGCAGGCATGGCAGCTTGAAAGCGATGCGAAAACCATCCTGTCCAAGCTGGGGATTCGGAATTATGAAGCGAAGATGGGAACGCTGTCGGGCGGCCAGCGTAAGCGGGTGGCATTAGCCGCCGCCTTGATTCAGCCTTCCGACTTGCTTATTTTGGACGAGCCGACCAACCACATTGACAATGAATCCGTTGCCTGGCTGGAGCAGTATTTGCAGAAGCGCCGCGGCGCGCTGCTCATGATTACGCATGACCGGTATTTTCTGGACCGGGTAGCCAATGTTATGCTGGAGCTGGATCACGGACGGCTGTTTCGATATGAGGCGAACTACAGCCGTTTTCTGGAGCTGAAGGCAGAACGCGAGGAGCGTGAAGCCGCTTCCGAGCAAAAGCGCCAAAATTTGCTGCGGAGCGAGCTTGCCTGGATCCGCAGAGGGGCCAAGGCCCGCACGACCAAGCAGAAGGCGAGGATTGAACGCTTCGAGAAACTCAAGGATCAGGAGATGGTGCACAGCTCCGGTGAACTGGACGTTTCGGTCGCTTCCACCCGCTTGGGACGCAAAATTCTGGAGATTGAAGGTCTCCGGATGAAGATCGACGACAAAACGTTAATTCAGGACCTTTCCTATATCGCCGTTCCCGAGGATCGGATAGGTATCGTAGGCCCGAACGGCAGCGGCAAATCCACGCTGCTCAATCTGATTGCCGGGCGGATTCAGCCGGGTGGCGGGGAAGTCGTGCTCGGACCGACGGTCAAGCTCGGTTATTTCACGCAGGAGCATCAGGAGATGGACGGCAGTCAGCGCGTGATTGAGTATATCAAGGATGAGGCCGAGGTTGTCCGCACGGCGGACGGTTCGGCGATTACCGCAGCCCAGATGCTGGAACGCTTTCTGTTCCCGCCCGCGCTGCAGTGGACGCCGATTGCGAAGCTGTCCGGAGGCGAGAAGCGCCGCTTGTATCTGCTGCGGGTGCTGATGAGCGCACCGAATGTGCTGCTGCTTGATGAACCGACCAATGATTTGGATATCCAGACATTGTCCGTCCTGGAGCAGTATTTGGATGAGTTCCCGGGCGTCTGTATCGTGGTATCCCATGATCGCTTTTTCCTGGATCGAACCGTGGACAAGATTATGGCTTTTGAGGGCGACGGTCAGATTCGTGTCCATGTCGGCTCTTACAGCGAATATGCGGAATGGATGCAGCGTCACGGCGGTGAAGCTTCCGGGAGCAAGGCGGAGGCATCCATAGCCAAATCTGCTTCGGGGAGCAGCGATGGCACGGACAGTGATTCAGCTAAAGAAGCGCCGCGTGAGCGCTTGAAATTCAGTTACAAAGAACAACGGGAGTTTGATCAGATTGACGGGCTCATCGAGGATACCGAGAGCAAGCTCGCTTCGATTCAATCCGAGATGGAGACCGCCGGCAGCGACGCAGCCAGGCTTCAGGAGCTGATGAAGGCTCAGGAGGAAACGGAACGTGAGCTGGAGCATCTGATGGAACGCTGGACCTATCTGAACGAGCTCGCGGAGAAGATTGAACAGAGCAAGAAATCGTAA", "partial": "0", "query_start": 51445, "query_end": 51879, "hit_start": 1026, "hit_end": 1416, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 29.94}, "gnl|BL_ORD_ID|1917|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "vgaC", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1000", "model_id": "2123", "ARO_accession": "3002831", "ARO_name": "vgaC", "ARO_category": {"36252": {"category_aro_accession": "3000113", "category_aro_cvterm_id": "36252", "category_aro_name": "vga-type ABC-F protein", "category_aro_description": "Vga-type plasmid-borne ABC-F proteins, expressed in staphylococci that confer resistance to streptogramin A antibiotics through ribosomal protection.", "category_aro_class_name": "AMR Gene Family"}, "35964": {"category_aro_accession": "0000046", "category_aro_cvterm_id": "35964", "category_aro_name": "lincomycin", "category_aro_description": "Lincomycin is a lincosamide antibiotic that comes from the actinomyces Streptomyces lincolnensis. It binds to the 23s portion of the 50S subunit of bacterial ribosomes and inhibit early elongation of peptide chain by inhibiting transpeptidase reaction.", "category_aro_class_name": "Antibiotic"}, "35983": {"category_aro_accession": "0000066", "category_aro_cvterm_id": "35983", "category_aro_name": "clindamycin", "category_aro_description": "Clindamycin is a lincosamide antibiotic that blocks A-site aminoacyl-tRNA binding. It is usually used to treat infections with anaerobic bacteria but can also be used to treat some protozoal diseases, such as malaria.", "category_aro_class_name": "Antibiotic"}, "37013": {"category_aro_accession": "3000669", "category_aro_cvterm_id": "37013", "category_aro_name": "virginiamycin M1", "category_aro_description": "Virginiamycin M1 is a streptogramin A antibiotic.", "category_aro_class_name": "Antibiotic"}, "37015": {"category_aro_accession": "3000671", "category_aro_cvterm_id": "37015", "category_aro_name": "tiamulin", "category_aro_description": "Tiamulin is a pleuromutilin derivative currently used in veterinary medicine. It binds to the 23 rRNA of the 50S ribosomal subunit to inhibit protein translation.", "category_aro_class_name": "Antibiotic"}, "37714": {"category_aro_accession": "3001315", "category_aro_cvterm_id": "37714", "category_aro_name": "valnemulin", "category_aro_description": "Two semi-synthetic pleuromutilin derivatives, tiamulin and valnemulin, have been developed as antibiotics for veterinary use.", "category_aro_class_name": "Antibiotic"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35952": {"category_aro_accession": "0000034", "category_aro_cvterm_id": "35952", "category_aro_name": "streptogramin A antibiotic", "category_aro_description": "Streptogramin A antibiotics are cyclic polyketide peptide hybrids that bind to the ribosomal peptidyl transfer centre. Structural variation arises from substituting a proline for its desaturated derivative and by its substitution for Ala or Cys. Used alone, streptogramin A antibiotics are bacteriostatic, but is bactericidal when used with streptogramin B antibiotics.", "category_aro_class_name": "Drug Class"}, "37014": {"category_aro_accession": "3000670", "category_aro_cvterm_id": "37014", "category_aro_name": "pleuromutilin antibiotic", "category_aro_description": "Pleuromutilins are natural fungal products that target bacterial protein translation by binding the the 23S rRNA, blocking the ribosome P site at the 50S subunit. They are mostly used for agriculture and veterinary purposes.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.31744e-09, "max_identities": 54, "bit_score": 55.4546, "cvterm_id": "35508", "query": "LRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVV---SVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSV-LSVFQNVEFPLLLQRKLNASERRTRVM-TLLEQVGLEKHAKHRP-NELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHD--------AKVMTHANAVVRLADG", "match": " +  T ++Y G+ ++I GP+GSGKTT   L+  + T  +GV    SV                    IG+  Q+   + V  S+ +NV+         N+S++   ++ T+L ++       ++P + LSGG+R +VA+ + LV+    ++ DEPT  LD+   + + +L+ E       + IF +HD         +++   N  + + DG", "sequence_from_db": "WKKATFQIYGGDKLAIIGPNGSGKTT---LVKKIITQENGVTISPSV-------------------KIGYFSQNLMTLDVNKSILENVQ---------NSSKQEESLIRTVLARMHFFDEDVYKPVHVLSGGERVKVALTKLLVSDINTLVLDEPTNYLDTEALKALENLLNEYT----GSIIFVSHDRTFTENIATRILEIRNKKIEIFDG", "sequence_from_broadstreet": "MVLLEAKNIKHYIKDRLLLKIDELKIEHNDRIGLVGVNGSGKTTLLNILAEKFIPDEGTITPYAQSEILPQLKKTDAAKSGGEITQEYIQQTLNSAPALLLADEPTTNLDTDHIEWVEKKLKRWQGAFVLVSHDREFLDALCSVIWELEDGEITEYKGNYSDYLKQKEVEKQQQQSTYEKYEKEKKQLEKAIQLKEEKAQRATKKPKNLSASERRIKGSKPYFAKKQKKLHKTAGALETRVEKLEKVEKIKDQPPIKMDLPNERNLKNRVIIRVEDLEGLVPKQLLWKKATFQIYGGDKLAIIGPNGSGKTTLVKKIITQENGVTISPSVKIGYFSQNLMTLDVNKSILENVQNSSKQEESLIRTVLARMHFFDEDVYKPVHVLSGGERVKVALTKLLVSDINTLVLDEPTNYLDTEALKALENLLNEYTGSIIFVSHDRTFTENIATRILEIRNKKIEIFDGTYQQFKNRSTKKERDFQQEEQLLLDTKISEVLSRLSMEPSQALEKEFQNLLKEKSKLKE", "dna_sequence_from_broadstreet": "ATGGTTTTACTAGAGGCCAAAAATATAAAACACTACATCAAAGATCGCTTATTATTAAAGATTGATGAATTAAAAATTGAACATAATGACCGGATTGGCTTGGTAGGTGTAAATGGAAGTGGAAAAACAACTTTGTTAAATATCCTTGCTGAAAAATTTATTCCTGACGAGGGGACAATCACGCCGTATGCCCAGAGTGAGATATTGCCACAGTTAAAAAAGACCGATGCGGCAAAAAGTGGGGGCGAAATTACTCAGGAATATATTCAACAAACGTTAAATAGTGCTCCAGCTCTTTTATTAGCAGACGAACCGACGACCAATCTAGATACAGATCATATCGAATGGGTTGAAAAAAAATTGAAGCGTTGGCAGGGGGCCTTCGTTCTTGTTTCCCATGACCGAGAATTTTTAGACGCTCTGTGTTCTGTTATTTGGGAACTGGAAGATGGTGAAATAACGGAGTACAAGGGCAATTATAGTGATTATCTCAAGCAAAAAGAAGTAGAAAAGCAACAACAACAATCCACATATGAAAAATATGAAAAAGAAAAAAAACAGCTGGAGAAAGCAATCCAACTAAAAGAAGAAAAGGCCCAACGAGCAACTAAAAAGCCTAAAAATTTATCTGCTTCTGAGAGACGAATAAAGGGATCGAAGCCTTACTTCGCAAAAAAACAGAAAAAACTGCATAAAACTGCAGGTGCTCTTGAAACAAGAGTAGAGAAATTAGAAAAAGTAGAGAAAATAAAAGATCAGCCACCTATTAAAATGGATTTACCAAATGAAAGAAATCTTAAAAATCGTGTGATTATTCGGGTTGAGGATCTAGAAGGACTTGTTCCCAAGCAGTTACTTTGGAAAAAGGCAACTTTTCAAATTTATGGTGGGGACAAACTAGCTATCATAGGACCCAATGGTAGTGGAAAAACAACTTTAGTTAAAAAAATAATAACTCAAGAAAATGGTGTCACTATTTCTCCGTCTGTTAAGATCGGTTACTTTAGTCAGAATCTAATGACGCTAGATGTAAACAAATCTATTTTAGAGAACGTTCAAAATTCTTCGAAACAAGAAGAATCACTGATTCGAACGGTACTAGCTAGAATGCATTTCTTTGATGAAGATGTATACAAACCTGTGCATGTGCTAAGCGGTGGTGAAAGAGTAAAAGTTGCACTGACAAAACTATTAGTGAGCGATATCAATACACTCGTTTTAGATGAACCAACGAATTACTTGGATACGGAAGCACTCAAAGCATTAGAAAACCTCTTGAATGAATATACGGGAAGTATTATTTTTGTTTCTCATGATCGTACCTTTACCGAAAATATCGCTACTCGAATTTTAGAAATACGTAATAAAAAAATTGAGATATTTGATGGGACGTACCAACAATTCAAAAATAGATCTACTAAAAAGGAACGGGATTTTCAGCAAGAAGAGCAGTTACTACTAGATACAAAGATATCCGAAGTACTTAGCCGCTTAAGTATGGAACCTTCCCAAGCTTTGGAAAAAGAATTTCAAAACCTCCTAAAAGAAAAAAGTAAGTTAAAGGAGTAA", "partial": "0", "query_start": 51418, "query_end": 52011, "hit_start": 858, "hit_end": 1389, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 25.47}, "gnl|BL_ORD_ID|1917|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "vgaC", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1000", "model_id": "2123", "ARO_accession": "3002831", "ARO_name": "vgaC", "ARO_category": {"36252": {"category_aro_accession": "3000113", "category_aro_cvterm_id": "36252", "category_aro_name": "vga-type ABC-F protein", "category_aro_description": "Vga-type plasmid-borne ABC-F proteins, expressed in staphylococci that confer resistance to streptogramin A antibiotics through ribosomal protection.", "category_aro_class_name": "AMR Gene Family"}, "35964": {"category_aro_accession": "0000046", "category_aro_cvterm_id": "35964", "category_aro_name": "lincomycin", "category_aro_description": "Lincomycin is a lincosamide antibiotic that comes from the actinomyces Streptomyces lincolnensis. It binds to the 23s portion of the 50S subunit of bacterial ribosomes and inhibit early elongation of peptide chain by inhibiting transpeptidase reaction.", "category_aro_class_name": "Antibiotic"}, "35983": {"category_aro_accession": "0000066", "category_aro_cvterm_id": "35983", "category_aro_name": "clindamycin", "category_aro_description": "Clindamycin is a lincosamide antibiotic that blocks A-site aminoacyl-tRNA binding. It is usually used to treat infections with anaerobic bacteria but can also be used to treat some protozoal diseases, such as malaria.", "category_aro_class_name": "Antibiotic"}, "37013": {"category_aro_accession": "3000669", "category_aro_cvterm_id": "37013", "category_aro_name": "virginiamycin M1", "category_aro_description": "Virginiamycin M1 is a streptogramin A antibiotic.", "category_aro_class_name": "Antibiotic"}, "37015": {"category_aro_accession": "3000671", "category_aro_cvterm_id": "37015", "category_aro_name": "tiamulin", "category_aro_description": "Tiamulin is a pleuromutilin derivative currently used in veterinary medicine. It binds to the 23 rRNA of the 50S ribosomal subunit to inhibit protein translation.", "category_aro_class_name": "Antibiotic"}, "37714": {"category_aro_accession": "3001315", "category_aro_cvterm_id": "37714", "category_aro_name": "valnemulin", "category_aro_description": "Two semi-synthetic pleuromutilin derivatives, tiamulin and valnemulin, have been developed as antibiotics for veterinary use.", "category_aro_class_name": "Antibiotic"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35952": {"category_aro_accession": "0000034", "category_aro_cvterm_id": "35952", "category_aro_name": "streptogramin A antibiotic", "category_aro_description": "Streptogramin A antibiotics are cyclic polyketide peptide hybrids that bind to the ribosomal peptidyl transfer centre. Structural variation arises from substituting a proline for its desaturated derivative and by its substitution for Ala or Cys. Used alone, streptogramin A antibiotics are bacteriostatic, but is bactericidal when used with streptogramin B antibiotics.", "category_aro_class_name": "Drug Class"}, "37014": {"category_aro_accession": "3000670", "category_aro_cvterm_id": "37014", "category_aro_name": "pleuromutilin antibiotic", "category_aro_description": "Pleuromutilins are natural fungal products that target bacterial protein translation by binding the the 23S rRNA, blocking the ribosome P site at the 50S subunit. They are mostly used for agriculture and veterinary purposes.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.73816e-06, "max_identities": 28, "bit_score": 44.2838, "cvterm_id": "35508", "query": "SGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVV-RLADGKI", "match": "SGG+  +  + + L + P L+LADEPT NLD+    +I  + K+L R +G  F+  +HD + +    +V+  L DG+I", "sequence_from_db": "SGGEITQEYIQQTLNSAPALLLADEPTTNLDT---DHIEWVEKKLKRWQG-AFVLVSHDREFLDALCSVIWELEDGEI", "sequence_from_broadstreet": "MVLLEAKNIKHYIKDRLLLKIDELKIEHNDRIGLVGVNGSGKTTLLNILAEKFIPDEGTITPYAQSEILPQLKKTDAAKSGGEITQEYIQQTLNSAPALLLADEPTTNLDTDHIEWVEKKLKRWQGAFVLVSHDREFLDALCSVIWELEDGEITEYKGNYSDYLKQKEVEKQQQQSTYEKYEKEKKQLEKAIQLKEEKAQRATKKPKNLSASERRIKGSKPYFAKKQKKLHKTAGALETRVEKLEKVEKIKDQPPIKMDLPNERNLKNRVIIRVEDLEGLVPKQLLWKKATFQIYGGDKLAIIGPNGSGKTTLVKKIITQENGVTISPSVKIGYFSQNLMTLDVNKSILENVQNSSKQEESLIRTVLARMHFFDEDVYKPVHVLSGGERVKVALTKLLVSDINTLVLDEPTNYLDTEALKALENLLNEYTGSIIFVSHDRTFTENIATRILEIRNKKIEIFDGTYQQFKNRSTKKERDFQQEEQLLLDTKISEVLSRLSMEPSQALEKEFQNLLKEKSKLKE", "dna_sequence_from_broadstreet": "ATGGTTTTACTAGAGGCCAAAAATATAAAACACTACATCAAAGATCGCTTATTATTAAAGATTGATGAATTAAAAATTGAACATAATGACCGGATTGGCTTGGTAGGTGTAAATGGAAGTGGAAAAACAACTTTGTTAAATATCCTTGCTGAAAAATTTATTCCTGACGAGGGGACAATCACGCCGTATGCCCAGAGTGAGATATTGCCACAGTTAAAAAAGACCGATGCGGCAAAAAGTGGGGGCGAAATTACTCAGGAATATATTCAACAAACGTTAAATAGTGCTCCAGCTCTTTTATTAGCAGACGAACCGACGACCAATCTAGATACAGATCATATCGAATGGGTTGAAAAAAAATTGAAGCGTTGGCAGGGGGCCTTCGTTCTTGTTTCCCATGACCGAGAATTTTTAGACGCTCTGTGTTCTGTTATTTGGGAACTGGAAGATGGTGAAATAACGGAGTACAAGGGCAATTATAGTGATTATCTCAAGCAAAAAGAAGTAGAAAAGCAACAACAACAATCCACATATGAAAAATATGAAAAAGAAAAAAAACAGCTGGAGAAAGCAATCCAACTAAAAGAAGAAAAGGCCCAACGAGCAACTAAAAAGCCTAAAAATTTATCTGCTTCTGAGAGACGAATAAAGGGATCGAAGCCTTACTTCGCAAAAAAACAGAAAAAACTGCATAAAACTGCAGGTGCTCTTGAAACAAGAGTAGAGAAATTAGAAAAAGTAGAGAAAATAAAAGATCAGCCACCTATTAAAATGGATTTACCAAATGAAAGAAATCTTAAAAATCGTGTGATTATTCGGGTTGAGGATCTAGAAGGACTTGTTCCCAAGCAGTTACTTTGGAAAAAGGCAACTTTTCAAATTTATGGTGGGGACAAACTAGCTATCATAGGACCCAATGGTAGTGGAAAAACAACTTTAGTTAAAAAAATAATAACTCAAGAAAATGGTGTCACTATTTCTCCGTCTGTTAAGATCGGTTACTTTAGTCAGAATCTAATGACGCTAGATGTAAACAAATCTATTTTAGAGAACGTTCAAAATTCTTCGAAACAAGAAGAATCACTGATTCGAACGGTACTAGCTAGAATGCATTTCTTTGATGAAGATGTATACAAACCTGTGCATGTGCTAAGCGGTGGTGAAAGAGTAAAAGTTGCACTGACAAAACTATTAGTGAGCGATATCAATACACTCGTTTTAGATGAACCAACGAATTACTTGGATACGGAAGCACTCAAAGCATTAGAAAACCTCTTGAATGAATATACGGGAAGTATTATTTTTGTTTCTCATGATCGTACCTTTACCGAAAATATCGCTACTCGAATTTTAGAAATACGTAATAAAAAAATTGAGATATTTGATGGGACGTACCAACAATTCAAAAATAGATCTACTAAAAAGGAACGGGATTTTCAGCAAGAAGAGCAGTTACTACTAGATACAAAGATATCCGAAGTACTTAGCCGCTTAAGTATGGAACCTTCCCAAGCTTTGGAAAAAGAATTTCAAAACCTCCTAAAAGAAAAAAGTAAGTTAAAGGAGTAA", "partial": "0", "query_start": 51787, "query_end": 52017, "hit_start": 237, "hit_end": 459, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 35.9}, "gnl|BL_ORD_ID|1917|hsp_num:2": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "vgaC", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1000", "model_id": "2123", "ARO_accession": "3002831", "ARO_name": "vgaC", "ARO_category": {"36252": {"category_aro_accession": "3000113", "category_aro_cvterm_id": "36252", "category_aro_name": "vga-type ABC-F protein", "category_aro_description": "Vga-type plasmid-borne ABC-F proteins, expressed in staphylococci that confer resistance to streptogramin A antibiotics through ribosomal protection.", "category_aro_class_name": "AMR Gene Family"}, "35964": {"category_aro_accession": "0000046", "category_aro_cvterm_id": "35964", "category_aro_name": "lincomycin", "category_aro_description": "Lincomycin is a lincosamide antibiotic that comes from the actinomyces Streptomyces lincolnensis. It binds to the 23s portion of the 50S subunit of bacterial ribosomes and inhibit early elongation of peptide chain by inhibiting transpeptidase reaction.", "category_aro_class_name": "Antibiotic"}, "35983": {"category_aro_accession": "0000066", "category_aro_cvterm_id": "35983", "category_aro_name": "clindamycin", "category_aro_description": "Clindamycin is a lincosamide antibiotic that blocks A-site aminoacyl-tRNA binding. It is usually used to treat infections with anaerobic bacteria but can also be used to treat some protozoal diseases, such as malaria.", "category_aro_class_name": "Antibiotic"}, "37013": {"category_aro_accession": "3000669", "category_aro_cvterm_id": "37013", "category_aro_name": "virginiamycin M1", "category_aro_description": "Virginiamycin M1 is a streptogramin A antibiotic.", "category_aro_class_name": "Antibiotic"}, "37015": {"category_aro_accession": "3000671", "category_aro_cvterm_id": "37015", "category_aro_name": "tiamulin", "category_aro_description": "Tiamulin is a pleuromutilin derivative currently used in veterinary medicine. It binds to the 23 rRNA of the 50S ribosomal subunit to inhibit protein translation.", "category_aro_class_name": "Antibiotic"}, "37714": {"category_aro_accession": "3001315", "category_aro_cvterm_id": "37714", "category_aro_name": "valnemulin", "category_aro_description": "Two semi-synthetic pleuromutilin derivatives, tiamulin and valnemulin, have been developed as antibiotics for veterinary use.", "category_aro_class_name": "Antibiotic"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35952": {"category_aro_accession": "0000034", "category_aro_cvterm_id": "35952", "category_aro_name": "streptogramin A antibiotic", "category_aro_description": "Streptogramin A antibiotics are cyclic polyketide peptide hybrids that bind to the ribosomal peptidyl transfer centre. Structural variation arises from substituting a proline for its desaturated derivative and by its substitution for Ala or Cys. Used alone, streptogramin A antibiotics are bacteriostatic, but is bactericidal when used with streptogramin B antibiotics.", "category_aro_class_name": "Drug Class"}, "37014": {"category_aro_accession": "3000670", "category_aro_cvterm_id": "37014", "category_aro_name": "pleuromutilin antibiotic", "category_aro_description": "Pleuromutilins are natural fungal products that target bacterial protein translation by binding the the 23S rRNA, blocking the ribosome P site at the 50S subunit. They are mostly used for agriculture and veterinary purposes.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.83789, "max_identities": 11, "bit_score": 26.1794, "cvterm_id": "35508", "query": "LEVYPGEFISIAGPSGSGKTTALNLIG", "match": "L++   + I + G +GSGKTT LN++ ", "sequence_from_db": "LKIEHNDRIGLVGVNGSGKTTLLNILA", "sequence_from_broadstreet": "MVLLEAKNIKHYIKDRLLLKIDELKIEHNDRIGLVGVNGSGKTTLLNILAEKFIPDEGTITPYAQSEILPQLKKTDAAKSGGEITQEYIQQTLNSAPALLLADEPTTNLDTDHIEWVEKKLKRWQGAFVLVSHDREFLDALCSVIWELEDGEITEYKGNYSDYLKQKEVEKQQQQSTYEKYEKEKKQLEKAIQLKEEKAQRATKKPKNLSASERRIKGSKPYFAKKQKKLHKTAGALETRVEKLEKVEKIKDQPPIKMDLPNERNLKNRVIIRVEDLEGLVPKQLLWKKATFQIYGGDKLAIIGPNGSGKTTLVKKIITQENGVTISPSVKIGYFSQNLMTLDVNKSILENVQNSSKQEESLIRTVLARMHFFDEDVYKPVHVLSGGERVKVALTKLLVSDINTLVLDEPTNYLDTEALKALENLLNEYTGSIIFVSHDRTFTENIATRILEIRNKKIEIFDGTYQQFKNRSTKKERDFQQEEQLLLDTKISEVLSRLSMEPSQALEKEFQNLLKEKSKLKE", "dna_sequence_from_broadstreet": "ATGGTTTTACTAGAGGCCAAAAATATAAAACACTACATCAAAGATCGCTTATTATTAAAGATTGATGAATTAAAAATTGAACATAATGACCGGATTGGCTTGGTAGGTGTAAATGGAAGTGGAAAAACAACTTTGTTAAATATCCTTGCTGAAAAATTTATTCCTGACGAGGGGACAATCACGCCGTATGCCCAGAGTGAGATATTGCCACAGTTAAAAAAGACCGATGCGGCAAAAAGTGGGGGCGAAATTACTCAGGAATATATTCAACAAACGTTAAATAGTGCTCCAGCTCTTTTATTAGCAGACGAACCGACGACCAATCTAGATACAGATCATATCGAATGGGTTGAAAAAAAATTGAAGCGTTGGCAGGGGGCCTTCGTTCTTGTTTCCCATGACCGAGAATTTTTAGACGCTCTGTGTTCTGTTATTTGGGAACTGGAAGATGGTGAAATAACGGAGTACAAGGGCAATTATAGTGATTATCTCAAGCAAAAAGAAGTAGAAAAGCAACAACAACAATCCACATATGAAAAATATGAAAAAGAAAAAAAACAGCTGGAGAAAGCAATCCAACTAAAAGAAGAAAAGGCCCAACGAGCAACTAAAAAGCCTAAAAATTTATCTGCTTCTGAGAGACGAATAAAGGGATCGAAGCCTTACTTCGCAAAAAAACAGAAAAAACTGCATAAAACTGCAGGTGCTCTTGAAACAAGAGTAGAGAAATTAGAAAAAGTAGAGAAAATAAAAGATCAGCCACCTATTAAAATGGATTTACCAAATGAAAGAAATCTTAAAAATCGTGTGATTATTCGGGTTGAGGATCTAGAAGGACTTGTTCCCAAGCAGTTACTTTGGAAAAAGGCAACTTTTCAAATTTATGGTGGGGACAAACTAGCTATCATAGGACCCAATGGTAGTGGAAAAACAACTTTAGTTAAAAAAATAATAACTCAAGAAAATGGTGTCACTATTTCTCCGTCTGTTAAGATCGGTTACTTTAGTCAGAATCTAATGACGCTAGATGTAAACAAATCTATTTTAGAGAACGTTCAAAATTCTTCGAAACAAGAAGAATCACTGATTCGAACGGTACTAGCTAGAATGCATTTCTTTGATGAAGATGTATACAAACCTGTGCATGTGCTAAGCGGTGGTGAAAGAGTAAAAGTTGCACTGACAAAACTATTAGTGAGCGATATCAATACACTCGTTTTAGATGAACCAACGAATTACTTGGATACGGAAGCACTCAAAGCATTAGAAAACCTCTTGAATGAATATACGGGAAGTATTATTTTTGTTTCTCATGATCGTACCTTTACCGAAAATATCGCTACTCGAATTTTAGAAATACGTAATAAAAAAATTGAGATATTTGATGGGACGTACCAACAATTCAAAAATAGATCTACTAAAAAGGAACGGGATTTTCAGCAAGAAGAGCAGTTACTACTAGATACAAAGATATCCGAAGTACTTAGCCGCTTAAGTATGGAACCTTCCCAAGCTTTGGAAAAAGAATTTCAAAACCTCCTAAAAGAAAAAAGTAAGTTAAAGGAGTAA", "partial": "0", "query_start": 51433, "query_end": 51513, "hit_start": 69, "hit_end": 150, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 40.74}, "gnl|BL_ORD_ID|1490|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "vgaE", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1020", "model_id": "1626", "ARO_accession": "3002833", "ARO_name": "vgaE", "ARO_category": {"36252": {"category_aro_accession": "3000113", "category_aro_cvterm_id": "36252", "category_aro_name": "vga-type ABC-F protein", "category_aro_description": "Vga-type plasmid-borne ABC-F proteins, expressed in staphylococci that confer resistance to streptogramin A antibiotics through ribosomal protection.", "category_aro_class_name": "AMR Gene Family"}, "35983": {"category_aro_accession": "0000066", "category_aro_cvterm_id": "35983", "category_aro_name": "clindamycin", "category_aro_description": "Clindamycin is a lincosamide antibiotic that blocks A-site aminoacyl-tRNA binding. It is usually used to treat infections with anaerobic bacteria but can also be used to treat some protozoal diseases, such as malaria.", "category_aro_class_name": "Antibiotic"}, "37013": {"category_aro_accession": "3000669", "category_aro_cvterm_id": "37013", "category_aro_name": "virginiamycin M1", "category_aro_description": "Virginiamycin M1 is a streptogramin A antibiotic.", "category_aro_class_name": "Antibiotic"}, "37015": {"category_aro_accession": "3000671", "category_aro_cvterm_id": "37015", "category_aro_name": "tiamulin", "category_aro_description": "Tiamulin is a pleuromutilin derivative currently used in veterinary medicine. It binds to the 23 rRNA of the 50S ribosomal subunit to inhibit protein translation.", "category_aro_class_name": "Antibiotic"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35952": {"category_aro_accession": "0000034", "category_aro_cvterm_id": "35952", "category_aro_name": "streptogramin A antibiotic", "category_aro_description": "Streptogramin A antibiotics are cyclic polyketide peptide hybrids that bind to the ribosomal peptidyl transfer centre. Structural variation arises from substituting a proline for its desaturated derivative and by its substitution for Ala or Cys. Used alone, streptogramin A antibiotics are bacteriostatic, but is bactericidal when used with streptogramin B antibiotics.", "category_aro_class_name": "Drug Class"}, "37014": {"category_aro_accession": "3000670", "category_aro_cvterm_id": "37014", "category_aro_name": "pleuromutilin antibiotic", "category_aro_description": "Pleuromutilins are natural fungal products that target bacterial protein translation by binding the the 23S rRNA, blocking the ribosome P site at the 50S subunit. They are mostly used for agriculture and veterinary purposes.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.9988e-09, "max_identities": 51, "bit_score": 54.299, "cvterm_id": "35536", "query": "TLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTER--QLTHLRLHTIGFIFQSFNLVSV-LSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGL-EKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTH-ANAVVRLADGKI", "match": "+L +Y G+ ++I G +G+GKTT L                     KK+ ER  ++       IG+  Q   ++    ++ +N++        L +S+  T + T+L ++   ++    +   LSGG++ +VA+A+  ++   +++ DEPT  LD  + + +  LMK  +     T +F THD  ++T+ A  ++ + DGKI", "sequence_from_db": "SLYLYGGDKVAIIGKNGTGKTTLL---------------------KKIVERDERIAIPEKVRIGYFSQHLTILDDDKTIIENIQ--------LTSSQDETLIRTVLARMHFWDEDVYKKVGILSGGEKVKVALAKLFLSDVNMLVLDEPTNFLDIESLEALETLMKSYH----GTILFVTHDRTLVTNIATKIIDIKDGKI", "sequence_from_broadstreet": "MLLFEGTSLKKHIQDRLLFDIDLIQVHEHQRIGLVGRNGTGKTSLLKIITGEELVDGGNVNHFTSVKLVPQFKETRSEKSGGEITQQYLQLAFNEKPGLLILDEPTTHLDTQRIDWLEKKLANYQGAFVVVSHDRTFLNNVCTEIWEIEDGSLNAFKGDYNAYAEQKELIKTQQQIAFEKYEREKKQLEKAIRQKEERAQRATKKPKNLSSSEARITGAKTHYANIQKKLRGSAKALETRLEQLDRIDKVKELPEIKMDILNKESLTNQSVLRAENIKGEVDGRKLWNPFSLYLYGGDKVAIIGKNGTGKTTLLKKIVERDERIAIPEKVRIGYFSQHLTILDDDKTIIENIQLTSSQDETLIRTVLARMHFWDEDVYKKVGILSGGEKVKVALAKLFLSDVNMLVLDEPTNFLDIESLEALETLMKSYHGTILFVTHDRTLVTNIATKIIDIKDGKITVFDGSYEAYEEWLENQTKSNNDDQLLLIETKISDVLGRLSLEPSRELEDEFQRLLKEKKELTKKL", "dna_sequence_from_broadstreet": "ATGTTATTATTTGAAGGTACATCATTGAAAAAACACATACAAGACAGATTATTATTTGATATAGATTTAATACAAGTACATGAACATCAGCGAATAGGATTAGTAGGTAGGAATGGAACGGGGAAAACAAGTCTATTAAAAATTATTACAGGTGAAGAACTAGTTGATGGAGGGAATGTTAATCATTTTACCTCTGTAAAATTAGTACCACAATTTAAAGAAACAAGATCGGAGAAAAGTGGTGGAGAAATAACGCAACAATATTTGCAATTAGCATTTAATGAAAAGCCAGGATTATTAATTTTAGATGAACCAACGACTCATTTAGATACACAAAGAATTGATTGGTTAGAAAAGAAATTAGCAAACTATCAAGGAGCATTTGTTGTCGTATCACATGATCGGACATTTCTAAATAATGTGTGTACTGAAATATGGGAAATAGAAGATGGTAGTCTAAACGCGTTTAAAGGGGATTATAATGCTTATGCGGAACAAAAGGAATTAATAAAAACACAGCAGCAGATTGCATTTGAAAAGTACGAACGAGAGAAAAAGCAATTAGAAAAAGCAATACGACAAAAAGAGGAAAGAGCACAGCGAGCAACAAAGAAACCTAAAAATCTGAGTTCTTCAGAGGCAAGAATAACAGGAGCTAAAACCCATTATGCCAATATACAGAAAAAGTTGAGGGGTTCTGCAAAAGCATTAGAAACAAGGTTGGAACAACTGGATAGGATTGACAAGGTGAAAGAACTACCTGAAATTAAGATGGATATATTAAATAAAGAAAGTCTAACAAACCAGTCTGTGTTACGCGCTGAAAACATTAAGGGAGAGGTTGACGGACGTAAGCTTTGGAATCCCTTTAGTTTATATTTATATGGCGGCGATAAAGTTGCTATCATTGGGAAAAATGGCACGGGTAAAACAACCTTACTTAAAAAAATAGTTGAGCGAGATGAAAGAATAGCAATCCCAGAAAAGGTGAGGATAGGTTATTTTTCCCAACACCTCACAATTCTCGATGATGATAAAACAATCATAGAAAATATACAATTGACCTCTAGTCAGGATGAAACATTAATTAGAACAGTTTTAGCAAGAATGCATTTTTGGGATGAAGATGTCTATAAAAAGGTCGGCATATTAAGTGGTGGTGAAAAAGTAAAAGTAGCACTAGCTAAACTATTCTTAAGTGACGTGAATATGCTGGTGTTAGATGAACCTACAAATTTTTTAGATATTGAATCTTTAGAAGCGCTAGAAACATTAATGAAAAGTTATCATGGAACGATTCTATTTGTTACTCACGACCGAACGTTAGTAACAAATATAGCTACAAAAATAATTGATATAAAAGATGGTAAGATAACAGTATTCGATGGATCATACGAAGCATATGAAGAGTGGTTAGAGAATCAAACAAAGTCCAACAATGATGATCAACTTTTACTAATCGAAACTAAAATATCTGACGTTCTGGGTAGGTTGAGTTTGGAGCCTTCACGAGAGTTAGAAGATGAATTTCAAAGATTATTGAAAGAAAAGAAAGAACTGACTAAAAAACTATAA", "partial": "0", "query_start": 51430, "query_end": 52017, "hit_start": 870, "hit_end": 1374, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 25.37}, "gnl|BL_ORD_ID|1490|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "vgaE", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1020", "model_id": "1626", "ARO_accession": "3002833", "ARO_name": "vgaE", "ARO_category": {"36252": {"category_aro_accession": "3000113", "category_aro_cvterm_id": "36252", "category_aro_name": "vga-type ABC-F protein", "category_aro_description": "Vga-type plasmid-borne ABC-F proteins, expressed in staphylococci that confer resistance to streptogramin A antibiotics through ribosomal protection.", "category_aro_class_name": "AMR Gene Family"}, "35983": {"category_aro_accession": "0000066", "category_aro_cvterm_id": "35983", "category_aro_name": "clindamycin", "category_aro_description": "Clindamycin is a lincosamide antibiotic that blocks A-site aminoacyl-tRNA binding. It is usually used to treat infections with anaerobic bacteria but can also be used to treat some protozoal diseases, such as malaria.", "category_aro_class_name": "Antibiotic"}, "37013": {"category_aro_accession": "3000669", "category_aro_cvterm_id": "37013", "category_aro_name": "virginiamycin M1", "category_aro_description": "Virginiamycin M1 is a streptogramin A antibiotic.", "category_aro_class_name": "Antibiotic"}, "37015": {"category_aro_accession": "3000671", "category_aro_cvterm_id": "37015", "category_aro_name": "tiamulin", "category_aro_description": "Tiamulin is a pleuromutilin derivative currently used in veterinary medicine. It binds to the 23 rRNA of the 50S ribosomal subunit to inhibit protein translation.", "category_aro_class_name": "Antibiotic"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35952": {"category_aro_accession": "0000034", "category_aro_cvterm_id": "35952", "category_aro_name": "streptogramin A antibiotic", "category_aro_description": "Streptogramin A antibiotics are cyclic polyketide peptide hybrids that bind to the ribosomal peptidyl transfer centre. Structural variation arises from substituting a proline for its desaturated derivative and by its substitution for Ala or Cys. Used alone, streptogramin A antibiotics are bacteriostatic, but is bactericidal when used with streptogramin B antibiotics.", "category_aro_class_name": "Drug Class"}, "37014": {"category_aro_accession": "3000670", "category_aro_cvterm_id": "37014", "category_aro_name": "pleuromutilin antibiotic", "category_aro_description": "Pleuromutilins are natural fungal products that target bacterial protein translation by binding the the 23S rRNA, blocking the ribosome P site at the 50S subunit. They are mostly used for agriculture and veterinary purposes.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0064618, "max_identities": 25, "bit_score": 35.039, "cvterm_id": "35536", "query": "KHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTH-ANAVVRLADGKI", "match": "K   +E SGG+  +  +  A   +P L++ DEPT +LD+   Q I  L K+L   +G  F+  +HD   + +    +  + DG +", "sequence_from_db": "KETRSEKSGGEITQQYLQLAFNEKPGLLILDEPTTHLDT---QRIDWLEKKLANYQG-AFVVVSHDRTFLNNVCTEIWEIEDGSL", "sequence_from_broadstreet": "MLLFEGTSLKKHIQDRLLFDIDLIQVHEHQRIGLVGRNGTGKTSLLKIITGEELVDGGNVNHFTSVKLVPQFKETRSEKSGGEITQQYLQLAFNEKPGLLILDEPTTHLDTQRIDWLEKKLANYQGAFVVVSHDRTFLNNVCTEIWEIEDGSLNAFKGDYNAYAEQKELIKTQQQIAFEKYEREKKQLEKAIRQKEERAQRATKKPKNLSSSEARITGAKTHYANIQKKLRGSAKALETRLEQLDRIDKVKELPEIKMDILNKESLTNQSVLRAENIKGEVDGRKLWNPFSLYLYGGDKVAIIGKNGTGKTTLLKKIVERDERIAIPEKVRIGYFSQHLTILDDDKTIIENIQLTSSQDETLIRTVLARMHFWDEDVYKKVGILSGGEKVKVALAKLFLSDVNMLVLDEPTNFLDIESLEALETLMKSYHGTILFVTHDRTLVTNIATKIIDIKDGKITVFDGSYEAYEEWLENQTKSNNDDQLLLIETKISDVLGRLSLEPSRELEDEFQRLLKEKKELTKKL", "dna_sequence_from_broadstreet": "ATGTTATTATTTGAAGGTACATCATTGAAAAAACACATACAAGACAGATTATTATTTGATATAGATTTAATACAAGTACATGAACATCAGCGAATAGGATTAGTAGGTAGGAATGGAACGGGGAAAACAAGTCTATTAAAAATTATTACAGGTGAAGAACTAGTTGATGGAGGGAATGTTAATCATTTTACCTCTGTAAAATTAGTACCACAATTTAAAGAAACAAGATCGGAGAAAAGTGGTGGAGAAATAACGCAACAATATTTGCAATTAGCATTTAATGAAAAGCCAGGATTATTAATTTTAGATGAACCAACGACTCATTTAGATACACAAAGAATTGATTGGTTAGAAAAGAAATTAGCAAACTATCAAGGAGCATTTGTTGTCGTATCACATGATCGGACATTTCTAAATAATGTGTGTACTGAAATATGGGAAATAGAAGATGGTAGTCTAAACGCGTTTAAAGGGGATTATAATGCTTATGCGGAACAAAAGGAATTAATAAAAACACAGCAGCAGATTGCATTTGAAAAGTACGAACGAGAGAAAAAGCAATTAGAAAAAGCAATACGACAAAAAGAGGAAAGAGCACAGCGAGCAACAAAGAAACCTAAAAATCTGAGTTCTTCAGAGGCAAGAATAACAGGAGCTAAAACCCATTATGCCAATATACAGAAAAAGTTGAGGGGTTCTGCAAAAGCATTAGAAACAAGGTTGGAACAACTGGATAGGATTGACAAGGTGAAAGAACTACCTGAAATTAAGATGGATATATTAAATAAAGAAAGTCTAACAAACCAGTCTGTGTTACGCGCTGAAAACATTAAGGGAGAGGTTGACGGACGTAAGCTTTGGAATCCCTTTAGTTTATATTTATATGGCGGCGATAAAGTTGCTATCATTGGGAAAAATGGCACGGGTAAAACAACCTTACTTAAAAAAATAGTTGAGCGAGATGAAAGAATAGCAATCCCAGAAAAGGTGAGGATAGGTTATTTTTCCCAACACCTCACAATTCTCGATGATGATAAAACAATCATAGAAAATATACAATTGACCTCTAGTCAGGATGAAACATTAATTAGAACAGTTTTAGCAAGAATGCATTTTTGGGATGAAGATGTCTATAAAAAGGTCGGCATATTAAGTGGTGGTGAAAAAGTAAAAGTAGCACTAGCTAAACTATTCTTAAGTGACGTGAATATGCTGGTGTTAGATGAACCTACAAATTTTTTAGATATTGAATCTTTAGAAGCGCTAGAAACATTAATGAAAAGTTATCATGGAACGATTCTATTTGTTACTCACGACCGAACGTTAGTAACAAATATAGCTACAAAAATAATTGATATAAAAGATGGTAAGATAACAGTATTCGATGGATCATACGAAGCATATGAAGAGTGGTTAGAGAATCAAACAAAGTCCAACAATGATGATCAACTTTTACTAATCGAAACTAAAATATCTGACGTTCTGGGTAGGTTGAGTTTGGAGCCTTCACGAGAGTTAGAAGATGAATTTCAAAGATTATTGAAAGAAAAGAAAGAACTGACTAAAAAACTATAA", "partial": "0", "query_start": 51766, "query_end": 52017, "hit_start": 216, "hit_end": 459, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 29.41}, "gnl|BL_ORD_ID|1602|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "lsaC", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "960", "model_id": "1748", "ARO_accession": "3003112", "ARO_name": "lsaC", "ARO_category": {"41696": {"category_aro_accession": "3004472", "category_aro_cvterm_id": "41696", "category_aro_name": "lsa-type ABC-F protein", "category_aro_description": "A subgroup of the ABC-F protein subfamily of ATP-binding cassette proteins. lsa-type ABC-F proteins confer resistance to streptogramin, lincosamide and pleuromutilin antibiotics through antibiotic target protection of the ribosome.", "category_aro_class_name": "AMR Gene Family"}, "35964": {"category_aro_accession": "0000046", "category_aro_cvterm_id": "35964", "category_aro_name": "lincomycin", "category_aro_description": "Lincomycin is a lincosamide antibiotic that comes from the actinomyces Streptomyces lincolnensis. It binds to the 23s portion of the 50S subunit of bacterial ribosomes and inhibit early elongation of peptide chain by inhibiting transpeptidase reaction.", "category_aro_class_name": "Antibiotic"}, "35983": {"category_aro_accession": "0000066", "category_aro_cvterm_id": "35983", "category_aro_name": "clindamycin", "category_aro_description": "Clindamycin is a lincosamide antibiotic that blocks A-site aminoacyl-tRNA binding. It is usually used to treat infections with anaerobic bacteria but can also be used to treat some protozoal diseases, such as malaria.", "category_aro_class_name": "Antibiotic"}, "37716": {"category_aro_accession": "3001317", "category_aro_cvterm_id": "37716", "category_aro_name": "pleuromutilin", "category_aro_description": "Pleuromutilin is a natural product antibiotic produced by Clitopilus passeckerianus. Related antibiotics of clinical significance, such as tiamulin and retapamulin, are semi-synthetic derivatives of this compound.", "category_aro_class_name": "Antibiotic"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "37014": {"category_aro_accession": "3000670", "category_aro_cvterm_id": "37014", "category_aro_name": "pleuromutilin antibiotic", "category_aro_description": "Pleuromutilins are natural fungal products that target bacterial protein translation by binding the the 23S rRNA, blocking the ribosome P site at the 50S subunit. They are mostly used for agriculture and veterinary purposes.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.25128e-09, "max_identities": 57, "bit_score": 53.9138, "cvterm_id": "36847", "query": "QPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLI--------GCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLL--LQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTH-ANAVVRL", "match": " P++S+ +++  Y  GK Q+  L  ++ ++  G+ ++I G +GSGK+T + ++        G V  AS+  +S   QDT  LT     +  +H                  Q V+  L   + RKL+ +         L ++ ++ +        S GQ+++V +A +L     + + DEP   LD ++   I +++KE N     T IF  HD   +   AN ++RL", "sequence_from_db": "NPLISVCDLSSYY--GKKQI--LSNISFDIKQGDIVAIYGGNGSGKSTLIKILLGLNHEYSGDVKLASNLKISYVPQDTSNLTGSLNEY--IHK-----------------QGVDETLCKTILRKLDFARE-------LFEIDMKNY--------SDGQKKKVLIAVSLSKSAHIFIWDEPLNYLDVISRIQIEEIIKEAN----PTLIFVEHDKSFVEDIANKIIRL", "sequence_from_broadstreet": "MSTIKIENLTFSYYGYVKPVFENVSFSFDTNWKTGLIGRNGIGKSTLFKLLLNQEVYKGKISKSVDFIKFPPNLSDTSKLGIELYRELISDEEEWKLFRELHLLKVDESLIYRKFETLSKGEQTKILLAILFTREDGFLLIDEPTNHLDMDGRKIVSEYLKNKKGFLLISHDRDFLDGCINHIISINRNSIDVQSGNFTSWYENKLMKDQFEISQNEKLRKDIKRLKEAARQSQIWSDKVENTKNGVKVSGVKPDKGHIGHQSAKMMKKSKNLENRQNKAIEEKQNLLKDIETKESLLLHPLHHHKNPLISVCDLSSYYGKKQILSNISFDIKQGDIVAIYGGNGSGKSTLIKILLGLNHEYSGDVKLASNLKISYVPQDTSNLTGSLNEYIHKQGVDETLCKTILRKLDFARELFEIDMKNYSDGQKKKVLIAVSLSKSAHIFIWDEPLNYLDVISRIQIEEIIKEANPTLIFVEHDKSFVEDIANKIIRL", "dna_sequence_from_broadstreet": "ATGTCAACAATTAAAATTGAAAACCTTACTTTCTCATATTATGGCTATGTAAAACCTGTATTTGAAAATGTATCATTTTCATTTGATACGAACTGGAAAACAGGACTAATAGGAAGAAACGGAATTGGGAAATCAACACTATTTAAGCTGCTTCTAAACCAAGAAGTTTATAAGGGGAAAATCAGCAAAAGTGTTGACTTTATTAAATTCCCACCCAATTTAAGTGATACTTCAAAATTAGGGATTGAGTTATATAGAGAACTAATATCAGATGAGGAAGAATGGAAATTATTTAGAGAACTTCATTTGCTAAAGGTAGATGAGAGTCTTATTTACAGAAAGTTTGAAACGCTTTCTAAAGGAGAACAAACAAAAATCCTTTTAGCTATTTTGTTTACAAGAGAAGATGGTTTTTTACTTATAGATGAACCAACAAACCATTTAGATATGGACGGAAGAAAAATTGTCAGTGAATATCTGAAAAATAAAAAAGGTTTTTTGCTTATATCACATGATAGAGATTTTTTAGATGGTTGTATCAATCATATTATTTCTATTAACAGGAATTCTATTGATGTCCAATCAGGAAATTTTACATCGTGGTATGAAAATAAATTGATGAAAGACCAATTTGAGATTAGTCAAAATGAGAAATTAAGAAAAGATATTAAACGATTAAAAGAAGCTGCAAGACAAAGTCAAATTTGGTCTGATAAAGTTGAAAATACTAAAAACGGCGTGAAAGTATCAGGTGTAAAACCAGACAAGGGGCATATAGGTCATCAGTCAGCTAAGATGATGAAAAAATCTAAGAATTTGGAGAATAGACAAAATAAGGCAATAGAAGAAAAACAGAATTTACTAAAAGATATTGAAACAAAGGAAAGTCTATTATTGCATCCGTTACATCACCACAAAAATCCTCTAATATCAGTTTGCGATTTATCATCATATTATGGAAAAAAGCAGATATTAAGTAATATAAGTTTTGATATAAAGCAAGGTGATATAGTGGCTATATATGGGGGTAATGGTAGCGGAAAATCAACCTTGATTAAAATTTTATTAGGTCTAAATCACGAGTATTCAGGTGATGTAAAATTAGCAAGTAATTTAAAAATATCATATGTTCCTCAAGATACATCCAATTTAACAGGTAGCCTAAACGAGTATATTCATAAGCAAGGTGTTGATGAAACATTGTGCAAAACAATTCTTAGAAAATTAGATTTTGCAAGAGAATTATTTGAAATAGATATGAAGAACTATAGCGATGGACAAAAAAAGAAAGTTTTAATTGCTGTAAGTTTGTCAAAGTCAGCTCATATATTTATTTGGGACGAACCACTGAATTATTTAGATGTAATATCAAGAATACAGATTGAGGAAATTATAAAAGAAGCAAATCCTACACTCATATTTGTGGAACACGATAAGAGTTTTGTAGAAGATATAGCGAATAAAATAATACGATTATAA", "partial": "0", "query_start": 51352, "query_end": 52002, "hit_start": 918, "hit_end": 1476, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 25.0}, "gnl|BL_ORD_ID|1602|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "lsaC", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "960", "model_id": "1748", "ARO_accession": "3003112", "ARO_name": "lsaC", "ARO_category": {"41696": {"category_aro_accession": "3004472", "category_aro_cvterm_id": "41696", "category_aro_name": "lsa-type ABC-F protein", "category_aro_description": "A subgroup of the ABC-F protein subfamily of ATP-binding cassette proteins. lsa-type ABC-F proteins confer resistance to streptogramin, lincosamide and pleuromutilin antibiotics through antibiotic target protection of the ribosome.", "category_aro_class_name": "AMR Gene Family"}, "35964": {"category_aro_accession": "0000046", "category_aro_cvterm_id": "35964", "category_aro_name": "lincomycin", "category_aro_description": "Lincomycin is a lincosamide antibiotic that comes from the actinomyces Streptomyces lincolnensis. It binds to the 23s portion of the 50S subunit of bacterial ribosomes and inhibit early elongation of peptide chain by inhibiting transpeptidase reaction.", "category_aro_class_name": "Antibiotic"}, "35983": {"category_aro_accession": "0000066", "category_aro_cvterm_id": "35983", "category_aro_name": "clindamycin", "category_aro_description": "Clindamycin is a lincosamide antibiotic that blocks A-site aminoacyl-tRNA binding. It is usually used to treat infections with anaerobic bacteria but can also be used to treat some protozoal diseases, such as malaria.", "category_aro_class_name": "Antibiotic"}, "37716": {"category_aro_accession": "3001317", "category_aro_cvterm_id": "37716", "category_aro_name": "pleuromutilin", "category_aro_description": "Pleuromutilin is a natural product antibiotic produced by Clitopilus passeckerianus. Related antibiotics of clinical significance, such as tiamulin and retapamulin, are semi-synthetic derivatives of this compound.", "category_aro_class_name": "Antibiotic"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "37014": {"category_aro_accession": "3000670", "category_aro_cvterm_id": "37014", "category_aro_name": "pleuromutilin antibiotic", "category_aro_description": "Pleuromutilins are natural fungal products that target bacterial protein translation by binding the the 23S rRNA, blocking the ribosome P site at the 50S subunit. They are mostly used for agriculture and veterinary purposes.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0205546, "max_identities": 26, "bit_score": 33.113, "cvterm_id": "36847", "query": "LQRKLNASERRTRVMTLLEQVGLEKHAKHRPNE-LSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHD", "match": "L R+L + E   ++   L  + +++   +R  E LS G++ ++ +A         +L DEPT +LD + G+ I+   + L  K+G  F+  +HD", "sequence_from_db": "LYRELISDEEEWKLFRELHLLKVDESLIYRKFETLSKGEQTKILLAILFTREDGFLLIDEPTNHLD-MDGRKIVS--EYLKNKKG--FLLISHD", "sequence_from_broadstreet": "MSTIKIENLTFSYYGYVKPVFENVSFSFDTNWKTGLIGRNGIGKSTLFKLLLNQEVYKGKISKSVDFIKFPPNLSDTSKLGIELYRELISDEEEWKLFRELHLLKVDESLIYRKFETLSKGEQTKILLAILFTREDGFLLIDEPTNHLDMDGRKIVSEYLKNKKGFLLISHDRDFLDGCINHIISINRNSIDVQSGNFTSWYENKLMKDQFEISQNEKLRKDIKRLKEAARQSQIWSDKVENTKNGVKVSGVKPDKGHIGHQSAKMMKKSKNLENRQNKAIEEKQNLLKDIETKESLLLHPLHHHKNPLISVCDLSSYYGKKQILSNISFDIKQGDIVAIYGGNGSGKSTLIKILLGLNHEYSGDVKLASNLKISYVPQDTSNLTGSLNEYIHKQGVDETLCKTILRKLDFARELFEIDMKNYSDGQKKKVLIAVSLSKSAHIFIWDEPLNYLDVISRIQIEEIIKEANPTLIFVEHDKSFVEDIANKIIRL", "dna_sequence_from_broadstreet": "ATGTCAACAATTAAAATTGAAAACCTTACTTTCTCATATTATGGCTATGTAAAACCTGTATTTGAAAATGTATCATTTTCATTTGATACGAACTGGAAAACAGGACTAATAGGAAGAAACGGAATTGGGAAATCAACACTATTTAAGCTGCTTCTAAACCAAGAAGTTTATAAGGGGAAAATCAGCAAAAGTGTTGACTTTATTAAATTCCCACCCAATTTAAGTGATACTTCAAAATTAGGGATTGAGTTATATAGAGAACTAATATCAGATGAGGAAGAATGGAAATTATTTAGAGAACTTCATTTGCTAAAGGTAGATGAGAGTCTTATTTACAGAAAGTTTGAAACGCTTTCTAAAGGAGAACAAACAAAAATCCTTTTAGCTATTTTGTTTACAAGAGAAGATGGTTTTTTACTTATAGATGAACCAACAAACCATTTAGATATGGACGGAAGAAAAATTGTCAGTGAATATCTGAAAAATAAAAAAGGTTTTTTGCTTATATCACATGATAGAGATTTTTTAGATGGTTGTATCAATCATATTATTTCTATTAACAGGAATTCTATTGATGTCCAATCAGGAAATTTTACATCGTGGTATGAAAATAAATTGATGAAAGACCAATTTGAGATTAGTCAAAATGAGAAATTAAGAAAAGATATTAAACGATTAAAAGAAGCTGCAAGACAAAGTCAAATTTGGTCTGATAAAGTTGAAAATACTAAAAACGGCGTGAAAGTATCAGGTGTAAAACCAGACAAGGGGCATATAGGTCATCAGTCAGCTAAGATGATGAAAAAATCTAAGAATTTGGAGAATAGACAAAATAAGGCAATAGAAGAAAAACAGAATTTACTAAAAGATATTGAAACAAAGGAAAGTCTATTATTGCATCCGTTACATCACCACAAAAATCCTCTAATATCAGTTTGCGATTTATCATCATATTATGGAAAAAAGCAGATATTAAGTAATATAAGTTTTGATATAAAGCAAGGTGATATAGTGGCTATATATGGGGGTAATGGTAGCGGAAAATCAACCTTGATTAAAATTTTATTAGGTCTAAATCACGAGTATTCAGGTGATGTAAAATTAGCAAGTAATTTAAAAATATCATATGTTCCTCAAGATACATCCAATTTAACAGGTAGCCTAAACGAGTATATTCATAAGCAAGGTGTTGATGAAACATTGTGCAAAACAATTCTTAGAAAATTAGATTTTGCAAGAGAATTATTTGAAATAGATATGAAGAACTATAGCGATGGACAAAAAAAGAAAGTTTTAATTGCTGTAAGTTTGTCAAAGTCAGCTCATATATTTATTTGGGACGAACCACTGAATTATTTAGATGTAATATCAAGAATACAGATTGAGGAAATTATAAAAGAAGCAAATCCTACACTCATATTTGTGGAACACGATAAGAGTTTTGTAGAAGATATAGCGAATAAAATAATACGATTATAA", "partial": "0", "query_start": 51685, "query_end": 51963, "hit_start": 249, "hit_end": 516, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 27.66}, "gnl|BL_ORD_ID|4728|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "salE", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5740", "ARO_accession": "3007029", "ARO_name": "salE", "ARO_category": {"45589": {"category_aro_accession": "3007030", "category_aro_cvterm_id": "45589", "category_aro_name": "sal-type ABC-F protein", "category_aro_description": "Sal proteins are a part of the ABC-F proteins, expressed in staphylococci that confer resistance to group A streptogramin, lincosamide, and pleuromutilin antibiotics through ribosomal protection.", "category_aro_class_name": "AMR Gene Family"}, "37015": {"category_aro_accession": "3000671", "category_aro_cvterm_id": "37015", "category_aro_name": "tiamulin", "category_aro_description": "Tiamulin is a pleuromutilin derivative currently used in veterinary medicine. It binds to the 23 rRNA of the 50S ribosomal subunit to inhibit protein translation.", "category_aro_class_name": "Antibiotic"}, "37713": {"category_aro_accession": "3001314", "category_aro_cvterm_id": "37713", "category_aro_name": "retapamulin", "category_aro_description": "Retapamulin is a semi-synthetic pleuromutilin antibiotic approved for the treatment of skin infections.", "category_aro_class_name": "Antibiotic"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35952": {"category_aro_accession": "0000034", "category_aro_cvterm_id": "35952", "category_aro_name": "streptogramin A antibiotic", "category_aro_description": "Streptogramin A antibiotics are cyclic polyketide peptide hybrids that bind to the ribosomal peptidyl transfer centre. Structural variation arises from substituting a proline for its desaturated derivative and by its substitution for Ala or Cys. Used alone, streptogramin A antibiotics are bacteriostatic, but is bactericidal when used with streptogramin B antibiotics.", "category_aro_class_name": "Drug Class"}, "37014": {"category_aro_accession": "3000670", "category_aro_cvterm_id": "37014", "category_aro_name": "pleuromutilin antibiotic", "category_aro_description": "Pleuromutilins are natural fungal products that target bacterial protein translation by binding the the 23S rRNA, blocking the ribosome P site at the 50S subunit. They are mostly used for agriculture and veterinary purposes.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.1209e-08, "max_identities": 49, "bit_score": 52.7582, "cvterm_id": "45588", "query": "LRGVTLEVYPGEFISIAGPSGSGKTTALNLIG--------CVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNE-LSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTH", "match": "++ V L+   GE I++ G +G GKTT L  +          +D   +   ++ G D       +L HL+              +++  ++ V   +     LN  E    ++T  +Q+ L +    +P + LSGGQ+ R+A+ RA ++   L+L DEPT +LD    Q +ID +    ++   T I+ +H", "sequence_from_db": "IQSVDLQFEKGEHIAVIGNNGVGKTTLLKALNNKYKEDTYLMDQNMTTFGNMTGIDYVISLNTELFHLK-------------QALMDNYEKVSDYI----ALNGYEFEQTIITKAKQMALTEADLDKPIKVLSGGQQTRLALLRAFISNKPLILLDEPTNHLD----QEMIDQLINHIQQSKRTIIYVSH", "sequence_from_broadstreet": "MSFYFAQKPFEMFGKTLIQSVDLQFEKGEHIAVIGNNGVGKTTLLKALNNKYKEDTYLMDQNMTTFGNMTGIDYVISLNTELFHLKQALMDNYEKVSDYIALNGYEFEQTIITKAKQMALTEADLDKPIKVLSGGQQTRLALLRAFISNKPLILLDEPTNHLDQEMIDQLINHIQQSKRTIIYVSHHRGFIDQTASHVIEITPESTRKFNGNYKQYKEIKDLESQTEQRIYNKQQKEIQDLERTIKRVQTWHHSAQQKASVRNPIEQKKLSKLAQRAKVKEKQLNQKLQEKHIQEPSKETKSYYFSHQTSLPKRFLIRFEDVSVNIDGQAIYKHAHFEMKQNENILLTGPNGSGKSLFIALIRQHLSPDEGIIEITPSLKIGYFDHTNNNLNEAESPLSMLLVRTNITRSQAQTLLASFNFDKDQIKKPIRYLSMGEKSRLQFVLLYFSGANLLVLDEPTNYFDIVTQDLILSMIQSFTGQVLIVTHDSYLQSQFKAVHWEIKNQQLYNVSLTHTRESNLDETLKLLGEYKFIDENGHFETDN", "dna_sequence_from_broadstreet": "ATGTCTTTTTATTTTGCCCAAAAACCTTTTGAAATGTTTGGAAAAACACTGATTCAGTCAGTGGATTTACAATTTGAAAAGGGTGAACATATTGCTGTGATTGGTAATAATGGCGTTGGGAAAACGACTTTATTAAAAGCATTAAATAATAAGTATAAAGAAGATACTTATTTGATGGACCAAAACATGACTACCTTTGGAAACATGACGGGGATAGACTATGTAATAAGCTTAAACACAGAATTGTTTCATTTAAAACAAGCGTTAATGGATAACTATGAAAAAGTTTCAGATTATATCGCTTTAAATGGCTATGAATTTGAACAAACCATTATAACTAAAGCGAAGCAAATGGCTCTAACGGAAGCAGATCTTGACAAACCAATTAAAGTATTAAGCGGCGGCCAACAAACTAGGCTTGCTTTATTGAGAGCATTTATTTCAAACAAACCATTGATATTGCTGGACGAACCAACCAATCATTTAGACCAAGAAATGATAGACCAATTGATTAACCATATACAACAATCAAAACGCACAATCATATATGTGTCGCATCATAGAGGATTTATAGATCAGACCGCGAGTCATGTTATAGAAATAACACCCGAAAGTACAAGAAAATTTAATGGCAATTATAAGCAATACAAAGAGATAAAAGATTTAGAAAGTCAAACAGAACAACGTATATATAATAAACAACAAAAAGAAATACAAGACCTCGAACGTACGATCAAACGCGTACAAACATGGCATCATTCTGCTCAGCAAAAAGCAAGTGTACGTAATCCGATTGAACAGAAAAAGTTGAGCAAATTAGCGCAAAGGGCAAAGGTGAAGGAAAAACAATTAAACCAAAAATTACAAGAAAAACATATTCAAGAACCGAGTAAAGAAACAAAGTCATATTACTTTAGTCATCAGACTAGCCTTCCTAAACGTTTCTTAATTCGTTTTGAAGATGTTAGCGTTAATATTGATGGACAAGCTATATATAAACACGCTCATTTTGAAATGAAACAAAATGAAAATATATTACTTACTGGTCCAAATGGAAGTGGTAAATCGCTTTTCATCGCTTTGATTAGACAGCATTTATCACCAGACGAAGGTATTATAGAGATTACGCCATCGTTAAAGATAGGTTACTTTGATCATACAAATAACAATCTAAATGAAGCAGAATCTCCATTATCAATGTTGTTAGTAAGAACTAACATAACGCGTAGCCAAGCGCAGACATTACTTGCTTCATTTAATTTTGATAAGGATCAAATCAAAAAACCAATTCGCTATTTGTCTATGGGGGAAAAAAGTCGTTTACAATTTGTATTATTATATTTTTCAGGTGCTAATTTATTAGTATTGGATGAGCCTACGAACTATTTTGATATTGTAACTCAAGATTTAATTTTAAGTATGATTCAAAGTTTTACCGGTCAAGTATTGATTGTTACACATGATTCATATTTACAATCTCAATTTAAAGCTGTACATTGGGAAATAAAAAATCAACAACTTTATAATGTATCTTTAACTCATACGCGTGAATCAAACTTAGATGAAACCCTTAAGTTACTAGGTGAATATAAATTTATAGATGAAAATGGTCATTTTGAAACAGACAACTAG", "partial": "0", "query_start": 51418, "query_end": 51960, "hit_start": 51, "hit_end": 558, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 25.79}, "gnl|BL_ORD_ID|4728|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "salE", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5740", "ARO_accession": "3007029", "ARO_name": "salE", "ARO_category": {"45589": {"category_aro_accession": "3007030", "category_aro_cvterm_id": "45589", "category_aro_name": "sal-type ABC-F protein", "category_aro_description": "Sal proteins are a part of the ABC-F proteins, expressed in staphylococci that confer resistance to group A streptogramin, lincosamide, and pleuromutilin antibiotics through ribosomal protection.", "category_aro_class_name": "AMR Gene Family"}, "37015": {"category_aro_accession": "3000671", "category_aro_cvterm_id": "37015", "category_aro_name": "tiamulin", "category_aro_description": "Tiamulin is a pleuromutilin derivative currently used in veterinary medicine. It binds to the 23 rRNA of the 50S ribosomal subunit to inhibit protein translation.", "category_aro_class_name": "Antibiotic"}, "37713": {"category_aro_accession": "3001314", "category_aro_cvterm_id": "37713", "category_aro_name": "retapamulin", "category_aro_description": "Retapamulin is a semi-synthetic pleuromutilin antibiotic approved for the treatment of skin infections.", "category_aro_class_name": "Antibiotic"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35952": {"category_aro_accession": "0000034", "category_aro_cvterm_id": "35952", "category_aro_name": "streptogramin A antibiotic", "category_aro_description": "Streptogramin A antibiotics are cyclic polyketide peptide hybrids that bind to the ribosomal peptidyl transfer centre. Structural variation arises from substituting a proline for its desaturated derivative and by its substitution for Ala or Cys. Used alone, streptogramin A antibiotics are bacteriostatic, but is bactericidal when used with streptogramin B antibiotics.", "category_aro_class_name": "Drug Class"}, "37014": {"category_aro_accession": "3000670", "category_aro_cvterm_id": "37014", "category_aro_name": "pleuromutilin antibiotic", "category_aro_description": "Pleuromutilins are natural fungal products that target bacterial protein translation by binding the the 23S rRNA, blocking the ribosome P site at the 50S subunit. They are mostly used for agriculture and veterinary purposes.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000150287, "max_identities": 48, "bit_score": 40.0466, "cvterm_id": "45588", "query": "LEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPL-LLQRKLNASERRTRVMTLLEQVGLEKHAKHRP-NELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAV", "match": " E+   E I + GP+GSGK+  + LI    +   G++ +    T  L            IG+   + N ++        E PL +L  + N +  R++  TLL     +K    +P   LS G++ R+       +   L++ DEPT   D VT   I+ +++      G   I  THD+ + +   AV", "sequence_from_db": "FEMKQNENILLTGPNGSGKSLFIALIRQHLSPDEGIIEI----TPSL-----------KIGYFDHTNNNLN------EAESPLSMLLVRTNIT--RSQAQTLLASFNFDKDQIKKPIRYLSMGEKSRLQFVLLYFSGANLLVLDEPTNYFDIVTQDLILSMIQSFT---GQVLIV-THDSYLQSQFKAV", "sequence_from_broadstreet": "MSFYFAQKPFEMFGKTLIQSVDLQFEKGEHIAVIGNNGVGKTTLLKALNNKYKEDTYLMDQNMTTFGNMTGIDYVISLNTELFHLKQALMDNYEKVSDYIALNGYEFEQTIITKAKQMALTEADLDKPIKVLSGGQQTRLALLRAFISNKPLILLDEPTNHLDQEMIDQLINHIQQSKRTIIYVSHHRGFIDQTASHVIEITPESTRKFNGNYKQYKEIKDLESQTEQRIYNKQQKEIQDLERTIKRVQTWHHSAQQKASVRNPIEQKKLSKLAQRAKVKEKQLNQKLQEKHIQEPSKETKSYYFSHQTSLPKRFLIRFEDVSVNIDGQAIYKHAHFEMKQNENILLTGPNGSGKSLFIALIRQHLSPDEGIIEITPSLKIGYFDHTNNNLNEAESPLSMLLVRTNITRSQAQTLLASFNFDKDQIKKPIRYLSMGEKSRLQFVLLYFSGANLLVLDEPTNYFDIVTQDLILSMIQSFTGQVLIVTHDSYLQSQFKAVHWEIKNQQLYNVSLTHTRESNLDETLKLLGEYKFIDENGHFETDN", "dna_sequence_from_broadstreet": "ATGTCTTTTTATTTTGCCCAAAAACCTTTTGAAATGTTTGGAAAAACACTGATTCAGTCAGTGGATTTACAATTTGAAAAGGGTGAACATATTGCTGTGATTGGTAATAATGGCGTTGGGAAAACGACTTTATTAAAAGCATTAAATAATAAGTATAAAGAAGATACTTATTTGATGGACCAAAACATGACTACCTTTGGAAACATGACGGGGATAGACTATGTAATAAGCTTAAACACAGAATTGTTTCATTTAAAACAAGCGTTAATGGATAACTATGAAAAAGTTTCAGATTATATCGCTTTAAATGGCTATGAATTTGAACAAACCATTATAACTAAAGCGAAGCAAATGGCTCTAACGGAAGCAGATCTTGACAAACCAATTAAAGTATTAAGCGGCGGCCAACAAACTAGGCTTGCTTTATTGAGAGCATTTATTTCAAACAAACCATTGATATTGCTGGACGAACCAACCAATCATTTAGACCAAGAAATGATAGACCAATTGATTAACCATATACAACAATCAAAACGCACAATCATATATGTGTCGCATCATAGAGGATTTATAGATCAGACCGCGAGTCATGTTATAGAAATAACACCCGAAAGTACAAGAAAATTTAATGGCAATTATAAGCAATACAAAGAGATAAAAGATTTAGAAAGTCAAACAGAACAACGTATATATAATAAACAACAAAAAGAAATACAAGACCTCGAACGTACGATCAAACGCGTACAAACATGGCATCATTCTGCTCAGCAAAAAGCAAGTGTACGTAATCCGATTGAACAGAAAAAGTTGAGCAAATTAGCGCAAAGGGCAAAGGTGAAGGAAAAACAATTAAACCAAAAATTACAAGAAAAACATATTCAAGAACCGAGTAAAGAAACAAAGTCATATTACTTTAGTCATCAGACTAGCCTTCCTAAACGTTTCTTAATTCGTTTTGAAGATGTTAGCGTTAATATTGATGGACAAGCTATATATAAACACGCTCATTTTGAAATGAAACAAAATGAAAATATATTACTTACTGGTCCAAATGGAAGTGGTAAATCGCTTTTCATCGCTTTGATTAGACAGCATTTATCACCAGACGAAGGTATTATAGAGATTACGCCATCGTTAAAGATAGGTTACTTTGATCATACAAATAACAATCTAAATGAAGCAGAATCTCCATTATCAATGTTGTTAGTAAGAACTAACATAACGCGTAGCCAAGCGCAGACATTACTTGCTTCATTTAATTTTGATAAGGATCAAATCAAAAAACCAATTCGCTATTTGTCTATGGGGGAAAAAAGTCGTTTACAATTTGTATTATTATATTTTTCAGGTGCTAATTTATTAGTATTGGATGAGCCTACGAACTATTTTGATATTGTAACTCAAGATTTAATTTTAAGTATGATTCAAAGTTTTACCGGTCAAGTATTGATTGTTACACATGATTCATATTTACAATCTCAATTTAAAGCTGTACATTGGGAAATAAAAAATCAACAACTTTATAATGTATCTTTAACTCATACGCGTGAATCAAACTTAGATGAAACCCTTAAGTTACTAGGTGAATATAAATTTATAGATGAAAATGGTCATTTTGAAACAGACAACTAG", "partial": "0", "query_start": 51433, "query_end": 51993, "hit_start": 1008, "hit_end": 1494, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 25.4}, "gnl|BL_ORD_ID|2247|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "vga(E) Staphylococcus cohnii", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1000", "model_id": "3400", "ARO_accession": "3004715", "ARO_name": "vga(E) Staphylococcus cohnii", "ARO_category": {"36252": {"category_aro_accession": "3000113", "category_aro_cvterm_id": "36252", "category_aro_name": "vga-type ABC-F protein", "category_aro_description": "Vga-type plasmid-borne ABC-F proteins, expressed in staphylococci that confer resistance to streptogramin A antibiotics through ribosomal protection.", "category_aro_class_name": "AMR Gene Family"}, "35964": {"category_aro_accession": "0000046", "category_aro_cvterm_id": "35964", "category_aro_name": "lincomycin", "category_aro_description": "Lincomycin is a lincosamide antibiotic that comes from the actinomyces Streptomyces lincolnensis. It binds to the 23s portion of the 50S subunit of bacterial ribosomes and inhibit early elongation of peptide chain by inhibiting transpeptidase reaction.", "category_aro_class_name": "Antibiotic"}, "35983": {"category_aro_accession": "0000066", "category_aro_cvterm_id": "35983", "category_aro_name": "clindamycin", "category_aro_description": "Clindamycin is a lincosamide antibiotic that blocks A-site aminoacyl-tRNA binding. It is usually used to treat infections with anaerobic bacteria but can also be used to treat some protozoal diseases, such as malaria.", "category_aro_class_name": "Antibiotic"}, "37013": {"category_aro_accession": "3000669", "category_aro_cvterm_id": "37013", "category_aro_name": "virginiamycin M1", "category_aro_description": "Virginiamycin M1 is a streptogramin A antibiotic.", "category_aro_class_name": "Antibiotic"}, "37015": {"category_aro_accession": "3000671", "category_aro_cvterm_id": "37015", "category_aro_name": "tiamulin", "category_aro_description": "Tiamulin is a pleuromutilin derivative currently used in veterinary medicine. It binds to the 23 rRNA of the 50S ribosomal subunit to inhibit protein translation.", "category_aro_class_name": "Antibiotic"}, "37713": {"category_aro_accession": "3001314", "category_aro_cvterm_id": "37713", "category_aro_name": "retapamulin", "category_aro_description": "Retapamulin is a semi-synthetic pleuromutilin antibiotic approved for the treatment of skin infections.", "category_aro_class_name": "Antibiotic"}, "37714": {"category_aro_accession": "3001315", "category_aro_cvterm_id": "37714", "category_aro_name": "valnemulin", "category_aro_description": "Two semi-synthetic pleuromutilin derivatives, tiamulin and valnemulin, have been developed as antibiotics for veterinary use.", "category_aro_class_name": "Antibiotic"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35952": {"category_aro_accession": "0000034", "category_aro_cvterm_id": "35952", "category_aro_name": "streptogramin A antibiotic", "category_aro_description": "Streptogramin A antibiotics are cyclic polyketide peptide hybrids that bind to the ribosomal peptidyl transfer centre. Structural variation arises from substituting a proline for its desaturated derivative and by its substitution for Ala or Cys. Used alone, streptogramin A antibiotics are bacteriostatic, but is bactericidal when used with streptogramin B antibiotics.", "category_aro_class_name": "Drug Class"}, "37014": {"category_aro_accession": "3000670", "category_aro_cvterm_id": "37014", "category_aro_name": "pleuromutilin antibiotic", "category_aro_description": "Pleuromutilins are natural fungal products that target bacterial protein translation by binding the the 23S rRNA, blocking the ribosome P site at the 50S subunit. They are mostly used for agriculture and veterinary purposes.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.27615e-08, "max_identities": 50, "bit_score": 52.7582, "cvterm_id": "36766", "query": "TLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVS-VLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGL-EKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTH-ANAVVRLADGKI", "match": "+L +Y G+ ++I G +GSGKTT L  I   D   +    V                    IG+  Q   +++   S+ +NV+          +S+  T + T+L ++   ++    +   LSGG++ ++A+A+  ++   +++ DEPT  LD    + +  LMK  +     T +F THD  ++ + A  ++ + DGKI", "sequence_from_db": "SLYLYGGDKVAIIGKNGSGKTTLLKKIVKQDEGVTIPEKV-------------------KIGYFSQHLTILNDEKSIIENVQST--------SSQNETLIRTVLARMHFWDEDVYKKVGILSGGEKVKLALAKLFLSEVNMLVLDEPTNFLDIAALEALETLMKSYH----GTILFVTHDRMLVKNIATKIIDIKDGKI", "sequence_from_broadstreet": "MLLFEGTSIKKQLHDRVLFDIDLIQVHDNQRIGLVGRNGTGKTSLLKIITGEELPDEGNISPFTSVKLVPQFKESRLEKSGGEITQQYLQNAFNGNPGLLLLDEPTTHLDTERIAWLEKKIRNYQGAAVVVSHDRTFLNNVCTDIWEIEKNTLKIFKGNYDEYAKQKEILKKQKQTEFEKYEREKQKLERAIRQKEERAQRATKKPKNLSSSEARIVGAKTHYANIQKKLRSSAKALETRLEQLDKVDKVKELPEIKMDMLNEENLTNQSVLRAENIKGEIEERKLWEPFSLYLYGGDKVAIIGKNGSGKTTLLKKIVKQDEGVTIPEKVKIGYFSQHLTILNDEKSIIENVQSTSSQNETLIRTVLARMHFWDEDVYKKVGILSGGEKVKLALAKLFLSEVNMLVLDEPTNFLDIAALEALETLMKSYHGTILFVTHDRMLVKNIATKIIDIKDGKITVFDGSYEAYEEWLENKTKSNNDDQLLLIETKISDVLGRLSLEPSQELEDEFQRLLKEKKELTRGE", "dna_sequence_from_broadstreet": "ATGCTATTATTTGAAGGAACATCAATCAAAAAACAATTACATGACAGAGTGCTATTTGATATTGATTTAATACAAGTGCATGATAATCAACGTATAGGCTTAGTAGGTAGGAATGGAACAGGAAAAACAAGCCTATTAAAAATTATTACAGGTGAAGAATTACCTGATGAAGGTAATATCTCTCCTTTTACCTCTGTGAAATTAGTGCCACAATTTAAAGAATCAAGATTGGAGAAAAGTGGTGGCGAAATAACACAGCAATATTTACAGAACGCATTCAATGGGAATCCAGGCTTACTGCTTTTAGATGAACCGACAACACACTTAGATACGGAAAGAATTGCTTGGCTAGAAAAAAAGATAAGAAACTATCAAGGAGCAGCTGTCGTAGTATCTCATGATCGGACATTTTTAAATAATGTATGTACTGACATATGGGAAATTGAAAAAAATACGTTAAAAATATTTAAAGGAAATTATGATGAATATGCAAAGCAAAAAGAAATACTTAAAAAACAAAAACAAACTGAATTTGAAAAGTATGAACGTGAGAAACAAAAATTAGAAAGAGCAATACGTCAAAAAGAAGAAAGAGCTCAACGAGCAACAAAAAAACCTAAGAATCTAAGTTCATCTGAAGCGAGAATAGTGGGTGCTAAAACCCACTACGCCAACATACAGAAAAAGCTGAGAAGTTCGGCAAAAGCTTTAGAAACAAGACTGGAACAATTGGATAAGGTTGACAAGGTGAAAGAGCTGCCTGAAATTAAGATGGATATGTTAAATGAAGAAAACTTAACAAACCAATCTGTATTACGTGCTGAAAATATTAAGGGAGAGATTGAAGAACGTAAGCTCTGGGAACCCTTTAGCTTATATTTATATGGAGGAGATAAAGTTGCTATCATTGGAAAAAATGGCTCAGGTAAAACAACGTTGCTTAAAAAAATAGTGAAGCAAGATGAAGGAGTGACAATTCCAGAAAAAGTAAAGATAGGTTACTTCTCTCAACACTTAACCATCCTAAATGATGAGAAATCAATCATAGAAAATGTACAATCGACCTCTAGTCAAAATGAGACATTAATAAGAACAGTTTTAGCAAGAATGCATTTTTGGGATGAAGATGTCTATAAAAAGGTAGGCATATTAAGTGGTGGTGAAAAAGTAAAGCTAGCTTTAGCTAAACTATTTTTAAGTGAGGTGAATATGCTCGTTTTAGATGAGCCGACTAACTTTTTAGACATTGCAGCTTTAGAAGCGCTAGAAACATTAATGAAAAGTTATCATGGAACGATTCTATTTGTTACTCACGACCGAATGTTAGTAAAAAATATAGCTACAAAAATAATTGATATAAAAGATGGTAAGATAACAGTATTCGATGGATCGTACGAAGCATATGAAGAGTGGCTGGAGAATAAAACAAAGTCTAACAATGATGACCAACTTTTATTAATTGAAACTAAAATATCTGATGTTCTGGGTAGGTTGAGCTTGGAACCTTCGCAAGAGTTAGAAGATGAATTTCAAAGATTATTGAAAGAAAAGAAAGAACTGACTAGAGGGGAATAA", "partial": "0", "query_start": 51430, "query_end": 52017, "hit_start": 870, "hit_end": 1374, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 25.13}, "gnl|BL_ORD_ID|2247|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "vga(E) Staphylococcus cohnii", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1000", "model_id": "3400", "ARO_accession": "3004715", "ARO_name": "vga(E) Staphylococcus cohnii", "ARO_category": {"36252": {"category_aro_accession": "3000113", "category_aro_cvterm_id": "36252", "category_aro_name": "vga-type ABC-F protein", "category_aro_description": "Vga-type plasmid-borne ABC-F proteins, expressed in staphylococci that confer resistance to streptogramin A antibiotics through ribosomal protection.", "category_aro_class_name": "AMR Gene Family"}, "35964": {"category_aro_accession": "0000046", "category_aro_cvterm_id": "35964", "category_aro_name": "lincomycin", "category_aro_description": "Lincomycin is a lincosamide antibiotic that comes from the actinomyces Streptomyces lincolnensis. It binds to the 23s portion of the 50S subunit of bacterial ribosomes and inhibit early elongation of peptide chain by inhibiting transpeptidase reaction.", "category_aro_class_name": "Antibiotic"}, "35983": {"category_aro_accession": "0000066", "category_aro_cvterm_id": "35983", "category_aro_name": "clindamycin", "category_aro_description": "Clindamycin is a lincosamide antibiotic that blocks A-site aminoacyl-tRNA binding. It is usually used to treat infections with anaerobic bacteria but can also be used to treat some protozoal diseases, such as malaria.", "category_aro_class_name": "Antibiotic"}, "37013": {"category_aro_accession": "3000669", "category_aro_cvterm_id": "37013", "category_aro_name": "virginiamycin M1", "category_aro_description": "Virginiamycin M1 is a streptogramin A antibiotic.", "category_aro_class_name": "Antibiotic"}, "37015": {"category_aro_accession": "3000671", "category_aro_cvterm_id": "37015", "category_aro_name": "tiamulin", "category_aro_description": "Tiamulin is a pleuromutilin derivative currently used in veterinary medicine. It binds to the 23 rRNA of the 50S ribosomal subunit to inhibit protein translation.", "category_aro_class_name": "Antibiotic"}, "37713": {"category_aro_accession": "3001314", "category_aro_cvterm_id": "37713", "category_aro_name": "retapamulin", "category_aro_description": "Retapamulin is a semi-synthetic pleuromutilin antibiotic approved for the treatment of skin infections.", "category_aro_class_name": "Antibiotic"}, "37714": {"category_aro_accession": "3001315", "category_aro_cvterm_id": "37714", "category_aro_name": "valnemulin", "category_aro_description": "Two semi-synthetic pleuromutilin derivatives, tiamulin and valnemulin, have been developed as antibiotics for veterinary use.", "category_aro_class_name": "Antibiotic"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35952": {"category_aro_accession": "0000034", "category_aro_cvterm_id": "35952", "category_aro_name": "streptogramin A antibiotic", "category_aro_description": "Streptogramin A antibiotics are cyclic polyketide peptide hybrids that bind to the ribosomal peptidyl transfer centre. Structural variation arises from substituting a proline for its desaturated derivative and by its substitution for Ala or Cys. Used alone, streptogramin A antibiotics are bacteriostatic, but is bactericidal when used with streptogramin B antibiotics.", "category_aro_class_name": "Drug Class"}, "37014": {"category_aro_accession": "3000670", "category_aro_cvterm_id": "37014", "category_aro_name": "pleuromutilin antibiotic", "category_aro_description": "Pleuromutilins are natural fungal products that target bacterial protein translation by binding the the 23S rRNA, blocking the ribosome P site at the 50S subunit. They are mostly used for agriculture and veterinary purposes.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.194983, "max_identities": 21, "bit_score": 30.4166, "cvterm_id": "36766", "query": "ELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHD", "match": "E SGG+  +  +  A    P L+L DEPT +LD+   + I  L K++   +G   + S HD", "sequence_from_db": "EKSGGEITQQYLQNAFNGNPGLLLLDEPTTHLDT---ERIAWLEKKIRNYQGAAVVVS-HD", "sequence_from_broadstreet": "MLLFEGTSIKKQLHDRVLFDIDLIQVHDNQRIGLVGRNGTGKTSLLKIITGEELPDEGNISPFTSVKLVPQFKESRLEKSGGEITQQYLQNAFNGNPGLLLLDEPTTHLDTERIAWLEKKIRNYQGAAVVVSHDRTFLNNVCTDIWEIEKNTLKIFKGNYDEYAKQKEILKKQKQTEFEKYEREKQKLERAIRQKEERAQRATKKPKNLSSSEARIVGAKTHYANIQKKLRSSAKALETRLEQLDKVDKVKELPEIKMDMLNEENLTNQSVLRAENIKGEIEERKLWEPFSLYLYGGDKVAIIGKNGSGKTTLLKKIVKQDEGVTIPEKVKIGYFSQHLTILNDEKSIIENVQSTSSQNETLIRTVLARMHFWDEDVYKKVGILSGGEKVKLALAKLFLSEVNMLVLDEPTNFLDIAALEALETLMKSYHGTILFVTHDRMLVKNIATKIIDIKDGKITVFDGSYEAYEEWLENKTKSNNDDQLLLIETKISDVLGRLSLEPSQELEDEFQRLLKEKKELTRGE", "dna_sequence_from_broadstreet": "ATGCTATTATTTGAAGGAACATCAATCAAAAAACAATTACATGACAGAGTGCTATTTGATATTGATTTAATACAAGTGCATGATAATCAACGTATAGGCTTAGTAGGTAGGAATGGAACAGGAAAAACAAGCCTATTAAAAATTATTACAGGTGAAGAATTACCTGATGAAGGTAATATCTCTCCTTTTACCTCTGTGAAATTAGTGCCACAATTTAAAGAATCAAGATTGGAGAAAAGTGGTGGCGAAATAACACAGCAATATTTACAGAACGCATTCAATGGGAATCCAGGCTTACTGCTTTTAGATGAACCGACAACACACTTAGATACGGAAAGAATTGCTTGGCTAGAAAAAAAGATAAGAAACTATCAAGGAGCAGCTGTCGTAGTATCTCATGATCGGACATTTTTAAATAATGTATGTACTGACATATGGGAAATTGAAAAAAATACGTTAAAAATATTTAAAGGAAATTATGATGAATATGCAAAGCAAAAAGAAATACTTAAAAAACAAAAACAAACTGAATTTGAAAAGTATGAACGTGAGAAACAAAAATTAGAAAGAGCAATACGTCAAAAAGAAGAAAGAGCTCAACGAGCAACAAAAAAACCTAAGAATCTAAGTTCATCTGAAGCGAGAATAGTGGGTGCTAAAACCCACTACGCCAACATACAGAAAAAGCTGAGAAGTTCGGCAAAAGCTTTAGAAACAAGACTGGAACAATTGGATAAGGTTGACAAGGTGAAAGAGCTGCCTGAAATTAAGATGGATATGTTAAATGAAGAAAACTTAACAAACCAATCTGTATTACGTGCTGAAAATATTAAGGGAGAGATTGAAGAACGTAAGCTCTGGGAACCCTTTAGCTTATATTTATATGGAGGAGATAAAGTTGCTATCATTGGAAAAAATGGCTCAGGTAAAACAACGTTGCTTAAAAAAATAGTGAAGCAAGATGAAGGAGTGACAATTCCAGAAAAAGTAAAGATAGGTTACTTCTCTCAACACTTAACCATCCTAAATGATGAGAAATCAATCATAGAAAATGTACAATCGACCTCTAGTCAAAATGAGACATTAATAAGAACAGTTTTAGCAAGAATGCATTTTTGGGATGAAGATGTCTATAAAAAGGTAGGCATATTAAGTGGTGGTGAAAAAGTAAAGCTAGCTTTAGCTAAACTATTTTTAAGTGAGGTGAATATGCTCGTTTTAGATGAGCCGACTAACTTTTTAGACATTGCAGCTTTAGAAGCGCTAGAAACATTAATGAAAAGTTATCATGGAACGATTCTATTTGTTACTCACGACCGAATGTTAGTAAAAAATATAGCTACAAAAATAATTGATATAAAAGATGGTAAGATAACAGTATTCGATGGATCGTACGAAGCATATGAAGAGTGGCTGGAGAATAAAACAAAGTCTAACAATGATGACCAACTTTTATTAATTGAAACTAAAATATCTGATGTTCTGGGTAGGTTGAGCTTGGAACCTTCGCAAGAGTTAGAAGATGAATTTCAAAGATTATTGAAAGAAAAGAAAGAACTGACTAGAGGGGAATAA", "partial": "0", "query_start": 51781, "query_end": 51963, "hit_start": 231, "hit_end": 402, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 34.43}, "gnl|BL_ORD_ID|2247|hsp_num:2": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "vga(E) Staphylococcus cohnii", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1000", "model_id": "3400", "ARO_accession": "3004715", "ARO_name": "vga(E) Staphylococcus cohnii", "ARO_category": {"36252": {"category_aro_accession": "3000113", "category_aro_cvterm_id": "36252", "category_aro_name": "vga-type ABC-F protein", "category_aro_description": "Vga-type plasmid-borne ABC-F proteins, expressed in staphylococci that confer resistance to streptogramin A antibiotics through ribosomal protection.", "category_aro_class_name": "AMR Gene Family"}, "35964": {"category_aro_accession": "0000046", "category_aro_cvterm_id": "35964", "category_aro_name": "lincomycin", "category_aro_description": "Lincomycin is a lincosamide antibiotic that comes from the actinomyces Streptomyces lincolnensis. It binds to the 23s portion of the 50S subunit of bacterial ribosomes and inhibit early elongation of peptide chain by inhibiting transpeptidase reaction.", "category_aro_class_name": "Antibiotic"}, "35983": {"category_aro_accession": "0000066", "category_aro_cvterm_id": "35983", "category_aro_name": "clindamycin", "category_aro_description": "Clindamycin is a lincosamide antibiotic that blocks A-site aminoacyl-tRNA binding. It is usually used to treat infections with anaerobic bacteria but can also be used to treat some protozoal diseases, such as malaria.", "category_aro_class_name": "Antibiotic"}, "37013": {"category_aro_accession": "3000669", "category_aro_cvterm_id": "37013", "category_aro_name": "virginiamycin M1", "category_aro_description": "Virginiamycin M1 is a streptogramin A antibiotic.", "category_aro_class_name": "Antibiotic"}, "37015": {"category_aro_accession": "3000671", "category_aro_cvterm_id": "37015", "category_aro_name": "tiamulin", "category_aro_description": "Tiamulin is a pleuromutilin derivative currently used in veterinary medicine. It binds to the 23 rRNA of the 50S ribosomal subunit to inhibit protein translation.", "category_aro_class_name": "Antibiotic"}, "37713": {"category_aro_accession": "3001314", "category_aro_cvterm_id": "37713", "category_aro_name": "retapamulin", "category_aro_description": "Retapamulin is a semi-synthetic pleuromutilin antibiotic approved for the treatment of skin infections.", "category_aro_class_name": "Antibiotic"}, "37714": {"category_aro_accession": "3001315", "category_aro_cvterm_id": "37714", "category_aro_name": "valnemulin", "category_aro_description": "Two semi-synthetic pleuromutilin derivatives, tiamulin and valnemulin, have been developed as antibiotics for veterinary use.", "category_aro_class_name": "Antibiotic"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35952": {"category_aro_accession": "0000034", "category_aro_cvterm_id": "35952", "category_aro_name": "streptogramin A antibiotic", "category_aro_description": "Streptogramin A antibiotics are cyclic polyketide peptide hybrids that bind to the ribosomal peptidyl transfer centre. Structural variation arises from substituting a proline for its desaturated derivative and by its substitution for Ala or Cys. Used alone, streptogramin A antibiotics are bacteriostatic, but is bactericidal when used with streptogramin B antibiotics.", "category_aro_class_name": "Drug Class"}, "37014": {"category_aro_accession": "3000670", "category_aro_cvterm_id": "37014", "category_aro_name": "pleuromutilin antibiotic", "category_aro_description": "Pleuromutilins are natural fungal products that target bacterial protein translation by binding the the 23S rRNA, blocking the ribosome P site at the 50S subunit. They are mostly used for agriculture and veterinary purposes.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.84414, "max_identities": 11, "bit_score": 25.409, "cvterm_id": "36766", "query": "LEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVS", "match": "++V+  + I + G +G+GKT+ L +I   +    G +S", "sequence_from_db": "IQVHDNQRIGLVGRNGTGKTSLLKIITGEELPDEGNIS", "sequence_from_broadstreet": "MLLFEGTSIKKQLHDRVLFDIDLIQVHDNQRIGLVGRNGTGKTSLLKIITGEELPDEGNISPFTSVKLVPQFKESRLEKSGGEITQQYLQNAFNGNPGLLLLDEPTTHLDTERIAWLEKKIRNYQGAAVVVSHDRTFLNNVCTDIWEIEKNTLKIFKGNYDEYAKQKEILKKQKQTEFEKYEREKQKLERAIRQKEERAQRATKKPKNLSSSEARIVGAKTHYANIQKKLRSSAKALETRLEQLDKVDKVKELPEIKMDMLNEENLTNQSVLRAENIKGEIEERKLWEPFSLYLYGGDKVAIIGKNGSGKTTLLKKIVKQDEGVTIPEKVKIGYFSQHLTILNDEKSIIENVQSTSSQNETLIRTVLARMHFWDEDVYKKVGILSGGEKVKLALAKLFLSEVNMLVLDEPTNFLDIAALEALETLMKSYHGTILFVTHDRMLVKNIATKIIDIKDGKITVFDGSYEAYEEWLENKTKSNNDDQLLLIETKISDVLGRLSLEPSQELEDEFQRLLKEKKELTRGE", "dna_sequence_from_broadstreet": "ATGCTATTATTTGAAGGAACATCAATCAAAAAACAATTACATGACAGAGTGCTATTTGATATTGATTTAATACAAGTGCATGATAATCAACGTATAGGCTTAGTAGGTAGGAATGGAACAGGAAAAACAAGCCTATTAAAAATTATTACAGGTGAAGAATTACCTGATGAAGGTAATATCTCTCCTTTTACCTCTGTGAAATTAGTGCCACAATTTAAAGAATCAAGATTGGAGAAAAGTGGTGGCGAAATAACACAGCAATATTTACAGAACGCATTCAATGGGAATCCAGGCTTACTGCTTTTAGATGAACCGACAACACACTTAGATACGGAAAGAATTGCTTGGCTAGAAAAAAAGATAAGAAACTATCAAGGAGCAGCTGTCGTAGTATCTCATGATCGGACATTTTTAAATAATGTATGTACTGACATATGGGAAATTGAAAAAAATACGTTAAAAATATTTAAAGGAAATTATGATGAATATGCAAAGCAAAAAGAAATACTTAAAAAACAAAAACAAACTGAATTTGAAAAGTATGAACGTGAGAAACAAAAATTAGAAAGAGCAATACGTCAAAAAGAAGAAAGAGCTCAACGAGCAACAAAAAAACCTAAGAATCTAAGTTCATCTGAAGCGAGAATAGTGGGTGCTAAAACCCACTACGCCAACATACAGAAAAAGCTGAGAAGTTCGGCAAAAGCTTTAGAAACAAGACTGGAACAATTGGATAAGGTTGACAAGGTGAAAGAGCTGCCTGAAATTAAGATGGATATGTTAAATGAAGAAAACTTAACAAACCAATCTGTATTACGTGCTGAAAATATTAAGGGAGAGATTGAAGAACGTAAGCTCTGGGAACCCTTTAGCTTATATTTATATGGAGGAGATAAAGTTGCTATCATTGGAAAAAATGGCTCAGGTAAAACAACGTTGCTTAAAAAAATAGTGAAGCAAGATGAAGGAGTGACAATTCCAGAAAAAGTAAAGATAGGTTACTTCTCTCAACACTTAACCATCCTAAATGATGAGAAATCAATCATAGAAAATGTACAATCGACCTCTAGTCAAAATGAGACATTAATAAGAACAGTTTTAGCAAGAATGCATTTTTGGGATGAAGATGTCTATAAAAAGGTAGGCATATTAAGTGGTGGTGAAAAAGTAAAGCTAGCTTTAGCTAAACTATTTTTAAGTGAGGTGAATATGCTCGTTTTAGATGAGCCGACTAACTTTTTAGACATTGCAGCTTTAGAAGCGCTAGAAACATTAATGAAAAGTTATCATGGAACGATTCTATTTGTTACTCACGACCGAATGTTAGTAAAAAATATAGCTACAAAAATAATTGATATAAAAGATGGTAAGATAACAGTATTCGATGGATCGTACGAAGCATATGAAGAGTGGCTGGAGAATAAAACAAAGTCTAACAATGATGACCAACTTTTATTAATTGAAACTAAAATATCTGATGTTCTGGGTAGGTTGAGCTTGGAACCTTCGCAAGAGTTAGAAGATGAATTTCAAAGATTATTGAAAGAAAAGAAAGAACTGACTAGAGGGGAATAA", "partial": "0", "query_start": 51433, "query_end": 51546, "hit_start": 69, "hit_end": 183, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 28.95}, "gnl|BL_ORD_ID|110|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "srmB", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1050", "model_id": "128", "ARO_accession": "3002828", "ARO_name": "srmB", "ARO_category": {"45630": {"category_aro_accession": "3007068", "category_aro_cvterm_id": "45630", "category_aro_name": "Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins", "category_aro_description": "ABC-F subfamily ATP-binding cassette ribosomal protection proteins of unknown, unclear or miscellaneous classification which nevertheless confer resistance to antibiotics through ribosomal protection and not through antibiotic efflux. These proteins should be further reviewed to elucidate associated genes, their function, origin and classification.", "category_aro_class_name": "AMR Gene Family"}, "36295": {"category_aro_accession": "3000156", "category_aro_cvterm_id": "36295", "category_aro_name": "spiramycin", "category_aro_description": "Spiramycin is a 16-membered macrolide and is natural product produced by Streptomyces ambofaciens. It binds to the 50S subunit of bacterial ribosomes and inhibits peptidyl transfer activity to disrupt protein synthesis.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.61788e-08, "max_identities": 69, "bit_score": 51.2174, "cvterm_id": "36864", "query": "SPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGL--EKHAKHRPNELSGGQRQRVAVARALVTRP-KLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTH-ANAVVRLADGKI", "match": "+P   L FA RI T      A P + + +  LT+V      G++ V      +L + PGE + + GP+G+GK+T L ++       SG +  DG   +     ++ HLR     +       ++VL  F          R+    +   ++++L    GL      + R  +LS GQR+R+ +AR LV+ P  L+L DEPT +L  V    + +L + L    G   +  THD ++ +    A + + DG+I", "sequence_from_db": "APADPLSFAARIDT------AGPEAEEAVAELTDVRVA---GRLAVD-----SLTIRPGERLLVTGPNGAGKSTLLRVL-------SGELEPDGGSVR--VGCRVGHLRQDETPWAPG----LTVLRAFAQ-------GREGYLEDHAEKLLSL----GLFSPSDLRRRVKDLSYGQRRRIEIAR-LVSDPMDLLLLDEPTNHLTPVL---VEELEQALADYRGAVVVV-THDRRMRSRFTGARLTMGDGRI", "sequence_from_broadstreet": "MSIAQYALHDITKRYHDCVVLDRVGFSIKPGEKVGVIGDNGSGKSTLLKILAGRVEPDNGALTVVAPGGVGYLAQTLELPLDATVQDAVDLALSDLRELEAAMREAEAELGESDENGSERELSAGLQRYAALVEQYQARGGYEADVRVEVALHGLGLPSLDRDRKLGTLSGGERSRLALAATLASSPELLLLDEPTNDLDDRAMEWLEDHLAGHRGTVIAVTHDRVFLDRLTTTILEVDSGSVTRYGNGYEGYLTAKAVERERRLREYEEWRAELDRNRGLITSNVARMDGIPRKMSLSVFGHGAYRRRGRDHGAMVRIRNAKQRVAQLTENPVHAPADPLSFAARIDTAGPEAEEAVAELTDVRVAGRLAVDSLTIRPGERLLVTGPNGAGKSTLLRVLSGELEPDGGSVRVGCRVGHLRQDETPWAPGLTVLRAFAQGREGYLEDHAEKLLSLGLFSPSDLRRRVKDLSYGQRRRIEIARLVSDPMDLLLLDEPTNHLTPVLVEELEQALADYRGAVVVVTHDRRMRSRFTGARLTMGDGRIAEFSAG", "dna_sequence_from_broadstreet": "GTGTCGATTGCGCAATACGCCCTACACGACATCACGAAGCGCTACCACGACTGTGTCGTGCTCGACCGGGTCGGTTTCAGCATCAAGCCGGGCGAGAAGGTCGGCGTGATCGGCGACAACGGTTCCGGCAAGTCCACGCTGCTCAAGATCCTCGCCGGCCGCGTGGAGCCCGACAACGGCGCGCTCACCGTGGTCGCTCCCGGCGGCGTCGGCTACCTGGCGCAGACACTGGAACTGCCCCTCGACGCCACCGTCCAGGACGCCGTCGACCTGGCCCTGTCCGACCTGCGCGAGCTCGAAGCGGCGATGCGCGAGGCCGAGGCGGAGCTGGGCGAGAGCGACGAGAACGGCTCCGAGCGCGAGCTGTCCGCCGGCCTCCAGCGCTACGCCGCTCTGGTCGAGCAGTACCAGGCGCGTGGCGGCTACGAGGCCGACGTGCGCGTGGAGGTCGCGCTGCACGGCCTCGGACTGCCGAGCCTGGACCGCGACCGCAAGCTCGGAACCCTCTCCGGTGGCGAACGCTCCCGCCTCGCGCTCGCCGCGACCCTCGCCTCGTCGCCGGAGCTGCTGCTCCTGGACGAACCGACCAACGACCTCGACGACCGGGCGATGGAATGGCTGGAGGACCACCTGGCCGGCCACCGCGGCACGGTGATCGCGGTCACCCACGACCGGGTCTTCCTCGACCGGCTCACCACCACGATCCTGGAGGTCGACTCCGGCAGCGTCACCCGCTACGGCAACGGCTACGAGGGCTACCTGACGGCCAAGGCCGTGGAACGCGAGCGGCGGCTGCGGGAGTACGAGGAGTGGCGTGCCGAACTCGACCGCAACCGCGGGCTGATCACCTCCAACGTGGCGCGGATGGACGGCATCCCGCGCAAGATGTCCCTCTCCGTGTTCGGCCACGGCGCCTACCGCAGGCGAGGGCGCGACCACGGCGCGATGGTGCGGATCCGCAACGCGAAGCAACGCGTGGCGCAGCTGACCGAGAACCCGGTCCACGCTCCCGCCGACCCGTTGTCCTTCGCCGCCCGCATCGACACCGCGGGCCCGGAGGCGGAGGAGGCGGTGGCCGAACTCACCGACGTGCGCGTCGCGGGTCGGCTCGCCGTGGACTCCCTGACGATCCGGCCCGGCGAACGGCTGCTCGTCACAGGTCCCAACGGTGCGGGCAAGTCCACCTTGTTGCGGGTGCTGTCCGGGGAACTGGAGCCGGACGGCGGCTCGGTGCGCGTCGGCTGCCGGGTCGGTCATCTGCGGCAGGACGAGACGCCCTGGGCGCCCGGACTGACCGTGCTGCGGGCCTTCGCCCAGGGCCGGGAGGGCTACCTGGAGGACCACGCGGAGAAACTGCTGTCGCTCGGCCTGTTCAGCCCGTCCGACCTGCGGCGACGCGTGAAGGATCTGTCCTACGGGCAGCGCCGCCGGATCGAGATCGCCCGGCTGGTGAGCGACCCGATGGACCTGCTGCTGCTGGACGAGCCCACCAACCACCTCACCCCGGTGCTGGTGGAGGAGTTGGAGCAGGCACTCGCGGACTACCGCGGCGCCGTCGTGGTCGTCACCCACGACCGTCGGATGCGGTCCCGGTTCACCGGCGCCCGGCTGACCATGGGAGACGGGCGCATCGCCGAGTTCAGCGCCGGCTGA", "partial": "0", "query_start": 51274, "query_end": 52017, "hit_start": 1005, "hit_end": 1632, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 27.38}, "gnl|BL_ORD_ID|110|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "srmB", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1050", "model_id": "128", "ARO_accession": "3002828", "ARO_name": "srmB", "ARO_category": {"45630": {"category_aro_accession": "3007068", "category_aro_cvterm_id": "45630", "category_aro_name": "Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins", "category_aro_description": "ABC-F subfamily ATP-binding cassette ribosomal protection proteins of unknown, unclear or miscellaneous classification which nevertheless confer resistance to antibiotics through ribosomal protection and not through antibiotic efflux. These proteins should be further reviewed to elucidate associated genes, their function, origin and classification.", "category_aro_class_name": "AMR Gene Family"}, "36295": {"category_aro_accession": "3000156", "category_aro_cvterm_id": "36295", "category_aro_name": "spiramycin", "category_aro_description": "Spiramycin is a 16-membered macrolide and is natural product produced by Streptomyces ambofaciens. It binds to the 50S subunit of bacterial ribosomes and inhibits peptidyl transfer activity to disrupt protein synthesis.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.54036e-07, "max_identities": 66, "bit_score": 47.7506, "cvterm_id": "36864", "query": "SLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKL----------------NASERR-----TRVMTLLEQ-------------------VGLEKHAKHRP-NELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHD", "match": "+L ++TK Y         L  V   + PGE + + G +GSGK+T L ++       +G V  D           LT +    +G++ Q+  L    +V   V+  L   R+L                N SER       R   L+EQ                   +GL    + R    LSGG+R R+A+A  L + P+L+L DEPT +LD    + + D    L    GT  I  THD", "sequence_from_db": "ALHDITKRYH----DCVVLDRVGFSIKPGEKVGVIGDNGSGKSTLLKIL-------AGRVEPDNG--------ALTVVAPGGVGYLAQTLELPLDATVQDAVDLALSDLRELEAAMREAEAELGESDENGSERELSAGLQRYAALVEQYQARGGYEADVRVEVALHGLGLPSLDRDRKLGTLSGGERSRLALAATLASSPELLLLDEPTNDLDDRAMEWLED---HLAGHRGTV-IAVTHD", "sequence_from_broadstreet": "MSIAQYALHDITKRYHDCVVLDRVGFSIKPGEKVGVIGDNGSGKSTLLKILAGRVEPDNGALTVVAPGGVGYLAQTLELPLDATVQDAVDLALSDLRELEAAMREAEAELGESDENGSERELSAGLQRYAALVEQYQARGGYEADVRVEVALHGLGLPSLDRDRKLGTLSGGERSRLALAATLASSPELLLLDEPTNDLDDRAMEWLEDHLAGHRGTVIAVTHDRVFLDRLTTTILEVDSGSVTRYGNGYEGYLTAKAVERERRLREYEEWRAELDRNRGLITSNVARMDGIPRKMSLSVFGHGAYRRRGRDHGAMVRIRNAKQRVAQLTENPVHAPADPLSFAARIDTAGPEAEEAVAELTDVRVAGRLAVDSLTIRPGERLLVTGPNGAGKSTLLRVLSGELEPDGGSVRVGCRVGHLRQDETPWAPGLTVLRAFAQGREGYLEDHAEKLLSLGLFSPSDLRRRVKDLSYGQRRRIEIARLVSDPMDLLLLDEPTNHLTPVLVEELEQALADYRGAVVVVTHDRRMRSRFTGARLTMGDGRIAEFSAG", "dna_sequence_from_broadstreet": "GTGTCGATTGCGCAATACGCCCTACACGACATCACGAAGCGCTACCACGACTGTGTCGTGCTCGACCGGGTCGGTTTCAGCATCAAGCCGGGCGAGAAGGTCGGCGTGATCGGCGACAACGGTTCCGGCAAGTCCACGCTGCTCAAGATCCTCGCCGGCCGCGTGGAGCCCGACAACGGCGCGCTCACCGTGGTCGCTCCCGGCGGCGTCGGCTACCTGGCGCAGACACTGGAACTGCCCCTCGACGCCACCGTCCAGGACGCCGTCGACCTGGCCCTGTCCGACCTGCGCGAGCTCGAAGCGGCGATGCGCGAGGCCGAGGCGGAGCTGGGCGAGAGCGACGAGAACGGCTCCGAGCGCGAGCTGTCCGCCGGCCTCCAGCGCTACGCCGCTCTGGTCGAGCAGTACCAGGCGCGTGGCGGCTACGAGGCCGACGTGCGCGTGGAGGTCGCGCTGCACGGCCTCGGACTGCCGAGCCTGGACCGCGACCGCAAGCTCGGAACCCTCTCCGGTGGCGAACGCTCCCGCCTCGCGCTCGCCGCGACCCTCGCCTCGTCGCCGGAGCTGCTGCTCCTGGACGAACCGACCAACGACCTCGACGACCGGGCGATGGAATGGCTGGAGGACCACCTGGCCGGCCACCGCGGCACGGTGATCGCGGTCACCCACGACCGGGTCTTCCTCGACCGGCTCACCACCACGATCCTGGAGGTCGACTCCGGCAGCGTCACCCGCTACGGCAACGGCTACGAGGGCTACCTGACGGCCAAGGCCGTGGAACGCGAGCGGCGGCTGCGGGAGTACGAGGAGTGGCGTGCCGAACTCGACCGCAACCGCGGGCTGATCACCTCCAACGTGGCGCGGATGGACGGCATCCCGCGCAAGATGTCCCTCTCCGTGTTCGGCCACGGCGCCTACCGCAGGCGAGGGCGCGACCACGGCGCGATGGTGCGGATCCGCAACGCGAAGCAACGCGTGGCGCAGCTGACCGAGAACCCGGTCCACGCTCCCGCCGACCCGTTGTCCTTCGCCGCCCGCATCGACACCGCGGGCCCGGAGGCGGAGGAGGCGGTGGCCGAACTCACCGACGTGCGCGTCGCGGGTCGGCTCGCCGTGGACTCCCTGACGATCCGGCCCGGCGAACGGCTGCTCGTCACAGGTCCCAACGGTGCGGGCAAGTCCACCTTGTTGCGGGTGCTGTCCGGGGAACTGGAGCCGGACGGCGGCTCGGTGCGCGTCGGCTGCCGGGTCGGTCATCTGCGGCAGGACGAGACGCCCTGGGCGCCCGGACTGACCGTGCTGCGGGCCTTCGCCCAGGGCCGGGAGGGCTACCTGGAGGACCACGCGGAGAAACTGCTGTCGCTCGGCCTGTTCAGCCCGTCCGACCTGCGGCGACGCGTGAAGGATCTGTCCTACGGGCAGCGCCGCCGGATCGAGATCGCCCGGCTGGTGAGCGACCCGATGGACCTGCTGCTGCTGGACGAGCCCACCAACCACCTCACCCCGGTGCTGGTGGAGGAGTTGGAGCAGGCACTCGCGGACTACCGCGGCGCCGTCGTGGTCGTCACCCACGACCGTCGGATGCGGTCCCGGTTCACCGGCGCCCGGCTGACCATGGGAGACGGGCGCATCGCCGAGTTCAGCGCCGGCTGA", "partial": "0", "query_start": 51364, "query_end": 51963, "hit_start": 18, "hit_end": 672, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 27.39}, "gnl|BL_ORD_ID|2069|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "optrA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1300", "model_id": "2263", "ARO_accession": "3003746", "ARO_name": "optrA", "ARO_category": {"45630": {"category_aro_accession": "3007068", "category_aro_cvterm_id": "45630", "category_aro_name": "Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins", "category_aro_description": "ABC-F subfamily ATP-binding cassette ribosomal protection proteins of unknown, unclear or miscellaneous classification which nevertheless confer resistance to antibiotics through ribosomal protection and not through antibiotic efflux. These proteins should be further reviewed to elucidate associated genes, their function, origin and classification.", "category_aro_class_name": "AMR Gene Family"}, "35989": {"category_aro_accession": "0000072", "category_aro_cvterm_id": "35989", "category_aro_name": "linezolid", "category_aro_description": "Linezolid is a synthetic antibiotic used for the treatment of serious infections caused by Gram-positive bacteria that are resistant to several other antibiotics. It inhibits protein synthesis by binding to domain V of the 23S rRNA of the 50S subunit of bacterial ribosomes.", "category_aro_class_name": "Antibiotic"}, "36524": {"category_aro_accession": "3000385", "category_aro_cvterm_id": "36524", "category_aro_name": "chloramphenicol", "category_aro_description": "Chloramphenicol is a bacteriostatic antimicrobial originally derived from the bacterium Streptomyces venezuelae. It was the first antibiotic to be manufactured synthetically on a large scale. It functions by inhibiting peptidyl transferase activity of the bacterial ribosome, binding to A2451 and A2452 residues in the 23S rRNA of the 50S ribosomal subunit and preventing peptide bond formation.", "category_aro_class_name": "Antibiotic"}, "36600": {"category_aro_accession": "3000461", "category_aro_cvterm_id": "36600", "category_aro_name": "florfenicol", "category_aro_description": "Florfenicol is a fluorine derivative of chloramphenicol, where the nitro group (-NO2) is substituted by a sulfomethyl group (-SO2CH3) and the hydroxyl group (-OH), by a fluorine group (-F). The action mechanism is the same as chloramphenicol's, where the antibiotic binds to the 23S RNA of the 50S subunit of bacterial ribosomes to inhibit protein synthesis.", "category_aro_class_name": "Antibiotic"}, "40599": {"category_aro_accession": "3003897", "category_aro_cvterm_id": "40599", "category_aro_name": "tedizolid", "category_aro_description": "Tedizolid is a synthetic oxazolidinone antibiotic that is administered to the patient as a prodrug that is activated in vivo. It acts as an inhibitor of protein synthesis by binding the 50S subunit of the ribosome and preventing formation of the 70S initiation complex. It is active against Gram-positive pathogens.", "category_aro_class_name": "Antibiotic"}, "36218": {"category_aro_accession": "3000079", "category_aro_cvterm_id": "36218", "category_aro_name": "oxazolidinone antibiotic", "category_aro_description": "Oxazolidinones are a class of synthetic antibiotics discovered the the 1980's.  They inhibit protein synthesis by binding to domain V of the 23S rRNA of the 50S subunit of bacterial ribosomes.  Linezolid is the only member of this class currently in clinical use.", "category_aro_class_name": "Drug Class"}, "36526": {"category_aro_accession": "3000387", "category_aro_cvterm_id": "36526", "category_aro_name": "phenicol antibiotic", "category_aro_description": "Phenicols are broad spectrum bacteriostatic antibiotics acting on bacterial protein synthesis. More specifically, the phenicols block peptide elongation by binding to the peptidyltansferase centre of the 70S ribosome.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.90811e-08, "max_identities": 59, "bit_score": 50.8322, "cvterm_id": "35918", "query": "ALRGVTLEVYPGEFISIAGPSGSGKTTALN-LIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVS-VLSVFQNV-----EFPLLLQRKLNASERRT---------RVM------------TLLEQVGLEKHAKHRP-NELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAE", "match": " L  + +E+   E I+I G +G GKTT L  +IG ++    G    + Q   K     +++LR   + F  +S ++V  V +VF+ +     +   L+ +  N  + +          R M            T++  +G  +    +P +E SGGQR ++A  + L+T+P ++L DEPT +LD  T    I  ++   R   +T +  +HD           R+   +I+D++   E", "sequence_from_db": "VLENIGIEINDNEKIAIVGRNGCGKTTLLKAIIGEIE-LEEGTGESEFQ-VIKTGNPYISYLR--QMPFEDESISMVDEVRTVFKTLIDMENKMKQLIDKMENQYDDKIINEYSDISERYMALGGLTYQKEYETMIRSMGFTEADYKKPISEFSGGQRTKIAFIKILLTKPDILLLDEPTNHLDIET----IQWLESYLRSYKSTLVIISHD-----------RMFLNRIVDKVYEIE", "sequence_from_broadstreet": "MSKATFAIASTNAKEDMKMQYKIINGAVYYDGNMVLENIGIEINDNEKIAIVGRNGCGKTTLLKAIIGEIELEEGTGESEFQVIKTGNPYISYLRQMPFEDESISMVDEVRTVFKTLIDMENKMKQLIDKMENQYDDKIINEYSDISERYMALGGLTYQKEYETMIRSMGFTEADYKKPISEFSGGQRTKIAFIKILLTKPDILLLDEPTNHLDIETIQWLESYLRSYKSTLVIISHDRMFLNRIVDKVYEIEWGETKCYKGNYSAFEEQKRENHIKQQKDYDLQQIEIERITRLIERFRYKPTKAKMVQSKIKLLQRMQILNAPDQYDTKTYMSKFQPRISSSRQVLSASELVIGYDTPLAKVNFNLERGQKLGIVGSNGIGKSTLLKTLMGGVAALSGDFKFGYNVEISYFDQQLAQISGDDTLFEIFQSEYPELNDTEVRTALGSFQFSGDDVFRPVSSLSGGEKVRLTLCKLLYKRTNVLILDEPTNHMDIIGKENLENILCSYQGTIIFVSHDRYFTNKIADRLLVFDKDGVEFVQSTYGEYEKKRMNSEKPFNNIKVEQKVEKNNTVKGDRNSIEKEKVKKEKRIEKLEVLINQYDEELERLNKIISEPNNSSDYIVLTEIQKSIDDVKRCQGNYFNEWEQLMRELEVM", "dna_sequence_from_broadstreet": "TTGTCCAAAGCCACCTTTGCAATTGCTAGTACTAACGCAAAGGAGGATATGAAAATGCAATACAAAATAATTAATGGTGCCGTTTACTATGATGGTAATATGGTGTTGGAAAACATCGGTATTGAAATCAATGATAATGAAAAGATTGCTATTGTTGGTAGAAATGGATGTGGAAAAACAACCTTGCTAAAAGCTATTATAGGCGAAATTGAATTAGAAGAAGGAACTGGTGAAAGTGAGTTTCAAGTAATAAAGACCGGTAACCCTTATATTAGCTATTTAAGACAGATGCCTTTTGAAGATGAAAGTATATCAATGGTGGATGAAGTCCGTACGGTATTTAAGACGCTTATTGATATGGAAAACAAGATGAAACAGCTGATAGATAAAATGGAGAATCAATATGATGATAAAATCATCAATGAATACTCTGATATCAGTGAAAGGTATATGGCTCTTGGAGGTCTAACCTACCAAAAAGAATATGAAACGATGATTCGTAGTATGGGTTTTACTGAAGCAGATTATAAAAAACCCATTTCTGAATTTTCAGGTGGTCAGCGAACTAAGATAGCTTTTATAAAAATACTTTTAACAAAGCCAGACATTCTATTACTTGATGAACCTACTAACCACCTTGATATAGAAACAATACAATGGTTGGAGAGTTATTTGAGAAGTTATAAATCTACATTGGTTATTATTTCCCATGATAGAATGTTTCTTAATCGAATTGTGGATAAGGTTTATGAAATCGAATGGGGAGAGACCAAATGTTATAAAGGTAATTATTCAGCCTTTGAGGAGCAAAAACGAGAAAATCATATCAAACAGCAAAAAGATTACGACTTGCAACAGATAGAAATTGAAAGGATTACACGCTTGATTGAACGTTTTCGTTATAAACCTACGAAAGCTAAAATGGTGCAATCTAAAATTAAATTATTACAGCGTATGCAAATATTAAATGCACCAGACCAATACGATACAAAAACTTATATGTCTAAATTTCAACCGAGAATCAGTAGTTCAAGGCAAGTATTAAGTGCTTCAGAACTTGTGATAGGCTATGATACTCCTCTTGCAAAGGTTAATTTCAACCTTGAAAGGGGACAGAAGCTTGGAATTGTTGGGAGTAATGGTATTGGTAAATCCACGTTGCTTAAAACACTTATGGGTGGTGTGGCAGCATTGTCTGGAGATTTTAAATTCGGATACAATGTTGAAATTAGCTATTTTGACCAACAGCTTGCTCAAATCAGTGGAGATGATACACTATTCGAAATTTTTCAAAGCGAATACCCTGAGCTAAATGACACAGAGGTCAGAACTGCTCTTGGCTCATTTCAGTTTAGTGGAGATGATGTTTTTAGACCGGTGTCCTCTTTGTCAGGTGGAGAAAAGGTTAGATTGACATTATGTAAATTATTATATAAACGTACTAATGTTTTAATCTTAGATGAACCGACAAACCACATGGATATTATTGGAAAAGAGAATTTAGAGAATATCTTATGCAGTTATCAAGGTACAATTATTTTTGTGTCACATGATAGATATTTTACTAATAAGATTGCTGACAGATTACTTGTTTTTGATAAGGATGGTGTAGAGTTTGTACAATCTACTTATGGTGAGTACGAGAAAAAAAGGATGAATTCTGAAAAGCCATTTAATAACATTAAAGTTGAGCAGAAAGTAGAGAAAAATAACACAGTAAAAGGCGATCGTAACTCCATTGAGAAGGAGAAGGTTAAGAAGGAGAAACGAATTGAAAAGCTTGAAGTGTTAATAAATCAATATGATGAAGAATTAGAAAGATTGAATAAAATCATTTCTGAACCAAACAATTCTTCTGATTATATAGTACTGACGGAAATACAAAAATCAATTGATGATGTTAAAAGGTGTCAGGGTAATTATTTTAATGAATGGGAACAGTTGATGAGAGAATTGGAAGTTATGTAA", "partial": "0", "query_start": 51415, "query_end": 52041, "hit_start": 102, "hit_end": 759, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 24.79}, "gnl|BL_ORD_ID|2069|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "optrA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1300", "model_id": "2263", "ARO_accession": "3003746", "ARO_name": "optrA", "ARO_category": {"45630": {"category_aro_accession": "3007068", "category_aro_cvterm_id": "45630", "category_aro_name": "Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins", "category_aro_description": "ABC-F subfamily ATP-binding cassette ribosomal protection proteins of unknown, unclear or miscellaneous classification which nevertheless confer resistance to antibiotics through ribosomal protection and not through antibiotic efflux. These proteins should be further reviewed to elucidate associated genes, their function, origin and classification.", "category_aro_class_name": "AMR Gene Family"}, "35989": {"category_aro_accession": "0000072", "category_aro_cvterm_id": "35989", "category_aro_name": "linezolid", "category_aro_description": "Linezolid is a synthetic antibiotic used for the treatment of serious infections caused by Gram-positive bacteria that are resistant to several other antibiotics. It inhibits protein synthesis by binding to domain V of the 23S rRNA of the 50S subunit of bacterial ribosomes.", "category_aro_class_name": "Antibiotic"}, "36524": {"category_aro_accession": "3000385", "category_aro_cvterm_id": "36524", "category_aro_name": "chloramphenicol", "category_aro_description": "Chloramphenicol is a bacteriostatic antimicrobial originally derived from the bacterium Streptomyces venezuelae. It was the first antibiotic to be manufactured synthetically on a large scale. It functions by inhibiting peptidyl transferase activity of the bacterial ribosome, binding to A2451 and A2452 residues in the 23S rRNA of the 50S ribosomal subunit and preventing peptide bond formation.", "category_aro_class_name": "Antibiotic"}, "36600": {"category_aro_accession": "3000461", "category_aro_cvterm_id": "36600", "category_aro_name": "florfenicol", "category_aro_description": "Florfenicol is a fluorine derivative of chloramphenicol, where the nitro group (-NO2) is substituted by a sulfomethyl group (-SO2CH3) and the hydroxyl group (-OH), by a fluorine group (-F). The action mechanism is the same as chloramphenicol's, where the antibiotic binds to the 23S RNA of the 50S subunit of bacterial ribosomes to inhibit protein synthesis.", "category_aro_class_name": "Antibiotic"}, "40599": {"category_aro_accession": "3003897", "category_aro_cvterm_id": "40599", "category_aro_name": "tedizolid", "category_aro_description": "Tedizolid is a synthetic oxazolidinone antibiotic that is administered to the patient as a prodrug that is activated in vivo. It acts as an inhibitor of protein synthesis by binding the 50S subunit of the ribosome and preventing formation of the 70S initiation complex. It is active against Gram-positive pathogens.", "category_aro_class_name": "Antibiotic"}, "36218": {"category_aro_accession": "3000079", "category_aro_cvterm_id": "36218", "category_aro_name": "oxazolidinone antibiotic", "category_aro_description": "Oxazolidinones are a class of synthetic antibiotics discovered the the 1980's.  They inhibit protein synthesis by binding to domain V of the 23S rRNA of the 50S subunit of bacterial ribosomes.  Linezolid is the only member of this class currently in clinical use.", "category_aro_class_name": "Drug Class"}, "36526": {"category_aro_accession": "3000387", "category_aro_cvterm_id": "36526", "category_aro_name": "phenicol antibiotic", "category_aro_description": "Phenicols are broad spectrum bacteriostatic antibiotics acting on bacterial protein synthesis. More specifically, the phenicols block peptide elongation by binding to the peptidyltansferase centre of the 70S ribosome.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.91017e-07, "max_identities": 67, "bit_score": 48.9062, "cvterm_id": "35918", "query": "QTIMSQVTALPGSTQPIVSLTEVTKTYS--LGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALN-LIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGF-IFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRP-NELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRI", "match": "+T MS+      S++ ++S +E+   Y   L KV     RG  L         I G +G GK+T L  L+G V  A SG             ++QL  +      F IFQS             E+P     +LN +E RT + +             RP + LSGG++ R+ + + L  R  +++ DEPT ++D +  +N+ ++   L   +G T IF +HD           R    KI DR+", "sequence_from_db": "KTYMSKFQPRISSSRQVLSASELVIGYDTPLAKVNFNLERGQKL--------GIVGSNGIGKSTLLKTLMGGV-AALSGDFKFGYNVEISYFDQQLAQISGDDTLFEIFQS-------------EYP-----ELNDTEVRTALGSF----QFSGDDVFRPVSSLSGGEKVRLTLCKLLYKRTNVLILDEPTNHMDIIGKENLENI---LCSYQG-TIIFVSHD-----------RYFTNKIADRL", "sequence_from_broadstreet": "MSKATFAIASTNAKEDMKMQYKIINGAVYYDGNMVLENIGIEINDNEKIAIVGRNGCGKTTLLKAIIGEIELEEGTGESEFQVIKTGNPYISYLRQMPFEDESISMVDEVRTVFKTLIDMENKMKQLIDKMENQYDDKIINEYSDISERYMALGGLTYQKEYETMIRSMGFTEADYKKPISEFSGGQRTKIAFIKILLTKPDILLLDEPTNHLDIETIQWLESYLRSYKSTLVIISHDRMFLNRIVDKVYEIEWGETKCYKGNYSAFEEQKRENHIKQQKDYDLQQIEIERITRLIERFRYKPTKAKMVQSKIKLLQRMQILNAPDQYDTKTYMSKFQPRISSSRQVLSASELVIGYDTPLAKVNFNLERGQKLGIVGSNGIGKSTLLKTLMGGVAALSGDFKFGYNVEISYFDQQLAQISGDDTLFEIFQSEYPELNDTEVRTALGSFQFSGDDVFRPVSSLSGGEKVRLTLCKLLYKRTNVLILDEPTNHMDIIGKENLENILCSYQGTIIFVSHDRYFTNKIADRLLVFDKDGVEFVQSTYGEYEKKRMNSEKPFNNIKVEQKVEKNNTVKGDRNSIEKEKVKKEKRIEKLEVLINQYDEELERLNKIISEPNNSSDYIVLTEIQKSIDDVKRCQGNYFNEWEQLMRELEVM", "dna_sequence_from_broadstreet": "TTGTCCAAAGCCACCTTTGCAATTGCTAGTACTAACGCAAAGGAGGATATGAAAATGCAATACAAAATAATTAATGGTGCCGTTTACTATGATGGTAATATGGTGTTGGAAAACATCGGTATTGAAATCAATGATAATGAAAAGATTGCTATTGTTGGTAGAAATGGATGTGGAAAAACAACCTTGCTAAAAGCTATTATAGGCGAAATTGAATTAGAAGAAGGAACTGGTGAAAGTGAGTTTCAAGTAATAAAGACCGGTAACCCTTATATTAGCTATTTAAGACAGATGCCTTTTGAAGATGAAAGTATATCAATGGTGGATGAAGTCCGTACGGTATTTAAGACGCTTATTGATATGGAAAACAAGATGAAACAGCTGATAGATAAAATGGAGAATCAATATGATGATAAAATCATCAATGAATACTCTGATATCAGTGAAAGGTATATGGCTCTTGGAGGTCTAACCTACCAAAAAGAATATGAAACGATGATTCGTAGTATGGGTTTTACTGAAGCAGATTATAAAAAACCCATTTCTGAATTTTCAGGTGGTCAGCGAACTAAGATAGCTTTTATAAAAATACTTTTAACAAAGCCAGACATTCTATTACTTGATGAACCTACTAACCACCTTGATATAGAAACAATACAATGGTTGGAGAGTTATTTGAGAAGTTATAAATCTACATTGGTTATTATTTCCCATGATAGAATGTTTCTTAATCGAATTGTGGATAAGGTTTATGAAATCGAATGGGGAGAGACCAAATGTTATAAAGGTAATTATTCAGCCTTTGAGGAGCAAAAACGAGAAAATCATATCAAACAGCAAAAAGATTACGACTTGCAACAGATAGAAATTGAAAGGATTACACGCTTGATTGAACGTTTTCGTTATAAACCTACGAAAGCTAAAATGGTGCAATCTAAAATTAAATTATTACAGCGTATGCAAATATTAAATGCACCAGACCAATACGATACAAAAACTTATATGTCTAAATTTCAACCGAGAATCAGTAGTTCAAGGCAAGTATTAAGTGCTTCAGAACTTGTGATAGGCTATGATACTCCTCTTGCAAAGGTTAATTTCAACCTTGAAAGGGGACAGAAGCTTGGAATTGTTGGGAGTAATGGTATTGGTAAATCCACGTTGCTTAAAACACTTATGGGTGGTGTGGCAGCATTGTCTGGAGATTTTAAATTCGGATACAATGTTGAAATTAGCTATTTTGACCAACAGCTTGCTCAAATCAGTGGAGATGATACACTATTCGAAATTTTTCAAAGCGAATACCCTGAGCTAAATGACACAGAGGTCAGAACTGCTCTTGGCTCATTTCAGTTTAGTGGAGATGATGTTTTTAGACCGGTGTCCTCTTTGTCAGGTGGAGAAAAGGTTAGATTGACATTATGTAAATTATTATATAAACGTACTAATGTTTTAATCTTAGATGAACCGACAAACCACATGGATATTATTGGAAAAGAGAATTTAGAGAATATCTTATGCAGTTATCAAGGTACAATTATTTTTGTGTCACATGATAGATATTTTACTAATAAGATTGCTGACAGATTACTTGTTTTTGATAAGGATGGTGTAGAGTTTGTACAATCTACTTATGGTGAGTACGAGAAAAAAAGGATGAATTCTGAAAAGCCATTTAATAACATTAAAGTTGAGCAGAAAGTAGAGAAAAATAACACAGTAAAAGGCGATCGTAACTCCATTGAGAAGGAGAAGGTTAAGAAGGAGAAACGAATTGAAAAGCTTGAAGTGTTAATAAATCAATATGATGAAGAATTAGAAAGATTGAATAAAATCATTTCTGAACCAAACAATTCTTCTGATTATATAGTACTGACGGAAATACAAAAATCAATTGATGATGTTAAAAGGTGTCAGGGTAATTATTTTAATGAATGGGAACAGTTGATGAGAGAATTGGAAGTTATGTAA", "partial": "0", "query_start": 51310, "query_end": 52029, "hit_start": 990, "hit_end": 1587, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 27.35}, "gnl|BL_ORD_ID|138|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "vgaALC", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1050", "model_id": "159", "ARO_accession": "3002830", "ARO_name": "vgaALC", "ARO_category": {"36252": {"category_aro_accession": "3000113", "category_aro_cvterm_id": "36252", "category_aro_name": "vga-type ABC-F protein", "category_aro_description": "Vga-type plasmid-borne ABC-F proteins, expressed in staphylococci that confer resistance to streptogramin A antibiotics through ribosomal protection.", "category_aro_class_name": "AMR Gene Family"}, "35964": {"category_aro_accession": "0000046", "category_aro_cvterm_id": "35964", "category_aro_name": "lincomycin", "category_aro_description": "Lincomycin is a lincosamide antibiotic that comes from the actinomyces Streptomyces lincolnensis. It binds to the 23s portion of the 50S subunit of bacterial ribosomes and inhibit early elongation of peptide chain by inhibiting transpeptidase reaction.", "category_aro_class_name": "Antibiotic"}, "35983": {"category_aro_accession": "0000066", "category_aro_cvterm_id": "35983", "category_aro_name": "clindamycin", "category_aro_description": "Clindamycin is a lincosamide antibiotic that blocks A-site aminoacyl-tRNA binding. It is usually used to treat infections with anaerobic bacteria but can also be used to treat some protozoal diseases, such as malaria.", "category_aro_class_name": "Antibiotic"}, "37013": {"category_aro_accession": "3000669", "category_aro_cvterm_id": "37013", "category_aro_name": "virginiamycin M1", "category_aro_description": "Virginiamycin M1 is a streptogramin A antibiotic.", "category_aro_class_name": "Antibiotic"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35952": {"category_aro_accession": "0000034", "category_aro_cvterm_id": "35952", "category_aro_name": "streptogramin A antibiotic", "category_aro_description": "Streptogramin A antibiotics are cyclic polyketide peptide hybrids that bind to the ribosomal peptidyl transfer centre. Structural variation arises from substituting a proline for its desaturated derivative and by its substitution for Ala or Cys. Used alone, streptogramin A antibiotics are bacteriostatic, but is bactericidal when used with streptogramin B antibiotics.", "category_aro_class_name": "Drug Class"}, "37014": {"category_aro_accession": "3000670", "category_aro_cvterm_id": "37014", "category_aro_name": "pleuromutilin antibiotic", "category_aro_description": "Pleuromutilins are natural fungal products that target bacterial protein translation by binding the the 23S rRNA, blocking the ribosome P site at the 50S subunit. They are mostly used for agriculture and veterinary purposes.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.43404e-07, "max_identities": 53, "bit_score": 49.2914, "cvterm_id": "36827", "query": "LGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSV-LSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRP-NELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAK--------VMTHANAVVRLADG", "match": "L K +  ++RG       G+ ++I G +G+GKTT +  I   +   S   SV                    IG+  Q  + + +  S+ +NV+         ++ +  T + T+L ++   +   ++P + LSGG+R +VA+ +  ++    ++ DEPT  LD    +    L+KE N     + IF +HD K        +MT  N  +++ DG", "sequence_from_db": "LWKAKSFSIRG-------GDKMAIIGSNGTGKTTFIKKIVHGNPGISLSPSV-------------------KIGYFSQKIDTLELDKSILENVQS--------SSQQNETLIRTILARMHFFRDDVYKPISVLSGGERVKVALTKVFLSEVNTLVLDEPTNFLDMEAIEAFESLLKEYN----GSIIFVSHDRKFIEKVATRIMTIDNKEIKIFDG", "sequence_from_broadstreet": "MKILLEGLHIKHYVQDRLLLNINRLKIYQNDRIGLIGKNGSGKTTLLHILYKKIVPEEGIVKQFSHCELIPQLKLIESTKSGGEVTRNYIRQALDKNPELLLADEPTTNLDNNYIEKLEQDLKNWHGAFIIVSHDRAFLDNLCTTIWEIDEGRITEYKGNYSNYVEQKELERHREELEYEKYEKEKKRLEKAINIKEQKAQRATKKPKNLSSSEGKIKVTKPYFASKQKKLRKTVKSLETRLEKLERVEKRNELPPLKMDLVNLESVKNRTIIRGEDVSGTIEGRVLWKAKSFSIRGGDKMAIIGSNGTGKTTFIKKIVHGNPGISLSPSVKIGYFSQKIDTLELDKSILENVQSSSQQNETLIRTILARMHFFRDDVYKPISVLSGGERVKVALTKVFLSEVNTLVLDEPTNFLDMEAIEAFESLLKEYNGSIIFVSHDRKFIEKVATRIMTIDNKEIKIFDGTYEQFKQAEKPTRNIKEDKKLLLETKITEVLSRLSIEPSEELEQEFQNLINEKRNLDK", "dna_sequence_from_broadstreet": "ATGAAAATACTGTTAGAGGGACTTCATATAAAACATTATGTTCAAGATCGTTTATTGTTGAACATAAATCGCCTAAAGATTTATCAGAATGATCGTATTGGTTTAATTGGTAAAAATGGAAGTGGAAAAACAACGTTACTTCACATATTATATAAAAAAATTGTGCCTGAAGAAGGTATTGTAAAACAATTTTCACATTGTGAACTTATTCCTCAATTGAAGCTCATAGAATCAACTAAAAGTGGTGGTGAAGTAACACGAAACTATATTCGGCAAGCGCTTGATAAAAATCCAGAACTGCTATTAGCAGATGAACCAACAACTAACTTAGATAATAACTATATAGAAAAATTAGAACAGGATTTAAAAAATTGGCATGGAGCATTTATTATAGTTTCACATGATCGCGCTTTTTTAGATAACTTATGTACTACTATATGGGAAATTGACGAGGGGAGAATAACTGAATATAAGGGGAATTATAGTAACTATGTTGAACAAAAAGAATTAGAAAGACATCGAGAAGAATTAGAATATGAAAAATATGAAAAAGAAAAGAAACGATTGGAAAAAGCTATAAATATAAAAGAACAGAAAGCTCAACGAGCAACTAAAAAACCGAAAAACTTAAGTTCATCTGAAGGCAAAATAAAAGTAACAAAGCCATACTTTGCAAGTAAGCAAAAGAAGTTACGAAAAACTGTAAAATCTCTAGAAACCAGACTAGAAAAACTTGAAAGGGTCGAAAAGAGAAACGAACTTCCTCCACTTAAAATGGATTTAGTGAACTTAGAAAGTGTAAAAAATAGAACTATAATACGTGGTGAAGATGTCTCGGGTACAATTGAAGGACGGGTATTGTGGAAAGCAAAAAGTTTTAGTATTCGCGGAGGAGACAAGATGGCAATTATCGGATCTAATGGTACAGGAAAGACAACGTTTATTAAAAAAATTGTGCATGGGAATCCTGGTATTTCATTATCGCCATCTGTCAAAATCGGTTATTTTAGCCAAAAAATAGATACATTAGAATTAGATAAGAGTATTTTAGAAAATGTTCAATCTTCTTCACAACAAAATGAAACTCTTATTCGAACTATTCTAGCTAGAATGCATTTTTTTAGAGATGATGTTTATAAACCAATAAGTGTCTTAAGTGGTGGAGAGCGAGTTAAAGTAGCACTAACTAAAGTATTCTTAAGTGAAGTTAATACGTTGGTACTAGATGAACCAACAAACTTTCTTGATATGGAAGCTATAGAGGCGTTTGAATCTTTGTTAAAGGAATATAATGGCAGTATAATCTTTGTATCTCACGATCGTAAATTTATCGAAAAAGTAGCCACTCGAATAATGACAATTGATAATAAAGAAATAAAAATATTTGATGGCACATATGAACAATTTAAACAAGCTGAAAAGCCAACAAGGAATATTAAAGAAGATAAAAAACTTTTACTTGAGACAAAAATTACAGAAGTACTCAGTCGATTGAGTATTGAACCTTCGGAAGAATTAGAACAAGAGTTTCAAAACTTAATAAATGAAAAAAGAAATTTAGATAAATAA", "partial": "0", "query_start": 51394, "query_end": 52011, "hit_start": 858, "hit_end": 1392, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 24.54}, "gnl|BL_ORD_ID|138|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "vgaALC", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1050", "model_id": "159", "ARO_accession": "3002830", "ARO_name": "vgaALC", "ARO_category": {"36252": {"category_aro_accession": "3000113", "category_aro_cvterm_id": "36252", "category_aro_name": "vga-type ABC-F protein", "category_aro_description": "Vga-type plasmid-borne ABC-F proteins, expressed in staphylococci that confer resistance to streptogramin A antibiotics through ribosomal protection.", "category_aro_class_name": "AMR Gene Family"}, "35964": {"category_aro_accession": "0000046", "category_aro_cvterm_id": "35964", "category_aro_name": "lincomycin", "category_aro_description": "Lincomycin is a lincosamide antibiotic that comes from the actinomyces Streptomyces lincolnensis. It binds to the 23s portion of the 50S subunit of bacterial ribosomes and inhibit early elongation of peptide chain by inhibiting transpeptidase reaction.", "category_aro_class_name": "Antibiotic"}, "35983": {"category_aro_accession": "0000066", "category_aro_cvterm_id": "35983", "category_aro_name": "clindamycin", "category_aro_description": "Clindamycin is a lincosamide antibiotic that blocks A-site aminoacyl-tRNA binding. It is usually used to treat infections with anaerobic bacteria but can also be used to treat some protozoal diseases, such as malaria.", "category_aro_class_name": "Antibiotic"}, "37013": {"category_aro_accession": "3000669", "category_aro_cvterm_id": "37013", "category_aro_name": "virginiamycin M1", "category_aro_description": "Virginiamycin M1 is a streptogramin A antibiotic.", "category_aro_class_name": "Antibiotic"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35952": {"category_aro_accession": "0000034", "category_aro_cvterm_id": "35952", "category_aro_name": "streptogramin A antibiotic", "category_aro_description": "Streptogramin A antibiotics are cyclic polyketide peptide hybrids that bind to the ribosomal peptidyl transfer centre. Structural variation arises from substituting a proline for its desaturated derivative and by its substitution for Ala or Cys. Used alone, streptogramin A antibiotics are bacteriostatic, but is bactericidal when used with streptogramin B antibiotics.", "category_aro_class_name": "Drug Class"}, "37014": {"category_aro_accession": "3000670", "category_aro_cvterm_id": "37014", "category_aro_name": "pleuromutilin antibiotic", "category_aro_description": "Pleuromutilins are natural fungal products that target bacterial protein translation by binding the the 23S rRNA, blocking the ribosome P site at the 50S subunit. They are mostly used for agriculture and veterinary purposes.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.03498e-05, "max_identities": 25, "bit_score": 43.5134, "cvterm_id": "36827", "query": "SGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTH-ANAVVRLADGKI", "match": "SGG+  R  + +AL   P+L+LADEPT NLD+    N I+ +++  +     FI  +HD   + +    +  + +G+I", "sequence_from_db": "SGGEVTRNYIRQALDKNPELLLADEPTTNLDN----NYIEKLEQDLKNWHGAFIIVSHDRAFLDNLCTTIWEIDEGRI", "sequence_from_broadstreet": "MKILLEGLHIKHYVQDRLLLNINRLKIYQNDRIGLIGKNGSGKTTLLHILYKKIVPEEGIVKQFSHCELIPQLKLIESTKSGGEVTRNYIRQALDKNPELLLADEPTTNLDNNYIEKLEQDLKNWHGAFIIVSHDRAFLDNLCTTIWEIDEGRITEYKGNYSNYVEQKELERHREELEYEKYEKEKKRLEKAINIKEQKAQRATKKPKNLSSSEGKIKVTKPYFASKQKKLRKTVKSLETRLEKLERVEKRNELPPLKMDLVNLESVKNRTIIRGEDVSGTIEGRVLWKAKSFSIRGGDKMAIIGSNGTGKTTFIKKIVHGNPGISLSPSVKIGYFSQKIDTLELDKSILENVQSSSQQNETLIRTILARMHFFRDDVYKPISVLSGGERVKVALTKVFLSEVNTLVLDEPTNFLDMEAIEAFESLLKEYNGSIIFVSHDRKFIEKVATRIMTIDNKEIKIFDGTYEQFKQAEKPTRNIKEDKKLLLETKITEVLSRLSIEPSEELEQEFQNLINEKRNLDK", "dna_sequence_from_broadstreet": "ATGAAAATACTGTTAGAGGGACTTCATATAAAACATTATGTTCAAGATCGTTTATTGTTGAACATAAATCGCCTAAAGATTTATCAGAATGATCGTATTGGTTTAATTGGTAAAAATGGAAGTGGAAAAACAACGTTACTTCACATATTATATAAAAAAATTGTGCCTGAAGAAGGTATTGTAAAACAATTTTCACATTGTGAACTTATTCCTCAATTGAAGCTCATAGAATCAACTAAAAGTGGTGGTGAAGTAACACGAAACTATATTCGGCAAGCGCTTGATAAAAATCCAGAACTGCTATTAGCAGATGAACCAACAACTAACTTAGATAATAACTATATAGAAAAATTAGAACAGGATTTAAAAAATTGGCATGGAGCATTTATTATAGTTTCACATGATCGCGCTTTTTTAGATAACTTATGTACTACTATATGGGAAATTGACGAGGGGAGAATAACTGAATATAAGGGGAATTATAGTAACTATGTTGAACAAAAAGAATTAGAAAGACATCGAGAAGAATTAGAATATGAAAAATATGAAAAAGAAAAGAAACGATTGGAAAAAGCTATAAATATAAAAGAACAGAAAGCTCAACGAGCAACTAAAAAACCGAAAAACTTAAGTTCATCTGAAGGCAAAATAAAAGTAACAAAGCCATACTTTGCAAGTAAGCAAAAGAAGTTACGAAAAACTGTAAAATCTCTAGAAACCAGACTAGAAAAACTTGAAAGGGTCGAAAAGAGAAACGAACTTCCTCCACTTAAAATGGATTTAGTGAACTTAGAAAGTGTAAAAAATAGAACTATAATACGTGGTGAAGATGTCTCGGGTACAATTGAAGGACGGGTATTGTGGAAAGCAAAAAGTTTTAGTATTCGCGGAGGAGACAAGATGGCAATTATCGGATCTAATGGTACAGGAAAGACAACGTTTATTAAAAAAATTGTGCATGGGAATCCTGGTATTTCATTATCGCCATCTGTCAAAATCGGTTATTTTAGCCAAAAAATAGATACATTAGAATTAGATAAGAGTATTTTAGAAAATGTTCAATCTTCTTCACAACAAAATGAAACTCTTATTCGAACTATTCTAGCTAGAATGCATTTTTTTAGAGATGATGTTTATAAACCAATAAGTGTCTTAAGTGGTGGAGAGCGAGTTAAAGTAGCACTAACTAAAGTATTCTTAAGTGAAGTTAATACGTTGGTACTAGATGAACCAACAAACTTTCTTGATATGGAAGCTATAGAGGCGTTTGAATCTTTGTTAAAGGAATATAATGGCAGTATAATCTTTGTATCTCACGATCGTAAATTTATCGAAAAAGTAGCCACTCGAATAATGACAATTGATAATAAAGAAATAAAAATATTTGATGGCACATATGAACAATTTAAACAAGCTGAAAAGCCAACAAGGAATATTAAAGAAGATAAAAAACTTTTACTTGAGACAAAAATTACAGAAGTACTCAGTCGATTGAGTATTGAACCTTCGGAAGAATTAGAACAAGAGTTTCAAAACTTAATAAATGAAAAAAGAAATTTAGATAAATAA", "partial": "0", "query_start": 51787, "query_end": 52017, "hit_start": 240, "hit_end": 462, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 32.05}, "gnl|BL_ORD_ID|138|hsp_num:2": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "vgaALC", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1050", "model_id": "159", "ARO_accession": "3002830", "ARO_name": "vgaALC", "ARO_category": {"36252": {"category_aro_accession": "3000113", "category_aro_cvterm_id": "36252", "category_aro_name": "vga-type ABC-F protein", "category_aro_description": "Vga-type plasmid-borne ABC-F proteins, expressed in staphylococci that confer resistance to streptogramin A antibiotics through ribosomal protection.", "category_aro_class_name": "AMR Gene Family"}, "35964": {"category_aro_accession": "0000046", "category_aro_cvterm_id": "35964", "category_aro_name": "lincomycin", "category_aro_description": "Lincomycin is a lincosamide antibiotic that comes from the actinomyces Streptomyces lincolnensis. It binds to the 23s portion of the 50S subunit of bacterial ribosomes and inhibit early elongation of peptide chain by inhibiting transpeptidase reaction.", "category_aro_class_name": "Antibiotic"}, "35983": {"category_aro_accession": "0000066", "category_aro_cvterm_id": "35983", "category_aro_name": "clindamycin", "category_aro_description": "Clindamycin is a lincosamide antibiotic that blocks A-site aminoacyl-tRNA binding. It is usually used to treat infections with anaerobic bacteria but can also be used to treat some protozoal diseases, such as malaria.", "category_aro_class_name": "Antibiotic"}, "37013": {"category_aro_accession": "3000669", "category_aro_cvterm_id": "37013", "category_aro_name": "virginiamycin M1", "category_aro_description": "Virginiamycin M1 is a streptogramin A antibiotic.", "category_aro_class_name": "Antibiotic"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35952": {"category_aro_accession": "0000034", "category_aro_cvterm_id": "35952", "category_aro_name": "streptogramin A antibiotic", "category_aro_description": "Streptogramin A antibiotics are cyclic polyketide peptide hybrids that bind to the ribosomal peptidyl transfer centre. Structural variation arises from substituting a proline for its desaturated derivative and by its substitution for Ala or Cys. Used alone, streptogramin A antibiotics are bacteriostatic, but is bactericidal when used with streptogramin B antibiotics.", "category_aro_class_name": "Drug Class"}, "37014": {"category_aro_accession": "3000670", "category_aro_cvterm_id": "37014", "category_aro_name": "pleuromutilin antibiotic", "category_aro_description": "Pleuromutilins are natural fungal products that target bacterial protein translation by binding the the 23S rRNA, blocking the ribosome P site at the 50S subunit. They are mostly used for agriculture and veterinary purposes.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.44076, "max_identities": 13, "bit_score": 29.261, "cvterm_id": "36827", "query": "LEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVV", "match": "L++Y  + I + G +GSGKTT L+++        G+V", "sequence_from_db": "LKIYQNDRIGLIGKNGSGKTTLLHILYKKIVPEEGIV", "sequence_from_broadstreet": "MKILLEGLHIKHYVQDRLLLNINRLKIYQNDRIGLIGKNGSGKTTLLHILYKKIVPEEGIVKQFSHCELIPQLKLIESTKSGGEVTRNYIRQALDKNPELLLADEPTTNLDNNYIEKLEQDLKNWHGAFIIVSHDRAFLDNLCTTIWEIDEGRITEYKGNYSNYVEQKELERHREELEYEKYEKEKKRLEKAINIKEQKAQRATKKPKNLSSSEGKIKVTKPYFASKQKKLRKTVKSLETRLEKLERVEKRNELPPLKMDLVNLESVKNRTIIRGEDVSGTIEGRVLWKAKSFSIRGGDKMAIIGSNGTGKTTFIKKIVHGNPGISLSPSVKIGYFSQKIDTLELDKSILENVQSSSQQNETLIRTILARMHFFRDDVYKPISVLSGGERVKVALTKVFLSEVNTLVLDEPTNFLDMEAIEAFESLLKEYNGSIIFVSHDRKFIEKVATRIMTIDNKEIKIFDGTYEQFKQAEKPTRNIKEDKKLLLETKITEVLSRLSIEPSEELEQEFQNLINEKRNLDK", "dna_sequence_from_broadstreet": "ATGAAAATACTGTTAGAGGGACTTCATATAAAACATTATGTTCAAGATCGTTTATTGTTGAACATAAATCGCCTAAAGATTTATCAGAATGATCGTATTGGTTTAATTGGTAAAAATGGAAGTGGAAAAACAACGTTACTTCACATATTATATAAAAAAATTGTGCCTGAAGAAGGTATTGTAAAACAATTTTCACATTGTGAACTTATTCCTCAATTGAAGCTCATAGAATCAACTAAAAGTGGTGGTGAAGTAACACGAAACTATATTCGGCAAGCGCTTGATAAAAATCCAGAACTGCTATTAGCAGATGAACCAACAACTAACTTAGATAATAACTATATAGAAAAATTAGAACAGGATTTAAAAAATTGGCATGGAGCATTTATTATAGTTTCACATGATCGCGCTTTTTTAGATAACTTATGTACTACTATATGGGAAATTGACGAGGGGAGAATAACTGAATATAAGGGGAATTATAGTAACTATGTTGAACAAAAAGAATTAGAAAGACATCGAGAAGAATTAGAATATGAAAAATATGAAAAAGAAAAGAAACGATTGGAAAAAGCTATAAATATAAAAGAACAGAAAGCTCAACGAGCAACTAAAAAACCGAAAAACTTAAGTTCATCTGAAGGCAAAATAAAAGTAACAAAGCCATACTTTGCAAGTAAGCAAAAGAAGTTACGAAAAACTGTAAAATCTCTAGAAACCAGACTAGAAAAACTTGAAAGGGTCGAAAAGAGAAACGAACTTCCTCCACTTAAAATGGATTTAGTGAACTTAGAAAGTGTAAAAAATAGAACTATAATACGTGGTGAAGATGTCTCGGGTACAATTGAAGGACGGGTATTGTGGAAAGCAAAAAGTTTTAGTATTCGCGGAGGAGACAAGATGGCAATTATCGGATCTAATGGTACAGGAAAGACAACGTTTATTAAAAAAATTGTGCATGGGAATCCTGGTATTTCATTATCGCCATCTGTCAAAATCGGTTATTTTAGCCAAAAAATAGATACATTAGAATTAGATAAGAGTATTTTAGAAAATGTTCAATCTTCTTCACAACAAAATGAAACTCTTATTCGAACTATTCTAGCTAGAATGCATTTTTTTAGAGATGATGTTTATAAACCAATAAGTGTCTTAAGTGGTGGAGAGCGAGTTAAAGTAGCACTAACTAAAGTATTCTTAAGTGAAGTTAATACGTTGGTACTAGATGAACCAACAAACTTTCTTGATATGGAAGCTATAGAGGCGTTTGAATCTTTGTTAAAGGAATATAATGGCAGTATAATCTTTGTATCTCACGATCGTAAATTTATCGAAAAAGTAGCCACTCGAATAATGACAATTGATAATAAAGAAATAAAAATATTTGATGGCACATATGAACAATTTAAACAAGCTGAAAAGCCAACAAGGAATATTAAAGAAGATAAAAAACTTTTACTTGAGACAAAAATTACAGAAGTACTCAGTCGATTGAGTATTGAACCTTCGGAAGAATTAGAACAAGAGTTTCAAAACTTAATAAATGAAAAAAGAAATTTAGATAAATAA", "partial": "0", "query_start": 51433, "query_end": 51543, "hit_start": 72, "hit_end": 183, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 35.14}, "gnl|BL_ORD_ID|527|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "vgaA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1050", "model_id": "579", "ARO_accession": "3002829", "ARO_name": "vgaA", "ARO_category": {"36252": {"category_aro_accession": "3000113", "category_aro_cvterm_id": "36252", "category_aro_name": "vga-type ABC-F protein", "category_aro_description": "Vga-type plasmid-borne ABC-F proteins, expressed in staphylococci that confer resistance to streptogramin A antibiotics through ribosomal protection.", "category_aro_class_name": "AMR Gene Family"}, "35983": {"category_aro_accession": "0000066", "category_aro_cvterm_id": "35983", "category_aro_name": "clindamycin", "category_aro_description": "Clindamycin is a lincosamide antibiotic that blocks A-site aminoacyl-tRNA binding. It is usually used to treat infections with anaerobic bacteria but can also be used to treat some protozoal diseases, such as malaria.", "category_aro_class_name": "Antibiotic"}, "37013": {"category_aro_accession": "3000669", "category_aro_cvterm_id": "37013", "category_aro_name": "virginiamycin M1", "category_aro_description": "Virginiamycin M1 is a streptogramin A antibiotic.", "category_aro_class_name": "Antibiotic"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35952": {"category_aro_accession": "0000034", "category_aro_cvterm_id": "35952", "category_aro_name": "streptogramin A antibiotic", "category_aro_description": "Streptogramin A antibiotics are cyclic polyketide peptide hybrids that bind to the ribosomal peptidyl transfer centre. Structural variation arises from substituting a proline for its desaturated derivative and by its substitution for Ala or Cys. Used alone, streptogramin A antibiotics are bacteriostatic, but is bactericidal when used with streptogramin B antibiotics.", "category_aro_class_name": "Drug Class"}, "37014": {"category_aro_accession": "3000670", "category_aro_cvterm_id": "37014", "category_aro_name": "pleuromutilin antibiotic", "category_aro_description": "Pleuromutilins are natural fungal products that target bacterial protein translation by binding the the 23S rRNA, blocking the ribosome P site at the 50S subunit. They are mostly used for agriculture and veterinary purposes.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.79627e-07, "max_identities": 53, "bit_score": 48.9062, "cvterm_id": "35508", "query": "LGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSV-LSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRP-NELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAK--------VMTHANAVVRLADG", "match": "L K +  ++RG       G+ ++I G +G+GKTT +  I   +   S   SV                    IG+  Q  + + +  S+ +NV+         ++ +  T + T+L ++   +   ++P + LSGG+R +VA+ +  ++    ++ DEPT  LD    +    L+KE N     + IF +HD K        +MT  N  +++ DG", "sequence_from_db": "LWKAKSFSIRG-------GDKMAIIGSNGTGKTTFIKKIVHGNPGISLSPSV-------------------KIGYFSQKIDTLELDKSILENVQS--------SSQQNETLIRTILARMHFFRDDVYKPISVLSGGERVKVALTKVFLSEVNTLVLDEPTNFLDMEAIEAFESLLKEYN----GSIIFVSHDRKFIEKVATRIMTIDNKEIKIFDG", "sequence_from_broadstreet": "MKIMLEGLNIKHYVQDRLLLNINRLKIYQNDRIGLIGKNGSGKTTLLHILYKKIVPEEGIVKQFSHCELIPQLKLIESTKSGGEVTRNYIRQALDKNPELLLADEPTTNLDNNYIEKLEQDLKNWHGAFIIVSHDRAFLDNLCTTIWEIDEGRITEYKGNYSNYVEQKELERHREELEYEKYEKEKKRLEKAINIKEQKAQRATKKPKNLSLSEGKIKGAKPYFAGKQKKLRKTVKSLETRLEKLESVEKRNELPPLKMDLVNLESVKNRTIIRGEDVSGTIEGRVLWKAKSFSIRGGDKMAIIGSNGTGKTTFIKKIVHGNPGISLSPSVKIGYFSQKIDTLELDKSILENVQSSSQQNETLIRTILARMHFFRDDVYKPISVLSGGERVKVALTKVFLSEVNTLVLDEPTNFLDMEAIEAFESLLKEYNGSIIFVSHDRKFIEKVATRIMTIDNKEIKIFDGTYEQFKQAEKPTRNIKEDKKLLLETKITEVLSRLSIEPSEELEQEFQNLINEKRNLDK", "dna_sequence_from_broadstreet": "ATGAAAATAATGTTAGAGGGACTTAATATAAAACATTATGTTCAAGATCGTTTATTGTTGAACATAAATCGCCTAAAGATTTATCAGAATGATCGTATTGGTTTAATTGGTAAAAATGGAAGTGGAAAAACAACGTTACTTCACATATTATATAAAAAAATTGTGCCTGAAGAAGGTATTGTAAAACAATTTTCACATTGTGAACTTATTCCTCAATTGAAGCTCATAGAATCAACTAAAAGTGGTGGTGAAGTAACACGAAACTATATTCGGCAAGCGCTTGATAAAAATCCAGAACTGCTATTAGCAGATGAACCAACAACTAACTTAGATAATAACTATATAGAAAAATTAGAACAGGATTTAAAAAATTGGCATGGAGCATTTATTATAGTTTCACATGATCGCGCTTTTTTAGATAACTTGTGTACTACTATATGGGAAATTGACGAGGGAAGAATAACTGAATATAAGGGGAATTATAGTAACTATGTTGAACAAAAAGAATTAGAAAGACATCGAGAAGAATTAGAATATGAAAAATATGAAAAAGAAAAGAAACGATTGGAAAAAGCTATAAATATAAAAGAACAGAAAGCTCAACGAGCAACTAAAAAACCGAAAAACTTAAGTTTATCTGAAGGCAAAATAAAAGGAGCAAAGCCATACTTTGCAGGTAAGCAAAAGAAGTTACGAAAAACTGTAAAATCTCTAGAAACCAGACTAGAAAAACTTGAAAGCGTCGAAAAGAGAAACGAACTTCCTCCACTTAAAATGGATTTAGTGAACTTAGAAAGTGTAAAAAATAGAACTATAATACGTGGTGAAGATGTCTCGGGTACAATTGAAGGACGGGTATTGTGGAAAGCAAAAAGTTTTAGTATTCGCGGAGGAGACAAGATGGCAATTATCGGATCTAATGGTACAGGAAAGACAACGTTTATTAAAAAAATTGTGCATGGGAATCCTGGTATTTCATTATCGCCATCTGTCAAAATCGGTTATTTTAGCCAAAAAATAGATACATTAGAATTAGATAAGAGCATTTTAGAAAATGTTCAATCTTCTTCACAACAAAATGAAACTCTTATTCGAACTATTCTAGCTAGAATGCATTTTTTTAGAGATGATGTTTATAAACCAATAAGTGTCTTAAGTGGTGGAGAGCGAGTTAAAGTAGCACTAACTAAAGTATTCTTAAGTGAAGTTAATACGTTGGTACTAGATGAACCAACAAACTTTCTTGATATGGAAGCTATAGAGGCGTTTGAATCTTTGTTAAAGGAATATAATGGCAGTATAATCTTTGTATCTCACGATCGTAAATTTATCGAAAAAGTAGCCACTCGAATAATGACAATTGATAATAAAGAAATAAAAATATTTGATGGCACATATGAACAATTTAAACAAGCTGAAAAGCCAACAAGGAATATTAAAGAAGATAAAAAACTTTTACTTGAGACAAAAATTACAGAAGTACTCAGTCGATTGAGTATTGAACCTTCGGAAGAATTAGAACAAGAGTTTCAAAACTTAATAAATGAAAAAAGAAATTTGGATAAATAA", "partial": "0", "query_start": 51394, "query_end": 52011, "hit_start": 858, "hit_end": 1392, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 24.54}, "gnl|BL_ORD_ID|527|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "vgaA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1050", "model_id": "579", "ARO_accession": "3002829", "ARO_name": "vgaA", "ARO_category": {"36252": {"category_aro_accession": "3000113", "category_aro_cvterm_id": "36252", "category_aro_name": "vga-type ABC-F protein", "category_aro_description": "Vga-type plasmid-borne ABC-F proteins, expressed in staphylococci that confer resistance to streptogramin A antibiotics through ribosomal protection.", "category_aro_class_name": "AMR Gene Family"}, "35983": {"category_aro_accession": "0000066", "category_aro_cvterm_id": "35983", "category_aro_name": "clindamycin", "category_aro_description": "Clindamycin is a lincosamide antibiotic that blocks A-site aminoacyl-tRNA binding. It is usually used to treat infections with anaerobic bacteria but can also be used to treat some protozoal diseases, such as malaria.", "category_aro_class_name": "Antibiotic"}, "37013": {"category_aro_accession": "3000669", "category_aro_cvterm_id": "37013", "category_aro_name": "virginiamycin M1", "category_aro_description": "Virginiamycin M1 is a streptogramin A antibiotic.", "category_aro_class_name": "Antibiotic"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35952": {"category_aro_accession": "0000034", "category_aro_cvterm_id": "35952", "category_aro_name": "streptogramin A antibiotic", "category_aro_description": "Streptogramin A antibiotics are cyclic polyketide peptide hybrids that bind to the ribosomal peptidyl transfer centre. Structural variation arises from substituting a proline for its desaturated derivative and by its substitution for Ala or Cys. Used alone, streptogramin A antibiotics are bacteriostatic, but is bactericidal when used with streptogramin B antibiotics.", "category_aro_class_name": "Drug Class"}, "37014": {"category_aro_accession": "3000670", "category_aro_cvterm_id": "37014", "category_aro_name": "pleuromutilin antibiotic", "category_aro_description": "Pleuromutilins are natural fungal products that target bacterial protein translation by binding the the 23S rRNA, blocking the ribosome P site at the 50S subunit. They are mostly used for agriculture and veterinary purposes.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.07262e-05, "max_identities": 25, "bit_score": 43.5134, "cvterm_id": "35508", "query": "SGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTH-ANAVVRLADGKI", "match": "SGG+  R  + +AL   P+L+LADEPT NLD+    N I+ +++  +     FI  +HD   + +    +  + +G+I", "sequence_from_db": "SGGEVTRNYIRQALDKNPELLLADEPTTNLDN----NYIEKLEQDLKNWHGAFIIVSHDRAFLDNLCTTIWEIDEGRI", "sequence_from_broadstreet": "MKIMLEGLNIKHYVQDRLLLNINRLKIYQNDRIGLIGKNGSGKTTLLHILYKKIVPEEGIVKQFSHCELIPQLKLIESTKSGGEVTRNYIRQALDKNPELLLADEPTTNLDNNYIEKLEQDLKNWHGAFIIVSHDRAFLDNLCTTIWEIDEGRITEYKGNYSNYVEQKELERHREELEYEKYEKEKKRLEKAINIKEQKAQRATKKPKNLSLSEGKIKGAKPYFAGKQKKLRKTVKSLETRLEKLESVEKRNELPPLKMDLVNLESVKNRTIIRGEDVSGTIEGRVLWKAKSFSIRGGDKMAIIGSNGTGKTTFIKKIVHGNPGISLSPSVKIGYFSQKIDTLELDKSILENVQSSSQQNETLIRTILARMHFFRDDVYKPISVLSGGERVKVALTKVFLSEVNTLVLDEPTNFLDMEAIEAFESLLKEYNGSIIFVSHDRKFIEKVATRIMTIDNKEIKIFDGTYEQFKQAEKPTRNIKEDKKLLLETKITEVLSRLSIEPSEELEQEFQNLINEKRNLDK", "dna_sequence_from_broadstreet": "ATGAAAATAATGTTAGAGGGACTTAATATAAAACATTATGTTCAAGATCGTTTATTGTTGAACATAAATCGCCTAAAGATTTATCAGAATGATCGTATTGGTTTAATTGGTAAAAATGGAAGTGGAAAAACAACGTTACTTCACATATTATATAAAAAAATTGTGCCTGAAGAAGGTATTGTAAAACAATTTTCACATTGTGAACTTATTCCTCAATTGAAGCTCATAGAATCAACTAAAAGTGGTGGTGAAGTAACACGAAACTATATTCGGCAAGCGCTTGATAAAAATCCAGAACTGCTATTAGCAGATGAACCAACAACTAACTTAGATAATAACTATATAGAAAAATTAGAACAGGATTTAAAAAATTGGCATGGAGCATTTATTATAGTTTCACATGATCGCGCTTTTTTAGATAACTTGTGTACTACTATATGGGAAATTGACGAGGGAAGAATAACTGAATATAAGGGGAATTATAGTAACTATGTTGAACAAAAAGAATTAGAAAGACATCGAGAAGAATTAGAATATGAAAAATATGAAAAAGAAAAGAAACGATTGGAAAAAGCTATAAATATAAAAGAACAGAAAGCTCAACGAGCAACTAAAAAACCGAAAAACTTAAGTTTATCTGAAGGCAAAATAAAAGGAGCAAAGCCATACTTTGCAGGTAAGCAAAAGAAGTTACGAAAAACTGTAAAATCTCTAGAAACCAGACTAGAAAAACTTGAAAGCGTCGAAAAGAGAAACGAACTTCCTCCACTTAAAATGGATTTAGTGAACTTAGAAAGTGTAAAAAATAGAACTATAATACGTGGTGAAGATGTCTCGGGTACAATTGAAGGACGGGTATTGTGGAAAGCAAAAAGTTTTAGTATTCGCGGAGGAGACAAGATGGCAATTATCGGATCTAATGGTACAGGAAAGACAACGTTTATTAAAAAAATTGTGCATGGGAATCCTGGTATTTCATTATCGCCATCTGTCAAAATCGGTTATTTTAGCCAAAAAATAGATACATTAGAATTAGATAAGAGCATTTTAGAAAATGTTCAATCTTCTTCACAACAAAATGAAACTCTTATTCGAACTATTCTAGCTAGAATGCATTTTTTTAGAGATGATGTTTATAAACCAATAAGTGTCTTAAGTGGTGGAGAGCGAGTTAAAGTAGCACTAACTAAAGTATTCTTAAGTGAAGTTAATACGTTGGTACTAGATGAACCAACAAACTTTCTTGATATGGAAGCTATAGAGGCGTTTGAATCTTTGTTAAAGGAATATAATGGCAGTATAATCTTTGTATCTCACGATCGTAAATTTATCGAAAAAGTAGCCACTCGAATAATGACAATTGATAATAAAGAAATAAAAATATTTGATGGCACATATGAACAATTTAAACAAGCTGAAAAGCCAACAAGGAATATTAAAGAAGATAAAAAACTTTTACTTGAGACAAAAATTACAGAAGTACTCAGTCGATTGAGTATTGAACCTTCGGAAGAATTAGAACAAGAGTTTCAAAACTTAATAAATGAAAAAAGAAATTTGGATAAATAA", "partial": "0", "query_start": 51787, "query_end": 52017, "hit_start": 240, "hit_end": 462, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 32.05}, "gnl|BL_ORD_ID|527|hsp_num:2": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "vgaA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1050", "model_id": "579", "ARO_accession": "3002829", "ARO_name": "vgaA", "ARO_category": {"36252": {"category_aro_accession": "3000113", "category_aro_cvterm_id": "36252", "category_aro_name": "vga-type ABC-F protein", "category_aro_description": "Vga-type plasmid-borne ABC-F proteins, expressed in staphylococci that confer resistance to streptogramin A antibiotics through ribosomal protection.", "category_aro_class_name": "AMR Gene Family"}, "35983": {"category_aro_accession": "0000066", "category_aro_cvterm_id": "35983", "category_aro_name": "clindamycin", "category_aro_description": "Clindamycin is a lincosamide antibiotic that blocks A-site aminoacyl-tRNA binding. It is usually used to treat infections with anaerobic bacteria but can also be used to treat some protozoal diseases, such as malaria.", "category_aro_class_name": "Antibiotic"}, "37013": {"category_aro_accession": "3000669", "category_aro_cvterm_id": "37013", "category_aro_name": "virginiamycin M1", "category_aro_description": "Virginiamycin M1 is a streptogramin A antibiotic.", "category_aro_class_name": "Antibiotic"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35952": {"category_aro_accession": "0000034", "category_aro_cvterm_id": "35952", "category_aro_name": "streptogramin A antibiotic", "category_aro_description": "Streptogramin A antibiotics are cyclic polyketide peptide hybrids that bind to the ribosomal peptidyl transfer centre. Structural variation arises from substituting a proline for its desaturated derivative and by its substitution for Ala or Cys. Used alone, streptogramin A antibiotics are bacteriostatic, but is bactericidal when used with streptogramin B antibiotics.", "category_aro_class_name": "Drug Class"}, "37014": {"category_aro_accession": "3000670", "category_aro_cvterm_id": "37014", "category_aro_name": "pleuromutilin antibiotic", "category_aro_description": "Pleuromutilins are natural fungal products that target bacterial protein translation by binding the the 23S rRNA, blocking the ribosome P site at the 50S subunit. They are mostly used for agriculture and veterinary purposes.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.507179, "max_identities": 13, "bit_score": 28.8758, "cvterm_id": "35508", "query": "LEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVV", "match": "L++Y  + I + G +GSGKTT L+++        G+V", "sequence_from_db": "LKIYQNDRIGLIGKNGSGKTTLLHILYKKIVPEEGIV", "sequence_from_broadstreet": "MKIMLEGLNIKHYVQDRLLLNINRLKIYQNDRIGLIGKNGSGKTTLLHILYKKIVPEEGIVKQFSHCELIPQLKLIESTKSGGEVTRNYIRQALDKNPELLLADEPTTNLDNNYIEKLEQDLKNWHGAFIIVSHDRAFLDNLCTTIWEIDEGRITEYKGNYSNYVEQKELERHREELEYEKYEKEKKRLEKAINIKEQKAQRATKKPKNLSLSEGKIKGAKPYFAGKQKKLRKTVKSLETRLEKLESVEKRNELPPLKMDLVNLESVKNRTIIRGEDVSGTIEGRVLWKAKSFSIRGGDKMAIIGSNGTGKTTFIKKIVHGNPGISLSPSVKIGYFSQKIDTLELDKSILENVQSSSQQNETLIRTILARMHFFRDDVYKPISVLSGGERVKVALTKVFLSEVNTLVLDEPTNFLDMEAIEAFESLLKEYNGSIIFVSHDRKFIEKVATRIMTIDNKEIKIFDGTYEQFKQAEKPTRNIKEDKKLLLETKITEVLSRLSIEPSEELEQEFQNLINEKRNLDK", "dna_sequence_from_broadstreet": "ATGAAAATAATGTTAGAGGGACTTAATATAAAACATTATGTTCAAGATCGTTTATTGTTGAACATAAATCGCCTAAAGATTTATCAGAATGATCGTATTGGTTTAATTGGTAAAAATGGAAGTGGAAAAACAACGTTACTTCACATATTATATAAAAAAATTGTGCCTGAAGAAGGTATTGTAAAACAATTTTCACATTGTGAACTTATTCCTCAATTGAAGCTCATAGAATCAACTAAAAGTGGTGGTGAAGTAACACGAAACTATATTCGGCAAGCGCTTGATAAAAATCCAGAACTGCTATTAGCAGATGAACCAACAACTAACTTAGATAATAACTATATAGAAAAATTAGAACAGGATTTAAAAAATTGGCATGGAGCATTTATTATAGTTTCACATGATCGCGCTTTTTTAGATAACTTGTGTACTACTATATGGGAAATTGACGAGGGAAGAATAACTGAATATAAGGGGAATTATAGTAACTATGTTGAACAAAAAGAATTAGAAAGACATCGAGAAGAATTAGAATATGAAAAATATGAAAAAGAAAAGAAACGATTGGAAAAAGCTATAAATATAAAAGAACAGAAAGCTCAACGAGCAACTAAAAAACCGAAAAACTTAAGTTTATCTGAAGGCAAAATAAAAGGAGCAAAGCCATACTTTGCAGGTAAGCAAAAGAAGTTACGAAAAACTGTAAAATCTCTAGAAACCAGACTAGAAAAACTTGAAAGCGTCGAAAAGAGAAACGAACTTCCTCCACTTAAAATGGATTTAGTGAACTTAGAAAGTGTAAAAAATAGAACTATAATACGTGGTGAAGATGTCTCGGGTACAATTGAAGGACGGGTATTGTGGAAAGCAAAAAGTTTTAGTATTCGCGGAGGAGACAAGATGGCAATTATCGGATCTAATGGTACAGGAAAGACAACGTTTATTAAAAAAATTGTGCATGGGAATCCTGGTATTTCATTATCGCCATCTGTCAAAATCGGTTATTTTAGCCAAAAAATAGATACATTAGAATTAGATAAGAGCATTTTAGAAAATGTTCAATCTTCTTCACAACAAAATGAAACTCTTATTCGAACTATTCTAGCTAGAATGCATTTTTTTAGAGATGATGTTTATAAACCAATAAGTGTCTTAAGTGGTGGAGAGCGAGTTAAAGTAGCACTAACTAAAGTATTCTTAAGTGAAGTTAATACGTTGGTACTAGATGAACCAACAAACTTTCTTGATATGGAAGCTATAGAGGCGTTTGAATCTTTGTTAAAGGAATATAATGGCAGTATAATCTTTGTATCTCACGATCGTAAATTTATCGAAAAAGTAGCCACTCGAATAATGACAATTGATAATAAAGAAATAAAAATATTTGATGGCACATATGAACAATTTAAACAAGCTGAAAAGCCAACAAGGAATATTAAAGAAGATAAAAAACTTTTACTTGAGACAAAAATTACAGAAGTACTCAGTCGATTGAGTATTGAACCTTCGGAAGAATTAGAACAAGAGTTTCAAAACTTAATAAATGAAAAAAGAAATTTGGATAAATAA", "partial": "0", "query_start": 51433, "query_end": 51543, "hit_start": 72, "hit_end": 183, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 35.14}, "gnl|BL_ORD_ID|1678|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "vgaB", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1080", "model_id": "1817", "ARO_accession": "3000118", "ARO_name": "vgaB", "ARO_category": {"36252": {"category_aro_accession": "3000113", "category_aro_cvterm_id": "36252", "category_aro_name": "vga-type ABC-F protein", "category_aro_description": "Vga-type plasmid-borne ABC-F proteins, expressed in staphylococci that confer resistance to streptogramin A antibiotics through ribosomal protection.", "category_aro_class_name": "AMR Gene Family"}, "37013": {"category_aro_accession": "3000669", "category_aro_cvterm_id": "37013", "category_aro_name": "virginiamycin M1", "category_aro_description": "Virginiamycin M1 is a streptogramin A antibiotic.", "category_aro_class_name": "Antibiotic"}, "37018": {"category_aro_accession": "3000674", "category_aro_cvterm_id": "37018", "category_aro_name": "dalfopristin", "category_aro_description": "Dalfopristin is a water-soluble semi-synthetic derivative of pristinamycin IIA. It is produced by Streptomyces pristinaespiralis and is used in combination with quinupristin in a 7:3 ratio. Both work together to inhibit protein synthesis, and is active against Gram-positive bacteria.", "category_aro_class_name": "Antibiotic"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35952": {"category_aro_accession": "0000034", "category_aro_cvterm_id": "35952", "category_aro_name": "streptogramin A antibiotic", "category_aro_description": "Streptogramin A antibiotics are cyclic polyketide peptide hybrids that bind to the ribosomal peptidyl transfer centre. Structural variation arises from substituting a proline for its desaturated derivative and by its substitution for Ala or Cys. Used alone, streptogramin A antibiotics are bacteriostatic, but is bactericidal when used with streptogramin B antibiotics.", "category_aro_class_name": "Drug Class"}, "37014": {"category_aro_accession": "3000670", "category_aro_cvterm_id": "37014", "category_aro_name": "pleuromutilin antibiotic", "category_aro_description": "Pleuromutilins are natural fungal products that target bacterial protein translation by binding the the 23S rRNA, blocking the ribosome P site at the 50S subunit. They are mostly used for agriculture and veterinary purposes.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.12158e-07, "max_identities": 48, "bit_score": 48.521, "cvterm_id": "35508", "query": "LEVYPGEFISIAGPSGSGKTTALNLI-GCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHD--------AKVMTHANAVVRLADGKILDRITPAE", "match": "L++Y G+ I I G +G GKTT L +I G ++     ++  +    K +++ +  H ++    +           S+FQ       ++ K N                         + +SGG++ R  +A     +  L+L DEPT+NLD + G   I+L+    ++   TF+  +HD         K+    N  +R   G   + I   E", "sequence_from_db": "LKIYSGDKIGIVGKNGVGKTTLLKIIKGLIEIDEGNIIISEKTTIKYISQLEEPHSKIIDGKY----------ASIFQ-------VENKWN-------------------------DNMSGGEKTRFKLAEGFQDQCSLMLVDEPTSNLD-IEG---IELITNTFKEYRDTFLVVSHDRIFLDQVCTKIFEIENGYIREFIGNYTNYIEQKE", "sequence_from_broadstreet": "MLKIDMKNVKKYYADKLILNIKELKIYSGDKIGIVGKNGVGKTTLLKIIKGLIEIDEGNIIISEKTTIKYISQLEEPHSKIIDGKYASIFQVENKWNDNMSGGEKTRFKLAEGFQDQCSLMLVDEPTSNLDIEGIELITNTFKEYRDTFLVVSHDRIFLDQVCTKIFEIENGYIREFIGNYTNYIEQKEMLLRKQQEEYEKYNSKRKQLEQAIKLKENKAQGMIKPPSKTMGTSESRIWKMQHATKQKKMHRNTKSLETRIDKLNHVEKIKELPSIKMDLPNREQFHGRNVISLKNLSIKFNNQFLWRDASFVIKGGEKVAIIGNNGVGKTTLLKLILEKVESVIISPSVKIGYVSQNLDVLQSHKSILENVMSTSIQDETIARIVLARLHFYRNDVHKEINVLSGGEQIKVAFAKLFVSDCNTLILDEPTNYLDIDAVEALEELLITYEGVVLFASHDKKFIQNLAEQLLIIENNKVKKFEGTYIEYLKIKDKPKLNTNEKELKEKKMILEMQISSLLSKISMEENEEKNKELDEKYKLKLKELKSLNKNI", "dna_sequence_from_broadstreet": "ATGCTTAAAATCGACATGAAGAATGTAAAAAAATATTATGCAGATAAATTAATTTTAAATATAAAAGAACTAAAGATTTATAGTGGGGATAAAATAGGTATTGTAGGTAAGAATGGAGTTGGCAAAACAACACTTTTAAAAATAATAAAAGGACTAATAGAGATTGACGAAGGAAATATAATTATAAGTGAAAAAACAACTATTAAATATATCTCTCAATTAGAAGAACCACATAGTAAGATAATTGATGGAAAATATGCTTCAATATTTCAAGTTGAAAATAAGTGGAATGACAATATGAGTGGTGGTGAAAAAACTAGATTTAAACTAGCAGAGGGATTTCAAGATCAATGTTCTTTAATGCTCGTAGATGAACCTACAAGTAATTTAGATATCGAAGGAATAGAGTTGATAACAAATACTTTTAAAGAGTACCGTGATACTTTTTTGGTAGTATCTCATGATAGAATTTTTTTAGATCAAGTTTGTACAAAAATTTTTGAAATTGAAAATGGATATATTAGAGAATTCATCGGTAATTATACAAACTATATAGAGCAAAAAGAAATGCTTCTACGAAAGCAACAAGAAGAATACGAAAAGTATAATTCTAAAAGAAAGCAATTGGAGCAAGCTATAAAGCTAAAAGAGAATAAGGCGCAAGGAATGATTAAGCCCCCTTCAAAAACAATGGGAACATCTGAATCTAGAATATGGAAAATGCAACATGCTACTAAACAAAAAAAGATGCATAGAAATACGAAATCGTTGGAAACACGAATAGATAAATTAAATCATGTAGAAAAAATAAAAGAGCTTCCTTCTATTAAAATGGATTTACCTAATAGAGAGCAATTTCATGGTCGCAATGTAATTAGTTTAAAAAACTTATCTATAAAATTTAATAATCAATTTCTTTGGAGAGATGCTTCATTTGTCATTAAAGGTGGAGAAAAGGTTGCTATAATTGGTAACAATGGTGTAGGAAAAACAACATTGTTGAAGCTGATTCTAGAAAAAGTAGAATCAGTAATAATATCACCATCAGTTAAAATTGGATACGTCAGTCAAAACTTAGATGTTCTACAATCTCATAAATCTATCTTAGAAAATGTTATGTCTACCTCCATTCAAGATGAAACAATAGCAAGAATTGTTCTAGCAAGATTACATTTTTATCGCAATGATGTTCATAAAGAAATAAATGTTTTGAGTGGTGGAGAACAAATAAAGGTTGCTTTTGCCAAGCTATTTGTTAGCGATTGTAATACATTAATTCTTGATGAACCAACAAACTATTTGGATATCGATGCTGTTGAGGCATTAGAAGAATTGTTAATTACCTATGAAGGTGTTGTGTTATTTGCTTCCCATGATAAAAAATTTATACAAAACCTAGCTGAACAATTGTTAATAATAGAAAATAATAAAGTGAAAAAATTCGAAGGAACATATATAGAATATTTAAAAATTAAAGATAAACCAAAATTAAATACAAATGAAAAAGAACTCAAAGAAAAAAAGATGATACTAGAAATGCAAATTTCATCATTATTAAGTAAAATCTCAATGGAAGAAAATGAAGAAAAAAACAAAGAATTAGATGAAAAGTACAAATTGAAATTAAAAGAATTGAAAAGCCTAAATAAAAATATTTAA", "partial": "0", "query_start": 51433, "query_end": 52041, "hit_start": 69, "hit_end": 567, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 22.64}, "gnl|BL_ORD_ID|1678|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "vgaB", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1080", "model_id": "1817", "ARO_accession": "3000118", "ARO_name": "vgaB", "ARO_category": {"36252": {"category_aro_accession": "3000113", "category_aro_cvterm_id": "36252", "category_aro_name": "vga-type ABC-F protein", "category_aro_description": "Vga-type plasmid-borne ABC-F proteins, expressed in staphylococci that confer resistance to streptogramin A antibiotics through ribosomal protection.", "category_aro_class_name": "AMR Gene Family"}, "37013": {"category_aro_accession": "3000669", "category_aro_cvterm_id": "37013", "category_aro_name": "virginiamycin M1", "category_aro_description": "Virginiamycin M1 is a streptogramin A antibiotic.", "category_aro_class_name": "Antibiotic"}, "37018": {"category_aro_accession": "3000674", "category_aro_cvterm_id": "37018", "category_aro_name": "dalfopristin", "category_aro_description": "Dalfopristin is a water-soluble semi-synthetic derivative of pristinamycin IIA. It is produced by Streptomyces pristinaespiralis and is used in combination with quinupristin in a 7:3 ratio. Both work together to inhibit protein synthesis, and is active against Gram-positive bacteria.", "category_aro_class_name": "Antibiotic"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35952": {"category_aro_accession": "0000034", "category_aro_cvterm_id": "35952", "category_aro_name": "streptogramin A antibiotic", "category_aro_description": "Streptogramin A antibiotics are cyclic polyketide peptide hybrids that bind to the ribosomal peptidyl transfer centre. Structural variation arises from substituting a proline for its desaturated derivative and by its substitution for Ala or Cys. Used alone, streptogramin A antibiotics are bacteriostatic, but is bactericidal when used with streptogramin B antibiotics.", "category_aro_class_name": "Drug Class"}, "37014": {"category_aro_accession": "3000670", "category_aro_cvterm_id": "37014", "category_aro_name": "pleuromutilin antibiotic", "category_aro_description": "Pleuromutilins are natural fungal products that target bacterial protein translation by binding the the 23S rRNA, blocking the ribosome P site at the 50S subunit. They are mostly used for agriculture and veterinary purposes.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.94833e-06, "max_identities": 56, "bit_score": 45.0542, "cvterm_id": "35508", "query": "LRFAERIQTIMSQVTALPGSTQ----PIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLV-SVLSVFQNVEFPLLLQRKLNAS-ERRTRVMTLLEQVGLEKHAKHRP-NELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTH", "match": "L   E+I+ + S    LP   Q     ++SL  ++  ++         R  +  +  GE ++I G +G GKTT L LI  ++   S ++S   +                 IG++ Q+ +++ S  S+ +NV         ++ S +  T    +L ++   ++  H+  N LSGG++ +VA A+  V+    ++ DEPT  LD     + ++ ++EL        +F++HD K + +", "sequence_from_db": "LNHVEKIKELPSIKMDLPNREQFHGRNVISLKNLSIKFN----NQFLWRDASFVIKGGEKVAIIGNNGVGKTTLLKLI--LEKVESVIISPSVK-----------------IGYVSQNLDVLQSHKSILENV---------MSTSIQDETIARIVLARLHFYRNDVHKEINVLSGGEQIKVAFAKLFVSDCNTLILDEPTNYLDI----DAVEALEELLITYEGVVLFASHDKKFIQN", "sequence_from_broadstreet": "MLKIDMKNVKKYYADKLILNIKELKIYSGDKIGIVGKNGVGKTTLLKIIKGLIEIDEGNIIISEKTTIKYISQLEEPHSKIIDGKYASIFQVENKWNDNMSGGEKTRFKLAEGFQDQCSLMLVDEPTSNLDIEGIELITNTFKEYRDTFLVVSHDRIFLDQVCTKIFEIENGYIREFIGNYTNYIEQKEMLLRKQQEEYEKYNSKRKQLEQAIKLKENKAQGMIKPPSKTMGTSESRIWKMQHATKQKKMHRNTKSLETRIDKLNHVEKIKELPSIKMDLPNREQFHGRNVISLKNLSIKFNNQFLWRDASFVIKGGEKVAIIGNNGVGKTTLLKLILEKVESVIISPSVKIGYVSQNLDVLQSHKSILENVMSTSIQDETIARIVLARLHFYRNDVHKEINVLSGGEQIKVAFAKLFVSDCNTLILDEPTNYLDIDAVEALEELLITYEGVVLFASHDKKFIQNLAEQLLIIENNKVKKFEGTYIEYLKIKDKPKLNTNEKELKEKKMILEMQISSLLSKISMEENEEKNKELDEKYKLKLKELKSLNKNI", "dna_sequence_from_broadstreet": "ATGCTTAAAATCGACATGAAGAATGTAAAAAAATATTATGCAGATAAATTAATTTTAAATATAAAAGAACTAAAGATTTATAGTGGGGATAAAATAGGTATTGTAGGTAAGAATGGAGTTGGCAAAACAACACTTTTAAAAATAATAAAAGGACTAATAGAGATTGACGAAGGAAATATAATTATAAGTGAAAAAACAACTATTAAATATATCTCTCAATTAGAAGAACCACATAGTAAGATAATTGATGGAAAATATGCTTCAATATTTCAAGTTGAAAATAAGTGGAATGACAATATGAGTGGTGGTGAAAAAACTAGATTTAAACTAGCAGAGGGATTTCAAGATCAATGTTCTTTAATGCTCGTAGATGAACCTACAAGTAATTTAGATATCGAAGGAATAGAGTTGATAACAAATACTTTTAAAGAGTACCGTGATACTTTTTTGGTAGTATCTCATGATAGAATTTTTTTAGATCAAGTTTGTACAAAAATTTTTGAAATTGAAAATGGATATATTAGAGAATTCATCGGTAATTATACAAACTATATAGAGCAAAAAGAAATGCTTCTACGAAAGCAACAAGAAGAATACGAAAAGTATAATTCTAAAAGAAAGCAATTGGAGCAAGCTATAAAGCTAAAAGAGAATAAGGCGCAAGGAATGATTAAGCCCCCTTCAAAAACAATGGGAACATCTGAATCTAGAATATGGAAAATGCAACATGCTACTAAACAAAAAAAGATGCATAGAAATACGAAATCGTTGGAAACACGAATAGATAAATTAAATCATGTAGAAAAAATAAAAGAGCTTCCTTCTATTAAAATGGATTTACCTAATAGAGAGCAATTTCATGGTCGCAATGTAATTAGTTTAAAAAACTTATCTATAAAATTTAATAATCAATTTCTTTGGAGAGATGCTTCATTTGTCATTAAAGGTGGAGAAAAGGTTGCTATAATTGGTAACAATGGTGTAGGAAAAACAACATTGTTGAAGCTGATTCTAGAAAAAGTAGAATCAGTAATAATATCACCATCAGTTAAAATTGGATACGTCAGTCAAAACTTAGATGTTCTACAATCTCATAAATCTATCTTAGAAAATGTTATGTCTACCTCCATTCAAGATGAAACAATAGCAAGAATTGTTCTAGCAAGATTACATTTTTATCGCAATGATGTTCATAAAGAAATAAATGTTTTGAGTGGTGGAGAACAAATAAAGGTTGCTTTTGCCAAGCTATTTGTTAGCGATTGTAATACATTAATTCTTGATGAACCAACAAACTATTTGGATATCGATGCTGTTGAGGCATTAGAAGAATTGTTAATTACCTATGAAGGTGTTGTGTTATTTGCTTCCCATGATAAAAAATTTATACAAAACCTAGCTGAACAATTGTTAATAATAGAAAATAATAAAGTGAAAAAATTCGAAGGAACATATATAGAATATTTAAAAATTAAAGATAAACCAAAATTAAATACAAATGAAAAAGAACTCAAAGAAAAAAAGATGATACTAGAAATGCAAATTTCATCATTATTAAGTAAAATCTCAATGGAAGAAAATGAAGAAAAAAACAAAGAATTAGATGAAAAGTACAAATTGAAATTAAAAGAATTGAAAAGCCTAAATAAAAATATTTAA", "partial": "0", "query_start": 51289, "query_end": 51981, "hit_start": 789, "hit_end": 1395, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 23.53}, "gnl|BL_ORD_ID|1105|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "msrA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "800", "model_id": "1200", "ARO_accession": "3000251", "ARO_name": "msrA", "ARO_category": {"41695": {"category_aro_accession": "3004471", "category_aro_cvterm_id": "41695", "category_aro_name": "msr-type ABC-F protein", "category_aro_description": "msr-type ABC-F subfamily ribosomal protection proteins expression in Staphylococci species and confer resistance to erythromycin and streptogramin B antibiotics through antibiotic target protection mechanisms.", "category_aro_class_name": "AMR Gene Family"}, "35925": {"category_aro_accession": "0000006", "category_aro_cvterm_id": "35925", "category_aro_name": "erythromycin", "category_aro_description": "Erythromycin is a macrolide antibiotic with a 14-carbon ring that has an antimicrobial spectrum similar to or slightly wider than that of penicillin, and is often used for people that have an allergy to penicillins. Erythromycin may possess bacteriocidal activity, particularly at higher concentrations by binding to the 50S subunit of the bacterial 70S rRNA complex, inhibiting peptidyl-tRNA translocation. Thus, protein synthesis and subsequently structure/function processes critical for life or replication are inhibited.", "category_aro_class_name": "Antibiotic"}, "36723": {"category_aro_accession": "3000584", "category_aro_cvterm_id": "36723", "category_aro_name": "quinupristin", "category_aro_description": "Quinupristin is a type B streptogramin and a semisynthetic derivative of pristinamycin 1A. It is a component of the drug Synercid and interacts with the 50S subunit of the bacterial ribosome to inhibit protein synthesis.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35967": {"category_aro_accession": "0000050", "category_aro_cvterm_id": "35967", "category_aro_name": "streptogramin B antibiotic", "category_aro_description": "Streptogramin B antibiotics are are cyclic hepta- or hexa-depsipeptides.  Type B streptogramins block the peptide exit tunnel of the 50S bacterial ribosome. The general composition of group B streptogramins is 3-hydroxypicolinic acid-L-Thr-D-aminobutyric acid (or D-Ala)-L-Pro-L-Phe (or 4-N-,N-(dimethylamino)-L-Phe)-X-L-phenylglycine. Used alone, streptogramin B antibiotics are bacteriostatic, but is bactericidal when used with streptogramin A antibiotics.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.96122e-07, "max_identities": 46, "bit_score": 48.1358, "cvterm_id": "36868", "query": "LRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTH", "match": "L  V  ++  G+ I++ G +G GKTT L  I            ++G D     + Q+ + R       ++    VS+L           L  + ++SE  +R   +L  +GL +  +   N LSGG+R ++++A    T+  +++ DEPT  LD  T    ++ ++    K     +F++HD + + H", "sequence_from_db": "LTQVRFQIPYGKNIALVGANGVGKTTLLEAI---------YHQIEGIDCS--PKVQMAYYR----QLAYEDMRDVSLLQY---------LMDETDSSESFSRA--ILNNLGLNEALERSCNVLSGGERTKLSLAVLFSTKANMLILDEPTNFLDIKT----LEALEMFMNKYPGIILFTSHDTRFVKH", "sequence_from_broadstreet": "MEQYTIKFNQINHKLTDLRSLNIDHLYAYQFEKIALIGGNGTGKTTLLNMIAQKTKPESGTVETNGEIQYFEQLNMDVENDFNTLDGSLMSELHIPMHTTDSMSGGEKAKYKLRNVISNYSPILLLDEPTNHLDKIGKDYLNNILKYYYGTLIIVSHDRALIDQIADTIWDIQEDGTIRVFKGNYTQYQNQYEQEQLEQQRKYEQYISEKQRLSQASKAKRNQAQQMAQASSKQKNKSIAPDRLSASKEKGTVEKAAQKQAKHIEKRMEHLEEVEKPQSYHEFNFPQNKIYDIHNNYPIIAQNLTLVKGSQKLLTQVRFQIPYGKNIALVGANGVGKTTLLEAIYHQIEGIDCSPKVQMAYYRQLAYEDMRDVSLLQYLMDETDSSESFSRAILNNLGLNEALERSCNVLSGGERTKLSLAVLFSTKANMLILDEPTNFLDIKTLEALEMFMNKYPGIILFTSHDTRFVKHVSDKKWELTGQSIHDIT", "dna_sequence_from_broadstreet": "ATGGAACAATATACAATTAAATTTAACCAAATCAATCATAAATTGACAGATTTACGATCACTTAACATCGATCATCTTTATGCTTACCAATTTGAAAAAATAGCACTTATTGGGGGTAATGGTACTGGTAAAACCACATTACTAAATATGATTGCTCAAAAAACAAAACCAGAATCTGGAACAGTTGAAACGAATGGCGAAATTCAATATTTTGAACAGCTTAACATGGATGTGGAAAATGATTTTAACACGTTAGACGGTAGTTTAATGAGTGAACTCCATATACCTATGCATACAACCGACAGTATGAGTGGTGGTGAAAAAGCAAAATATAAATTACGTAATGTCATATCAAATTATAGTCCGATATTACTTTTAGATGAACCTACAAATCACTTGGATAAAATTGGTAAAGATTATCTGAATAATATTTTAAAATATTACTATGGTACTTTAATTATAGTAAGTCACGATAGAGCACTTATAGACCAAATTGCTGACACAATTTGGGATATACAAGAAGATGGCACAATAAGAGTGTTTAAAGGTAATTACACACAGTATCAAAATCAATATGAACAAGAACAGTTAGAACAACAACGTAAATATGAACAGTATATAAGTGAAAAACAAAGATTGTCCCAAGCCAGTAAAGCTAAACGAAATCAAGCGCAACAAATGGCACAAGCATCATCAAAACAAAAAAATAAAAGTATAGCACCAGATCGTTTAAGTGCATCAAAAGAAAAAGGCACGGTTGAGAAGGCTGCTCAAAAACAAGCTAAGCATATTGAAAAAAGAATGGAACATTTGGAAGAAGTTGAAAAACCACAAAGTTATCATGAATTCAATTTTCCACAAAATAAAATTTATGATATCCATAATAATTATCCAATCATTGCACAAAATCTAACATTGGTTAAAGGAAGTCAAAAACTGCTAACACAAGTACGATTCCAAATACCATATGGCAAAAATATAGCGCTCGTAGGTGCAAATGGTGTAGGTAAGACAACTTTACTTGAAGCTATTTACCACCAAATAGAGGGAATTGATTGTTCTCCTAAAGTGCAAATGGCATACTATCGTCAACTTGCTTATGAAGACATGCGTGACGTTTCATTATTGCAATATTTAATGGATGAAACGGATTCATCAGAATCATTCAGTAGAGCTATTTTAAATAACTTGGGTTTAAATGAAGCACTTGAGCGTTCTTGTAATGTTTTGAGTGGTGGGGAAAGAACGAAATTATCGTTAGCAGTATTATTTTCAACGAAAGCGAATATGTTAATTTTGGATGAACCAACTAATTTTTTAGATATTAAAACATTAGAAGCATTAGAAATGTTTATGAATAAATATCCTGGAATCATTTTGTTTACATCACATGATACAAGGTTTGTTAAACATGTATCAGATAAAAAATGGGAATTAACAGGACAATCTATTCATGATATAACTTAA", "partial": "0", "query_start": 51418, "query_end": 51981, "hit_start": 939, "hit_end": 1413, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 24.47}, "gnl|BL_ORD_ID|1105|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "msrA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "800", "model_id": "1200", "ARO_accession": "3000251", "ARO_name": "msrA", "ARO_category": {"41695": {"category_aro_accession": "3004471", "category_aro_cvterm_id": "41695", "category_aro_name": "msr-type ABC-F protein", "category_aro_description": "msr-type ABC-F subfamily ribosomal protection proteins expression in Staphylococci species and confer resistance to erythromycin and streptogramin B antibiotics through antibiotic target protection mechanisms.", "category_aro_class_name": "AMR Gene Family"}, "35925": {"category_aro_accession": "0000006", "category_aro_cvterm_id": "35925", "category_aro_name": "erythromycin", "category_aro_description": "Erythromycin is a macrolide antibiotic with a 14-carbon ring that has an antimicrobial spectrum similar to or slightly wider than that of penicillin, and is often used for people that have an allergy to penicillins. Erythromycin may possess bacteriocidal activity, particularly at higher concentrations by binding to the 50S subunit of the bacterial 70S rRNA complex, inhibiting peptidyl-tRNA translocation. Thus, protein synthesis and subsequently structure/function processes critical for life or replication are inhibited.", "category_aro_class_name": "Antibiotic"}, "36723": {"category_aro_accession": "3000584", "category_aro_cvterm_id": "36723", "category_aro_name": "quinupristin", "category_aro_description": "Quinupristin is a type B streptogramin and a semisynthetic derivative of pristinamycin 1A. It is a component of the drug Synercid and interacts with the 50S subunit of the bacterial ribosome to inhibit protein synthesis.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35967": {"category_aro_accession": "0000050", "category_aro_cvterm_id": "35967", "category_aro_name": "streptogramin B antibiotic", "category_aro_description": "Streptogramin B antibiotics are are cyclic hepta- or hexa-depsipeptides.  Type B streptogramins block the peptide exit tunnel of the 50S bacterial ribosome. The general composition of group B streptogramins is 3-hydroxypicolinic acid-L-Thr-D-aminobutyric acid (or D-Ala)-L-Pro-L-Phe (or 4-N-,N-(dimethylamino)-L-Phe)-X-L-phenylglycine. Used alone, streptogramin B antibiotics are bacteriostatic, but is bactericidal when used with streptogramin A antibiotics.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000136451, "max_identities": 39, "bit_score": 40.0466, "cvterm_id": "36868", "query": "LEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHD", "match": "L  Y  E I++ G +G+GKTT LN+I       SG V  +G+                 I + F+  N+  V + F  ++  L+ +  +                       H  + +SGG++ +  +   +     ++L DEPT +LD +      D +  + +    T I  +HD", "sequence_from_db": "LYAYQFEKIALIGGNGTGKTTLLNMIAQKTKPESGTVETNGE-----------------IQY-FEQLNM-DVENDFNTLDGSLMSELHI---------------------PMHTTDSMSGGEKAKYKLRNVISNYSPILLLDEPTNHLDKIGK----DYLNNILKYYYGTLIIVSHD", "sequence_from_broadstreet": "MEQYTIKFNQINHKLTDLRSLNIDHLYAYQFEKIALIGGNGTGKTTLLNMIAQKTKPESGTVETNGEIQYFEQLNMDVENDFNTLDGSLMSELHIPMHTTDSMSGGEKAKYKLRNVISNYSPILLLDEPTNHLDKIGKDYLNNILKYYYGTLIIVSHDRALIDQIADTIWDIQEDGTIRVFKGNYTQYQNQYEQEQLEQQRKYEQYISEKQRLSQASKAKRNQAQQMAQASSKQKNKSIAPDRLSASKEKGTVEKAAQKQAKHIEKRMEHLEEVEKPQSYHEFNFPQNKIYDIHNNYPIIAQNLTLVKGSQKLLTQVRFQIPYGKNIALVGANGVGKTTLLEAIYHQIEGIDCSPKVQMAYYRQLAYEDMRDVSLLQYLMDETDSSESFSRAILNNLGLNEALERSCNVLSGGERTKLSLAVLFSTKANMLILDEPTNFLDIKTLEALEMFMNKYPGIILFTSHDTRFVKHVSDKKWELTGQSIHDIT", "dna_sequence_from_broadstreet": "ATGGAACAATATACAATTAAATTTAACCAAATCAATCATAAATTGACAGATTTACGATCACTTAACATCGATCATCTTTATGCTTACCAATTTGAAAAAATAGCACTTATTGGGGGTAATGGTACTGGTAAAACCACATTACTAAATATGATTGCTCAAAAAACAAAACCAGAATCTGGAACAGTTGAAACGAATGGCGAAATTCAATATTTTGAACAGCTTAACATGGATGTGGAAAATGATTTTAACACGTTAGACGGTAGTTTAATGAGTGAACTCCATATACCTATGCATACAACCGACAGTATGAGTGGTGGTGAAAAAGCAAAATATAAATTACGTAATGTCATATCAAATTATAGTCCGATATTACTTTTAGATGAACCTACAAATCACTTGGATAAAATTGGTAAAGATTATCTGAATAATATTTTAAAATATTACTATGGTACTTTAATTATAGTAAGTCACGATAGAGCACTTATAGACCAAATTGCTGACACAATTTGGGATATACAAGAAGATGGCACAATAAGAGTGTTTAAAGGTAATTACACACAGTATCAAAATCAATATGAACAAGAACAGTTAGAACAACAACGTAAATATGAACAGTATATAAGTGAAAAACAAAGATTGTCCCAAGCCAGTAAAGCTAAACGAAATCAAGCGCAACAAATGGCACAAGCATCATCAAAACAAAAAAATAAAAGTATAGCACCAGATCGTTTAAGTGCATCAAAAGAAAAAGGCACGGTTGAGAAGGCTGCTCAAAAACAAGCTAAGCATATTGAAAAAAGAATGGAACATTTGGAAGAAGTTGAAAAACCACAAAGTTATCATGAATTCAATTTTCCACAAAATAAAATTTATGATATCCATAATAATTATCCAATCATTGCACAAAATCTAACATTGGTTAAAGGAAGTCAAAAACTGCTAACACAAGTACGATTCCAAATACCATATGGCAAAAATATAGCGCTCGTAGGTGCAAATGGTGTAGGTAAGACAACTTTACTTGAAGCTATTTACCACCAAATAGAGGGAATTGATTGTTCTCCTAAAGTGCAAATGGCATACTATCGTCAACTTGCTTATGAAGACATGCGTGACGTTTCATTATTGCAATATTTAATGGATGAAACGGATTCATCAGAATCATTCAGTAGAGCTATTTTAAATAACTTGGGTTTAAATGAAGCACTTGAGCGTTCTTGTAATGTTTTGAGTGGTGGGGAAAGAACGAAATTATCGTTAGCAGTATTATTTTCAACGAAAGCGAATATGTTAATTTTGGATGAACCAACTAATTTTTTAGATATTAAAACATTAGAAGCATTAGAAATGTTTATGAATAAATATCCTGGAATCATTTTGTTTACATCACATGATACAAGGTTTGTTAAACATGTATCAGATAAAAAATGGGAATTAACAGGACAATCTATTCATGATATAACTTAA", "partial": "0", "query_start": 51433, "query_end": 51963, "hit_start": 75, "hit_end": 474, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 22.03}, "gnl|BL_ORD_ID|1272|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "oleB", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1100", "model_id": "1388", "ARO_accession": "3003036", "ARO_name": "oleB", "ARO_category": {"45630": {"category_aro_accession": "3007068", "category_aro_cvterm_id": "45630", "category_aro_name": "Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins", "category_aro_description": "ABC-F subfamily ATP-binding cassette ribosomal protection proteins of unknown, unclear or miscellaneous classification which nevertheless confer resistance to antibiotics through ribosomal protection and not through antibiotic efflux. These proteins should be further reviewed to elucidate associated genes, their function, origin and classification.", "category_aro_class_name": "AMR Gene Family"}, "37247": {"category_aro_accession": "3000867", "category_aro_cvterm_id": "37247", "category_aro_name": "oleandomycin", "category_aro_description": "Oleandomycin is a 14-membered macrolide produced by Streptomyces antibioticus. It is ssimilar to erythromycin, and contains a desosamine amino sugar and an oleandrose sugar. It targets the 50S ribosomal subunit to prevent protein synthesis.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.70966e-07, "max_identities": 56, "bit_score": 47.7506, "cvterm_id": "36823", "query": "PALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDG---------------QDT-KKLTERQLTHLRLHTIGFI--------FQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGK", "match": "P L GV   V  GE + I G +GSGK+T L ++  VD    G V V                 +DT +   +  L  LR    G           +   L  +L  + ++      +    A  R    M  L   G+      R   LSGG++ R+ +A  L   P+L+L DEPT +LD       ++ ++E  R    + +  +HD   +      +   DG+", "sequence_from_db": "PLLDGVNQSVALGERVGIIGENGSGKSTLLRMLAGVDRPDGGQVLVRAPGGCGYLPQTPDLPPEDTVQDAIDHALAELRSLERGLREAEQALAGAEPEELEGLLGAYGDLLEAFEARDGYAADARVDAAMHGLGLAGIT--GDRRLGSLSGGEQARLNLACLLAASPQLMLLDEPTNHLDV----GALEWLEERLRAHRGSVLVVSHDRVFLERVATALWEVDGE", "sequence_from_broadstreet": "MQNAHRSDTGAAALTGTPEKLLPTQPETGSFQVVLDDVVRAPGGRPLLDGVNQSVALGERVGIIGENGSGKSTLLRMLAGVDRPDGGQVLVRAPGGCGYLPQTPDLPPEDTVQDAIDHALAELRSLERGLREAEQALAGAEPEELEGLLGAYGDLLEAFEARDGYAADARVDAAMHGLGLAGITGDRRLGSLSGGEQARLNLACLLAASPQLMLLDEPTNHLDVGALEWLEERLRAHRGSVLVVSHDRVFLERVATALWEVDGERRTVNRHGGGYAGYLQAKAAARRRWEQAYQDWLEDLARQRELARSAADHLATGPRRNTERSNQRHQRNVEKQISARVRNAKERVRRLEENPVPRPPQPMRFRARVEGGGTVGRGGALAELYKVTVGTRLDVPSFTVDPGERILITGHNGAGKSTLLRVLAGDLAPDQGECERPERIGWLPQETEITDRQQSLLAAFAAGLPGIAEEHRGALLGFGLFRPSALGTAVGDLSTGQLRRLALARLLRDPADLLLLDEPTNHLSPALVEDLEEALAHYRGALVVVSHDRMFAQRFTGRRMHMEGGRFVE", "dna_sequence_from_broadstreet": "ATGCAGAACGCACACCGTTCCGATACCGGCGCCGCGGCGCTCACCGGCACGCCGGAAAAGCTCCTTCCCACGCAACCTGAGACCGGTTCCTTCCAGGTCGTCCTCGACGACGTCGTCCGGGCACCCGGCGGACGGCCGCTGTTGGACGGCGTCAACCAGTCGGTGGCACTCGGCGAGCGCGTCGGCATCATCGGTGAGAACGGATCGGGCAAGTCGACCCTGCTCCGCATGCTCGCCGGCGTGGACCGCCCGGACGGTGGCCAGGTCCTCGTCCGGGCTCCCGGCGGCTGCGGCTACCTCCCCCAGACACCGGACCTGCCCCCGGAGGACACCGTTCAGGACGCCATCGACCACGCCCTCGCCGAACTGCGCTCCCTGGAGCGGGGGTTGCGTGAGGCGGAGCAGGCGCTGGCCGGGGCGGAGCCCGAGGAGCTGGAGGGCCTGCTCGGCGCCTACGGCGACCTGCTGGAGGCGTTCGAGGCCCGCGACGGCTACGCGGCGGACGCCCGTGTCGACGCGGCGATGCACGGCCTCGGTCTGGCGGGCATCACGGGCGACCGGCGGCTCGGCAGCCTCTCCGGAGGTGAGCAGGCGCGTCTCAACCTGGCCTGCCTGCTGGCCGCGTCCCCGCAGCTGATGCTGCTCGACGAACCCACCAACCACCTCGACGTCGGGGCGCTGGAGTGGCTGGAGGAGCGCCTGCGGGCCCACCGCGGCAGCGTGCTGGTCGTCTCGCACGACCGGGTCTTCCTGGAGCGCGTGGCCACCGCCCTGTGGGAGGTGGACGGCGAGCGGCGCACCGTCAACCGGCACGGCGGCGGTTACGCGGGATACCTGCAAGCCAAGGCGGCCGCGCGGCGCCGCTGGGAGCAGGCTTACCAGGACTGGCTGGAGGACCTGGCACGCCAGCGGGAACTGGCCCGCAGCGCCGCCGACCACCTGGCCACCGGCCCGCGGCGCAACACCGAGCGGTCGAACCAGCGCCACCAGCGCAACGTGGAGAAGCAGATCTCCGCGCGGGTCCGCAACGCCAAGGAGCGGGTCCGCCGGCTGGAGGAGAACCCGGTGCCGCGGCCCCCTCAACCCATGCGTTTCCGGGCCCGGGTGGAGGGTGGCGGCACGGTCGGGCGCGGCGGGGCACTCGCCGAGCTGTACAAGGTCACCGTCGGCACGCGGCTCGACGTCCCGTCCTTCACCGTCGACCCCGGTGAGCGCATCCTGATCACGGGGCACAACGGCGCGGGCAAGAGCACCCTGCTGCGCGTGCTGGCCGGTGACCTGGCGCCCGATCAGGGCGAGTGCGAGCGCCCGGAGCGCATCGGCTGGCTGCCGCAGGAGACGGAGATCACCGACCGGCAGCAGAGCCTGCTGGCGGCCTTCGCGGCGGGGCTGCCCGGCATCGCGGAGGAACACCGGGGCGCGCTCCTGGGATTCGGGCTCTTCCGGCCCTCGGCGCTGGGCACCGCGGTGGGAGACCTGTCCACCGGGCAGTTGAGGCGGCTGGCCCTGGCCCGTCTGCTGCGCGACCCGGCGGACCTGCTGCTGCTCGACGAGCCGACGAACCACCTGTCGCCCGCGCTCGTGGAGGACCTGGAGGAGGCGCTGGCGCACTACCGGGGCGCACTGGTCGTGGTCTCCCACGACCGCATGTTCGCGCAGCGGTTCACCGGTCGCCGCATGCACATGGAGGGTGGCCGCTTCGTGGAGTGA", "partial": "0", "query_start": 51412, "query_end": 52014, "hit_start": 135, "hit_end": 792, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 24.89}, "gnl|BL_ORD_ID|1272|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "oleB", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1100", "model_id": "1388", "ARO_accession": "3003036", "ARO_name": "oleB", "ARO_category": {"45630": {"category_aro_accession": "3007068", "category_aro_cvterm_id": "45630", "category_aro_name": "Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins", "category_aro_description": "ABC-F subfamily ATP-binding cassette ribosomal protection proteins of unknown, unclear or miscellaneous classification which nevertheless confer resistance to antibiotics through ribosomal protection and not through antibiotic efflux. These proteins should be further reviewed to elucidate associated genes, their function, origin and classification.", "category_aro_class_name": "AMR Gene Family"}, "37247": {"category_aro_accession": "3000867", "category_aro_cvterm_id": "37247", "category_aro_name": "oleandomycin", "category_aro_description": "Oleandomycin is a 14-membered macrolide produced by Streptomyces antibioticus. It is ssimilar to erythromycin, and contains a desosamine amino sugar and an oleandrose sugar. It targets the 50S ribosomal subunit to prevent protein synthesis.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.959387, "max_identities": 24, "bit_score": 28.1054, "cvterm_id": "36823", "query": "EAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLI", "match": "E  P    P P +RF  R++   +             +L E+ K     ++ VP     +  V PGE I I G +G+GK+T L ++", "sequence_from_db": "EENPVPRPPQP-MRFRARVEGGGTVGRG--------GALAELYKVTVGTRLDVP-----SFTVDPGERILITGHNGAGKSTLLRVL", "sequence_from_broadstreet": "MQNAHRSDTGAAALTGTPEKLLPTQPETGSFQVVLDDVVRAPGGRPLLDGVNQSVALGERVGIIGENGSGKSTLLRMLAGVDRPDGGQVLVRAPGGCGYLPQTPDLPPEDTVQDAIDHALAELRSLERGLREAEQALAGAEPEELEGLLGAYGDLLEAFEARDGYAADARVDAAMHGLGLAGITGDRRLGSLSGGEQARLNLACLLAASPQLMLLDEPTNHLDVGALEWLEERLRAHRGSVLVVSHDRVFLERVATALWEVDGERRTVNRHGGGYAGYLQAKAAARRRWEQAYQDWLEDLARQRELARSAADHLATGPRRNTERSNQRHQRNVEKQISARVRNAKERVRRLEENPVPRPPQPMRFRARVEGGGTVGRGGALAELYKVTVGTRLDVPSFTVDPGERILITGHNGAGKSTLLRVLAGDLAPDQGECERPERIGWLPQETEITDRQQSLLAAFAAGLPGIAEEHRGALLGFGLFRPSALGTAVGDLSTGQLRRLALARLLRDPADLLLLDEPTNHLSPALVEDLEEALAHYRGALVVVSHDRMFAQRFTGRRMHMEGGRFVE", "dna_sequence_from_broadstreet": "ATGCAGAACGCACACCGTTCCGATACCGGCGCCGCGGCGCTCACCGGCACGCCGGAAAAGCTCCTTCCCACGCAACCTGAGACCGGTTCCTTCCAGGTCGTCCTCGACGACGTCGTCCGGGCACCCGGCGGACGGCCGCTGTTGGACGGCGTCAACCAGTCGGTGGCACTCGGCGAGCGCGTCGGCATCATCGGTGAGAACGGATCGGGCAAGTCGACCCTGCTCCGCATGCTCGCCGGCGTGGACCGCCCGGACGGTGGCCAGGTCCTCGTCCGGGCTCCCGGCGGCTGCGGCTACCTCCCCCAGACACCGGACCTGCCCCCGGAGGACACCGTTCAGGACGCCATCGACCACGCCCTCGCCGAACTGCGCTCCCTGGAGCGGGGGTTGCGTGAGGCGGAGCAGGCGCTGGCCGGGGCGGAGCCCGAGGAGCTGGAGGGCCTGCTCGGCGCCTACGGCGACCTGCTGGAGGCGTTCGAGGCCCGCGACGGCTACGCGGCGGACGCCCGTGTCGACGCGGCGATGCACGGCCTCGGTCTGGCGGGCATCACGGGCGACCGGCGGCTCGGCAGCCTCTCCGGAGGTGAGCAGGCGCGTCTCAACCTGGCCTGCCTGCTGGCCGCGTCCCCGCAGCTGATGCTGCTCGACGAACCCACCAACCACCTCGACGTCGGGGCGCTGGAGTGGCTGGAGGAGCGCCTGCGGGCCCACCGCGGCAGCGTGCTGGTCGTCTCGCACGACCGGGTCTTCCTGGAGCGCGTGGCCACCGCCCTGTGGGAGGTGGACGGCGAGCGGCGCACCGTCAACCGGCACGGCGGCGGTTACGCGGGATACCTGCAAGCCAAGGCGGCCGCGCGGCGCCGCTGGGAGCAGGCTTACCAGGACTGGCTGGAGGACCTGGCACGCCAGCGGGAACTGGCCCGCAGCGCCGCCGACCACCTGGCCACCGGCCCGCGGCGCAACACCGAGCGGTCGAACCAGCGCCACCAGCGCAACGTGGAGAAGCAGATCTCCGCGCGGGTCCGCAACGCCAAGGAGCGGGTCCGCCGGCTGGAGGAGAACCCGGTGCCGCGGCCCCCTCAACCCATGCGTTTCCGGGCCCGGGTGGAGGGTGGCGGCACGGTCGGGCGCGGCGGGGCACTCGCCGAGCTGTACAAGGTCACCGTCGGCACGCGGCTCGACGTCCCGTCCTTCACCGTCGACCCCGGTGAGCGCATCCTGATCACGGGGCACAACGGCGCGGGCAAGAGCACCCTGCTGCGCGTGCTGGCCGGTGACCTGGCGCCCGATCAGGGCGAGTGCGAGCGCCCGGAGCGCATCGGCTGGCTGCCGCAGGAGACGGAGATCACCGACCGGCAGCAGAGCCTGCTGGCGGCCTTCGCGGCGGGGCTGCCCGGCATCGCGGAGGAACACCGGGGCGCGCTCCTGGGATTCGGGCTCTTCCGGCCCTCGGCGCTGGGCACCGCGGTGGGAGACCTGTCCACCGGGCAGTTGAGGCGGCTGGCCCTGGCCCGTCTGCTGCGCGACCCGGCGGACCTGCTGCTGCTCGACGAGCCGACGAACCACCTGTCGCCCGCGCTCGTGGAGGACCTGGAGGAGGCGCTGGCGCACTACCGGGGCGCACTGGTCGTGGTCTCCCACGACCGCATGTTCGCGCAGCGGTTCACCGGTCGCCGCATGCACATGGAGGGTGGCCGCTTCGTGGAGTGA", "partial": "0", "query_start": 51253, "query_end": 51510, "hit_start": 1053, "hit_end": 1269, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 27.91}, "gnl|BL_ORD_ID|4726|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "salC", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5738", "ARO_accession": "3007027", "ARO_name": "salC", "ARO_category": {"45589": {"category_aro_accession": "3007030", "category_aro_cvterm_id": "45589", "category_aro_name": "sal-type ABC-F protein", "category_aro_description": "Sal proteins are a part of the ABC-F proteins, expressed in staphylococci that confer resistance to group A streptogramin, lincosamide, and pleuromutilin antibiotics through ribosomal protection.", "category_aro_class_name": "AMR Gene Family"}, "35964": {"category_aro_accession": "0000046", "category_aro_cvterm_id": "35964", "category_aro_name": "lincomycin", "category_aro_description": "Lincomycin is a lincosamide antibiotic that comes from the actinomyces Streptomyces lincolnensis. It binds to the 23s portion of the 50S subunit of bacterial ribosomes and inhibit early elongation of peptide chain by inhibiting transpeptidase reaction.", "category_aro_class_name": "Antibiotic"}, "35983": {"category_aro_accession": "0000066", "category_aro_cvterm_id": "35983", "category_aro_name": "clindamycin", "category_aro_description": "Clindamycin is a lincosamide antibiotic that blocks A-site aminoacyl-tRNA binding. It is usually used to treat infections with anaerobic bacteria but can also be used to treat some protozoal diseases, such as malaria.", "category_aro_class_name": "Antibiotic"}, "37013": {"category_aro_accession": "3000669", "category_aro_cvterm_id": "37013", "category_aro_name": "virginiamycin M1", "category_aro_description": "Virginiamycin M1 is a streptogramin A antibiotic.", "category_aro_class_name": "Antibiotic"}, "37015": {"category_aro_accession": "3000671", "category_aro_cvterm_id": "37015", "category_aro_name": "tiamulin", "category_aro_description": "Tiamulin is a pleuromutilin derivative currently used in veterinary medicine. It binds to the 23 rRNA of the 50S ribosomal subunit to inhibit protein translation.", "category_aro_class_name": "Antibiotic"}, "37713": {"category_aro_accession": "3001314", "category_aro_cvterm_id": "37713", "category_aro_name": "retapamulin", "category_aro_description": "Retapamulin is a semi-synthetic pleuromutilin antibiotic approved for the treatment of skin infections.", "category_aro_class_name": "Antibiotic"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35952": {"category_aro_accession": "0000034", "category_aro_cvterm_id": "35952", "category_aro_name": "streptogramin A antibiotic", "category_aro_description": "Streptogramin A antibiotics are cyclic polyketide peptide hybrids that bind to the ribosomal peptidyl transfer centre. Structural variation arises from substituting a proline for its desaturated derivative and by its substitution for Ala or Cys. Used alone, streptogramin A antibiotics are bacteriostatic, but is bactericidal when used with streptogramin B antibiotics.", "category_aro_class_name": "Drug Class"}, "37014": {"category_aro_accession": "3000670", "category_aro_cvterm_id": "37014", "category_aro_name": "pleuromutilin antibiotic", "category_aro_description": "Pleuromutilins are natural fungal products that target bacterial protein translation by binding the the 23S rRNA, blocking the ribosome P site at the 50S subunit. They are mostly used for agriculture and veterinary purposes.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.95473e-07, "max_identities": 52, "bit_score": 47.3654, "cvterm_id": "42526", "query": "IVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNE----LSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHD", "match": "+V    VT +Y+    + P    V+  +   + + I G +GSGK+T + LI    T   G V V              H  L  IG+  Q FN    L++   V   ++  +++  +E RT +             ++R N+    LS G++ R+   +   + P +++ DEPT   D    + II L++     +G+T I S HD", "sequence_from_db": "LVKFKNVTFSYN----EKPIFNDVSFHIKRNQNVIIEGQNGSGKSTLIKLILGQLTPDEGEVIV--------------HPELE-IGYFSQDFN---NLNMKNTVLEEIMSIQEMKEAEARTILANYY-------FNENRINDVVANLSMGEKCRIQFVKLYFSNPHILILDEPTNYFDIEMQEKIIQLIQSF---QGSTLIIS-HD", "sequence_from_broadstreet": "MLFLFEKKSLEIDNKLLIPSLTFIIEENEHLAIVGINGIGKSTLLNKIHHKENIETAMMEQDLTKYGTLNVMEYIMLTYPQLSSLRENLSDLDNINRYIELDGYEIEQNIIIEGKKLGLTERHFDQLISTLSGGEQTKVSFLKVKLDKARLLLIDEPTNHMDEEMKVWLTNAFKQEKRAILFVSHDKTFLNETPDAILELSSSGATKYSGQYDNYKQQKDLEYKTIKLQYEKQEKEQRAIEETIKKYKEWYQKASQKASVRNPYQQKQLSKLAKKFKSKEYQMNKKLEQTNLSDPEEEGKTFSMQHHAFKSHYLVKFKNVTFSYNEKPIFNDVSFHIKRNQNVIIEGQNGSGKSTLIKLILGQLTPDEGEVIVHPELEIGYFSQDFNNLNMKNTVLEEIMSIQEMKEAEARTILANYYFNENRINDVVANLSMGEKCRIQFVKLYFSNPHILILDEPTNYFDIEMQEKIIQLIQSFQGSTLIISHDKYFKEKLKDQIWTIKNLDLVHENLKIENPLNADSIKNQLNELEQYTDERNRETEF", "dna_sequence_from_broadstreet": "ATGCTATTTTTATTTGAAAAAAAGTCTTTAGAGATTGACAATAAACTGCTCATACCTTCACTAACATTTATTATTGAAGAAAATGAACATTTGGCAATAGTCGGCATAAATGGTATCGGAAAATCTACACTTTTAAATAAAATCCATCATAAAGAAAATATTGAAACAGCAATGATGGAACAAGATTTAACTAAATATGGAACTTTAAATGTCATGGAGTATATTATGTTAACTTATCCACAATTATCATCGTTAAGAGAAAATCTAAGTGATTTGGATAATATAAATAGATATATTGAATTAGACGGTTACGAAATTGAGCAAAACATTATAATTGAAGGAAAAAAGTTAGGATTAACAGAAAGGCACTTTGATCAATTAATTTCTACTTTAAGTGGTGGTGAGCAAACAAAAGTTTCGTTTTTGAAAGTTAAATTAGATAAAGCACGATTATTATTAATTGATGAACCAACTAACCATATGGATGAAGAAATGAAAGTATGGTTAACTAATGCATTTAAACAAGAAAAACGTGCAATATTATTTGTTTCTCACGATAAGACTTTTTTAAATGAAACACCAGACGCAATTTTGGAACTGAGTAGTAGTGGTGCAACAAAATACTCAGGTCAGTATGACAATTACAAGCAACAAAAAGATTTAGAATATAAAACGATTAAGCTACAATACGAAAAACAAGAAAAAGAGCAACGAGCAATTGAAGAAACAATTAAAAAATATAAAGAATGGTATCAAAAAGCTTCACAAAAAGCTTCAGTAAGAAATCCTTATCAACAAAAACAACTTAGCAAGCTTGCGAAAAAGTTTAAATCGAAAGAATATCAAATGAATAAAAAACTTGAACAAACCAATTTATCAGATCCTGAAGAGGAAGGAAAAACATTTTCAATGCAACATCACGCCTTCAAATCTCATTATTTAGTTAAATTTAAAAATGTGACATTTTCATATAATGAAAAGCCTATTTTTAATGATGTCTCTTTTCATATTAAGCGAAATCAAAATGTTATCATTGAAGGTCAAAATGGCTCAGGTAAATCTACTTTGATCAAGTTGATACTAGGTCAACTGACACCTGATGAGGGAGAAGTAATCGTACATCCTGAATTAGAAATAGGTTATTTTTCACAAGATTTTAATAACTTAAATATGAAAAATACTGTGTTAGAAGAAATAATGTCTATTCAAGAAATGAAAGAAGCGGAAGCAAGAACAATTTTAGCGAATTATTATTTTAATGAAAATAGAATTAATGATGTTGTTGCCAATTTATCTATGGGTGAAAAATGTAGAATACAGTTTGTTAAATTGTATTTTTCAAATCCACATATACTCATATTAGATGAGCCAACTAACTATTTTGATATTGAAATGCAAGAAAAAATCATACAATTAATTCAATCTTTTCAAGGATCAACACTTATCATTTCACATGATAAATATTTTAAAGAAAAGCTTAAAGATCAAATTTGGACAATAAAGAATCTAGATTTGGTACATGAAAATCTTAAAATTGAGAATCCATTAAATGCTGATTCTATTAAAAATCAATTAAATGAATTAGAGCAATATACCGACGAAAGAAATAGAGAAACAGAGTTCTAG", "partial": "0", "query_start": 51358, "query_end": 51963, "hit_start": 939, "hit_end": 1458, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 25.24}, "gnl|BL_ORD_ID|4726|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "salC", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5738", "ARO_accession": "3007027", "ARO_name": "salC", "ARO_category": {"45589": {"category_aro_accession": "3007030", "category_aro_cvterm_id": "45589", "category_aro_name": "sal-type ABC-F protein", "category_aro_description": "Sal proteins are a part of the ABC-F proteins, expressed in staphylococci that confer resistance to group A streptogramin, lincosamide, and pleuromutilin antibiotics through ribosomal protection.", "category_aro_class_name": "AMR Gene Family"}, "35964": {"category_aro_accession": "0000046", "category_aro_cvterm_id": "35964", "category_aro_name": "lincomycin", "category_aro_description": "Lincomycin is a lincosamide antibiotic that comes from the actinomyces Streptomyces lincolnensis. It binds to the 23s portion of the 50S subunit of bacterial ribosomes and inhibit early elongation of peptide chain by inhibiting transpeptidase reaction.", "category_aro_class_name": "Antibiotic"}, "35983": {"category_aro_accession": "0000066", "category_aro_cvterm_id": "35983", "category_aro_name": "clindamycin", "category_aro_description": "Clindamycin is a lincosamide antibiotic that blocks A-site aminoacyl-tRNA binding. It is usually used to treat infections with anaerobic bacteria but can also be used to treat some protozoal diseases, such as malaria.", "category_aro_class_name": "Antibiotic"}, "37013": {"category_aro_accession": "3000669", "category_aro_cvterm_id": "37013", "category_aro_name": "virginiamycin M1", "category_aro_description": "Virginiamycin M1 is a streptogramin A antibiotic.", "category_aro_class_name": "Antibiotic"}, "37015": {"category_aro_accession": "3000671", "category_aro_cvterm_id": "37015", "category_aro_name": "tiamulin", "category_aro_description": "Tiamulin is a pleuromutilin derivative currently used in veterinary medicine. It binds to the 23 rRNA of the 50S ribosomal subunit to inhibit protein translation.", "category_aro_class_name": "Antibiotic"}, "37713": {"category_aro_accession": "3001314", "category_aro_cvterm_id": "37713", "category_aro_name": "retapamulin", "category_aro_description": "Retapamulin is a semi-synthetic pleuromutilin antibiotic approved for the treatment of skin infections.", "category_aro_class_name": "Antibiotic"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35952": {"category_aro_accession": "0000034", "category_aro_cvterm_id": "35952", "category_aro_name": "streptogramin A antibiotic", "category_aro_description": "Streptogramin A antibiotics are cyclic polyketide peptide hybrids that bind to the ribosomal peptidyl transfer centre. Structural variation arises from substituting a proline for its desaturated derivative and by its substitution for Ala or Cys. Used alone, streptogramin A antibiotics are bacteriostatic, but is bactericidal when used with streptogramin B antibiotics.", "category_aro_class_name": "Drug Class"}, "37014": {"category_aro_accession": "3000670", "category_aro_cvterm_id": "37014", "category_aro_name": "pleuromutilin antibiotic", "category_aro_description": "Pleuromutilins are natural fungal products that target bacterial protein translation by binding the the 23S rRNA, blocking the ribosome P site at the 50S subunit. They are mostly used for agriculture and veterinary purposes.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.43622e-07, "max_identities": 48, "bit_score": 46.9802, "cvterm_id": "42526", "query": "GKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSF----NLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGL-EKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHA-NAVVRLA", "match": " K+ +P+L   T  +   E ++I G +G GK+T LN I   +   + ++  D      LT+    +  L+ + +I  ++    +L   LS   N+   +    +L+  E    ++   +++GL E+H     + LSGG++ +V+  +  + + +L+L DEPT ++D      + +  K+    E    +F +HD   +    +A++ L+", "sequence_from_db": "NKLLIPSL---TFIIEENEHLAIVGINGIGKSTLLNKIHHKENIETAMMEQD------LTK----YGTLNVMEYIMLTYPQLSSLRENLSDLDNINRYI----ELDGYEIEQNIIIEGKKLGLTERHFDQLISTLSGGEQTKVSFLKVKLDKARLLLIDEPTNHMDEEMKVWLTNAFKQ----EKRAILFVSHDKTFLNETPDAILELS", "sequence_from_broadstreet": "MLFLFEKKSLEIDNKLLIPSLTFIIEENEHLAIVGINGIGKSTLLNKIHHKENIETAMMEQDLTKYGTLNVMEYIMLTYPQLSSLRENLSDLDNINRYIELDGYEIEQNIIIEGKKLGLTERHFDQLISTLSGGEQTKVSFLKVKLDKARLLLIDEPTNHMDEEMKVWLTNAFKQEKRAILFVSHDKTFLNETPDAILELSSSGATKYSGQYDNYKQQKDLEYKTIKLQYEKQEKEQRAIEETIKKYKEWYQKASQKASVRNPYQQKQLSKLAKKFKSKEYQMNKKLEQTNLSDPEEEGKTFSMQHHAFKSHYLVKFKNVTFSYNEKPIFNDVSFHIKRNQNVIIEGQNGSGKSTLIKLILGQLTPDEGEVIVHPELEIGYFSQDFNNLNMKNTVLEEIMSIQEMKEAEARTILANYYFNENRINDVVANLSMGEKCRIQFVKLYFSNPHILILDEPTNYFDIEMQEKIIQLIQSFQGSTLIISHDKYFKEKLKDQIWTIKNLDLVHENLKIENPLNADSIKNQLNELEQYTDERNRETEF", "dna_sequence_from_broadstreet": "ATGCTATTTTTATTTGAAAAAAAGTCTTTAGAGATTGACAATAAACTGCTCATACCTTCACTAACATTTATTATTGAAGAAAATGAACATTTGGCAATAGTCGGCATAAATGGTATCGGAAAATCTACACTTTTAAATAAAATCCATCATAAAGAAAATATTGAAACAGCAATGATGGAACAAGATTTAACTAAATATGGAACTTTAAATGTCATGGAGTATATTATGTTAACTTATCCACAATTATCATCGTTAAGAGAAAATCTAAGTGATTTGGATAATATAAATAGATATATTGAATTAGACGGTTACGAAATTGAGCAAAACATTATAATTGAAGGAAAAAAGTTAGGATTAACAGAAAGGCACTTTGATCAATTAATTTCTACTTTAAGTGGTGGTGAGCAAACAAAAGTTTCGTTTTTGAAAGTTAAATTAGATAAAGCACGATTATTATTAATTGATGAACCAACTAACCATATGGATGAAGAAATGAAAGTATGGTTAACTAATGCATTTAAACAAGAAAAACGTGCAATATTATTTGTTTCTCACGATAAGACTTTTTTAAATGAAACACCAGACGCAATTTTGGAACTGAGTAGTAGTGGTGCAACAAAATACTCAGGTCAGTATGACAATTACAAGCAACAAAAAGATTTAGAATATAAAACGATTAAGCTACAATACGAAAAACAAGAAAAAGAGCAACGAGCAATTGAAGAAACAATTAAAAAATATAAAGAATGGTATCAAAAAGCTTCACAAAAAGCTTCAGTAAGAAATCCTTATCAACAAAAACAACTTAGCAAGCTTGCGAAAAAGTTTAAATCGAAAGAATATCAAATGAATAAAAAACTTGAACAAACCAATTTATCAGATCCTGAAGAGGAAGGAAAAACATTTTCAATGCAACATCACGCCTTCAAATCTCATTATTTAGTTAAATTTAAAAATGTGACATTTTCATATAATGAAAAGCCTATTTTTAATGATGTCTCTTTTCATATTAAGCGAAATCAAAATGTTATCATTGAAGGTCAAAATGGCTCAGGTAAATCTACTTTGATCAAGTTGATACTAGGTCAACTGACACCTGATGAGGGAGAAGTAATCGTACATCCTGAATTAGAAATAGGTTATTTTTCACAAGATTTTAATAACTTAAATATGAAAAATACTGTGTTAGAAGAAATAATGTCTATTCAAGAAATGAAAGAAGCGGAAGCAAGAACAATTTTAGCGAATTATTATTTTAATGAAAATAGAATTAATGATGTTGTTGCCAATTTATCTATGGGTGAAAAATGTAGAATACAGTTTGTTAAATTGTATTTTTCAAATCCACATATACTCATATTAGATGAGCCAACTAACTATTTTGATATTGAAATGCAAGAAAAAATCATACAATTAATTCAATCTTTTCAAGGATCAACACTTATCATTTCACATGATAAATATTTTAAAGAAAAGCTTAAAGATCAAATTTGGACAATAAAGAATCTAGATTTGGTACATGAAAATCTTAAAATTGAGAATCCATTAAATGCTGATTCTATTAAAAATCAATTAAATGAATTAGAGCAATATACCGACGAAAGAAATAGAGAAACAGAGTTCTAG", "partial": "0", "query_start": 51397, "query_end": 52005, "hit_start": 39, "hit_end": 603, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 22.97}, "gnl|BL_ORD_ID|1891|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "msrC", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "950", "model_id": "2054", "ARO_accession": "3002819", "ARO_name": "msrC", "ARO_category": {"41695": {"category_aro_accession": "3004471", "category_aro_cvterm_id": "41695", "category_aro_name": "msr-type ABC-F protein", "category_aro_description": "msr-type ABC-F subfamily ribosomal protection proteins expression in Staphylococci species and confer resistance to erythromycin and streptogramin B antibiotics through antibiotic target protection mechanisms.", "category_aro_class_name": "AMR Gene Family"}, "35925": {"category_aro_accession": "0000006", "category_aro_cvterm_id": "35925", "category_aro_name": "erythromycin", "category_aro_description": "Erythromycin is a macrolide antibiotic with a 14-carbon ring that has an antimicrobial spectrum similar to or slightly wider than that of penicillin, and is often used for people that have an allergy to penicillins. Erythromycin may possess bacteriocidal activity, particularly at higher concentrations by binding to the 50S subunit of the bacterial 70S rRNA complex, inhibiting peptidyl-tRNA translocation. Thus, protein synthesis and subsequently structure/function processes critical for life or replication are inhibited.", "category_aro_class_name": "Antibiotic"}, "36723": {"category_aro_accession": "3000584", "category_aro_cvterm_id": "36723", "category_aro_name": "quinupristin", "category_aro_description": "Quinupristin is a type B streptogramin and a semisynthetic derivative of pristinamycin 1A. It is a component of the drug Synercid and interacts with the 50S subunit of the bacterial ribosome to inhibit protein synthesis.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35967": {"category_aro_accession": "0000050", "category_aro_cvterm_id": "35967", "category_aro_name": "streptogramin B antibiotic", "category_aro_description": "Streptogramin B antibiotics are are cyclic hepta- or hexa-depsipeptides.  Type B streptogramins block the peptide exit tunnel of the 50S bacterial ribosome. The general composition of group B streptogramins is 3-hydroxypicolinic acid-L-Thr-D-aminobutyric acid (or D-Ala)-L-Pro-L-Phe (or 4-N-,N-(dimethylamino)-L-Phe)-X-L-phenylglycine. Used alone, streptogramin B antibiotics are bacteriostatic, but is bactericidal when used with streptogramin A antibiotics.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.07821e-06, "max_identities": 50, "bit_score": 46.595, "cvterm_id": "36779", "query": "TLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTH-ANAVVRLADGKI", "match": "+L VY  + I I G +G GKTT L LI      + G +  +           +T   L  + ++ ++ +L        N+E     Q KL  +  R                     + SGG+ +++ + R L +  + +L DEPT +LD  +   +I+   EL    G T IF +HD   +   A  V  + DG+I", "sequence_from_db": "SLRVYQQDRIGIIGENGVGKTTLLKLIVGELIPNQGKIQTE-----------ITFNYLPQLTYLAEAKDL--------NLELASHFQLKLEETSER---------------------KWSGGEERKIELIRLLSSYEQGMLLDEPTTHLDRKSMDRLIE---ELRYYYG-TLIFVSHDRYFLDELATKVWEVKDGEI", "sequence_from_broadstreet": "MENLAVNITNLQVRFGNQLELSIDSLRVYQQDRIGIIGENGVGKTTLLKLIVGELIPNQGKIQTEITFNYLPQLTYLAEAKDLNLELASHFQLKLEETSERKWSGGEERKIELIRLLSSYEQGMLLDEPTTHLDRKSMDRLIEELRYYYGTLIFVSHDRYFLDELATKVWEVKDGEIREFPENYSAYLTQRELEKKTQLREAESIMKEKKRLEKSIQEKKKQAEKLEKVSSKKKKQQIRPDRLSSSKQKDSVQKAIQKNTKTLERRLQKIGETTKPQQMKQIRFPVPKSLELHNRYPIMGQNIQLERSGRTLLINSDFQFSLGKKIAIVGENGSGKTTLLEHIRKQGEGILLSPKVSFQVYQQKDYQMTSEESVIRFVMRQTEFSESLVRSLLNHLGFAQETLTKPLCTLSGGEATRLTIALLFTKPSNVLLLDEPTNFIDVATIEALEQLMQVYPGTILFTSHDSYFVERTADEVYEIKGQKIKKVLTRNF", "dna_sequence_from_broadstreet": "ATGGAAAATTTAGCAGTAAATATAACAAACCTGCAAGTTCGTTTTGGTAACCAGTTAGAATTATCTATTGATTCTCTTCGTGTCTATCAGCAAGATCGGATAGGAATCATAGGGGAAAATGGAGTCGGTAAAACAACGTTGCTGAAACTGATAGTCGGTGAACTTATCCCCAATCAAGGGAAAATCCAAACAGAGATCACTTTCAACTATCTGCCTCAATTAACCTATCTTGCTGAGGCAAAGGACCTAAATTTGGAATTAGCCAGTCATTTCCAGTTGAAACTGGAAGAAACTTCGGAACGGAAATGGAGTGGAGGGGAAGAACGAAAGATCGAGTTGATACGTCTTCTTTCTTCTTATGAACAAGGGATGCTTCTAGACGAGCCGACAACCCATCTAGATAGAAAAAGTATGGATCGACTAATTGAAGAGCTTCGTTATTATTATGGCACGCTGATTTTTGTTAGTCATGACCGCTATTTTCTAGATGAGTTGGCAACGAAAGTCTGGGAAGTAAAAGACGGAGAAATCCGAGAGTTTCCGGAGAATTATAGTGCCTATCTCACTCAAAGGGAATTGGAGAAAAAGACTCAGCTACGAGAAGCAGAGTCGATCATGAAAGAGAAAAAACGATTGGAAAAATCGATCCAAGAAAAGAAAAAACAAGCGGAAAAGTTAGAAAAAGTGTCCAGTAAAAAGAAAAAGCAACAAATCAGACCGGATCGGTTGTCTTCCTCTAAACAAAAAGACAGTGTACAAAAAGCCATCCAAAAGAATACGAAAACATTAGAGAGAAGACTCCAAAAAATAGGAGAAACAACCAAACCGCAACAGATGAAACAAATCCGTTTTCCAGTACCAAAATCTCTTGAACTCCACAATCGTTATCCAATCATGGGACAAAATATCCAATTGGAAAGAAGCGGAAGAACATTACTGATAAATAGCGATTTTCAATTTTCTTTAGGTAAAAAAATCGCGATTGTCGGCGAAAATGGATCAGGTAAGACAACTTTATTGGAACATATCCGCAAACAAGGAGAAGGAATCCTTCTCTCTCCGAAAGTAAGCTTTCAAGTATATCAGCAAAAGGATTATCAAATGACATCTGAAGAATCCGTCATTCGTTTTGTCATGAGACAAACAGAGTTTTCGGAATCACTTGTCCGCAGTTTGTTGAATCATTTAGGGTTTGCTCAGGAAACTCTGACGAAACCGTTGTGTACGTTAAGTGGGGGAGAAGCGACTCGTTTGACGATTGCTTTGCTTTTTACTAAGCCAAGTAATGTGTTGCTGTTAGATGAACCGACTAATTTCATTGATGTGGCAACGATCGAAGCTTTAGAGCAGCTGATGCAAGTATATCCGGGAACGATTTTGTTTACTTCACATGATTCCTACTTTGTCGAGCGTACGGCTGATGAAGTTTATGAAATAAAAGGGCAGAAAATAAAAAAAGTACTTACGAGAAATTTTTAA", "partial": "0", "query_start": 51430, "query_end": 52017, "hit_start": 72, "hit_end": 531, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 25.38}, "gnl|BL_ORD_ID|1891|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "msrC", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "950", "model_id": "2054", "ARO_accession": "3002819", "ARO_name": "msrC", "ARO_category": {"41695": {"category_aro_accession": "3004471", "category_aro_cvterm_id": "41695", "category_aro_name": "msr-type ABC-F protein", "category_aro_description": "msr-type ABC-F subfamily ribosomal protection proteins expression in Staphylococci species and confer resistance to erythromycin and streptogramin B antibiotics through antibiotic target protection mechanisms.", "category_aro_class_name": "AMR Gene Family"}, "35925": {"category_aro_accession": "0000006", "category_aro_cvterm_id": "35925", "category_aro_name": "erythromycin", "category_aro_description": "Erythromycin is a macrolide antibiotic with a 14-carbon ring that has an antimicrobial spectrum similar to or slightly wider than that of penicillin, and is often used for people that have an allergy to penicillins. Erythromycin may possess bacteriocidal activity, particularly at higher concentrations by binding to the 50S subunit of the bacterial 70S rRNA complex, inhibiting peptidyl-tRNA translocation. Thus, protein synthesis and subsequently structure/function processes critical for life or replication are inhibited.", "category_aro_class_name": "Antibiotic"}, "36723": {"category_aro_accession": "3000584", "category_aro_cvterm_id": "36723", "category_aro_name": "quinupristin", "category_aro_description": "Quinupristin is a type B streptogramin and a semisynthetic derivative of pristinamycin 1A. It is a component of the drug Synercid and interacts with the 50S subunit of the bacterial ribosome to inhibit protein synthesis.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35967": {"category_aro_accession": "0000050", "category_aro_cvterm_id": "35967", "category_aro_name": "streptogramin B antibiotic", "category_aro_description": "Streptogramin B antibiotics are are cyclic hepta- or hexa-depsipeptides.  Type B streptogramins block the peptide exit tunnel of the 50S bacterial ribosome. The general composition of group B streptogramins is 3-hydroxypicolinic acid-L-Thr-D-aminobutyric acid (or D-Ala)-L-Pro-L-Phe (or 4-N-,N-(dimethylamino)-L-Phe)-X-L-phenylglycine. Used alone, streptogramin B antibiotics are bacteriostatic, but is bactericidal when used with streptogramin A antibiotics.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000283613, "max_identities": 53, "bit_score": 39.2762, "cvterm_id": "36779", "query": "GEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRP-NELSGGQRQRVAVARALVTRP-KLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTH-ANAVVRLADGKI", "match": "G+ I+I G +GSGKTT L  I                  +K  E  L   ++    +  + + + S  SV + V       R+   SE  + V +LL  +G  +    +P   LSGG+  R+ +A  L T+P  ++L DEPT  +D  T    I+ +++L +    T +F++HD+  +   A+ V  +   KI", "sequence_from_db": "GKKIAIVGENGSGKTTLLEHI------------------RKQGEGILLSPKVSFQVYQQKDYQMTSEESVIRFV------MRQTEFSE--SLVRSLLNHLGFAQETLTKPLCTLSGGEATRLTIA-LLFTKPSNVLLLDEPTNFIDVAT----IEALEQLMQVYPGTILFTSHDSYFVERTADEVYEIKGQKI", "sequence_from_broadstreet": "MENLAVNITNLQVRFGNQLELSIDSLRVYQQDRIGIIGENGVGKTTLLKLIVGELIPNQGKIQTEITFNYLPQLTYLAEAKDLNLELASHFQLKLEETSERKWSGGEERKIELIRLLSSYEQGMLLDEPTTHLDRKSMDRLIEELRYYYGTLIFVSHDRYFLDELATKVWEVKDGEIREFPENYSAYLTQRELEKKTQLREAESIMKEKKRLEKSIQEKKKQAEKLEKVSSKKKKQQIRPDRLSSSKQKDSVQKAIQKNTKTLERRLQKIGETTKPQQMKQIRFPVPKSLELHNRYPIMGQNIQLERSGRTLLINSDFQFSLGKKIAIVGENGSGKTTLLEHIRKQGEGILLSPKVSFQVYQQKDYQMTSEESVIRFVMRQTEFSESLVRSLLNHLGFAQETLTKPLCTLSGGEATRLTIALLFTKPSNVLLLDEPTNFIDVATIEALEQLMQVYPGTILFTSHDSYFVERTADEVYEIKGQKIKKVLTRNF", "dna_sequence_from_broadstreet": "ATGGAAAATTTAGCAGTAAATATAACAAACCTGCAAGTTCGTTTTGGTAACCAGTTAGAATTATCTATTGATTCTCTTCGTGTCTATCAGCAAGATCGGATAGGAATCATAGGGGAAAATGGAGTCGGTAAAACAACGTTGCTGAAACTGATAGTCGGTGAACTTATCCCCAATCAAGGGAAAATCCAAACAGAGATCACTTTCAACTATCTGCCTCAATTAACCTATCTTGCTGAGGCAAAGGACCTAAATTTGGAATTAGCCAGTCATTTCCAGTTGAAACTGGAAGAAACTTCGGAACGGAAATGGAGTGGAGGGGAAGAACGAAAGATCGAGTTGATACGTCTTCTTTCTTCTTATGAACAAGGGATGCTTCTAGACGAGCCGACAACCCATCTAGATAGAAAAAGTATGGATCGACTAATTGAAGAGCTTCGTTATTATTATGGCACGCTGATTTTTGTTAGTCATGACCGCTATTTTCTAGATGAGTTGGCAACGAAAGTCTGGGAAGTAAAAGACGGAGAAATCCGAGAGTTTCCGGAGAATTATAGTGCCTATCTCACTCAAAGGGAATTGGAGAAAAAGACTCAGCTACGAGAAGCAGAGTCGATCATGAAAGAGAAAAAACGATTGGAAAAATCGATCCAAGAAAAGAAAAAACAAGCGGAAAAGTTAGAAAAAGTGTCCAGTAAAAAGAAAAAGCAACAAATCAGACCGGATCGGTTGTCTTCCTCTAAACAAAAAGACAGTGTACAAAAAGCCATCCAAAAGAATACGAAAACATTAGAGAGAAGACTCCAAAAAATAGGAGAAACAACCAAACCGCAACAGATGAAACAAATCCGTTTTCCAGTACCAAAATCTCTTGAACTCCACAATCGTTATCCAATCATGGGACAAAATATCCAATTGGAAAGAAGCGGAAGAACATTACTGATAAATAGCGATTTTCAATTTTCTTTAGGTAAAAAAATCGCGATTGTCGGCGAAAATGGATCAGGTAAGACAACTTTATTGGAACATATCCGCAAACAAGGAGAAGGAATCCTTCTCTCTCCGAAAGTAAGCTTTCAAGTATATCAGCAAAAGGATTATCAAATGACATCTGAAGAATCCGTCATTCGTTTTGTCATGAGACAAACAGAGTTTTCGGAATCACTTGTCCGCAGTTTGTTGAATCATTTAGGGTTTGCTCAGGAAACTCTGACGAAACCGTTGTGTACGTTAAGTGGGGGAGAAGCGACTCGTTTGACGATTGCTTTGCTTTTTACTAAGCCAAGTAATGTGTTGCTGTTAGATGAACCGACTAATTTCATTGATGTGGCAACGATCGAAGCTTTAGAGCAGCTGATGCAAGTATATCCGGGAACGATTTTGTTTACTTCACATGATTCCTACTTTGTCGAGCGTACGGCTGATGAAGTTTATGAAATAAAAGGGCAGAAAATAAAAAAAGTACTTACGAGAAATTTTTAA", "partial": "0", "query_start": 51448, "query_end": 52017, "hit_start": 966, "hit_end": 1452, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 27.46}, "gnl|BL_ORD_ID|4707|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "YojI", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1050", "model_id": "2424", "ARO_accession": "3003952", "ARO_name": "YojI", "ARO_category": {"36002": {"category_aro_accession": "0010001", "category_aro_cvterm_id": "36002", "category_aro_name": "ATP-binding cassette (ABC) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. ATP-binding cassette (ABC) transporters are present in all cells of all organisms and use the energy of ATP binding/hydrolysis to transport substrates across cell membranes.", "category_aro_class_name": "AMR Gene Family"}, "40721": {"category_aro_accession": "3003951", "category_aro_cvterm_id": "40721", "category_aro_name": "microcin J25", "category_aro_description": "Microcin J25 is a peptide antibiotic that inhibits transcription by bacterial RNA polymerase. MccJ25 is produced by Escherichia coli strains that harbor a plasmid-borne antibiotic-synthesis and antibiotic-export cassette, consisting of a gene for MccJ25 precursor (a 58 residue linear peptide), two genes for factors that process MccJ25 precursor into MccJ25, and one gene for export of MccJ25.", "category_aro_class_name": "Antibiotic"}, "36192": {"category_aro_accession": "3000053", "category_aro_cvterm_id": "36192", "category_aro_name": "peptide antibiotic", "category_aro_description": "Peptide antibiotics have a wide range of antibacterial mechanisms, depending on the amino acids that make up the antibiotic, although most act to disrupt the cell membrane in some manner. Subclasses of peptide antibiotics can include additional sidechains of other types, such as lipids in the case of the lipopeptide antibiotics.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.92981e-06, "max_identities": 50, "bit_score": 45.4394, "cvterm_id": "36849", "query": "VTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPN---------ELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKI", "match": "+ L +  GE + + G +GSGK+T   L+  +    SG + +DG   K ++  Q    R            L S  +VF +V     L  +L   E +     L+E+   +    H+           +LS GQ++RVA+  AL     ++L DE  A+ D    +    ++  L ++ G T    +HD     HA+ ++ + +G++", "sequence_from_db": "INLTIKRGELLFLIGGNGSGKSTLAMLLTGLYQPQSGEILLDG---KPVSGEQPEDYR-----------KLFS--AVFTDV----WLFDQLLGPEGKPANPQLVEKWLAQLKMAHKLELSNGRIVNLKLSKGQKKRVALLLALAEERDIILLDEWAADQDPHFRREFYQVLLPLMQEMGKTIFAISHDDHYFIHADRLLEMRNGQL", "sequence_from_broadstreet": "MELLVLVWRQYRWPFISVMALSLASAALGIGLIAFINQRLIETADTSLLVLPEFLGLLLLLMAVTLGSQLALTTLGHHFVYRLRSEFIKRILDTHVERIEQLGSASLLAGLTSDVRNITIAFVRLPELVQGIILTIGSAAYLWMLSGKMLLVTAIWMAITIWGGFVLVARVYKHMATLRETEDKLYTDFQTVLEGRKELTLNRERAEYVFNNLYIPDAQEYRHHIIRADTFHLSAVNWSNIMMLGAIGLVFWMANSLGWADTNVAATYSLTLLFLRTPLLSAVGALPTLLTAQVAFNKLNKFALAPFKAEFPRPQAFPNWQTLELRNVTFAYQDNAFSVGPINLTIKRGELLFLIGGNGSGKSTLAMLLTGLYQPQSGEILLDGKPVSGEQPEDYRKLFSAVFTDVWLFDQLLGPEGKPANPQLVEKWLAQLKMAHKLELSNGRIVNLKLSKGQKKRVALLLALAEERDIILLDEWAADQDPHFRREFYQVLLPLMQEMGKTIFAISHDDHYFIHADRLLEMRNGQLSELTGEERDAASRDAVARTA", "dna_sequence_from_broadstreet": "ATGGAACTTCTTGTACTTGTCTGGCGGCAGTATCGCTGGCCATTTATCAGTGTGATGGCGCTAAGCCTCGCCAGTGCGGCATTAGGCATTGGCTTAATTGCTTTTATCAATCAGCGCCTTATCGAAACGGCGGATACCAGTCTGCTGGTGTTGCCGGAGTTTCTGGGATTATTGCTGCTGTTGATGGCAGTCACTCTCGGATCGCAACTGGCGCTCACCACTTTGGGGCATCACTTCGTTTACCGACTGCGTAGTGAATTTATCAAGCGGATTCTGGATACTCACGTCGAGCGCATTGAACAACTCGGTAGCGCCTCGTTGCTGGCGGGGTTAACCAGCGATGTGCGCAATATCACCATTGCTTTTGTGCGTCTGCCGGAACTGGTGCAGGGGATCATTCTCACTATCGGTTCAGCGGCGTATCTGTGGATGCTGTCGGGCAAAATGTTGCTGGTAACGGCTATCTGGATGGCGATCACCATCTGGGGCGGTTTTGTGCTGGTGGCGCGGGTGTACAAACATATGGCGACCCTGCGTGAAACCGAAGACAAGCTGTACACGGATTTTCAAACTGTACTTGAAGGGCGCAAAGAGCTGACTCTGAACCGGGAACGCGCCGAGTATGTGTTTAACAACCTCTACATTCCTGATGCGCAAGAGTATCGCCACCATATTATTCGCGCAGACACCTTCCATCTTAGTGCCGTGAACTGGTCAAACATCATGATGCTGGGCGCAATCGGCCTGGTGTTCTGGATGGCGAACAGCCTCGGTTGGGCTGATACCAACGTTGCCGCGACCTATTCGTTGACGCTTTTATTCCTGCGTACGCCGCTGCTTTCGGCGGTTGGCGCATTGCCGACGCTGCTGACGGCGCAGGTGGCGTTTAACAAGCTGAACAAATTCGCGCTCGCGCCTTTCAAAGCAGAGTTTCCGCGCCCGCAGGCGTTTCCCAACTGGCAAACGCTGGAGCTGCGTAACGTGACGTTTGCTTATCAGGATAACGCGTTTTCCGTTGGTCCGATTAATCTCACCATCAAACGTGGCGAGCTGCTGTTTCTGATTGGCGGCAACGGTAGCGGAAAATCGACGCTGGCGATGTTGTTGACGGGCTTGTATCAGCCACAAAGCGGCGAAATCTTGCTGGATGGCAAACCTGTCAGCGGCGAACAACCGGAAGATTATCGCAAACTGTTTTCGGCAGTGTTTACCGATGTCTGGCTGTTTGATCAACTGCTGGGGCCGGAGGGTAAACCCGCTAACCCGCAACTGGTTGAGAAGTGGCTGGCGCAGCTGAAAATGGCTCATAAGCTTGAGTTAAGCAACGGGCGTATTGTTAACCTGAAGTTATCAAAAGGGCAGAAAAAACGCGTGGCGCTGTTGCTGGCGCTGGCAGAAGAACGCGATATTATCCTGCTGGATGAATGGGCGGCGGATCAGGATCCACACTTCCGTCGTGAGTTTTATCAGGTGTTGCTGCCGCTGATGCAGGAGATGGGTAAAACTATTTTCGCTATCAGTCATGATGATCATTACTTTATCCACGCCGACCGCCTGCTGGAAATGCGCAATGGGCAACTTAGCGAGCTGACGGGCGAAGAGCGCGATGCCGCTTCGCGTGATGCCGTTGCCCGGACGGCATAA", "partial": "0", "query_start": 51427, "query_end": 52017, "hit_start": 1023, "hit_end": 1581, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 24.27}, "gnl|BL_ORD_ID|1191|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "lsaA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1000", "model_id": "1298", "ARO_accession": "3000300", "ARO_name": "lsaA", "ARO_category": {"41696": {"category_aro_accession": "3004472", "category_aro_cvterm_id": "41696", "category_aro_name": "lsa-type ABC-F protein", "category_aro_description": "A subgroup of the ABC-F protein subfamily of ATP-binding cassette proteins. lsa-type ABC-F proteins confer resistance to streptogramin, lincosamide and pleuromutilin antibiotics through antibiotic target protection of the ribosome.", "category_aro_class_name": "AMR Gene Family"}, "35983": {"category_aro_accession": "0000066", "category_aro_cvterm_id": "35983", "category_aro_name": "clindamycin", "category_aro_description": "Clindamycin is a lincosamide antibiotic that blocks A-site aminoacyl-tRNA binding. It is usually used to treat infections with anaerobic bacteria but can also be used to treat some protozoal diseases, such as malaria.", "category_aro_class_name": "Antibiotic"}, "36723": {"category_aro_accession": "3000584", "category_aro_cvterm_id": "36723", "category_aro_name": "quinupristin", "category_aro_description": "Quinupristin is a type B streptogramin and a semisynthetic derivative of pristinamycin 1A. It is a component of the drug Synercid and interacts with the 50S subunit of the bacterial ribosome to inhibit protein synthesis.", "category_aro_class_name": "Antibiotic"}, "37018": {"category_aro_accession": "3000674", "category_aro_cvterm_id": "37018", "category_aro_name": "dalfopristin", "category_aro_description": "Dalfopristin is a water-soluble semi-synthetic derivative of pristinamycin IIA. It is produced by Streptomyces pristinaespiralis and is used in combination with quinupristin in a 7:3 ratio. Both work together to inhibit protein synthesis, and is active against Gram-positive bacteria.", "category_aro_class_name": "Antibiotic"}, "37716": {"category_aro_accession": "3001317", "category_aro_cvterm_id": "37716", "category_aro_name": "pleuromutilin", "category_aro_description": "Pleuromutilin is a natural product antibiotic produced by Clitopilus passeckerianus. Related antibiotics of clinical significance, such as tiamulin and retapamulin, are semi-synthetic derivatives of this compound.", "category_aro_class_name": "Antibiotic"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35952": {"category_aro_accession": "0000034", "category_aro_cvterm_id": "35952", "category_aro_name": "streptogramin A antibiotic", "category_aro_description": "Streptogramin A antibiotics are cyclic polyketide peptide hybrids that bind to the ribosomal peptidyl transfer centre. Structural variation arises from substituting a proline for its desaturated derivative and by its substitution for Ala or Cys. Used alone, streptogramin A antibiotics are bacteriostatic, but is bactericidal when used with streptogramin B antibiotics.", "category_aro_class_name": "Drug Class"}, "35967": {"category_aro_accession": "0000050", "category_aro_cvterm_id": "35967", "category_aro_name": "streptogramin B antibiotic", "category_aro_description": "Streptogramin B antibiotics are are cyclic hepta- or hexa-depsipeptides.  Type B streptogramins block the peptide exit tunnel of the 50S bacterial ribosome. The general composition of group B streptogramins is 3-hydroxypicolinic acid-L-Thr-D-aminobutyric acid (or D-Ala)-L-Pro-L-Phe (or 4-N-,N-(dimethylamino)-L-Phe)-X-L-phenylglycine. Used alone, streptogramin B antibiotics are bacteriostatic, but is bactericidal when used with streptogramin A antibiotics.", "category_aro_class_name": "Drug Class"}, "37014": {"category_aro_accession": "3000670", "category_aro_cvterm_id": "37014", "category_aro_name": "pleuromutilin antibiotic", "category_aro_description": "Pleuromutilins are natural fungal products that target bacterial protein translation by binding the the 23S rRNA, blocking the ribosome P site at the 50S subunit. They are mostly used for agriculture and veterinary purposes.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.29485e-06, "max_identities": 44, "bit_score": 45.0542, "cvterm_id": "40154", "query": "PGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALN-LIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSF-NLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHA-KHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNI", "match": "P   + ++++ E+   Y    +  P    ++  +  GE + I G +GSGK++ +  L+G     S G  ++  Q                TI ++ Q + +    LS F         + +L+     T+ +  L ++G+E+    +R  ++S GQR++V VA++L    +L + DEP   LD    Q +", "sequence_from_db": "PTHHKTLLTVEELRLGYEKNWLFTP----ISFSINAGEIVGITGKNGSGKSSLIQYLLGDFSGDSEGEATLAHQ---------------LTISYVRQDYEDNQGTLSEFAE-------KNQLDY----TQFLNNLRKLGMERAVFTNRIEQMSMGQRKKVEVAKSLSQSAELYIWDEPLNYLDVFNHQQL", "sequence_from_broadstreet": "MSKIELKQLSFAYDNQEALLFDQANITMDTNWKLGLIGRNGRGKTTLLRLLQKQLDYQGEILHQVDFVYFPQTVAEEQQLTYYVLQEVTSFEQWKLERELTLLNVDPEVLWRPFSSLSGGEKTKVLLGLLFIEENAFPLIDEPTNHLDLAGRQQVAEYLKKKKHGFILVSHDRAFVDEVVDHILAIEKSQLTLYQGDFSIYEEQKKLRDAFELAENEKIKKEVNRLKETARKKAEWSMNREGDKYGNAKEKGSGAIFDTGAIGARAARVMKRSKHIQQRAETQLAEKEKLLKDLEYIDPLSMDYQPTHHKTLLTVEELRLGYEKNWLFTPISFSINAGEIVGITGKNGSGKSSLIQYLLGDFSGDSEGEATLAHQLTISYVRQDYEDNQGTLSEFAEKNQLDYTQFLNNLRKLGMERAVFTNRIEQMSMGQRKKVEVAKSLSQSAELYIWDEPLNYLDVFNHQQLEALILSVRPAMLVIEHDAHFMKKITDKKIALKS", "dna_sequence_from_broadstreet": "ATGTCGAAAATTGAACTAAAACAACTATCTTTTGCCTATGATAATCAAGAAGCGTTGCTTTTTGATCAGGCAAATATCACGATGGATACCAATTGGAAATTAGGATTGATTGGCCGCAATGGCCGTGGGAAAACAACCTTATTAAGATTGTTACAAAAGCAGTTGGATTACCAAGGAGAGATTCTTCATCAAGTCGATTTCGTCTATTTTCCACAAACAGTTGCAGAAGAACAACAGCTCACTTATTATGTCTTACAAGAGGTGACTTCTTTTGAACAGTGGAAATTAGAACGAGAATTAACGCTTTTAAACGTTGATCCTGAAGTTTTATGGCGGCCCTTTTCTTCTTTATCAGGCGGCGAAAAGACGAAAGTTTTATTAGGTCTTCTTTTTATTGAAGAAAATGCCTTTCCTTTAATTGACGAGCCAACAAATCATTTAGATCTAGCTGGCAGACAACAAGTGGCTGAATATTTGAAGAAAAAGAAACACGGGTTTATTTTAGTCAGCCACGATCGGGCATTTGTTGATGAAGTGGTTGATCATATTTTGGCGATTGAAAAAAGTCAATTGACACTGTATCAAGGGGATTTTTCTATTTATGAAGAGCAAAAAAAATTAAGAGATGCTTTTGAACTAGCAGAAAATGAAAAAATCAAAAAAGAAGTCAATCGCTTGAAAGAAACCGCTCGTAAAAAAGCGGAATGGTCGATGAACCGTGAAGGTGATAAGTACGGCAATGCTAAAGAAAAAGGGAGCGGGGCGATTTTTGATACAGGAGCCATTGGTGCCCGGGCAGCGCGCGTAATGAAGCGCTCGAAACACATTCAACAACGTGCCGAAACACAATTAGCAGAAAAAGAAAAACTATTAAAAGATCTTGAGTATATTGATCCTTTGTCAATGGATTATCAGCCAACGCATCACAAAACATTATTGACGGTGGAAGAGCTTCGTCTAGGCTACGAGAAAAATTGGCTATTTACGCCAATTTCTTTTTCAATAAACGCGGGAGAAATTGTCGGAATAACAGGAAAAAATGGCTCAGGAAAATCGAGCTTGATTCAGTATTTGTTGGGGGATTTTTCTGGAGATTCAGAAGGAGAAGCCACTCTGGCTCACCAATTAACCATTTCTTATGTGCGCCAAGATTATGAAGACAATCAAGGAACTTTATCCGAATTTGCAGAGAAAAATCAGTTAGATTACACCCAATTTTTAAATAACTTACGAAAACTTGGGATGGAGCGCGCCGTTTTCACTAATCGAATTGAACAAATGAGTATGGGGCAACGGAAAAAAGTCGAAGTAGCCAAATCATTGTCTCAATCAGCTGAACTTTATATTTGGGATGAACCCCTTAATTACTTGGATGTGTTTAATCATCAACAATTAGAAGCGCTAATCTTATCTGTGAGGCCTGCAATGCTAGTGATTGAGCATGATGCACATTTCATGAAGAAAATAACGGATAAAAAAATTGCCTTGAAATCATAA", "partial": "0", "query_start": 51340, "query_end": 51900, "hit_start": 915, "hit_end": 1395, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 23.16}, "gnl|BL_ORD_ID|1191|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "lsaA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1000", "model_id": "1298", "ARO_accession": "3000300", "ARO_name": "lsaA", "ARO_category": {"41696": {"category_aro_accession": "3004472", "category_aro_cvterm_id": "41696", "category_aro_name": "lsa-type ABC-F protein", "category_aro_description": "A subgroup of the ABC-F protein subfamily of ATP-binding cassette proteins. lsa-type ABC-F proteins confer resistance to streptogramin, lincosamide and pleuromutilin antibiotics through antibiotic target protection of the ribosome.", "category_aro_class_name": "AMR Gene Family"}, "35983": {"category_aro_accession": "0000066", "category_aro_cvterm_id": "35983", "category_aro_name": "clindamycin", "category_aro_description": "Clindamycin is a lincosamide antibiotic that blocks A-site aminoacyl-tRNA binding. It is usually used to treat infections with anaerobic bacteria but can also be used to treat some protozoal diseases, such as malaria.", "category_aro_class_name": "Antibiotic"}, "36723": {"category_aro_accession": "3000584", "category_aro_cvterm_id": "36723", "category_aro_name": "quinupristin", "category_aro_description": "Quinupristin is a type B streptogramin and a semisynthetic derivative of pristinamycin 1A. It is a component of the drug Synercid and interacts with the 50S subunit of the bacterial ribosome to inhibit protein synthesis.", "category_aro_class_name": "Antibiotic"}, "37018": {"category_aro_accession": "3000674", "category_aro_cvterm_id": "37018", "category_aro_name": "dalfopristin", "category_aro_description": "Dalfopristin is a water-soluble semi-synthetic derivative of pristinamycin IIA. It is produced by Streptomyces pristinaespiralis and is used in combination with quinupristin in a 7:3 ratio. Both work together to inhibit protein synthesis, and is active against Gram-positive bacteria.", "category_aro_class_name": "Antibiotic"}, "37716": {"category_aro_accession": "3001317", "category_aro_cvterm_id": "37716", "category_aro_name": "pleuromutilin", "category_aro_description": "Pleuromutilin is a natural product antibiotic produced by Clitopilus passeckerianus. Related antibiotics of clinical significance, such as tiamulin and retapamulin, are semi-synthetic derivatives of this compound.", "category_aro_class_name": "Antibiotic"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35952": {"category_aro_accession": "0000034", "category_aro_cvterm_id": "35952", "category_aro_name": "streptogramin A antibiotic", "category_aro_description": "Streptogramin A antibiotics are cyclic polyketide peptide hybrids that bind to the ribosomal peptidyl transfer centre. Structural variation arises from substituting a proline for its desaturated derivative and by its substitution for Ala or Cys. Used alone, streptogramin A antibiotics are bacteriostatic, but is bactericidal when used with streptogramin B antibiotics.", "category_aro_class_name": "Drug Class"}, "35967": {"category_aro_accession": "0000050", "category_aro_cvterm_id": "35967", "category_aro_name": "streptogramin B antibiotic", "category_aro_description": "Streptogramin B antibiotics are are cyclic hepta- or hexa-depsipeptides.  Type B streptogramins block the peptide exit tunnel of the 50S bacterial ribosome. The general composition of group B streptogramins is 3-hydroxypicolinic acid-L-Thr-D-aminobutyric acid (or D-Ala)-L-Pro-L-Phe (or 4-N-,N-(dimethylamino)-L-Phe)-X-L-phenylglycine. Used alone, streptogramin B antibiotics are bacteriostatic, but is bactericidal when used with streptogramin A antibiotics.", "category_aro_class_name": "Drug Class"}, "37014": {"category_aro_accession": "3000670", "category_aro_cvterm_id": "37014", "category_aro_name": "pleuromutilin antibiotic", "category_aro_description": "Pleuromutilins are natural fungal products that target bacterial protein translation by binding the the 23S rRNA, blocking the ribosome P site at the 50S subunit. They are mostly used for agriculture and veterinary purposes.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00117693, "max_identities": 45, "bit_score": 37.3502, "cvterm_id": "40154", "query": "ISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLR--LHTIGFIF--QSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRP-NELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHD", "match": "+ + G +G GKTT L L+                      ++QL +    LH + F++  Q+      L+ +   E     Q KL       R +TLL    ++     RP + LSGG++ +V +    +      L DEPT +LD    Q + + +K+  +K G  FI  +HD", "sequence_from_db": "LGLIGRNGRGKTTLLRLL----------------------QKQLDYQGEILHQVDFVYFPQTVAEEQQLTYYVLQEVTSFEQWKLE------RELTLL---NVDPEVLWRPFSSLSGGEKTKVLLGLLFIEENAFPLIDEPTNHLDLAGRQQVAEYLKK--KKHG--FILVSHD", "sequence_from_broadstreet": "MSKIELKQLSFAYDNQEALLFDQANITMDTNWKLGLIGRNGRGKTTLLRLLQKQLDYQGEILHQVDFVYFPQTVAEEQQLTYYVLQEVTSFEQWKLERELTLLNVDPEVLWRPFSSLSGGEKTKVLLGLLFIEENAFPLIDEPTNHLDLAGRQQVAEYLKKKKHGFILVSHDRAFVDEVVDHILAIEKSQLTLYQGDFSIYEEQKKLRDAFELAENEKIKKEVNRLKETARKKAEWSMNREGDKYGNAKEKGSGAIFDTGAIGARAARVMKRSKHIQQRAETQLAEKEKLLKDLEYIDPLSMDYQPTHHKTLLTVEELRLGYEKNWLFTPISFSINAGEIVGITGKNGSGKSSLIQYLLGDFSGDSEGEATLAHQLTISYVRQDYEDNQGTLSEFAEKNQLDYTQFLNNLRKLGMERAVFTNRIEQMSMGQRKKVEVAKSLSQSAELYIWDEPLNYLDVFNHQQLEALILSVRPAMLVIEHDAHFMKKITDKKIALKS", "dna_sequence_from_broadstreet": "ATGTCGAAAATTGAACTAAAACAACTATCTTTTGCCTATGATAATCAAGAAGCGTTGCTTTTTGATCAGGCAAATATCACGATGGATACCAATTGGAAATTAGGATTGATTGGCCGCAATGGCCGTGGGAAAACAACCTTATTAAGATTGTTACAAAAGCAGTTGGATTACCAAGGAGAGATTCTTCATCAAGTCGATTTCGTCTATTTTCCACAAACAGTTGCAGAAGAACAACAGCTCACTTATTATGTCTTACAAGAGGTGACTTCTTTTGAACAGTGGAAATTAGAACGAGAATTAACGCTTTTAAACGTTGATCCTGAAGTTTTATGGCGGCCCTTTTCTTCTTTATCAGGCGGCGAAAAGACGAAAGTTTTATTAGGTCTTCTTTTTATTGAAGAAAATGCCTTTCCTTTAATTGACGAGCCAACAAATCATTTAGATCTAGCTGGCAGACAACAAGTGGCTGAATATTTGAAGAAAAAGAAACACGGGTTTATTTTAGTCAGCCACGATCGGGCATTTGTTGATGAAGTGGTTGATCATATTTTGGCGATTGAAAAAAGTCAATTGACACTGTATCAAGGGGATTTTTCTATTTATGAAGAGCAAAAAAAATTAAGAGATGCTTTTGAACTAGCAGAAAATGAAAAAATCAAAAAAGAAGTCAATCGCTTGAAAGAAACCGCTCGTAAAAAAGCGGAATGGTCGATGAACCGTGAAGGTGATAAGTACGGCAATGCTAAAGAAAAAGGGAGCGGGGCGATTTTTGATACAGGAGCCATTGGTGCCCGGGCAGCGCGCGTAATGAAGCGCTCGAAACACATTCAACAACGTGCCGAAACACAATTAGCAGAAAAAGAAAAACTATTAAAAGATCTTGAGTATATTGATCCTTTGTCAATGGATTATCAGCCAACGCATCACAAAACATTATTGACGGTGGAAGAGCTTCGTCTAGGCTACGAGAAAAATTGGCTATTTACGCCAATTTCTTTTTCAATAAACGCGGGAGAAATTGTCGGAATAACAGGAAAAAATGGCTCAGGAAAATCGAGCTTGATTCAGTATTTGTTGGGGGATTTTTCTGGAGATTCAGAAGGAGAAGCCACTCTGGCTCACCAATTAACCATTTCTTATGTGCGCCAAGATTATGAAGACAATCAAGGAACTTTATCCGAATTTGCAGAGAAAAATCAGTTAGATTACACCCAATTTTTAAATAACTTACGAAAACTTGGGATGGAGCGCGCCGTTTTCACTAATCGAATTGAACAAATGAGTATGGGGCAACGGAAAAAAGTCGAAGTAGCCAAATCATTGTCTCAATCAGCTGAACTTTATATTTGGGATGAACCCCTTAATTACTTGGATGTGTTTAATCATCAACAATTAGAAGCGCTAATCTTATCTGTGAGGCCTGCAATGCTAGTGATTGAGCATGATGCACATTTCATGAAGAAAATAACGGATAAAAAAATTGCCTTGAAATCATAA", "partial": "0", "query_start": 51457, "query_end": 51963, "hit_start": 99, "hit_end": 516, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 25.86}, "gnl|BL_ORD_ID|959|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "vgaD", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1020", "model_id": "1046", "ARO_accession": "3002832", "ARO_name": "vgaD", "ARO_category": {"36252": {"category_aro_accession": "3000113", "category_aro_cvterm_id": "36252", "category_aro_name": "vga-type ABC-F protein", "category_aro_description": "Vga-type plasmid-borne ABC-F proteins, expressed in staphylococci that confer resistance to streptogramin A antibiotics through ribosomal protection.", "category_aro_class_name": "AMR Gene Family"}, "37018": {"category_aro_accession": "3000674", "category_aro_cvterm_id": "37018", "category_aro_name": "dalfopristin", "category_aro_description": "Dalfopristin is a water-soluble semi-synthetic derivative of pristinamycin IIA. It is produced by Streptomyces pristinaespiralis and is used in combination with quinupristin in a 7:3 ratio. Both work together to inhibit protein synthesis, and is active against Gram-positive bacteria.", "category_aro_class_name": "Antibiotic"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35952": {"category_aro_accession": "0000034", "category_aro_cvterm_id": "35952", "category_aro_name": "streptogramin A antibiotic", "category_aro_description": "Streptogramin A antibiotics are cyclic polyketide peptide hybrids that bind to the ribosomal peptidyl transfer centre. Structural variation arises from substituting a proline for its desaturated derivative and by its substitution for Ala or Cys. Used alone, streptogramin A antibiotics are bacteriostatic, but is bactericidal when used with streptogramin B antibiotics.", "category_aro_class_name": "Drug Class"}, "37014": {"category_aro_accession": "3000670", "category_aro_cvterm_id": "37014", "category_aro_name": "pleuromutilin antibiotic", "category_aro_description": "Pleuromutilins are natural fungal products that target bacterial protein translation by binding the the 23S rRNA, blocking the ribosome P site at the 50S subunit. They are mostly used for agriculture and veterinary purposes.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.57899e-06, "max_identities": 49, "bit_score": 45.0542, "cvterm_id": "36779", "query": "GEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFN-LVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNE-LSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTH-ANAVVRLADGKILD", "match": "GE  +I G +G GKTT L  I  ++   +  +S   +                 IG+  Q+ + L + +S+ +NV           A +  T V T+L ++   +   ++  + LSGG+R +VA A+  V+    ++ DEPT  LD     + I+ ++EL        +F +HD + + + A+ ++ L+D K+++", "sequence_from_db": "GEKAAIIGNNGVGKTTLLKQI--LERVPAVTISPAAK-----------------IGYFSQNLDTLDTHVSILENV--------MSTAIQDETTVRTVLARLHFYREDVYKEVQVLSGGERVKVAFAKLFVSDYNTLILDEPTNYLDI----DAIEALEELLINYEGAVLFVSHDCRFVQNIASKIIELSDQKVIE", "sequence_from_broadstreet": "MLILEANHIEKSINDRKLLDVTHLQIHYEDRIGVVGRNGSGKTTLLSILAGEIEADKGEVKTSASRYFLPQLKETDTFRSGGEITKSYIDKALAMKAEILFADEPTTNLDTHNIKELEKHFSRYRGAIILVSHNRYFLDQICTKIWEIEDGEVKEIHGNYTSYVKQKELLRRQQQEEYEKYITKKKQLERAVTMKEQKAQKMIKPPSKQMGTSESRIWKMQHATKQKKMHQNIKALETRVEKLERVKKPKDYPAVKMKLSNQDQIQGRNVLRVKDLSVSFGNHVLWTDASFTIKGGEKAAIIGNNGVGKTTLLKQILERVPAVTISPAAKIGYFSQNLDTLDTHVSILENVMSTAIQDETTVRTVLARLHFYREDVYKEVQVLSGGERVKVAFAKLFVSDYNTLILDEPTNYLDIDAIEALEELLINYEGAVLFVSHDCRFVQNIASKIIELSDQKVIEFLGSYKAFRERSQETERDYMKEELLKIEIKLTQMISEMNDEASNELEKEFQMLIHERNQLRNQVNN", "dna_sequence_from_broadstreet": "ATGCTCATTCTTGAAGCGAATCATATTGAAAAATCTATAAATGACCGGAAACTTTTAGATGTTACTCATCTACAAATTCATTATGAGGATCGGATTGGTGTAGTTGGTCGTAATGGAAGCGGGAAAACGACATTATTATCTATATTGGCTGGTGAAATAGAAGCAGATAAAGGTGAAGTGAAAACAAGTGCAAGTCGCTACTTTTTACCTCAATTGAAGGAGACGGATACTTTCAGAAGTGGTGGTGAGATAACAAAAAGCTATATTGACAAAGCATTAGCGATGAAGGCGGAAATATTGTTTGCCGACGAACCAACTACAAACCTTGATACCCACAATATAAAAGAACTTGAAAAGCATTTCAGTCGATATCGGGGGGCAATCATTCTTGTATCACATAACCGGTATTTTTTAGATCAAATTTGTACAAAAATATGGGAAATTGAAGATGGAGAAGTGAAAGAAATTCACGGTAACTATACAAGTTATGTAAAACAAAAAGAACTACTTCGTCGACAGCAACAAGAGGAATATGAAAAATATATAACGAAGAAAAAGCAACTGGAGCGAGCTGTTACCATGAAAGAACAAAAGGCGCAAAAAATGATTAAGCCTCCTTCTAAACAAATGGGTACTTCTGAATCTCGAATATGGAAGATGCAGCATGCGACTAAACAAAAGAAAATGCATCAAAATATTAAGGCTCTTGAAACACGTGTTGAAAAACTAGAGCGTGTGAAAAAACCAAAAGATTATCCGGCTGTCAAAATGAAGTTGTCTAACCAAGATCAAATACAGGGGCGCAATGTACTTCGGGTAAAAGACTTATCTGTTTCCTTTGGGAATCATGTGCTTTGGACAGATGCTTCTTTTACCATTAAAGGCGGGGAGAAGGCTGCCATTATTGGCAATAATGGGGTCGGTAAAACAACATTGTTGAAACAAATTTTAGAAAGGGTACCAGCGGTAACAATATCACCCGCAGCAAAAATCGGCTATTTTAGCCAGAATTTGGATACGCTTGATACGCATGTGTCGATCTTAGAAAATGTCATGTCCACCGCTATTCAAGATGAAACTACTGTACGGACTGTTCTCGCAAGATTACATTTCTACCGGGAGGATGTTTATAAGGAAGTTCAAGTCCTAAGTGGTGGGGAACGTGTGAAGGTTGCTTTTGCAAAACTATTTGTTAGCGACTATAATACGTTGATTCTGGATGAACCAACAAATTATTTAGACATTGATGCCATAGAAGCGTTAGAGGAGCTCCTAATTAACTATGAGGGGGCAGTACTATTTGTATCTCATGATTGTCGTTTCGTTCAAAATATTGCATCCAAAATTATTGAACTATCCGACCAGAAGGTTATAGAGTTTCTTGGAAGCTATAAAGCGTTTAGAGAAAGATCTCAAGAGACAGAGCGTGACTATATGAAGGAAGAACTTCTTAAAATTGAGATCAAACTCACTCAAATGATTAGTGAAATGAATGACGAGGCATCAAATGAATTAGAAAAAGAATTCCAAATGTTGATTCATGAACGTAATCAGTTAAGAAATCAAGTAAACAATTAG", "partial": "0", "query_start": 51448, "query_end": 52023, "hit_start": 885, "hit_end": 1377, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 25.13}, "gnl|BL_ORD_ID|959|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "vgaD", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1020", "model_id": "1046", "ARO_accession": "3002832", "ARO_name": "vgaD", "ARO_category": {"36252": {"category_aro_accession": "3000113", "category_aro_cvterm_id": "36252", "category_aro_name": "vga-type ABC-F protein", "category_aro_description": "Vga-type plasmid-borne ABC-F proteins, expressed in staphylococci that confer resistance to streptogramin A antibiotics through ribosomal protection.", "category_aro_class_name": "AMR Gene Family"}, "37018": {"category_aro_accession": "3000674", "category_aro_cvterm_id": "37018", "category_aro_name": "dalfopristin", "category_aro_description": "Dalfopristin is a water-soluble semi-synthetic derivative of pristinamycin IIA. It is produced by Streptomyces pristinaespiralis and is used in combination with quinupristin in a 7:3 ratio. Both work together to inhibit protein synthesis, and is active against Gram-positive bacteria.", "category_aro_class_name": "Antibiotic"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35952": {"category_aro_accession": "0000034", "category_aro_cvterm_id": "35952", "category_aro_name": "streptogramin A antibiotic", "category_aro_description": "Streptogramin A antibiotics are cyclic polyketide peptide hybrids that bind to the ribosomal peptidyl transfer centre. Structural variation arises from substituting a proline for its desaturated derivative and by its substitution for Ala or Cys. Used alone, streptogramin A antibiotics are bacteriostatic, but is bactericidal when used with streptogramin B antibiotics.", "category_aro_class_name": "Drug Class"}, "37014": {"category_aro_accession": "3000670", "category_aro_cvterm_id": "37014", "category_aro_name": "pleuromutilin antibiotic", "category_aro_description": "Pleuromutilins are natural fungal products that target bacterial protein translation by binding the the 23S rRNA, blocking the ribosome P site at the 50S subunit. They are mostly used for agriculture and veterinary purposes.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.68225e-05, "max_identities": 22, "bit_score": 41.2022, "cvterm_id": "36779", "query": "SGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKI", "match": "SGG+  +  + +AL  + +++ ADEPT NLD+    NI +L K  +R  G   + S +   +      +  + DG++", "sequence_from_db": "SGGEITKSYIDKALAMKAEILFADEPTTNLDT---HNIKELEKHFSRYRGAIILVSHNRYFLDQICTKIWEIEDGEV", "sequence_from_broadstreet": "MLILEANHIEKSINDRKLLDVTHLQIHYEDRIGVVGRNGSGKTTLLSILAGEIEADKGEVKTSASRYFLPQLKETDTFRSGGEITKSYIDKALAMKAEILFADEPTTNLDTHNIKELEKHFSRYRGAIILVSHNRYFLDQICTKIWEIEDGEVKEIHGNYTSYVKQKELLRRQQQEEYEKYITKKKQLERAVTMKEQKAQKMIKPPSKQMGTSESRIWKMQHATKQKKMHQNIKALETRVEKLERVKKPKDYPAVKMKLSNQDQIQGRNVLRVKDLSVSFGNHVLWTDASFTIKGGEKAAIIGNNGVGKTTLLKQILERVPAVTISPAAKIGYFSQNLDTLDTHVSILENVMSTAIQDETTVRTVLARLHFYREDVYKEVQVLSGGERVKVAFAKLFVSDYNTLILDEPTNYLDIDAIEALEELLINYEGAVLFVSHDCRFVQNIASKIIELSDQKVIEFLGSYKAFRERSQETERDYMKEELLKIEIKLTQMISEMNDEASNELEKEFQMLIHERNQLRNQVNN", "dna_sequence_from_broadstreet": "ATGCTCATTCTTGAAGCGAATCATATTGAAAAATCTATAAATGACCGGAAACTTTTAGATGTTACTCATCTACAAATTCATTATGAGGATCGGATTGGTGTAGTTGGTCGTAATGGAAGCGGGAAAACGACATTATTATCTATATTGGCTGGTGAAATAGAAGCAGATAAAGGTGAAGTGAAAACAAGTGCAAGTCGCTACTTTTTACCTCAATTGAAGGAGACGGATACTTTCAGAAGTGGTGGTGAGATAACAAAAAGCTATATTGACAAAGCATTAGCGATGAAGGCGGAAATATTGTTTGCCGACGAACCAACTACAAACCTTGATACCCACAATATAAAAGAACTTGAAAAGCATTTCAGTCGATATCGGGGGGCAATCATTCTTGTATCACATAACCGGTATTTTTTAGATCAAATTTGTACAAAAATATGGGAAATTGAAGATGGAGAAGTGAAAGAAATTCACGGTAACTATACAAGTTATGTAAAACAAAAAGAACTACTTCGTCGACAGCAACAAGAGGAATATGAAAAATATATAACGAAGAAAAAGCAACTGGAGCGAGCTGTTACCATGAAAGAACAAAAGGCGCAAAAAATGATTAAGCCTCCTTCTAAACAAATGGGTACTTCTGAATCTCGAATATGGAAGATGCAGCATGCGACTAAACAAAAGAAAATGCATCAAAATATTAAGGCTCTTGAAACACGTGTTGAAAAACTAGAGCGTGTGAAAAAACCAAAAGATTATCCGGCTGTCAAAATGAAGTTGTCTAACCAAGATCAAATACAGGGGCGCAATGTACTTCGGGTAAAAGACTTATCTGTTTCCTTTGGGAATCATGTGCTTTGGACAGATGCTTCTTTTACCATTAAAGGCGGGGAGAAGGCTGCCATTATTGGCAATAATGGGGTCGGTAAAACAACATTGTTGAAACAAATTTTAGAAAGGGTACCAGCGGTAACAATATCACCCGCAGCAAAAATCGGCTATTTTAGCCAGAATTTGGATACGCTTGATACGCATGTGTCGATCTTAGAAAATGTCATGTCCACCGCTATTCAAGATGAAACTACTGTACGGACTGTTCTCGCAAGATTACATTTCTACCGGGAGGATGTTTATAAGGAAGTTCAAGTCCTAAGTGGTGGGGAACGTGTGAAGGTTGCTTTTGCAAAACTATTTGTTAGCGACTATAATACGTTGATTCTGGATGAACCAACAAATTATTTAGACATTGATGCCATAGAAGCGTTAGAGGAGCTCCTAATTAACTATGAGGGGGCAGTACTATTTGTATCTCATGATTGTCGTTTCGTTCAAAATATTGCATCCAAAATTATTGAACTATCCGACCAGAAGGTTATAGAGTTTCTTGGAAGCTATAAAGCGTTTAGAGAAAGATCTCAAGAGACAGAGCGTGACTATATGAAGGAAGAACTTCTTAAAATTGAGATCAAACTCACTCAAATGATTAGTGAAATGAATGACGAGGCATCAAATGAATTAGAAAAAGAATTCCAAATGTTGATTCATGAACGTAATCAGTTAAGAAATCAAGTAAACAATTAG", "partial": "0", "query_start": 51787, "query_end": 52017, "hit_start": 237, "hit_end": 459, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 28.57}, "gnl|BL_ORD_ID|959|hsp_num:2": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "vgaD", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1020", "model_id": "1046", "ARO_accession": "3002832", "ARO_name": "vgaD", "ARO_category": {"36252": {"category_aro_accession": "3000113", "category_aro_cvterm_id": "36252", "category_aro_name": "vga-type ABC-F protein", "category_aro_description": "Vga-type plasmid-borne ABC-F proteins, expressed in staphylococci that confer resistance to streptogramin A antibiotics through ribosomal protection.", "category_aro_class_name": "AMR Gene Family"}, "37018": {"category_aro_accession": "3000674", "category_aro_cvterm_id": "37018", "category_aro_name": "dalfopristin", "category_aro_description": "Dalfopristin is a water-soluble semi-synthetic derivative of pristinamycin IIA. It is produced by Streptomyces pristinaespiralis and is used in combination with quinupristin in a 7:3 ratio. Both work together to inhibit protein synthesis, and is active against Gram-positive bacteria.", "category_aro_class_name": "Antibiotic"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35952": {"category_aro_accession": "0000034", "category_aro_cvterm_id": "35952", "category_aro_name": "streptogramin A antibiotic", "category_aro_description": "Streptogramin A antibiotics are cyclic polyketide peptide hybrids that bind to the ribosomal peptidyl transfer centre. Structural variation arises from substituting a proline for its desaturated derivative and by its substitution for Ala or Cys. Used alone, streptogramin A antibiotics are bacteriostatic, but is bactericidal when used with streptogramin B antibiotics.", "category_aro_class_name": "Drug Class"}, "37014": {"category_aro_accession": "3000670", "category_aro_cvterm_id": "37014", "category_aro_name": "pleuromutilin antibiotic", "category_aro_description": "Pleuromutilins are natural fungal products that target bacterial protein translation by binding the the 23S rRNA, blocking the ribosome P site at the 50S subunit. They are mostly used for agriculture and veterinary purposes.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.44094, "max_identities": 13, "bit_score": 27.335, "cvterm_id": "36779", "query": "LEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVV", "match": "L+++  + I + G +GSGKTT L+++     A  G V", "sequence_from_db": "LQIHYEDRIGVVGRNGSGKTTLLSILAGEIEADKGEV", "sequence_from_broadstreet": "MLILEANHIEKSINDRKLLDVTHLQIHYEDRIGVVGRNGSGKTTLLSILAGEIEADKGEVKTSASRYFLPQLKETDTFRSGGEITKSYIDKALAMKAEILFADEPTTNLDTHNIKELEKHFSRYRGAIILVSHNRYFLDQICTKIWEIEDGEVKEIHGNYTSYVKQKELLRRQQQEEYEKYITKKKQLERAVTMKEQKAQKMIKPPSKQMGTSESRIWKMQHATKQKKMHQNIKALETRVEKLERVKKPKDYPAVKMKLSNQDQIQGRNVLRVKDLSVSFGNHVLWTDASFTIKGGEKAAIIGNNGVGKTTLLKQILERVPAVTISPAAKIGYFSQNLDTLDTHVSILENVMSTAIQDETTVRTVLARLHFYREDVYKEVQVLSGGERVKVAFAKLFVSDYNTLILDEPTNYLDIDAIEALEELLINYEGAVLFVSHDCRFVQNIASKIIELSDQKVIEFLGSYKAFRERSQETERDYMKEELLKIEIKLTQMISEMNDEASNELEKEFQMLIHERNQLRNQVNN", "dna_sequence_from_broadstreet": "ATGCTCATTCTTGAAGCGAATCATATTGAAAAATCTATAAATGACCGGAAACTTTTAGATGTTACTCATCTACAAATTCATTATGAGGATCGGATTGGTGTAGTTGGTCGTAATGGAAGCGGGAAAACGACATTATTATCTATATTGGCTGGTGAAATAGAAGCAGATAAAGGTGAAGTGAAAACAAGTGCAAGTCGCTACTTTTTACCTCAATTGAAGGAGACGGATACTTTCAGAAGTGGTGGTGAGATAACAAAAAGCTATATTGACAAAGCATTAGCGATGAAGGCGGAAATATTGTTTGCCGACGAACCAACTACAAACCTTGATACCCACAATATAAAAGAACTTGAAAAGCATTTCAGTCGATATCGGGGGGCAATCATTCTTGTATCACATAACCGGTATTTTTTAGATCAAATTTGTACAAAAATATGGGAAATTGAAGATGGAGAAGTGAAAGAAATTCACGGTAACTATACAAGTTATGTAAAACAAAAAGAACTACTTCGTCGACAGCAACAAGAGGAATATGAAAAATATATAACGAAGAAAAAGCAACTGGAGCGAGCTGTTACCATGAAAGAACAAAAGGCGCAAAAAATGATTAAGCCTCCTTCTAAACAAATGGGTACTTCTGAATCTCGAATATGGAAGATGCAGCATGCGACTAAACAAAAGAAAATGCATCAAAATATTAAGGCTCTTGAAACACGTGTTGAAAAACTAGAGCGTGTGAAAAAACCAAAAGATTATCCGGCTGTCAAAATGAAGTTGTCTAACCAAGATCAAATACAGGGGCGCAATGTACTTCGGGTAAAAGACTTATCTGTTTCCTTTGGGAATCATGTGCTTTGGACAGATGCTTCTTTTACCATTAAAGGCGGGGAGAAGGCTGCCATTATTGGCAATAATGGGGTCGGTAAAACAACATTGTTGAAACAAATTTTAGAAAGGGTACCAGCGGTAACAATATCACCCGCAGCAAAAATCGGCTATTTTAGCCAGAATTTGGATACGCTTGATACGCATGTGTCGATCTTAGAAAATGTCATGTCCACCGCTATTCAAGATGAAACTACTGTACGGACTGTTCTCGCAAGATTACATTTCTACCGGGAGGATGTTTATAAGGAAGTTCAAGTCCTAAGTGGTGGGGAACGTGTGAAGGTTGCTTTTGCAAAACTATTTGTTAGCGACTATAATACGTTGATTCTGGATGAACCAACAAATTATTTAGACATTGATGCCATAGAAGCGTTAGAGGAGCTCCTAATTAACTATGAGGGGGCAGTACTATTTGTATCTCATGATTGTCGTTTCGTTCAAAATATTGCATCCAAAATTATTGAACTATCCGACCAGAAGGTTATAGAGTTTCTTGGAAGCTATAAAGCGTTTAGAGAAAGATCTCAAGAGACAGAGCGTGACTATATGAAGGAAGAACTTCTTAAAATTGAGATCAAACTCACTCAAATGATTAGTGAAATGAATGACGAGGCATCAAATGAATTAGAAAAAGAATTCCAAATGTTGATTCATGAACGTAATCAGTTAAGAAATCAAGTAAACAATTAG", "partial": "0", "query_start": 51433, "query_end": 51543, "hit_start": 69, "hit_end": 180, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 35.14}, "gnl|BL_ORD_ID|2051|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "salA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1100", "model_id": "2265", "ARO_accession": "3003749", "ARO_name": "salA", "ARO_category": {"45589": {"category_aro_accession": "3007030", "category_aro_cvterm_id": "45589", "category_aro_name": "sal-type ABC-F protein", "category_aro_description": "Sal proteins are a part of the ABC-F proteins, expressed in staphylococci that confer resistance to group A streptogramin, lincosamide, and pleuromutilin antibiotics through ribosomal protection.", "category_aro_class_name": "AMR Gene Family"}, "35964": {"category_aro_accession": "0000046", "category_aro_cvterm_id": "35964", "category_aro_name": "lincomycin", "category_aro_description": "Lincomycin is a lincosamide antibiotic that comes from the actinomyces Streptomyces lincolnensis. It binds to the 23s portion of the 50S subunit of bacterial ribosomes and inhibit early elongation of peptide chain by inhibiting transpeptidase reaction.", "category_aro_class_name": "Antibiotic"}, "35983": {"category_aro_accession": "0000066", "category_aro_cvterm_id": "35983", "category_aro_name": "clindamycin", "category_aro_description": "Clindamycin is a lincosamide antibiotic that blocks A-site aminoacyl-tRNA binding. It is usually used to treat infections with anaerobic bacteria but can also be used to treat some protozoal diseases, such as malaria.", "category_aro_class_name": "Antibiotic"}, "37013": {"category_aro_accession": "3000669", "category_aro_cvterm_id": "37013", "category_aro_name": "virginiamycin M1", "category_aro_description": "Virginiamycin M1 is a streptogramin A antibiotic.", "category_aro_class_name": "Antibiotic"}, "37015": {"category_aro_accession": "3000671", "category_aro_cvterm_id": "37015", "category_aro_name": "tiamulin", "category_aro_description": "Tiamulin is a pleuromutilin derivative currently used in veterinary medicine. It binds to the 23 rRNA of the 50S ribosomal subunit to inhibit protein translation.", "category_aro_class_name": "Antibiotic"}, "37713": {"category_aro_accession": "3001314", "category_aro_cvterm_id": "37713", "category_aro_name": "retapamulin", "category_aro_description": "Retapamulin is a semi-synthetic pleuromutilin antibiotic approved for the treatment of skin infections.", "category_aro_class_name": "Antibiotic"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35952": {"category_aro_accession": "0000034", "category_aro_cvterm_id": "35952", "category_aro_name": "streptogramin A antibiotic", "category_aro_description": "Streptogramin A antibiotics are cyclic polyketide peptide hybrids that bind to the ribosomal peptidyl transfer centre. Structural variation arises from substituting a proline for its desaturated derivative and by its substitution for Ala or Cys. Used alone, streptogramin A antibiotics are bacteriostatic, but is bactericidal when used with streptogramin B antibiotics.", "category_aro_class_name": "Drug Class"}, "37014": {"category_aro_accession": "3000670", "category_aro_cvterm_id": "37014", "category_aro_name": "pleuromutilin antibiotic", "category_aro_description": "Pleuromutilins are natural fungal products that target bacterial protein translation by binding the the 23S rRNA, blocking the ribosome P site at the 50S subunit. They are mostly used for agriculture and veterinary purposes.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.88647e-06, "max_identities": 46, "bit_score": 44.2838, "cvterm_id": "36794", "query": "KVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLT-HLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGL-EKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHA-NAVVRLA-DG", "match": "KV +P L   T  +   E ++I G +G GK+T L +I    +  S ++           E+ LT +     + +I +S+  ++ + +  N    +    +L+       ++T  +++G+ E+  + + + LSGG++ +V+  +  +++  L+L DEPT ++D    + +    K+  R      +F +HD   +    +A++ L+ DG", "sequence_from_db": "KVLIPEL---TFSIEDHEHLAIVGVNGVGKSTLLKVIHQDQSVDSAMM-----------EQDLTPYYDWTVMDYIIESYPEIAKIRLQLNHTDMINKYIELDGYIIEGEIVTEAKKLGIKEEQLEQKISTLSGGEQTKVSFLKVKMSKASLLLIDEPTNHMDLEMKEWLTKAFKQEQR----AILFVSHDRTFLNETPDAILELSLDG", "sequence_from_broadstreet": "MLFLFEEKALEVEHKVLIPELTFSIEDHEHLAIVGVNGVGKSTLLKVIHQDQSVDSAMMEQDLTPYYDWTVMDYIIESYPEIAKIRLQLNHTDMINKYIELDGYIIEGEIVTEAKKLGIKEEQLEQKISTLSGGEQTKVSFLKVKMSKASLLLIDEPTNHMDLEMKEWLTKAFKQEQRAILFVSHDRTFLNETPDAILELSLDGAKKYIGKYDKYKQQKDIEHETLKLQYEKQQKEQAAIEETIKKYKAWYQKAEQSASVRSPYQQKQLSKLAKRFKSKEQQLNRKLDQEHIPNPHKKEKTFSIQHHNFKSHYLVQFNHVSFAYDNRKIFDDVSFYIKRNQNVIVEGRNGTGKSTLIKLILGELEPTKGDITVHPELEIGYFSQDFENLNMHHTVLDEILEIPEMKEADARTILASFYFDKDRINDVVETLSMGEKCRLQFVKLYFSNPHIMILDEPTNYFDIGMQENIIQLIQSFQGSVLIVSHDNYFKSQIKDQTWTIKNHQMTHENVQVKDPINTESMKHHLKELEQYTDERNRETEF", "dna_sequence_from_broadstreet": "ATGCTATTTTTATTTGAAGAAAAAGCATTAGAAGTTGAACATAAAGTATTAATACCCGAGTTGACTTTTTCAATAGAGGACCATGAACATTTAGCAATCGTTGGTGTTAATGGTGTTGGAAAATCAACATTATTAAAAGTCATTCATCAAGATCAATCAGTTGATTCAGCGATGATGGAACAAGATTTAACACCTTATTATGATTGGACTGTTATGGATTATATAATTGAATCATATCCTGAAATCGCAAAGATTAGATTGCAACTTAATCATACAGATATGATTAATAAATATATTGAATTAGATGGATACATTATAGAAGGTGAAATCGTAACAGAAGCAAAAAAGCTCGGAATAAAAGAGGAACAACTAGAACAGAAAATTTCTACTTTAAGTGGTGGAGAACAAACAAAAGTATCATTTTTAAAAGTGAAAATGTCTAAAGCATCATTACTATTAATCGATGAACCAACAAACCACATGGATTTAGAAATGAAGGAATGGTTGACGAAAGCTTTTAAACAAGAACAACGTGCTATATTATTTGTATCTCATGACCGAACATTTTTAAATGAAACGCCAGATGCTATATTAGAATTGAGTCTTGATGGGGCTAAGAAGTATATCGGTAAATACGATAAATACAAACAACAAAAAGATATAGAGCATGAAACATTAAAGCTACAGTATGAAAAACAACAAAAAGAACAAGCGGCCATTGAAGAAACGATTAAAAAATATAAAGCATGGTATCAAAAAGCAGAACAAAGTGCTTCTGTGAGAAGCCCATATCAACAAAAACAATTAAGTAAGTTAGCGAAACGGTTTAAATCAAAAGAACAACAATTAAATCGTAAACTTGATCAAGAGCATATCCCAAATCCACATAAAAAAGAGAAAACTTTCTCAATACAACATCATAATTTTAAATCACATTATTTAGTTCAATTTAATCATGTTTCGTTTGCTTATGATAACCGGAAAATATTCGATGATGTATCATTCTATATTAAGCGAAATCAAAATGTTATTGTTGAAGGCAGAAATGGTACAGGTAAATCAACTTTAATCAAATTGATACTCGGTGAACTCGAGCCAACTAAAGGTGATATAACTGTTCATCCAGAATTAGAAATTGGATATTTCTCTCAAGATTTTGAGAATTTAAATATGCATCATACTGTCTTAGATGAAATATTAGAAATTCCTGAAATGAAAGAAGCAGATGCAAGAACCATATTAGCAAGCTTTTATTTTGATAAAGATAGGATAAATGATGTTGTTGAAACACTATCGATGGGTGAAAAATGTAGGTTACAATTTGTAAAATTATATTTTTCAAATCCTCATATTATGATATTAGATGAGCCAACAAACTATTTCGATATTGGCATGCAAGAAAATATCATTCAATTAATACAATCATTTCAAGGTTCGGTCCTTATTGTATCTCATGATAATTATTTTAAATCACAAATTAAAGATCAGACTTGGACTATAAAAAATCATCAAATGACGCATGAAAATGTTCAAGTCAAAGATCCTATTAATACAGAATCTATGAAACATCATTTAAAAGAATTAGAACAATATACAGATGAAAGAAATCGTGAAACAGAGTTCTAG", "partial": "0", "query_start": 51400, "query_end": 52011, "hit_start": 42, "hit_end": 612, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 22.12}, "gnl|BL_ORD_ID|2051|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "salA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1100", "model_id": "2265", "ARO_accession": "3003749", "ARO_name": "salA", "ARO_category": {"45589": {"category_aro_accession": "3007030", "category_aro_cvterm_id": "45589", "category_aro_name": "sal-type ABC-F protein", "category_aro_description": "Sal proteins are a part of the ABC-F proteins, expressed in staphylococci that confer resistance to group A streptogramin, lincosamide, and pleuromutilin antibiotics through ribosomal protection.", "category_aro_class_name": "AMR Gene Family"}, "35964": {"category_aro_accession": "0000046", "category_aro_cvterm_id": "35964", "category_aro_name": "lincomycin", "category_aro_description": "Lincomycin is a lincosamide antibiotic that comes from the actinomyces Streptomyces lincolnensis. It binds to the 23s portion of the 50S subunit of bacterial ribosomes and inhibit early elongation of peptide chain by inhibiting transpeptidase reaction.", "category_aro_class_name": "Antibiotic"}, "35983": {"category_aro_accession": "0000066", "category_aro_cvterm_id": "35983", "category_aro_name": "clindamycin", "category_aro_description": "Clindamycin is a lincosamide antibiotic that blocks A-site aminoacyl-tRNA binding. It is usually used to treat infections with anaerobic bacteria but can also be used to treat some protozoal diseases, such as malaria.", "category_aro_class_name": "Antibiotic"}, "37013": {"category_aro_accession": "3000669", "category_aro_cvterm_id": "37013", "category_aro_name": "virginiamycin M1", "category_aro_description": "Virginiamycin M1 is a streptogramin A antibiotic.", "category_aro_class_name": "Antibiotic"}, "37015": {"category_aro_accession": "3000671", "category_aro_cvterm_id": "37015", "category_aro_name": "tiamulin", "category_aro_description": "Tiamulin is a pleuromutilin derivative currently used in veterinary medicine. It binds to the 23 rRNA of the 50S ribosomal subunit to inhibit protein translation.", "category_aro_class_name": "Antibiotic"}, "37713": {"category_aro_accession": "3001314", "category_aro_cvterm_id": "37713", "category_aro_name": "retapamulin", "category_aro_description": "Retapamulin is a semi-synthetic pleuromutilin antibiotic approved for the treatment of skin infections.", "category_aro_class_name": "Antibiotic"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35952": {"category_aro_accession": "0000034", "category_aro_cvterm_id": "35952", "category_aro_name": "streptogramin A antibiotic", "category_aro_description": "Streptogramin A antibiotics are cyclic polyketide peptide hybrids that bind to the ribosomal peptidyl transfer centre. Structural variation arises from substituting a proline for its desaturated derivative and by its substitution for Ala or Cys. Used alone, streptogramin A antibiotics are bacteriostatic, but is bactericidal when used with streptogramin B antibiotics.", "category_aro_class_name": "Drug Class"}, "37014": {"category_aro_accession": "3000670", "category_aro_cvterm_id": "37014", "category_aro_name": "pleuromutilin antibiotic", "category_aro_description": "Pleuromutilins are natural fungal products that target bacterial protein translation by binding the the 23S rRNA, blocking the ribosome P site at the 50S subunit. They are mostly used for agriculture and veterinary purposes.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000588332, "max_identities": 54, "bit_score": 38.1206, "cvterm_id": "36794", "query": "IVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSF-NLVSVLSVFQNV-EFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNE----LSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKV---------------MTHANAVVR", "match": "+V    V+  Y   K+       V+  +   + + + G +G+GK+T + LI      + G ++V              H  L  IG+  Q F NL    +V   + E P     ++  ++ RT + +           K R N+    LS G++ R+   +   + P +++ DEPT   D    +NII L++     +G+  I S HD                  MTH N  V+", "sequence_from_db": "LVQFNHVSFAYDNRKI----FDDVSFYIKRNQNVIVEGRNGTGKSTLIKLILGELEPTKGDITV--------------HPEL-EIGYFSQDFENLNMHHTVLDEILEIP-----EMKEADARTILASFY-------FDKDRINDVVETLSMGEKCRLQFVKLYFSNPHIMILDEPTNYFDIGMQENIIQLIQSF---QGSVLIVS-HDNYFKSQIKDQTWTIKNHQMTHENVQVK", "sequence_from_broadstreet": "MLFLFEEKALEVEHKVLIPELTFSIEDHEHLAIVGVNGVGKSTLLKVIHQDQSVDSAMMEQDLTPYYDWTVMDYIIESYPEIAKIRLQLNHTDMINKYIELDGYIIEGEIVTEAKKLGIKEEQLEQKISTLSGGEQTKVSFLKVKMSKASLLLIDEPTNHMDLEMKEWLTKAFKQEQRAILFVSHDRTFLNETPDAILELSLDGAKKYIGKYDKYKQQKDIEHETLKLQYEKQQKEQAAIEETIKKYKAWYQKAEQSASVRSPYQQKQLSKLAKRFKSKEQQLNRKLDQEHIPNPHKKEKTFSIQHHNFKSHYLVQFNHVSFAYDNRKIFDDVSFYIKRNQNVIVEGRNGTGKSTLIKLILGELEPTKGDITVHPELEIGYFSQDFENLNMHHTVLDEILEIPEMKEADARTILASFYFDKDRINDVVETLSMGEKCRLQFVKLYFSNPHIMILDEPTNYFDIGMQENIIQLIQSFQGSVLIVSHDNYFKSQIKDQTWTIKNHQMTHENVQVKDPINTESMKHHLKELEQYTDERNRETEF", "dna_sequence_from_broadstreet": "ATGCTATTTTTATTTGAAGAAAAAGCATTAGAAGTTGAACATAAAGTATTAATACCCGAGTTGACTTTTTCAATAGAGGACCATGAACATTTAGCAATCGTTGGTGTTAATGGTGTTGGAAAATCAACATTATTAAAAGTCATTCATCAAGATCAATCAGTTGATTCAGCGATGATGGAACAAGATTTAACACCTTATTATGATTGGACTGTTATGGATTATATAATTGAATCATATCCTGAAATCGCAAAGATTAGATTGCAACTTAATCATACAGATATGATTAATAAATATATTGAATTAGATGGATACATTATAGAAGGTGAAATCGTAACAGAAGCAAAAAAGCTCGGAATAAAAGAGGAACAACTAGAACAGAAAATTTCTACTTTAAGTGGTGGAGAACAAACAAAAGTATCATTTTTAAAAGTGAAAATGTCTAAAGCATCATTACTATTAATCGATGAACCAACAAACCACATGGATTTAGAAATGAAGGAATGGTTGACGAAAGCTTTTAAACAAGAACAACGTGCTATATTATTTGTATCTCATGACCGAACATTTTTAAATGAAACGCCAGATGCTATATTAGAATTGAGTCTTGATGGGGCTAAGAAGTATATCGGTAAATACGATAAATACAAACAACAAAAAGATATAGAGCATGAAACATTAAAGCTACAGTATGAAAAACAACAAAAAGAACAAGCGGCCATTGAAGAAACGATTAAAAAATATAAAGCATGGTATCAAAAAGCAGAACAAAGTGCTTCTGTGAGAAGCCCATATCAACAAAAACAATTAAGTAAGTTAGCGAAACGGTTTAAATCAAAAGAACAACAATTAAATCGTAAACTTGATCAAGAGCATATCCCAAATCCACATAAAAAAGAGAAAACTTTCTCAATACAACATCATAATTTTAAATCACATTATTTAGTTCAATTTAATCATGTTTCGTTTGCTTATGATAACCGGAAAATATTCGATGATGTATCATTCTATATTAAGCGAAATCAAAATGTTATTGTTGAAGGCAGAAATGGTACAGGTAAATCAACTTTAATCAAATTGATACTCGGTGAACTCGAGCCAACTAAAGGTGATATAACTGTTCATCCAGAATTAGAAATTGGATATTTCTCTCAAGATTTTGAGAATTTAAATATGCATCATACTGTCTTAGATGAAATATTAGAAATTCCTGAAATGAAAGAAGCAGATGCAAGAACCATATTAGCAAGCTTTTATTTTGATAAAGATAGGATAAATGATGTTGTTGAAACACTATCGATGGGTGAAAAATGTAGGTTACAATTTGTAAAATTATATTTTTCAAATCCTCATATTATGATATTAGATGAGCCAACAAACTATTTCGATATTGGCATGCAAGAAAATATCATTCAATTAATACAATCATTTCAAGGTTCGGTCCTTATTGTATCTCATGATAATTATTTTAAATCACAAATTAAAGATCAGACTTGGACTATAAAAAATCATCAAATGACGCATGAAAATGTTCAAGTCAAAGATCCTATTAATACAGAATCTATGAAACATCATTTAAAAGAATTAGAACAATATACAGATGAAAGAAATCGTGAAACAGAGTTCTAG", "partial": "0", "query_start": 51358, "query_end": 51999, "hit_start": 939, "hit_end": 1539, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 22.98}, "gnl|BL_ORD_ID|236|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "lsaE", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "800", "model_id": "264", "ARO_accession": "3003206", "ARO_name": "lsaE", "ARO_category": {"41696": {"category_aro_accession": "3004472", "category_aro_cvterm_id": "41696", "category_aro_name": "lsa-type ABC-F protein", "category_aro_description": "A subgroup of the ABC-F protein subfamily of ATP-binding cassette proteins. lsa-type ABC-F proteins confer resistance to streptogramin, lincosamide and pleuromutilin antibiotics through antibiotic target protection of the ribosome.", "category_aro_class_name": "AMR Gene Family"}, "35964": {"category_aro_accession": "0000046", "category_aro_cvterm_id": "35964", "category_aro_name": "lincomycin", "category_aro_description": "Lincomycin is a lincosamide antibiotic that comes from the actinomyces Streptomyces lincolnensis. It binds to the 23s portion of the 50S subunit of bacterial ribosomes and inhibit early elongation of peptide chain by inhibiting transpeptidase reaction.", "category_aro_class_name": "Antibiotic"}, "37716": {"category_aro_accession": "3001317", "category_aro_cvterm_id": "37716", "category_aro_name": "pleuromutilin", "category_aro_description": "Pleuromutilin is a natural product antibiotic produced by Clitopilus passeckerianus. Related antibiotics of clinical significance, such as tiamulin and retapamulin, are semi-synthetic derivatives of this compound.", "category_aro_class_name": "Antibiotic"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "37014": {"category_aro_accession": "3000670", "category_aro_cvterm_id": "37014", "category_aro_name": "pleuromutilin antibiotic", "category_aro_description": "Pleuromutilins are natural fungal products that target bacterial protein translation by binding the the 23S rRNA, blocking the ribosome P site at the 50S subunit. They are mostly used for agriculture and veterinary purposes.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.48355e-06, "max_identities": 29, "bit_score": 43.8986, "cvterm_id": "35918", "query": "RVMTLLEQVGLEKHAKHRP-NELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHA", "match": "R ++LL+   +++ A +RP N LS G++ +V +A   +T    +L DEPT +LD +  +N++     L RK+G  FI  +HD  ++   ", "sequence_from_db": "REISLLD---VQEDALYRPFNTLSNGEQTKVLLAALFLTASCFLLIDEPTNHLD-IDARNVV--QNYLKRKKG--FILVSHDRSLLDQC", "sequence_from_broadstreet": "MSLINVSNLTFSYEGSYDNIFENVSFQIDTDWKLGFIGRNGRGKTTFLNLLLGKYAYSGNISSTVKFEYFPYDVEDKSLYTIEVMKSICTECMDWEIFREISLLDVQEDALYRPFNTLSNGEQTKVLLAALFLTASCFLLIDEPTNHLDIDARNVVQNYLKRKKGFILVSHDRSLLDQCVDHILSINKTNIEIQKGNFTSWWENKTLQDNFELAENKKLLKEIGRLSYAAKRSSNWSNKVEKSKYGTTNSGSKLDKGYVGHKAAKAMKRAKNIESRHQEAVLQKSELLHNIEQYDDLKISPLEFHKECLIEANDLSLSYGDKEVCSNLNFRVNIGDRVAIIGKNGSGKSSILKLINGDDIKFTGNFMLASGLKISYISQDTSYLKGNLSEFAYNNKIDETLFKTILRKLDFNREQFDKNMVDFSAGQKKKVLIAKSLCESAHLYIWDEPLNYIDIFSRIQIEKMILEYCPTLLFVEHDDAFCNNICTKNINLGL", "dna_sequence_from_broadstreet": "ATGTCCTTAATAAATGTTTCAAATCTAACTTTTTCATATGAAGGAAGTTATGACAATATTTTTGAAAATGTAAGTTTTCAGATAGATACAGATTGGAAACTCGGTTTTATTGGAAGAAACGGACGCGGTAAAACTACTTTCTTAAATTTACTGCTTGGCAAATATGCGTATTCCGGCAATATAAGTTCTACAGTTAAGTTTGAGTATTTTCCTTATGATGTGGAAGATAAGAGTCTATATACAATTGAAGTAATGAAGAGTATTTGTACGGAATGTATGGATTGGGAGATTTTTCGTGAAATATCATTGCTTGATGTTCAAGAAGATGCTTTATATCGTCCGTTTAATACATTGTCAAATGGTGAGCAAACGAAGGTCCTTCTTGCAGCTTTATTCCTTACAGCGAGTTGTTTCCTGCTTATTGATGAACCTACAAACCATCTTGACATCGATGCACGTAATGTAGTGCAAAACTATTTGAAACGCAAGAAGGGGTTTATTTTGGTATCTCATGATAGAAGCTTACTTGATCAATGTGTTGACCATATACTATCTATCAATAAAACGAATATCGAAATCCAAAAGGGAAATTTTACTTCTTGGTGGGAGAACAAAACGTTACAAGATAATTTTGAACTGGCAGAAAACAAGAAACTCCTTAAAGAAATAGGAAGGTTGTCTTATGCAGCAAAACGTAGTTCAAACTGGTCAAATAAAGTAGAAAAAAGTAAATATGGAACAACAAATTCTGGTTCAAAACTGGATAAGGGTTATGTTGGACATAAGGCTGCAAAAGCGATGAAACGTGCCAAAAATATTGAGTCAAGACATCAGGAAGCCGTTTTACAAAAATCAGAACTGCTCCACAACATTGAACAATATGATGACTTAAAAATTTCACCACTTGAATTTCACAAAGAGTGCTTAATAGAAGCGAATGATTTATCATTGTCTTATGGAGATAAAGAAGTATGCAGTAATCTTAATTTCAGAGTCAATATTGGTGATAGAGTTGCCATTATCGGAAAAAATGGGAGTGGTAAGTCTAGTATCCTAAAATTGATTAATGGAGATGATATTAAATTTACCGGAAATTTTATGCTAGCAAGTGGACTAAAAATTTCTTATATTTCGCAAGATACTTCATATTTAAAAGGTAATCTATCTGAATTTGCCTATAATAATAAGATCGATGAAACTCTATTTAAAACGATTCTTCGTAAACTGGATTTTAATAGAGAGCAGTTTGATAAGAACATGGTGGATTTTAGTGCTGGTCAGAAAAAGAAAGTACTAATTGCTAAAAGCCTTTGTGAAAGTGCACATTTGTATATATGGGATGAGCCATTGAACTATATTGATATTTTTTCACGTATCCAAATTGAAAAAATGATTTTGGAATATTGTCCTACACTATTGTTTGTGGAGCATGATGATGCTTTTTGCAATAACATTTGTACGAAAAATATTAATTTAGGTTTGTAG", "partial": "0", "query_start": 51721, "query_end": 51984, "hit_start": 294, "hit_end": 537, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 32.58}, "gnl|BL_ORD_ID|236|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "lsaE", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "800", "model_id": "264", "ARO_accession": "3003206", "ARO_name": "lsaE", "ARO_category": {"41696": {"category_aro_accession": "3004472", "category_aro_cvterm_id": "41696", "category_aro_name": "lsa-type ABC-F protein", "category_aro_description": "A subgroup of the ABC-F protein subfamily of ATP-binding cassette proteins. lsa-type ABC-F proteins confer resistance to streptogramin, lincosamide and pleuromutilin antibiotics through antibiotic target protection of the ribosome.", "category_aro_class_name": "AMR Gene Family"}, "35964": {"category_aro_accession": "0000046", "category_aro_cvterm_id": "35964", "category_aro_name": "lincomycin", "category_aro_description": "Lincomycin is a lincosamide antibiotic that comes from the actinomyces Streptomyces lincolnensis. It binds to the 23s portion of the 50S subunit of bacterial ribosomes and inhibit early elongation of peptide chain by inhibiting transpeptidase reaction.", "category_aro_class_name": "Antibiotic"}, "37716": {"category_aro_accession": "3001317", "category_aro_cvterm_id": "37716", "category_aro_name": "pleuromutilin", "category_aro_description": "Pleuromutilin is a natural product antibiotic produced by Clitopilus passeckerianus. Related antibiotics of clinical significance, such as tiamulin and retapamulin, are semi-synthetic derivatives of this compound.", "category_aro_class_name": "Antibiotic"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "37014": {"category_aro_accession": "3000670", "category_aro_cvterm_id": "37014", "category_aro_name": "pleuromutilin antibiotic", "category_aro_description": "Pleuromutilins are natural fungal products that target bacterial protein translation by binding the the 23S rRNA, blocking the ribosome P site at the 50S subunit. They are mostly used for agriculture and veterinary purposes.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00510031, "max_identities": 46, "bit_score": 35.039, "cvterm_id": "35918", "query": "QVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPL--LLQRKLNASERRTRVMTLLEQVGLEKHAKHRPN-ELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHD", "match": "+++ L    + ++   +++ +Y  G  +V +   +   V  G+ ++I G +GSGK++ L LI             +G D K             T  F+  S   +S +S  Q+  +    L +   N     T   T+L ++   +    +   + S GQ+++V +A++L     L + DEP   +D  +   I  ++ E       T +F  HD", "sequence_from_db": "KISPLEFHKECLIEANDLSLSY--GDKEVCS--NLNFRVNIGDRVAIIGKNGSGKSSILKLI-------------NGDDIK------------FTGNFMLASGLKISYIS--QDTSYLKGNLSEFAYNNKIDETLFKTILRKLDFNREQFDKNMVDFSAGQKKKVLIAKSLCESAHLYIWDEPLNYIDIFSRIQIEKMILEY----CPTLLFVEHD", "sequence_from_broadstreet": "MSLINVSNLTFSYEGSYDNIFENVSFQIDTDWKLGFIGRNGRGKTTFLNLLLGKYAYSGNISSTVKFEYFPYDVEDKSLYTIEVMKSICTECMDWEIFREISLLDVQEDALYRPFNTLSNGEQTKVLLAALFLTASCFLLIDEPTNHLDIDARNVVQNYLKRKKGFILVSHDRSLLDQCVDHILSINKTNIEIQKGNFTSWWENKTLQDNFELAENKKLLKEIGRLSYAAKRSSNWSNKVEKSKYGTTNSGSKLDKGYVGHKAAKAMKRAKNIESRHQEAVLQKSELLHNIEQYDDLKISPLEFHKECLIEANDLSLSYGDKEVCSNLNFRVNIGDRVAIIGKNGSGKSSILKLINGDDIKFTGNFMLASGLKISYISQDTSYLKGNLSEFAYNNKIDETLFKTILRKLDFNREQFDKNMVDFSAGQKKKVLIAKSLCESAHLYIWDEPLNYIDIFSRIQIEKMILEYCPTLLFVEHDDAFCNNICTKNINLGL", "dna_sequence_from_broadstreet": "ATGTCCTTAATAAATGTTTCAAATCTAACTTTTTCATATGAAGGAAGTTATGACAATATTTTTGAAAATGTAAGTTTTCAGATAGATACAGATTGGAAACTCGGTTTTATTGGAAGAAACGGACGCGGTAAAACTACTTTCTTAAATTTACTGCTTGGCAAATATGCGTATTCCGGCAATATAAGTTCTACAGTTAAGTTTGAGTATTTTCCTTATGATGTGGAAGATAAGAGTCTATATACAATTGAAGTAATGAAGAGTATTTGTACGGAATGTATGGATTGGGAGATTTTTCGTGAAATATCATTGCTTGATGTTCAAGAAGATGCTTTATATCGTCCGTTTAATACATTGTCAAATGGTGAGCAAACGAAGGTCCTTCTTGCAGCTTTATTCCTTACAGCGAGTTGTTTCCTGCTTATTGATGAACCTACAAACCATCTTGACATCGATGCACGTAATGTAGTGCAAAACTATTTGAAACGCAAGAAGGGGTTTATTTTGGTATCTCATGATAGAAGCTTACTTGATCAATGTGTTGACCATATACTATCTATCAATAAAACGAATATCGAAATCCAAAAGGGAAATTTTACTTCTTGGTGGGAGAACAAAACGTTACAAGATAATTTTGAACTGGCAGAAAACAAGAAACTCCTTAAAGAAATAGGAAGGTTGTCTTATGCAGCAAAACGTAGTTCAAACTGGTCAAATAAAGTAGAAAAAAGTAAATATGGAACAACAAATTCTGGTTCAAAACTGGATAAGGGTTATGTTGGACATAAGGCTGCAAAAGCGATGAAACGTGCCAAAAATATTGAGTCAAGACATCAGGAAGCCGTTTTACAAAAATCAGAACTGCTCCACAACATTGAACAATATGATGACTTAAAAATTTCACCACTTGAATTTCACAAAGAGTGCTTAATAGAAGCGAATGATTTATCATTGTCTTATGGAGATAAAGAAGTATGCAGTAATCTTAATTTCAGAGTCAATATTGGTGATAGAGTTGCCATTATCGGAAAAAATGGGAGTGGTAAGTCTAGTATCCTAAAATTGATTAATGGAGATGATATTAAATTTACCGGAAATTTTATGCTAGCAAGTGGACTAAAAATTTCTTATATTTCGCAAGATACTTCATATTTAAAAGGTAATCTATCTGAATTTGCCTATAATAATAAGATCGATGAAACTCTATTTAAAACGATTCTTCGTAAACTGGATTTTAATAGAGAGCAGTTTGATAAGAACATGGTGGATTTTAGTGCTGGTCAGAAAAAGAAAGTACTAATTGCTAAAAGCCTTTGTGAAAGTGCACATTTGTATATATGGGATGAGCCATTGAACTATATTGATATTTTTTCACGTATCCAAATTGAAAAAATGATTTTGGAATATTGTCCTACACTATTGTTTGTGGAGCATGATGATGCTTTTTGCAATAACATTTGTACGAAAAATATTAATTTAGGTTTGTAG", "partial": "0", "query_start": 51325, "query_end": 51963, "hit_start": 891, "hit_end": 1434, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 21.3}, "gnl|BL_ORD_ID|2308|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "tetA(46)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1100", "model_id": "2643", "ARO_accession": "3004032", "ARO_name": "tetA(46)", "ARO_category": {"36002": {"category_aro_accession": "0010001", "category_aro_cvterm_id": "36002", "category_aro_name": "ATP-binding cassette (ABC) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. ATP-binding cassette (ABC) transporters are present in all cells of all organisms and use the energy of ATP binding/hydrolysis to transport substrates across cell membranes.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.683e-06, "max_identities": 54, "bit_score": 43.8986, "cvterm_id": "41065", "query": "ALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPL--LLQRKLNASERRTRVMTLLEQV--GLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILD", "match": "+L G+   +  G+ + I G +G+GKTT +           G   V+ Q         +       IG++ Q   L S  S+ +N+        Q  L  +  +      LE++  G++     +   +SGGQ+QR+++ARA +    L+L D+  + +D+ T Q IID +++  RK+ TT I S H    +  A+ ++ L  G+I++", "sequence_from_db": "SLSGIDWTIQRGQTVGIVGRTGAGKTTLVRQFLRQYPVGEGEFLVNQQPIVDYNRHSIEE----KIGYVSQEHILFSK-SIRENIALGKKGASQEDLMEAVAQAAFADDLERMSHGMDTLIGEKGVSVSGGQKQRISLARAFLRDADLLLLDDSLSAVDAKTEQAIIDTIQK-ERKDKTTIIVS-HRLSAVHQADWIIVLDQGQIVE", "sequence_from_broadstreet": "MIRAIWEYIRERKWRYVKIAMVLILYDYTLLIPTQVIQRLVDHLSQQTLTQSNFVWDMVLLVGSAILNYLTAFYWQLRLFQSSVHFKATLQGQAFRKLVAMRRPFFEKFRSGDLLTRFTTDVDGMADMAGYGMMVLLFGGGLFAFIIPTMFFISWQLTLISFIPMIFLVVSTYFLSRKQEEYVEQNREAVAQLNDEVLESIEGIRVMRAYSRRDQQVKQFQKKTASLSKTGDKIASIQYSFGPLALLFIGFSTVLLLLFGGQSLASGQLSLGKLLALQLYLVFLIEPMWMMTDLILVYQTGQMSYKKLKEVIDETDDLEPDGTHYLEQIDSVEFKDYSFSYPGAERKSLSGIDWTIQRGQTVGIVGRTGAGKTTLVRQFLRQYPVGEGEFLVNQQPIVDYNRHSIEEKIGYVSQEHILFSKSIRENIALGKKGASQEDLMEAVAQAAFADDLERMSHGMDTLIGEKGVSVSGGQKQRISLARAFLRDADLLLLDDSLSAVDAKTEQAIIDTIQKERKDKTTIIVSHRLSAVHQADWIIVLDQGQIVEEGRASDLLAQEGWYYEQYQRQQKQEGE", "dna_sequence_from_broadstreet": "ATGATCAGAGCTATTTGGGAGTATATCAGGGAGCGCAAGTGGCGATATGTGAAGATCGCTATGGTACTGATTCTTTATGATTACACTTTATTGATCCCGACGCAAGTCATTCAGCGCTTAGTGGATCATTTGAGTCAGCAGACGCTGACGCAATCGAACTTTGTATGGGATATGGTCCTCTTGGTGGGATCAGCCATCCTCAATTACCTGACGGCTTTTTATTGGCAGTTGCGACTCTTTCAGTCGTCAGTCCATTTCAAGGCGACCCTTCAGGGACAAGCTTTTCGTAAGCTAGTAGCTATGCGGCGTCCCTTTTTTGAGAAATTTCGCTCAGGGGACCTCTTGACGCGCTTTACGACGGATGTGGATGGCATGGCCGATATGGCTGGTTACGGGATGATGGTGCTCCTGTTTGGCGGTGGCTTGTTTGCCTTTATTATTCCGACCATGTTTTTCATTTCTTGGCAATTAACCTTGATTTCCTTTATTCCCATGATCTTCCTTGTCGTCTCTACCTATTTTTTGAGTAGAAAGCAGGAGGAGTATGTTGAGCAAAACCGGGAAGCGGTTGCTCAGTTGAACGATGAAGTCTTGGAGTCCATCGAAGGGATCCGGGTCATGCGGGCCTATAGTAGACGGGATCAGCAGGTCAAACAGTTTCAGAAGAAAACGGCTAGTCTATCCAAAACAGGGGACAAAATTGCTTCTATCCAATATTCTTTTGGCCCCTTAGCCCTGTTGTTTATTGGATTCTCGACAGTCTTGCTCCTGCTATTTGGAGGACAGTCCCTAGCAAGTGGGCAGTTGAGCCTTGGCAAGCTATTGGCCTTGCAACTGTATTTGGTCTTTTTAATTGAGCCTATGTGGATGATGACGGACCTGATCTTGGTCTATCAGACAGGGCAAATGTCCTATAAAAAACTAAAAGAAGTGATTGATGAGACAGATGATCTTGAGCCAGATGGTACACACTATTTAGAGCAGATCGATTCGGTAGAGTTTAAGGATTATTCCTTCAGTTATCCTGGTGCTGAGCGAAAGAGCCTATCAGGCATTGATTGGACTATCCAGCGAGGACAGACGGTTGGAATTGTTGGTCGTACCGGTGCAGGAAAGACTACCCTGGTTCGACAATTCTTGCGGCAATACCCAGTTGGTGAGGGAGAATTCTTGGTCAACCAGCAACCGATCGTGGACTACAACCGACACTCGATTGAAGAAAAAATTGGTTATGTTTCCCAAGAACATATTTTATTTTCTAAGTCTATCCGTGAGAATATAGCGCTTGGTAAAAAAGGAGCCAGCCAAGAAGACTTGATGGAAGCAGTAGCCCAAGCTGCTTTTGCGGATGATCTCGAGCGGATGTCTCATGGAATGGACACCCTGATCGGTGAGAAAGGGGTCTCTGTATCAGGAGGTCAAAAACAGCGGATCTCTTTGGCGCGTGCCTTCTTAAGAGATGCAGATCTCTTGTTGTTAGATGATTCCCTTTCGGCAGTGGATGCGAAGACCGAACAGGCCATTATTGACACCATTCAAAAAGAACGAAAAGACAAGACGACCATCATTGTTTCTCATCGCTTGTCGGCTGTCCATCAGGCTGATTGGATCATCGTCTTGGATCAAGGACAGATTGTTGAAGAAGGCAGGGCTAGTGATTTATTAGCTCAAGAGGGCTGGTATTATGAACAATACCAACGGCAACAAAAACAGGAAGGAGAATAA", "partial": "0", "query_start": 51415, "query_end": 52023, "hit_start": 1041, "hit_end": 1641, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 26.09}, "gnl|BL_ORD_ID|2587|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "vmlR", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1000", "model_id": "2907", "ARO_accession": "3004476", "ARO_name": "vmlR", "ARO_category": {"45630": {"category_aro_accession": "3007068", "category_aro_cvterm_id": "45630", "category_aro_name": "Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins", "category_aro_description": "ABC-F subfamily ATP-binding cassette ribosomal protection proteins of unknown, unclear or miscellaneous classification which nevertheless confer resistance to antibiotics through ribosomal protection and not through antibiotic efflux. These proteins should be further reviewed to elucidate associated genes, their function, origin and classification.", "category_aro_class_name": "AMR Gene Family"}, "35964": {"category_aro_accession": "0000046", "category_aro_cvterm_id": "35964", "category_aro_name": "lincomycin", "category_aro_description": "Lincomycin is a lincosamide antibiotic that comes from the actinomyces Streptomyces lincolnensis. It binds to the 23s portion of the 50S subunit of bacterial ribosomes and inhibit early elongation of peptide chain by inhibiting transpeptidase reaction.", "category_aro_class_name": "Antibiotic"}, "37021": {"category_aro_accession": "3000677", "category_aro_cvterm_id": "37021", "category_aro_name": "virginiamycin S2", "category_aro_description": "Virginiamycin S2 is a streptogramin B antibiotic.", "category_aro_class_name": "Antibiotic"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35967": {"category_aro_accession": "0000050", "category_aro_cvterm_id": "35967", "category_aro_name": "streptogramin B antibiotic", "category_aro_description": "Streptogramin B antibiotics are are cyclic hepta- or hexa-depsipeptides.  Type B streptogramins block the peptide exit tunnel of the 50S bacterial ribosome. The general composition of group B streptogramins is 3-hydroxypicolinic acid-L-Thr-D-aminobutyric acid (or D-Ala)-L-Pro-L-Phe (or 4-N-,N-(dimethylamino)-L-Phe)-X-L-phenylglycine. Used alone, streptogramin B antibiotics are bacteriostatic, but is bactericidal when used with streptogramin A antibiotics.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.35023e-05, "max_identities": 41, "bit_score": 43.1282, "cvterm_id": "39579", "query": "LRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGV-VSVDGQDTKKLTERQLTHLRLHTIGFIFQS-FNL---VSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRP-NELSGGQRQRVAVARALVTRPKLVLADEPTANLD", "match": " +     +  GE ++I GP+GSGKTT LN+I   +TA   V VS                     IG++ Q  F+L    +   +F+N  F           + R  V  L+  +G        P   +S G+R ++ +   ++    +++ DEPT +LD", "sequence_from_db": "FKNANFTIQHGEKVAIIGPNGSGKTTLLNIILGQETAEGSVWVSPSA-----------------NIGYLTQEVFDLPLEQTPEELFENETF-----------KARGHVQNLMRHLGFTAAQWTEPIKHMSMGERVKIKLMAYILEEKDVLILDEPTNHLD", "sequence_from_broadstreet": "MKEIVTLTNVSYEVKDQTVFKHVNASVQQGDIIGIIGKNGAGKSTLLHLIHNDLAPAQGQILRKDIKLALVEQETAAYSFADQTPAEKKLLEKWHVPLRDFHQLSGGEKLKARLAKGLSEDADLLLLDEPTNHLDEKSLQFLIQQLKHYNGTVILVSHDRYFLDEAATKIWSLEDQTLIEFKGNYSGYMKFREKKRLTQQREYEKQQKMVERIEAQMNGLASWSEKAHAQSTKKEGFKEYHRVKAKRTDAQIKSKQKRLEKELEKAKAEPVTPEYTVRFSIDTTHKTGKRFLEVQNVTKAFGERTLFKNANFTIQHGEKVAIIGPNGSGKTTLLNIILGQETAEGSVWVSPSANIGYLTQEVFDLPLEQTPEELFENETFKARGHVQNLMRHLGFTAAQWTEPIKHMSMGERVKIKLMAYILEEKDVLILDEPTNHLDLPSREQLEETLSQYSGTLLAVSHDRYFLEKTTNSKLVISNNGIEKQLNDVPSERNEREELRLKLETERQEVLGKLSFMTPNDKGYKELDQAFNELTKRIKELDHQDKKD", "dna_sequence_from_broadstreet": "ATGAAAGAGATCGTAACATTAACAAACGTTAGCTATGAAGTAAAGGATCAAACTGTTTTTAAACATGTAAACGCCAGTGTTCAGCAAGGAGATATCATTGGGATTATCGGCAAAAACGGCGCTGGGAAATCTACGTTGCTGCACCTCATTCACAATGACTTAGCCCCTGCACAGGGTCAAATCCTTCGGAAGGATATAAAACTGGCTTTGGTTGAACAGGAAACCGCGGCGTATTCCTTTGCGGATCAGACACCTGCCGAAAAGAAGTTACTGGAGAAATGGCATGTGCCTCTTCGTGATTTTCATCAGTTAAGCGGCGGTGAAAAACTGAAAGCGCGGCTGGCGAAAGGACTATCAGAGGATGCAGATCTGCTGCTGTTAGATGAACCGACAAACCACCTTGATGAAAAAAGCTTGCAATTTCTCATCCAACAGCTGAAACATTATAACGGCACTGTGATTCTCGTTTCTCACGATCGATATTTTTTAGACGAAGCCGCAACAAAAATATGGTCGCTTGAGGATCAGACGCTGATTGAATTCAAAGGGAATTACTCCGGGTATATGAAGTTCCGGGAGAAGAAAAGACTCACCCAGCAGCGTGAATATGAAAAGCAGCAAAAAATGGTTGAACGGATTGAAGCACAAATGAATGGGCTCGCTTCTTGGTCGGAAAAAGCCCATGCTCAATCGACGAAAAAGGAAGGGTTTAAAGAATATCACCGGGTAAAAGCGAAGCGTACGGATGCCCAGATAAAATCCAAGCAGAAGCGGCTTGAAAAAGAGCTTGAAAAAGCAAAGGCGGAACCCGTTACCCCAGAATATACAGTCCGCTTTTCAATCGATACAACCCACAAAACAGGAAAACGTTTTTTAGAAGTTCAGAATGTAACAAAAGCGTTTGGAGAAAGGACTCTCTTTAAAAACGCAAACTTTACAATTCAGCACGGCGAAAAGGTTGCGATCATAGGCCCCAATGGCAGCGGAAAAACGACATTACTGAACATCATTCTGGGACAGGAAACAGCAGAAGGAAGTGTATGGGTGTCGCCGTCCGCAAACATCGGCTATTTAACGCAGGAGGTGTTTGATTTGCCTTTAGAACAAACACCGGAAGAGTTATTTGAGAATGAAACATTCAAAGCAAGGGGGCACGTTCAAAATCTGATGAGGCACTTAGGTTTTACAGCCGCCCAATGGACTGAACCGATCAAGCATATGAGTATGGGTGAGCGTGTAAAGATCAAGCTGATGGCATATATTCTGGAGGAAAAAGACGTGCTGATTTTAGATGAGCCGACAAACCATCTCGACCTGCCGTCACGCGAACAGCTGGAAGAAACACTGTCACAATACAGCGGCACATTGCTGGCGGTTTCACATGACCGATACTTTCTCGAAAAAACAACAAACAGTAAACTCGTCATCTCAAACAACGGCATCGAAAAGCAGTTAAACGACGTTCCTTCAGAAAGAAATGAGCGGGAGGAGCTTCGGTTAAAGCTTGAGACAGAAAGACAAGAAGTGCTGGGAAAGCTCAGTTTTATGACGCCAAATGATAAAGGGTATAAGGAGCTTGATCAGGCTTTCAATGAGCTTACGAAACGAATAAAAGAGCTGGATCATCAAGACAAAAAAGACTGA", "partial": "0", "query_start": 51418, "query_end": 51879, "hit_start": 918, "hit_end": 1314, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 25.62}, "gnl|BL_ORD_ID|2587|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "vmlR", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1000", "model_id": "2907", "ARO_accession": "3004476", "ARO_name": "vmlR", "ARO_category": {"45630": {"category_aro_accession": "3007068", "category_aro_cvterm_id": "45630", "category_aro_name": "Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins", "category_aro_description": "ABC-F subfamily ATP-binding cassette ribosomal protection proteins of unknown, unclear or miscellaneous classification which nevertheless confer resistance to antibiotics through ribosomal protection and not through antibiotic efflux. These proteins should be further reviewed to elucidate associated genes, their function, origin and classification.", "category_aro_class_name": "AMR Gene Family"}, "35964": {"category_aro_accession": "0000046", "category_aro_cvterm_id": "35964", "category_aro_name": "lincomycin", "category_aro_description": "Lincomycin is a lincosamide antibiotic that comes from the actinomyces Streptomyces lincolnensis. It binds to the 23s portion of the 50S subunit of bacterial ribosomes and inhibit early elongation of peptide chain by inhibiting transpeptidase reaction.", "category_aro_class_name": "Antibiotic"}, "37021": {"category_aro_accession": "3000677", "category_aro_cvterm_id": "37021", "category_aro_name": "virginiamycin S2", "category_aro_description": "Virginiamycin S2 is a streptogramin B antibiotic.", "category_aro_class_name": "Antibiotic"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35967": {"category_aro_accession": "0000050", "category_aro_cvterm_id": "35967", "category_aro_name": "streptogramin B antibiotic", "category_aro_description": "Streptogramin B antibiotics are are cyclic hepta- or hexa-depsipeptides.  Type B streptogramins block the peptide exit tunnel of the 50S bacterial ribosome. The general composition of group B streptogramins is 3-hydroxypicolinic acid-L-Thr-D-aminobutyric acid (or D-Ala)-L-Pro-L-Phe (or 4-N-,N-(dimethylamino)-L-Phe)-X-L-phenylglycine. Used alone, streptogramin B antibiotics are bacteriostatic, but is bactericidal when used with streptogramin A antibiotics.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.67253e-05, "max_identities": 54, "bit_score": 43.1282, "cvterm_id": "39579", "query": "QPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEK---HAKHRP----NELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHA", "match": "+ IV+LT V+  Y +    V   + V   V  G+ I I G +G+GK+T L+LI       + +    GQ  +K                               +++  L+        E+ T   +  +Q   EK      H P    ++LSGG++ +  +A+ L     L+L DEPT +LD  + Q +I  +K  N     T I  +HD   +  A", "sequence_from_db": "KEIVTLTNVS--YEVKDQTV--FKHVNASVQQGDIIGIIGKNGAGKSTLLHLI------HNDLAPAQGQILRK-------------------------------DIKLALV--------EQETAAYSFADQTPAEKKLLEKWHVPLRDFHQLSGGEKLKARLAKGLSEDADLLLLDEPTNHLDEKSLQFLIQQLKHYN----GTVILVSHDRYFLDEA", "sequence_from_broadstreet": "MKEIVTLTNVSYEVKDQTVFKHVNASVQQGDIIGIIGKNGAGKSTLLHLIHNDLAPAQGQILRKDIKLALVEQETAAYSFADQTPAEKKLLEKWHVPLRDFHQLSGGEKLKARLAKGLSEDADLLLLDEPTNHLDEKSLQFLIQQLKHYNGTVILVSHDRYFLDEAATKIWSLEDQTLIEFKGNYSGYMKFREKKRLTQQREYEKQQKMVERIEAQMNGLASWSEKAHAQSTKKEGFKEYHRVKAKRTDAQIKSKQKRLEKELEKAKAEPVTPEYTVRFSIDTTHKTGKRFLEVQNVTKAFGERTLFKNANFTIQHGEKVAIIGPNGSGKTTLLNIILGQETAEGSVWVSPSANIGYLTQEVFDLPLEQTPEELFENETFKARGHVQNLMRHLGFTAAQWTEPIKHMSMGERVKIKLMAYILEEKDVLILDEPTNHLDLPSREQLEETLSQYSGTLLAVSHDRYFLEKTTNSKLVISNNGIEKQLNDVPSERNEREELRLKLETERQEVLGKLSFMTPNDKGYKELDQAFNELTKRIKELDHQDKKD", "dna_sequence_from_broadstreet": "ATGAAAGAGATCGTAACATTAACAAACGTTAGCTATGAAGTAAAGGATCAAACTGTTTTTAAACATGTAAACGCCAGTGTTCAGCAAGGAGATATCATTGGGATTATCGGCAAAAACGGCGCTGGGAAATCTACGTTGCTGCACCTCATTCACAATGACTTAGCCCCTGCACAGGGTCAAATCCTTCGGAAGGATATAAAACTGGCTTTGGTTGAACAGGAAACCGCGGCGTATTCCTTTGCGGATCAGACACCTGCCGAAAAGAAGTTACTGGAGAAATGGCATGTGCCTCTTCGTGATTTTCATCAGTTAAGCGGCGGTGAAAAACTGAAAGCGCGGCTGGCGAAAGGACTATCAGAGGATGCAGATCTGCTGCTGTTAGATGAACCGACAAACCACCTTGATGAAAAAAGCTTGCAATTTCTCATCCAACAGCTGAAACATTATAACGGCACTGTGATTCTCGTTTCTCACGATCGATATTTTTTAGACGAAGCCGCAACAAAAATATGGTCGCTTGAGGATCAGACGCTGATTGAATTCAAAGGGAATTACTCCGGGTATATGAAGTTCCGGGAGAAGAAAAGACTCACCCAGCAGCGTGAATATGAAAAGCAGCAAAAAATGGTTGAACGGATTGAAGCACAAATGAATGGGCTCGCTTCTTGGTCGGAAAAAGCCCATGCTCAATCGACGAAAAAGGAAGGGTTTAAAGAATATCACCGGGTAAAAGCGAAGCGTACGGATGCCCAGATAAAATCCAAGCAGAAGCGGCTTGAAAAAGAGCTTGAAAAAGCAAAGGCGGAACCCGTTACCCCAGAATATACAGTCCGCTTTTCAATCGATACAACCCACAAAACAGGAAAACGTTTTTTAGAAGTTCAGAATGTAACAAAAGCGTTTGGAGAAAGGACTCTCTTTAAAAACGCAAACTTTACAATTCAGCACGGCGAAAAGGTTGCGATCATAGGCCCCAATGGCAGCGGAAAAACGACATTACTGAACATCATTCTGGGACAGGAAACAGCAGAAGGAAGTGTATGGGTGTCGCCGTCCGCAAACATCGGCTATTTAACGCAGGAGGTGTTTGATTTGCCTTTAGAACAAACACCGGAAGAGTTATTTGAGAATGAAACATTCAAAGCAAGGGGGCACGTTCAAAATCTGATGAGGCACTTAGGTTTTACAGCCGCCCAATGGACTGAACCGATCAAGCATATGAGTATGGGTGAGCGTGTAAAGATCAAGCTGATGGCATATATTCTGGAGGAAAAAGACGTGCTGATTTTAGATGAGCCGACAAACCATCTCGACCTGCCGTCACGCGAACAGCTGGAAGAAACACTGTCACAATACAGCGGCACATTGCTGGCGGTTTCACATGACCGATACTTTCTCGAAAAAACAACAAACAGTAAACTCGTCATCTCAAACAACGGCATCGAAAAGCAGTTAAACGACGTTCCTTCAGAAAGAAATGAGCGGGAGGAGCTTCGGTTAAAGCTTGAGACAGAAAGACAAGAAGTGCTGGGAAAGCTCAGTTTTATGACGCCAAATGATAAAGGGTATAAGGAGCTTGATCAGGCTTTCAATGAGCTTACGAAACGAATAAAAGAGCTGGATCATCAAGACAAAAAAGACTGA", "partial": "0", "query_start": 51352, "query_end": 51984, "hit_start": 3, "hit_end": 498, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 24.77}, "gnl|BL_ORD_ID|2257|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "tva(A)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1000", "model_id": "3484", "ARO_accession": "3004730", "ARO_name": "tva(A)", "ARO_category": {"45630": {"category_aro_accession": "3007068", "category_aro_cvterm_id": "45630", "category_aro_name": "Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins", "category_aro_description": "ABC-F subfamily ATP-binding cassette ribosomal protection proteins of unknown, unclear or miscellaneous classification which nevertheless confer resistance to antibiotics through ribosomal protection and not through antibiotic efflux. These proteins should be further reviewed to elucidate associated genes, their function, origin and classification.", "category_aro_class_name": "AMR Gene Family"}, "37716": {"category_aro_accession": "3001317", "category_aro_cvterm_id": "37716", "category_aro_name": "pleuromutilin", "category_aro_description": "Pleuromutilin is a natural product antibiotic produced by Clitopilus passeckerianus. Related antibiotics of clinical significance, such as tiamulin and retapamulin, are semi-synthetic derivatives of this compound.", "category_aro_class_name": "Antibiotic"}, "37014": {"category_aro_accession": "3000670", "category_aro_cvterm_id": "37014", "category_aro_name": "pleuromutilin antibiotic", "category_aro_description": "Pleuromutilins are natural fungal products that target bacterial protein translation by binding the the 23S rRNA, blocking the ribosome P site at the 50S subunit. They are mostly used for agriculture and veterinary purposes.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.54217e-05, "max_identities": 21, "bit_score": 42.3578, "cvterm_id": "42835", "query": "HRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVM", "match": "+R + LS G+R+R+ +A AL + P +++ DEPT ++D      +I+++K L+       I  +HD   +", "sequence_from_db": "YRFDTLSFGERKRLQIASALYSNPDILVLDEPTNHIDIECKDILINVIKRLD----CIVIIISHDIDFL", "sequence_from_broadstreet": "MFIKFNKVSFSYDSSDNILNDVSFHIDNSCTAIVGENGCGKTTLAKLITGILKPNSGSIEYSNKNIITAYCDQECINLPDNAENLFYDDSSYSGYLTSIFKIDYNYLYRFDTLSFGERKRLQIASALYSNPDILVLDEPTNHIDIECKDILINVIKRLDCIVIIISHDIDFLDELVEKCIFIRNGNCKIRIGNYTQCRGYEKDEEDYNFSLYEESRKKAKILENRYKKLQNESDAKKSKCGSKRHIDKKDHDAKGKIDAARLAGKDSRLATKAKQAKSLYNNTVMEMESLYTKKREVMDMEFIGERYKGKFLFYLEAGETKINSIVLRHPELIVKKDSRIGIEGVNGAGKTSLLNYIIETMYDNSIDKEKIIYIPQDIDRESWNNTFNNIKALDHESLGFLMSFVNRLGSNAKSVINSLNHSPGEMRKIMLGMAVIKKPYIIMLDEPTNHLDIDSIERLEEALISFNCALIIVSHNRNFIKNAVNTLWSIKIEYNYSILDIKNTI", "dna_sequence_from_broadstreet": "ATGTTTATAAAATTCAATAAAGTTTCTTTTTCTTATGATAGTTCTGATAATATATTAAATGATGTTTCTTTTCATATAGATAATTCATGCACTGCAATAGTAGGTGAAAATGGATGCGGTAAAACCACGCTAGCTAAACTTATAACAGGTATATTAAAGCCTAATTCAGGAAGCATAGAATATTCAAATAAAAATATTATAACTGCTTACTGCGATCAGGAATGTATCAACTTACCTGATAATGCTGAAAATTTATTTTATGATGATAGTTCATACTCAGGATATTTAACTTCTATATTTAAAATAGATTATAATTATTTATATAGATTTGATACTCTTAGTTTCGGAGAGAGAAAAAGACTACAAATAGCTTCTGCTTTATACTCTAATCCTGATATATTGGTATTAGATGAGCCTACGAATCATATTGATATAGAATGCAAAGATATACTTATTAATGTAATAAAAAGACTCGATTGTATAGTTATAATTATAAGCCATGATATTGATTTTCTTGATGAGTTAGTAGAAAAATGTATATTTATAAGAAATGGAAATTGCAAGATAAGAATAGGTAATTACACTCAATGCAGAGGATATGAAAAAGACGAAGAAGATTATAATTTTAGTTTATATGAGGAAAGCAGGAAGAAAGCTAAAATATTAGAAAATAGATACAAAAAACTACAAAATGAATCGGATGCTAAAAAAAGCAAATGCGGAAGTAAAAGACATATAGATAAAAAAGATCATGATGCTAAGGGAAAAATAGACGCAGCAAGACTTGCAGGTAAAGATTCAAGACTTGCAACTAAGGCTAAGCAGGCCAAAAGTTTATACAATAATACAGTAATGGAAATGGAATCTCTTTATACTAAGAAAAGAGAAGTTATGGATATGGAGTTTATTGGAGAAAGGTATAAAGGAAAATTTTTATTTTATCTTGAGGCAGGAGAAACAAAAATAAATAGTATAGTTCTAAGACATCCCGAACTTATAGTGAAAAAAGACAGCAGAATAGGTATTGAAGGTGTAAACGGGGCAGGTAAAACCAGTTTATTAAATTATATAATTGAAACAATGTATGATAATTCTATAGATAAAGAAAAGATAATATATATTCCTCAGGATATAGATAGAGAAAGTTGGAATAATACTTTTAATAATATAAAGGCATTGGATCATGAATCATTAGGTTTTTTAATGAGTTTTGTAAATAGACTAGGAAGCAATGCTAAATCTGTGATTAATTCATTGAATCATAGTCCGGGTGAGATGCGTAAAATAATGCTTGGAATGGCGGTTATAAAAAAGCCTTATATTATAATGTTAGATGAGCCTACGAATCATCTGGATATAGACTCAATAGAGCGTTTAGAGGAGGCTTTAATTTCTTTTAATTGTGCTTTGATTATAGTAAGTCATAATAGAAATTTTATTAAAAATGCAGTAAATACTTTATGGAGTATAAAAATAGAATATAATTACAGTATTTTAGATATTAAAAACACTATATAA", "partial": "0", "query_start": 51769, "query_end": 51975, "hit_start": 321, "hit_end": 516, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 30.43}, "gnl|BL_ORD_ID|2257|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "tva(A)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1000", "model_id": "3484", "ARO_accession": "3004730", "ARO_name": "tva(A)", "ARO_category": {"45630": {"category_aro_accession": "3007068", "category_aro_cvterm_id": "45630", "category_aro_name": "Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins", "category_aro_description": "ABC-F subfamily ATP-binding cassette ribosomal protection proteins of unknown, unclear or miscellaneous classification which nevertheless confer resistance to antibiotics through ribosomal protection and not through antibiotic efflux. These proteins should be further reviewed to elucidate associated genes, their function, origin and classification.", "category_aro_class_name": "AMR Gene Family"}, "37716": {"category_aro_accession": "3001317", "category_aro_cvterm_id": "37716", "category_aro_name": "pleuromutilin", "category_aro_description": "Pleuromutilin is a natural product antibiotic produced by Clitopilus passeckerianus. Related antibiotics of clinical significance, such as tiamulin and retapamulin, are semi-synthetic derivatives of this compound.", "category_aro_class_name": "Antibiotic"}, "37014": {"category_aro_accession": "3000670", "category_aro_cvterm_id": "37014", "category_aro_name": "pleuromutilin antibiotic", "category_aro_description": "Pleuromutilins are natural fungal products that target bacterial protein translation by binding the the 23S rRNA, blocking the ribosome P site at the 50S subunit. They are mostly used for agriculture and veterinary purposes.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000379977, "max_identities": 42, "bit_score": 38.891, "cvterm_id": "42835", "query": "KVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNEL--SGGQRQRVAVARALVTRPKLVLADEPTANLD", "match": "K+    LR   L V     I I G +G+GKT+ LN I  ++T      S+D +                 I +I Q  +  S  + F N+        K    E    +M+ + ++G   +AK   N L  S G+ +++ +  A++ +P +++ DEPT +LD", "sequence_from_db": "KINSIVLRHPELIVKKDSRIGIEGVNGAGKTSLLNYI--IETMYDN--SIDKE----------------KIIYIPQDIDRESWNNTFNNI--------KALDHESLGFLMSFVNRLG--SNAKSVINSLNHSPGEMRKIMLGMAVIKKPYIIMLDEPTNHLD", "sequence_from_broadstreet": "MFIKFNKVSFSYDSSDNILNDVSFHIDNSCTAIVGENGCGKTTLAKLITGILKPNSGSIEYSNKNIITAYCDQECINLPDNAENLFYDDSSYSGYLTSIFKIDYNYLYRFDTLSFGERKRLQIASALYSNPDILVLDEPTNHIDIECKDILINVIKRLDCIVIIISHDIDFLDELVEKCIFIRNGNCKIRIGNYTQCRGYEKDEEDYNFSLYEESRKKAKILENRYKKLQNESDAKKSKCGSKRHIDKKDHDAKGKIDAARLAGKDSRLATKAKQAKSLYNNTVMEMESLYTKKREVMDMEFIGERYKGKFLFYLEAGETKINSIVLRHPELIVKKDSRIGIEGVNGAGKTSLLNYIIETMYDNSIDKEKIIYIPQDIDRESWNNTFNNIKALDHESLGFLMSFVNRLGSNAKSVINSLNHSPGEMRKIMLGMAVIKKPYIIMLDEPTNHLDIDSIERLEEALISFNCALIIVSHNRNFIKNAVNTLWSIKIEYNYSILDIKNTI", "dna_sequence_from_broadstreet": "ATGTTTATAAAATTCAATAAAGTTTCTTTTTCTTATGATAGTTCTGATAATATATTAAATGATGTTTCTTTTCATATAGATAATTCATGCACTGCAATAGTAGGTGAAAATGGATGCGGTAAAACCACGCTAGCTAAACTTATAACAGGTATATTAAAGCCTAATTCAGGAAGCATAGAATATTCAAATAAAAATATTATAACTGCTTACTGCGATCAGGAATGTATCAACTTACCTGATAATGCTGAAAATTTATTTTATGATGATAGTTCATACTCAGGATATTTAACTTCTATATTTAAAATAGATTATAATTATTTATATAGATTTGATACTCTTAGTTTCGGAGAGAGAAAAAGACTACAAATAGCTTCTGCTTTATACTCTAATCCTGATATATTGGTATTAGATGAGCCTACGAATCATATTGATATAGAATGCAAAGATATACTTATTAATGTAATAAAAAGACTCGATTGTATAGTTATAATTATAAGCCATGATATTGATTTTCTTGATGAGTTAGTAGAAAAATGTATATTTATAAGAAATGGAAATTGCAAGATAAGAATAGGTAATTACACTCAATGCAGAGGATATGAAAAAGACGAAGAAGATTATAATTTTAGTTTATATGAGGAAAGCAGGAAGAAAGCTAAAATATTAGAAAATAGATACAAAAAACTACAAAATGAATCGGATGCTAAAAAAAGCAAATGCGGAAGTAAAAGACATATAGATAAAAAAGATCATGATGCTAAGGGAAAAATAGACGCAGCAAGACTTGCAGGTAAAGATTCAAGACTTGCAACTAAGGCTAAGCAGGCCAAAAGTTTATACAATAATACAGTAATGGAAATGGAATCTCTTTATACTAAGAAAAGAGAAGTTATGGATATGGAGTTTATTGGAGAAAGGTATAAAGGAAAATTTTTATTTTATCTTGAGGCAGGAGAAACAAAAATAAATAGTATAGTTCTAAGACATCCCGAACTTATAGTGAAAAAAGACAGCAGAATAGGTATTGAAGGTGTAAACGGGGCAGGTAAAACCAGTTTATTAAATTATATAATTGAAACAATGTATGATAATTCTATAGATAAAGAAAAGATAATATATATTCCTCAGGATATAGATAGAGAAAGTTGGAATAATACTTTTAATAATATAAAGGCATTGGATCATGAATCATTAGGTTTTTTAATGAGTTTTGTAAATAGACTAGGAAGCAATGCTAAATCTGTGATTAATTCATTGAATCATAGTCCGGGTGAGATGCGTAAAATAATGCTTGGAATGGCGGTTATAAAAAAGCCTTATATTATAATGTTAGATGAGCCTACGAATCATCTGGATATAGACTCAATAGAGCGTTTAGAGGAGGCTTTAATTTCTTTTAATTGTGCTTTGATTATAGTAAGTCATAATAGAAATTTTATTAAAAATGCAGTAAATACTTTATGGAGTATAAAAATAGAATATAATTACAGTATTTTAGATATTAAAAACACTATATAA", "partial": "0", "query_start": 51400, "query_end": 51879, "hit_start": 960, "hit_end": 1356, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 25.93}, "gnl|BL_ORD_ID|2805|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "msrH", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "900", "model_id": "3822", "ARO_accession": "3005088", "ARO_name": "msrH", "ARO_category": {"41695": {"category_aro_accession": "3004471", "category_aro_cvterm_id": "41695", "category_aro_name": "msr-type ABC-F protein", "category_aro_description": "msr-type ABC-F subfamily ribosomal protection proteins expression in Staphylococci species and confer resistance to erythromycin and streptogramin B antibiotics through antibiotic target protection mechanisms.", "category_aro_class_name": "AMR Gene Family"}, "35925": {"category_aro_accession": "0000006", "category_aro_cvterm_id": "35925", "category_aro_name": "erythromycin", "category_aro_description": "Erythromycin is a macrolide antibiotic with a 14-carbon ring that has an antimicrobial spectrum similar to or slightly wider than that of penicillin, and is often used for people that have an allergy to penicillins. Erythromycin may possess bacteriocidal activity, particularly at higher concentrations by binding to the 50S subunit of the bacterial 70S rRNA complex, inhibiting peptidyl-tRNA translocation. Thus, protein synthesis and subsequently structure/function processes critical for life or replication are inhibited.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.34974e-05, "max_identities": 26, "bit_score": 41.2022, "cvterm_id": "43299", "query": "KHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVV-RLADGKI", "match": "K +   LSGG+  R+ + +  + R  +++ DEPT  LD    + +  ++KE    +GT  I S HD K + H + +V R+ + K+", "sequence_from_db": "KKKVQNLSGGESIRLVLCQLFLGRYNILVLDEPTNFLDIFCIEALESILKEY---KGTVIIIS-HDKKFVEHVSDIVYRIENQKL", "sequence_from_broadstreet": "MEQICFELENIELSYLDKKVLDIDRLAIHQFDRIGIVGRNGAGKSTLLKIIGGIINPSRGKVNQYVEYGYFEQLEGPIAKATNPRLLGKLQVKENASNLSGGEQTRLKLAQLFTHFYDALLIDEPTTHLDQDGISFLIEELKNYYGALILISHDRAFLDELVTTIWEIDEGTVKIYSGNYSDYMRQKQIERTQQVYNHEQFLKEKNRLEKASLEKMKKAEKIAKSTSMSKKESKAKPNRMFESKSKGTSQKSLQRAAKAIEQRINQLQVVEAPNDDYVIHFHSTNNISKLHNKFPIMGDCITLEIDDKVLLKETSFQFPLGKTIAITGKNGSGKTTLIRHIIENGEGITISPKAEIGIYEQMGYQFDEDKTVLSYIKDRSDYDESKIRSVLNAMSFTGNDLKKKVQNLSGGESIRLVLCQLFLGRYNILVLDEPTNFLDIFCIEALESILKEYKGTVIIISHDKKFVEHVSDIVYRIENQKLKLVN", "dna_sequence_from_broadstreet": "ATGGAACAAATATGTTTTGAATTAGAGAATATTGAATTAAGTTATTTAGATAAAAAAGTGTTGGATATTGATCGATTAGCTATTCATCAGTTTGATAGAATAGGTATTGTGGGAAGAAATGGAGCAGGAAAAAGTACATTATTGAAAATAATTGGTGGTATTATTAATCCTTCTAGAGGAAAGGTTAATCAATATGTAGAGTACGGGTATTTCGAACAATTAGAAGGTCCGATAGCTAAAGCAACTAATCCGCGCTTATTAGGTAAGTTGCAAGTAAAAGAGAACGCTAGTAATTTAAGTGGTGGTGAACAGACAAGGCTCAAACTTGCGCAATTATTTACCCATTTTTATGATGCGTTGTTAATTGATGAGCCTACAACACATTTGGATCAAGATGGTATCTCATTTCTTATCGAAGAACTTAAGAATTATTATGGTGCTTTAATTTTAATAAGTCATGATCGTGCATTTCTGGATGAACTTGTTACAACAATATGGGAAATTGATGAAGGTACAGTTAAAATATATTCTGGAAATTATAGTGATTATATGAGGCAGAAGCAAATAGAAAGAACGCAACAAGTTTACAATCATGAACAATTTTTGAAAGAAAAGAATAGGCTTGAAAAAGCATCACTAGAAAAAATGAAAAAAGCTGAAAAAATTGCTAAATCTACTTCGATGTCAAAGAAAGAGTCTAAGGCAAAGCCAAATCGTATGTTCGAATCAAAGTCGAAAGGCACAAGTCAGAAATCGTTACAACGTGCTGCAAAAGCAATCGAGCAAAGAATAAACCAACTGCAAGTTGTAGAAGCACCAAATGATGATTACGTCATTCATTTCCATTCGACTAATAATATATCAAAATTGCATAATAAATTTCCGATTATGGGGGATTGTATAACGCTAGAGATAGATGATAAAGTACTATTAAAAGAAACAAGTTTTCAATTTCCTTTAGGTAAAACAATAGCAATTACTGGTAAGAATGGTTCAGGTAAAACAACATTGATTCGTCATATTATTGAAAATGGTGAGGGTATCACTATTTCCCCAAAAGCAGAGATTGGAATATATGAACAAATGGGTTATCAGTTCGATGAAGATAAAACTGTTTTATCGTATATAAAAGATAGAAGTGATTATGATGAAAGTAAAATACGTTCTGTTCTTAATGCGATGAGTTTTACTGGTAATGACTTGAAGAAGAAAGTTCAAAACTTAAGTGGAGGAGAATCAATACGGTTAGTATTATGTCAACTTTTTTTAGGAAGGTATAATATTTTAGTTCTAGATGAGCCAACAAACTTTTTAGATATTTTTTGTATTGAAGCATTAGAGAGTATTTTAAAAGAATACAAAGGTACTGTAATTATTATTTCACATGATAAAAAATTTGTTGAACATGTTTCTGATATAGTTTATAGAATAGAAAACCAAAAATTGAAATTAGTAAATTGA", "partial": "0", "query_start": 51766, "query_end": 52017, "hit_start": 1203, "hit_end": 1446, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 30.59}, "gnl|BL_ORD_ID|2805|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "msrH", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "900", "model_id": "3822", "ARO_accession": "3005088", "ARO_name": "msrH", "ARO_category": {"41695": {"category_aro_accession": "3004471", "category_aro_cvterm_id": "41695", "category_aro_name": "msr-type ABC-F protein", "category_aro_description": "msr-type ABC-F subfamily ribosomal protection proteins expression in Staphylococci species and confer resistance to erythromycin and streptogramin B antibiotics through antibiotic target protection mechanisms.", "category_aro_class_name": "AMR Gene Family"}, "35925": {"category_aro_accession": "0000006", "category_aro_cvterm_id": "35925", "category_aro_name": "erythromycin", "category_aro_description": "Erythromycin is a macrolide antibiotic with a 14-carbon ring that has an antimicrobial spectrum similar to or slightly wider than that of penicillin, and is often used for people that have an allergy to penicillins. Erythromycin may possess bacteriocidal activity, particularly at higher concentrations by binding to the 50S subunit of the bacterial 70S rRNA complex, inhibiting peptidyl-tRNA translocation. Thus, protein synthesis and subsequently structure/function processes critical for life or replication are inhibited.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00296001, "max_identities": 43, "bit_score": 35.8094, "cvterm_id": "43299", "query": "LEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHD", "match": "L ++  + I I G +G+GK+T L +IG +   S G V                              N       F+ +E P+       A     R++  L+        K   + LSGG++ R+ +A+        +L DEPT +LD      I  L++EL    G   + S HD", "sequence_from_db": "LAIHQFDRIGIVGRNGAGKSTLLKIIGGIINPSRGKV------------------------------NQYVEYGYFEQLEGPI-------AKATNPRLLGKLQ-------VKENASNLSGGEQTRLKLAQLFTHFYDALLIDEPTTHLDQ---DGISFLIEELKNYYGALILIS-HD", "sequence_from_broadstreet": "MEQICFELENIELSYLDKKVLDIDRLAIHQFDRIGIVGRNGAGKSTLLKIIGGIINPSRGKVNQYVEYGYFEQLEGPIAKATNPRLLGKLQVKENASNLSGGEQTRLKLAQLFTHFYDALLIDEPTTHLDQDGISFLIEELKNYYGALILISHDRAFLDELVTTIWEIDEGTVKIYSGNYSDYMRQKQIERTQQVYNHEQFLKEKNRLEKASLEKMKKAEKIAKSTSMSKKESKAKPNRMFESKSKGTSQKSLQRAAKAIEQRINQLQVVEAPNDDYVIHFHSTNNISKLHNKFPIMGDCITLEIDDKVLLKETSFQFPLGKTIAITGKNGSGKTTLIRHIIENGEGITISPKAEIGIYEQMGYQFDEDKTVLSYIKDRSDYDESKIRSVLNAMSFTGNDLKKKVQNLSGGESIRLVLCQLFLGRYNILVLDEPTNFLDIFCIEALESILKEYKGTVIIISHDKKFVEHVSDIVYRIENQKLKLVN", "dna_sequence_from_broadstreet": "ATGGAACAAATATGTTTTGAATTAGAGAATATTGAATTAAGTTATTTAGATAAAAAAGTGTTGGATATTGATCGATTAGCTATTCATCAGTTTGATAGAATAGGTATTGTGGGAAGAAATGGAGCAGGAAAAAGTACATTATTGAAAATAATTGGTGGTATTATTAATCCTTCTAGAGGAAAGGTTAATCAATATGTAGAGTACGGGTATTTCGAACAATTAGAAGGTCCGATAGCTAAAGCAACTAATCCGCGCTTATTAGGTAAGTTGCAAGTAAAAGAGAACGCTAGTAATTTAAGTGGTGGTGAACAGACAAGGCTCAAACTTGCGCAATTATTTACCCATTTTTATGATGCGTTGTTAATTGATGAGCCTACAACACATTTGGATCAAGATGGTATCTCATTTCTTATCGAAGAACTTAAGAATTATTATGGTGCTTTAATTTTAATAAGTCATGATCGTGCATTTCTGGATGAACTTGTTACAACAATATGGGAAATTGATGAAGGTACAGTTAAAATATATTCTGGAAATTATAGTGATTATATGAGGCAGAAGCAAATAGAAAGAACGCAACAAGTTTACAATCATGAACAATTTTTGAAAGAAAAGAATAGGCTTGAAAAAGCATCACTAGAAAAAATGAAAAAAGCTGAAAAAATTGCTAAATCTACTTCGATGTCAAAGAAAGAGTCTAAGGCAAAGCCAAATCGTATGTTCGAATCAAAGTCGAAAGGCACAAGTCAGAAATCGTTACAACGTGCTGCAAAAGCAATCGAGCAAAGAATAAACCAACTGCAAGTTGTAGAAGCACCAAATGATGATTACGTCATTCATTTCCATTCGACTAATAATATATCAAAATTGCATAATAAATTTCCGATTATGGGGGATTGTATAACGCTAGAGATAGATGATAAAGTACTATTAAAAGAAACAAGTTTTCAATTTCCTTTAGGTAAAACAATAGCAATTACTGGTAAGAATGGTTCAGGTAAAACAACATTGATTCGTCATATTATTGAAAATGGTGAGGGTATCACTATTTCCCCAAAAGCAGAGATTGGAATATATGAACAAATGGGTTATCAGTTCGATGAAGATAAAACTGTTTTATCGTATATAAAAGATAGAAGTGATTATGATGAAAGTAAAATACGTTCTGTTCTTAATGCGATGAGTTTTACTGGTAATGACTTGAAGAAGAAAGTTCAAAACTTAAGTGGAGGAGAATCAATACGGTTAGTATTATGTCAACTTTTTTTAGGAAGGTATAATATTTTAGTTCTAGATGAGCCAACAAACTTTTTAGATATTTTTTGTATTGAAGCATTAGAGAGTATTTTAAAAGAATACAAAGGTACTGTAATTATTATTTCACATGATAAAAAATTTGTTGAACATGTTTCTGATATAGTTTATAGAATAGAAAACCAAAAATTGAAATTAGTAAATTGA", "partial": "0", "query_start": 51433, "query_end": 51963, "hit_start": 75, "hit_end": 462, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 24.29}, "gnl|BL_ORD_ID|4749|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "msr(G)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "600", "model_id": "5743", "ARO_accession": "3007042", "ARO_name": "msr(G)", "ARO_category": {"41695": {"category_aro_accession": "3004471", "category_aro_cvterm_id": "41695", "category_aro_name": "msr-type ABC-F protein", "category_aro_description": "msr-type ABC-F subfamily ribosomal protection proteins expression in Staphylococci species and confer resistance to erythromycin and streptogramin B antibiotics through antibiotic target protection mechanisms.", "category_aro_class_name": "AMR Gene Family"}, "35925": {"category_aro_accession": "0000006", "category_aro_cvterm_id": "35925", "category_aro_name": "erythromycin", "category_aro_description": "Erythromycin is a macrolide antibiotic with a 14-carbon ring that has an antimicrobial spectrum similar to or slightly wider than that of penicillin, and is often used for people that have an allergy to penicillins. Erythromycin may possess bacteriocidal activity, particularly at higher concentrations by binding to the 50S subunit of the bacterial 70S rRNA complex, inhibiting peptidyl-tRNA translocation. Thus, protein synthesis and subsequently structure/function processes critical for life or replication are inhibited.", "category_aro_class_name": "Antibiotic"}, "36297": {"category_aro_accession": "3000158", "category_aro_cvterm_id": "36297", "category_aro_name": "azithromycin", "category_aro_description": "Azithromycin is a 15-membered macrolide and falls under the subclass of azalide. Like other macrolides, azithromycin binds bacterial ribosomes to inhibit protein synthesis. The nitrogen substitution at the C-9a position prevents its degradation.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000113963, "max_identities": 52, "bit_score": 40.4318, "cvterm_id": "43299", "query": "LEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTH-ANAVVRLADGKILDRITPAEAQKVMA", "match": "L V+  + I I G +G+GK+T L L+  +   ++G V+                 RL   G+             F+ +E P +          R     LL ++ + K +    N+LSGG++ R+ +A+      + +L DEPT +LD    + I  L+ EL    G   + S HD  V+      +  + +GK+  RI        MA", "sequence_from_db": "LAVHQFDRIGIVGKNGAGKSTLLKLLAGIIKPTTGKVN-----------------RLVENGY-------------FEQLETPSV----------RDADPVLLGKLDVPKDS----NQLSGGEQTRMKLAKLFTHYYEALLIDEPTTHLDQ---EGISFLLDELRYYYGALVLIS-HDRSVLDELVTTIWEVHEGKV--RIYSGNYSDYMA", "sequence_from_broadstreet": "MEQICFELENVEVTYLDKEVLKIERLAVHQFDRIGIVGKNGAGKSTLLKLLAGIIKPTTGKVNRLVENGYFEQLETPSVRDADPVLLGKLDVPKDSNQLSGGEQTRMKLAKLFTHYYEALLIDEPTTHLDQEGISFLLDELRYYYGALVLISHDRSVLDELVTTIWEVHEGKVRIYSGNYSDYMAQKKLEREQQSQAHEQFIKEKSRLEKAAQEKMKKAEKVAQAGRLSKKDANAKPDKSFMTKSKGTSQKAMQRAAKAIEQRMEKLQEVDAVKEDRQINFHQSRNLELHNKFPIMADRFTLQVDNKVLLNEVSFQMPLGKKIAISGKNGAGKSTLLHHIAINAPGLTISPKAKIGYFRQMSYQYTRDETVLEFLKNRSEYDERFLRSVLHSMLFVGTDILKSVKSLSGGEAIRLQLCQLFLGEYNILLLDEPTNFLDIYAIEALERFITAYKGTIIFVSHDRRFIDCVADCIYFIEDQQLKLRG", "dna_sequence_from_broadstreet": "ATGGAACAAATCTGTTTTGAATTAGAAAATGTAGAAGTGACATATCTAGATAAAGAGGTTTTAAAGATTGAAAGATTAGCTGTACACCAATTTGACCGTATCGGCATAGTCGGTAAAAATGGTGCAGGTAAAAGCACGTTACTAAAATTACTGGCGGGTATCATTAAGCCAACAACGGGAAAGGTGAATCGGCTTGTTGAGAATGGCTATTTTGAGCAACTTGAAACTCCATCAGTACGTGATGCTGATCCAGTGTTACTTGGAAAATTAGACGTACCAAAAGACTCTAATCAGCTAAGCGGTGGGGAACAAACAAGGATGAAACTCGCTAAATTGTTTACTCATTATTATGAAGCTTTATTAATTGATGAGCCGACTACTCACTTAGACCAAGAGGGGATTTCGTTTTTGCTCGATGAACTTAGGTATTACTATGGAGCGCTTGTATTAATTAGTCATGACCGTTCTGTATTAGATGAACTAGTTACGACAATTTGGGAAGTTCATGAAGGTAAGGTACGAATCTATTCAGGAAATTACAGCGACTACATGGCACAAAAGAAGTTAGAACGTGAACAGCAGAGTCAAGCACATGAACAGTTCATAAAAGAAAAGAGCAGGTTAGAAAAAGCAGCACAAGAAAAAATGAAGAAAGCTGAAAAAGTTGCACAAGCAGGTCGATTGTCAAAAAAAGATGCGAATGCAAAGCCGGATAAGTCCTTTATGACAAAATCCAAAGGTACGAGCCAAAAAGCTATGCAGCGTGCAGCAAAGGCCATTGAGCAACGAATGGAAAAACTTCAGGAAGTCGATGCTGTAAAAGAGGATAGGCAAATAAACTTCCATCAATCGAGAAATTTAGAGCTGCATAATAAATTTCCGATAATGGCAGACCGATTTACTCTTCAAGTGGATAACAAAGTATTATTAAATGAAGTAAGTTTTCAAATGCCGCTTGGTAAAAAAATTGCAATTTCGGGTAAAAATGGTGCTGGCAAAAGTACTTTACTCCACCATATTGCTATCAATGCGCCAGGTTTAACAATTTCACCAAAAGCAAAAATTGGATACTTTCGTCAAATGAGCTATCAATATACAAGGGATGAAACGGTATTGGAATTTCTGAAAAATCGTTCTGAATACGATGAGAGATTTTTACGAAGCGTTCTACATTCCATGTTGTTTGTCGGCACAGATATATTAAAAAGTGTAAAATCATTAAGTGGTGGTGAAGCGATTCGTCTACAATTATGTCAATTATTTTTAGGAGAGTATAATATTTTATTGTTAGATGAACCAACCAATTTTTTAGATATCTATGCTATTGAAGCGTTAGAAAGATTTATTACAGCATATAAAGGCACTATTATCTTCGTATCACATGATCGCAGGTTTATTGATTGTGTAGCAGATTGTATATATTTCATTGAAGATCAACAGCTAAAATTAAGGGGTTGA", "partial": "0", "query_start": 51433, "query_end": 52059, "hit_start": 75, "hit_end": 555, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 24.76}, "gnl|BL_ORD_ID|4749|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "msr(G)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "600", "model_id": "5743", "ARO_accession": "3007042", "ARO_name": "msr(G)", "ARO_category": {"41695": {"category_aro_accession": "3004471", "category_aro_cvterm_id": "41695", "category_aro_name": "msr-type ABC-F protein", "category_aro_description": "msr-type ABC-F subfamily ribosomal protection proteins expression in Staphylococci species and confer resistance to erythromycin and streptogramin B antibiotics through antibiotic target protection mechanisms.", "category_aro_class_name": "AMR Gene Family"}, "35925": {"category_aro_accession": "0000006", "category_aro_cvterm_id": "35925", "category_aro_name": "erythromycin", "category_aro_description": "Erythromycin is a macrolide antibiotic with a 14-carbon ring that has an antimicrobial spectrum similar to or slightly wider than that of penicillin, and is often used for people that have an allergy to penicillins. Erythromycin may possess bacteriocidal activity, particularly at higher concentrations by binding to the 50S subunit of the bacterial 70S rRNA complex, inhibiting peptidyl-tRNA translocation. Thus, protein synthesis and subsequently structure/function processes critical for life or replication are inhibited.", "category_aro_class_name": "Antibiotic"}, "36297": {"category_aro_accession": "3000158", "category_aro_cvterm_id": "36297", "category_aro_name": "azithromycin", "category_aro_description": "Azithromycin is a 15-membered macrolide and falls under the subclass of azalide. Like other macrolides, azithromycin binds bacterial ribosomes to inhibit protein synthesis. The nitrogen substitution at the C-9a position prevents its degradation.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.195182, "max_identities": 20, "bit_score": 30.0314, "cvterm_id": "43299", "query": "LSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTH-ANAVVRLADGKI", "match": "LSGG+  R+ + +  +    ++L DEPT  LD       I+ ++        T IF +HD + +   A+ +  + D ++", "sequence_from_db": "LSGGEAIRLQLCQLFLGEYNILLLDEPTNFLDIYA----IEALERFITAYKGTIIFVSHDRRFIDCVADCIYFIEDQQL", "sequence_from_broadstreet": "MEQICFELENVEVTYLDKEVLKIERLAVHQFDRIGIVGKNGAGKSTLLKLLAGIIKPTTGKVNRLVENGYFEQLETPSVRDADPVLLGKLDVPKDSNQLSGGEQTRMKLAKLFTHYYEALLIDEPTTHLDQEGISFLLDELRYYYGALVLISHDRSVLDELVTTIWEVHEGKVRIYSGNYSDYMAQKKLEREQQSQAHEQFIKEKSRLEKAAQEKMKKAEKVAQAGRLSKKDANAKPDKSFMTKSKGTSQKAMQRAAKAIEQRMEKLQEVDAVKEDRQINFHQSRNLELHNKFPIMADRFTLQVDNKVLLNEVSFQMPLGKKIAISGKNGAGKSTLLHHIAINAPGLTISPKAKIGYFRQMSYQYTRDETVLEFLKNRSEYDERFLRSVLHSMLFVGTDILKSVKSLSGGEAIRLQLCQLFLGEYNILLLDEPTNFLDIYAIEALERFITAYKGTIIFVSHDRRFIDCVADCIYFIEDQQLKLRG", "dna_sequence_from_broadstreet": "ATGGAACAAATCTGTTTTGAATTAGAAAATGTAGAAGTGACATATCTAGATAAAGAGGTTTTAAAGATTGAAAGATTAGCTGTACACCAATTTGACCGTATCGGCATAGTCGGTAAAAATGGTGCAGGTAAAAGCACGTTACTAAAATTACTGGCGGGTATCATTAAGCCAACAACGGGAAAGGTGAATCGGCTTGTTGAGAATGGCTATTTTGAGCAACTTGAAACTCCATCAGTACGTGATGCTGATCCAGTGTTACTTGGAAAATTAGACGTACCAAAAGACTCTAATCAGCTAAGCGGTGGGGAACAAACAAGGATGAAACTCGCTAAATTGTTTACTCATTATTATGAAGCTTTATTAATTGATGAGCCGACTACTCACTTAGACCAAGAGGGGATTTCGTTTTTGCTCGATGAACTTAGGTATTACTATGGAGCGCTTGTATTAATTAGTCATGACCGTTCTGTATTAGATGAACTAGTTACGACAATTTGGGAAGTTCATGAAGGTAAGGTACGAATCTATTCAGGAAATTACAGCGACTACATGGCACAAAAGAAGTTAGAACGTGAACAGCAGAGTCAAGCACATGAACAGTTCATAAAAGAAAAGAGCAGGTTAGAAAAAGCAGCACAAGAAAAAATGAAGAAAGCTGAAAAAGTTGCACAAGCAGGTCGATTGTCAAAAAAAGATGCGAATGCAAAGCCGGATAAGTCCTTTATGACAAAATCCAAAGGTACGAGCCAAAAAGCTATGCAGCGTGCAGCAAAGGCCATTGAGCAACGAATGGAAAAACTTCAGGAAGTCGATGCTGTAAAAGAGGATAGGCAAATAAACTTCCATCAATCGAGAAATTTAGAGCTGCATAATAAATTTCCGATAATGGCAGACCGATTTACTCTTCAAGTGGATAACAAAGTATTATTAAATGAAGTAAGTTTTCAAATGCCGCTTGGTAAAAAAATTGCAATTTCGGGTAAAAATGGTGCTGGCAAAAGTACTTTACTCCACCATATTGCTATCAATGCGCCAGGTTTAACAATTTCACCAAAAGCAAAAATTGGATACTTTCGTCAAATGAGCTATCAATATACAAGGGATGAAACGGTATTGGAATTTCTGAAAAATCGTTCTGAATACGATGAGAGATTTTTACGAAGCGTTCTACATTCCATGTTGTTTGTCGGCACAGATATATTAAAAAGTGTAAAATCATTAAGTGGTGGTGAAGCGATTCGTCTACAATTATGTCAATTATTTTTAGGAGAGTATAATATTTTATTGTTAGATGAACCAACCAATTTTTTAGATATCTATGCTATTGAAGCGTTAGAAAGATTTATTACAGCATATAAAGGCACTATTATCTTCGTATCACATGATCGCAGGTTTATTGATTGTGTAGCAGATTGTATATATTTCATTGAAGATCAACAGCTAAAATTAAGGGGTTGA", "partial": "0", "query_start": 51784, "query_end": 52017, "hit_start": 1218, "hit_end": 1443, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 25.32}, "gnl|BL_ORD_ID|4725|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "salB", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5737", "ARO_accession": "3007026", "ARO_name": "salB", "ARO_category": {"45589": {"category_aro_accession": "3007030", "category_aro_cvterm_id": "45589", "category_aro_name": "sal-type ABC-F protein", "category_aro_description": "Sal proteins are a part of the ABC-F proteins, expressed in staphylococci that confer resistance to group A streptogramin, lincosamide, and pleuromutilin antibiotics through ribosomal protection.", "category_aro_class_name": "AMR Gene Family"}, "35964": {"category_aro_accession": "0000046", "category_aro_cvterm_id": "35964", "category_aro_name": "lincomycin", "category_aro_description": "Lincomycin is a lincosamide antibiotic that comes from the actinomyces Streptomyces lincolnensis. It binds to the 23s portion of the 50S subunit of bacterial ribosomes and inhibit early elongation of peptide chain by inhibiting transpeptidase reaction.", "category_aro_class_name": "Antibiotic"}, "35983": {"category_aro_accession": "0000066", "category_aro_cvterm_id": "35983", "category_aro_name": "clindamycin", "category_aro_description": "Clindamycin is a lincosamide antibiotic that blocks A-site aminoacyl-tRNA binding. It is usually used to treat infections with anaerobic bacteria but can also be used to treat some protozoal diseases, such as malaria.", "category_aro_class_name": "Antibiotic"}, "37013": {"category_aro_accession": "3000669", "category_aro_cvterm_id": "37013", "category_aro_name": "virginiamycin M1", "category_aro_description": "Virginiamycin M1 is a streptogramin A antibiotic.", "category_aro_class_name": "Antibiotic"}, "37015": {"category_aro_accession": "3000671", "category_aro_cvterm_id": "37015", "category_aro_name": "tiamulin", "category_aro_description": "Tiamulin is a pleuromutilin derivative currently used in veterinary medicine. It binds to the 23 rRNA of the 50S ribosomal subunit to inhibit protein translation.", "category_aro_class_name": "Antibiotic"}, "37713": {"category_aro_accession": "3001314", "category_aro_cvterm_id": "37713", "category_aro_name": "retapamulin", "category_aro_description": "Retapamulin is a semi-synthetic pleuromutilin antibiotic approved for the treatment of skin infections.", "category_aro_class_name": "Antibiotic"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35952": {"category_aro_accession": "0000034", "category_aro_cvterm_id": "35952", "category_aro_name": "streptogramin A antibiotic", "category_aro_description": "Streptogramin A antibiotics are cyclic polyketide peptide hybrids that bind to the ribosomal peptidyl transfer centre. Structural variation arises from substituting a proline for its desaturated derivative and by its substitution for Ala or Cys. Used alone, streptogramin A antibiotics are bacteriostatic, but is bactericidal when used with streptogramin B antibiotics.", "category_aro_class_name": "Drug Class"}, "37014": {"category_aro_accession": "3000670", "category_aro_cvterm_id": "37014", "category_aro_name": "pleuromutilin antibiotic", "category_aro_description": "Pleuromutilins are natural fungal products that target bacterial protein translation by binding the the 23S rRNA, blocking the ribosome P site at the 50S subunit. They are mostly used for agriculture and veterinary purposes.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000147478, "max_identities": 48, "bit_score": 40.0466, "cvterm_id": "39555", "query": "LRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSF-NL---VSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEK-HAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHD", "match": " +    E+   + + I G +GSGK+T + LI       SG V                H  L  IG+  Q F NL    SVL    ++E  ++           T   T+L     +K     +  +LS G++ R+   +   + P +++ DEPT   D    + II L++  N   G   I S HD", "sequence_from_db": "FKDTYFEIKRNQTVIIEGKNGSGKSTLIQLILGNLLPMSGAVK--------------KHPDL-DIGYFSQDFQNLNPNNSVLEEVMDIENMMI-----------TDARTILASFYFDKSRMNDKVRQLSMGEKCRLQFVKLYFSNPHILILDEPTNYFDISMQEKIIQLIQSFN---GAVIIVS-HD", "sequence_from_broadstreet": "MLFLFEEKPLEIENKQLIKRLSFHIEDHEHLALIGVNGIGKSTLLHHIHKNELIDTAMMEQDLSKHDDIDVMDYVMSAYPKLVELRKDLSDIDSLNSYIELDGYNVENNIIIEGNKLGLSSTHFEQKIGTLSGGEQTKVSFLKVILSDAPLLLIDEPTNHMDKEMKVWLIKAFKSEQRAILFVSHDREFLNETPDAILELTKDGATRYSGHYDDYKNQKDIEIETEKLKYEKEQKEQKAIEESIKKYKEWYQRAAQKASVRSPYAQKQLSKLAKRFKSKEHQLNRKLEESKSDNPLEENKSFSIENNEFKSHYLVRFENVSFSYKSREIFKDTYFEIKRNQTVIIEGKNGSGKSTLIQLILGNLLPMSGAVKKHPDLDIGYFSQDFQNLNPNNSVLEEVMDIENMMITDARTILASFYFDKSRMNDKVRQLSMGEKCRLQFVKLYFSNPHILILDEPTNYFDISMQEKIIQLIQSFNGAVIIVSHDEIFKDEIRDQVWKIENCKLIHENVSINTPIDAESMKDELKILEQYTDERNKETDF", "dna_sequence_from_broadstreet": "ATGCTATTTTTATTTGAAGAAAAACCATTAGAAATTGAGAATAAACAGCTTATAAAACGTTTGTCATTTCATATCGAAGACCATGAGCATTTAGCCCTTATCGGTGTTAATGGTATTGGTAAATCTACGCTATTACATCATATTCATAAAAATGAATTGATTGATACAGCTATGATGGAACAAGATTTAAGTAAACATGATGATATTGATGTTATGGATTATGTCATGTCTGCATATCCAAAGTTAGTTGAATTGAGAAAAGATTTATCTGACATTGATTCTTTAAATAGTTATATAGAATTAGACGGATATAACGTTGAAAATAACATTATTATTGAAGGAAATAAATTAGGATTATCATCAACACATTTTGAGCAAAAGATAGGCACTTTAAGTGGTGGTGAGCAAACTAAAGTCTCATTTTTAAAAGTTATTTTATCAGATGCACCATTATTATTAATAGACGAACCAACTAACCATATGGATAAAGAGATGAAAGTGTGGTTAATAAAAGCTTTTAAATCAGAACAAAGAGCTATTCTATTCGTATCGCATGATAGAGAGTTTTTAAATGAAACACCAGATGCTATTTTAGAACTCACAAAAGATGGTGCAACTCGATATTCAGGTCATTATGATGATTATAAAAATCAAAAAGATATTGAAATTGAAACAGAAAAATTAAAATATGAAAAAGAACAGAAAGAACAAAAAGCAATAGAAGAAAGTATTAAGAAATACAAAGAATGGTATCAAAGGGCTGCTCAGAAAGCTTCTGTTCGTAGTCCATATGCTCAAAAACAATTAAGTAAATTAGCTAAAAGATTTAAATCAAAAGAACATCAGTTAAATCGTAAATTAGAAGAATCAAAATCTGATAATCCGTTAGAAGAAAATAAATCCTTTTCTATAGAAAATAATGAATTTAAATCACATTATTTAGTAAGATTCGAAAATGTTTCATTTTCATATAAGAGTCGTGAAATTTTTAAAGACACTTATTTTGAAATAAAGAGAAATCAAACTGTAATTATAGAAGGTAAAAATGGGTCCGGTAAATCTACATTGATACAATTAATTTTAGGTAACTTATTACCAATGAGTGGAGCTGTCAAAAAGCACCCAGACTTAGACATAGGATACTTCTCGCAAGATTTTCAAAATTTAAACCCAAACAACTCGGTATTAGAAGAAGTTATGGATATTGAGAATATGATGATAACAGACGCGAGGACTATTTTAGCGAGTTTTTATTTTGATAAGAGCAGGATGAATGATAAAGTTCGTCAGTTATCAATGGGAGAAAAGTGCAGGTTACAATTTGTAAAATTATATTTTTCTAACCCACACATCTTAATTTTAGATGAACCAACTAATTATTTTGATATTAGTATGCAAGAGAAAATCATACAATTAATCCAAAGTTTTAATGGTGCAGTAATTATTGTGTCGCATGATGAAATTTTTAAAGATGAAATAAGAGACCAAGTTTGGAAGATTGAAAACTGTAAGCTCATTCATGAAAATGTATCTATTAATACACCTATTGATGCTGAATCGATGAAGGATGAGTTAAAAATATTAGAGCAATATACAGATGAAAGAAATAAAGAAACAGACTTCTAG", "partial": "0", "query_start": 51418, "query_end": 51963, "hit_start": 987, "hit_end": 1458, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 25.67}, "gnl|BL_ORD_ID|4725|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "salB", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5737", "ARO_accession": "3007026", "ARO_name": "salB", "ARO_category": {"45589": {"category_aro_accession": "3007030", "category_aro_cvterm_id": "45589", "category_aro_name": "sal-type ABC-F protein", "category_aro_description": "Sal proteins are a part of the ABC-F proteins, expressed in staphylococci that confer resistance to group A streptogramin, lincosamide, and pleuromutilin antibiotics through ribosomal protection.", "category_aro_class_name": "AMR Gene Family"}, "35964": {"category_aro_accession": "0000046", "category_aro_cvterm_id": "35964", "category_aro_name": "lincomycin", "category_aro_description": "Lincomycin is a lincosamide antibiotic that comes from the actinomyces Streptomyces lincolnensis. It binds to the 23s portion of the 50S subunit of bacterial ribosomes and inhibit early elongation of peptide chain by inhibiting transpeptidase reaction.", "category_aro_class_name": "Antibiotic"}, "35983": {"category_aro_accession": "0000066", "category_aro_cvterm_id": "35983", "category_aro_name": "clindamycin", "category_aro_description": "Clindamycin is a lincosamide antibiotic that blocks A-site aminoacyl-tRNA binding. It is usually used to treat infections with anaerobic bacteria but can also be used to treat some protozoal diseases, such as malaria.", "category_aro_class_name": "Antibiotic"}, "37013": {"category_aro_accession": "3000669", "category_aro_cvterm_id": "37013", "category_aro_name": "virginiamycin M1", "category_aro_description": "Virginiamycin M1 is a streptogramin A antibiotic.", "category_aro_class_name": "Antibiotic"}, "37015": {"category_aro_accession": "3000671", "category_aro_cvterm_id": "37015", "category_aro_name": "tiamulin", "category_aro_description": "Tiamulin is a pleuromutilin derivative currently used in veterinary medicine. It binds to the 23 rRNA of the 50S ribosomal subunit to inhibit protein translation.", "category_aro_class_name": "Antibiotic"}, "37713": {"category_aro_accession": "3001314", "category_aro_cvterm_id": "37713", "category_aro_name": "retapamulin", "category_aro_description": "Retapamulin is a semi-synthetic pleuromutilin antibiotic approved for the treatment of skin infections.", "category_aro_class_name": "Antibiotic"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35952": {"category_aro_accession": "0000034", "category_aro_cvterm_id": "35952", "category_aro_name": "streptogramin A antibiotic", "category_aro_description": "Streptogramin A antibiotics are cyclic polyketide peptide hybrids that bind to the ribosomal peptidyl transfer centre. Structural variation arises from substituting a proline for its desaturated derivative and by its substitution for Ala or Cys. Used alone, streptogramin A antibiotics are bacteriostatic, but is bactericidal when used with streptogramin B antibiotics.", "category_aro_class_name": "Drug Class"}, "37014": {"category_aro_accession": "3000670", "category_aro_cvterm_id": "37014", "category_aro_name": "pleuromutilin antibiotic", "category_aro_description": "Pleuromutilins are natural fungal products that target bacterial protein translation by binding the the 23S rRNA, blocking the ribosome P site at the 50S subunit. They are mostly used for agriculture and veterinary purposes.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000604176, "max_identities": 43, "bit_score": 38.1206, "cvterm_id": "39555", "query": "LRGVTLEVYPGEFISIAGPSGSGKTTALNLI---GCVDTASSGVVSVDGQDTKKLTERQLT-HLRLHTIGFIFQSF-NLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEK-HAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHA-NAVVRLA-DG", "match": "++ ++  +   E +++ G +G GK+T L+ I     +DTA              + E+ L+ H  +  + ++  ++  LV +     +++  L    +L+       ++    ++GL   H + +   LSGG++ +V+  + +++   L+L DEPT ++D      +I   K     E    +F +HD + +    +A++ L  DG", "sequence_from_db": "IKRLSFHIEDHEHLALIGVNGIGKSTLLHHIHKNELIDTA--------------MMEQDLSKHDDIDVMDYVMSAYPKLVELRKDLSDID-SLNSYIELDGYNVENNIIIEGNKLGLSSTHFEQKIGTLSGGEQTKVSFLKVILSDAPLLLIDEPTNHMDKEMKVWLIKAFK----SEQRAILFVSHDREFLNETPDAILELTKDG", "sequence_from_broadstreet": "MLFLFEEKPLEIENKQLIKRLSFHIEDHEHLALIGVNGIGKSTLLHHIHKNELIDTAMMEQDLSKHDDIDVMDYVMSAYPKLVELRKDLSDIDSLNSYIELDGYNVENNIIIEGNKLGLSSTHFEQKIGTLSGGEQTKVSFLKVILSDAPLLLIDEPTNHMDKEMKVWLIKAFKSEQRAILFVSHDREFLNETPDAILELTKDGATRYSGHYDDYKNQKDIEIETEKLKYEKEQKEQKAIEESIKKYKEWYQRAAQKASVRSPYAQKQLSKLAKRFKSKEHQLNRKLEESKSDNPLEENKSFSIENNEFKSHYLVRFENVSFSYKSREIFKDTYFEIKRNQTVIIEGKNGSGKSTLIQLILGNLLPMSGAVKKHPDLDIGYFSQDFQNLNPNNSVLEEVMDIENMMITDARTILASFYFDKSRMNDKVRQLSMGEKCRLQFVKLYFSNPHILILDEPTNYFDISMQEKIIQLIQSFNGAVIIVSHDEIFKDEIRDQVWKIENCKLIHENVSINTPIDAESMKDELKILEQYTDERNKETDF", "dna_sequence_from_broadstreet": "ATGCTATTTTTATTTGAAGAAAAACCATTAGAAATTGAGAATAAACAGCTTATAAAACGTTTGTCATTTCATATCGAAGACCATGAGCATTTAGCCCTTATCGGTGTTAATGGTATTGGTAAATCTACGCTATTACATCATATTCATAAAAATGAATTGATTGATACAGCTATGATGGAACAAGATTTAAGTAAACATGATGATATTGATGTTATGGATTATGTCATGTCTGCATATCCAAAGTTAGTTGAATTGAGAAAAGATTTATCTGACATTGATTCTTTAAATAGTTATATAGAATTAGACGGATATAACGTTGAAAATAACATTATTATTGAAGGAAATAAATTAGGATTATCATCAACACATTTTGAGCAAAAGATAGGCACTTTAAGTGGTGGTGAGCAAACTAAAGTCTCATTTTTAAAAGTTATTTTATCAGATGCACCATTATTATTAATAGACGAACCAACTAACCATATGGATAAAGAGATGAAAGTGTGGTTAATAAAAGCTTTTAAATCAGAACAAAGAGCTATTCTATTCGTATCGCATGATAGAGAGTTTTTAAATGAAACACCAGATGCTATTTTAGAACTCACAAAAGATGGTGCAACTCGATATTCAGGTCATTATGATGATTATAAAAATCAAAAAGATATTGAAATTGAAACAGAAAAATTAAAATATGAAAAAGAACAGAAAGAACAAAAAGCAATAGAAGAAAGTATTAAGAAATACAAAGAATGGTATCAAAGGGCTGCTCAGAAAGCTTCTGTTCGTAGTCCATATGCTCAAAAACAATTAAGTAAATTAGCTAAAAGATTTAAATCAAAAGAACATCAGTTAAATCGTAAATTAGAAGAATCAAAATCTGATAATCCGTTAGAAGAAAATAAATCCTTTTCTATAGAAAATAATGAATTTAAATCACATTATTTAGTAAGATTCGAAAATGTTTCATTTTCATATAAGAGTCGTGAAATTTTTAAAGACACTTATTTTGAAATAAAGAGAAATCAAACTGTAATTATAGAAGGTAAAAATGGGTCCGGTAAATCTACATTGATACAATTAATTTTAGGTAACTTATTACCAATGAGTGGAGCTGTCAAAAAGCACCCAGACTTAGACATAGGATACTTCTCGCAAGATTTTCAAAATTTAAACCCAAACAACTCGGTATTAGAAGAAGTTATGGATATTGAGAATATGATGATAACAGACGCGAGGACTATTTTAGCGAGTTTTTATTTTGATAAGAGCAGGATGAATGATAAAGTTCGTCAGTTATCAATGGGAGAAAAGTGCAGGTTACAATTTGTAAAATTATATTTTTCTAACCCACACATCTTAATTTTAGATGAACCAACTAATTATTTTGATATTAGTATGCAAGAGAAAATCATACAATTAATCCAAAGTTTTAATGGTGCAGTAATTATTGTGTCGCATGATGAAATTTTTAAAGATGAAATAAGAGACCAAGTTTGGAAGATTGAAAACTGTAAGCTCATTCATGAAAATGTATCTATTAATACACCTATTGATGCTGAATCGATGAAGGATGAGTTAAAAATATTAGAGCAATATACAGATGAAAGAAATAAAGAAACAGACTTCTAG", "partial": "0", "query_start": 51418, "query_end": 52011, "hit_start": 51, "hit_end": 612, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 20.87}, "gnl|BL_ORD_ID|4750|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "msr(I)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "600", "model_id": "5744", "ARO_accession": "3007043", "ARO_name": "msr(I)", "ARO_category": {"41695": {"category_aro_accession": "3004471", "category_aro_cvterm_id": "41695", "category_aro_name": "msr-type ABC-F protein", "category_aro_description": "msr-type ABC-F subfamily ribosomal protection proteins expression in Staphylococci species and confer resistance to erythromycin and streptogramin B antibiotics through antibiotic target protection mechanisms.", "category_aro_class_name": "AMR Gene Family"}, "35944": {"category_aro_accession": "0000025", "category_aro_cvterm_id": "35944", "category_aro_name": "fosfomycin", "category_aro_description": "Fosfomycin (also known as phosphomycin and phosphonomycin) is a broad-spectrum antibiotic produced by certain Streptomyces species. It is effective on gram positive and negative bacteria as it targets the cell wall, an essential feature shared by both bacteria. Its specific target is MurA (MurZ in E.coli), which attaches phosphoenolpyruvate (PEP) to UDP-N-acetylglucosamine, a step of commitment to cell wall synthesis. In the active site of MurA, the active cysteine molecule is alkylated which stops the catalytic reaction.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "45731": {"category_aro_accession": "3007149", "category_aro_cvterm_id": "45731", "category_aro_name": "phosphonic acid antibiotic", "category_aro_description": "A group of antibiotics derived from phosphonic acids.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000234214, "max_identities": 54, "bit_score": 39.2762, "cvterm_id": "36764", "query": "TYSLGKVQVPALRGVTLE-----VYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTH-ANAVVRLADGKI", "match": " + L K++V  L    LE     V+  + I I G +G GK+T L L+      + G V           +RQ+ +      G+             F+ VE P    + ++   +      LL Q+ +++++K     LSGG++ R+ +A+      + +L DEPT +LD    + I  L++EL    G   + S HD  V+      +  + DGK+", "sequence_from_db": "CFELEKIEVTYLDKKVLEIDRLAVHQFDRIGIVGKNGVGKSTLLKLLAGHIQPTVGKV-----------KRQVEY------GY-------------FEQVEGP----KDISTDPK------LLSQLHVDENSKG----LSGGEQTRLKLAQLFTDYYESLLIDEPTTHLDQ---EGISFLIEELKYYYGALVLIS-HDRYVLDELVTTIWEVDDGKV", "sequence_from_broadstreet": "MEQICFELEKIEVTYLDKKVLEIDRLAVHQFDRIGIVGKNGVGKSTLLKLLAGHIQPTVGKVKRQVEYGYFEQVEGPKDISTDPKLLSQLHVDENSKGLSGGEQTRLKLAQLFTDYYESLLIDEPTTHLDQEGISFLIEELKYYYGALVLISHDRYVLDELVTTIWEVDDGKVKVYSGDYSEYIEQKKLERSKQTQAHEQFLKEKKRLEKAAEEKMKKAEKIAKSSAKSKDSKVKANRMFESKSKGTTQKALQRAAKAVEQRVKKLEVIDAPKKEQTIRFHQTNIILELHNKFPIMADQLTITVGNKILLNNVNFQFALGETIAITGKNGSGKSTLIHHILQREKGITISPKAVIGSYEQMGYQFKTDETVMDFMKNRSDYGESKIRSVLYAMSFTGNDLKKSVQKLSGGEATRLVLCQLFLGRYNVLILDEPTNFLDVFCIEALETFLKGYEGTVILISHDKTFLDRVADSEYVLENQNLKKNR", "dna_sequence_from_broadstreet": "ATGGAACAAATTTGTTTTGAATTAGAAAAAATTGAAGTAACTTATTTAGATAAAAAAGTATTAGAGATAGATCGTTTAGCAGTTCATCAATTTGATAGAATTGGTATTGTTGGAAAAAATGGTGTTGGTAAGAGTACTCTGCTAAAATTACTTGCAGGTCATATTCAACCTACAGTTGGAAAAGTAAAGCGTCAAGTAGAATATGGTTATTTTGAACAGGTAGAAGGTCCTAAAGATATATCAACAGATCCTAAGTTACTTAGCCAATTACATGTTGATGAGAATTCGAAAGGGCTAAGTGGTGGTGAACAAACAAGATTAAAACTTGCACAGTTATTTACGGACTATTATGAATCTTTATTAATTGATGAGCCAACTACACATTTGGACCAAGAAGGTATATCATTTTTAATAGAAGAGTTGAAATACTATTATGGGGCACTGGTATTAATAAGTCATGACCGATATGTTTTAGATGAACTTGTGACTACAATTTGGGAAGTTGATGATGGGAAAGTAAAAGTATATTCAGGAGATTACAGTGAATATATCGAGCAAAAGAAACTTGAAAGATCAAAACAAACTCAGGCTCATGAACAGTTCTTAAAGGAAAAAAAACGTTTAGAAAAAGCAGCAGAAGAAAAAATGAAAAAAGCAGAAAAAATTGCTAAATCTTCTGCTAAATCAAAAGACTCTAAAGTAAAAGCAAATCGTATGTTTGAATCAAAATCAAAGGGTACAACTCAAAAAGCGTTACAACGTGCTGCTAAGGCTGTTGAACAAAGAGTAAAAAAACTTGAAGTTATAGATGCGCCTAAAAAAGAACAAACTATCCGTTTTCATCAAACAAATATCATACTTGAGTTACATAACAAGTTTCCAATTATGGCTGATCAATTAACGATTACAGTAGGAAATAAGATACTTTTAAACAATGTTAACTTTCAATTTGCATTAGGTGAAACGATTGCTATTACTGGTAAAAATGGTTCTGGGAAATCAACATTAATTCACCACATATTACAACGTGAAAAAGGAATTACTATTTCTCCAAAGGCTGTTATAGGCTCTTATGAGCAGATGGGATATCAATTTAAAACTGATGAAACTGTAATGGACTTTATGAAAAATAGAAGCGATTATGGAGAAAGTAAAATACGTTCTGTACTATATGCTATGAGTTTTACTGGGAATGATTTAAAAAAGAGTGTTCAAAAATTAAGTGGTGGCGAGGCGACTCGTTTAGTCCTATGTCAATTATTTCTAGGAAGATACAACGTTTTGATTTTAGATGAACCTACTAACTTTTTAGATGTTTTTTGTATTGAAGCTTTAGAAACATTTTTAAAAGGCTATGAAGGAACAGTTATACTAATATCACATGATAAAACATTTTTAGATCGTGTAGCTGATAGTGAATACGTTCTAGAAAATCAGAACCTTAAAAAAAATAGATAG", "partial": "0", "query_start": 51385, "query_end": 52017, "hit_start": 12, "hit_end": 519, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 24.88}, "gnl|BL_ORD_ID|4750|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "msr(I)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "600", "model_id": "5744", "ARO_accession": "3007043", "ARO_name": "msr(I)", "ARO_category": {"41695": {"category_aro_accession": "3004471", "category_aro_cvterm_id": "41695", "category_aro_name": "msr-type ABC-F protein", "category_aro_description": "msr-type ABC-F subfamily ribosomal protection proteins expression in Staphylococci species and confer resistance to erythromycin and streptogramin B antibiotics through antibiotic target protection mechanisms.", "category_aro_class_name": "AMR Gene Family"}, "35944": {"category_aro_accession": "0000025", "category_aro_cvterm_id": "35944", "category_aro_name": "fosfomycin", "category_aro_description": "Fosfomycin (also known as phosphomycin and phosphonomycin) is a broad-spectrum antibiotic produced by certain Streptomyces species. It is effective on gram positive and negative bacteria as it targets the cell wall, an essential feature shared by both bacteria. Its specific target is MurA (MurZ in E.coli), which attaches phosphoenolpyruvate (PEP) to UDP-N-acetylglucosamine, a step of commitment to cell wall synthesis. In the active site of MurA, the active cysteine molecule is alkylated which stops the catalytic reaction.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "45731": {"category_aro_accession": "3007149", "category_aro_cvterm_id": "45731", "category_aro_name": "phosphonic acid antibiotic", "category_aro_description": "A group of antibiotics derived from phosphonic acids.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0876474, "max_identities": 45, "bit_score": 31.187, "cvterm_id": "36764", "query": "LRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVV----SVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTR-VMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHD", "match": "L  V  +   GE I+I G +GSGK+T   LI  +     G+     +V G                  +G+ F++    +V+   +N         + +  E + R V+  +   G     K    +LSGG+  R+ + +  + R  +++ DEPT  LD    + +   +K     EGT  + S HD", "sequence_from_db": "LNNVNFQFALGETIAITGKNGSGKST---LIHHILQREKGITISPKAVIGS--------------YEQMGYQFKTDE--TVMDFMKN---------RSDYGESKIRSVLYAMSFTG--NDLKKSVQKLSGGEATRLVLCQLFLGRYNVLILDEPTNFLDVFCIEALETFLKGY---EGTVILIS-HD", "sequence_from_broadstreet": "MEQICFELEKIEVTYLDKKVLEIDRLAVHQFDRIGIVGKNGVGKSTLLKLLAGHIQPTVGKVKRQVEYGYFEQVEGPKDISTDPKLLSQLHVDENSKGLSGGEQTRLKLAQLFTDYYESLLIDEPTTHLDQEGISFLIEELKYYYGALVLISHDRYVLDELVTTIWEVDDGKVKVYSGDYSEYIEQKKLERSKQTQAHEQFLKEKKRLEKAAEEKMKKAEKIAKSSAKSKDSKVKANRMFESKSKGTTQKALQRAAKAVEQRVKKLEVIDAPKKEQTIRFHQTNIILELHNKFPIMADQLTITVGNKILLNNVNFQFALGETIAITGKNGSGKSTLIHHILQREKGITISPKAVIGSYEQMGYQFKTDETVMDFMKNRSDYGESKIRSVLYAMSFTGNDLKKSVQKLSGGEATRLVLCQLFLGRYNVLILDEPTNFLDVFCIEALETFLKGYEGTVILISHDKTFLDRVADSEYVLENQNLKKNR", "dna_sequence_from_broadstreet": "ATGGAACAAATTTGTTTTGAATTAGAAAAAATTGAAGTAACTTATTTAGATAAAAAAGTATTAGAGATAGATCGTTTAGCAGTTCATCAATTTGATAGAATTGGTATTGTTGGAAAAAATGGTGTTGGTAAGAGTACTCTGCTAAAATTACTTGCAGGTCATATTCAACCTACAGTTGGAAAAGTAAAGCGTCAAGTAGAATATGGTTATTTTGAACAGGTAGAAGGTCCTAAAGATATATCAACAGATCCTAAGTTACTTAGCCAATTACATGTTGATGAGAATTCGAAAGGGCTAAGTGGTGGTGAACAAACAAGATTAAAACTTGCACAGTTATTTACGGACTATTATGAATCTTTATTAATTGATGAGCCAACTACACATTTGGACCAAGAAGGTATATCATTTTTAATAGAAGAGTTGAAATACTATTATGGGGCACTGGTATTAATAAGTCATGACCGATATGTTTTAGATGAACTTGTGACTACAATTTGGGAAGTTGATGATGGGAAAGTAAAAGTATATTCAGGAGATTACAGTGAATATATCGAGCAAAAGAAACTTGAAAGATCAAAACAAACTCAGGCTCATGAACAGTTCTTAAAGGAAAAAAAACGTTTAGAAAAAGCAGCAGAAGAAAAAATGAAAAAAGCAGAAAAAATTGCTAAATCTTCTGCTAAATCAAAAGACTCTAAAGTAAAAGCAAATCGTATGTTTGAATCAAAATCAAAGGGTACAACTCAAAAAGCGTTACAACGTGCTGCTAAGGCTGTTGAACAAAGAGTAAAAAAACTTGAAGTTATAGATGCGCCTAAAAAAGAACAAACTATCCGTTTTCATCAAACAAATATCATACTTGAGTTACATAACAAGTTTCCAATTATGGCTGATCAATTAACGATTACAGTAGGAAATAAGATACTTTTAAACAATGTTAACTTTCAATTTGCATTAGGTGAAACGATTGCTATTACTGGTAAAAATGGTTCTGGGAAATCAACATTAATTCACCACATATTACAACGTGAAAAAGGAATTACTATTTCTCCAAAGGCTGTTATAGGCTCTTATGAGCAGATGGGATATCAATTTAAAACTGATGAAACTGTAATGGACTTTATGAAAAATAGAAGCGATTATGGAGAAAGTAAAATACGTTCTGTACTATATGCTATGAGTTTTACTGGGAATGATTTAAAAAAGAGTGTTCAAAAATTAAGTGGTGGCGAGGCGACTCGTTTAGTCCTATGTCAATTATTTCTAGGAAGATACAACGTTTTGATTTTAGATGAACCTACTAACTTTTTAGATGTTTTTTGTATTGAAGCTTTAGAAACATTTTTAAAAGGCTATGAAGGAACAGTTATACTAATATCACATGATAAAACATTTTTAGATCGTGTAGCTGATAGTGAATACGTTCTAGAAAATCAGAACCTTAAAAAAAATAGATAG", "partial": "0", "query_start": 51418, "query_end": 51963, "hit_start": 927, "hit_end": 1386, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 24.06}, "gnl|BL_ORD_ID|4773|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "lsaD", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "900", "model_id": "3847", "ARO_accession": "3005121", "ARO_name": "lsaD", "ARO_category": {"41696": {"category_aro_accession": "3004472", "category_aro_cvterm_id": "41696", "category_aro_name": "lsa-type ABC-F protein", "category_aro_description": "A subgroup of the ABC-F protein subfamily of ATP-binding cassette proteins. lsa-type ABC-F proteins confer resistance to streptogramin, lincosamide and pleuromutilin antibiotics through antibiotic target protection of the ribosome.", "category_aro_class_name": "AMR Gene Family"}, "35964": {"category_aro_accession": "0000046", "category_aro_cvterm_id": "35964", "category_aro_name": "lincomycin", "category_aro_description": "Lincomycin is a lincosamide antibiotic that comes from the actinomyces Streptomyces lincolnensis. It binds to the 23s portion of the 50S subunit of bacterial ribosomes and inhibit early elongation of peptide chain by inhibiting transpeptidase reaction.", "category_aro_class_name": "Antibiotic"}, "35983": {"category_aro_accession": "0000066", "category_aro_cvterm_id": "35983", "category_aro_name": "clindamycin", "category_aro_description": "Clindamycin is a lincosamide antibiotic that blocks A-site aminoacyl-tRNA binding. It is usually used to treat infections with anaerobic bacteria but can also be used to treat some protozoal diseases, such as malaria.", "category_aro_class_name": "Antibiotic"}, "37013": {"category_aro_accession": "3000669", "category_aro_cvterm_id": "37013", "category_aro_name": "virginiamycin M1", "category_aro_description": "Virginiamycin M1 is a streptogramin A antibiotic.", "category_aro_class_name": "Antibiotic"}, "37015": {"category_aro_accession": "3000671", "category_aro_cvterm_id": "37015", "category_aro_name": "tiamulin", "category_aro_description": "Tiamulin is a pleuromutilin derivative currently used in veterinary medicine. It binds to the 23 rRNA of the 50S ribosomal subunit to inhibit protein translation.", "category_aro_class_name": "Antibiotic"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35952": {"category_aro_accession": "0000034", "category_aro_cvterm_id": "35952", "category_aro_name": "streptogramin A antibiotic", "category_aro_description": "Streptogramin A antibiotics are cyclic polyketide peptide hybrids that bind to the ribosomal peptidyl transfer centre. Structural variation arises from substituting a proline for its desaturated derivative and by its substitution for Ala or Cys. Used alone, streptogramin A antibiotics are bacteriostatic, but is bactericidal when used with streptogramin B antibiotics.", "category_aro_class_name": "Drug Class"}, "37014": {"category_aro_accession": "3000670", "category_aro_cvterm_id": "37014", "category_aro_name": "pleuromutilin antibiotic", "category_aro_description": "Pleuromutilins are natural fungal products that target bacterial protein translation by binding the the 23S rRNA, blocking the ribosome P site at the 50S subunit. They are mostly used for agriculture and veterinary purposes.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000364867, "max_identities": 51, "bit_score": 38.891, "cvterm_id": "43338", "query": "ISIAGPSGSGKTTALN-LIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHT-IGFIF--QSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRP-NELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHD----AKVMTHANAVVR", "match": "+ + G +G GKTT L  L+G VD                       HL + T   F++  Q+ N    L++F   E     Q +L       R +TL+   G++     RP N LSGG++ +  +A   +      L DEPT +LD  + + +   + E   K+G  +I  +HD     K   H  A+ R", "sequence_from_db": "LGLVGRNGRGKTTLLKILLGEVDV----------------------HLEIKTNKSFVYFPQTINDKDQLTLFVLQELADFEQWELE------RELTLM---GVDLDTLWRPFNSLSGGEQTKTLLALLFLDEHNYPLIDEPTNHLDKASREKVAAYLSE---KKG--YILISHDRNFLNKTTDHTLAIER", "sequence_from_broadstreet": "MSNIKINNLTFGYTDQLIFDNVNINIDDQWKLGLVGRNGRGKTTLLKILLGEVDVHLEIKTNKSFVYFPQTINDKDQLTLFVLQELADFEQWELERELTLMGVDLDTLWRPFNSLSGGEQTKTLLALLFLDEHNYPLIDEPTNHLDKASREKVAAYLSEKKGYILISHDRNFLNKTTDHTLAIERADLQVYAGNFAIYEEEKRLRDLTEKAQDDKLRKEIGRLKQTAREKEAWSRNLEATKSRKKRGFDSETKRVDKGFIGRKAANMMQKSKNLEKRMKEDIADKELLLKNWEEVPGLEMSVLESHQKRLLTVENLAAGFEDFLFEPVSFTLEQGQVLALTGENGRGKSSLMKVLTGEFTGRYVGTFELAHNLVISEVRQLADNRGFLNEFAKKENLELELFLNNLRKLGVERKVFEQKIENMSQGQQRKVELARALSQPAHIYLWDEPLNYLDVFNQEQIIQMIKRSKPSMLVIEHDQYFVDQVADAQIELIKSSV", "dna_sequence_from_broadstreet": "ATGTCGAATATTAAAATAAATAATTTAACATTTGGTTATACCGATCAGCTTATTTTTGACAATGTAAATATCAATATTGATGACCAATGGAAGCTGGGATTGGTTGGCCGTAACGGGAGAGGGAAAACTACACTTTTAAAAATCCTTCTTGGAGAAGTGGATGTACATCTTGAAATTAAAACCAATAAGAGCTTTGTGTATTTTCCTCAGACGATTAATGATAAAGACCAGTTGACCTTATTTGTCTTGCAAGAGTTAGCTGACTTTGAGCAGTGGGAACTTGAGCGTGAATTGACACTAATGGGCGTAGATTTAGATACTTTATGGCGTCCTTTCAATAGTCTTTCTGGTGGAGAGCAAACAAAGACACTCTTAGCACTTTTATTCTTGGATGAGCATAATTATCCGCTCATCGATGAGCCAACCAATCATCTTGATAAAGCTTCACGTGAGAAAGTTGCAGCCTACTTGTCAGAAAAAAAGGGATATATTTTAATCTCACATGACCGTAATTTTCTCAATAAGACGACAGATCATACACTTGCGATAGAGCGTGCGGACTTACAAGTATATGCAGGTAATTTTGCTATCTACGAGGAGGAAAAAAGATTGCGAGATCTCACGGAAAAGGCACAAGATGATAAACTCAGGAAAGAAATCGGTAGATTGAAACAAACGGCGCGTGAAAAAGAAGCGTGGTCGCGTAACTTAGAAGCAACAAAATCCCGTAAGAAACGAGGTTTTGATTCGGAAACAAAACGTGTTGATAAAGGTTTTATTGGACGAAAAGCAGCAAATATGATGCAAAAGTCTAAAAATCTCGAAAAGCGCATGAAAGAGGATATCGCTGACAAGGAACTACTTCTAAAAAATTGGGAAGAAGTACCTGGATTGGAAATGAGTGTCTTAGAGAGTCATCAAAAACGCTTACTGACAGTGGAAAATTTAGCGGCTGGATTTGAAGACTTTCTTTTTGAACCTGTGTCTTTTACACTTGAACAAGGTCAGGTGCTTGCACTAACAGGAGAAAATGGTAGAGGAAAATCTTCTCTAATGAAAGTCCTCACAGGTGAATTTACTGGCCGTTATGTTGGAACATTTGAGTTGGCCCATAACTTGGTCATTTCCGAAGTAAGACAACTTGCAGATAATAGAGGGTTTCTGAACGAGTTTGCCAAAAAAGAAAACTTAGAATTAGAACTTTTTCTCAACAATTTGCGCAAATTAGGCGTAGAGCGCAAAGTTTTTGAGCAAAAAATCGAAAATATGAGTCAGGGACAGCAGCGTAAAGTCGAACTGGCCCGCGCCTTAAGTCAGCCGGCGCATATTTATCTTTGGGATGAACCCCTCAACTATCTTGATGTTTTTAATCAAGAACAAATTATTCAAATGATAAAGAGAAGCAAGCCTAGTATGCTTGTCATTGAGCACGATCAGTATTTTGTTGATCAAGTAGCAGATGCCCAAATCGAACTCATAAAAAGCAGCGTTTAA", "partial": "0", "query_start": 51457, "query_end": 51999, "hit_start": 93, "hit_end": 555, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 26.84}, "gnl|BL_ORD_ID|4773|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "lsaD", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "900", "model_id": "3847", "ARO_accession": "3005121", "ARO_name": "lsaD", "ARO_category": {"41696": {"category_aro_accession": "3004472", "category_aro_cvterm_id": "41696", "category_aro_name": "lsa-type ABC-F protein", "category_aro_description": "A subgroup of the ABC-F protein subfamily of ATP-binding cassette proteins. lsa-type ABC-F proteins confer resistance to streptogramin, lincosamide and pleuromutilin antibiotics through antibiotic target protection of the ribosome.", "category_aro_class_name": "AMR Gene Family"}, "35964": {"category_aro_accession": "0000046", "category_aro_cvterm_id": "35964", "category_aro_name": "lincomycin", "category_aro_description": "Lincomycin is a lincosamide antibiotic that comes from the actinomyces Streptomyces lincolnensis. It binds to the 23s portion of the 50S subunit of bacterial ribosomes and inhibit early elongation of peptide chain by inhibiting transpeptidase reaction.", "category_aro_class_name": "Antibiotic"}, "35983": {"category_aro_accession": "0000066", "category_aro_cvterm_id": "35983", "category_aro_name": "clindamycin", "category_aro_description": "Clindamycin is a lincosamide antibiotic that blocks A-site aminoacyl-tRNA binding. It is usually used to treat infections with anaerobic bacteria but can also be used to treat some protozoal diseases, such as malaria.", "category_aro_class_name": "Antibiotic"}, "37013": {"category_aro_accession": "3000669", "category_aro_cvterm_id": "37013", "category_aro_name": "virginiamycin M1", "category_aro_description": "Virginiamycin M1 is a streptogramin A antibiotic.", "category_aro_class_name": "Antibiotic"}, "37015": {"category_aro_accession": "3000671", "category_aro_cvterm_id": "37015", "category_aro_name": "tiamulin", "category_aro_description": "Tiamulin is a pleuromutilin derivative currently used in veterinary medicine. It binds to the 23 rRNA of the 50S ribosomal subunit to inhibit protein translation.", "category_aro_class_name": "Antibiotic"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35952": {"category_aro_accession": "0000034", "category_aro_cvterm_id": "35952", "category_aro_name": "streptogramin A antibiotic", "category_aro_description": "Streptogramin A antibiotics are cyclic polyketide peptide hybrids that bind to the ribosomal peptidyl transfer centre. Structural variation arises from substituting a proline for its desaturated derivative and by its substitution for Ala or Cys. Used alone, streptogramin A antibiotics are bacteriostatic, but is bactericidal when used with streptogramin B antibiotics.", "category_aro_class_name": "Drug Class"}, "37014": {"category_aro_accession": "3000670", "category_aro_cvterm_id": "37014", "category_aro_name": "pleuromutilin antibiotic", "category_aro_description": "Pleuromutilins are natural fungal products that target bacterial protein translation by binding the the 23S rRNA, blocking the ribosome P site at the 50S subunit. They are mostly used for agriculture and veterinary purposes.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00355578, "max_identities": 19, "bit_score": 35.8094, "cvterm_id": "43338", "query": "QVGLEKHA-KHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMK", "match": "++G+E+   + +   +S GQ+++V +ARAL     + L DEP   LD    + II ++K", "sequence_from_db": "KLGVERKVFEQKIENMSQGQQRKVELARALSQPAHIYLWDEPLNYLDVFNQEQIIQMIK", "sequence_from_broadstreet": "MSNIKINNLTFGYTDQLIFDNVNINIDDQWKLGLVGRNGRGKTTLLKILLGEVDVHLEIKTNKSFVYFPQTINDKDQLTLFVLQELADFEQWELERELTLMGVDLDTLWRPFNSLSGGEQTKTLLALLFLDEHNYPLIDEPTNHLDKASREKVAAYLSEKKGYILISHDRNFLNKTTDHTLAIERADLQVYAGNFAIYEEEKRLRDLTEKAQDDKLRKEIGRLKQTAREKEAWSRNLEATKSRKKRGFDSETKRVDKGFIGRKAANMMQKSKNLEKRMKEDIADKELLLKNWEEVPGLEMSVLESHQKRLLTVENLAAGFEDFLFEPVSFTLEQGQVLALTGENGRGKSSLMKVLTGEFTGRYVGTFELAHNLVISEVRQLADNRGFLNEFAKKENLELELFLNNLRKLGVERKVFEQKIENMSQGQQRKVELARALSQPAHIYLWDEPLNYLDVFNQEQIIQMIKRSKPSMLVIEHDQYFVDQVADAQIELIKSSV", "dna_sequence_from_broadstreet": "ATGTCGAATATTAAAATAAATAATTTAACATTTGGTTATACCGATCAGCTTATTTTTGACAATGTAAATATCAATATTGATGACCAATGGAAGCTGGGATTGGTTGGCCGTAACGGGAGAGGGAAAACTACACTTTTAAAAATCCTTCTTGGAGAAGTGGATGTACATCTTGAAATTAAAACCAATAAGAGCTTTGTGTATTTTCCTCAGACGATTAATGATAAAGACCAGTTGACCTTATTTGTCTTGCAAGAGTTAGCTGACTTTGAGCAGTGGGAACTTGAGCGTGAATTGACACTAATGGGCGTAGATTTAGATACTTTATGGCGTCCTTTCAATAGTCTTTCTGGTGGAGAGCAAACAAAGACACTCTTAGCACTTTTATTCTTGGATGAGCATAATTATCCGCTCATCGATGAGCCAACCAATCATCTTGATAAAGCTTCACGTGAGAAAGTTGCAGCCTACTTGTCAGAAAAAAAGGGATATATTTTAATCTCACATGACCGTAATTTTCTCAATAAGACGACAGATCATACACTTGCGATAGAGCGTGCGGACTTACAAGTATATGCAGGTAATTTTGCTATCTACGAGGAGGAAAAAAGATTGCGAGATCTCACGGAAAAGGCACAAGATGATAAACTCAGGAAAGAAATCGGTAGATTGAAACAAACGGCGCGTGAAAAAGAAGCGTGGTCGCGTAACTTAGAAGCAACAAAATCCCGTAAGAAACGAGGTTTTGATTCGGAAACAAAACGTGTTGATAAAGGTTTTATTGGACGAAAAGCAGCAAATATGATGCAAAAGTCTAAAAATCTCGAAAAGCGCATGAAAGAGGATATCGCTGACAAGGAACTACTTCTAAAAAATTGGGAAGAAGTACCTGGATTGGAAATGAGTGTCTTAGAGAGTCATCAAAAACGCTTACTGACAGTGGAAAATTTAGCGGCTGGATTTGAAGACTTTCTTTTTGAACCTGTGTCTTTTACACTTGAACAAGGTCAGGTGCTTGCACTAACAGGAGAAAATGGTAGAGGAAAATCTTCTCTAATGAAAGTCCTCACAGGTGAATTTACTGGCCGTTATGTTGGAACATTTGAGTTGGCCCATAACTTGGTCATTTCCGAAGTAAGACAACTTGCAGATAATAGAGGGTTTCTGAACGAGTTTGCCAAAAAAGAAAACTTAGAATTAGAACTTTTTCTCAACAATTTGCGCAAATTAGGCGTAGAGCGCAAAGTTTTTGAGCAAAAAATCGAAAATATGAGTCAGGGACAGCAGCGTAAAGTCGAACTGGCCCGCGCCTTAAGTCAGCCGGCGCATATTTATCTTTGGGATGAACCCCTCAACTATCTTGATGTTTTTAATCAAGAACAAATTATTCAAATGATAAAGAGAAGCAAGCCTAGTATGCTTGTCATTGAGCACGATCAGTATTTTGTTGATCAAGTAGCAGATGCCCAAATCGAACTCATAAAAAGCAGCGTTTAA", "partial": "0", "query_start": 51742, "query_end": 51915, "hit_start": 1221, "hit_end": 1398, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 32.2}, "gnl|BL_ORD_ID|27|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "msrE", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "950", "model_id": "33", "ARO_accession": "3003109", "ARO_name": "msrE", "ARO_category": {"41695": {"category_aro_accession": "3004471", "category_aro_cvterm_id": "41695", "category_aro_name": "msr-type ABC-F protein", "category_aro_description": "msr-type ABC-F subfamily ribosomal protection proteins expression in Staphylococci species and confer resistance to erythromycin and streptogramin B antibiotics through antibiotic target protection mechanisms.", "category_aro_class_name": "AMR Gene Family"}, "35925": {"category_aro_accession": "0000006", "category_aro_cvterm_id": "35925", "category_aro_name": "erythromycin", "category_aro_description": "Erythromycin is a macrolide antibiotic with a 14-carbon ring that has an antimicrobial spectrum similar to or slightly wider than that of penicillin, and is often used for people that have an allergy to penicillins. Erythromycin may possess bacteriocidal activity, particularly at higher concentrations by binding to the 50S subunit of the bacterial 70S rRNA complex, inhibiting peptidyl-tRNA translocation. Thus, protein synthesis and subsequently structure/function processes critical for life or replication are inhibited.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00037993, "max_identities": 28, "bit_score": 38.891, "cvterm_id": "35507", "query": "LSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLM-KELNRKEGTTFIFSTHDAKVMTH-ANAVVRLADGKI", "match": "+SGG+  R  +A A   +   +LADEPT++LD     N IDL+  +L   +G   + S HD   +    + +  L DGKI", "sequence_from_db": "MSGGEETRAKIAAAFSQQVHGILADEPTSHLD----LNGIDLLIGQLKAFDGALLVIS-HDRYFLDMVVDKIWELKDGKI", "sequence_from_broadstreet": "MSLIIKARNIRLDYAGRDVLDIDELEIHSYDRIGLVGDNGAGKSSLLKVLNGEIVLAEATLQRFGDFAHISQLGGIEIETVEDRAMLSRLGVSNVQNDTMSGGEETRAKIAAAFSQQVHGILADEPTSHLDLNGIDLLIGQLKAFDGALLVISHDRYFLDMVVDKIWELKDGKITEYWGGYSDYLRQKEEERQHQAVEYELMMKERERLESAVQEKRQQANRLDNKKKGEKSKNSTESAGRLGHAKMTGTKQRKLYQAAKSMEKRLAALEDIQAPEHLRSIRFRQSSALELHNKFPITADGLSLKFGSRTIFDDANFIIPLGAKVAITGSNGTGKTSLLKMISERADGLTISPKAEIGYFTQTGYKFNTHKSVLSFMQEECEYTVAEIRAVLASMGIGANDIQKNLSDLSGGEIIKLLLSKMLLGKYNILLMDEPGNYLDLKSIAALETMMKSYAGTIIFVSHDKQLVDNIADIIYEIKDHKIIKTFERDC", "dna_sequence_from_broadstreet": "ATGAGTTTAATTATTAAAGCGAGAAACATACGCTTGGATTATGCTGGGCGTGATGTTTTGGATATTGATGAATTGGAAATTCACTCTTATGACCGTATTGGTCTTGTGGGTGATAACGGAGCAGGAAAGAGTAGTTTACTCAAAGTACTTAATGGCGAAATTGTTTTAGCCGAAGCGACATTACAGCGTTTTGGTGATTTTGCACATATCAGCCAACTGGGCGGAATCGAAATAGAAACGGTCGAAGACCGGGCAATGTTATCTCGCCTTGGTGTTTCCAATGTACAAAACGACACAATGAGTGGCGGAGAGGAAACTCGTGCAAAAATTGCTGCCGCATTTTCCCAACAAGTACATGGCATTCTAGCGGATGAACCAACCAGCCACCTTGATCTCAATGGAATAGATCTACTTATTGGTCAACTTAAAGCATTTGATGGAGCATTACTTGTTATCAGTCATGACCGATATTTTCTTGATATGGTTGTAGACAAGATATGGGAGTTAAAAGACGGTAAAATTACGGAATATTGGGGTGGTTACTCGGATTACTTGCGTCAAAAAGAAGAAGAGCGACAACACCAAGCCGTAGAATATGAGCTGATGATGAAGGAACGGGAGCGATTAGAATCTGCTGTGCAAGAAAAACGCCAGCAAGCTAATCGATTAGACAATAAGAAAAAAGGAGAAAAATCCAAAAACTCTACCGAAAGTGCTGGACGACTTGGGCATGCAAAAATGACTGGCACCAAGCAAAGAAAACTGTATCAGGCAGCTAAGAGTATGGAAAAGCGTTTGGCTGCATTAGAAGATATTCAAGCACCAGAGCATTTGCGTTCTATTCGTTTTCGTCAAAGTTCAGCCCTAGAACTGCACAATAAGTTCCCGATTACGGCAGATGGTCTGAGCTTAAAATTTGGTAGCCGTACTATCTTTGATGACGCTAACTTTATAATACCGCTTGGCGCTAAAGTCGCTATAACTGGATCGAATGGAACAGGGAAAACGTCCTTGTTAAAAATGATATCAGAACGTGCTGATGGATTAACCATATCTCCAAAAGCTGAAATTGGCTACTTTACACAAACAGGATATAAATTTAACACGCATAAATCTGTGCTCTCCTTTATGCAGGAAGAGTGCGAGTACACAGTTGCGGAAATTCGTGCAGTATTGGCTTCAATGGGGATCGGAGCGAATGATATTCAAAAAAACTTATCCGACTTATCGGGAGGTGAAATCATCAAACTGCTTTTATCCAAAATGCTTTTAGGAAAATATAATATTTTGCTTATGGATGAACCAGGAAACTATCTTGACCTAAAAAGTATTGCCGCATTAGAAACAATGATGAAGTCCTATGCAGGAACTATTATCTTCGTATCTCATGACAAGCAATTGGTCGATAATATTGCTGACATTATCTACGAGATCAAAGACCACAAAATCATCAAGACTTTTGAGAGAGATTGTTAA", "partial": "0", "query_start": 51784, "query_end": 52017, "hit_start": 297, "hit_end": 522, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 35.0}, "gnl|BL_ORD_ID|27|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "msrE", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "950", "model_id": "33", "ARO_accession": "3003109", "ARO_name": "msrE", "ARO_category": {"41695": {"category_aro_accession": "3004471", "category_aro_cvterm_id": "41695", "category_aro_name": "msr-type ABC-F protein", "category_aro_description": "msr-type ABC-F subfamily ribosomal protection proteins expression in Staphylococci species and confer resistance to erythromycin and streptogramin B antibiotics through antibiotic target protection mechanisms.", "category_aro_class_name": "AMR Gene Family"}, "35925": {"category_aro_accession": "0000006", "category_aro_cvterm_id": "35925", "category_aro_name": "erythromycin", "category_aro_description": "Erythromycin is a macrolide antibiotic with a 14-carbon ring that has an antimicrobial spectrum similar to or slightly wider than that of penicillin, and is often used for people that have an allergy to penicillins. Erythromycin may possess bacteriocidal activity, particularly at higher concentrations by binding to the 50S subunit of the bacterial 70S rRNA complex, inhibiting peptidyl-tRNA translocation. Thus, protein synthesis and subsequently structure/function processes critical for life or replication are inhibited.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00449891, "max_identities": 45, "bit_score": 35.4242, "cvterm_id": "35507", "query": "GEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQS---FNL-VSVLSVFQN-VEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRP-NELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTH-ANAVVRLADGKIL", "match": "G  ++I G +G+GKT+ L +I   + A    +S   +                 IG+  Q+   FN   SVLS  Q   E+ +              +  +L  +G+  +   +  ++LSGG+  ++ +++ L+ +  ++L DEP   LD  +    I  ++ + +    T IF +HD +++ + A+ +  + D KI+", "sequence_from_db": "GAKVAITGSNGTGKTSLLKMIS--ERADGLTISPKAE-----------------IGYFTQTGYKFNTHKSVLSFMQEECEYTV------------AEIRAVLASMGIGANDIQKNLSDLSGGEIIKLLLSKMLLGKYNILLMDEPGNYLDLKS----IAALETMMKSYAGTIIFVSHDKQLVDNIADIIYEIKDHKII", "sequence_from_broadstreet": "MSLIIKARNIRLDYAGRDVLDIDELEIHSYDRIGLVGDNGAGKSSLLKVLNGEIVLAEATLQRFGDFAHISQLGGIEIETVEDRAMLSRLGVSNVQNDTMSGGEETRAKIAAAFSQQVHGILADEPTSHLDLNGIDLLIGQLKAFDGALLVISHDRYFLDMVVDKIWELKDGKITEYWGGYSDYLRQKEEERQHQAVEYELMMKERERLESAVQEKRQQANRLDNKKKGEKSKNSTESAGRLGHAKMTGTKQRKLYQAAKSMEKRLAALEDIQAPEHLRSIRFRQSSALELHNKFPITADGLSLKFGSRTIFDDANFIIPLGAKVAITGSNGTGKTSLLKMISERADGLTISPKAEIGYFTQTGYKFNTHKSVLSFMQEECEYTVAEIRAVLASMGIGANDIQKNLSDLSGGEIIKLLLSKMLLGKYNILLMDEPGNYLDLKSIAALETMMKSYAGTIIFVSHDKQLVDNIADIIYEIKDHKIIKTFERDC", "dna_sequence_from_broadstreet": "ATGAGTTTAATTATTAAAGCGAGAAACATACGCTTGGATTATGCTGGGCGTGATGTTTTGGATATTGATGAATTGGAAATTCACTCTTATGACCGTATTGGTCTTGTGGGTGATAACGGAGCAGGAAAGAGTAGTTTACTCAAAGTACTTAATGGCGAAATTGTTTTAGCCGAAGCGACATTACAGCGTTTTGGTGATTTTGCACATATCAGCCAACTGGGCGGAATCGAAATAGAAACGGTCGAAGACCGGGCAATGTTATCTCGCCTTGGTGTTTCCAATGTACAAAACGACACAATGAGTGGCGGAGAGGAAACTCGTGCAAAAATTGCTGCCGCATTTTCCCAACAAGTACATGGCATTCTAGCGGATGAACCAACCAGCCACCTTGATCTCAATGGAATAGATCTACTTATTGGTCAACTTAAAGCATTTGATGGAGCATTACTTGTTATCAGTCATGACCGATATTTTCTTGATATGGTTGTAGACAAGATATGGGAGTTAAAAGACGGTAAAATTACGGAATATTGGGGTGGTTACTCGGATTACTTGCGTCAAAAAGAAGAAGAGCGACAACACCAAGCCGTAGAATATGAGCTGATGATGAAGGAACGGGAGCGATTAGAATCTGCTGTGCAAGAAAAACGCCAGCAAGCTAATCGATTAGACAATAAGAAAAAAGGAGAAAAATCCAAAAACTCTACCGAAAGTGCTGGACGACTTGGGCATGCAAAAATGACTGGCACCAAGCAAAGAAAACTGTATCAGGCAGCTAAGAGTATGGAAAAGCGTTTGGCTGCATTAGAAGATATTCAAGCACCAGAGCATTTGCGTTCTATTCGTTTTCGTCAAAGTTCAGCCCTAGAACTGCACAATAAGTTCCCGATTACGGCAGATGGTCTGAGCTTAAAATTTGGTAGCCGTACTATCTTTGATGACGCTAACTTTATAATACCGCTTGGCGCTAAAGTCGCTATAACTGGATCGAATGGAACAGGGAAAACGTCCTTGTTAAAAATGATATCAGAACGTGCTGATGGATTAACCATATCTCCAAAAGCTGAAATTGGCTACTTTACACAAACAGGATATAAATTTAACACGCATAAATCTGTGCTCTCCTTTATGCAGGAAGAGTGCGAGTACACAGTTGCGGAAATTCGTGCAGTATTGGCTTCAATGGGGATCGGAGCGAATGATATTCAAAAAAACTTATCCGACTTATCGGGAGGTGAAATCATCAAACTGCTTTTATCCAAAATGCTTTTAGGAAAATATAATATTTTGCTTATGGATGAACCAGGAAACTATCTTGACCTAAAAAGTATTGCCGCATTAGAAACAATGATGAAGTCCTATGCAGGAACTATTATCTTCGTATCTCATGACAAGCAATTGGTCGATAATATTGCTGACATTATCTACGAGATCAAAGACCACAAAATCATCAAGACTTTTGAGAGAGATTGTTAA", "partial": "0", "query_start": 51448, "query_end": 52020, "hit_start": 963, "hit_end": 1452, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 22.73}, "gnl|BL_ORD_ID|2202|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "lin", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "900", "model_id": "3361", "ARO_accession": "3004651", "ARO_name": "lin", "ARO_category": {"36360": {"category_aro_accession": "3000221", "category_aro_cvterm_id": "36360", "category_aro_name": "lincosamide nucleotidyltransferase (LNU)", "category_aro_description": "Resistance to the lincosamide antibiotic by ATP-dependent modification of the 3' and/or 4'-hydroxyl groups of the methylthiolincosamide sugar.", "category_aro_class_name": "AMR Gene Family"}, "35964": {"category_aro_accession": "0000046", "category_aro_cvterm_id": "35964", "category_aro_name": "lincomycin", "category_aro_description": "Lincomycin is a lincosamide antibiotic that comes from the actinomyces Streptomyces lincolnensis. It binds to the 23s portion of the 50S subunit of bacterial ribosomes and inhibit early elongation of peptide chain by inhibiting transpeptidase reaction.", "category_aro_class_name": "Antibiotic"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000397956, "max_identities": 16, "bit_score": 38.5058, "cvterm_id": "42702", "query": "SGGQRQRVAVARALVTRPKLVLADEPTANLD", "match": "SGG++ R A   A+   P ++LADEPT+NLD", "sequence_from_db": "SGGEKTRKATQHAMRQNPSVLLADEPTSNLD", "sequence_from_broadstreet": "MSTIEINQLKIEVADRVLVEIPHLLVSKKARIGIIGQNGLGKTTLMEVIAGAKEATSGTVTTQGKLAYIKQLSTDTSTKSGGEKTRKATQHAMRQNPSVLLADEPTSNLDVESVKHLERQWSDFHGALIIISHDRAFLDALCTEIWEIKNQKIHVYKGNYHAYLEQKQQQENQAELAYKEFKNKKKQLQASQTHHEIEAGRIVKPGKRLNNKEASAFKAGKGTQQKKQHSTIKALEKRIERLGNVEKPHTTKPIKIITPDNRVIKKGNTILSAKETAYEIAGRKLFETKAFSIKAGDKVALIGENASGKTTFLKEIIQENPNLLCNPQAKIAYFDQELNGLNQTKSLLENISEISVQTKQVNREVLGSMHFKESDLHKEVRMLSGGERVKLLLSMLLLSDANFLILDEPTNYLDIYAMEALETLIKQFAGTVLFVSHDRTFVNHVAEQLLVIENNEMNFHRMTFAEYEESKAPSRITEEDKLILEMRMSEIAAKLMQPNLKPTEKAILEQDYQEIITKRQQFS", "dna_sequence_from_broadstreet": "ATGTCTACAATCGAAATAAATCAATTAAAAATAGAAGTAGCAGATAGAGTTTTAGTAGAAATTCCTCATCTGCTAGTTAGTAAAAAAGCAAGAATCGGCATCATCGGTCAAAATGGTCTAGGAAAAACAACACTAATGGAAGTGATTGCTGGCGCTAAAGAAGCGACATCTGGCACGGTGACTACACAAGGAAAACTTGCTTACATCAAACAACTTTCCACGGATACAAGTACGAAAAGCGGTGGTGAAAAAACAAGAAAAGCTACTCAACACGCGATGCGCCAAAATCCAAGTGTTCTCCTAGCAGACGAACCAACAAGCAATCTTGATGTCGAAAGCGTCAAACATTTAGAACGTCAGTGGAGCGATTTCCACGGTGCGCTCATAATTATCTCGCATGACCGCGCTTTTTTAGATGCACTTTGTACAGAAATATGGGAAATCAAAAACCAAAAAATTCACGTGTACAAAGGAAACTACCACGCGTATTTAGAACAAAAACAACAACAAGAAAACCAAGCAGAACTTGCATACAAAGAATTTAAAAACAAAAAGAAACAATTGCAAGCATCTCAAACACATCACGAAATCGAAGCAGGTCGTATCGTTAAACCCGGGAAACGCTTAAACAACAAAGAAGCCAGCGCATTTAAAGCTGGAAAAGGAACACAACAAAAGAAACAACATAGTACAATCAAAGCTTTAGAAAAACGAATTGAACGGCTTGGTAATGTCGAAAAACCACATACAACTAAACCAATCAAAATTATCACCCCAGACAATCGCGTTATAAAAAAAGGCAACACGATACTAAGTGCCAAAGAAACAGCTTACGAAATTGCCGGACGAAAACTATTTGAAACAAAAGCTTTTTCTATTAAAGCAGGGGATAAAGTGGCGCTGATCGGTGAAAATGCAAGTGGGAAAACTACATTTTTAAAAGAAATAATCCAAGAAAATCCTAATCTCTTATGTAATCCCCAAGCGAAAATTGCTTATTTCGACCAAGAATTGAATGGATTAAACCAAACGAAATCCCTATTAGAAAACATCTCGGAAATTAGCGTTCAAACCAAGCAAGTAAACAGAGAAGTACTAGGTAGTATGCATTTTAAAGAAAGCGATTTGCATAAGGAAGTGCGCATGCTCTCTGGCGGGGAACGAGTGAAGTTGCTGCTCAGTATGCTCCTTCTTAGTGACGCCAATTTCTTGATTCTTGATGAACCAACCAACTATTTGGATATCTACGCAATGGAAGCGCTGGAAACGTTAATCAAACAATTTGCGGGGACGGTACTCTTCGTTTCTCATGATAGAACTTTTGTTAATCATGTGGCAGAACAGTTACTTGTTATCGAAAATAATGAAATGAATTTCCACCGGATGACTTTTGCAGAATATGAAGAAAGTAAAGCACCAAGCCGGATTACAGAAGAAGATAAGTTGATTTTAGAAATGCGTATGTCAGAAATTGCGGCAAAACTCATGCAACCCAATTTAAAGCCCACAGAAAAAGCCATACTCGAACAAGATTATCAAGAAATTATCACAAAAAGACAGCAATTTAGTTAA", "partial": "0", "query_start": 51787, "query_end": 51879, "hit_start": 237, "hit_end": 330, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 51.61}, "gnl|BL_ORD_ID|2202|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "lin", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "900", "model_id": "3361", "ARO_accession": "3004651", "ARO_name": "lin", "ARO_category": {"36360": {"category_aro_accession": "3000221", "category_aro_cvterm_id": "36360", "category_aro_name": "lincosamide nucleotidyltransferase (LNU)", "category_aro_description": "Resistance to the lincosamide antibiotic by ATP-dependent modification of the 3' and/or 4'-hydroxyl groups of the methylthiolincosamide sugar.", "category_aro_class_name": "AMR Gene Family"}, "35964": {"category_aro_accession": "0000046", "category_aro_cvterm_id": "35964", "category_aro_name": "lincomycin", "category_aro_description": "Lincomycin is a lincosamide antibiotic that comes from the actinomyces Streptomyces lincolnensis. It binds to the 23s portion of the 50S subunit of bacterial ribosomes and inhibit early elongation of peptide chain by inhibiting transpeptidase reaction.", "category_aro_class_name": "Antibiotic"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0516835, "max_identities": 26, "bit_score": 31.9574, "cvterm_id": "42702", "query": "LSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTH-ANAVVRLADGKI-LDRITPAEAQKVMAVS", "match": "LSGG+R ++ ++  L++    ++ DEPT  LD    + +  L+K+       T +F +HD   + H A  ++ + + ++   R+T AE ++  A S", "sequence_from_db": "LSGGERVKLLLSMLLLSDANFLILDEPTNYLDIYAMEALETLIKQF----AGTVLFVSHDRTFVNHVAEQLLVIENNEMNFHRMTFAEYEESKAPS", "sequence_from_broadstreet": "MSTIEINQLKIEVADRVLVEIPHLLVSKKARIGIIGQNGLGKTTLMEVIAGAKEATSGTVTTQGKLAYIKQLSTDTSTKSGGEKTRKATQHAMRQNPSVLLADEPTSNLDVESVKHLERQWSDFHGALIIISHDRAFLDALCTEIWEIKNQKIHVYKGNYHAYLEQKQQQENQAELAYKEFKNKKKQLQASQTHHEIEAGRIVKPGKRLNNKEASAFKAGKGTQQKKQHSTIKALEKRIERLGNVEKPHTTKPIKIITPDNRVIKKGNTILSAKETAYEIAGRKLFETKAFSIKAGDKVALIGENASGKTTFLKEIIQENPNLLCNPQAKIAYFDQELNGLNQTKSLLENISEISVQTKQVNREVLGSMHFKESDLHKEVRMLSGGERVKLLLSMLLLSDANFLILDEPTNYLDIYAMEALETLIKQFAGTVLFVSHDRTFVNHVAEQLLVIENNEMNFHRMTFAEYEESKAPSRITEEDKLILEMRMSEIAAKLMQPNLKPTEKAILEQDYQEIITKRQQFS", "dna_sequence_from_broadstreet": "ATGTCTACAATCGAAATAAATCAATTAAAAATAGAAGTAGCAGATAGAGTTTTAGTAGAAATTCCTCATCTGCTAGTTAGTAAAAAAGCAAGAATCGGCATCATCGGTCAAAATGGTCTAGGAAAAACAACACTAATGGAAGTGATTGCTGGCGCTAAAGAAGCGACATCTGGCACGGTGACTACACAAGGAAAACTTGCTTACATCAAACAACTTTCCACGGATACAAGTACGAAAAGCGGTGGTGAAAAAACAAGAAAAGCTACTCAACACGCGATGCGCCAAAATCCAAGTGTTCTCCTAGCAGACGAACCAACAAGCAATCTTGATGTCGAAAGCGTCAAACATTTAGAACGTCAGTGGAGCGATTTCCACGGTGCGCTCATAATTATCTCGCATGACCGCGCTTTTTTAGATGCACTTTGTACAGAAATATGGGAAATCAAAAACCAAAAAATTCACGTGTACAAAGGAAACTACCACGCGTATTTAGAACAAAAACAACAACAAGAAAACCAAGCAGAACTTGCATACAAAGAATTTAAAAACAAAAAGAAACAATTGCAAGCATCTCAAACACATCACGAAATCGAAGCAGGTCGTATCGTTAAACCCGGGAAACGCTTAAACAACAAAGAAGCCAGCGCATTTAAAGCTGGAAAAGGAACACAACAAAAGAAACAACATAGTACAATCAAAGCTTTAGAAAAACGAATTGAACGGCTTGGTAATGTCGAAAAACCACATACAACTAAACCAATCAAAATTATCACCCCAGACAATCGCGTTATAAAAAAAGGCAACACGATACTAAGTGCCAAAGAAACAGCTTACGAAATTGCCGGACGAAAACTATTTGAAACAAAAGCTTTTTCTATTAAAGCAGGGGATAAAGTGGCGCTGATCGGTGAAAATGCAAGTGGGAAAACTACATTTTTAAAAGAAATAATCCAAGAAAATCCTAATCTCTTATGTAATCCCCAAGCGAAAATTGCTTATTTCGACCAAGAATTGAATGGATTAAACCAAACGAAATCCCTATTAGAAAACATCTCGGAAATTAGCGTTCAAACCAAGCAAGTAAACAGAGAAGTACTAGGTAGTATGCATTTTAAAGAAAGCGATTTGCATAAGGAAGTGCGCATGCTCTCTGGCGGGGAACGAGTGAAGTTGCTGCTCAGTATGCTCCTTCTTAGTGACGCCAATTTCTTGATTCTTGATGAACCAACCAACTATTTGGATATCTACGCAATGGAAGCGCTGGAAACGTTAATCAAACAATTTGCGGGGACGGTACTCTTCGTTTCTCATGATAGAACTTTTGTTAATCATGTGGCAGAACAGTTACTTGTTATCGAAAATAATGAAATGAATTTCCACCGGATGACTTTTGCAGAATATGAAGAAAGTAAAGCACCAAGCCGGATTACAGAAGAAGATAAGTTGATTTTAGAAATGCGTATGTCAGAAATTGCGGCAAAACTCATGCAACCCAATTTAAAGCCCACAGAAAAAGCCATACTCGAACAAGATTATCAAGAAATTATCACAAAAAGACAGCAATTTAGTTAA", "partial": "0", "query_start": 51784, "query_end": 52065, "hit_start": 1146, "hit_end": 1422, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 27.08}, "gnl|BL_ORD_ID|2202|hsp_num:2": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "lin", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "900", "model_id": "3361", "ARO_accession": "3004651", "ARO_name": "lin", "ARO_category": {"36360": {"category_aro_accession": "3000221", "category_aro_cvterm_id": "36360", "category_aro_name": "lincosamide nucleotidyltransferase (LNU)", "category_aro_description": "Resistance to the lincosamide antibiotic by ATP-dependent modification of the 3' and/or 4'-hydroxyl groups of the methylthiolincosamide sugar.", "category_aro_class_name": "AMR Gene Family"}, "35964": {"category_aro_accession": "0000046", "category_aro_cvterm_id": "35964", "category_aro_name": "lincomycin", "category_aro_description": "Lincomycin is a lincosamide antibiotic that comes from the actinomyces Streptomyces lincolnensis. It binds to the 23s portion of the 50S subunit of bacterial ribosomes and inhibit early elongation of peptide chain by inhibiting transpeptidase reaction.", "category_aro_class_name": "Antibiotic"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.160658, "max_identities": 14, "bit_score": 30.4166, "cvterm_id": "42702", "query": "ISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQ", "match": "I I G +G GKTT + +I     A+SG V+  G+", "sequence_from_db": "IGIIGQNGLGKTTLMEVIAGAKEATSGTVTTQGK", "sequence_from_broadstreet": "MSTIEINQLKIEVADRVLVEIPHLLVSKKARIGIIGQNGLGKTTLMEVIAGAKEATSGTVTTQGKLAYIKQLSTDTSTKSGGEKTRKATQHAMRQNPSVLLADEPTSNLDVESVKHLERQWSDFHGALIIISHDRAFLDALCTEIWEIKNQKIHVYKGNYHAYLEQKQQQENQAELAYKEFKNKKKQLQASQTHHEIEAGRIVKPGKRLNNKEASAFKAGKGTQQKKQHSTIKALEKRIERLGNVEKPHTTKPIKIITPDNRVIKKGNTILSAKETAYEIAGRKLFETKAFSIKAGDKVALIGENASGKTTFLKEIIQENPNLLCNPQAKIAYFDQELNGLNQTKSLLENISEISVQTKQVNREVLGSMHFKESDLHKEVRMLSGGERVKLLLSMLLLSDANFLILDEPTNYLDIYAMEALETLIKQFAGTVLFVSHDRTFVNHVAEQLLVIENNEMNFHRMTFAEYEESKAPSRITEEDKLILEMRMSEIAAKLMQPNLKPTEKAILEQDYQEIITKRQQFS", "dna_sequence_from_broadstreet": "ATGTCTACAATCGAAATAAATCAATTAAAAATAGAAGTAGCAGATAGAGTTTTAGTAGAAATTCCTCATCTGCTAGTTAGTAAAAAAGCAAGAATCGGCATCATCGGTCAAAATGGTCTAGGAAAAACAACACTAATGGAAGTGATTGCTGGCGCTAAAGAAGCGACATCTGGCACGGTGACTACACAAGGAAAACTTGCTTACATCAAACAACTTTCCACGGATACAAGTACGAAAAGCGGTGGTGAAAAAACAAGAAAAGCTACTCAACACGCGATGCGCCAAAATCCAAGTGTTCTCCTAGCAGACGAACCAACAAGCAATCTTGATGTCGAAAGCGTCAAACATTTAGAACGTCAGTGGAGCGATTTCCACGGTGCGCTCATAATTATCTCGCATGACCGCGCTTTTTTAGATGCACTTTGTACAGAAATATGGGAAATCAAAAACCAAAAAATTCACGTGTACAAAGGAAACTACCACGCGTATTTAGAACAAAAACAACAACAAGAAAACCAAGCAGAACTTGCATACAAAGAATTTAAAAACAAAAAGAAACAATTGCAAGCATCTCAAACACATCACGAAATCGAAGCAGGTCGTATCGTTAAACCCGGGAAACGCTTAAACAACAAAGAAGCCAGCGCATTTAAAGCTGGAAAAGGAACACAACAAAAGAAACAACATAGTACAATCAAAGCTTTAGAAAAACGAATTGAACGGCTTGGTAATGTCGAAAAACCACATACAACTAAACCAATCAAAATTATCACCCCAGACAATCGCGTTATAAAAAAAGGCAACACGATACTAAGTGCCAAAGAAACAGCTTACGAAATTGCCGGACGAAAACTATTTGAAACAAAAGCTTTTTCTATTAAAGCAGGGGATAAAGTGGCGCTGATCGGTGAAAATGCAAGTGGGAAAACTACATTTTTAAAAGAAATAATCCAAGAAAATCCTAATCTCTTATGTAATCCCCAAGCGAAAATTGCTTATTTCGACCAAGAATTGAATGGATTAAACCAAACGAAATCCCTATTAGAAAACATCTCGGAAATTAGCGTTCAAACCAAGCAAGTAAACAGAGAAGTACTAGGTAGTATGCATTTTAAAGAAAGCGATTTGCATAAGGAAGTGCGCATGCTCTCTGGCGGGGAACGAGTGAAGTTGCTGCTCAGTATGCTCCTTCTTAGTGACGCCAATTTCTTGATTCTTGATGAACCAACCAACTATTTGGATATCTACGCAATGGAAGCGCTGGAAACGTTAATCAAACAATTTGCGGGGACGGTACTCTTCGTTTCTCATGATAGAACTTTTGTTAATCATGTGGCAGAACAGTTACTTGTTATCGAAAATAATGAAATGAATTTCCACCGGATGACTTTTGCAGAATATGAAGAAAGTAAAGCACCAAGCCGGATTACAGAAGAAGATAAGTTGATTTTAGAAATGCGTATGTCAGAAATTGCGGCAAAACTCATGCAACCCAATTTAAAGCCCACAGAAAAAGCCATACTCGAACAAGATTATCAAGAAATTATCACAAAAAGACAGCAATTTAGTTAA", "partial": "0", "query_start": 51457, "query_end": 51558, "hit_start": 93, "hit_end": 195, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 41.18}, "gnl|BL_ORD_ID|2804|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "msrF", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "900", "model_id": "3821", "ARO_accession": "3005087", "ARO_name": "msrF", "ARO_category": {"41695": {"category_aro_accession": "3004471", "category_aro_cvterm_id": "41695", "category_aro_name": "msr-type ABC-F protein", "category_aro_description": "msr-type ABC-F subfamily ribosomal protection proteins expression in Staphylococci species and confer resistance to erythromycin and streptogramin B antibiotics through antibiotic target protection mechanisms.", "category_aro_class_name": "AMR Gene Family"}, "35925": {"category_aro_accession": "0000006", "category_aro_cvterm_id": "35925", "category_aro_name": "erythromycin", "category_aro_description": "Erythromycin is a macrolide antibiotic with a 14-carbon ring that has an antimicrobial spectrum similar to or slightly wider than that of penicillin, and is often used for people that have an allergy to penicillins. Erythromycin may possess bacteriocidal activity, particularly at higher concentrations by binding to the 50S subunit of the bacterial 70S rRNA complex, inhibiting peptidyl-tRNA translocation. Thus, protein synthesis and subsequently structure/function processes critical for life or replication are inhibited.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000574676, "max_identities": 23, "bit_score": 38.1206, "cvterm_id": "43299", "query": "LSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRIT", "match": "LSGG+  R+ + +  + R  +++ DEPT  LD    + +   ++E    EGT  + S HD K + H +  +   + K L+ + ", "sequence_from_db": "LSGGEATRLVLCQLFLGRYNILILDEPTNFLDIFCIEALERFIEEY---EGTIILIS-HDKKFVDHVSDTIYKIENKKLNLVN", "sequence_from_broadstreet": "MEQICFELENVEVTFLDKKILEIDRLAVHQFDRIGIVGKNGAGKSTLLKILGGIIKPTRGKVNRYIDYGYFEQVESPKVSMADPRLLGKLNVKVDSNNLSGGELTRLKIAQLFTDYYESLLIDEPTTHLDQDGISFLIDKLKYYYGALVLISHDRNLLDELVTTIWEIDDGMIKVYSGNYSEYLRQKKVEREQQAHDFDLYLKEKNRLEKAAKEKMNKAEKIANSSSMSKKESKAKANRMFESKSKGTSQKSLQRAAKAVEKRIEQLEVVDAPKEIHTIQFHQTHSTPPLHNKFPILGDRLTLQAGDKTLLEETSFQFPLGKTIAITGNNGSGKTTLIHHIIQKGEGITISPKAVIGFYEQMGYQFNEDKTVLSYMKARSDYDESKIRSVLHAMNFNGNDLKKNVRYLSGGEATRLVLCQLFLGRYNILILDEPTNFLDIFCIEALERFIEEYEGTIILISHDKKFVDHVSDTIYKIENKKLNLVN", "dna_sequence_from_broadstreet": "ATGGAACAAATATGTTTTGAATTAGAAAATGTTGAAGTAACTTTTTTAGATAAAAAAATATTGGAGATTGATCGCTTAGCTGTTCATCAGTTTGATCGAATAGGTATTGTTGGAAAAAATGGGGCAGGAAAAAGTACATTATTGAAAATACTTGGTGGTATTATTAAGCCTACTAGAGGAAAAGTAAATCGTTATATAGATTACGGATATTTTGAACAAGTAGAAAGTCCTAAAGTCAGTATGGCTGATCCACGCTTATTAGGAAAATTAAATGTAAAAGTAGATTCAAATAATCTAAGTGGTGGTGAACTAACAAGACTGAAAATTGCTCAATTATTTACAGACTATTATGAATCGTTGTTAATTGATGAGCCTACGACACATTTAGATCAAGATGGAATTTCATTTCTCATAGATAAATTAAAGTATTATTATGGTGCATTAGTTTTAATCAGTCATGACCGCAATCTACTAGATGAACTCGTTACTACTATATGGGAAATTGATGATGGTATGATTAAAGTATATTCTGGAAATTACAGTGAGTATTTGAGACAGAAGAAGGTGGAAAGAGAGCAACAAGCGCATGATTTCGATCTATATTTGAAAGAAAAGAATAGGCTTGAAAAAGCAGCTAAGGAAAAAATGAATAAAGCTGAAAAAATTGCCAATTCGTCTTCAATGTCAAAGAAAGAATCCAAAGCAAAGGCAAACCGTATGTTTGAATCAAAATCAAAAGGTACAAGTCAGAAATCACTACAACGAGCTGCAAAAGCTGTTGAAAAAAGAATAGAGCAACTTGAAGTAGTGGATGCACCTAAAGAAATTCACACAATTCAATTTCATCAGACTCACTCCACACCACCATTACACAACAAGTTTCCAATATTGGGAGATCGTTTAACTCTACAAGCAGGGGATAAAACACTCTTAGAAGAAACGAGTTTTCAATTTCCATTAGGAAAAACTATAGCAATTACAGGTAATAATGGTTCTGGTAAAACGACATTGATTCATCATATTATTCAAAAGGGTGAAGGTATTACTATATCTCCTAAAGCTGTGATTGGATTTTATGAACAAATGGGATATCAGTTCAATGAAGATAAAACTGTATTATCTTATATGAAAGCTAGAAGTGATTATGATGAAAGTAAAATACGTTCAGTTTTACACGCTATGAATTTCAATGGTAATGACTTGAAAAAGAATGTACGATATTTAAGTGGAGGAGAAGCAACTCGATTAGTATTATGTCAGCTTTTTTTAGGAAGATATAATATTTTGATTCTAGATGAGCCAACAAACTTTTTAGACATTTTTTGTATAGAAGCATTAGAGAGATTTATAGAAGAATATGAAGGGACTATTATTCTTATTTCGCATGATAAGAAGTTTGTAGATCATGTATCTGATACTATTTATAAAATAGAAAATAAAAAGTTGAATTTGGTAAATTAA", "partial": "0", "query_start": 51784, "query_end": 52032, "hit_start": 1221, "hit_end": 1458, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 27.71}, "gnl|BL_ORD_ID|2804|hsp_num:1": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "msrF", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "900", "model_id": "3821", "ARO_accession": "3005087", "ARO_name": "msrF", "ARO_category": {"41695": {"category_aro_accession": "3004471", "category_aro_cvterm_id": "41695", "category_aro_name": "msr-type ABC-F protein", "category_aro_description": "msr-type ABC-F subfamily ribosomal protection proteins expression in Staphylococci species and confer resistance to erythromycin and streptogramin B antibiotics through antibiotic target protection mechanisms.", "category_aro_class_name": "AMR Gene Family"}, "35925": {"category_aro_accession": "0000006", "category_aro_cvterm_id": "35925", "category_aro_name": "erythromycin", "category_aro_description": "Erythromycin is a macrolide antibiotic with a 14-carbon ring that has an antimicrobial spectrum similar to or slightly wider than that of penicillin, and is often used for people that have an allergy to penicillins. Erythromycin may possess bacteriocidal activity, particularly at higher concentrations by binding to the 50S subunit of the bacterial 70S rRNA complex, inhibiting peptidyl-tRNA translocation. Thus, protein synthesis and subsequently structure/function processes critical for life or replication are inhibited.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000763311, "max_identities": 51, "bit_score": 37.7354, "cvterm_id": "43299", "query": "TYSLGKVQVPALRGVTLE-----VYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTH-ANAVVRLADGKI", "match": " + L  V+V  L    LE     V+  + I I G +G+GK+T L ++G +   + G V+                 R    G+             F+ VE P     K++ ++ R     LL ++    + K   N LSGG+  R+ +A+      + +L DEPT +LD      +ID +K          +  +HD  ++      +  + DG I", "sequence_from_db": "CFELENVEVTFLDKKILEIDRLAVHQFDRIGIVGKNGAGKSTLLKILGGIIKPTRGKVN-----------------RYIDYGY-------------FEQVESP-----KVSMADPR-----LLGKL----NVKVDSNNLSGGELTRLKIAQLFTDYYESLLIDEPTTHLDQDGISFLIDKLKYYY----GALVLISHDRNLLDELVTTIWEIDDGMI", "sequence_from_broadstreet": "MEQICFELENVEVTFLDKKILEIDRLAVHQFDRIGIVGKNGAGKSTLLKILGGIIKPTRGKVNRYIDYGYFEQVESPKVSMADPRLLGKLNVKVDSNNLSGGELTRLKIAQLFTDYYESLLIDEPTTHLDQDGISFLIDKLKYYYGALVLISHDRNLLDELVTTIWEIDDGMIKVYSGNYSEYLRQKKVEREQQAHDFDLYLKEKNRLEKAAKEKMNKAEKIANSSSMSKKESKAKANRMFESKSKGTSQKSLQRAAKAVEKRIEQLEVVDAPKEIHTIQFHQTHSTPPLHNKFPILGDRLTLQAGDKTLLEETSFQFPLGKTIAITGNNGSGKTTLIHHIIQKGEGITISPKAVIGFYEQMGYQFNEDKTVLSYMKARSDYDESKIRSVLHAMNFNGNDLKKNVRYLSGGEATRLVLCQLFLGRYNILILDEPTNFLDIFCIEALERFIEEYEGTIILISHDKKFVDHVSDTIYKIENKKLNLVN", "dna_sequence_from_broadstreet": "ATGGAACAAATATGTTTTGAATTAGAAAATGTTGAAGTAACTTTTTTAGATAAAAAAATATTGGAGATTGATCGCTTAGCTGTTCATCAGTTTGATCGAATAGGTATTGTTGGAAAAAATGGGGCAGGAAAAAGTACATTATTGAAAATACTTGGTGGTATTATTAAGCCTACTAGAGGAAAAGTAAATCGTTATATAGATTACGGATATTTTGAACAAGTAGAAAGTCCTAAAGTCAGTATGGCTGATCCACGCTTATTAGGAAAATTAAATGTAAAAGTAGATTCAAATAATCTAAGTGGTGGTGAACTAACAAGACTGAAAATTGCTCAATTATTTACAGACTATTATGAATCGTTGTTAATTGATGAGCCTACGACACATTTAGATCAAGATGGAATTTCATTTCTCATAGATAAATTAAAGTATTATTATGGTGCATTAGTTTTAATCAGTCATGACCGCAATCTACTAGATGAACTCGTTACTACTATATGGGAAATTGATGATGGTATGATTAAAGTATATTCTGGAAATTACAGTGAGTATTTGAGACAGAAGAAGGTGGAAAGAGAGCAACAAGCGCATGATTTCGATCTATATTTGAAAGAAAAGAATAGGCTTGAAAAAGCAGCTAAGGAAAAAATGAATAAAGCTGAAAAAATTGCCAATTCGTCTTCAATGTCAAAGAAAGAATCCAAAGCAAAGGCAAACCGTATGTTTGAATCAAAATCAAAAGGTACAAGTCAGAAATCACTACAACGAGCTGCAAAAGCTGTTGAAAAAAGAATAGAGCAACTTGAAGTAGTGGATGCACCTAAAGAAATTCACACAATTCAATTTCATCAGACTCACTCCACACCACCATTACACAACAAGTTTCCAATATTGGGAGATCGTTTAACTCTACAAGCAGGGGATAAAACACTCTTAGAAGAAACGAGTTTTCAATTTCCATTAGGAAAAACTATAGCAATTACAGGTAATAATGGTTCTGGTAAAACGACATTGATTCATCATATTATTCAAAAGGGTGAAGGTATTACTATATCTCCTAAAGCTGTGATTGGATTTTATGAACAAATGGGATATCAGTTCAATGAAGATAAAACTGTATTATCTTATATGAAAGCTAGAAGTGATTATGATGAAAGTAAAATACGTTCAGTTTTACACGCTATGAATTTCAATGGTAATGACTTGAAAAAGAATGTACGATATTTAAGTGGAGGAGAAGCAACTCGATTAGTATTATGTCAGCTTTTTTTAGGAAGATATAATATTTTGATTCTAGATGAGCCAACAAACTTTTTAGACATTTTTTGTATAGAAGCATTAGAGAGATTTATAGAAGAATATGAAGGGACTATTATTCTTATTTCGCATGATAAGAAGTTTGTAGATCATGTATCTGATACTATTTATAAAATAGAAAATAAAAAGTTGAATTTGGTAAATTAA", "partial": "0", "query_start": 51385, "query_end": 52017, "hit_start": 12, "hit_end": 519, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 23.5}, "gnl|BL_ORD_ID|2120|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 51238, "orf_end": 52080, "orf_from": "BGC0001413.1|Cystobactamide_25 ", "model_name": "Corynebacterium striatum tetA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "900", "model_id": "3337", "ARO_accession": "3004639", "ARO_name": "Corynebacterium striatum tetA", "ARO_category": {"36003": {"category_aro_accession": "0010002", "category_aro_cvterm_id": "36003", "category_aro_name": "major facilitator superfamily (MFS) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Major facilitator superfamily (MFS) transporters and ABC transporters comprise the two largest and most functionally diverse of the transporter superfamilies. However, MFS transporters are distinct from ABC transporters in both their primary sequence and structure and in the mechanism of energy coupling. As secondary transporters they are, like RND and SMR transporters, energized by the electrochemical proton gradient.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37012": {"category_aro_accession": "3000668", "category_aro_cvterm_id": "37012", "category_aro_name": "oxytetracycline", "category_aro_description": "Oxytetracycline is a derivative of tetracycline with a 5-hydroxyl group. Its activity is similar to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00402397, "max_identities": 23, "bit_score": 35.4242, "cvterm_id": "39554", "query": "ELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVT", "match": " LSGGQRQRVA+ARAL   P++++ D+PT  LDSVT", "sequence_from_db": "NLSGGQRQRVALARALAADPEVLILDDPTTGLDSVT", "sequence_from_broadstreet": "MKTYSWFVPPAPPADDPARLHPARWSSGNRVVRDMVGAYPGVLVLHILSYLIGSGISAFVPVVVGMIVDGLVGEEKFNAWWLFAVLVGIFIIQFIGEATGDGLATASVRRVTHNAQQHLSSGVLRRGAGAMSPGTVLNTIDADANTVGRYRELLSFPLMAIGYAVCAMVAMWSVSPWISLAIPASALIIALFAAWTAGPVTRVSLKRRAAEADVAGLATDASQGIRTVKGLGAGATVATRFHAETAKANGLMLTHLRVEVWLGFARFCVAWLCNLGIVGLSAWMTLRGEITPGQLTSVALLVQPALTMAGLAFGDLASGWGRAVASGQRIEQLHHAGDDAAGPEPTDTPVPGAGLWILEPAERSYATAAAWAQRADVLFPPHTVNVFEGTIADNVNPRGDVPEDVVKQALAAAHCQDILRRLGGINEAGELPDAPLGEAGLNLSGGQRQRVALARALAADPEVLILDDPTTGLDSVTQADVVAAVAALRADKTTVVITGNAAWQHAGTELEVA", "dna_sequence_from_broadstreet": "ATGAAGACGTACAGCTGGTTCGTCCCGCCCGCGCCGCCAGCGGACGATCCGGCGCGGCTCCACCCAGCACGCTGGAGCAGCGGGAACCGTGTGGTCAGGGACATGGTAGGCGCATACCCGGGCGTGCTAGTGCTGCACATTCTGAGCTACCTCATCGGCTCCGGCATCTCCGCGTTTGTGCCGGTGGTGGTGGGCATGATCGTGGACGGCCTGGTGGGGGAAGAAAAGTTCAACGCATGGTGGCTCTTCGCAGTATTGGTCGGCATCTTCATCATCCAGTTCATCGGCGAGGCCACCGGCGACGGCCTGGCCACAGCCTCGGTGCGCCGCGTGACCCACAACGCGCAGCAGCACCTGTCCTCGGGCGTGCTGCGCCGCGGGGCGGGAGCGATGAGCCCCGGCACCGTACTCAACACCATCGACGCGGACGCGAACACCGTCGGCCGCTACCGCGAGCTGCTGTCGTTTCCGCTCATGGCCATCGGCTACGCGGTCTGCGCGATGGTGGCGATGTGGTCGGTCTCCCCGTGGATCTCACTGGCCATCCCGGCCAGCGCGCTGATCATCGCTCTGTTCGCCGCGTGGACCGCGGGGCCGGTGACGCGGGTGTCGTTGAAGCGTCGCGCCGCGGAGGCGGATGTCGCTGGCTTGGCCACGGATGCGTCGCAAGGCATTCGCACCGTCAAAGGCCTAGGCGCGGGTGCAACCGTGGCAACACGTTTTCACGCCGAAACGGCGAAGGCGAACGGCTTGATGCTCACGCACCTGCGTGTGGAGGTGTGGCTCGGTTTCGCCAGGTTTTGCGTGGCGTGGCTGTGCAACCTTGGCATCGTGGGCTTGAGCGCGTGGATGACGCTGCGCGGGGAGATCACCCCGGGGCAGCTGACATCCGTGGCACTGTTGGTGCAGCCTGCGTTGACCATGGCGGGCTTAGCGTTCGGCGACCTGGCCAGCGGGTGGGGCAGGGCCGTCGCGAGTGGCCAGCGCATCGAGCAGCTGCACCACGCGGGCGATGACGCGGCGGGGCCTGAGCCGACAGACACCCCGGTCCCAGGCGCGGGGCTGTGGATTCTCGAGCCGGCGGAGCGTTCCTACGCCACCGCCGCCGCGTGGGCGCAGCGCGCAGACGTGCTGTTCCCGCCGCACACCGTCAACGTGTTTGAGGGCACCATCGCAGACAACGTGAACCCGCGCGGGGATGTGCCGGAGGACGTCGTCAAGCAGGCGCTCGCCGCCGCCCACTGCCAAGACATCCTCCGCAGGCTCGGCGGTATCAACGAAGCAGGCGAGTTGCCGGACGCGCCGCTGGGGGAGGCCGGCCTGAACCTTTCCGGCGGGCAGCGCCAGCGCGTCGCGCTTGCCAGGGCGCTCGCCGCCGACCCGGAGGTGCTCATCCTGGACGACCCGACCACGGGGCTCGATTCCGTGACACAGGCGGACGTCGTGGCAGCCGTCGCCGCGCTCAGAGCAGACAAAACCACCGTGGTCATCACCGGAAACGCCGCGTGGCAGCACGCTGGAACCGAATTGGAGGTGGCGTAG", "partial": "0", "query_start": 51781, "query_end": 51888, "hit_start": 1323, "hit_end": 1431, "orf_dna_sequence": "GCGCACGCCCACGCCGAGGCGCCCCCCTCCCAGGCGTCCCCCACCCCATCCCTCCGTTTCGCGGAAAGGATCCAAACAATCATGAGCCAGGTCACTGCCCTCCCCGGCAGCACCCAGCCGATCGTCTCCCTCACCGAGGTTACCAAGACGTACTCCCTGGGTAAGGTGCAGGTGCCCGCACTCCGAGGCGTGACGCTAGAGGTGTACCCGGGAGAGTTCATCTCCATCGCCGGCCCATCGGGCAGTGGCAAGACGACGGCGCTCAATCTCATCGGCTGCGTGGACACGGCCTCCTCGGGCGTGGTGAGCGTGGATGGCCAGGACACCAAGAAGCTCACCGAGCGGCAGCTCACCCACTTGCGGCTGCACACCATCGGCTTCATCTTCCAGAGCTTCAACCTCGTCTCGGTGCTCAGCGTCTTCCAGAACGTAGAGTTCCCCCTGCTGCTGCAGCGCAAGCTCAACGCCTCCGAGCGCCGCACGCGCGTGATGACGCTGCTGGAGCAGGTGGGCCTGGAGAAGCACGCCAAACACCGCCCCAATGAGCTGTCTGGAGGCCAGCGCCAGCGCGTGGCCGTGGCGCGCGCTCTCGTCACCCGGCCCAAGCTGGTGCTCGCCGACGAGCCCACCGCCAACCTCGACTCCGTCACCGGCCAGAACATCATCGACCTGATGAAGGAGCTCAACCGCAAGGAGGGCACCACCTTCATCTTCTCCACCCACGACGCCAAGGTGATGACCCACGCCAACGCCGTGGTGCGCCTGGCGGACGGGAAGATCCTCGACCGCATCACGCCGGCCGAGGCCCAGAAGGTCATGGCCGTGAGCGAGGGGGGCCACTAA", "orf_prot_sequence": "AHAHAEAPPSQASPTPSLRFAERIQTIMSQVTALPGSTQPIVSLTEVTKTYSLGKVQVPALRGVTLEVYPGEFISIAGPSGSGKTTALNLIGCVDTASSGVVSVDGQDTKKLTERQLTHLRLHTIGFIFQSFNLVSVLSVFQNVEFPLLLQRKLNASERRTRVMTLLEQVGLEKHAKHRPNELSGGQRQRVAVARALVTRPKLVLADEPTANLDSVTGQNIIDLMKELNRKEGTTFIFSTHDAKVMTHANAVVRLADGKILDRITPAEAQKVMAVSEGGH", "perc_identity": 63.89}}}